PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Man, ZQ; Kondo, Y; Koga, H; Umino, H; Nakayama, K; Shin, HW				Man, Zhiqiu; Kondo, Yumika; Koga, Hiroshi; Umino, Hiroyuki; Nakayama, Kazuhisa; Shin, Hye-Won			Arfaptins Are Localized to the trans-Golgi by Interaction with Arl1, but Not Arfs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTORS; NUCLEOTIDE-EXCHANGE FACTORS; INHIBITS PHOSPHOLIPASE-D; RAC1-INTERACTING PROTEIN; MEMBRANE TRAFFICKING; SHIGA-TOXIN; IN-VIVO; NETWORK; DOMAINS; BINDING	Arfaptins (arfaptin-1 and arfaptin-2/POR1) were originally identified as binding partners of the Arf small GTPases. Both proteins contain a BAR (Bin/Amphiphysin/Rvs) domain, which participates in membrane deformation. Here we show that arfaptins associate with trans-Golgi membranes. Unexpectedly, Arl1 (Arf-like 1), but not Arfs, determines the trans-Golgi association of arfaptins. We also demonstrate that arfaptins interact with Arl1 through their BAR domain-containing region and compete for Arl1 binding with golgin-97 and golgin-245/p230, both of which also bind to Arl1 through their GRIP (golgin-97/RanBP2/Imh1p/p230) domains. However, arfaptins and these golgins show only limited colocalization at the trans-Golgi. Time-lapse imaging of cells overexpressing fluorescent protein-tagged arfaptins and golgin-97 reveals that arfaptins, but not golgin-97, are included in vesicular and tubular structures emanating from the Golgi region. These observations indicate that arfaptins are recruited onto trans-Golgi membranes by interacting with Arl1, and capable of inducing membrane deformation via their BAR domains.	[Man, Zhiqiu; Kondo, Yumika; Koga, Hiroshi; Umino, Hiroyuki; Nakayama, Kazuhisa; Shin, Hye-Won] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Shin, Hye-Won] Kyoto Univ, Career Path Promot Unit Young Life Scientists, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Kyoto University	Nakayama, K (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan.	kazunaka@pharm.kyoto-u.ac.jp	Shin, Hye-Won/P-5398-2018; Nakayama, Kazuhisa/ABF-2924-2020	Shin, Hye-Won/0000-0002-9138-9554; Nakayama, Kazuhisa/0000-0001-7701-7183	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for Promotion of Science; Targeted Proteins Research Program; Special Coordination Fund for Promoting Science and Technology; Takeda Science Foundation; Hayashi Memorial Foundation for Female Natural Scientists	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Special Coordination Fund for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists)	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the Japan Society for Promotion of Science; the Targeted Proteins Research Program; the Special Coordination Fund for Promoting Science and Technology; the Takeda Science Foundation; and the Hayashi Memorial Foundation for Female Natural Scientists.	Boman AL, 1999, CELL MOTIL CYTOSKEL, V44, P119, DOI 10.1002/(SICI)1097-0169(199910)44:2<119::AID-CM4>3.3.CO;2-3; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; D'Souza-Schorey C, 1997, EMBO J, V16, P5445, DOI 10.1093/emboj/16.17.5445; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gillingham AK, 2003, BBA-MOL CELL RES, V1641, P71, DOI 10.1016/S0167-4889(03)00088-0; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gleeson PA, 2004, TRAFFIC, V5, P315, DOI 10.1111/j.1398-9219.2004.00182.x; Hosaka M, 1996, J BIOCHEM-TOKYO, V120, P813; Jackson C L, 2000, Subcell Biochem, V34, P233; Jackson CL, 2003, CURR BIOL, V13, pR174, DOI 10.1016/S0960-9822(03)00116-7; Johannes L, 1997, J BIOL CHEM, V272, P19554, DOI 10.1074/jbc.272.31.19554; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Kain R, 1998, J BIOL CHEM, V273, P981, DOI 10.1074/jbc.273.2.981; Kanoh H, 1997, J BIOL CHEM, V272, P5421, DOI 10.1074/jbc.272.9.5421; Lieu ZZ, 2008, P NATL ACAD SCI USA, V105, P3351, DOI 10.1073/pnas.0800137105; Liu J, 2010, CURR OPIN CELL BIOL, V22, P36, DOI 10.1016/j.ceb.2009.11.009; Lock JG, 2005, TRAFFIC, V6, P1142, DOI 10.1111/j.1600-0854.2005.00349.x; Lu L, 2003, MOL BIOL CELL, V14, P3767, DOI 10.1091/mbc.E03-01-0864; Lu L, 2004, MOL BIOL CELL, V15, P4426, DOI 10.1091/mbc.E03-12-0872; Lu L, 2001, J CELL SCI, V114, P4543; Lupashin V, 2005, BBA-MOL CELL RES, V1744, P325, DOI 10.1016/j.bbamcr.2005.03.013; Manolea F, 2010, MOL BIOL CELL, V21, P1836, DOI 10.1091/mbc.E10-01-0016; Miserey-Lenkei S, 2010, NAT CELL BIOL, V12, P645, DOI 10.1038/ncb2067; MOSS J, 1995, J BIOL CHEM, V270, P12327, DOI 10.1074/jbc.270.21.12327; Munro S, 2005, BIOCHEM SOC T, V33, P601, DOI 10.1042/BST0330601; Nakayama K, 2005, METHOD ENZYMOL, V404, P367, DOI 10.1016/S0076-6879(05)04032-2; Nishimoto-Morita K, 2009, J BIOL CHEM, V284, P10583, DOI 10.1074/jbc.M900847200; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Peters PJ, 2002, NAT CELL BIOL, V4, P240, DOI 10.1038/ncb761; Rangone H, 2005, J BIOL CHEM, V280, P22021, DOI 10.1074/jbc.M407528200; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shin HW, 2005, J CELL SCI, V118, P4039, DOI 10.1242/jcs.02524; Shin HW, 2004, J BIOCHEM, V136, P761, DOI 10.1093/jb/mvh185; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; Shin HW, 1997, J BIOCHEM-TOKYO, V122, P525; Shin OH, 2001, BIOCHEM BIOPH RES CO, V285, P1267, DOI 10.1006/bbrc.2001.5330; Takatsu H, 2002, BIOCHEM J, V365, P369, DOI 10.1042/BJ20020428; Tarricone C, 2001, NATURE, V411, P215, DOI 10.1038/35075620; Toda K, 1999, FEBS LETT, V442, P221, DOI 10.1016/S0014-5793(98)01646-9; Van Valkenburgh H, 2001, J BIOL CHEM, V276, P22826, DOI 10.1074/jbc.M102359200; VanAelst L, 1996, EMBO J, V15, P3778, DOI 10.1002/j.1460-2075.1996.tb00751.x; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Williger BT, 1999, FEBS LETT, V443, P197, DOI 10.1016/S0014-5793(98)01707-4; Williger BT, 1999, FEBS LETT, V454, P85, DOI 10.1016/S0014-5793(99)00771-1; Yoshimura S, 2004, J BIOCHEM, V135, P201, DOI 10.1093/jb/mvh024; Yoshino A, 2005, J CELL SCI, V118, P2279, DOI 10.1242/jcs.02358	48	39	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11569	11578		10.1074/jbc.M110.201442	http://dx.doi.org/10.1074/jbc.M110.201442			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21239483	Green Published, hybrid			2022-12-27	WOS:000288797100067
J	Ha, BH; Jeon, YJ; Shin, SC; Tatsumi, K; Komatsu, M; Tanaka, K; Watson, CM; Wallis, G; Chung, CH; Kim, EE				Ha, Byung Hak; Jeon, Young Joo; Shin, Sang Chul; Tatsumi, Kanako; Komatsu, Masaaki; Tanaka, Keiji; Watson, Christopher M.; Wallis, Gillian; Chung, Chin Ha; Kim, Eunice EunKyeong			Structure of Ubiquitin-fold Modifier 1-specific Protease UfSP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEUBIQUITINATING ENZYMES; CRYSTAL-STRUCTURE; HUMAN ATG4B; MECHANISM; AUTOPHAGY; UFM1; UBIQUITIN-FOLD-MODIFIER-1; RECOGNITION; SPECIFICITY; CATALYSIS	Ubiquitin- fold modifier 1 (Ufm1)-specific protease 2 (UfSP2) is a cysteine protease that is responsible for the release of Ufm1 from Ufm1-conjugated cellular proteins, as well as for the generation of mature Ufm1 from its precursor. The 2.6A resolution crystal structure of mouse UfSP2 reveals that it is composed of two domains. The C-terminal catalytic domain is similar to UfSP1 with Cys294, Asp418, His420, Tyr282, and a regulatory loop participating in catalysis. The novel N-terminal domain shows a unique structure and plays a role in the recognition of its cellular substrate C20orf116 and thus in the recruitment of UfSP2 to the endoplasmic reticulum, where C20orf116 predominantly localizes. Mutagenesis studies were carried out to provide the structural basis for understanding the loss of catalytic activity observed in a recently identified UfSP2 mutation that is associated with an autosomal dominant form of hip dysplasia.	[Ha, Byung Hak; Jeon, Young Joo; Chung, Chin Ha] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Ha, Byung Hak; Shin, Sang Chul; Kim, Eunice EunKyeong] Korea Inst Sci & Technol, Div Life Sci, Seoul 136791, South Korea; [Tatsumi, Kanako; Komatsu, Masaaki; Tanaka, Keiji] Tokyo Metropolitan Inst Med Sci, Tokyo 1568506, Japan; [Watson, Christopher M.; Wallis, Gillian] Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 9PT, Lancs, England; [Watson, Christopher M.; Wallis, Gillian] Univ Manchester, Sch Translat Med, Manchester M13 9PT, Lancs, England	Seoul National University (SNU); Korea Institute of Science & Technology (KIST); Tokyo Metropolitan Institute of Medical Science; University of Manchester; University of Manchester	Chung, CH (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	eunice@kist.re.kr; chchung@snu.ac.kr	Komatsu, Masaaki/B-8321-2011	Komatsu, Masaaki/0000-0001-7672-7722; Watson, Christopher Mark/0000-0003-2371-1844; Jeon, Young Joo/0000-0003-1004-5336	Functional Proteomics Center [FPR08B2-280]; Korea Ministry of Science and Technology; Korea Research Foundation [KRF-2005-084-C00025]; Korea Science and Engineering Foundation [M10533010001-05N3301]	Functional Proteomics Center; Korea Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); Korea Research Foundation(National Research Foundation of Korea); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported in part by Functional Proteomics Center Grant FPR08B2-280, the 21C Frontier Research and Development Program of the Korea Ministry of Science and Technology, a Korea Institute of Science and Technology Institutional Program grant (to E. E. K.), Korea Research Foundation Grant KRF-2005-084-C00025, and Korea Science and Engineering Foundation Grant M10533010001-05N3301 (to C. H. C.).	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Drag M, 2008, IUBMB LIFE, V60, P734, DOI 10.1002/iub.113; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ha BH, 2008, BMB REP, V41, P435, DOI 10.5483/BMBRep.2008.41.6.435; Ha BH, 2008, J BIOL CHEM, V283, P14893, DOI 10.1074/jbc.M708756200; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Kang SH, 2007, J BIOL CHEM, V282, P5256, DOI 10.1074/jbc.M610590200; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; Kumanomidou T, 2006, J MOL BIOL, V355, P612, DOI 10.1016/j.jmb.2005.11.018; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Ohsumi Y, 2001, NAT REV MOL CELL BIO, V2, P211, DOI 10.1038/35056522; Otto HH, 1997, CHEM REV, V97, P133, DOI 10.1021/cr950025u; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Reverter D, 2006, NAT STRUCT MOL BIOL, V13, P1060, DOI 10.1038/nsmb1168; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Reyes-Turcu FE, 2009, CHEM REV, V109, P1495, DOI 10.1021/cr800470j; Roby P, 1999, AM J HUM GENET, V64, P904, DOI 10.1086/302291; Sasakawa H, 2006, BIOCHEM BIOPH RES CO, V343, P21, DOI 10.1016/j.bbrc.2006.02.107; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Schlieker C, 2007, MOL CELL, V25, P677, DOI 10.1016/j.molcel.2007.01.033; Singhal S, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S3; Sugawara K, 2005, J BIOL CHEM, V280, P40058, DOI 10.1074/jbc.M509158200; Tatsumi K, 2010, J BIOL CHEM, V285, P5417, DOI 10.1074/jbc.M109.036814; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Terwilliger TC, 1996, ACTA CRYSTALLOGR D, V52, P749, DOI 10.1107/S0907444996000832	35	38	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10248	10257		10.1074/jbc.M110.172171	http://dx.doi.org/10.1074/jbc.M110.172171			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21228277	Green Published, hybrid			2022-12-27	WOS:000288547000042
J	Ramakrishna, S; Suresh, B; Lee, EJ; Lee, HJ; Ahn, WS; Baek, KH				Ramakrishna, Suresh; Suresh, Bharathi; Lee, Eung-Ji; Lee, Hey-Jin; Ahn, Woong-Shick; Baek, Kwang-Hyun			Lys-63-specific Deubiquitination of SDS3 by USP17 Regulates HDAC Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; UBIQUITIN-PROTEASOME PATHWAY; HISTONE DEACETYLASES; POLYUBIQUITIN CHAINS; MULTIUBIQUITIN CHAIN; INTEGRAL COMPONENT; PROTEIN; ACTIVATION; ENZYMES; CANCER	SDS3 is a key component of the histone deacetylase (HDAC)-dependent Sin3A co-repressor complex, serving to maintain its HDAC activity. Here, we report both exogenous and endogenous functional interaction between deubiquitinating enzyme USP17 and human SDS3 by MALDI-TOF-MS, co-immunoprecipitation assay, and GST pull-down assay. In this study, we demonstrated that SDS3 readily undergoes endogenous polyubiquitination, which is associated specifically with Lys-63-branched polyubiquitin chains and not with Lys-48-branched polyubiquitin chains. Further, we also demonstrated that USP17 specifically deubiquitinates Lys-63-linked ubiquitin chains from SDS3 and regulates its biological functions. The deubiquitinating activity of USP17 on SDS3 negatively regulates SDS3-associated HDAC activity. The constitutive expression of USP17 and its substrate SDS3 was involved in the inhibition of anchorage-independent tumor growth and blocks cell proliferation, leading to apoptosis in cervical carcinoma cells. Furthermore, we showed that USP17 and SDS3 mutually interact with each other to regulate cancer cell viability. These data support the possibility that SDS3, being a substrate of USP17, may play an important role in developing a novel therapeutic means to inhibit specific HDAC activities in cancer.	[Baek, Kwang-Hyun] CHA Univ, CHA Gen Hosp, CHA Stem Cell Inst, Dept Biomed Sci, Seoul 135081, South Korea; [Ahn, Woong-Shick] Catholic Univ Korea, Coll Med, Catholic Res Inst Med Sci, Seoul 150727, South Korea	Pochon Cha University; Catholic University of Korea	Baek, KH (corresponding author), CHA Univ, CHA Gen Hosp, CHA Stem Cell Inst, Dept Biomed Sci, 606-16 Yeoksam,1 Dong, Seoul 135081, South Korea.	baek@cha.ac.kr	Ramakrishna, Suresh/AAX-4096-2021	Baek, Kwang-Hyun/0000-0001-7662-7190	Korea Research Foundation, Korean Government [KRF-2008-313-C00718]; Ministry for Health, Welfare and Family Affairs, Republic of Korea [0820330]	Korea Research Foundation, Korean Government(National Research Foundation of KoreaKorean Government); Ministry for Health, Welfare and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Korea Research Foundation Grant KRF-2008-313-C00718 funded by the Korean Government and by National Research and Development Program for Cancer Control, Ministry for Health, Welfare and Family Affairs, Republic of Korea Grant 0820330.	Al-Hakim AK, 2008, BIOCHEM J, V411, P249, DOI 10.1042/BJ20080067; Alland L, 2002, MOL CELL BIOL, V22, P2743, DOI 10.1128/MCB.22.8.2743-2750.2002; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; ARNASON T, 1994, MOL CELL BIOL, V14, P7876, DOI 10.1128/MCB.14.12.7876; Ayer DE, 1999, TRENDS CELL BIOL, V9, P193, DOI 10.1016/S0962-8924(99)01536-6; Baek KH, 2006, CURR PROTEIN PEPT SC, V7, P171, DOI 10.2174/138920306776359740; Baek KH, 2004, J BIOL CHEM, V279, P2368, DOI 10.1074/jbc.M304774200; Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Burrows JF, 2009, J BIOL CHEM, V284, P9587, DOI 10.1074/jbc.M807216200; Burrows JF, 2005, GENOMICS, V85, P524, DOI 10.1016/j.ygeno.2004.11.013; Burrows JF, 2004, J BIOL CHEM, V279, P13993, DOI 10.1074/jbc.M311291200; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; David G, 2006, ONCOGENE, V25, P7354, DOI 10.1038/sj.onc.1209734; David G, 2003, GENE DEV, V17, P2396, DOI 10.1101/gad.1109403; Ghatak S, 2002, J BIOL CHEM, V277, P38013, DOI 10.1074/jbc.M202404200; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hussain S, 2009, CELL CYCLE, V8, P1688, DOI 10.4161/cc.8.11.8739; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim YS, 2006, PROTEOMICS, V6, P3445, DOI 10.1002/pmic.200500775; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lechner T, 2000, J BIOL CHEM, V275, P40961, DOI 10.1074/jbc.M005730200; Lee MY, 2008, J CELL BIOCHEM, V105, P1420, DOI 10.1002/jcb.21961; McFarlane C, 2010, CANCER RES, V70, P3329, DOI 10.1158/0008-5472.CAN-09-4152; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Schreiber-Agus N, 1998, BIOESSAYS, V20, P808, DOI 10.1002/(SICI)1521-1878(199810)20:10<808::AID-BIES6>3.0.CO;2-U; Shin JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-292; SPENCE J, 1995, MOL CELL BIOL, V15, P1265; Terzic J, 2007, BIOCHEM SOC T, V35, P942, DOI 10.1042/BST0350942; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Wang M, 2006, EMBO J, V25, P1710, DOI 10.1038/sj.emboj.7601061; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384	40	31	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10505	10514		10.1074/jbc.M110.162321	http://dx.doi.org/10.1074/jbc.M110.162321			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21239494	Green Published, hybrid			2022-12-27	WOS:000288547000067
J	Pelz, C; Steininger, S; Weiss, C; Coscia, F; Vogelmann, R				Pelz, Christiane; Steininger, Sylvia; Weiss, Claudia; Coscia, Fabian; Vogelmann, Roger			A Novel Inhibitory Domain of Helicobacter pylori Protein CagA Reduces CagA Effects on Host Cell Biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC EPITHELIAL-CELLS; APICAL-JUNCTIONAL COMPLEX; FOCAL ADHESION KINASE; VIRULENCE FACTOR CAGA; TYROSINE PHOSPHORYLATION; BETA-CATENIN; E-CADHERIN; IV SECRETION; MDCK CELLS; ACTIVATION	The Helicobacter pylori protein CagA (cytotoxin-associated gene A) is associated with an increased risk for gastric cancer formation. After attachment to epithelial cells, the bacteria inject CagA via a type IV secretion apparatus into host cells, where it exerts its biological activity. Host cell responses to intracellular CagA have been linked exclusively to signaling motifs in the C terminus of the CagA protein. Little is known about the functional role of the remaining CagA protein. Using transgenic expression of CagA mutants in epithelial cells, we were able to identify a novel CagA inhibitory domain at the N terminus consisting of the first 200 amino acids. This domain localizes to cell-cell contacts and increases the rate and strength of cell-cell adhesion in epithelial cells. Thus, it compensates for the loss of cell-cell adhesion induced by the C terminus of the CagA protein. Consistent with its stabilizing role on cell-cell adhesion, the CagA N terminus domain reduces the CagA-induced beta-catenin transcriptional activity in the nucleus. Furthermore, it inhibits apical surface constriction and cell elongations, host cell phenotypes induced by the C terminus in polarized epithelia. Therefore, our study suggests that CagA contains an intrinsic inhibitory domain that reduces host cell responses to CagA, which have been associated with the formation of cancer.	[Pelz, Christiane; Steininger, Sylvia; Weiss, Claudia; Coscia, Fabian; Vogelmann, Roger] Tech Univ Munich, Dept Internal Med 2, Klinikum Rechts Isar, D-81675 Munich, Germany; [Vogelmann, Roger] Univ Heidelberg, Dept Med 2, Univ Hosp Mannheim, D-68167 Mannheim, Germany	Technical University of Munich; Ruprecht Karls University Heidelberg	Vogelmann, R (corresponding author), Ismaninger Str 22, D-81675 Munich, Germany.	roger.vogelmann@lrz.tum.de	Coscia, Fabian/AAD-3899-2020	Coscia, Fabian/0000-0002-2244-5081	Deutsche Krebshilfe; Max-Eder Nachwuchsgruppenprogramm [107238]; Kommission fur Klinische Forschung (KKF); Second Department of Internal Medicine, Klinikum rechts der Isar, Munich, Germany	Deutsche Krebshilfe(Deutsche Krebshilfe); Max-Eder Nachwuchsgruppenprogramm(Deutsche Krebshilfe); Kommission fur Klinische Forschung (KKF); Second Department of Internal Medicine, Klinikum rechts der Isar, Munich, Germany	This work was supported by the Deutsche Krebshilfe, Max-Eder Nachwuchsgruppenprogramm 107238, the Kommission fur Klinische Forschung (KKF) Program Klinikum rechts der Isar, and generous financial support from Roland M. Schmid (Second Department of Internal Medicine, Klinikum rechts der Isar, Munich, Germany).	Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Asahi M, 2000, J EXP MED, V191, P593, DOI 10.1084/jem.191.4.593; Backert S, 2010, HELICOBACTER, V15, P163, DOI 10.1111/j.1523-5378.2010.00759.x; Bagnoli F, 2005, P NATL ACAD SCI USA, V102, P16339, DOI 10.1073/pnas.0502598102; Barth AIM, 1997, J CELL BIOL, V136, P693, DOI 10.1083/jcb.136.3.693; BLASER MJ, 1995, CANCER RES, V55, P2111; Bohm H, 1997, CURR BIOL, V7, P603, DOI 10.1016/S0960-9822(06)00260-0; Brandt S, 2005, P NATL ACAD SCI USA, V102, P9300, DOI 10.1073/pnas.0409873102; Brenner H, 2004, AM J EPIDEMIOL, V159, P252, DOI 10.1093/aje/kwh039; Caca K, 1999, CELL GROWTH DIFFER, V10, P369; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Churin Y, 2003, J CELL BIOL, V161, P249, DOI 10.1083/jcb.200208039; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; El-Etr SH, 2004, J INFECT DIS, V190, P1516, DOI 10.1086/424526; Etienne-Manneville S, 2008, ONCOGENE, V27, P6970, DOI 10.1038/onc.2008.347; Franco AT, 2005, P NATL ACAD SCI USA, V102, P10646, DOI 10.1073/pnas.0504927102; Hatakeyama M, 2008, CURR OPIN MICROBIOL, V11, P30, DOI 10.1016/j.mib.2007.12.003; Higashi H, 2005, J BIOL CHEM, V280, P23130, DOI 10.1074/jbc.M503583200; Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Hirata Y, 2002, GASTROENTEROLOGY, V123, P1962, DOI 10.1053/gast.2002.37044; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Malfertheiner P, 2005, AM J GASTROENTEROL, V100, P2100, DOI 10.1111/j.1572-0241.2005.41688.x; Miura M, 2009, INT J CANCER, V125, P2497, DOI 10.1002/ijc.24740; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; Murata-Kamiya N, 2010, CELL HOST MICROBE, V7, P399, DOI 10.1016/j.chom.2010.04.005; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; NELSON WJ, 1990, J CELL BIOL, V110, P349, DOI 10.1083/jcb.110.2.349; NELSON WJ, 1987, NATURE, V328, P533, DOI 10.1038/328533a0; Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497; Ohnishi N, 2008, P NATL ACAD SCI USA, V105, P1003, DOI 10.1073/pnas.0711183105; Poppe M, 2007, ONCOGENE, V26, P3462, DOI 10.1038/sj.onc.1210139; Saadat I, 2007, NATURE, V447, P330, DOI 10.1038/nature05765; Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559; Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200; Selbach M, 2009, CELL HOST MICROBE, V5, P397, DOI 10.1016/j.chom.2009.03.004; Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x; Stewart A, 2002, BIOCHEM BIOPH RES CO, V299, P62, DOI 10.1016/S0006-291X(02)02547-0; Suzuki M, 2005, J EXP MED, V202, P1235, DOI 10.1084/jem.20051027; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; Tammer I, 2007, GASTROENTEROLOGY, V132, P1309, DOI 10.1053/j.gastro.2007.01.050; Tan SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000407; Tsutsumi R, 2006, MOL CELL BIOL, V26, P261, DOI 10.1128/MCB.26.1.261-276.2006; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Vogelmann R, 2005, MOL BIOL CELL, V16, P701, DOI 10.1091/mbc.E04-09-0827; Wessler S, 2008, TRENDS MICROBIOL, V16, P397, DOI 10.1016/j.tim.2008.05.005; Wiedemann T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004754; Yokoyama K, 2005, P NATL ACAD SCI USA, V102, P9661, DOI 10.1073/pnas.0502529102	51	21	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8999	9008		10.1074/jbc.M110.166504	http://dx.doi.org/10.1074/jbc.M110.166504			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21212271	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000288247700031
J	Chiappini, F; Cunha, LL; Harris, JC; Hollenberg, AN				Chiappini, Franck; Cunha, Lucas L.; Harris, Jamie C.; Hollenberg, Anthony N.			Lack of cAMP-response Element-binding Protein 1 in the Hypothalamus Causes Obesity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASOPRESSIN GENE-EXPRESSION; TRANSCRIPTION FACTOR CREB; CENTRAL-NERVOUS-SYSTEM; BROWN ADIPOSE-TISSUE; MELANOCORTIN-4 RECEPTOR; PARAVENTRICULAR NUCLEUS; FOOD-INTAKE; ENERGY-BALANCE; MESSENGER-RNA; ADAPTIVE THERMOGENESIS	The melanocortin system in the hypothalamus controls food intake and energy expenditure. Its disruption causes severe obesity in mice and humans. cAMP-response element-binding protein 1 (CREB1) has been postulated to play an important role downstream of the melanocortin-4 receptor (MC4R), but this hypothesis has never been confirmed in vivo. To test this, we generated mice that lack CREB1 in SIM1-expressing neurons, of the paraventricular nucleus (PVN), which are known to be MC4R-positive. Interestingly, CREB1(Delta SIM1) mice developed obesity as a result of decreased energy expenditure and impairment in maintaining their core body temperature and not because of hyperphagia, defining a new role for CREB1 in the PVN. In addition, the lack of CREB1 in the PVN caused a reduction in vasopressin expression but did not affect adrenal or thyroid function. Surprisingly, MC4R function tested pharmacologically was normal in CREB1(Delta SIM1) mice, suggesting that CREB1 is not required for intact MC4R signaling. Thus CREB1 may affect other pathways that are implicated in the regulation of body weight.	Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Hollenberg, AN (corresponding author), 330 Brookline Ave,E CLS 0728, Boston, MA 02215 USA.	thollenb@bidmc.harvard.edu	Cunha, Lucas Leite/AAK-9877-2020; Chiappini, Franck/AAB-9894-2021	Cunha, Lucas Leite/0000-0002-1513-1455; Chiappini, Franck/0000-0002-2684-1241	American Diabetes Association; NIH [R01 DK078090, NIH/5P01DK056116-10]; Takeda Pharmaceuticals; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078090, P01DK056116] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Smith Family Pinnacle Award from the American Diabetes Association (to A. N. H.), NIH Grant R01 DK078090 (to A. N. H.), and a research grant from Takeda Pharmaceuticals. The comprehensive laboratory animal monitoring system is a part of the Physiological Core (Dr. Maratos-Flier, Beth Israel Deaconess Medical Center), supported by NIH Grant (NIH/5P01DK056116-10).	Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Balthasar N, 2006, OBESITY, V14, P222; Benoit SC, 2000, J NEUROSCI, V20, P3442, DOI 10.1523/JNEUROSCI.20-09-03442.2000; Bleckmann SC, 2002, MOL CELL BIOL, V22, P1919, DOI 10.1128/MCB.22.6.1919-1925.2002; Blendy JA, 1996, EMBO J, V15, P1098, DOI 10.1002/j.1460-2075.1996.tb00447.x; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; Chen AS, 2000, TRANSGENIC RES, V9, P145, DOI 10.1023/A:1008983615045; Chen M, 2009, CELL METAB, V9, P548, DOI 10.1016/j.cmet.2009.05.004; Christoffolete MA, 2004, DIABETES, V53, P577, DOI 10.2337/diabetes.53.3.577; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Czyzyk TA, 2008, P NATL ACAD SCI USA, V105, P276, DOI 10.1073/pnas.0710607105; Daniels D, 2003, BRAIN RES, V986, P1, DOI 10.1016/S0006-8993(03)03162-7; Duan J, 2007, OBESITY, V15, P2624, DOI 10.1038/oby.2007.314; Duplan SM, 2009, EUR J NEUROSCI, V30, P2239, DOI 10.1111/j.1460-9568.2009.07028.x; Fan W, 2005, PEPTIDES, V26, P1800, DOI 10.1016/j.peptides.2004.11.033; GROSS DS, 1985, J HISTOCHEM CYTOCHEM, V33, P11, DOI 10.1177/33.1.2578140; Harris M, 2001, J CLIN INVEST, V107, P111, DOI 10.1172/JCI10741; Haus-Seuffert P, 2000, MOL CELL BIOCHEM, V212, P5, DOI 10.1023/A:1007111818628; Holder JL, 2000, HUM MOL GENET, V9, P101; Hollenberg AN, 2008, THYROID, V18, P131, DOI 10.1089/thy.2007.0251; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Itoi K, 2004, J NEUROENDOCRINOL, V16, P348, DOI 10.1111/j.0953-8194.2004.01172.x; Iwasaki Y, 1997, ENDOCRINOLOGY, V138, P5266, DOI 10.1210/en.138.12.5266; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kishi T, 2003, J COMP NEUROL, V457, P213, DOI 10.1002/cne.10454; KISS JZ, 1984, P NATL ACAD SCI-BIOL, V81, P1854, DOI 10.1073/pnas.81.6.1854; Kovacs KJ, 1996, J NEUROSCI, V16, P262; Kublaoui BM, 2008, MOL ENDOCRINOL, V22, P1723, DOI 10.1210/me.2008-0067; Kublaoui BM, 2006, MOL ENDOCRINOL, V20, P2483, DOI 10.1210/me.2005-0483; Kublaoui BM, 2006, ENDOCRINOLOGY, V147, P4542, DOI 10.1210/en.2006-0453; Kuwahara S, 2003, J NEUROSCI, V23, P10231; Lechan RM, 2006, PEPTIDES, V27, P310, DOI 10.1016/j.peptides.2005.01.033; Lechan RM, 2006, PROG BRAIN RES, V153, P209, DOI 10.1016/S0079-6123(06)53012-2; Lee EJ, 2001, EUR J BIOCHEM, V268, P582, DOI 10.1046/j.1432-1327.2001.01900.x; Lerner RG, 2009, EMBO REP, V10, P1175, DOI 10.1038/embor.2009.177; Liu HY, 2003, J NEUROSCI, V23, P7143, DOI 10.1523/JNEUROSCI.23-18-07143.2003; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Mantamadiotis T, 2006, MOL ENDOCRINOL, V20, P204, DOI 10.1210/me.2005-0195; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Michaud JL, 2001, HUM MOL GENET, V10, P1465, DOI 10.1093/hmg/10.14.1465; MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298; Nieuwenhuizen AG, 2008, PHYSIOL BEHAV, V94, P169, DOI 10.1016/j.physbeh.2007.12.011; Parlato R, 2006, GENESIS, V44, P454, DOI 10.1002/dvg.20236; Parlato R, 2007, DEVELOPMENT, V134, P1663, DOI 10.1242/dev.02838; Patten CS, 2007, REGUL PEPTIDES, V142, P111, DOI 10.1016/j.regpep.2007.02.005; RUPPERT S, 1992, EMBO J, V11, P1503, DOI 10.1002/j.1460-2075.1992.tb05195.x; SAPER CB, 1976, BRAIN RES, V117, P305, DOI 10.1016/0006-8993(76)90738-1; Sarkar S, 2002, BRAIN RES, V945, P50, DOI 10.1016/S0006-8993(02)02619-7; Sassone-Corsi P, 1998, INT J BIOCHEM CELL B, V30, P27, DOI 10.1016/S1357-2725(97)00093-9; Sawchenko PE, 1998, J COMP NEUROL, V402, P435; SAWCHENKO PE, 1982, BRAIN RES REV, V4, P275, DOI 10.1016/0165-0173(82)90010-8; Segal-Lieberman G, 2003, P NATL ACAD SCI USA, V100, P10085, DOI 10.1073/pnas.1633636100; Selkirk JV, 2006, J BIOMOL SCREEN, V11, P351, DOI 10.1177/1087057106286608; Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497; Sugrue ML, 2010, ENDOCRINOLOGY, V151, P793, DOI 10.1210/en.2009-0976; SWANSON LW, 1980, J COMP NEUROL, V194, P555, DOI 10.1002/cne.901940306; Valassi E, 2008, NUTR METAB CARDIOVAS, V18, P158, DOI 10.1016/j.numecd.2007.06.004; Vella KR, 2007, J NEUROENDOCRINOL, V19, P499, DOI 10.1111/j.1365-2826.2007.01556.x; Voss-Andreae A, 2007, ENDOCRINOLOGY, V148, P1550, DOI 10.1210/en.2006-1389; Xie T, 2008, ENDOCRINOLOGY, V149, P2443, DOI 10.1210/en.2007-1458; Yang C, 2006, J NEUROSCI, V26, P7116, DOI 10.1523/JNEUROSCI.0672-06.2006; Yeo GSH, 2000, QJM-INT J MED, V93, P7, DOI 10.1093/qjmed/93.1.7	68	23	23	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8094	8105		10.1074/jbc.M110.178186	http://dx.doi.org/10.1074/jbc.M110.178186			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21209091	hybrid, Green Published			2022-12-27	WOS:000288013300040
J	Yu, QJ; Ghisla, S; Hirschberg, J; Mann, V; Beyer, P				Yu, Qiuju; Ghisla, Sandro; Hirschberg, Joseph; Mann, Varda; Beyer, Peter			Plant Carotene Cis-Trans Isomerase CRTISO A NEW MEMBER OF THE FAD(RED)-DEPENDENT FLAVOPROTEINS CATALYZING NON-REDOX REACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYTOENE DESATURATION; DIPHOSPHATE ISOMERASE; MOLECULAR-OXYGEN; BETA-CAROTENE; BIOSYNTHESIS; LYCOPENE; FLAVIN; STEREOCHEMISTRY; CHROMOPLASTS; INHIBITION	The carotene cis-trans isomerase CRTISO is a constituent of the carotene desaturation pathway as evolved in cyanobacteria and prevailing in plants, in which a tetra-cis-lycopene species, termed prolycopene, is formed. CRTISO, an evolutionary descendant of the bacterial carotene desaturase CRTI, catalyzes the cis-to-trans isomerization reactions leading to all-trans-lycopene, the substrate for the subsequent lycopene cyclization to form all-trans-alpha/beta-carotene. CRTISO and CRTI share a dinucleotide binding motif at the N terminus. Here we report that this site is occupied by FAD in CRTISO. The reduced form of this cofactor catalyzes a reaction not involving net redox changes. Results obtained with C(1)- and C(5)-deaza-FAD suggest mechanistic similarities with type II isopentenyl diphosphate: dimethylallyl diphosphate isomerase (IDI-2). CRTISO, together with lycopene cyclase CRTY and IDI-2, thus represents the third enzyme in isoprenoid metabolism belonging to the class of non-redox enzymes depending on reduced flavin for activity. The regional specificity and the kinetics of the isomerization reaction were investigated in vitro using purified enzyme and biphasic liposome-based systems carrying specific cis-configured lycopene species as substrates. The reaction proceeded from cis to trans, recognizing half-sides of the symmetrical prolycopene and was accompanied by one trans-to-cis isomerization step specific for the C(5)-C(6) double bond. Rice lycopene beta-cyclase (OsLCY-b), when additionally introduced into the biphasic in vitro system used, was found to be stereospecific for all-trans-lycopene and allowed the CRTISO reaction to proceed toward completion by modifying the thermodynamics of the overall reaction.	[Yu, Qiuju; Beyer, Peter] Univ Freiburg, Fac Biol, Ctr Biol Signaling Studies Bioss, D-79104 Freiburg, Germany; [Ghisla, Sandro] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Hirschberg, Joseph; Mann, Varda] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel	University of Freiburg; University of Konstanz; Hebrew University of Jerusalem	Beyer, P (corresponding author), Univ Freiburg, Fac Biol, Ctr Biol Signaling Studies Bioss, D-79104 Freiburg, Germany.	peter.beyer@biologie.uni-freiburg.de			German-Israel Foundation; Excellence Initiative of the German Federal and State Governments [EXC 294]	German-Israel Foundation(German-Israeli Foundation for Scientific Research and Development); Excellence Initiative of the German Federal and State Governments	This work was supported by The German-Israel Foundation and by the Excellence Initiative of the German Federal and State Governments (EXC 294).	Bartley GE, 1999, EUR J BIOCHEM, V259, P396, DOI 10.1046/j.1432-1327.1999.00051.x; Ben-Amot A., 1997, FOOD CHEM, V62, P515; BEYER P, 1989, EUR J BIOCHEM, V184, P141, DOI 10.1111/j.1432-1033.1989.tb15000.x; Carol P, 1999, PLANT CELL, V11, P57, DOI 10.1105/tpc.11.1.57; Chen Y, 2010, PLANT PHYSIOL, V153, P66, DOI 10.1104/pp.110.153916; CLOUGH JM, 1979, J CHEM SOC CHEM COMM, P616, DOI 10.1039/c39790000616; DellaPenna D, 2006, ANNU REV PLANT BIOL, V57, P711, DOI 10.1146/annurev.arplant.56.032604.144301; ECKSTEIN JW, 1993, BIOCHEMISTRY-US, V32, P404, DOI 10.1021/bi00053a004; Edmondson D, 1999, METH MOL B, V131, P157; EUGSTER CH, 1979, PURE APPL CHEM, V51, P463, DOI 10.1351/pac197951030463; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; GHISLA S, 1974, BIOCHEMISTRY-US, V13, P589, DOI 10.1021/bi00700a029; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Gradinaru R, 2007, BIOCHEMISTRY-US, V46, P2497, DOI 10.1021/bi0614582; Guo WH, 2008, J PHYS CHEM B, V112, P12158, DOI 10.1021/jp8019705; HENGARTNER U, 1992, HELV CHIM ACTA, V75, P1848, DOI 10.1002/hlca.19920750611; Hersh L B, 1980, Methods Enzymol, V66, P277; Isaacson T, 2004, PLANT PHYSIOL, V136, P4246, DOI 10.1104/pp.104.052092; Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303; Kao YT, 2008, J AM CHEM SOC, V130, P13132, DOI 10.1021/ja8045469; Kittleman W, 2007, BIOCHEMISTRY-US, V46, P8401, DOI 10.1021/bi700286a; Klassen JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011257; MAYER MP, 1990, EUR J BIOCHEM, V191, P359, DOI 10.1111/j.1432-1033.1990.tb19130.x; Mialoundama AS, 2010, PLANT PHYSIOL, V153, P970, DOI 10.1104/pp.110.155440; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Norris SR, 1995, PLANT CELL, V7, P2139, DOI 10.1105/tpc.7.12.2139; Park H, 2002, PLANT CELL, V14, P321, DOI 10.1105/tpc.010302; ROMER S, 1991, PHOTOCHEM PHOTOBIOL, V53, P535, DOI 10.1111/j.1751-1097.1991.tb03666.x; SANDMANN G, 1991, ARCH MICROBIOL, V155, P229, DOI 10.1007/BF00252205; Sandmann G, 2009, ARCH BIOCHEM BIOPHYS, V483, P169, DOI 10.1016/j.abb.2008.10.004; Schulz C. E., 1992, CURR OPIN STRUC BIOL, V2, P61; Schwartz SH, 1997, SCIENCE, V276, P1872, DOI 10.1126/science.276.5320.1872; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; STRICKLAND S, 1975, J BIOL CHEM, V250, P4048; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Unno H, 2009, J BIOL CHEM, V284, P9160, DOI 10.1074/jbc.M808438200; Veprintsev DB, 2006, P NATL ACAD SCI USA, V103, P2115, DOI 10.1073/pnas.0511130103; von Lintig J, 2010, ANNU REV NUTR, V30, P35, DOI 10.1146/annurev-nutr-080508-141027; Yu QJ, 2010, J BIOL CHEM, V285, P12109, DOI 10.1074/jbc.M109.091843; ZUMBRUNN A, 1985, HELV CHIM ACTA, V68, P1519, DOI 10.1002/hlca.19850680604	40	64	66	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8666	8676		10.1074/jbc.M110.208017	http://dx.doi.org/10.1074/jbc.M110.208017			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21209101	hybrid, Green Published			2022-12-27	WOS:000288013300092
J	Chang, CH; Lai, LC; Cheng, HC; Chen, KR; Syue, YZ; Lu, HC; Lin, WY; Chen, SH; Huang, HS; Shiau, AL; Lei, HY; Qin, J; Ling, P				Chang, Chun-Hung; Lai, Li-Chun; Cheng, Hung-Chi; Chen, Kuan-Ru; Syue, Ying-Zhang; Lu, Hsueh-Chi; Lin, Wan-Ying; Chen, Shun-Hua; Huang, Huei-Sheng; Shiau, Ai-Li; Lei, Huan-Yao; Qin, Jun; Ling, Pin			TBK1-associated Protein in Endolysosomes (TAPE) Is an Innate Immune Regulator Modulating the TLR3 and TLR4 Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PATTERN-RECOGNITION RECEPTORS; TOLL-LIKE RECEPTOR-3; C2 DOMAIN PROTEIN; ANTIVIRAL IMMUNITY; MENTAL-RETARDATION; CYTOPLASMIC DNA; INTERFERON-BETA; CYTOSOLIC DNA; IKK-EPSILON	The innate immune system elicits the first wave of immune responses against pathogen infection. Its operational modes are complex and have yet to be defined. Here, we report the identification of an innate immune regulator termed TAPE (TBK1-associated protein in endolysosomes), previously known as CC2D1A/Freud-1/Aki-1, which modulates the TLR3 and TLR4 pathways. We found that TAPE activated the TBK1, NF-kappa B, and ERK pathways leading to IFN-beta and inflammatory cytokine induction. TAPE was shown to colocalize with endosomal marker Rab5 and lysosomal marker LAMP1 in mammalian cells, suggesting that TAPE resided in endolysosomes. Knockdown of TAPE selectively impaired the TLR3 and endocytic TLR4 pathways to IFN-beta induction. Furthermore, TAPE interacted and synergized with Trif to activate IFN-beta. TAPE knockdown failed to block Trif-mediated IFN-beta induction, whereas Trif knockdown impaired the TLR3 and TAPE cooperation on IFN-beta induction, suggesting that TAPE acts upstream of Trif. Together, our data demonstrate a central role for TAPE in linking TLR3 and TLR4 to innate immune defenses at an early step.	[Chang, Chun-Hung; Chen, Kuan-Ru; Syue, Ying-Zhang; Lu, Hsueh-Chi; Lin, Wan-Ying; Chen, Shun-Hua; Shiau, Ai-Li; Lei, Huan-Yao; Ling, Pin] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan; [Lai, Li-Chun; Huang, Huei-Sheng; Ling, Pin] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Cheng, Hung-Chi] Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol, Tainan 70101, Taiwan; [Qin, Jun] Baylor Coll Med, Verna & Mars McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; Baylor College of Medicine	Ling, P (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan.	lingpin@mail.ncku.edu.tw	Huang, Huei-Sheng/F-9945-2011; shiau, A-Li/C-2885-2012; LING, PIN/C-6764-2009	shiau, A-Li/0000-0003-2449-8547; 	National Science Council in Taiwan [NSC 97-2320-B-006-014-MY3, NSC 98-2321-B-006-008]; National Cheng-Kung University [C023]	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); National Cheng-Kung University	This work was support by National Science Council in Taiwan Grants NSC 97-2320-B-006-014-MY3 and NSC 98-2321-B-006-008 and by National Cheng-Kung University Intramural Grant C023.	Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; CHEN SH, 1993, ANTIVIR RES, V22, P15, DOI 10.1016/0166-3542(93)90083-U; Chen SH, 2008, J CLIN INVEST, V118, P3470, DOI 10.1172/JCI35114; Childress JL, 2006, CURR BIOL, V16, P2228, DOI 10.1016/j.cub.2006.09.031; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Gallagher CM, 2006, DEV CELL, V11, P641, DOI 10.1016/j.devcel.2006.09.014; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; Ishii KJ, 2008, NATURE, V451, P725, DOI 10.1038/nature06537; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jackson AL, 2010, NAT REV DRUG DISCOV, V9, P57, DOI 10.1038/nrd3010; Jaekel R, 2006, DEV CELL, V11, P655, DOI 10.1016/j.devcel.2006.09.019; Jung SY, 2005, MOL ENDOCRINOL, V19, P2451, DOI 10.1210/me.2004-0476; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Nakamura A, 2008, MOL CELL BIOL, V28, P5996, DOI 10.1128/MCB.00114-08; Nakamura A, 2009, J CELL BIOL, V187, P607, DOI 10.1083/jcb.200906019; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Ou XM, 2003, J NEUROSCI, V23, P7415; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Rogaeva A, 2007, J NEUROSCI RES, V85, P2833, DOI 10.1002/jnr.21277; Rogaeva A, 2007, EUR J NEUROSCI, V26, P965, DOI 10.1111/j.1460-9568.2007.05727.x; Ryzhakov G, 2007, EMBO J, V26, P3180, DOI 10.1038/sj.emboj.7601743; Sasai M, 2006, J IMMUNOL, V177, P8676, DOI 10.4049/jimmunol.177.12.8676; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Seya T, 2009, IMMUNOL REV, V227, P44, DOI 10.1111/j.1600-065X.2008.00723.x; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522; Zhao M, 2010, J BIOL CHEM, V285, P24372, DOI 10.1074/jbc.M109.100057	46	24	25	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7043	7051		10.1074/jbc.M110.164632	http://dx.doi.org/10.1074/jbc.M110.164632			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21189260	Green Published, hybrid			2022-12-27	WOS:000287737300021
J	Rana, T; Misra, S; Mittal, MK; Farrow, AL; Wilson, KT; Linton, MF; Fazio, S; Willis, IM; Chaudhuri, G				Rana, Tanu; Misra, Smita; Mittal, Mukul K.; Farrow, Anitra L.; Wilson, Keith T.; Linton, MacRae F.; Fazio, Sergio; Willis, Ian M.; Chaudhuri, Gautam			Mechanism of Down-regulation of RNA Polymerase III-transcribed Non-coding RNA Genes in Macrophages by Leishmania	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASE-ACTIVATED RECEPTORS; DIFFERENTIAL EXPRESSION; GP63 LEVEL; B2 RNA; INFECTION; AMAZONENSIS; REPRESSOR; PROMASTIGOTES; DETERMINANTS; DEGRADATION	The parasitic protozoan Leishmania invades mammalian macrophages to establish infection. We reported previously that Leishmania manipulates the expression of several non-coding RNA genes (e. g. Alu RNA, B1 RNA, and signal recognition particle RNA) in macrophages to favor the establishment of their infection in the phagolysosomes of these cells (Ueda, Y., and Chaudhuri, G. (2000) J. Biol. Chem. 275, 19428-19432; Misra, S., Tripathi, M. K., and Chaudhuri, G. (2005) J. Biol. Chem. 280, 29364-29373). We report here the mechanism of this down-regulation. We found that the non-coding RNA (ncRNA) genes that are repressed by Leishmania infection in macrophages contain a "B-box" in their promoters and thus require the polymerase III transcription factor TFIIIC for their expression. We also found that Leishmania promastigotes through their surface protease (leishmanolysin or gp63) activate the thrombin receptor PAR1 in the macrophages. This activation of PAR1 raised the cytosolic concentration of Ca2+ into the micromolar range, thereby activating the Ca2+-dependent protease mu-calpain. mu-Calpain then degraded TFIIIC110 to inhibit the expression of the selected ncRNA genes. Avirulent stocks of Leishmania not expressing surface gp63 failed to down-regulate ncRNAs in the exposed macrophages. Inhibition of PAR1 or calpain 1 in macrophages made them resistant to Leishmania infection. These data suggest that macrophage PAR1 and calpain 1 are potential drug targets against leishmaniasis.	[Rana, Tanu; Misra, Smita; Mittal, Mukul K.; Farrow, Anitra L.; Chaudhuri, Gautam] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA; [Wilson, Keith T.] Vanderbilt Univ, Div Gastroenterol, Nashville, TN 37232 USA; [Linton, MacRae F.; Fazio, Sergio] Vanderbilt Univ, Div Cardiovasc Med, Nashville, TN 37232 USA; [Wilson, Keith T.] Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN 37212 USA; [Willis, Ian M.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA; [Willis, Ian M.] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10461 USA	Meharry Medical College; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Chaudhuri, G (corresponding author), Meharry Med Coll, Dept Microbiol & Immunol, 1005 DB Todd Jr Blvd, Nashville, TN 37208 USA.	gchaudhuri@mmc.edu		Willis, Ian/0000-0001-6599-2395; Mittal, Mukul/0000-0002-9795-7372; Wilson, Keith/0000-0003-4421-1830	National Institutes of Health, NIAID [5R01AI042327, 1R21AI076757-01A1]; National Institutes of Health, NIGMS [3 S06 GM008037-34-S2];  [R01HL65709];  [R01HL57986];  [1R01GM085177];  [2T32AI007281-21A1];  [5R25GM059994-10]; National Center for Complementary & Integrative Health [R01AT004821] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065709, R01HL057986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076757, T32AI007281, R01AI042327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM059994, S06GM008037, R01GM085177] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; ; ; ; ; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01AI042327 and 1R21AI076757-01A1 from the NIAID and Grant 3 S06 GM008037-34-S2 from the NIGMS (to G. C.), Grants R01HL65709 and R01HL57986 (to S. F.), Grant 1R01GM085177 (to I. M. W.), and Institutional Training Grants 2T32AI007281-21A1 and 5R25GM059994-10 (as a graduate student stipend to A. L. F.).	Alexander J, 1999, J CELL SCI, V112, P2993; Allen TA, 2004, NAT STRUCT MOL BIOL, V11, P816, DOI 10.1038/nsmb813; Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Bahou WF, 2003, CURR TOP DEV BIOL, V54, P343, DOI 10.1016/S0070-2153(03)54014-5; Bates PA, 2006, TRENDS PARASITOL, V22, P447, DOI 10.1016/j.pt.2006.08.003; Benyamin Y, 2006, FEBS J, V273, P3413, DOI 10.1111/j.1742-4658.2006.05353.x; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Blackwell JM, 2009, PARASITE IMMUNOL, V31, P254, DOI 10.1111/j.1365-3024.2009.01102.x; BRITTINGHAM A, 1995, J IMMUNOL, V155, P3102; Carissimi C, 2009, AUTOIMMUN REV, V8, P520, DOI 10.1016/j.autrev.2009.01.008; CHANG KP, 1990, ANNU REV MICROBIOL, V44, P499, DOI 10.1146/annurev.mi.44.100190.002435; CHAUDHURI G, 1989, J BIOL CHEM, V264, P7483; Chen DQ, 2000, INFECT IMMUN, V68, P80, DOI 10.1128/IAI.68.1.80-86.2000; Colognato R, 2003, BLOOD, V102, P2645, DOI 10.1182/blood-2002-08-2497; Corradin S, 2002, BIOCHEM J, V367, P761, DOI 10.1042/BJ20020386; Coughlin Sr, 2002, COLD SPRING HARB SYM, V67, P197, DOI 10.1101/sqb.2002.67.197; Dahl JA, 2007, FRONT BIOSCI-LANDMRK, V12, P4925, DOI 10.2741/2438; Demarchi F, 2007, CELL CYCLE, V6, P136; Denkers EY, 2005, TRENDS PARASITOL, V21, P35, DOI 10.1016/j.pt.2004.10.004; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; Englert M, 2004, BIOCHIMIE, V86, P867, DOI 10.1016/j.biochi.2004.10.012; Espinoza CA, 2007, RNA, V13, P583, DOI 10.1261/rna.310307; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; Goerge T, 2006, CANCER RES, V66, P7766, DOI 10.1158/0008-5472.CAN-05-3897; Goodrich JA, 2006, NAT REV MOL CELL BIO, V7, P612, DOI 10.1038/nrm1946; Gregory DJ, 2005, PARASITOLOGY, V130, pS27, DOI 10.1017/S0031182005008139; Grudnik P, 2009, BIOL CHEM, V390, P775, DOI 10.1515/BC.2009.102; Handman E, 2002, TRENDS PARASITOL, V18, P332, DOI 10.1016/S1471-4922(02)02352-8; Handman E, 2000, ADV PARASIT, V44, P1; Huang Y, 2001, NUCLEIC ACIDS RES, V29, P2675, DOI 10.1093/nar/29.13.2675; Innes F, 2006, NUCLEIC ACIDS RES, V34, P3399, DOI 10.1093/nar/gkl432; Kuchay SM, 2007, CURR OPIN HEMATOL, V14, P249, DOI 10.1097/MOH.0b013e3280ef68f8; LIU X, 1992, P NATL ACAD SCI USA, V89, P4991, DOI 10.1073/pnas.89.11.4991; Ludeman MJ, 2005, J BIOL CHEM, V280, P13122, DOI 10.1074/jbc.M410381200; Mariner PD, 2008, MOL CELL, V29, P499, DOI 10.1016/j.molcel.2007.12.013; Matlashewski G, 2001, MED MICROBIOL IMMUN, V190, P37, DOI 10.1007/s004300100076; Mattick JS, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000459; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; MCGWIRE B, 1994, MOL BIOCHEM PARASIT, V66, P345, DOI 10.1016/0166-6851(94)90160-0; Misra S, 2005, J BIOL CHEM, V280, P29364, DOI 10.1074/jbc.M504162200; Misra S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-50; Mittal MK, 2011, J BIOL CHEM, V286, P469, DOI 10.1074/jbc.M110.164384; Naderer T, 2004, CURR MOL MED, V4, P649, DOI 10.2174/1566524043360069; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Penela P, 2003, CELL SIGNAL, V15, P973, DOI 10.1016/S0898-6568(03)00099-8; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Peters NC, 2009, CELL MICROBIOL, V11, P1290, DOI 10.1111/j.1462-5822.2009.01348.x; Petrocca F, 2009, ADV IMMUNOL, V102, P227, DOI 10.1016/S0065-2776(09)01204-8; Ponicsan SL, 2010, CURR OPIN GENET DEV, V20, P149, DOI 10.1016/j.gde.2010.01.004; Rasbach KA, 2008, ARCH BIOCHEM BIOPHYS, V478, P130, DOI 10.1016/j.abb.2008.08.003; RICHES DWH, 1988, J IMMUNOL, V141, P180; Sambrano GR, 2000, J BIOL CHEM, V275, P6819, DOI 10.1074/jbc.275.10.6819; Schmidlin Fabien, 2001, Current Opinion in Pharmacology, V1, P575, DOI 10.1016/S1471-4892(01)00099-6; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Soh UJK, 2010, BRIT J PHARMACOL, V160, P191, DOI 10.1111/j.1476-5381.2010.00705.x; STURGES MR, 1994, J BIOL CHEM, V269, P5712; Taganov KD, 2007, IMMUNITY, V26, P133, DOI 10.1016/j.immuni.2007.02.005; Thiakaki M, 2006, MICROBES INFECT, V8, P1455, DOI 10.1016/j.micinf.2006.01.006; Traynelis SF, 2007, CURR OPIN HEMATOL, V14, P230, DOI 10.1097/MOH.0b013e3280dce568; Tripathi MK, 2005, J BIOL CHEM, V280, P17163, DOI 10.1074/jbc.M501375200; TZINIA AK, 1991, MOL BIOCHEM PARASIT, V47, P83, DOI 10.1016/0166-6851(91)90150-5; Ueda Y, 2000, J BIOL CHEM, V275, P19428, DOI 10.1074/jbc.M001336200; van Zon A, 2001, J BIOL CHEM, V276, P37715, DOI 10.1074/jbc.M106055200; Vanderheyden V, 2009, BBA-MOL CELL RES, V1793, P959, DOI 10.1016/j.bbamcr.2008.12.003; Walters RD, 2009, IUBMB LIFE, V61, P831, DOI 10.1002/iub.227; WILLIS IM, 1993, EUR J BIOCHEM, V212, P1, DOI 10.1111/j.1432-1033.1993.tb17626.x; Yao CQ, 2010, INFECT IMMUN, V78, P22, DOI 10.1128/IAI.00776-09; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1; Zheng H, 2010, IUBMB LIFE, V62, P112, DOI 10.1002/iub.293	69	22	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6614	6626		10.1074/jbc.M110.181735	http://dx.doi.org/10.1074/jbc.M110.181735			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21149457	hybrid, Green Published			2022-12-27	WOS:000287476400070
J	Vetterli, L; Brun, T; Giovannoni, L; Bosco, D; Maechler, P				Vetterli, Laurene; Brun, Thierry; Giovannoni, Laurianne; Bosco, Domenico; Maechler, Pierre			Resveratrol Potentiates Glucose-stimulated Insulin Secretion in INS-1E beta-Cells and Human Islets through a SIRT1-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; UNCOUPLING PROTEIN-2; CALORIE RESTRICTION; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; INCREASED DOSAGE; GENE-EXPRESSION; SIRT1; SIRTUINS; METABOLISM	Resveratrol, a polyphenol compound, is known for its effects on energy homeostasis. With properties of energy sensors mediating effects of calorie restriction, sirtuins are targets of resveratrol. The mammalian sirtuin homolog SIRT1 is a protein deacetylase playing a role in glucose metabolism and islet function. Here, we investigated the effects of resveratrol and possible link with SIRT1 in beta-cells. Insulinoma INS-1E cells and human islets were cultured with resveratrol before analyzing their physiological responses. Treatment of INS-1E cells for 24 h with 25 mu M resveratrol resulted in marked potentiation of glucose-stimulated insulin secretion. This effect was associated with elevated glycolytic flux, resulting in increased glucose oxidation, ATP generation, and mitochondrial oxygen consumption. Such changes correlated with up-regulation of key genes for beta-cell function, i.e. Glut2, glucokinase, Pdx-1, Hnf-1 alpha, and Tfam. In human islets, chronic resveratrol treatment similarly increased both the glucose secretory response and expression of the same set of genes, eventually restoring the glucose response in islets obtained from one type 2 diabetic donor. Overexpression of Sirt1 in INS-1E cells potentiated resveratrol effects on insulin secretion. Conversely, inhibition of SIRT1 achieved either by expression of an inactive mutant or by using the EX-527 inhibitor, both abolished resveratrol effects on glucose responses. Treatment of INS-1E cells with EX-527 also prevented resveratrol-induced up-regulation of Glut2, glucokinase, Pdx-1, and Tfam. Resveratrol markedly enhanced the glucose response of INS-1E cells and human islets, even after removal of the compound from the medium. These effects were mediated by and fully dependent on active SIRT1, defining a new role for SIRT1 in the regulation of insulin secretion.	[Vetterli, Laurene; Brun, Thierry; Maechler, Pierre] Univ Geneva, Med Ctr, Dept Cell Physiol & Metab, CH-1211 Geneva, Switzerland; [Giovannoni, Laurianne; Bosco, Domenico] Univ Geneva, Med Ctr, Dept Surg, CH-1211 Geneva, Switzerland; Geneva Univ Hosp, CH-1211 Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva	Maechler, P (corresponding author), Univ Geneva, Med Ctr, Dept Cell Physiol & Metab, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.	Pierre.Maechler@unige.ch	giovannoni, laurianne/AAH-2648-2022; giovannoni, laurianne/AFM-0316-2022	Maechler, Pierre/0000-0002-2005-1433; Bosco, Domenico/0000-0003-3453-9613; BRUN, Thierry/0000-0002-1659-4283	Swiss National Science Foundation; State of Geneva; Juvenile Diabetes Research Foundation	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); State of Geneva; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This work was supported by the Swiss National Science Foundation (to P. M.) and the State of Geneva.; We are grateful to Deborah Strebel, Clarissa Bartley, and Gaelle Chaffard for technical assistance; Francoise Assimacopoulos-Jeannet for helpful scientific advice; and to Joseph Rodgers and Pere Puigserver for SIRT1-related adenoviruses and accompanying precious instructions. Fresh human islets were obtained thanks to the European Consortium for Islet Transplantation "Islet for Research" distribution program sponsored by the Juvenile Diabetes Research Foundation. This study was part of the Geneva Programme for Metabolic Disorders (GeMet).	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Ashcroft FM, 2005, J CLIN INVEST, V115, P2047, DOI 10.1172/JCI25495; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398; Boj SF, 2001, P NATL ACAD SCI USA, V98, P14481, DOI 10.1073/pnas.241349398; Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200; Broca C, 2003, FEBS LETT, V545, P167, DOI 10.1016/S0014-5793(03)00526-X; Casimir M, 2009, BIOCHEM J, V424, P459, DOI 10.1042/BJ20090729; Chan AYM, 2008, J BIOL CHEM, V283, P24194, DOI 10.1074/jbc.M802869200; Chan CB, 2001, DIABETES, V50, P1302, DOI 10.2337/diabetes.50.6.1302; Chen WP, 2007, EUR J PHARMACOL, V568, P269, DOI 10.1016/j.ejphar.2007.04.062; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; de Andrade PBM, 2006, DIABETOLOGIA, V49, P1816, DOI 10.1007/s00125-006-0301-9; Dhahbi JM, 1999, AM J PHYSIOL-ENDOC M, V277, pE352, DOI 10.1152/ajpendo.1999.277.2.E352; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; Gauthier BR, 2009, CELL METAB, V10, P110, DOI 10.1016/j.cmet.2009.07.002; Guarente L, 2000, GENE DEV, V14, P1021; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hong Y, 2001, ENDOCRINOLOGY, V142, P249, DOI 10.1210/en.142.1.249; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; Jakab M, 2008, CELL PHYSIOL BIOCHEM, V22, P567, DOI 10.1159/000185541; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Leclerc I, 2004, AM J PHYSIOL-ENDOC M, V286, pE1023, DOI 10.1152/ajpendo.00532.2003; Li N, 2009, J BIOL CHEM, V284, P23602, DOI 10.1074/jbc.M109.024323; Maechler P, 2006, INT J BIOCHEM CELL B, V38, P696, DOI 10.1016/j.biocel.2005.12.006; Maechler P, 1999, NATURE, V402, P685, DOI 10.1038/45280; Maechler P, 1998, FEBS LETT, V422, P328, DOI 10.1016/S0014-5793(97)01618-9; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Michan S, 2007, BIOCHEM J, V404, P1, DOI 10.1042/BJ20070140; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Nicholls DG, 2006, BBA-BIOENERGETICS, V1757, P459, DOI 10.1016/j.bbabio.2006.02.005; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Produit-Zengaffinen N, 2007, DIABETOLOGIA, V50, P84, DOI 10.1007/s00125-006-0499-6; Pugh TD, 1999, NEUROBIOL AGING, V20, P157, DOI 10.1016/S0197-4580(99)00043-3; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Shih DQ, 2001, DIABETES, V50, P2472, DOI 10.2337/diabetes.50.11.2472; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Su HC, 2006, AM J PHYSIOL-ENDOC M, V290, pE1339, DOI 10.1152/ajpendo.00487.2005; Suchankova G, 2009, BIOCHEM BIOPH RES CO, V378, P836, DOI 10.1016/j.bbrc.2008.11.130; Szkudelski T, 2006, EUR J PHARMACOL, V552, P176, DOI 10.1016/j.ejphar.2006.09.046; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Waeber G, 1996, MOL ENDOCRINOL, V10, P1327, DOI 10.1210/me.10.11.1327; Wang HY, 2001, J BIOL CHEM, V276, P25279, DOI 10.1074/jbc.M101233200; Wang HY, 2000, EMBO J, V19, P4257, DOI 10.1093/emboj/19.16.4257; Watada H, 1996, DIABETES, V45, P1826, DOI 10.2337/diabetes.45.12.1826; Woods TM, 2004, ANN PHARMACOTHER, V38, P887, DOI 10.1345/aph.1D219; Yang SN, 2005, AM J PHYSIOL-ENDOC M, V288, pE16, DOI 10.1152/ajpendo.00042.2004	67	119	122	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6049	6060		10.1074/jbc.M110.176842	http://dx.doi.org/10.1074/jbc.M110.176842			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21163946	Green Published, hybrid			2022-12-27	WOS:000287476400013
J	Tran, JR; Tomsic, LR; Brodsky, JL				Tran, Joseph R.; Tomsic, Lauren R.; Brodsky, Jeffrey L.			A Cdc48p-associated Factor Modulates Endoplasmic Reticulum-associated Degradation, Cell Stress, and Ubiquitinated Protein Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; AAA-ATPASE CDC48/P97; TRANSMEMBRANE CONDUCTANCE REGULATOR; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEIN; QUALITY-CONTROL; TRANSCRIPTIONAL REGULATOR; MISFOLDED GLYCOPROTEINS; SHUTTLE VECTORS; UBX DOMAIN	The hexameric AAA-ATPase, Cdc48p, catalyzes an array of cellular activities, including endoplasmic reticulum (ER)-associated degradation (ERAD), ER/Golgi membrane dynamics, and DNA replication. Accumulating data suggest that unique Cdc48p partners, such as Npl4p-Ufd1p and Ubx1p/Shp1p (p47 in vertebrates), target Cdc48p for these diverse functions. Other Cdc48p-associated proteins have been identified, but the interplay among these factors and their activities is largely cryptic. We now report on a previously uncharacterized Cdc48p-associated protein, Ydr049p, also known as Vms1p, which binds Cdc48p at both the ER membrane and in the cytosol under non-stressed conditions. Loss of YDR049 modestly slows the degradation of the cystic fibrosis transmembrane conductance regulator but does not impede substrate ubiquitination, suggesting that Ydr049p acts at a postubiquitination step in the ERAD pathway. Consistent with Ydr049p playing a role in Cdc48p substrate release, ydr049 mutant cells accumulate Cdc48p-bound ubiquitinated proteins at the ER membrane. Moreover, YDR049 interacts with genes encoding select UBX (ubiquitin regulatory X) and UFD (ubiquitin fusion degradation) proteins, which are Cdc48p partners. Exacerbated growth defects are apparent in some of the mutant combinations, and synergistic effects on the degradation of cystic fibrosis transmembrane conductance regulator and CPY*, which is a soluble ERAD substrate, are evident in specific ydr049-ufd and -ubx mutants. These data suggest that Ydr049p acts in parallel with Cdc48p partners to modulate ERAD and other cellular activities.	[Tran, Joseph R.; Tomsic, Lauren R.; Brodsky, Jeffrey L.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Tran, Joseph R.] Univ Pittsburgh, Sch Med, Grad Program Biochem & Mol Genet, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Brodsky, JL (corresponding author), Univ Pittsburgh, Dept Biol Sci, A320 Langley Hall,4942 5th Ave, Pittsburgh, PA 15260 USA.	jbrodsky@pitt.edu			National Institutes of Health [GM75061, DK 79307]; Cystic Fibrosis Foundation [BRODSK08XXO, TRAN07HO]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM75061. This work was also supported by Cystic Fibrosis Foundation Therapeutics Grant BRODSK08XXO (to J.L.B.).; Supported by Cystic Fibrosis Foundation Grant TRAN07HO.; Supported by an undergraduate research fellowship from the Howard Hughes Medical Institute.; We thank Karen Arndt and Margaret Shirra for help with genetic analysis; Bob Duda and Roger Hendrix for reagents; Alexander Buchberger, Stefan Jentsch, Mark Rose, and Rasmus Hartmann-Petersen for generous gifts of antibodies; the Pittsburgh Center for Kidney Research for use of core microscopy facilities (supported by National Institutes of Health Grant DK 79307); and Ora Weisz and Christopher J. Guerriero for help with microscopy.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Adams A., 1998, METHODS YEAST GENETI, P19; Ahner A, 2007, MOL BIOL CELL, V18; Alberts SM, 2009, J BIOL CHEM, V284, P16082, DOI 10.1074/jbc.M809282200; Arteaga MF, 2006, P NATL ACAD SCI USA, V103, P11178, DOI 10.1073/pnas.0604816103; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Braun RJ, 2006, J BIOL CHEM, V281, P25757, DOI 10.1074/jbc.M513699200; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; BRODSKY JL, 1993, J CELL BIOL, V120, P95, DOI 10.1083/jcb.120.1.95; Buck TM, 2010, MOL BIOL CELL, V21, P1047, DOI 10.1091/mbc.E09-11-0944; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Cheng YL, 2010, J CELL SCI, V123, P2024, DOI 10.1242/jcs.066043; Cheong H, 2008, METHOD ENZYMOL, V451, P1, DOI 10.1016/S0076-6879(08)03201-1; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Coughlan CM, 2004, J BIOL CHEM, V279, P15289, DOI 10.1074/jbc.M309673200; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; Decottignies A, 2004, YEAST, V21, P127, DOI 10.1002/yea.1071; DeHoratius C, 1996, MOL BIOL CELL, V7, P1835, DOI 10.1091/mbc.7.11.1835; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; DESHAIES RJ, 1989, J CELL BIOL, V109, P2653, DOI 10.1083/jcb.109.6.2653; Fleming JA, 2002, P NATL ACAD SCI USA, V99, P1461, DOI 10.1073/pnas.032516399; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Gnann A, 2004, MOL BIOL CELL, V15, P4125, DOI 10.1091/mbc.e04-01-0024; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; Hartmann-Petersen R, 2004, CURR BIOL, V14, P824, DOI 10.1016/j.cub.2004.04.029; Heo JM, 2010, MOL CELL, V40, P465, DOI 10.1016/j.molcel.2010.10.021; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Kabani M, 2002, MOL CELL BIOL, V22, P4677, DOI 10.1128/MCB.22.13.4677-4689.2002; Kanehara K, 2010, J CELL BIOL, V188, P707, DOI 10.1083/jcb.200907055; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Kota J, 2007, J CELL BIOL, V176, P617, DOI 10.1083/jcb.200612100; Krick R, 2010, J CELL BIOL, V190, P965, DOI 10.1083/jcb.201002075; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Madeo F, 1998, MOL BIOL CELL, V9, P131, DOI 10.1091/mbc.9.1.131; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; MOIR D, 1982, GENETICS, V100, P547; Mullally JE, 2006, MOL CELL BIOL, V26, P822, DOI 10.1128/MCB.26.3.822-830.2006; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; Seeley ES, 2002, MOL BIOL CELL, V13, P782, DOI 10.1091/mbc.01-10-0512; SIKORSKI RS, 1989, GENETICS, V122, P19; STIRLING CJ, 1992, MOL BIOL CELL, V3, P129, DOI 10.1091/mbc.3.2.129; Tresse E, 2010, AUTOPHAGY, V6, P217, DOI 10.4161/auto.6.2.11014; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wilson JD, 2006, TRAFFIC, V7, P1213, DOI 10.1111/j.1600-0854.2006.00460.x; Wright R, 2003, YEAST, V20, P881, DOI 10.1002/yea.994; Xie W, 2010, SEMIN CELL DEV BIOL, V21, P533, DOI 10.1016/j.semcdb.2010.02.007; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; ZHANG SR, 1995, MOL CELL BIOL, V15, P2037; Zhang Yimao, 2002, Methods Mol Med, V70, P257; Zhang YM, 2001, MOL BIOL CELL, V12, P1303, DOI 10.1091/mbc.12.5.1303	85	32	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5744	5755		10.1074/jbc.M110.179259	http://dx.doi.org/10.1074/jbc.M110.179259			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148305	Green Published, hybrid			2022-12-27	WOS:000287230600083
J	Bavencoffe, A; Kondratskyi, A; Gkika, D; Mauroy, B; Shuba, Y; Prevarskaya, N; Skryma, R				Bavencoffe, Alexis; Kondratskyi, Artem; Gkika, Dimitra; Mauroy, Brigitte; Shuba, Yaroslav; Prevarskaya, Natalia; Skryma, Roman			Complex Regulation of the TRPM8 Cold Receptor Channel ROLE OF ARACHIDONIC ACID RELEASE FOLLOWING M3 MUSCARINIC RECEPTOR STIMULATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; PHOSPHOLIPASE A(2); EPITHELIAL-CELLS; CALCIUM-ENTRY; ACTIVATION; MECHANISM; DESENSITIZATION; PROLIFERATION; MODULATION; SENSATION	Cold/menthol-activated TRPM8 (transient receptor potential channel melastatin member 8) is primarily expressed in sensory neurons, where it constitutes the principal receptor of environmental innocuous cold. TRPM8 has been shown to be regulated by multiple influences such as phosphorylation, pH, Ca2+, and lipid messengers. One such messenger is arachidonic acid (AA), which has been shown to inhibit TRPM8 channel activity. However, the physiological pathways mediating the inhibitory effect of AA on TRPM8 still remain unknown. Here, we demonstrate that TRPM8 is regulated via M3 muscarinic acetylcholine receptor-coupled signaling cascade based on the activation of cytosolic phospholipase A2 (cPLA2) and cPLA2-catalyzed derivation of AA. Stimulation of M3 receptors heterologously co-expressed with TRPM8 in HEK-293 cells by nonselective muscarinic agonist, oxotremorine methiodide (Oxo-M), caused inhibition of TRPM8-mediated membrane current, which could be mimicked by AA and antagonized by pharmacological or siRNA-mediated cPLA2 silencing. Our results demonstrate the intracellular functional link between M3 receptor and TRPM8 channel via cPLA2/AA and suggest a novel physiological mechanism of arachidonate-mediated regulation of TRPM8 channel activity through muscarinic receptors. We also summarize the existing TRPM8 regulations and discuss their physiological and pathological significance.	[Bavencoffe, Alexis; Gkika, Dimitra; Mauroy, Brigitte; Prevarskaya, Natalia; Skryma, Roman] USTL, Inserm U1003, Equipe Labellise Ligue Natl Canc, F-59656 Villeneuve Dascq, France; [Kondratskyi, Artem; Shuba, Yaroslav] Natl Acad Sci Ukraine, AA Bogomolets Physiol Inst, UA-01024 Kiev, Ukraine; [Kondratskyi, Artem; Shuba, Yaroslav] Natl Acad Sci Ukraine, Int Ctr Mol Physiol, UA-01024 Kiev, Ukraine; [Mauroy, Brigitte] Univ Catholique Lille, F-59000 Lille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology; National Academy of Sciences Ukraine; Universite Catholique de Lille	Prevarskaya, N (corresponding author), USTL, Inserm U1003, Equipe Labellise Ligue Natl Canc, F-59656 Villeneuve Dascq, France.	natacha.prevarskaya@univ-lille1.fr; roman.skryma@univ-lille1.fr	Gkika, Dimitra/S-3054-2019; Shuba, Yaroslav/AAT-6758-2021	Gkika, Dimitra/0000-0001-8612-0836; Bavencoffe, Alexis Guillaume/0000-0001-5659-5988; Kondratskyi, Artem/0000-0003-3290-0524; Prevarskaya, natacha/0000-0003-0316-197X	INSERM; La Ligue Nationale Contre le Cancer; le Ministere de l'Education Nationale; Region Nord/Pas-de-Calais; New Independent States of the Former Soviet Union [05-1000008-8223]; Institut National du Cancer	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); La Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); le Ministere de l'Education Nationale; Region Nord/Pas-de-Calais(Region Hauts-de-FranceEuropean Commission); New Independent States of the Former Soviet Union; Institut National du Cancer(Institut National du Cancer (INCA) France)	This work was supported by grants from INSERM, La Ligue Nationale Contre le Cancer, le Ministere de l'Education Nationale, the Region Nord/Pas-de-Calais, and The international Association for the Promotion of Co-operation with Scientists from the New Independent States of the Former Soviet Union 05-1000008-8223.; Supported by a postdoctoral fellowship from the Institut National du Cancer.	Abe J, 2006, NEUROSCI LETT, V397, P140, DOI 10.1016/j.neulet.2005.12.005; Abeele FV, 2006, J BIOL CHEM, V281, P40174, DOI 10.1074/jbc.M605779200; Andersson DA, 2007, J NEUROSCI, V27, P3347, DOI 10.1523/JNEUROSCI.4846-06.2007; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bavencoffe A, 2010, J BIOL CHEM, V285, P9410, DOI 10.1074/jbc.M109.069377; Bidaux G, 2007, J CLIN INVEST, V117, P1647, DOI 10.1172/JCI30168; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Daniels RL, 2009, J BIOL CHEM, V284, P1570, DOI 10.1074/jbc.M807270200; De Blas GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006095; De Petrocellis L, 2007, EXP CELL RES, V313, P1911, DOI 10.1016/j.yexcr.2007.01.008; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; FELDER CC, 1995, FASEB J, V9, P619, DOI 10.1096/fasebj.9.8.7768353; Gentry C, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-4; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; GKIKA D, 2010, ONCOGENE IN PRESS; Johnson CD, 2009, AM J PHYSIOL-HEART C, V296, pH1868, DOI 10.1152/ajpheart.01112.2008; Kullmann FA, 2009, AM J PHYSIOL-RENAL, V296, pF892, DOI 10.1152/ajprenal.90718.2008; Lefkimmiatis K, 2009, NAT CELL BIOL, V11, P433, DOI 10.1038/ncb1850; Li Q, 2009, ONCOLOGY-BASEL, V77, P335, DOI 10.1159/000264627; Liu BY, 2005, J NEUROSCI, V25, P1674, DOI 10.1523/JNEUROSCI.3632-04.2005; Mahieu F, 2010, J PHYSIOL-LONDON, V588, P315, DOI 10.1113/jphysiol.2009.183582; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Michel MC, 2006, BRIT J PHARMACOL, V147, pS88, DOI 10.1038/sj.bjp.0706619; Mignen O, 2005, J CELL SCI, V118, P5615, DOI 10.1242/jcs.02663; Mukerji Gaurav, 2006, BMC Urol, V6, P6, DOI 10.1186/1471-2490-6-6; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; Osterhout JL, 2000, J BIOL CHEM, V275, P8248, DOI 10.1074/jbc.275.11.8248; Pawliczak R, 2004, J BIOL CHEM, V279, P48550, DOI 10.1074/jbc.M408926200; Premkumar LS, 2005, J NEUROSCI, V25, P11322, DOI 10.1523/JNEUROSCI.3006-05.2005; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Sabnis AS, 2008, AM J RESP CELL MOL, V39, P466, DOI 10.1165/rcmb.2007-0440OC; Shuttleworth TJ, 1998, J BIOL CHEM, V273, P32636, DOI 10.1074/jbc.273.49.32636; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/jbc.M503544200; Tsavaler L, 2001, CANCER RES, V61, P3760; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Voets T., 2007, V179, P329; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wolf MJ, 1997, J BIOL CHEM, V272, P1522, DOI 10.1074/jbc.272.3.1522; Wondergem R, 2008, BIOCHEM BIOPH RES CO, V372, P210, DOI 10.1016/j.bbrc.2008.05.032; Xing H, 2007, J NEUROSCI, V27, P13680, DOI 10.1523/JNEUROSCI.2203-07.2007; Yang ZH, 2009, ASIAN J ANDROL, V11, P157, DOI 10.1038/aja.2009.1	44	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9849	9855		10.1074/jbc.M110.162016	http://dx.doi.org/10.1074/jbc.M110.162016			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21245133	Green Published, hybrid			2022-12-27	WOS:000288247700108
J	Chavarria, M; Santiago, C; Platero, R; Krell, T; Casasnovas, JM; de Lorenzo, V				Chavarria, Max; Santiago, Cesar; Platero, Raul; Krell, Tino; Casasnovas, Jose M.; de Lorenzo, Victor			Fructose 1-Phosphate Is the Preferred Effector of the Metabolic Regulator Cra of Pseudomonas putida	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; ESCHERICHIA-COLI; LACTOSE REPRESSOR; CRYSTAL-STRUCTURE; TRANSCRIPTIONAL ACTIVATION; PHOSPHOTRANSFERASE SYSTEM; GENE-EXPRESSION; PROTEIN; FRUR; ULTRACENTRIFUGATION	The catabolite repressor/activator (Cra) protein is a global sensor and regulator of carbon fluxes through the central metabolic pathways of Gram-negative bacteria. To examine the nature of the effector (or effectors) that signal such fluxes to the protein of Pseudomonas putida, the Cra factor of this soil microorganism has been purified and characterized and its three-dimensional structure determined. Analytical ultracentrifugation, gel filtration, and mobility shift assays showed that the effector-free Cra is a dimer that binds an operator DNA sequence in the promoter region of the fruBKA cluster. Furthermore, fructose 1-phosphate (F1P) was found to most efficiently dissociate the Cra-DNA complex. Thermodynamic parameters of the F1P-Cra-DNA interaction calculated by isothermal titration calorimetry revealed that the factor associates tightly to the DNA sequence 5'-TTAAACGTTTCA-3' (K-D = 26.3 +/- 3.1 nM) and that F1P binds the protein with an apparent stoichiometry of 1.06 +/- 0.06 molecules per Cra monomer and a K-D of 209 +/- 20 nM. Other possible effectors, like fructose 1,6-bisphosphate, did not display a significant affinity for the regulator under the assay conditions. Moreover, the structure of Cra and its co-crystal with F1P at a 2-angstrom resolution revealed that F1P fits optimally the geometry of the effector pocket. Our results thus single out F1P as the preferred metabolic effector of the Cra protein of P. putida.	[Chavarria, Max; Platero, Raul; de Lorenzo, Victor] CSIC, Ctr Nacl Biotecnol, Syst Biol Program, Madrid 28049, Spain; [Santiago, Cesar; Casasnovas, Jose M.] CSIC, Ctr Nacl Biotecnol, Xray Crystallog Unit, Madrid 28049, Spain; [Krell, Tino] CSIC, Environm Protect Dept, Estn Expt Zaidin, E-18008 Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	de Lorenzo, V (corresponding author), CSIC, Ctr Nacl Biotecnol, Syst Biol Program, Campus Cantoblanco, Madrid 28049, Spain.	vdlorenzo@cnb.csic.es	Chavarria, Max/J-3940-2019; Casasnovas, Jose M/L-6299-2014; Krell, Tino/G-7296-2015; Santiago, César/K-4240-2014	Chavarria, Max/0000-0001-5901-3576; Casasnovas, Jose M/0000-0002-2873-6410; Krell, Tino/0000-0002-9040-3166; Santiago, César/0000-0002-5149-1722; Platero, Raul/0000-0001-5331-1396; de Lorenzo, Victor/0000-0002-6041-2731	Spanish Ministry of Science and Innovation; European Union; Autonomous Community of Madrid; Universidad de Costa Rica; CSIC; Centro Nacional de Biotecnologia; Consejo Superior de Investigaciones Cientificas	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); Autonomous Community of Madrid; Universidad de Costa Rica; CSIC; Centro Nacional de Biotecnologia; Consejo Superior de Investigaciones Cientificas	This work was supported by grants of the CONSOLIDER program of the Spanish Ministry of Science and Innovation, by the BACSINE and MICROME Contracts of the European Union, and by funds of the Autonomous Community of Madrid. This work was also supported by a doctoral scholarship of the Universidad de Costa Rica and the CSIC (to M.C.). C.S. was supported by the Centro Nacional de Biotecnologia, Consejo Superior de Investigaciones Cientificas.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALBERTI S, 1993, EMBO J, V12, P3227, DOI 10.1002/j.1460-2075.1993.tb05992.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bledig SA, 1996, J BACTERIOL, V178, P280, DOI 10.1128/jb.178.1.280-283.1996; CHAKERIAN AE, 1991, J BIOL CHEM, V266, P1371; CHEN J, 1992, J BIOL CHEM, V267, P13843; Cole JL, 2004, METHOD ENZYMOL, V384, P212; CORTAY JC, 1994, J BIOL CHEM, V269, P14885; Daddaoua A, 2010, J BACTERIOL, V192, P4357, DOI 10.1128/JB.00520-10; Downs DM, 2006, ANNU REV MICROBIOL, V60, P533, DOI 10.1146/annurev.micro.60.080805.142308; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kotte O, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.10; Krell T., 2007, PSEUDOMONAS MODEL SY, P255; Laue T, 1992, ULTRACENTRIFUGATION, P90; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miller J. H., 1972, EXPT MOL GENETICS, P431; Munch R, 2003, NUCLEIC ACIDS RES, V31, P266, DOI 10.1093/nar/gkg037; Negre D, 1998, J MOL BIOL, V276, P355, DOI 10.1006/jmbi.1997.1548; Negre D, 1996, MOL MICROBIOL, V21, P257, DOI 10.1046/j.1365-2958.1996.6341350.x; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; Nogales J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-79; Ow DSW, 2007, J BIOTECHNOL, V131, P261, DOI 10.1016/j.jbiotec.2007.07.508; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Penin F, 1997, J MOL BIOL, V270, P496, DOI 10.1006/jmbi.1997.1123; Pfluger K, 2008, J BACTERIOL, V190, P3374, DOI 10.1128/JB.02002-07; Prost JF, 1999, J BACTERIOL, V181, P893, DOI 10.1128/JB.181.3.893-898.1999; Puchalka J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000210; RAMSEIER TM, 1995, MOL MICROBIOL, V16, P1157, DOI 10.1111/j.1365-2958.1995.tb02339.x; RAMSEIER TM, 1993, J MOL BIOL, V234, P28, DOI 10.1006/jmbi.1993.1561; Ramseier TM, 1996, CURR MICROBIOL, V33, P270, DOI 10.1007/s002849900112; Saier MH, 1996, J BACTERIOL, V178, P3411, DOI 10.1128/jb.178.12.3411-3417.1996; Sarkar D, 2008, ARCH MICROBIOL, V190, P559, DOI 10.1007/s00203-008-0406-2; SAWYER MH, 1977, ARCH MICROBIOL, V112, P49, DOI 10.1007/BF00446653; SCARABEL M, 1995, GENE, V153, P9, DOI 10.1016/0378-1119(94)00660-K; Schuck P, 2004, BIOPHYS CHEM, V108, P187, DOI 10.1016/j.bpc.2003.10.016; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SCHUMACHER MA, 1995, CELL, V83, P147, DOI 10.1016/0092-8674(95)90243-0; SCHUMACHER MA, 1994, SCIENCE, V266, P763, DOI 10.1126/science.7973627; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Shimada T, 2005, GENES CELLS, V10, P907, DOI 10.1111/j.1365-2443.2005.00888.x; Shimada T, 2011, J BACTERIOL, V193, P649, DOI 10.1128/JB.01214-10; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Velazquez F, 2004, J BACTERIOL, V186, P8267, DOI 10.1128/JB.186.24.8267-8275.2004; Velazquez F, 2007, J BACTERIOL, V189, P4529, DOI 10.1128/JB.00033-07; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wernimont A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005094; Wilson CJ, 2005, P NATL ACAD SCI USA, V102, P14563, DOI 10.1073/pnas.0505808102	53	19	19	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9351	9359		10.1074/jbc.M110.187583	http://dx.doi.org/10.1074/jbc.M110.187583			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21239488	hybrid, Green Published			2022-12-27	WOS:000288247700064
J	Chuang, TW; Peng, PJ; Tarn, WY				Chuang, Tzu-Wei; Peng, Pey-Jey; Tarn, Woan-Yuh			The Exon Junction Complex Component Y14 Modulates the Activity of the Methylosome in Biogenesis of Spliceosomal Small Nuclear Ribonucleoproteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSKAR MESSENGER-RNA; SM PROTEINS; BINDING PROTEIN; IMPORTIN-BETA; PRMT5; METHYLATION; CORE; SNRNPS; PICLN; GENE	The RNA-binding protein Y14 heterodimerizes with Mago as the core of the exon junction complex during precursor mRNA splicing and plays a role in mRNA surveillance in the cytoplasm. Using the Y14/Magoh heterodimer as bait in a screening for its interacting partners, we identified the protein-arginine methyltransferase PRMT5 as a candidate. We show that Y14 and Magoh, but not other factors of the exon junction complex, interact with the cytoplasmic PRMT5-containing methylosome. We further provide evidence that Y14 promoted the activity of PRMT5 in methylation of Sm proteins of the small nuclear ribonucleoprotein core, whereas knockdown of Y14 reduced their methylation level. Moreover, Y14 overexpression induced the formation of a large, active, and small nuclear ribonucleoprotein (snRNP)-associated methylosome complex. However, Y14 may only transiently associate with the snRNP assembly complex in the cytoplasm. Together, our results suggest that Y14 facilitates Sm protein methylation probably by its activity in promoting the formation or stability of the methylosome-containing complex. We hypothesize that Y14 provides a regulatory link between pre-mRNA splicing and snRNP biogenesis.	[Chuang, Tzu-Wei; Peng, Pey-Jey; Tarn, Woan-Yuh] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [Chuang, Tzu-Wei] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 10002, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Tarn, WY (corresponding author), Acad Sinica, Inst Biomed Sci, 128 Acad Rd Sect 2, Taipei 11529, Taiwan.	wtarn@ibms.sinica.edu.tw	Tarn, Woan-Yuh/N-8464-2018		Academia Sinica investigator award	Academia Sinica investigator award(Academia Sinica - Taiwan)	This work was supported by an Academia Sinica investigator award (to W.-Y.T.).	BLACK DL, 1989, MOL CELL BIOL, V9, P3350, DOI 10.1128/MCB.9.8.3350; Bono F, 2004, EMBO REP, V5, P304, DOI 10.1038/sj.embor.7400091; Bono F, 2010, MOL CELL, V37, P211, DOI 10.1016/j.molcel.2010.01.007; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Branscombe TL, 2001, J BIOL CHEM, V276, P32971, DOI 10.1074/jbc.M105412200; Chari A, 2008, CELL, V135, P497, DOI 10.1016/j.cell.2008.09.020; Degot S, 2004, J BIOL CHEM, V279, P33702, DOI 10.1074/jbc.M402754200; Diem MD, 2007, NAT STRUCT MOL BIOL, V14, P1173, DOI 10.1038/nsmb1321; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fribourg S, 2003, NAT STRUCT BIOL, V10, P433, DOI 10.1038/nsb926; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; Hsu IW, 2005, J BIOL CHEM, V280, P34507, DOI 10.1074/jbc.M507658200; Huber J, 1998, EMBO J, V17, P4114, DOI 10.1093/emboj/17.14.4114; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Li C, 2003, MOL CELL BIOL, V23, P7363, DOI 10.1128/MCB.23.20.7363-7376.2003; MATTAJ IW, 1986, CELL, V46, P905, DOI 10.1016/0092-8674(86)90072-3; Meister G, 2001, CURR BIOL, V11, P1990, DOI 10.1016/S0960-9822(01)00592-9; Meister G, 2002, EMBO J, V21, P5853, DOI 10.1093/emboj/cdf585; Mohr SE, 2001, GENE DEV, V15, P2886; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; Pal S, 2007, EMBO J, V26, P3558, DOI 10.1038/sj.emboj.7601794; Palacios I, 1997, EMBO J, V16, P6783, DOI 10.1093/emboj/16.22.6783; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pesiridis GS, 2009, J BIOL CHEM, V284, P21347, DOI 10.1074/jbc.M109.015578; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; Reichert VL, 2002, GENE DEV, V16, P2778, DOI 10.1101/gad.1030602; Rho J, 2001, J BIOL CHEM, V276, P11393, DOI 10.1074/jbc.M008660200; Richard S, 2005, BIOCHEM J, V388, P379, DOI 10.1042/BJ20040373; Shi H, 2003, GENE DEV, V17, P971, DOI 10.1101/gad.260403; Tange TO, 2005, RNA, V11, P1869, DOI 10.1261/rna.2155905; Urlaub H, 2001, EMBO J, V20, P187, DOI 10.1093/emboj/20.1.187; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	43	26	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8722	8728		10.1074/jbc.M110.190587	http://dx.doi.org/10.1074/jbc.M110.190587			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21209085	Green Published, hybrid			2022-12-27	WOS:000288247700003
J	Costa, MJ; So, AYL; Kaasik, K; Krueger, KC; Pillsbury, ML; Fu, YH; Ptacek, LJ; Yamamoto, KR; Feldman, BJ				Costa, Maria Jose; So, Alex Y. -L.; Kaasik, Krista; Krueger, Katherine C.; Pillsbury, Marlisa L.; Fu, Ying-Hui; Ptacek, Louis J.; Yamamoto, Keith R.; Feldman, Brian J.			Circadian Rhythm Gene Period 3 Is an Inhibitor of the Adipocyte Cell Fate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; INSULIN-RESISTANCE; MAMMALIAN CLOCK; PPAR-GAMMA; OBESITY; TIME; ADIPOGENESIS; OSCILLATORS; FIBROBLASTS; EXPRESSION	Glucocorticoids rapidly and robustly induce cell fate decisions in various multipotent cells, although the precise mechanisms of these important cellular events are not understood. Here we showed that glucocorticoids repressed Per3 expression and that this repression was critical for advancing mesenchymal stem cells to the adipocyte fate. Exogenous expression of Per3 inhibited adipogenesis, whereas knocking out Per3 enhanced that fate. Moreover, we found that PER3 formed a complex with PPAR gamma and inhibited PPAR gamma-mediated transcriptional activation via Ppar gamma response elements. Consistent with these findings, Per3 knock-out mice displayed alterations in body composition, with both increased adipose and decreased muscle tissue compared with wild-type mice. Our findings identify Per3 as potent mediator of cell fate that functions by altering the transcriptional activity of PPAR gamma.	[Costa, Maria Jose; Krueger, Katherine C.; Feldman, Brian J.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Feldman, Brian J.] Stanford Univ, Program Regenerat Med, Stanford, CA 94305 USA; [So, Alex Y. -L.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [So, Alex Y. -L.; Pillsbury, Marlisa L.; Yamamoto, Keith R.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Kaasik, Krista; Fu, Ying-Hui; Ptacek, Louis J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Ptacek, Louis J.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Stanford University; Stanford University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Feldman, BJ (corresponding author), Lokey Stem Cell Res Bldg,265 Campus Dr, Stanford, CA 94305 USA.	feldman@stanford.edu	Costa, Maria Jose/I-7754-2013	Costa, Maria Jose/0000-0001-6111-7614	National Institutes of Health [1-DP2-OD006740, DK73697, CA20535, HL59596, T32 DK007217-35, GM 56847]; Stanford Dean's Fellowship; NATIONAL CANCER INSTITUTE [R37CA020535, R01CA020535] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK073697, T32DK007217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056847] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006740] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Dean's Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Director's New Innovator Award Program 1-DP2-OD006740 (to B. J. F.) and Grants DK73697 (to B. J. F.), CA20535 (to K. R. Y.), and HL59596 (to Y.-H. F. and L. J. P.).; Funded in part by a Stanford Dean's Fellowship award.; Funded in part by National Institutes of Health Training Grant T32 DK007217-35.; Funded in part by National Institutes of Health Training Grant GM 56847.	ANDERSON DJ, 1986, CELL, V47, P1079, DOI 10.1016/0092-8674(86)90823-8; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Bae K, 2007, J BIOL RHYTHM, V22, P85, DOI 10.1177/0748730406296718; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Brommage R, 2003, AM J PHYSIOL-ENDOC M, V285, pE454, DOI 10.1152/ajpendo.00470.2002; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dallmann R, 2010, CHRONOBIOL INT, V27, P1317, DOI 10.3109/07420528.2010.489166; Feldman BJ, 2009, PEDIATR RES, V65, P249, DOI 10.1203/PDR.0b013e3181989667; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; GRAVES RA, 1992, MOL CELL BIOL, V12, P1202, DOI 10.1128/MCB.12.3.1202; Grimaldi B, 2010, CELL METAB, V12, P509, DOI 10.1016/j.cmet.2010.10.005; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; HUANG ZJ, 1993, NATURE, V364, P259, DOI 10.1038/364259a0; Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342; Lefstin JA, 1998, NATURE, V392, P885, DOI 10.1038/31860; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; MacDougald OA, 2002, TRENDS ENDOCRIN MET, V13, P5, DOI 10.1016/S1043-2760(01)00517-3; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; ORTH DN, 1995, NEW ENGL J MED, V332, P791, DOI 10.1056/NEJM199503233321207; Petersen KF, 2006, OBESITY, V14, p34S, DOI 10.1038/oby.2006.280; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Roberge C, 2007, AM J PHYSIOL-ENDOC M, V293, pE1465, DOI 10.1152/ajpendo.00516.2007; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; So AYL, 2009, P NATL ACAD SCI USA, V106, P17582, DOI 10.1073/pnas.0909733106; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Wang J, 2008, MOL CELL BIOL, V28, P2213, DOI 10.1128/MCB.01608-07; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	44	69	76	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9063	9070		10.1074/jbc.M110.164558	http://dx.doi.org/10.1074/jbc.M110.164558			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21228270	Green Published, hybrid			2022-12-27	WOS:000288247700037
J	Sricholpech, M; Perdivara, I; Nagaoka, H; Yokoyama, M; Tomer, KB; Yamauchi, M				Sricholpech, Marnisa; Perdivara, Irina; Nagaoka, Hideaki; Yokoyama, Megumi; Tomer, Kenneth B.; Yamauchi, Mitsuo			Lysyl Hydroxylase 3 Glucosylates Galactosylhydroxylysine Residues in Type I Collagen in Osteoblast Culture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKING; BONE-COLLAGEN; GALACTOSYL-HYDROXYLYSINE; POSTTRANSLATIONAL MODIFICATIONS; OSTEOGENESIS IMPERFECTA; LYSINE HYDROXYLATION; TRABECULAR BONE; LYSYL-HYDROXYLASE-3 LH3; BIOCHEMICAL MARKER; URINARY-EXCRETION	Lysyl hydroxylase 3 (LH3), encoded by Plod3, is the multifunctional collagen-modifying enzyme possessing LH, hydroxylysine galactosyltransferase (GT), and galactosylhydroxylysine-glucosyltransferase (GGT) activities. Although an alteration in type I collagen glycosylation has been implicated in several osteogenic disorders, the role of LH3 in bone physiology has never been investigated. To elucidate the function of LH3 in bone type I collagen modifications, we used a short hairpin RNA technology in a mouse osteoblastic cell line, MC3T3-E1; generated single cell-derived clones stably suppressing LH3 (short hairpin (Sh) clones); and characterized the phenotype. Plod3 expression and the LH3 protein levels in the Sh clones were significantly suppressed when compared with the controls, MC3T3-E1, and the clone transfected with an empty vector. In comparison with controls, type I collagen synthesized by Sh clones (Sh collagen) showed a significant decrease in the extent of glucosylgalactosylhydroxylysine with a concomitant increase of galactosylhydroxylysine, whereas the total number of hydroxylysine residues was essentially unchanged. In an in vitro fibrillogenesis assay, Sh collagen showed accelerated fibrillogenesis compared with the controls. In addition, when recombinant LH3-V5/His protein was generated in 293 cells and subjected to GGT/GT activity assay, it showed GGT but not GT activity against denatured type I collagen. The results from this study clearly indicate that the major function of LH3 in osteoblasts is to glucosylate galactosylhydroxylysine residues in type I collagen and that an impairment of this LH3 function significantly affects type I collagen fibrillogenesis.	[Sricholpech, Marnisa; Nagaoka, Hideaki; Yokoyama, Megumi; Yamauchi, Mitsuo] Univ N Carolina, NC Oral Hlth Inst, Sch Dent, Chapel Hill, NC 27599 USA; [Perdivara, Irina; Tomer, Kenneth B.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Yamauchi, M (corresponding author), Univ N Carolina, NC Oral Hlth Inst, Sch Dent, CB 7454, Chapel Hill, NC 27599 USA.	mitsuo_yamauchi@dentistry.unc.edu	Tomer, Kenneth B/E-8018-2013	Sricholpech, Marnisa/0000-0003-2139-0688	National Institutes of Health [R21DE019569, R01 DE10489]; NIEHS [ES050171]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21DE019569 and R01 DE10489 and Intramural Research Program NIEHS Project ES050171.	AGUILAR JH, 1973, J BIOL CHEM, V248, P5106; Al-Dehaimi AW, 1999, CLIN CHEM, V45, P676; AMUDESWARI S, 1987, COLLAGEN REL RES, V7, P215; ASKENASI R, 1973, BIOCHIM BIOPHYS ACTA, V304, P375, DOI 10.1016/0304-4165(73)90256-0; Bank RA, 1999, P NATL ACAD SCI USA, V96, P1054, DOI 10.1073/pnas.96.3.1054; BATEMAN JF, 1984, BIOCHEM J, V217, P103, DOI 10.1042/bj2170103; Batge B, 1997, J BIOCHEM, V122, P109; Bettica P, 1996, J CLIN ENDOCR METAB, V81, P542, DOI 10.1210/jc.81.2.542; BUTLER WT, 1966, J BIOL CHEM, V241, P3882; Carter EM, 2009, CURR OPIN PEDIATR, V21, P46, DOI 10.1097/MOP.0b013e32832185c5; CETTA G, 1983, CONNECT TISSUE RES, V11, P103, DOI 10.3109/03008208309004847; CETTA G, 1982, BIOCHEM J, V204, P61, DOI 10.1042/bj2040061; CUNNINGH.LW, 1968, J BIOL CHEM, V243, P2390; CUNNINGHAM LW, 1967, J BIOL CHEM, V242, P2570; Dominguez LJ, 2005, BIOCHEM BIOPH RES CO, V330, P1, DOI 10.1016/j.bbrc.2005.02.050; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Eyre D, 2002, MOL GENET METAB, V76, P211, DOI 10.1016/S1096-7192(02)00036-7; EYRE DR, 1973, BIOCHEM BIOPH RES CO, V52, P663, DOI 10.1016/0006-291X(73)90764-X; EYRE DR, 1973, BIOCHEM J, V135, P393, DOI 10.1042/bj1350393; Garza H, 1996, J CHROMATOGR A, V732, P385, DOI 10.1016/0021-9673(95)01296-6; Gineyts E, 2001, RHEUMATOLOGY, V40, P315, DOI 10.1093/rheumatology/40.3.315; Gordon MK, 2010, CELL TISSUE RES, V339, P247, DOI 10.1007/s00441-009-0844-4; GUITTON JD, 1981, BIOSCIENCE REP, V1, P945, DOI 10.1007/BF01114964; Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508; Heikkinen J, 2000, J BIOL CHEM, V275, P36158, DOI 10.1074/jbc.M006203200; HENKEL W, 1976, EUR J BIOCHEM, V69, P223, DOI 10.1111/j.1432-1033.1976.tb10877.x; LEHMANN HW, 1995, J CANCER RES CLIN, V121, P413, DOI 10.1007/BF01212948; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOU MF, 1971, CLIN CHEM, V17, P782; Mercer DK, 2003, BIOCHEM BIOPH RES CO, V307, P803, DOI 10.1016/S0006-291X(03)01262-2; MICHALSKY M, 1995, CLIN CHIM ACTA, V234, P101, DOI 10.1016/0009-8981(94)05981-W; MICHALSKY M, 1993, BIOCHEM BIOPH RES CO, V192, P1281, DOI 10.1006/bbrc.1993.1555; Moro L, 1997, EUR J CLIN CHEM CLIN, V35, P29; MORO L, 1993, BIOCHIM BIOPHYS ACTA, V1156, P288, DOI 10.1016/0304-4165(93)90044-9; Moro L, 1997, EUR J CLIN CHEM CLIN, V35, P269; Moro L, 2000, CALCIFIED TISSUE INT, V66, P151, DOI 10.1007/s002230010030; Myers LK, 2004, J IMMUNOL, V172, P2970, DOI 10.4049/jimmunol.172.5.2970; MYLLYLA R, 1975, EUR J BIOCHEM, V58, P517, DOI 10.1111/j.1432-1033.1975.tb02400.x; Notbohm H, 1999, J BIOL CHEM, V274, P8988, DOI 10.1074/jbc.274.13.8988; ODELL V, 1974, J CHROMATOGR, V88, P245, DOI 10.1016/S0021-9673(00)83148-9; OIKARINEN A, 1977, BIOCHEM J, V166, P357, DOI 10.1042/bj1660357; Parisuthiman D, 2005, J BONE MINER RES, V20, P1878, DOI 10.1359/JBMR.050612; Pecile A, 1996, J ENDOCRINOL, V150, P383, DOI 10.1677/joe.0.1500383; PECZON BD, 1979, J CHROMATOGR, V169, P351, DOI 10.1016/0021-9673(75)85060-6; Pornprasertsuk S, 2004, J BONE MINER RES, V19, P1349, DOI 10.1359/JBMR.040323; RAUCH F, 1995, J CLIN ENDOCR METAB, V80, P1295, DOI 10.1210/jc.80.4.1295; Rautavuoma K, 2004, P NATL ACAD SCI USA, V101, P14120, DOI 10.1073/pnas.0404966101; Rautavuoma K, 2002, J BIOL CHEM, V277, P23084, DOI 10.1074/jbc.M112077200; Risteli M, 2004, J BIOL CHEM, V279, P37535, DOI 10.1074/jbc.M405638200; Risteli M, 2009, J BIOL CHEM, V284, P28204, DOI 10.1074/jbc.M109.038190; ROBINS SP, 1983, BIOCHEM J, V215, P167, DOI 10.1042/bj2150167; Ruotsalainen H, 2006, J CELL SCI, V119, P625, DOI 10.1242/jcs.02780; Salo AM, 2006, J CELL PHYSIOL, V207, P644, DOI 10.1002/jcp.20596; Salo AM, 2008, AM J HUM GENET, V83, P495, DOI 10.1016/j.ajhg.2008.09.004; SAVOLAINEN ER, 1981, NEW ENGL J MED, V304, P197, DOI 10.1056/NEJM198101223040403; Schegg B, 2009, MOL CELL BIOL, V29, P943, DOI 10.1128/MCB.02085-07; SEGREST JP, 1970, J CLIN INVEST, V49, P1497, DOI 10.1172/JCI106367; Sipila L, 2007, J BIOL CHEM, V282, P33381, DOI 10.1074/jbc.M704198200; Takaluoma K, 2007, MATRIX BIOL, V26, P396, DOI 10.1016/j.matbio.2007.01.002; Takaluoma K, 2007, J BIOL CHEM, V282, P6588, DOI 10.1074/jbc.M608830200; TENNI R, 1993, AM J MED GENET, V45, P252, DOI 10.1002/ajmg.1320450219; TENNI R, 1984, ITAL J BIOCHEM, V33, P117; TORREBLANCO A, 1992, J BIOL CHEM, V267, P2650; Uzawa K, 2003, BIOCHEM BIOPH RES CO, V305, P484, DOI 10.1016/S0006-291X(03)00799-X; Uzawa K, 1999, J BONE MINER RES, V14, P1272, DOI 10.1359/jbmr.1999.14.8.1272; van der Slot AJ, 2003, J BIOL CHEM, V278, P40967, DOI 10.1074/jbc.M307380200; VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Wang CG, 2002, MATRIX BIOL, V21, P559, DOI 10.1016/S0945-053X(02)00071-9; Wang CG, 2000, DNA CELL BIOL, V19, P71, DOI 10.1089/104454900314582; Wang CG, 2002, J BIOL CHEM, V277, P18568, DOI 10.1074/jbc.M201389200; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578; WOOD GC, 1960, BIOCHEM J, V75, P588, DOI 10.1042/bj0750588; YAMAUCHI M, 1987, J BIOL CHEM, V262, P11428; Yamauchi Mitsuo, 2008, V446, P95, DOI 10.1007/978-1-60327-084-7_7; YANG CLL, 1993, EUR J BIOCHEM, V213, P1297, DOI 10.1111/j.1432-1033.1993.tb17881.x; Zuurmond AM, 2005, MATRIX BIOL, V24, P261, DOI 10.1016/j.matbio.2005.04.002	78	44	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8846	8856		10.1074/jbc.M110.178509	http://dx.doi.org/10.1074/jbc.M110.178509			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21220425	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000288247700015
J	Di Stefano, V; Giacca, M; Capogrossi, MC; Crescenzi, M; Martelli, F				Di Stefano, Valeria; Giacca, Mauro; Capogrossi, Maurizio C.; Crescenzi, Marco; Martelli, Fabio			Knockdown of Cyclin-dependent Kinase Inhibitors Induces Cardiomyocyte Re-entry in the Cell Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AURORA-B KINASE; GROWTH-FACTOR-I; CARDIAC MYOCYTES; MYOCARDIAL REGENERATION; CARDIOVASCULAR-DISEASE; ADULT CARDIOMYOCYTES; SKELETAL-MUSCLE; GENE-EXPRESSION; MICE LACKING; MAMMALIAN CARDIOMYOCYTES	Proliferation of mammalian cardiomyocytes stops rapidly after birth and injured hearts do not regenerate adequately. High cyclin-dependent kinase inhibitor (CKI) levels have been observed in cardiomyocytes, but their role in maintaining cardiomyocytes in a post-mitotic state is still unknown. In this report, it was investigated whether CKI knockdown by RNA interference induced cardiomyocyte proliferation. We found that triple transfection with p21(Waf1), p27(Kip1), and p57(Kip2) siRNAs induced both neonatal and adult cardiomyocyte to enter S phase and increased the nuclei/cardiomyocyte ratio; furthermore, a subpopulation of cardiomyocytes progressed beyond karyokynesis, as assessed by the detection of mid-body structures and by straight cardiomyocyte counting. Intriguingly, cardiomyocyte proliferation occurred in the absence of overt DNA damage and aberrant mitotic figures. Finally, CKI knockdown and DNA synthesis reactivation correlated with a dramatic change in adult cardiomyocyte morphology that may be a prerequisite for cell division. In conclusion, CKI expression plays an active role in maintaining cardiomyocyte withdrawal from the cell cycle.	[Capogrossi, Maurizio C.; Martelli, Fabio] Ist Dermopat Immacolata IRCCS, Vasc Pathol Lab, I-00167 Rome, Italy; [Di Stefano, Valeria] IRCCS Policlin San Donato, Mol Cardiol Lab, I-20097 San Donato Milanese, Italy; [Giacca, Mauro] Int Ctr Genet Engn & Biotechnol, Mol Med Lab, I-34149 Trieste, Italy; [Crescenzi, Marco] Ist Super Sanita, Dept Environm & Primary Prevent, I-00161 Rome, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Policlinico San Donato; International Center for Genetic Engineering & Biotechnology (ICGEB); Istituto Superiore di Sanita (ISS)	Martelli, F (corresponding author), Ist Dermopat Immacolata IRCCS, Vasc Pathol Lab, Via Monti Creta 104, I-00167 Rome, Italy.	f.martelli@idi.it	Giacca, Mauro/J-9287-2016; Crescenzi, Marco/J-3603-2018; Martelli, Fabio/AAL-3788-2020	Giacca, Mauro/0000-0003-2927-7225; Crescenzi, Marco/0000-0003-0156-1494; Martelli, Fabio/0000-0002-8624-7738	Ministero della Salute [RF06, RF07, RC09-11]	Ministero della Salute(Ministry of Health, Italy)	This work was supported in part by Ministero della Salute (RF06, RF07, and RC09-11).	Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Bicknell KA, 2003, J PHARM PHARMACOL, V55, P571, DOI 10.1211/002235703765344487; Bicknell KA, 2008, CURR OPIN PHARMACOL, V8, P193, DOI 10.1016/j.coph.2007.12.015; Bicknell KA, 2007, J MOL CELL CARDIOL, V42, P706, DOI 10.1016/j.yjmcc.2007.01.006; Bird SD, 2003, CARDIOVASC RES, V58, P423, DOI 10.1016/S0008-6363(03)00253-0; Bockstaele L, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-25; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Boni A, 2008, P NATL ACAD SCI USA, V105, P15529, DOI 10.1073/pnas.0808357105; Borges A, 1997, J MOL CELL CARDIOL, V29, P2717, DOI 10.1006/jmcc.1997.0503; Burton PBJ, 1999, EUR HEART J, V20, P604, DOI 10.1053/euhj.1998.1231; Busk PK, 2003, CELL CYCLE, V2, P91, DOI 10.4161/cc.2.2.298; Busk PK, 2005, EXP CELL RES, V304, P149, DOI 10.1016/j.yexcr.2004.10.022; Campa VM, 2008, J CELL BIOL, V183, P129, DOI 10.1083/jcb.200806104; CAPASSO JM, 1992, AM J PHYSIOL, V262, pH486, DOI 10.1152/ajpheart.1992.262.2.H486; Chen HW, 2004, HEART, V90, P927, DOI 10.1136/hrt.2002.006734; Cheng RK, 2007, CIRC RES, V100, P1741, DOI 10.1161/CIRCRESAHA.107.153544; Collesi C, 2008, J CELL BIOL, V183, P117, DOI 10.1083/jcb.200806091; Ebelt H, 2005, CIRC RES, V96, P509, DOI 10.1161/01.RES.0000159705.17322.57; Engel FB, 2005, CELL CYCLE, V4, P1360, DOI 10.4161/cc.4.10.2081; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Engel FB, 2003, MOL CELL BIOL, V23, P555, DOI 10.1128/MCB.23.2.555-565.2003; Engel FB, 2006, P NATL ACAD SCI USA, V103, P15546, DOI 10.1073/pnas.0607382103; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Gowdak LHW, 2000, CIRCULATION, V102, P565; Hahn WC, 1999, NAT MED, V5, P1164, DOI 10.1038/13495; Haley Sheila A., 2008, BMC Physiology, V8, P4, DOI 10.1186/1472-6793-8-4; Harper JW, 1997, CANCER SURV, V29, P91; Hosoda T, 2010, CIRC J, V74, P13, DOI 10.1253/circj.CJ-09-0665; Kajstura J, 2006, ANTIOXID REDOX SIGN, V8, P2125, DOI 10.1089/ars.2006.8.2125; Kiyokawa H, 1996, CELL, V85, P721, DOI 10.1016/S0092-8674(00)81238-6; Koh KN, 1998, J MOL CELL CARDIOL, V30, P463, DOI 10.1006/jmcc.1997.0611; Kozar K, 2005, CELL CYCLE, V4, P388, DOI 10.4161/cc.4.3.1551; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Leri A, 2008, CURR PROB CARDIOLOGY, V33, P91, DOI 10.1016/j.cpcardiol.2007.11.002; Li GM, 1998, CIRCULATION, V98, pII144; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacLellan WR, 2005, MOL CELL BIOL, V25, P2486, DOI 10.1128/MCB.25.6.2486-2497.2005; McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331; MUHLHAUSER J, 1995, CIRC RES, V77, P1077, DOI 10.1161/01.RES.77.6.1077; Murata-Hori M, 2002, MOL BIOL CELL, V13, P1099, DOI 10.1091/mbc.01-09-0467; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; Oh H, 2001, P NATL ACAD SCI USA, V98, P10308, DOI 10.1073/pnas.191169098; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Orlandi A, 2008, AM J PHYSIOL-HEART C, V294, pH1541, DOI 10.1152/ajpheart.01285.2007; Pajalunga D, 2007, J CELL BIOL, V176, P807, DOI 10.1083/jcb.200608109; Pasumarthi KBS, 2002, CIRC RES, V90, P1044, DOI 10.1161/01.RES.0000020201.44772.67; Poindexter BJ, 2001, CELL CALCIUM, V30, P373, DOI 10.1054/ceca.2001.0249; Poolman RA, 1998, J MOL CELL CARDIOL, V30, P2121, DOI 10.1006/jmcc.1998.0808; Poolman RA, 1998, INT J CARDIOL, V67, P133, DOI 10.1016/S0167-5273(98)00320-9; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; Sacco A, 2003, ONCOGENE, V22, P4027, DOI 10.1038/sj.onc.1206353; Schluter KD, 1999, AM J PHYSIOL-HEART C, V276, pH1655, DOI 10.1152/ajpheart.1999.276.5.H1655; Serrano AL, 2004, CIRC RES, V94, P575, DOI 10.1161/01.RES.0000122141.18795.9C; SHAN B, 1994, MOL CELL BIOL, V14, P8166, DOI 10.1128/MCB.14.12.8166; Shay JW, 2001, SCIENCE, V291, P839, DOI 10.1126/science.1058546; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Stephen MJ, 2009, OPEN CARDIOVASC MED, V3, P1, DOI 10.2174/1874192400903010001; Tamamori-Adachi M, 2008, CELL CYCLE, V7, P3768, DOI 10.4161/cc.7.23.7239; Tiemann K, 2009, EMBO MOL MED, V1, P142, DOI 10.1002/emmm.200900023; Toyoda M, 2003, DEV CELL, V5, P85, DOI 10.1016/S1534-5807(03)00189-8; Tseng AS, 2006, CHEM BIOL, V13, P957, DOI 10.1016/j.chembiol.2006.08.004; Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103; von Harsdorf R, 1999, CIRC RES, V85, P128, DOI 10.1161/01.RES.85.2.128; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Westbury J, 2001, MECH DEVELOP, V109, P83, DOI 10.1016/S0925-4773(01)00512-3; Wheatley SP, 2001, CURR BIOL, V11, P886, DOI 10.1016/S0960-9822(01)00238-X; Williams GT, 2006, GENE THER MOL BIOL, V10B, P255; Woo YJ, 2007, J THORAC CARDIOV SUR, V133, P927, DOI 10.1016/j.jtcvs.2006.07.057; Yan Y, 1997, GENE DEV, V11, P973, DOI 10.1101/gad.11.8.973; Zaccagnini G, 2004, CIRCULATION, V109, P2917, DOI 10.1161/01.CIR.0000129309.58874.0F; Zaccagnini G, 2007, J BIOL CHEM, V282, P31453, DOI 10.1074/jbc.M702511200; Zhang PM, 1998, GENE DEV, V12, P3162, DOI 10.1101/gad.12.20.3162; Zhang PM, 1997, NATURE, V387, P151, DOI 10.1038/387151a0; Zhong WG, 2006, EMBO J, V25, P3869, DOI 10.1038/sj.emboj.7601252	82	57	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8644	8654		10.1074/jbc.M110.184549	http://dx.doi.org/10.1074/jbc.M110.184549			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21209082	Green Published, hybrid			2022-12-27	WOS:000288013300090
J	Jan, A; Adolfsson, O; Allaman, I; Buccarello, AL; Magistretti, PJ; Pfeifer, A; Muhs, A; Lashuel, HA				Jan, Asad; Adolfsson, Oskar; Allaman, Igor; Buccarello, Anna-Lucia; Magistretti, Pierre J.; Pfeifer, Andrea; Muhs, Andreas; Lashuel, Hilal A.			A beta 42 Neurotoxicity Is Mediated by Ongoing Nucleated Polymerization Process Rather than by Discrete A beta 42 Species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA-PROTEIN; GAMMA-SECRETASE INHIBITOR; INSULIN-DEGRADING ENZYME; APP TRANSGENIC MICE; ALZHEIMERS-DISEASE; IN-VITRO; CEREBROSPINAL-FLUID; PLAQUE-FORMATION; MOUSE MODEL; PEPTIDE	The identification of toxic A beta species and/or the process of their formation is crucial for understanding the mechanism(s) of A beta neurotoxicity in Alzheimer disease and also for the development of effective diagnostic and therapeutic interventions. To elucidate the structural basis of A beta toxicity, we developed different procedures to isolate A beta species of defined size and morphology distribution, and we investigated their toxicity in different cell lines and primary neurons. We observed that crude A beta 42 preparations, containing a monomeric and heterogeneous mixture of A beta 42 oligomers, were more toxic than purified monomeric, protofibrillar fractions, or fibrils. The toxicity of protofibrils was directly linked to their interactions with monomeric A beta 42 and strongly dependent on their ability to convert into amyloid fibrils. Subfractionation of protofibrils diminished their fibrillization and toxicity, whereas reintroduction of monomeric A beta 42 into purified protofibril fractions restored amyloid formation and enhanced their toxicity. Selective removal of monomeric A beta 42 from these preparations, using insulin-degrading enzyme, reversed the toxicity of A beta 42 protofibrils. Together, our findings demonstrate that A beta 42 toxicity is not linked to specific prefibrillar aggregate(s) but rather to the ability of these species to grow and undergo fibril formation, which depends on the presence of monomeric A beta 42. These findings contribute significantly to the understanding of amyloid formation and toxicity in Alzheimer disease, provide novel insight into mechanisms of A beta protofibril toxicity, and important implications for designing anti-amyloid therapies.	[Jan, Asad; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Lab Mol Neurobiol & Neuroprote, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Adolfsson, Oskar; Buccarello, Anna-Lucia; Pfeifer, Andrea; Muhs, Andreas] Ecole Polytech Fed Lausanne, AC Immune, PSE B, CH-1015 Lausanne, Switzerland; [Allaman, Igor; Magistretti, Pierre J.] Ecole Polytech Fed Lausanne, Lab Neuroenerget & Cellular Dynam, Brain Mind Inst, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Lashuel, HA (corresponding author), Ecole Polytech Fed Lausanne, Lab Mol Neurobiol & Neuroprote, Brain Mind Inst, CH-1015 Lausanne, Switzerland.	hilal.lashuel@epfl.ch	Jan, Asad/AAZ-2920-2021; Lashuel, Hilal/M-3500-2017; Jan, Asad/D-4389-2009; Allaman, Igor/R-8092-2016	Jan, Asad/0000-0002-3636-0070; Jan, Asad/0000-0002-3636-0070; Allaman, Igor/0000-0002-7525-0536; Magistretti, Pierre Julius/0000-0002-6678-320X	Swiss Federal Institute of Technology Lausanne; Swiss National Foundation [310000-110027]	Swiss Federal Institute of Technology Lausanne; Swiss National Foundation(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss Federal Institute of Technology Lausanne and Grant 310000-110027 from the Swiss National Foundation.	Aisen PS, 2007, CURR ALZHEIMER RES, V4, P473, DOI 10.2174/156720507781788882; Allaman I, 2010, J NEUROSCI, V30, P3326, DOI 10.1523/JNEUROSCI.5098-09.2010; Barten DM, 2005, J PHARMACOL EXP THER, V312, P635, DOI 10.1124/jpet.104.075408; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2006, METHOD ENZYMOL, V413, P217, DOI 10.1016/S0076-6879(06)13012-8; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Eisele YS, 2009, P NATL ACAD SCI USA, V106, P12926, DOI 10.1073/pnas.0903200106; Engel MFM, 2008, P NATL ACAD SCI USA, V105, P6033, DOI 10.1073/pnas.0708354105; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Friedman R, 2009, J MOL BIOL, V387, P407, DOI 10.1016/j.jmb.2008.12.036; Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106; Glenner G G, 1984, Appl Pathol, V2, P357; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harper JD, 1997, CHEM BIOL, V4, P951, DOI 10.1016/S1074-5521(97)90303-3; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hawkes CA, 2010, EUR J NEUROSCI, V31, P203, DOI 10.1111/j.1460-9568.2009.07052.x; Hepler RW, 2006, BIOCHEMISTRY-US, V45, P15157, DOI 10.1021/bi061850f; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Jan A, 2008, J BIOL CHEM, V283, P28176, DOI 10.1074/jbc.M803159200; Jan A, 2010, NAT PROTOC, V5, P1186, DOI 10.1038/nprot.2010.72; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Kanemitsu H, 2003, NEUROSCI LETT, V350, P113, DOI 10.1016/S0304-3940(03)00898-X; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Kodali R, 2007, CURR OPIN STRUC BIOL, V17, P48, DOI 10.1016/j.sbi.2007.01.007; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lanz TA, 2003, J PHARMACOL EXP THER, V305, P864, DOI 10.1124/jpet.102.048280; Lashuel HA, 2003, J MOL BIOL, V332, P795, DOI 10.1016/S0022-2836(03)00927-6; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Leissring MA, 2008, J BIOL CHEM, V283, P29645, DOI 10.1074/jbc.R800022200; Luheshi LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000334; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; McLaurin J, 2002, NAT MED, V8, P1263, DOI 10.1038/nm790; Meberg PJ, 2003, METHOD CELL BIOL, V71, P111, DOI 10.1016/S0091-679X(03)01007-0; MERZ PA, 1983, ACTA NEUROPATHOL, V60, P113, DOI 10.1007/BF00685355; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morelli L, 2003, J BIOL CHEM, V278, P23221, DOI 10.1074/jbc.M300276200; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Morgan D M, 1998, Methods Mol Biol, V79, P179; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Okada T, 2008, J MOL BIOL, V382, P1066, DOI 10.1016/j.jmb.2008.07.072; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Sato T, 2006, BIOCHEMISTRY-US, V45, P5503, DOI 10.1021/bi052485f; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Selkoe DJ, 2003, ANNU REV PHARMACOL, V43, P545, DOI 10.1146/annurev.pharmtox.43.100901.140248; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; SISODIA SS, 1992, ANN NY ACAD SCI, V674, P53, DOI 10.1111/j.1749-6632.1992.tb27476.x; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552; Whalen BM, 2005, NEUROBIOL DIS, V20, P254, DOI 10.1016/j.nbd.2005.03.007; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0	60	153	155	0	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8585	8596		10.1074/jbc.M110.172411	http://dx.doi.org/10.1074/jbc.M110.172411			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21156804	Green Published, hybrid			2022-12-27	WOS:000288013300085
J	Lee, KW; Lee, DJ; Lee, JY; Kang, DH; Kwon, J; Kang, SW				Lee, Kyung Wha; Lee, Doo Jae; Lee, Joo Young; Kang, Dong Hoon; Kwon, Jongbum; Kang, Sang Won			Peroxiredoxin II Restrains DNA Damage-induced Death in Cancer Cells by Positively Regulating JNK-dependent DNA Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; SIGNAL-TRANSDUCTION; HYDROGEN-PEROXIDE; MAMMALIAN PEROXIREDOXIN; TUMOR-CELLS; C-MYC; ACTIVATION; RADIATION; APOPTOSIS; STRESS	The 2-Cys peroxiredoxins (Prx) belong to a family of antioxidant enzymes that detoxify reactive oxygen and nitrogen species and are distributed throughout the intracellular and extracellular compartments. However, the presence and role of 2-Cys Prxs in the nucleus have not been studied. This study demonstrates that the PrxII located in the nucleus protects cancer cells from DNA damage-induced cell death. Although the two cytosolic 2-Cys Prxs, PrxI and PrxII, were found in the nucleus, only PrxII knockdown selectively and markedly increased cell death in the cancer cells treated with DNA-damaging agents. The increased death was completely reverted by the nuclearly targeted expression of PrxII in an activity-independent manner. Furthermore, the antioxidant butylated hydroxyanisole did not influence the etoposide-induced cell death. Mechanistically, the knockdown of Prx II expression impaired the DNA repair process by reducing the activation of the JNK/c-Jun pathway. These results suggest that PrxII is likely to be attributed to a tumor survival factor positively regulating JNK-dependent DNA repair with its inhibition possibly sensitizing cancer cells to chemotherapeutic agents.	[Lee, Kyung Wha; Lee, Joo Young; Kwon, Jongbum; Kang, Sang Won] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Lee, Doo Jae; Kang, Dong Hoon; Kwon, Jongbum; Kang, Sang Won] Ewha Womans Univ, Ctr Cell Signaling & Drug Discovery Res, Seoul 120750, South Korea; [Kwon, Jongbum; Kang, Sang Won] Ewha Womans Univ, Dept Life Sci, Seoul 120750, South Korea	Ewha Womans University; Ewha Womans University; Ewha Womans University	Kang, SW (corresponding author), 11-1 Daehyun Dong, Seoul 120750, South Korea.	kangsw@ewha.ac.kr			Ministry of Education, Science and Technology [2009-0054572, FPR08-B1-190]; KOSEF through the Center for Cell Signaling and Drug Discovery Research [R15-2006-020]; Brain Korea 21; LG Foundation	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); KOSEF through the Center for Cell Signaling and Drug Discovery Research; Brain Korea 21(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); LG Foundation	This work was supported in part by Mid-career Researcher Program through National Research Foundation of Korea Grant 2009-0054572 funded by the Ministry of Education, Science and Technology, by 21C Frontier Functional Proteomics Project FPR08-B1-190 funded by the Ministry of Education, Science and Technology, and by KOSEF through the Center for Cell Signaling and Drug Discovery Research Grant R15-2006-020 at Ewha Womans University.; Recipient of the Brain Korea 21 grant.; Supported by Exchange Professor Program of LG Foundation. To whom correspondence should be addressed: 11-1 Daehyun-dong, Seodaemun-gu, Seoul 120-750, Korea. Fax:82-2-3277-3760; E-mail: kangsw@ewha.ac.kr.	Brigelius-Flohe R, 1999, FREE RADICAL BIO MED, V27, P951, DOI 10.1016/S0891-5849(99)00173-2; Cao JX, 2009, EMBO J, V28, P1505, DOI 10.1038/emboj.2009.101; CERUTTI PA, 1994, LANCET, V344, P862, DOI 10.1016/S0140-6736(94)92832-0; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; Chang TS, 2004, J BIOL CHEM, V279, P41975, DOI 10.1074/jbc.M407707200; Chen MF, 2006, INT J RADIAT ONCOL, V64, P581, DOI 10.1016/j.ijrobp.2005.10.012; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Egler RA, 2005, ONCOGENE, V24, P8038, DOI 10.1038/sj.onc.1208821; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Halliwell B., 2007, FREE RADICAL BIO MED, P70; Hayakawa J, 2004, MOL CELL, V16, P521, DOI 10.1016/j.molcel.2004.10.024; Hayakawa J, 2003, J BIOL CHEM, V278, P20582, DOI 10.1074/jbc.M210992200; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Kang SW, 2005, TRENDS MOL MED, V11, P571, DOI 10.1016/j.molmed.2005.10.006; Kang SW, 2004, J BIOL CHEM, V279, P2535, DOI 10.1074/jbc.M307698200; Kim YJ, 2006, CANCER RES, V66, P7136, DOI 10.1158/0008-5472.CAN-05-4446; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kurosu T, 2003, ONCOGENE, V22, P4459, DOI 10.1038/sj.onc.1206755; Lee JY, 2009, FREE RADICAL BIO MED, V47, P1162, DOI 10.1016/j.freeradbiomed.2009.07.027; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Low FM, 2008, ANTIOXID REDOX SIGN, V10, P1621, DOI 10.1089/ars.2008.2081; Manta B, 2009, ARCH BIOCHEM BIOPHYS, V484, P146, DOI 10.1016/j.abb.2008.11.017; Marnett LJ, 2003, J CLIN INVEST, V111, P583, DOI 10.1172/JCI200318022; Mizutani H, 2002, J BIOL CHEM, V277, P30684, DOI 10.1074/jbc.M204353200; Mu ZM, 2002, J BIOL CHEM, V277, P43175, DOI 10.1074/jbc.M206066200; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Park SH, 2000, CLIN CANCER RES, V6, P4915; Rhee S G, 2000, Sci STKE, V2000, ppe1; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Senturker S, 2002, ARCH BIOCHEM BIOPHYS, V397, P262, DOI 10.1006/abbi.2001.2681; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Smith-Pearson PS, 2008, FREE RADICAL BIO MED, V45, P1178, DOI 10.1016/j.freeradbiomed.2008.07.015; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200; Wang TL, 2005, CANCER RES, V65, P10338, DOI 10.1158/0008-5472.CAN-04-4614; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Wu D, 2006, ONCOGENE, V25, P1153, DOI 10.1038/sj.onc.1209148; Yan Y, 2007, ONCOGENE, V26, P4689, DOI 10.1038/sj.onc.1210268; Yan Y, 2008, CANCER RES, V68, P5113, DOI 10.1158/0008-5472.CAN-07-5818; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Zhang B, 2005, J RADIAT RES, V46, P305, DOI 10.1269/jrr.46.305; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005	54	45	49	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8394	8404		10.1074/jbc.M110.179416	http://dx.doi.org/10.1074/jbc.M110.179416			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21148313	hybrid, Green Published			2022-12-27	WOS:000288013300068
J	Neutzner, A; Neutzner, M; Benischke, AS; Ryu, SW; Frank, S; Youle, RJ; Karbowski, M				Neutzner, Albert; Neutzner, Melanie; Benischke, Anne-Sophie; Ryu, Seung-Wook; Frank, Stephan; Youle, Richard J.; Karbowski, Mariusz			A Systematic Search for Endoplasmic Reticulum (ER) Membrane-associated RING Finger Proteins Identifies Nixin/ZNRF4 as a Regulator of Calnexin Stability and ER Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; QUALITY-CONTROL; UBIQUITIN; LIGASE; DEGRADATION; PROTEOMICS; MEDIATORS; PATHWAYS; TOPOLOGY; DATABASE	To identify novel regulators of endoplasmic reticulum (ER)-linked protein degradation and ER function, we determined the entire inventory of membrane-spanning RING finger E3 ubiquitin ligases localized to the ER. We identified 24 ER membrane-anchored ubiquitin ligases and found Nixin/ZNRF4 to be central for the regulation of calnexin turnover. Ectopic expression of wild type Nixin induced a dramatic down-regulation of the ER-localized chaperone calnexin that was prevented by inactivation of the Nixin RING domain. Importantly, Nixin physically interacts with calnexin in a glycosylation-independent manner, induces calnexin ubiquitination, and p97-dependent degradation, indicating an ER-associated degradation-like mechanism of calnexin turnover.	[Neutzner, Albert; Ryu, Seung-Wook; Youle, Richard J.; Karbowski, Mariusz] NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; [Neutzner, Albert; Neutzner, Melanie; Benischke, Anne-Sophie] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland; [Neutzner, Albert; Neutzner, Melanie; Benischke, Anne-Sophie] Univ Basel Hosp, Univ Eye Clin, CH-4031 Basel, Switzerland; [Neutzner, Melanie; Frank, Stephan] Univ Basel, Inst Pathol, Dept Neuropathol, CH-4031 Basel, Switzerland; [Ryu, Seung-Wook] Korea Adv Inst Sci & Technol, Dept Bio & Brain Engn, Taejon 305701, South Korea; [Karbowski, Mariusz] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Karbowski, Mariusz] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Basel; University of Basel; University of Basel; Korea Advanced Institute of Science & Technology (KAIST); University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Neutzner, A (corresponding author), NINDS, Biochem Sect, Surg Neurol Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	albert.neutzner@unibas.ch; mkarbowski@umaryland.edu	Neutzner, Albert/ABC-4368-2020	Neutzner, Albert/0000-0001-9254-5558	National Institutes of Health from NIGMS [RO1 GM083131]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003123, ZIANS003127] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM083131 from NIGMS (to M. K.).	Ain Q, 2007, HUM GENET, V122, P445, DOI 10.1007/s00439-007-0418-z; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Delom F, 2007, CELL DEATH DIFFER, V14, P586, DOI 10.1038/sj.cdd.4402012; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Foster LJ, 2006, CELL, V125, P187, DOI 10.1016/j.cell.2006.03.022; Fujii T, 1999, GENOMICS, V57, P94, DOI 10.1006/geno.1998.5738; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Hirsch C, 2004, BBA-MOL CELL RES, V1695, P215, DOI 10.1016/j.bbamcr.2004.10.006; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; KOBATA A, 1979, ANAL BIOCHEM, V100, P1, DOI 10.1016/0003-2697(79)90102-7; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Laney J. D., 2002, CURRENT PROTOCOLS PR, P1; Lerner M, 2007, MOL BIOL CELL, V18, P1670, DOI 10.1091/mbc.E06-03-0248; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Mahon P, 2000, PROTEIN SCI, V9, P1930, DOI 10.1110/ps.9.10.1930; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Okumoto K, 1998, HUM MOL GENET, V7, P1399, DOI 10.1093/hmg/7.9.1399; Oliver JD, 1996, J BIOL CHEM, V271, P13691, DOI 10.1074/jbc.271.23.13691; PIND S, 1994, J BIOL CHEM, V269, P12784; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ruddock LW, 2006, J CELL SCI, V119, P4373, DOI 10.1242/jcs.03225; Santoni V, 2000, ELECTROPHORESIS, V21, P1054, DOI 10.1002/(SICI)1522-2683(20000401)21:6<1054::AID-ELPS1054>3.3.CO;2-#; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158; Yates JR, 2005, NAT REV MOL CELL BIO, V6, P702, DOI 10.1038/nrm1711; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zhang Q, 2009, CELL RES, V19, P348, DOI 10.1038/cr.2008.285	38	47	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8633	8643		10.1074/jbc.M110.197459	http://dx.doi.org/10.1074/jbc.M110.197459			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21205830	hybrid, Green Published			2022-12-27	WOS:000288013300089
J	Voxeur, A; Gilbert, L; Rihouey, C; Driouich, A; Rothan, C; Baldet, P; Lerouge, P				Voxeur, Aline; Gilbert, Louise; Rihouey, Christophe; Driouich, Azeddine; Rothan, Christophe; Baldet, Pierre; Lerouge, Patrice			Silencing of the GDP-D-mannose 3,5-Epimerase Affects the Structure and Cross-linking of the Pectic Polysaccharide Rhamnogalacturonan II and Plant Growth in Tomato	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL POLYSACCHARIDE; BORATE ESTER; ARABIDOPSIS; MUTANT; DIMER; BIOSYNTHESIS; PATHWAYS; FUCOSE	L-Galactose (L-Gal), a monosaccharide involved in L-ascorbate and rhamnogalacturonan II (RG-II) biosynthesis in plants, is produced in the cytosol by a GDP-D-mannose 3,5-epimerase (GME). It has been recently reported that the partial inactivation of GME induced growth defects affecting both cell division and cell expansion (Gilbert, L., Alhagdow, M., Nunes-Nesi, A., Quemener, B., Guillon, F., Bouchet, B., Faurobert, M., Gouble, B., Page, D., Garcia, V., Petit, J., Stevens, R., Causse, M., Fernie, A. R., Lahaye, M., Rothan, C., and Baldet, P. (2009) Plant J. 60, 499-508). In the present study, we show that the silencing of the two GME genes in tomato leaves resulted in approximately a 60% decrease in terminal L-Gal content in the side chain A of RG-II as well as in a lower capacity of RG-II to perform in muro cross-linking. In addition, we show that unlike supplementation with L-Gal or ascorbate, supplementation of GME-silenced lines with boric acid was able to restore both the wild-type growth phenotype of tomato seedlings and an efficient in muro boron-mediated cross-linking of RG-II. Our findings suggest that developmental phenotypes in GME-deficient lines are due to the structural alteration of RG-II and further underline the crucial role of the cross-linking of RG-II in the formation of the pectic network required for normal plant growth and development.	[Voxeur, Aline; Driouich, Azeddine; Lerouge, Patrice] Univ Rouen, Inst Federatif Rech 23, Equipe Associee 4358, Lab Glycobiol & Matrice Extracellulaire Vegetale, F-76821 Mont St Aignan, France; [Rihouey, Christophe] Univ Rouen, Inst Federatif Rech 23, UMR 6270, F-76821 Mont St Aignan, France; [Gilbert, Louise; Rothan, Christophe; Baldet, Pierre] Univ Bordeaux, Inst Federatif Rech 103, Inst Natl Rech Agron, UMR Biol Fruit 619, F-33883 Villenave Dornon, France	Universite de Rouen Normandie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite de Rouen Normandie; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Lerouge, P (corresponding author), Univ Rouen, Lab Glyco MEV, UPRES EA 4358, IFRMP 23, F-76821 Mont St Aignan, France.	patrice.lerouge@univ-rouen.fr	Voxeur, Aline/O-7149-2015; Voxeur, Aline/C-1117-2011	Voxeur, Aline/0000-0001-9452-6756; Baldet, Pierre/0000-0001-7351-1803; ROTHAN, Christophe/0000-0002-6831-2823	University of Rouen	University of Rouen	This work was supported by the University of Rouen.	Ahn JW, 2006, J BIOL CHEM, V281, P13708, DOI 10.1074/jbc.M512403200; Alhagdow M, 2007, PLANT PHYSIOL, V145, P1408, DOI 10.1104/pp.107.106500; Delmas F, 2008, J EXP BOT, V59, P2639, DOI 10.1093/jxb/ern118; Doco T, 1997, CARBOHYD RES, V297, P181, DOI 10.1016/S0008-6215(96)00260-1; Fleischer A, 1999, PLANT PHYSIOL, V121, P829, DOI 10.1104/pp.121.3.829; GERWIG GJ, 1979, CARBOHYD RES, V77, P1, DOI 10.1016/S0008-6215(00)83788-X; Gilbert L, 2009, PLANT J, V60, P499, DOI 10.1111/j.1365-313X.2009.03972.x; Ishii T, 1999, J BIOL CHEM, V274, P13098, DOI 10.1074/jbc.274.19.13098; Ishii T, 2001, PLANT PHYSIOL, V126, P1698, DOI 10.1104/pp.126.4.1698; Johnson MA, 2004, GENETICS, V168, P971, DOI 10.1534/genetics.104.029447; Kobayashi M, 1996, PLANT PHYSIOL, V110, P1017, DOI 10.1104/pp.110.3.1017; Laing WA, 2007, P NATL ACAD SCI USA, V104, P9534, DOI 10.1073/pnas.0701625104; Noguchi K, 1997, PLANT PHYSIOL, V115, P901, DOI 10.1104/pp.115.3.901; O'Neill MA, 2004, ANNU REV PLANT BIOL, V55, P109, DOI 10.1146/annurev.arplant.55.031903.141750; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; ONeill MA, 1996, J BIOL CHEM, V271, P22923, DOI 10.1074/jbc.271.37.22923; Perez S, 2003, BIOCHIMIE, V85, P109, DOI 10.1016/S0300-9084(03)00053-1; Rayon C, 1999, PLANT PHYSIOL, V119, P725, DOI 10.1104/pp.119.2.725; Reiter WD, 2001, PLANT MOL BIOL, V47, P95, DOI 10.1023/A:1010671129803; Reuhs BL, 2004, PLANTA, V219, P147, DOI 10.1007/s00425-004-1205-x; Seveno M, 2009, PLANTA, V230, P947, DOI 10.1007/s00425-009-0996-1; SPELLMAN MW, 1983, CARBOHYD RES, V122, P131, DOI 10.1016/0008-6215(83)88413-4; Wolucka BA, 2007, PHYTOCHEMISTRY, V68, P2602, DOI 10.1016/j.phytochem.2007.08.034	23	40	43	2	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8014	8020		10.1074/jbc.M110.198614	http://dx.doi.org/10.1074/jbc.M110.198614			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21224383	Green Published, hybrid			2022-12-27	WOS:000288013300032
J	Zhu, XD; Zhuang, Y; Ben, JJ; Qian, LL; Huang, HP; Bai, H; Sha, JH; He, ZG; Chen, Q				Zhu, Xu-Dong; Zhuang, Yan; Ben, Jing-Jing; Qian, Ling-Ling; Huang, Han-Peng; Bai, Hui; Sha, Jia-Hao; He, Zhi-Gang; Chen, Qi			Caveolae-dependent Endocytosis Is Required for Class A Macrophage Scavenger Receptor-mediated Apoptosis in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; FOAM CELL-FORMATION; CYTOPLASMIC DOMAIN; LIPID UPTAKE; PLASMA-MEMBRANE; CLATHRIN; ATHEROSCLEROSIS; INTERNALIZATION; BINDING; CHOLESTEROL	SR-A (classAmacrophage scavenger receptor) is a transmembrane receptor that can bind many different ligands, including modified lipoproteins that are relevant to the development of vascular diseases. However, the precise endocytic pathways of SR-A/mediated ligands internalization are not fully characterized. In this study, we show that the SR-A/ligand complex can be endocytosed by both clathrin-and caveolae-dependent pathways. Internalizations of SR-A-lipoprotein (such as acLDL) complexes primarily go through clathrin-dependent endocytosis. In contrast, macrophage apoptosis triggered by SR-A-fucoidan internalization requires caveolae-dependent endocytosis. The caveolae-dependent process activates p38 kinase and JNK signaling, whereas the clathrin-mediated endocytosis elicits ERK signaling. Our results suggest that different SR-A endocytic pathways have distinct functional consequences due to the activation of different signaling cascades in macrophages.	[Zhu, Xu-Dong; Zhuang, Yan; Ben, Jing-Jing; Qian, Ling-Ling; Huang, Han-Peng; Bai, Hui; Chen, Qi] Nanjing Med Univ, Atherosclerosis Res Ctr, Key Lab Human Funct Genom, Nanjing 210029, Peoples R China; [Zhu, Xu-Dong; Sha, Jia-Hao; Chen, Qi] Nanjing Med Univ, Inst Reprod Med, Nanjing 210029, Peoples R China; [He, Zhi-Gang] Harvard Univ, Sch Med, Childrens Hosp, Div Neurosci, Boston, MA 02115 USA	Nanjing Medical University; Nanjing Medical University; Harvard University; Boston Children's Hospital; Harvard Medical School	Chen, Q (corresponding author), Nanjing Med Univ, Atherosclerosis Res Ctr, Key Lab Human Funct Genom, Nanjing 210029, Peoples R China.	qichen@njmu.edu.cn			National Natural Science Foundation of China [30730044, 81070120, 81000118]; National Basic Research Program (973) [2011CB503900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973)(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grants 30730044 and 81070120 and National Basic Research Program (973) Grant 2011CB503900 (to Q.C.) and National Natural Science Foundation of China Grant 81000118 (to J.-J.B.).	Aoki T, 1999, EXP CELL RES, V253, P629, DOI 10.1006/excr.1999.4652; Ben JJ, 2009, J MOL CELL CARDIOL, V47, P646, DOI 10.1016/j.yjmcc.2009.08.011; Bowdish DME, 2009, IMMUNOL REV, V227, P19, DOI 10.1111/j.1600-065X.2008.00728.x; Chang CW, 2009, J BIOL CHEM, V284, P33195, DOI 10.1074/jbc.M109.020586; Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; Chen Y, 2006, ARTERIOSCL THROM VAS, V26, P1317, DOI 10.1161/01.ATV.0000220171.50282.0c; De Donatis A, 2008, J BIOL CHEM, V283, P19948, DOI 10.1074/jbc.M709428200; Deng YB, 2003, CELL, V115, P61, DOI 10.1016/S0092-8674(03)00757-8; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Fong LG, 1999, J BIOL CHEM, V274, P36808, DOI 10.1074/jbc.274.51.36808; Frank PG, 2004, ARTERIOSCL THROM VAS, V24, P98, DOI 10.1161/01.ATV.0000101182.89118.E5; FREEMAN M, 1990, P NATL ACAD SCI USA, V87, P8810, DOI 10.1073/pnas.87.22.8810; Gargalovic P, 2003, J LIPID RES, V44, P1622, DOI 10.1194/jlr.M300140-JLR200; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Hartung A, 2006, MOL CELL BIOL, V26, P7791, DOI 10.1128/MCB.00022-06; Jones NL, 2000, ARTERIOSCL THROM VAS, V20, P773, DOI 10.1161/01.ATV.20.3.773; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kholodenko BN, 2002, TRENDS CELL BIOL, V12, P173, DOI 10.1016/S0962-8924(02)02251-1; Kim S, 2004, MICROB PATHOGENESIS, V37, P11, DOI 10.1016/j.micpath.2004.04.002; Kosswig N, 2003, J BIOL CHEM, V278, P34219, DOI 10.1074/jbc.M303465200; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Liao HS, 1999, ARTERIOSCL THROM VAS, V19, P1872, DOI 10.1161/01.ATV.19.8.1872; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Miaczynska M, 2008, J CELL BIOL, V180, P7, DOI 10.1083/jcb.200711073; Mills IG, 2007, SEMIN CELL DEV BIOL, V18, P459, DOI 10.1016/j.semcdb.2007.07.001; MOMMAASKIENHUIS AM, 1985, HISTOCHEMISTRY, V83, P29, DOI 10.1007/BF00495296; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; Morimoto K, 1999, BIOL PHARM BULL, V22, P1022; Murphy JE, 2005, ATHEROSCLEROSIS, V182, P1, DOI 10.1016/j.atherosclerosis.2005.03.036; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Porras A, 2004, MOL BIOL CELL, V15, P922, DOI 10.1091/mbc.E03-08-0592; Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084; Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Seimon TA, 2006, P NATL ACAD SCI USA, V103, P19794, DOI 10.1073/pnas.0609671104; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Tabas I, 2005, ARTERIOSCL THROM VAS, V25, P2255, DOI 10.1161/01.ATV.0000184783.04864.9f; Tabas I, 2004, CELL DEATH DIFFER, V11, pS12, DOI 10.1038/sj.cdd.4401444; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Wang XH, 2009, BBA-MOL CELL BIOL L, V1791, P76, DOI 10.1016/j.bbalip.2008.10.011; Wang XM, 2006, AM J RESP CELL MOL, V34, P434, DOI 10.1165/rcmb.2005-0376OC; Yao DY, 2002, MOL BIOL CELL, V13, P4001, DOI 10.1091/mbc.02-07-0104; Young A, 2007, SEMIN CELL DEV BIOL, V18, P448, DOI 10.1016/j.semcdb.2007.07.006	49	86	87	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8231	8239		10.1074/jbc.M110.145888	http://dx.doi.org/10.1074/jbc.M110.145888			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21205827	hybrid, Green Published			2022-12-27	WOS:000288013300053
J	Balakrishnan, L; Bambara, RA				Balakrishnan, Lata; Bambara, Robert A.			Eukaryotic Lagging Strand DNA Replication Employs a Multi-pathway Mechanism That Protects Genome Integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BASE EXCISION-REPAIR; CELL NUCLEAR ANTIGEN; POLYMERASE-BETA; FLAP ENDONUCLEASE-1; SACCHAROMYCES-CEREVISIAE; OKAZAKI FRAGMENTS; PRIMER REMOVAL; HUMAN FEN1; IN-VIVO; ACETYLATION	In eukaryotic nuclear DNA replication, one strand of DNA is synthesized continuously, but the other is made as Okazaki fragments that are later joined. Discontinuous synthesis is inherently more complex, and fragmented intermediates create risks for disruptions of genome integrity. Genetic analyses and biochemical reconstitutions indicate that several parallel pathways evolved to ensure that the fragments are made and joined with integrity. An RNA primer is removed from each fragment before joining by a process involving polymerase-dependent displacement into a single-stranded flap. Evidence in vitro suggests that, with most fragments, short flaps are displaced and efficiently cleaved. Some flaps can become long, but these are also removed to allow joining. Rarely, a flap can form structure, necessitating displacement of the entire fragment. There is now evidence that post-translational protein modification regulates the flow through the pathways to favor protection of genomic information in regions of actively transcribed chromatin.	[Balakrishnan, Lata; Bambara, Robert A.] Univ Rochester, Dept Biochem & Biophys, Sch Med & Dent, Rochester, NY 14642 USA	University of Rochester	Bambara, RA (corresponding author), Univ Rochester, Dept Biochem & Biophys, Sch Med & Dent, Rochester, NY 14642 USA.	robert_bambara@urmc.rochester.edu			National Institutes of Health [GM024441]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM024441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM024441 (to R. A. B.). This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Arezi B, 2000, TRENDS BIOCHEM SCI, V25, P572, DOI 10.1016/S0968-0004(00)01680-7; Ayyagari R, 2003, J BIOL CHEM, V278, P1618, DOI 10.1074/jbc.M209801200; Bae KH, 2003, NUCLEIC ACIDS RES, V31, P3006, DOI 10.1093/nar/gkg422; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Balakrishnan L, 2010, J BIOL CHEM, V285, P4398, DOI 10.1074/jbc.M109.086397; Bambara RA, 1997, J BIOL CHEM, V272, P4647, DOI 10.1074/jbc.272.8.4647; Bhakat KK, 2006, MOL CELL BIOL, V26, P1654, DOI 10.1128/MCB.26.5.1654-1665.2006; Bhakat KK, 2003, EMBO J, V22, P6299, DOI 10.1093/emboj/cdg595; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; BURGERS PMJ, 1991, J BIOL CHEM, V266, P22698; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Friedrich-Heineken E, 2003, J MOL BIOL, V328, P73, DOI 10.1016/S0022-2836(03)00270-5; Georgescu RE, 2009, EMBO J, V28, P2981, DOI 10.1038/emboj.2009.233; Gloor JW, 2010, J BIOL CHEM, V285, P34922, DOI 10.1074/jbc.M110.165902; Guo ZG, 2010, NAT CHEM BIOL, V6, P766, DOI [10.1038/NCHEMBIO.422, 10.1038/nchembio.422]; Hasan S, 2002, MOL CELL, V10, P1213, DOI 10.1016/S1097-2765(02)00745-1; Hasan S, 2001, MOL CELL, V7, P1221, DOI 10.1016/S1097-2765(01)00272-6; Henneke G, 2003, ONCOGENE, V22, P4301, DOI 10.1038/sj.onc.1206606; Henry RA, 2010, J BIOL CHEM, V285, P28496, DOI 10.1074/jbc.M110.131870; Johnson A, 2005, ANNU REV BIOCHEM, V74, P283, DOI 10.1146/annurev.biochem.73.011303.073859; Kornberg A., 1992, DNA REPLICATION; Kucherlapati M, 2002, P NATL ACAD SCI USA, V99, P9924, DOI 10.1073/pnas.152321699; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Lieber MR, 1997, BIOESSAYS, V19, P233, DOI 10.1002/bies.950190309; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; McInerney P, 2007, MOL CELL, V27, P527, DOI 10.1016/j.molcel.2007.06.019; Memisoglu A, 2000, MUTAT RES-FUND MOL M, V451, P39, DOI 10.1016/S0027-5107(00)00039-7; Muftuoglu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001918; Naryzhny SN, 2004, J BIOL CHEM, V279, P20194, DOI 10.1074/jbc.M312850200; OKAZAKI R, 1968, P NATL ACAD SCI USA, V59, P598, DOI 10.1073/pnas.59.2.598; Pandey M, 2009, NATURE, V462, P940, DOI 10.1038/nature08611; Pavlov YI, 2006, CURR BIOL, V16, P202, DOI 10.1016/j.cub.2005.12.002; Piersen CE, 1996, J BIOL CHEM, V271, P17811, DOI 10.1074/jbc.271.30.17811; Pike JE, 2010, J BIOL CHEM, V285, P41712, DOI 10.1074/jbc.M110.146894; Pursell ZF, 2007, SCIENCE, V317, P127, DOI 10.1126/science.1144067; Rossi ML, 2008, J BIOL CHEM, V283, P27483, DOI 10.1074/jbc.M804550200; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Ryu GH, 2004, NUCLEIC ACIDS RES, V32, P4205, DOI 10.1093/nar/gkh720; SAKABE K, 1966, BIOCHIM BIOPHYS ACTA, V129, P651, DOI 10.1016/0005-2787(66)90088-8; SETLOW P, 1972, J BIOL CHEM, V247, P224; Stewart JA, 2008, J BIOL CHEM, V283, P31356, DOI 10.1074/jbc.M805965200; Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x; TSURIMOTO T, 1990, NATURE, V346, P534, DOI 10.1038/346534a0; WAGA S, 1994, J BIOL CHEM, V269, P10923; Waga S, 1998, ANNU REV BIOCHEM, V67, P721, DOI 10.1146/annurev.biochem.67.1.721; Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5; Wilson SH, 1998, MUTAT RES-DNA REPAIR, V407, P203, DOI 10.1016/S0921-8777(98)00002-0; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Zheng L, 2008, MOL CELL, V32, P325, DOI 10.1016/j.molcel.2008.09.024; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599	53	38	38	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6865	6870		10.1074/jbc.R110.209502	http://dx.doi.org/10.1074/jbc.R110.209502			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177245	Green Published, hybrid			2022-12-27	WOS:000287737300001
J	Jerke, U; Rolle, S; Dittmar, G; Bayat, B; Santoso, S; Sporbert, A; Luft, F; Kettritz, R				Jerke, Uwe; Rolle, Susanne; Dittmar, Gunnar; Bayat, Behnaz; Santoso, Sentot; Sporbert, Anje; Luft, Friedrich; Kettritz, Ralph			Complement Receptor Mac-1 Is an Adaptor for NB1 (CD177)-mediated PR3-ANCA Neutrophil Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; MEMBRANE PROTEINASE-3 EXPRESSION; SYSTEMIC VASCULITIS; ANTIMYELOPEROXIDASE ANTIBODIES; WEGENERS-GRANULOMATOSIS; ANTIGEN PROTEINASE-3; SIGNAL-TRANSDUCTION; SURFACE EXPRESSION; IN-VIVO; GLOMERULONEPHRITIS	The glycosylphosphatidylinositol (GPI)-anchored neutrophil-specific receptor NB1 (CD177) presents the autoantigen proteinase 3 (PR3) on the membrane of a neutrophil subset. PR3-ANCA-activated neutrophils participate in small-vessel vasculitis. Since NB1 lacks an intracellular domain, we characterized components of the NB1 signaling complex that are pivotal for neutrophil activation. PR3-ANCA resulted in degranulation and superoxide production in the mNB1(pos)/PR3(high) neutrophils, but not in the mNB1(neg)/PR3(low) subset, whereas MPO-ANCA and fMLP caused similar responses. The NB1 signaling complex that was precipitated from plasma membranes contained the transmembrane receptor Mac-1 (CD11b/CD18) as shown by MS/MS analysis and immunoblotting. NB1 co-precipitation was less for CD11a and not detectable for CD11c. NB1 showed direct protein-protein interactions with both CD11b and CD11a by surface plasmon resonance analysis (SPR). However, when these integrins were presented as heterodimeric transmembrane proteins on transfected cells, only CD11b/CD18 (Mac-1)-transfected cells adhered to immobilized NB1 protein. This adhesion was inhibited by mAb against NB1, CD11b, and CD18. NB1, PR3, and Mac-1 were located within lipid rafts. In addition, confocal microscopy showed the strongest NB1 co-localization with CD11b and CD18 on the neutrophil. Stimulation with NB1-activating mAb triggered degranulation and superoxide production in mNB1(pos)/mPR3(high) neutrophils, and this effect was reduced using blocking antibodies to CD11b. CD11b blockade also inhibited PR3-ANCA-induced neutrophil activation, even when beta 2-integrin ligand-dependent signals were omitted. We establish the pivotal role of the NB1-Mac-1 receptor interaction for PR3-ANCA-mediated neutrophil activation.	[Jerke, Uwe; Rolle, Susanne; Luft, Friedrich; Kettritz, Ralph] Fac Med Charite, ECRC, D-13125 Berlin, Germany; [Dittmar, Gunnar; Sporbert, Anje] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Bayat, Behnaz; Santoso, Sentot] Univ Giessen, Inst Clin Immunol & Transfus Med, D-35385 Giessen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Justus Liebig University Giessen	Kettritz, R (corresponding author), Fac Med Charite, ECRC, Lindenberger Weg 80, D-13125 Berlin, Germany.	kettritz@charite.de	Dittmar, Gunnar/C-6333-2019; Dittmar, Gunnar/B-6383-2016	Dittmar, Gunnar/0000-0003-3647-8623; Dittmar, Gunnar/0000-0003-3647-8623; Jerke, Uwe/0000-0001-6887-8010; Luft, Friedrich/0000-0002-8635-1199; Kettritz, Ralph/0000-0001-5821-6718	Deutsche Forschungsgemeinschaft [DFG: KE 576/7-1]; Experimental and Clinical Research Center (ECRC) Berlin-Buch; Transregional Collaborative Research Center [SFB/TRR84]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Experimental and Clinical Research Center (ECRC) Berlin-Buch; Transregional Collaborative Research Center	This work was supported by the Deutsche Forschungsgemeinschaft (DFG: KE 576/7-1), and a grant from the Experimental and Clinical Research Center (ECRC) Berlin-Buch and from the Transregional Collaborative Research Center (SFB/TRR84) supported this study.	Bauer S, 2007, J LEUKOCYTE BIOL, V81, P458, DOI 10.1189/jlb.0806514; Bayat B, 2010, J IMMUNOL, V184, P3889, DOI 10.4049/jimmunol.0903136; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; BOHUSLAV J, 1995, J EXP MED, V181, P1381, DOI 10.1084/jem.181.4.1381; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; David A, 2003, J LEUKOCYTE BIOL, V74, P551, DOI 10.1189/jlb.1202624; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; FALK RJ, 1990, P NATL ACAD SCI USA, V87, P4115, DOI 10.1073/pnas.87.11.4115; FALK RJ, 1988, NEW ENGL J MED, V318, P1651, DOI 10.1056/NEJM198806233182504; HALBWACHSMECARELLI L, 1995, FEBS LETT, V374, P29, DOI 10.1016/0014-5793(95)01073-N; Hu N, 2009, ARTHRITIS RHEUM-US, V60, P1548, DOI 10.1002/art.24442; Kjeldsen L, 1999, J IMMUNOL METHODS, V232, P131, DOI 10.1016/S0022-1759(99)00171-4; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; Korkmaz B, 2008, J BIOL CHEM, V283, P35976, DOI 10.1074/jbc.M806754200; Kowalski MP, 2007, SCIENCE, V317, P130, DOI 10.1126/science.1142311; Little MA, 2005, BLOOD, V106, P2050, DOI 10.1182/blood-2005-03-0921; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Petty HR, 1996, IMMUNOL TODAY, V17, P209, DOI 10.1016/0167-5699(96)30013-3; Peyron P, 2000, J IMMUNOL, V165, P5186, DOI 10.4049/jimmunol.165.9.5186; Pfister H, 2004, BLOOD, V104, P1411, DOI 10.1182/blood-2004-01-0267; PICK E, 1981, J IMMUNOL METHODS, V46, P211, DOI 10.1016/0022-1759(81)90138-1; Pocock CF, 2001, BRIT J HAEMATOL, V113, P483, DOI 10.1046/j.1365-2141.2001.02779.x; Rarok AA, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000028642.26222.00; Sachs UJH, 2006, BLOOD, V107, P1217, DOI 10.1182/blood-2005-04-1744; Sachs UJH, 2007, J BIOL CHEM, V282, P23603, DOI 10.1074/jbc.M701120200; Santoso S, 2002, J EXP MED, V196, P679, DOI 10.1084/jem.20020267; SAVAGE COS, 1992, AM J PATHOL, V141, P335; Schreiber A, 2005, J AM SOC NEPHROL, V16, P2216, DOI 10.1681/ASN.2004070609; Schreiber A, 2004, KIDNEY INT, V65, P2172, DOI 10.1111/j.1523-1755.2004.00640.x; Schreiber A, 2003, J AM SOC NEPHROL, V14, P68, DOI 10.1097/01.ASN.0000040751.83734.D1; Schreiber A, 2006, J AM SOC NEPHROL, V17, P3355, DOI 10.1681/ASN.2006070718; Socher I, 2009, TRANSFUSION, V49, P943, DOI 10.1111/j.1537-2995.2008.02065.x; STOCKL J, 1995, J IMMUNOL, V154, P5452; VANDERWOUDE FJ, 1985, LANCET, V1, P425; von Vietinghoff S, 2008, CLIN EXP IMMUNOL, V152, P508, DOI 10.1111/j.1365-2249.2008.03663.x; von Vietinghoff S, 2007, BLOOD, V109, P4487, DOI 10.1182/blood-2006-10-055327; von Vietinghoff S, 2006, J AM SOC NEPHROL, V17, P3185, DOI 10.1681/ASN.2006050522; Watanabe T, 2002, BIOCHEM BIOPH RES CO, V294, P692, DOI 10.1016/S0006-291X(02)00538-7; Witko-Sarsat V, 1999, J AM SOC NEPHROL, V10, P1224; Xiao H, 2002, J CLIN INVEST, V110, P955, DOI 10.1172/JCI200215918; Xiao H, 2005, AM J PATHOL, V167, P39, DOI 10.1016/S0002-9440(10)62951-3	41	59	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7070	7081		10.1074/jbc.M110.171256	http://dx.doi.org/10.1074/jbc.M110.171256			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193407	hybrid, Green Published			2022-12-27	WOS:000287737300024
J	Kim, JH; Lee, JO; Lee, SK; Moon, JW; You, GY; Kim, SJ; Park, SH; Park, JM; Lim, SY; Suh, PG; Uhm, KO; Song, MS; Kim, HS				Kim, Ji Hae; Lee, Jung Ok; Lee, Soo Kyung; Moon, Ji Wook; You, Ga Young; Kim, Su Jin; Park, Sun-Hwa; Park, Ji Man; Lim, Se Young; Suh, Pann-Ghill; Uhm, Kyung-Ok; Song, Min Seok; Kim, Hyeon Soo			The Glutamate Agonist Homocysteine Sulfinic Acid Stimulates Glucose Uptake through the Calcium-dependent AMPK-p38 MAPK-Protein Kinase C zeta Pathway in Skeletal Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT PANCREATIC-ISLETS; DIABETES-MELLITUS; AMINO-ACIDS; VASCULAR-DISEASE; NMDA RECEPTOR; UP-REGULATION; FATTY-ACID; EXPRESSION; HYPERHOMOCYST(E)INEMIA; LOCALIZATION	Homocysteine sulfinic acid (HCSA) is a homologue of the amino acid cysteine and a selective metabotropic glutamate receptor (mGluR) agonist. However, the metabolic role of HCSA is poorly understood. In this study, we showed that HCSA and glutamate stimulated glucose uptake in C2C12 mouse myoblast cells and increased AMP-activated protein kinase (AMPK) phosphorylation. RT-PCR and Western blot analysis revealed that C2C12 expresses mGluR5. HCSA transiently increased the intracellular calcium concentration. Although alpha-methyl-4-carboxyphenylglycine, a metabotropic glutamate receptor antagonist, blocked the action of HCSA in intracellular calcium response and AMPK phosphorylation, 6-cyano-7-nitroquinoxaline-2,3-dione, an AMPA antagonist, did not exhibit such effects. Knockdown of mGluR5 with siRNA blocked HCSA-induced AMPK phosphorylation. Pretreatment of cells with STO-609, a calmodulin-dependent protein kinase kinase (CaMKK) inhibitor, blocked HCSA-induced AMPK phosphorylation, and knockdown of CaMKK blocked HCSA-induced AMPK phosphorylation. In addition, HCSA activated p38 mitogen-activated protein kinase (MAPK). Expression of dominant-negative AMPK suppressed HCSA-mediated phosphorylation of p38 MAPK, and inhibition of AMPK and p38 MAPK blocked HCSA-induced glucose uptake. Phosphorylation of protein kinase C zeta (PKC zeta) was also increased by HCSA. Pharmacologic inhibition or knockdown of p38 MAPK blocked HCSA-induced PKC zeta phosphorylation, and knockdown of PKC zeta suppressed the HCSA-induced increase of cell surface GLUT4. The stimulatory effect of HCSA on cell surface GLUT4 was impaired in FITC-conjugated PKC zeta siRNA-transfected cells. Together, the above results suggest that HCSA may have a beneficial role in glucose metabolism in skeletal muscle cells via stimulation of AMPK.	[Kim, Ji Hae; Lee, Jung Ok; Lee, Soo Kyung; Moon, Ji Wook; You, Ga Young; Kim, Su Jin; Park, Sun-Hwa; Kim, Hyeon Soo] Korea Univ, Coll Med, Dept Anat, Seoul 136701, South Korea; [Park, Ji Man; Lim, Se Young; Suh, Pann-Ghill] Ulsan Natl Inst Sci & Technol, Sch Nanobiosci & Chem Engn, Ulsan 689798, South Korea; [Uhm, Kyung-Ok] Natl Inst Geriatr & Gerontol, Dept Alzheimers Dis Res, Aichi 4748522, Japan; [Song, Min Seok] Cornell Univ, Weil Med Coll, Dept Med Genet, New York, NY 10021 USA	Korea University; Korea University Medicine (KU Medicine); Ulsan National Institute of Science & Technology (UNIST); National Center for Geriatrics & Gerontology; Cornell University	Kim, HS (corresponding author), Korea Univ, Coll Med, Dept Anat, Anam Dong 5 Ga, Seoul 136701, South Korea.	anatomykim@korea.ac.kr	Suh, Pann-Ghill/F-3610-2010	Song, Minseok/0000-0001-9561-8505	Korean Government [2010-0011053]	Korean Government(Korean Government)	This work was supported by Grant 2010-0011053 from the National Research Foundation of Korea, funded by the Korean Government. We declare that there are no conflicts of interest.	Ai H, 2002, AM J PHYSIOL-ENDOC M, V282, pE1291, DOI 10.1152/ajpendo.00167.2001; Antonescu CN, 2005, ENDOCRINOLOGY, V146, P3773, DOI 10.1210/en.2005-0404; Bennett MR, 1999, NEUROCHEM INT, V35, P269, DOI 10.1016/S0197-0186(99)00068-6; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Brunelli G, 2005, P NATL ACAD SCI USA, V102, P8752, DOI 10.1073/pnas.0500530102; CARLTON SM, 1995, NEUROSCI LETT, V197, P25, DOI 10.1016/0304-3940(95)11889-5; DO KQ, 1988, J NEURAL TRANSM, V72, P185, DOI 10.1007/BF01243418; Durand P, 2001, LAB INVEST, V81, P645, DOI 10.1038/labinvest.3780275; Frati C, 2000, J CELL PHYSIOL, V183, P364, DOI 10.1002/(SICI)1097-4652(200006)183:3<364::AID-JCP9>3.3.CO;2-O; Gill SS, 1998, BRAIN RES BULL, V46, P429, DOI 10.1016/S0361-9230(98)00012-4; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gu YC, 2000, J BIOL CHEM, V275, P34252, DOI 10.1074/jbc.M004520200; Hankey GJ, 2001, CURR OPIN NEUROL, V14, P95, DOI 10.1097/00019052-200102000-00015; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; HENIN N, 1995, FASEB J, V9, P541, DOI 10.1096/fasebj.9.7.7737463; Hofmann MA, 1997, DIABETES CARE, V20, P1880, DOI 10.2337/diacare.20.12.1880; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Joseph A, 2008, NEUROSCIENCE, V156, P298, DOI 10.1016/j.neuroscience.2008.07.022; KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431; Kingston AE, 1998, NEUROPHARMACOLOGY, V37, P277, DOI 10.1016/S0028-3908(98)00018-5; Kinnamon SC, 2009, ANN NY ACAD SCI, V1170, P55, DOI 10.1111/j.1749-6632.2009.04106.x; Levine J, 2002, AM J PSYCHIAT, V159, P1790, DOI 10.1176/appi.ajp.159.10.1790; Makinde AO, 1997, CIRC RES, V80, P482, DOI 10.1161/01.RES.80.4.482; McCully KS, 1996, NAT MED, V2, P386, DOI 10.1038/nm0496-386; Miller JW, 2000, NUTRITION, V16, P675, DOI 10.1016/S0899-9007(00)00307-5; Munshi MN, 1996, METABOLISM, V45, P133, DOI 10.1016/S0026-0495(96)90211-5; Sajan MP, 2006, J BIOL CHEM, V281, P17466, DOI 10.1074/jbc.M510803200; SANTHOSHKUMAR CR, 1994, ANAL BIOCHEM, V220, P249, DOI 10.1006/abio.1994.1335; Shi Q, 2003, J PHARMACOL EXP THER, V305, P131, DOI 10.1124/jpet.102.047092; Storto M, 2001, J ENDOCRINOL, V170, P71, DOI 10.1677/joe.0.1700071; Storto M, 2000, J NEUROIMMUNOL, V109, P112, DOI 10.1016/S0165-5728(00)00269-1; Thompson GA, 1996, PHARMACOL THERAPEUT, V72, P25, DOI 10.1016/S0163-7258(96)00097-6; Tomiyama M, 2005, MOL BRAIN RES, V136, P275, DOI 10.1016/j.molbrainres.2005.02.003; Tong QC, 2002, AM J PHYSIOL-ENDOC M, V282, pE1324, DOI 10.1152/ajpendo.00460.2001; Trudeau F, 2004, EUR J PHARMACOL, V490, P177, DOI 10.1016/j.ejphar.2004.02.055; Weaver CD, 1996, J BIOL CHEM, V271, P12977, DOI 10.1074/jbc.271.22.12977; Wijesekara N, 2006, AM J PHYSIOL-ENDOC M, V290, pE1276, DOI 10.1152/ajpendo.00573.2005; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	39	27	28	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7567	7576		10.1074/jbc.M110.149328	http://dx.doi.org/10.1074/jbc.M110.149328			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193401	Green Published, hybrid			2022-12-27	WOS:000287737300070
J	Manna, SK; Gangadharan, C; Edupalli, D; Raviprakash, N; Navneetha, T; Mahali, S; Thoh, M				Manna, Sunil K.; Gangadharan, Charitha; Edupalli, Damodar; Raviprakash, Nune; Navneetha, Thota; Mahali, Sidharth; Thoh, Maikho			Ras Puts the Brake on Doxorubicin-mediated Cell Death in p53-expressing Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSCRIPTION FACTOR KAPPAB; K-RAS; RELA PHOSPHORYLATION; P53 INDUCTION; CYCLE ARREST; TUMOR-CELLS; DNA-DAMAGE; MUTANT P53; APOPTOSIS	Doxorubicin is one of the most effective molecules used in the treatment of various tumors. Contradictory reports often open windows to understand the role of p53 tumor suppressor in doxorubicin-mediated cell death. In this report, we provide evidences that doxorubicin induced more cell death in p53-negative tumor cells. Several cells, having p53 basal expression, showed increase in p53 DNA binding upon doxorubicin treatment. Doxorubicin induced cell death in p53-positive cells through expression of p53-dependent genes and activation of caspases and caspase-mediated cleavage of cellular proteins. Surprisingly, in p53-negative cells, doxorubicin-mediated cell death was more aggressive (faster and intense). Doxorubicin increased the amount of Fas ligand (FasL) by enhancing activator protein (AP) 1 DNA binding in both p53-positive and p53-negative cells, but the basal expression of Fas was higher in p53-negative cells. Anti-FasL antibody considerably protected doxorubicin-mediated cell death in both types of cells. Activation of caspases was faster in p53-negative cells upon doxorubicin treatment. In contrast, the basal expression of Ras oncoprotein was higher in p53-positive cells, which might increase the basal expression of Fas in these cells. Overexpression of Ras decreased the amount of Fas in p53-negative cells, thereby decreasing doxorubicin-mediated aggressive cell death. Overall, this study will help to understand the much studied chemotherapeutic drug, doxorubicin-mediated cell signaling cascade, that leads to cell death in p53-positive and -negative cells. High basal expression of Fas might be an important determinant in doxorubicin-mediated cell death in p53-negative cells.	[Manna, Sunil K.; Gangadharan, Charitha; Edupalli, Damodar; Raviprakash, Nune; Navneetha, Thota; Mahali, Sidharth; Thoh, Maikho] Ctr DNA Fingerprinting & Diagnost, Immunol Lab, Hyderabad 500001, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Manna, SK (corresponding author), Ctr DNA Fingerprinting & Diagnost, Immunol Lab, Hyderabad 500001, Andhra Pradesh, India.	manna@cdfd.org.in			Department of Science and Technology (DST), Government of India; Centre for DNA Fingerprinting and Diagnostics (CDFD); Council for Scientific and Industrial Research (CSIR) Government of India	Department of Science and Technology (DST), Government of India(Department of Science & Technology (India)); Centre for DNA Fingerprinting and Diagnostics (CDFD); Council for Scientific and Industrial Research (CSIR) Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant from the Department of Science and Technology (DST), Government of India, and a core grant from the Centre for DNA Fingerprinting and Diagnostics (CDFD). This work was also supported by Council for Scientific and Industrial Research (CSIR), Government of India fellowships (to C. G., S. M., and M. T.).	BLUM RH, 1974, ANN INTERN MED, V80, P249, DOI 10.7326/0003-4819-80-2-249; Bose JS, 2009, J MED CHEM, V52, P3184, DOI 10.1021/jm8015766; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Fang L, 2001, EMBO J, V20, P1931, DOI 10.1093/emboj/20.8.1931; Faris M, 1998, MOL CELL BIOL, V18, P5414, DOI 10.1128/MCB.18.9.5414; Fischer Uwe M, 2006, Interact Cardiovasc Thorac Surg, V5, P531, DOI 10.1510/icvts.2006.130765; Fleischer A, 2004, FEBS LETT, V557, P283, DOI 10.1016/S0014-5793(03)01519-9; Gangadharan C, 2010, BREAST CANCER RES TR, V120, P671, DOI 10.1007/s10549-009-0493-z; Gangadharan C, 2009, J CELL BIOCHEM, V107, P203, DOI 10.1002/jcb.22115; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; HARRIS JR, 1993, CANC PRINCIPLES PRAC, P1264; Harwood FG, 2000, J BIOL CHEM, V275, P10023, DOI 10.1074/jbc.275.14.10023; Hui L, 2006, ONCOGENE, V25, P7305, DOI 10.1038/sj.onc.1209735; Konishi H, 2007, CANCER RES, V67, P8460, DOI 10.1158/0008-5472.CAN-07-0108; Kotamraju S, 2002, J BIOL CHEM, V277, P17179, DOI 10.1074/jbc.M111604200; L'Ecuyer T, 2006, AM J PHYSIOL-HEART C, V291, pH1273, DOI 10.1152/ajpheart.00738.2005; Lee SH, 2009, NEOPLASIA, V11, P22, DOI 10.1593/neo.81006; Lee SW, 2000, P NATL ACAD SCI USA, V97, P8302, DOI 10.1073/pnas.150024397; Levina V, 2008, INT J CANCER, V123, P2031, DOI 10.1002/ijc.23732; Manna SK, 2007, CELL DEATH DIFFER, V14, P158, DOI 10.1038/sj.cdd.4401929; Manna SK, 2006, J CELL PHYSIOL, V207, P195, DOI 10.1002/jcp.20555; Manna SK, 2010, J BIOL CHEM, V285, P22318, DOI 10.1074/jbc.M110.131797; Manna SK, 2010, J BIOL CHEM, V285, P11617, DOI 10.1074/jbc.M109.094961; Manna SK, 2009, MOL IMMUNOL, V46, P1340, DOI 10.1016/j.molimm.2008.11.014; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Ongusaha PP, 2003, EMBO J, V22, P1289, DOI 10.1093/emboj/cdg129; Peli J, 1999, EMBO J, V18, P1824, DOI 10.1093/emboj/18.7.1824; Raghavendra PB, 2007, APOPTOSIS, V12, P307, DOI 10.1007/s10495-006-0626-3; Shimokawa I., 2004, GERIATRIC GERONTOL I, V4, pS149, DOI [10.1111/j.1447-0594.2004.00183.x, DOI 10.1111/J.1447-0594.2004.00183.X]; Shiohara M, 1996, J CELL PHYSIOL, V166, P568, DOI 10.1002/(SICI)1097-4652(199603)166:3<568::AID-JCP11>3.0.CO;2-3; Sreenivasan Y, 2003, BIOCHEM PHARMACOL, V66, P2223, DOI 10.1016/j.bcp.2003.07.010; Thoh M, 2010, J BIOL CHEM, V285, P5888, DOI 10.1074/jbc.M109.065847; Tomita Y, 2006, J BIOL CHEM, V281, P8600, DOI 10.1074/jbc.M507611200; Ujhazy P, 2003, CANCER IMMUNOL IMMUN, V52, P463, DOI 10.1007/s00262-003-0391-x; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Yaswen P, 2007, CELL, V128, P233, DOI 10.1016/j.cell.2007.01.005; Yeh YC, 2007, BIOCHEM PHARMACOL, V74, P969, DOI 10.1016/j.bcp.2007.06.031; Zalcenstein A, 2003, ONCOGENE, V22, P5667, DOI 10.1038/sj.onc.1206724; Zhu JY, 1998, CELL, V93, P851, DOI 10.1016/S0092-8674(00)81445-2	40	11	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7339	7347		10.1074/jbc.M110.191916	http://dx.doi.org/10.1074/jbc.M110.191916			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21156795	Green Published, hybrid			2022-12-27	WOS:000287737300050
J	Ryu, JH; Li, SH; Park, HS; Park, JW; Lee, B; Chun, YS				Ryu, Ji-Hye; Li, Shan-Hua; Park, Hyoung-Sook; Park, Jong-Wan; Lee, ByungLan; Chun, Yang-Sook			Hypoxia-inducible Factor alpha Subunit Stabilization by NEDD8 Conjugation Is Reactive Oxygen Species-dependent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL COMPLEX-III; UBIQUITIN-LIKE PROTEIN; FACTOR 1-ALPHA; HIF-ALPHA; FACTOR-I; CANCER; FACTOR-1-ALPHA; DEGRADATION; UBIQUITYLATION; HYDROXYLATION	Hypoxia-inducible factor alpha proteins (HIF-alpha s) are regulated oxygen dependently and transactivate numerous genes essential for cellular adaptation to hypoxia. NEDD8, a member of the ubiquitin-like family, covalently binds to its substrate proteins, and thus, regulates their stabilities and functions. In the present study, we examined the possibility that the HIF signaling is regulated by the neddylation. HIF-1 alpha expression and activity were inhibited by knocking down APPBP1 E1 enzyme for NEDD8 conjugation but enhanced by ectopically expressing NEDD8. HIF-1 alpha and HIF-2 alpha were identified to be covalently modified by NEDD8. NEDD8 stabilized HIF-1 alpha even in normoxia and further increased its level in hypoxia, which also occurred in von Hippel-Lindau (VHL) protein-or p53-null cell lines. The HIF-1 alpha-stabilizing effect of NEDD8 was diminished by antioxidants and mitochondrial respiratory chain blockers. This suggests that the NEDD8 effect is concerned with reactive oxygen species driven from mitochondria rather than with the prolyl hydroxylase (PHD)/VHL-dependent oxygen-sensing system. Based on these findings, we propose that NEDD8 is an ancillary player to regulate the stability of HIF-1 alpha. Furthermore, given the positive role played by HIF-alpha s in cancer promotion, the NEDD8 conjugation process could be a potential target for cancer therapy.	[Ryu, Ji-Hye; Li, Shan-Hua; Park, Hyoung-Sook; Chun, Yang-Sook] Seoul Natl Univ, Coll Med, Dept Physiol, Ischem Hypox Dis Inst, Seoul 110799, South Korea; [Park, Jong-Wan] Seoul Natl Univ, Dept Pharmacol, Coll Med, Ischem Hypox Dis Inst, Seoul 110799, South Korea; [Lee, ByungLan] Seoul Natl Univ, Dept Anat, Coll Med, Ischem Hypox Dis Inst, Seoul 110799, South Korea; [Li, Shan-Hua] Xiamen Univ, Dept Basic Med Sci, Coll Med, Xiamen 361005, Fujian, Peoples R China	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Xiamen University	Chun, YS (corresponding author), Seoul Natl Univ, Coll Med, Dept Physiol, Ischem Hypox Dis Inst, 28 Yongon Dong, Seoul 110799, South Korea.	chunys@snu.ac.kr	Chun, Yang Sook/J-2789-2012; Park, Jong-Wan/J-2758-2012; Lee, Byung Lan/J-5577-2012		Ministry of Education, Science and Technology [2009-0090188]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (Grant 2009-0090188).	Adams J, 2002, CURR OPIN ONCOL, V14, P628, DOI 10.1097/00001622-200211000-00007; An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Belozerov VE, 2005, ANTI-CANCER DRUG, V16, P901, DOI 10.1097/01.cad.0000180116.85912.69; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chun YS, 2002, BIOCHEM J, V362, P71, DOI 10.1042/0264-6021:3620071; Gong LM, 1999, J BIOL CHEM, V274, P12036, DOI 10.1074/jbc.274.17.12036; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jaffray EG, 2006, METHODS, V38, P35, DOI 10.1016/j.ymeth.2005.07.020; Katschinski DM, 2004, CELL PHYSIOL BIOCHEM, V14, P351, DOI 10.1159/000080345; Kawanami D, 2009, J BIOL CHEM, V284, P20522, DOI 10.1074/jbc.M109.025346; Koh MY, 2008, MOL CELL BIOL, V28, P7081, DOI 10.1128/MCB.00773-08; KUMAR S, 1993, BIOCHEM BIOPH RES CO, V195, P393, DOI 10.1006/bbrc.1993.2056; Liakopoulos D, 1999, P NATL ACAD SCI USA, V96, P5510, DOI 10.1073/pnas.96.10.5510; Lim JH, 2006, MOL PHARMACOL, V70, P1856, DOI 10.1124/mol.106.028076; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Mansfield KD, 2005, CELL METAB, V1, P393, DOI 10.1016/j.cmet.2005.05.003; Meehan KL, 2002, PROSTATE, V50, P54, DOI 10.1002/pros.10032; Miyauchi Y, 2008, J BIOL CHEM, V283, P16622, DOI 10.1074/jbc.M710599200; Mori F, 2005, NEUROPATH APPL NEURO, V31, P53, DOI 10.1111/j.1365-2990.2004.00603.x; Ohh M, 2002, EMBO REP, V3, P177, DOI 10.1093/embo-reports/kvf028; Ravi R, 2000, GENE DEV, V14, P34; Russell RC, 2008, EMBO REP, V9, P486, DOI 10.1038/embor.2008.19; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Shin DH, 2008, BLOOD, V111, P3131, DOI 10.1182/blood-2007-11-120576; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; SULAN RI, 2006, NEOPLASIA, V8, P956; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016	32	63	66	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6963	6970		10.1074/jbc.M110.188706	http://dx.doi.org/10.1074/jbc.M110.188706			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193393	Green Published, hybrid			2022-12-27	WOS:000287737300012
J	Vionnet, C; Roubaty, C; Ejsing, CS; Knudsen, J; Conzelmann, A				Vionnet, Christine; Roubaty, Carole; Ejsing, Christer S.; Knudsen, Jens; Conzelmann, Andreas			Yeast Cells Lacking All Known Ceramide Synthases Continue to Make Complex Sphingolipids and to Incorporate Ceramides into Glycosylphosphatidylinositol (GPI) Anchors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE ATPASE; CHAIN FATTY-ACIDS; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; HEAT-STRESS; ENDOPLASMIC-RETICULUM; SPHINGOID BASE; AUR1 GENE; PROTEINS; AUREOBASIDIN	In yeast, the inositolphosphorylceramides mostly contain C26:0 fatty acids. Inositolphosphorylceramides were considered to be important for viability because the inositolphosphorylceramide synthase AUR1 is essential. However, lcb1 Delta cells, unable to make sphingoid bases and inositolphosphorylceramides, are viable if they harbor SLC1-1, a gain of function mutation in the 1-acyl-glycerol-3-phosphate acyltransferase SLC1. SLC1-1 allows the incorporation of C26:0 fatty acids into phosphatidylinositol (PI), thus generating PI '', an abnormal, C26-containing PI, presumably acting as surrogate for inositolphosphorylceramide. Here we show that the lethality of the simultaneous deletion of the known ceramide synthases LAG1/LAC1/LIP1 and YPC1/YDC1 can be rescued by the expression of SLC1-1 or the overexpression of AUR1. Moreover, lag1 Delta lac1 Delta ypc1 Delta ydc1 Delta (4 Delta) quadruple mutants have been reported to be viable in certain genetic backgrounds but to still make some abnormal uncharacterized inositol-containing sphingolipids. Indeed, we find that 4 Delta quadruple mutants make substantial amounts of unphysiological inositolphosphorylphytosphingosines but that they also still make small amounts of normal inositolphosphorylceramides. Moreover, 4 Delta strains incorporate exogenously added sphingoid bases into inositolphosphorylceramides, indicating that these cells still possess an unknown pathway allowing the synthesis of ceramides. 4 Delta cells also still add quite normal amounts of ceramides to glycosylphosphatidylinositol anchors. Synthesis of inositolphosphorylceramides and inositolphosphorylphytosphingosines is operated by Aur1p and is essential for growth of all 4 Delta cells unless they contain SLC1-1. PI '', however, is made without the help of Aur1p. Furthermore, mannosylation of PI '' is required for the survival of sphingolipid-deficient strains, which depend on SLC1-1. In contrast to lcb1 Delta SLC1-1, 4 Delta SLC1-1 cells grow at 37 degrees C but remain thermosensitive at 44 degrees C.	[Vionnet, Christine; Roubaty, Carole; Conzelmann, Andreas] Univ Fribourg, Dept Med, CH-1700 Fribourg, Switzerland; [Ejsing, Christer S.; Knudsen, Jens] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense M, Denmark	University of Fribourg; University of Southern Denmark	Conzelmann, A (corresponding author), Univ Fribourg, Dept Med, Chemin Musee 5, CH-1700 Fribourg, Switzerland.	andreas.conzelmann@unifr.ch	Ejsing, Christer S/R-5922-2016	Ejsing, Christer S./0000-0003-4963-0276	Swiss National Science Foundation [31-67188.01]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Grant 31-67188.01 from the Swiss National Science Foundation.	Barz WP, 1999, MOL BIOL CELL, V10, P1043, DOI 10.1091/mbc.10.4.1043; Benghezal M, 2007, J BIOL CHEM, V282, P30845, DOI 10.1074/jbc.M702719200; Cerantola V, 2007, BIOCHEM J, V401, P205, DOI 10.1042/BJ20061128; Cerantola V, 2009, MOL MICROBIOL, V71, P1523, DOI 10.1111/j.1365-2958.2009.06628.x; Chung NJ, 2001, J BIOL CHEM, V276, P35614, DOI 10.1074/jbc.M105653200; Dickson RC, 1999, BBA-MOL CELL BIOL L, V1438, P305, DOI 10.1016/S1388-1981(99)00068-2; Dickson RC, 2002, BBA-MOL CELL BIOL L, V1583, P13, DOI 10.1016/S1388-1981(02)00210-X; Dickson RC, 1997, J BIOL CHEM, V272, P30196, DOI 10.1074/jbc.272.48.30196; Dickson RC, 2008, J LIPID RES, V49, P909, DOI 10.1194/jlr.R800003-JLR200; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; DMELLO NP, 1994, J BIOL CHEM, V269, P15451; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Endo M, 1997, ANTIMICROB AGENTS CH, V41, P672, DOI 10.1128/AAC.41.3.672; FANKHAUSER C, 1993, J BIOL CHEM, V268, P26365; Friant S, 2003, EMBO J, V22, P3783, DOI 10.1093/emboj/cdg375; Fujita M, 2008, BBA-GEN SUBJECTS, V1780, P410, DOI 10.1016/j.bbagen.2007.08.009; Gaigg B, 2005, J BIOL CHEM, V280, P22515, DOI 10.1074/jbc.M413472200; Gaigg B, 2006, J BIOL CHEM, V281, P34135, DOI 10.1074/jbc.M603791200; Ghugtyal V, 2007, MOL MICROBIOL, V65, P1493, DOI 10.1111/j.1365-2958.2007.05883.x; Guillas I, 2000, METHOD ENZYMOL, V312, P506; Guillas I, 2001, EMBO J, V20, P2655, DOI 10.1093/emboj/20.11.2655; Hansen J, 2003, FEMS YEAST RES, V4, P323, DOI 10.1016/S1567-1356(03)00178-8; HANSON BA, 1980, J LIPID RES, V21, P309; HashidaOkado T, 1996, MOL GEN GENET, V251, P236; Hearn JD, 2003, J BIOL CHEM, V278, P3679, DOI 10.1074/jbc.M209170200; HEIDLER SA, 1995, ANTIMICROB AGENTS CH, V39, P2765, DOI 10.1128/AAC.39.12.2765; Jenkins GM, 1997, J BIOL CHEM, V272, P32566, DOI 10.1074/jbc.272.51.32566; Jiang JC, 1998, GENOME RES, V8, P1259, DOI 10.1101/gr.8.12.1259; LESTER RL, 1993, J BIOL CHEM, V268, P845; Lisman Q, 2004, J BIOL CHEM, V279, P1020, DOI 10.1074/jbc.M306119200; Mao CG, 2000, J BIOL CHEM, V275, P6876, DOI 10.1074/jbc.275.10.6876; Matmati N, 2009, J BIOL CHEM, V284, P8241, DOI 10.1074/jbc.M900004200; Meier KD, 2006, MOL BIOL CELL, V17, P1164, DOI 10.1091/mbc.E05-11-1039; Mir SS, 2009, MOL CELL BIOL, V29, P187, DOI 10.1128/MCB.02271-07; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MUNN AL, 1994, J CELL BIOL, V127, P373, DOI 10.1083/jcb.127.2.373; Nagiec MM, 1998, J BIOL CHEM, V273, P19437, DOI 10.1074/jbc.273.31.19437; Nagiec MM, 1997, J BIOL CHEM, V272, P9809, DOI 10.1074/jbc.272.15.9809; NAGIEC MM, 1993, J BIOL CHEM, V268, P22156; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; PATTON JL, 1992, J BACTERIOL, V174, P7180, DOI 10.1128/jb.174.22.7180-7184.1992; PINTO WJ, 1992, J BACTERIOL, V174, P2565, DOI 10.1128/jb.174.8.2565-2574.1992; Pittet M, 2006, GLYCOBIOLOGY, V16, P155, DOI 10.1093/glycob/cwj043; Reggiori F, 1998, J BIOL CHEM, V273, P30550, DOI 10.1074/jbc.273.46.30550; Reggiori F, 1997, EMBO J, V16, P3506, DOI 10.1093/emboj/16.12.3506; Sato K, 2009, MOL BIOL CELL, V20, P4444, DOI 10.1091/mbc.E09-03-0235; Schneiter R, 2004, BIOCHEM J, V381, P941, DOI 10.1042/BJ20040320; Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Sims KJ, 2004, BIOCHEM CELL BIOL, V82, P45, DOI 10.1139/o03-086; Thevissen K, 2005, FEBS LETT, V579, P1973, DOI 10.1016/j.febslet.2005.02.043; Uemura S, 2003, J BIOL CHEM, V278, P45049, DOI 10.1074/jbc.M305498200; Umemura M, 2007, MOL BIOL CELL, V18, P4304, DOI 10.1091/mbc.E07-05-0482; Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562; Voth WP, 2003, YEAST, V20, P985, DOI 10.1002/yea.1018; Wells GB, 1998, J BIOL CHEM, V273, P7235, DOI 10.1074/jbc.273.13.7235; Winter E, 2002, TRENDS BIOCHEM SCI, V27, P381, DOI 10.1016/S0968-0004(02)02154-0; Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824; Zhu YH, 2006, J BIOL CHEM, V281, P19830, DOI 10.1074/jbc.M601425200	59	17	17	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6769	6779		10.1074/jbc.M110.176875	http://dx.doi.org/10.1074/jbc.M110.176875			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21173150	hybrid, Green Published			2022-12-27	WOS:000287476400084
J	Yadav, S; Aneja, R; Kumar, P; Datt, M; Sinha, S; Sahni, G				Yadav, Suman; Aneja, Rachna; Kumar, Prakash; Datt, Manish; Sinha, Sonali; Sahni, Girish			Identification through Combinatorial Random and Rational Mutagenesis of a Substrate-interacting Exosite in the gamma Domain of Streptokinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDE CHLOROMETHYL KETONES; BLOOD-COAGULATION PROTEINASES; PLASMINOGEN-ACTIVATOR COMPLEX; MACROMOLECULAR SUBSTRATE; FLUORESCENCE PROBES; CATALYTIC DOMAIN; RECOMBINANT STAPHYLOKINASE; CONFORMATIONAL ACTIVATION; AFFINITY-CHROMATOGRAPHY; SPECTROSCOPIC PROBES	To identify new structure-function correlations in the gamma domain of streptokinase, mutants were generated by error-prone random mutagenesis of the gamma domain and its adjoining region in the beta domain followed by functional screening specifically for substrate plasminogen activation. Single-site mutants derived from various multipoint mutation clusters identified the importance of discrete residues in the gamma domain that are important for substrate processing. Among the various residues, aspartate at position 328 was identified as critical for substrate human plasminogen activation through extensive mutagenesis of its side chain, namely D328R, D328H, D328N, and D328A. Other mutants found to be important in substrate plasminogen activation were, namely, R319H, N339S, K334A, K334E, and L335Q. When examined for their 1:1 interaction with human plasmin, these mutants were found to retain the native-like high affinity for plasmin and also to generate amidolytic activity with partner plasminogen in a manner similar to wild type streptokinase. Moreover, cofactor activities of the mutants precomplexed with plasmin against microplasminogen as the substrate as well as in silico modeling studies suggested that the region 315-340 of the gamma domain interacts with the serine protease domain of the macromolecular substrate. Overall, our results identify the presence of a substrate specific exosite in the gamma domain of streptokinase.	[Yadav, Suman; Aneja, Rachna; Kumar, Prakash; Datt, Manish; Sinha, Sonali; Sahni, Girish] Inst Microbial Technol, CSIR, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Sahni, G (corresponding author), Inst Microbial Technol, CSIR, Sector 39-A, Chandigarh 160036, India.	sahni@imtech.res.in	Datt, Manish/AAD-6989-2019; Sinha, Prakash Kumar/K-6048-2013	Sinha, Prakash Kumar/0000-0002-2067-5676; Datt, Manish/0000-0002-9578-4113	Council of Scientific and Industrial Research, India	Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	This study was largely supported with intramural funds from the Council of Scientific and Industrial Research, India.	Aneja R, 2009, J BIOL CHEM, V284, P32642, DOI 10.1074/jbc.M109.046573; BAJAJ AP, 1977, J BIOL CHEM, V252, P492; Bock PE, 2007, J THROMB HAEMOST, V5, P81, DOI 10.1111/j.1538-7836.2007.02496.x; BOCK PE, 1993, METHOD ENZYMOL, V222, P478; Bock PE, 1996, J BIOL CHEM, V271, P1072, DOI 10.1074/jbc.271.2.1072; BOCK PE, 1992, J BIOL CHEM, V267, P14963; BOCK PE, 1988, BIOCHEMISTRY-US, V27, P6633, DOI 10.1021/bi00417a063; BOCK PE, 1992, J BIOL CHEM, V267, P14974; Boskovic DS, 2000, J BIOL CHEM, V275, P38561, DOI 10.1074/jbc.M006637200; Boxrud PD, 2000, J BIOL CHEM, V275, P14579, DOI 10.1074/jbc.275.19.14579; Boxrud PD, 2000, BIOCHEMISTRY-US, V39, P13974, DOI 10.1021/bi000594i; Boxrud PD, 2004, J BIOL CHEM, V279, P36633, DOI 10.1074/jbc.M405264200; Boxrud PD, 2004, J BIOL CHEM, V279, P36642, DOI 10.1074/jbc.M405265200; Boxrud PD, 2001, J BIOL CHEM, V276, P26084, DOI 10.1074/jbc.M101966200; CHASE T, 1969, BIOCHEMISTRY-US, V8, P2212, DOI 10.1021/bi00833a063; Chaudhary A, 1999, PROTEIN SCI, V8, P2791; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; COLLEN D, 1993, EUR J BIOCHEM, V216, P307, DOI 10.1111/j.1432-1033.1993.tb18147.x; COLLEN D, 1993, J BIOL CHEM, V268, P8284; Dahiya M, 2005, FEBS LETT, V579, P1565, DOI 10.1016/j.febslet.2005.01.066; DAMASCHUN G, 1992, EUR BIOPHYS J BIOPHY, V20, P355; DAWSON KM, 1994, BIOCHEMISTRY-US, V33, P12042, DOI 10.1021/bi00206a005; DERENZO EC, 1967, J BIOL CHEM, V242, P533; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Dhar J, 2002, J BIOL CHEM, V277, P13257, DOI 10.1074/jbc.M108422200; Fay WP, 1998, THROMB HAEMOSTASIS, V79, P985; HUANG TT, 1989, MOL MICROBIOL, V3, P197, DOI 10.1111/j.1365-2958.1989.tb01808.x; Huntington JA, 2005, J THROMB HAEMOST, V3, P1861, DOI 10.1111/j.1538-7836.2005.01363.x; JACKSON KW, 1982, BIOCHEMISTRY-US, V21, P6620, DOI 10.1021/bi00269a001; Jespers L, 1998, BIOCHEMISTRY-US, V37, P6380, DOI 10.1021/bi972807i; Kim DM, 2002, BIOCHEM BIOPH RES CO, V290, P585, DOI 10.1006/bbrc.2001.6238; Lin LF, 1996, BIOCHEMISTRY-US, V35, P16879, DOI 10.1021/bi961531w; MALKE H, 1984, MOL GEN GENET, V196, P360, DOI 10.1007/BF00328072; MALKE H, 1984, P NATL ACAD SCI-BIOL, V81, P3557, DOI 10.1073/pnas.81.11.3557; MCCLINTOCK DK, 1971, BIOCHEM BIOPH RES CO, V43, P694, DOI 10.1016/0006-291X(71)90670-X; Mundada LV, 2003, J BIOL CHEM, V278, P24421, DOI 10.1074/jbc.M301825200; Nihalani D, 1997, PROTEIN SCI, V6, P1284, DOI 10.1002/pro.5560060616; Nihalani D, 1995, BIOCHEM BIOPH RES CO, V217, P1245, DOI 10.1006/bbrc.1995.2902; Nihalani D, 1998, PROTEIN SCI, V7, P637, DOI 10.1002/pro.5560070313; Parrado J, 1996, PROTEIN SCI, V5, P693; Parry MAA, 2000, TRENDS BIOCHEM SCI, V25, P53, DOI 10.1016/S0968-0004(99)01521-2; Parry MAA, 1998, NAT STRUCT BIOL, V5, P917, DOI 10.1038/2359; PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0; Pratap J, 1996, BIOCHEM BIOPH RES CO, V227, P303, DOI 10.1006/bbrc.1996.1504; RADEK JT, 1989, J BIOL CHEM, V264, P9915; RADEK JT, 1993, METHOD ENZYMOL, V223, P145; REDDY KNN, 1972, J BIOL CHEM, V247, P1683; REED GL, 1995, BIOCHEMISTRY-US, V34, P10266, DOI 10.1021/bi00032a021; Reed GL, 1999, P NATL ACAD SCI USA, V96, P8879, DOI 10.1073/pnas.96.16.8879; ROBBINS KC, 1981, METHOD ENZYMOL, V80, P379; ROBBINS KC, 1983, THROMB HAEMOSTASIS, V50, P787; RODRIGUEZ P, 1995, EUR J BIOCHEM, V229, P83, DOI 10.1111/j.1432-1033.1995.0083l.x; Sazonova IY, 2001, J BIOL CHEM, V276, P12609, DOI 10.1074/jbc.M009265200; SCHICK LA, 1973, BIOCHEMISTRY-US, V12, P4315, DOI 10.1021/bi00746a003; SUMMARIA L, 1982, BIOCHEMISTRY-US, V21, P2056, DOI 10.1021/bi00538a012; Sundram V, 2003, J BIOL CHEM, V278, P30569, DOI 10.1074/jbc.M303799200; Tharp AC, 2009, J BIOL CHEM, V284, P19511, DOI 10.1074/jbc.M109.005512; Wakeham N, 2002, PROTEIN ENG, V15, P753, DOI 10.1093/protein/15.9.753; Wang SG, 1999, BIOCHEMISTRY-US, V38, P5232, DOI 10.1021/bi981915h; Wang SG, 2000, EUR J BIOCHEM, V267, P3994, DOI 10.1046/j.1432-1327.2000.01434.x; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; Wang XQ, 1999, FEBS LETT, V459, P85, DOI 10.1016/S0014-5793(99)01214-4; Wang XQ, 2000, J MOL BIOL, V295, P903, DOI 10.1006/jmbi.1999.3397; WOHL RC, 1980, J BIOL CHEM, V255, P2005; WOHL RC, 1984, BIOCHEMISTRY-US, V23, P3799, DOI 10.1021/bi00312a002; Wu DH, 2001, J BIOL CHEM, V276, P15025, DOI 10.1074/jbc.M005935200; Yadav S, 2008, BBA-PROTEINS PROTEOM, V1784, P1310, DOI 10.1016/j.bbapap.2008.05.013; YOUNG KC, 1995, J BIOL CHEM, V270, P29601, DOI 10.1074/jbc.270.49.29601	68	10	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6458	6469		10.1074/jbc.M110.152355	http://dx.doi.org/10.1074/jbc.M110.152355			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21169351	Green Published, hybrid			2022-12-27	WOS:000287476400056
J	Wang, A; Savas, U; Stout, CD; Johnson, EF				Wang, An; Savas, Uzen; Stout, C. David; Johnson, Eric F.			Structural Characterization of the Complex between alpha-Naphthoflavone and Human Cytochrome P450 1B1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGSTROM RESOLUTION; BINDING; CYP1B1; INHIBITORS; P4502C5; ADAPTATIONS; METABOLISM; INDUCTION; OXIDATION; ENZYMES	The atomic structure of human P450 1B1 was determined by x-ray crystallography to 2.7 angstrom resolution with alpha-naphthoflavone (ANF) bound in the active site cavity. Although the amino acid sequences of human P450s 1B1 and 1A2 have diverged significantly, both enzymes exhibit narrow active site cavities, which underlie similarities in their substrate profiles. Helix I residues adopt a relatively flat conformation in both enzymes, and a characteristic distortion of helix F places Phe(231) in 1B1 and Phe(226) in 1A2 in similar positions for pi-pi stacking with ANF. ANF binds in a distinctly different orientation in P450 1B1 from that observed for 1A2. This reflects, in part, divergent conformations of the helix B'-C loop that are stabilized by different hydrogen-bonding interactions in the two enzymes. Additionally, differences between the two enzymes for other amino acids that line the edges of the cavity contribute to distinct orientations of ANF in the two active sites. Thus, the narrow cavity is conserved in both P450 subfamily 1A and P450 subfamily 1B with sequence divergence around the edges of the cavity that modify substrate and inhibitor binding. The conservation of these P450 1B1 active site amino acid residues across vertebrate species suggests that these structural features are conserved.	[Stout, C. David] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Stout, CD (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd,MB8, La Jolla, CA 92037 USA.	dave@scripps.edu; johnson@scripps.edu			National Institutes of Health [GM031001]; United States Department of Energy, Office of Biological and Environmental Research; National Center for Research Resources; NIGMS of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031001] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM031001 (to E.F.J.).; Portions of the research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the United States Department of Energy, Office of Biological and Environmental Research, and by the National Center for Research Resources, Biomedical Technology Program, and NIGMS of the National Institutes of Health.	ANDRIES MJ, 1990, MOL PHARMACOL, V37, P990; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAUER E, 1995, CHEM RES TOXICOL, V8, P136, DOI 10.1021/tx00043a018; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bruno RD, 2007, BIOORGAN MED CHEM, V15, P5047, DOI 10.1016/j.bmc.2007.05.046; Buters JTM, 1999, P NATL ACAD SCI USA, V96, P1977, DOI 10.1073/pnas.96.5.1977; Choudhary D, 2009, XENOBIOTICA, V39, P606, DOI 10.1080/00498250903000198; Chun YJ, 2003, MED RES REV, V23, P657, DOI 10.1002/med.10050; Cosme J, 2000, J BIOL CHEM, V275, P2545, DOI 10.1074/jbc.275.4.2545; Goldstone HMH, 2006, J MOL EVOL, V62, P708, DOI 10.1007/s00239-005-0134-z; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Lee AJ, 2003, ENDOCRINOLOGY, V144, P3382, DOI 10.1210/en.2003-0192; Luch A, 1998, CHEM RES TOXICOL, V11, P686, DOI 10.1021/tx970236p; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Petrek M, 2007, STRUCTURE, V15, P1357, DOI 10.1016/j.str.2007.10.007; Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Sansen S, 2007, J BIOL CHEM, V282, P14348, DOI 10.1074/jbc.M611692200; Schoch GA, 2004, J BIOL CHEM, V279, P9497, DOI 10.1074/jbc.M312516200; Shimada T, 1998, CHEM RES TOXICOL, V11, P1048, DOI 10.1021/tx980090+; Sissung TM, 2006, MOL CANCER RES, V4, P135, DOI 10.1158/1541-7786.MCR-05-0101; Thomas JH, 2007, PLOS GENET, V3, P720, DOI 10.1371/journal.pgen.0030067; Tu Y, 2008, DRUG METAB DISPOS, V36, P2371, DOI 10.1124/dmd.108.022640; Vasiliou V, 2008, ANNU REV PHARMACOL, V48, P333, DOI 10.1146/annurev.pharmtox.48.061807.154729; vonWachenfeldt C, 1997, ARCH BIOCHEM BIOPHYS, V339, P107, DOI 10.1006/abbi.1996.9859; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Wester MR, 2003, BIOCHEMISTRY-US, V42, P9335, DOI 10.1021/bi034556l; Wester MR, 2003, BIOCHEMISTRY-US, V42, P6370, DOI 10.1021/bi0273922; Williams PA, 2000, MOL CELL, V5, P121, DOI 10.1016/S1097-2765(00)80408-6; Zheng WC, 2003, ARCH BIOCHEM BIOPHYS, V416, P53, DOI 10.1016/S0003-9861(03)00282-0	31	127	130	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5736	5743		10.1074/jbc.M110.204420	http://dx.doi.org/10.1074/jbc.M110.204420			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21147782	Green Published, hybrid			2022-12-27	WOS:000287230600082
J	Jawhar, S; Wirths, O; Schilling, S; Graubner, S; Demuth, HU; Bayer, TA				Jawhar, Sadim; Wirths, Oliver; Schilling, Stephan; Graubner, Sigrid; Demuth, Hans-Ulrich; Bayer, Thomas A.			Overexpression of Glutaminyl Cyclase, the Enzyme Responsible for Pyroglutamate A beta Formation, Induces Behavioral Deficits, and Glutaminyl Cyclase Knock-out Rescues the Behavioral Phenotype in 5XFAD Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; PEPTIDES IN-VITRO; ALZHEIMERS-DISEASE; TERMINAL HETEROGENEITY; TRANSGENIC MOUSE; SYNDROME BRAINS; PLAQUE CORE; DEPOSITS; MODEL; NEURODEGENERATION	Pyroglutamate-modified A beta (A beta pE3-42) peptides are gaining considerable attention as potential key players in the pathology of Alzheimer disease (AD) due to their abundance in AD brain, high aggregation propensity, stability, and cellular toxicity. Overexpressing A beta pE3-42 induced a severe neuron loss and neurological phenotype in TBA2 mice. In vitro and in vivo experiments have recently proven that the enzyme glutaminyl cyclase (QC) catalyzes the formation of A beta pE3-42. The aim of the present work was to analyze the role of QC in an AD mouse model with abundant A beta pE3-42 formation. 5XFAD mice were crossed with transgenic mice expressing human QC (hQC) under the control of the Thy1 promoter. 5XFAD/hQC bigenic mice showed significant elevation in TBS, SDS, and formic acid-soluble A beta pE3-42 peptides and aggregation in plaques. In 6-month-old 5XFAD/hQC mice, a significant motor and working memory impairment developed compared with 5XFAD. The contribution of endogenous QC was studied by generating 5XFAD/QC-KO mice (mouse QC knock-out). 5XFAD/QC-KO mice showed a significant rescue of the wild-type mice behavioral phenotype, demonstrating the important contribution of endogenous mouse QC and transgenic overexpressed QC. These data clearly demonstrate that QC is crucial for modulating A beta pE3-42 levels in vivo and prove on a genetic base the concept that reduction of QC activity is a promising new therapeutic approach for AD.	[Schilling, Stephan; Demuth, Hans-Ulrich] Probiodrug AG, D-06120 Halle, Saale, Germany; [Jawhar, Sadim; Wirths, Oliver; Bayer, Thomas A.] Univ Med Goettingen, Dept Mol Psychiat, D-37075 Gottingen, Germany; [Jawhar, Sadim; Wirths, Oliver; Bayer, Thomas A.] Univ Med Goettingen, Alzheimer PhD Grad Sch, D-37075 Gottingen, Germany; [Graubner, Sigrid] Ingenium Pharmaceut GmbH, D-82152 Munich, Germany	Vivoryon Therapeutics	Demuth, HU (corresponding author), Probiodrug AG, Weinbergweg 22, D-06120 Halle, Saale, Germany.	Hans-Ulrich.Demuth@probiodrug.de; tbayer@gwdg.de	Wirths, Oliver/C-7342-2019	Wirths, Oliver/0000-0002-4115-0334	German Federal Department of Education, Science and Technology [3013185]	German Federal Department of Education, Science and Technology	This work was supported by the German Federal Department of Education, Science and Technology, Grant 3013185 to a collaborative consortium led by H.-U. D.'s group, including T. A. B.'s team.	Breyhan H, 2009, ACTA NEUROPATHOL, V117, P677, DOI 10.1007/s00401-009-0539-7; Casas C, 2004, AM J PATHOL, V165, P1289, DOI 10.1016/S0002-9440(10)63388-3; Cynis H, 2008, BIOCHEMISTRY-US, V47, P7405, DOI 10.1021/bi800250p; Cynis H, 2006, BBA-PROTEINS PROTEOM, V1764, P1618, DOI 10.1016/j.bbapap.2006.08.003; GOREVIC PD, 1986, J NEUROPATH EXP NEUR, V45, P647, DOI 10.1097/00005072-198611000-00004; Guntert A, 2006, NEUROSCIENCE, V143, P461, DOI 10.1016/j.neuroscience.2006.08.027; Harigaya Y, 2000, BIOCHEM BIOPH RES CO, V276, P422, DOI 10.1006/bbrc.2000.3490; Hartlage-Rubsamen M, 2009, INT J DEV NEUROSCI, V27, P825, DOI 10.1016/j.ijdevneu.2009.08.007; He WL, 1999, BIOCHEMISTRY-US, V38, P10871, DOI 10.1021/bi990563r; Hosoda R, 1998, J NEUROPATH EXP NEUR, V57, P1089, DOI 10.1097/00005072-199811000-00012; Iwatsubo T, 1996, AM J PATHOL, V149, P1823; Jawhar S, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.027; Kuo YM, 1997, BIOCHEM BIOPH RES CO, V237, P188, DOI 10.1006/bbrc.1997.7083; Kuo YM, 1998, BBA-MOL BASIS DIS, V1406, P291, DOI 10.1016/S0925-4439(98)00014-3; Kuo YM, 2001, J BIOL CHEM, V276, P12991, DOI 10.1074/jbc.M007859200; Maeda J, 2007, J NEUROSCI, V27, P10957, DOI 10.1523/JNEUROSCI.0673-07.2007; Marcello A, 2011, NEUROBIOL AGING, V32, P1379, DOI 10.1016/j.neurobiolaging.2009.08.011; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Miravalle L, 2005, BIOCHEMISTRY-US, V44, P10810, DOI 10.1021/bi0508237; MORI H, 1992, J BIOL CHEM, V267, P17082; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; Piccini A, 2007, ARCH NEUROL-CHICAGO, V64, P738, DOI 10.1001/archneur.64.5.738; PIKE CJ, 1995, J BIOL CHEM, V270, P23895, DOI 10.1074/jbc.270.41.23895; Portelius E, 2010, ACTA NEUROPATHOL, V120, P185, DOI 10.1007/s00401-010-0690-1; Russo C, 1997, FEBS LETT, V409, P411, DOI 10.1016/S0014-5793(97)00564-4; Russo C, 2002, J NEUROCHEM, V82, P1480, DOI 10.1046/j.1471-4159.2002.01107.x; Russo C, 2001, NEUROBIOL DIS, V8, P173, DOI 10.1006/nbdi.2000.0357; Saido TC, 1996, NEUROSCI LETT, V215, P173, DOI 10.1016/0304-3940(96)12970-0; Schilling S, 2004, FEBS LETT, V563, P191, DOI 10.1016/S0014-5793(04)00300-X; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2006, BIOCHEMISTRY-US, V45, P12393, DOI 10.1021/bi0612667; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; SELKOE DJ, 1986, J NEUROCHEM, V46, P1820; Sevalle J, 2009, J NEUROCHEM, V109, P248, DOI 10.1111/j.1471-4159.2009.05950.x; Stephan A, 2009, FEBS J, V276, P6522, DOI 10.1111/j.1742-4658.2009.07337.x; Tekirian TL, 1998, J NEUROPATH EXP NEUR, V57, P76, DOI 10.1097/00005072-199801000-00009; Wirths O, 2010, J NEURAL TRANSM, V117, P85, DOI 10.1007/s00702-009-0314-x; Wirths O, 2009, ACTA NEUROPATHOL, V118, P487, DOI 10.1007/s00401-009-0557-5	40	73	79	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4454	4460		10.1074/jbc.M110.185819	http://dx.doi.org/10.1074/jbc.M110.185819			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21148560	Green Published, hybrid			2022-12-27	WOS:000286975700045
J	Kapoor, N; Galang, G; Marban, E; Cho, HC				Kapoor, Nidhi; Galang, Giselle; Marban, Eduardo; Cho, Hee Cheol			Transcriptional Suppression of Connexin43 by TBX18 Undermines Cell-Cell Electrical Coupling in Postnatal Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION CHANNELS; PACEMAKER FUNCTION; CONDUCTION SYSTEM; SINOATRIAL NODE; CARDIAC-PACEMAKER; HUMAN HEART; EXPRESSION; TURNOVER; DIFFERENTIATION; HETEROGENEITY	T-box transcription factors figure prominently in embryonic cardiac cell lineage specifications. Mesenchymal precursor cells expressing Tbx18 give rise to the heart's pacemaker, the sinoatrial node (SAN). We sought to identify targets of TBX18 transcriptional regulation in the heart by forced adenoviral overexpression in postnatal cardiomyocytes. Neonatal rat cardiomyocytes (NRCMs) transduced with GFP showed sarcolemmal, punctate Cx43 expression. In contrast, TBX18-transduced NRCMs exhibited sparse Cx43 expression. Both the transcript and protein levels of Cx43 were greatly down-regulated within 2 days of TBX18 transduction. Direct injection of TBX18 in the guinea pig heart in vivo inhibited Cx43 expression. The repressor activity of TBX18 on Cx43 was highly specific; protein levels of Cx45 and Cx40, which comprise the main gap junctions in the SAN and conduction system, were unchanged by TBX18. A reporter-based promoter assay demonstrated that TBX18 directly represses the Cx43 promoter. Phenotypically, TBX18-NRCMs exhibited slowed intercellular calcein dye transfer kinetics (421 +/- 54 versus control 127 +/- 43 ms). Intracellular Ca2+ oscillations in control NRCM monolayers were highly synchronized. In contrast, TBX18 overexpression led to asynchronous Ca2+ oscillations, demonstrating reduced cell-cell coupling. Decreased coupling led to slow electrical propagation; conduction velocity in TBX18 NRCMs slowed by more than 50% relative to control (2.9 +/- 0.5 versus 14.3 +/- 0.9 cm/s). Taken together, TBX18 specifically and directly represses Cx43 transcript and protein levels. Cx43 suppression leads to significant electrical uncoupling, but the preservation of other gap junction proteins supports slow action potential propagation, recapitulating a key phenotypic hallmark of the SAN.	[Kapoor, Nidhi; Galang, Giselle; Marban, Eduardo; Cho, Hee Cheol] Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Cho, HC (corresponding author), Cedars Sinai Heart Inst, 8700 Beverly Blvd,1090 Davis Bldg, Los Angeles, CA 90048 USA.	ChoHC@cshs.org	Marban, Eduardo/GWC-8514-2022		Heart Rhythm Society	Heart Rhythm Society	Supported by a fellowship from the Heart Rhythm Society.	Bakker ML, 2008, CIRC RES, V102, P1340, DOI 10.1161/CIRCRESAHA.107.169565; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; Brown DD, 2005, DEVELOPMENT, V132, P553, DOI 10.1242/dev.01596; BURT JM, 1991, AM J PHYSIOL, V260, pC439, DOI 10.1152/ajpcell.1991.260.3.C439; BURT JM, 1988, P NATL ACAD SCI USA, V85, P3431, DOI 10.1073/pnas.85.10.3431; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Chandler NJ, 2009, CIRCULATION, V119, P1562, DOI 10.1161/CIRCULATIONAHA.108.804369; Chatterjee B, 2005, DEV DYNAM, V233, P890, DOI 10.1002/dvdy.20426; Christoffels VM, 2010, CIRC RES, V106, P240, DOI 10.1161/CIRCRESAHA.109.205419; Christoffels VM, 2009, NATURE, V458, pE8, DOI 10.1038/nature07916; Coppen SR, 1999, J HISTOCHEM CYTOCHEM, V47, P907, DOI 10.1177/002215549904700708; DAVIS LM, 1995, J CARDIOVASC ELECTR, V6, P813, DOI 10.1111/j.1540-8167.1995.tb00357.x; Elzarrad MK, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-20; Farin HF, 2007, J BIOL CHEM, V282, P25748, DOI 10.1074/jbc.M703724200; Fedorov VV, 2009, CIRC RES, V104, P915, DOI 10.1161/CIRCRESAHA.108.193193; Hoogaars WMH, 2007, CELL MOL LIFE SCI, V64, P646, DOI 10.1007/s00018-007-6518-z; Hoogaars WMH, 2007, GENE DEV, V21, P1098, DOI 10.1101/gad.416007; Joung Boyoung, 2009, Korean Circ J, V39, P217, DOI 10.4070/kcj.2009.39.6.217; JOYNER RW, 1986, BIOPHYS J, V50, P1157, DOI 10.1016/S0006-3495(86)83559-7; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; Leaf DE, 2008, CIRC RES, V103, P1001, DOI 10.1161/CIRCRESAHA.107.168997; Leutenegger A, 2007, FEBS J, V274, P2496, DOI 10.1111/j.1742-4658.2007.05785.x; Maltsev VA, 2008, CARDIOVASC RES, V77, P274, DOI 10.1093/cvr/cvm058; McNally EM, 2009, CIRC RES, V104, P285, DOI 10.1161/CIRCRESAHA.109.193680; MOMMERSTEEG MT, 2010, CARDIOVASC RES; MORENO AP, 1995, AM J PHYSIOL-CELL PH, V268, pC356, DOI 10.1152/ajpcell.1995.268.2.C356; OKITA K, 2008, SCIENCE; Saffitz JE, 2000, CIRC RES, V87, P835, DOI 10.1161/01.RES.87.10.835; Sekar RB, 2009, CIRC RES, V104, P355, DOI 10.1161/CIRCRESAHA.108.178335; Singh MK, 2005, DEVELOPMENT, V132, P2697, DOI 10.1242/dev.01854; Snarr BS, 2007, CIRC RES, V101, P971, DOI 10.1161/CIRCRESAHA.107.162206; Valiunas V, 2000, CIRC RES, V86, pE42, DOI 10.1161/01.RES.86.2.e42; Valiunas V, 2002, J GEN PHYSIOL, V119, P147, DOI 10.1085/jgp.119.2.147; Verheijck EE, 2001, CARDIOVASC RES, V52, P40, DOI 10.1016/S0008-6363(01)00364-9; Vinogradova TM, 2005, ANN NY ACAD SCI, V1047, P138, DOI 10.1196/annals.1341.013; Vozzi C, 1999, J MOL CELL CARDIOL, V31, P991, DOI 10.1006/jmcc.1999.0937; WADE MH, 1986, SCIENCE, V232, P525, DOI 10.1126/science.3961495; Wiese C, 2009, CIRC RES, V104, P388, DOI 10.1161/CIRCRESAHA.108.187062; Yang BF, 2007, NAT MED, V13, P486, DOI 10.1038/nm1569; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	40	52	54	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 22	2011	286	16					14073	14079		10.1074/jbc.M110.185298	http://dx.doi.org/10.1074/jbc.M110.185298			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	750NW	21205823	Green Published, hybrid			2022-12-27	WOS:000289556200030
J	Gunawardena, HP; Huang, Y; Kenjale, R; Wang, HY; Xie, L; Chen, XA				Gunawardena, Harsha P.; Huang, Yi; Kenjale, Roma; Wang, Haiyang; Xie, Ling; Chen, Xian			Unambiguous Characterization of Site-specific Phosphorylation of Leucine-rich Repeat Fli-I-interacting Protein 2 (LRRFIP2) in Toll-like Receptor 4 (TLR4)-mediated Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSFER DISSOCIATION; COLLISION-INDUCED DISSOCIATION; PROTEOMIC APPROACH; SEQUENCE-ANALYSIS; MASS; IDENTIFICATION; FRAGMENTATION; PATHWAYS; ACCURATE; COMPLEX	In the TLR4 signaling pathways, we previously characterized a signal regulator, LRRFIP2, that modulates the time course-dependent changes in NF-kappa B activity through its dynamic interaction with the TLR adaptor protein, MyD88. However, little is known about the driving force behind the LPS-inducible dynamics between LRRFIP2 and MyD88. We have therefore designed a multiplex label-free quantitative proteomics method to investigate dynamic changes of LRRFIP2 phosphorylation upon LPS stimulation. Given our observation that LRRFIP2 binds to MyD88 through its serine-rich domain in which most of serine residues have the propensity to be phosphorylated, we used collision-activated dissociation- and electron transfer dissociation-based methods in a complementary manner to unambiguously localize phosphorylation sites in the peptides constituting the serine-rich domain. Among 23 phosphorylation sites identified and first quantified by the label-free approach and then verified by the AACT/SILAC (amino acid-coded tagging/stable isotope labeling in cell culture)-based quantitation method, phosphorylation at serine 202 showed a significant LPS-induced dynamic change during the full-course cellular response to LPS stimulation. The substitution of serine 202 with nonphosphorylated residues by site-directed mutagenesis resulted in a weakened LRRFIP2-MyD88 interaction and a concurrently reduced activity in downstream NF-kappa B. Taking these results together, phosphorylation at serine 202 was found to regulate the dynamics of the LRRFIP2-MyD88 interaction, which in turn modulated the strength and duration of TLR4 signaling. Strategically, we have demonstrated the importance of precise identification of the biologically relevant phosphorylation site(s) using comprehensive mass spectrometry-based quantitative proteomics approaches in guiding downstream biological characterization experiments, which could otherwise be both time-and cost-consuming for a large number of phosphorylation possibilities.	[Gunawardena, Harsha P.; Chen, Xian] Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA; [Huang, Yi; Kenjale, Roma; Wang, Haiyang; Xie, Ling; Chen, Xian] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Chen, XA (corresponding author), Univ N Carolina, Program Mol Biol & Biotechnol, Chapel Hill, NC 27599 USA.	xianc@email.unc.edu			National Institutes of Health [1R01A1064806-01A2]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded, in whole or in part, by National Institutes of Health Grant 1R01A1064806-01A2.	AMANKWA LN, 1995, PROTEIN SCI, V4, P113; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boersema PJ, 2009, J MASS SPECTROM, V44, P861, DOI 10.1002/jms.1599; Chen X, 2000, ANAL CHEM, V72, P1134, DOI 10.1021/ac9911600; Dai PG, 2009, J IMMUNOL, V182, P3450, DOI 10.4049/jimmunol.0802260; Du YC, 2006, MOL CELL PROTEOMICS, V5, P1033, DOI 10.1074/mcp.M500327-MCP200; DUNNE A, 2003, SCI STKE, pRE3, DOI DOI 10.1126/STKE.2003.171.RE3; Faux MC, 1996, TRENDS BIOCHEM SCI, V21, P312, DOI 10.1016/0968-0004(96)10040-2; Gu S, 2008, PROTEOMICS, V8, P3061, DOI 10.1002/pmic.200700715; Gunawardena HP, 2006, ANAL CHEM, V78, P3788, DOI 10.1021/ac060164j; Gunawardena HP, 2005, J AM CHEM SOC, V127, P12627, DOI 10.1021/ja0526057; Hatao F, 2008, FEMS IMMUNOL MED MIC, V53, P260, DOI 10.1111/j.1574-695X.2008.00425.x; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Kandasamy K, 2009, ANAL CHEM, V81, P7170, DOI 10.1021/ac9006107; KREBS EG, 1994, TRENDS BIOCHEM SCI, V19, P439, DOI 10.1016/0968-0004(94)90125-2; Ladner RD, 1996, J BIOL CHEM, V271, P7752, DOI 10.1074/jbc.271.13.7752; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Mann M, 2002, TRENDS BIOTECHNOL, V20, P261, DOI 10.1016/S0167-7799(02)01944-3; McAlister GC, 2007, ANAL CHEM, V79, P3525, DOI 10.1021/ac070020k; Molina H, 2008, ANAL CHEM, V80, P4825, DOI 10.1021/ac8007785; O'Neill LAJ, 2003, BIOCHEM SOC T, V31, P643, DOI 10.1042/BST0310643; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Palumbo AM, 2008, ANAL CHEM, V80, P9735, DOI 10.1021/ac801768s; Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400; RESING KA, 1995, BIOCHEMISTRY-US, V34, P9477, DOI 10.1021/bi00029a024; Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Syka JEP, 2004, P NATL ACAD SCI USA, V101, P9528, DOI 10.1073/pnas.0402700101; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang TY, 2005, J PROTEOME RES, V4, P941, DOI 10.1021/pr050031z; WANG YK, 1993, J BIOL CHEM, V268, P14269; Wolf-Yadlin A, 2007, P NATL ACAD SCI USA, V104, P5860, DOI 10.1073/pnas.0608638104; YIP TT, 1992, FEBS LETT, V308, P149, DOI 10.1016/0014-5793(92)81264-M; Zhu HN, 2002, RAPID COMMUN MASS SP, V16, P2115, DOI 10.1002/rcm.831; Zhu HN, 2002, ANAL CHEM, V74, P1687, DOI 10.1021/ac010853p; Zubarev RA, 1999, J AM CHEM SOC, V121, P2857, DOI 10.1021/ja981948k	43	19	21	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					10897	10910		10.1074/jbc.M110.168179	http://dx.doi.org/10.1074/jbc.M110.168179			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21220426	Green Published, hybrid			2022-12-27	WOS:000288797100002
J	Boivin, S; Hart, DJ				Boivin, Stephane; Hart, Darren J.			Interaction of the Influenza A Virus Polymerase PB2 C-terminal Region with Importin alpha Isoforms Provides Insights into Host Adaptation and Polymerase Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNAL; RNA-POLYMERASE; KARYOPHERIN ALPHA; CRYSTALLOGRAPHIC ANALYSIS; FUNCTIONAL DOMAINS; STRUCTURAL BASIS; MOLECULAR-BASIS; BINDING-SITE; SUBUNIT PB2; AVIAN-LIKE	In the adaptation of avian viruses to mammalian hosts, mutations in the viral polymerase, notably in the PB2 subunit, play an important role. A PB2 C-terminal domain rich in putative host adaptation residues has been shown to bind importin alpha nuclear import receptors. Adaptation has been proposed to involve binding of PB2 to importins of the new host. To date PB2-importin complexes have been characterized semiquantitatively with no precise measurement of binding parameters. To investigate the effects of adaptive mutations on importin interaction and selectivity, surface plasmon resonance was used to compare the binding rate constants and affinities of avian H5N1 and human H3N2 PB2 C-terminal variants with importin isoforms human alpha 1, 3, 5 and 7, and avian alpha 1. Using purified proteins eliminates host environment effects and permits measurement of intrinsic affinities and rates of complex formation and dissociation. Two effects were observed: first, adaptive mutations D701N, R702K, and S714R in the nuclear localization signal domain increased 2-4-fold the association rates with avian and human importins; second, measurement of different structural forms of the PB2 C terminus demonstrated that the upstream 627 domain reduced binding affinity, consistent with a steric clash predicted from crystal structures. From these kinetic data, structural analyses, and the data of others, a model is proposed in which an increase in charged surface residues during host adaptation increases the association rate of PB2 to cytoplasmic importins and where the C-terminal 627-nuclear localization signal domain may reorganize upon importin binding, consistent with a role in active polymerase assembly.	[Hart, Darren J.] European Mol Biol Lab, Grenoble Outstn, F-38042 Grenoble 9, France; UJF EMBL CNRS, UMI 3265, Unit Virus Host Cell Interact, F-38042 Grenoble 9, France	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Hart, DJ (corresponding author), European Mol Biol Lab, Grenoble Outstn, 6 Rue Jules Horowitz,BP181, F-38042 Grenoble 9, France.	hart@embl.fr	Boivin, Stephane/K-4018-2012; Hart, Darren/C-4858-2015	Hart, Darren/0000-0002-3502-2002; Boivin, Stephane/0000-0003-1460-326X	Fondation Innovations en Infectiologie (FINOVI); European Union FLUPOL [SP5B-CT-2007-044263]	Fondation Innovations en Infectiologie (FINOVI); European Union FLUPOL	This work was supported by the Fondation Innovations en Infectiologie (FINOVI) and European Union FLUPOL Contract SP5B-CT-2007-044263.	Boivin S, 2010, J BIOL CHEM, V285, P28411, DOI 10.1074/jbc.R110.117531; Boulo S, 2007, VIRUS RES, V124, P12, DOI 10.1016/j.virusres.2006.09.013; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Chen H, 2007, VIRUS RES, V128, P159, DOI 10.1016/j.virusres.2007.04.017; Clarke PR, 2001, TRENDS CELL BIOL, V11, P366, DOI 10.1016/S0962-8924(01)02071-2; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; DELALUNA S, 1989, VIRUS RES, V13, P143, DOI 10.1016/0168-1702(89)90012-9; Dunham EJ, 2009, J VIROL, V83, P5485, DOI 10.1128/JVI.02565-08; Fanara P, 2000, J BIOL CHEM, V275, P21218, DOI 10.1074/jbc.M002217200; Finkelstein DB, 2007, J VIROL, V81, P10292, DOI 10.1128/JVI.00921-07; Fislova T, 2010, J VIROL, V84, P8691, DOI 10.1128/JVI.00813-10; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; Gabriel G, 2007, J VIROL, V81, P9601, DOI 10.1128/JVI.00666-07; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Hodel AE, 2006, J BIOL CHEM, V281, P23545, DOI 10.1074/jbc.M601718200; Honda A, 1997, BIOL CHEM, V378, P483; Hu W, 1999, J BIOL CHEM, V274, P15820, DOI 10.1074/jbc.274.22.15820; Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191; Huet S, 2010, J VIROL, V84, P1254, DOI 10.1128/JVI.01533-09; Jans DA, 2000, BIOESSAYS, V22, P532, DOI 10.1002/(SICI)1521-1878(200006)22:6<532::AID-BIES6>3.0.CO;2-O; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kuzuhara T, 2009, J BIOL CHEM, V284, P6855, DOI 10.1074/jbc.C800224200; Li ZJ, 2005, J VIROL, V79, P12058, DOI 10.1128/JVI.79.18.12058-12064.2005; Mehle A, 2008, CELL HOST MICROBE, V4, P111, DOI 10.1016/j.chom.2008.06.007; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Melen K, 2003, J BIOL CHEM, V278, P28193, DOI 10.1074/jbc.M303571200; Miotto O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009025; Miotto O, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S1-S7; Moncorge O, 2010, J VIROL, V84, P9978, DOI 10.1128/JVI.01134-10; MUKAIGAWA J, 1991, J VIROL, V65, P245, DOI 10.1128/JVI.65.1.245-253.1991; Naffakh N, 2000, J GEN VIROL, V81, P1283, DOI 10.1099/0022-1317-81-5-1283; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; NATH ST, 1990, MOL CELL BIOL, V10, P4139, DOI 10.1128/MCB.10.8.4139; Neumann G, 1997, J VIROL, V71, P9690, DOI 10.1128/JVI.71.12.9690-9700.1997; NIETO A, 1994, J GEN VIROL, V75, P29, DOI 10.1099/0022-1317-75-1-29; Noah DL, 2005, ADV VIRUS RES, V65, P121, DOI 10.1016/S0065-3527(05)65004-X; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; ONEILL RE, 1995, VIROLOGY, V206, P116, DOI 10.1016/S0042-6822(95)80026-3; Poole E, 2004, VIROLOGY, V321, P120, DOI 10.1016/j.virol.2003.12.022; Quynh ML, 2009, J VIROL, V83, P5278, DOI 10.1128/JVI.00063-09; Resa-Infante P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003904; Schwab MS, 1997, EUR J CELL BIOL, V73, P287; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Tamuri AU, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000564; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Tarendeau F, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000136; Tejomurtula J, 2009, BIOL REPROD, V81, P333, DOI 10.1095/biolreprod.109.077396; Tworowski D, 2003, PROTEIN SCI, V12, P1247, DOI 10.1110/ps.0301203; Wang P, 1997, J VIROL, V71, P1850, DOI 10.1128/JVI.71.3.1850-1856.1997; Weber F, 1998, VIROLOGY, V250, P9, DOI 10.1006/viro.1998.9329; Yang SNY, 2010, J BIOL CHEM, V285, P19935, DOI 10.1074/jbc.M109.079574; Zhou HX, 2005, PHYS BIOL, V2, pR1, DOI 10.1088/1478-3975/2/3/R01; ZHOU HX, 1993, BIOPHYS J, V64, P1711, DOI 10.1016/S0006-3495(93)81543-1	64	59	61	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10439	10448		10.1074/jbc.M110.182964	http://dx.doi.org/10.1074/jbc.M110.182964			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21216958	hybrid, Green Published			2022-12-27	WOS:000288547000060
J	Thibault, D; Albert, PR; Pineyro, G; Trudeau, LE				Thibault, Dominic; Albert, Paul R.; Pineyro, Graciela; Trudeau, Louis-Eric			Neurotensin Triggers Dopamine D2 Receptor Desensitization through a Protein Kinase C and beta-Arrestin1-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIPSYCHOTIC-DRUGS; RAT-BRAIN; NEURONS; PHOSPHORYLATION; INTERNALIZATION; TRAFFICKING; INHIBITION; CONDUCTANCE; EXPRESSION; ISOFORMS	The peptide neurotensin (NT) is known to exert a potent excitatory effect on the dopaminergic system by inhibiting D2 dopamine (DA) receptor (D2R) function. This regulation is dependent on activation of PKC, a well known effector of the type 1 NT receptor (NTR1). Because PKC phosphorylation of the D2R has recently been shown to induce its internalization, we hypothesized that NT acts to reduce D2R function through heterologous desensitization of the D2R. In the present study, we first used HEK-293 cells to demonstrate that NT induces PKC-dependent D2R internalization. Furthermore, internalization displayed faster kinetics in cells expressing the D2R short isoform, known to act as an autoreceptor in DA neurons, than in cells expressing the long isoform, known to act as a postsynaptic D2R. In patch clamp experiments on cultured DA neurons, overexpression of a mutant D2S lacking three key PKC phosphorylation sites abrogated the ability of NT to reduce D2R-mediated cell firing inhibition. Short interfering RNA-mediated inhibition of beta-arrestin1 and dynamin2, proteins important for receptor desensitization, reduced agonist-induced desensitization of D2R function, but only the inhibition of beta-arrestin1 reduced the effect of NT on D2R function. Taken together, our data suggest that NT acutely regulates D2 autoreceptor function and DA neuron excitability through PKC-mediated phosphorylation of the D2R, leading to heterologous receptor desensitization.	[Thibault, Dominic; Pineyro, Graciela; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Thibault, Dominic; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Dept Physiol, Montreal, PQ H3C 3J7, Canada; [Pineyro, Graciela; Trudeau, Louis-Eric] Univ Montreal, Fac Med, Dept Psychiat, Montreal, PQ H3C 3J7, Canada; [Thibault, Dominic; Trudeau, Louis-Eric] Univ Montreal, Grp Rech Syst Nerveux Cent, Montreal, PQ H3C 3J7, Canada; [Pineyro, Graciela] Univ Montreal, Ctr Hosp Univ St Justine, Ctr Rech, Montreal, PQ H3T 1C5, Canada; [Albert, Paul R.] Univ Ottawa, Ottawa Hosp, Res Inst, Ottawa, ON K1H 8M5, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; University of Ottawa; Ottawa Hospital Research Institute	Trudeau, LE (corresponding author), Univ Montreal, Fac Med, Dept Pharmacol, CP 6128,Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	louis-eric.trudeau@umontreal.ca	Albert, Paul/E-4804-2010; Trudeau, Louis-Eric/AAE-4782-2020	Albert, Paul/0000-0002-1809-3554; Trudeau, Louis-Eric/0000-0003-4684-1377; Pineyro, Graciela/0000-0001-9709-651X	Canadian Institutes of Health Research [MOP-49591]; Ontario Mental Health Foundation; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Mental Health Foundation; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by Canadian Institutes of Health Research Grant MOP-49591 (to L.-E. T.) and a graduate studentship (to D. T.), an Ontario Mental Health Foundation grant (to P. R. A.), and an infrastructure grant from the Fonds de la Recherche en Sante du Quebec to the Groupe de Recherche sur le Systeme Nerveux Central.	Beaulieu JM, 2005, CELL, V122, P261, DOI 10.1016/j.cell.2005.05.012; BEAUREGARD M, 1992, NEUROSCIENCE, V47, P613, DOI 10.1016/0306-4522(92)90170-7; Binder EB, 2001, J NEUROSCI, V21, P601, DOI 10.1523/JNEUROSCI.21-02-00601.2001; Botto JM, 1998, BIOCHEM BIOPH RES CO, V243, P585, DOI 10.1006/bbrc.1997.8071; Boules M, 2007, CNS DRUGS, V21, P13, DOI 10.2165/00023210-200721010-00002; Caceda R, 2005, J NEUROSCI, V25, P11748, DOI 10.1523/JNEUROSCI.4282-05.2005; Caceda R, 2006, PEPTIDES, V27, P2385, DOI 10.1016/j.peptides.2006.04.024; Cathala L, 1997, J PHYSIOL-LONDON, V503, P87, DOI 10.1111/j.1469-7793.1997.087bi.x; Dal Bo G, 2008, NEUROSCIENCE, V156, P59, DOI 10.1016/j.neuroscience.2008.07.032; Diaz-Cabiale Z, 2002, NEUROREPORT, V13, P763, DOI 10.1097/00001756-200205070-00006; Farkas RH, 1997, NEUROSCI LETT, V231, P21, DOI 10.1016/S0304-3940(97)00530-2; Fasano C, 2008, EUR J NEUROSCI, V28, P1480, DOI 10.1111/j.1460-9568.2008.06450.x; Fassio A, 2000, NEUROPHARMACOLOGY, V39, P1430, DOI 10.1016/S0028-3908(00)00060-5; Feifel D, 2010, NEUROPHARMACOLOGY, V58, P173, DOI 10.1016/j.neuropharm.2009.07.002; Feifel D, 2009, NEUROPSYCHOPHARMACOL, V34, P2011, DOI 10.1038/npp.2009.15; GARVER DL, 1991, AM J PSYCHIAT, V148, P484; Gurevich EV, 2002, NEUROSCIENCE, V109, P421, DOI 10.1016/S0306-4522(01)00511-5; Ito K, 1999, EUR J BIOCHEM, V260, P112, DOI 10.1046/j.1432-1327.1999.00125.x; Iwata K, 1999, EUR J BIOCHEM, V263, P596, DOI 10.1046/j.1432-1327.1999.00549.x; JIANG ZG, 1994, J PHYSIOL-LONDON, V474, P119, DOI 10.1113/jphysiol.1994.sp020007; Jomphe C, 2006, EUR J NEUROSCI, V24, P2789, DOI 10.1111/j.1460-9568.2006.05151.x; Jomphe C, 2005, J NEUROSCI METH, V146, P1, DOI 10.1016/j.jneumeth.2005.01.014; Kabbani N, 2004, CELL SIGNAL, V16, P497, DOI 10.1016/j.cellsig.2003.09.011; KENNEDY RT, 1992, J NEUROCHEM, V59, P449, DOI 10.1111/j.1471-4159.1992.tb09391.x; Khan ZU, 1998, J COMP NEUROL, V402, P353, DOI 10.1002/(SICI)1096-9861(19981221)402:3<353::AID-CNE5>3.0.CO;2-4; KIM KM, 1995, NEUROSCIENCE, V69, P1145, DOI 10.1016/0306-4522(95)00326-E; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; Kinkead B, 2005, J PHARMACOL EXP THER, V315, P256, DOI 10.1124/jpet.105.087437; Kinkead B, 2002, CURR OPIN PHARMACOL, V2, P99, DOI 10.1016/S1471-4892(01)00128-X; LACEY MG, 1987, J PHYSIOL-LONDON, V392, P397, DOI 10.1113/jphysiol.1987.sp016787; LI XM, 1994, NEUROREPORT, V5, P1621, DOI 10.1097/00001756-199408150-00020; Li ZM, 2010, BRAIN RES, V1311, P28, DOI 10.1016/j.brainres.2009.11.048; Liang YQ, 2010, NEUROPHARMACOLOGY, V58, P1199, DOI 10.1016/j.neuropharm.2010.02.015; Lindgren N, 2003, P NATL ACAD SCI USA, V100, P4305, DOI 10.1073/pnas.0730708100; LIU YF, 1992, J NEUROCHEM, V59, P2311; Matsushita N, 2002, J NEUROCHEM, V82, P295, DOI 10.1046/j.1471-4159.2002.00972.x; Mechanic JA, 2009, EUR NEUROPSYCHOPHARM, V19, P466, DOI 10.1016/j.euroneuro.2009.01.004; Mendez JA, 2008, J NEUROSCI, V28, P6309, DOI 10.1523/JNEUROSCI.1331-08.2008; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Morris SJ, 2007, EUR J PHARMACOL, V577, P44, DOI 10.1016/j.ejphar.2007.08.027; Namkung Y, 2004, J BIOL CHEM, V279, P49533, DOI 10.1074/jbc.M408319200; Namkung Y, 2009, J BIOL CHEM, V284, P34103, DOI 10.1074/jbc.M109.055707; Namkung Y, 2009, J BIOL CHEM, V284, P15038, DOI 10.1074/jbc.M900388200; Nemeroff C B, 1989, J Neuropsychiatry Clin Neurosci, V1, P16; NICOT A, 1995, J NEUROSCI RES, V40, P667, DOI 10.1002/jnr.490400512; Norman C, 2008, J PSYCHOPHARMACOL, V22, P300, DOI 10.1177/0269881107083838; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Radke JM, 1998, P NATL ACAD SCI USA, V95, P11462, DOI 10.1073/pnas.95.19.11462; Sawamoto K, 2001, J NEUROSCI, V21, P3895, DOI 10.1523/JNEUROSCI.21-11-03895.2001; Sharma RP, 1997, AM J PSYCHIAT, V154, P1019; SHI WX, 1992, ANN NY ACAD SCI, V668, P129, DOI 10.1111/j.1749-6632.1992.tb27345.x; Skinbjerg M, 2009, SYNAPSE, V63, P621, DOI 10.1002/syn.20636; St-Gelais F, 2004, J NEUROSCI, V24, P2566, DOI 10.1523/JNEUROSCI.5376-03.2004; St-Gelais F, 2006, J PSYCHIATR NEUROSCI, V31, P229; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Uchida S, 2000, NEUROPHARMACOLOGY, V39, P191, DOI 10.1016/S0028-3908(99)00111-2; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Vandenbulcke F, 2000, J CELL SCI, V113, P2963; WATSON MA, 1992, J NEUROCHEM, V59, P1967, DOI 10.1111/j.1471-4159.1992.tb11035.x; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; WU T, 1995, NEUROSCI LETT, V184, P121, DOI 10.1016/0304-3940(94)11185-L; WU T, 1995, BRAIN RES, V683, P242, DOI 10.1016/0006-8993(95)00379-5; Zhang J, 1999, J BIOL CHEM, V274, P10999, DOI 10.1074/jbc.274.16.10999	63	44	45	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9174	9184		10.1074/jbc.M110.166454	http://dx.doi.org/10.1074/jbc.M110.166454			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21233215	hybrid, Green Published			2022-12-27	WOS:000288247700048
J	Biswas, KH; Visweswariah, SS				Biswas, Kabir H.; Visweswariah, Sandhya S.			Distinct Allostery Induced in the Cyclic GMP-binding, Cyclic GMP-specific Phosphodiesterase (PDE5) by Cyclic GMP, Sildenafil, and Metal Ions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CGMP-SPECIFIC PHOSPHODIESTERASE; CONFORMATIONAL-CHANGE; GAF DOMAIN; REGULATORY DOMAIN; CATALYTIC DOMAIN; INDUCED FIT; MECHANISM; INHIBITORS; EXPRESSION; DIMERIZATION	The activity of many proteins orchestrating different biological processes is regulated by allostery, where ligand binding at one site alters the function of another site. Allosteric changes can be brought about by either a change in the dynamics of a protein, or alteration in its mean structure. We have investigated the mechanisms of allostery induced by chemically distinct ligands in the cGMP-binding, cGMP-specific phosphodiesterase, PDE5. PDE5 is the target for catalytic site inhibitors, such as sildenafil, that are used for the treatment of erectile dysfunction and pulmonary hypertension. PDE5 is a multidomain protein and contains two N-terminal cGMP-specific phosphodiesterase, bacterial adenylyl cyclase, FhLA transcriptional regulator (GAF) domains, and a C-terminal catalytic domain. Cyclic GMP binding to the GAFa domain and sildenafil binding to the catalytic domain result in conformational changes, which to date have been studied either with individual domains or with purified enzyme. Employing intramolecular bioluminescence resonance energy transfer, which can monitor conformational changes both in vitro and in intact cells, we show that binding of cGMP and sildenafil to PDE5 results in distinct conformations of the protein. Metal ions bound to the catalytic site also allosterically modulated cGMP- and sildenafil-induced conformational changes. The sildenafil-induced conformational change was temperature-sensitive, whereas cGMP-induced conformational change was independent of temperature. This indicates that different allosteric ligands can regulate the conformation of a multidomain protein by distinct mechanisms. Importantly, this novel PDE5 sensor has general physiological and clinical relevance because it allows the identification of regulators that can modulate PDE5 conformation in vivo.	[Biswas, Kabir H.; Visweswariah, Sandhya S.] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Visweswariah, SS (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Sir CV Raman Ave, Bangalore 560041, Karnataka, India.	sandhya@mrdg.iisc.ernet.in	Biswas, Kabir H/AAG-9156-2019; Visweswariah, Sandhya/Q-7500-2019	Biswas, Kabir H/0000-0001-9194-4127; Visweswariah, Sandhya/0000-0003-2786-7344	Department of Biotechnology, Government of India; Indian Institute of Science; Council of Scientific and Industrial Research, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Indian Institute of Science; Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Department of Biotechnology, Government of India, and the Indian Institute of Science.; Recipient of a senior research fellowship from the Council of Scientific and Industrial Research, Government of India.	Bakre MM, 2000, EUR J BIOCHEM, V267, P179, DOI 10.1046/j.1432-1327.2000.00986.x; Bakre MM, 2000, J CELL BIOCHEM, V77, P159; Biswas KH, 2008, BIOCHEMISTRY-US, V47, P3534, DOI 10.1021/bi702025w; Blount MA, 2007, J PHARMACOL EXP THER, V323, P730, DOI 10.1124/jpet.107.126540; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Cann M, 2007, MOL MICROBIOL, V64, P461, DOI 10.1111/j.1365-2958.2007.05669.x; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Corbin J. D., 2003, HDB CELL SIGNALING, P465; Corbin JD, 2009, CELL SIGNAL, V21, P1768, DOI 10.1016/j.cellsig.2009.07.012; Corbin JD, 2000, EUR J BIOCHEM, V267, P2760, DOI 10.1046/j.1432-1327.2000.01297.x; Corbin JD, 2003, MOL PHARMACOL, V63, P1364, DOI 10.1124/mol.63.6.1364; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; Dacres H, 2009, ANAL BIOCHEM, V385, P194, DOI 10.1016/j.ab.2008.10.040; del Sol A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r92; Dolci S, 2006, BIOCHEM BIOPH RES CO, V341, P837, DOI 10.1016/j.bbrc.2006.01.035; Feng M, 2004, NAT STRUCT MOL BIOL, V11, P450, DOI 10.1038/nsmb754; Fenton AW, 2008, TRENDS BIOCHEM SCI, V33, P420, DOI 10.1016/j.tibs.2008.05.009; Francis SH, 2008, INT J IMPOT RES, V20, P333, DOI 10.1038/ijir.2008.4; Francis S. H., 2006, CYCLIC NUCL PHOSPHOD, P135; Francis SH, 2002, J BIOL CHEM, V277, P47581, DOI 10.1074/jbc.M206088200; FRANCIS SH, 1994, J BIOL CHEM, V269, P22477; Francis SH, 2000, BIOCHEMISTRY-US, V39, P9591, DOI 10.1021/bi000392m; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Gierasch LM, 2009, NAT CHEM BIOL, V5, P774, DOI 10.1038/nchembio.241; Hammes GG, 2009, P NATL ACAD SCI USA, V106, P13737, DOI 10.1073/pnas.0907195106; Heikaus CC, 2008, J BIOL CHEM, V283, P22749, DOI 10.1074/jbc.M801577200; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Hilser VJ, 2010, SCIENCE, V327, P653, DOI 10.1126/science.1186121; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lin CS, 2004, INT J IMPOT RES, V16, pS8, DOI 10.1038/sj.ijir.3901207; Lin CS, 2000, BIOCHEM BIOPH RES CO, V268, P628, DOI 10.1006/bbrc.2000.2187; Lin CS, 2002, INT J IMPOT RES, V14, P15, DOI 10.1038/sj.ijir.3900802; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Matthiesen K, 2009, BIOCHEM J, V423, P401, DOI 10.1042/BJ20090982; Mullershausen F, 2003, J CELL BIOL, V160, P719, DOI 10.1083/jcb.200211041; Okada D, 2002, BIOCHEMISTRY-US, V41, P9672, DOI 10.1021/bi025727+; Pandit J, 2009, P NATL ACAD SCI USA, V106, P18225, DOI 10.1073/pnas.0907635106; Rotella DP, 2002, NAT REV DRUG DISCOV, V1, P674, DOI 10.1038/nrd893; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; Rybalkin SD, 2003, EMBO J, V22, P469, DOI 10.1093/emboj/cdg051; Rybalkina IG, 2010, MOL PHARMACOL, V77, P670, DOI 10.1124/mol.109.062299; Shenoy AR, 2003, ANAL BIOCHEM, V319, P335, DOI 10.1016/S0003-2697(03)00286-0; Sopory S, 2004, CELL SIGNAL, V16, P681, DOI 10.1016/j.cellsig.2003.11.004; Sopory S, 2003, FEBS LETT, V539, P161, DOI 10.1016/S0014-5793(03)00219-9; Sullivan SM, 2008, P NATL ACAD SCI USA, V105, P13829, DOI 10.1073/pnas.0805364105; Sung BJ, 2003, NATURE, V425, P98, DOI 10.1038/nature01914; Touyz R. M., 2003, Molecular Aspects of Medicine, V24, P107, DOI 10.1016/S0098-2997(02)00094-8; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Turko IV, 1999, MOL PHARMACOL, V56, P124, DOI 10.1124/mol.56.1.124; Turko IV, 1998, BIOCHEMISTRY-US, V37, P4200, DOI 10.1021/bi972448r; Wang H, 2008, MOL PHARMACOL, V73, P104, DOI 10.1124/mol.107.040212; Wang HC, 2006, J BIOL CHEM, V281, P21469, DOI 10.1074/jbc.M512527200; Wilson LS, 2008, P NATL ACAD SCI USA, V105, P13650, DOI 10.1073/pnas.0804738105; Wolf FI, 2008, CLIN SCI, V114, P27, DOI 10.1042/CS20070129; Yago MD, 2000, FRONT BIOSCI-LANDMRK, V5, pD602, DOI 10.2741/Yago; Zhang KYJ, 2004, MOL CELL, V15, P279, DOI 10.1016/j.molcel.2004.07.005; Zoraghi R, 2005, J BIOL CHEM, V280, P12051, DOI 10.1074/jbc.M413611200	60	18	18	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8545	8554		10.1074/jbc.M110.193185	http://dx.doi.org/10.1074/jbc.M110.193185			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21193396	hybrid, Green Published			2022-12-27	WOS:000288013300081
J	Eyre, DR; Weis, M; Hudson, DM; Wu, JJ; Kim, L				Eyre, David R.; Weis, MaryAnn; Hudson, David M.; Wu, Jiann-Jiu; Kim, Lammy			A Novel 3-Hydroxyproline (3Hyp)-rich Motif Marks the Triple-helical C Terminus of Tendon Type I Collagen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECESSIVE OSTEOGENESIS IMPERFECTA; AMINO-ACID; IDENTIFICATION; DEFICIENCY; MUTATIONS; PROTEINS; RESIDUES; CLEAVAGE; FIBRILS; DECORIN	Because of its unique physical and chemical properties, rat tail tendon collagen has long been favored for crystallographic and biochemical studies of fibril structure. In studies of the distribution of 3-hydroxyproline in type I collagen of rat bone, skin, and tail tendon by mass spectrometry, the repeating sequences of Gly-Pro-Pro (GPP) triplets at the C terminus of alpha 1(I) and alpha 2(I) chains were shown to be heavily 3-hydroxylated in tendon but not in skin and bone. By isolating the tryptic peptides and subjecting them to Edman sequence analysis, the presence of repeating 3-hydroxyprolines in consecutive GPP triplets adjacent to 4-hydroxyproline was confirmed as a unique feature of the tendon collagen. A 1960s study by Piez et al. (Piez, K. A., Eigner, E. A., and Lewis, M. S. (1963) Biochemistry 2, 58-66) in which they compared the amino acid compositions of rat skin and tail tendon type I collagen chains indeed showed 3-4 residues of 3Hyp in tendon alpha 1(I) and alpha 2(I) chains but only one 3Hyp residue in skin alpha 1(I) and none in alpha 2(I). The present work therefore confirms this difference and localizes the additional 3Hyp to the GPP repeat at the C terminus of the triple-helix. We speculate on the significance in terms of a potential function in contributing to the unique assembly mechanism and molecular packing in tendon collagen fibrils and on mechanisms that could regulate 3-hydroxylation at this novel substrate site in a tissue-specific manner.	[Eyre, David R.; Weis, MaryAnn; Hudson, David M.; Wu, Jiann-Jiu; Kim, Lammy] Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Eyre, DR (corresponding author), Univ Washington, Dept Orthopaed & Sports Med, Seattle, WA 98195 USA.	deyre@u.washington.edu			NIAMS [AR37694, AR37318]; University of Washington; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD070394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR036794, R37AR037318, R01AR037318] Funding Source: NIH RePORTER	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Washington(University of Washington); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR37694 and AR37318 from the NIAMS (to D. R. E.). This work was also supported by funds from the Ernest M. Burgess Endowed Chair research program of the University of Washington.	Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Bayer ML, 2010, BIOMATERIALS, V31, P4889, DOI 10.1016/j.biomaterials.2010.02.062; BRODSKY B, 1980, BIOCHIM BIOPHYS ACTA, V621, P162, DOI 10.1016/0005-2795(80)90072-0; Bulleid NJ, 1997, EMBO J, V16, P6694, DOI 10.1093/emboj/16.22.6694; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Canty EG, 2004, J CELL BIOL, V165, P553, DOI 10.1083/jcb.200312071; EYRE D, 1987, METHOD ENZYMOL, V144, P115; Eyre DR, 2008, METHODS, V45, P65, DOI 10.1016/j.ymeth.2008.01.002; FIETZEK PP, 1972, EUR J BIOCHEM, V30, P163, DOI 10.1111/j.1432-1033.1972.tb02083.x; Garrone R., 1985, BIOL INVERTEBRATE VE, V93, P157; Geng YQ, 2006, MATRIX BIOL, V25, P484, DOI 10.1016/j.matbio.2006.08.259; Hanna SL, 2000, MICROBIOL-UK, V146, P2495, DOI 10.1099/00221287-146-10-2495; Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Kapacce Z, 2008, MATRIX BIOL, V27, P371, DOI 10.1016/j.matbio.2007.11.006; Kefalides N A, 1973, Int Rev Connect Tissue Res, V6, P63; KESSLER A, 1960, J BIOL CHEM, V235, P989; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Matsushima N, 2000, PROTEINS, V38, P210, DOI 10.1002/(SICI)1097-0134(20000201)38:2<210::AID-PROT9>3.0.CO;2-1; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; OGLE JD, 1962, J BIOL CHEM, V237, P3667; Ottani V, 2002, MICRON, V33, P587, DOI 10.1016/S0968-4328(02)00033-1; PIEZ KA, 1963, BIOCHEMISTRY-US, V2, P58, DOI 10.1021/bi00901a012; Schumacher MA, 2006, J BIOL CHEM, V281, P27566, DOI 10.1074/jbc.M602797200; Tiainen P, 2008, J BIOL CHEM, V283, P19432, DOI 10.1074/jbc.M802973200; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Weis MA, 2010, J BIOL CHEM, V285, P2580, DOI 10.1074/jbc.M109.068726; WU JJ, 1992, J BIOL CHEM, V267, P23007; Zhang G., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P5; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776	31	39	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7732	7736		10.1074/jbc.C110.195768	http://dx.doi.org/10.1074/jbc.C110.195768			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21239503	Green Published, hybrid			2022-12-27	WOS:000288013300004
J	Zhou, LJ; Chavez-Gutierrez, L; Bockstael, K; Sannerud, R; Annaert, W; May, PC; Karran, E; De Strooper, B				Zhou, Lujia; Chavez-Gutierrez, Lucia; Bockstael, Katrijn; Sannerud, Ragna; Annaert, Wim; May, Patrick C.; Karran, Eric; De Strooper, Bart			Inhibition of beta-Secretase in Vivo via Antibody Binding to Unique Loops (D and F) of BACE1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-PRECURSOR-PROTEIN; BRAIN DRUG-DELIVERY; ALZHEIMERS-DISEASE; A-BETA; MOUSE MODEL; HIPPOCAMPAL-NEURONS; NERVOUS-SYSTEM; MICE; SITE; SPECIFICITY	beta-Secretase (BACE1) is an attractive drug target for Alzheimer disease. However, the design of clinical useful inhibitors targeting its active site has been extremely challenging. To identify alternative drug targeting sites we have generated a panel of BACE1 monoclonal antibodies (mAbs) that interfere with BACE1 activity in various assays and determined their binding epitopes. mAb 1A11 inhibited BACE1 in vitro using a large APP sequence based substrate (IC50 similar to 0.76 nM), in primary neurons (EC50 similar to 1.8 nM), and in mouse brain after stereotactic injection. Paradoxically, mAb 1A11 increased BACE1 activity in vitro when a short synthetic peptide was used as substrate, indicating that mAb 1A11 does not occupy the active-site. Epitope mapping revealed that mAb 1A11 binds to adjacent loops D and F, which together with nearby helix A, distinguishes BACE1 from other aspartyl proteases. Interestingly, mutagenesis of loop F and helix A decreased or increased BACE1 activity, identifying them as enzymatic regulatory elements and as potential alternative sites for inhibitor design. In contrast, mAb 5G7 was a potent BACE1 inhibitor in cell-free enzymatic assays (IC50 similar to 0.47 nM) but displayed no inhibitory effect in primary neurons. Its epitope, a surface helix 299-312, is inaccessible in membrane-anchored BACE1. Remarkably, mutagenesis of helix 299-312 strongly reduced BACE1 ectodomain shedding, suggesting that this helix plays a role in BACE1 cellular biology. In conclusion, this study generated highly selective and potent BACE1 inhibitory mAbs, which recognize unique structural and functional elements in BACE1, and uncovered interesting alternative sites on BACE1 that could become targets for drug development.	[Zhou, Lujia; Chavez-Gutierrez, Lucia; Bockstael, Katrijn; Sannerud, Ragna; Annaert, Wim; De Strooper, Bart] KULeuven, Dept Mol & Dev Genet, VIB, B-3000 Louvain, Belgium; [Zhou, Lujia; Chavez-Gutierrez, Lucia; Bockstael, Katrijn; Sannerud, Ragna; Annaert, Wim; De Strooper, Bart] KULeuven, Ctr Human Genet, B-3000 Louvain, Belgium; [May, Patrick C.] Eli Lilly & Co, Lilly Res Labs, Neurosci Discovery Res, Indianapolis, IN 46285 USA; [Karran, Eric] Johnson & Johnson Pharmaceut Res & Dev, B-2340 Beerse, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; Eli Lilly; Johnson & Johnson; Janssen Pharmaceuticals	De Strooper, B (corresponding author), Herestr 49,Box 602, B-3000 Louvain, Belgium.	Bart.DeStrooper@cme.vib-kuleuven.be	De Strooper, Bart/F-6507-2012; Sannerud, Ragna/AAA-6497-2021; Chávez-Gutiérrez, Lucía/E-2657-2017	De Strooper, Bart/0000-0001-5455-5819; Sannerud, Ragna/0000-0002-6694-3154	VIB; Eli Lilly; O; SA0-FRMA; Federal Office for Scientific Affairs, Belgium (IUAP) [P6/43/]; KULeuven; Flemish Government; European Union [FZ-2007-200611]	VIB; Eli Lilly(Eli Lilly); O; SA0-FRMA; Federal Office for Scientific Affairs, Belgium (IUAP); KULeuven(KU Leuven); Flemish Government(European Commission); European Union(European Commission)	This work was supported by VIB, Eli Lilly, FWO, SA0-FRMA (grant cycle 2008/2009), the Federal Office for Scientific Affairs, Belgium (IUAP P6/43/), a Methusalem grant of the KULeuven and the Flemish Government, and Memosad (FZ-2007-200611) of the European Union.	Alam MI, 2010, EUR J PHARM SCI, V40, P385, DOI 10.1016/j.ejps.2010.05.003; Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; BINDER LI, 1986, ANN NY ACAD SCI, V466, P145, DOI 10.1111/j.1749-6632.1986.tb38392.x; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; Chang WP, 2007, FASEB J, V21, P3184, DOI 10.1096/fj.06-7993com; Charlwood J, 2001, J BIOL CHEM, V276, P16739, DOI 10.1074/jbc.M009361200; CHECLER F, 1995, J NEUROCHEM, V65, P1431; Costantini C, 2007, BIOCHEM J, V407, P383, DOI 10.1042/BJ20070040; Creemers JWM, 2001, J BIOL CHEM, V276, P4211, DOI 10.1074/jbc.M006947200; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Doan KMM, 2002, J PHARMACOL EXP THER, V303, P1029, DOI 10.1124/jpet.102.039255; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Erlanson DA, 2004, J MED CHEM, V47, P3463, DOI 10.1021/jm040031v; Fukumoto H, 2010, J NEUROSCI, V30, P11157, DOI 10.1523/JNEUROSCI.2884-10.2010; Golde Todd E., 2006, Current Alzheimer Research, V3, P421, DOI 10.2174/156720506779025189; Gorfe AA, 2005, STRUCTURE, V13, P1487, DOI 10.1016/j.str.2005.06.015; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Herzig MC, 2004, NAT NEUROSCI, V7, P954, DOI 10.1038/nn1302; Hoey SE, 2009, J NEUROSCI, V29, P4442, DOI 10.1523/JNEUROSCI.6017-08.2009; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Hong L, 2004, BIOCHEMISTRY-US, V43, P4689, DOI 10.1021/bi0498252; Hong L, 2002, BIOCHEMISTRY-US, V41, P10963, DOI 10.1021/bi026232n; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Hussain I, 2003, J BIOL CHEM, V278, P36264, DOI 10.1074/jbc.M304186200; Hussain I, 2007, J NEUROCHEM, V100, P802, DOI 10.1111/j.1471-4159.2006.04260.x; Kimberly WT, 2005, J NEUROSCI, V25, P5533, DOI 10.1523/JNEUROSCI.4883-04.2005; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; Meredith JE, 2008, J PHARMACOL EXP THER, V326, P502, DOI 10.1124/jpet.108.138974; Mohajeri MH, 2004, NEURODEGENER DIS, V1, P160, DOI 10.1159/000080981; Patel MM, 2009, CNS DRUGS, V23, P35, DOI 10.2165/0023210-200923010-00003; Patel S, 2004, J MOL BIOL, V343, P407, DOI 10.1016/j.jmb.2004.08.018; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Rajendran L, 2008, SCIENCE, V320, P520, DOI 10.1126/science.1156609; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Sankaranarayanan S, 2008, J PHARMACOL EXP THER, V324, P957, DOI 10.1124/jpet.107.130039; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Silvestri R, 2009, MED RES REV, V29, P295, DOI 10.1002/med.20132; Simons M, 1996, J NEUROSCI, V16, P899; Singer O, 2005, NAT NEUROSCI, V8, P1343, DOI 10.1038/nn1531; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; THORNTON JM, 1986, EMBO J, V5, P409, DOI 10.1002/j.1460-2075.1986.tb04226.x; Turner RT, 2005, BIOCHEMISTRY-US, V44, P105, DOI 10.1021/bi048106k; Turner RT, 2002, BIOCHEMISTRY-US, V41, P8742, DOI 10.1021/bi025926t; Turner RT, 2001, BIOCHEMISTRY-US, V40, P10001, DOI 10.1021/bi015546s; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Yang HC, 2004, J NEUROCHEM, V91, P1249, DOI 10.1111/j.1471-4159.2004.02764.x; Zhou YH, 2007, IMMUNOL CELL BIOL, V85, P73, DOI 10.1038/sj.icb.7100004	62	43	51	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8677	8687		10.1074/jbc.M110.194860	http://dx.doi.org/10.1074/jbc.M110.194860			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21209097	Green Published, hybrid			2022-12-27	WOS:000288013300093
J	Allende, ML; Bektas, M; Lee, BG; Bonifacino, E; Kang, JM; Tuymetova, G; Chen, WP; Saba, JD; Proia, RL				Allende, Maria L.; Bektas, Meryem; Lee, Bridgin G.; Bonifacino, Eliana; Kang, Jiman; Tuymetova, Galina; Chen, WeiPing; Saba, Julie D.; Proia, Richard L.			Sphingosine-1-phosphate Lyase Deficiency Produces a Pro-inflammatory Response While Impairing Neutrophil Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOSINE 1-PHOSPHATE RECEPTOR; VASCULAR S1P GRADIENT; DOUBLE-NULL MICE; P-SELECTIN; IN-VIVO; BIOACTIVE SPHINGOLIPIDS; LEUKOCYTE RECRUITMENT; LYMPHOCYTE EGRESS; ENDOTHELIAL-CELLS; KINASE 1	Sphingosine-1-phosphate (S1P) lyase catalyzes the degradation of S1P, a potent signaling lysosphingolipid. Mice with an inactive S1P lyase gene are impaired in the capacity to degrade S1P, resulting in highly elevated S1P levels. These S1P lyase-deficient mice have low numbers of lymphocytes and high numbers of neutrophils in their blood. We found that the S1P lyase-deficient mice exhibited features of an inflammatory response including elevated levels of pro-inflammatory cytokines and an increased expression of genes in liver associated with an acute-phase response. However, the recruitment of their neutrophils into inflamed tissues was impaired and their neutrophils were defective in migration to chemotactic stimulus. The IL-23/IL-17/granulocyte-colony stimulating factor (G-CSF) cytokine-controlled loop regulating neutrophil homeostasis, which is dependent on neutrophil trafficking to tissues, was disturbed in S1P lyase-deficient mice. Deletion of the S1P4 receptor partially decreased the neutrophilia and inflammation in S1P lyase-deficient mice, implicating S1P receptor signaling in the phenotype. Thus, a genetic block in S1P degradation elicits a pro-inflammatory response but impairs neutrophil migration from blood into tissues.	[Allende, Maria L.; Bektas, Meryem; Lee, Bridgin G.; Bonifacino, Eliana; Kang, Jiman; Tuymetova, Galina; Proia, Richard L.] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA; [Chen, WeiPing] NIDDK, Microarray Core Lab, NIH, Bethesda, MD 20892 USA; [Saba, Julie D.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Proia, RL (corresponding author), NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA.	proia@nih.gov	Proia, Richard L/A-7908-2012; Chen, Wei/GZK-7348-2022	Bektas, Meryem/0000-0001-8080-7557; Proia, Richard/0000-0003-0456-1270	National Institutes of Health, NIDDK [CA77528]; National Institutes of Health [C06 RR018823]; NATIONAL CANCER INSTITUTE [R01CA077528] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056014, ZIADK056015, ZIADK056017, ZIADK056018] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, NIDDK by Public Health Service Grant CA77528 (to J.D.S.) and National Institutes of Health Grant C06 RR018823 (to the Medical University of South Carolina Lipomics Core).	Adamson AS, 2009, CURR OPIN IMMUNOL, V21, P161, DOI 10.1016/j.coi.2009.03.013; Allende ML, 2008, FASEB J, V22, P307, DOI 10.1096/fj.07-9087com; Allende ML, 2010, J EXP MED, V207, P1113, DOI 10.1084/jem.20092210; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Allende ML, 2003, BLOOD, V102, P3665, DOI 10.1182/blood-2003-02-0460; Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; Alvarez SE, 2010, NATURE, V465, P1084, DOI 10.1038/nature09128; Baker DA, 2010, J IMMUNOL, V185, P2570, DOI 10.4049/jimmunol.1000644; Barreiro O, 2010, CARDIOVASC RES, V86, P174, DOI 10.1093/cvr/cvq001; Bektas M, 2010, J BIOL CHEM, V285, P10880, DOI 10.1074/jbc.M109.081489; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BORNFELDT KE, 1995, J CELL BIOL, V130, P193, DOI 10.1083/jcb.130.1.193; Candelore MR, 2002, BIOCHEM BIOPH RES CO, V297, P600; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Collins RG, 2001, BLOOD, V98, P727, DOI 10.1182/blood.V98.3.727; Coxon A, 1996, IMMUNITY, V5, P653, DOI 10.1016/S1074-7613(00)80278-2; Ding ZM, 1999, J IMMUNOL, V163, P5029; El Alwani M, 2006, PHARMACOL THERAPEUT, V112, P171, DOI 10.1016/j.pharmthera.2006.04.004; Etzioni A, 2007, ADV EXP MED BIOL, V601, P51; Forlow SB, 2002, FASEB J, V16, P1488, DOI 10.1096/fj.02-0230com; Forlow SB, 2001, AM J PHYSIOL-HEART C, V280, pH634, DOI 10.1152/ajpheart.2001.280.2.H634; Forlow SB, 2000, J CLIN INVEST, V106, P1457, DOI 10.1172/JCI10555; Frenette PS, 1996, CELL, V84, P563, DOI 10.1016/S0092-8674(00)81032-6; Fyrst H, 2010, NAT CHEM BIOL, V6, P489, DOI [10.1038/NCHEMBIO.392, 10.1038/nchembio.392]; Graler MH, 1998, GENOMICS, V53, P164, DOI 10.1006/geno.1998.5491; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hla T, 2008, BBA-MOL CELL BIOL L, V1781, P477, DOI 10.1016/j.bbalip.2008.07.003; Ishii M, 2010, J EXP MED, V207, P2793, DOI 10.1084/jem.20101474; Ito K, 2007, BIOCHEM BIOPH RES CO, V357, P212, DOI 10.1016/j.bbrc.2007.03.123; Jolly PS, 2005, BLOOD, V105, P4736, DOI 10.1182/blood-2004-12-4686; Kabashima K, 2006, J EXP MED, V203, P2683, DOI 10.1084/jem.20061289; Kim RH, 2009, BBA-MOL CELL BIOL L, V1791, P692, DOI 10.1016/j.bbalip.2009.02.011; Kono M, 2008, BBA-MOL CELL BIOL L, V1781, P435, DOI 10.1016/j.bbalip.2008.07.001; KUIJPERS TW, 1991, BLOOD, V78, P1105; Lee H, 2010, NAT MED, V16, P1421, DOI 10.1038/nm.2250; Lekstrom-Himes JA, 2000, NEW ENGL J MED, V343, P1703, DOI 10.1056/NEJM200012073432307; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liao JJ, 2007, J IMMUNOL, V178, P5425, DOI 10.4049/jimmunol.178.9.5425; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; MAYADAS TN, 1993, CELL, V74, P541, DOI 10.1016/0092-8674(93)80055-J; McKenzie BS, 2006, TRENDS IMMUNOL, V27, P17, DOI 10.1016/j.it.2005.10.003; McVerry BJ, 2005, CELL SIGNAL, V17, P131, DOI 10.1016/j.cellsig.2004.08.006; Michaud J, 2010, J IMMUNOL, V184, P1475, DOI 10.4049/jimmunol.0901586; Niessen F, 2008, NATURE, V452, P654, DOI 10.1038/nature06663; Okamoto H, 2000, MOL CELL BIOL, V20, P9247, DOI 10.1128/MCB.20.24.9247-9261.2000; Olivera A, 2010, J CLIN INVEST, V120, P1429, DOI 10.1172/JCI40659; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Pereira JP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009277; Puneet P, 2010, SCIENCE, V328, P1290, DOI 10.1126/science.1188635; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Robinson SD, 1999, P NATL ACAD SCI USA, V96, P11452, DOI 10.1073/pnas.96.20.11452; Rosen H, 2005, NAT REV IMMUNOL, V5, P560, DOI 10.1038/nri1650; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; Schmahl J, 2007, NAT GENET, V39, P52, DOI 10.1038/ng1922; Schwab SR, 2005, SCIENCE, V309, P1735, DOI 10.1126/science.1113640; Skoura A, 2009, J LIPID RES, V50, pS293, DOI 10.1194/jlr.R800047-JLR200; Smith E, 2007, J IMMUNOL, V179, P8274, DOI 10.4049/jimmunol.179.12.8274; Snider AJ, 2009, FASEB J, V23, P143, DOI 10.1096/fj.08-118109; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; TEDDER TF, 1995, J EXP MED, V181, P2259, DOI 10.1084/jem.181.6.2259; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Venkataraman K, 2006, BIOCHEM J, V397, P461, DOI 10.1042/BJ20060251; Vogel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004112; Walzer T, 2007, NAT IMMUNOL, V8, P1337, DOI 10.1038/ni1523; Wang WG, 2005, FASEB J, V19, P1731, DOI 10.1096/fj.05-3730fje; Weber C, 2009, J IMMUNOL, V183, P4292, DOI 10.4049/jimmunol.0901724; WILSON RW, 1993, J IMMUNOL, V151, P1571; Xia P, 2002, J BIOL CHEM, V277, P7996, DOI 10.1074/jbc.M111423200; Yatomi Y, 2000, BLOOD, V96, P3431; Zachariah MA, 2010, SCIENCE, V328, P1129, DOI 10.1126/science.1188222	73	127	133	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7348	7358		10.1074/jbc.M110.171819	http://dx.doi.org/10.1074/jbc.M110.171819			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21173151	Green Published, hybrid			2022-12-27	WOS:000287737300051
J	Liao, MJ; Zhang, Y; Kang, JH; Dufau, ML				Liao, Mingjuan; Zhang, Ying; Kang, Jung-Hoon; Dufau, Maria L.			Coactivator Function of Positive Cofactor 4 ( PC4) in Sp1-directed Luteinizing Hormone Receptor (LHR) Gene Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE 1; SP1 SITES; REGULATE TRANSCRIPTION; PROLACTIN RECEPTOR; P53 FUNCTION; DNA-BINDING; PROMOTER; ACTIVATION; PROTEIN; EXPRESSION	The LHR has an essential role in sexual development and reproductive function, and its transcription is subjected to several modes of regulation. In this study, we investigated PC4 coactivator function in the control of LHR transcription. Knockdown of PC4 by siRNA inhibited the LHR basal promoter activity and trichostatin A (TSA)-induced gene transcriptional activation and expression in MCF-7 cells. While overexpression of PC4 alone had no effect on the LHR gene, it significantly enhanced Sp1-but not Sp3-mediated LHR transcriptional activity. PC4 directly interacts with Sp1 at the LHR promoter, and this interaction is negatively regulated by PC4 phosphorylation. The coactivator domain (22-91 aa) of PC4 and DNA binding domain of Sp1 are essential for PC4/Sp1 interaction. ChIP assay revealed significant occupancy of PC4 at the LHR promoter that increased upon TSA treatment. Disruption of PC4 expression significantly reduced TSA-induced recruitment of TFIIB and RNAP II, at the promoter. PC4 functions are beyond TSA-induced phosphatase release, PI3K-mediated Sp1 phosphorylation, and HDAC1/2/mSin3A co-repressor release indicating its role as linker coactivator of Sp1 and the transcriptional machinery. These findings demonstrated a critical aspect of LHR modulation whereby PC4 acts as a coactivator of Sp1 to contribute to the human of LHR transcription.	[Liao, Mingjuan; Zhang, Ying; Kang, Jung-Hoon; Dufau, Maria L.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Mol Endocrinol Sect, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Dufau, ML (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Mol Endocrinol Sect, Program Dev Endocrinol & Genet, NIH, Bldg 49,Rm 6A-36, Bethesda, MD 20892 USA.	dufaum@mail.nih.gov			National Institutes of Health through the Eunice Kennedy Shriver National Institute of Child Health and Human Development; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000150] Funding Source: NIH RePORTER	National Institutes of Health through the Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program through the Eunice Kennedy Shriver National Institute of Child Health and Human Development.	Banerjee S, 2004, MOL CELL BIOL, V24, P2052, DOI 10.1128/MCB.24.5.2052-2062.2004; Batta K, 2007, MOL CELL BIOL, V27, P7603, DOI 10.1128/MCB.01064-07; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; Conesa C, 2010, RNA BIOL, V7, P287, DOI 10.4161/rna.7.3.11491; Das C, 2010, J MOL BIOL, V397, P1, DOI 10.1016/j.jmb.2009.12.058; Doetzlhofer A, 1999, MOL CELL BIOL, V19, P5504; Dong J, 2006, J BIOL CHEM, V281, P18825, DOI 10.1074/jbc.M512826200; Dufau ML, 1998, ANNU REV PHYSIOL, V60, P461, DOI 10.1146/annurev.physiol.60.1.461; DUFAU ML, 2007, CONT ENDOCRINOLOGY, P227; GE H, 1994, P NATL ACAD SCI USA, V91, P12691, DOI 10.1073/pnas.91.26.12691; GE H, 1994, CELL, V78, P513, DOI 10.1016/0092-8674(94)90428-6; Geng Y, 1999, BIOCHEM BIOPH RES CO, V263, P366, DOI 10.1006/bbrc.1999.1374; Haile DT, 1999, J BIOL CHEM, V274, P2113, DOI 10.1074/jbc.274.4.2113; Holloway AF, 2000, J BIOL CHEM, V275, P21668, DOI 10.1074/jbc.M909058199; Hu ZZ, 1998, J BIOL CHEM, V273, P26225, DOI 10.1074/jbc.273.40.26225; Huang LL, 2000, ONCOGENE, V19, P5712, DOI 10.1038/sj.onc.1203963; Kadam S, 2000, GENE DEV, V14, P2441, DOI 10.1101/gad.828000; KAISER K, 1995, EMBO J, V14, P3520, DOI 10.1002/j.1460-2075.1995.tb07358.x; Kannan F, 1999, MOL CELL BIOL, V19, P899; Kim SN, 2009, MOL CANCER RES, V7, P735, DOI 10.1158/1541-7786.MCR-08-0296; KRETZSCHMAR M, 1994, CELL, V78, P525, DOI 10.1016/0092-8674(94)90429-4; Kumar BRP, 2001, J BIOL CHEM, V276, P16804, DOI 10.1074/jbc.M100934200; Lee JA, 2005, J BIOL CHEM, V280, P28061, DOI 10.1074/jbc.M414134200; Liao MJ, 2008, MOL ENDOCRINOL, V22, P1449, DOI 10.1210/me.2008-0035; Luo Y, 1998, MOL CELL BIOL, V18, P3803, DOI 10.1128/MCB.18.7.3803; Rosonina E, 2009, MOL CELL BIOL, V29, P2308, DOI 10.1128/MCB.01841-08; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Suzuki T, 2000, GENES CELLS, V5, P29, DOI 10.1046/j.1365-2443.2000.00302.x; Tsai-Morris CH, 1998, J CLIN ENDOCR METAB, V83, P288, DOI 10.1210/jc.83.1.288; TSAIMORRIS CH, 1994, J BIOL CHEM, V269, P15868; TSAIMORRIS CH, 1993, J BIOL CHEM, V268, P4447; UJHAZY P, 1994, INT J CANCER, V59, P83, DOI 10.1002/ijc.2910590117; Wang X, 2008, ONCOGENE, V27, P1894, DOI 10.1038/sj.onc.1210821; Zhang Y, 2005, MOL CELL BIOL, V25, P7929, DOI 10.1128/MCB.25.18.7929-7939.2005; Zhang Y, 2003, MOL CELL BIOL, V23, P6958, DOI 10.1128/MCB.23.19.6958-6972.2003; Zhang Y, 2002, J BIOL CHEM, V277, P33431, DOI 10.1074/jbc.M204417200; Zhang Y, 2000, J BIOL CHEM, V275, P2763, DOI 10.1074/jbc.275.4.2763; Zhang Y, 2001, MOL ENDOCRINOL, V15, P1891, DOI 10.1210/me.15.11.1891; Zhang Y, 2008, J BIOL CHEM, V283, P24039, DOI 10.1074/jbc.M801878200; Zhang Y, 2006, MOL CELL BIOL, V26, P6748, DOI 10.1128/MCB.00560-06; Zhong L, 2003, GENE, V320, P155, DOI 10.1016/S0378-1119(03)00823-0	42	12	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7681	7691		10.1074/jbc.M110.188532	http://dx.doi.org/10.1074/jbc.M110.188532			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193408	Green Published, hybrid			2022-12-27	WOS:000287737300081
J	Wei, L; Jiang, P; Xu, WX; Li, H; Zhang, H; Yan, LY; Chan-Park, MB; Liu, XW; Tang, K; Mu, YG; Pervushin, K				Wei, Lei; Jiang, Ping; Xu, Weixin; Li, Hai; Zhang, Hua; Yan, Liangyu; Chan-Park, Mary B.; Liu, Xue-Wei; Tang, Kai; Mu, Yuguang; Pervushin, Konstantin			The Molecular Basis of Distinct Aggregation Pathways of Islet Amyloid Polypeptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRIL FORMATION; BETA-PROTEIN; ALPHA-SYNUCLEIN; NMR-SPECTROSCOPY; HUMAN AMYLIN; IN-VITRO; ALZHEIMERS-DISEASE; TRANSGENIC MICE; OLIGOMERS; INSULIN	Abnormal aggregation of islet amyloid polypeptide (IAPP) into amyloid fibrils is a hallmark of type 2 diabetes. In this study, we investigated the initial oligomerization and subsequent addition of monomers to growing aggregates of human IAPP at the residue-specific level using NMR, atomic force microscopy, mass spectroscopy, and computational simulations. We found that in solution IAPPs rapidly associate into transient low-order oligomers such as dimers and trimers via interactions between histidine 18 and tyrosine 37. This initial event is proceeded by slow aggregation into higher-order spherical oligomers and elongated fibrils. In these two morphologically distinct types of aggregates IAPPs adopt structures with markedly different residual flexibility. Here we show that the anti-amyloidogenic compound resveratrol inhibits oligomerization and amyloid formation via binding to histidine 18, supporting the finding that this residue is crucial for on-pathway oligomer formation.	[Mu, Yuguang] Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore; [Li, Hai; Zhang, Hua] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore; [Yan, Liangyu; Chan-Park, Mary B.] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore; [Liu, Xue-Wei] Nanyang Technol Univ, Sch Phys & Math Sci, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Mu, YG (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore 639798, Singapore.	ygmu@ntu.edu.sg; kpervushin@ntu.edu.sg	Zhang, Hua/A-1302-2009; Mu, Yuguang/A-9558-2010; xu, weixin/B-5519-2011; Chan-Park, Mary B/G-6196-2010; Li, Hai/E-7555-2011; Pervushin, Konstantin/AAJ-6580-2020; Tang, Kai/A-2194-2011	Zhang, Hua/0000-0001-9518-740X; Chan-Park, Mary B/0000-0003-3761-7517; Li, Hai/0000-0002-9659-1153; Pervushin, Konstantin/0000-0002-6393-4340; , Dahabada/0000-0002-5411-9264	MOE [T206B3210RS]; Singapore National Research Foundation [NRF-CRP2-2007-02]	MOE(Ministry of Higher Education & Scientific Research (MHESR)); Singapore National Research Foundation(National Research Foundation, Singapore)	This work was supported in part by AcRF Tier 2 by the MOE (T206B3210RS) (to Y. M. and K. P.) and a competitive research program grant from the Singapore National Research Foundation (NRF-CRP2-2007-02) (to M. B. C.-P.).	Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; CHARGE SBP, 1995, BIOCHEMISTRY-US, V34, P14588, DOI 10.1021/bi00044a038; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Dobson CM, 2006, PROTEIN PEPTIDE LETT, V13, P219, DOI 10.2174/092986606775338362; Evers F, 2009, J AM CHEM SOC, V131, P9516, DOI 10.1021/ja8097417; Farrell D, 2010, PROTEINS, V78, P843, DOI 10.1002/prot.22611; FOX N, 1993, FEBS LETT, V323, P40, DOI 10.1016/0014-5793(93)81444-5; Giannakis E, 2008, BBA-BIOMEMBRANES, V1778, P1112, DOI 10.1016/j.bbamem.2008.01.012; Gilead S, 2006, ANGEW CHEM INT EDIT, V45, P6476, DOI 10.1002/anie.200602034; Gilead S, 2008, EXP DIABETES RES, DOI 10.1155/2008/256954; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Grant MA, 2007, P NATL ACAD SCI USA, V104, P16522, DOI 10.1073/pnas.0705197104; Green JD, 2004, J BIOL CHEM, V279, P12206, DOI 10.1074/jbc.M312452200; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Jaikaran ETAS, 2004, BIOCHEM J, V377, P709, DOI 10.1042/bj20030852; Jaikaran ETAS, 2001, J MOL BIOL, V308, P515, DOI 10.1006/jmbi.2001.4593; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kayed R, 1999, J MOL BIOL, V287, P781, DOI 10.1006/jmbi.1999.2646; Kudva YC, 1998, BIOCHEM J, V331, P809, DOI 10.1042/bj3310809; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; LeVine H, 1999, METHOD ENZYMOL, V309, P274; LeVine H, 1999, METHOD ENZYMOL, V309, P467; Lin CY, 2007, DIABETES, V56, P1324, DOI 10.2337/db06-1579; Lomakin A, 2003, P NATL ACAD SCI USA, V100, P10254, DOI 10.1073/pnas.1334069100; Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Meier JJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE1317, DOI 10.1152/ajpendo.00082.2006; Nilsson MR, 1999, J MOL BIOL, V294, P1375, DOI 10.1006/jmbi.1999.3286; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Peng Y, 2005, J PHYS CHEM B, V109, P15145, DOI 10.1021/jp0511956; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Serpell LC, 2000, J MOL BIOL, V300, P1033, DOI 10.1006/jmbi.2000.3908; Sette M, 1999, RNA, V5, P82, DOI 10.1017/S1355838299981487; Smith AM, 2006, J MOL BIOL, V364, P9, DOI 10.1016/j.jmb.2006.08.081; Soong R, 2009, J AM CHEM SOC, V131, P7079, DOI 10.1021/ja900285z; Sunde M, 1998, Q REV BIOPHYS, V31, P1, DOI 10.1017/S0033583598003400; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; SZYPERSKI T, 1994, BIOCHEMISTRY-US, V33, P9303, DOI 10.1021/bi00197a034; Tieleman DP, 1997, BBA-REV BIOMEMBRANES, V1331, P235, DOI 10.1016/S0304-4157(97)00008-7; Vaiana SM, 2008, BIOPHYS J, V94, pL45, DOI 10.1529/biophysj.107.125146; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wei L, 2009, BIOCHEMISTRY-US, V48, P2368, DOI 10.1021/bi802097b; WESTERMARK P, 1973, ACTA PATH MICRO IM A, VA 81, P291; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Williamson JA, 2009, J MOL BIOL, V393, P383, DOI 10.1016/j.jmb.2009.07.077; Wiltzius JJW, 2008, PROTEIN SCI, V17, P1467, DOI 10.1110/ps.036509.108; Xu WX, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3123532; Yong W, 2002, P NATL ACAD SCI USA, V99, P150, DOI 10.1073/pnas.012584899	58	93	94	1	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6291	6300		10.1074/jbc.M110.166678	http://dx.doi.org/10.1074/jbc.M110.166678			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21148563	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000287476400039
J	Polanska, UM; Edwards, E; Fernig, DG; Kinnunen, TK				Polanska, Urszula M.; Edwards, Elisabeth; Fernig, David G.; Kinnunen, Tarja K.			The Cooperation of FGF Receptor and Klotho Is Involved in Excretory Canal Development and Regulation of Metabolic Homeostasis in Caenorhabditis elegans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTS ENCODING MEMBRANE; C-ELEGANS; BETA-KLOTHO; SIGNALING PATHWAY; TRPV5 CHANNEL; GENE; PROTEIN; SYSTEM; CELL; MAINTENANCE	FGFs have traditionally been associated with cell proliferation, morphogenesis, and development; yet, a subfamily of FGFs (FGF19, -21, and -23) functions as hormones to regulate glucose, lipid, phosphate, and vitamin D metabolism with impact on energy balance and aging. In mammals, Klotho and beta-Klotho are type 1 transmembrane proteins that function as obligatory co-factors for endocrine FGFs to bind to their cognate FGF receptors (FGFRs). Mutations in Klotho/beta-Klotho or fgf19, -21, or -23 are associated with a number of human diseases, including autosomal dominant hypophosphatemic rickets, premature aging disorders, and diabetes. The Caenorhabditis elegans genome contains two paralogues of Klotho/beta-Klotho, klo-1, and klo-2. klo-1 is expressed in the C. elegans excretory canal, which is structurally and functionally paralogous to the vertebrate kidney. KLO-1 associates with EGL-15/FGFR, suggesting a role for KLO-1 in the fluid homeostasis phenotype described previously for egl-15/fgfr mutants. Altered levels of EGL-15/FGFR signaling lead to defects in excretory canal development and function in C. elegans. These results suggest an evolutionarily conserved function for the FGFR-Klotho complex in the development of excretory organs such as the mammalian kidney and the worm excretory canal. These results also suggest an evolutionarily conserved function for the FGFR-Klotho axis in metabolic regulation.	[Polanska, Urszula M.; Edwards, Elisabeth; Fernig, David G.; Kinnunen, Tarja K.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 7ZB, Merseyside, England	University of Liverpool	Kinnunen, TK (corresponding author), Univ Liverpool, Inst Integrat Biol, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England.	T.K.Kinnunen@liverpool.ac.uk	Fernig, David G/A-3590-2008	Fernig, David G/0000-0003-4875-4293; Kinnunen, Dr Tarja K/0000-0001-5630-2233	National Institutes of Health National Center for Research Resources; C. elegans Knock-out Consortium; European Union; North West Cancer Research Fund; Cancer and Polio Research Fund; Medical Research Council; Medical Research Council [G0601549] Funding Source: researchfish; MRC [G0601549] Funding Source: UKRI	National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); C. elegans Knock-out Consortium; European Union(European Commission); North West Cancer Research Fund; Cancer and Polio Research Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Some strains used in this study were obtained from the Caenorhabditis Genetics Center, which is supported by the National Institutes of Health National Center for Research Resources, and by the C. elegans Knock-out Consortium. This work was supported by a European Union Marie Curie Early Stage Training Programme (to U. M. P.), by the North West Cancer Research Fund and the Cancer and Polio Research Fund (to D. G. F.), and by the Medical Research Council (to T. K. K.).	Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Birnbaum D, 2005, DEV DYNAM, V232, P247, DOI 10.1002/dvdy.20219; Bloch L, 2009, FEBS LETT, V583, P3221, DOI 10.1016/j.febslet.2009.09.009; Borland CZ, 2001, BIOESSAYS, V23, P1120, DOI 10.1002/bies.10007; BRENNER S, 1974, GENETICS, V77, P71; Buechner M, 2002, TRENDS CELL BIOL, V12, P479, DOI 10.1016/S0962-8924(02)02364-4; Bulow HE, 2004, NEURON, V42, P367, DOI 10.1016/S0896-6273(04)00246-6; Burdine RD, 1997, P NATL ACAD SCI USA, V94, P2433, DOI 10.1073/pnas.94.6.2433; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; DEVORE DL, 1995, CELL, V83, P611, DOI 10.1016/0092-8674(95)90101-9; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Ito S, 2005, J CLIN INVEST, V115, P2202, DOI 10.1172/JCI23076; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Kharitonenkov A, 2009, CURR OPIN PHARMACOL, V9, P805, DOI 10.1016/j.coph.2009.07.001; Kokel M, 1998, GENE DEV, V12, P1425, DOI 10.1101/gad.12.10.1425; Kuro-o M, 2006, CURR OPIN NEPHROL HY, V15, P437, DOI 10.1097/01.mnh.0000232885.81142.83; Kuro-o M, 2010, PFLUG ARCH EUR J PHY, V459, P333, DOI 10.1007/s00424-009-0722-7; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Lin BC, 2007, J BIOL CHEM, V282, P27277, DOI 10.1074/jbc.M704244200; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; NELSON FK, 1984, J EXP ZOOL, V231, P45, DOI 10.1002/jez.1402310107; NELSON FK, 1983, J ULTRA MOL STRUCT R, V82, P156; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Ornitz DM, 2001, GENOME BIOL, V2; Polanska UM, 2009, J BIOL CHEM, V284, P33030, DOI 10.1074/jbc.M109.058925; Polanska UM, 2009, DEV DYNAM, V238, P277, DOI 10.1002/dvdy.21757; Razzaque MS, 2007, J ENDOCRINOL, V194, P1, DOI 10.1677/JOE-07-0095; Roubin R, 1999, ONCOGENE, V18, P6741, DOI 10.1038/sj.onc.1203074; Sasson IE, 2004, DEVELOPMENT, V131, P5381, DOI 10.1242/dev.01423; Selfors LM, 1998, P NATL ACAD SCI USA, V95, P6903, DOI 10.1073/pnas.95.12.6903; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shiraki-Iida T, 1998, FEBS LETT, V424, P6, DOI 10.1016/S0014-5793(98)00127-6; Teramoto T, 2005, CELL METAB, V1, P343, DOI 10.1016/j.cmet.2005.04.007; Tohyama O, 2004, J BIOL CHEM, V279, P9777, DOI 10.1074/jbc.M312392200; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315	42	18	21	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5657	5666		10.1074/jbc.M110.173039	http://dx.doi.org/10.1074/jbc.M110.173039			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21177529	Green Published, hybrid			2022-12-27	WOS:000287230600075
J	Zhang, LY; Fujita, T; Wu, G; Xiao, XA; Wan, Y				Zhang, Liyong; Fujita, Takeo; Wu, George; Xiao, Xiao; Wan, Yong			Phosphorylation of the Anaphase-promoting Complex/Cdc27 Is Involved in TGF-beta Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; PROTEIN-KINASE CK2; MITOTIC PROGRESSION; CANCER; SNON; SKI; SMAD3; GENE; CDH1; DIFFERENTIATION	Loss of TGF-beta-induced growth inhibition is a hallmark of many human tumors. Previous studies implied that activation of the anaphase-promoting complex (APC/cyclosome) is involved in the TGF-beta signaling pathway, which facilitates the destruction of SnoN, a transcriptional co-suppressor, which leads in turn to the transactivation of TGF-beta-responsive genes for cell cycle arrest. The function of APC was demonstrated in TGF-beta signal transduction, but the mechanism by which it is activated in response to TGF-beta signaling remains unclear. We report here that phosphorylation of Cdc27, a core subunit of APC, in response to TGF-beta signaling can facilitate the activation of APC. We have demonstrated that casein kinase II (CKII) is involved in the phosphorylation of Cdc27 in response to TGF-beta signaling. Depletion of CKII by shRNA abolishes the TGF-beta-induced phosphorylation of Cdc27 and subsequent degradation of SnoN. Disruptive mutation of Cdc27 (S154A) attenuates TGF-beta-induced SnoN degradation. In addition, expression of a phosphorylation-resistant Cdc27 mutant significantly attenuates TGF-beta-induced growth inhibition. Together, the results suggest that phosphorylation of Cdc27 by CKII is involved in TGF-beta-induced activation of APC.	[Wan, Yong] Univ Pittsburgh, Hillman Canc Ctr, Dept Cell Biol & Physiol, Sch Med, Pittsburgh, PA 15213 USA; [Zhang, Liyong; Fujita, Takeo; Wu, George; Xiao, Xiao; Wan, Yong] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA; [Fujita, Takeo] Natl Canc Ctr Hosp, Kashiwa, Chiba 2778577, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Cancer Center - Japan	Wan, Y (corresponding author), Univ Pittsburgh, Hillman Canc Ctr, Dept Cell Biol & Physiol, Sch Med, Suite 2-6C,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	yow4@pitt.edu		Zhang, Liyong/0000-0002-6952-7463	National Institutes of Health [CA115943]; NATIONAL CANCER INSTITUTE [R01CA115943, R01CA154695] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA115943.	Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Block K, 2001, J BIOL CHEM, V276, P41049, DOI 10.1074/jbc.M106453200; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Clarke DC, 2008, TRENDS CELL BIOL, V18, P430, DOI 10.1016/j.tcb.2008.06.006; Cooper CD, 2002, J BIOL CHEM, V277, P44962, DOI 10.1074/jbc.M209427200; Fujita T, 2008, MOL BIOL CELL, V19, P5446, DOI 10.1091/mbc.E08-03-0289; Gao Y, 2009, J VIROL, V83, P2393, DOI 10.1128/JVI.02339-08; Guo X, 2008, ONCOGENE, V27, P7235, DOI 10.1038/onc.2008.337; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Imoto I, 2001, BIOCHEM BIOPH RES CO, V286, P559, DOI 10.1006/bbrc.2001.5428; Kim EK, 2009, GENE, V431, P55, DOI 10.1016/j.gene.2008.10.020; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555; Lee NY, 2009, FASEB J, V23, P3712, DOI 10.1096/fj.09-131607; Liu WJ, 2007, MOL CELL BIOL, V27, P2967, DOI 10.1128/MCB.01830-06; Luo KX, 2004, CURR OPIN GENET DEV, V14, P65, DOI 10.1016/j.gde.2003.11.003; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Negulescu O, 2002, KIDNEY INT, V62, P1989, DOI 10.1046/j.1523-1755.2002.00679.x; NOMURA N, 1989, NUCLEIC ACIDS RES, V17, P5489, DOI 10.1093/nar/17.14.5489; Palframan WJ, 2006, SCIENCE, V313, P680, DOI 10.1126/science.1127205; Pallares J, 2009, AM J PATHOL, V174, P287, DOI 10.2353/ajpath.2009.080552; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; ROBERTS AB, 1990, PHILOS T R SOC B, V327, P145, DOI 10.1098/rstb.1990.0050; Shen J, 2001, J IMMUNOL, V167, P4919, DOI 10.4049/jimmunol.167.9.4919; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Singh NN, 2006, ARTERIOSCL THROM VAS, V26, P1323, DOI 10.1161/01.ATV.0000220383.19192.55; Soufi A, 2009, NUCLEIC ACIDS RES, V37, P3288, DOI 10.1093/nar/gkp197; St-Denis NA, 2009, CELL MOL LIFE SCI, V66, P1817, DOI 10.1007/s00018-009-9150-2; St-Denis NA, 2009, MOL CELL BIOL, V29, P2068, DOI 10.1128/MCB.01563-08; Stroschein SL, 2001, GENE DEV, V15, P2822; Stroschein SL, 1999, SCIENCE, V286, P771, DOI 10.1126/science.286.5440.771; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Sun Y, 1999, MOL CELL, V4, P499, DOI 10.1016/S1097-2765(00)80201-4; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Waddell DS, 2004, J BIOL CHEM, V279, P29236, DOI 10.1074/jbc.M400880200; Wan Y, 2001, P NATL ACAD SCI USA, V98, P13066, DOI 10.1073/pnas.231487598; Wan Y, 1996, NATURE, V380, P541, DOI 10.1038/380541a0; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Wu G, 2007, MOL BIOL CELL, V18, P1018, DOI 10.1091/mbc.E06-09-0809	42	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10041	10050		10.1074/jbc.M110.205518	http://dx.doi.org/10.1074/jbc.M110.205518			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21209074	hybrid, Green Published			2022-12-27	WOS:000288547000018
J	Cherney, MM; Lecaille, F; Kienitz, M; Nallaseth, FS; Li, ZQ; James, MNG; Bromme, D				Cherney, Maia M.; Lecaille, Fabien; Kienitz, Martin; Nallaseth, Ferez S.; Li, Zhenqiang; James, Michael N. G.; Broemme, Dieter			Structure-Activity Analysis of Cathepsin K/Chondroitin 4-Sulfate Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGENOLYTIC ACTIVITY; PROTEASE; CRYSTAL; EXPRESSION; SYSTEM	In the presence of oligomeric chondroitin 4-sulfate (C4-S), cathepsin K (catK) forms a specific complex that was shown to be the source of the major collagenolytic activity in bone osteoclasts. C4-S forms multiple contacts with amino acid residues on the backside of the catK molecule that help to facilitate complex formation. As cathepsin L does not exhibit a significant collagenase activity in the presence or in the absence of C4-S, we substituted the C4-S interacting residues in catK with those of cathepsin L. Variants revealed altered collagenolytic activities with the largest inhibitory effect shown by the hexavariant M5. None of the variants showed a reduction in their gelatinolytic and peptidolytic activities when compared with wild-type catK, indicating no structural alteration within their active sites. However, the crystal structure of the M5 variant in the presence of oligomeric C4-S revealed a different binding of chondroitin 4-sulfate. C4-S is not continuously ordered as it is in the wildtype catK.C4-S complex. The orientation and the direction of the hexasaccharide on the catK surface have changed, so that the hexasaccharide is positioned between two symmetry-related molecules. Only one M5 variant molecule of the dimer that is present in the asymmetric unit interacts with C4-S. These substitutions have changed the mode of catK binding to C4-S and, as a result, have likely affected the collagenolytic potential of the variant. The data presented here support our hypothesis that distinct catK/C4-S interactions are necessary for the collagenolytic activity of the enzyme.	[Cherney, Maia M.; Kienitz, Martin; James, Michael N. G.] Univ Alberta, Grp Prot Struct & Funct, Dept Biochem, Sch Mol & Syst Med, Edmonton, AB T6G 2H7, Canada; [Lecaille, Fabien; Nallaseth, Ferez S.; Li, Zhenqiang; Broemme, Dieter] Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA	University of Alberta; Icahn School of Medicine at Mount Sinai	James, MNG (corresponding author), Univ British Columbia, Inst Life Sci, 2350 Hlth Sci Mall,Rm 4558, Vancouver, BC V6T 1Z3, Canada.	michael.james@ualberta.ca; dbromme@interchange.ubc.ca	Lecaille, Fabien/GRY-5313-2022	James, Michael/0000-0002-5978-4562; Lecaille, Fabien/0000-0003-1060-4222	Canada Research Chair; National Institutes of Health [AR 48669]; Canadian Institutes of Health Research [FRN 12831]; Alberta Heritage Foundation for Medical Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048669] Funding Source: NIH RePORTER	Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by a Canada Research Chair Award (Protease in Diseases to D. B.), National Institutes of Health Grant AR 48669 (to D. B.), and Canadian Institutes of Health Research Grant FRN 12831 (to M. N. G. J.) and from the Alberta Heritage Foundation for Medical Research (to M. N. G. J.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BARRETT AJ, 1981, ACTA BIOL MED GER, V40, P1513; Bromme D, 2004, METHODS, V32, P199, DOI 10.1016/S1046-2023(03)00212-3; Bromme D, 1996, J BIOL CHEM, V271, P2126, DOI 10.1074/jbc.271.4.2126; BROMME D, 1995, BIOL CHEM H-S, V376, P379, DOI 10.1515/bchm3.1995.376.6.379; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; DeLano W.L, PYMOL MOL GRAPHICS S; Drake FH, 1996, J BIOL CHEM, V271, P12511, DOI 10.1074/jbc.271.21.12511; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; Hou WS, 1999, J CLIN INVEST, V103, P731, DOI 10.1172/JCI653; Hou WS, 2001, AM J PATHOL, V159, P2167, DOI 10.1016/S0002-9440(10)63068-4; Kafienah W, 1998, BIOCHEM J, V331, P727, DOI 10.1042/bj3310727; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lecaille F, 2002, BIOCHEMISTRY-US, V41, P8447, DOI 10.1021/bi025638x; Li ZQ, 2008, J MOL BIOL, V383, P78, DOI 10.1016/j.jmb.2008.07.038; Li ZQ, 2004, J BIOL CHEM, V279, P5470, DOI 10.1074/jbc.M310349200; Li ZQ, 2002, J BIOL CHEM, V277, P28669, DOI 10.1074/jbc.M204004200; Li ZQ, 2000, BIOCHEMISTRY-US, V39, P529, DOI 10.1021/bi992251u; Linnevers CJ, 1997, PROTEIN SCI, V6, P919; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; STRYNADKA NCJ, 1989, ANNU REV BIOCHEM, V58, P951, DOI 10.1146/annurev.bi.58.070189.004511; Wilson S, 2009, AM J PATHOL, V175, P2053, DOI 10.2353/ajpath.2009.090211; Yamashita DS, 2006, J MED CHEM, V49, P1597, DOI 10.1021/jm050915u	27	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8988	8998		10.1074/jbc.M110.126706	http://dx.doi.org/10.1074/jbc.M110.126706			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21193413	hybrid, Green Published			2022-12-27	WOS:000288247700030
J	Gruenig, MC; Lu, D; Won, SJ; Dulberger, CL; Manlick, AJ; Keck, JL; Cox, MM				Gruenig, Marielle C.; Lu, Duo; Won, Sang Joon; Dulberger, Charles L.; Manlick, Angela J.; Keck, James L.; Cox, Michael M.			Creating Directed Double-strand Breaks with the Ref Protein A NOVEL RecA-DEPENDENT NUCLEASE FROM BACTERIOPHAGE P1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL RECA PROTEIN; ESCHERICHIA-COLI-RECA; LEXA REPRESSOR; HOMOLOGOUS RECOMBINATION; ATP HYDROLYSIS; SOS INDUCTION; DNA; CLEAVAGE; MECHANISM; FILAMENT	The bacteriophage P1-encoded Ref protein enhances RecA-dependent recombination in vivo by an unknown mechanism. We demonstrate that Ref is a new type of enzyme; that is, a RecA-dependent nuclease. Ref binds to ss-and dsDNA but does not cleave any DNA substrate until RecA protein and ATP are added to form RecA nucleoprotein filaments. Ref cleaves only where RecA protein is bound. RecA functions as a co-nuclease in the Ref/RecA system. Ref nuclease activity can be limited to the targeted strands of short RecA-containing D-loops. The result is a uniquely programmable endonuclease activity, producing targeted double-strand breaks at any chosen DNA sequence in an oligonucleotide-directed fashion. We present evidence indicating that cleavage occurs in the RecA filament groove. The structure of the Ref protein has been determined to 1.4 angstrom resolution. The core structure, consisting of residues 77-186, consists of a central 2-stranded beta-hairpin that is sandwiched between several alpha-helicaland extended loop elements. The N-terminal 76 amino acid residues are disordered; this flexible region is required for optimal activity. The overall structure of Ref, including several putative active site histidine residues, defines a new subclass of HNH-family nucleases. We propose that enhancement of recombination by Ref reflects the introduction of directed, recombinogenic double-strand breaks.	[Gruenig, Marielle C.; Won, Sang Joon; Dulberger, Charles L.; Manlick, Angela J.; Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53575 USA; [Lu, Duo; Keck, James L.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Cox, MM (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53575 USA.	cox@biochem.wisc.edu		Keck, James/0000-0002-5961-0220	National Institutes of Health [GM32335, GM068061]; William R. and Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068061, R01GM032335, U01GM032335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William R. and Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM32335 (to M. M. C.) and GM068061 (NIGMS; to J. L. K.). This work was also supported by a William R. and Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowship (to M. C. G.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAGDASARIAN M, 1992, MOL MICROBIOL, V6, P885, DOI 10.1111/j.1365-2958.1992.tb01539.x; BAILONE A, 1988, MOL GEN GENET, V214, P389, DOI 10.1007/BF00330471; BRENNER SL, 1987, J BIOL CHEM, V262, P4011; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Churchill JJ, 2000, J MOL BIOL, V297, P537, DOI 10.1006/jmbi.2000.3590; Churchill JJ, 1999, GENE DEV, V13, P901, DOI 10.1101/gad.13.7.901; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; CRAIG NL, 1981, J BIOL CHEM, V256, P8039; Drees JC, 2006, J BIOL CHEM, V281, P4708, DOI 10.1074/jbc.M513592200; Drees JC, 2004, J BIOL CHEM, V279, P52991, DOI 10.1074/jbc.M409050200; Drees JC, 2004, MOL CELL, V15, P789, DOI 10.1016/j.molcel.2004.08.026; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frank EG, 2000, J MOL BIOL, V297, P585, DOI 10.1006/jmbi.2000.3591; GarinotSchneider C, 1996, J MOL BIOL, V260, P731, DOI 10.1006/jmbi.1996.0433; GEISELMANN J, 1993, P NATL ACAD SCI USA, V90, P7754, DOI 10.1073/pnas.90.16.7754; Gruenig MC, 2008, MOL MICROBIOL, V69, P1165, DOI 10.1111/j.1365-2958.2008.06341.x; Harmon FG, 1996, J BIOL CHEM, V271, P23874, DOI 10.1074/jbc.271.39.23874; Haruta N, 2003, J BIOL CHEM, V278, P52710, DOI 10.1074/jbc.M308563200; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; HUNT JB, 1984, J BIOL CHEM, V259, P4793; Jiang QF, 2009, NATURE, V460, P359, DOI 10.1038/nature08178; KIM B, 1993, CELL, V73, P1165, DOI 10.1016/0092-8674(93)90645-7; KOCH WH, 1992, MOL GEN GENET, V233, P443, DOI 10.1007/BF00265442; LAVERY PE, 1992, J BIOL CHEM, V267, P20648; Lobocka MB, 2004, J BACTERIOL, V186, P7032, DOI 10.1128/JB.186.21.7032-7068.2004; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LU SD, 1989, J BACTERIOL, V171, P3427, DOI 10.1128/jb.171.6.3427-3432.1989; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Lusetti SL, 2004, J BIOL CHEM, V279, P30037, DOI 10.1074/jbc.M403064200; MARRIONE PE, 1995, BIOCHEMISTRY-US, V34, P9809, DOI 10.1021/bi00030a019; Mate MJ, 2004, J BIOL CHEM, V279, P34763, DOI 10.1074/jbc.M403719200; McIlwraith MJ, 2001, J MOL BIOL, V305, P23, DOI 10.1006/jmbi.2000.4268; Mehta P, 2004, PROTEIN SCI, V13, P295, DOI 10.1110/ps.03115604; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; NEUENDORF SK, 1986, J BIOL CHEM, V261, P8276; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel M, 2010, CRIT REV BIOCHEM MOL, V45, P171, DOI 10.3109/10409238.2010.480968; Petrova V, 2009, MOL CELL, V36, P121, DOI 10.1016/j.molcel.2009.07.026; Robu ME, 2004, J BIOL CHEM, V279, P10973, DOI 10.1074/jbc.M312184200; Shigemori Y, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh004; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; SLILATY SN, 1987, P NATL ACAD SCI USA, V84, P3987, DOI 10.1073/pnas.84.12.3987; Soultanas P, 2000, CURR OPIN STRUC BIOL, V10, P124, DOI 10.1016/S0959-440X(99)00059-7; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Stohl EA, 2003, J BIOL CHEM, V278, P2278, DOI 10.1074/jbc.M210496200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VanLoock MS, 2003, J MOL BIOL, V333, P345, DOI 10.1016/j.jmb.2003.08.053; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Walker GC, 2000, BACTERIAL STRESS RESPONSES, P131; WINDLE BE, 1986, P NATL ACAD SCI USA, V83, P3885, DOI 10.1073/pnas.83.11.3885; WINDLE BE, 1988, J BACTERIOL, V170, P4881, DOI 10.1128/jb.170.10.4881-4889.1988; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yarmolinsky MB, 2004, J BACTERIOL, V186, P7025, DOI 10.1128/JB.186.21.7025-7028.2004; YONG YQ, 1995, J BIOL CHEM, V270, P24509, DOI 10.1074/jbc.270.41.24509; YU X, 1993, J MOL BIOL, V231, P29, DOI 10.1006/jmbi.1993.1254; YU X, 1992, J MOL BIOL, V227, P334, DOI 10.1016/0022-2836(92)90702-L	59	12	15	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8240	8251		10.1074/jbc.M110.205088	http://dx.doi.org/10.1074/jbc.M110.205088			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21193392	Green Published, hybrid			2022-12-27	WOS:000288013300054
J	Ohnsorg, PM; Rohrer, L; Perisa, D; Kateifides, A; Chroni, A; Kardassis, D; Zannis, VI; von Eckardstein, A				Ohnsorg, Pascale M.; Rohrer, Lucia; Perisa, Damir; Kateifides, Andreas; Chroni, Angeliki; Kardassis, Dimitris; Zannis, Vassilis I.; von Eckardstein, Arnold			Carboxyl Terminus of Apolipoprotein A-I (ApoA-I) Is Necessary for the Transport of Lipid-free ApoA-I but Not Prelipidated ApoA-I Particles through Aortic Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEIN; SCAVENGER RECEPTOR BI; CHOLESTEROL EFFLUX; CELLULAR CHOLESTEROL; SR-BI; BINDING; HDL; ABCA1; MUTATIONS; MODEL	High density lipoproteins (HDL) and apolipoprotein A-I (apoA-I) must leave the circulation and pass the endothelium to exert their atheroprotective actions in the arterial wall. We previously demonstrated that the transendothelial transport of apoA-I involves ATP-binding cassette transporter (ABC) A1 and re-secretion of lipidated particles. Transendothelial transport of HDL is modulated by ABCG1 and the scavenger receptor BI (SR-BI). We hypothesize that apoA-I transport is started by the ABCA1-mediated generation of a lipidated particle which is then transported by ABCA1-independent pathways. To test this hypothesis we analyzed the endothelial binding and transport properties of initially lipid-free as well as prelipidated apoA-I mutants. Lipid-free apoA-I mutants with a defective carboxyl-terminal domain showed an 80% decreased specific binding and 90% decreased specific transport by aortic endothelial cells. After prior cell-free lipidation of the mutants, the resulting HDL-like particles were transported through endothelial cells by an ABCG1- and SR-BI-dependent process. ApoA-I mutants with deletions of either the amino terminus or both the amino and carboxyl termini showed dramatic increases in nonspecific binding but no specific binding or transport. Prior cell-free lipidation did not rescue these anomalies. Our findings of stringent structure-function relationships underline the specificity of transendothelial apoA-I transport and suggest that lipidation of initially lipid-free apoA-I is necessary but not sufficient for specific transendothelial transport. Our data also support the model of a two-step process for the transendothelial transport of apoA-I in which apoA-I is initially lipidated by ABCA1 and then further processed by ABCA1-independent mechanisms.	[Ohnsorg, Pascale M.; Rohrer, Lucia; Perisa, Damir; von Eckardstein, Arnold] Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland; [Ohnsorg, Pascale M.; von Eckardstein, Arnold] Univ Zurich, CH-8091 Zurich, Switzerland; [Ohnsorg, Pascale M.; von Eckardstein, Arnold] ETH, Competence Ctr Syst Physiol & Metab Dis, CH-8091 Zurich, Switzerland; [Rohrer, Lucia; Perisa, Damir; von Eckardstein, Arnold] Univ Zurich, Ctr Integrat Human Physiol, CH-8091 Zurich, Switzerland; [Kateifides, Andreas; Zannis, Vassilis I.] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Chroni, Angeliki] Natl Ctr Sci Res Demokritos, Inst Biol, Athens 15310, Greece; [Kateifides, Andreas; Kardassis, Dimitris; Zannis, Vassilis I.] Univ Crete, Sch Med, Dept Biochem, Div Basic Sci,Inst Mol Biol & Biotechnol, Iraklion 71201, Greece	University of Zurich; University Zurich Hospital; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); Boston University; National Centre of Scientific Research "Demokritos"; University of Crete	von Eckardstein, A (corresponding author), Univ Zurich Hosp, Inst Clin Chem, Raemistr 100, CH-8091 Zurich, Switzerland.	arnold.voneckardstein@usz.ch	Perisa, Damir/I-4217-2012; Kateifides, Andreas/E-9269-2011	Chroni, Angeliki/0000-0003-3107-1189; Zannis, Vassilis/0000-0002-1295-7155	National Institutes of Health [HL48739]; Swiss National Research Foundation [3100AO-116404/1, 31003A_130836/1]; European Grant [LSHM-CT-2006-0376331]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); European Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL48739. This work was also supported by Swiss National Research Foundation Grants 3100AO-116404/1, 31003A_130836/1 and European Grant LSHM-CT-2006-0376331.	Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; Azuma Y, 2009, GENES CELLS, V14, P191, DOI 10.1111/j.1365-2443.2008.01261.x; Borhani DW, 1999, ACTA CRYSTALLOGR D, V55, P1578, DOI 10.1107/S0907444999008914; BROWN WV, 1969, J BIOL CHEM, V244, P5687; Cavelier C, 2006, CIRC RES, V99, P1060, DOI 10.1161/01.RES.0000250567.17569.b3; Chroni A, 2005, BIOCHEMISTRY-US, V44, P14353, DOI 10.1021/bi050962o; Chroni A, 2004, BIOCHEMISTRY-US, V43, P2126, DOI 10.1021/bi035813p; Chroni A, 2003, J BIOL CHEM, V278, P6719, DOI 10.1074/jbc.M205232200; Chroni A, 2007, BIOCHEMISTRY-US, V46, P5697, DOI 10.1021/bi602354t; Curtiss LK, 2006, ARTERIOSCL THROM VAS, V26, P12, DOI 10.1161/01.ATV.0000194291.94269.5a; Fitzgerald ML, 2004, J LIPID RES, V45, P287, DOI 10.1194/jlr.M300355-JLR200; Gajdusek C. M., 1983, IN VITRO, V19, P394; Gorshkova IN, 2002, BIOCHEMISTRY-US, V41, P10529, DOI 10.1021/bi025807d; HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182; Jessup W, 2006, CURR OPIN LIPIDOL, V17, P247, DOI 10.1097/01.mol.0000226116.35555.eb; Koukos G, 2007, BIOCHEM J, V406, P167, DOI 10.1042/BJ20070296; Le Goff W, 2004, ARTERIOSCL THROM VAS, V24, P2155, DOI 10.1161/01.ATV.0000144811.94581.52; Li L, 2004, J MOL BIOL, V343, P1293, DOI 10.1016/j.jmb.2004.09.017; Liadaki KN, 2000, J BIOL CHEM, V275, P21262, DOI 10.1074/jbc.M002310200; Liu LJ, 2003, J BIOL CHEM, V278, P42976, DOI 10.1074/jbc.M308420200; Liu T, 2002, J BIOL CHEM, V277, P21576, DOI 10.1074/jbc.M112103200; Lorenzi I, 2008, BBA-MOL CELL BIOL L, V1781, P306, DOI 10.1016/j.bbalip.2008.04.006; Lorenzi I, 2008, J MOL MED, V86, P171, DOI 10.1007/s00109-007-0267-1; Marcel YL, 2003, CURR OPIN LIPIDOL, V14, P151, DOI 10.1097/00041433-200304000-00006; Miller YI, 2010, SUBCELL BIOCHEM, V51, P229, DOI 10.1007/978-90-481-8622-8_8; Minshall R. D., 2006, V176, P107; NOLTE RT, 1992, BIOPHYS J, V63, P1221, DOI 10.1016/S0006-3495(92)81698-3; Oram JF, 2003, ARTERIOSCL THROM VAS, V23, P720, DOI 10.1161/01.ATV.0000054662.44688.9A; Reardon CA, 2001, BIOCHEMISTRY-US, V40, P13670, DOI 10.1021/bi011451e; Rohrer L, 2006, BBA-MOL CELL BIOL L, V1761, P186, DOI 10.1016/j.bbalip.2006.01.009; Rohrer L, 2009, CIRC RES, V104, P1142, DOI 10.1161/CIRCRESAHA.108.190587; Segrest JP, 1999, J BIOL CHEM, V274, P31755, DOI 10.1074/jbc.274.45.31755; Sekine Y, 2010, MOL CANCER RES, V8, P1284, DOI 10.1158/1541-7786.MCR-10-0008; Silva RAGD, 2005, BIOCHEMISTRY-US, V44, P2759, DOI 10.1021/bi047717+; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Tanaka M, 2005, BIOCHEMISTRY-US, V44, P10689, DOI 10.1021/bi050853+; Tanaka M, 2008, BIOCHEMISTRY-US, V47, P2172, DOI 10.1021/bi702332b; Tanaka M, 2006, BIOCHEMISTRY-US, V45, P10351, DOI 10.1021/bi060726t; Thomas MJ, 2008, J LIPID RES, V49, P1875, DOI 10.1194/jlr.R800010-JLR200; Vaughan AM, 2006, J LIPID RES, V47, P2433, DOI 10.1194/jlr.M600218-JLR200; Vedhachalam C, 2007, J BIOL CHEM, V282, P25123, DOI 10.1074/jbc.M704590200; Von Eckardstein A, 2010, EXPERT REV CARDIOVAS, V8, P345, DOI 10.1586/ERC.10.6; von Eckardstein A, 2009, CURR OPIN LIPIDOL, V20, P197, DOI 10.1097/MOL.0b013e32832afd63; Zannis V., 2007, HIGH DENSITY LIPOPRO, P237; Zannis VI, 2006, J MOL MED, V84, P276, DOI 10.1007/s00109-005-0030-4	45	24	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7744	7754		10.1074/jbc.M110.193524	http://dx.doi.org/10.1074/jbc.M110.193524			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21209084	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000288013300006
J	Schieber, C; Howitt, J; Putz, U; White, JM; Parish, CL; Donnelly, PS; Tan, SS				Schieber, Christine; Howitt, Jason; Putz, Ulrich; White, Jonathan M.; Parish, Clare L.; Donnelly, Paul S.; Tan, Seong-Seng			Cellular Up-regulation of Nedd4 Family Interacting Protein 1 (Ndfip1) using Low Levels of Bioactive Cobalt Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METAL-BASED THERAPEUTICS; AMYLOID-BETA-PEPTIDE; UBIQUITIN LIGASE; CYTOTOXICITY; ACTIVATION; MECHANISM; PROMOTES; COPPER; DAMAGE; DMT1	The delivery of metal ions using cell membrane-permeable metal complexes represents a method for activating cellular pathways. Here, we report the synthesis and characterization of new [Co-III(salen)(acac)] complexes capable of up-regulating the ubiquitin ligase adaptor protein Ndfip1. Ndfip1 is a neuroprotective protein that is up-regulated in the brain after injury and functions in combination with Nedd4 ligases to ubiquitinate harmful proteins for removal. We previously showed that Ndfip1 can be increased in human neurons using CoCl2 that is toxic at high concentration. Here we demonstrate a similar effect can be achieved by low concentrations of synthetic Co-III complexes that are non-toxic and designed to be activated following cellular entry. Activation is achieved by intracellular reduction of Co-III to Co-II leading to release of Co-II ions for Ndfip1 up-regulation. The cellular benefit of Ndfip1 up-regulation by Co-III complexes includes demonstrable protection against cell death in SH-SY5Y cells during stress. In vivo, focal delivery of Co-III complexes into the adult mouse brain was observed to up-regulate Ndfip1 in neurons. These results demonstrate that a cellular response pathway can be advantageously manipulated by chemical modification of metal complexes, and represents a significant step of harnessing low concentration metal complexes for therapeutic benefit.	[Schieber, Christine; White, Jonathan M.; Donnelly, Paul S.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Sch Chem, Parkville, Vic 3010, Australia; [Schieber, Christine; Howitt, Jason; Putz, Ulrich; Parish, Clare L.; Tan, Seong-Seng] Univ Melbourne, Florey Neurosci Inst, Parkville, Vic 3010, Australia; [Schieber, Christine; Howitt, Jason; Putz, Ulrich; Parish, Clare L.; Tan, Seong-Seng] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3010, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne	Donnelly, PS (corresponding author), Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Sch Chem, Victoria, Parkville, Vic 3010, Australia.	pauld@unimelb.edu.au; stan@florey.edu.au	Parish, Clare/A-3380-2014	Parish, Clare/0000-0001-8212-9884; Howitt, Jason/0000-0001-9922-7931	Victorian Neurotrauma Initiative of the TAC; National Health and Medical Research Council (NHMRC)	Victorian Neurotrauma Initiative of the TAC; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study was supported by grants under the Victorian Neurotrauma Initiative of the TAC, and the National Health and Medical Research Council (NH&MRC).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Ait-Aissa S, 2000, TOXICOLOGY, V145, P147, DOI 10.1016/S0300-483X(00)00145-1; BAILES RH, 1947, J AM CHEM SOC, V69, P1886, DOI 10.1021/ja01200a013; Bigotto A., 1970, INORG CHIM ACTA REV, V4, P41; Bjorklund O, 2008, EUR J PHARMACOL, V596, P6, DOI 10.1016/j.ejphar.2008.08.002; Bush AI, 2000, CURR OPIN CHEM BIOL, V4, P184, DOI 10.1016/S1367-5931(99)00073-3; Choi JH, 2009, BIOCHEM J, V424, P285, DOI 10.1042/BJ20090371; COZENS RJ, 1972, AUST J CHEM, V25, P911, DOI 10.1071/CH9720911; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Donnelly PS, 2008, J BIOL CHEM, V283, P4568, DOI 10.1074/jbc.M705957200; Dreos R, 2003, INORG CHIM ACTA, V349, P239, DOI 10.1016/S0020-1693(03)00038-0; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Failes TW, 2007, CHEM-EUR J, V13, P2974, DOI 10.1002/chem.200601137; Foot NJ, 2008, BLOOD, V112, P4268, DOI 10.1182/blood-2008-04-150953; FUJII Y, 1970, B CHEM SOC JPN, V43, P1722, DOI 10.1246/bcsj.43.1722; Hall Matthew D., 2007, DALTON T, P3983; Hambley TW, 2007, SCIENCE, V318, P1392, DOI 10.1126/science.1150504; Hambley TW, 2007, DALTON T, P4929, DOI 10.1039/b706075k; Harvey KF, 2002, J BIOL CHEM, V277, P9307, DOI 10.1074/jbc.M110443200; Howitt J, 2009, P NATL ACAD SCI USA, V106, P15489, DOI 10.1073/pnas.0904880106; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mund T, 2010, P NATL ACAD SCI USA, V107, P11429, DOI 10.1073/pnas.0911714107; Oliver PM, 2006, IMMUNITY, V25, P929, DOI 10.1016/j.immuni.2006.10.012; Picard V, 2000, J BIOL CHEM, V275, P35738, DOI 10.1074/jbc.M005387200; Putz U, 2008, J BIOL CHEM, V283, P32621, DOI 10.1074/jbc.M804120200; Sang Q, 2006, J NEUROSCI, V26, P7234, DOI 10.1523/JNEUROSCI.1398-06.2006; Tan XL, 2008, NEUROSCI LETT, V441, P272, DOI 10.1016/j.neulet.2008.06.050; TEICHER BA, 1990, CANCER RES, V50, P6971; White AR, 2006, J BIOL CHEM, V281, P17670, DOI 10.1074/jbc.M602487200; White AR, 2003, J NEUROSCI RES, V71, P889, DOI 10.1002/jnr.10537; Yamada S., 1966, COORDIN CHEM REV, V1, P415; Yamamoto N, 2008, J BIOL INORG CHEM, V13, P861, DOI 10.1007/s00775-008-0374-7; Zhang XA, 2007, J ALLOY COMPD, V432, P247, DOI 10.1016/j.jallcom.2006.05.107	33	15	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8555	8564		10.1074/jbc.M110.203448	http://dx.doi.org/10.1074/jbc.M110.203448			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21187286	Green Published, hybrid			2022-12-27	WOS:000288013300082
J	Wang, H; Nora, GJ; Ghodke, H; Opresko, PL				Wang, Hong; Nora, Gerald J.; Ghodke, Harshad; Opresko, Patricia L.			Single Molecule Studies of Physiologically Relevant Telomeric Tails Reveal POT1 Mechanism for Promoting G-quadruplex Unfolding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; BINDING PROTEIN; FISSION YEAST; DNA-DAMAGE; SEQUENCE; END; TETRAPLEX; K+; VISUALIZATION; PROTECTION	Human telomeres are composed of duplex TTAGGG repeats and a 3' single-stranded DNA tail. The telomeric DNA is protected and regulated by the shelterin proteins, including the protection of telomeres 1 (POT1) protein that binds telomeric single-stranded DNA. The single-stranded tail can fold into G-quadruplex (G4) DNA. Both POT1 and G4 DNA play important roles in regulating telomere length homeostasis. To date, most studies have focused on individual quadruplexes formed by four TTAGGG repeats. Telomeric tails in human cells have on average six times as many repeats, and no structural studies have examined POT1 binding in competition with G4 DNA folding. Using single molecule atomic force microscopy imaging, we observed that the majority of the telomeric tails of 16 repeats formed two quadruplexes even though four were possible. The result that physiological telomeric tails rarely form the maximum potential number of G4 units provides a structural basis for the coexistence of G4 and POT1 on the same DNA molecule, which is observed directly in the captured atomic force microscopy images. We further observed that POT1 is significantly more effective in disrupting quadruplex DNA on long telomeric tails than an antisense oligonucleotide, indicating a novel POT1 activity beyond simply preventing quadruplex folding.	[Wang, Hong] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15213 USA; [Wang, Hong; Ghodke, Harshad] Univ Pittsburgh, Inst Canc, Hillman Canc Ctr, Pittsburgh, PA 15213 USA; [Nora, Gerald J.; Opresko, Patricia L.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA; [Nora, Gerald J.; Ghodke, Harshad; Opresko, Patricia L.] Univ Pittsburgh, Mol Biophys & Struct Biol Grad Program, Pittsburgh, PA 15260 USA; [Nora, Gerald J.; Ghodke, Harshad; Opresko, Patricia L.] Carnegie Mellon Univ, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Wang, H (corresponding author), 5117 Ctr Ave,Ste 2-6, Pittsburgh, PA 15213 USA.	wangh4@upmc.edu; plo4@pitt.edu	Wang, Hong/F-3164-2014; Ghodke, Harshad/AAE-1599-2019	Wang, Hong/0000-0003-0165-3559; Ghodke, Harshad/0000-0002-6628-876X; Opresko, Patricia/0000-0002-6470-2189	National Institutes of Health [ES0515052, 1K99ES016758-01, F30AG032861]; Ellison Medical Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K99ES016758, R01ES015052, R00ES016758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F30AG032861] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants ES0515052 (to P. L. O.), 1K99ES016758-01 (to H. W.), and F30AG032861 (to G. J. N.). This work was also supported by the Ellison Medical Foundation (to P. L. O.).	Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; BALAGURUMOORTHY P, 1994, J BIOL CHEM, V269, P21858; Baumann P, 2001, SCIENCE, V292, P1171, DOI 10.1126/science.1060036; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Chang CC, 2007, NUCLEIC ACIDS RES, V35, P2846, DOI 10.1093/nar/gkm155; Dai JX, 2007, NUCLEIC ACIDS RES, V35, P4927, DOI 10.1093/nar/gkm522; Hansma HG, 1996, NUCLEIC ACIDS RES, V24, P713, DOI 10.1093/nar/24.4.713; Hockemeyer D, 2005, EMBO J, V24, P2667, DOI 10.1038/sj.emboj.7600733; Janicijevic A, 2003, J MICROSC-OXFORD, V212, P264, DOI 10.1111/j.1365-2818.2003.01254.x; Kan ZY, 2007, NUCLEIC ACIDS RES, V35, P3646, DOI 10.1093/nar/gkm203; Lei M, 2004, NAT STRUCT MOL BIOL, V11, P1223, DOI 10.1038/nsmb867; Li J, 2005, NUCLEIC ACIDS RES, V33, P4649, DOI 10.1093/nar/gki782; Lyubchenko YL, 1997, P NATL ACAD SCI USA, V94, P496, DOI 10.1073/pnas.94.2.496; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; MARSH TC, 1995, NUCLEIC ACIDS RES, V23, P696, DOI 10.1093/nar/23.4.696; Neaves KJ, 2009, NUCLEIC ACIDS RES, V37, P6269, DOI 10.1093/nar/gkp679; Opresko PL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004825; Opresko PL, 2005, J BIOL CHEM, V280, P32069, DOI 10.1074/jbc.M505211200; Palm W, 2009, MOL CELL BIOL, V29, P471, DOI 10.1128/MCB.01352-08; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Petraccone L, 2010, BIOPOLYMERS, V93, P533, DOI 10.1002/bip.21392; Petraccone L, 2008, J AM CHEM SOC, V130, P16530, DOI 10.1021/ja8075567; Price CM, 2006, NAT STRUCT MOL BIOL, V13, P673, DOI 10.1038/nsmb0806-673; Ratcliff GC, 2001, J AM CHEM SOC, V123, P5632, DOI 10.1021/ja005750n; Renciuk D, 2009, NUCLEIC ACIDS RES, V37, P6625, DOI 10.1093/nar/gkp701; Rizzo A, 2009, NUCLEIC ACIDS RES, V37, P5353, DOI 10.1093/nar/gkp582; Roy R, 2009, NATURE, V461, P1092, DOI 10.1038/nature08442; SMITH FW, 1992, NATURE, V356, P164, DOI 10.1038/356164a0; Sowd G, 2008, NUCLEIC ACIDS RES, V36, P4242, DOI 10.1093/nar/gkn385; Sowd G, 2009, J BIOL CHEM, V284, P34682, DOI 10.1074/jbc.M109.049031; Tang J, 2008, NUCLEIC ACIDS RES, V36, P1200, DOI 10.1093/nar/gkm1137; Torigoe H, 2007, J BIOCHEM, V141, P57, DOI 10.1093/jb/mvm011; Verdun RE, 2005, MOL CELL, V20, P551, DOI 10.1016/j.molcel.2005.09.024; Vorlickova M, 2005, NUCLEIC ACIDS RES, V33, P5851, DOI 10.1093/nar/gki898; Wang H., 2007, PROTEIN INTERACTIONS, P39; Wang QA, 2010, ANAL CHEM, V82, P9469, DOI 10.1021/ac102168m; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; Xu Y, 2009, ANGEW CHEM INT EDIT, V48, P7833, DOI 10.1002/anie.200903858; Yang Y, 2003, METHODS, V29, P175, DOI 10.1016/S1046-2023(02)00308-0; Yoshimura SH, 2004, GENES CELLS, V9, P205, DOI 10.1111/j.1356-9597.2004.00719.x; Yu HQ, 2006, J AM CHEM SOC, V128, P15461, DOI 10.1021/ja064536h; Zaug AJ, 2005, P NATL ACAD SCI USA, V102, P10864, DOI 10.1073/pnas.0504744102; Zhang ML, 2010, NAT STRUCT MOL BIOL, V17, P202, DOI 10.1038/nsmb.1760; Zhang XY, 2003, J BIOMOL STRUCT DYN, V20, P693, DOI 10.1080/07391102.2003.10506886	45	69	69	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7479	7489		10.1074/jbc.M110.205641	http://dx.doi.org/10.1074/jbc.M110.205641			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21183684	Green Published, hybrid			2022-12-27	WOS:000287737300062
J	Ye, QQ; Li, ZC; Tian, JA; Xie, JX; Liu, LJ; Xie, ZJ				Ye, Qiqi; Li, Zhichuan; Tian, Jiang; Xie, Jeffrey X.; Liu, Lijun; Xie, Zijian			Identification of a Potential Receptor That Couples Ion Transport to Protein Kinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/K+-ATPASE; NA/K-ATPASE; TYROSINE KINASE; ALPHA-SUBUNIT; SIGNALING MICRODOMAIN; STRUCTURAL BASIS; SRC FAMILY; NA+,K+-ATPASE; BINDING; COMPLEX	In our previous studies, we have demonstrated that the Src-coupled alpha 1 Na/K-ATPase works as a receptor for cardiotonic steroids, such as ouabain, to regulate cellular protein kinase cascades. Here, we explore further the structural determinants of the interaction between the alpha 1 Na/K-ATPase and Src and demonstrate that the Src-coupled alpha 1 Na/K-ATPase allows the cell to decode the transmembrane transport activity of the Na/K-ATPase to turn on/off protein kinases. The alpha 1 Na/K-ATPase undergoes E1/E2 conformational transition during an ion pumping cycle. The amount of E1 and E2 Na/K-ATPase is regulated by extracellular K+ and intracellular Na+. Using purified enzyme preparations we find that the E1 Na/K-ATPase can bind both the Src SH2 and kinase domains simultaneously and keep Src in an inactive state. Conversely, the E1 to E2 transition releases the kinase domain and activates the associated Src. Moreover, we demonstrate that changes in E1/E2 Na/K-ATPase by either Na+ or K+ are capable of regulating Src and Src effectors in live cells. Together, the data suggest that the Src-coupled alpha 1 Na/K-ATPase may act as a Na+/K+ receptor, allowing salt to regulate cellular function through Src and Src effectors.	Univ Toledo, Coll Med, Dept Physiol, Toledo, OH 43614 USA; Univ Toledo, Coll Med, Dept Pharmacol, Toledo, OH 43614 USA; Univ Toledo, Coll Med, Dept Med, Toledo, OH 43614 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Xie, ZJ (corresponding author), Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Mail Stop 1008,3000 Arlington Ave, Toledo, OH 43614 USA.	Zi-jian.Xie@utoledo.edu	Li, Zhichuan/Q-7379-2017		NHLBI [HL-36573]; NIGMS [GM-78565]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL036573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078565] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-36573 from NHLBI and GM-78565 from NIGMS.	Abram CL, 2000, EXP CELL RES, V254, P1, DOI 10.1006/excr.1999.4732; AKERA T, 1991, LIFE SCI, V48, P97, DOI 10.1016/0024-3205(91)90402-W; Barwe SP, 2005, MOL BIOL CELL, V16, P1082, DOI 10.1091/mbc.E04-05-0427; Boerner RJ, 1996, BIOCHEMISTRY-US, V35, P9519, DOI 10.1021/bi960248u; BOWEN JW, 1987, AM J PHYSIOL, V252, pC179, DOI 10.1152/ajpcell.1987.252.2.C179; Cai HP, 2008, AM J PHYSIOL-CELL PH, V294, pC555, DOI 10.1152/ajpcell.00475.2007; CARILLI CT, 1982, J BIOL CHEM, V257, P5601; Chen Y, 2008, J BIOL CHEM, V283, P1128, DOI 10.1074/jbc.M708025200; Danko S, 2004, J BIOL CHEM, V279, P14991, DOI 10.1074/jbc.M313363200; DAWSON DC, 1990, AM J PHYSIOL, V259, pC181, DOI 10.1152/ajpcell.1990.259.2.C181; Geys SA, 2009, BIOPHYS J, V96, P4561, DOI 10.1016/j.bpj.2009.03.002; Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200; HEGYVARY C, 1976, BIOCHIM BIOPHYS ACTA, V422, P365, DOI 10.1016/0005-2744(76)90148-0; HOFFMAN PG, 1971, J GEN PHYSIOL, V58, P438, DOI 10.1085/jgp.58.4.438; HUANG WH, 1990, BIOCHIM BIOPHYS ACTA, V1030, P65, DOI 10.1016/0005-2736(90)90239-K; JORDAN C, 1995, J BIOL CHEM, V270, P29971; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; JORGENSEN PL, 1992, ACTA PHYSIOL SCAND, V146, P89; JORGENSEN PL, 1988, J MEMBRANE BIOL, V103, P95, DOI 10.1007/BF01870942; Kimura T, 2007, MOL BIOL CELL, V18, P4508, DOI 10.1091/mbc.E06-08-0711; KROGH A, 1946, PROC R SOC SER B-BIO, V133, P140, DOI 10.1098/rspb.1946.0008; Li ZC, 2009, J BIOL CHEM, V284, P21066, DOI 10.1074/jbc.M109.013821; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; Lin DH, 2004, AM J PHYSIOL-RENAL, V286, pF881, DOI 10.1152/ajprenal.00301.2003; Liu GQ, 1996, FEBS LETT, V390, P323, DOI 10.1016/0014-5793(96)00687-4; Liu JA, 2010, BBA-MOL BASIS DIS, V1802, P1237, DOI 10.1016/j.bbadis.2010.01.013; Liu LJ, 2007, MOL CELL BIOCHEM, V306, P231, DOI 10.1007/s11010-007-9574-7; Ma YC, 2000, CELL, V102, P635, DOI 10.1016/S0092-8674(00)00086-6; MISSIAEN L, 1988, BIOCHEM J, V253, P827, DOI 10.1042/bj2530827; Miyakawa-Naito A, 2003, J BIOL CHEM, V278, P50355, DOI 10.1074/jbc.M305378200; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; POST RL, 1969, J GEN PHYSIOL, V54, pS306, DOI 10.1085/jgp.54.1.306; SCHULTZ SG, 1981, AM J PHYSIOL, V241, pF579, DOI 10.1152/ajprenal.1981.241.6.F579; Shirakabe K, 2006, P NATL ACAD SCI USA, V103, P9542, DOI 10.1073/pnas.0602250103; Tatosyan AG, 2000, BIOCHEMISTRY-MOSCOW+, V65, P49; TAYLOR JS, 1981, J BIOL CHEM, V256, P9793; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Wang HJ, 2004, J BIOL CHEM, V279, P17250, DOI 10.1074/jbc.M313239200; Wang WH, 2004, ANNU REV PHYSIOL, V66, P547, DOI 10.1146/annurev.physiol.66.032102.112025; Xie Zijian, 2003, Mol Interv, V3, P157, DOI 10.1124/mi.3.3.157; Yuan ZK, 2005, MOL BIOL CELL, V16, P4034, DOI 10.1091/mbc.E05-04-0295; Yudowski GA, 2000, P NATL ACAD SCI USA, V97, P6556, DOI 10.1073/pnas.100128297; Zhang SB, 2006, J BIOL CHEM, V281, P21954, DOI 10.1074/jbc.M601578200; ZOLOTARJOVA N, 1995, J BIOL CHEM, V270, P3989, DOI 10.1074/jbc.270.8.3989	47	29	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6225	6232		10.1074/jbc.M110.202051	http://dx.doi.org/10.1074/jbc.M110.202051			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21189264	hybrid, Green Published			2022-12-27	WOS:000287476400032
J	Zhao, DZ; Bakirtzi, K; Zhan, YN; Zeng, HY; Koon, HW; Pothoulakis, C				Zhao, Dezheng; Bakirtzi, Kyriaki; Zhan, Yanai; Zeng, Huiyan; Koon, Hon Wai; Pothoulakis, Charalabos			Insulin-like Growth Factor-1 Receptor Transactivation Modulates the Inflammatory and Proliferative Responses of Neurotensin in Human Colonic Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; PROTEINASE-ACTIVATED RECEPTOR-1; TUMOR-NECROSIS-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; SIGNAL-TRANSDUCTION; HUMAN COLONOCYTES; SMALL-INTESTINE; INTERLEUKIN-8 EXPRESSION; EXPERIMENTAL COLITIS; ULCERATIVE-COLITIS	Neurotensin (NT) is a gastrointestinal neuropeptide that modulates intestinal inflammation and healing by binding to its high-affinity receptor NTR1. The dual role of NT in inflammation and healing is demonstrated in models of colitis induced by Clostridium difficile toxin A and dextran sulfate sodium, respectively, and involves NF-kappa B-dependent IL-8 expression and EGF receptor-mediated MAPK activation in human colonocytes. However, the detailed signaling pathways involved in these responses remain to be elucidated. We report here that NT/NTR1 coupling in human colonic epithelial NCM460 cells activates tyrosine phosphorylation of the insulin-like growth factor-1 receptor (IGF-1R) in a time-and dose-dependent manner. NT also rapidly induces Src tyrosine phosphorylation, whereas pretreatment of cells with the Src inhibitor PP2 before NT exposure decreases NT-induced IGF-1R phosphorylation. In addition, inhibition of IGF-1R activation by either its specific antagonist AG1024 or siRNA against IGF-1 significantly reduces NT-induced IL-8 expression and NF-kappa B-dependent reporter gene expression. Pretreatment with AG1024 also inhibits Akt activation and apoptosis induced by NT. Silencing of Akt expression by siRNA also substantially attenuates NT-induced IL-8 promoter activity and NF-kappa B-dependent reporter gene expression. This is the first report to indicate that NT transactivates IGF-1R and that this response is linked to Akt phosphorylation and NF-kappa B activation, contributing to both pro-inflammatory and tissue repair signaling pathways in response to NT in colonic epithelial cells. We propose that IGF-1R activation represents a previously unrecognized key pathway involved in the mechanisms by which NT and NTR1 modulate colonic inflammation and inflammatory bowel disease.	[Zhao, Dezheng; Zhan, Yanai] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gastroenterol, Boston, MA USA; [Zeng, Huiyan] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Vasc Med,Dept Med, Boston, MA USA; [Zhao, Dezheng; Zhan, Yanai] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Vasc Biol, Boston, MA USA; [Bakirtzi, Kyriaki; Koon, Hon Wai; Pothoulakis, Charalabos] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Inflammatory Bowel Dis, Div Digest Dis, Los Angeles, CA 90095 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zhao, DZ (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Ctr Vasc Biol, 99 Brookline Ave,RN270J, Boston, MA 02115 USA.	dzhao@bidmc.harvard.edu; cpothoulakis@mednet.ucla.edu			National Institute of Health [K01 DK064920, R21 DK080970, DK060729]; American Cancer Society [RSG-07-178-CSM]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK080970, K01DK064920, R01DK060729] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institute of Health Grants K01 DK064920 and R21 DK080970 (to D. Z.) and DK060729 (to C. P.). This work was also supported by American Cancer Society Research Scholar Grant RSG-07-178-CSM (to D. Z.).	AMAR S, 1986, FEBS LETT, V201, P31, DOI 10.1016/0014-5793(86)80565-8; Amorino GP, 2007, ONCOGENE, V26, P745, DOI 10.1038/sj.onc.1209814; Ballinger A, 2002, HORM RES, V58, P7, DOI 10.1159/000064756; BOZOU JC, 1989, BIOCHEM J, V264, P871, DOI 10.1042/bj2640871; Brun P, 2005, AM J PHYSIOL-GASTR L, V288, pG621, DOI 10.1152/ajpgi.00140.2004; BURAKOFF R, 1995, GASTROENTEROLOGY, V109, P348, DOI 10.1016/0016-5085(95)90320-8; CARRAWAY R, 1976, J BIOL CHEM, V251, P7045; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; Castagliuolo I, 1996, P NATL ACAD SCI USA, V93, P12611, DOI 10.1073/pnas.93.22.12611; Castagliuolo I, 1999, J CLIN INVEST, V103, P843, DOI 10.1172/JCI4217; Cenac N, 2005, INFLAMM BOWEL DIS, V11, P792, DOI 10.1097/01.mib.0000177506.71784.bd; Du J, 2001, CIRC RES, V88, P1044, DOI 10.1161/hh1001.090840; Ehlers RA, 1998, SURGERY, V124, P239, DOI 10.1067/msy.1998.90370; Ehlers RA, 2000, BIOCHEM BIOPH RES CO, V269, P704, DOI 10.1006/bbrc.2000.2335; Eivindson M, 2007, GROWTH HORM IGF RES, V17, P33, DOI 10.1016/j.ghir.2006.10.003; El Yafi F, 2005, CLIN EXP IMMUNOL, V139, P526, DOI 10.1111/j.1365-2249.2004.02724.x; Fichtner-Feigl S, 2008, GASTROENTEROLOGY, V135, P2003, DOI 10.1053/j.gastro.2008.08.055; Guha S, 2003, CANCER RES, V63, P2379; Guha S, 2002, CANCER RES, V62, P1632; Gulluoglu BM, 1999, DIGEST DIS SCI, V44, P1531, DOI 10.1023/A:1026646523284; Hassan S, 2004, REGUL PEPTIDES, V120, P155, DOI 10.1016/j.regpep.2004.03.004; HEINZERIAN P, 1991, ENDOCRINOLOGY, V129, P1769, DOI 10.1210/endo-129-4-1769; Himpe E, 2009, BIOFACTORS, V35, P76, DOI 10.1002/biof.20; Howarth GS, 1998, SCAND J GASTROENTERO, V33, P180; IZUKURA M, 1992, ANN SURG, V215, P520, DOI 10.1097/00000658-199205000-00015; Katsanos KH, 2001, GROWTH HORM IGF RES, V11, P364, DOI 10.1054/ghir.2001.0248; Keummerle JF, 2001, J BIOL CHEM, V276, P7187, DOI 10.1074/jbc.M011145200; Koon HW, 2007, P NATL ACAD SCI USA, V104, P2013, DOI 10.1073/pnas.0610664104; Koon HW, 2006, J IMMUNOL, V176, P5050, DOI 10.4049/jimmunol.176.8.5050; Koon HW, 2009, P NATL ACAD SCI USA, V106, P8766, DOI 10.1073/pnas.0903499106; Koon HW, 2004, J BIOL CHEM, V279, P45519, DOI 10.1074/jbc.M408523200; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Madge LA, 2000, J BIOL CHEM, V275, P15458, DOI 10.1074/jbc.M001237200; Maoret JJ, 1999, INT J CANCER, V80, P448, DOI 10.1002/(SICI)1097-0215(19990129)80:3<448::AID-IJC19>3.0.CO;2-N; Mazella J, 1998, J BIOL CHEM, V273, P26273, DOI 10.1074/jbc.273.41.26273; Ozes ON, 1999, NATURE, V401, P82; PoinotChazel G, 1996, BIOCHEM J, V320, P145, DOI 10.1042/bj3200145; Pothoulakis C, 1998, ANN NY ACAD SCI, V840, P635, DOI 10.1111/j.1749-6632.1998.tb09602.x; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; RAO GN, 1995, J BIOL CHEM, V270, P27871, DOI 10.1074/jbc.270.46.27871; REASBECK PG, 1984, GASTROENTEROLOGY, V86, P1552; Reddy SAG, 2000, J IMMUNOL, V164, P1355, DOI 10.4049/jimmunol.164.3.1355; Riegler M, 2000, GASTROENTEROLOGY, V119, P348, DOI 10.1053/gast.2000.9310; Sipos Ferenc, 2006, Orvosi Hetilap, V147, P1835; Sizemore N, 1999, MOL CELL BIOL, V19, P4798; Sumitomo M, 2001, CANCER RES, V61, P3294; THOR K, 1986, GASTROENTEROLOGY, V90, P27, DOI 10.1016/0016-5085(86)90070-3; Vergnolle N, 2004, J CLIN INVEST, V114, P1444, DOI 10.1172/JCI200421689; Vincent JP, 1999, TRENDS PHARMACOL SCI, V20, P302, DOI 10.1016/S0165-6147(99)01357-7; WIKLUND B, 1984, REGUL PEPTIDES, V8, P33, DOI 10.1016/0167-0115(84)90026-0; WOOD JG, 1988, AM J PHYSIOL, V255, pG813, DOI 10.1152/ajpgi.1988.255.6.G813; Xie P, 2000, J BIOL CHEM, V275, P24907, DOI 10.1074/jbc.M001051200; Yoshinaga K, 1992, Surg Oncol, V1, P127, DOI 10.1016/0960-7404(92)90025-G; Zahradka P, 2004, ENDOCRINOLOGY, V145, P2978, DOI 10.1210/en.2004-0029; Zhao DZ, 2005, MOL PHARMACOL, V67, P2025, DOI 10.1124/mol.104.010801; Zhao DZ, 2004, J BIOL CHEM, V279, P43547, DOI 10.1074/jbc.M401453200; Zhao DZ, 2003, EXPERT OPIN THER TAR, V7, P583, DOI 10.1517/eott.7.5.583.22527; Zhao DZ, 2003, AM J PHYSIOL-CELL PH, V284, pC1397, DOI 10.1152/ajpcell.00328.2002; Zhao DZ, 2001, J BIOL CHEM, V276, P44464, DOI 10.1074/jbc.M104942200	59	34	39	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6092	6099		10.1074/jbc.M110.192534	http://dx.doi.org/10.1074/jbc.M110.192534			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21212273	Green Published, hybrid			2022-12-27	WOS:000287476400018
J	Fujita, K; Sakamoto, S; Ono, Y; Wakao, M; Suda, Y; Kitahara, K; Suganuma, T				Fujita, Kiyotaka; Sakamoto, Shiho; Ono, Yuki; Wakao, Masahiro; Suda, Yasuo; Kitahara, Kanefumi; Suganuma, Toshihiko			Molecular Cloning and Characterization of a beta-L-Arabinobiosidase in Bifidobacterium longum That Belongs to a Novel Glycoside Hydrolase Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANION-EXCHANGE CHROMATOGRAPHY; PULSED AMPEROMETRIC DETECTION; ALPHA-L-ARABINOFURANOSIDASE; HYDROXYPROLINE-ARABINOSIDES; SEQUENCE SIMILARITIES; POTENTIAL PREBIOTICS; SOLANUM-TUBEROSUM; POTATO LECTIN; IN-VITRO; CARBOHYDRATE	Extensin is a glycoprotein that is rich in hydroxyprolines linked to beta-L-arabinofuranosides. In this study, we cloned a hypBA2 gene that encodes a novel beta-L-arabinobiosidase from Bifidobacterium longum JCM 1217. This enzyme does not have any sequence similarity with other glycoside hydrolase families but has 38-98% identity to hypothetical proteins in Bifidobacterium and Xanthomonas strains. The recombinant enzyme liberated L-arabinofuranose (Araf)-beta 1,2-Araf disaccharide from carrot extensin, potato lectin, and Araf-beta 1,2-Araf-beta 1,2-Araf-beta-Hyp (Ara(3)-Hyp) but not Araf-alpha 1,3-Araf-beta 1,2-Araf-beta 1,2-Araf-beta-Hyp (Ara(4)-Hyp) or Araf-beta 1,2-Araf-beta-Hyp (Ara(2)-Hyp), which indicated that it was specific for unmodified Ara(3)-Hyp substrate. The enzyme also transglycosylated 1-alkanols with retention of the anomeric configuration. This is the first report of an enzyme that hydrolyzes Hyplinked beta-L-arabinofuranosides, which defines a new family of glycoside hydrolases, glycoside hydrolase family 121.	[Fujita, Kiyotaka; Sakamoto, Shiho; Ono, Yuki; Kitahara, Kanefumi; Suganuma, Toshihiko] Kagoshima Univ, Fac Agr, Kagoshima 8900065, Japan; [Wakao, Masahiro; Suda, Yasuo] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 8900065, Japan	Kagoshima University; Kagoshima University	Fujita, K (corresponding author), Kagoshima Univ, Fac Agr, Kagoshima 8900065, Japan.	kfujita@ms.kagoshima-u.ac.jp		Fujita, Kiyotaka/0000-0002-3780-3750	Japan Society for the Promotion of Science [22780094]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grant-in-aid for Young Scientists (B) 22780094 from the Japan Society for the Promotion of Science.	AKIYAMA Y, 1980, AGR BIOL CHEM TOKYO, V44, P2487, DOI 10.1080/00021369.1980.10864347; ASHFORD D, 1982, BIOCHEM J, V201, P199, DOI 10.1042/bj2010199; BIAVATI B, 1982, INT J SYST BACTERIOL, V32, P358, DOI 10.1099/00207713-32-3-358; Bollig K, 2007, CARBOHYD RES, V342, P2557, DOI 10.1016/j.carres.2007.08.008; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; Campargue C, 1998, ANAL BIOCHEM, V257, P20, DOI 10.1006/abio.1997.2526; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cardoso SM, 2002, CARBOHYD RES, V337, P917, DOI 10.1016/S0008-6215(02)00082-4; Ciopraga J, 2000, J BIOCHEM, V128, P855, DOI 10.1093/oxfordjournals.jbchem.a022824; Ficko-Blean E, 2006, J BIOL CHEM, V281, P37748, DOI 10.1074/jbc.M606126200; Fujita K, 2005, J BIOL CHEM, V280, P37415, DOI 10.1074/jbc.M506874200; Gray W.R., 1967, METHODS ENZYMOL, V11, P139, DOI [10.1016/S0076-6879(67)11014-8, DOI 10.1016/S0076-6879(67)11014-8]; Gueimonde M, 2007, ARCH MICROBIOL, V187, P145, DOI 10.1007/s00203-006-0181-x; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; HOLMES EW, 1979, ANAL BIOCHEM, V93, P167, DOI 10.1016/S0003-2697(79)80060-3; Ichinose H, 2009, J BIOL CHEM, V284, P25097, DOI 10.1074/jbc.M109.022723; JOSELEAU JP, 1977, CARBOHYD RES, V58, P165, DOI 10.1016/S0008-6215(00)83412-6; KIELISZEWSKI MJ, 1994, PLANT J, V5, P849, DOI 10.1046/j.1365-313X.1994.5060849.x; KIELISZEWSKI MJ, 1994, PLANT J, V5, P157, DOI 10.1046/j.1365-313X.1994.05020157.x; Kitaoka M, 2005, APPL ENVIRON MICROB, V71, P3158, DOI 10.1128/AEM.71.6.3158-3162.2005; Kosugi A, 2002, J BACTERIOL, V184, P6859, DOI 10.1128/JB.184.24.6859-6865.2002; LAMPORT DTA, 1971, PLANT PHYSIOL, V48, P454, DOI 10.1104/pp.48.4.454; Magliano TMA, 1998, J EXP BOT, V49, P1491, DOI 10.1093/jexbot/49.326.1491; Nishimoto M, 2007, APPL ENVIRON MICROB, V73, P6444, DOI 10.1128/AEM.01425-07; Pastell H, 2009, J AGR FOOD CHEM, V57, P8598, DOI 10.1021/jf901397b; ROY D, 1990, J APPL BACTERIOL, V69, P739, DOI 10.1111/j.1365-2672.1990.tb01571.x; Salvador LD, 2000, J AGR FOOD CHEM, V48, P3448, DOI 10.1021/jf991089z; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Shallom D, 2002, J BIOL CHEM, V277, P43667, DOI 10.1074/jbc.M208285200; SHOWALTER AM, 1993, PLANT CELL, V5, P9, DOI 10.1105/tpc.5.1.9; Suzuki Y, 2004, J JPN SOC HORTIC SCI, V73, P574, DOI 10.2503/jjshs.73.574; Van Damme EJM, 2004, PLANT J, V37, P34, DOI 10.1046/j.1365-313X.2003.01929.x; Van Den Broek LAM, 2008, INNOV FOOD SCI EMERG, V9, P401, DOI 10.1016/j.ifset.2007.12.006; van den Broek LAM, 2008, MOL NUTR FOOD RES, V52, P146, DOI 10.1002/mnfr.200700121	36	39	40	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5143	5150		10.1074/jbc.M110.190512	http://dx.doi.org/10.1074/jbc.M110.190512			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21149454	hybrid, Green Published			2022-12-27	WOS:000287230600022
J	Samant, SA; Courson, DS; Sundaresan, NR; Pillai, VB; Tan, MJ; Zhao, YM; Shroff, SG; Rock, RS; Gupta, MP				Samant, Sadhana A.; Courson, David S.; Sundaresan, Nagalingam R.; Pillai, Vinodkumar B.; Tan, Minjia; Zhao, Yingming; Shroff, Sanjeev G.; Rock, Ronald S.; Gupta, Mahesh P.			HDAC3-dependent Reversible Lysine Acetylation of Cardiac Myosin Heavy Chain Isoforms Modulates Their Enzymatic and Motor Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE; MUSCLE-CONTRACTION; ATPASE ACTIVITY; HEART-FAILURE; ACTIN; PURIFICATION; EXPRESSION; PROTEINS; HYPOXIA; COMPLEX	Reversible lysine acetylation is a widespread post-translational modification controlling the activity of proteins in different subcellular compartments. We previously demonstrated that a class II histone deacetylase (HDAC), HDAC4, and a histone acetyltransferase, PCAF, associate with cardiac sarcomeres, and a class I and II HDAC inhibitor, trichostatin A, enhances contractile activity of myofilaments. In this study, we show that a class I HDAC, HDAC3, is also present at cardiac sarcomeres. By immunohistochemical and electron microscopic analyses, we found that HDAC3 was localized to the A band of sarcomeres and was capable of deacetylating myosin heavy chain (MHC) isoforms. The motor domains of both cardiac alpha- and beta-MHC isoforms were found to be reversibly acetylated. Biomechanical studies revealed that lysine acetylation significantly decreased the K-m for the actin-activated ATPase activity of both alpha- and beta-MHC isoforms. By an in vitro motility assay, we found that lysine acetylation increased the actin sliding velocity of alpha-myosin by 20% and beta-myosin by 36%, compared to their respective non-acetylated isoforms. Moreover, myosin acetylation was found to be sensitive to cardiac stress. During induction of hypertrophy, myosin isoform acetylation increased progressively with duration of stress stimuli, independent of isoform shift, suggesting that lysine acetylation of myosin could be an early response of myofilaments to increase contractile performance of the heart. These studies provide the first evidence for localization of HDAC3 at myofilaments and uncover a novel mechanism modulating the motor activity of cardiac MHC isoforms.	[Samant, Sadhana A.; Sundaresan, Nagalingam R.; Pillai, Vinodkumar B.; Gupta, Mahesh P.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Courson, David S.; Rock, Ronald S.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Tan, Minjia; Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Shroff, Sanjeev G.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15261 USA	University of Chicago; University of Chicago; University of Chicago; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gupta, MP (corresponding author), Univ Chicago, Dept Surg, MC 5040,5841 S Maryland Ave, Chicago, IL 60637 USA.	mgupta@surgery.bsd.uchicago.edu	Tan, Minjia/C-4491-2014	Tan, Minjia/0000-0002-6784-9653	National Institutes of Health [RO1 HL-77788, HL-83423]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077788, R01HL083423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 HL-77788 and HL-83423.	Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Chen Y, 2009, P NATL ACAD SCI USA, V106, P761, DOI 10.1073/pnas.0811739106; CLARK WA, 1982, J BIOL CHEM, V257, P5449; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; Fiske CH, 1925, J BIOL CHEM, V66, P375; Geeves MA, 1999, ANNU REV BIOCHEM, V68, P687, DOI 10.1146/annurev.biochem.68.1.687; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gupta MP, 2008, J BIOL CHEM, V283, P10135, DOI 10.1074/jbc.M710277200; Gupta MP, 2007, J MOL CELL CARDIOL, V43, P388, DOI 10.1016/j.yjmcc.2007.07.045; Jacques AM, 2008, CARDIOVASC RES, V79, P481, DOI 10.1093/cvr/cvn094; Kamitomo M, 2002, J SOC GYNECOL INVEST, V9, P335, DOI 10.1016/S1071-5576(02)00180-6; Khochbin S, 2001, CURR OPIN GENET DEV, V11, P162, DOI 10.1016/S0959-437X(00)00174-X; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Krenz M, 2007, J BIOL CHEM, V282, P24057, DOI 10.1074/jbc.M704574200; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Longworth MS, 2006, ONCOGENE, V25, P4495, DOI 10.1038/sj.onc.1209473; McKinsey TA, 2002, CURR OPIN CELL BIOL, V14, P763, DOI 10.1016/S0955-0674(02)00389-7; Nagy S, 2008, P NATL ACAD SCI USA, V105, P9616, DOI 10.1073/pnas.0802592105; Nakao K, 1997, J CLIN INVEST, V100, P2362, DOI 10.1172/JCI119776; Pillai JB, 2008, AM J PHYSIOL-HEART C, V294, pH1388, DOI 10.1152/ajpheart.01339.2007; POLLARD TD, 1982, METHOD CELL BIOL, V24, P333; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Roels B, 2008, AM J PHYSIOL-REG I, V294, pR1911, DOI 10.1152/ajpregu.00210.2006; Ruppel KM, 1996, ANNU REV CELL DEV BI, V12, P543, DOI 10.1146/annurev.cellbio.12.1.543; SCHLUTER JM, 1994, AM J PHYSIOL, V266, pC1699, DOI 10.1152/ajpcell.1994.266.6.C1699; Sundaresan N, 2009, CIRCULATION, V119, P3603; UCHIDA K, 1977, J BIOCHEM, V82, P469; Waltregny D, 2005, FASEB J, V19, P966, DOI 10.1096/fj.04-2303fje; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002	32	37	40	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5567	5577		10.1074/jbc.M110.163865	http://dx.doi.org/10.1074/jbc.M110.163865			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21177250	Green Published, hybrid			2022-12-27	WOS:000287230600066
J	Sato, T; Kudo, T; Ikehara, Y; Ogawa, H; Hirano, T; Kiyohara, K; Hagiwara, K; Togayachi, A; Ema, M; Takahashi, S; Kimata, K; Watanabe, H; Narimatsu, H				Sato, Takashi; Kudo, Takashi; Ikehara, Yuzuru; Ogawa, Hiroyasu; Hirano, Tomoko; Kiyohara, Katsue; Hagiwara, Kozue; Togayachi, Akira; Ema, Masatsugu; Takahashi, Satoru; Kimata, Koji; Watanabe, Hideto; Narimatsu, Hisashi			Chondroitin Sulfate N-Acetylgalactosaminyltransferase 1 Is Necessary for Normal Endochondral Ossification and Aggrecan Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA-SUPERFAMILY; MOLECULAR-CLONING; GLUCURONIC-ACID; IN-VIVO; CARTILAGE; MICE; GENE; ELONGATION; INITIATION; DELETION	Chondroitin sulfate (CS) is a glycosaminoglycan, consisting of repeating disaccharide units of N-acetylgalactosamine and glucuronic acid residues, and plays important roles in development and homeostasis of organs and tissues. Here, we generated and analyzed mice lacking chondroitin sulfate N-acetylgalactosaminyltransferase 1 (CSGalNAcT-1). Csgalnact1(-/-) mice were viable and fertile but exhibited slight dwarfism. Biochemically, the level of CS in Csgalnact1(-/-) cartilage was reduced to similar to 50% that of wild-type cartilage, whereas its chain length was similar to wild-type mice, indicating that CSGalNAcT-1 participates in the CS chain initiation as suggested in the previous study (Sakai, K., Kimata, K., Sato, T., Gotoh, M., Narimatsu, H., Shinomiya, K., and Watanabe, H. (2007) J. Biol. Chem. 282, 4152-4161). Histologically, the growth plate of Csgalnact1(-/-) mice contained shorter and slightly disorganized chondrocyte columns with a reduced volume of the extracellular matrix principally in the proliferative layer. Immunohistochemical analysis revealed that the level of both aggrecan and link protein 1 were decreased in Csgalnact1(-/-) cartilage. Western blot analysis demonstrated an increase in processed forms of aggrecan core protein. These results suggest that CSGalNAcT-1 is required for normal levels of CS biosynthesis in cartilage. Our observations suggest that CSGalNAcT-1 is necessary for normal levels of endochondral ossification, and the decrease in CS amount in the growth plate by its absence causes a rapid catabolism of aggrecan.	[Sato, Takashi; Ikehara, Yuzuru; Hirano, Tomoko; Kiyohara, Katsue; Togayachi, Akira; Narimatsu, Hisashi] Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Open Space Lab, Tsukuba, Ibaraki 3058568, Japan; [Kudo, Takashi; Hagiwara, Kozue; Ema, Masatsugu; Takahashi, Satoru] Univ Tsukuba, Grad Sch Comprehens Human Sci, Doctoral Program Life Syst Med Sci, Dept Anat & Embryol, Tsukuba, Ibaraki 3058575, Japan; [Ogawa, Hiroyasu; Kimata, Koji; Watanabe, Hideto] Aichi Med Univ, Inst Mol Sci Med, Nagakute, Aichi 4801195, Japan; [Ogawa, Hiroyasu] Gifu Univ, Grad Sch Med, Dept Orthopaed Surg, Gifu 5011194, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; Aichi Medical University; Gifu University	Narimatsu, H (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Ctr Med Glycosci, Open Space Lab, Cent 2,1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.	h.narimatsu@aist.go.jp	Ikehara, yuzuru/L-7696-2018; Narimatsu, Hisashi/M-4757-2018; Sato, Takashi/M-2577-2018; Togayachi, Akira/M-4144-2018; Ikehara, yuzuru/R-2239-2019; Sato, Masa/P-6487-2019	Ikehara, yuzuru/0000-0002-1915-9172; Narimatsu, Hisashi/0000-0002-8402-133X; Sato, Takashi/0000-0002-9973-8923; Togayachi, Akira/0000-0003-3600-9149; Ikehara, yuzuru/0000-0002-1915-9172; Ema, Masatsugu/0000-0003-0645-6183; Kudo, Takashi/0000-0001-5477-7235; Watanabe, Hideto/0000-0001-5291-0696; Ogawa, Hiroyasu/0000-0002-4737-6481	New Energy and Industrial Technology Development Organization	New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO))	This work was performed as a part of the Medical Glycomics Project supported by the New Energy and Industrial Technology Development Organization. This work was supported in part by grants-in-aid for scientific research (B) (to H.W.) and grants-in-aid for priority areas (to H.W.).	AMIZUKA N, 1994, J CELL BIOL, V126, P1611, DOI 10.1083/jcb.126.6.1611; Amizuka N, 1996, ENDOCRINOLOGY, V137, P5055, DOI 10.1210/en.137.11.5055; Dityatev A, 2007, DEV NEUROBIOL, V67, P570, DOI 10.1002/dneu.20361; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Gotoh M, 2002, J BIOL CHEM, V277, P38189, DOI 10.1074/jbc.M203619200; Gotoh M, 2002, J BIOL CHEM, V277, P38179, DOI 10.1074/jbc.M202601200; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; HASCALL VC, 1982, METHOD ENZYMOL, V82, P769; Hiraoka S, 2007, NAT MED, V13, P1363, DOI 10.1038/nm1655; Ishii M, 2008, J BIOL CHEM, V283, P32610, DOI 10.1074/jbc.M806331200; Kiani C, 2002, CELL RES, V12, P19, DOI 10.1038/sj.cr.7290106; Kitagawa H, 2003, J BIOL CHEM, V278, P23666, DOI 10.1074/jbc.M302493200; Kitagawa H, 2001, J BIOL CHEM, V276, P38721, DOI 10.1074/jbc.M106871200; Kluppel M, 2005, DEVELOPMENT, V132, P3989, DOI 10.1242/dev.01948; Muramatsu T, 2002, J BIOCHEM, V132, P359, DOI 10.1093/oxfordjournals.jbchem.a003231; Nadanaka S, 2008, J BIOCHEM, V144, P7, DOI 10.1093/jb/mvn040; Nagase H, 2003, ARTHRITIS RES THER, V5, P94, DOI 10.1186/ar630; Ninomiya T, 2002, J BIOL CHEM, V277, P21567, DOI 10.1074/jbc.M201719200; NIWA H, 1993, J BIOCHEM-TOKYO, V113, P343, DOI 10.1093/oxfordjournals.jbchem.a124049; Oshita H, 2004, BIOCHEM J, V382, P253, DOI 10.1042/BJ20040113; Pratta MA, 2000, J BIOL CHEM, V275, P39096, DOI 10.1074/jbc.M006201200; Sakai K, 2007, J BIOL CHEM, V282, P4152, DOI 10.1074/jbc.M606870200; Sato T, 2003, J BIOL CHEM, V278, P3063, DOI 10.1074/jbc.M208886200; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Tanimoto Y, 2008, COMPARATIVE MED, V58, P347; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Uyama T, 2002, J BIOL CHEM, V277, P8841, DOI 10.1074/jbc.M111434200; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Watanabe H, 1997, P NATL ACAD SCI USA, V94, P6943, DOI 10.1073/pnas.94.13.6943; Watanabe H, 1998, J BIOCHEM, V124, P687, DOI 10.1093/oxfordjournals.jbchem.a022166; WATANABE H, 1994, NAT GENET, V7, P154, DOI 10.1038/ng0694-154; Watanabe H, 1999, NAT GENET, V21, P225, DOI 10.1038/6016; Yada T, 2003, J BIOL CHEM, V278, P39711, DOI 10.1074/jbc.M304421200; Yada T, 2003, J BIOL CHEM, V278, P30235, DOI 10.1074/jbc.M303657200	36	53	56	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5803	5812		10.1074/jbc.M110.159244	http://dx.doi.org/10.1074/jbc.M110.159244			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148564	Green Published, hybrid			2022-12-27	WOS:000287230600089
J	Werner-Allen, JW; Lee, CJ; Liu, P; Nicely, NI; Wang, S; Greenleaf, AL; Zhou, P				Werner-Allen, Jon W.; Lee, Chul-Jin; Liu, Pengda; Nicely, Nathan I.; Wang, Su; Greenleaf, Arno L.; Zhou, Pei			cis-Proline-mediated Ser(P)(5) Dephosphorylation by the RNA Polymerase II C-terminal Domain Phosphatase Ssu72	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESS1 PROLYL-ISOMERASE; MESSENGER-RNA; TRANSCRIPTION TERMINATION; SACCHAROMYCES-CEREVISIAE; ASSOCIATING PROTEINS; TYROSINE-PHOSPHATASE; CIS/TRANS ISOMERASES; YEAST; PHOSPHORYLATION; RECOGNITION	RNA polymerase II coordinates co-transcriptional events by recruiting distinct sets of nuclear factors to specific stages of transcription via changes of phosphorylation patterns along its C-terminal domain (CTD). Although it has become increasingly clear that proline isomerization also helps regulate CTD-associated processes, the molecular basis of its role is unknown. Here, we report the structure of the Ser(P)(5) CTD phosphatase Ssu72 in complex with substrate, revealing a remarkable CTD conformation with the Ser(P)(5)-Pro(6) motif in the cis configuration. We show that the cis-Ser(P)(5)-Pro(6) isomer is the minor population in solution and that Ess1-catalyzed cis-trans-proline isomerization facilitates rapid dephosphorylation by Ssu72, providing an explanation for recently discovered in vivo connections between these enzymes and a revised model for CTD-mediated small nuclear RNA termination. This work presents the first structural evidence of a cis-proline-specific enzyme and an unexpected mechanism of isomer-based regulation of phosphorylation, with broad implications for CTD biology.	Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Zhou, P (corresponding author), 270 Sands Bldg,Res Dr, Durham, NC 27710 USA.	peizhou@biochem.duke.edu	, PEP-MX Core/AGV-4051-2022; Zhou, Pei/O-6704-2019	Zhou, Pei/0000-0002-7823-3416	National Institutes of Health [GM079376, GM040505]; Kamin Fellowship; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040505, R01GM079376] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kamin Fellowship; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM079376 (to P.Z.) and GM040505 (to A.L.G.). This work was also supported by a Kamin Fellowship (to J.W.W.-A.).; Crystal screening was performed at the Duke University Medical Center X-ray Crystallography Shared Resource. Data were collected at the Southeast Regional Collaborative Access Team (SER-CAT) 22-ID beamline at the Advanced Photon Source, Argonne National Laboratory. Supporting institutions may be found on the SER-CAT web page. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract Number W-31-109-Eng-38. We thank Louis Metzger and Jeffrey Boyles for enlightening discussions.	Ansari A, 2005, GENE DEV, V19, P2969, DOI 10.1101/gad.1362305; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Buratowski S, 2009, MOL CELL, V36, P541, DOI 10.1016/j.molcel.2009.10.019; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Femino A, 1998, SCIENCE, V280, P585, DOI 10.1126/science.280.5363.585; Ganem C, 2003, EMBO J, V22, P1588, DOI 10.1093/emboj/cdg141; Gemmill TR, 2005, J BIOL CHEM, V280, P15510, DOI 10.1074/jbc.M412172200; Ghazy MA, 2009, MOL CELL BIOL, V29, P2296, DOI 10.1128/MCB.01514-08; Hausmann S, 2005, J BIOL CHEM, V280, P37681, DOI 10.1074/jbc.M505292200; Hausmann S, 2002, J BIOL CHEM, V277, P21213, DOI 10.1074/jbc.M202056200; Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011; Kops O, 2002, FEBS LETT, V513, P305, DOI 10.1016/S0014-5793(02)02288-3; Krishnamurthy S, 2004, MOL CELL, V14, P387, DOI 10.1016/S1097-2765(04)00235-7; Krishnamurthy S, 2009, MOL CELL BIOL, V29, P2925, DOI 10.1128/MCB.01655-08; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Meinhart A, 2003, J BIOL CHEM, V278, P15917, DOI 10.1074/jbc.M301643200; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Nedea E, 2003, J BIOL CHEM, V278, P33000, DOI 10.1074/jbc.M304454200; Noble CG, 2005, NAT STRUCT MOL BIOL, V12, P144, DOI 10.1038/nsmb887; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Palancade B, 2004, J MOL BIOL, V335, P415, DOI 10.1016/j.jmb.2003.10.036; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Phatnani HP, 2004, BIOCHEMISTRY-US, V43, P15702, DOI 10.1021/bi048364h; Reyes-Reyes M, 2007, MOL CELL BIOL, V27, P926, DOI 10.1128/MCB.01361-06; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; Schutkowski M, 1998, BIOCHEMISTRY-US, V37, P5566, DOI 10.1021/bi973060z; Shaw PE, 2007, EMBO REP, V8, P40, DOI 10.1038/sj.embor.7400873; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Singh N, 2009, MOL CELL, V36, P255, DOI 10.1016/j.molcel.2009.08.018; Steinmetz EJ, 2003, MOL CELL BIOL, V23, P6339, DOI 10.1128/MCB.23.18.6339-6349.2003; Sun ZW, 1996, MOL CELL BIOL, V16, P1557; Toth G, 2001, PROTEINS, V43, P373, DOI 10.1002/prot.1050; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Wang SS, 2000, BIOCHEMISTRY-US, V39, P1903, DOI 10.1021/bi991348d; Weiwad M, 2004, J MOL BIOL, V339, P635, DOI 10.1016/j.jmb.2004.02.021; Wu WH, 1999, GENETICS, V153, P643; Xiang KH, 2010, NATURE, V467, P729, DOI 10.1038/nature09391; Xu YX, 2003, GENE DEV, V17, P2765, DOI 10.1101/gad.1135503; Xu YX, 2004, CELL CYCLE, V3, P432; Yeo M, 2003, J BIOL CHEM, V278, P26078, DOI 10.1074/jbc.M301791200; Zhang Y, 2006, MOL CELL, V24, P759, DOI 10.1016/j.molcel.2006.10.027; Zhang ZY, 2003, PROG NUCLEIC ACID RE, V73, P171, DOI 10.1016/S0079-6603(03)01006-7; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X	44	97	98	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5717	5726		10.1074/jbc.M110.197129	http://dx.doi.org/10.1074/jbc.M110.197129			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21159777	hybrid, Green Published			2022-12-27	WOS:000287230600080
J	Birukou, I; Soman, J; Olson, JS				Birukou, Ivan; Soman, Jayashree; Olson, John S.			Blocking the Gate to Ligand Entry in Human Hemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLUTION CRYSTAL-STRUCTURES; MOLECULAR-DYNAMICS SIMULATION; SPERM-WHALE MYOGLOBIN; R-STATE HEMOGLOBIN; CARBON-MONOXIDE; DISTAL HISTIDINE; MIGRATION PATHWAYS; STRUCTURAL DETERMINANTS; INTERNAL CAVITIES; BINDING PATHWAYS	His(E7) to Trp replacements in HbA lead to markedly biphasic bimolecular CO rebinding after laser photolysis. For isolated mutant subunits, the fraction of fast phase increases with increasing [CO], suggesting a competition between binding to an open conformation with an empty E7 channel and relaxation to blocked or closed, slowly reacting states. The rate of conformational relaxation of the open state is similar to 18,000 s(-1) in alpha subunits and similar to 10-fold faster in beta subunits, similar to 175,000 s(-1). Crystal structures were determined for tetrameric alpha(WT)beta(Trp-63) HbCO, alpha(Trp-58)beta(WT) deoxyHb, and Trp-64 deoxy-and CO-Mb as controls. In Trp-63(E7) beta CO, the indole side chain is located in the solvent interface, blocking entry into the E7 channel. Similar blocked Trp-64(E7) conformations are observed in the mutant Mb crystal structures. In Trp-58(E7) deoxy-alpha subunits, the indole side chain fills both the channel and the distal pocket, forming a completely closed state. The bimolecular rate constant for CO binding, k'(CO), to the open conformations of both mutant Hb subunits is similar to 80-90 mu M-1 s(-1), whereas k'(CO) for the completely closed states is 1000-fold slower, similar to 0.08 mu M-1 s(-1). A transient intermediate with k'(CO) approximate to 0.7 mu M-1 s(-1) is observed after photolysis of Trp-63(E7) beta CO subunits and indicates that the indole ring blocks the entrance to the E7 channel, as observed in the crystal structures of Trp(E7) deoxyMb and beta CO subunits. Thus, either blocking or completely filling the E7 channel dramatically slows bimolecular binding, providing strong evidence that the E7 channel is the major pathway (>= 90%) for ligand entry in human hemoglobin.	Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77005 USA; Rice Univ, WM Keck Ctr Computat Biol, Houston, TX 77005 USA	Rice University; Rice University	Olson, JS (corresponding author), 6100 Main St, Houston, TX 77005 USA.	olson@rice.edu		Olson, John/0000-0002-0760-5403	National Institutes of Health [GM035649, HL047020]; Robert A. Welch Foundation [C0612]; Welch Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035649] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM035649 and HL047020. This work was also supported by Robert A. Welch Foundation Grant C0612 (to J. S. O.) and a Welch Foundation pre-doctoral fellowship (to I. B.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 1968, J CRYST GROWTH, DOI [rg/10.1016/00220248(68)900717, DOI 10.1016/0022-0248(68)90071-7]; Aranda R, 2006, ACTA CRYSTALLOGR D, V62, P776, DOI 10.1107/S0907444906017318; ArredondoPeter R, 1997, PLANT PHYSIOL, V115, P1259, DOI 10.1104/pp.115.3.1259; Bidon-Chanal A, 2007, J AM CHEM SOC, V129, P6782, DOI 10.1021/ja0689987; Birukou I, 2010, J BIOL CHEM, V285, P8840, DOI 10.1074/jbc.M109.053934; Blouin GC, 2010, BIOCHEMISTRY-US, V49, P4987, DOI 10.1021/bi1001745; Boechi L, 2008, PROTEINS, V73, P372, DOI 10.1002/prot.22072; Bossa C, 2005, BIOPHYS J, V89, P465, DOI 10.1529/biophysj.104.055020; Bossa C, 2004, BIOPHYS J, V86, P3855, DOI 10.1529/biophysj.103.037432; Brucker EA, 2000, ACTA CRYSTALLOGR D, V56, P812, DOI 10.1107/S0907444900006557; Brucker EA, 1996, J BIOL CHEM, V271, P25419, DOI 10.1074/jbc.271.41.25419; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunori M, 2004, J STRUCT BIOL, V147, P223, DOI 10.1016/j.jsb.2004.04.008; CARVER TE, 1992, J BIOL CHEM, V267, P14443; Cohen J, 2008, METHOD ENZYMOL, V437, P439, DOI 10.1016/S0076-6879(07)37022-5; Cohen J, 2007, BIOPHYS J, V93, P3591, DOI 10.1529/biophysj.107.108712; ELBER R, 1990, J AM CHEM SOC, V112, P9161, DOI 10.1021/ja00181a020; Elber R, 2008, J PHYS CHEM B, V112, P6147, DOI 10.1021/jp0769779; Elber R, 2010, CURR OPIN STRUC BIOL, V20, P162, DOI 10.1016/j.sbi.2010.01.002; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esquerra RM, 2010, PHYS CHEM CHEM PHYS, V12, P10270, DOI 10.1039/c003606b; Franzen S, 2002, P NATL ACAD SCI USA, V99, P16754, DOI 10.1073/pnas.252590999; Franzen S, 2002, J AM CHEM SOC, V124, P13271, DOI 10.1021/ja017708d; Goldbeck RA, 2006, P NATL ACAD SCI USA, V103, P1254, DOI 10.1073/pnas.0507840103; Goldbeck RA, 2009, J AM CHEM SOC, V131, P12265, DOI 10.1021/ja903409j; Golden SD, 2008, METHOD ENZYMOL, V437, P417, DOI 10.1016/S0076-6879(07)37021-3; Halder P, 2007, PROTEINS, V66, P172, DOI 10.1002/prot.21210; Hargrove MS, 2000, BIOPHYS J, V79, P2733, DOI 10.1016/S0006-3495(00)76512-X; Hargrove MS, 1997, J BIOL CHEM, V272, P17385, DOI 10.1074/jbc.272.28.17385; HUANG XH, 1994, NAT STRUCT BIOL, V1, P226, DOI 10.1038/nsb0494-226; Ionascu D, 2005, J AM CHEM SOC, V127, P16921, DOI 10.1021/ja054249y; Jenkins JD, 2009, ACTA CRYSTALLOGR D, V65, P41, DOI 10.1107/S0907444908037256; Knapp JE, 2009, STRUCTURE, V17, P1494, DOI 10.1016/j.str.2009.09.004; Kozlowski PM, 2001, J PORPHYR PHTHALOCYA, V5, P312, DOI 10.1002/jpp.318; LAI HH, 1995, PROTEINS, V22, P322, DOI 10.1002/prot.340220404; LI TS, 1994, BIOCHEMISTRY-US, V33, P1433, DOI 10.1021/bi00172a021; Marti MA, 2007, PROTEINS, V68, P480, DOI 10.1002/prot.21454; MATHEWS AJ, 1991, J BIOL CHEM, V266, P21631; MIMS MP, 1983, J BIOL CHEM, V258, P4219; MORIKIS D, 1989, BIOCHEMISTRY-US, V28, P4791, DOI 10.1021/bi00437a041; Mouawad L, 2005, BBA-GEN SUBJECTS, V1724, P385, DOI 10.1016/j.bbagen.2005.05.014; Nienhaus K, 2007, BIOCHEMISTRY-US, V46, P14018, DOI 10.1021/bi7016798; Olson JS, 2007, IUBMB LIFE, V59, P552, DOI 10.1080/15216540701230495; Olson JS, 1997, J BIOL INORG CHEM, V2, P544, DOI 10.1007/s007750050169; Olson JS, 1996, J BIOL CHEM, V271, P17593, DOI 10.1074/jbc.271.30.17593; Olson JS, 2003, METH MOLEC MED, V82, P65; Park SY, 2006, J MOL BIOL, V360, P690, DOI 10.1016/j.jmb.2006.05.036; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Phillips GN, 1999, J PHYS CHEM B, V103, P8817, DOI 10.1021/jp9918205; Puranik M, 2004, J BIOL CHEM, V279, P21096, DOI 10.1074/jbc.M400613200; QUILLIN ML, 1995, J MOL BIOL, V245, P416, DOI 10.1006/jmbi.1994.0034; QUILLIN ML, 1993, J MOL BIOL, V234, P140, DOI 10.1006/jmbi.1993.1569; Ruscio JZ, 2008, P NATL ACAD SCI USA, V105, P9204, DOI 10.1073/pnas.0710825105; Salter MD, 2008, J BIOL CHEM, V283, P35689, DOI 10.1074/jbc.M805727200; Savino C, 2009, BIOPOLYMERS, V91, P1097, DOI 10.1002/bip.21201; SCHOENBORN BP, 1965, NATURE, V207, P28, DOI 10.1038/207028a0; Schotte F, 2004, J STRUCT BIOL, V147, P235, DOI 10.1016/j.jsb.2004.06.009; Scott EE, 1997, BIOCHEMISTRY-US, V36, P11909, DOI 10.1021/bi970719s; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; SHEN TJ, 1993, P NATL ACAD SCI USA, V90, P8108, DOI 10.1073/pnas.90.17.8108; Shen TJ, 1997, PROTEIN ENG, V10, P1085, DOI 10.1093/protein/10.9.1085; Smagghe BJ, 2009, BIOPOLYMERS, V91, P1083, DOI 10.1002/bip.21256; Sottini S, 2005, J AM CHEM SOC, V127, P17427, DOI 10.1021/ja056101k; Sottini S, 2005, J PHYS CHEM B, V109, P11411, DOI 10.1021/jp0514224; Spiro TG, 2001, ACCOUNTS CHEM RES, V34, P137, DOI 10.1021/ar000108j; SPRINGER BA, 1987, P NATL ACAD SCI USA, V84, P8961, DOI 10.1073/pnas.84.24.8961; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; Srajer V, 2001, BIOCHEMISTRY-US, V40, P13802, DOI 10.1021/bi010715u; Tetreau C, 2004, BIOPHYS J, V86, P435, DOI 10.1016/S0006-3495(04)74120-X; TIAN WD, 1993, J MOL BIOL, V233, P155, DOI 10.1006/jmbi.1993.1491; Tian WD, 1996, BIOCHEMISTRY-US, V35, P3487, DOI 10.1021/bi952474u; TILTON RF, 1984, BIOCHEMISTRY-US, V23, P2849, DOI 10.1021/bi00308a002; Tomita A, 2009, P NATL ACAD SCI USA, V106, P2612, DOI 10.1073/pnas.0807774106; Trent JT, 2001, BIOCHEMISTRY-US, V40, P6155, DOI 10.1021/bi0100790; Trevaskis B, 1997, P NATL ACAD SCI USA, V94, P12230, DOI 10.1073/pnas.94.22.12230; Unzai S, 1998, J BIOL CHEM, V273, P23150, DOI 10.1074/jbc.273.36.23150; Vinogradov SN, 2008, J BIOL CHEM, V283, P8773, DOI 10.1074/jbc.R700029200; Vinogradov SN, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-31; Yang F, 1996, J MOL BIOL, V256, P762, DOI 10.1006/jmbi.1996.0123; Zhang ZY, 2009, J PHYS CHEM B, V113, P10923, DOI 10.1021/jp9031805	81	32	32	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10515	10529		10.1074/jbc.M110.176271	http://dx.doi.org/10.1074/jbc.M110.176271			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21193395	Green Published, hybrid			2022-12-27	WOS:000288547000068
J	Carvajal-Yepes, M; Himmelsbach, K; Schaedler, S; Ploen, D; Krause, J; Ludwig, L; Weiss, T; Klingel, K; Hildt, E				Carvajal-Yepes, Monica; Himmelsbach, Kiyoshi; Schaedler, Stephanie; Ploen, Daniela; Krause, Janis; Ludwig, Leopold; Weiss, Thomas; Klingel, Karin; Hildt, Eberhard			Hepatitis C Virus Impairs the Induction of Cytoprotective Nrf2 Target Genes by Delocalization of Small Maf Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HEPATOCYTES; OXIDATIVE STRESS; VIRAL-HEPATITIS; NS5A; REPLICATION; ACTIVATION; DEGRADATION; EXPRESSION; INFECTION; APOPTOSIS	The expression of a variety of cytoprotective genes is regulated by short cis-acting elements in their promoters, called antioxidant response elements (AREs). A central regulator of ARE-mediated gene expression is the NF-E2-related factor 2 (Nrf2). Nrf2/ARE-regulated genes are crucial for the maintenance of cellular integrity. Hepatitis C virus inhibits the induction of ARE-regulated genes, but neither induction nor inhibition of ARE-regulated gene expression affects HCV replication directly. In HCV-replicating cells the core protein triggers the delocalization of sMaf proteins from the nucleus to the replicon complex. Here sMafs bind to NS3. The extranuclear sMaf proteins prevent Nrf2 from entry in the nucleus and thereby inhibit the induction of Nrf2/ARE-regulated genes. This results in the decreased expression of cytoprotective genes. Consistent with this finding, the elimination of ROI is impaired in HCV-replicating cells as demonstrated by elevated protein oxidation or 8-OH-dG formation, reflecting DNA damage. In conclusion, these data identified a novel mechanism of Nrf2 regulation and suggest that the HCV-dependent inhibition of Nrf2/ARE-regulated genes confers to the HCV-associated pathogenesis by elevation of intracellular ROI that affect integrity of the host genome and regenerative processes.	[Carvajal-Yepes, Monica; Himmelsbach, Kiyoshi; Schaedler, Stephanie; Ploen, Daniela; Hildt, Eberhard] Univ Kiel, Inst Infect Med, D-24105 Kiel, Germany; [Carvajal-Yepes, Monica; Himmelsbach, Kiyoshi; Schaedler, Stephanie; Krause, Janis; Hildt, Eberhard] Univ Freiburg, Dept Internal Med 2, D-79106 Freiburg, Germany; [Carvajal-Yepes, Monica; Schaedler, Stephanie] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany; [Klingel, Karin] Univ Tubingen, Dept Mol Pathol, D-72076 Tubingen, Germany; [Ludwig, Leopold] Tech Univ Munich, Dept Med 2, D-81675 Munich, Germany; [Weiss, Thomas] Univ Regensburg, Ctr Liver Cell Res, D-93053 Regensburg, Germany	University of Kiel; University of Freiburg; University of Freiburg; Eberhard Karls University of Tubingen; Technical University of Munich; University of Regensburg	Hildt, E (corresponding author), Paul Ehrlich Inst, Div Virol, Paul Ehrlich Str 51-59, D-63225 Langen, Germany.	hileb@pei.de	Hildt, Eberhard/A-1040-2015; Weiss, Thomas S./G-3989-2012	Weiss, Thomas S./0000-0003-0336-0581; Himmelsbach, Kiyoshi/0000-0002-1840-6012; Bender, Daniela/0000-0002-8991-126X				Aleksunes LM, 2007, TOXICOL PATHOL, V35, P459, DOI 10.1080/01926230701311344; Bartosch B, 2009, J HEPATOL, V51, P810, DOI 10.1016/j.jhep.2009.05.008; Beyer TA, 2008, EMBO J, V27, P212, DOI 10.1038/sj.emboj.7601950; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Boudreau HE, 2009, J VIROL, V83, P12934, DOI 10.1128/JVI.01059-09; Brandenburg B, 2005, HEPATOLOGY, V42, P1300, DOI 10.1002/hep.20950; Breusing N, 2008, BIOL CHEM, V389, P203, DOI 10.1515/BC.2008.029; Burckstummer T, 2006, FEBS LETT, V580, P575, DOI 10.1016/j.febslet.2005.12.071; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Chou AH, 2005, J IMMUNOL, V174, P2160, DOI 10.4049/jimmunol.174.4.2160; Dhakshinamoorthy S, 2000, J BIOL CHEM, V275, P40134, DOI 10.1074/jbc.M003531200; Dionisio N, 2009, J HEPATOL, V50, P872, DOI 10.1016/j.jhep.2008.12.026; Ehrhardt C., 2006, SIGNAL TRANSDUCT BAN, V6, P179, DOI [10.1002/sita.200500073, DOI 10.1002/SITA.200500073]; Frese M, 2003, J GEN VIROL, V84, P1253, DOI 10.1099/vir.0.18997-0; HIJIKATA M, 1993, P NATL ACAD SCI USA, V90, P10773, DOI 10.1073/pnas.90.22.10773; Himmelsbach K, 2009, GUT, V58, P1644, DOI 10.1136/gut.2009.182212; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jung T, 2007, ARCH BIOCHEM BIOPHYS, V462, P231, DOI 10.1016/j.abb.2007.01.030; Keller UAD, 2006, MOL CELL BIOL, V26, P3773, DOI 10.1128/MCB.26.10.3773-3784.2006; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Kwak MK, 2006, BIOCHEM BIOPH RES CO, V345, P1350, DOI 10.1016/j.bbrc.2006.05.043; Lan L, 2008, J IMMUNOL, V181, P4926, DOI 10.4049/jimmunol.181.7.4926; Lehmann E, 2010, HEPATOLOGY, V51, P398, DOI 10.1002/hep.23339; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Oyadomari S, 2006, CELL, V126, P727, DOI 10.1016/j.cell.2006.06.051; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Robek MD, 2007, J VIROL, V81, P483, DOI 10.1128/JVI.01779-06; Sauter D, 2009, J HEPATOL, V50, P861, DOI 10.1016/j.jhep.2008.11.024; Schaedler S, 2010, J BIOL CHEM, V285, P41074, DOI 10.1074/jbc.M110.145862; Spaziani A, 2006, J BIOL CHEM, V281, P10983, DOI 10.1074/jbc.M512536200; Steinmann E, 2008, J VIROL, V82, P7034, DOI 10.1128/JVI.00118-08; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; Vasiliou Vasilis, 2006, Human Genomics, V2, P329; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wasserman WW, 1997, P NATL ACAD SCI USA, V94, P5361, DOI 10.1073/pnas.94.10.5361; Xu WH, 2008, LAB INVEST, V88, P1068, DOI 10.1038/labinvest.2008.75; Zhu ZW, 2008, HEPATOLOGY, V48, P1430, DOI 10.1002/hep.22491	43	80	83	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8941	8951		10.1074/jbc.M110.186684	http://dx.doi.org/10.1074/jbc.M110.186684			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21216956	Green Published, hybrid			2022-12-27	WOS:000288247700026
J	Greenough, MA; Volitakis, I; Li, QX; Laughton, K; Evin, G; Ho, M; Dalziel, AH; Camakaris, J; Bush, AI				Greenough, Mark A.; Volitakis, Irene; Li, Qiao-Xin; Laughton, Katrina; Evin, Genevieve; Ho, Michael; Dalziel, Andrew H.; Camakaris, James; Bush, Ashley I.			Presenilins Promote the Cellular Uptake of Copper and Zinc and Maintain Copper Chaperone of SOD1-dependent Copper/Zinc Superoxide Dismutase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; A-BETA; SYNAPTIC ZINC; TRANSPORTER; ACTIVATION; EXPRESSION; ABSENCE; CELLS; BRAIN; MOUSE	Dyshomeostasis of extracellular zinc and copper has been implicated in beta-amyloid aggregation, the major pathology associated with Alzheimer disease. Presenilin mediates the proteolytic cleavage of the beta-amyloid precursor protein to release beta-amyloid, and mutations in presenilin can cause familial Alzheimer disease. We tested whether presenilin expression affects copper and zinc transport. Studying murine embryonic fibroblasts (MEFs) from presenilin knock-out mice or RNA interference of presenilin expression in HEK293T cells, we observed a marked decrease in saturable uptake of radiolabeled copper and zinc. Measurement of basal metal levels in 6-month-old presenilin 1 heterozygous knock-out (PS1(+/-)) mice revealed significant deficiencies of copper and zinc in several tissues, including brain. Copper/zinc superoxide dismutase (SOD1) activity was significantly decreased in both presenilin knock-out MEFs and brain tissue of presenilin 1 heterozygous knock-out mice. In the MEFs and PS1(+/-) brains, copper chaperone of SOD1 (CCS) levels were decreased. Zinc-dependent alkaline phosphatase activity was not decreased in the PS null MEFs. These data indicate that presenilins are important for cellular copper and zinc turnover, influencing SOD1 activity, and having the potential to indirectly impact beta-amyloid aggregation through metal ion clearance.	[Greenough, Mark A.; Volitakis, Irene; Dalziel, Andrew H.; Bush, Ashley I.] Mental Hlth Res Inst, Parkville, Vic 3052, Australia; [Greenough, Mark A.; Dalziel, Andrew H.; Camakaris, James] Univ Melbourne, Dept Genet, Melbourne, Vic 3010, Australia; [Volitakis, Irene; Li, Qiao-Xin; Laughton, Katrina; Evin, Genevieve; Ho, Michael; Bush, Ashley I.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne	Bush, AI (corresponding author), Mental Hlth Res Inst, 155 Oak St, Parkville, Vic 3052, Australia.	a.bush@mhri.edu.au	Bush, Ashley I/A-1186-2007; Greenough, Mark/AAK-1615-2021; Bush, Ashley/Y-2457-2019; Evin, Genevieve M/E-5891-2013	Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069; Volitakis, Irene/0000-0003-0766-817X; Greenough, Mark/0000-0001-6767-0584	Australian Research Council; National Health & Medical Research Council; Australian Institute of Nuclear Science Engineering; Australian National Health & Medical Research Council [567171]	Australian Research Council(Australian Research Council); National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Institute of Nuclear Science Engineering; Australian National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by funds from the Australian Research Council and the National Health & Medical Research Council. <SUP>64</SUP>Cu was obtained via a grant from the Australian Institute of Nuclear Science & Engineering.; Supported by Australian National Health & Medical Research Council Biomedical Research Scholarship 567171.	Angeletti B, 2005, J BIOL CHEM, V280, P17930, DOI 10.1074/jbc.M412034200; Annaert WG, 2001, NEURON, V32, P579, DOI 10.1016/S0896-6273(01)00512-8; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Bergmans BA, 2010, LANCET NEUROL, V9, P215, DOI 10.1016/S1474-4422(09)70332-1; BUSH AI, 1994, J BIOL CHEM, V269, P12152; CAMAKARIS J, 1995, HUM MOL GENET, V4, P2117, DOI 10.1093/hmg/4.11.2117; Carroll MC, 2006, J BIOL CHEM, V281, P28648, DOI 10.1074/jbc.M600138200; Carroll MC, 2004, P NATL ACAD SCI USA, V101, P5964, DOI 10.1073/pnas.0308298101; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; Cole TB, 1999, P NATL ACAD SCI USA, V96, P1716, DOI 10.1073/pnas.96.4.1716; Culvenor JG, 2004, EUR J BIOCHEM, V271, P375, DOI 10.1046/j.1432-1033.2003.03936.x; Culvenor JG, 2000, EXP CELL RES, V255, P192, DOI 10.1006/excr.1999.4791; Dalby B, 2004, METHODS, V33, P95, DOI 10.1016/j.ymeth.2003.11.023; de Hoef DLV, 2009, GENESIS, V47, P246, DOI 10.1002/dvg.20485; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Duce JA, 2010, PROG NEUROBIOL, V92, P1, DOI 10.1016/j.pneurobio.2010.04.003; Eisses JF, 2005, J BIOL CHEM, V280, P37159, DOI 10.1074/jbc.M508822200; Evin G, 2005, BIOCHEMISTRY-US, V44, P4332, DOI 10.1021/bi0481702; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; GETZ J, 2010, ARCH BIOCHEM BIOPHYS, V417, P227; Gray EH, 2010, J ALZHEIMERS DIS, V21, P1101, DOI 10.3233/JAD-2010-100717; Green KN, 2008, J CELL BIOL, V181, P1107, DOI 10.1083/jcb.200706171; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Guo Q, 1999, J NEUROCHEM, V72, P1019, DOI 10.1046/j.1471-4159.1999.0721019.x; HESSE L, 1994, FEBS LETT, V349, P109, DOI 10.1016/0014-5793(94)00658-X; Hung YH, 2010, J BIOL INORG CHEM, V15, P61, DOI 10.1007/s00775-009-0600-y; Le Du MH, 2001, J BIOL CHEM, V276, P9158, DOI 10.1074/jbc.M009250200; Lee J, 2002, J BIOL CHEM, V277, P4380, DOI 10.1074/jbc.M104728200; Lee J, 2002, J BIOL CHEM, V277, P40253, DOI 10.1074/jbc.M208002200; Lee JH, 2010, CELL, V141, P1146, DOI 10.1016/j.cell.2010.05.008; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; Leissring MA, 2000, J CELL BIOL, V149, P793, DOI 10.1083/jcb.149.4.793; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; Leutner S, 2000, NEUROSCI LETT, V292, P87, DOI 10.1016/S0304-3940(00)01449-X; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Linkous DH, 2008, J HISTOCHEM CYTOCHEM, V56, P3, DOI 10.1369/jhc.6A7035.2007; Lutsenko S, 2010, CURR OPIN CHEM BIOL, V14, P211, DOI 10.1016/j.cbpa.2010.01.003; Maynard CJ, 2006, J INORG BIOCHEM, V100, P952, DOI 10.1016/j.jinorgbio.2006.02.010; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Nyabi O, 2003, J BIOL CHEM, V278, P43430, DOI 10.1074/jbc.M306957200; Peskin AV, 2000, CLIN CHIM ACTA, V293, P157, DOI 10.1016/S0009-8981(99)00246-6; Ris L, 2003, J BIOL CHEM, V278, P44393, DOI 10.1074/jbc.M300971200; Schlief ML, 2005, J NEUROSCI, V25, P239, DOI 10.1523/JNEUROSCI.3699-04.2005; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Touret N, 2003, J BIOL CHEM, V278, P25548, DOI 10.1074/jbc.M212374200; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Tuerk MJ, 2009, CURR OPIN GASTROEN, V25, P136, DOI 10.1097/MOG.0b013e328321b395; Vetrivel KS, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-4; Wang DS, 2002, NEUROSCI LETT, V328, P117, DOI 10.1016/S0304-3940(02)00498-6; Wang RS, 2006, P NATL ACAD SCI USA, V103, P353, DOI 10.1073/pnas.0509822102; Wolfe MS, 2009, SEMIN CELL DEV BIOL, V20, P219, DOI 10.1016/j.semcdb.2008.12.011; Wong PC, 2000, P NATL ACAD SCI USA, V97, P2886, DOI 10.1073/pnas.040461197; Yoo AS, 2000, NEURON, V27, P561, DOI 10.1016/S0896-6273(00)00066-0	57	60	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9776	9786		10.1074/jbc.M110.163964	http://dx.doi.org/10.1074/jbc.M110.163964			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21239495	Green Published, hybrid			2022-12-27	WOS:000288247700100
J	Hasan, A; Pokeza, N; Shaw, L; Lee, HS; Lazzaro, D; Chintala, H; Rosenbaum, D; Grant, MB; Chaqour, B				Hasan, Adeel; Pokeza, Nataliya; Shaw, Lynn; Lee, Hyun-Seung; Lazzaro, Douglas; Chintala, Hemabindu; Rosenbaum, Daniel; Grant, Maria B.; Chaqour, Brahim			The Matricellular Protein Cysteine-rich Protein 61 (CCN1/Cyr61) Enhances Physiological Adaptation of Retinal Vessels and Reduces Pathological Neovascularization Associated with Ischemic Retinopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; OXYGEN-INDUCED RETINOPATHY; MESENCHYMAL STEM-CELLS; SMOOTH-MUSCLE-CELLS; PROGENITOR CELLS; MECHANICAL REGULATION; VASCULAR DEVELOPMENT; ANGIOGENESIS; CYR61; GENE	Retinal vascular damages are the cardinal hallmarks of retinopathy of prematurity (ROP), a leading cause of vision impairment and blindness in childhood. Both angiogenesis and vasculogenesis are disrupted in the hyperoxia-induced vaso-obliteration phase, and recapitulated, although aberrantly, in the subsequent ischemia-induced neovessel formation phase of ROP. Yet, whereas the histopathological features of ROP are well characterized, many key modulators with a therapeutic potential remain unknown. The CCN1 protein also known as cysteine-rich protein 61 (Cyr61) is a dynamically expressed, matricellular protein required for proper angiogenesis and vasculogenesis during development. The expression of CCN1 becomes abnormally reduced during the hyperoxic and ischemic phases of ROP modeled in the mouse eye with oxygen-induced retinopathy (OIR). Lentivirus-mediated re-expression of CCN1 enhanced physiological adaptation of the retinal vasculature to hyperoxia and reduced pathological angiogenesis following ischemia. Remarkably, injection into the vitreous of OIR mice of hematopoietic stem cells (HSCs) engineered to express CCN1 harnessed ischemia-induced neovessel outgrowth without adversely affecting the physiological adaptation of retinal vessels to hyperoxia. In vitro exposure of HSCs to recombinant CCN1 induced integrin-dependent cell adhesion, migration, and expression of specific endothelial cell markers as well as many components of the Wnt signaling pathway including Wnt ligands, their receptors, inhibitors, and downstream targets. CCN1-induced Wnt signaling mediated, at least in part, adhesion and endothelial differentiation of cultured HSCs, and inhibition of Wnt signaling interfered with normalization of the retinal vasculature induced by CCN1-primed HSCs in OIR mice. These newly identified functions of CCN1 suggest its possible therapeutic utility in ischemic retinopathy.	[Lazzaro, Douglas; Chaqour, Brahim] Suny Downstate Med Ctr, SUNY Eye Inst, Brooklyn, NY 11203 USA; [Hasan, Adeel; Pokeza, Nataliya; Lee, Hyun-Seung; Chintala, Hemabindu; Chaqour, Brahim] Suny Downstate Med Ctr, Dept Cell Biol, Brooklyn, NY 11203 USA; [Lazzaro, Douglas; Chaqour, Brahim] Suny Downstate Med Ctr, Dept Ophthalmol, Brooklyn, NY 11203 USA; [Rosenbaum, Daniel] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; [Shaw, Lynn; Grant, Maria B.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Shaw, Lynn; Grant, Maria B.] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL 32610 USA; [Shaw, Lynn; Grant, Maria B.] Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA; [Shaw, Lynn; Grant, Maria B.] Univ Florida, Dept Psychiat, Gainesville, FL 32610 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Chaqour, B (corresponding author), Suny Downstate Med Ctr, SUNY Eye Inst, 450 Clarkson Ave,Box 5, Brooklyn, NY 11203 USA.	bchaqour@downstate.edu	Chaqour, Brahim/AEH-1314-2022	Chaqour, Brahim/0000-0002-8516-4324	National Institutes of Health [EY019387-01A1]; NATIONAL EYE INSTITUTE [R01EY012601, R21EY019387, P30EY021721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant EY019387-01A1 (to B. C.).	ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Asahara T, 2005, E SCHERING RES FDN W, V54, P111; Asahara T, 2007, YAKUGAKU ZASSHI, V127, P841, DOI 10.1248/yakushi.127.841; Bai T, 2010, J IMMUNOL, V184, P3223, DOI 10.4049/jimmunol.0902792; Bhatwadekar AD, 2009, INVEST OPHTH VIS SCI, V50, P4967, DOI 10.1167/iovs.09-3616; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Brooks SE, 2001, INVEST OPHTH VIS SCI, V42, P222; Chang KH, 2007, P NATL ACAD SCI USA, V104, P10595, DOI 10.1073/pnas.0702072104; Chaqour B, 2006, FEBS J, V273, P3639, DOI 10.1111/j.1742-4658.2006.05360.x; Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200; Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Connor KM, 2007, NAT MED, V13, P868, DOI 10.1038/nm1591; Dace DS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003381; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Davies M, 2006, MOL VIS, V12, P467; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Estrada R, 2009, J CELL PHYSIOL, V219, P563, DOI 10.1002/jcp.21701; Fataccioli V, 2002, HUM GENE THER, V13, P1461, DOI 10.1089/10430340260185094; Francischetti IMB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009356; Franco CA, 2009, CURR OPIN GENET DEV, V19, P476, DOI 10.1016/j.gde.2009.09.004; Friedlander Martin, 2007, Angiogenesis, V10, P89, DOI 10.1007/s10456-007-9070-4; Gardiner TA, 2005, AM J PATHOL, V166, P637, DOI 10.1016/S0002-9440(10)62284-5; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Grote K, 2007, BLOOD, V110, P877, DOI 10.1182/blood-2006-07-036202; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Guthrie SM, 2005, BLOOD, V105, P1916, DOI 10.1182/blood-2004-09-3415; Hanna M, 2009, J BIOL CHEM, V284, P23125, DOI 10.1074/jbc.M109.019059; Hubert KE, 2009, AM J PATHOL, V175, P2697, DOI 10.2353/ajpath.2009.090099; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; Ishida S, 2003, J EXP MED, V198, P483, DOI 10.1084/jem.20022027; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Katsube K, 2009, DEV GROWTH DIFFER, V51, P55, DOI 10.1111/j.1440-169X.2009.01077.x; Kireeva ML, 1997, EXP CELL RES, V233, P63, DOI 10.1006/excr.1997.3548; Kwon SM, 2008, CIRCULATION, V118, P157, DOI 10.1161/CIRCULATIONAHA.107.754978; LANG R, 1994, DEVELOPMENT, V120, P3395; Liu BY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008611; Liu HB, 2008, ENDOCRINOLOGY, V149, P1666, DOI 10.1210/en.2007-1415; Masckauchan THN, 2006, PHYSIOLOGY, V21, P181, DOI 10.1152/physiol.00058.2005; McLeod DS, 2006, DEV DYNAM, V235, P3336, DOI 10.1002/dvdy.20988; Mo FE, 2002, MOL CELL BIOL, V22, P8709, DOI 10.1128/MCB.22.24.8709-8720.2002; Monkley SJ, 1996, DEVELOPMENT, V122, P3343; Otani A, 2002, P NATL ACAD SCI USA, V99, P178, DOI 10.1073/pnas.012601899; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; Pollan C, 2009, NEONATAL NETW, V28, P93, DOI 10.1891/0730-0832.28.2.93; Rayssac A, 2009, MOL THER, V17, P2010, DOI 10.1038/mt.2009.211; Schutze N, 2005, PROTEIN EXPRES PURIF, V42, P219, DOI 10.1016/j.pep.2005.03.031; Schutze N, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-45; Shintani S, 2001, CIRCULATION, V103, P897, DOI 10.1161/01.CIR.103.6.897; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Suzuma K, 2000, J BIOL CHEM, V275, P40725, DOI 10.1074/jbc.M006509200; Uno K, 2007, DEV DYNAM, V236, P981, DOI 10.1002/dvdy.21122; Wang ZS, 2005, MOL CELL BIOL, V25, P5022, DOI 10.1128/MCB.25.12.5022-5030.2005; Yang R, 2008, PHYSIOL GENOMICS, V36, P1, DOI 10.1152/physiolgenomics.90291.2008; Yoshida Y, 2007, BIOCHEM BIOPH RES CO, V355, P611, DOI 10.1016/j.bbrc.2007.01.195; Zhang C, 2002, INVEST OPHTH VIS SCI, V43, P3059; Zhou DM, 2005, J APPL PHYSIOL, V98, P2344, DOI 10.1152/japplphysiol.01093.2004	59	32	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9542	9554		10.1074/jbc.M110.198689	http://dx.doi.org/10.1074/jbc.M110.198689			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21212276	Green Published, hybrid			2022-12-27	WOS:000288247700080
J	Kim, CH; Leung, A; Huh, YH; Yang, E; Kim, DJ; Leblanc, P; Ryu, H; Kim, K; Kim, DW; Garland, EM; Raj, SR; Biaggioni, I; Robertson, D; Kim, KS				Kim, Chun-Hyung; Leung, Amanda; Huh, Yang Hoon; Yang, Eungi; Kim, Deog-Joong; Leblanc, Pierre; Ryu, Hoon; Kim, Kyungjin; Kim, Dong-Wook; Garland, Emily M.; Raj, Satish R.; Biaggioni, Italo; Robertson, David; Kim, Kwang-Soo			Norepinephrine Deficiency Is Caused by Combined Abnormal mRNA Processing and Defective Protein Trafficking of Dopamine beta-Hydroxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETORY GRANULE BIOGENESIS; MOUSE FETAL DEVELOPMENT; HUMAN-DISEASE; GENE; CHAPERONES; MUTATIONS; CATECHOLAMINES; NORADRENALINE; FAILURE; STORAGE	Human norepinephrine (NE) deficiency (or dopamine beta-hydroxylase (DBH) deficiency) is a rare congenital disorder of primary autonomic failure, in which neurotransmitters NE and epinephrine are undetectable. Although potential pathogenic mutations, such as a common splice donor site mutation (IVS1 + 2T -> C) and various missense mutations, in NE deficiency patients were identified, molecular mechanisms underlying this disease remain unknown. Here, we show that the IVS1 + 2T -> C mutation results in a non-detectable level of DBH protein production and that all three missense mutations tested lead to the DBH protein being trapped in the endoplasmic reticulum (ER). Supporting the view that mutant DBH induces an ER stress response, exogenous expression of mutant DBH dramatically induced expression of BiP, a master ER chaperone. Furthermore, we found that a pharmacological chaperone, glycerol, significantly rescued defective trafficking of mutant DBH proteins. Taken together, we propose that NE deficiency is caused by the combined abnormal processing of DBH mRNA and defective protein trafficking and that this disease could be treated by a pharmacological chaperone(s).	[Kim, Chun-Hyung; Leung, Amanda; Yang, Eungi; Kim, Deog-Joong; Leblanc, Pierre; Kim, Kwang-Soo] Harvard Univ, Sch Med, Mol Neurobiol Lab, McLean Hosp, Belmont, MA 02478 USA; [Huh, Yang Hoon] Boston Biomed Res Inst, Watertown, MA 02472 USA; [Ryu, Hoon] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Kim, Kyungjin] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Kim, Dong-Wook] Yonsei Univ, Coll Med, Dept Physiol, Seoul 120752, South Korea; [Garland, Emily M.; Raj, Satish R.; Biaggioni, Italo; Robertson, David] Vanderbilt Univ, Auton Dysfunct Ctr, Nashville, TN 37232 USA; [Garland, Emily M.; Raj, Satish R.; Biaggioni, Italo; Robertson, David] Vanderbilt Univ, Dept Clin Pharmacol, Nashville, TN 37232 USA	Harvard University; McLean Hospital; Boston Biomedical Research Institute; Boston University; Seoul National University (SNU); Yonsei University; Yonsei University Health System; Vanderbilt University; Vanderbilt University	Kim, CH (corresponding author), Harvard Univ, Sch Med, Mol Neurobiol Lab, McLean Hosp, 115 Mill St, Belmont, MA 02478 USA.	chkim@mclean.harvard.edu; kskim@mclean.harvard.edu	Leblanc, Pierre/AAB-3554-2020	Leblanc, Pierre/0000-0001-8756-2396; Ryu, Hoon/0000-0001-6544-3732	National Institutes of Health [MH48866, MH087903, P01 HL056693, HL071784, UL1 RR024975D]; Brain Research Center; Dongyang Corporation Co. in the Republic of Korea; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002497, UL1RR024975] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL056693, R01HL071784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087903, R21MH087903, R01MH048866, R29MH048866] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Research Center; Dongyang Corporation Co. in the Republic of Korea; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grant MH48866 (to K.-S.K.), MH087903 (to K.-S.K.), P01 HL056693 (to D. R.), HL071784 (to D. R.), and UL1 RR024975D. This work was also supported by international grants from the Brain Research Center and the Dongyang Corporation Co. in the Republic of Korea.	Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; AXELROD J, 1972, NEW ENGL J MED, V287, P237, DOI 10.1056/NEJM197208032870508; Bernier V, 2004, TRENDS ENDOCRIN MET, V15, P222, DOI 10.1016/j.tem.2004.05.003; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; Deinum J, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.009282; Garland EM, 2002, ANN NY ACAD SCI, V971, P506, DOI 10.1111/j.1749-6632.2002.tb04515.x; Goldstein DS, 2006, CARDIOVASC DRUG REV, V24, P189, DOI 10.1111/j.1527-3466.2006.00189.x; Goldstein DS, 2003, J PHARMACOL EXP THER, V305, P800, DOI 10.1124/jpet.103.049270; Hendershot LM, 2004, MT SINAI J MED, V71, P289; INTVELD AJM, 1987, LANCET, V1, P183; Katayama T, 1999, NAT CELL BIOL, V1, P479, DOI 10.1038/70265; Kim CH, 2002, AM J MED GENET, V108, P140, DOI 10.1002/ajmg.10196; Lamande SR, 1999, SEMIN CELL DEV BIOL, V10, P455, DOI 10.1006/scdb.1999.0317; Macario AJL, 2005, NEW ENGL J MED, V353, P1489, DOI 10.1056/NEJMra050111; MATHIAS CJ, 1990, Q J MED, V75, P617; NAGATSU T, 1972, CLIN CHEM, V18, P980; OCONNOR DT, 1994, CLIN SCI, V86, P149, DOI 10.1042/cs0860149; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Oyarce AM, 2000, J BIOL CHEM, V275, P3270, DOI 10.1074/jbc.275.5.3270; RAPOPORT TA, 1992, SCIENCE, V258, P931, DOI 10.1126/science.1332192; ROBERTSON D, 1986, NEW ENGL J MED, V314, P1494, DOI 10.1056/NEJM198606053142307; STEWART LC, 1988, ANNU REV BIOCHEM, V57, P551; Teraoka SN, 1999, AM J HUM GENET, V64, P1617, DOI 10.1086/302418; THOMAS SA, 1995, NATURE, V374, P643, DOI 10.1038/374643a0; TISCHLER AS, 1975, NATURE, V258, P341, DOI 10.1038/258341a0; Tooze SA, 2001, TRENDS CELL BIOL, V11, P116, DOI 10.1016/S0962-8924(00)01907-3; Ulloa-Aguirre A, 2004, TRAFFIC, V5, P821, DOI 10.1111/j.1600-0854.2004.00232.x; Vorechovsky I, 2006, NUCLEIC ACIDS RES, V34, P4630, DOI 10.1093/nar/gkl535; WEINSHILBOUM RM, 1971, SCIENCE, V174, P1349, DOI 10.1126/science.174.4016.1349; ZHOU QY, 1995, NATURE, V374, P640, DOI 10.1038/374640a0	32	18	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9196	9204		10.1074/jbc.M110.192351	http://dx.doi.org/10.1074/jbc.M110.192351			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21209083	Green Published, hybrid			2022-12-27	WOS:000288247700050
J	Kim, Y; Konno, H; Sugano, Y; Hisabori, T				Kim, Yusung; Konno, Hiroki; Sugano, Yasushi; Hisabori, Toru			Redox Regulation of Rotation of the Cyanobacterial F-1-ATPase Containing Thiol Regulation Switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPLAST ATP SYNTHASE; COUPLING FACTOR-I; GAMMA-SUBUNIT; EPSILON-SUBUNIT; F-1 MOTOR; CHLAMYDOMONAS-REINHARDTII; INVERSE REGULATION; ESCHERICHIA-COLI; CYSTEINE BRIDGE; CDNA SEQUENCE	F-1-ATP synthase (F-1-ATPase) is equipped with a special mechanism that prevents the wasteful reverse reaction, ATP hydrolysis, when there is insufficient proton motive force to drive ATP synthesis. Chloroplast F-1-ATPase is subject to redox regulation, whereby ATP hydrolysis activity is regulated by formation and reduction of the disulfide bond located on the gamma subunit. To understand the molecular mechanism of this redox regulation, we constructed a chimeric F-1 complex (alpha(3)beta(3)gamma(redox)) using cyanobacterial F-1, which mimics the regulatory properties of the chloroplast F-1-ATPase, allowing the study of its regulation at the single molecule level. The redox state of the gamma subunit did not affect the ATP binding rate to the catalytic site(s) and the torque for rotation. However, the long pauses caused by ADP inhibition were frequently observed in the oxidized state. In addition, the duration of continuous rotation was relatively shorter in the oxidized alpha(3)beta(3)gamma(redox) complex. These findings lead us to conclude that redox regulation of CF1-ATPase is achieved by controlling the probability of ADP inhibition via the gamma subunit inserted region, a sequence feature observed in both cyanobacterial and chloroplast ATPase gamma subunits, which is important for ADP inhibition (Sunamura, E., Konno, H., Imashimizu-Kobayashi, M., Sugano, Y., and Hisabori, T. (2010) Plant Cell Physiol. 51, 855-865).	[Kim, Yusung; Konno, Hiroki; Sugano, Yasushi; Hisabori, Toru] Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Tokyo Institute of Technology	Hisabori, T (corresponding author), Tokyo Inst Technol, Chem Resources Lab, Midori Ku, Nagatsuta 4259-R1-8, Yokohama, Kanagawa 2268503, Japan.	thisabor@res.titech.ac.jp	; Hisabori, Toru/E-5205-2014	Sugano, Yasushi/0000-0001-8463-5131; Hisabori, Toru/0000-0003-2046-0277	Ministry of Education, Culture, Sports, Science and Technology, Japan [18074002]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (No. 18074002, to T. H.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan and in part by the Management Expenses Grants for National Universities Corporations from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Adachi K, 2007, CELL, V130, P309, DOI 10.1016/j.cell.2007.05.020; Bald D, 2001, J BIOL CHEM, V276, P39505, DOI 10.1074/jbc.C100436200; Bald D, 2000, J BIOL CHEM, V275, P12757, DOI 10.1074/jbc.275.17.12757; DUNN SD, 1990, BIOCHEMISTRY-US, V29, P4335, DOI 10.1021/bi00470a011; Hayashi K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.218103; Hirono-Hara Y, 2005, P NATL ACAD SCI USA, V102, P4288, DOI 10.1073/pnas.0406486102; Hirono-Hara Y, 2001, P NATL ACAD SCI USA, V98, P13649, DOI 10.1073/pnas.241365698; Hisabori T, 1999, FEBS LETT, V463, P35, DOI 10.1016/S0014-5793(99)01602-6; Konno H, 2000, BIOCHEM J, V352, P783, DOI 10.1042/0264-6021:3520783; Konno H, 2006, EMBO J, V25, P4596, DOI 10.1038/sj.emboj.7601348; Krenn BE, 1997, BIOCHEM J, V323, P841, DOI 10.1042/bj3230841; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; Meiss E, 2008, J BIOL CHEM, V283, P24594, DOI 10.1074/jbc.M802574200; MIKI J, 1988, FEBS LETT, V232, P221, DOI 10.1016/0014-5793(88)80421-6; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; Motohashi K, 2006, J BIOL CHEM, V281, P35039, DOI 10.1074/jbc.M605938200; NALIN CM, 1984, J BIOL CHEM, V259, P7275; NELSON N, 1972, J BIOL CHEM, V247, P7657; Nowak KF, 2004, BIOCHEMISTRY-US, V43, P3273, DOI 10.1021/bi035820d; ROSS SA, 1995, J BIOL CHEM, V270, P9813, DOI 10.1074/jbc.270.17.9813; Schwarz O, 1997, J BIOL CHEM, V272, P16924, DOI 10.1074/jbc.272.27.16924; Shimabukuro K, 2003, P NATL ACAD SCI USA, V100, P14731, DOI 10.1073/pnas.2434983100; SMITH JB, 1977, BIOCHEMISTRY-US, V16, P306, DOI 10.1021/bi00621a023; Sunamura EI, 2010, PLANT CELL PHYSIOL, V51, P855, DOI 10.1093/pcp/pcq061; Ueoka-Nakanishi H, 2004, J BIOL CHEM, V279, P16272, DOI 10.1074/jbc.M400607200; WERNERGRUNE S, 1994, MOL GEN GENET, V244, P144; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; WOLOSIUK RA, 1977, NATURE, V266, P565, DOI 10.1038/266565a0; Wu G, 2008, PHOTOSYNTH RES, V97, P185, DOI 10.1007/s11120-008-9315-0; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513; YU LM, 1988, J BIOL CHEM, V263, P19342	32	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9071	9078		10.1074/jbc.M110.200584	http://dx.doi.org/10.1074/jbc.M110.200584			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21193405	Green Published, hybrid			2022-12-27	WOS:000288247700038
J	Ufret-Vincenty, CA; Klein, RM; Hua, L; Angueyra, J; Gordon, SE				Ufret-Vincenty, Carmen A.; Klein, Rebecca M.; Hua, Li; Angueyra, Juan; Gordon, Sharona E.			Localization of the PIP2 Sensor of TRPV1 Ion Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSAICIN RECEPTOR; PROTEIN; DESENSITIZATION; SENSITIZATION; ACTIVATION; INHIBITION; BRADYKININ; NEURONS; SITE	Although a large number of ion channels are now believed to be regulated by phosphoinositides, particularly phosphoinositide 4,5-bisphosphate (PIP2), the mechanisms involved in phosphoinositide regulation are unclear. For the TRP superfamily of ion channels, the role and mechanism of PIP2 modulation has been especially difficult to resolve. Outstanding questions include: is PIP2 the endogenous regulatory lipid; does PIP2 potentiate all TRPs or are some TRPs inhibited by PIP2; where does PIP2 interact with TRP channels; and is the mechanism of modulation conserved among disparate subfamilies? We first addressed whether the PIP2 sensor resides within the primary sequence of the channel itself, or, as recently proposed, within an accessory integral membrane protein called Pirt. Here we show that Pirt does not alter the phosphoinositide sensitivity of TRPV1 in HEK-293 cells, that there is no FRET between TRPV1 and Pirt, and that dissociated dorsal root ganglion neurons from Pirt knock-out mice have an apparent affinity for PIP2 indistinguishable from that of their wild-type littermates. We followed by focusing on the role of the C terminus of TRPV1 in sensing PIP2. Here, we show that the distal C-terminal region is not required for PIP2 regulation, as PIP2 activation remains intact in channels in which the distal C-terminal has been truncated. Furthermore, we used a novel in vitro binding assay to demonstrate that the proximal C-terminal region of TRPV1 is sufficient for PIP2 binding. Together, our data suggest that the proximal C-terminal region of TRPV1 can interact directly with PIP2 and may play a key role in PIP2 regulation of the channel.	[Ufret-Vincenty, Carmen A.; Klein, Rebecca M.; Hua, Li; Angueyra, Juan; Gordon, Sharona E.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Gordon, SE (corresponding author), Box 357290,1959 NE Pacific St, Seattle, WA 98195 USA.	seg@u.washington.edu	Angueyra, Juan/HCI-8722-2022	Angueyra, Juan/0000-0002-9217-3069	National Institutes of Health [R01EY17564, T32EY007031, T32NS007332]; National Eye Institute [P30EY01730]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025429] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017564, T32EY007031, P30EY001730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007332] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EY17564 (to S. E. G.), T32EY007031 (to R. M. K.), T32NS007332 (to C. A. U.-V.), and National Eye Institute Core Grant for Vision Research P30EY01730.	Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Binshtok AM, 2007, NATURE, V449, P607, DOI 10.1038/nature06191; Bonnington JK, 2003, J PHYSIOL-LONDON, V551, P433, DOI 10.1113/jphysiol.2003.039990; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Docherty RJ, 1996, PFLUG ARCH EUR J PHY, V431, P828, DOI 10.1007/BF02332166; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P81, DOI 10.1085/jgp.200910344; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; GORDON SE, 1995, NEURON, V14, P177; Haider S, 2007, EMBO J, V26, P3749, DOI 10.1038/sj.emboj.7601809; Hilgemann DW, 2004, SCIENCE, V304, P223, DOI 10.1126/science.1097439; Kim AY, 2008, CELL, V133, P475, DOI 10.1016/j.cell.2008.02.053; Klein RM, 2008, J BIOL CHEM, V283, P26208, DOI 10.1074/jbc.M801912200; Lee SY, 2005, ARCH PHARM RES, V28, P405, DOI 10.1007/BF02977669; Lukacs V, 2007, J NEUROSCI, V27, P7070, DOI 10.1523/JNEUROSCI.1866-07.2007; Mandadi S, 2004, CELL CALCIUM, V35, P471, DOI 10.1016/j.ceca.2003.11.003; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Mercado J, 2010, J NEUROSCI, V30, P13338, DOI 10.1523/JNEUROSCI.2108-10.2010; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sikand P, 2007, J PHYSIOL-LONDON, V581, P631, DOI 10.1113/jphysiol.2006.118620; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Toth A, 2005, MOL BRAIN RES, V135, P162, DOI 10.1016/j.molbrainres.2004.12.003; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; Wang HB, 2006, BIOL CHEM, V387, P11, DOI 10.1515/BC.2006.003; Yao J, 2009, PLOS BIOL, V7, P350, DOI 10.1371/journal.pbio.1000046; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhang Z, 2005, J BIOL CHEM, V280, P39185, DOI 10.1074/jbc.M506965200; Zheng Jie, 2006, V337, P65; Zhu WG, 2007, MOL CELL NEUROSCI, V34, P689, DOI 10.1016/j.mcn.2007.01.005	38	95	98	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9688	9698		10.1074/jbc.M110.192526	http://dx.doi.org/10.1074/jbc.M110.192526			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21224382	Green Published, hybrid			2022-12-27	WOS:000288247700093
J	Zhang, T; Yao, SH; Wang, P; Yin, CR; Xiao, C; Qian, ML; Liu, DH; Zheng, LM; Meng, WT; Zhu, HY; Liu, J; Xu, H; Mo, XM				Zhang, Ting; Yao, Shaohua; Wang, Ping; Yin, Chaoran; Xiao, Chun; Qian, Meilin; Liu, Donghui; Zheng, Lemin; Meng, Wentong; Zhu, Hongyan; Liu, Jin; Xu, Hong; Mo, Xianming			ApoA-II Directs Morphogenetic Movements of Zebrafish Embryo by Preventing Chromosome Fusion during Nuclear Division in Yolk Syncytial Layer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN A-II; EEL ANGUILLA-JAPONICA; MYOCARDIAL MIGRATION; INSULIN-RESISTANCE; MULTIGENE FAMILY; E GENE; CELL; EXPRESSION; ORGANIZATION; GASTRULATION	The high density lipoprotein (HDL) represents a class of lipid- and protein-containing particles and consists of two major apolipoproteins apoA-I and apoA-II. ApoA-II has been shown to be involved in the pathogenesis of insulin resistance, adiposity, diabetes, and metabolic syndrome. In embryo, apoa2 mRNAs are abundant in the liver, brain, lung, placenta, and in fish yolk syncytial layer (YSL), suggesting that apoa2 may perform a function during embryonic development. Here we find out that apoa2 modulates zebrafish embryonic development by regulating the organization of YSL. Disruption of apoa2 function in zebrafish caused chromosome fusing, which strongly blocked YSL nuclear division, inducing disorders in YSL organization and finally disturbing the embryonic epiboly. Purified native human apoA-II was able specifically to rescue the defects and induced nuclear division in zebrafish embryos and in human HeLa cells. The C terminus of apoA-II was required for the proper chromosome separation during nuclear division of YSL in zebrafish embryos and in human HeLa cells. Our data indicate that organization of YSL is required for blastoderm patterning and morphogenesis and suggest that apolipoprotein apoA-II is a novel factor of nuclear division in YSL involved in the regulation of early zebrafish embryonic morphogenesis and in mammalian cells for proliferation.	[Zhang, Ting; Yao, Shaohua; Wang, Ping; Yin, Chaoran; Xiao, Chun; Qian, Meilin; Meng, Wentong; Zhu, Hongyan; Liu, Jin; Xu, Hong; Mo, Xianming] Sichuan Univ, Lab Stem Cell Biol, State Key Lab Biotherapy, W China Hosp,W China Med Sch, Chengdu 610041, Peoples R China; [Liu, Donghui; Zheng, Lemin] Peking Univ, Hlth Sci Ctr, Minist Educ, Inst Cardiovasc Sci, Beijing 100191, Peoples R China; [Liu, Donghui; Zheng, Lemin] Peking Univ, Hlth Sci Ctr, Minist Educ, Key Lab Mol Cardiovasc Sci, Beijing 100191, Peoples R China	Sichuan University; Peking University; Peking University	Xu, H (corresponding author), Keyuan 4 Lu, Chengdu 610041, Peoples R China.	xuhongm@yahoo.com; xmingmo@scu.edu.cn	Mo, Xianming/AAM-2167-2021	Donghui, Liu/0000-0001-6568-5424; Zhang, Ting/0000-0002-8645-581X; Yin, Chaoran/0000-0002-4193-7022; Yao, Shaohua/0000-0002-0191-4889	National Basic Research Program of China [2009CB941200]; Nature Science Foundation of China [30771228, 30771227]	National Basic Research Program of China(National Basic Research Program of China); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (2009CB941200) and the Nature Science Foundation of China (to H. X. (30771228) and to X. M. (30771227)).	Ando S, 2005, BIOSCI BIOTECH BIOCH, V69, P2258, DOI 10.1271/bbb.69.2258; Carvalho L, 2009, DEVELOPMENT, V136, P1305, DOI 10.1242/dev.026922; Castellani LW, 2008, J BIOL CHEM, V283, P11633, DOI 10.1074/jbc.M708995200; Castellani LW, 2001, DIABETES, V50, P643, DOI 10.2337/diabetes.50.3.643; Chen SR, 2000, DEVELOPMENT, V127, P4681; Cheng JC, 2004, DEV DYNAM, V231, P313, DOI 10.1002/dvdy.20144; Choudhury M, 2009, ACTA BIOCH BIOPH SIN, V41, P370, DOI 10.1093/abbs/gmp015; Cooper MS, 2007, J EXP ZOOL PART B, V308B, P591, DOI 10.1002/jez.b.21142; D'Amico LA, 2001, DEV DYNAM, V222, P611, DOI 10.1002/dvdy.1216; Ebert AM, 2008, P NATL ACAD SCI USA, V105, P198, DOI 10.1073/pnas.0707948105; Fan X, 2007, DEV BIOL, V310, P363, DOI 10.1016/j.ydbio.2007.08.008; Gingerich JL, 2006, DEV DYNAM, V235, P2749, DOI 10.1002/dvdy.20918; Hancock JF, 2005, METHODS, V37, P165, DOI 10.1016/j.ymeth.2005.05.018; Havel R J, 1975, Adv Exp Med Biol, V63, P37; Hirata T, 2000, BIOCHEM BIOPH RES CO, V271, P603, DOI 10.1006/bbrc.2000.2672; Ho CY, 1999, CURR BIOL, V9, P1131, DOI 10.1016/S0960-9822(99)80485-0; Hsu HJ, 2006, NATURE, V439, P480, DOI 10.1038/nature04436; Ishida M, 2007, J REPROD DEVELOP, V53, P69, DOI 10.1262/jrd.18002; Kikuchi Y, 2001, GENE DEV, V15, P1493, DOI 10.1101/gad.892301; KIMMEL CB, 1985, DEV BIOL, V108, P86, DOI 10.1016/0012-1606(85)90011-9; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kondo H, 2005, GENE, V346, P257, DOI 10.1016/j.gene.2004.11.015; Kondo H, 2001, BBA-MOL CELL BIOL L, V1531, P132, DOI 10.1016/S1388-1981(01)00099-3; Lange PH, 2005, NAT CLIN PRACT UROL, V2, P151, DOI 10.1038/ncpuro0149; LI WH, 1988, J LIPID RES, V29, P245; Li Z, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-117; Mizuno T, 1999, MECH DEVELOP, V81, P51, DOI 10.1016/S0925-4773(98)00202-0; Monnot MJ, 1999, DEV DYNAM, V214, P207, DOI 10.1002/(SICI)1097-0177(199903)214:3<207::AID-AJA4>3.0.CO;2-5; Montero JA, 2004, TRENDS CELL BIOL, V14, P620, DOI 10.1016/j.tcb.2004.09.008; Paolucci M, 1998, COMP BIOCHEM PHYS B, V119, P647, DOI 10.1016/S0305-0491(98)00040-6; Poupard G, 2000, CELL TISSUE RES, V300, P251, DOI 10.1007/s004419900158; Provost PR, 2009, J ENDOCRINOL, V200, P321, DOI 10.1677/JOE-08-0238; Sakaguchi T, 2006, DEVELOPMENT, V133, P4063, DOI 10.1242/dev.02581; SOLNICAKREZEL L, 1994, DEVELOPMENT, V120, P2443; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Trinh LA, 2004, DEV CELL, V6, P371; TRINKAUS JP, 1993, J EXP ZOOL, V265, P258, DOI 10.1002/jez.1402650308; Weiser DC, 2009, DEVELOPMENT, V136, P2375, DOI 10.1242/dev.034892; Weng W, 1996, P NATL ACAD SCI USA, V93, P14788, DOI 10.1073/pnas.93.25.14788; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wilkins SJ, 2008, DEV BIOL, V314, P12, DOI 10.1016/j.ydbio.2007.10.050; Yamanaka Y, 1998, GENE DEV, V12, P2345, DOI 10.1101/gad.12.15.2345; Zalik SE, 1999, BIOCHEM CELL BIOL, V77, P527, DOI 10.1139/bcb-77-6-527; Zhou L, 2005, COMP BIOCHEM PHYS B, V142, P432, DOI 10.1016/j.cbpb.2005.09.007	44	15	17	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9514	9525		10.1074/jbc.M110.134908	http://dx.doi.org/10.1074/jbc.M110.134908			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21212265	Green Published, hybrid			2022-12-27	WOS:000288247700078
J	Doi, S; Zou, YL; Togao, O; Pastor, JV; John, GB; Wang, L; Shiizaki, K; Gotschall, R; Schiavi, S; Yorioka, N; Takahashi, M; Boothman, DA; Kuro-o, M				Doi, Shigehiro; Zou, Yonglong; Togao, Osamu; Pastor, Johanne V.; John, George B.; Wang, Lei; Shiizaki, Kazuhiro; Gotschall, Russell; Schiavi, Susan; Yorioka, Noriaki; Takahashi, Masaya; Boothman, David A.; Kuro-o, Makoto			Klotho Inhibits Transforming Growth Factor-beta 1 (TGF-beta 1) Signaling and Suppresses Renal Fibrosis and Cancer Metastasis in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; UNILATERAL URETERAL OBSTRUCTION; FIBROBLAST GROWTH FACTOR-23; TGF-BETA; FUNCTIONAL VARIANT; TRPV5 CHANNEL; BREAST-CANCER; FGF RECEPTOR; DISEASE; MECHANISMS	Fibrosis is a pathological process characterized by infiltration and proliferation of mesenchymal cells in interstitial space. A substantial portion of these cells is derived from residing non-epithelial and/or epithelial cells that have acquired the ability to migrate and proliferate. The mesenchymal transition is also observed in cancer cells to confer the ability to metastasize. Here, we show that renal fibrosis induced by unilateral ureteral obstruction and metastasis of human cancer xenografts are suppressed by administration of secreted Klotho protein to mice. Klotho is a single-pass transmembrane protein expressed in renal tubular epithelial cells. The extracellular domain of Klotho is secreted by ectodomain shedding. Secreted Klotho protein directly binds to the type-II TGF-beta receptor and inhibits TGF-beta 1 binding to cell surface receptors, thereby inhibiting TGF-beta 1 signaling. Klotho suppresses TGF-beta 1-induced epithelial-to-mesenchymal transition (EMT) responses in cultured cells, including decreased epithelial marker expression, increased mesenchymal marker expression, and/or increased cell migration. In addition to TGF-beta 1 signaling, secreted Klotho has been shown to inhibit Wnt and IGF-1 signaling that can promote EMT. These results have raised the possibility that secreted Klotho may function as an endogenous anti-EMT factor by inhibiting multiple growth factor signaling pathways simultaneously.	[Zou, Yonglong; Boothman, David A.] Univ Texas SW Med Ctr Dallas, Dept Oncol, Dallas, TX 75390 USA; [Doi, Shigehiro; Pastor, Johanne V.; John, George B.; Wang, Lei; Shiizaki, Kazuhiro; Kuro-o, Makoto] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Togao, Osamu; Takahashi, Masaya] Univ Texas SW Med Ctr Dallas, Adv Imaging Res Ctr, Dallas, TX 75390 USA; [Gotschall, Russell; Schiavi, Susan] Genzyme Corp, Cambridge, MA 02142 USA; [Yorioka, Noriaki] Grad Sch Biomed Sci, Dept Adv Nephrol, Minami Ku, Hiroshima 7348551, Japan	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Sanofi-Aventis; Genzyme Corporation	Boothman, DA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Oncol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	david.boothman@utsouthwestern.edu; makoto.kuro-o@utsouthwestern.edu	Togao, Osamu/AAE-4702-2022; Boothman, David/Q-7776-2019; Doi, Shigehiro/AAQ-2655-2020	Gotschall, Robert Russell/0000-0002-5050-1386	National Institutes of Health [R01AG019712, R01CA102792, R01CA129011]; Dept. of Energy [DE-FG02-09ER64789]; Genzyme; Philips Japan; NATIONAL CANCER INSTITUTE [R01CA102792, R01CA129011, U24CA126608, P30CA142543, R01CA139217] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB009147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG019712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dept. of Energy; Genzyme(Sanofi-AventisGenzyme Corporation); Philips Japan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part by Grants R01AG019712 (to M. K.), R01CA102792 (to D. A. B.), R01CA129011 (to M. T.), and R21EB009147 (to M. T.) from the National Institutes of Health. This work was also supported by the Dept. of Energy (DE-FG02-09ER64789, to D. A. B.), Genzyme (Genzyme Renal Innovations Program, to M. K.), and Philips Japan (Cooperative Research Grant, to M. T.). R. G. and S. S. are employees of Genzyme Corporation.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Arking DE, 2002, P NATL ACAD SCI USA, V99, P856, DOI 10.1073/pnas.022484299; Bloch L, 2009, FEBS LETT, V583, P3221, DOI 10.1016/j.febslet.2009.09.009; Boutet A, 2006, EMBO J, V25, P5603, DOI 10.1038/sj.emboj.7601421; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Cha SK, 2009, MOL PHARMACOL, V76, P38, DOI 10.1124/mol.109.055780; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; DasGupta R, 1999, DEVELOPMENT, V126, P4557; El Chaar M, 2007, AM J PHYSIOL-RENAL, V292, pF1291, DOI 10.1152/ajprenal.00327.2005; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Ganapathy V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-122; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Haruna Y, 2007, P NATL ACAD SCI USA, V104, P2331, DOI 10.1073/pnas.0611079104; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kato Y, 2000, BIOCHEM BIOPH RES CO, V267, P597, DOI 10.1006/bbrc.1999.2009; Kawai T, 2009, LAB INVEST, V89, P47, DOI 10.1038/labinvest.2008.104; Klahr S, 2002, AM J PHYSIOL-RENAL, V283, pF861, DOI 10.1152/ajprenal.00362.2001; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lee J, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-109; Ling H, 2003, J AM SOC NEPHROL, V14, P377, DOI 10.1097/01.ASN.0000042168.43665.9B; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Lyng H, 2000, MAGNET RESON MED, V43, P828, DOI 10.1002/1522-2594(200006)43:6<828::AID-MRM8>3.0.CO;2-P; Mitani H, 2002, HYPERTENSION, V39, P838, DOI 10.1161/01.HYP.0000013734.33441.EA; Mitsiades CS, 2004, CANCER CELL, V5, P221, DOI 10.1016/S1535-6108(04)00050-9; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Sugiura H, 2005, NEPHROL DIAL TRANSPL, V20, P2636, DOI 10.1093/ndt/gfi165; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Togao O, 2010, RADIOLOGY, V255, P772, DOI 10.1148/radiol.10091735; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Weroha S, 2008, J MAMMARY GLAND BIOL, V13, P471, DOI 10.1007/s10911-008-9104-6; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Wolf I, 2010, ONCOGENE, V29, P26, DOI 10.1038/onc.2009.301; Wolf I, 2008, ONCOGENE, V27, P7094, DOI 10.1038/onc.2008.292; Xu YF, 2007, J MAGN RESON IMAGING, V26, P678, DOI 10.1002/jmri.20979; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580; Yu XJ, 2005, ENDOCRINOLOGY, V146, P4647, DOI 10.1210/en.2005-0670; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	51	385	424	0	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8655	8665		10.1074/jbc.M110.174037	http://dx.doi.org/10.1074/jbc.M110.174037			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21209102	Green Published, hybrid			2022-12-27	WOS:000288013300091
J	Fukuda, Y; Aguilar-Bryan, L; Vaxillaire, M; Dechaume, A; Wang, Y; Dean, M; Moitra, K; Bryan, J; Schuetz, JD				Fukuda, Yu; Aguilar-Bryan, Lydia; Vaxillaire, Martine; Dechaume, Aurelie; Wang, Yao; Dean, Michael; Moitra, Karobi; Bryan, Joseph; Schuetz, John D.			Conserved Intramolecular Disulfide Bond Is Critical to Trafficking and Fate of ATP-binding Cassette (ABC) Transporters ABCB6 and Sulfonylurea Receptor 1 (SUR1)/ABCC8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUALITY-CONTROL; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; PLASMA-MEMBRANE; CYSTIC-FIBROSIS; N-GLYCOSYLATION; PROTEIN; CHANNELS; OLIGOSACCHARIDES; IDENTIFICATION	The ATP-binding cassette (ABC) transporter ABCB6 is a mitochondrial porphyrin transporter that activates porphyrin biosynthesis. ABCB6 lacks a canonical mitochondrial targeting sequence but reportedly traffics to other cellular compartments such as the plasma membrane. How ABCB6 reaches these destinations is unknown. In this study, we show that endogenous ABCB6 is glycosylated in multiple cell types, indicating trafficking through the endoplasmic reticulum (ER), and has only one atypical site for glycosylation (NXC) in its amino terminus. ABCB6 remained glycosylated when the highly conserved cysteine (Cys-8) was substituted with serine to make a consensus site, NXS. However, this substitution blocked ER exit and produced ABCB6 degradation, which was mostly reversed by the proteasomal inhibitor MG132. The amino terminus of ABCB6 has an additional highly conserved ER luminal cysteine (Cys-26). When Cys-26 was mutated alone or in combination with Cys-8, it also resulted in instability and ER retention. Further analysis revealed that these two cysteines form a disulfide bond. We discovered that other ABC transporters with an amino terminus in the ER had similarly configured conserved cysteines. This analysis led to the discovery of a disease-causing mutation in the sulfonylurea receptor 1 (SUR1)/ABCC8 from a patient with hyperinsulinemic hypoglycemia. The mutant allele only contains a mutation in a conserved amino-terminal cysteine, producing SUR1 that fails to reach the cell surface. These results suggest that for ABC transporters the propensity to form a disulfide bond in the ER defines a unique checkpoint that determines whether a protein is ER-retained.	[Fukuda, Yu; Wang, Yao; Schuetz, John D.] St Jude Childrens Hosp, Dept Pharmaceut Sci, Memphis, TN 38105 USA; [Fukuda, Yu] Univ Tennessee, Hlth Sci Ctr, Coll Grad Hlth Sci, Interdisciplinary Program, Memphis, TN 38163 USA; [Aguilar-Bryan, Lydia; Bryan, Joseph] Pacific NW Res Inst, Seattle, WA 98122 USA; [Vaxillaire, Martine; Dechaume, Aurelie] CNRS, Inst Biol, UMR Unit 8090, F-59019 Lille, France; [Vaxillaire, Martine; Dechaume, Aurelie] Inst Pasteur, F-59019 Lille, France; [Dean, Michael; Moitra, Karobi] NCI, Expt Immunol Lab, NIH, Frederick, MD 21702 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Schuetz, JD (corresponding author), St Jude Childrens Hosp, Dept Pharmaceut Sci, MS 313,262 Danny Thomas Pl, Memphis, TN 38105 USA.	John.Schuetz@stjude.org	Dean, Michael C/G-8172-2012; Fukuda, Yu/GLT-1434-2022; Dean, Michael/R-7501-2019	Dean, Michael C/0000-0003-2234-0631; Fukuda, Yu/0000-0001-6182-540X	National Institutes of Health [ES058571, P30 CA21745, CA21865]; American Lebanese Syrian Associated Charities; Thrasher Foundation; NATIONAL CANCER INSTITUTE [ZIABC011301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Thrasher Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants ES058571, P30 CA21745, and CA21865. This work was also supported by the American Lebanese Syrian Associated Charities and by a grant from the Thrasher Foundation (to L. A.-B.).	Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; Aguilar-Bryan L, 2008, ENDOCR REV, V29, P265, DOI 10.1210/er.2007-0029; ALBERINI CM, 1990, NATURE, V347, P485, DOI 10.1038/347485a0; BAUSE E, 1983, BIOCHEM J, V209, P331, DOI 10.1042/bj2090331; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Dean M, 2005, METHOD ENZYMOL, V400, P409, DOI 10.1016/S0076-6879(05)00024-8; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Fitzgerald ML, 2001, J BIOL CHEM, V276, P15137, DOI 10.1074/jbc.M100474200; Goldenberg NM, 2007, MOL BIOL CELL, V18, P4762, DOI 10.1091/mbc.E06-11-0991; GRINNELL BW, 1991, J BIOL CHEM, V266, P9778; Hernandez MV, 2010, MOL BIOL CELL, V21, P1387, DOI 10.1091/mbc.E09-10-0880; Isidoro C, 1996, J BIOL CHEM, V271, P26138, DOI 10.1074/jbc.271.42.26138; Jalil YA, 2008, AM J PHYSIOL-CELL PH, V294, pC579, DOI 10.1152/ajpcell.00612.2006; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Krishnamurthy PC, 2006, NATURE, V443, P586, DOI 10.1038/nature05125; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Krogh TN, 1997, EUR J BIOCHEM, V244, P334, DOI 10.1111/j.1432-1033.1997.00334.x; Lynch J, 2009, CANCER RES, V69, P5560, DOI 10.1158/0008-5472.CAN-09-0078; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Mitsuhashi N, 2000, J BIOL CHEM, V275, P17536, DOI 10.1074/jbc.275.23.17536; Negroiu G, 2000, J BIOL CHEM, V275, P32200, DOI 10.1074/jbc.M005186200; Park B, 2006, CELL, V127, P369, DOI 10.1016/j.cell.2006.08.041; Paterson JK, 2007, BIOCHEMISTRY-US, V46, P9443, DOI 10.1021/bi700015m; RIORDAN JR, 1989, SCIENCE, V245, P1066; Satomi Y, 2004, FEBS LETT, V576, P51, DOI 10.1016/j.febslet.2004.08.061; Sharma N, 1999, J BIOL CHEM, V274, P20628, DOI 10.1074/jbc.274.29.20628; Sigrist Christian J A, 2002, Brief Bioinform, V3, P265, DOI 10.1093/bib/3.3.265; SITIA R, 1990, CELL, V60, P781, DOI 10.1016/0092-8674(90)90092-S; TITANI K, 1986, BIOCHEMISTRY-US, V25, P3171, DOI 10.1021/bi00359a015; Tsuchida M, 2008, BIOCHEM BIOPH RES CO, V369, P369, DOI 10.1016/j.bbrc.2008.02.027; Tusnady GE, 2006, FEBS LETT, V580, P1017, DOI 10.1016/j.febslet.2005.11.040; Vance BA, 1997, J BIOL CHEM, V272, P23117, DOI 10.1074/jbc.272.37.23117; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Wakabayashi K, 2007, J BIOL CHEM, V282, P27841, DOI 10.1074/jbc.C700133200; Wang ZV, 2007, MOL CELL BIOL, V27, P3716, DOI 10.1128/MCB.00931-06; Westlake CJ, 2005, MOL BIOL CELL, V16, P2483, DOI 10.1091/mbc.E04-12-1113; Wijnholds J, 1997, NAT MED, V3, P1275, DOI 10.1038/nm1197-1275; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	41	29	30	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8481	8492		10.1074/jbc.M110.174516	http://dx.doi.org/10.1074/jbc.M110.174516			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21199866	Green Published, hybrid			2022-12-27	WOS:000288013300076
J	Liu, YT; Dan, QJ; Wang, JW; Feng, YG; Chen, L; Liang, JA; Li, QX; Lin, SC; Wang, ZX; Wu, JW				Liu, Yi-Tong; Dan, Qiong-Jie; Wang, Jiawei; Feng, Yingang; Chen, Lei; Liang, Juan; Li, Qinxi; Lin, Sheng-Cai; Wang, Zhi-Xin; Wu, Jia-Wei			Molecular Basis of Wnt Activation via the DIX Domain Protein Ccd1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE COILED-COIL-DIX1 CCD1; POSITIVE REGULATOR; SIGNALING PATHWAY; LRP6 PHOSPHORYLATION; CELL POLARITY; AXIN; RECRUITMENT; ASSEMBLIES; EXPRESSION; SOFTWARE	The Wnt signaling plays pivotal roles in embryogenesis and cancer, and the three DIX domain-containing proteins, Dvl, Axin, and Ccd1, play distinct roles in the initiation and regulation of canonical Wnt signaling. Overexpressed Dvl has a tendency to form large polymers in a cytoplasmic punctate pattern, whereas the biologically active Dvl in fact forms low molecular weight oligomers. The molecular basis for how the polymeric sizes of Dvl proteins are controlled upon Wnt signaling remains unclear. Here we show that Ccd1 up-regulates canonical Wnt signaling via acting synergistically with Dvl. We determined the crystal structures of wild type Ccd1-DIX and mutant Dvl1-DIX(Y17D), which pack into "head-to-tail" helical filaments. Structural analyses reveal two sites crucial for intra-filament homo-and hetero-interaction and a third site for inter-filament homo-assembly. Systematic mutagenesis studies identified critical residues from all three sites required for Dvl homo-oligomerization, puncta formation, and stimulation of Wnt signaling. Remarkably, Ccd1 forms a hetero-complex with Dvl through the "head" of Dvl-DIX and the "tail" of Ccd1-DIX, depolymerizes Dvl homo-assembly, and thereby controls the size of Dvl polymer. These data together suggest a molecular mechanism for Ccd1-mediated Wnt activation in that Ccd1 converts latent polymeric Dvl to a biologically active oligomer(s).	[Liu, Yi-Tong; Wang, Jiawei; Chen, Lei; Liang, Juan; Wang, Zhi-Xin; Wu, Jia-Wei] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Dan, Qiong-Jie; Feng, Yingang; Wang, Zhi-Xin] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Li, Qinxi; Lin, Sheng-Cai] Xiamen Univ, Sch Life Sci, MOE Key Lab Cell Biol & Tumor Cell Engn, Xiamen 361005, Fujian, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS; Xiamen University	Wu, JW (corresponding author), Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China.	jiaweiwu@mail.tsinghua.edu.cn	Feng, Yingang/B-6304-2008; Lin, SC/G-4666-2010; Wang, Jiawei/D-1144-2010; wang, zhixin/GZH-2500-2022; Li, QX/G-4669-2010	Feng, Yingang/0000-0002-0879-1316; Wang, Jiawei/0000-0001-9893-8539; 	Ministry of Science and Technology of China [2007CB914400, 2011CB910803]; National Natural Science Foundation of China [31070643]; Tsinghua University [09THZ02235]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University	This work was supported in part by Ministry of Science and Technology of China Grants 2007CB914400 and 2011CB910803, National Natural Science Foundation of China Grant 31070643, and Tsinghua University Grant 09THZ02235.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Ehebauer MT, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-70; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Greco TL, 1996, MAMM GENOME, V7, P475, DOI 10.1007/s003359900144; Ikeuchi Y, 2009, J NEUROSCI, V29, P4312, DOI 10.1523/JNEUROSCI.0126-09.2009; Kishida M, 2001, J BIOL CHEM, V276, P33147, DOI 10.1074/jbc.M103555200; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Klingensmith J, 1996, MECH DEVELOP, V58, P15, DOI 10.1016/S0925-4773(96)00549-7; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu ZL, 2008, J BIOL CHEM, V283, P13132, DOI 10.1074/jbc.M710595200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan WJ, 2008, SCIENCE, V321, P1350, DOI 10.1126/science.1160741; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Pizzuti A, 1996, HUM MOL GENET, V5, P953, DOI 10.1093/hmg/5.7.953; Qiao F, 2004, CELL, V118, P163, DOI 10.1016/j.cell.2004.07.010; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Sakanaka C, 1999, J BIOL CHEM, V274, P14090, DOI 10.1074/jbc.274.20.14090; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Schwarz-Romond T, 2007, J CELL SCI, V120, P2402, DOI 10.1242/jcs.002956; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Shiomi K, 2005, MOL BRAIN RES, V135, P169, DOI 10.1016/j.molbrainres.2004.12.002; Shiomi K, 2003, CURR BIOL, V13, P73, DOI 10.1016/S0960-9822(02)01398-2; Singh KK, 2010, NEURON, V67, P33, DOI 10.1016/j.neuron.2010.06.002; Smalley MJ, 2005, J CELL SCI, V118, P5279, DOI 10.1242/jcs.02647; Smalley MJ, 1999, EMBO J, V18, P2823, DOI 10.1093/emboj/18.10.2823; Soma K, 2006, GENE EXPR PATTERNS, V6, P325, DOI 10.1016/j.modgep.2005.06.013; SUMIMOTO H, 2007, SCI STKE, pRE6, DOI DOI 10.1126/STKE.4012007RE6; Tsang M, 1996, DEV DYNAM, V207, P253, DOI 10.1002/(SICI)1097-0177(199611)207:3<253::AID-AJA2>3.0.CO;2-G; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wang L, 2010, CANCER SCI, V101, P700, DOI 10.1111/j.1349-7006.2009.01448.x; Wong CK, 2004, J BIOL CHEM, V279, P39366, DOI 10.1074/jbc.M404598200; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1	44	33	37	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8597	8608		10.1074/jbc.M110.186742	http://dx.doi.org/10.1074/jbc.M110.186742			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21189423	Green Published, hybrid			2022-12-27	WOS:000288013300086
J	Zhang, QC; Yeh, TL; Leyva, A; Frank, LG; Miller, J; Kim, YE; Langen, R; Finkbeiner, S; Amzel, ML; Ross, CA; Poirier, MA				Zhang, Qi Charles; Yeh, Tzu-lan; Leyva, Alfonso; Frank, Leslie G.; Miller, Jason; Kim, Yujin E.; Langen, Ralf; Finkbeiner, Steven; Amzel, Mario L.; Ross, Christopher A.; Poirier, Michelle A.			A Compact beta Model of huntingtin Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAG REPEAT LENGTH; MUTANT HUNTINGTIN; MONOCLONAL-ANTIBODIES; CLINICAL PROGRESSION; POLYGLUTAMINE LENGTH; NEURONAL DEATH; DISEASE; AGGREGATION; FRAGMENTS; OLIGOMERS	Huntington disease results from an expanded polyglutamine region in the N terminus of the huntingtin protein. HD pathology is characterized by neuronal degeneration and protein inclusions containing N-terminal fragments of mutant huntingtin. Structural information is minimal, though it is believed that mutant huntingtin polyglutamine adopts beta structure upon conversion to a toxic form. To this end, we designed mammalian cell expression constructs encoding compact beta variants of Htt exon 1 N-terminal fragment and tested their ability to aggregate and induce toxicity in cultured neuronal cells. In parallel, we performed molecular dynamics simulations, which indicate that constructs with expanded polyglutamine beta-strands are stabilized by main-chain hydrogen bonding. Finally, we found a correlation between the reactivity to 3B5H10, an expanded polyglutamine antibody that recognizes a compact beta rich hairpin structure, and the ability to induce cell toxicity. These data are consistent with an important role for a compact beta structure in mutant huntingtin-induced cell toxicity.	[Ross, Christopher A.; Poirier, Michelle A.] Childrens Med Surg Ctr, Div Neurobiol, Dept Psychiat, Baltimore, MD 21287 USA; [Yeh, Tzu-lan; Leyva, Alfonso; Amzel, Mario L.] Johns Hopkins Univ, Sch Med, Dept Biochem & Biophys, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21287 USA; [Ross, Christopher A.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA; [Miller, Jason] Univ Calif San Francisco, Chem & Chem Biol Grad Program, San Francisco, CA 94158 USA; [Miller, Jason] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94158 USA; [Miller, Jason; Finkbeiner, Steven] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Finkbeiner, Steven] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Biochem, Los Angeles, CA 90089 USA; Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Mol Biol, Los Angeles, CA 90089 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Southern California; University of Southern California	Poirier, MA (corresponding author), Childrens Med Surg Ctr, Div Neurobiol, Dept Psychiat, 8-121,600 N Wolfe St, Baltimore, MD 21287 USA.	mpoirie1@jhmi.edu	Nucifora, Leslie/X-2716-2019; Ross, Christopher A/H-8395-2013; Kim, Yujin/P-4270-2014	Kim, Yujin/0000-0003-4290-0974; Miller, Jason/0000-0002-2784-9560; Amzel, L. Mario/0000-0002-0129-9572	National Institutes of Health [R01NS053679, P01NS16375, 2NS45091, AG027936]; DOE [DE-FG02-04ER25626]; National Institutes of Health-NIGMS; University of California at San Francisco Hillblom Center for the Biology of Aging; Huntington Disease Society of America Coalition for the Cure; CHDI, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016375, R01NS053679, R01NS045091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); National Institutes of Health-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of California at San Francisco Hillblom Center for the Biology of Aging(University of California System); Huntington Disease Society of America Coalition for the Cure; CHDI, Inc.; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS053679 (to M. A. P.), P01NS16375 (to C. A. R.), 2NS45091 (to S. F.), AG027936 (to R. L.), and DOE DE-FG02-04ER25626 (to M. L. A.), the National Institutes of Health-NIGMS UCSF Medical Scientist Training Program (to J. M.), and a fellowship from the University of California at San Francisco Hillblom Center for the Biology of Aging (to J. M.). This work was also supported by the Huntington Disease Society of America Coalition for the Cure and by CHDI, Inc.	ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; DUYAO M, 1993, NAT GENET, V4, P387, DOI 10.1038/ng0893-387; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Kim YJ, 2001, P NATL ACAD SCI USA, V98, P12784, DOI 10.1073/pnas.221451398; Kim YE, 2010, NAT METHODS, V7, P67, DOI [10.1038/nmeth.1405, 10.1038/NMETH.1405]; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Legleiter J, 2009, J BIOL CHEM, V284, P21647, DOI 10.1074/jbc.M109.016923; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Miller J, 2010, J NEUROSCI, V30, P10541, DOI 10.1523/JNEUROSCI.0146-10.2010; PERUTZ M, 1994, PROTEIN SCI, V3, P1629, DOI 10.1002/pro.5560031002; Peters-Libeu C, 2005, ACTA CRYSTALLOGR F, V61, P1065, DOI 10.1107/S1744309105036547; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Poirier MA, 2005, HUM MOL GENET, V14, P765, DOI 10.1093/hmg/ddi071; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Ratovitski T, 2007, CELL CYCLE, V6, P2970, DOI 10.4161/cc.6.23.4992; Ravina B, 2008, MOVEMENT DISORD, V23, P1223, DOI 10.1002/mds.21988; Rosenblatt A, 2006, NEUROLOGY, V66, P1016, DOI 10.1212/01.wnl.0000204230.16619.d9; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Ross CA, 2003, P NATL ACAD SCI USA, V100, P1, DOI 10.1073/pnas.0237018100; Ross CA, 1997, MEDICINE, V76, P305, DOI 10.1097/00005792-199709000-00001; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	31	44	44	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8188	8196		10.1074/jbc.M110.192013	http://dx.doi.org/10.1074/jbc.M110.192013			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21209075	Green Published, hybrid			2022-12-27	WOS:000288013300049
J	Zhang, ZL; Xu, JJ; Sheng, ZT; Sui, YP; Palli, SR				Zhang, Zhaolin; Xu, Jingjing; Sheng, Zhentao; Sui, Yipeng; Palli, Subba R.			Steroid Receptor Co-activator Is Required for Juvenile Hormone Signal Transduction through a bHLH-PAS Transcription Factor, Methoprene Tolerant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOOP-HELIX PROTEINS; GENE-PRODUCT; DROSOPHILA-MELANOGASTER; TRIBOLIUM-CASTANEUM; MOLECULAR ACTIONS; DNA-BINDING; STATUS-QUO; METAMORPHOSIS; ECDYSONE; INSECT	Metamorphosis in insects is regulated by juvenile hormone (JH) and ecdysteroids. The mechanism of 20-hydroxyecdysone (20E), but not of JH action, is well understood. A basic helixloop-helix (bHLH)-Per-Arnt-Sim (PAS) family member, methoprene tolerant (Met), plays an important role in JH action. Microarray analysis and RNA interference (RNAi) were used to identify 69 genes that require Met for their hydroprene-regulated expression in the red flour beetle, Tribolium castaneum. Quantitative real time PCR analysis confirmed microarray data for 13 of the 16 hydroprene-response genes tested. The members of the bHLH-PAS family often function as heterodimers to regulate gene expression and Met is a member of this family. To determine whether other members of the bHLH-PAS family are required for the expression of JH-response genes, we employed RNAi to knockdown the expression of all 11 members of the bHLH-PAS family and studied the expression of JH-response genes in RNAi insects. These studies showed that besides Met, another member of this family, steroid receptor co-activator (SRC) is required for the expression of 15 JH-response genes tested. Moreover, studies in JH responsive Aag-2 cells revealed that Aedes aegypti homologues of both Met and SRC are required for the expression of the JH-response gene, kr-h1, and SRC is required for expression of ecdysone-response genes. These data suggest the steroid receptor co-activator plays key roles in both JH and 20E action suggesting that this may be an important molecule that mediates cross-talk between JH and 20E to prevent metamorphosis.	[Zhang, Zhaolin; Xu, Jingjing; Sheng, Zhentao; Sui, Yipeng; Palli, Subba R.] Univ Kentucky, Coll Agr, Dept Entomol, Lexington, KY 40546 USA	University of Kentucky	Palli, SR (corresponding author), Univ Kentucky, Coll Agr, Dept Entomol, Lexington, KY 40546 USA.	rpalli@uky.edu	Xu, Jingjing/H-2267-2013; Zhang, Zhaolin/E-6183-2012; sheng, Zhentao Sheng/E-8962-2017; PALLI, SUBBA REDDY/AAU-8289-2020	PALLI, SUBBA REDDY/0000-0002-0873-3247; Xu, Jingjing/0000-0003-1976-3721	National Institutes of Health [GM070559-06]; Kentucky Agricultural Experimental Station [11-08-014]; NCRR IDeA [INBRE-P20 RR016481, COBRE-P20RR018733]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481, P20RR018733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070559] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Agricultural Experimental Station; NCRR IDeA; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM070559-06. This is contribution 11-08-014 from the Kentucky Agricultural Experimental Station.; We thank Dr. Nigel Cooper and Xiahong Li, University of Louisville, for help with microarray analysis. The University of Louisville microarray facility is supported by NCRR IDeA Awards INBRE-P20 RR016481 and COBRE-P20RR018733.	Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Ashok M, 1998, P NATL ACAD SCI USA, V95, P2761, DOI 10.1073/pnas.95.6.2761; Bai JW, 2000, CELL, V103, P1047, DOI 10.1016/S0092-8674(00)00208-7; Bitra K, 2009, ARCH INSECT BIOCHEM, V70, P90, DOI 10.1002/arch.20281; Bitra K, 2009, GENE, V448, P74, DOI 10.1016/j.gene.2009.08.003; Emmons RB, 1999, DEVELOPMENT, V126, P3937; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; GOODMAN WG, 2005, COMPREHENSIVE MOL IN, V3, P319; Hartfelder K, 2000, BRAZ J MED BIOL RES, V33, P157, DOI 10.1590/S0100-879X2000000200003; Hassan BA, 2000, GENE DEV, V14, P1852; JAN YN, 1993, CELL, V75, P827, DOI 10.1016/0092-8674(93)90525-U; Jang ACC, 2009, NAT CELL BIOL, V11, P569, DOI 10.1038/ncb1863; Konopova B, 2007, P NATL ACAD SCI USA, V104, P10488, DOI 10.1073/pnas.0703719104; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Miura K, 2005, FEBS J, V272, P1169, DOI 10.1111/j.1742-4658.2005.04552.x; Moore AW, 2000, P NATL ACAD SCI USA, V97, P10436, DOI 10.1073/pnas.170301897; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Parthasarathy R, 2008, MECH DEVELOP, V125, P601, DOI 10.1016/j.mod.2008.03.004; Parthasarathy R, 2007, MECH DEVELOP, V124, P23, DOI 10.1016/j.mod.2006.09.002; Parthasarathy R, 2010, INSECT BIOCHEM MOLEC, V40, P405, DOI 10.1016/j.ibmb.2010.03.006; Parthasarathy R, 2009, MECH DEVELOP, V126, P563, DOI 10.1016/j.mod.2009.03.005; Pursley S, 2000, INSECT BIOCHEM MOLEC, V30, P839, DOI 10.1016/S0965-1748(00)00056-4; RIDDIFORD LM, 1994, ADV INSECT PHYSIOL, V24, P213, DOI 10.1016/S0065-2806(08)60084-3; Riddiford LM, 1996, ARCH INSECT BIOCHEM, V32, P271, DOI 10.1002/(SICI)1520-6327(1996)32:3/4&lt;271::AID-ARCH2&gt;3.0.CO;2-W; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Swanson HI, 2002, CHEM-BIOL INTERACT, V141, P63, DOI 10.1016/S0009-2797(02)00066-2; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Wheeler DE, 2003, BIOESSAYS, V25, P994, DOI 10.1002/bies.10337; Wilson TG, 1998, P NATL ACAD SCI USA, V95, P14040, DOI 10.1073/pnas.95.24.14040; Wilson TG, 2006, GENETICS, V172, P253, DOI 10.1534/genetics.105.046631; Wu Y, 2006, MECH DEVELOP, V123, P530, DOI 10.1016/j.mod.2006.05.005; Wyatt GR, 1996, ADV INSECT PHYSIOL, V26, P1, DOI 10.1016/S0065-2806(08)60030-2; Zelzer E, 1997, GENE DEV, V11, P2079, DOI 10.1101/gad.11.16.2079; Zhu JS, 2006, MOL CELL BIOL, V26, P9402, DOI 10.1128/MCB.01318-06	35	148	158	4	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8437	8447		10.1074/jbc.M110.191684	http://dx.doi.org/10.1074/jbc.M110.191684			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21190938	Green Published, hybrid			2022-12-27	WOS:000288013300072
J	Alvarez-Flores, MP; Furlin, D; Ramos, OHP; Balan, A; Konno, K; Chudzinski-Tavassi, AM				Alvarez-Flores, Miryam Paola; Furlin, Daniel; Ramos, Oscar H. P.; Balan, Andrea; Konno, Katsuhiro; Chudzinski-Tavassi, Ana Marisa			Losac, the First Hemolin that Exhibits Procogulant Activity through Selective Factor X Proteolytic Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COAGULATION FACTOR-X; INSECT-IMMUNE PROTEIN; RUSSELLS VIPER VENOM; NEURAL CELL-ADHESION; IMMUNOGLOBULIN SUPERFAMILY; CATALYTIC ANTIBODIES; CRYSTAL-STRUCTURE; BLOOD-COAGULATION; MANDUCA-SEXTA; PHOSPHOLIPID-VESICLES	Envenoming by the contact of human skin with Lonomia obliqua caterpillars promotes a hemorrhagic syndrome characterized by a consumptive coagulopathy. Losac (Lonomia obliqua Stuart factor activator) is a component of the bristle of L. obliqua that is probably partially responsible for the observed syndrome because it activates factor X and is recognized by an effective antilonomic serum. Here we unveil the proteolytic activity of Losac and demonstrate the feasibility of its recombinant production. On the other hand, Losac has no homology to known proteases, but it can be inhibited by PMSF, a serine protease inhibitor. Instead, it shows closer homology to members of the hemolin family of proteins, a group of cell adhesion molecules. The recombinant protein (rLosac) shortened the coagulation time of normal and deficient plasmas, whereas it was ineffective in factor X-deficient plasma unless reconstituted with this protein. rLosac was able to activate factor X in a dose-and time-dependent manner but not gamma-carboxyglutamic acid domainless factor X. Moreover, phospholipids and calcium ions increased rLosac activity. Also, rLosac had no effect on fibrin or fibrinogen, indicating its specificity for blood coagulation activation. Linear double reciprocal plots indicate that rLosac follows a Michaelis-Menten kinetics. Cleavage of factor X by rLosac resulted in fragments that are compatible with those generated by RVV-X (a well known factor X activator). Together, our results validate Losac as the first protein from the hemolin family exhibiting procoagulant activity through selective proteolysis on coagulation factor X.	[Alvarez-Flores, Miryam Paola; Furlin, Daniel; Ramos, Oscar H. P.; Chudzinski-Tavassi, Ana Marisa] Inst Butantan, Lab Bioquim & Biofis, BR-05503900 Sao Paulo, Brazil; [Balan, Andrea] Ctr Pesquisa Energia & Mat, Lab Nacl Biociencias, BR-13083970 Campinas, SP, Brazil; [Konno, Katsuhiro; Chudzinski-Tavassi, Ana Marisa] Inst Butantan, Ctr Toxinol Aplicada, BR-05503900 Sao Paulo, Brazil	Instituto Butantan; Instituto Butantan	Chudzinski-Tavassi, AM (corresponding author), Biochem & Biophys Lab, Av Vital Brasil 1500, BR-05503900 Sao Paulo, Brazil.	amchudzinski@butantan.gov.br	Balan, Andrea/D-1891-2014; Alvarez-Flores, Miryam/I-1848-2012; Pereira Ramos, Oscar Henrique/E-1862-2013	Balan, Andrea/0000-0001-6199-3198; Alvarez-Flores, Miryam/0000-0002-7986-923X; Pereira Ramos, Oscar Henrique/0000-0002-5788-4500; Konno, Katsuhiro/0000-0002-1949-1845	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [07/51813-0, 07/51889-7, 08/54092-5]; Conselho Nacional de Desenvolvimento Cientfico e Tecnologico; Centro de Toxinologia Aplicada	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientfico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Centro de Toxinologia Aplicada	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grants 07/51813-0, 07/51889-7, and 08/54092-5 and fellowships from Conselho Nacional de Desenvolvimento Cientfico e Tecnologico (to M. P. A.-F. and A. M. C.-T.). This work was also supported by grants from Centro de Toxinologia Aplicada.	Flores MPA, 2009, PATHOPHYSIOL HAEMO T, V37, P1, DOI 10.1159/000320067; Aye TT, 2008, J INSECT PHYSIOL, V54, P1301, DOI 10.1016/j.jinsphys.2008.07.003; BARENHOLZ Y, 1977, BIOCHEMISTRY-US, V16, P2806, DOI 10.1021/bi00631a035; Belogurov A, 2009, BIOESSAYS, V31, P1161, DOI 10.1002/bies.200900020; Bettencourt R, 2000, MECH DEVELOP, V95, P301, DOI 10.1016/S0925-4773(00)00359-2; Bettencourt R, 1997, EUR J BIOCHEM, V250, P630, DOI 10.1111/j.1432-1033.1997.00630.x; Bettencourt R, 2002, INSECT MOL BIOL, V11, P267, DOI 10.1046/j.1365-2583.2002.00334.x; Bettencourt R, 1999, EUR J BIOCHEM, V266, P964, DOI 10.1046/j.1432-1327.1999.00934.x; BIEBER AJ, 1989, CELL, V59, P447, DOI 10.1016/0092-8674(89)90029-9; BOM VJJ, 1990, BIOCHEM J, V265, P327, DOI 10.1042/bj2650327; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Chen HS, 2008, FEBS J, V275, P3944, DOI 10.1111/j.1742-4658.2008.06540.x; Chudzinski-Tavassi AM, 2005, PATHOPHYSIOL HAEMO T, V34, P228, DOI 10.1159/000092429; Daffre S, 1997, FEBS LETT, V408, P127, DOI 10.1016/S0014-5793(97)00397-9; Dahlback B, 2005, J INTERN MED, V257, P209, DOI 10.1111/j.1365-2796.2004.01444.x; DISCIPIO RG, 1977, BIOCHEMISTRY-US, V16, P5253, DOI 10.1021/bi00643a015; DUFFY EJ, 1992, J BIOL CHEM, V267, P7821; Faye Ingrid, 1998, P173; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; Gabibov A, 2006, IMMUNOL LETT, V103, P1, DOI 10.1016/j.imlet.2005.10.012; Golinelli-Pimpaneau B, 2000, CURR OPIN STRUC BIOL, V10, P697, DOI 10.1016/S0959-440X(00)00157-3; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GUO JC, 1995, P NATL ACAD SCI USA, V92, P1694, DOI 10.1073/pnas.92.5.1694; Hanson CV, 2005, CURR OPIN BIOTECH, V16, P631, DOI 10.1016/j.copbio.2005.10.003; Haspel J, 2000, J NEUROBIOL, V42, P287, DOI 10.1002/(SICI)1097-4695(20000215)42:3<287::AID-NEU1>3.3.CO;2-O; Hoffman M, 2007, HEMATOL ONCOL CLIN N, V21, P1, DOI 10.1016/j.hoc.2006.11.004; JESPERSEN J, 1983, HAEMOSTASIS, V13, P301; KAMINISHI H, 1994, FEMS MICROBIOL LETT, V121, P327, DOI 10.1016/0378-1097(94)90312-3; KANOST MR, 1994, ARCH INSECT BIOCHEM, V27, P123, DOI 10.1002/arch.940270205; Lacroix-Desmazes S, 2006, IMMUNOL LETT, V103, P3, DOI 10.1016/j.imlet.2005.10.007; LADENDORFF NE, 1991, ARCH INSECT BIOCHEM, V18, P285, DOI 10.1002/arch.940180410; LanzMendoza H, 1996, CELL IMMUNOL, V169, P47, DOI 10.1006/cimm.1996.0089; Li WL, 2005, DEV COMP IMMUNOL, V29, P853, DOI 10.1016/j.dci.2005.02.003; LINDSTROMDINNETZ I, 1995, EUR J BIOCHEM, V230, P920, DOI 10.1111/j.1432-1033.1995.tb20637.x; Liu HL, 2011, J BIOL CHEM, V286, P797, DOI 10.1074/jbc.M110.180281; MERTENS K, 1980, BIOCHEM J, V185, P647, DOI 10.1042/bj1850647; Mitsuda Y, 2004, BIOTECHNOL BIOENG, V86, P217, DOI 10.1002/bit.20031; Morita Takashi, 1998, P179; Narasaki R, 2005, J BIOL CHEM, V280, P14278, DOI 10.1074/jbc.M500241200; Paola M, 2006, BIOCHEM BIOPH RES CO, V343, P1216, DOI 10.1016/j.bbrc.2006.03.068; POLLACK SJ, 1986, SCIENCE, V234, P1570, DOI 10.1126/science.3787262; Ramos CRR, 2001, MEM I OSWALDO CRUZ, V96, P131, DOI 10.1590/S0074-02762001000900019; Reis CV, 2006, BIOCHEM J, V398, P295, DOI 10.1042/BJ20060325; Richter G, 2002, BRIT J HAEMATOL, V119, P1042, DOI 10.1046/j.1365-2141.2002.03954.x; RISLER JL, 1988, J MOL BIOL, V204, P1019, DOI 10.1016/0022-2836(88)90058-7; Roxstrom-Lindquist K, 2005, INSECT MOL BIOL, V14, P645, DOI 10.1111/j.1365-2583.2005.00593.x; Rucinska M, 1997, Rocz Akad Med Bialymst, V42 Suppl 1, P110; SAKODA M, 1976, J BIOCHEM-TOKYO, V80, P547, DOI 10.1093/oxfordjournals.jbchem.a131310; SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7; Schmidt O, 2010, ANNU REV ENTOMOL, V55, P485, DOI 10.1146/annurev.ento.54.110807.090618; SKOGEN WF, 1983, BIOCHEM BIOPH RES CO, V111, P14, DOI 10.1016/S0006-291X(83)80110-7; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; SUN SC, 1990, SCIENCE, V250, P1729, DOI 10.1126/science.2270488; Takeda S, 2007, FEBS LETT, V581, P5859, DOI 10.1016/j.febslet.2007.11.062; TAKEYA H, 1992, J BIOL CHEM, V267, P14109; Tans G, 2001, HAEMOSTASIS, V31, P225; Uda T, 2004, J BIOSCI BIOENG, V97, P143, DOI 10.1016/S1389-1723(04)70183-8; VANDIEIJEN G, 1981, BIOCHEMISTRY-US, V20, P7096, DOI 10.1021/bi00528a007; Yu XQ, 2002, EUR J BIOCHEM, V269, P1827, DOI 10.1046/j.1432-1033.2002.02830.x; Yu XQ, 1999, ARCH INSECT BIOCHEM, V42, P198, DOI 10.1002/(SICI)1520-6327(199911)42:3&lt;198::AID-ARCH4&gt;3.0.CO;2-G; Zannin M, 2003, THROMB HAEMOSTASIS, V89, P355, DOI 10.1055/s-0037-1613453; ZHOU GW, 1994, SCIENCE, V265, P1059, DOI 10.1126/science.8066444	62	14	15	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6918	6928		10.1074/jbc.M110.167718	http://dx.doi.org/10.1074/jbc.M110.167718			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177860	Green Published, hybrid			2022-12-27	WOS:000287737300007
J	Zhao, HW; Zhou, D; Haddad, GG				Zhao, Huiwen W.; Zhou, Dan; Haddad, Gabriel G.			Antimicrobial Peptides Increase Tolerance to Oxidant Stress in Drosophila melanogaster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-S-TRANSFERASE; LUNG EPITHELIAL-CELLS; BUTHIONINE SULFOXIMINE; OXIDATIVE DAMAGE; SUPEROXIDE-DISMUTASE; REDOX STATE; NEUTROPHIL DEFENSINS; ENDOTHELIAL-CELLS; O-2 DEPRIVATION; HYPEROXIA	It is well appreciated that reactive oxygen species (ROS) are deleterious to mammals, including humans, especially when generated in abnormally large quantities from cellular metabolism. Whereas the mechanisms leading to the production of ROS are rather well delineated, the mechanisms underlying tissue susceptibility or tolerance to oxidant stress remain elusive. Through an experimental selection over many generations, we have previously generated Drosophila melanogaster flies that tolerate tremendous oxidant stress and have shown that the family of antimicrobial peptides (AMPs) is over-represented in these tolerant flies. Furthermore, we have also demonstrated that overexpression of even one AMP at a time (e. g. Diptericin) allows wild-type flies to survive much better in hyperoxia. In this study, we used a number of experimental approaches to investigate the potential mechanisms underlying hyperoxia tolerance in flies with AMP overexpression. We demonstrate that flies with Diptericin overexpression resist oxidative stress by increasing antioxidant enzyme activities and preventing an increase in ROS levels after hyperoxia. Depleting the GSH pool using buthionine sulfoximine limits fly survival, thus confirming that enhanced survival observed in these flies is related to improved redox homeostasis. We conclude that 1) AMPs play an important role in tolerance to oxidant stress, 2) overexpression of Diptericin changes the cellular redox balance between oxidant and antioxidant, and 3) this change in redox balance plays an important role in survival in hyperoxia.	[Zhao, Huiwen W.; Zhou, Dan; Haddad, Gabriel G.] Univ Calif San Diego, Dept Pediat, Div Resp Med, La Jolla, CA 92093 USA; [Haddad, Gabriel G.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Haddad, Gabriel G.] Rady Childrens Hosp, San Diego, CA 92123 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Haddad, GG (corresponding author), Univ Calif San Diego, Dept Pediat, Div Resp Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ghaddad@ucsd.edu		Zhou, Dan/0000-0001-6401-9040	National Institutes of Health [RO1NS037756, PO1HD032573]; American Heart Association [0835188N]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD032573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037756] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1NS037756 and PO1HD032573 (to G. G. H.). This work was also supported by American Heart Association Grant 0835188N (to D. Z.).	Abbott DA, 2009, APPL ENVIRON MICROB, V75, P2320, DOI 10.1128/AEM.00009-09; ABRAHAM SK, 1993, MUTAT RES, V301, P255, DOI 10.1016/0165-7992(93)90066-5; AGARWAL S, 1994, P NATL ACAD SCI USA, V91, P12332, DOI 10.1073/pnas.91.25.12332; Anderson CP, 1999, EXP CELL RES, V246, P183, DOI 10.1006/excr.1998.4303; Bals R, 2000, Respir Res, V1, P141, DOI 10.1186/rr25; Barker GF, 2006, AM J RESP CELL MOL, V35, P277, DOI 10.1165/rcmb.2005-0340OC; Bhandari V, 2007, J IMMUNOL, V178, P4993, DOI 10.4049/jimmunol.178.8.4993; Carnesecchi S, 2009, AM J RESP CRIT CARE, V180, P972, DOI 10.1164/rccm.200902-0296OC; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; Dasgupta C, 2009, AM J PHYSIOL-LUNG C, V296, pL1031, DOI 10.1152/ajplung.90392.2008; DeLaAsuncion JG, 1996, FASEB J, V10, P333, DOI 10.1096/fasebj.10.2.8641567; Dickinson DA, 2002, ANN NY ACAD SCI, V973, P488, DOI 10.1111/j.1749-6632.2002.tb04690.x; Droge W, 2002, EXP GERONTOL, V37, P1333, DOI 10.1016/S0531-5565(02)00175-4; Gorter AD, 1998, J INFECT DIS, V178, P1067, DOI 10.1086/515667; Gruenewald C, 2009, FREE RADICAL BIO MED, V46, P1668, DOI 10.1016/j.freeradbiomed.2009.03.025; Gu XL, 2003, AM J PHYSIOL-CELL PH, V285, pC546, DOI 10.1152/ajpcell.00424.2002; Haddad GG, 1997, P NATL ACAD SCI USA, V94, P10809, DOI 10.1073/pnas.94.20.10809; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Huang B, 2009, LUNG, V187, P421, DOI 10.1007/s00408-009-9177-z; Ilizarov AM, 2001, AM J RESP CELL MOL, V24, P436, DOI 10.1165/ajrcmb.24.4.4240; Jakubowski W, 2000, CELL BIOL INT, V24, P757, DOI 10.1006/cbir.2000.0556; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Ketterer B, 2001, CHEM-BIOL INTERACT, V138, P27, DOI 10.1016/S0009-2797(01)00277-0; Khurana V, 2008, J ALZHEIMERS DIS, V15, P541; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Li HM, 2008, INSECT MOL BIOL, V17, P325, DOI 10.1111/j.1365-2583.2008.00808.x; LINDAUSHEPARD B, 1994, J CELL PHYSIOL, V161, P237, DOI 10.1002/jcp.1041610207; LINDAUSHEPARD BA, 1993, FREE RADICAL BIO MED, V15, P581, DOI 10.1016/0891-5849(93)90160-V; Liu L, 2007, EUR J HEART FAIL, V9, P762, DOI 10.1016/j.ejheart.2007.03.007; Ma E, 2001, J CLIN INVEST, V107, P685, DOI 10.1172/JCI11625; Mantell LL, 2000, MOL GENET METAB, V71, P359, DOI 10.1006/mgme.2000.3046; Marengo B, 2008, FREE RADICAL BIO MED, V44, P474, DOI 10.1016/j.freeradbiomed.2007.10.031; Masalunga C, 2007, PEDIATR RES, V62, P78, DOI 10.1203/PDR.0b013e3180674dc6; Mockett RJ, 1999, FASEB J, V13, P1733, DOI 10.1096/fasebj.13.13.1733; MOORE AJ, 1994, PEPTIDE RES, V7, P265; Nagato A, 2009, EXP LUNG RES, V35, P713, DOI 10.3109/01902140902853184; Neretti N, 2009, P NATL ACAD SCI USA, V106, P2277, DOI 10.1073/pnas.0812484106; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; Park JM, 2004, GENE DEV, V18, P584, DOI 10.1101/gad.1168104; PARKES TL, 1993, GENOME, V36, P1007, DOI 10.1139/g93-134; Rebrin I, 2006, MECH AGEING DEV, V127, P869, DOI 10.1016/j.mad.2006.09.001; REED DJ, 1990, ENVIRON HEALTH PERSP, V84, P113, DOI 10.2307/3430712; Reliene R, 2006, CARCINOGENESIS, V27, P240, DOI 10.1093/carcin/bgi222; Ross CR, 2007, CHEM BIOL DRUG DES, V70, P154, DOI 10.1111/j.1747-0285.2007.00540.x; Sawicki R, 2003, BIOCHEM J, V370, P661, DOI 10.1042/BJ20021287; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; SOHAL RS, 1990, MECH AGEING DEV, V56, P223, DOI 10.1016/0047-6374(90)90084-S; SOHAL RS, 1994, FREE RADICAL BIO MED, V16, P621, DOI 10.1016/0891-5849(94)90062-0; SULLIVAN SJ, 1991, J CELL PHYSIOL, V147, P427, DOI 10.1002/jcp.1041470307; Suttmann Henrik, 2008, BMC Urol, V8, P5, DOI 10.1186/1471-2490-8-5; Taglialatela G, 1998, FREE RADICAL BIO MED, V25, P936, DOI 10.1016/S0891-5849(98)00131-2; Tandara AA, 2004, WORLD J SURG, V28, P294, DOI 10.1007/s00268-003-7400-2; THANISLASS J, 1995, BIOCHEM PHARMACOL, V50, P229, DOI 10.1016/0006-2952(95)00123-H; Tupling AR, 2007, J APPL PHYSIOL, V103, P1921, DOI 10.1152/japplphysiol.00529.2007; TURRENS JF, 1982, ARCH BIOCHEM BIOPHYS, V217, P401, DOI 10.1016/0003-9861(82)90518-5; TURRENS JF, 1982, ARCH BIOCHEM BIOPHYS, V217, P411, DOI 10.1016/0003-9861(82)90519-7; Tzou P, 2002, P NATL ACAD SCI USA, V99, P2152, DOI 10.1073/pnas.042411999; Udomsinprasert R, 2004, BIOCHEM J, V383, P483, DOI 10.1042/BJ20040519; Usui S, 2009, MOL THER, V17, P778, DOI 10.1038/mt.2009.47; van Wetering S, 1999, J ALLERGY CLIN IMMUN, V104, P1131, DOI 10.1016/S0091-6749(99)70004-7; Wartha F, 2007, CURR OPIN MICROBIOL, V10, P52, DOI 10.1016/j.mib.2006.12.005; Wartha F, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.121pe25; WEBSTER NR, 1987, BRIT J ANAESTH, V59, P760, DOI 10.1093/bja/59.6.760; Wong YL, 2001, TOXICOL LETT, V123, P179, DOI 10.1016/S0378-4274(01)00397-6; Wu JP, 2004, CIRCULATION, V109, P1660, DOI 10.1161/01.CIR.0000124067.35915.E0; Yang D, 2000, J LEUKOCYTE BIOL, V68, P9; Zhao HW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011701	67	38	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6211	6218		10.1074/jbc.M110.181206	http://dx.doi.org/10.1074/jbc.M110.181206			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21148307	Green Published, hybrid			2022-12-27	WOS:000287476400030
J	Chen, Q; Zhang, Y; Peng, HY; Lei, L; Kuang, HB; Zhang, L; Ning, LN; Cao, YJ; Duan, EK				Chen, Qi; Zhang, Ying; Peng, Hongying; Lei, Li; Kuang, Haibin; Zhang, Li; Ning, Lina; Cao, Yujing; Duan, Enkui			Transient beta(2)-Adrenoceptor Activation Confers Pregnancy Loss by Disrupting Embryo Spacing at Implantation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; MYOMETRIAL ACTIVITY; MOUSE BLASTOCYSTS; LIFE EVENTS; EXPRESSION; UTERUS; COMPLICATIONS; INVOLVEMENT; DEFICIENCY; ADRENALINE	Pregnancy loss is a serious social and medical issue, with one important cause associated with aberrant embryo implantation during early pregnancy. However, whether and how the process of embryo implantation is affected by environmental factors such as stress-induced sympathetic activation remained elusive. Here we report an unexpected, transient effect of beta(2)-adrenoreceptor (beta(2)-AR) activation (day 4 postcoitus) in disrupting embryo spacing at implantation, leading to substantially increased midterm pregnancy loss. The abnormal embryo spacing could be prevented by pretreatment of beta(2)-AR antagonist or genetic ablation of beta(2)-AR. Similar beta(2)-AR activation at day 5 postcoitus, when implantation sites have been established, did not affect embryo spacing or pregnancy outcome, indicating that the adverse effect of beta(2)-AR activation is limited to the preimplantation period before embryo attachment. In vitro and in vivo studies demonstrated that the transient beta(2)-AR activation abolished normal preimplantation uterine contractility without adversely affecting blastocyst quality. The contractility inhibition is mediated by activation of the cAMP-PKA pathway and accompanied by specific down-regulation of lpa3, a gene previously found to be critical for uterine contraction and embryo spacing. These results indicated that normal uterine contraction-mediated correct intrauterine embryo distribution is crucial for successful ongoing pregnancy. Abnormal beta(2)-AR activation at early pregnancy provided a molecular clue in explaining how maternal stress at early stages could adversely affect the pregnancy outcome.	[Duan, Enkui] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China; [Chen, Qi; Zhang, Ying; Lei, Li; Kuang, Haibin; Zhang, Li] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Duan, EK (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 100101, Peoples R China.	duane@ioz.ac.cn	Chen, Qi/K-4059-2019; Chen, Qi/W-1759-2019	Chen, Qi/0000-0001-6353-9589; Zhang, Ying/0000-0003-4082-5026; Kuang, haibin/0000-0003-4711-5449	National Basic Research Program of China [2011CB710905, 2007CB947401, 2011CB944401]; Chinese Academy of Sciences [KSCX2-YW-R-080]; National Natural Science Foundation of China [30770819]	National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2011CB710905 (to E. D.) and 2007CB947401 and 2011CB944401 (to Y. C.), Chinese Academy of Sciences Knowledge Innovation Program KSCX2-YW-R-080 (to E. D.), and National Natural Science Foundation of China Grant 30770819 (to Y. C.).	Allix S, 2008, BIOL REPROD, V79, P510, DOI 10.1095/biolreprod.107.066373; Berkman ND, 2003, AM J OBSTET GYNECOL, V188, P1648, DOI 10.1067/mob.2003.356; BRANDON JM, 1990, J REPROD FERTIL, V88, P151; Bulletti C, 2006, CURR OPIN OBSTET GYN, V18, P472, DOI 10.1097/01.gco.0000233946.20414.af; CRANE LH, 1991, REPROD FERT DEVELOP, V3, P233, DOI 10.1071/RD9910233; Dey SK, 2005, NATURE, V435, P34, DOI 10.1038/435034a; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Dey SK, 2010, J CLIN INVEST, V120, P952, DOI 10.1172/JCI42380; Ferry B, 1999, BIOL PSYCHIAT, V46, P1140, DOI 10.1016/S0006-3223(99)00157-2; Gold KJ, 2007, GEN HOSP PSYCHIAT, V29, P207, DOI 10.1016/j.genhosppsych.2007.02.002; Hama K, 2007, BIOL REPROD, V77, P954, DOI 10.1095/biolreprod.107.060293; Hamatani T, 2004, P NATL ACAD SCI USA, V101, P10326, DOI 10.1073/pnas.0402597101; Heuser CF, 1941, CONTRIB EMBRYOL, V29; Houdeau E, 1998, J COMP NEUROL, V399, P403; Im YB, 1998, J AUTON PHARMACOL, V18, P149, DOI 10.1046/j.1365-2680.1998.1830149.x; Irie K, 2001, BRIT J PHARMACOL, V133, P237, DOI 10.1038/sj.bjp.0704073; KENNEDY TG, 1977, BIOL REPROD, V16, P286, DOI 10.1095/biolreprod16.3.286; Kuang HB, 2009, J CELL PHYSIOL, V221, P448, DOI 10.1002/jcp.21877; Lee K, 2006, NAT GENET, V38, P1204, DOI 10.1038/ng1874; Lim HJ, 2010, J CLIN INVEST, V120, P1004, DOI 10.1172/JCI41210; Neugebauer R, 1996, AM J EPIDEMIOL, V143, P588; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; OHare T, 1995, BRIT J PSYCHIAT, V167, P799, DOI 10.1192/bjp.167.6.799; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P55, DOI 10.1073/pnas.90.1.55; Paria BC, 1999, DEVELOPMENT, V126, P1997; Pinborg A, 2006, BRIT J HOSP MED, V67, P417, DOI 10.12968/hmed.2006.67.8.21976; PUSEY J, 1980, BIOL REPROD, V23, P394, DOI 10.1095/biolreprod23.2.394; RESTALL BJ, 1971, J REPROD FERTIL, V24, P423, DOI 10.1530/jrf.0.0240423; Shumay E, 2007, J BIOL CHEM, V282, P21529, DOI 10.1074/jbc.M701998200; Song DK, 2000, BRIT J PHARMACOL, V130, P41, DOI 10.1038/sj.bjp.0703273; Song H, 2002, DEVELOPMENT, V129, P2879; van Oppenraaij RHF, 2009, HUM REPROD UPDATE, V15, P409, DOI 10.1093/humupd/dmp009; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang HB, 2004, NAT MED, V10, P1074, DOI 10.1038/nm1104; Wang J, 2000, DEVELOPMENT, V127, P33; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; WIMSATT WA, 1975, BIOL REPROD, V12, P1, DOI 10.1095/biolreprod12.1.1; Xie H, 2007, P NATL ACAD SCI USA, V104, P18315, DOI 10.1073/pnas.0707909104; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Yoshino O, 2010, HUM REPROD, V25, P2475, DOI 10.1093/humrep/deq222; Zhao P, 2008, ENDOCRINOLOGY, V149, P2782, DOI 10.1210/en.2007-1662	41	38	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4349	4356		10.1074/jbc.M110.197202	http://dx.doi.org/10.1074/jbc.M110.197202			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21148315	Green Published, hybrid			2022-12-27	WOS:000286975700034
J	Chen, WT; Liao, YH; Yu, HM; Cheng, IH; Chen, YR				Chen, Wei-Ting; Liao, Yi-Hung; Yu, Hui-Ming; Cheng, Irene H.; Chen, Yun-Ru			Distinct Effects of Zn2+, Cu2+, Fe3+, and Al3+ on Amyloid-beta Stability, Oligomerization, and Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; A-BETA; COPPER-BINDING; SYNAPTIC ZINC; METAL-IONS; PROTEIN; PEPTIDE; PRECURSOR; INSIGHTS; ALUMINUM	Abnormally high concentrations of Zn2+, Cu2+, and Fe3+ are present along with amyloid-beta (A beta) in the senile plaques in Alzheimer disease, where Al3+ is also detected. A beta aggregation is the key pathogenic event in Alzheimer disease, where A beta oligomers are the major culprits. The fundamental mechanism of these metal ions on A beta remains elusive. Here, we employ 4,4'-Bis(1-anilinonaphthalene 8-sulfonate) and tyrosine fluorescence, CD, stopped flow fluorescence, guanidine hydrochloride denaturation, and photo-induced cross-linking to elucidate the effect of Zn2+, Cu2+, Fe3+, and Al3+ on A beta at the early stage of the aggregation. Furthermore, thioflavin T assay, dot blotting, and transmission electron microscopy are utilized to examine A beta aggregation. Our results show that Al3+ and Zn2+, but not Cu2+ and Fe3+, induce larger hydrophobic exposures of A beta conformation, resulting in its significant destabilization at the early stage. The metal ion binding induces A beta conformational changes with micromolar binding affinities and millisecond binding kinetics. Cu2+ and Zn2+ induce similar assembly of transiently appearing A beta oligomers at the early state. During the aggregation, we found that Zn2+ exclusively promotes the annular protofibril formation without undergoing a nucleation process, whereas Cu2+ and Fe3+ inhibit fibril formation by prolonging the nucleation phases. Al3+ also inhibits fibril formation; however, the annular oligomers co-exist in the aggregation pathway. In conclusion, Zn2+, Cu2+, Fe3+, and Al3+ adopt distinct folding and aggregation mechanisms to affect A beta, where A beta destabilization promotes annular protofibril formation. Our study facilitates the understanding of annular A beta oligomer formation upon metal ion binding.	[Liao, Yi-Hung] Acad Sinica, Genom Res Ctr, Taiwan Int Grad Program, Chem Biol & Mol Biophys Program, Taipei 11574, Taiwan; [Chen, Wei-Ting; Cheng, Irene H.] Natl Yang Ming Univ, Inst Brain Sci, Taipei 11221, Taiwan; [Liao, Yi-Hung] Natl Taiwan Univ, Inst Biochem Sci, Taipei 10617, Taiwan	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Taiwan University	Chen, YR (corresponding author), Acad Sinica, Genom Res Ctr, 128 Acad Rd,Sec 2, Taipei 115, Taiwan.	yrchen@gate.sinica.edu.tw	Chen, Yun-Ru/C-9304-2014; CHEN, WEI-TING/AFL-9663-2022	Chen, Yun-Ru/0000-0002-6596-6338; CHEN, WEI-TING/0000-0003-2730-9529	Genomics Research Center (Academia Sinica, Taiwan, National Science Council, Taiwan) [98-2320-B-001-020-MY3, 96-2113-M-001-030-MY2, 97-2320-B-010-027-MY3]; National Health Research Institute [NHRI-EX98-9816NC]	Genomics Research Center (Academia Sinica, Taiwan, National Science Council, Taiwan)(Ministry of Science and Technology, TaiwanAcademia Sinica - Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan)	This work was supported by Grants 98-2320-B-001-020-MY3, 96-2113-M-001-030-MY2, and 97-2320-B-010-027-MY3 from the Genomics Research Center (Academia Sinica, Taiwan, National Science Council, Taiwan) and National Health Research Institute Grant NHRI-EX98-9816NC.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Atwood CS, 2000, J NEUROCHEM, V75, P1219, DOI 10.1046/j.1471-4159.2000.0751219.x; Bibl M, 2007, J NEUROCHEM, V103, P467, DOI 10.1111/j.1471-4159.2007.04763.x; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; BRAND L, 1972, ANNU REV BIOCHEM, V41, P843, DOI 10.1146/annurev.bi.41.070172.004211; BURDICK D, 1992, J BIOL CHEM, V267, P546; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Bush AI, 2003, TRENDS NEUROSCI, V26, P207, DOI 10.1016/S0166-2236(03)00067-5; Chen YR, 2004, PROTEIN SCI, V13, P2196, DOI 10.1110/ps.03521504; Chen YR, 2006, J BIOL CHEM, V281, P24414, DOI 10.1074/jbc.M602363200; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Deshpande A, 2009, J NEUROSCI, V29, P4004, DOI 10.1523/JNEUROSCI.5980-08.2009; Drago D, 2008, INT J BIOCHEM CELL B, V40, P731, DOI 10.1016/j.biocel.2007.10.014; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Faux NG, 2010, J ALZHEIMERS DIS, V20, P509, DOI 10.3233/JAD-2010-1390; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Frederickson CJ, 2001, BIOMETALS, V14, P353, DOI 10.1023/A:1012934207456; Frisardi V, 2010, J ALZHEIMERS DIS, V20, P17, DOI 10.3233/JAD-2009-1340; Garai K, 2007, BIOCHEMISTRY-US, V46, P10655, DOI 10.1021/bi700798b; Garzon-Rodriguez W, 1999, BIOORG MED CHEM LETT, V9, P2243, DOI 10.1016/S0960-894X(99)00357-1; Ha C, 2007, BIOCHEMISTRY-US, V46, P6118, DOI 10.1021/bi7000032; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Janssen JC, 2003, NEUROLOGY, V60, P235, DOI 10.1212/01.WNL.0000042088.22694.E3; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kawahara M, 2001, BRAIN RES BULL, V55, P211, DOI 10.1016/S0361-9230(01)00475-0; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lashuel HA, 2006, Q REV BIOPHYS, V39, P167, DOI 10.1017/S0033583506004422; Lazo ND, 2005, PROTEIN SCI, V14, P1581, DOI 10.1110/ps.041292205; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; LeVine H, 2002, ARCH BIOCHEM BIOPHYS, V404, P106; Lovell MA, 1999, BRAIN RES, V823, P88, DOI 10.1016/S0006-8993(99)01114-2; Ma QF, 2006, BIOPOLYMERS, V83, P20, DOI 10.1002/bip.20523; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Minicozzi V, 2008, J BIOL CHEM, V283, P10784, DOI 10.1074/jbc.M707109200; Mucke L, 2009, NATURE, V461, P895, DOI 10.1038/461895a; Nair NG, 2010, J ALZHEIMERS DIS, V20, P57, DOI 10.3233/JAD-2010-1346; Noy D, 2008, J AM CHEM SOC, V130, P1376, DOI 10.1021/ja076282l; Palmiter RD, 1996, P NATL ACAD SCI USA, V93, P14934, DOI 10.1073/pnas.93.25.14934; Ricchelli F, 2005, CELL MOL LIFE SCI, V62, P1724, DOI 10.1007/s00018-005-5141-0; Riek R, 2001, EUR J BIOCHEM, V268, P5930, DOI 10.1046/j.0014-2956.2001.02537.x; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Ryu J, 2008, BIOCHEMISTRY-US, V47, P5328, DOI 10.1021/bi800012e; Schoonenboom NS, 2005, ANN NEUROL, V58, P139, DOI 10.1002/ana.20508; Smith DP, 2007, BIOCHEMISTRY-US, V46, P2881, DOI 10.1021/bi0620961; Sparks DL, 2003, P NATL ACAD SCI USA, V100, P11065, DOI 10.1073/pnas.1832769100; Stellato F, 2006, EUR BIOPHYS J BIOPHY, V35, P340, DOI 10.1007/s00249-005-0041-7; Syme CD, 2006, BBA-PROTEINS PROTEOM, V1764, P246, DOI 10.1016/j.bbapap.2005.09.012; Syme CD, 2004, J BIOL CHEM, V279, P18169, DOI 10.1074/jbc.M313572200; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tougu V, 2008, J NEUROCHEM, V104, P1249, DOI 10.1111/j.1471-4159.2007.05061.x; Tougu V, 2009, J NEUROCHEM, V110, P1784, DOI 10.1111/j.1471-4159.2009.06269.x; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Vasudevaraju BP, 2008, INDIAN J MED RES, V128, P545; Wakutani Y, 2004, J NEUROL NEUROSUR PS, V75, P1039, DOI 10.1136/jnnp.2003.010611; Wu JW, 2010, J BIOL CHEM, V285, P6071, DOI 10.1074/jbc.M109.069542; Yoshiike Y, 2001, J BIOL CHEM, V276, P32293, DOI 10.1074/jbc.M010706200; Yu WH, 2001, BRAIN RES, V894, P37, DOI 10.1016/S0006-8993(00)03196-6; Yumoto S, 2009, J INORG BIOCHEM, V103, P1579, DOI 10.1016/j.jinorgbio.2009.07.023; Zatta P, 2009, TRENDS PHARMACOL SCI, V30, P346, DOI 10.1016/j.tips.2009.05.002	67	157	162	2	65	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9646	9656		10.1074/jbc.M110.177246	http://dx.doi.org/10.1074/jbc.M110.177246			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21216965	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000288247700089
J	Yang, Y; Shi, WW; Chen, XF; Cui, NR; Konduru, AS; Shi, Y; Trower, TC; Zhang, SA; Jiang, C				Yang, Yang; Shi, Weiwei; Chen, Xianfeng; Cui, Ningren; Konduru, Anuhya S.; Shi, Yun; Trower, Timothy C.; Zhang, Shuang; Jiang, Chun			Molecular Basis and Structural Insight of Vascular K-ATP Channel Gating by S-Glutathionylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE POTASSIUM CHANNELS; PROTEIN-KINASE-C; CRYSTAL-STRUCTURE; SMOOTH-MUSCLE; I-TASSER; KIR6.1/SUR2B CHANNEL; STRUCTURE PREDICTION; PHYSIOLOGICAL ROLES; DISULFIDE BOND; KAPPA-B	The vascular ATP-sensitive K+ (K-ATP) channel is targeted by a variety of vasoactive substances, playing an important role in vascular tone regulation. Our recent studies indicate that the vascular K-ATP channel is inhibited in oxidative stress via S-glutathionylation. Here we show evidence for the molecular basis of the S-glutathionylation and its structural impact on channel gating. By comparing the oxidant responses of the Kir6.1/SUR2B channel with the Kir6.2/SUR2B channel, we found that the Kir6.1 subunit was responsible for oxidant sensitivity. Oxidant screening of Kir6.1-Kir6.2 chimeras demonstrated that the N terminus and transmembrane domains of Kir6.1 were crucial. Systematic mutational analysis revealed three cysteine residues in these domains: Cys(43), Cys(120), and Cys(176). Among them, Cys(176) was prominent, contributing to > 80% of the oxidant sensitivity. The Kir6.1-C176A/SUR2B mutant channel, however, remained sensitive to both channel opener and inhibitor, which indicated that Cys(176) is not a general gating site in Kir6.1, in contrast to its counterpart (Cys(166)) in Kir6.2. A protein pull-down assay with biotinylated glutathione ethyl ester showed that mutation of Cys(176) impaired oxidant-induced incorporation of glutathione (GSH) into the Kir6.1 subunit. In contrast to Cys(176), Cys(43) had only a modest contribution to S-glutathionylation, and Cys(120) was modulated by extracellular oxidants but not intracellular GSSG. Simulation modeling of Kir6.1 S-glutathionylation suggested that after incorporation to residue 176, the GSH moiety occupied a space between the slide helix and two transmembrane helices. This prevented the inner transmembrane helix from undergoing conformational changes necessary for channel gating, retaining the channel in its closed state.	[Yang, Yang; Shi, Weiwei; Chen, Xianfeng; Cui, Ningren; Konduru, Anuhya S.; Shi, Yun; Trower, Timothy C.; Zhang, Shuang; Jiang, Chun] Georgia State Univ, Dept Biol, Atlanta, GA 30302 USA	University System of Georgia; Georgia State University	Jiang, C (corresponding author), Georgia State Univ, Dept Biol, 100 Piedmont Ave, Atlanta, GA 30302 USA.	cjiang@gsu.edu	Shi, Yun/B-5623-2009; Shi, Yun S/T-8845-2018; SHI, WEIWEI/B-3477-2008; Yang, Yang/B-3440-2008; Chen, Xianfeng/ABG-8256-2021; Konduru, Anuhya S/J-4765-2019	Shi, Yun/0000-0002-8842-9818; SHI, WEIWEI/0000-0001-6216-712X; Yang, Yang/0000-0003-4275-0515; Konduru, Anuhya S/0000-0002-6347-9464; Yang, Yang/0000-0001-6417-3654	National Institutes of Health [HD060959]; American Heart Association [09GRNT2010037]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD060959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant HD060959. This work was also supported by American Heart Association Grant 09GRNT2010037.	Akao M, 1997, J CLIN INVEST, V100, P3053, DOI 10.1172/JCI119860; Antcliff JF, 2005, EMBO J, V24, P229, DOI 10.1038/sj.emboj.7600487; Babenko AP, 2003, J BIOL CHEM, V278, P41577, DOI 10.1074/jbc.C300363200; Babenko AP, 2002, J BIOL CHEM, V277, P43997, DOI 10.1074/jbc.M208085200; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Cao K, 2002, BIOCHEM BIOPH RES CO, V296, P463, DOI 10.1016/S0006-291X(02)00892-6; Cho HC, 2000, BIOCHEMISTRY-US, V39, P4649, DOI 10.1021/bi992469g; Chutkow WA, 2002, J CLIN INVEST, V110, P203, DOI 10.1172/JCI200215672; Croker B, 2007, NAT GENET, V39, P1453, DOI 10.1038/ng.2007.25; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; Dalle-Donne I, 2009, TRENDS BIOCHEM SCI, V34, P85, DOI 10.1016/j.tibs.2008.11.002; Domene C, 2005, BIOPHYS J, V89, pL1, DOI 10.1529/biophysj.105.060855; Erdos B, 2004, STROKE, V35, P964, DOI 10.1161/01.STR.0000119753.05670.F1; Farzaneh T, 2008, CARDIOVASC RES, V79, P621, DOI 10.1093/cvr/cvn138; HARRISON RW, 1994, PROTEIN ENG, V7, P1353, DOI 10.1093/protein/7.11.1353; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Ichinari K, 1996, J MOL CELL CARDIOL, V28, P1867, DOI 10.1006/jmcc.1996.0179; Kane GC, 2006, FASEB J, V20, P2271, DOI 10.1096/fj.06-6349com; Kil IS, 2008, BIOCHEM BIOPH RES CO, V373, P169, DOI 10.1016/j.bbrc.2008.06.007; Krippeit-Drews P, 1999, J PHYSIOL-LONDON, V514, P471, DOI 10.1111/j.1469-7793.1999.471ae.x; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Leyland ML, 1999, PFLUG ARCH EUR J PHY, V438, P778, DOI 10.1007/s004240051106; Light PE, 2000, P NATL ACAD SCI USA, V97, P9058, DOI 10.1073/pnas.160068997; Lin YF, 2000, EMBO J, V19, P942, DOI 10.1093/emboj/19.5.942; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Miki T, 2002, NAT MED, V8, P466, DOI 10.1038/nm0502-466; Miki T, 2005, J MOL CELL CARDIOL, V38, P917, DOI 10.1016/j.yjmcc.2004.11.019; Miura H, 2003, CIRC RES, V92, P151, DOI 10.1161/01.RES.0000052671.53256.49; Morrissey Alison, 2005, BMC Physiol, V5, P1, DOI 10.1186/1472-6793-5-1; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; Proks P, 2009, PROG BIOPHYS MOL BIO, V99, P7, DOI 10.1016/j.pbiomolbio.2008.10.002; Rojas A, 2007, BBA-BIOMEMBRANES, V1768, P39, DOI 10.1016/j.bbamem.2006.06.027; Ross J, 2003, AM J PHYSIOL-REG I, V285, pR149, DOI 10.1152/ajpregu.00003.2003; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Shi WW, 2007, AM J PHYSIOL-REG I, V293, pR191, DOI 10.1152/ajpregu.00047.2007; Shi WW, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.058313; Shi Y, 2008, J BIOL CHEM, V283, P7523, DOI 10.1074/jbc.M709941200; Shi Y, 2008, J BIOL CHEM, V283, P2488, DOI 10.1074/jbc.M708769200; Shi Y, 2007, AM J PHYSIOL-REG I, V293, pR1205, DOI 10.1152/ajpregu.00337.2007; Soundarapandian MM, 2007, J NEUROCHEM, V103, P1982, DOI 10.1111/j.1471-4159.2007.04883.x; Sun XF, 2004, BIOCHEM PHARMACOL, V67, P147, DOI 10.1016/j.bcp.2003.08.041; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Teramoto N, 2006, J PHYSIOL-LONDON, V572, P617, DOI 10.1113/jphysiol.2006.105973; Thorneloe KS, 2002, J PHYSIOL-LONDON, V541, P65, DOI 10.1113/jphysiol.2002.018101; Tokube K, 1998, PFLUG ARCH EUR J PHY, V437, P155, DOI 10.1007/s004240050760; Trapp S, 1998, J GEN PHYSIOL, V112, P333, DOI 10.1085/jgp.112.3.333; Tricarico D, 2006, P NATL ACAD SCI USA, V103, P1118, DOI 10.1073/pnas.0505974103; Wang W, 2005, J GEN PHYSIOL, V125, P127, DOI 10.1085/jgp.200409115; Yang Y, 2008, BBA-BIOMEMBRANES, V1778, P88, DOI 10.1016/j.bbamem.2007.08.030; Yang Y, 2010, J BIOL CHEM, V285, P38641, DOI 10.1074/jbc.M110.162578; Yokoshiki H, 1998, AM J PHYSIOL-CELL PH, V274, pC25, DOI 10.1152/ajpcell.1998.274.1.C25; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; Zmijewski JW, 2009, J BIOL CHEM, V284, P22213, DOI 10.1074/jbc.M109.028902	57	33	34	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9298	9307		10.1074/jbc.M110.195123	http://dx.doi.org/10.1074/jbc.M110.195123			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21216949	hybrid, Green Published			2022-12-27	WOS:000288247700060
J	Hughes, KJ; Meares, GP; Hansen, PA; Corbett, JA				Hughes, Katherine J.; Meares, Gordon P.; Hansen, Polly A.; Corbett, John A.			FoxO1 and SIRT1 Regulate beta-Cell Responses to Nitric Oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOLATED RAT ISLETS; INDUCED APOPTOSIS; DNA-DAMAGE; TRANSCRIPTION FACTORS; SYNTHASE EXPRESSION; INSULIN-SECRETION; INHIBITION; ACTIVATION; INTERLEUKIN-1-BETA; LANGERHANS	For many cell types, including pancreatic beta-cells, nitric oxide is a mediator of cell death; paradoxically, nitric oxide can also activate pathways that promote the repair of cellular damage. In this report, a role for FoxO1-dependent transcriptional activation and its regulation by SIRT1 in determining the cellular response to nitric oxide is provided. In response to nitric oxide, FoxO1 translocates from the cytoplasm to the nucleus and stimulates the expression of the DNA repair gene GADD45 alpha, resulting in FoxO1-dependent DNA repair. FoxO1-dependent gene expression appears to be regulated by the NAD(+)-dependent deacetylase SIRT1. In response to SIRT1 inhibitors, the FoxO1-dependent protective actions of nitric oxide (GADD45 alpha expression and DNA repair) are attenuated, and FoxO1 activates a proapoptotic program that includes PUMA (p53-up-regulated mediator of apoptosis) mRNA accumulation and caspase-3 cleavage. These findings support primary roles for FoxO1 and SIRT1 in regulating the cellular responses of beta-cells to nitric oxide.	[Hansen, Polly A.; Corbett, John A.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Meares, Gordon P.] Univ Alabama Birmingham, Comprehens Diabet Ctr, Dept Med, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA	Medical College of Wisconsin; Saint Louis University; University of Alabama System; University of Alabama Birmingham	Corbett, JA (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jcorbett@mcw.edu	Meares, Gordon/AAJ-6716-2020	Meares, Gordon/0000-0002-0805-0155	National Institutes of Health [DK52194, AI-44458]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044458, T32AI007051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052194] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK52194 and AI-44458 (to J. A. C.).	Baur JA, 2010, BBA-PROTEINS PROTEOM, V1804, P1626, DOI 10.1016/j.bbapap.2009.10.025; Brown GC, 2002, FREE RADICAL BIO MED, V33, P1440, DOI 10.1016/S0891-5849(02)01112-7; Brune B, 2005, ANTIOXID REDOX SIGN, V7, P497, DOI 10.1089/ars.2005.7.497; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burney S, 1999, MUTAT RES-FUND MOL M, V424, P37, DOI 10.1016/S0027-5107(99)00006-8; Calabrese V, 2009, ANTIOXID REDOX SIGN, V11, P2717, DOI 10.1089/ARS.2009.2721; CARRIER F, 1994, J BIOL CHEM, V269, P32672; Collier JJ, 2006, DIABETES, V55, P1398, DOI 10.2337/db05-1000; COMENS PG, 1987, DIABETES, V36, P963, DOI 10.2337/diabetes.36.8.963; CORBETT JA, 1992, DIABETES, V41, P552, DOI 10.2337/diabetes.41.4.552; CORBETT JA, 1992, BIOCHEM J, V287, P229, DOI 10.1042/bj2870229; CORBETT JA, 1992, J CLIN INVEST, V90, P2384, DOI 10.1172/JCI116129; CORBETT JA, 1994, BIOCHEM J, V299, P719, DOI 10.1042/bj2990719; DELANEY CA, 1993, FEBS LETT, V333, P291, DOI 10.1016/0014-5793(93)80673-I; Eizirik DL, 1996, MOL CELL ENDOCRINOL, V118, P71, DOI 10.1016/0303-7207(96)03768-9; Eizirik DL, 1996, DIABETOLOGIA, V39, P875; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Grunnet LG, 2009, DIABETES, V58, P1807, DOI 10.2337/db08-0178; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Gurzov EN, 2009, CELL DEATH DIFFER, V16, P1539, DOI 10.1038/cdd.2009.99; Hayakawa J, 2003, J BIOL CHEM, V278, P20582, DOI 10.1074/jbc.M210992200; Heitmeier MR, 1997, J BIOL CHEM, V272, P13697, DOI 10.1074/jbc.272.21.13697; Heitmeyer M. R, 2000, NITRIC OXIDE BIOL PA, P785; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Hughes KJ, 2009, AM J PHYSIOL-ENDOC M, V297, pE1187, DOI 10.1152/ajpendo.00214.2009; Kelly Colleen B, 2003, Methods Mol Med, V83, P3; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kobayashi Y, 2005, INT J MOL MED, V16, P237; Kornberg MD, 2010, NAT CELL BIOL, V12, P1094, DOI 10.1038/ncb2114; Koster JC, 2000, CELL, V100, P645, DOI 10.1016/S0092-8674(00)80701-1; Liu DB, 2000, DIABETES, V49, P1116, DOI 10.2337/diabetes.49.7.1116; Mandrup-Poulsen T, 2003, BIOCHEM PHARMACOL, V66, P1433, DOI 10.1016/S0006-2952(03)00494-5; McLaughlin LM, 2005, CANCER RES, V65, P6097, DOI 10.1158/0008-5472.CAN-04-4254; Meares GP, 2010, J BIOL CHEM, V285, P3191, DOI 10.1074/jbc.M109.047365; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; PALMER JP, 1989, DIABETES, V38, P1211, DOI 10.2337/diabetes.38.10.1211; Pillai JB, 2005, J BIOL CHEM, V280, P43121, DOI 10.1074/jbc.M506162200; Qiang L, 2010, J BIOL CHEM, V285, P27396, DOI 10.1074/jbc.M110.140228; Rosales AL, 2004, FREE RADICAL RES, V38, P665, DOI 10.1080/10715760410001697609; Scarim AL, 2003, ENDOCRINOLOGY, V144, P3415, DOI 10.1210/en.2002-0112; Scarim AL, 1997, ENDOCRINOLOGY, V138, P5301, DOI 10.1210/en.138.12.5301; Scarim AL, 1998, ENDOCRINOLOGY, V139, P5050, DOI 10.1210/en.139.12.5050; SOUTHERN C, 1990, FEBS LETT, V276, P42, DOI 10.1016/0014-5793(90)80502-A; Steer SA, 2006, PLOS MED, V3, P253, DOI 10.1371/journal.pmed.0030017; Storling J, 2005, DIABETOLOGIA, V48, P2039, DOI 10.1007/s00125-005-1912-2; Szabo C, 2005, PHARMACOL RES, V52, P60, DOI 10.1016/j.phrs.2005.02.015; Thomas HE, 2009, APOPTOSIS, V14, P1389, DOI 10.1007/s10495-009-0339-5; Wang XJ, 2002, J BIOL CHEM, V277, P15697, DOI 10.1074/jbc.M112068200; WELSH N, 1991, ENDOCRINOLOGY, V129, P3167, DOI 10.1210/endo-129-6-3167; White BH, 1997, J NEUROSCI, V17, P1582; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Zhang J, 2003, BIOESSAYS, V25, P808, DOI 10.1002/bies.10317	57	47	50	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8338	8348		10.1074/jbc.M110.204768	http://dx.doi.org/10.1074/jbc.M110.204768			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21196578	Green Published, hybrid			2022-12-27	WOS:000288013300062
J	McGlinchey, RP; Shewmaker, F; Hu, KN; McPhie, P; Tycko, R; Wickner, RB				McGlinchey, Ryan P.; Shewmaker, Frank; Hu, Kan-nian; McPhie, Peter; Tycko, Robert; Wickner, Reed B.			Repeat Domains of Melanosome Matrix Protein Pmel17 Orthologs Form Amyloid Fibrils at the Acidic Melanosomal pH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; NUCLEAR-MAGNETIC-RESONANCE; BETA-SHEET STRUCTURE; PINK-EYED DILUTION; SECONDARY-STRUCTURE; EXPERIMENTAL CONSTRAINTS; MURINE MELANOMA; POLAR ZIPPERS; PRION; PARALLEL	Most amyloids are pathological, but fragments of Pmel17 form a functional amyloid in vertebrate melanosomes essential for melanin synthesis and deposition. We previously reported that only at the mildly acidic pH (4-5.5) typical of melanosomes, the repeat domain (RPT) of human Pmel17 can form amyloid in vitro. Combined with the known presence of RPT in the melanosome filaments and the requirement of this domain for filament formation, we proposed that RPT may be the core of the amyloid formed in vivo. Although most of Pmel17 is highly conserved across a broad range of vertebrates, the RPT domains vary dramatically, with no apparent homology in some cases. Here, we report that the RPT domains of mouse and zebrafish, as well as a small splice variant of human Pmel17, all form amyloid specifically at mildly acid pH (pH similar to 5.0). Protease digestion, mass per unit length measurements, and solid-state NMR experiments suggest that amyloid of the mouse RPT has an in-register parallel beta-sheet architecture with two RPT molecules per layer, similar to amyloid of the A beta peptide. Although there is no sequence conservation between human and zebrafish RPT, amyloid formation at acid pH is conserved.	[McGlinchey, Ryan P.; Shewmaker, Frank; McPhie, Peter; Wickner, Reed B.] NIDDK, Lab Biochem & Genet, NIH, Bethesda, MD 20892 USA; [Hu, Kan-nian; Tycko, Robert] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Wickner, RB (corresponding author), NIDDK, Lab Biochem & Genet, NIH, Bldg 8,Rm 225,8 Ctr Dr,MSC0830, Bethesda, MD 20892 USA.	wickner@helix.nih.gov	Hu, Kan-Nian/AAH-2411-2020		National Institutes of Health NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK024964, ZIADK024950, ZIADK075031, ZIADK075018] Funding Source: NIH RePORTER	National Institutes of Health NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health NIDDK Intramural Program.	ADEMA GJ, 1993, AM J PATHOL, V143, P1579; Antzutkin ON, 2000, P NATL ACAD SCI USA, V97, P13045, DOI 10.1073/pnas.230315097; Baxa U, 2007, BIOCHEMISTRY-US, V46, P13149, DOI 10.1021/bi700826b; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Benzinger TLS, 1998, P NATL ACAD SCI USA, V95, P13407, DOI 10.1073/pnas.95.23.13407; Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072; BHATNAGAR V, 1993, ARCH BIOCHEM BIOPHYS, V307, P183, DOI 10.1006/abbi.1993.1577; Brilliant MH, 2001, PIGM CELL RES, V14, P86, DOI 10.1034/j.1600-0749.2001.140203.x; Chan JCC, 2005, BIOCHEMISTRY-US, V44, P10669, DOI 10.1021/bi050724t; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chen B, 2009, P NATL ACAD SCI USA, V106, P14339, DOI 10.1073/pnas.0907821106; Der-Sarkissian A, 2003, J BIOL CHEM, V278, P37530, DOI 10.1074/jbc.M305266200; DEVI CC, 1987, EUR J BIOCHEM, V166, P705, DOI 10.1111/j.1432-1033.1987.tb13569.x; Dunn LC, 1930, J HERED, V21, P495, DOI 10.1093/oxfordjournals.jhered.a103275; HEARING VJ, 1973, J ULTRA MOL STRUCT R, V43, P88, DOI 10.1016/S0022-5320(73)90072-5; Hoashi T, 2006, J BIOL CHEM, V281, P21198, DOI 10.1074/jbc.M601643200; Ishii Y, 2001, J CHEM PHYS, V114, P8473, DOI 10.1063/1.1359445; Kryndushkin DS, 2008, EMBO J, V27, P2725, DOI 10.1038/emboj.2008.198; KWON BS, 1991, P NATL ACAD SCI USA, V88, P9228, DOI 10.1073/pnas.88.20.9228; Leonhardt RM, 2010, J BIOL CHEM, V285, P16166, DOI 10.1074/jbc.M109.097725; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Margittai M, 2008, Q REV BIOPHYS, V41, P265, DOI 10.1017/S0033583508004733; McGlinchey RP, 2009, P NATL ACAD SCI USA, V106, P13731, DOI 10.1073/pnas.0906509106; McPhie P, 2001, ANAL BIOCHEM, V293, P109, DOI 10.1006/abio.2001.5113; Morcombe CR, 2004, J AM CHEM SOC, V126, P7196, DOI 10.1021/ja047919t; MORRIS GA, 1979, J AM CHEM SOC, V101, P760, DOI 10.1021/ja00497a058; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nichols SE, 2003, J INVEST DERMATOL, V121, P821, DOI 10.1046/j.1523-1747.2003.12474.x; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Petkova AT, 2002, J MAGN RESON, V155, P293, DOI 10.1006/jmre.2002.2519; Pfefferkorn C. M., 2010, P NATL ACAD IN PRESS; Puri N, 2000, J INVEST DERMATOL, V115, P607, DOI 10.1046/j.1523-1747.2000.00108.x; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Ross ED, 2005, P NATL ACAD SCI USA, V102, P12825, DOI 10.1073/pnas.0506136102; Ross ED, 2004, MOL CELL BIOL, V24, P7206, DOI 10.1128/MCB.24.16.7206-7213.2004; SAEKI H, 1983, J CELL PHYSIOL, V116, P93, DOI 10.1002/jcp.1041160114; Saupe SJ, 2007, PRION, V1, P110, DOI 10.4161/pri.1.2.4666; Shewmaker F, 2006, P NATL ACAD SCI USA, V103, P19754, DOI 10.1073/pnas.0609638103; Shewmaker F, 2009, BIOCHEMISTRY-US, V48, P5074, DOI 10.1021/bi900345q; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Theos AC, 2006, DEV CELL, V10, P343, DOI 10.1016/j.devcel.2006.01.012; Theos AC, 2005, PIGM CELL RES, V18, P322, DOI 10.1111/j.1600-0749.2005.00269.x; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Valencia JC, 2007, J BIOL CHEM, V282, P11266, DOI 10.1074/jbc.M608449200; Valencia JC, 2006, PIGM CELL RES, V19, P250, DOI 10.1111/j.1600-0749.2006.00308.x; Watt B, 2009, J BIOL CHEM, V284, P35543, DOI 10.1074/jbc.M109.047449; Wickner RB, 2008, P NATL ACAD SCI USA, V105, P2403, DOI 10.1073/pnas.0712032105; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; Wosten HAB, 2000, BBA-REV BIOMEMBRANES, V1469, P79, DOI 10.1016/S0304-4157(00)00002-2; Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29	55	36	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8385	8393		10.1074/jbc.M110.197152	http://dx.doi.org/10.1074/jbc.M110.197152			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21148556	Green Published, hybrid			2022-12-27	WOS:000288013300067
J	Barria, MA; Telling, GC; Gambetti, P; Mastrianni, JA; Soto, C				Barria, Marcelo A.; Telling, Glenn C.; Gambetti, Pierluigi; Mastrianni, James A.; Soto, Claudio			Generation of a New Form of Human PrPSc in Vitro by Interspecies Transmission from Cervid Prions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC WASTING DISEASE; CREUTZFELDT-JAKOB-DISEASE; CYCLIC AMPLIFICATION; PROTEIN; ELK; REPLICATION; DEER; PROPAGATION; ADAPTATION	Prion diseases are infectious neurodegenerative disorders that affect humans and animals and that result from the conversion of normal prion protein (PrPC) into the misfolded prion protein (PrPSc). Chronic wasting disease (CWD) is a prion disorder of increasing prevalence within the United States that affects a large population of wild and captive deer and elk. Determining the risk of transmission of CWD to humans is of utmost importance, considering that people can be infected by animal prions, resulting in new fatal diseases. To study the possibility that human PrPC can be converted into the misfolded form by CWD PrPSc, we performed experiments using the protein mis-folding cyclic amplification technique, which mimics in vitro the process of prion replication. Our results show that cervid PrPSc can induce the conversion of human PrPC but only after the CWD prion strain has been stabilized by successive passages in vitro or in vivo. Interestingly, the newly generated human PrPSc exhibits a distinct biochemical pattern that differs from that of any of the currently known forms of human PrPSc. Our results also have profound implications for understanding the mechanisms of the prion species barrier and indicate that the transmission barrier is a dynamic process that depends on the strain and moreover the degree of adaptation of the strain. If our findings are corroborated by infectivity assays, they will imply that CWD prions have the potential to infect humans and that this ability progressively increases with CWD spreading.	[Barria, Marcelo A.; Soto, Claudio] Univ Texas Med Sch Houston, Dept Neurol, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Houston, TX 77030 USA; [Telling, Glenn C.] Univ Kentucky, Med Ctr, Sanders Brown Ctr Aging, Dept Microbiol, Lexington, KY 40506 USA; [Telling, Glenn C.] Univ Kentucky, Med Ctr, Sanders Brown Ctr Aging, Dept Immunol, Lexington, KY 40506 USA; [Telling, Glenn C.] Univ Kentucky, Med Ctr, Sanders Brown Ctr Aging, Dept Mol Genet & Neurol, Lexington, KY 40506 USA; [Gambetti, Pierluigi] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA; [Mastrianni, James A.] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA	University of Texas System; University of Texas Health Science Center Houston; University of Kentucky; University of Kentucky; University of Kentucky; Case Western Reserve University; University of Chicago	Soto, C (corresponding author), Univ Texas Med Sch Houston, Dept Neurol, Mitchell Ctr Alzheimers Dis & Related Brain Disor, 6431 Fannin St, Houston, TX 77030 USA.	claudio.soto@uth.tmc.edu	Telling, Glenn C/G-1217-2019	Telling, Glenn C/0000-0002-6294-1805; Barria Matus, Marcelo/0000-0003-4789-7401	National Institutes of Health [R01NS049173, P01AI77774, P01AG14359]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI077774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS049173, P01AI77774, and P01AG14359. Dr. Soto is the inventor of several patents related to PMCA technology and is currently Founder, Chief Scientific Officer, and Vice President of Amprion Inc., a biotechnological company focusing on the commercial exploitation of PMCA for prion diagnosis.	Angers RC, 2010, SCIENCE, V328, P1154, DOI 10.1126/science.1187107; Barria MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000421; Belay ED, 2001, ARCH NEUROL-CHICAGO, V58, P1673, DOI 10.1001/archneur.58.10.1673; Bosque Patrick J, 2002, Curr Neurol Neurosci Rep, V2, P488, DOI 10.1007/s11910-002-0034-1; BROWN P, 1991, LANCET, V337, P269, DOI 10.1016/0140-6736(91)90873-N; Browning SR, 2004, J VIROL, V78, P13345, DOI 10.1128/JVI.78.23.13345-13350.2004; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2005, NAT MED, V11, P982, DOI 10.1038/nm1286; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; Castilla J, 2006, METHOD ENZYMOL, V412, P3, DOI 10.1016/s0076-6879(06)12001-7; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Green KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000139; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Jones M, 2008, NEUROREPORT, V19, P1783, DOI 10.1097/WNR.0b013e328318edfa; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kong QZ, 2005, J NEUROSCI, V25, P7944, DOI 10.1523/JNEUROSCI.2467-05.2005; Kurt TD, 2009, VIROLOGY, V387, P235, DOI 10.1016/j.virol.2009.02.025; Marsh RF, 2005, J VIROL, V79, P13794, DOI 10.1128/JVI.79.21.13794-13796.2005; Meyerett C, 2008, VIROLOGY, V382, P267, DOI 10.1016/j.virol.2008.09.023; Miller MW, 2004, CURR TOP MICROBIOL, V284, P193; Moore RA, 2005, ARCH VIROL, P187; Murayama Y, 2007, NEUROSCI LETT, V413, P270, DOI 10.1016/j.neulet.2006.11.056; Race B, 2009, EMERG INFECT DIS, V15, P1366, DOI 10.3201/eid1509.090253; Race R, 2002, J INFECT DIS, V186, pS166, DOI 10.1086/344267; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saa Paula, 2004, V299, P53; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sandberg MK, 2010, J GEN VIROL, V91, P2651, DOI 10.1099/vir.0.024380-0; Seidel B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000435; Sigurdson CJ, 2007, BBA-MOL BASIS DIS, V1772, P610, DOI 10.1016/j.bbadis.2006.10.010; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; Tamguney G, 2006, J VIROL, V80, P9104, DOI 10.1128/JVI.00098-06; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Thorne L, 2008, J GEN VIROL, V89, P3177, DOI 10.1099/vir.0.2008/004226-0; Xie ZL, 2006, J BIOL CHEM, V281, P4199, DOI 10.1074/jbc.M509052200	37	79	79	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7490	7495		10.1074/jbc.M110.198465	http://dx.doi.org/10.1074/jbc.M110.198465			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21209079	hybrid, Green Published			2022-12-27	WOS:000287737300063
J	Engels, B; Heinig, U; Grothe, T; Stadler, M; Jennewein, S				Engels, Benedikt; Heinig, Uwe; Grothe, Torsten; Stadler, Marc; Jennewein, Stefan			Cloning and Characterization of an Armillaria gallica cDNA Encoding Protoilludene Synthase, Which Catalyzes the First Committed Step in the Synthesis of Antimicrobial Melleolides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARISTOLOCHENE SYNTHASE; CRYSTAL-STRUCTURE; SESQUITERPENE SYNTHASES; TRICHODIENE SYNTHASE; ASPERGILLUS-TERREUS; DITERPENE CYCLASE; TERPENE SYNTHASES; GENE-CLUSTER; CYCLIZATION; BIOSYNTHESIS	Melleolides and related fungal sesquiterpenoid aryl esters are antimicrobial and cytotoxic natural products derived from cultures of the Homobasidiomycetes genus Armillaria. The initial step in the biosynthesis of all melleolides involves cyclization of the universal sesquiterpene precursor farnesyl diphosphate to produce protoilludene, a reaction catalyzed by protoilludene synthase. We achieved the partial purification of protoilludene synthase from a mycelial culture of Armillaria gallica and found that 6-protoilludene was its exclusive reaction product. Therefore, a further isomerization reaction is necessary to convert the 6-7 double bond into the 7-8 double bond found in melleolides. We expressed an A. gallica protoilludene synthase cDNA in Escherichia coli, and this also led to the exclusive production of 6-protoilludene. Sequence comparison of the isolated sesquiterpene synthase revealed a distant relationship to other fungal terpene synthases. The isolation of the genomic sequence identified the 6-protoilludene synthase to be present as a single copy gene in the genome of A. gallica, possessing an open reading frame interrupted with eight introns.	[Engels, Benedikt; Heinig, Uwe; Jennewein, Stefan] Fraunhofer Inst Mol & Angew Okol, D-52074 Aachen, Germany; [Grothe, Torsten; Stadler, Marc] Intermed Discovery, D-44227 Dortmund, Germany; [Stadler, Marc] Univ Bayreuth, Dept Mycol, D-95440 Bayreuth, Germany	Fraunhofer Gesellschaft; University of Bayreuth	Jennewein, S (corresponding author), Fraunhofer Inst Mol & Angew Okol, Forckenbeckstr 6, D-52074 Aachen, Germany.	stefan.jennewein@ime.fraunhofer.de	Stadler, Marc/AHB-7016-2022; Stadler, Marc/P-8882-2014	Stadler, Marc/0000-0002-7284-8671; Stadler, Marc/0000-0002-7284-8671; GROTHE, TORSTEN/0000-0003-3298-4924	Arbeitsgemeinschaft industrielle Forschungsvereinigungen (Otto von Guericke) Pro Inno II	Arbeitsgemeinschaft industrielle Forschungsvereinigungen (Otto von Guericke) Pro Inno II	This work was supported by a grant from Arbeitsgemeinschaft industrielle Forschungsvereinigungen (Otto von Guericke) Pro Inno II.	Abraham WR, 2001, CURR MED CHEM, V8, P583, DOI 10.2174/0929867013373147; Agger S, 2009, MOL MICROBIOL, V72, P1181, DOI 10.1111/j.1365-2958.2009.06717.x; ARNONE A, 1986, PHYTOCHEMISTRY, V25, P471, DOI 10.1016/S0031-9422(00)85503-X; AYER WA, 1981, TETRAHEDRON, V37, P2199, DOI 10.1016/S0040-4020(01)97979-7; Cane DE, 2000, ARCH BIOCHEM BIOPHYS, V376, P354, DOI 10.1006/abbi.2000.1734; CANE DE, 1995, BIOCHEMISTRY-US, V34, P2480, DOI 10.1021/bi00008a011; Caruthers JM, 2000, J BIOL CHEM, V275, P25533, DOI 10.1074/jbc.M000433200; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Conolly JD, 1991, DICT TERPENOIDS; Dairi T, 2001, J BACTERIOL, V183, P6085, DOI 10.1128/JB.183.20.6085-6094.2001; Davis EM, 2000, TOP CURR CHEM, V209, P53; Hamano Y, 2002, J BIOL CHEM, V277, P37098, DOI 10.1074/jbc.M206382200; HEINZL S, 2006, CHEMOTHER J, V15, P40; HOHN TM, 1989, GENE, V79, P131, DOI 10.1016/0378-1119(89)90098-X; HOHN TM, 1995, MOL GEN GENET, V248, P95, DOI 10.1007/BF02456618; HOHN TM, 1989, ARCH BIOCHEM BIOPHYS, V272, P137, DOI 10.1016/0003-9861(89)90204-X; Jennewein S, 2004, CHEM BIOL, V11, P379, DOI 10.1016/j.chembiol.2004.02.022; Joulain D., 1998, ATLAS SPECTRAL DATA; Kawaide H, 2006, BIOSCI BIOTECH BIOCH, V70, P583, DOI 10.1271/bbb.70.583; Kawaide H, 1997, J BIOL CHEM, V272, P21706, DOI 10.1074/jbc.272.35.21706; Kirk PM., 2008, DICT FUNGI, V10th ed; Laatsch H., 2010, ANTIBASE 2010 NATURA; Lesburg CA, 1997, SCIENCE, V277, P1820, DOI 10.1126/science.277.5333.1820; Lopez-Gallego F, 2010, CHEMBIOCHEM, V11, P1093, DOI 10.1002/cbic.200900671; Lorenzen K, 1998, CURR ORG CHEM, V2, P329; NOZOE S, 1977, TETRAHEDRON LETT, P1381; OBUCHI T, 1990, PLANTA MED, V56, P198, DOI 10.1055/s-2006-960925; ODURO KA, 1976, T BRIT MYCOL SOC, V66, P195, DOI 10.1016/S0007-1536(76)80045-9; Pinedo C, 2008, ACS CHEM BIOL, V3, P791, DOI 10.1021/cb800225v; Rynkiewicz MJ, 2001, P NATL ACAD SCI USA, V98, P13543, DOI 10.1073/pnas.231313098; Sacchettini JC, 1997, SCIENCE, V277, P1788, DOI 10.1126/science.277.5333.1788; Shishova EY, 2007, BIOCHEMISTRY-US, V46, P1941, DOI 10.1021/bi0622524; SMITH ML, 1992, NATURE, V356, P428, DOI 10.1038/356428a0; Stadler Marc, 2003, Mycological Progress, V2, P95, DOI 10.1007/s11557-006-0048-1; Tainter F.H., 1996, PRINCIPLES FOREST PA; Tholl D, 2006, CURR OPIN PLANT BIOL, V9, P297, DOI 10.1016/j.pbi.2006.03.014; Toyomasu T, 2004, BIOSCI BIOTECH BIOCH, V68, P146, DOI 10.1271/bbb.68.146; Toyomasu T, 2007, P NATL ACAD SCI USA, V104, P3084, DOI 10.1073/pnas.0608426104; Trapp SC, 2001, GENETICS, V158, P811; Vedula LS, 2008, ARCH BIOCHEM BIOPHYS, V469, P184, DOI 10.1016/j.abb.2007.10.015	40	51	68	3	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6871	6878		10.1074/jbc.M110.165845	http://dx.doi.org/10.1074/jbc.M110.165845			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21148562	Green Published, hybrid			2022-12-27	WOS:000287737300002
J	Murata, H; Sakaguchi, M; Jin, Y; Sakaguchi, Y; Futami, J; Yamada, H; Kataoka, K; Huh, NH				Murata, Hitoshi; Sakaguchi, Masakiyo; Jin, Yu; Sakaguchi, Yoshihiko; Futami, Jun-ichiro; Yamada, Hidenori; Kataoka, Ken; Huh, Nam-ho			A New Cytosolic Pathway from a Parkinson Disease-associated Kinase, BRPK/PINK1 ACTIVATION OF AKT VIA MTORC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY-ONSET PARKINSONISM; RICTOR-MTOR COMPLEX; OXIDATIVE STRESS; PINK1; MUTATIONS; GROWTH; GENE; AKT/PKB; PHOSPHORYLATION; MICE	Accumulating evidence indicates that dysfunction of mitochondria is a common feature of Parkinson disease. Functional loss of a familial Parkinson disease-linked gene, BRPK/PINK1 (PINK1), results in deterioration of mitochondrial functions and eventual neuronal cell death. A mitochondrial chaperone protein has been shown to be a substrate of PINK1 kinase activity. In this study, we demonstrated that PINK1 has another action point in the cytoplasm. Phosphorylation of Akt at Ser-473 was enhanced by overexpression of PINK1, and the Akt activation was crucial for protection of SH-SY5Y cells from various cytotoxic agents, including oxidative stress. Enhanced Akt phosphorylation was not due to activation of phosphatidylinositol 3-kinase but due to activation of mammalian target of rapamycin complex 2 (mTORC2) by PINK1. Rictor, a specific component of mTORC2, was phosphorylated by overexpression of PINK1. Furthermore, overexpression of PINK1 enhanced cell motility. These results indicate that PINK1 exerts its cytoprotective function not only in mitochondria but also in the cytoplasm through activation of mTORC2.	[Kataoka, Ken; Huh, Nam-ho] Okayama Univ, Dept Cell Biol, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, Okayama 7008558, Japan; [Sakaguchi, Yoshihiko] Miyazaki Univ, Interdisciplinary Res Org, Miyazaki 8891692, Japan; [Futami, Jun-ichiro; Yamada, Hidenori] Okayama Univ, Dept Biosci & Biotechnol, Grad Sch Nat Sci & Technol, Kita Ku, Okayama 7008530, Japan	Okayama University; University of Miyazaki; Okayama University	Huh, NH (corresponding author), Okayama Univ, Dept Cell Biol, Grad Sch Med Dent & Pharmaceut Sci, Kita Ku, 2-5-1 Shikatacho, Okayama 7008558, Japan.	namu@md.okayama-u.ac.jp	Sakaguchi, Masakiyo/B-2280-2011; FUTAMI, Junichiro/B-2578-2011; YAMADA, Hidenori/B-2639-2011; MURATA, Hitoshi/B-2327-2011; HUH, Nam-ho/B-1613-2011; KATAOKA, Ken/B-1607-2011	FUTAMI, Junichiro/0000-0002-0020-2855; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20015031]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant 20015031 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to N. H.).	Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Biskup S, 2008, J NEUROL, V255, P8, DOI 10.1007/s00415-008-5005-2; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Criscuolo C, 2006, MOVEMENT DISORD, V21, P1265, DOI 10.1002/mds.20933; Dagda RK, 2009, J BIOL CHEM, V284, P13843, DOI 10.1074/jbc.M808515200; Deng H, 2005, BIOCHEM BIOPH RES CO, V337, P1133, DOI 10.1016/j.bbrc.2005.09.178; Farkas LM, 2002, J NEURAL TRANSM, V109, P267, DOI 10.1007/s007020200022; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Greenamyre JT, 2001, IUBMB LIFE, V52, P135, DOI 10.1080/15216540152845939; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kessler KR, 2005, J NEURAL TRANSM, V112, P1345, DOI 10.1007/s00702-005-0281-9; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Klein C, 2006, NAT CLIN PRACT NEURO, V2, P136, DOI 10.1038/ncpneuro0126; Lin W, 2008, J NEUROCHEM, V106, P464, DOI 10.1111/j.1471-4159.2008.05398.x; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223; Nakajima A, 2003, CANCER LETT, V201, P195, DOI 10.1016/S0304-3835(03)00443-9; Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Ries V, 2006, P NATL ACAD SCI USA, V103, P18757, DOI 10.1073/pnas.0606401103; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Strauss KM, 2005, HUM MOL GENET, V14, P2099, DOI 10.1093/hmg/ddi215; Takatori S, 2008, NEUROSCI LETT, V430, P13, DOI 10.1016/j.neulet.2007.10.019; Unoki M, 2001, ONCOGENE, V20, P4457, DOI 10.1038/sj.onc.1204608; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	41	97	101	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7182	7189		10.1074/jbc.M110.179390	http://dx.doi.org/10.1074/jbc.M110.179390			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177249	Green Published, hybrid			2022-12-27	WOS:000287737300035
J	Haldar, S; Saini, A; Nanda, JS; Saini, S; Singh, J				Haldar, Swati; Saini, Ashok; Nanda, Jagpreet Singh; Saini, Sharanjot; Singh, Jagmohan			Role of Swi6/HP1 Self-association-mediated Recruitment of Clr4/Suv39 in Establishment and Maintenance of Heterochromatin in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							H3 LYSINE-9 METHYLATION; HISTONE H3; SHADOW DOMAIN; HP1 PROTEINS; TRANSCRIPTION; COMPLEX; RNAI; METHYLTRANSFERASE; CHROMODOMAIN; DIMERIZATION	Swi6/HP1, an evolutionarily conserved protein, is critical for heterochromatin assembly in fission yeast and higher eukaryotes. In fission yeast, histone deacetylation by histone deacetylases is thought to be followed by H3-Lys-9 methylation by the histone methyltransferase Clr4/Suv39H1.H3-Lys-9-Me2 interacts with the chromodomain of Swi6/HP1. Swi6/HP1 is thought to act downstream of Clr4/Suv39, and further self-association of Swi6/HP1 is assumed to stabilize the heterochromatin structure. Here, we show that the self-association-defective mutant of Swi6 does not interact with Clr4. It not only fails to localize to heterochromatin loci but also interferes with heterochromatic localization of H3-Lys-9-Me2 (and thereby Clr4) and the endogenous Swi6 in a dominant negative manner. Thus, self-association of Swi6/HP1 helps in binding to and recruitment of Clr4 and thereby in establishment and maintenance of heterochromatin by a concerted rather than a sequential mechanism.	[Haldar, Swati; Saini, Ashok; Nanda, Jagpreet Singh; Saini, Sharanjot; Singh, Jagmohan] Inst Microbial Technol, Sector 39A, Chandigarh 160036, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Singh, J (corresponding author), Inst Microbial Technol, Sector 39A, Chandigarh 160036, India.	jag@imtech.res.in	Haldar, Swati/AAH-5388-2021	saini, ashok/0000-0001-6530-4281; Haldar, Swati/0000-0002-1566-1907; Nanda, Jagpreet Singh/0000-0002-8096-7654	Council of Scientific and Industrial Research, New Delhi, India	Council of Scientific and Industrial Research, New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by intramural support from the Council of Scientific and Industrial Research, New Delhi, India.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; Arney KL, 2002, INT J DEV BIOL, V46, P317; Bailis JM, 2003, NAT CELL BIOL, V5, P1111, DOI 10.1038/ncb1069; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Cowieson NP, 2000, CURR BIOL, V10, P517, DOI 10.1016/S0960-9822(00)00467-X; Dubey RN, 2009, J BIOL CHEM, V284, P7165, DOI 10.1074/jbc.M806461200; EKWALL K, 1999, CHROMOSOME STRUCTURA, P38; Fischer T, 2009, P NATL ACAD SCI USA, V106, P8998, DOI 10.1073/pnas.0813063106; Grewal SIS, 2010, CURR OPIN GENET DEV, V20, P134, DOI 10.1016/j.gde.2010.02.003; Grewal SIS, 2002, CURR OPIN GENET DEV, V12, P178, DOI 10.1016/S0959-437X(02)00284-8; Grewal SIS, 1996, CELL, V86, P95, DOI 10.1016/S0092-8674(00)80080-X; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; Klar AJS, 2007, ANNU REV GENET, V41, P213, DOI 10.1146/annurev.genet.39.073103.094316; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Motamedi MR, 2008, MOL CELL, V32, P778, DOI 10.1016/j.molcel.2008.10.026; Nakayama J, 2000, CELL, V101, P307, DOI 10.1016/S0092-8674(00)80840-5; Norwood LE, 2006, J BIOL CHEM, V281, P18668, DOI 10.1074/jbc.M512454200; Pidoux AL, 2000, J CELL SCI, V113, P4177; Sadaie M, 2008, MOL CELL BIOL, V28, P6973, DOI 10.1128/MCB.00791-08; Shimada A, 2009, GENE DEV, V23, P18, DOI 10.1101/gad.1708009; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; THON G, 1993, GENETICS, V134, P1045; THON G, 1994, GENETICS, V138, P29; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang GZ, 2000, MOL CELL BIOL, V20, P6970, DOI 10.1128/MCB.20.18.6970-6983.2000; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Yamamoto K, 2003, BIOCHEM BIOPH RES CO, V301, P287, DOI 10.1016/S0006-291X(02)03021-8; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406	34	26	26	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9308	9320		10.1074/jbc.M110.143198	http://dx.doi.org/10.1074/jbc.M110.143198			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21224386	hybrid, Green Published			2022-12-27	WOS:000288247700061
J	Pisani, F; Mastrototaro, M; Rossi, A; Nicchia, GP; Tortorella, C; Ruggieri, M; Trojano, M; Frigeri, A; Svelto, M				Pisani, Francesco; Mastrototaro, Mauro; Rossi, Andrea; Nicchia, Grazia Paola; Tortorella, Carla; Ruggieri, Maddalena; Trojano, Maria; Frigeri, Antonio; Svelto, Maria			Identification of Two Major Conformational Aquaporin-4 Epitopes for Neuromyelitis Optica Autoantibody Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-SCLEROSIS; ARRAY-FORMATION; PROTEIN; DISTINCTION; TRANSPORT; MECHANISM; ANTIBODY; LESIONS; MARKER	Neuromyelitis optica (NMO) is an autoimmune demyelinating disease characterized by the presence of anti-aquaporin-4 (AQP4) antibodies in the patient sera. We recently reported that these autoantibodies are able to bind AQP4 when organized in the supramolecular structure called the orthogonal array of particles (OAP). To map the antigenic determinants, we produced a series of AQP4 mutants based on multiple alignment sequence analysis between AQP4 and other OAP-forming AQPs. Mutations were introduced in the three extracellular loops (A, C, and E), and the binding capacity of NMO sera was tested on AQP4 mutants. Results indicate that one group of sera was able to recognize a limited portion of loop C containing the amino acid sequence (146)GVT(T/M)V-150. A second group of sera was characterized by a predominant role of loop A. Deletion of four AQP4-specific amino acids ((61)G(S/T)E(N/K)(64)) in loop A substantially affected the binding of this group of sera. However, the binding capacity was further reduced when amino acids in loop A were mutated together with those in loop E or when those in loop C were mutated in combination with loop E. Finally, a series of AQP0 mutants were produced in which the extracellular loops were progressively changed to make them identical to AQP4. Results showed that none of the mutants was able to reproduce in AQP0 the NMO-IgG epitopes, indicating that the extracellular loop sequence by itself was not sufficient to determine the rearrangement required to create the epitopes. Although our data highlight the complexity of the disease, this study identifies key immunodominant epitopes and provides direct evidence that the transition from AQP4 tetramers to AQP4-OAPs involves conformational changes of the extracellular loops.	[Pisani, Francesco; Mastrototaro, Mauro; Rossi, Andrea; Nicchia, Grazia Paola; Frigeri, Antonio; Svelto, Maria] Univ Bari, Dept Gen & Environm Physiol, Ctr Excellence Comparat Genom, I-70126 Bari, Italy; [Tortorella, Carla; Ruggieri, Maddalena; Trojano, Maria] Univ Bari, Dept Neurol & Psychiat Sci, I-70126 Bari, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Frigeri, A (corresponding author), Univ Bari, Dept Gen & Environm Physiol, Ctr Excellence Comparat Genom, I-70126 Bari, Italy.	a.frigeri@biologia.uniba.it	PISANI, Francesco/AAC-1749-2019; Tortorella, Carla/J-2557-2012; frigeri, Antonio/AAC-6336-2022; Svelto, Maria/P-6186-2014	PISANI, Francesco/0000-0001-8511-117X; Tortorella, Carla/0000-0001-9037-7300; Frigeri, Antonio/0000-0002-5284-2934; Rossi, Andrea/0000-0001-5863-6448; Trojano, Maria/0000-0002-6329-8946; Svelto, Maria/0000-0002-5584-9541	Apulia Region [PS124]; Rete Nazionale di Proteomica [RBRN07BMCT_009]	Apulia Region; Rete Nazionale di Proteomica	This work was supported by the Apulia Region Grant Progetto Strategico APQ Ricerca PS124 (Neurobiotech) and Rete Nazionale di Proteomica Project RBRN07BMCT_009.	Correale J, 2004, NEUROLOGY, V63, P2363, DOI 10.1212/01.WNL.0000148481.80152.BF; Crane JM, 2008, MOL BIOL CELL, V19, P3369, DOI 10.1091/mbc.E08-03-0322; FRIGERI A, 1995, J CELL SCI, V108, P2993; Graber DJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-22; Haase CG, 2001, NEUROSCI LETT, V307, P131, DOI 10.1016/S0304-3940(01)01949-8; Harries WEC, 2004, P NATL ACAD SCI USA, V101, P14045, DOI 10.1073/pnas.0405274101; Hinson SR, 2010, NEUROSCIENCE, V168, P1009, DOI 10.1016/j.neuroscience.2009.08.032; Hinson SR, 2008, J EXP MED, V205, P2473, DOI 10.1084/jem.20081241; Hinson SR, 2009, ARCH NEUROL-CHICAGO, V66, P1164, DOI 10.1001/archneurol.2009.188; Hiroaki Y, 2006, J MOL BIOL, V355, P628, DOI 10.1016/j.jmb.2005.10.081; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; Lalive PH, 2006, NEUROLOGY, V67, P176, DOI 10.1212/01.wnl.0000223346.09426.34; LeCaherec F, 1996, J CELL SCI, V109, P1285; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Marnetto F, 2009, J NEUROIMMUNOL, V217, P74, DOI 10.1016/j.jneuroim.2009.10.002; Matsuoka T, 2007, BRAIN, V130, P1206, DOI 10.1093/brain/awm027; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Nicchia GP, 2009, GLIA, V57, P1363, DOI 10.1002/glia.20855; Nielsen S, 1997, J NEUROSCI, V17, P171; Pittock SJ, 2008, ARCH NEUROL-CHICAGO, V65, P78, DOI 10.1001/archneurol.2007.17; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Rossi A, 2010, J BIOL CHEM, V285, P4562, DOI 10.1074/jbc.M109.069245; Saikali P, 2009, AUTOIMMUN REV, V9, P132, DOI 10.1016/j.autrev.2009.04.004; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Tani T, 2009, J NEUROIMMUNOL, V211, P110, DOI 10.1016/j.jneuroim.2009.04.001	26	50	52	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9216	9224		10.1074/jbc.M110.123000	http://dx.doi.org/10.1074/jbc.M110.123000			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21212277	Green Published, hybrid			2022-12-27	WOS:000288247700052
J	Im, CH; Hwang, SM; Son, YS; Heo, JB; Bang, WY; Suwastika, IN; Shiina, T; Bahk, JD				Im, Chak Han; Hwang, Sung Min; Son, Young Sim; Heo, Jae Bok; Bang, Woo Young; Suwastika, I. Nengah; Shiina, Takashi; Bahk, Jeong Dong			Nuclear/Nucleolar GTPase 2 Proteins as a Subfamily of YlqF/YawG GTPases Function in Pre-60S Ribosomal Subunit Maturation of Mono- and Dicotyledonous Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS GTPASE; ESCHERICHIA-COLI; BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; NUCLEOTIDE-BINDING; NUCLEAR EXPORT; PRE-RIBOSOMES; RNA; BIOGENESIS	The YlqF/YawG families are important GTPases involved in ribosome biogenesis, cell proliferation, or cell growth, however, no plant homologs have yet to be characterized. Here we isolated rice (Oryza sativa) and Arabidopsis nuclear/nucleolar GTPase 2 (OsNug2 and AtNug2, respectively) that belong to the YawG subfamily and characterized them for pre-60S ribosomal subunit maturation. They showed typical intrinsic YlqF/YawG family GTPase activities in bacteria and yeasts with k(cat) values 0.12 +/- 0.007 min(-1) (n = 6) and 0.087 +/- 0.002 min(-1) (n = 4), respectively, and addition of 60S ribosomal subunits stimulated their activities in vitro. In addition, OsNug2 rescued the lethality of the yeast nug2 null mutant through recovery of 25S pre-rRNA processing. By yeast two-hybrid screening five clones, including a putative one of 60S ribosomal proteins, OsL10a, were isolated. Subcellular localization and pulldown assays resulted in that the N-terminal region of OsNug2 is sufficient for nucleolar/nuclear targeting and association with OsL10a. OsNug2 is physically associated with pre-60S ribosomal complexes highly enriched in the 25S, 5.8S, and 5S rRNA, and its interaction was stimulated by exogenous GTP. Furthermore, the AtNug2 knockdown mutant constructed by the RNAi method showed defective growth on the medium containing cycloheximide. Expression pattern analysis revealed that the distribution of AtNug2 mainly in the meristematic region underlies its potential role in active plant growth. Finally, it is concluded that Nug2/Nog2p GTPase from mono-and didicoty-ledonous plants is linked to the pre-60S ribosome complex and actively processed 27S into 25S during the ribosomal large subunit maturation process, i.e. prior to export to the cytoplasm.	[Im, Chak Han; Hwang, Sung Min; Son, Young Sim; Heo, Jae Bok; Bang, Woo Young; Bahk, Jeong Dong] Gyeongsang Natl Univ, Grad Sch, Div Appl Life Sci BK21, Jinju 660701, South Korea; [Suwastika, I. Nengah] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; [Shiina, Takashi] Kyoto Prefectural Univ, Grad Sch Human & Environm Sci, Sakyo Ku, Kyoto 6068522, Japan	Gyeongsang National University; Kyoto University; Kyoto Prefectural University	Bahk, JD (corresponding author), Gyeongsang Natl Univ, Grad Sch, Div Appl Life Sci BK21, Jinju 660701, South Korea.	jdbahk@gnu.ac.kr	Suwastika, I Nengah/R-7439-2019	Suwastika, I Nengah/0000-0001-5648-3169	Ministry of Education and Science Technology of Korea; Gyeongsang National University of Korea, Jinju, Korea; Gyeongsang National University of Korea; Grants-in-Aid for Scientific Research [22370022] Funding Source: KAKEN	Ministry of Education and Science Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Gyeongsang National University of Korea, Jinju, Korea; Gyeongsang National University of Korea; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the BK21 program of the Ministry of Education and Science Technology of Korea.; Graduate student supported by the BK21 program, Gyeongsang National University of Korea, Jinju, Korea.; Postdoctoral student supported by the BK21 program, Gyeongsang National University of Korea.	BABA A, 1986, PLANT CELL PHYSIOL, V27, P463; Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2; Bassler J, 2006, J BIOL CHEM, V281, P24737, DOI 10.1074/jbc.M604261200; Bharat A, 2006, J BACTERIOL, V188, P7992, DOI 10.1128/JB.00959-06; Byrne ME, 2009, TRENDS PLANT SCI, V14, P512, DOI 10.1016/j.tplants.2009.06.009; Campbell TL, 2005, BIOCHEM J, V389, P843, DOI 10.1042/BJ20041873; Chen SB, 2006, MOL PLANT PATHOL, V7, P417, DOI 10.1111/j.1364-3703.2006.00346.x; Daigle DM, 2004, J BACTERIOL, V186, P1381, DOI 10.1128/JB.186.5.1381-1387.2004; Daigle DM, 2002, BIOCHEMISTRY-US, V41, P11109, DOI 10.1021/bi020355q; Degenhardt RF, 2008, PLANT PHYSIOL, V147, P128, DOI 10.1104/pp.107.111799; Du XM, 2006, MOL BIOL CELL, V17, P460, DOI 10.1091/mbc.E05-09-0848; Dutca LM, 2005, MOL CELL, V20, P497, DOI 10.1016/j.molcel.2005.11.006; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Furukawa T, 1998, PLANT CELL PHYSIOL, V39, P43, DOI 10.1093/oxfordjournals.pcp.a029287; Giavalisco P, 2005, PLANT MOL BIOL, V57, P577, DOI 10.1007/s11103-005-0699-3; Granato DC, 2005, FEBS J, V272, P4450, DOI 10.1111/j.1742-4658.2005.04861.x; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Granneman S, 2004, EXP CELL RES, V296, P43, DOI 10.1016/j.yexcr.2004.03.016; Hedges J, 2005, EMBO J, V24, P567, DOI 10.1038/sj.emboj.7600547; Heo JB, 2005, PLANT CELL PHYSIOL, V46, P2005, DOI 10.1093/pcp/pci215; Himeno H, 2004, NUCLEIC ACIDS RES, V32, P5303, DOI 10.1093/nar/gkh861; Jain N, 2009, BIOCHEM BIOPH RES CO, V379, P201, DOI 10.1016/j.bbrc.2008.12.072; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jiang MX, 2006, J BACTERIOL, V188, P6757, DOI 10.1128/JB.00444-06; Kallstrom G, 2003, MOL CELL BIOL, V23, P4344, DOI 10.1128/MCB.23.12.4344-4355.2003; Karbstein K, 2005, MOL CELL, V20, P633, DOI 10.1016/j.molcel.2005.09.017; Karbstein K, 2007, BIOPOLYMERS, V87, P1, DOI 10.1002/bip.20762; Kressler D, 1999, MOL CELL BIOL, V19, P7897; Leipe DD, 2002, J MOL BIOL, V317, P41, DOI 10.1006/jmbi.2001.5378; Matsuo Y, 2006, J BIOL CHEM, V281, P8110, DOI 10.1074/jbc.M512556200; Matsuo Y, 2007, J BIOL CHEM, V282, P25270, DOI 10.1074/jbc.M703894200; McIntosh KB, 2005, GENOME, V48, P443, DOI [10.1139/g05-007, 10.1139/G05-007]; Menne TF, 2007, NAT GENET, V39, P486, DOI 10.1038/ng1994; Muench SP, 2006, P NATL ACAD SCI USA, V103, P12359, DOI 10.1073/pnas.0602585103; Nishimura T, 2005, PLANT CELL, V17, P2940, DOI 10.1105/tpc.105.036533; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Petricka JJ, 2007, PLANT PHYSIOL, V144, P173, DOI 10.1104/pp.106.093575; Pinon V, 2008, DEVELOPMENT, V135, P1315, DOI 10.1242/dev.016469; Pontvianne F, 2007, MOL BIOL CELL, V18, P369, DOI 10.1091/mbc.E06-08-0751; Popescu SC, 2004, PLANT J, V39, P29, DOI 10.1111/j.1365-313X.2004.02109.x; Sato A, 2005, GENES CELLS, V10, P393, DOI 10.1111/j.1365-2443.2005.00851.x; Saveanu C, 2001, EMBO J, V20, P6475, DOI 10.1093/emboj/20.22.6475; Sayed A, 1999, BIOCHEM BIOPH RES CO, V264, P51, DOI 10.1006/bbrc.1999.1471; Schaefer L, 2006, J BACTERIOL, V188, P8252, DOI 10.1128/JB.01213-06; Seo HS, 1997, EUR J BIOCHEM, V249, P293, DOI 10.1111/j.1432-1033.1997.00293.x; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Uicker WC, 2006, MOL MICROBIOL, V59, P528, DOI 10.1111/j.1365-2958.2005.04948.x; Uicker WC, 2007, J BACTERIOL, V189, P2926, DOI 10.1128/JB.01654-06; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Warner JR, 2001, CELL, V107, P133, DOI 10.1016/S0092-8674(01)00531-1; Wicker-Planquart C, 2008, J BACTERIOL, V190, P681, DOI 10.1128/JB.01193-07; Wood AJ, 2000, J EXP BOT, V51, P1655, DOI 10.1093/jexbot/51.351.1655; Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013	55	17	23	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8620	8632		10.1074/jbc.M110.200816	http://dx.doi.org/10.1074/jbc.M110.200816			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21205822	hybrid, Green Published			2022-12-27	WOS:000288013300088
J	Manz, B; Gotz, V; Wunderlich, K; Eisel, J; Kirchmair, J; Stech, J; Stech, O; Chase, G; Frank, R; Schwemmle, M				Maenz, Benjamin; Goetz, Veronika; Wunderlich, Kerstin; Eisel, Jessica; Kirchmair, Johannes; Stech, Juergen; Stech, Olga; Chase, Geoffrey; Frank, Ronald; Schwemmle, Martin			Disruption of the Viral Polymerase Complex Assembly as a Novel Approach to Attenuate Influenza A Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE; PANDEMIC INFLUENZA; H5N1 VIRUS; SUBUNIT; VACCINE; HEMAGGLUTININ; INTERFERON; ADAPTATION; TROPISM; BINDING	To develop a novel attenuation strategy applicable to all influenza A viruses, we targeted the highly conserved protein-protein interaction of the viral polymerase subunits PA and PB1. We postulated that impaired binding between PA and PB1 would negatively affect trimeric polymerase complex formation, leading to reduced viral replication efficiency in vivo. As proof of concept, we introduced single or multiple amino acid substitutions into the protein-protein-binding domains of either PB1 or PA, or both, to decrease binding affinity and polymerase activity substantially. As expected, upon generation of recombinant influenza A viruses (SC35M strain) containing these mutations, many pseudo-revertants appeared that partially restored PA-PB1 binding and polymerase activity. These polymerase assembly mutants displayed drastic attenuation in cell culture and mice. The attenuation of the polymerase assembly mutants was maintained in IFN alpha/beta receptor knock-out mice. As exemplified using a H5N1 polymerase assembly mutant, this attenuation strategy can be also applied to other highly pathogenic influenza A virus strains. Thus, we provide proof of principle that targeted mutation of the highly conserved interaction domains of PA and PB1 represents a novel strategy to attenuate influenza A viruses.	[Maenz, Benjamin; Goetz, Veronika; Wunderlich, Kerstin; Eisel, Jessica; Chase, Geoffrey; Schwemmle, Martin] Univ Freiburg, Dept Virol, D-79104 Freiburg, Germany; [Kirchmair, Johannes] Univ Innsbruck, Dept Pharmaceut Chem, A-6020 Innsbruck, Austria; [Stech, Juergen; Stech, Olga] Friedrich Loeffler Inst, D-17493 Greifswald, Germany; [Frank, Ronald] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany	University of Freiburg; University of Innsbruck; Friedrich Loeffler Institute; Helmholtz Association; Helmholtz-Center for Infection Research	Schwemmle, M (corresponding author), Hermann Herder Str 11, D-79104 Freiburg, Germany.	martin.schwemmle@uniklinik-freiburg.de	Kirchmair, Johannes/J-1559-2012	Kirchmair, Johannes/0000-0003-2667-5877; Stech, Juergen/0000-0002-3187-702X	Deutsche Forschungsgemeinschaft (DFG); Bundesministerium fur Bildung und Forschung (BMBF, FluResearchNet); Excellence Initiative of the German Research Foundation (Spe-mann Graduate School) [GSC-4]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF, FluResearchNet)(Federal Ministry of Education & Research (BMBF)); Excellence Initiative of the German Research Foundation (Spe-mann Graduate School)	This study was supported by grants from the Deutsche Forschungsgemeinschaft (DFG) and the Bundesministerium fur Bildung und Forschung (BMBF, FluResearchNet). This study was also supported by a grant from the Excellence Initiative of the German Research Foundation (GSC-4, Spe-mann Graduate School) (to K. W.).	Ambrose CS, 2008, INFLUENZA OTHER RESP, V2, P193, DOI 10.1111/j.1750-2659.2008.00056.x; Brownlee GG, 2002, J VIROL, V76, P7103, DOI 10.1128/JVI.76.14.7103-7113.2002; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Garcia-Sastre A, 1998, J VIROL, V72, P8550; Ghanem A, 2007, J VIROL, V81, P7801, DOI 10.1128/JVI.00724-07; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Liu HX, 2010, MOL PHARMACEUT, V7, P75, DOI 10.1021/mp900131p; MAASSAB HF, 1967, NATURE, V213, P612, DOI 10.1038/213612a0; Manz B, 2010, J VIROL, V84, P8316, DOI 10.1128/JVI.00850-10; Monto AS, 2009, NEW ENGL J MED, V361, P1260, DOI 10.1056/NEJMoa0808652; Mueller S, 2010, NAT BIOTECHNOL, V28, P723, DOI 10.1038/nbt.1636; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; MUSTER T, 1991, P NATL ACAD SCI USA, V88, P5177, DOI 10.1073/pnas.88.12.5177; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Ohtsu Y, 2002, MICROBIOL IMMUNOL, V46, P167, DOI 10.1111/j.1348-0421.2002.tb02682.x; Perales B, 1997, J VIROL, V71, P1381, DOI 10.1128/JVI.71.2.1381-1385.1997; PEREZ DR, 1995, J VIROL, V69, P6932; Perez DR, 2001, J VIROL, V75, P8127, DOI 10.1128/JVI.75.17.8127-8136.2001; Puthavathana P, 2005, J GEN VIROL, V86, P423, DOI 10.1099/vir.0.80368-0; Salomon R, 2009, CELL, V136, P402, DOI 10.1016/j.cell.2009.01.029; Stech J, 2005, NAT MED, V11, P683, DOI 10.1038/nm1256; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; Talon J, 2000, P NATL ACAD SCI USA, V97, P4309, DOI 10.1073/pnas.070525997; Tumpey TM, 2009, ANNU REV MICROBIOL, V63, P79, DOI 10.1146/annurev.micro.091208.073359; Wunderlich K, 2010, J BIOL CHEM, V285, P16704, DOI 10.1074/jbc.M110.102533; Wunderlich K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007517	28	31	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8414	8424		10.1074/jbc.M110.205534	http://dx.doi.org/10.1074/jbc.M110.205534			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21183679	Green Published, hybrid			2022-12-27	WOS:000288013300070
J	Brockmeyer, C; Paster, W; Pepper, D; Tan, CP; Trudgian, DC; McGowan, S; Fu, G; Gascoigne, NRJ; Acuto, O; Salek, M				Brockmeyer, Claudia; Paster, Wolfgang; Pepper, David; Tan, Choon P.; Trudgian, David C.; McGowan, Simon; Fu, Guo; Gascoigne, Nicholas R. J.; Acuto, Oreste; Salek, Mogjiborahman			T Cell Receptor (TCR)-induced Tyrosine Phosphorylation Dynamics Identifies THEMIS as a New TCR Signalosome Component	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINEAGE COMMITMENT; THYMOCYTE DEVELOPMENT; SIGNALING NETWORKS; HNRNP K; PROTEIN; FAMILY; ACTIVATION; SELECTION; EXPRESSION; KINASES	Stimulation of the T cell antigen receptor (TCR) induces formation of a phosphorylation-dependent signaling network via multiprotein complexes, whose compositions and dynamics are incompletely understood. Using stable isotope labeling by amino acids in cell culture (SILAC)-based quantitative proteomics, we investigated the kinetics of signal propagation after TCR-induced protein tyrosine phosphorylation. We confidently assigned 77 proteins (of 758 identified) as a direct or indirect consequence of tyrosine phosphorylation that proceeds in successive "signaling waves" revealing the temporal pace at which tyrosine kinases activate cellular functions. The first wave includes thymocyte-expressed molecule involved in selection (THEMIS), a protein recently implicated in thymocyte development but whose signaling role is unclear. We found that tyrosine phosphorylation of THEMIS depends on the presence of the scaffold proteins Linker for activation of T cells (LAT) and SH2 domain-containing lymphocyte protein of 76 kDa (SLP-76). THEMIS associates with LAT, presumably via the adapter growth factor receptor-bound protein 2 (Grb2) and with phospholipase C gamma 1 (PLC-gamma 1). RNAi-mediated THEMIS knock-down inhibited TCR-induced IL-2 gene expression due to reduced ERK and nuclear factor of activated T cells (NFAT)/activator protein 1 (AP-1) signaling, whereas JNK, p38, or nuclear factor kappa B (NF-kappa B) activation were unaffected. Our study reveals the dynamics of TCR-dependent signaling networks and suggests a specific role for THEMIS in early TCR signalosome function.	[Brockmeyer, Claudia; Paster, Wolfgang; Pepper, David; Tan, Choon P.; Acuto, Oreste; Salek, Mogjiborahman] Univ Oxford, Sir William Dunn Sch Pathol, Cell Signalling Lab T, Oxford OX1 3RE, England; [Trudgian, David C.] Univ Oxford, Sir William Dunn Sch Pathol, Prote Facil, Oxford OX1 3RE, England; [McGowan, Simon] Univ Oxford, John Radcliffe Hosp, Computat Biol Res Grp, Oxford OX3 9DS, England; [Fu, Guo; Gascoigne, Nicholas R. J.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	University of Oxford; University of Oxford; University of Oxford; Scripps Research Institute	Acuto, O (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, Cell Signalling Lab T, S Parks Rd, Oxford OX1 3RE, England.	oreste.acuto@path.ox.ac.uk; mogjib.salek@path.ox.ac.uk	Trudgian, David/D-4785-2012	Trudgian, David/0000-0002-7084-6787; McGowan, Simon/0000-0001-9720-1914; Salek, Mogjiborahman/0000-0002-6664-4752; Paster, Wolfgang/0000-0002-5537-2886	Wellcome Trust [GR076558MA]; EU-FP7 [201106]; Lincoln College, University of Oxford; Austrian Science Fund (FWF)	Wellcome Trust(Wellcome TrustEuropean Commission); EU-FP7(European Commission); Lincoln College, University of Oxford; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Wellcome Trust Grant GR076558MA and EU-FP7 "Sybilla" Grant 201106 (to O. A.).; Supported in part by a Sloane Robinson Graduate Award from Lincoln College, University of Oxford.; Supported by the Erwin Schrodinger Fellowship from the Austrian Science Fund (FWF).	Acuto O, 2008, NAT REV IMMUNOL, V8, P699, DOI 10.1038/nri2397; Adachi S, 2002, CELL IMMUNOL, V215, P45, DOI 10.1016/S0008-8749(02)00012-6; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Brill LM, 2004, ANAL CHEM, V76, P2763, DOI 10.1021/ac035352d; Brugnera E, 2002, NAT CELL BIOL, V4, P574, DOI 10.1038/ncb824; Busa R, 2010, NUCLEIC ACIDS RES, V38, P3005, DOI 10.1093/nar/gkq004; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dustin ML, 2009, IMMUNITY, V30, P482, DOI 10.1016/j.immuni.2009.03.010; Elias JE, 2005, NAT METHODS, V2, P667, DOI 10.1038/NMETH785; Elias JE, 2004, NAT BIOTECHNOL, V22, P214, DOI 10.1038/nbt930; Feng L, 2009, GENE DEV, V23, P719, DOI 10.1101/gad.1770609; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Fu G, 2009, NAT IMMUNOL, V10, P848, DOI 10.1038/ni.1766; Fukui Y, 2001, NATURE, V412, P826, DOI 10.1038/35090591; Fusaki N, 1997, J BIOL CHEM, V272, P6214, DOI 10.1074/jbc.272.10.6214; Gao J, 2003, J PROTEOME RES, V2, P643, DOI 10.1021/pr034038x; Giorgi C, 2007, SEMIN CELL DEV BIOL, V18, P186, DOI 10.1016/j.semcdb.2007.01.002; Henegouwen PMPVE, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-24; Houtman JCD, 2005, J IMMUNOL, V175, P2449, DOI 10.4049/jimmunol.175.4.2449; Hu QZ, 2005, J MASS SPECTROM, V40, P430, DOI 10.1002/jms.856; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Johnson AL, 2009, NAT IMMUNOL, V10, P831, DOI 10.1038/ni.1769; Kakugawa K, 2009, MOL CELL BIOL, V29, P5128, DOI 10.1128/MCB.00793-09; Kaye J, 2000, IMMUNOL RES, V21, P71, DOI 10.1385/IR:21:2-3:71; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kim JE, 2006, J IMMUNOL, V176, P2833, DOI 10.4049/jimmunol.176.5.2833; Komada M, 2005, J BIOCHEM, V137, P1, DOI 10.1093/jb/mvi001; Kruger M, 2008, P NATL ACAD SCI USA, V105, P2451, DOI 10.1073/pnas.0711713105; Ku GM, 2001, EMBO J, V20, P457, DOI 10.1093/emboj/20.3.457; Lesourne R, 2009, NAT IMMUNOL, V10, P840, DOI 10.1038/ni.1768; Liu HB, 2010, P NATL ACAD SCI USA, V107, P10166, DOI 10.1073/pnas.0909112107; Lucas JA, 2007, J IMMUNOL, V179, P7561, DOI 10.4049/jimmunol.179.11.7561; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Makarov A, 2000, ANAL CHEM, V72, P1156, DOI 10.1021/ac991131p; Matsumoto M, 2009, PROTEOMICS, V9, P3549, DOI 10.1002/pmic.200900011; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Naarmann IS, 2008, J BIOL CHEM, V283, P18461, DOI 10.1074/jbc.M710328200; Nguyen V, 2009, MOL CELL PROTEOMICS, V8, P2418, DOI 10.1074/mcp.M800307-MCP200; Nika K, 2010, IMMUNITY, V32, P766, DOI 10.1016/j.immuni.2010.05.011; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Ostareck-Lederer A, 2002, MOL CELL BIOL, V22, P4535, DOI 10.1128/MCB.22.13.4535-4543.2002; Paronetto MP, 2010, CANCER RES, V70, P229, DOI 10.1158/0008-5472.CAN-09-2788; Patrick MS, 2009, P NATL ACAD SCI USA, V106, P16345, DOI 10.1073/pnas.0908593106; Phee H, 2005, NAT IMMUNOL, V6, P608, DOI 10.1038/ni1199; Priatel JJ, 2002, IMMUNITY, V17, P617, DOI 10.1016/S1074-7613(02)00451-X; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Salomon AR, 2003, P NATL ACAD SCI USA, V100, P443, DOI 10.1073/pnas.2436191100; Sanui T, 2003, BLOOD, V102, P2948, DOI 10.1182/blood-2003-01-0173; Schaeffer EM, 2000, J EXP MED, V192, P987, DOI 10.1084/jem.192.7.987; Shao G, 2009, GENE DEV, V23, P740, DOI 10.1101/gad.1739609; Singer A, 2004, ADV IMMUNOL, V83, P91; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; Wilkinson B, 2001, CELL IMMUNOL, V211, P86, DOI 10.1006/cimm.2001.1827; Yablonski D, 1998, SCIENCE, V281, P413, DOI 10.1126/science.281.5375.413; Yamada M, 2002, MOL CELL BIOL, V22, P8648, DOI 10.1128/MCB.22.24.8648-8658.2002; Yokoyama N, 2005, BIOCHEMISTRY-US, V44, P8841, DOI 10.1021/bi0500832; Yoon HY, 2008, TRAFFIC, V9, P2236, DOI 10.1111/j.1600-0854.2008.00839.x	66	63	64	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7535	7547		10.1074/jbc.M110.201236	http://dx.doi.org/10.1074/jbc.M110.201236			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21189249	Green Published, hybrid			2022-12-27	WOS:000287737300067
J	Guadall, A; Orriols, M; Rodriguez-Calvo, R; Calvayrac, O; Crespo, J; Aledo, R; Martinez-Gonzalez, J; Rodriguez, C				Guadall, Anna; Orriols, Mar; Rodriguez-Calvo, Ricardo; Calvayrac, Olivier; Crespo, Javier; Aledo, Rosa; Martinez-Gonzalez, Jose; Rodriguez, Cristina			Fibulin-5 Is Up-regulated by Hypoxia in Endothelial Cells through a Hypoxia-inducible Factor-1 (HIF-1 alpha)-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; ELASTIC FIBER FORMATION; LYSYL OXIDASE LOX; ALPHA-5 INTEGRIN; BINDING-PROTEIN; DOWN-REGULATION; FACTOR 1-ALPHA; TUMOR-GROWTH; CUTIS LAXA; TGF-BETA	Hypoxia modulates gene expression and affects multiple aspects of endothelial cell biology. Fibulin-5 (FBLN5) is an extracellular matrix protein essential for elastic fiber assembly and vasculogenesis that participates in vascular remodeling and controls endothelial cell adhesion, motility, and proliferation. In this context, we aimed to analyze FBLN5 regulation by hypoxia in endothelial cells. Hypoxia (1% O-2) increased FBLN5 mRNA levels in endothelial cells in a time-dependent manner. Maximal induction (similar to 2.5-fold) was achieved after 24 h of hypoxia. This effect paralleled an increase in both intracellular and extracellular FBLN5 protein levels. The increase in FBLN5 mRNA levels observed in hypoxic cells was blocked by inhibitors of the PI3K/Akt/mTOR pathway (LY294002 and rapamycin) and mimicked by dimethyl oxal glycine, which prevents proline hydroxylase-mediated degradation of HIF-1 alpha. Silencing of HIF-1 alpha completely prevented hypoxia-induced FBLN5 up-regulation. Accordingly, both hypoxia and HIF-1 alpha overexpression increased FBLN5 transcriptional activity. Serial promoter deletion and mutagenesis studies revealed the involvement of a putative hypoxia response element (HRE) located at -78 bp. In fact, EMSA and ChIP assays demonstrated increased HIF-1 binding to this site in hypoxic cells. Interestingly, the rate of endothelial cells undergoing apoptosis in cultures exposed to hypoxia increased in FBLN5 knockdown cells, suggesting that hypoxia-induced FBLN5 expression contributes to preserve cell survival. These results provide evidence that HIF-1 signaling underlies the increase of FBLN5 expression elicited by hypoxia in endothelial cells and suggest that FBLN5 induction could be involved in the adaptive survival response of endothelial cells to hypoxia.	[Guadall, Anna; Orriols, Mar; Rodriguez-Calvo, Ricardo; Calvayrac, Olivier; Crespo, Javier; Aledo, Rosa; Martinez-Gonzalez, Jose; Rodriguez, Cristina] Hosp Santa Creu & Sant Pau, Ctr Invest Cardiovasc, CSIC, Inst Catala Ciencies Cardiovasc,Inst Invest Biome, Barcelona 08025, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); Hospital of Santa Creu i Sant Pau	Rodriguez, C (corresponding author), Hosp Santa Creu & St Pau Pabellon 11, Ctr Invest Cardiovasc, CSIC, Inst Catala Ciencies Cardiovasc, St Antoni Maria Claret 167, Barcelona 08025, Spain.	crodriguezs@csic-iccc.org	Guadall, Anna/I-1709-2014; Guadall, Anna/AAG-1691-2019; Rodriguez-Calvo, Ricardo/R-6645-2018; Rodriguez-Calvo, Ricardo/AAB-4054-2019; Rodriguez, Cristina/D-3099-2011; Calvayrac, Olivier/A-7145-2016	Guadall, Anna/0000-0002-7821-8582; Guadall, Anna/0000-0002-7821-8582; Rodriguez-Calvo, Ricardo/0000-0001-7513-0983; Rodriguez-Calvo, Ricardo/0000-0001-7513-0983; Rodriguez, Cristina/0000-0002-6472-5647; Calvayrac, Olivier/0000-0002-0908-8323; Martinez-Gonzalez, Jose/0000-0002-3894-7166	Ministerio de Ciencia e Innovacion-Instituto de Salud Carlos III [PS09/01797, SAF2009-11949, RD06/0014/0027]; Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias	Ministerio de Ciencia e Innovacion-Instituto de Salud Carlos III(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III)	This work was supported in part by Grants PS09/01797 and SAF2009-11949 and Red Tematica de Investigacion Cardiovascular (RD06/0014/0027) from the Ministerio de Ciencia e Innovacion-Instituto de Salud Carlos III (Fondo de Investigaciones Sanitarias).; Supported by a fellowship from Instituto de Salud Carlos III-Fondo de Investigaciones Sanitarias.; Supported by the Ministerio de Ciencia e Innovacion (Juan de la Cierva program).	Abedin SA, 2009, CARCINOGENESIS, V30, P449, DOI 10.1093/carcin/bgp005; Albig Allan R, 2005, Future Oncol, V1, P23, DOI 10.1517/14796694.1.1.23; Albig AR, 2006, CANCER RES, V66, P2621, DOI 10.1158/0008-5472.CAN-04-4096; Albig AR, 2004, DNA CELL BIOL, V23, P367, DOI 10.1089/104454904323145254; Alvarez-Tejado M, 2001, J BIOL CHEM, V276, P22368, DOI 10.1074/jbc.M011688200; Avraamides CJ, 2008, NAT REV CANCER, V8, P604, DOI 10.1038/nrc2353; Chapman SL, 2010, ARTERIOSCL THROM VAS, V30, P68, DOI 10.1161/ATVBAHA.109.196725; Choi J, 2009, MATRIX BIOL, V28, P211, DOI 10.1016/j.matbio.2009.03.004; del Peso L, 2003, J BIOL CHEM, V278, P48690, DOI 10.1074/jbc.M308862200; Economopoulou M, 2009, NAT MED, V15, P553, DOI 10.1038/nm.1947; Gonzalez-Diez M, 2008, THROMB HAEMOSTASIS, V100, P119, DOI 10.1160/TH07-11-0675; Hirai M, 2007, J CELL BIOL, V176, P1061, DOI 10.1083/jcb.200611026; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Hu QR, 2006, HUM MOL GENET, V15, P3379, DOI 10.1093/hmg/ddl414; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jean JC, 2002, AM J PHYSIOL-LUNG C, V282, pL75, DOI 10.1152/ajplung.2002.282.1.L75; Kowal RC, 1999, CIRC RES, V84, P1166, DOI 10.1161/01.RES.84.10.1166; Kuang PP, 2006, AM J PHYSIOL-CELL PH, V291, pC1412, DOI 10.1152/ajpcell.00087.2006; Kuang PP, 2003, AM J PHYSIOL-LUNG C, V285, pL1147, DOI 10.1152/ajplung.00098.2003; Lee MJ, 2004, J AM COLL SURGEONS, V199, P403, DOI 10.1016/j.jamcollsurg.2004.04.021; Lee YH, 2008, CARCINOGENESIS, V29, P2243, DOI 10.1093/carcin/bgn199; Loeys B, 2002, HUM MOL GENET, V11, P2113, DOI 10.1093/hmg/11.18.2113; Lomas AC, 2007, BIOCHEM J, V405, P417, DOI 10.1042/BJ20070400; Luo YX, 2006, MOL PHARMACOL, V69, P1953, DOI 10.1124/mol.105.017905; Madge LA, 2000, J BIOL CHEM, V275, P15458, DOI 10.1074/jbc.M001237200; Martinez-Gonzalez J, 2004, ATHEROSCLEROSIS, V174, P305, DOI 10.1016/j.atherosclerosis.2004.01.037; Martinez-Gonzalez J, 2008, J NUTR, V138, P443, DOI 10.1093/jn/138.3.443; Martorell L, 2007, J THROMB HAEMOST, V5, P1766, DOI 10.1111/j.1538-7836.2007.02627.x; Martorell L, 2009, MOL CELL BIOL, V29, P5828, DOI 10.1128/MCB.00945-09; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Nakamura T, 1999, J BIOL CHEM, V274, P22476, DOI 10.1074/jbc.274.32.22476; Nguyen AD, 2004, CIRC RES, V95, P1067, DOI 10.1161/01.RES.0000149568.85071.FB; Nonaka R, 2009, CLIN BIOCHEM, V42, P713, DOI 10.1016/j.clinbiochem.2008.12.020; Orbe J, 2009, ARTERIOSCL THROM VAS, V29, P2109, DOI 10.1161/ATVBAHA.109.194589; Preis M, 2006, BIOCHEM BIOPH RES CO, V348, P1024, DOI 10.1016/j.bbrc.2006.07.156; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Raposo B, 2004, ATHEROSCLEROSIS, V177, P1, DOI 10.1016/j.atherosclerosis.2004.06.015; Rius J, 2006, ATHEROSCLEROSIS, V184, P276, DOI 10.1016/j.atherosclerosis.2005.04.008; Rodriguez C, 2008, ATHEROSCLEROSIS, V196, P558, DOI 10.1016/j.atherosclerosis.2007.06.002; Rodriguez C, 2003, CARDIOVASC RES, V58, P178, DOI 10.1016/S0008-6363(02)00856-8; Rodriguez C, 2009, CARDIOVASC RES, V83, P595, DOI 10.1093/cvr/cvp136; Rohwer N, 2008, CANCER RES, V68, P10113, DOI 10.1158/0008-5472.CAN-08-1839; Ryu MH, 2010, BIOCHEM BIOPH RES CO, V393, P11, DOI 10.1016/j.bbrc.2010.01.060; Safran M, 2003, J CLIN INVEST, V111, P779, DOI 10.1172/JCI200318181; Schiemann WP, 2002, J BIOL CHEM, V277, P27367, DOI 10.1074/jbc.M200148200; Schluterman MK, 2010, DIS MODEL MECH, V3, P333, DOI 10.1242/dmm.003707; Semenza GL, 2000, J CLIN INVEST, V106, P809, DOI 10.1172/JCI11223; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Soderberg MW, 2009, MOL HUM REPROD, V15, P251, DOI 10.1093/molehr/gap011; Spencer JA, 2005, P NATL ACAD SCI USA, V102, P2946, DOI 10.1073/pnas.0500058102; Stone EM, 2004, NEW ENGL J MED, V351, P346, DOI 10.1056/NEJMoa040833; Sullivan KM, 2007, LAB INVEST, V87, P818, DOI 10.1038/labinvest.3700594; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Walton HL, 2000, J CELL BIOCHEM, V78, P674, DOI 10.1002/1097-4644(20000915)78:4<674::AID-JCB16>3.0.CO;2-G; Williamson MR, 2007, BIOMATERIALS, V28, P5307, DOI 10.1016/j.biomaterials.2007.08.019; Wolf D, 2008, J VIROL, V82, P4675, DOI 10.1128/JVI.02445-07; Xie L, 2008, EXP BIOL MED, V233, P155, DOI 10.3181/0706-RM-167; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Yue W, 2009, CANCER RES, V69, P6339, DOI 10.1158/0008-5472.CAN-09-0398; Zhang H, 2003, BLOOD, V101, P2253, DOI 10.1182/blood-2002-02-0629; Zhou SM, 2010, BIOCHEM BIOPH RES CO, V398, P247, DOI 10.1016/j.bbrc.2010.06.068	62	52	56	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7093	7103		10.1074/jbc.M110.162917	http://dx.doi.org/10.1074/jbc.M110.162917			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193390	hybrid, Green Published			2022-12-27	WOS:000287737300026
J	Yang, MT; Chang, CH; Wang, JM; Wu, TK; Wang, YK; Chang, CY; Li, TT				Yang, Ming-Te; Chang, Cheng-Hsiang; Wang, Jiou Ming; Wu, Tung Kung; Wang, Yu-Kuo; Chang, Chin-Yuan; Li, TienHsiung Thomas			Crystal Structure and Inhibition Studies of Transglutaminase from Streptomyces mobaraense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN CROSS-LINKING; MICROBIAL TRANSGLUTAMINASE; STREPTOVERTICILLIUM-MOBARAENSE; SUBSTRATE SPECIFICITIES; GUINEA-PIG; PURIFICATION; PEPTIDES; ENZYMES	The crystal structure of the microbial transglutaminase (MTGase) zymogen from Streptomyces mobaraense has been determined at 1.9-angstrom resolution using the molecular replacement method based on the crystal structure of the mature MTGase. The overall structure of this zymogen is similar to that of the mature form, consisting of a single disk-like domain with a deep active cleft at the edge of the molecule. A major portion of the prosequence (45 additional amino acid residues at the N terminus of the mature transglutaminase) folds into an L-shaped structure, consisting of an extended N-terminal segment linked with a one-turn short helix and a long alpha-helix. Two key residues in the short helix of the prosequence, Tyr-12 and Tyr-16, are located on top of the catalytic triad (Cys-110, Asp-301, and His-320) to block access of the substrate acyl donors and acceptors. Biochemical characterization of the mature MTGase, using N-alpha-benzyloxycarbonyl-L-glutaminylglycine as a substrate, revealed apparent K-m and k(cat)/K-m values of 52.66 mM and 40.42 mM(-1) min(-1), respectively. Inhibition studies using the partial prosequence SYAETYR and homologous sequence SQAETYR showed a noncompetitive inhibition mechanism with IC50 values of 0.75 and 0.65 mM, respectively, but no cross-linking product formation. Nevertheless, the prosequence homologous oligopeptide SQAETQR, with Tyr-12 and Tyr-16 each replaced with Gln, exhibited inhibitory activity with the formation of the SQAETQR-monodansylcadaverine fluorophore cross-linking product (SQAETQR-C-DNS). MALDI-TOF tandem MS analysis of SQAETQR-C-DNS revealed molecular masses corresponding to those of (N)SQAETQ(C)-C-DNS and C-DNS-(N)QR(C) sequences, suggesting the incorporation of C-DNS onto the C-terminal Gln residue of the prosequence homologous oligopeptide. These results support the putative functional roles of both Tyr residues in substrate binding and inhibition.	[Wang, Jiou Ming; Li, TienHsiung Thomas] Natl Chung Hsing Univ, Grad Inst Biochem, Taichung 40227, Taiwan; [Yang, Ming-Te] Natl Chung Hsing Univ, Grad Inst Mol Biol, Taichung 40227, Taiwan; [Chang, Cheng-Hsiang; Wu, Tung Kung; Wang, Yu-Kuo; Chang, Chin-Yuan] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 30010, Taiwan	National Chung Hsing University; National Chung Hsing University; National Yang Ming Chiao Tung University	Li, TT (corresponding author), Natl Chung Hsing Univ, Grad Inst Biochem, Taichung 40227, Taiwan.	lithomas@dragon.nchu.edu.tw	Chang, Chin-Yuan/AAM-5863-2021; Yang, Ming-Te/B-5626-2017	Chang, Chin-Yuan/0000-0001-7314-3967; Yang, Ming-Te/0000-0002-7644-0964	Institute of Biochemistry, National Chung Hsing University; Ministry of Education; National Chiao Tung University; National Science Council of the Republic of China [NSC 99-2113-M-009-004-MY2]	Institute of Biochemistry, National Chung Hsing University; Ministry of Education; National Chiao Tung University; National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported in part by intramural funding from the Institute of Biochemistry, National Chung Hsing University, and by the Ministry of Education Aiming for Top University Plan, the National Chiao Tung University, and National Science Council of the Republic of China Contract NSC 99-2113-M-009-004-MY2.	AESCHLIMANN D, 1994, THROMB HAEMOSTASIS, V71, P402; Ahvazi B, 2002, EMBO J, V21, P2055, DOI 10.1093/emboj/21.9.2055; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; CHUNG SI, 1972, P NATL ACAD SCI USA, V69, P303, DOI 10.1073/pnas.69.2.303; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; FOLK JE, 1966, J BIOL CHEM, V241, P5518; Hemung BO, 2008, J AGR FOOD CHEM, V56, P7510, DOI 10.1021/jf800856g; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kashiwagi T, 2002, J BIOL CHEM, V277, P44252, DOI 10.1074/jbc.M203933200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LORAND L, 1987, BIOCHEMISTRY-US, V26, P308, DOI 10.1021/bi00375a043; Melino G, 1998, Results Probl Cell Differ, V24, P175; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohtsuka T, 2001, J FOOD SCI, V66, P25, DOI 10.1111/j.1365-2621.2001.tb15576.x; Ohtsuka T, 2000, BIOSCI BIOTECH BIOCH, V64, P2608, DOI 10.1271/bbb.64.2608; Pasternack R, 1998, EUR J BIOCHEM, V257, P570, DOI 10.1046/j.1432-1327.1998.2570570.x; Pasternack R, 1997, ANAL BIOCHEM, V249, P54, DOI 10.1006/abio.1997.2139; Serafini-Fracassini D, 2008, ANN BOT-LONDON, V102, P145, DOI 10.1093/aob/mcn075; Shimba N, 2002, J AGR FOOD CHEM, V50, P1330, DOI 10.1021/jf010995k; Yokoyama K, 2004, APPL MICROBIOL BIOT, V64, P447, DOI 10.1007/s00253-003-1539-5; Zhu Y, 2008, TRENDS BIOTECHNOL, V26, P559, DOI 10.1016/j.tibtech.2008.06.006	21	37	43	3	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7301	7307		10.1074/jbc.M110.203315	http://dx.doi.org/10.1074/jbc.M110.203315			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193394	hybrid, Green Published			2022-12-27	WOS:000287737300046
J	Jeong, YS; Park, JS; Ko, Y; Kang, YK				Jeong, Young Sun; Park, Jung Sun; Ko, Yong; Kang, Yong-Kook			JHDM3A Module as an Effector Molecule in Guide-directed Modification of Target Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENT STEM-CELLS; HISTONE H3 LYSINE-9; SILENCED GENES; JMJD2 FAMILY; GENOME; METHYLATION; CANCER; 5-AZA-2'-DEOXYCYTIDINE; DEMETHYLATION; TRICHOSTATIN	With the objective of returning cells to their undifferentiated state through alteration of epigenetic states, small molecules have been used that specifically inhibit proteins involved in sustaining the epigenetic system. However, this chemical-based approach can cause chaotic epigenomic states due to random actions of the inhibitors. We investigated whether JHDM3A/JMJD2A, a trimethylated histone H3-lysine 9 (H3K9me3)-specific demethylase, could function as an effector molecule to selectively demethylate target chromatin, with the aid of a guide protein to serve as a delivery vehicle. JHDM3A, which normally locates in euchromatin, spread out to heterochromatin when it was fused to heterochromatin protein-1 alpha (HP1 alpha) or HP1 beta; in these cells, demethylation efficiency was also markedly increased. Two truncated modules, JHDM3A(GFP)(406) and JHDM3A(GFP)(701), had contrasting modes and efficiencies of H3K9me3 demethylation; JHDM3A(GFP)(406) showed a very uniform rate (similar to 80%) of demethylation, whereas JHDM3A(GFP)(701) had a broad methylation range of 4-80%. The methylation values were highly dependent on the presence of the guide proteins OCT4, CTCF, and HP1. Chromatin immunoprecipitation detected reduced H3K9me3 levels at OCT4 regulatory loci in the cells expressing OCT4-tagged JHDM3A(GFP)(701). Derepression of the Sox2 gene was observed in JHDM3A(GFP)(701)OCT4-expressing cells, but not in cells that expressed the JHDM3A(GFP)(701) module alone. JHDM3A(GFP)(701)-assisted OCT4 more efficiently turned on stem cell-related microRNAs than GFP-OCT4 itself. These results suggest that JHDM3A(GFP)(701) is a suitable catalytic module that can be targeted, under the control of a guide protein, to specific loci where the chromatin H3K9me3 status and the milieu of gene expression are to be modified.	[Jeong, Young Sun; Park, Jung Sun; Kang, Yong-Kook] KRIBB, Dev & Differentiat Res Ctr, Taejon 305806, South Korea; [Jeong, Young Sun; Ko, Yong] Korea Univ, Div Biotechnol, Coll Life Sci & Biotechnol, Seoul 136713, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea University	Kang, YK (corresponding author), 111 Gwahangno, Taejon 305806, South Korea.	ykkang@kribb.re.kr		Ko, Yong/0000-0001-5397-9695	Biogreen21 program; NRF [2010-0020563]; National Research foundation of Korea initiative	Biogreen21 program(Rural Development Administration (RDA), Republic of Korea); NRF; National Research foundation of Korea initiative(National Research Foundation of Korea)	This work was supported by the Biogreen21 program, the NRF program (2010-0020563), and the National Research foundation of Korea initiative program.	Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Chae JI, 2009, PROTEOMICS, V9, P1128, DOI 10.1002/pmic.200800234; Chavez L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-314; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Enright BP, 2003, BIOL REPROD, V69, P896, DOI 10.1095/biolreprod.103.017954; Grant S, 2009, CLIN CANCER RES, V15, P7111, DOI 10.1158/1078-0432.CCR-09-2399; Heller G, 2008, CANCER RES, V68, P44, DOI 10.1158/0008-5472.CAN-07-2531; Huang Y, 2009, CLIN CANCER RES, V15, P7217, DOI 10.1158/1078-0432.CCR-09-1293; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kang YK, 1999, J BIOL CHEM, V274, P36585, DOI 10.1074/jbc.274.51.36585; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Liu HL, 2004, DEVELOPMENT, V131, P2269, DOI 10.1242/dev.01116; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma DK, 2008, STEM CELLS, V26, P2131, DOI 10.1634/stemcells.2008-0388; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Surani MA, 2001, NATURE, V414, P122, DOI 10.1038/35102186; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Woo SM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-97; Wu LP, 2008, MOL CELL BIOL, V28, P3219, DOI 10.1128/MCB.01516-07; Yang ZQ, 2000, CANCER RES, V60, P4735; Yeo S, 2005, MOL CELLS, V20, P423	31	1	1	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4461	4470		10.1074/jbc.M110.176040	http://dx.doi.org/10.1074/jbc.M110.176040			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21148561	Green Published, hybrid			2022-12-27	WOS:000286975700046
J	Lee, S; Augustin, S; Tatsuta, T; Gerdes, F; Langer, T; Tsai, FTF				Lee, Sukyeong; Augustin, Steffen; Tatsuta, Takashi; Gerdes, Florian; Langer, Thomas; Tsai, Francis T. F.			Electron Cryomicroscopy Structure of a Membrane-anchored Mitochondrial AAA Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPASTIC PARAPLEGIA; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; FTSH; TRANSLOCATION; ATPASE; DEGRADATION; PORE; METALLOPROTEASE; INTERMEDIATE	FtsH-related AAA proteases are conserved membrane-anchored, ATP-dependent molecular machines, which mediate the processing and turnover of soluble and membrane-embedded proteins in eubacteria, mitochondria, and chloroplasts. Homo-and hetero-oligomeric proteolytic complexes exist, which are composed of homologous subunits harboring an ATPase domain of the AAA family and an H41 metallopeptidase domain. Mutations in subunits of mitochondrial m-AAA proteases have been associated with different neurodegenerative disorders in human, raising questions on the functional differences between homo-and hetero-oligomeric AAA proteases. Here, we have analyzed the hetero-oligomeric yeast m-AAA protease composed of homologous Yta10 and Yta12 subunits. We combined genetic and structural approaches to define the molecular determinants for oligomer assembly and to assess functional similarities between Yta10 and Yta12. We demonstrate that replacement of only two amino acid residues within the metallopeptidase domain of Yta12 allows its assembly into homo-oligomeric complexes. To provide a molecular explanation, we determined the 12A resolution structure of the intact yeast m-AAA protease with its transmembrane domains by electron cryomicroscopy (cryo-EM) and atomic structure fitting. The full-length m-AAA protease has a bipartite structure and is a hexamer in solution. We found that residues in Yta12, which facilitate homo-oligomerization when mutated, are located at the interface between neighboring protomers in the hexamer ring. Notably, the transmembrane and intermembrane space domains are separated from the main body, creating a passage on the matrix side, which is wide enough to accommodate unfolded but not folded polypeptides. These results suggest a mechanism regarding how proteins are recognized and degraded by m-AAA proteases.	[Lee, Sukyeong; Tsai, Francis T. F.] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Lee, Sukyeong; Tsai, Francis T. F.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Augustin, Steffen; Tatsuta, Takashi; Gerdes, Florian; Langer, Thomas] Univ Cologne, Inst Genet, Ctr Mol Med Cologne, D-50674 Cologne, Germany; [Langer, Thomas] Max Planck Inst Biol Aging, D-50931 Cologne, Germany	Baylor College of Medicine; Baylor College of Medicine; University of Cologne; Max Planck Society	Lee, S (corresponding author), Baylor Coll Med, Dept Biochem, 1 Baylor Plaza,MS BCM125, Houston, TX 77030 USA.	slee@bcm.edu; ftsai@bcm.edu		Langer, Thomas/0000-0003-1250-1462	National Institutes of Health [R01-AI076239]; Welch Foundation [Q-1530]; Department of Defense; American Cancer Society; American Heart Association Texas Affiliate; Deutsche Forschungsgemeinschaft; European Research Council; German-Israeli-Project DIP [F.5.1]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Department of Defense(United States Department of Defense); American Cancer Society(American Cancer Society); American Heart Association Texas Affiliate(American Heart Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); German-Israeli-Project DIP; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health Grant R01-AI076239, by Welch Foundation Grant Q-1530, Department of Defense, and American Cancer Society (to F. T. F. T.), by a grant from the American Heart Association Texas Affiliate (to S. L.), and by Deutsche Forschungsgemeinschaft and European Research Council grants and German-Israeli-Project DIP Grant F.5.1. (to T. L.).	Akiyama Y, 2000, EMBO J, V19, P3888, DOI 10.1093/emboj/19.15.3888; Arlt H, 1996, CELL, V85, P875, DOI 10.1016/S0092-8674(00)81271-4; Augustin S, 2009, MOL CELL, V35, P574, DOI 10.1016/j.molcel.2009.07.018; Bieniossek C, 2006, P NATL ACAD SCI USA, V103, P3066, DOI 10.1073/pnas.0600031103; Bieniossek C, 2009, P NATL ACAD SCI USA, V106, P21579, DOI 10.1073/pnas.0910708106; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Di Bella D, 2010, NAT GENET, V42, P313, DOI 10.1038/ng.544; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Graef M, 2007, MOL CELL BIOL, V27, P2476, DOI 10.1128/MCB.01721-06; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Jiang W, 2001, J MOL BIOL, V308, P1033, DOI 10.1006/jmbi.2001.4633; Koppen M, 2007, CRIT REV BIOCHEM MOL, V42, P221, DOI 10.1080/10409230701380452; Koppen M, 2007, MOL CELL BIOL, V27, P758, DOI 10.1128/MCB.01470-06; Korbel D, 2004, EMBO REP, V5, P698, DOI 10.1038/sj.embor.7400186; Lee S, 2007, MOL CELL, V25, P261, DOI 10.1016/j.molcel.2007.01.002; Leonhard K, 2000, MOL CELL, V5, P629, DOI 10.1016/S1097-2765(00)80242-7; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Park EY, 2005, J BIOL CHEM, V280, P22892, DOI 10.1074/jbc.M500035200; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Suno R, 2006, MOL CELL, V22, P575, DOI 10.1016/j.molcel.2006.04.020; Tatsuta T, 2007, EMBO J, V26, P325, DOI 10.1038/sj.emboj.7601514; Tatsuta T, 2009, RES MICROBIOL, V160, P711, DOI 10.1016/j.resmic.2009.09.005; Wang J, 2001, STRUCTURE, V9, P177, DOI 10.1016/S0969-2126(01)00570-6; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027	28	48	48	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4404	4411		10.1074/jbc.M110.158741	http://dx.doi.org/10.1074/jbc.M110.158741			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21147776	Green Published, hybrid			2022-12-27	WOS:000286975700040
J	Stocki, P; Wang, XN; Morris, NJ; Dickinson, AM				Stocki, Pawel; Wang, Xiao N.; Morris, Nicholas J.; Dickinson, Anne M.			HSP70 Natively and Specifically Associates with an N-terminal Dermcidin-derived Peptide That Contains an HLA-A*03 Antigenic Epitope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; SURVIVAL; CELLS; IDENTIFICATION; EXPRESSION; STRESS; APOPTOSIS; CONFERS	Tumor cells very often have elevated expression of HSP70, the anti-apoptotic properties of which contribute to overall tumor survival. Independent of its anti-apoptotic properties, HSP70 was also suggested to be involved in the antigen presentation process by chaperoning cytosolic peptides, thus protecting them from rapid degradation and securing the peptide pool for further processing. In this study, we identified a 33-amino acid N-terminal dermcidin (DCD)-derived peptide from the repertoire of in vivo HSP70-associated peptides isolated from a leukemic cell line, K562. The DCD peptide has been previously shown to be involved in tumorigenesis, to increase tumor survival rate, to improve tumor stress resistance, and to aid growth. We show that HSP70 is a specific binding partner for the DCD prosurvival peptide and define an ATP-dependent DCD-binding site (GNPCH). We also identify an HLA-A*03 antigenic epitope within the DCD peptide, which follows and partially overlaps the HSP70-binding site (CHEASAAQK). This study describes the interaction between HSP70 and the DCD-derived prosurvival peptide, an interaction that may direct the peptide toward antigen presentation and independently contribute to the prosurvival mechanism mediated by DCD.	[Dickinson, Anne M.] Newcastle Univ, Inst Cellular Med, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Morris, Nicholas J.] Newcastle Univ, Sch Biomed Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Dickinson, AM (corresponding author), Newcastle Univ, Inst Cellular Med, Sch Med, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	a.m.dickinson@ncl.ac.uk		Morris, Nicholas/0000-0002-8389-7508	Leukemia Research Fund [04070]; Tyneside Leukaemia Research Fund; European Commission [MRTN-CT-2004-512253]	Leukemia Research Fund; Tyneside Leukaemia Research Fund; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by Grant 04070 from the Leukemia Research Fund, a grant from the Tyneside Leukaemia Research Fund, and Trans-Net Grant MRTN-CT-2004-512253 from the European Commission.	Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; Cunningham TJ, 1998, J NEUROSCI, V18, P7047; Cunningham TJ, 2002, EXP NEUROL, V177, P32, DOI 10.1006/exnr.2002.7979; Elsner L, 2007, J IMMUNOL, V179, P5523, DOI 10.4049/jimmunol.179.8.5523; Gabai VL, 1997, J BIOL CHEM, V272, P18033, DOI 10.1074/jbc.272.29.18033; JAATTELA M, 1995, INT J CANCER, V60, P689, DOI 10.1002/ijc.2910600520; Jaattela M, 1998, EMBO J, V17, P6124, DOI 10.1093/emboj/17.21.6124; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Li ZH, 2005, CLIN CANCER RES, V11, P4460, DOI 10.1158/1078-0432.CCR-05-0250; Lowrie AG, 2006, BRIT J CANCER, V94, P1663, DOI 10.1038/sj.bjc.6603148; Multhoff G, 2001, CELL STRESS CHAPERON, V6, P337, DOI 10.1379/1466-1268(2001)006<0337:AMHPSN>2.0.CO;2; Multhoff G, 1999, EXP HEMATOL, V27, P1627, DOI 10.1016/S0301-472X(99)00104-6; Peng P, 1997, J IMMUNOL METHODS, V204, P13, DOI 10.1016/S0022-1759(97)00017-3; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Porter D, 2003, P NATL ACAD SCI USA, V100, P10931, DOI 10.1073/pnas.1932980100; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sato K, 2001, BLOOD, V98, P1852, DOI 10.1182/blood.V98.6.1852; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Stankiewicz AR, 2005, J BIOL CHEM, V280, P38729, DOI 10.1074/jbc.M509497200; Stewart GD, 2007, PROSTATE, V67, P1308, DOI 10.1002/pros.20618; Stocki P, 2010, CELL STRESS CHAPERON, V15, P729, DOI 10.1007/s12192-010-0184-z; Todorov P, 1996, NATURE, V379, P739, DOI 10.1038/379739a0; Todorov PT, 1996, CANCER RES, V56, P1256; Todorov PT, 1997, J BIOL CHEM, V272, P12279, DOI 10.1074/jbc.272.19.12279; UDONO H, 1993, J EXP MED, V178, P1391, DOI 10.1084/jem.178.4.1391; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546	30	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.179630	http://dx.doi.org/10.1074/jbc.M110.179630			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21216960	Green Published, hybrid			2022-12-27	WOS:000289077500091
J	Fumagalli, M; Daniele, S; Lecca, D; Lee, PR; Parravicini, C; Fields, RD; Rosa, P; Antonucci, F; Verderio, C; Trincavelli, ML; Bramanti, P; Martini, C; Abbracchio, MP				Fumagalli, Marta; Daniele, Simona; Lecca, Davide; Lee, Philip R.; Parravicini, Chiara; Fields, R. Douglas; Rosa, Patrizia; Antonucci, Flavia; Verderio, Claudia; Trincavelli, M. Letizia; Bramanti, Placido; Martini, Claudia; Abbracchio, Maria P.			Phenotypic Changes, Signaling Pathway, and Functional Correlates of GPR17-expressing Neural Precursor Cells during Oligodendrocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P2Y-LIKE RECEPTOR GPR17; ADENOSINE; MYELINATION; EXPRESSION; RAT; DESENSITIZATION; DERIVATIVES; ANTAGONISTS; ASTROCYTES; CULTURES	The developing and mature central nervous system contains neural precursor cells expressing the proteoglycan NG2. Some of these cells continuously differentiate to myelin-forming oligodendrocytes; knowledge of the destiny of NG2(+) precursors would benefit from the characterization of new key functional players. In this respect, the G protein-coupled membrane receptor GPR17 has recently emerged as a new timer of oligodendrogliogenesis. Here, we used purified oligodendrocyte precursor cells (OPCs) to fully define the immunophenotype of the GPR17-expressing cells during OPC differentiation, unveil its native signaling pathway, and assess the functional consequences of GPR17 activation by its putative endogenous ligands, uracil nucleotides and cysteinyl leukotrienes (cysLTs). GPR17 presence was restricted to very early differentiation stages and completely segregated from that of mature myelin. Specifically, GPR17 decorated two subsets of slowly proliferating NG2(+) OPCs: (i) morphologically immature cells expressing other early proteins like Olig2 and PDGF receptor-alpha, and (ii) ramified preoligodendrocytes already expressing more mature factors, like O4 and O1. Thus, GPR17 is a new marker of these transition stages. In OPCs, GPR17 activation by either uracil nucleotides or cysLTs resulted in potent inhibition of intracellular cAMP formation. This effect was counteracted by GPR17 antagonists and receptor silencing with siRNAs. Finally, uracil nucleotides promoted and GPR17 inhibition, by either antagonists or siRNAs, impaired the normal program of OPC differentiation. These data have implications for the in vivo behavior of NG2(+) OPCs and point to uracil nucleotides and cysLTs as main extrinsic local regulators of these cells under physiological conditions and during myelin repair.	[Fumagalli, Marta; Lecca, Davide; Parravicini, Chiara; Abbracchio, Maria P.] Univ Milan, Dept Pharmacol Sci, Lab Mol & Cellular Pharmacol Purinerg Transmiss, I-20133 Milan, Italy; [Daniele, Simona; Trincavelli, M. Letizia; Martini, Claudia] Univ Pisa, Dept Psychiat Neurobiol Pharmacol & Biotechnol, I-56126 Pisa, Italy; [Lee, Philip R.; Fields, R. Douglas] NIH, Nervous Syst Dev & Plast Sect, Bethesda, MD 20817 USA; [Rosa, Patrizia; Antonucci, Flavia; Verderio, Claudia] CNR, Dept Med Pharmacol, Inst Neurosci, I-20129 Milan, Italy; [Bramanti, Placido] Ctr Neurolesi Bonino Pulejo, I-98121 Messina, Italy	University of Milan; University of Pisa; National Institutes of Health (NIH) - USA; Consiglio Nazionale delle Ricerche (CNR); IRCCS Bonino Pulejo	Abbracchio, MP (corresponding author), Univ Milan, Dept Pharmacol Sci, Lab Mol & Cellular Pharmacol Purinerg Transmiss, Via Balzaretti 9, I-20133 Milan, Italy.	mariapia.abbracchio@unimi.it	Abbracchio, Maria Pia/B-9342-2014; Lecca, Davide/A-8850-2010; Messier, Claude/A-2322-2008; Bramanti, Placido/K-5117-2016; Daniele, Simona/AAB-8888-2019; Martini, Claudia/AAC-4089-2019; Verderio, Claudia/K-4415-2016; Fumagalli, Marta/AEP-4117-2022; Trincavelli, Maria Letizia/M-1921-2015	Abbracchio, Maria Pia/0000-0002-7833-3388; Lecca, Davide/0000-0002-3258-363X; Messier, Claude/0000-0002-4791-1763; Daniele, Simona/0000-0001-7391-3087; Martini, Claudia/0000-0001-9379-3027; Verderio, Claudia/0000-0001-7216-5873; Antonucci, Flavia/0000-0002-0198-4529; Rosa, Patrizia/0000-0002-2590-6955; Trincavelli, Maria Letizia/0000-0001-8124-977X; Fumagalli, Marta/0000-0002-0158-842X	NICHD, National Institutes of Health; Italian Ministero della Salute [RF-CNM-2007-662855]; PRIN-COFIN Project [2006059022, 2008XFMEA3]; FISM, Fondazione Italiana Sclerosi Multipla [COD. 2010/R/2]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000713] Funding Source: NIH RePORTER	NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Italian Ministero della Salute(Ministry of Health, Italy); PRIN-COFIN Project; FISM, Fondazione Italiana Sclerosi Multipla(Fondazione Italiana Sclerosi Multipla (FISM)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Intramural Research Program of the NICHD, National Institutes of Health. This work was also supported by Italian Ministero della Salute RF-CNM-2007-662855 and PRIN-COFIN Project Prot. 2006059022 and 2008XFMEA3 and by FISM, Fondazione Italiana Sclerosi Multipla COD. 2010/R/2.	Andres-Barquin PJ, 1999, EXP CELL RES, V247, P347, DOI 10.1006/excr.1998.4360; Bianco F, 2005, BRAIN RES REV, V48, P144, DOI 10.1016/j.brainresrev.2004.12.004; Cai Y, 2006, NEUROSCIENCE, V138, P133, DOI 10.1016/j.neuroscience.2005.11.041; Calleri E, 2010, J MED CHEM, V53, P3489, DOI 10.1021/jm901691y; Capra V, 2005, J CELL SCI, V118, P5625, DOI 10.1242/jcs.02668; Ceruti S, 2008, CELL CALCIUM, V43, P576, DOI 10.1016/j.ceca.2007.10.003; Ceruti S, 2009, BRAIN, V132, P2206, DOI 10.1093/brain/awp147; Chen Y, 2007, NAT PROTOC, V2, P1044, DOI 10.1038/nprot.2007.149; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Cheng XX, 2007, STEM CELLS, V25, P3204, DOI 10.1634/stemcells.2007-0284; Ciana P, 2006, EMBO J, V25, P4615, DOI 10.1038/sj.emboj.7601341; Colotta V, 2008, BIOORGAN MED CHEM, V16, P6086, DOI 10.1016/j.bmc.2008.04.039; Cosimelli B, 2008, J MED CHEM, V51, P1764, DOI 10.1021/jm701159t; Daniele S, 2010, CELL SIGNAL, V22, P697, DOI 10.1016/j.cellsig.2009.12.006; De Biase LM, 2010, J NEUROSCI, V30, P3600, DOI 10.1523/JNEUROSCI.6000-09.2010; Fumagalli M, 2004, BIOCHEM PHARMACOL, V68, P113, DOI 10.1016/j.bcp.2004.02.038; Fumagalli M, 2003, GLIA, V43, P218, DOI 10.1002/glia.10248; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Joubert L, 2010, J NEUROSCI RES, V88, P2546, DOI 10.1002/jnr.22434; Lecca D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003579; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Pugliese AM, 2009, AM J PHYSIOL-CELL PH, V297, pC1028, DOI 10.1152/ajpcell.00658.2008; Ravni A, 2008, MOL PHARMACOL, V73, P1688, DOI 10.1124/mol.107.044792; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Stachowiak EK, 2003, J NEUROCHEM, V84, P1296, DOI 10.1046/j.1471-4159.2003.01624.x; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; Temporini C, 2009, ANAL BIOCHEM, V384, P123, DOI 10.1016/j.ab.2008.09.010; Trincavelli ML, 2008, J CELL BIOCHEM, V104, P150, DOI 10.1002/jcb.21611; Walrafen P, 2005, BLOOD, V105, P600, DOI 10.1182/blood-2004-03-1216	29	135	143	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10593	10604		10.1074/jbc.M110.162867	http://dx.doi.org/10.1074/jbc.M110.162867			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21209081	hybrid, Green Published			2022-12-27	WOS:000288547000074
J	Huang, CJ; Chang, A				Huang, Chunjuan; Chang, Amy			pH-dependent Cargo Sorting from the Golgi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE ATPASE; VACUOLAR H+-ATPASE; YEAST SACCHAROMYCES-CEREVISIAE; CELL-SURFACE STABILITY; V-ATPASE; SECRETORY PATHWAY; BINDING-PROTEIN; QUALITY-CONTROL; PROTON PUMPS; GGA PROTEINS	The vacuolar proton-translocating ATPase (V-ATPase) plays a major role in organelle acidification and works together with other ion transporters to maintain pH homeostasis in eukaryotic cells. We analyzed a requirement for V-ATPase activity in protein trafficking in the yeast secretory pathway. Deficiency of V-ATPase activity caused by subunit deletion or glucose deprivation results in missorting of newly synthesized plasma membrane proteins Pma1 and Can1 directly from the Golgi to the vacuole. Vacuolar mislocalization of Pma1 is dependent on Gga adaptors although no Pma1 ubiquitination was detected. Proper cell surface targeting of Pma1 was rescued in V-ATPase-deficient cells by increasing the pH of the medium, suggesting that missorting is the result of aberrant cytosolic pH. In addition to mislocalization of the plasma membrane proteins, Golgi membrane proteins Kex2 and Vrg4 are also missorted to the vacuole upon loss of V-ATPase activity. Because the missorted cargos have distinct trafficking routes, we suggest a pH dependence for multiple cargo sorting events at the Golgi.	[Huang, Chunjuan; Chang, Amy] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Chang, A (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 830 N Univ, Ann Arbor, MI 48109 USA.	amychang@umich.edu	Chang, Amy/AAS-5491-2020	Chang, Amy/0000-0003-3682-6456	National Institutes of Health [GM 58212]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R55GM058212, R01GM058212] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM 58212.	Abe M, 2004, J CELL SCI, V117, P5687, DOI 10.1242/jcs.01491; Anand VC, 2009, MOL BIOL CELL, V20, P1592, DOI 10.1091/mbc.E08-08-0819; Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Ayscough KR, 2005, PROTOPLASMA, V226, P81, DOI 10.1007/s00709-005-0107-5; Babst M, 2004, NAT CELL BIOL, V6, P175, DOI 10.1038/ncb0304-175; Bagnat M, 2001, MOL BIOL CELL, V12, P4129, DOI 10.1091/mbc.12.12.4129; Balguerie A, 2002, EUKARYOT CELL, V1, P1021, DOI 10.1128/EC.1.6.1021-1031.2002; BENITO B, 1991, BIOCHIM BIOPHYS ACTA, V1063, P265, DOI 10.1016/0005-2736(91)90381-H; Bonifacino JS, 2004, NAT REV MOL CELL BIO, V5, P23, DOI 10.1038/nrm1279; Brickner JH, 1997, J CELL BIOL, V139, P23, DOI 10.1083/jcb.139.1.23; Catty P, 1997, FEBS LETT, V409, P325, DOI 10.1016/S0014-5793(97)00446-8; CHANG A, 1995, J CELL BIOL, V128, P39, DOI 10.1083/jcb.128.1.39; CHANG A, 1991, J CELL BIOL, V115, P289, DOI 10.1083/jcb.115.2.289; Chang A, 2002, METHOD ENZYMOL, V351, P339; Conibear E, 1998, BBA-MOL CELL RES, V1404, P211, DOI 10.1016/S0167-4889(98)00058-5; Curtis KK, 2002, J BIOL CHEM, V277, P8979, DOI 10.1074/jbc.M111708200; Curwin AJ, 2009, J BIOL CHEM, V284, P7364, DOI 10.1074/jbc.M808732200; DAVIS NG, 1993, J CELL BIOL, V122, P53, DOI 10.1083/jcb.122.1.53; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Gerhardt B, 1998, J BIOL CHEM, V273, P15818, DOI 10.1074/jbc.273.25.15818; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gong XH, 2001, P NATL ACAD SCI USA, V98, P9104, DOI 10.1073/pnas.161282998; HARSAY E, 1995, J CELL BIOL, V131, P297, DOI 10.1083/jcb.131.2.297; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; KLIONSKY DJ, 1992, J EXP BIOL, V172, P83; KLIONSKY DJ, 1992, J BIOL CHEM, V267, P3416; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Kuhlbrandt W, 2002, SCIENCE, V297, P1692, DOI 10.1126/science.1072574; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Liu Y, 2006, J CELL SCI, V119, P360, DOI 10.1242/jcs.02749; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Luo WJ, 2000, MOL BIOL CELL, V11, P579, DOI 10.1091/mbc.11.2.579; Martinez-Munoz GA, 2008, J BIOL CHEM, V283, P20309, DOI 10.1074/jbc.M710470200; MORANO KA, 1994, J CELL SCI, V107, P2813; Mullins C, 2001, MOL CELL BIOL, V21, P7981, DOI 10.1128/MCB.21.23.7981-7994.2001; NELSON H, 1990, P NATL ACAD SCI USA, V87, P3503, DOI 10.1073/pnas.87.9.3503; Nothwehr SF, 1996, MOL CELL BIOL, V16, P2700; Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9; Perzov N, 2002, J EXP BIOL, V205, P1209; PIPER RC, 1995, J CELL BIOL, V131, P603, DOI 10.1083/jcb.131.3.603; Pizzirusso M, 2004, MOL BIOL CELL, V15, P2401, DOI 10.1091/mbc.E03-10-0727; Recchi C, 2006, NAT CELL BIOL, V8, P107, DOI 10.1038/ncb0206-107; Rose M. D., 1990, METHODS YEAST GENETI, P198; ROTHMAN JH, 1989, EMBO J, V8, P2057, DOI 10.1002/j.1460-2075.1989.tb03614.x; ROTHMAN JH, 1990, CELL, V61, P1063, DOI 10.1016/0092-8674(90)90070-U; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; SCHANDEL KA, 1994, MOL CELL BIOL, V14, P7245, DOI 10.1128/MCB.14.11.7245; Scott PM, 2004, NAT CELL BIOL, V6, P252, DOI 10.1038/ncb1107; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; SERRANO R, 1986, NATURE, V319, P689, DOI 10.1038/319689a0; Sherman F., 1986, METHODS YEAST GENETI, P523; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; Spelbrink RG, 1999, MOL BIOL CELL, V10, P4263, DOI 10.1091/mbc.10.12.4263; SPORMANN DO, 1992, J BIOL CHEM, V267, P8021; STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; SWERDLOW PS, 1986, ANAL BIOCHEM, V156, P147, DOI 10.1016/0003-2697(86)90166-1; Toulmay A, 2007, BIOCHIMIE, V89, P249, DOI 10.1016/j.biochi.2006.07.020; UMEMOTO N, 1990, J BIOL CHEM, V265, P18447; VATER CA, 1992, J CELL BIOL, V119, P773, DOI 10.1083/jcb.119.4.773; Wang QQ, 2002, P NATL ACAD SCI USA, V99, P12853, DOI 10.1073/pnas.202115499; YAVER DS, 1993, J BIOL CHEM, V268, P10564; Yeung BG, 1999, MOL BIOL CELL, V10, P3643, DOI 10.1091/mbc.10.11.3643	66	41	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10058	10065		10.1074/jbc.M110.197889	http://dx.doi.org/10.1074/jbc.M110.197889			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21239492	Green Published, hybrid			2022-12-27	WOS:000288547000020
J	Sugiyama, R; Nishitsuji, H; Furukawa, A; Katahira, M; Habu, Y; Takeuchi, H; Ryo, A; Takaku, H				Sugiyama, Ryuichi; Nishitsuji, Hironori; Furukawa, Ayako; Katahira, Masato; Habu, Yuichiro; Takeuchi, Hiroaki; Ryo, Akihide; Takaku, Hiroshi			Heat Shock Protein 70 Inhibits HIV-1 Vif-mediated Ubiquitination and Degradation of APOBEC3G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CD4(+) T-CELLS; CYTIDINE DEAMINASE; REVERSE TRANSCRIPTION; ANTIVIRAL ACTIVITY; ENZYME APOBEC3G; MESSENGER-RNA; SOCS-BOX; PROTEIN; DNA	The cytidine deaminase APOBEC3G, which is incorporated into nascent virus particles, possesses potent antiviral activity and restricts Vif-deficient HIV-1 replication at the reverse transcription step through deamination-dependent and -independent effects. HIV-1 Vif counteracts the antiviral activity of APOBEC3G by inducing APOBEC3G polyubiquitination and its subsequent proteasomal degradation. In this study, we show that overexpression of heat shock protein 70 (HSP70) blocked the degradation of APOBEC3G in the ubiquitin-proteasome pathway by HIV-1 Vif, rendering the viral particles non-infectious. In addition, siRNA targeted knock-down of HSP70 expression enhanced the Vif-mediated degradation of APOBEC3G. A co-immunoprecipitation study revealed that overexpression of HSP70 inhibited APOBEC3G binding to HIV-1 Vif. Thus, we provide evidence for a host protein-mediated suppression of HIV-1 replication in an APOBEC3G-dependent manner.	[Sugiyama, Ryuichi; Nishitsuji, Hironori; Takaku, Hiroshi] Chiba Inst Technol, Dept Life & Environm Sci, Chiba 2750016, Japan; [Furukawa, Ayako; Katahira, Masato] Kyoto Univ, Inst Adv Energy, Kyoto 6110011, Japan; [Habu, Yuichiro] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Takeuchi, Hiroaki] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Minato Ku, Tokyo 1088639, Japan; [Ryo, Akihide] Yokohama City Univ, Sch Med, Dept Microbiol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan	Chiba Institute of Technology; Kyoto University; Colorado State University; University of Tokyo; Yokohama City University	Takaku, H (corresponding author), 2-17-1 Tsudanuma, Chiba 2750016, Japan.	hiroshi.takaku@it-chiba.ac.jp	Furukawa, Ayako/CAH-2120-2022; Takeuchi, Hiroaki/F-9728-2012	Takeuchi, Hiroaki/0000-0002-5689-9858	Ministry of Education, Science, Sports, and Culture of Japan [09309011]; Ministry of Health, Labor, and Welfare, Japan; MEXT [21370047 22121517]; JST-SENTAN; Naito Foundation; YCU-AMRC; Grants-in-Aid for Scientific Research [21370047] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST-SENTAN(Japan Science & Technology Agency (JST)); Naito Foundation(Naito Memorial Foundation); YCU-AMRC; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-aid for High Technology Research (No. 09309011) from the Ministry of Education, Science, Sports, and Culture of Japan and by a grant-in-aid for AIDS research from the Ministry of Health, Labor, and Welfare, Japan.; Supported by Grants from MEXT (21370047 & 22121517), JST-SENTAN, Naito Foundation, and YCU-AMRC.	Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Babaahmady K, 2007, J VIROL, V81, P3354, DOI 10.1128/JVI.02320-06; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bishop KN, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000231; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chase G, 2008, VIROLOGY, V377, P431, DOI 10.1016/j.virol.2008.04.040; Conticello SG, 2003, CURR BIOL, V13, P2009, DOI 10.1016/j.cub.2003.10.034; Douaisi M, 2004, BIOCHEM BIOPH RES CO, V321, P566, DOI 10.1016/j.bbrc.2004.07.005; GABUZDA DH, 1992, J VIROL, V66, P6489, DOI 10.1128/JVI.66.11.6489-6495.1992; Gallois-Montbrun S, 2008, J VIROL, V82, P5636, DOI 10.1128/JVI.00287-08; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Guo F, 2007, J VIROL, V81, P11322, DOI 10.1128/JVI.00162-07; Gurer C, 2002, J VIROL, V76, P4666, DOI 10.1128/JVI.76.9.4666-4670.2002; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Iwatani Y, 2007, NUCLEIC ACIDS RES, V35, P7096, DOI 10.1093/nar/gkm750; Karczewski MK, 1996, J VIROL, V70, P494, DOI 10.1128/JVI.70.1.494-507.1996; Kobayashi M, 2005, J BIOL CHEM, V280, P18573, DOI 10.1074/jbc.C500082200; Kremer M, 2005, VIROLOGY, V337, P175, DOI 10.1016/j.virol.2005.04.006; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Li XY, 2007, J BIOL CHEM, V282, P32065, DOI 10.1074/jbc.M703423200; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Mehle A, 2004, J BIOL CHEM, V279, P7792, DOI 10.1074/jbc.M313093200; Mehle A, 2007, J VIROL, V81, P13235, DOI 10.1128/JVI.00204-07; Mercenne G, 2010, NUCLEIC ACIDS RES, V38, P633, DOI 10.1093/nar/gkp1009; Nathans R, 2008, NAT BIOTECHNOL, V26, P1187, DOI 10.1038/nbt.1496; NEIDHARDT FC, 1984, ANNU REV GENET, V18, P295, DOI 10.1146/annurev.ge.18.120184.001455; Niewiadomska AM, 2007, J VIROL, V81, P9577, DOI 10.1128/JVI.02800-06; O'Keeffe B, 2000, J BIOL CHEM, V275, P279, DOI 10.1074/jbc.275.1.279; Padwad YS, 2009, IMMUNOBIOLOGY, V214, P422, DOI 10.1016/j.imbio.2008.11.010; Parent R, 2009, HEPATOLOGY, V49, P1798, DOI 10.1002/hep.22852; Pido-Lopez J, 2007, J IMMUNOL, V178, P1671, DOI 10.4049/jimmunol.178.3.1671; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; SenGupta D, 2004, J IMMUNOL, V173, P1987, DOI 10.4049/jimmunol.173.3.1987; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Ujino S, 2009, J BIOL CHEM, V284, P6841, DOI 10.1074/jbc.M806452200; VONSCHWEDLER U, 1993, J VIROL, V67, P4945, DOI 10.1128/JVI.67.8.4945-4955.1993; Wainberg Z, 1997, VIROLOGY, V233, P364, DOI 10.1006/viro.1997.8618; Wang T, 2007, J VIROL, V81, P13112, DOI 10.1128/JVI.00892-07; Watashi K, 2008, J VIROL, V82, P9928, DOI 10.1128/JVI.01017-08; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Yu YK, 2004, GENE DEV, V18, P2867, DOI 10.1101/gad.1250204; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	51	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10051	10057		10.1074/jbc.M110.166108	http://dx.doi.org/10.1074/jbc.M110.166108			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21228271	hybrid, Green Published			2022-12-27	WOS:000288547000019
J	Mayers, JR; Fyfe, I; Schuh, AL; Chapman, ER; Edwardson, JM; Audhya, A				Mayers, Jonathan R.; Fyfe, Ian; Schuh, Amber L.; Chapman, Edwin R.; Edwardson, J. Michael; Audhya, Anjon			ESCRT-0 Assembles as a Heterotetrameric Complex on Membranes and Binds Multiple Ubiquitinylated Cargoes Simultaneously	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISOTHERMAL TITRATION CALORIMETRY; UBIQUITINATED PROTEINS; MULTIVESICULAR BODIES; INTERACTING MOTIF; SORTING COMPLEX; MASTER MOLECULE; EARLY ENDOSOMES; HRS; DEGRADATION; DOMAINS	The ESCRT machinery consists of multiple protein complexes that collectively participate in the biogenesis of multivesicular endosomes (MVEs). The ESCRT-0 complex is composed of two subunits, Hrs and STAM, both of which can engage ubiquitinylated substrates destined for lysosomal degradation. Here, we conduct a comprehensive analysis of ESCRT-0:ubiquitin interactions using isothermal titration calorimetry and define the affinity of each ubiquitin-binding domain (UBD) within the intact ESCRT-0 complex. Our data demonstrate that ubiquitin binding is non-cooperative between the ESCRT-0 UBDs. Additionally, our findings show that the affinity of the Hrs double ubiquitin interacting motif (DUIM) for ubiquitin is more than 2-fold greater than that of UBDs found in STAM, suggesting that Hrs functions as the major ubiquitin-binding protein in ESCRT-0. In vivo, Hrs and STAM localize to endosomal membranes. To study recombinant ESCRT-0 assembly on lipid bilayers, we used atomic force microscopy. Our data show that ESCRT-0 forms mostly heterodimers and heterotetramers of Hrs and STAM when analyzed in the presence of membranes. Consistent with these findings, hydrodynamic analysis of endogenous ESCRT-0 indicates that it exists largely as a heterotetrameric complex of its two subunits. Based on these data, we present a revised model for ESCRT-0 function in cargo recruitment and concentration at the endosome.	[Mayers, Jonathan R.; Schuh, Amber L.; Audhya, Anjon] Univ Wisconsin, Sch Med, Dept Biomol Chem, Madison, WI 53706 USA; [Chapman, Edwin R.] Univ Wisconsin, Sch Med, Dept Physiol, Madison, WI 53706 USA; [Fyfe, Ian; Edwardson, J. Michael] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Cambridge	Audhya, A (corresponding author), Univ Wisconsin, Sch Med, Dept Biomol Chem, Madison, WI 53706 USA.	audhya@wisc.edu		Chapman, Edwin/0000-0001-9787-8140; Fyfe, Ian/0000-0002-9362-0254	National Institutes of Health [1R01GM088151-01A1, MH061876]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by Grants 1R01GM088151-01A1 (to A. A.) and MH061876 (to E. R. C.) from the National Institutes of Health.	Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Asao H, 1997, J BIOL CHEM, V272, P32785, DOI 10.1074/jbc.272.52.32785; Audhya A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000956; Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; Chanut-Delalande H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010245; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Dam TK, 2008, J BIOL CHEM, V283, P31366, DOI 10.1074/jbc.M806473200; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Hayakawa A, 2004, J BIOL CHEM, V279, P5958, DOI 10.1074/jbc.M310503200; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P272, DOI 10.1038/nsmb1051; Hong YH, 2009, FEBS LETT, V583, P287, DOI 10.1016/j.febslet.2008.12.034; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kobayashi H, 2005, J BIOL CHEM, V280, P10468, DOI 10.1074/jbc.M409969200; Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7; Mizuno E, 2004, J BIOCHEM, V135, P385, DOI 10.1093/jb/mvh046; Mizuno E, 2003, MOL BIOL CELL, V14, P3675, DOI 10.1091/mbc.E02-12-0823; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Pullan L, 2006, STRUCTURE, V14, P661, DOI 10.1016/j.str.2006.01.012; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Raiborg C, 2001, EMBO J, V20, P5008, DOI 10.1093/emboj/20.17.5008; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Ren JH, 2007, MOL BIOL CELL, V18, P324, DOI 10.1091/mbc.E06-06-0557; Ren XF, 2010, EMBO J, V29, P1045, DOI 10.1038/emboj.2010.6; Ren XF, 2009, STRUCTURE, V17, P406, DOI 10.1016/j.str.2009.01.012; Roxrud I, 2008, J CELL BIOL, V180, P1205, DOI 10.1083/jcb.200708115; Saksena S, 2009, BIOCHEM SOC T, V37, P167, DOI 10.1042/BST0370167; Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261; Shields SB, 2009, J CELL BIOL, V185, P213, DOI 10.1083/jcb.200811130; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Takata H, 2000, GENES CELLS, V5, P57, DOI 10.1046/j.1365-2443.2000.00303.x; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849	40	51	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9636	9645		10.1074/jbc.M110.185363	http://dx.doi.org/10.1074/jbc.M110.185363			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21193406	Green Published, hybrid			2022-12-27	WOS:000288247700088
J	Ozawa, D; Hasegawa, K; Lee, YH; Sakurai, K; Yanagi, K; Ookoshi, T; Goto, Y; Naiki, H				Ozawa, Daisaku; Hasegawa, Kazuhiro; Lee, Young-Ho; Sakurai, Kazumasa; Yanagi, Kotaro; Ookoshi, Tadakazu; Goto, Yuji; Naiki, Hironobu			Inhibition of beta(2)-Microglobulin Amyloid Fibril Formation by alpha(2)-Macroglobulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR CHAPERONE CLUSTERIN; NEUTRAL PH; PROTEINS; ALPHA-2-MACROGLOBULIN; BETA-2-MICROGLOBULIN; HEMODIALYSIS; NUCLEATION; COMPLEX; DISSOCIATION; AGGREGATION	The relationship between various amyloidoses and chaperones is gathering attention. In patients with dialysis-related amyloidosis, alpha(2)-macroglobulin (alpha 2M), an extracellular chaperone, forms a complex with beta(2)-microglobulin (beta 2-m), a major component of amyloid fibrils, but the molecular mechanisms and biological implications of the complex formation remain unclear. Here, we found that alpha 2M substoichiometrically inhibited the beta 2-m fibril formation at a neutral pH in the presence of SDS, a model for anionic lipids. Binding analysis showed that the binding affinity between alpha 2M and beta 2-m in the presence of SDS was higher than that in the absence of SDS. Importantly, SDS dissociated tetrameric alpha 2M into dimers with increased surface hydrophobicity. Western blot analysis revealed that both tetrameric and dimeric alpha 2M interacted with SDS-denatured beta 2-m. At a physiologically relevant acidic pH and in the presence of heparin, alpha 2M was also dissociated into dimers, and both tetrameric and dimeric alpha 2M interacted with beta 2-m, resulting in the inhibition of fibril growth reaction. These results suggest that under conditions where native beta 2-m is denatured, tetrameric alpha 2M is also converted to dimeric form with exposed hydrophobic surfaces to favor the hydrophobic interaction with denatured beta 2-m, thus dimeric alpha 2M as well as tetrameric alpha 2M may play an important role in controlling beta 2-m amyloid fibril formation.	[Ozawa, Daisaku; Hasegawa, Kazuhiro; Ookoshi, Tadakazu; Naiki, Hironobu] Univ Fukui, Fac Med Sci, Dept Pathol Sci, Fukui 9101193, Japan; [Lee, Young-Ho; Sakurai, Kazumasa; Yanagi, Kotaro; Goto, Yuji] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	University of Fukui; Osaka University	Naiki, H (corresponding author), Univ Fukui, Fac Med Sci, Dept Pathol Sci, Fukui 9101193, Japan.	naiki@u-fukui.ac.jp	Naiki, Hironobu/G-5599-2014		Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labour and Welfare, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by grants-in-aid for scientific research (B) (H. N.), scientific research on priority area "protein community" (H. N.), and scientific research (C) (K. H.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, and for research on specific diseases (H. N.) from the Ministry of Health, Labour and Welfare, Japan.	ARGILES A, 1989, CLIN SCI, V76, P547, DOI 10.1042/cs0760547; Calabrese MF, 2007, J MOL BIOL, V367, P1, DOI 10.1016/j.jmb.2006.12.034; Chiba T, 2003, J BIOL CHEM, V278, P47016, DOI 10.1074/jbc.M304473200; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Corazza A, 2010, J BIOL CHEM, V285, P5827, DOI 10.1074/jbc.M109.061168; FELDMAN SR, 1985, P NATL ACAD SCI USA, V82, P5700, DOI 10.1073/pnas.82.17.5700; French K, 2008, BIOCHEMISTRY-US, V47, P1176, DOI 10.1021/bi701976f; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Gouin-Charnet A, 2000, CLIN SCI, V98, P427, DOI 10.1042/CS19990234; Hasegawa K, 2008, BIOCHEM J, V416, P307, DOI 10.1042/BJ20080543; Haslbeck M, 2008, J MOL BIOL, V378, P362, DOI 10.1016/j.jmb.2008.01.095; Heegaard NHH, 2009, AMYLOID, V16, P151, DOI 10.1080/13506120903151775; JACOBUS WE, 1977, NATURE, V265, P756, DOI 10.1038/265756a0; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; JENSEN PEH, 1993, BIOCHIM BIOPHYS ACTA, V1164, P152, DOI 10.1016/0167-4838(93)90242-J; Kazama JJ, 2006, J BONE MINER METAB, V24, P182, DOI 10.1007/s00774-005-0669-5; Kelly JW, 1998, CURR OPIN STRUC BIOL, V8, P101, DOI 10.1016/S0959-440X(98)80016-X; Kihara M, 2005, J BIOL CHEM, V280, P12012, DOI 10.1074/jbc.M411949200; Kolodziej SJ, 2002, J BIOL CHEM, V277, P28031, DOI 10.1074/jbc.M202714200; Kumita JR, 2007, J MOL BIOL, V369, P157, DOI 10.1016/j.jmb.2007.02.095; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; Leake DS, 1997, ATHEROSCLEROSIS, V129, P149, DOI 10.1016/S0021-9150(96)06035-2; LIU D, 1987, Biochemistry, V26, P5221, DOI 10.1021/bi00391a001; Motomiya Y, 2003, KIDNEY INT, V64, P2244, DOI 10.1046/j.1523-1755.2003.00315.x; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; Naiki H, 1997, BIOCHEMISTRY-US, V36, P6243, DOI 10.1021/bi9624705; Naiki H, 2009, J BIOCHEM, V146, P751, DOI 10.1093/jb/mvp119; OKUBO H, 1984, INFLAMMATION, V8, P171, DOI 10.1007/BF00916092; Ookoshi T, 2008, NEPHROL DIAL TRANSPL, V23, P3247, DOI 10.1093/ndt/gfn231; PAP S, 1990, EUR J BIOCHEM, V191, P41, DOI 10.1111/j.1432-1033.1990.tb19091.x; Platt GW, 2008, J MOL BIOL, V378, P251, DOI 10.1016/j.jmb.2008.01.092; Poon S, 2002, J BIOL CHEM, V277, P39532, DOI 10.1074/jbc.M204855200; PUNNIAMOORTHY A, 1987, J ORAL PATHOL MED, V16, P36, DOI 10.1111/j.1600-0714.1987.tb00674.x; REDDY VY, 1994, J BIOL CHEM, V269, P4683; Relini A, 2008, J BIOL CHEM, V283, P4912, DOI 10.1074/jbc.M702712200; Relini A, 2006, J BIOL CHEM, V281, P16521, DOI 10.1074/jbc.M513827200; Sasahara K, 2008, BIOCHEMISTRY-US, V47, P2650, DOI 10.1021/bi701968g; Shanbhag VP, 1997, EUR J BIOCHEM, V244, P694, DOI 10.1111/j.1432-1033.1997.00694.x; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P11539; Wilson MR, 2008, MOL BIOSYST, V4, P42, DOI 10.1039/b712728f; Wyatt AR, 2010, J BIOL CHEM, V285, P3532, DOI 10.1074/jbc.M109.079566; Wyatt AR, 2009, J BIOL CHEM, V284, P21920, DOI 10.1074/jbc.M109.033688; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u; YATES CM, 1990, J NEUROCHEM, V55, P1624, DOI 10.1111/j.1471-4159.1990.tb04948.x; Yerbury JJ, 2007, FASEB J, V21, P2312, DOI 10.1096/fj.06-7986com; Yerbury JJ, 2010, CELL STRESS CHAPERON, V15, P115, DOI 10.1007/s12192-009-0122-0; Yerbury JJ, 2009, J BIOL CHEM, V284, P4246, DOI 10.1074/jbc.M807242200	47	17	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9668	9676		10.1074/jbc.M110.167965	http://dx.doi.org/10.1074/jbc.M110.167965			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21216953	Green Published, hybrid			2022-12-27	WOS:000288247700091
J	Walsh, R; Blumenberg, M				Walsh, Rebecca; Blumenberg, Miroslav			Specific and Shared Targets of Ephrin A Signaling in Epidermal Keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR TYROSINE KINASE; CULTURED KERATINOCYTES; EXPRESSION; GENES; DIFFERENTIATION; TUMOR; PROTEINS; LIGANDS; EPHA2; AP-1	Both ephrins (EFNs) and their receptors (Ephs) are membrane-bound, restricting their interactions to the sites of direct cell-to-cell interfaces. They are widely expressed, often co-expressed, and regulate developmental processes, cell adhesion, motility, survival, proliferation, and differentiation. Both tumor suppressor and oncogene activities are ascribed to EFNs and Ephs in various contexts. A major conundrum regarding the EFN/Eph system concerns their large number and functional redundancy given the promiscuous cross-activation of ligands and receptors and the overlapping intracellular signaling pathways. To address this issue, we treated human epidermal keratinocytes with five EFNAs individually and defined the transcriptional responses in the cells. We found that a large set of genes is coregulated by all EFNAs. However, although the responses to EFNA3, EFNA4, and EFNA5 are identical, the responses to EFNA1 and EFNA2 are characteristic and distinctive. All EFNAs induce epidermal differentiation markers and suppress cell adhesion genes, especially integrins. Ontological analysis showed that all EFNAs induce cornification and keratin genes while suppressing wound healing-associated, signaling, receptor, and extracellular matrix-associated genes. Transcriptional targets of AP1 are selectively suppressed by EFNAs. EFNA1 and EFNA2, but not the EFNA3, EFNA4, EFNA5 cluster, regulate the members of the ubiquitin-associated proteolysis genes. EFNA1 specifically induces collagen production. Our results demonstrate that the EFN-Eph interactions in the epidermis, although promiscuous, are not redundant but specific. This suggests that different members of the EFN/Eph system have specific, clearly demarcated functions.	[Blumenberg, Miroslav] NYU, Sch Med, Dept Dermatol, Inst Canc, New York, NY 10016 USA; NYU, Sch Med, Dept Biochem, Inst Canc, New York, NY 10016 USA	New York University; New York University	Blumenberg, M (corresponding author), NYU, Sch Med, Dept Dermatol, Inst Canc, 550 1st Ave, New York, NY 10016 USA.	Miroslav.Blumenberg@nyumc.org		Blumenberg, Miroslav/0000-0002-8672-7774	R.O. Perelman Department of Dermatology, NYU Langone Medical Center	R.O. Perelman Department of Dermatology, NYU Langone Medical Center	This work was supported by the R.O. Perelman Department of Dermatology, NYU Langone Medical Center.	ADAMS JC, 1989, NATURE, V340, P307, DOI 10.1038/340307a0; [Anonymous], 1997, Cell, V90, P403; Banno T, 2005, J BIOL CHEM, V280, P18973, DOI 10.1074/jbc.M411758200; Banno T, 2004, J BIOL CHEM, V279, P32633, DOI 10.1074/jbc.M400642200; Bardelli A, 2003, SCIENCE, V300, P949, DOI 10.1126/science.1082596; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Bernerd Francoise, 1993, Gene Expression, V3, P187; BOYD AW, 2001, SCI STKE, pRE20; Brantley-Sieders D, 2004, CURR PHARM DESIGN, V10, P3431, DOI 10.2174/1381612043383160; Brantley-Sieders Dana M., 2004, Angiogenesis, V7, P17, DOI 10.1023/B:AGEN.0000037340.33788.87; Bruckner K, 1998, CURR OPIN NEUROBIOL, V8, P375, DOI 10.1016/S0959-4388(98)80064-0; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Cahan P, 2005, GENE, V360, P78, DOI 10.1016/j.gene.2005.07.008; COOPER D, 1986, J BIOL CHEM, V261, P4646; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Dodelet VC, 2000, ONCOGENE, V19, P5614, DOI 10.1038/sj.onc.1203856; Efimova T, 1998, J BIOL CHEM, V273, P24387, DOI 10.1074/jbc.273.38.24387; Evans IR, 2007, J CELL SCI, V120, P289, DOI 10.1242/jcs.03333; Finelt N, 2005, CYTOKINE, V31, P305, DOI 10.1016/j.cyto.2005.05.005; Freywald A, 2003, J BIOL CHEM, V278, P10150, DOI 10.1074/jbc.M208179200; Gazel A, 2003, J INVEST DERMATOL, V121, P1459, DOI 10.1111/j.1523-1747.2003.12611.x; Gazel A, 2006, J INVEST DERMATOL, V126, P2647, DOI 10.1038/sj.jid.5700461; Gazel A, 2006, J BIOL CHEM, V281, P20530, DOI 10.1074/jbc.M602712200; Genander M, 2010, STEM CELLS, V28, P1196, DOI 10.1002/stem.442; Guo H, 2006, CANCER RES, V66, P7050, DOI 10.1158/0008-5472.CAN-06-0004; Hafner C, 2006, MODERN PATHOL, V19, P1369, DOI 10.1038/modpathol.3800660; Heroult M, 2006, EXP CELL RES, V312, P642, DOI 10.1016/j.yexcr.2005.10.028; Huusko P, 2004, NAT GENET, V36, P979, DOI 10.1038/ng1408; Klein R, 2004, CURR OPIN CELL BIOL, V16, P580, DOI 10.1016/j.ceb.2004.07.002; Lai KO, 2004, J BIOL CHEM, V279, P13383, DOI 10.1074/jbc.M313356200; Lee DD, 2010, METHODS MOL BIOL, V585, P193, DOI 10.1007/978-1-60761-380-0_15; Li DL, 2001, FASEB J, V15, P2533, DOI 10.1096/fj.01-0172fje; Lin S, 2010, MOL BIOL CELL, V21, P3902, DOI 10.1091/mbc.E10-03-0242; LINDBERG K, 1990, DIFFERENTIATION, V45, P230, DOI 10.1111/j.1432-0436.1990.tb00477.x; LU B, 1994, J BIOL CHEM, V269, P7443; Ma SH, 1997, GENE EXPRESSION, V6, P361; Miao H, 2005, J BIOL CHEM, V280, P923, DOI 10.1074/jbc.M411383200; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; Molenda M, 2006, MOL IMMUNOL, V43, P1933, DOI 10.1016/j.molimm.2005.12.003; Newman JC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r81; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Rossi A, 1998, J INVEST DERMATOL, V110, P34, DOI 10.1046/j.1523-1747.1998.00071.x; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Vihanto MM, 2005, FASEB J, V19, P1689, DOI 10.1096/fj.04-3647fje; Welter JF, 1995, ONCOGENE, V11, P2681; WELTER JF, 1995, J BIOL CHEM, V270, P12614, DOI 10.1074/jbc.270.21.12614; Yokote H, 2005, P NATL ACAD SCI USA, V102, P18866, DOI 10.1073/pnas.0509741102; Zhang GQ, 2008, CANCER RES, V68, P1691, DOI 10.1158/0008-5472.CAN-07-2372; Zhang LW, 2002, J INTERF CYTOK RES, V22, P95, DOI 10.1089/107999002753452700	53	35	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9419	9428		10.1074/jbc.M110.197087	http://dx.doi.org/10.1074/jbc.M110.197087			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21193391	hybrid, Green Published			2022-12-27	WOS:000288247700070
J	Xu, XF; Lee, YJ; Holm, JB; Terry, MD; Oswald, RE; Horne, WA				Xu, Xingfu; Lee, Yoon J.; Holm, Johanna B.; Terry, Mark D.; Oswald, Robert E.; Horne, William A.			The Ca2+ Channel beta 4c Subunit Interacts with Heterochromatin Protein 1 via a PXVXL Binding Motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESTIBULAR NUCLEUS NEURONS; INTRINSIC EXCITABILITY; CALCIUM-CHANNELS; STRUCTURAL BASIS; BETA(4) SUBUNIT; ALPHA-SUBUNIT; DOMAIN; HP1; COMPLEX; SYSTEM	The beta subunits of voltage-gated Ca2+ channels are best known for their roles in regulating surface expression and gating of voltage-gated Ca2+ channel alpha(1) subunits. Recent evidence, however, indicates that these proteins have a variety of Ca2+ channel-independent functions. For example, on the molecular level, they regulate gene expression, and on the whole animal level, they regulate early cell movements in zebrafish development. In the present study, an alternatively spliced, truncated beta 4 subunit (beta 4c) is identified in the human brain and shown to be highly expressed in nuclei of vestibular neurons. Pull-down assays, nuclear magnetic resonance, and isothermal titration calorimetry demonstrate that the protein interacts with the chromo shadow domain (CSD) of heterochromatin protein 1 gamma. Site-directed mutagenesis reveals that the primary CSD interaction occurs through a beta 4c C-terminal PXVXL consensus motif, adding the beta 4c subunit to a growing PXVXL protein family with epigenetic responsibilities. These proteins have multiple nuclear functions, including transcription regulation (TIF1 alpha) and nucleosome assembly (CAF1). An NMR-based two-site docking model of beta 4c in complex with dimerized CSD is presented. Possible roles for the interaction are discussed.	[Horne, William A.] Cornell Univ, Ctr Vet Med, Coll Vet Med, Dept Clin Sci, Ithaca, NY 14853 USA; [Oswald, Robert E.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Terry, Mark D.; Horne, William A.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Biomed Sci, Ft Collins, CO 80523 USA	Cornell University; Cornell University; Colorado State University	Horne, WA (corresponding author), Cornell Univ, Ctr Vet Med, Coll Vet Med, Dept Clin Sci, Box 32, Ithaca, NY 14853 USA.	wah27@cornell.edu	Xu, Xingfu/A-1359-2015	Xu, Xingfu/0000-0001-6231-269X; Holm, Johanna/0000-0002-7646-4085	National Institutes of Health [NS42600]; National Science Foundation [IOS 0719242]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS42600 (to W. A. H.). This work was also supported by National Science Foundation Grant IOS 0719242 (to W. A. H.).	Brasher SV, 2000, EMBO J, V19, P1587, DOI 10.1093/emboj/19.7.1587; Broussard DM, 2004, LEARN MEMORY, V11, P127, DOI 10.1101/lm.65804; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; Cavanagh J., 2006, PROTEIN NMR SPECTROS, P613; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Darlington CL, 2002, EUR J NEUROSCI, V15, P1719, DOI 10.1046/j.1460-9568.2002.02024.x; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DEWAARD M, 1994, NEURON, V13, P495, DOI 10.1016/0896-6273(94)90363-8; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Ebert AM, 2008, P NATL ACAD SCI USA, V105, P198, DOI 10.1073/pnas.0707948105; Ebert AM, 2008, PHYSIOL GENOMICS, V35, P133, DOI 10.1152/physiolgenomics.90264.2008; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Festenstein R, 2003, SCIENCE, V299, P719, DOI 10.1126/science.1078694; Foell JD, 2004, PHYSIOL GENOMICS, V17, P183, DOI 10.1152/physiolgenomics.00207.2003; Gittis AH, 2006, CURR OPIN NEUROBIOL, V16, P385, DOI 10.1016/j.conb.2006.06.012; Gray AC, 2007, CELL CALCIUM, V42, P409, DOI 10.1016/j.ceca.2007.04.003; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hanlon MR, 1999, FEBS LETT, V445, P366, DOI 10.1016/S0014-5793(99)00156-8; Helton TD, 2002, J NEUROSCI, V22, P1573, DOI 10.1523/JNEUROSCI.22-05-01573.2002; Hibino H, 2003, P NATL ACAD SCI USA, V100, P307, DOI 10.1073/pnas.0136791100; Huang Y, 2006, STRUCTURE, V14, P703, DOI 10.1016/j.str.2006.01.007; Khan Z, 2002, J NEUROSCI, V22, P8193; KNELLER DG, 1993, J CELL BIOCHEM, P254; Kobayashi T, 2007, BIOCHEM BIOPH RES CO, V360, P679, DOI 10.1016/j.bbrc.2007.06.112; Nelson AB, 2005, NEURON, V46, P623, DOI 10.1016/j.neuron.2005.04.009; Nozawa RS, 2010, NAT CELL BIOL, V12, P719, DOI 10.1038/ncb2075; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Smothers JF, 2000, CURR BIOL, V10, P27, DOI 10.1016/S0960-9822(99)00260-2; Subramanyam P, 2009, CHANNELS, V3, P343, DOI 10.4161/chan.3.5.9696; Thiru A, 2004, EMBO J, V23, P489, DOI 10.1038/sj.emboj.7600088; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Van Petegem F, 2008, STRUCTURE, V16, P280, DOI 10.1016/j.str.2007.11.010; van Rootselaar Anne-Fleur, 2009, Pract Neurol, V9, P102, DOI 10.1136/jnnp.2009.172213; Vendel AC, 2006, J NEUROSCI, V26, P2635, DOI 10.1523/JNEUROSCI.0067-06.2006; Vendel AC, 2006, PROTEIN SCI, V15, P378, DOI 10.1110/ps.051894506; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449	39	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9677	9687		10.1074/jbc.M110.187864	http://dx.doi.org/10.1074/jbc.M110.187864			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21220418	hybrid, Green Published			2022-12-27	WOS:000288247700092
J	Barzi, M; Kostrz, D; Menendez, A; Pons, S				Barzi, Mercedes; Kostrz, Dorota; Menendez, Anghara; Pons, Sebastian			Sonic Hedgehog-induced Proliferation Requires Specific G alpha Inhibitory Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; PRIMARY CILIUM; ADENYLYL-CYCLASE; MEDIATED PROLIFERATION; BETA-TRCP; CEREBELLUM; ACTIVATION; PHOSPHORYLATION; DROSOPHILA; GRADIENT	Proliferation of cerebellar granular neuronal precursors (CGNPs) is mediated by Sonic Hedgehog (Shh), which activates the Patched and Smoothened (Smo) receptor complex. Although its protein sequence suggests that Smo is a G protein coupled receptor (GPCR), the evidence that this receptor utilizes heterotrimeric G proteins as downstream effectors is controversial. In Drosophila, G alpha(i) is required for Hedgehog (Hh) activity, but the involvement of heterotrimeric G proteins in vertebrate Shh signaling has not yet been established. Here, we show that Shh-induced proliferation of rat CGNPs is enhanced strongly by the expression of the active forms of G alpha(i/o) proteins (G alpha(i1), G alpha(i2), G alpha(i3), and G alpha(o)) but not by members of another class (G alpha(12)) of heterotrimeric G proteins. Additionally, the mRNAs of these different G alpha(i) members display specific expression patterns in the developing cerebellum; only G alpha(i2) and G alpha(i3) are substantially expressed in the outer external granular layer, where CGNPs proliferate. Consistent with this, Shh-induced proliferation of CGNPs is reduced significantly by knockdowns of G alpha(i2) and G alpha(i3) but not by silencing of other members of the G alpha(i/o) class. Finally, our results demonstrate that G alpha(i2) and G alpha(i3) locate to the primary cilium when expressed in CGNP cultures. In summary, we conclude that the proliferative effects of Shh on CGNPs are mediated by the combined activity of G alpha(i2) and G alpha(i3) proteins.	[Pons, Sebastian] IDIBAPS, CSIC, IIBB, Dept Cell Death & Proliferat,Inst Biomed Res Barc, Barcelona 08036, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Pons, S (corresponding author), IDIBAPS, CSIC, IIBB, Dept Cell Death & Proliferat,Inst Biomed Res Barc, Rosello 161,6th Floor, Barcelona 08036, Spain.	spfnqi@iibb.csic.es	Pons, Sebastian/K-7794-2014	Pons, Sebastian/0000-0003-1027-0621; Menendez, Anghara/0000-0001-6513-0584	Spanish Ministry of Education [BFU2008-02424/BFI]	Spanish Ministry of Education(Spanish Government)	This work was supported by Spanish Ministry of Education Grant BFU2008-02424/BFI.	Altman J, 1997, DEV CEREBELLAR SYSTE; Barzi M, 2010, J CELL SCI, V123, P62, DOI 10.1242/jcs.060020; Bishop GA, 2007, J COMP NEUROL, V505, P562, DOI 10.1002/cne.21510; Boehlke C, 2010, J CELL SCI, V123, P1460, DOI 10.1242/jcs.058883; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Dahmane N, 1999, DEVELOPMENT, V126, P3089; DeCamp DL, 2000, J BIOL CHEM, V275, P26322, DOI 10.1074/jbc.M004055200; Diel S, 2006, J BIOL CHEM, V281, P288, DOI 10.1074/jbc.M511045200; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Hammerschmidt M, 1998, DEV BIOL, V194, P166, DOI 10.1006/dbio.1997.8796; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Iyer GH, 2005, J BIOL CHEM, V280, P8800, DOI 10.1074/jbc.M407586200; Kasai K, 2004, GENES CELLS, V9, P49, DOI 10.1111/j.1356-9597.2004.00701.x; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Low WC, 2008, DEV BIOL, V321, P188, DOI 10.1016/j.ydbio.2008.06.014; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; McConnachie G, 2006, TRENDS MOL MED, V12, P317, DOI 10.1016/j.molmed.2006.05.008; Megason SG, 2002, DEVELOPMENT, V129, P2087; Milenkovic L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3117pe14; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Ogden SK, 2008, NATURE, V456, P967, DOI 10.1038/nature07459; Oldham WM, 2007, ADV PROTEIN CHEM, V74, P67, DOI 10.1016/S0065-3233(07)74002-0; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; Ramon y Cajal S., 1911, HISTOLOGIE SYSTEMS N; Riobo NA, 2007, BIOCHEM J, V403, P369, DOI 10.1042/BJ20061723; Riobo NA, 2006, P NATL ACAD SCI USA, V103, P12607, DOI 10.1073/pnas.0600880103; Rios I, 2004, DEVELOPMENT, V131, P3159, DOI 10.1242/dev.01188; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Ruiz-Gomez A, 2007, BBA-BIOMEMBRANES, V1768, P901, DOI 10.1016/j.bbamem.2006.09.020; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Wang Y, 2009, P NATL ACAD SCI USA, V106, P2623, DOI 10.1073/pnas.0812110106; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Yu JZ, 2009, J BIOL CHEM, V284, P10462, DOI 10.1074/jbc.M809166200	38	36	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8067	8074		10.1074/jbc.M110.178772	http://dx.doi.org/10.1074/jbc.M110.178772			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21209076	Green Published, hybrid			2022-12-27	WOS:000288013300037
J	Brandenburger, T; Strehler, EE; Filoteo, AG; Caride, AJ; Aumuller, G; Post, H; Schwarz, A; Wilhelm, B				Brandenburger, Timo; Strehler, Emanuel E.; Filoteo, Adelaida G.; Caride, Ariel J.; Aumueller, Gerhard; Post, Heidi; Schwarz, Anja; Wilhelm, Beate			Switch of PMCA4 Splice Variants in Bovine Epididymis Results in Altered Isoform Expression during Functional Sperm Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE CA2+-ATPASE; RAT COAGULATING GLAND; CALCIUM-PUMP ISOFORMS; CA2+ PUMP; MESSENGER-RNAS; MALE-FERTILITY; CALMODULIN-BINDING; KNOCKOUT MICE; MOUSE SPERM; RT-PCR	Ca2+ and Ca2+-dependent signals are essential for sperm maturation and fertilization. In mouse sperm the plasma membrane Ca2+-ATPase (PMCA) isoform 4 plays a crucial role in Ca2+ transport. The two major splice variants of PMCA4 are PMCA4a and PMCA4b. PMCA4a differs from PMCA4b in the mechanism of calmodulin binding and activation. PMCA4a shows a much higher basal activity and is more effective than PMCA4b in returning Ca2+ to resting levels. Knock-out mice carrying a PMCA4-null mutation are infertile because their sperm cannot achieve a hyperactivated state of motility. As sperm reach functional maturity during their transit through the epididymis, the expression of PMCA4a and 4b was assessed in bull testis and epididymis. Quantitative PCR revealed that PMCA4b is the major splice variant in testis, caput, and corpus epididymidis. In contrast, PMCA4a is the major splice variant in cauda epididymidis, whereas sperm are transcriptionally silent. Immunohistochemical staining using a new antibody against bovine PMCA4a located the PMCA4a to the apical membrane of the epithelium of cauda epididymidis, whereas testis, caput, and corpus epididymidis were negative. Western blotting of testis, epididymis, and sperm isolated from caput and cauda epididymidis showed a much higher level of PMCA4a in cauda epididymidis and sperm from cauda epididymidis compared with testis membranes and sperm from caput epididymidis. These findings suggest that PMCA4a is transferred to bovine sperm membranes in cauda epididymidis. This isoform switch may facilitate a higher calcium turnover in sperm necessary to traverse the female genital tract.	[Brandenburger, Timo; Aumueller, Gerhard; Post, Heidi; Schwarz, Anja; Wilhelm, Beate] Univ Marburg, Dept Anat & Cell Biol, D-35037 Marburg, Germany; [Brandenburger, Timo] Univ Hosp Dusseldorf, Dept Anesthesiol, D-40225 Dusseldorf, Germany; [Strehler, Emanuel E.; Filoteo, Adelaida G.; Caride, Ariel J.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Philipps University Marburg; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Mayo Clinic	Brandenburger, T (corresponding author), Moorenstr 5, D-40225 Dusseldorf, Germany.	timo.brandenburger@med.uni-duesseldorf.de	Brandenburger, Timo/AAJ-9090-2021; Schwarz, Anja/AAG-2530-2021	, Anja/0000-0001-9567-0717	National Institutes of Health [NS51769]; Deutsche Forschungsgemeinschaft; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS51769 (to E. E. S.). This work was also supported by the Deutsche Forschungsgemeinschaft Graduiertenkolleg 533 Giessen-Marburg Project A1 (to T. B., G. A., and B. W.).	BABCOCK DF, 1987, J BIOL CHEM, V262, P15041; BEGIN S, 1995, MOL REPROD DEV, V41, P249, DOI 10.1002/mrd.1080410216; BOUE F, 1994, BIOL REPROD, V51, P577, DOI 10.1095/biolreprod51.4.577; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRANDT P, 1992, J NEUROCHEM, V59, P1566, DOI 10.1111/j.1471-4159.1992.tb08476.x; BRANDT P, 1992, J BIOL CHEM, V267, P4376; Caride AJ, 1999, J BIOL CHEM, V274, P35227, DOI 10.1074/jbc.274.49.35227; Caride AJ, 2007, J BIOL CHEM, V282, P25640, DOI 10.1074/jbc.M701129200; Cooper T. G., 1999, EPIDIDYMIS; Cooper TG, 1996, ANDROLOGIA, V28, P57; COOPER TG, 1995, ADV EXP MED BIOL, V377, P87; DEJAEGERE S, 1993, BIOCHIM BIOPHYS ACTA, V1173, P188, DOI 10.1016/0167-4781(93)90180-L; ENYEDI A, 1993, J BIOL CHEM, V268, P10621; Filoteo AG, 1997, J BIOL CHEM, V272, P23741, DOI 10.1074/jbc.272.38.23741; FRIEDMAN PA, 1995, PHYSIOL REV, V75, P429, DOI 10.1152/physrev.1995.75.3.429; Haendler B, 1999, J CELL PHYSIOL, V178, P371, DOI 10.1002/(SICI)1097-4652(199903)178:3<371::AID-JCP11>3.0.CO;2-N; Hoenderop JGJ, 2002, FASEB J, V16, P1398, DOI 10.1096/fj.02-0225com; HOWARD A, 1993, AM J PHYSIOL, V265, pG917, DOI 10.1152/ajpgi.1993.265.5.G917; JONES R, 1989, OXFORD REV REPROD B, V11, P285; Jones R, 1998, J REPROD FERTIL, P73; KEETON TP, 1995, BIOCHEM J, V306, P779, DOI 10.1042/bj3060779; KEETON TP, 1993, J BIOL CHEM, V268, P2740; Kirchhoff C, 1996, MOL HUM REPROD, V2, P177, DOI 10.1093/molehr/2.3.177; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; Lalancette C, 2008, J CELL BIOCHEM, V104, P1570, DOI 10.1002/jcb.21756; Larsson Dennis, 2002, Journal of Biomedicine & Biotechnology, V2, P117, DOI 10.1155/S1110724302205045; Lee MG, 1997, J BIOL CHEM, V272, P15771, DOI 10.1074/jbc.272.25.15771; Lessard C, 2000, J ANDROL, V21, P700; O'Toole CMB, 2000, MOL BIOL CELL, V11, P1571, DOI 10.1091/mbc.11.5.1571; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Penheiter AR, 2003, BIOCHEMISTRY-US, V42, P12115, DOI 10.1021/bi027098+; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Post H, 2010, INT J ANDROL, V33, P775, DOI 10.1111/j.1365-2605.2009.01022.x; Post H, 2002, PROSTATE, V52, P159, DOI 10.1002/pros.10109; Prasad V, 2007, ANN NY ACAD SCI, V1099, P276, DOI 10.1196/annals.1387.029; Reinhardt TA, 2000, AM J PHYSIOL-CELL PH, V279, pC1595, DOI 10.1152/ajpcell.2000.279.5.C1595; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Sanchez-Luengo S, 2004, J ANDROL, V25, P234; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; SIKDAR R, 1991, MOL CELL BIOCHEM, V103, P121; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; STREHLER EE, 1990, J BIOL CHEM, V265, P2835; Strehler EE, 2004, CURR MOL MED, V4, P323, DOI 10.2174/1566524043360735; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Strehler EE, 2007, ANN NY ACAD SCI, V1099, P226, DOI 10.1196/annals.1387.023; Sullivan DA, 2003, J RHEUMATOL, V30, P2413; Sullivan R, 2005, BLOOD CELL MOL DIS, V35, P1, DOI 10.1016/j.bcmd.2005.03.005; Wennemuth G, 2003, J GEN PHYSIOL, V122, P115, DOI 10.1085/jgp.200308839; Wilhelm B, 1999, EUR J CELL BIOL, V78, P256, DOI 10.1016/S0171-9335(99)80059-4; Wilhelm B, 2008, HISTOCHEM CELL BIOL, V129, P331, DOI 10.1007/s00418-007-0362-y; Withers S, 2006, MOL CELL ENDOCRINOL, V250, P93, DOI 10.1016/j.mce.2005.12.028; ZACHARIAS DA, 1994, BIOTECHNIQUES, V17, P652	52	21	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7938	7946		10.1074/jbc.M110.142836	http://dx.doi.org/10.1074/jbc.M110.142836			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21187283	Green Published, hybrid			2022-12-27	WOS:000288013300024
J	Mittelstaet, J; Konevega, AL; Rodnina, MV				Mittelstaet, Joerg; Konevega, Andrey L.; Rodnina, Marina V.			Distortion of tRNA upon Near-cognate Codon Recognition on the Ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR TU; AMINOACYL-TRANSFER-RNA; GTP HYDROLYSIS; CRYSTAL-STRUCTURE; ACTIVE-ROLE; EF-TU; SELECTION; TRANSLATION; ACTIVATION; FIDELITY	The accurate decoding of the genetic information by the ribosome relies on the communication between the decoding center of the ribosome, where the tRNA anticodon interacts with the codon, and the GTPase center of EF-Tu, where GTP hydrolysis takes place. In the A/T state of decoding, the tRNA undergoes a large conformational change that results in a more open, distorted tRNA structure. Here we use a real-time transient fluorescence quenching approach to monitor the timing and the extent of the tRNA distortion upon reading cognate or near-cognate codons. The tRNA is distorted upon codon recognition and remains in that conformation until the tRNA is released from EF-Tu, although the extent of distortion gradually changes upon transition from the pre- to the post-hydrolysis steps of decoding. The timing and extent of the rearrangement is similar on cognate and near-cognate codons, suggesting that the tRNA distortion alone does not provide a specific switch for the preferential activation of GTP hydrolysis on the cognate codon. Thus, although the tRNA plays an active role in signal transmission between the decoding and GTPase centers, other regulators of signaling must be involved.	[Mittelstaet, Joerg; Konevega, Andrey L.; Rodnina, Marina V.] Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany	Max Planck Society	Rodnina, MV (corresponding author), Max Planck Inst Biophys Chem, Dept Phys Biochem, Fassberg 11, D-37077 Gottingen, Germany.	rodnina@mpibpc.mpg.de	Rodnina, Marina V./AAD-4667-2019; Konevega, Andrey L./B-7887-2008	Rodnina, Marina V./0000-0003-0105-3879; Konevega, Andrey L./0000-0003-0125-7150	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft.	BERCHTOLD H, 1993, NATURE, V365, P126, DOI 10.1038/365126a0; Blanchard SC, 2004, NAT STRUCT MOL BIOL, V11, P1008, DOI 10.1038/nsmb831; Cochella L, 2005, SCIENCE, V308, P1178, DOI 10.1126/science.1111408; Daviter T, 2003, J MOL BIOL, V332, P689, DOI 10.1016/S0022-2836(03)00947-1; Doose S, 2009, CHEMPHYSCHEM, V10, P1389, DOI 10.1002/cphc.200900238; Geggier P, 2010, J MOL BIOL, V399, P576, DOI 10.1016/j.jmb.2010.04.038; Gromadski KB, 2006, MOL CELL, V21, P369, DOI 10.1016/j.molcel.2005.12.018; Gromadski KB, 2004, MOL CELL, V13, P191, DOI 10.1016/S1097-2765(04)00005-X; Jenner L, 2010, NAT STRUCT MOL BIOL, V17, P1072, DOI 10.1038/nsmb.1880; Kothe U, 2004, J MOL BIOL, V336, P1011, DOI 10.1016/j.jmb.2003.12.080; Kothe U, 2006, BIOCHEMISTRY-US, V45, P12767, DOI 10.1021/bi061192z; Ledoux S, 2008, MOL CELL, V31, P114, DOI 10.1016/j.molcel.2008.04.026; Ledoux S, 2009, NAT STRUCT MOL BIOL, V16, P359, DOI 10.1038/nsmb.1581; McClory SP, 2010, RNA, V16, P1925, DOI 10.1261/rna.2228510; Milon P, 2007, METHOD ENZYMOL, V430, P1, DOI 10.1016/S0076-6879(07)30001-3; Mohr D, 2002, BIOCHEMISTRY-US, V41, P12520, DOI 10.1021/bi026301y; Ogle JM, 2002, CELL, V111, P721, DOI 10.1016/S0092-8674(02)01086-3; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Pan D, 2008, J BIOL CHEM, V283, P18431, DOI 10.1074/jbc.M801560200; Pape T, 1998, EMBO J, V17, P7490, DOI 10.1093/emboj/17.24.7490; Pape T, 1999, EMBO J, V18, P3800, DOI 10.1093/emboj/18.13.3800; Piepenburg O, 2000, BIOCHEMISTRY-US, V39, P1734, DOI 10.1021/bi992331y; ROBERTSON JM, 1981, J MOL BIOL, V151, P57, DOI 10.1016/0022-2836(81)90221-7; Rodnina MV, 2005, FEBS LETT, V579, P938, DOI 10.1016/j.febslet.2004.11.048; RODNINA MV, 1995, P NATL ACAD SCI USA, V92, P1945, DOI 10.1073/pnas.92.6.1945; Rodnina MV, 1996, J BIOL CHEM, V271, P646, DOI 10.1074/jbc.271.2.646; RODNINA MV, 1994, BIOCHEMISTRY-US, V33, P12267, DOI 10.1021/bi00206a033; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Sanbonmatsu KY, 2006, BIOCHIMIE, V88, P1075, DOI 10.1016/j.biochi.2006.07.002; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; SCHULTZ DW, 1994, J MOL BIOL, V235, P1381, DOI 10.1006/jmbi.1994.1095; Stark H, 2002, NAT STRUCT BIOL, V9, P849, DOI 10.1038/nsb859; Valle M, 2002, EMBO J, V21, P3557, DOI 10.1093/emboj/cdf326; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Voorhees RM, 2010, SCIENCE, V330, P835, DOI 10.1126/science.1194460; Vorstenbosch E, 1996, EMBO J, V15, P6766, DOI 10.1002/j.1460-2075.1996.tb01066.x; Whitford PC, 2010, RNA, V16, P1196, DOI 10.1261/rna.2035410; WINTERMEYER W, 1979, EUR J BIOCHEM, V98, P465; Zaher HS, 2009, CELL, V136, P746, DOI 10.1016/j.cell.2009.01.036	41	15	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8158	8164		10.1074/jbc.M110.210021	http://dx.doi.org/10.1074/jbc.M110.210021			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21212264	Green Published, hybrid			2022-12-27	WOS:000288013300046
J	Cheong, MC; Na, K; Kim, H; Jeong, SK; Joo, HJ; Chitwood, DJ; Paik, YK				Cheong, Mi Cheong; Na, Keun; Kim, Heekyeong; Jeong, Seul-Ki; Joo, Hyoe-Jin; Chitwood, David J.; Paik, Young-Ki			A Potential Biochemical Mechanism Underlying the Influence of Sterol Deprivation Stress on Caenorhabditis elegans Longevity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-ELEGANS; DAUER FORMATION; OXIDATIVE STRESS; LIFE-SPAN; ANESTHETIC SENSITIVITY; SIGNALING PATHWAY; GENE-EXPRESSION; WILD-TYPE; CHOLESTEROL; NEMATODE	To investigate the biochemical mechanism underlying the effect of sterol deprivation on longevity in Caenorhabditis elegans, we treated parent worms (P0) with 25-azacoprostane (Aza), which inhibits sitosterol-to-cholesterol conversion, and measured mean lifespan (MLS) in F2 worms. At 25 mu M (similar to EC50), Aza reduced total body sterol by 82.5%, confirming sterol depletion. Aza (25 mu M) treatment of wild-type (N2) C. elegans grown in sitosterol (5 mu g/ml) reduced MLS by 35%. Similar results were obtained for the stress-related mutants daf-16(mu86) and gas-1(fc21). Unexpectedly, Aza had essentially no effect on MLS in the stress-resistant daf-2(e1370) or mitochondrial complex II mutant mev-1(kn1) strains, indicating that Aza may target both insulin/IGF-1 signaling (IIS) and mitochondrial complex II. Aza increased reactive oxygen species (ROS) levels 2.7-fold in N2 worms, but did not affect ROS production by mev-1(kn1), suggesting a direct link between Aza treatment and mitochondrial ROS production. Moreover, expression of the stress-response transcription factor SKN-1 was decreased in amphid neurons by Aza and that of DAF-28 was increased when DAF-6 was involved, contributing to lifespan reduction.	[Cheong, Mi Cheong; Na, Keun; Kim, Heekyeong; Jeong, Seul-Ki; Joo, Hyoe-Jin; Paik, Young-Ki] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Dept Biomed Sci,WCU Program Grad Sch, Seoul 120749, South Korea; [Cheong, Mi Cheong; Na, Keun; Kim, Heekyeong; Jeong, Seul-Ki; Joo, Hyoe-Jin; Paik, Young-Ki] Yonsei Univ, Yonsei Proteome Res Ctr, Seoul 120749, South Korea; [Chitwood, David J.] ARS, Nematol Lab, USDA, Beltsville, MD 20705 USA	Yonsei University; Yonsei University; United States Department of Agriculture (USDA)	Paik, YK (corresponding author), 134 Shinchon Dong, Seoul 120749, South Korea.	paikyk@yonsei.ac.kr		Cheong, Mi Cheong/0000-0002-7604-6203	Ministry of Health and Welfare of Republic of Korea [A030003]; Ministry of Education, Science, and Technology [R31-2008-000-10086-0]	Ministry of Health and Welfare of Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported, in part, by the Korea Health 21 R&D project, Ministry of Health and Welfare of Republic of Korea Grant A030003 (to Y.K.-P.), and the WCU (World Class University) program through the National Research Foundation of Korea, funded by Ministry of Education, Science, and Technology Grant R31-2008-000-10086-0.	An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Boyd WA, 2010, NEUROTOXICOL TERATOL, V32, P68, DOI 10.1016/j.ntt.2008.12.004; Chitwood DJ, 1999, CRIT REV BIOCHEM MOL, V34, P273, DOI 10.1080/10409239991209309; CHITWOOD DJ, 1984, LIPIDS, V19, P500, DOI 10.1007/BF02534482; CHITWOOD DJ, 1991, LIPIDS, V26, P619, DOI 10.1007/BF02536426; Choi BK, 2003, MOL CELL PROTEOMICS, V2, P1086, DOI 10.1074/mcp.M300036-MCP200; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; FRIEDMAN DB, 1988, J GERONTOL, V43, pB102, DOI 10.1093/geronj/43.4.B102; Garza RM, 2005, NATURE, V435, P37, DOI 10.1038/435037a; Gems David, 2009, SEB Exp Biol Ser, V62, P31; Gerisch B, 2001, DEV CELL, V1, P841, DOI 10.1016/S1534-5807(01)00085-5; Gerisch G, 2007, CELL ADHES MIGR, V1, P145, DOI 10.4161/cam.1.3.4662; GIL G, 1985, CELL, V41, P249, DOI 10.1016/0092-8674(85)90078-9; GOTTLIEB S, 1994, GENETICS, V137, P107; Gutierrez-Zepeda A, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-54; Hannich JT, 2009, DEV CELL, V16, P833, DOI 10.1016/j.devcel.2009.04.012; Hao M, 2007, DIABETES, V56, P2328, DOI 10.2337/db07-0056; Hartman PS, 2001, MECH AGEING DEV, V122, P1187, DOI 10.1016/S0047-6374(01)00259-7; Hartwig K, 2009, GENES NUTR, V4, P59, DOI 10.1007/s12263-009-0113-x; Held JM, 2006, AGING CELL, V5, P283, DOI 10.1111/j.1474-9726.2006.00218.x; HIEB WF, 1968, SCIENCE, V160, P778, DOI 10.1126/science.160.3829.778; Honjoh S, 2009, NATURE, V457, P726, DOI 10.1038/nature07583; Horner MA, 2009, GENE DEV, V23, P2711, DOI 10.1101/gad.1833609; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Ichimiya H, 2002, MITOCHONDRION, V2, P191, DOI 10.1016/S1567-7249(02)00069-7; Ishii N, 2000, FREE RADICAL RES, V33, P857, DOI 10.1080/10715760000301371; Kayser EB, 2004, MECH AGEING DEV, V125, P455, DOI 10.1016/j.mad.2004.04.002; Kayser EB, 2001, J BIOL CHEM, V276, P20551, DOI 10.1074/jbc.M011066200; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kobayashi D, 2002, ANTIMICROB AGENTS CH, V46, P3113, DOI 10.1128/AAC.46.10.3113-3117.2002; Kondo M, 2005, MECH AGEING DEV, V126, P637, DOI 10.1016/j.mad.2004.11.011; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lee EY, 2005, BIOCHEM BIOPH RES CO, V328, P929, DOI 10.1016/j.bbrc.2005.01.050; Lee SJ, 2009, CELL METAB, V10, P379, DOI 10.1016/j.cmet.2009.10.003; Li J, 2004, DEVELOPMENT, V131, P5741, DOI 10.1242/dev.01408; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Lopez-Revuelta A, 2005, BBA-MOL CELL BIOL L, V1734, P74, DOI 10.1016/j.bbalip.2005.02.004; LOZANO R, 1984, COMP BIOCHEM PHYS C, V79, P21, DOI 10.1016/0742-8413(84)90156-7; Malone EA, 1996, GENETICS, V143, P1193; Marichal P, 1999, MICROBIOL-SGM, V145, P2701, DOI 10.1099/00221287-145-10-2701; Matyash V, 2004, PLOS BIOL, V2, P1561, DOI 10.1371/journal.pbio.0020280; Matyash V, 2001, MOL BIOL CELL, V12, P1725, DOI 10.1091/mbc.12.6.1725; Merris M, 2004, J LIPID RES, V45, P2044, DOI 10.1194/jlr.M400100-JLR200; Merris M, 2003, J LIPID RES, V44, P172, DOI 10.1194/jlr.M200323-JLR200; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Newsholme P, 2007, J PHYSIOL-LONDON, V583, P9, DOI 10.1113/jphysiol.2007.135871; Oh WS, 2009, PLOS ONE, V4, pA22, DOI 10.1371/journal.pone.0007593; Patel DS, 2008, DEVELOPMENT, V135, P2239, DOI 10.1242/dev.016972; Perens EA, 2005, DEV CELL, V8, P893, DOI 10.1016/j.devcel.2005.03.009; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; ROTHSTEIN M, 1968, COMP BIOCHEM PHYSIOL, V27, P309, DOI 10.1016/0010-406X(68)90773-1; Roux C, 2000, AM J CLIN NUTR, V71, p1270S, DOI 10.1093/ajcn/71.5.1270s; Sedensky MM, 2006, EXP GERONTOL, V41, P957, DOI 10.1016/j.exger.2006.06.056; Shim YH, 2002, MOL REPROD DEV, V61, P358, DOI 10.1002/mrd.10099; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Van Raamsdonk JM, 2010, ANTIOXID REDOX SIGN, V13, P1911, DOI 10.1089/ars.2010.3215; Vanfleteren JR, 1996, J EXP ZOOL, V274, P93, DOI 10.1002/(SICI)1097-010X(19960201)274:2&lt;93::AID-JEZ2&gt;3.0.CO;2-8; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; WARNER HR, 1994, FREE RADICAL BIO MED, V17, P249, DOI 10.1016/0891-5849(94)90080-9; Waterham HR, 2001, AM J HUM GENET, V69, P685, DOI 10.1086/323473	65	8	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7248	7256		10.1074/jbc.M110.189183	http://dx.doi.org/10.1074/jbc.M110.189183			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21186286	Green Published, hybrid			2022-12-27	WOS:000287737300041
J	Joo, HY; Jones, A; Yang, CY; Zhai, L; Smith, AD; Zhang, Z; Chandrasekharan, MB; Sun, ZW; Renfrow, MB; Wang, YM; Chang, CB; Wang, HB				Joo, Heui-Yun; Jones, Amada; Yang, Chunying; Zhai, Ling; Smith, Archer D.; Zhang, Zhuo; Chandrasekharan, Mahesh B.; Sun, Zu-wen; Renfrow, Matthew B.; Wang, Yanming; Chang, Chenbei; Wang, Hengbin			Regulation of Histone H2A and H2B Deubiquitination and Xenopus Development by USP12 and USP46	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE PROGRESSION; MASS-SPECTROMETRY; PROTEIN IDENTIFICATION; STATISTICAL-MODEL; H3K4 METHYLATION; GENE-EXPRESSION; CHROMATIN; UBIQUITINATION; UBIQUITYLATION; TRANSCRIPTION	Post-translational histone modifications play important roles in regulating gene expression programs, which in turn determine cell fate and lineage commitment during development. One such modification is histone ubiquitination, which primarily targets histone H2A and H2B. Although ubiquitination of H2A and H2B has been generally linked to gene silencing and gene activation, respectively, the functions of histone ubiquitination during eukaryote development are not well understood. Here, we identified USP12 and USP46 as histone H2A and H2B deubiquitinases that regulate Xenopus development. USP12 and USP46 prefer nucleosomal substrates and deubiquitinate both histone H2A and H2B in vitro and in vivo. WDR48, a WD40 repeat-containing protein, interacts with USP12 and USP46 and is required for the histone deubiquitination activity. Overexpression of either gene leads to gastrulation defects without affecting mesodermal cell fate, whereas knockdown of USP12 in Xenopus embryos results in reduction of a subset of mesodermal genes at gastrula stages. Immunohistochemical staining and chromatin immunoprecipitation assays revealed that USP12 regulates histone deubiquitination in the mesoderm and at specific gene promoters during Xenopus development. Taken together, this study identifies USP12 and USP46 as histone deubiquitinases for H2A and H2B and reveals that USP12 regulates Xenopus development during gastrula stages.	[Smith, Archer D.; Renfrow, Matthew B.] Univ Alabama, Dept Biochem & Mol Genet, Biomed FT ICR MS Lab, Birmingham, AL 35294 USA; [Chandrasekharan, Mahesh B.; Sun, Zu-wen] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Wang, Yanming] Penn State Univ, Ctr Gene Regulat, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Chang, Chenbei] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Alabama System; University of Alabama Birmingham	Wang, HB (corresponding author), Kaul Human Genet Bldg 402A,720 20th St S, Birmingham, AL 35294 USA.	hbwang@uab.edu	Yang, Chunying/C-2888-2011; Chandrasekharan, Mahesh/AAF-4793-2020	Wang, Yanming/0000-0002-0710-043X; Renfrow, Matthew B./0000-0002-4193-7305; Wang, Hengbin/0000-0003-2414-0609; Chandrasekharan, Mahesh/0000-0002-9956-8354	NCI, National Institutes of Health [CA13148-35]; National Institutes of Health [GM083029, GM081489]; NATIONAL CANCER INSTITUTE [P30CA013148, R01CA109355] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081489, R01GM083029] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA13148-35 from NCI (University of Alabama at Birmingham Comprehensive Cancer Center Collaborative Programmatic Development Grant Program to H. W. and C. C.).; Supported by National Institutes of Health Grant GM083029.; Supported by National Institutes of Health Grant GM081489. A Sidney Kimmel Scholar. To whom correspondence should be addressed: Kaul Human Genetics Bldg. 402A, 720 20th St. South, Birmingham, AL 35294. Tel.: 205-934-5286; Fax: 205-934-0758; E-mail: hbwang@uab.edu.	Blythe SA, 2009, DEV DYNAM, V238, P1422, DOI 10.1002/dvdy.21931; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Chandrasekharan MB, 2010, MOL CELL BIOL, V30, P3216, DOI 10.1128/MCB.01008-09; Chang CB, 1997, DEVELOPMENT, V124, P827; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Emre NCT, 2005, MOL CELL, V17, P585, DOI 10.1016/j.molcel.2005.01.007; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Espinosa JM, 2008, GENE DEV, V22, P2743, DOI 10.1101/gad.1732108; Gardner RG, 2005, MOL CELL BIOL, V25, P6123, DOI 10.1128/MCB.25.14.6123-6139.2005; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hirst M, 2009, INT J BIOCHEM CELL B, V41, P136, DOI 10.1016/j.biocel.2008.09.011; Hwang WW, 2003, MOL CELL, V11, P261, DOI 10.1016/S1097-2765(02)00826-2; Jason LJM, 2002, BIOESSAYS, V24, P166, DOI 10.1002/bies.10038; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; Kee Y, 2010, J BIOL CHEM, V285, P11252, DOI 10.1074/jbc.M109.095141; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Ko M, 2008, MUTAT RES-FUND MOL M, V647, P59, DOI 10.1016/j.mrfmmm.2008.08.004; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li PX, 2008, MOL CELL BIOL, V28, P4745, DOI 10.1128/MCB.01747-07; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mohn F, 2009, TRENDS GENET, V25, P129, DOI 10.1016/j.tig.2008.12.005; Nakagawa T, 2008, GENE DEV, V22, P37, DOI 10.1101/gad.1609708; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nicassio F, 2007, CURR BIOL, V17, P1972, DOI 10.1016/j.cub.2007.10.034; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Osley Mary Ann, 2006, Briefings in Functional Genomics & Proteomics, V5, P179, DOI 10.1093/bfgp/ell022; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Renfrow MB, 2007, ANAL BIOANAL CHEM, V389, P1397, DOI 10.1007/s00216-007-1500-z; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Shanbhag NM, 2010, CELL, V141, P970, DOI 10.1016/j.cell.2010.04.038; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; van der Knaap JA, 2005, MOL CELL, V17, P695, DOI 10.1016/j.molcel.2005.02.013; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang Y, 2009, MOL CELL, V33, P428, DOI 10.1016/j.molcel.2009.02.002; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Weake VM, 2008, EMBO J, V27, P394, DOI 10.1038/sj.emboj.7601966; Wood A, 2003, MOL CELL, V11, P267, DOI 10.1016/S1097-2765(02)00802-X; Zhang XY, 2008, CELL CYCLE, V7, P1522, DOI 10.4161/cc.7.11.5962; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024	55	79	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7190	7201		10.1074/jbc.M110.158311	http://dx.doi.org/10.1074/jbc.M110.158311			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21183687	hybrid, Green Published			2022-12-27	WOS:000287737300036
J	Peng, C; Cho, YY; Zhu, F; Zhang, JH; Wen, WH; Xu, YM; Yao, K; Ma, WY; Bode, AM; Dong, ZG				Peng, Cong; Cho, Yong-Yeon; Zhu, Feng; Zhang, Jishuai; Wen, Weihong; Xu, Yanming; Yao, Ke; Ma, Wei-Ya; Bode, Ann M.; Dong, Zigang			Phosphorylation of Caspase-8 (Thr-263) by Ribosomal S6 Kinase 2 (RSK2) Mediates Caspase-8 Ubiquitination and Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN LIGASE; CELL-SURVIVAL; HISTONE H3; APOPTOSIS; ACTIVATION; PATHWAY; GROWTH; TRANSFORMATION; DEGRADATION; REQUIREMENT	The ribosomal S6 kinase 2 (RSK2) is a member of the p90 ribosomal S6 kinase (p90RSK) family of proteins and plays a critical role in proliferation, cell cycle, and cell transformation. Here, we report that RSK2 phosphorylates caspase-8, and Thr-263 was identified as a novel caspase-8 phosphorylation site. In addition, we showed that EGF induces caspase-8 ubiquitination and degradation through the proteasome pathway, and phosphorylation of Thr-263 is associated with caspase-8 stability. Finally, RSK2 blocks Fas-induced apoptosis through its phosphorylation of caspase-8. These data provide a direct link between RSK2 and caspase-8 and identify a novel molecular mechanism for caspase-8 modulation by RSK2.	[Peng, Cong; Cho, Yong-Yeon; Zhu, Feng; Zhang, Jishuai; Wen, Weihong; Xu, Yanming; Yao, Ke; Ma, Wei-Ya; Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	University of Minnesota System	Dong, ZG (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	zgdong@hi.umn.edu	ZHU, Feng/C-1303-2010; 温, 家琦/GYV-3177-2022; Cho, Yong-Yeon/AAD-4263-2020; peng, cong/A-9454-2012	Zhu, Feng/0000-0003-1172-0102; Cho, Yong-Yeon/0000-0003-1107-2651	Hormel Foundation; National Institutes of Health [CA077646, CA111536, CA120388, CA027502, ES016548]; NATIONAL CANCER INSTITUTE [R01CA120388, R01CA077646, P01CA027502, R01CA111536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016548] Funding Source: NIH RePORTER	Hormel Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by The Hormel Foundation and by National Institutes of Health Grants CA077646, CA111536, CA120388, CA027502, and ES016548.	Anjum R, 2005, CURR BIOL, V15, P1762, DOI 10.1016/j.cub.2005.08.050; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Cho YY, 2007, CANCER RES, V67, P8104, DOI 10.1158/0008-5472.CAN-06-4668; Cho YY, 2007, J BIOL CHEM, V282, P8380, DOI 10.1074/jbc.M611322200; Cho YY, 2005, CANCER RES, V65, P3596, DOI 10.1158/0008-5472.CAN-04-3935; Eisinger-Mathason TSK, 2008, MOL CELL, V31, P722, DOI 10.1016/j.molcel.2008.06.025; Finlay D, 2007, CANCER RES, V67, P11704, DOI 10.1158/0008-5472.CAN-07-1906; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Huang HK, 2000, J BIOL CHEM, V275, P26661; Jin ZY, 2009, CELL, V137, P721, DOI 10.1016/j.cell.2009.03.015; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Kang SM, 2007, CANCER CELL, V12, P201, DOI 10.1016/j.ccr.2007.08.003; Mahadevan Louis C, 2004, Novartis Found Symp, V259, P102; McDonald ER, 2004, P NATL ACAD SCI USA, V101, P6170, DOI 10.1073/pnas.0307459101; Palmer A, 1998, EMBO J, V17, P5037, DOI 10.1093/emboj/17.17.5037; Peng C, 2010, FASEB J, V24, P3490, DOI 10.1096/fj.09-151290; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698; Tan MJ, 2006, NEOPLASIA, V8, P1042, DOI 10.1593/neo.06568; Vaidyanathan H, 2003, J BIOL CHEM, V278, P32367, DOI 10.1074/jbc.M303988200; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7	27	35	38	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6946	6954		10.1074/jbc.M110.172338	http://dx.doi.org/10.1074/jbc.M110.172338			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21183680	Green Published, hybrid			2022-12-27	WOS:000287737300010
J	Tochowicz, A; Goettig, P; Evans, R; Visse, R; Shitomi, Y; Palmisano, R; Ito, N; Richter, K; Maskos, K; Franke, D; Svergun, D; Nagase, H; Bode, W; Itoh, Y				Tochowicz, Anna; Goettig, Peter; Evans, Richard; Visse, Robert; Shitomi, Yasuyuki; Palmisano, Ralf; Ito, Noriko; Richter, Klaus; Maskos, Klaus; Franke, Daniel; Svergun, Dmitri; Nagase, Hideaki; Bode, Wolfram; Itoh, Yoshifumi			The Dimer Interface of the Membrane Type 1 Matrix Metalloproteinase Hemopexin Domain CRYSTAL STRUCTURE AND BIOLOGICAL FUNCTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCATTERING DATA-ANALYSIS; C-TERMINAL DOMAIN; CELL-MIGRATION; GELATINASE-A; PROMMP-2 ACTIVATION; TUMOR-CELLS; MT1-MMP; SURFACE; INVASION; COLLAGENASE	Homodimerization is an essential step for membrane type 1 matrix metalloproteinase (MT1-MMP) to activate proMMP-2 and to degrade collagen on the cell surface. To uncover the molecular basis of the hemopexin (Hpx) domain-driven dimerization of MT1-MMP, a crystal structure of the Hpx domain was solved at 1.7 angstrom resolution. Two interactions were identified as potential biological dimer interfaces in the crystal structure, and mutagenesis studies revealed that the biological dimer possesses a symmetrical interaction where blades II and III of molecule A interact with blades III and II of molecule B. The mutations of amino acids involved in the interaction weakened the dimer interaction of Hpx domains in solution, and incorporation of these mutations into the full-length enzyme significantly inhibited dimer-dependent functions on the cell surface, including proMMP-2 activation, collagen degradation, and invasion into the three-dimensional collagen matrix, whereas dimer-independent functions, including gelatin film degradation and two-dimensional cell migration, were not affected. These results shed light on the structural basis of MT1-MMP dimerization that is crucial to promote cellular invasion.	[Evans, Richard; Visse, Robert; Shitomi, Yasuyuki; Palmisano, Ralf; Ito, Noriko; Nagase, Hideaki; Itoh, Yoshifumi] Univ London Imperial Coll Sci Technol & Med, Fac Med, Kennedy Inst, Dept Matrix Biol,Rheumatol Div, London W6 8LH, England; [Maskos, Klaus; Bode, Wolfram] Max Planck Inst Biochem, Arbeitsgrp Proteinaseforsch, D-82152 Martinsried, Germany; [Richter, Klaus] Tech Univ Munich, Inst Organ Chem & Biochem, D-85747 Munich, Germany; [Franke, Daniel; Svergun, Dmitri] DESY, European Mol Biol Lab, Hamburg Outstn, D-22603 Hamburg, Germany	Imperial College London; University of Oxford; Max Planck Society; Technical University of Munich; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Itoh, Y (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Kennedy Inst, Dept Matrix Biol,Rheumatol Div, 65 Aspenlea Rd, London W6 8LH, England.	y.itoh@imperial.ac.uk	Goettig, Peter/R-7996-2017; Richter, Klaus/A-2673-2010; Goettig, Peter/K-4508-2019	Goettig, Peter/0000-0002-2430-1970; Richter, Klaus/0000-0002-8952-9642; Goettig, Peter/0000-0002-2430-1970; Svergun, Dmitri/0000-0003-0830-5696; Itoh, Yoshifumi/0000-0002-2128-2823; Palmisano, Ralf/0000-0003-4283-2115	National Institutes of Health [AR40994]; Cancer Research UK Project [C1507/A2670]; Arthritis Research UK (formerly Arthritis Research Campaign); Kennedy Institute of Rheumatology; Wellcome Trust [075473]; European Union [QLK3-CT-2002-02136, LSH-2002-2.2, LSHG-2006-018830]; Medical Research Council [G0802007] Funding Source: researchfish; MRC [G0802007] Funding Source: UKRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK Project(Cancer Research UK); Arthritis Research UK (formerly Arthritis Research Campaign)(Versus Arthritis); Kennedy Institute of Rheumatology; Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR40994. This work was also supported by Cancer Research UK Project Grant C1507/A2670, an Arthritis Research UK (formerly Arthritis Research Campaign) core grant for the Kennedy Institute of Rheumatology, Wellcome Trust Programme Grant 075473, and European Union Projects QLK3-CT-2002-02136 (MMP profiling), LSH-2002-2.2 (cancer degradome), and LSHG-2006-018830 (CAMP).	ALBRECHTBUEHLER G, 1977, CELL, V11, P395, DOI 10.1016/0092-8674(77)90057-5; Anilkumar N, 2005, FASEB J, V19, P1326, DOI 10.1096/fj.04-3651fje; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao J, 2004, J BIOL CHEM, V279, P14129, DOI 10.1074/jbc.M312120200; Cha HJ, 2002, J MOL BIOL, V320, P1065, DOI 10.1016/S0022-2836(02)00558-2; Deryugina EI, 2002, J BIOL CHEM, V277, P9749, DOI 10.1074/jbc.M110269200; Deryugina EI, 2000, INT J CANCER, V86, P15, DOI 10.1002/(SICI)1097-0215(20000401)86:1<15::AID-IJC3>3.0.CO;2-B; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Gohlke U, 1996, FEBS LETT, V378, P126, DOI 10.1016/0014-5793(95)01435-7; Gomis-Ruth F. X., 2004, HDB METALLOPROTEINS, P631; Gomis-Ruth FX, 2003, MOL BIOTECHNOL, V24, P157, DOI 10.1385/MB:24:2:157; GomisRuth FX, 1996, J MOL BIOL, V264, P556, DOI 10.1006/jmbi.1996.0661; Ingvarsen S, 2008, BIOL CHEM, V389, P943, DOI 10.1515/BC.2008.097; Itoh Y, 1999, J BIOL CHEM, V274, P34260, DOI 10.1074/jbc.274.48.34260; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Itoh Y, 2008, J BIOL CHEM, V283, P13053, DOI 10.1074/jbc.M709327200; Itoh Y, 2006, IUBMB LIFE, V58, P589, DOI 10.1080/15216540600962818; Itoh Y, 2006, MOL BIOL CELL, V17, P5390, DOI 10.1091/mbc.e06-08-0740; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lehti K, 2002, J BIOL CHEM, V277, P8440, DOI 10.1074/jbc.M109128200; LI J, 1995, STRUCTURE, V3, P541, DOI 10.1016/S0969-2126(01)00188-5; Li YY, 2004, CANCER RES, V64, P7058, DOI 10.1158/0008-5472.CAN-04-1038; LIBSON AM, 1995, NAT STRUCT BIOL, V2, P938, DOI 10.1038/nsb1195-938; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Miller MC, 2009, ARTHRITIS RHEUM-US, V60, P686, DOI 10.1002/art.24331; Ohuchi E, 1997, J BIOL CHEM, V272, P2446, DOI 10.1074/jbc.272.4.2446; OKADA Y, 1990, EUR J BIOCHEM, V194, P721, DOI 10.1111/j.1432-1033.1990.tb19462.x; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Rosenblum G, 2007, STRUCTURE, V15, P1227, DOI 10.1016/j.str.2007.07.019; Rozanov DV, 2004, J BIOL CHEM, V279, P4260, DOI 10.1074/jbc.M311569200; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; SATO H, 1994, NATURE, V370, P61, DOI 10.1038/370061a0; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; SWAMY M, 2006, SCI STKE, pPL14; Tallant C, 2010, BBA-MOL CELL RES, V1803, P20, DOI 10.1016/j.bbamcr.2009.04.003; Taniwaki K, 2007, CANCER RES, V67, P4311, DOI 10.1158/0008-5472.CAN-06-4761; Turk D, 1996, FEBS LETT, V384, P211, DOI 10.1016/0014-5793(96)00309-2; Uekita T, 2001, J CELL BIOL, V155, P1345, DOI 10.1083/jcb.200108112; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang P, 2004, J BIOL CHEM, V279, P51148, DOI 10.1074/jbc.M409074200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Wu YI, 2004, J BIOL CHEM, V279, P8278, DOI 10.1074/jbc.M311870200	51	47	49	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7587	7600		10.1074/jbc.M110.178434	http://dx.doi.org/10.1074/jbc.M110.178434			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193411	Green Published, hybrid			2022-12-27	WOS:000287737300072
J	Parra, MK; Gee, S; Mohandas, N; Conboy, JG				Parra, Marilyn K.; Gee, Sherry; Mohandas, Narla; Conboy, John G.			Efficient in Vivo Manipulation of Alternative Pre-mRNA Splicing Events Using Antisense Morpholinos in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESTORES DYSTROPHIN EXPRESSION; SPINAL MUSCULAR-ATROPHY; ERYTHROID-DIFFERENTIATION; PROTEIN 4.1R; REGULATORY ELEMENTS; GENE-EXPRESSION; CRITICAL EXON; MOTOR-NEURON; MOUSE MODEL; MDX MICE	Mammalian pre-mRNA alternative splicing mechanisms are typically studied using artificial minigenes in cultured cells, conditions that may not accurately reflect the physiological context of either the pre-mRNA or the splicing machinery. Here, we describe a strategy to investigate splicing of normal endogenous full-length pre-mRNAs under physiological conditions in live mice. This approach employs antisense vivo-morpholinos (vMOs) to mask cis-regulatory sequences or to disrupt splicing factor expression, allowing functional evaluation of splicing regulation in vivo. We applied this strategy to gain mechanistic insight into alternative splicing events involving exons 2 and 16 (E2 and E16) that control the structure and function of cytoskeletal protein 4.1R. In several mouse tissues, inclusion of E16 was substantially inhibited by interfering with a splicing enhancer mechanism using a target protector morpholino that blocked Fox2-dependent splicing enhancers in intron 16 or a splice-blocking morpholino that disrupted Fox2 expression directly. For E2, alternative 3'-splice site choice is coordinated with upstream promoter use across a long 5'-intron such that E1A splices almost exclusively to the distal acceptor (E2dis). vMOs were used to test the in vivo relevance of a deep intron element previously proposed to determine use of E2dis via a two-step intrasplicing model. Two independent vMOs designed against this intronic regulatory element inhibited intrasplicing, robustly switching E1A splicing to the proximal acceptor (E2prox). This finding strongly supports the in vivo physiological relevance of intrasplicing. vMOs represent a powerful tool for alternative splicing studies in vivo and may facilitate exploration of alternative splicing networks in vivo.	[Parra, Marilyn K.; Gee, Sherry; Conboy, John G.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Mohandas, Narla] New York Blood Ctr, New York, NY 10065 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; New York Blood Center	Conboy, JG (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, 1 Cyclotron Rd,Mailstop 84-171, Berkeley, CA 94720 USA.	jgconboy@lbl.gov			National Institutes of Health [HL45182, DK32094]; Office of Science, Office of Biological and Environmental Research, United States Department of Energy [DE-AC02-05CH11231]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL045182, R01HL045182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK032094] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Science, Office of Biological and Environmental Research, United States Department of Energy(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL45182 (to J. G. C.) and DK32094 (to N. M.). This work was also supported by the Director, Office of Science, Office of Biological and Environmental Research, United States Department of Energy under Contract DE-AC02-05CH11231.	Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Bauman J, 2009, OLIGONUCLEOTIDES, V19, P1, DOI 10.1089/oli.2008.0161; Bonano VI, 2006, RNA, V12, P2073, DOI 10.1261/rna.248506; Brudno M, 2001, NUCLEIC ACIDS RES, V29, P2338, DOI 10.1093/nar/29.11.2338; Castle JC, 2008, NAT GENET, V40, P1416, DOI 10.1038/ng.264; CONBOY JG, 1991, J BIOL CHEM, V266, P8273; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Damianov A, 2010, RNA, V16, P405, DOI 10.1261/rna.1838210; Das D, 2007, NUCLEIC ACIDS RES, V35, P4845, DOI 10.1093/nar/gkm485; Deguillien M, 2001, BLOOD, V98, P3809, DOI 10.1182/blood.V98.13.3809; DISCHER D, 1993, J BIOL CHEM, V268, P7186; Fagnani M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r108; Hou VC, 2002, EMBO J, V21, P6195, DOI 10.1093/emboj/cdf625; Hua YM, 2008, AM J HUM GENET, V82, P834, DOI 10.1016/j.ajhg.2008.01.014; Hua YM, 2007, PLOS BIOL, V5, P729, DOI 10.1371/journal.pbio.0050073; Hua YM, 2010, GENE DEV, V24, P1634, DOI 10.1101/gad.1941310; HUANG JP, 1993, J BIOL CHEM, V268, P3758; Huang SC, 2009, BLOOD, V114, P4233, DOI 10.1182/blood-2009-02-206219; Ip JY, 2007, RNA, V13, P563, DOI 10.1261/rna.457207; Jearawiriyapaisarn N, 2008, MOL THER, V16, P1624, DOI 10.1038/mt.2008.120; Jearawiriyapaisarn N, 2010, CARDIOVASC RES, V85, P444, DOI 10.1093/cvr/cvp335; Kuroyanagi H, 2009, CELL MOL LIFE SCI, V66, P3895, DOI 10.1007/s00018-009-0120-5; Lapuk A, 2010, MOL CANCER RES, V8, P961, DOI 10.1158/1541-7786.MCR-09-0528; Lopez-Bigas N, 2005, FEBS LETT, V579, P1900, DOI 10.1016/j.febslet.2005.02.047; Morcos PA, 2008, BIOTECHNIQUES, V45, P613, DOI 10.2144/000113005; Moroy T, 2007, RNA, V13, P1155, DOI 10.1261/rna.554607; Pan Q, 2006, GENE DEV, V20, P153, DOI 10.1101/gad.1382806; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Parra MK, 2008, EMBO J, V27, P122, DOI 10.1038/sj.emboj.7601957; Parra MK, 2003, BLOOD, V101, P4164, DOI 10.1182/blood-2002-06-1796; Ponthier JL, 2006, J BIOL CHEM, V281, P12468, DOI 10.1074/jbc.M511556200; Singh NN, 2009, RNA BIOL, V6, P341, DOI 10.4161/rna.6.3.8723; Singh NK, 2006, MOL CELL BIOL, V26, P1333, DOI 10.1128/MCB.26.4.1333-1346.2006; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; Svasti S, 2009, P NATL ACAD SCI USA, V106, P1205, DOI 10.1073/pnas.0812436106; Tan JS, 2005, GENOMICS, V86, P701, DOI 10.1016/j.ygeno.2005.08.005; Venables JP, 2009, NAT STRUCT MOL BIOL, V16, P670, DOI 10.1038/nsmb.1608; Williams JH, 2009, J NEUROSCI, V29, P7633, DOI 10.1523/JNEUROSCI.0950-09.2009; Wu B, 2009, MOL THER, V17, P864, DOI 10.1038/mt.2009.38; Yamamoto ML, 2009, BLOOD, V113, P3363, DOI 10.1182/blood-2008-05-160325; Yang G, 2005, BLOOD, V105, P2146, DOI 10.1182/blood-2004-05-1757; Yang G, 2008, BLOOD, V111, P392, DOI 10.1182/blood-2007-01-068940; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196	43	19	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6033	6039		10.1074/jbc.M110.158154	http://dx.doi.org/10.1074/jbc.M110.158154			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21156798	Green Published, hybrid			2022-12-27	WOS:000287476400011
J	Kny, M; Standera, S; Hartmann-Petersen, R; Kloetzel, PM; Seeger, M				Kny, Melanie; Standera, Sybille; Hartmann-Petersen, Rasmus; Kloetzel, Peter-Michael; Seeger, Michael			Herp Regulates Hrd1-mediated Ubiquitylation in a Ubiquitin-like Domain-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; HUMAN HRD1; ER; DEGRADATION; PATHWAY; LIGASE; COMPLEX; PROTEASOME; CYTOSOL	Accumulation of aberrant proteins in the endoplasmic reticulum (ER) triggers the unfolded protein response pathway that helps the cell to survive under these stress conditions. Herp is a mammalian ubiquitin domain protein, which is strongly induced by the unfolded protein response. It is involved in ER-associated protein degradation (ERAD) and interacts directly with the ubiquitin ligase Hrd1, which is found in high molecular mass complexes of the ER membrane. Here we present the first evidence that Herp regulates Hrd1-mediated ubiquitylation in a ubiquitin-like (UBL) domain-dependent manner. We found that upon exposure of cells to ER stress, elevation of Herp steady state levels is accompanied by an enhanced association of Herp with pre-existing Hrd1. Hrd1-associated Herp is rapidly degraded and substituted by de novo synthesized Herp, suggesting a continuous turnover of the protein at Hrd1 complexes. Further analysis revealed the presence of multiple Hrd1 copies in a single complex enabling binding of a variable number of Herp molecules. Efficient ubiquitylation of the Hrd1-specific ERAD substrate alpha 1-antitrypsin null Hong Kong (NHK) required the presence of the Herp UBL domain, which was also necessary for NHK degradation. In summary, we propose that binding of Herp to Hrd1-containing ERAD complexes positively regulates the ubiquitylation activity of these complexes, thus permitting survival of the cell during ER stress.	[Kny, Melanie; Standera, Sybille; Kloetzel, Peter-Michael; Seeger, Michael] Charite, Inst Biochem, D-13347 Berlin, Germany; [Hartmann-Petersen, Rasmus] Univ Copenhagen, Dept Biol, Prot Sci Sect, DK-2200 Copenhagen N, Denmark	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Copenhagen	Seeger, M (corresponding author), Charite, Inst Biochem, CC 2 Grundlagenmed,Oudenarder Str 16, D-13347 Berlin, Germany.	michael.seeger@charite.de	Hartmann-Petersen, Rasmus/K-4434-2014	Hartmann-Petersen, Rasmus/0000-0002-4155-7791; Kny, Melanie/0000-0001-7132-8079	Deutsche Forschungsgemeinschaft [SE 938/3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (SE 938/3).	Carroll SM, 2010, J BIOL CHEM, V285, P5146, DOI 10.1074/jbc.M109.067876; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Chan SL, 2004, J BIOL CHEM, V279, P28733, DOI 10.1074/jbc.M404272200; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Gao HY, 2010, HUM MOL GENET, V19, P16, DOI 10.1093/hmg/ddp463; Hori O, 2004, GENES CELLS, V9, P457, DOI 10.1111/j.1356-9597.2004.00735.x; Horn SC, 2009, MOL CELL, V36, P782, DOI 10.1016/j.molcel.2009.10.015; Kaneko M, 2002, FEBS LETT, V532, P147, DOI 10.1016/S0014-5793(02)03660-8; Kaneko M, 2007, FEBS LETT, V581, P5355, DOI 10.1016/j.febslet.2007.10.033; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kim I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007604; Kim TY, 2008, BIOCHEM BIOPH RES CO, V369, P741, DOI 10.1016/j.bbrc.2008.02.086; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Kokame K, 2000, J BIOL CHEM, V275, P32846, DOI 10.1074/jbc.M002063200; Li W, 2009, P NATL ACAD SCI USA, V106, P3722, DOI 10.1073/pnas.0808564106; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Ma YJ, 2004, J BIOL CHEM, V279, P13792, DOI 10.1074/jbc.M313724200; Meulmeester E, 2003, MOL CELL BIOL, V23, P4929, DOI 10.1128/MCB.23.14.4929-4938.2003; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sai XR, 2003, FEBS LETT, V553, P151, DOI 10.1016/S0014-5793(03)01009-3; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; Shen YX, 2007, BIOCHEM BIOPH RES CO, V352, P919, DOI 10.1016/j.bbrc.2006.11.121; van Laar T, 2000, FEBS LETT, V469, P123, DOI 10.1016/S0014-5793(00)01253-9; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656	28	50	50	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5151	5156		10.1074/jbc.M110.134551	http://dx.doi.org/10.1074/jbc.M110.134551			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21149444	Green Published, hybrid			2022-12-27	WOS:000287230600023
J	Suryadinata, R; Sadowski, M; Steel, R; Sarcevic, B				Suryadinata, Randy; Sadowski, Martin; Steel, Rohan; Sarcevic, Boris			Cyclin-dependent Kinase-mediated Phosphorylation of RBP1 and pRb Promotes Their Dissociation to Mediate Release of the SAP30 center dot mSin3 center dot HDAC Transcriptional Repressor Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEINS; CELL-CYCLE; RETINOBLASTOMA PROTEIN; HISTONE DEACETYLASE; BREAST-CANCER; DIFFERENTIAL PHOSPHORYLATION; GROWTH ARREST; IDENTIFICATION; PROGRESSION; INHIBITOR	Eukaryotic cell cycle progression is mediated by phosphorylation of protein substrates by cyclin-dependent kinases (CDKs). A critical substrate of CDKs is the product of the retinoblastoma tumor suppressor gene, pRb, which inhibits G(1)-S phase cell cycle progression by binding and repressing E2F transcription factors. CDK-mediated phosphorylation of pRb alleviates this inhibitory effect to promote G1-S phase cell cycle progression. pRb represses transcription by binding to the E2F transactivation domain and recruiting the mSin3 center dot histone deacetylase (HDAC) transcriptional repressor complex via the retinoblastoma-binding protein 1 (RBP1). RBP1 binds to the pocket region of pRb via an LXCXE motif and to the SAP30 subunit of the mSin3 center dot HDAC complex and, thus, acts as a bridging protein in this multisubunit complex. In the present study we identified RBP1 as a novel CDK substrate. RBP1 is phosphorylated by CDK2 on serines 864 and 1007, which are N- and C-terminal to the LXCXE motif, respectively. CDK2-mediated phosphorylation of RBP1 or pRb destabilizes their interaction in vitro, with concurrent phosphorylation of both proteins leading to their dissociation. Consistent with these findings, RBP1 phosphorylation is increased during progression from G1 into S-phase, with a concurrent decrease in its association with pRb in MCF-7 breast cancer cells. These studies provide new mechanistic insights into CDK-mediated regulation of the pRb tumor suppressor during cell cycle progression, demonstrating that CDK-mediated phosphorylation of both RBP1 and pRb induces their dissociation to mediate release of the mSin3 center dot HDAC transcriptional repressor complex from pRb to alleviate transcriptional repression of E2F.	[Suryadinata, Randy; Sadowski, Martin; Sarcevic, Boris] St Vincents Inst Med Res, Cell Cycle & Canc Unit, Fitzroy, Vic 3065, Australia; [Steel, Rohan] St Vincents Inst Med Res, Prot Chem Unit, Fitzroy, Vic 3065, Australia; [Sarcevic, Boris] Univ Melbourne, Dept Med, St Vincents Hosp, Melbourne, Vic 3065, Australia	St. Vincent's Institute of Medical Research; St. Vincent's Institute of Medical Research; St Vincent's Hospital Melbourne; University of Melbourne	Sarcevic, B (corresponding author), St Vincents Inst Med Res, Cell Cycle & Canc Unit, 9 Princes St, Fitzroy, Vic 3065, Australia.	bsarcevic@svi.edu.au	Suryadinata, Randy/C-2819-2013	/0000-0002-0423-6120; Sarcevic, Boris/0000-0002-8063-1050	Cancer Council Victoria; Department of Defense Breast Cancer Research [BC020800]	Cancer Council Victoria(Cancer Council VictoriaCanadian Institutes of Health Research (CIHR)); Department of Defense Breast Cancer Research(United States Department of Defense)	This work was supported by grants from the Cancer Council Victoria and the Department of Defense Breast Cancer Research Program (BC020800).	Ball LJ, 1997, EMBO J, V16, P2473, DOI 10.1093/emboj/16.9.2473; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Binda O, 2006, MOL CELL BIOL, V26, P1917, DOI 10.1128/MCB.26.5.1917-1931.2006; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Brown VD, 1999, MOL CELL BIOL, V19, P3246; Burke JR, 2010, J BIOL CHEM, V285, P16286, DOI 10.1074/jbc.M110.108167; Campbell DH, 1999, CANCER RES, V59, P5376; DEFEOJONES D, 1991, NATURE, V352, P251, DOI 10.1038/352251a0; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; EISSENBERG JC, 1990, P NATL ACAD SCI USA, V87, P9923, DOI 10.1073/pnas.87.24.9923; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; JESSUS C, 1992, CELL, V68, P323, DOI 10.1016/0092-8674(92)90473-P; Knudsen ES, 1996, J BIOL CHEM, V271, P8313, DOI 10.1074/jbc.271.14.8313; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lai A, 2001, MOL CELL BIOL, V21, P2918, DOI 10.1128/MCB.21.8.2918-2932.2001; Lai A, 2001, J BIOL CHEM, V276, P25823, DOI 10.1074/jbc.M100925200; Lai A, 1999, ONCOGENE, V18, P2091, DOI 10.1038/sj.onc.1202520; Laj A, 1999, MOL CELL BIOL, V19, P6632; Lee EY, 2002, CANCER CELL, V2, P463, DOI 10.1016/S1535-6108(02)00207-6; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; MEYERSON M, 1994, MOL CELL BIOL, V14, P2077, DOI 10.1128/MCB.14.3.2077; Mittnacht S, 1998, CURR OPIN GENET DEV, V8, P21, DOI 10.1016/S0959-437X(98)80057-9; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nash P, 2001, NATURE, V414, P514, DOI 10.1038/35107009; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Paro R, 1993, CURR OPIN CELL BIOL, V5, P999, DOI 10.1016/0955-0674(93)90084-4; Prall OWJ, 1997, J BIOL CHEM, V272, P10882; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; Sadowski M, 2007, BIOCHEM J, V405, P569, DOI 10.1042/BJ20061812; Sadowski M, 2010, MOL CELL BIOL, V30, P2316, DOI 10.1128/MCB.01094-09; Sarcevic B, 1997, J BIOL CHEM, V272, P33327, DOI 10.1074/jbc.272.52.33327; Sarcevic B, 2002, EMBO J, V21, P2009, DOI 10.1093/emboj/21.8.2009; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; SRINIVASAN J, 1995, BIOCHEM J, V309, P927, DOI 10.1042/bj3090927; Suryadinata R, 2010, BIOSCIENCE REP, V30, P243, DOI 10.1042/BSR20090171; Sutherland R.L., 1999, HUMAN CELL CULTURE, P79; SUZUKITAKAHASHI I, 1995, ONCOGENE, V10, P1691; Taya Y, 1997, TRENDS BIOCHEM SCI, V22, P14, DOI 10.1016/S0968-0004(96)10070-0; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wilsker D, 2005, GENOMICS, V86, P242, DOI 10.1016/j.ygeno.2005.03.013; Wilsker D, 2002, CELL GROWTH DIFFER, V13, P95; Wu JS, 2000, TRENDS BIOCHEM SCI, V25, P619, DOI 10.1016/S0968-0004(00)01718-7; Wu MY, 2008, JNCI-J NATL CANCER I, V100, P1247, DOI 10.1093/jnci/djn253; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1; Zhao JY, 1998, GENE DEV, V12, P456, DOI 10.1101/gad.12.4.456; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	61	21	22	3	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5108	5118		10.1074/jbc.M110.198473	http://dx.doi.org/10.1074/jbc.M110.198473			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148318	Green Published, hybrid			2022-12-27	WOS:000287230600018
J	Ti, SC; Pollard, TD				Ti, Shih-Chieh; Pollard, Thomas D.			Purification of Actin from Fission Yeast Schizosaccharomyces pombe and Characterization of Functional Differences from Muscle Actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOUND ADENOSINE 5'-TRIPHOSPHATE; POLY-L-PROLINE; F-ACTIN; NUCLEOTIDE EXCHANGE; ATP-ACTIN; ADP-ACTIN; CRYSTAL-STRUCTURES; FILAMENT TURNOVER; ARP2/3 COMPLEX; FORMIN CDC12P	Fission yeast Schizosaccharomyces pombe is an important genetic model organism for studying the mechanisms of endocytosis and cytokinesis. However, most work on the biochemical properties of fission yeast actin-binding proteins has been done with skeletal muscle actin for matters of convenience. When simulations of mathematical models of the mechanism of endocytosis were compared with events in live cells, some of the reactions appeared to be much faster than observed in biochemical experiments with muscle actin. Here, we used gelsolin affinity chromatography to purify actin from fission yeast. S. pombe actin shares many properties with skeletal muscle actin but has higher intrinsic nucleotide exchange rate, faster trimer nucleus formation, faster phosphate dissociation rate from polymerized actin, and faster nucleation of actin filaments with Arp2/3 complex. These properties close the gap between the biochemistry and predictions made by mathematical models of endocytosis in S. pombe cells.	[Ti, Shih-Chieh; Pollard, Thomas D.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Ti, Shih-Chieh; Pollard, Thomas D.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	thomas.pollard@yale.edu		Ti, Shih-Chieh/0000-0002-0517-0899	National Institutes of Health [GM-026338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grant GM-026338 (to T.D.P.).	Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Beltzner CC, 2008, J BIOL CHEM, V283, P7135, DOI 10.1074/jbc.M705894200; Berro J, 2010, MOL BIOL CELL, V21, P2905, DOI 10.1091/mbc.E10-06-0494; BERTAZZON A, 1990, BIOCHEMISTRY-US, V29, P291, DOI 10.1021/bi00453a040; Blanchoin L, 2002, BIOCHEMISTRY-US, V41, P597, DOI 10.1021/bi011214b; Bryan KE, 2005, J BIOL CHEM, V280, P1696, DOI 10.1074/jbc.M410180200; Buzan JM, 1996, P NATL ACAD SCI USA, V93, P91, DOI 10.1073/pnas.93.1.91; Cao WX, 2006, J MOL BIOL, V361, P257, DOI 10.1016/j.jmb.2006.06.019; CARLIER MF, 1987, BIOCHEM BIOPH RES CO, V143, P1069, DOI 10.1016/0006-291X(87)90361-5; CARLIER MF, 1988, J BIOL CHEM, V263, P817; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; CARLIER MF, 1986, BIOCHEMISTRY-US, V25, P7789, DOI 10.1021/bi00372a001; Chan C, 2009, CURR BIOL, V19, P537, DOI 10.1016/j.cub.2009.02.060; Christensen HEM, 1996, PLANT J, V10, P269, DOI 10.1046/j.1365-313X.1996.10020269.x; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; DE LA CRUZ EM, 1995, BIOCHEMISTRY-US, V34, P5452, DOI 10.1021/bi00016a016; Eads JC, 1998, BIOCHEMISTRY-US, V37, P11171, DOI 10.1021/bi9720033; Ezezika OC, 2009, J BIOL CHEM, V284, P2088, DOI 10.1074/jbc.M807073200; Galletta BJ, 2009, CURR OPIN CELL BIOL, V21, P20, DOI 10.1016/j.ceb.2009.01.006; GOLDSCHMIDTCLERMONT PJ, 1991, J CELL BIOL, V113, P1081, DOI 10.1083/jcb.113.5.1081; HADDAD JG, 1990, P NATL ACAD SCI USA, V87, P1381, DOI 10.1073/pnas.87.4.1381; HELMERHORST E, 1980, ANAL BIOCHEM, V104, P130, DOI 10.1016/0003-2697(80)90287-0; KAISER DA, 1989, CELL MOTIL CYTOSKEL, V14, P251, DOI 10.1002/cm.970140211; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kim E, 1996, BIOCHEMISTRY-US, V35, P16566, DOI 10.1021/bi9623892; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078; Kovar DR, 2000, PLANT CELL, V12, P583, DOI 10.1105/tpc.12.4.583; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Lu J, 2001, MOL BIOL CELL, V12, P1161, DOI 10.1091/mbc.12.4.1161; MOCKRIN SC, 1980, BIOCHEMISTRY-US, V19, P5359, DOI 10.1021/bi00564a033; NISHIDA E, 1985, BIOCHEMISTRY-US, V24, P1160, DOI 10.1021/bi00326a015; Ohki T, 2009, BIOCHEM BIOPH RES CO, V383, P146, DOI 10.1016/j.bbrc.2009.03.144; Perelroizen I, 1996, J BIOL CHEM, V271, P12302, DOI 10.1074/jbc.271.21.12302; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Pollard TD, 2010, NAT REV MOL CELL BIO, V11, P149, DOI 10.1038/nrm2834; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rould MA, 2006, J BIOL CHEM, V281, P31909, DOI 10.1074/jbc.M601973200; Schuler H, 2000, EUR J BIOCHEM, V267, P476, DOI 10.1046/j.1432-1327.2000.01023.x; Sept D, 2001, BIOPHYS J, V81, P667, DOI 10.1016/S0006-3495(01)75731-1; SIPICZKI M, 1995, ANTON LEEUW INT J G, V68, P119, DOI 10.1007/BF00873099; Sipiczki M, 2000, GENOME BIOL, V1, DOI DOI 10.1186/GB-2000-1-2-REVIEWS1011; Sirotkin V, 2010, MOL BIOL CELL, V21, P2894, DOI 10.1091/mbc.E10-02-0157; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Takaine M, 2007, J BIOL CHEM, V282, P21683, DOI 10.1074/jbc.M611371200; Vavylonis D, 2008, SCIENCE, V319, P97, DOI 10.1126/science.1151086; Wen KK, 2005, J BIOL CHEM, V280, P24168, DOI 10.1074/jbc.M502024200; Wen KK, 2008, J BIOL CHEM, V283, P9444, DOI 10.1074/jbc.M709806200; Wen KK, 2009, J BIOL CHEM, V284, P16776, DOI 10.1074/jbc.M109.006981; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Yao XY, 2001, J BIOL CHEM, V276, P25598, DOI 10.1074/jbc.M011797200	52	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5784	5792		10.1074/jbc.M110.199794	http://dx.doi.org/10.1074/jbc.M110.199794			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148484	Green Published, hybrid			2022-12-27	WOS:000287230600087
J	Yokoyama, K; Kaji, H; He, JS; Tanaka, C; Hazama, R; Kamigaki, T; Ku, YS; Tohyama, K; Tohyama, Y				Yokoyama, Kunio; Kaji, Hiroaki; He, Jinsong; Tanaka, Chisato; Hazama, Ryoichi; Kamigaki, Takashi; Ku, Yonson; Tohyama, Kaoru; Tohyama, Yumi			Rab27a Negatively Regulates Phagocytosis by Prolongation of the Actin-coating Stage around Phagosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE; SLAC2-A/MELANOPHILIN; TRAFFICKING; CORONIN-1; BINDING; CD47	Rab27a, a Rab family small GTPase, is involved in the exocytosis of secretory granules in melanocytes and cytotoxic T-cells. Rab27a mutations cause type 2 Griscelli syndrome, which is characterized by immunodeficiency, including uncontrolled macrophage activation known as hemophagocytic syndrome. However, the role of Rab27a in phagocytosis remains elusive. Here, using macrophage-like differentiated HL-60 cells and C3bi-opsonized zymosan as a pathogen-phagocyte model, we show that Rab27a negatively regulates complement-mediated phagocytic activity in association with F-actin remodeling. We found that transfection of Rab27a shRNA into HL-60 cells enhances complement-mediated phagocytosis. To clarify the mechanisms underlying the elevated phagocytosis in Rab27a knockdown cells, we analyzed the process of phagosome formation focusing on F-actin dynamics: F-actin assembly, followed by F-actin extension around the particles and the subsequent degradation of F-actin, leading to internalization of the particles enclosed in phagosomes. Microscopic analysis revealed that these actin-related processes, including F-actin coating and F-actin degradation, proceed more rapidly in Rab27a knockdown cells than in control HL-60 cells. Both elevated phagocytosis and accelerated F-actin remodeling were restored by expression of rescue-Rab27a and Rab27a-Q78L (GTP-bound form), but not by Rab27a-T23N (GDP-bound form). Furthermore, an increased accumulation of Coronin 1A surrounding F-actin coats was observed in Rab27a knockdown cells, suggesting that the function of Coronin 1A is related to the regulation of the F-actin coating. Our findings demonstrate that Rab27a plays a direct regulatory role in the nascent process of phagocytosis by prolongation of the stage of actin coating via suppression of Coronin 1A. This study may contribute to an explanation of the underlying mechanisms of excessive phagocytosis observed in Griscelli syndrome.	[Kaji, Hiroaki; Tanaka, Chisato; Hazama, Ryoichi; Tohyama, Yumi] Himeji Dokkyo Univ, Div Biochem, Fac Pharmaceut Sci, Himeji, Hyogo 6708524, Japan; [Kaji, Hiroaki] Himeji Dokkyo Univ, Fac Pharmaceut Sci, Dept Pharmaceut Hlth Care, Himeji, Hyogo 6708524, Japan; [Tohyama, Kaoru] Kawasaki Med Sch, Dept Lab Med, Kurashiki, Okayama 7010192, Japan; Kobe Univ, Grad Sch Med, Div Gastroenterol Surg, Kobe, Hyogo 6500017, Japan; [Ku, Yonson] Kobe Univ, Grad Sch Med, Div Hepatobiliary Pancreat Surg, Kobe, Hyogo 6500017, Japan; [Hazama, Ryoichi] Kobe Univ, Grad Sch Med, Div Biochem, Dept Mol & Cellular Biol, Kobe, Hyogo 6500017, Japan	Himeji Dokkyo University; Himeji Dokkyo University; Kawasaki Medical School; Kobe University; Kobe University; Kobe University	Tohyama, Y (corresponding author), Himeji Dokkyo Univ, Div Biochem, Fac Pharmaceut Sci, Himeji, Hyogo 6708524, Japan.	ytohyama@himeji-du.ac.jp			Japan Society for the Promotion of Sciences; KAKENHI	Japan Society for the Promotion of Sciences(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by KAKENHI and a grant-in-aid for scientific research (C) from the Japan Society for the Promotion of Sciences (to Y.T. and K.T.).	Chavas LMG, 2008, STRUCTURE, V16, P1468, DOI 10.1016/j.str.2008.07.015; Fairn GD, 2009, J CELL BIOL, V187, P701, DOI 10.1083/jcb.200909025; Fukuda M, 2005, J BIOCHEM, V137, P9, DOI 10.1093/jb/mvi002; Fukuda M, 2002, J BIOL CHEM, V277, P40118, DOI 10.1074/jbc.M205765200; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640; KATAGIRI K, 1991, J IMMUNOL, V146, P701; Kimura T, 2008, J CELL SCI, V121, P3092, DOI 10.1242/jcs.030544; Kimura T, 2010, BIOCHEM BIOPH RES CO, V395, P318, DOI 10.1016/j.bbrc.2010.03.173; Kukimoto-Niino M, 2008, STRUCTURE, V16, P1478, DOI 10.1016/j.str.2008.07.014; Kuroda TS, 2004, NAT CELL BIOL, V6, P1195, DOI 10.1038/ncb1197; Liebl D, 2009, J CELL SCI, V122, P2935, DOI 10.1242/jcs.048355; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Oku T, 2008, J BIOL CHEM, V283, P28918, DOI 10.1074/jbc.M709990200; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Scott CC, 2005, J CELL BIOL, V169, P139, DOI 10.1083/jcb.200412162; Shi YH, 2006, BLOOD, V107, P4554, DOI 10.1182/blood-2005-09-3616; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Tsujita K, 2010, J BIOL CHEM, V285, P6781, DOI 10.1074/jbc.M109.057018; Yan M, 2005, MOL BIOL CELL, V16, P3077, DOI 10.1091/mbc.E04-11-0989	25	26	26	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5375	5382		10.1074/jbc.M110.171702	http://dx.doi.org/10.1074/jbc.M110.171702			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21169636	hybrid, Green Published			2022-12-27	WOS:000287230600046
J	Fu, Y; Westenbroek, RE; Yu, FH; Clark, JP; Marshall, MR; Scheuer, T; Catterall, WA				Fu, Ying; Westenbroek, Ruth E.; Yu, Frank H.; Clark, John P., III; Marshall, Misty R.; Scheuer, Todd; Catterall, William A.			Deletion of the Distal C Terminus of Ca(V)1.2 Channels Leads to Loss of beta-Adrenergic Regulation and Heart Failure in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; HUMAN VENTRICULAR MYOCYTES; CARDIAC ALPHA(1) SUBUNIT; 2 SIZE FORMS; CALCIUM-CHANNEL; CA2+ CHANNELS; CARBOXYL-TERMINUS; SKELETAL-MUSCLE; ION CHANNELS; DEVELOPMENTAL-CHANGES	L-type calcium currents conducted by Ca(V)1.2 channels initiate excitation-contraction coupling in cardiac and vascular smooth muscle. In the heart, the distal portion of the C terminus (DCT) is proteolytically processed in vivo and serves as a noncovalently associated autoinhibitor of Ca(V)1.2 channel activity. This autoinhibitory complex, with A-kinase anchoring protein- 15 (AKAP15) bound to the DCT, is hypothesized to serve as the substrate for beta-adrenergic regulation in the fight-or-flight response. Mice expressing Ca(V)1.2 channels with the distal C terminus deleted (DCT-/-) develop cardiac hypertrophy and die prematurely after E15. Cardiac hypertrophy and survival rate were improved by drug treatments that reduce peripheral vascular resistance and hypertension, consistent with the hypothesis that Ca(V)1.2 hyperactivity in vascular smooth muscle causes hypertension, hypertrophy, and premature death. However, in contrast to expectation, L-type Ca2+ currents in cardiac myocytes from DCT-/- mice were dramatically reduced due to decreased cell-surface expression of Ca(V)1.2 protein, and the voltage dependence of activation and the kinetics of inactivation were altered. Ca(V)1.2 channels in DCT-/- myocytes fail to respond to activation of adenylyl cyclase by forskolin, and the localized expression of AKAP15 is reduced. Therefore, we conclude that the DCT of Ca(V)1.2 channels is required in vivo for normal vascular regulation, cell-surface expression of Ca(V)1.2 channels in cardiac myocytes, and beta-adrenergic stimulation of L-type Ca2+ currents in the heart.	[Fu, Ying; Westenbroek, Ruth E.; Yu, Frank H.; Clark, John P., III; Marshall, Misty R.; Scheuer, Todd; Catterall, William A.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Catterall, WA (corresponding author), Univ Washington, Dept Pharmacol, Mailstop 357280, Seattle, WA 98195 USA.	wcatt@uw.edu	Marshall, Misty R/E-5833-2016; Fu, Ying/E-5655-2012	Marshall, Misty R/0000-0002-1073-3131; Yu, Frank/0000-0001-9306-1731	National Institutes of Health [T32 GM07750, T32 NS07332, P01 HL44948, R01 HL85372]; American Heart Association [10POST2630160]; NATIONAL CANCER INSTITUTE [P01CA095616] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044948, R01HL085372] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS050606, T32NS007332] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Training Grants T32 GM07750 (to M. R. M.) and T32 NS07332 (to J. P. C.) and Research Grants P01 HL44948 and R01 HL85372 (to W. A. C.). This work was also supported by American Heart Association Postdoctoral Research Fellowship 10POST2630160 (to Y. F.).	An RH, 1996, CIRC RES, V78, P371, DOI 10.1161/01.RES.78.3.371; Anderson JR, 2010, CARDIOL REV, V18, P148, DOI 10.1097/CRD.0b013e3181d4e921; Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; BEUCKELMANN DJ, 1992, BASIC RES CARDIOL, V87, P235; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; BROGDEN RN, 1995, DRUGS, V49, P618, DOI 10.2165/00003495-199549040-00009; Brunet S, 2009, J GEN PHYSIOL, V134, P81, DOI 10.1085/jgp.200910209; Bunemann M, 1999, J BIOL CHEM, V274, P33851, DOI 10.1074/jbc.274.48.33851; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen XW, 2002, CIRC RES, V91, P517, DOI 10.1161/01.RES.0000033988.13062.7C; Davies MP, 1996, CIRC RES, V78, P15, DOI 10.1161/01.RES.78.1.15; DEEDWANIA PC, 1997, AM J HYPERTENS, V280, pS280; DEJONGH KS, 1989, P NATL ACAD SCI USA, V86, P8585; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; DEJONGH KS, 1991, P NATL ACAD SCI USA, V88, P10778, DOI 10.1073/pnas.88.23.10778; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Fernandez-Tenorio M, 2010, CIRC RES, V106, P1285, DOI 10.1161/CIRCRESAHA.109.213967; Fuller MD, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001152; Ganesan AN, 2006, CIRC RES, V98, pE11, DOI 10.1161/01.RES.0000202692.23001.e2; Gao TY, 1997, NEURON, V19, P185, DOI 10.1016/S0896-6273(00)80358-X; Gao TY, 1997, J BIOL CHEM, V272, P19401, DOI 10.1074/jbc.272.31.19401; Gao TY, 2001, J BIOL CHEM, V276, P21089, DOI 10.1074/jbc.M008000200; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Gray PC, 1998, NEURON, V20, P1017, DOI 10.1016/S0896-6273(00)80482-1; Gray PC, 1998, CURR OPIN NEUROBIOL, V8, P330, DOI 10.1016/S0959-4388(98)80057-3; HADLEY RW, 1992, AM J PHYSIOL, V262, pH472, DOI 10.1152/ajpheart.1992.262.2.H472; HADLEY RW, 1991, J GEN PHYSIOL, V98, P265, DOI 10.1085/jgp.98.2.265; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; HELL JW, 1993, J BIOL CHEM, V268, P19451; HESCHELER J, 1988, J PHYSIOL-LONDON, V404, P259, DOI 10.1113/jphysiol.1988.sp017289; Hulme JT, 2006, P NATL ACAD SCI USA, V103, P16574, DOI 10.1073/pnas.0607294103; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; Hulme JT, 2004, J MOL CELL CARDIOL, V37, P625, DOI 10.1016/j.yjmcc.2004.04.014; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; Hulme JT, 2002, J BIOL CHEM, V277, P4079, DOI 10.1074/jbc.M109814200; Kamp TJ, 2000, CIRC RES, V87, P1095, DOI 10.1161/01.RES.87.12.1095; Lemke T, 2008, J BIOL CHEM, V283, P34738, DOI 10.1074/jbc.M804981200; Luo ZY, 1998, NAT MED, V4, P1092, DOI 10.1038/2578; Meguro T, 1999, CIRC RES, V84, P735, DOI 10.1161/01.RES.84.6.735; Mikala G, 2003, MOL CELL BIOCHEM, V250, P81, DOI 10.1023/A:1024910605389; Mitterdorfer J, 1996, BIOCHEMISTRY-US, V35, P9400, DOI 10.1021/bi960683o; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Momma K, 2005, PEDIATR RES, V58, P42, DOI 10.1203/01.PDR.0000156370.50874.3C; Moosmang S, 2005, J NEUROSCI, V25, P9883, DOI 10.1523/JNEUROSCI.1531-05.2005; Moosmang S, 2003, EMBO J, V22, P6027, DOI 10.1093/emboj/cdg583; NORMAN RI, 1994, BIOCHEM SOC T, V22, P492, DOI 10.1042/bst0220492; Piacentino V, 2003, CIRC RES, V92, P651, DOI 10.1161/01.RES.0000062469.83985.9B; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; REUTER H, 1979, ANNU REV PHYSIOL, V41, P413, DOI 10.1146/annurev.ph.41.030179.002213; REUTER H, 1977, J PHYSIOL-LONDON, V264, P17, DOI 10.1113/jphysiol.1977.sp011656; SCHACHTER M, 1991, J CLIN PHARM THER, V16, P79, DOI 10.1111/j.1365-2710.1991.tb00288.x; Schroder E, 2009, CIRC RES, V104, P1373, DOI 10.1161/CIRCRESAHA.108.191387; Schulla V, 2003, EMBO J, V22, P3844, DOI 10.1093/emboj/cdg389; Seisenberger C, 2000, J BIOL CHEM, V275, P39193, DOI 10.1074/jbc.M006467200; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; SPERELAKIS N, 1976, AM J CARDIOL, V37, P1079, DOI 10.1016/0002-9149(76)90428-8; Steinberg SE, 2004, J MOL CELL CARDIOL, V37, P407, DOI 10.1016/j.yjmcc.2004.04.018; Striessnig J, 1999, CELL PHYSIOL BIOCHEM, V9, P242, DOI 10.1159/000016320; Sussman MA, 1998, SCIENCE, V281, P1690, DOI 10.1126/science.281.5383.1690; Toyoshima K, 2006, BIOL NEONATE, V89, P251, DOI 10.1159/000089954; TSIEN RW, 1972, NATURE-NEW BIOL, V240, P181, DOI 10.1038/newbio240181a0; TSIEN RW, 1986, J MOL CELL CARDIOL, V18, P691, DOI 10.1016/S0022-2828(86)80941-5; WEI XY, 1994, J BIOL CHEM, V269, P1635; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P	66	62	66	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.175307	http://dx.doi.org/10.1074/jbc.M110.175307			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21216955	Green Published, hybrid			2022-12-27	WOS:000289077500073
J	Simonson, MS; Ismail-Beigi, F				Simonson, Michael S.; Ismail-Beigi, Faramarz			Endothelin-1 Increases Collagen Accumulation in Renal Mesangial Cells by Stimulating a Chemokine and Cytokine Autocrine Signaling Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; EXPRESSION; FIBROSIS; OVEREXPRESSION; DYSFUNCTION; PHYSIOLOGY; DISCOVERY; RELEASE; GROWTH; INJURY	Endothelin-1 (ET-1), a potent vasoconstrictor, has been implicated in the pathogenesis of collagen accumulation, extracellular matrix remodeling, and renal and cardiac fibrosis in diabetes. However, the mechanism by which ET-1 promotes collagen accumulation remains unclear. Here, we analyzed the gene expression profile of ET-1-stimulated mesangial cells to identify determinants of collagen accumulation. In human mesangial cells (a microvascular pericyte that secretes excess collagen in diabetic glomerulosclerosis), ET-1 increased mRNA and protein for MCP-1 (macrophage chemoattractant protein-1) and IL-6. ET-1-induced MCP-1 and IL-6 mRNAs and proteins were blocked by an ETA (but not ETB) receptor antagonist. ET-1/ETA receptor signaling evoked a 7.4-fold increase in collagen accumulation. Exogenous addition of either recombinant MCP-1 or IL-6 increased collagen accumulation by 3.5-fold. Co-stimulation with both MCP-1 and IL-6 did not elevate collagen accumulation further. Neither an MCP-1-neutralizing antibody nor an MCP-1 receptor antagonist inhibited ET-1-induced collagen accumulation. Similarly, neutralizing antibodies against IL-6 or the gp130 subunit of the IL-6 receptor did not attenuate ET-1-induced collagen accumulation. However, co-incubation with MCP-1- and IL-6-neutralizing antibodies inhibited ET-1-induced collagen accumulation by 52%, suggesting a robust autocrine loop wherein MCP-1 and IL-6 are redundant. Taken together, these results demonstrate that an autocrine signaling loop involving MCP-1 and IL-6 contributes to ET-1-induced collagen accumulation.	[Simonson, Michael S.; Ismail-Beigi, Faramarz] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Ismail-Beigi, Faramarz] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Simonson, MS (corresponding author), Case Western Reserve Univ, Dept Med, Biomed Res Bldg 427,2109 Adelbert Rd, Cleveland, OH 44106 USA.	mss5@case.edu			Rosenberg Foundation of the Centers for Dialysis Care; Divisions of Nephrology and Hypertension and Endocrinology at Case Western Reserve University	Rosenberg Foundation of the Centers for Dialysis Care; Divisions of Nephrology and Hypertension and Endocrinology at Case Western Reserve University	This work was supported by the Rosenberg Foundation of the Centers for Dialysis Care and the Divisions of Nephrology and Hypertension and Endocrinology at Case Western Reserve University.	Amiri F, 2004, CIRCULATION, V110, P2233, DOI 10.1161/01.CIR.0000144462.08345.B9; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Benigni A, 1998, DIABETES, V47, P450, DOI 10.2337/diabetes.47.3.450; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Browatzki M, 2000, BASIC RES CARDIOL, V95, P98, DOI 10.1007/s003950050170; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chintalgattu V, 2004, J PHARMACOL EXP THER, V311, P691, DOI 10.1124/jpet.104.070151; Clozel M, 2005, ANN MED, V37, P2, DOI 10.1080/07853890410018925; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dhein S, 2000, J PHARMACOL EXP THER, V293, P351; Fioretto P, 2008, DIABETOLOGIA, V51, P1347, DOI 10.1007/s00125-008-1051-7; Gagliardini E, 2009, AM J PHYSIOL-RENAL, V297, pF1448, DOI 10.1152/ajprenal.00340.2009; Hocher B, 2001, NEPHRON, V87, P161, DOI 10.1159/000045906; Hocher B, 1997, J CLIN INVEST, V99, P1380, DOI 10.1172/JCI119297; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JIMENEZ W, 1985, HEPATOLOGY, V5, P815, DOI 10.1002/hep.1840050517; LOPEZDELEON A, 1985, J HISTOCHEM CYTOCHEM, V33, P737, DOI 10.1177/33.8.2410480; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; MENE P, 1989, PHYSIOL REV, V69, P1347, DOI 10.1152/physrev.1989.69.4.1347; Mishra R, 2003, AM J PHYSIOL-CELL PH, V285, pC1109, DOI 10.1152/ajpcell.00105.2003; Mishra R, 2002, AM J PHYSIOL-RENAL, V283, pF1151, DOI 10.1152/ajprenal.00103.2002; Mishra R, 2008, ARTERIOSCL THROM VAS, V28, P541, DOI 10.1161/ATVBAHA.107.157339; Rask-Madsen C, 2007, NAT CLIN PRACT ENDOC, V3, P46, DOI 10.1038/ncpendmet0366; Sasser JM, 2007, J AM SOC NEPHROL, V18, P143, DOI 10.1681/ASN.2006030208; Schlondorff D, 2009, J AM SOC NEPHROL, V20, P1179, DOI 10.1681/ASN.2008050549; Shindo T, 2002, J MOL MED, V80, P105, DOI 10.1007/s00109-001-0284-4; SHULTZ PJ, 1988, AM J PHYSIOL, V255, pF674, DOI 10.1152/ajprenal.1988.255.4.F674; Simonson M., 2001, HANDB EXP PHARM, P115; Simonson MS, 2007, KIDNEY INT, V71, P846, DOI 10.1038/sj.ki.5002180; SIMONSON MS, 1989, J CLIN INVEST, V83, P708, DOI 10.1172/JCI113935; Sodhi CP, 2001, AM J PHYSIOL-RENAL, V280, pF667, DOI 10.1152/ajprenal.2001.280.4.F667; Solini A, 2007, GROWTH FACTORS, V25, P392, DOI 10.1080/08977190801892341; Sorokin A, 2003, AM J PHYSIOL-RENAL, V285, pF579, DOI 10.1152/ajprenal.00019.2003; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; Sutcliffe AM, 2009, BRIT J PHARMACOL, V157, P436, DOI 10.1111/j.1476-5381.2009.00143.x; Watson AMD, 2010, DIABETOLOGIA, V53, P192, DOI 10.1007/s00125-009-1540-3; Xu SW, 2004, MOL BIOL CELL, V15, P2707, DOI 10.1091/mbc.E03-12-0902; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Yang LL, 2004, CIRCULATION, V109, P255, DOI 10.1161/01.CIR.0000105701.98663.D4	39	55	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11003	11008		10.1074/jbc.M110.190793	http://dx.doi.org/10.1074/jbc.M110.190793			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21169360	Green Published, hybrid			2022-12-27	WOS:000288797100012
J	Cooper, TH; Bailey-Hill, K; Leifert, WR; McMurchie, EJ; Asgari, S; Glatz, RV				Cooper, Tamara H.; Bailey-Hill, Kelly; Leifert, Wayne R.; McMurchie, Edward J.; Asgari, Sassan; Glatz, Richard V.			Identification of an in Vitro Interaction between an Insect Immune Suppressor Protein (CrV2) and G alpha Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COTESIA-PLUTELLAE BRACOVIRUS; HETEROTRIMERIC G-PROTEIN; TRANSIENT EXPRESSION; HEMOCYTE INACTIVATION; ANTIMICROBIAL PEPTIDE; RUBECULA BRACOVIRUS; GALLERIA-MELLONELLA; ENDOPARASITOID WASP; POLYDNAVIRUS GENES; SPREADING BEHAVIOR	The protein CrV2 is encoded by a polydnavirus integrated into the genome of the endoparasitoid Cotesia rubecula (Hymenoptera: Braconidae:Microgastrinae) and is expressed in host larvae with other gene products of the polydnavirus to allow successful development of the parasitoid. CrV2 expression has previously been associated with immune suppression, although the molecular basis for this was not known. Here, we have used time-resolved Forster resonance energy transfer (TR-FRET) to demonstrate high affinity binding of CrV2 to G alpha subunits (but not the G beta gamma dimer) of heterotrimeric G-proteins. Signals up to 5-fold above background were generated, and an apparent dissociation constant of 6.2 nM was calculated. Protease treatment abolished the TR-FRET signal, and the presence of unlabeled CrV2 or G alpha proteins also reduced the TR-FRET signal. The activation state of the G alpha subunit was altered with aluminum fluoride, and this decreased the affinity of the interaction with CrV2. It was also demonstrated that CrV2 preferentially bound to Drosophila G alpha(o) compared with rat G alpha(i1). In addition, three CrV2 homologs were detected in sequences derived from polydnaviruses from Cotesia plutellae and Cotesia congregata (including the immune-related early expressed transcript, EP2). These data suggest a potential mode-of-action of immune suppressors not previously reported, which in addition to furthering our understanding of insect immunity may have practical benefits such as facilitating development of novel controls for pest insect species.	[Cooper, Tamara H.; Bailey-Hill, Kelly; Glatz, Richard V.] S Australian Res & Dev Inst, Urrbrae, SA 5064, Australia; [Cooper, Tamara H.; Bailey-Hill, Kelly; Leifert, Wayne R.; McMurchie, Edward J.; Glatz, Richard V.] Commonwealth Sci & Ind Res Org, Div Mol & Hlth Technol, Adelaide, SA 5000, Australia; [Leifert, Wayne R.] Commonwealth Sci & Ind Res Org, Div Human Nutr, Adelaide, SA 5000, Australia; [Asgari, Sassan] Univ Queensland, Sch Biol Sci, St Lucia, Qld 4072, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland	Glatz, RV (corresponding author), GPO Box 397, Adelaide, SA 5001, Australia.	richard.glatz@sa.gov.au	Leifert, Wayne/H-4623-2013; Cooper, Tamara/F-3702-2013; Glatz, Richard/AAF-9483-2019; Asgari, Sassan/G-2678-2011	Leifert, Wayne/0000-0003-0535-7327; Glatz, Richard/0000-0001-8889-3701; Asgari, Sassan/0000-0001-7885-6544	OzNano2Life research initiative of the Australian Department of Education, Science, and Technology; CSIRO Emerging Science Area for Nanotechnology funding scheme; Australian Research Council [F09943013]; University of Queensland; Horticulture Australia Ltd. [VG08048]	OzNano2Life research initiative of the Australian Department of Education, Science, and Technology; CSIRO Emerging Science Area for Nanotechnology funding scheme; Australian Research Council(Australian Research Council); University of Queensland(University of Queensland); Horticulture Australia Ltd.(Horticulture Australia Limited)	This work was supported by the OzNano2Life research initiative of the Australian Department of Education, Science, and Technology, CSIRO Emerging Science Area for Nanotechnology funding scheme, Australian Research Council Grant F09943013, a University of Queensland grant (to S. A.), and a Horticulture Australia Ltd. Grant VG08048 (to R. G.).	Asgari S, 1996, J GEN VIROL, V77, P2653, DOI 10.1099/0022-1317-77-10-2653; Asgari S, 1997, J GEN VIROL, V78, P3061, DOI 10.1099/0022-1317-78-11-3061; Barandoc KP, 2009, COMP BIOCHEM PHYS D, V4, P218, DOI 10.1016/j.cbd.2009.03.003; Beck MH, 2007, P NATL ACAD SCI USA, V104, P19267, DOI 10.1073/pnas.0708056104; Beckage NE, 1998, BIOSCIENCE, V48, P305, DOI 10.2307/1313357; Beckage NE, 2004, ANNU REV ENTOMOL, V49, P299, DOI 10.1146/annurev.ento.49.061802.123324; Bezier A, 2009, SCIENCE, V323, P926, DOI 10.1126/science.1166788; Blackmer T, 2005, NAT NEUROSCI, V8, P421, DOI 10.1038/nn1423; Blazer LL, 2010, MOL PHARMACOL, V78, P524, DOI 10.1124/mol.110.065128; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cytrynska M, 2006, J INSECT PHYSIOL, V52, P744, DOI 10.1016/j.jinsphys.2006.04.002; Dowal L, 2001, BIOCHEMISTRY-US, V40, P414, DOI 10.1021/bi001923+; Gad W, 2008, J GEN VIROL, V89, P931, DOI 10.1099/vir.0.83585-0; Gitau CW, 2007, J INSECT PHYSIOL, V53, P676, DOI 10.1016/j.jinsphys.2007.04.008; Glatz R, 2004, J GEN VIROL, V85, P2873, DOI 10.1099/vir.0.80307-0; Glatz R, 2003, J BIOL CHEM, V278, P19743, DOI 10.1074/jbc.M301396200; Glatz RV, 2004, TRENDS MICROBIOL, V12, P545, DOI 10.1016/j.tim.2004.10.004; HARWOOD SH, 1994, INSECT BIOCHEM MOLEC, V24, P685, DOI 10.1016/0965-1748(94)90056-6; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; Ibrahim AMA, 2008, NATURWISSENSCHAFTEN, V95, P25, DOI 10.1007/s00114-007-0290-7; Knight PJK, 2004, ARCH INSECT BIOCHEM, V57, P142, DOI 10.1002/arch.20018; Kroemer JA, 2004, ANNU REV ENTOMOL, V49, P431, DOI 10.1146/annurev.ento.49.072103.120132; Kroemer JA, 2006, J VIROL, V80, P12219, DOI 10.1128/JVI.01187-06; Kurata S, 2006, IMMUNOBIOLOGY, V211, P237, DOI 10.1016/j.imbio.2005.10.016; Kwon B, 2008, DEV COMP IMMUNOL, V32, P932, DOI 10.1016/j.dci.2008.01.005; Labropoulou V, 2008, CELL MICROBIOL, V10, P2118, DOI 10.1111/j.1462-5822.2008.01195.x; LANG J, 1995, EMBO J, V14, P3635, DOI 10.1002/j.1460-2075.1995.tb00033.x; Lee S, 2008, COMP BIOCHEM PHYS A, V149, P351, DOI 10.1016/j.cbpa.2008.01.007; Leifert WR, 2006, ANAL BIOCHEM, V355, P201, DOI 10.1016/j.ab.2006.04.042; Lentschat A, 2005, J IMMUNOL, V174, P4252, DOI 10.4049/jimmunol.174.7.4252; Malagoli D, 2000, PEPTIDES, V21, P175, DOI 10.1016/S0196-9781(99)00203-X; Marin D, 2005, J INSECT PHYSIOL, V51, P575, DOI 10.1016/j.jinsphys.2005.02.010; NAKAMURA T, 1988, J BIOL CHEM, V263, P16709; Nalini M, 2008, J INSECT PHYSIOL, V54, P1125, DOI 10.1016/j.jinsphys.2008.04.023; Nalini M, 2007, J INSECT PHYSIOL, V53, P1283, DOI 10.1016/j.jinsphys.2007.07.004; NISHIOKA T, 2007, BIOMEMS BIOMEDICAL N, V3, P437; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Ozaki A, 2005, FEBS J, V272, P3863, DOI 10.1111/j.1742-4658.2005.04800.x; Raftos DA, 2004, DEV COMP IMMUNOL, V28, P181, DOI 10.1016/S0145-305X(03)00136-8; Roda A, 2009, ANAL BIOANAL CHEM, V393, P109, DOI 10.1007/s00216-008-2435-8; Sarvazyan NA, 1998, J BIOL CHEM, V273, P7934, DOI 10.1074/jbc.273.14.7934; Selvin PR, 2002, ANNU REV BIOPH BIOM, V31, P275, DOI 10.1146/annurev.biophys.31.101101.140927; Shia M, 2008, VIROLOGY, V375, P374, DOI 10.1016/j.virol.2008.02.027; Solon E, 1996, DEV COMP IMMUNOL, V20, P307, DOI 10.1016/S0145-305X(96)00022-5; SONDEK J, 1994, NATURE, V372, P276, DOI 10.1038/372276a0; STOLTZ DB, 1990, J GEN VIROL, V71, P1051, DOI 10.1099/0022-1317-71-5-1051; STOLTZ DB, 1993, PARASITES PATHOGENS, P80; STRAND MR, 1995, J GEN VIROL, V76, P283, DOI 10.1099/0022-1317-76-2-283; Teramato T, 2003, J INSECT PHYSIOL, V49, P463, DOI 10.1016/S0022-1910(03)00063-5; Volkoff AN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000923; Wall MA, 1998, STRUCTURE, V6, P1169, DOI 10.1016/S0969-2126(98)00117-8; WEBB BA, 2005, 8 INT COMM TAX VIR, P255; WEBB BA, 2005, COMPREHENSIVE MOL IN, P260	54	11	11	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10466	10475		10.1074/jbc.M110.214726	http://dx.doi.org/10.1074/jbc.M110.214726			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21233205	Green Published, hybrid			2022-12-27	WOS:000288547000063
J	Bush, DJ; Kirillova, O; Clark, SA; Davulcu, O; Fabiola, F; Xie, Q; Somasundaram, T; Ellington, WR; Chapman, MS				Bush, D. Jeffrey; Kirillova, Olga; Clark, Shawn A.; Davulcu, Omar; Fabiola, Felcy; Xie, Qing; Somasundaram, Thayumanasamy; Ellington, W. Ross; Chapman, Michael S.			The Structure of Lombricine Kinase IMPLICATIONS FOR PHOSPHAGEN KINASE CONFORMATIONAL CHANGES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE KINASE; CREATINE-KINASE; CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; INDUCED-FIT; REFINEMENT; SYSTEM; CONSEQUENCES; GLYCOCYAMINE; MUTAGENESIS	Lombricine kinase is a member of the phosphagen kinase family and a homolog of creatine and arginine kinases, enzymes responsible for buffering cellular ATP levels. Structures of lombricine kinase from the marine worm Urechis caupo were determined by x-ray crystallography. One form was crystallized as a nucleotide complex, and the other was substrate-free. The two structures are similar to each other and more similar to the substrate-free forms of homologs than to the substrate-bound forms of the other phosphagen kinases. Active site specificity loop 309-317, which is disordered in substrate-free structures of homologs and is known from the NMR of arginine kinase to be inherently dynamic, is resolved in both lombricine kinase structures, providing an improved basis for understanding the loop dynamics. Phosphagen kinases undergo a segmented closing on substrate binding, but the lombricine kinase ADP complex is in the open form more typical of substrate-free homologs. Through a comparison with prior complexes of intermediate structure, a correlation was revealed between the overall enzyme conformation and the substrate interactions of His(178). Comparative modeling provides a rationale for the more relaxed specificity of these kinases, of which the natural substrates are among the largest of the phosphagen substrates.	[Bush, D. Jeffrey; Clark, Shawn A.] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Kirillova, Olga; Davulcu, Omar; Xie, Qing; Chapman, Michael S.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Sch Med, Portland, OR 97239 USA; [Fabiola, Felcy; Somasundaram, Thayumanasamy] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA; [Ellington, W. Ross] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; Oregon Health & Science University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Chapman, MS (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Sch Med L224, Portland, OR 97239 USA.	chapmami@ohsu.edu		Somasundaram, Thayumanasamy/0000-0002-3629-5117; Chapman, Michael/0000-0001-8525-8585	National Institutes of Health [GM55837, GM77643, GM78538, RR-01646]; American Heart Association [0315101B]; National Science Foundation [DMR 0225180]; U. S. Department of Energy [W-31-109-Eng-38]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078538, R01GM077643, R01GM055837] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); U. S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM55837, GM77643, and GM78538 (to M.S.C.). This work was also supported by Predoctoral Fellowship 0315101B from the American Heart Association (to D.J.B.).; Diffraction data were collected at the Cornell High Energy Synchrotron Source and its MacCHESS resource, supported by the National Science Foundation (DMR 0225180) and the National Institutes of Health (RR-01646) and also at the Southeast Regional Collaborative Access Team (SER-CAT) 22-BM beamline at the Advanced Photon Source, supported by the U. S. Department of Energy (W-31-109-Eng-38).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Azzi A, 2004, PROTEIN SCI, V13, P575, DOI 10.1110/ps.03428304; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BLETHEN SL, 1972, ARCH BIOCHEM BIOPHYS, V149, P244, DOI 10.1016/0003-9861(72)90319-0; Boehr DD, 2008, SCIENCE, V320, P1429, DOI 10.1126/science.1158818; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Bong SM, 2008, FEBS LETT, V582, P3959, DOI 10.1016/j.febslet.2008.10.039; BOYER R, 1998, CONCEPTS BIOCH; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chapman MS., 2006, CREATINE KINASE, P69; Chen LH, 1996, BIOCHEMISTRY-US, V35, P7895, DOI 10.1021/bi952798i; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Davulcu O, 2009, STRUCTURE, V17, P1356, DOI 10.1016/j.str.2009.08.014; DUMAS C, 1983, FEBS LETT, V153, P128, DOI 10.1016/0014-5793(83)80132-X; Eder M, 1999, PROTEIN SCI, V8, P2258; Eder M, 2000, PROTEINS, V39, P216, DOI 10.1002/(SICI)1097-0134(20000515)39:3<216::AID-PROT40>3.0.CO;2-#; Ellington WR, 2001, ANNU REV PHYSIOL, V63, P289, DOI 10.1146/annurev.physiol.63.1.289; Ellington WR, 2002, BIOCHEM BIOPH RES CO, V291, P939, DOI 10.1006/bbrc.2002.6539; Ellington WR, 1998, BIOL BULL-US, V195, P264, DOI 10.2307/1543138; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez P, 2007, PROTEINS, V69, P209, DOI 10.1002/prot.21557; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Forstner M, 1997, PROTEIN SCI, V6, P331; Forstner M, 1998, BIOPHYS J, V75, P1016, DOI 10.1016/S0006-3495(98)77590-3; FritzWolf K, 1996, NATURE, V381, P341, DOI 10.1038/381341a0; FURTER R, 1993, BIOCHEMISTRY-US, V32, P7022, DOI 10.1021/bi00078a030; Gattis JL, 2004, BIOCHEMISTRY-US, V43, P8680, DOI 10.1021/bi049793i; GERSTEIN M, 1991, J MOL BIOL, V220, P133, DOI 10.1016/0022-2836(91)90387-L; Grosse-Kunstleve RW, 2001, ACTA CRYSTALLOGR D, V57, P1390, DOI 10.1107/S090744490101246X; HANSEN DE, 1981, J BIOL CHEM, V256, P5967; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hosfield D, 2003, J STRUCT BIOL, V142, P207, DOI 10.1016/S1047-8477(03)00051-0; HOWLIN B, 1989, ACTA CRYSTALLOGR A, V45, P851, DOI 10.1107/S0108767389009177; Jones TA, 2004, ACTA CRYSTALLOGR D, V60, P2115, DOI 10.1107/S0907444904023509; Jourden MJ, 2007, BBA-PROTEINS PROTEOM, V1774, P1519, DOI 10.1016/j.bbapap.2007.10.001; Kirillova O, 2006, BIOINFORMATICS, V22, P1660, DOI 10.1093/bioinformatics/btl152; KLEYWEGT GJ, 1996, CCP4 ESF EACBM NEWSL, V32, P32; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lahiri SD, 2002, BIOCHEMISTRY-US, V41, P13861, DOI 10.1021/bi026655p; Lim K, 2010, BIOCHEMISTRY-US, V49, P2031, DOI 10.1021/bi9020988; Ma BY, 1999, PROTEIN ENG, V12, P713, DOI 10.1093/protein/12.9.713; MAGGIO ET, 1977, J BIOL CHEM, V252, P1202; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MURALI N, 1993, BIOCHEMISTRY-US, V32, P12941, DOI 10.1021/bi00210a049; MURALI N, 1994, BIOCHEMISTRY-US, V33, P14227, DOI 10.1021/bi00251a035; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Niu XG, 2011, J MOL BIOL, V405, P479, DOI 10.1016/j.jmb.2010.11.007; Novak WRP, 2004, BIOCHEMISTRY-US, V43, P13766, DOI 10.1021/bi049060y; Ohren JF, 2007, ACTA CRYSTALLOGR D, V63, P381, DOI 10.1107/S0907444906056204; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pruett PS, 2003, J BIOL CHEM, V278, P26952, DOI 10.1074/jbc.M212931200; RAO BDN, 1976, J BIOL CHEM, V251, P6981; Rao JK, 1998, FEBS LETT, V439, P133; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rhee S, 1997, BIOCHEMISTRY-US, V36, P7664, DOI 10.1021/bi9700429; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schlattner U, 1998, MOL CELL BIOCHEM, V184, P125, DOI 10.1023/A:1006851330913; Shen YQ, 2001, ACTA CRYSTALLOGR D, V57, P1196, DOI 10.1107/S0907444901007703; Suzuki T, 2000, J BIOL CHEM, V275, P23884, DOI 10.1074/jbc.M002926200; Suzuki T, 1999, BIOCHEM J, V340, P671, DOI 10.1042/0264-6021:3400671; Suzuki T, 2009, COMP BIOCHEM PHYS B, V152, P60, DOI 10.1016/j.cbpb.2008.09.087; Szebenyi DME, 1997, J SYNCHROTRON RADIAT, V4, P128, DOI 10.1107/S0909049597000204; Tanaka K, 2004, FEBS LETT, V573, P78, DOI 10.1016/j.febslet.2004.07.061; Tisi D, 2001, ACTA CRYSTALLOGR D, V57, P187, DOI 10.1107/S0907444900015614; TOMBES RM, 1985, CELL, V41, P325, DOI 10.1016/0092-8674(85)90085-6; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu XA, 2010, FASEB J, V24, P242, DOI 10.1096/fj.09-140194; Yousef MS, 2003, PROTEIN SCI, V12, P103, DOI 10.1110/ps.0226303; Yousef MS, 2002, ACTA CRYSTALLOGR D, V58, P2009, DOI 10.1107/S0907444902014683; Zhou GF, 1998, P NATL ACAD SCI USA, V95, P8449, DOI 10.1073/pnas.95.15.8449	76	18	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9338	9350		10.1074/jbc.M110.202796	http://dx.doi.org/10.1074/jbc.M110.202796			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21212263	Green Published, hybrid			2022-12-27	WOS:000288247700063
J	Kazi, A; Sun, JZ; Doi, K; Sung, SS; Takahashi, Y; Yin, H; Rodriguez, JM; Becerril, J; Berndt, N; Hamilton, AD; Wang, HG; Sebti, SM				Kazi, Aslamuzzaman; Sun, Jiazhi; Doi, Kenichiro; Sung, Shen-Shu; Takahashi, Yoshinori; Yin, Hang; Rodriguez, Johanna M.; Becerril, Jorge; Berndt, Norbert; Hamilton, Andrew D.; Wang, Hong-Gang; Sebti, Said M.			The BH3 alpha-Helical Mimic BH3-M6 Disrupts Bcl-X-L, Bcl-2, and MCL-1 Protein-Protein Interactions with Bax, Bak, Bad, or Bim and Induces Apoptosis in a Bax- and Bim-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITORS; MIMETIC ABT-737; PROTEASOME INHIBITOR; FAMILY PROTEINS; CONFORMATIONAL-CHANGE; ACCURATE DOCKING; IN-VITRO; CANCER; RESISTANCE; EXPRESSION	A critical hallmark of cancer cell survival is evasion of apoptosis. This is commonly due to overexpression of anti-apoptotic proteins such as Bcl-2, Bcl-X-L, and Mcl-1, which bind to the BH3 alpha-helical domain of pro-apoptotic proteins such as Bax, Bak, Bad, and Bim, and inhibit their function. We designed a BH3 alpha-helical mimetic BH3-M6 that binds to Bcl-X-L and Mcl-1 and prevents their binding to fluorescently labeled Bak- or Bim-BH3 peptides in vitro. Using several approaches, we demonstrate that BH3-M6 is a pan-Bcl-2 antagonist that inhibits the binding of Bcl-X-L, Bcl-2, and Mcl-1 to multi-domain Bax or Bak, or BH3-only Bim or Bad in cell-free systems and in intact human cancer cells, freeing up pro-apoptotic proteins to induce apoptosis. BH3-M6 disruption of these protein-protein interactions is associated with cytochrome c release from mitochondria, caspase-3 activation and PARP cleavage. Using caspase inhibitors and Bax and Bak siRNAs, we demonstrate that BH3-M6-induced apoptosis is caspase- and Bax-, but not Bak-dependent. Furthermore, BH3-M6 disrupts Bcl-X-L/Bim, Bcl-2/Bim, and Mcl-1/Bim protein-protein interactions and frees up Bim to induce apoptosis in human cancer cells that depend for tumor survival on the neutralization of Bim with Bcl-X-L, Bcl-2, or Mcl-1. Finally, BH3-M6 sensitizes cells to apoptosis induced by the proteasome inhibitor CEP-1612.	[Kazi, Aslamuzzaman; Sun, Jiazhi; Sung, Shen-Shu; Takahashi, Yoshinori; Berndt, Norbert; Wang, Hong-Gang; Sebti, Said M.] Univ S Florida, Drug Discovery Dept, H Lee Moffitt Canc Ctr, Tampa, FL 33612 USA; [Kazi, Aslamuzzaman; Sun, Jiazhi; Sung, Shen-Shu; Takahashi, Yoshinori; Berndt, Norbert; Wang, Hong-Gang; Sebti, Said M.] Univ S Florida, Dept Oncol Sci, Tampa, FL 33612 USA; [Kazi, Aslamuzzaman; Sun, Jiazhi; Sung, Shen-Shu; Takahashi, Yoshinori; Berndt, Norbert; Wang, Hong-Gang; Sebti, Said M.] Univ S Florida, Dept Mol Med, Tampa, FL 33612 USA; [Doi, Kenichiro] Penn State Univ, Dept Pharmacol, Hershey, PA 17033 USA; [Yin, Hang; Rodriguez, Johanna M.; Becerril, Jorge; Hamilton, Andrew D.] Yale Univ, Dept Chem, New Haven, CT 06511 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Yale University	Sebti, SM (corresponding author), 12902 Magnolia Dr,SRB3-DRDIS, Tampa, FL 33612 USA.	said.sebti@moffitt.org	Wang, Hong-Gang/A-3018-2015; YIN, HANG/O-2097-2014	Wang, Hong-Gang/0000-0003-0551-0571; YIN, HANG/0000-0002-9762-4818; Takahashi, Yoshinori/0000-0002-8004-4817	National Institutes of Health [CA118210, GM69850]; NATIONAL CANCER INSTITUTE [P30CA076292, P01CA118210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069850] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded, in whole or in part, by National Institutes of Health P01 Grants CA118210 and GM69850.	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Amundson SA, 2000, CANCER RES, V60, P6101; Azmi AS, 2009, J CELL PHYSIOL, V218, P13, DOI 10.1002/jcp.21567; Bruncko M, 2007, J MED CHEM, V50, P641, DOI 10.1021/jm061152t; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Degterev A, 2001, NAT CELL BIOL, V3, P173, DOI 10.1038/35055085; Ewings KE, 2007, CELL CYCLE, V6, P2236, DOI 10.4161/cc.6.18.4728; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Iqbal J, 2006, J CLIN ONCOL, V24, P961, DOI 10.1200/JCO.2005.03.4264; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kazi A, 2002, MOL PHARMACOL, V62, P765, DOI 10.1124/mol.62.4.765; Kazi A, 2009, CELL CYCLE, V8, P1940, DOI 10.4161/cc.8.12.8798; Kazi A, 2009, MOL CELL BIOL, V29, P2254, DOI 10.1128/MCB.01029-08; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Kitada S, 1998, BLOOD, V91, P3379, DOI 10.1182/blood.V91.9.3379; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Korsmeyer SJ, 1999, CANCER RES, V59, p1693S; Kramer MHH, 1998, BLOOD, V92, P3152, DOI 10.1182/blood.V92.9.3152.421a07_3152_3162; Kutzki O, 2002, J AM CHEM SOC, V124, P11838, DOI 10.1021/ja026861k; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Miller LA, 2009, J INVEST DERMATOL, V129, P964, DOI 10.1038/jid.2008.327; Mohammad RM, 2007, CLIN CANCER RES, V13, P2226, DOI 10.1158/1078-0432.CCR-06-1574; Nguyen M, 2007, P NATL ACAD SCI USA, V104, P19512, DOI 10.1073/pnas.0709443104; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Paoluzzi L, 2008, BLOOD, V112, P2906, DOI 10.1182/blood-2007-12-130781; Paoluzzi L, 2008, BLOOD, V111, P5350, DOI 10.1182/blood-2007-12-129833; Pellecchia M, 2004, CURR PHARM DESIGN, V10, P1387, DOI 10.2174/1381612043384880; Reed JC, 1996, J CELL BIOCHEM, V60, P23, DOI 10.1002/(SICI)1097-4644(19960101)60:1<23::AID-JCB5>3.3.CO;2-3; Saxena A, 2004, AM J HEMATOL, V75, P22, DOI 10.1002/ajh.10453; Sun JZ, 2001, CANCER RES, V61, P1280; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Wang JL, 2000, CANCER RES, V60, P1498; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Yamaguchi H, 2002, J BIOL CHEM, V277, P41604, DOI 10.1074/jbc.M207516200; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yin H, 2005, J AM CHEM SOC, V127, P10191, DOI 10.1021/ja050122x; Youle RJ, 2007, SCIENCE, V315, P776, DOI 10.1126/science.1138870	50	97	106	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9382	9392		10.1074/jbc.M110.203638	http://dx.doi.org/10.1074/jbc.M110.203638			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21148306	hybrid, Green Published			2022-12-27	WOS:000288247700067
J	Park, R; Wang'ondu, R; Heston, L; Shedd, D; Miller, G				Park, Richard; Wang'ondu, Ruth; Heston, Lee; Shedd, Duane; Miller, George			Efficient Induction of Nuclear Aggresomes by Specific Single Missense Mutations in the DNA-binding Domain of a Viral AP-1 Homolog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; ZEBRA PROTEIN; TRANSCRIPTIONAL ACTIVATION; EXPANDED POLYGLUTAMINE; HUNTINGTONS-DISEASE; ZTA TRANSACTIVATOR; CRYSTAL-STRUCTURE; INCLUSION-BODIES; GENE-EXPRESSION; BODY FORMATION	Nuclear aggresomes induced by proteins containing an expanded polyglutamine (polyQ) tract are pathologic hallmarks of certain neurodegenerative diseases. Some GFP fusion proteins lacking a polyQ tract may also induce nuclear aggresomes in cultured cells. Here we identify single missense mutations within the basic DNA recognition region of Bam HI Z E B virus replication activator (ZEBRA), an Epstein-Barr virus (EBV)-encoded basic zipper protein without a polyQ tract, that efficiently induced the formation of nuclear aggresomes. Wild-type (WT) ZEBRA was diffusely distributed within the nucleus. Four non-DNA-binding mutants, Z(R179E), Z(R183E), Z(R190E), and Z(K178D) localized to the periphery of large intranuclear spheres, to discrete nuclear aggregates, and to the cytoplasm. Other non-DNA-binding mutants, Z(N182K), Z(N182E), and Z(S186E), did not exhibit this phenotype. The interior of the spheres contained promyelocytic leukemia and HSP70 proteins. ZEBRA mutants directly induced the nuclear aggresome pathway in cells with and without EBV. Specific cellular proteins (SC35 and HDAC6) and viral proteins (WT ZEBRA, Rta, and BMLF1) but not other cellular or viral proteins were recruited to nuclear aggresomes. Co-transfection of WT ZEBRA with aggresome-inducing mutants Z(R183E) and Z(R179E) inhibited late lytic viral protein expression and lytic viral DNA amplification. This is the first reported instance in which nuclear aggresomes are induced by single missense mutations in a viral or cellular protein. We discuss conformational changes in the mutant viral AP-1 proteins that may lead to formation of nuclear aggresomes.	[Heston, Lee; Shedd, Duane; Miller, George] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; [Park, Richard; Miller, George] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Wang'ondu, Ruth] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06520 USA; [Miller, George] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA	Yale University; Yale University; Yale University; Yale University	Miller, G (corresponding author), Yale Univ, Sch Med, Dept Pediat, 333 Cedar St,420 LSOG,POB 208064, New Haven, CT 06520 USA.	George.Miller@yale.edu		wangondu, ruth/0000-0002-4586-8933	National Institutes of Health [CA12055, CA16038]; Medical Scientist Training Program [2T32GM07205]; NATIONAL CANCER INSTITUTE [R37CA012055, P01CA016038, R01CA012055] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA12055 and CA16038 and Training Grant 2T32GM07205 from the Medical Scientist Training Program (to R. W.).	Adamson AL, 1999, J VIROL, V73, P6551, DOI 10.1128/JVI.73.8.6551-6558.1999; Adamson AL, 2001, J VIROL, V75, P2388, DOI 10.1128/JVI.75.5.2388-2399.2001; Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; ASCOLI CA, 1991, J CELL BIOL, V112, P785, DOI 10.1083/jcb.112.5.785; Bell P, 2000, J VIROL, V74, P11800, DOI 10.1128/JVI.74.24.11800-11810.2000; Bertrand L, 2010, J VIROL, V84, P109, DOI 10.1128/JVI.01428-09; Boyault C, 2007, GENE DEV, V21, P2172, DOI 10.1101/gad.436407; Chai YH, 2001, J BIOL CHEM, V276, P44889, DOI 10.1074/jbc.M106575200; CHANG YN, 1990, J VIROL, V64, P3358, DOI 10.1128/JVI.64.7.3358-3369.1990; Chen L, 2001, VIROLOGY, V288, P119, DOI 10.1006/viro.2001.1057; CHI TH, 1995, NATURE, V377, P254, DOI 10.1038/377254a0; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245; Dovey CL, 2004, J PATHOL, V203, P877, DOI 10.1002/path.1604; DYCK JA, 1994, CELL, V76, P333, DOI 10.1016/0092-8674(94)90340-9; El-Guindy AS, 2004, J VIROL, V78, P7634, DOI 10.1128/JVI.78.14.7634-7644.2004; ELLENBERGER TE, 1992, CELL, V71, P1223, DOI 10.1016/S0092-8674(05)80070-4; FARRELL PJ, 1989, EMBO J, V8, P127, DOI 10.1002/j.1460-2075.1989.tb03356.x; Feederle R, 2000, EMBO J, V19, P3080, DOI 10.1093/emboj/19.12.3080; Fink AL, 1998, FOLD DES, V3, pR9, DOI 10.1016/S1359-0278(98)00002-9; Francis AL, 1997, J VIROL, V71, P3054, DOI 10.1128/JVI.71.4.3054-3061.1997; Friedman MJ, 2007, NAT NEUROSCI, V10, P1519, DOI 10.1038/nn2011; Fu LW, 2005, NEUROBIOL DIS, V20, P656, DOI 10.1016/j.nbd.2005.05.015; Fu LW, 2005, MOL BIOL CELL, V16, P4905, DOI 10.1091/mbc.E05-01-0019; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; GLOVER JNM, 1995, NATURE, V373, P257, DOI 10.1038/373257a0; GRAHAM FL, 1974, NATURE, V251, P687, DOI 10.1038/251687a0; Heston L, 2006, J VIROL, V80, P9115, DOI 10.1128/JVI.00909-06; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Johnston JA, 2000, P NATL ACAD SCI USA, V97, P12571, DOI 10.1073/pnas.220417997; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kamil JP, 2007, J VIROL, V81, P10659, DOI 10.1128/JVI.00497-07; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lehman AM, 1998, J BIOL CHEM, V273, P932, DOI 10.1074/jbc.273.2.932; LIEBERMAN PM, 1990, J VIROL, V64, P1143, DOI 10.1128/JVI.64.3.1143-1155.1990; LIEBERMAN PM, 1994, GENE DEV, V8, P995, DOI 10.1101/gad.8.9.995; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Lymberopoulos MH, 2007, VIROLOGY, V363, P397, DOI 10.1016/j.virol.2007.01.028; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Miranker AD, 2005, NATURE, V437, P197, DOI 10.1038/437197a; Moran DM, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-32; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Park R, 2008, VIROLOGY, V382, P145, DOI 10.1016/j.virol.2008.09.009; PEARSON GR, 1983, J VIROL, V47, P193, DOI 10.1128/JVI.47.1.193-201.1983; Petosa C, 2006, MOL CELL, V21, P565, DOI 10.1016/j.molcel.2006.01.006; Prichard MN, 2008, J VIROL, V82, P5054, DOI 10.1128/JVI.02174-07; Qin QY, 2006, J CELL BIOL, V172, P497, DOI 10.1083/jcb.200505079; RAABTRAUB N, 1986, CELL, V47, P883, DOI 10.1016/0092-8674(86)90803-2; Sambashivan S, 2005, NATURE, V437, P266, DOI 10.1038/nature03916; Schelcher C, 2007, J VIROL, V81, P7149, DOI 10.1128/JVI.00215-07; Schmidt U, 2006, J CELL BIOL, V172, P373, DOI 10.1083/jcb.200503061; SCHMIDTZACHMANN MS, 1993, J CELL SCI, V105, P799; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; TOKUYASU KT, 1983, J CELL BIOL, V97, P562, DOI 10.1083/jcb.97.2.562; Wang P, 2005, J VIROL, V79, P13298, DOI 10.1128/JVI.79.21.13298-13309.2005; Wanker EE, 2000, BIOL CHEM, V381, P937, DOI 10.1515/BC.2000.114; YOUNG LS, 1991, J VIROL, V65, P2868, DOI 10.1128/JVI.65.6.2868-2874.1991; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	63	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9748	9762		10.1074/jbc.M110.198325	http://dx.doi.org/10.1074/jbc.M110.198325			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21233201	Green Published, hybrid			2022-12-27	WOS:000288247700098
J	Tsvetkov, P; Adamovich, Y; Elliott, E; Shaul, Y				Tsvetkov, Peter; Adamovich, Yaarit; Elliott, Evan; Shaul, Yosef			E3 Ligase STUB1/CHIP Regulates NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Accumulation in Aged Brain, a Process Impaired in Certain Alzheimer Disease Patients	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; PROTEASOMAL DEGRADATION; NAD(P)H-QUINONE OXIDOREDUCTASE-1; OXIDATIVE STRESS; DT-DIAPHORASE; PHOSPHORYLATED TAU; CHIP; POLYMORPHISM; ASSOCIATION; P53	NAD(P) H: quinone oxidoreductase 1 (NQO1) is a flavoenzyme that is important in maintaining the cellular redox state and regulating protein degradation. The NQO1 polymorphism C609T has been associated with increased susceptibility to various age-related pathologies. We show here that NQO1 protein level is regulated by the E3 ligase STUB1/CHIP (C terminus of Hsc70-interacting protein). NQO1 binds STUB1 via the Hsc70-interacting domain (tetratricopeptide repeat domain) and undergoes ubiquitination and degradation. We demonstrate here that the product of the C609T polymorphism (P187S) is a stronger STUB1 interactor with increased susceptibility to ubiquitination by the E3 ligase STUB1. Furthermore, age-dependent decrease of STUB1 correlates with increased NQO1 accumulation. Remarkably, examination of hippocampi from Alzheimer disease patients revealed that in half of the cases examined the NQO1 protein level was undetectable due to C609T polymorphism, suggesting that the age-dependent accumulation of NQO1 is impaired in certain Alzheimer disease patients.	[Tsvetkov, Peter; Adamovich, Yaarit; Shaul, Yosef] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Elliott, Evan] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Shaul, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	yosef.shaul@weizmann.ac.il	Tsvetkov, Peter/D-6458-2011; Tsvetkov, Peter/J-9878-2019	Tsvetkov, Peter/0000-0002-7577-2342; Elliott, Evan/0000-0002-1630-969X; Adamovich, Yaarit/0000-0001-9583-0338	Israel Science Foundation [1040/03-18.2]; Federal German Ministry for Education and Research; Minerva Foundation	Israel Science Foundation(Israel Science Foundation); Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Minerva Foundation	This work was supported by Grant 1040/03-18.2 from the Israel Science Foundation and a grant from the Minerva Foundation with funding from the Federal German Ministry for Education and Research.	Adler J, 2010, MOL CELL BIOL, V30, P3767, DOI 10.1128/MCB.00899-09; Al-Ramahi I, 2006, J BIOL CHEM, V281, P26714, DOI 10.1074/jbc.M601603200; Anwar A, 2002, J BIOL CHEM, V277, P14060, DOI 10.1074/jbc.M111576200; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Bian JT, 2008, J MOL NEUROSCI, V34, P235, DOI 10.1007/s12031-008-9036-z; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Chen HW, 1999, CANCER RES, V59, P3045; Cheng XR, 2007, NEUROBIOL AGING, V28, P497, DOI 10.1016/j.neurobiolaging.2006.02.004; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; Dickey CA, 2007, TRENDS MOL MED, V13, P32, DOI 10.1016/j.molmed.2006.11.003; Dinkova-Kostova AT, 2010, ARCH BIOCHEM BIOPHYS, V501, P116, DOI 10.1016/j.abb.2010.03.019; Dinkova-Kostova LT, 2000, FREE RADICAL BIO MED, V29, P231, DOI 10.1016/S0891-5849(00)00300-2; Elliott E, 2007, J BIOL CHEM, V282, P37276, DOI 10.1074/jbc.M706379200; Elliott E, 2009, J NEUROCHEM, V109, P1168, DOI 10.1111/j.1471-4159.2009.06047.x; Esser C, 2005, J BIOL CHEM, V280, P27443, DOI 10.1074/jbc.M501574200; Friguet B, 2006, FEBS LETT, V580, P2910, DOI 10.1016/j.febslet.2006.03.028; Gaedigk A, 1998, PHARMACOGENETICS, V8, P305, DOI 10.1097/00008571-199808000-00004; Gaikwad A, 2001, J BIOL CHEM, V276, P22559, DOI 10.1074/jbc.M101053200; Garate M, 2008, EMBO REP, V9, P576, DOI 10.1038/embor.2008.48; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Hwang JR, 2005, CELL STRESS CHAPERON, V10, P147, DOI 10.1379/CSC-90R.1; Hyun DH, 2006, P NATL ACAD SCI USA, V103, P19908, DOI 10.1073/pnas.0608008103; Jaiswal AK, 2000, FREE RADICAL BIO MED, V29, P254, DOI 10.1016/S0891-5849(00)00306-3; Kajiro M, 2009, NAT CELL BIOL, V11, P312, DOI 10.1038/ncb1839; Ko HS, 2009, P NATL ACAD SCI USA, V106, P2897, DOI 10.1073/pnas.0810123106; Lafuente MJ, 2000, CARCINOGENESIS, V21, P1813, DOI 10.1093/carcin/21.10.1813; Loffek S, 2010, HUM MUTAT, V31, P466, DOI 10.1002/humu.21222; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Markesbery WR, 1997, FREE RADICAL BIO MED, V23, P134, DOI 10.1016/S0891-5849(96)00629-6; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Menzel HJ, 2004, BRIT J CANCER, V90, P1989, DOI 10.1038/sj.bjc.6601779; Moran JL, 1999, P NATL ACAD SCI USA, V96, P8150, DOI 10.1073/pnas.96.14.8150; Muller P, 2008, ONCOGENE, V27, P3371, DOI 10.1038/sj.onc.1211010; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Radjendirane V, 1998, J BIOL CHEM, V273, P7382, DOI 10.1074/jbc.273.13.7382; Raina AK, 1999, REDOX REP, V4, P23, DOI 10.1179/135100099101534701; Ross D, 2004, METHOD ENZYMOL, V382, P115; SantaCruz KS, 2004, NEUROBIOL AGING, V25, P63, DOI 10.1016/S0197-4580(03)00117-9; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Shin YG, 2005, J BIOL CHEM, V280, P23727, DOI 10.1074/jbc.M503326200; Siegel D, 2001, MOL PHARMACOL, V59, P263, DOI 10.1124/mol.59.2.263; Smith MT, 2001, BLOOD, V97, P1422, DOI 10.1182/blood.V97.5.1422; Sollner S, 2007, FEBS J, V274, P1328, DOI 10.1111/j.1742-4658.2007.05682.x; Sollner S, 2009, EMBO REP, V10, P65, DOI 10.1038/embor.2008.218; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Talalay P, 2004, METHOD ENZYMOL, V382, P355; Traver RD, 1997, BRIT J CANCER, V75, P69, DOI 10.1038/bjc.1997.11; Tsvetkov P, 2010, CELL DEATH DIFFER, V17, P103, DOI 10.1038/cdd.2009.67; Tsvetkov P, 2005, P NATL ACAD SCI USA, V102, P5535, DOI 10.1073/pnas.0501828102; Tsvetkov P, 2009, J BIOL CHEM, V284, P26234, DOI 10.1074/jbc.M109.040493; Varadarajan S, 2000, J STRUCT BIOL, V130, P184, DOI 10.1006/jsbi.2000.4274; Wang BB, 2006, NEUROSCI LETT, V409, P179, DOI 10.1016/j.neulet.2006.09.042; Wiemels JL, 1999, CANCER RES, V59, P4095	57	45	46	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8839	8845		10.1074/jbc.M110.193276	http://dx.doi.org/10.1074/jbc.M110.193276			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21220432	Green Published, hybrid			2022-12-27	WOS:000288247700014
J	Hutchinson, JA; Shanware, NP; Chang, HY; Tibbetts, RS				Hutchinson, John A.; Shanware, Naval P.; Chang, Haeyoon; Tibbetts, Randal S.			Regulation of Ribosomal Protein S6 Phosphorylation by Casein Kinase 1 and Protein Phosphatase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SIZE; IDENTIFICATION; TRANSLATION; ACTIVATION; INITIATION; INSULIN; SERUM	Ribosomal protein S6 (rpS6) is a critical component of the 40 S ribosomal subunit that mediates translation initiation at the 5'-m7GpppG cap of mRNA. In response to mitogenic stimuli, rpS6 undergoes ordered C-terminal phosphorylation by p70 S6 kinases and p90 ribosomal S6 kinases on four conserved Ser residues (Ser-235, Ser-236, Ser-240, and Ser-244) whose modification potentiates rpS6 cap binding activity. A fifth site, Ser-247, is also known to be phosphorylated, but its function and regulation are not well characterized. In this study, we employed phospho-specific antibodies to show that Ser-247 is a target of the casein kinase 1 (CK1) family of protein kinases. CK1-dependent phosphorylation of Ser-247 was induced by mitogenic stimuli and required prior phosphorylation of upstream S6 kinase/ribosomal S6 kinase residues. CK1-mediated phosphorylation of Ser-247 also enhanced the phosphorylation of upstream sites, which implies that bidirectional synergy between C-terminal phospho-residues is required to sustain rpS6 phosphorylation. Consistent with this idea, CK1-dependent phosphorylation of rpS6 promotes its association with the mRNA cap-binding complex in vitro. Additionally, we show that protein phosphatase 1 (PP1) antagonizes rpS6 C terminus phosphorylation and cap binding in intact cells. These findings further our understanding of rpS6 phospho-regulation and define a direct link between CK1 and translation initiation.	[Hutchinson, John A.; Shanware, Naval P.; Chang, Haeyoon; Tibbetts, Randal S.] Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Hutchinson, John A.; Tibbetts, Randal S.] Univ Wisconsin, Mol & Environm Toxicol Ctr, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Shanware, Naval P.; Tibbetts, Randal S.] Univ Wisconsin, Mol & Cellular Pharmacol Program, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Tibbetts, RS (corresponding author), Univ Wisconsin, Dept Pharmacol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	rstibbetts@wisc.edu		Tibbetts, Randal/0000-0003-2245-2297	National Institutes of Health [CA124722]; National Institutes of Health through the NIEHS [T32ES007015]; American Cancer Society; Greater Milwaukee Foundation; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA124722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health through the NIEHS; American Cancer Society(American Cancer Society); Greater Milwaukee Foundation; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA124722 (to R. S. T.) and National Institutes of Health Grant T32ES007015 through the NIEHS (to J. A. H.). This work was also supported by grants from the American Cancer Society and a Shaw Scientist Award from the Greater Milwaukee Foundation (to R. S. T.) and an American Heart Association Predoctoral Fellowship (to N. P. S.).	BELANDIA B, 1994, MOL CELL BIOL, V14, P200, DOI 10.1128/MCB.14.1.200; BURKHARD SJ, 1983, J BIOL CHEM, V258, P4003; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; DUNCAN R, 1982, EUR J BIOCHEM, V123, P535; Gao ZH, 2000, BIOCHEM BIOPH RES CO, V268, P562, DOI 10.1006/bbrc.2000.2168; HAAS DW, 1991, ARCH BIOCHEM BIOPHYS, V284, P84, DOI 10.1016/0003-9861(91)90267-M; Knippschild U, 2005, CELL SIGNAL, V17, P675, DOI 10.1016/j.cellsig.2004.12.011; KRIEG J, 1988, J BIOL CHEM, V263, P11473; MARTINPEREZ J, 1983, P NATL ACAD SCI-BIOL, V80, P926, DOI 10.1073/pnas.80.4.926; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Meyuhas O, 2008, INT REV CEL MOL BIO, V268, P1, DOI 10.1016/S1937-6448(08)00801-0; OLIVIER AR, 1988, P NATL ACAD SCI USA, V85, P4720, DOI 10.1073/pnas.85.13.4720; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Rena G, 2004, EMBO REP, V5, P60, DOI 10.1038/sj.embor.7400048; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Shima H, 1998, EMBO J, V17, P6649, DOI 10.1093/emboj/17.22.6649; THOMAS G, 1982, CELL, V30, P235, DOI 10.1016/0092-8674(82)90029-0; WETTENHALL REH, 1992, J BIOL CHEM, V267, P9021	21	69	71	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8688	8696		10.1074/jbc.M110.141754	http://dx.doi.org/10.1074/jbc.M110.141754			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21233202	hybrid, Green Published			2022-12-27	WOS:000288013300094
J	Konig, J; Wyllie, S; Wells, G; Stevens, MF; Wyatt, PG; Fairlamb, AH				Koenig, Janine; Wyllie, Susan; Wells, Geoffrey; Stevens, Malcolm F.; Wyatt, Paul G.; Fairlamb, Alan H.			Antitumor Quinol PMX464 Is a Cytocidal Anti-trypanosomal Inhibitor Targeting Trypanothione Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDOX-SENSITIVE OLIGOMERIZATION; CANCER CELL-LINES; TRYPANOSOMA-BRUCEI; TRYPAREDOXIN PEROXIDASES; CRITHIDIA-FASCICULATA; AFRICAN TRYPANOSOMES; CRYSTAL-STRUCTURE; MOLECULAR CHARACTERIZATION; SUBSTRATE-SPECIFICITY; THIOREDOXIN INHIBITOR	Better drugs are urgently needed for the treatment of African sleeping sickness. We tested a series of promising anticancer agents belonging to the 4-substituted 4-hydroxycyclohexa-2,5-dienones class ("quinols") and identified several with potent trypanocidal activity (EC50 < 100 nM). In mammalian cells, quinols are proposed to inhibit the thioredoxin/thioredoxin reductase system, which is absent from trypanosomes. Studies with the prototypical 4-benzothiazole-substituted quinol, PMX464, established that PMX464 is rapidly cytocidal, similar to the arsenical drug, melarsen oxide. Cell lysis by PMX464 was accelerated by addition of sublethal concentrations of glucose oxidase implicating oxidant defenses in the mechanism of action. Whole cells treated with PMX464 showed a loss of trypanothione (T(SH)(2)), a unique dithiol in trypanosomes, and tryparedoxin peroxidase (TryP), a 2-Cys peroxiredoxin similar to mammalian thioredoxin peroxidase. Enzyme assays revealed that T(SH)(2), TryP, and a glutathione peroxidase- like tryparedoxin-dependent peroxidase were inhibited in time-and concentration-dependent manners. The inhibitory activities of various quinol analogues against these targets showed a good correlation with growth inhibition of Trypanosoma brucei. The monothiols glutathione and L-cysteine bound in a 2: 1 ratio with PMX464 with K-d values of 6 and 27 mu M, respectively, whereas T(SH)(2) bound more tightly in a 1: 1 ratio with a K-d value of 430 nM. Overexpression of trypanothione synthetase in T. brucei decreased sensitivity to PMX464 indicating that the key metabolite T(SH)(2) is a target for quinols. Thus, the quinol pharmacophore represents a novel lead structure for the development of a new drug against African sleeping sickness.	[Koenig, Janine; Wyllie, Susan; Wyatt, Paul G.; Fairlamb, Alan H.] Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland; [Wells, Geoffrey; Stevens, Malcolm F.] Univ Nottingham, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England	University of Dundee; University of Nottingham	Fairlamb, AH (corresponding author), Univ Dundee, Coll Life Sci, Div Biol Chem & Drug Discovery, Dundee DD1 5EH, Scotland.	a.h.fairlamb@dundee.ac.uk	Fairlamb, Alan/A-5272-2009; Wyllie, Susan/AAI-4430-2021	Fairlamb, Alan/0000-0001-5134-0329; Wyatt, Paul/0000-0002-0397-245X; Wyllie, Susan/0000-0001-8810-5605; Wells, Geoffrey/0000-0002-0253-911X	Wellcome Trust [WT 079838, WT 077705, WT 083481]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Grants WT 079838, WT 077705, and WT 083481.	ABOAGYEKWARTENG T, 1992, MOL MICROBIOL, V6, P3089, DOI 10.1111/j.1365-2958.1992.tb01766.x; Alphey MS, 2008, BIOCHEM J, V414, P375, DOI 10.1042/BJ20080889; Alphey MS, 2003, J BIOL CHEM, V278, P25919, DOI 10.1074/jbc.M301526200; Alphey MS, 1999, J BIOL CHEM, V274, P25613, DOI 10.1074/jbc.274.36.25613; Alphey MS, 2000, J MOL BIOL, V300, P903, DOI 10.1006/jmbi.2000.3881; Ariyanayagam MR, 2001, MOL BIOCHEM PARASIT, V115, P189, DOI 10.1016/S0166-6851(01)00285-7; Augustyns K, 2001, CURR PHARM DESIGN, V7, P1117, DOI 10.2174/1381612013397564; Balasegaram M, 2006, B WORLD HEALTH ORGAN, V84, P783, DOI 10.2471/BLT.06.031955; Balasegaram M, 2009, T ROY SOC TROP MED H, V103, P280, DOI 10.1016/j.trstmh.2008.09.005; Berry JM, 2005, J MED CHEM, V48, P639, DOI 10.1021/jm040859h; Bond CS, 1999, STRUCTURE, V7, P81, DOI 10.1016/S0969-2126(99)80011-2; Bradshaw TD, 2005, CANCER RES, V65, P3911, DOI 10.1158/0008-5472.CAN-04-4141; Budde H, 2003, BIOL CHEM, V384, P619, DOI 10.1515/BC.2003.069; Callister ME, 2008, BRIT J PHARMACOL, V155, P661, DOI 10.1038/bjp.2008.258; Chew EH, 2008, FASEB J, V22, P2072, DOI 10.1096/fj.07-101477; Chew EH, 2006, BIOCHEM BIOPH RES CO, V346, P242, DOI 10.1016/j.bbrc.2006.05.106; Comini MA, 2007, BIOCHEM J, V402, P43, DOI 10.1042/BJ20061341; CUNNINGHAM ML, 1994, EUR J BIOCHEM, V221, P285, DOI 10.1111/j.1432-1033.1994.tb18740.x; Dormeyer M, 2001, J BIOL CHEM, V276, P10602, DOI 10.1074/jbc.M010352200; FAIRLAMB AH, 1987, MOL BIOCHEM PARASIT, V24, P185, DOI 10.1016/0166-6851(87)90105-8; FAIRLAMB AH, 1992, ANNU REV MICROBIOL, V46, P695, DOI 10.1146/annurev.micro.46.1.695; FAIRLAMB AH, 1985, SCIENCE, V227, P1485, DOI 10.1126/science.3883489; FAIRLAMB AH, 1989, P NATL ACAD SCI USA, V86, P2607, DOI 10.1073/pnas.86.8.2607; Flohe L, 1999, FREE RADICAL BIO MED, V27, P966, DOI 10.1016/S0891-5849(99)00172-0; GETHING MJH, 1972, EUR J BIOCHEM, V30, P352; Greig N, 2009, FEBS J, V276, P376, DOI 10.1111/j.1742-4658.2008.06788.x; HENDERSON GB, 1987, MOL BIOCHEM PARASIT, V24, P39, DOI 10.1016/0166-6851(87)90113-7; Hillebrand H, 2003, J BIOL CHEM, V278, P6809, DOI 10.1074/jbc.M210392200; Hopkins AL, 2006, CURR OPIN STRUC BIOL, V16, P127, DOI 10.1016/j.sbi.2006.01.013; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Jones DC, 2010, MOL BIOCHEM PARASIT, V169, P12, DOI 10.1016/j.molbiopara.2009.09.002; Kang SW, 2005, TRENDS MOL MED, V11, P571, DOI 10.1016/j.molmed.2005.10.006; Konig J, 2007, FEBS J, V274, P5643, DOI 10.1111/j.1742-4658.2007.06087.x; Konig J, 2003, J BIOL CHEM, V278, P24409, DOI 10.1074/jbc.M301145200; Krauth-Siegel RL, 2003, BIOL CHEM, V384, P539, DOI 10.1515/BC.2003.062; Krieger S, 2000, MOL MICROBIOL, V35, P542, DOI 10.1046/j.1365-2958.2000.01721.x; Lion CJ, 2006, BIOORG MED CHEM LETT, V16, P5005, DOI 10.1016/j.bmcl.2006.07.072; Ludemann H, 1998, FEBS LETT, V431, P381, DOI 10.1016/S0014-5793(98)00793-5; Mortimer CG, 2006, J MED CHEM, V49, P179, DOI 10.1021/jm050942k; Mukherjee A, 2005, BRIT J CANCER, V92, P350, DOI 10.1038/sj.bjc.6602338; Mukhopadhyay R, 1996, P NATL ACAD SCI USA, V93, P10383, DOI 10.1073/pnas.93.19.10383; Pallis M, 2003, BIOCHEM PHARMACOL, V66, P1695, DOI 10.1016/S0006-2952(03)00471-4; Pineyro MD, 2005, J STRUCT BIOL, V150, P11, DOI 10.1016/j.jsb.2004.12.005; Schlecker T, 2005, J BIOL CHEM, V280, P14385, DOI 10.1074/jbc.M413338200; Schlecker T, 2007, BIOCHEM J, V405, P445, DOI 10.1042/BJ20070259; Stuart K, 2008, J CLIN INVEST, V118, P1301, DOI 10.1172/JCI33945; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tetaud E, 2001, MOL BIOCHEM PARASIT, V116, P171, DOI 10.1016/S0166-6851(01)00320-6; Torrie LS, 2009, J BIOL CHEM, V284, P36137, DOI 10.1074/jbc.M109.045336; Trujillo M, 2004, J BIOL CHEM, V279, P34175, DOI 10.1074/jbc.M404317200; Wells G, 2003, J MED CHEM, V46, P532, DOI 10.1021/jm020984y; Wilkinson SR, 2003, J BIOL CHEM, V278, P31640, DOI 10.1074/jbc.M303035200; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Wyllie S, 2004, J BIOL CHEM, V279, P39925, DOI 10.1074/jbc.M405635200; Wyllie S, 2009, MOL MICROBIOL, V74, P529, DOI 10.1111/j.1365-2958.2009.06761.x	56	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8523	8533		10.1074/jbc.M110.214833	http://dx.doi.org/10.1074/jbc.M110.214833			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21212280	Green Published, hybrid			2022-12-27	WOS:000288013300079
J	Zhang, JH; Fukuhara, S; Sako, K; Takenouchi, T; Kitani, H; Kume, T; Koh, GY; Mochizuki, N				Zhang, Jianghui; Fukuhara, Shigetomo; Sako, Keisuke; Takenouchi, Takato; Kitani, Hiroshi; Kume, Tsutomu; Koh, Gou Young; Mochizuki, Naoki			Angiopoietin-1/Tie2 Signal Augments Basal Notch Signal Controlling Vascular Quiescence by Inducing Delta-Like 4 Expression through AKT-mediated Activation of beta-Catenin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITS TUMOR-GROWTH; TIE2 RECEPTOR; CELL-CELL; VESSEL FORMATION; ANGIOGENESIS; LIGAND; PATHWAY; DLL4; MATRIX; VEGF	Angiopoietin-1 (Ang1) regulates both vascular quiescence and angiogenesis through the receptor tyrosine kinase Tie2. We and another group previously showed that Ang1 and Tie2 form distinct signaling complexes at cell-cell and cell-matrix contacts. We further demonstrated that the former up-regulates Notch ligand delta-like 4 (Dll4) only in the presence of cell-cell contacts. Because Dll4/Notch signal restricts sprouting angiogenesis and promotes vascular stabilization, we investigated the mechanism of how the Ang1/Tie2 signal induces Dll4 expression to clarify the role of the Dll4/Notch signal in Ang1/Tie2 signal-mediated vascular quiescence. Under confluent endothelial cells, the basal Notch signal was observed. Ang1, moreover, induced Dll4 expression and production of the Notch intracellular domain (NICD). Ang1 stimulated transcriptional activity of beta-catenin through phosphoinositide 3-kinase (PI3K)/AKT-mediated phosphorylation of glycogen synthase kinase 3 beta (GSK3 beta). Correspondingly, the GSK3 beta inhibitor up-regulated Dll4, whereas depletion of beta-catenin by siRNA blocked Ang1-induced Dll4 expression, indicating the indispensability of beta-catenin in Ang1-mediated up-regulation of Dll4. In addition, Dll4 expression by the GSK3 beta inhibitor was only observed in confluent cells, and was impeded by DAPT, a gamma-secretase inhibitor, implying requirement of the Notch signal in beta-catenin-dependent Dll4 expression. Consistently, we found that either Ang1 or NICD up-regulates Dll4 through the RBP-J binding site within intron 3 of the DLL4 gene and that beta-catenin forms a complex with NICD/RBP-J to enhance Dll4 expression. Ang1 induced the deposition of extracellular matrix that is preferable for basement membrane formation through Dll4/Notch signaling. Collectively, the Ang1/Tie2 signal potentiates basal Notch signal controlling vascular quiescence by up-regulating Dll4 through AKT-mediated activation of beta-catenin.	[Zhang, Jianghui; Fukuhara, Shigetomo; Sako, Keisuke; Mochizuki, Naoki] Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Cell Biol, Osaka 5658565, Japan; [Takenouchi, Takato; Kitani, Hiroshi] Natl Inst Agrobiol Sci, Transgenic Anim Res Ctr, Ibaraki 3058634, Japan; [Takenouchi, Takato] Tokyo Metropolitan Inst Neurosci, Lab Chem & Metab, Tokyo 1838526, Japan; [Kume, Tsutomu] Northwestern Univ, Feinberg Cardiovasc Res Inst, Chicago, IL 60611 USA; [Koh, Gou Young] Korea Adv Inst Sci & Technol, Biomed Res Ctr, Taejon 305701, South Korea; [Koh, Gou Young] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	National Cerebral & Cardiovascular Center - Japan; National Institute of Agrobiological Sciences - Japan; Tokyo Metropolitan Institute for Neuroscience; Tokyo Metropolitan Institute of Medical Science; Northwestern University; Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Fukuhara, S (corresponding author), Natl Cerebral & Cardiovasc Ctr Res Inst, Dept Cell Biol, 5-7-1 Fujishirodai, Osaka 5658565, Japan.	fuku@ri.ncvc.go.jp; nmochizu@ri.ncvc.go.jp	Koh, Gou Young/C-1615-2011	sako, keisuke/0000-0002-6453-8075	Ministry of Education, Science, Sports and Culture of Japan; Ministry of Health, Labor, and Welfare of Japan; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; Naito Foundation; Takeda Science Foundation; Sagawa Foundation for Promotion of Cancer Research; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kowa Life Science Foundation; Kanae Foundation for the Promotion of Medical Science; Novartis Foundation (Japan) for the Promotion of Science; Senri Life Science Foundation; Mitsubishi Foundation; AstraZeneca; Grants-in-Aid for Scientific Research [22113009, 22390040] Funding Source: KAKEN; NATIONAL EYE INSTITUTE [R01EY019484] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074121] Funding Source: NIH RePORTER	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Sagawa Foundation for Promotion of Cancer Research; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Kowa Life Science Foundation; Kanae Foundation for the Promotion of Medical Science; Novartis Foundation (Japan) for the Promotion of Science(Novartis); Senri Life Science Foundation; Mitsubishi Foundation; AstraZeneca(AstraZeneca); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants from the Ministry of Education, Science, Sports and Culture of Japan (to S. F. and N. M.), the Ministry of Health, Labor, and Welfare of Japan (to N. M.), and the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (to S. F. and N. M.), grants from the Naito Foundation (to S. F.), Takeda Science Foundation (to S. F. and N. M.), the Sagawa Foundation for Promotion of Cancer Research (to S. F.), Mochida Memorial Foundation for Medical and Pharmaceutical Research (to S. F.), Kowa Life Science Foundation (to S. F.), Kanae Foundation for the Promotion of Medical Science (to S. F.), The Novartis Foundation (Japan) for the Promotion of Science (to S. F.), Senri Life Science Foundation (to S. F.), the Mitsubishi Foundation (to N. M.), and a AstraZeneca Research Grant (to N. M.).	Aoki K, 2005, MOL BIOL CELL, V16, P2207, DOI 10.1091/mbc.e04-10-0904; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Asahara T, 1998, CIRC RES, V83, P233, DOI 10.1161/01.RES.83.3.233; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Benedito R, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-117; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Cho CH, 2004, P NATL ACAD SCI USA, V101, P5547, DOI 10.1073/pnas.0307574101; Corada M, 2010, DEV CELL, V18, P938, DOI 10.1016/j.devcel.2010.05.006; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; Dou GR, 2008, FASEB J, V22, P1606, DOI 10.1096/fj.07-9998com; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Eklund L, 2006, EXP CELL RES, V312, P630, DOI 10.1016/j.yexcr.2005.09.002; Falcon BL, 2009, AM J PATHOL, V175, P2159, DOI 10.2353/ajpath.2009.090391; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Fukuhara S, 2000, J BIOL CHEM, V275, P21730, DOI 10.1074/jbc.M002410200; Fukuhara S, 2005, MOL CELL BIOL, V25, P136, DOI 10.1128/MCB.25.1.136-146.2005; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Fukuhara S, 2010, HISTOL HISTOPATHOL, V25, P387, DOI 10.14670/HH-25.387; Gridley T, 1997, MOL CELL NEUROSCI, V9, P103, DOI 10.1006/mcne.1997.0610; Hawighorst T, 2002, AM J PATHOL, V160, P1381, DOI 10.1016/S0002-9440(10)62565-5; Iivanainen E, 2003, FASEB J, V17, P1609, DOI 10.1096/fj.02-0939com; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Kobayashi H, 2006, BLOOD, V108, P1260, DOI 10.1182/blood-2005-09-012807; Koh W, 2008, METHOD ENZYMOL, V443, P83, DOI 10.1016/S0076-6879(08)02005-3; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Li JL, 2007, CANCER RES, V67, P11244, DOI 10.1158/0008-5472.CAN-07-0969; Lin PN, 1997, J CLIN INVEST, V100, P2072, DOI 10.1172/JCI119740; Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Machein MR, 2004, AM J PATHOL, V165, P1557, DOI 10.1016/S0002-9440(10)63413-X; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Peters KG, 2004, RECENT PROG HORM RES, V59, P51, DOI 10.1210/rp.59.1.51; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Sako K, 2009, J BIOL CHEM, V284, P5592, DOI 10.1074/jbc.M806928200; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Seo S, 2006, DEV BIOL, V294, P458, DOI 10.1016/j.ydbio.2006.03.035; Shimizu T, 2008, MOL CELL BIOL, V28, P7427, DOI 10.1128/MCB.01962-07; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9; Trindade A, 2008, BLOOD, V112, P1720, DOI 10.1182/blood-2007-09-112748; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Wong AL, 1997, CIRC RES, V81, P567, DOI 10.1161/01.RES.81.4.567; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yamamizu K, 2010, J CELL BIOL, V189, P325, DOI 10.1083/jcb.200904114; Yana I, 2007, J CELL SCI, V120, P1607, DOI 10.1242/jcs.000679	50	83	87	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8055	8066		10.1074/jbc.M110.192641	http://dx.doi.org/10.1074/jbc.M110.192641			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21212269	Green Published, hybrid			2022-12-27	WOS:000288013300036
J	Dluzen, D; Li, GF; Tacelosky, D; Moreau, M; Liu, DX				Dluzen, Douglas; Li, Guangfu; Tacelosky, Diana; Moreau, Matthew; Liu, David X.			BCL-2 Is a Downstream Target of ATF5 That Mediates the Prosurvival Function of ATF5 in a Cell Type-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR ATF5; NEURAL PROGENITOR CELLS; EPITHELIAL-CELLS; EXPRESSION; GENE; APOPTOSIS; PROMOTER; SURVIVAL; PROTEIN; FAMILY	ATF5 loss of function has been shown previously to cause apoptotic cell death in glioblastoma and breast cancer cells but not in non-transformed astrocytes and human breast epithelial cells. The mechanism for the cell type-dependent survival function of ATF5 is unknown. We report here that the anti-apoptotic factor BCL-2 is a downstream target of ATF5 that mediates the prosurvival function of ATF5 in C6 glioma cells and MCF-7 breast cancer cells. ATF5 binds to an ATF5-specific regulatory element that is downstream of and adjacent to the negative regulatory element in the BCL-2 P2 promoter, stimulating BCL-2 expression. Highlighting the critical role of BCL-2 in ATF5-dependent cancer cell survival, expression of BCL-2 blocks death of C6 and MCF-7 cells induced by dominant-negative ATF5, and depletion of BCL-2 impairs ATF5-promoted cell survival. Moreover, we found that BCL-2 expression is not regulated by ATF5 in non-transformed rat astrocytes, mouse embryonic fibroblasts, and human breast epithelial cells, where expression of BCL-2 but not ATF5 is required for cell survival. These findings identify BCL-2 as an essential mediator for the cancer-specific cell survival function of ATF5 in glioblastoma and breast cancer cells and provide direct evidence that the cell type-specific function of ATF5 derives from differential regulation of downstream targets by ATF5 in different types of cells.	[Dluzen, Douglas; Li, Guangfu; Tacelosky, Diana; Moreau, Matthew; Liu, David X.] Penn State Univ, Dept Neural & Behav Sci, Coll Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Liu, DX (corresponding author), Penn State Univ, Dept Neural & Behav Sci, Coll Med, Hershey, PA 17033 USA.	dliu@psu.edu		Li, Guangfu/0000-0002-9817-568X; Dluzen, Douglas/0000-0002-9426-5071	American Cancer Society; United States Department of Defense	American Cancer Society(American Cancer Society); United States Department of Defense(United States Department of Defense)	This work was supported in part by grants from the American Cancer Society and United States Department of Defense.	Angelastro JM, 2003, J NEUROSCI, V23, P4590; Angelastro JM, 2006, ONCOGENE, V25, P907, DOI 10.1038/sj.onc.1209116; Angelastro JM, 2005, J NEUROSCI, V25, P3889, DOI 10.1523/JNEUROSCI.3447-04.2005; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; CHEN HM, 1995, MOL CELL BIOL, V15, P3840; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Cole R, 2001, PROTOCOLS NEURAL CEL, P117, DOI [10.1385/1-59259-207-4:117, DOI 10.1385/1-59259-207-4:117]; Decary S, 2002, MOL CELL BIOL, V22, P7877, DOI 10.1128/MCB.22.22.7877-7888.2002; Garbe JC, 2007, CELL CYCLE, V6, P1927, DOI 10.4161/cc.6.15.4519; Gho JWM, 2008, CANCER RES, V68, P6743, DOI 10.1158/0008-5472.CAN-07-6469; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; Harris MH, 2000, CELL DEATH DIFFER, V7, P1182, DOI 10.1038/sj.cdd.4400781; Heckman CA, 2003, ONCOGENE, V22, P7891, DOI 10.1038/sj.onc.1206639; HOCKENBERY DM, 1991, P NATL ACAD SCI USA, V88, P6961, DOI 10.1073/pnas.88.16.6961; Ji L, 1996, J BIOL CHEM, V271, P22687, DOI 10.1074/jbc.271.37.22687; Li GF, 2009, MOL CANCER RES, V7, P933, DOI 10.1158/1541-7786.MCR-08-0365; Liu DX, 2001, NEURON, V32, P425, DOI 10.1016/S0896-6273(01)00495-0; Ma Q, 2007, J CELL BIOCHEM, V101, P477, DOI 10.1002/jcb.21198; Mason JL, 2005, MOL CELL NEUROSCI, V29, P372, DOI 10.1016/j.mcn.2005.03.004; MIYASHITA T, 1994, CANCER RES, V54, P3131; Monaco SE, 2007, INT J CANCER, V120, P1883, DOI 10.1002/ijc.22469; NOVACK DV, 1994, AM J PATHOL, V145, P61; Pascual M, 2008, DRUG METAB DISPOS, V36, P1063, DOI 10.1124/dmd.107.019380; Persengiev SP, 2002, GENE DEV, V16, P1806, DOI 10.1101/gad.992202; Peters CS, 2001, J BIOL CHEM, V276, P13718, DOI 10.1074/jbc.M011562200; SETO M, 1988, EMBO J, V7, P123, DOI 10.1002/j.1460-2075.1988.tb02791.x; Sheng Z, 2010, NAT MED, V16, P671, DOI 10.1038/nm.2158; Wang H, 2007, CELL BIOL INT, V31, P1309, DOI 10.1016/j.cellbi.2007.05.002; Wei YY, 2006, BIOCHEM BIOPH RES CO, V339, P591, DOI 10.1016/j.bbrc.2005.11.054; Yamazaki T, 2010, LIFE SCI, V87, P294, DOI 10.1016/j.lfs.2010.07.006; YOUNG RL, 1993, MOL CELL BIOL, V13, P3686, DOI 10.1128/MCB.13.6.3686	32	60	65	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7705	7713		10.1074/jbc.M110.207639	http://dx.doi.org/10.1074/jbc.M110.207639			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21212266	Green Published, hybrid			2022-12-27	WOS:000287737300083
J	Kong, RR; Zhang, LL; Hu, LL; Peng, QH; Han, W; Du, XJ; Ke, Y				Kong, Ruirui; Zhang, Liangliang; Hu, Lelin; Peng, Qunhui; Han, Wei; Du, Xiaojuan; Ke, Yang			hALP, A Novel Transcriptional U Three Protein (t-UTP), Activates RNA Polymerase I Transcription by Binding and Acetylating the Upstream Binding Factor (UBF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-RIBOSOMAL-RNA; NUCLEOLAR TRANSCRIPTION; RDNA TRANSCRIPTION; GENE-TRANSCRIPTION; COMPLEX SL1; HUMAN-CELLS; PHOSPHORYLATION; PROMOTER; RECRUITMENT; SUBUNIT	Transcription of ribosome RNA precursor (pre-rRNA) and pre-rRNA processing are coordinated by a subset of U three proteins (UTPs) known as transcriptional UTPs (t-UTPs), which participate in pre-rRNA transcription in addition to participation in 18 S rRNA processing. However, the mechanism by which t-UTPs function in pre-rRNA transcription remains undetermined. In the present study, we identified hALP, a histone acetyl-transferase as a novel t-UTP. We first showed that hALP is nucleolar, and is associated with U3 snoRNA and required for 18 S rRNA processing. Moreover, depletion of hALP resulted in a decreased level of 47 S pre-rRNA. Ectopic expression of hALP activated the rDNA promoter luciferase reporter and knockdown of hALP inhibited the reporter. In addition, hALP bound rDNA. Taken together these data identify hALP as a novel t-UTP. Immunoprecipitation and GST pulldown experiments showed that hALP binds the upstream binding factor (UBF) in vivo and in vitro. It is of importance that hALP acetylated UBF depending on HAT in vivo, and hALP but not hALP (Delta HAT) facilitated the nuclear translocation of the RNA polymerase I (Pol I)-associated factor 53 (PAF53) from the cytoplasm and promoted the association of UBF with PAF53. Thus, we provide a mechanism in which a novel t-UTP activates Pol I transcription by binding and acetylating UBF.	[Zhang, Liangliang; Hu, Lelin; Han, Wei; Du, Xiaojuan; Ke, Yang] Peking Univ, Canc Res Ctr, Hlth Sci Ctr, Beijing 100191, Peoples R China; [Kong, Ruirui; Peng, Qunhui; Ke, Yang] Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res,Minist Educ, Beijing 100142, Peoples R China; [Kong, Ruirui; Peng, Qunhui; Ke, Yang] Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Dept Genet, Beijing 100142, Peoples R China; [Zhang, Liangliang; Hu, Lelin; Du, Xiaojuan] Peking Univ, Dept Cell Biol, Hlth Sci Ctr, Beijing 100191, Peoples R China	Peking University; Peking University; Peking University; Peking University	Du, XJ (corresponding author), Peking Univ, Canc Res Ctr, Hlth Sci Ctr, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	duxiaojuan100@hsc.pku.edu.cn; keyang@hsc.pku.edu.cn	Du, Xiaojuan/AAY-1186-2021		National Natural Science Foundation of China [30571038, 30771224]; National High Technology Research and Development Program of China (863 Program) [2008AA02Z131, 2006AA02A402]; National Basic Research Program of China (973 Program) [2010CB529303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by Grants 30571038 and 30771224 from the National Natural Science Foundation of China, Grants 2008AA02Z131 and 2006AA02A402 from the National High Technology Research and Development Program of China (863 Program), and Grant No. 2010CB529303 from the National Basic Research Program of China (973 Program).	Balakin AG, 1996, CELL, V86, P823, DOI 10.1016/S0092-8674(00)80156-7; BELL SP, 1988, SCIENCE, V241, P1192, DOI 10.1126/science.3413483; Bernstein KA, 2004, EUKARYOT CELL, V3, P1619, DOI 10.1128/EC.3.6.1619-1626.2004; CAVANAUGH AH, 1995, NATURE, V374, P177, DOI 10.1038/374177a0; Chi YH, 2007, J BIOL CHEM, V282, P27447, DOI 10.1074/jbc.M703098200; CLOS J, 1986, P NATL ACAD SCI USA, V83, P604, DOI 10.1073/pnas.83.3.604; COMAI L, 1992, CELL, V68, P965, DOI 10.1016/0092-8674(92)90039-F; Decatur WA, 2003, J BIOL CHEM, V278, P695, DOI 10.1074/jbc.R200023200; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; EBERHARD D, 1993, NUCLEIC ACIDS RES, V21, P4180, DOI 10.1093/nar/21.18.4180; Fu D, 2007, MOL CELL, V28, P773, DOI 10.1016/j.molcel.2007.09.023; Gallagher JEG, 2004, GENE DEV, V18, P2506, DOI 10.1101/gad.1226604; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Granneman S, 2005, CURR OPIN CELL BIOL, V17, P281, DOI 10.1016/j.ceb.2005.04.001; Guan Li-zhao, 2008, Beijing Da Xue Xue Bao Yi Xue Ban, V40, P347; HADJIOLOVA KV, 1993, EUR J BIOCHEM, V212, P211, DOI 10.1111/j.1432-1033.1993.tb17652.x; Halkidou K, 2004, NUCLEIC ACIDS RES, V32, P1654, DOI 10.1093/nar/gkh296; Hanada K, 1996, EMBO J, V15, P2217, DOI 10.1002/j.1460-2075.1996.tb00575.x; Hannan KM, 2000, ONCOGENE, V19, P4988, DOI 10.1038/sj.onc.1203875; Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Hirschler-Laszkiewicz I, 2001, NUCLEIC ACIDS RES, V29, P4114, DOI 10.1093/nar/29.20.4114; Hublitz P, 2005, GENE DEV, V19, P2912, DOI 10.1101/gad.351205; JANTZEN HM, 1992, GENE DEV, V6, P1950, DOI 10.1101/gad.6.10.1950; JANTZEN HM, 1990, NATURE, V344, P830, DOI 10.1038/344830a0; KASS S, 1990, CELL, V60, P897, DOI 10.1016/0092-8674(90)90338-F; Kopp K, 2007, MOL BIOL CELL, V18, P394, DOI 10.1091/mbc.E06-03-0249; LEARNED RM, 1986, CELL, V45, P847, DOI 10.1016/0092-8674(86)90559-3; LEARNED RM, 1985, MOL CELL BIOL, V5, P1358, DOI 10.1128/MCB.5.6.1358; Lin CY, 2006, NUCLEIC ACIDS RES, V34, P4752, DOI 10.1093/nar/gkl581; Lv JJ, 2003, BIOCHEM BIOPH RES CO, V311, P506, DOI 10.1016/j.bbrc.2003.09.235; Mais C, 2005, GENE DEV, V19, P50, DOI 10.1101/gad.310705; Meraner J, 2006, NUCLEIC ACIDS RES, V34, P1798, DOI 10.1093/nar/gkl101; Milkereit P, 2003, NUCLEIC ACIDS RES, V31, P799, DOI 10.1093/nar/gkg165; MILLER L, 1969, CHROMOSOMA, V28, P430; MOUGEY EB, 1993, MOL CELL BIOL, V13, P5990, DOI 10.1128/MCB.13.10.5990; Muth V, 2001, EMBO J, V20, P1353, DOI 10.1093/emboj/20.6.1353; OMAHONY DJ, 1992, J BIOL CHEM, V267, P35; Pelletier G, 2000, MOL CELL, V6, P1059, DOI 10.1016/S1097-2765(00)00104-0; Pluk H, 1998, MOL CELL BIOL, V18, P488, DOI 10.1128/MCB.18.1.488; Prieto JL, 2007, GENE DEV, V21, P2041, DOI 10.1101/gad.436707; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shen Q, 2009, EXP CELL RES, V315, P1653, DOI 10.1016/j.yexcr.2009.03.007; Sheng Z, 2005, MOL CELL BIOL, V25, P9419, DOI 10.1128/MCB.25.21.9419-9426.2005; Stefanovsky VY, 2001, MOL CELL, V8, P1063, DOI 10.1016/S1097-2765(01)00384-7; Strezoska Z, 2002, J BIOL CHEM, V277, P29617, DOI 10.1074/jbc.M204381200; Tuan JC, 1999, MOL CELL BIOL, V19, P2872; Voit R, 1999, EMBO J, V18, P1891, DOI 10.1093/emboj/18.7.1891; Voit R, 1997, MOL CELL BIOL, V17, P4230, DOI 10.1128/MCB.17.8.4230; VOIT R, 1992, EMBO J, V11, P2211, DOI 10.1002/j.1460-2075.1992.tb05280.x; Voit R, 2001, P NATL ACAD SCI USA, V98, P13631, DOI 10.1073/pnas.231071698; Wang Y, 2007, BBA-MOL CELL RES, V1773, P863, DOI 10.1016/j.bbamcr.2007.04.002; Zhai WG, 1997, GENE DEV, V11, P1605, DOI 10.1101/gad.11.12.1605; Zhai WG, 2000, MOL CELL BIOL, V20, P5930, DOI 10.1128/MCB.20.16.5930-5938.2000	57	31	32	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7139	7148		10.1074/jbc.M110.173393	http://dx.doi.org/10.1074/jbc.M110.173393			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177859	Green Published, hybrid			2022-12-27	WOS:000287737300031
J	Nageshan, RK; Roy, N; Hehl, AB; Tatu, U				Nageshan, Rishi Kumar; Roy, Nainita; Hehl, Adrian B.; Tatu, Utpal			Post-transcriptional Repair of a Split Heat Shock Protein 90 Gene by mRNA trans-Splicing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIARDIA-LAMBLIA; GENOME SEQUENCE; DRUG TARGET; HSP90; EXPRESSION; EVOLUTION; GROWTH; HEAT-SHOCK-PROTEIN-90; CAPACITOR; PARASITE	Heat shock protein 90 participates in diverse biological processes ranging from protein folding, cell cycle, signal transduction and development to evolution in all eukaryotes. It is also critically involved in regulating growth of protozoa such as Dictyostelium discoideum, Leishmania donovani, Plasmodium falciparum, Trypanosoma cruzi, and Trypanosoma evansi. Selective inhibition of Hsp90 has also been explored as an intervention strategy against important human diseases such as cancer, malaria, or trypanosomiasis. Giardia lamblia, a simple protozoan parasite of humans and animals, is an important cause of diarrheal disease with significant morbidity and some mortality in tropical countries. Here we show that the G. lamblia cytosolic hsp90 ( glhsp90) is split in two similar sized fragments located 777 kb apart on the same scaffold. Intrigued by this unique arrangement, which appears to be specific for the Giardiinae, we have investigated the biosynthesis of GlHsp90. We used genome sequencing to confirm the split nature of the giardial hsp90. However, a specific antibody raised against the peptide detected a product with a mass of about 80 kDa, suggesting a post-transcriptional rescue of the genomic defect. We show evidence for the joining of the two independent Hsp90 transcripts in-trans to one long mature mRNA presumably by RNA splicing. The splicing junction carries hallmarks of classical cis-spliced introns, suggesting that the regular cis-splicing machinery may be sufficient for repair of the open reading frame. A complementary 26-nt sequence in the "intron" regions adjacent to the splice sites may assist in positioning the two pre-mRNAs for processing. This is the first example of post-transcriptional rescue of a split gene by trans-splicing.	[Hehl, Adrian B.] Univ Zurich, Inst Parasitol, CH-8046 Zurich, Switzerland; [Nageshan, Rishi Kumar; Roy, Nainita; Tatu, Utpal] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India	University of Zurich; Indian Institute of Science (IISC) - Bangalore	Hehl, AB (corresponding author), Univ Zurich, Inst Parasitol, Winterthurerstr 266A, CH-8046 Zurich, Switzerland.	adrian.hehl@access.uzh.ch; tatu@biochem.iisc.ernet.in	Bhowmick, Nainita Roy/AAS-2908-2021	Tatu, Utpal/0000-0003-0404-8872; Hehl, Adrian/0000-0002-2110-4445; Nageshan, Rishi Kumar/0000-0003-1592-4452	Department of Science and Technology, New Delhi; Department of Biotechnology, New Delhi, India; MALSIG; Council of Scientific and Industrial Research; Swiss National Science Foundation [31003A125389]; United Grants Commission, New Delhi, India	Department of Science and Technology, New Delhi(Department of Science & Technology (India)); Department of Biotechnology, New Delhi, India(Department of Biotechnology (DBT) India); MALSIG; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); United Grants Commission, New Delhi, India	This work was supported by grants from the Department of Science and Technology, New Delhi, the Department of Biotechnology, New Delhi, India, and MALSIG, by a Junior Research Fellowship from the Council of Scientific and Industrial Research and United Grants Commission, New Delhi, India (to R. K. N and N. R.), and by Swiss National Science Foundation Grant 31003A125389 (to A. B. H.).	Adam RD, 2000, INT J PARASITOL, V30, P475, DOI 10.1016/S0020-7519(99)00191-5; Ahn HJ, 2003, BIOCHEM BIOPH RES CO, V311, P654, DOI 10.1016/j.bbrc.2003.10.045; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Chen B, 2005, GENOMICS, V86, P627, DOI 10.1016/j.ygeno.2005.08.012; Chen B, 2005, INSECT MOL BIOL, V14, P697, DOI 10.1111/j.1365-2583.2005.00602.x; Cowen LE, 2005, SCIENCE, V309, P2185, DOI 10.1126/science.1118370; Devaney E, 2005, INT J PARASITOL, V35, P627, DOI 10.1016/j.ijpara.2005.01.007; DIAMOND LS, 1978, T ROY SOC TROP MED H, V72, P431, DOI 10.1016/0035-9203(78)90144-X; Echeverria PC, 2005, J MOL BIOL, V350, P723, DOI 10.1016/j.jmb.2005.05.031; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Franzen O, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000560; HANNON GJ, 1992, SCIENCE, V258, P1775, DOI 10.1126/science.1465612; Harris JC, 2000, MICROBIOL-SGM, V146, P3119, DOI 10.1099/00221287-146-12-3119; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Nakai H, 2000, NAT BIOTECHNOL, V18, P527, DOI 10.1038/75390; Neckers L, 2008, CELL HOST MICROBE, V4, P519, DOI 10.1016/j.chom.2008.10.011; Nixon JEJ, 2002, P NATL ACAD SCI USA, V99, P3701, DOI 10.1073/pnas.042700299; Pallavi R, 2010, J BIOL CHEM, V285, P37964, DOI 10.1074/jbc.M110.155317; Pan F, 2000, J EXP ZOOL, V287, P199, DOI 10.1002/1097-010X(20000801)287:3&lt;199::AID-JEZ2&gt;3.0.CO;2-3; Pavithra SR, 2004, J BIOL CHEM, V279, P46692, DOI 10.1074/jbc.M409165200; Peroval M, 2006, INT J PARASITOL, V36, P1205, DOI 10.1016/j.ijpara.2006.04.006; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sawarkar R, 2008, J MOL BIOL, V383, P24, DOI 10.1016/j.jmb.2008.08.006; Simpson AGB, 2002, CURR BIOL, V12, pR691, DOI 10.1016/S0960-9822(02)01207-1; Wiesgigl M, 2001, MOL BIOL CELL, V12, P3307, DOI 10.1091/mbc.12.11.3307; YEE J, 1992, J BIOL CHEM, V267, P7539	29	32	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7116	7122		10.1074/jbc.C110.208389	http://dx.doi.org/10.1074/jbc.C110.208389			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21209094	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000287737300028
J	Yamauchi, Y; Hasegawa, A; Taninaka, A; Mizutani, M; Sugimoto, Y				Yamauchi, Yasuo; Hasegawa, Ayaka; Taninaka, Ai; Mizutani, Masaharu; Sugimoto, Yukihiro			NADPH-dependent Reductases Involved in the Detoxification of Reactive Carbonyls in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAS-CHROMATOGRAPHIC ANALYSIS; LIPID-PEROXIDATION; ALDEHYDE DEHYDROGENASE; ARABIDOPSIS-THALIANA; PROTEIN MODIFICATION; TRANSGENIC PLANTS; GLYOXALASE-I; METHYLGLYOXAL; STRESS; OVEREXPRESSION	Reactive carbonyls, especially alpha,beta-unsaturated carbonyls produced through lipid peroxidation, damage biomolecules such as proteins and nucleotides; elimination of these carbonyls is therefore essential for maintaining cellular homeostasis. In this study, we focused on an NADPH-dependent detoxification of reactive carbonyls in plants and explored the enzyme system involved in this detoxification process. Using acrolein (CH2 = CHCHO) as a model alpha,beta-unsaturated carbonyl, we purified a predominant NADPH-dependent acrolein-reducing enzyme from cucumber leaves, and we identified the enzyme as an alkenal/one oxidoreductase (AOR) catalyzing reduction of an alpha,beta-unsaturated bond. Cloning of cDNA encoding AORs revealed that cucumber contains two distinct AORs, chloroplastic AOR and cytosolic AOR. Homologs of cucumber AORs were found among various plant species, including Arabidopsis, and we confirmed that a homolog of Arabidopsis (At1g23740) also had AOR activity. Phylogenetic analysis showed that these AORs belong to a novel class of AORs. They preferentially reduced alpha,beta-unsaturated ketones rather than alpha,beta-unsaturated aldehydes. Furthermore, we selected candidates of other classes of enzymes involved in NADPH-dependent reduction of carbonyls based on the bioinformatic information, and we found that an aldo-keto reductase (At2g37770) and aldehyde reductases (At1g54870 and At3g04000) were implicated in the reduction of an aldehyde group of saturated aldehydes and methylglyoxal as well as alpha,beta-unsaturated aldehydes in chloroplasts. These results suggest that different classes of NADPH-dependent reductases cooperatively contribute to the detoxification of reactive carbonyls.	[Yamauchi, Yasuo; Hasegawa, Ayaka; Mizutani, Masaharu; Sugimoto, Yukihiro] Kobe Univ, Lab Funct Phytochem, Grad Sch Agr Sci, Nada Ku, Kobe, Hyogo 6578501, Japan; [Taninaka, Ai] Kobe Univ, Fac Agr, Nada Ku, Kobe, Hyogo 6578501, Japan	Kobe University; Kobe University	Yamauchi, Y (corresponding author), Kobe Univ, Lab Funct Phytochem, Grad Sch Agr Sci, Nada Ku, Rokkodai 1-1, Kobe, Hyogo 6578501, Japan.	yamauchi@kobe-u.ac.jp		Mizutani, Masaharu/0000-0002-4321-0644	Ministry of Education, Culture, Sports, Science, and Technology of Japan [21658112]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid for Exploratory Research 21658112 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to Y. Y.).	Almeras E, 2003, PLANT J, V34, P202, DOI 10.1046/j.1365-313X.2003.01718.x; Burczynski ME, 2001, J BIOL CHEM, V276, P2890, DOI 10.1074/jbc.M006655200; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; DENNIS KJ, 1990, LIPIDS, V25, P460, DOI 10.1007/BF02538089; Dick RA, 2001, J BIOL CHEM, V276, P40803, DOI 10.1074/jbc.M105487200; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Forrest GL, 2000, CANCER RES, V60, P5158; FOYER C, 1983, PLANTA, V157, P239, DOI 10.1007/BF00405188; Goulas E, 2006, PLANT J, V47, P720, DOI 10.1111/j.1365-313X.2006.02821.x; Hanson MR, 2001, J EXP BOT, V52, P529, DOI 10.1093/jexbot/52.356.529; HARTLEY DP, 1995, ARCH BIOCHEM BIOPHYS, V316, P197, DOI 10.1006/abbi.1995.1028; KOLB NS, 1994, MOL PHARMACOL, V45, P797; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mano J, 2005, PLANT PHYSIOL, V139, P1773, DOI 10.1104/pp.105.070391; Mano J, 2002, PLANT CELL PHYSIOL, V43, P1445, DOI 10.1093/pcp/pcf187; Mano J, 2010, PLANT BIOTECHNOL-NAR, V27, P193, DOI 10.5511/plantbiotechnology.27.193; Mano J, 2009, PLANTA, V230, P639, DOI 10.1007/s00425-009-0964-9; Manriquez D, 2006, PLANT MOL BIOL, V61, P675, DOI 10.1007/s11103-006-0040-9; Millar AH, 2000, FEBS LETT, V481, P117, DOI 10.1016/S0014-5793(00)01976-1; NIYATISHIRKHODAEE F, 1993, J AGR FOOD CHEM, V41, P227, DOI 10.1021/jf00026a016; Oberschall A, 2000, PLANT J, V24, P437, DOI 10.1046/j.1365-313x.2000.00885.x; Perez JM, 2008, J BIOL CHEM, V283, P7346, DOI 10.1074/jbc.M708846200; RICHARD JP, 1984, J AM CHEM SOC, V106, P4926, DOI 10.1021/ja00329a050; Rutschow H, 2008, PLANT PHYSIOL, V148, P156, DOI 10.1104/pp.108.124545; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SELLIN S, 1991, BIOCHEMISTRY-US, V30, P2514, DOI 10.1021/bi00223a031; Shipanova IN, 1997, ARCH BIOCHEM BIOPHYS, V344, P29, DOI 10.1006/abbi.1997.0195; Sommer A, 2001, BIOCHEM J, V353, P445, DOI 10.1042/0264-6021:3530445; Sunkar R, 2003, PLANT J, V35, P452, DOI 10.1046/j.1365-313X.2003.01819.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Yadav SK, 2005, BIOCHEM BIOPH RES CO, V337, P61, DOI 10.1016/j.bbrc.2005.08.263; Yadav SK, 2005, FEBS LETT, V579, P6265, DOI 10.1016/j.febslet.2005.10.006; Yamauchi Y, 2002, PLANT CELL PHYSIOL, V43, P1334, DOI 10.1093/pcp/pcf162; Yamauchi Y, 2008, PLANT PHYSIOL BIOCH, V46, P786, DOI 10.1016/j.plaphy.2008.04.018; Yamauchi Y, 2010, PLANTA, V231, P1077, DOI 10.1007/s00425-010-1112-2; Ye S, 2003, J BACTERIOL, V185, P4144, DOI 10.1128/JB.185.14.4144-4151.2003; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	38	122	132	5	48	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6999	7009		10.1074/jbc.M110.202226	http://dx.doi.org/10.1074/jbc.M110.202226			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21169366	Green Published, hybrid			2022-12-27	WOS:000287737300016
J	Hamacher-Brady, A; Stein, HA; Turschner, S; Toegel, I; Mora, R; Jennewein, N; Efferth, T; Eils, R; Brady, NR				Hamacher-Brady, Anne; Stein, Henning A.; Turschner, Simon; Toegel, Ina; Mora, Rodrigo; Jennewein, Nina; Efferth, Thomas; Eils, Roland; Brady, Nathan R.			Artesunate Activates Mitochondrial Apoptosis in Breast Cancer Cells via Iron-catalyzed Lysosomal Reactive Oxygen Species Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA/REPERFUSION INJURY; MEMBRANE PERMEABILIZATION; ANTIMALARIAL-DRUG; OXIDATIVE STRESS; TUMOR-CELLS; IN-VIVO; CYSTEINE CATHEPSINS; ARTEMISININ; AUTOPHAGY; PROTEIN	The antimalarial agent artesunate (ART) activates programmed cell death (PCD) in cancer cells in a manner dependent on the presence of iron and the generation of reactive oxygen species. In malaria parasites, ART cytotoxicity originates from interactions with heme-derived iron within the food vacuole. The analogous digestive compartment of mammalian cells, the lysosome, similarly contains high levels of redox-active iron and in response to specific stimuli can initiate mitochondrial apoptosis. We thus investigated the role of lysosomes in ART-induced PCD and determined that in MCF-7 breast cancer cells ART activates lysosome-dependent mitochondrial outer membrane permeabilization. ART impacted endolysosomal and autophagosomal compartments, inhibiting autophagosome turnover and causing perinuclear clustering of autophagosomes, early and late endosomes, and lysosomes. Lysosomal iron chelation blocked all measured parameters of ART-induced PCD, whereas lysosomal iron loading enhanced death, thus identifying lysosomal iron as the lethal source of reactive oxygen species upstream of mitochondrial outer membrane permeabilization. Moreover, lysosomal inhibitors chloroquine and bafilomycin A1 reduced ART-activated PCD, evidencing a requirement for lysosomal function during PCD signaling. ART killing did not involve activation of the BH3-only protein, Bid, yet ART enhanced TNF-mediated Bid cleavage. We additionally demonstrated the lysosomal PCD pathway in T47D and MDA-MB-231 breast cancer cells. Importantly, non-tumorigenic MCF-10A cells resisted ART-induced PCD. Together, our data suggest that ART triggers PCD via engagement of distinct, interconnected PCD pathways, with hierarchical signaling from lysosomes to mitochondria, suggesting a potential clinical use of ART for targeting lysosomes in cancer treatment.	[Hamacher-Brady, Anne; Turschner, Simon; Mora, Rodrigo; Eils, Roland; Brady, Nathan R.] German Canc Res Ctr, Div Theoret Bioinformat, Appl Syst Biol Grp, D-69120 Heidelberg, Germany; [Hamacher-Brady, Anne; Toegel, Ina; Jennewein, Nina; Eils, Roland] German Canc Res Ctr, Inst Pharm & Mol Biotechnol, BioQuant Ctr, D-69120 Heidelberg, Germany; [Efferth, Thomas] Johannes Gutenberg Univ Mainz, Dept Pharmaceut Biol, Inst Pharm, D-55128 Mainz, Germany; [Stein, Henning A.; Brady, Nathan R.] Heidelberg Univ, Dept Surg, Fac Med, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz; Ruprecht Karls University Heidelberg	Eils, R (corresponding author), German Canc Res Ctr, Div Theoret Bioinformat, Appl Syst Biol Grp, D-69120 Heidelberg, Germany.	r.eils@dkfz.de; n.brady@dkfz.de	Brady, Nathan/H-2452-2013; Hamacher-Brady, Anne/G-4268-2013; Eils, Roland/B-6121-2009	Eils, Roland/0000-0002-0034-4036; Brady, Nathan/0000-0002-1901-5996; Efferth, Thomas/0000-0002-3096-3292; Hamacher-Brady, Anne/0000-0001-5042-1338	Helmholtz Association; Bundesministerium fur Bildung und Forschung (BMBF); ENDOCYTE Marie Curie Research Training Network	Helmholtz Association(Helmholtz Association); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); ENDOCYTE Marie Curie Research Training Network(European Commission)	This work was supported by SBCancer within the Helmholtz Alliance on Systems Biology, funded by the Initiative and Networking Fund of the Helmholtz Association.; Supported by the Bundesministerium fur Bildung und Forschung (BMBF)-funded ForSys Centre Viroquant. To whom correspondence may be addressed. E-mail: r.eils@dkfz.de.; Supported by a fellowship from the ENDOCYTE Marie Curie Research Training Network. To whom correspondence may be addressed. E-mail: n.brady@dkfz.de.	Berger TG, 2005, ONCOL REP, V14, P1599; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Brady NR, 2006, BBA-BIOENERGETICS, V1757, P667, DOI 10.1016/j.bbabio.2006.04.011; BRIDGES KR, 1987, J BIOL CHEM, V262, P14773; Brown CL, 2005, TRAFFIC, V6, P1114, DOI 10.1111/j.1600-0854.2005.00347.x; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Cable H, 1999, J PHARM PHARMACOL, V51, P131, DOI 10.1211/0022357991772231; Chen H, 2009, ANTI-CANCER DRUG, V20, P131, DOI 10.1097/CAD.0b013e3283212ade; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Conus S, 2008, J EXP MED, V205, P685, DOI 10.1084/jem.20072152; Dell'Eva R, 2004, BIOCHEM PHARMACOL, V68, P2359, DOI 10.1016/j.bcp.2004.08.021; Dikic I, 2003, BIOCHEM SOC T, V31, P1178; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Efferth T, 2006, CURR DRUG TARGETS, V7, P407, DOI 10.2174/138945006776359412; Efferth T, 2005, IN VIVO, V19, P225; Efferth T, 2004, FREE RADICAL BIO MED, V37, P998, DOI 10.1016/j.freeradbiomed.2004.06.023; Efferth T, 2003, INT J ONCOL, V23, P1231; Efferth T, 2003, MOL PHARMACOL, V64, P382, DOI 10.1124/mol.64.2.382; Efferth T, 2001, INT J ONCOL, V18, P767; Efferth T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000693; Guicciardi ME, 2000, J CLIN INVEST, V106, P1127, DOI 10.1172/JCI9914; Hamacher-Brady A, 2007, CELL DEATH DIFFER, V14, P146, DOI 10.1038/sj.cdd.4401936; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Hou JM, 2008, CLIN CANCER RES, V14, P5519, DOI 10.1158/1078-0432.CCR-08-0197; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kelter G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000798; Kirkegaard T, 2009, BBA-MOL CELL RES, V1793, P746, DOI 10.1016/j.bbamcr.2008.09.008; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Konkimalla VB, 2009, CURR CANCER DRUG TAR, V9, P72, DOI 10.2174/156800909787314020; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kurz T, 2008, HISTOCHEM CELL BIOL, V129, P389, DOI 10.1007/s00418-008-0394-y; Kurz T, 2007, ARCH BIOCHEM BIOPHYS, V462, P220, DOI 10.1016/j.abb.2007.01.013; Lai H, 2005, LIFE SCI, V76, P1267, DOI 10.1016/j.lfs.2004.08.020; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li PCH, 2008, CANCER RES, V68, P4347, DOI 10.1158/0008-5472.CAN-07-2970; Lu M, 2005, ONCOGENE, V24, P4362, DOI 10.1038/sj.onc.1208661; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Maclean KH, 2008, J CLIN INVEST, V118, P79, DOI 10.1172/JCI33700; MIURA T, 1993, BIOCHEM MOL BIOL INT, V31, P125; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Orrell C, 2008, EUR J CLIN PHARMACOL, V64, P683, DOI 10.1007/s00228-007-0452-8; Ortiz-Ferron G, 2006, CELL DEATH DIFFER, V13, P1857, DOI 10.1038/sj.cdd.4401875; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pandey AV, 1999, J BIOL CHEM, V274, P19383, DOI 10.1074/jbc.274.27.19383; Plantin-Carrenard E, 2003, CELL BIOL TOXICOL, V19, P121, DOI 10.1023/A:1023311307034; Rasheed SAK, 2010, INT J CANCER, V127, P1475, DOI 10.1002/ijc.25315; Ravikumar B, 2008, J CELL SCI, V121, P1649, DOI 10.1242/jcs.025726; Shacka JJ, 2006, MOL PHARMACOL, V69, P1125, DOI 10.1124/mol.105.018408; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Singh NP, 2001, LIFE SCI, V70, P49, DOI 10.1016/S0024-3205(01)01372-8; Steffan JJ, 2010, J CELL SCI, V123, P1151, DOI 10.1242/jcs.063644; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Swift LM, 2000, AM J PHYSIOL-HEART C, V278, pH982, DOI 10.1152/ajpheart.2000.278.3.H982; Taylor WRJ, 2004, DRUG SAFETY, V27, P25, DOI 10.2165/00002018-200427010-00003; Uchiyama A, 2008, HEPATOLOGY, V48, P1644, DOI 10.1002/hep.22498; Vasiljeva O, 2008, BIOCHIMIE, V90, P380, DOI 10.1016/j.biochi.2007.10.004; Werneburg N, 2004, AM J PHYSIOL-GASTR L, V287, pG436, DOI 10.1152/ajpgi.00019.2004; Werneburg NW, 2007, J BIOL CHEM, V282, P28960, DOI 10.1074/jbc.M705671200; Werneburg NW, 2002, AM J PHYSIOL-GASTR L, V283, pG947, DOI 10.1152/ajpgi.00151.2002; Wiley SE, 2007, P NATL ACAD SCI USA, V104, P5318, DOI 10.1073/pnas.0701078104; WOERDENBAG HJ, 1993, J NAT PROD, V56, P849, DOI 10.1021/np50096a007; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Wu GD, 2004, VASC PHARMACOL, V41, P205, DOI 10.1016/j.vph.2004.11.001; Xu H, 2007, RHEUMATOLOGY, V46, P920, DOI 10.1093/rheumatology/kem014; Yang SH, 2007, ONCOL REP, V17, P1229; Yin XM, 2006, GENE, V369, P7, DOI 10.1016/j.gene.2005.10.038; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Youns M, 2009, BIOCHEM PHARMACOL, V78, P273, DOI 10.1016/j.bcp.2009.04.014; Yu Y, 2007, CELL CYCLE, V6, P1982, DOI 10.4161/cc.6.16.4603; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	77	165	181	1	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6587	6601		10.1074/jbc.M110.210047	http://dx.doi.org/10.1074/jbc.M110.210047			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21149439	Green Published, hybrid			2022-12-27	WOS:000287476400068
J	Cuello, F; Bardswell, SC; Haworth, RS; Ehler, E; Sadayappan, S; Kentish, JC; Avkiran, M				Cuello, Friederike; Bardswell, Sonya C.; Haworth, Robert S.; Ehler, Elisabeth; Sadayappan, Sakthivel; Kentish, Jonathan C.; Avkiran, Metin			Novel Role for p90 Ribosomal S6 Kinase in the Regulation of Cardiac Myofilament Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN-C; NA+-H+ EXCHANGER; TROPONIN-I PHOSPHORYLATION; HEART-FAILURE; VENTRICULAR MYOCYTES; EMERGING ROLES; ERK PATHWAY; RSK; ACTIVATION; INHIBITOR	In myocardium, the 90-kDa ribosomal S6 kinase (RSK) is activated by diverse stimuli and regulates the sarcolemmal Na+/H+ exchanger through direct phosphorylation. Only limited information is available on other cardiac RSK substrates and functions. We evaluated cardiac myosin-binding protein C (cMyBP-C), a sarcomeric regulatory phosphoprotein, as a potential RSK substrate. In rat ventricular myocytes, RSK activation by endothelin 1 (ET1) increased cMyBP-C phosphorylation at Ser(282), which was inhibited by the selective RSK inhibitor D1870. Neither ET1 nor D1870 affected the phosphorylation status of Ser(273) or Ser(302), cMyBP-C residues additionally targeted by cAMP-dependent protein kinase (PKA). Complementary genetic gain- and loss-of-function experiments, through the adenoviral expression of wild-type or kinase-inactive RSK isoforms, confirmed RSK-mediated phosphorylation of cMyBP-C at Ser(282). Kinase assays utilizing as substrate wild-type or mutated (S273A, S282A, S302A) recombinant cMyBP-C fragments revealed direct and selective Ser(282) phosphorylation by RSK. Immunolabeling with a Ser(P)(282) antibody and confocal fluorescence microscopy showed RSK-mediated phosphorylation of cMyBP-C across the C-zones of sarcomeric A-bands. In chemically permeabilized mouse ventricular muscles, active RSK again induced selective Ser(282) phosphorylation in cMyBP-C, accompanied by significant reduction in Ca2+ sensitivity of force development and significant acceleration of cross-bridge cycle kinetics, independently of troponin I phosphorylation at Ser(22)/Ser(23). The magnitudes of these RSK-induced changes were comparable with those induced by PKA, which phosphorylated cMyBP-C additionally at Ser(273) and Ser(302). We conclude that Ser(282) in cMyBP-C is a novel cardiac RSK substrate and its selective phosphorylation appears to regulate cardiac myofilament function.	[Avkiran, Metin] Kings Coll London, British Heart Fdn Ctr, Div Cardiovasc, St Thomas Hosp,Rayne Inst, London SE1 7EH, England; [Sadayappan, Sakthivel] Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 60153 USA	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Loyola University Chicago	Avkiran, M (corresponding author), Kings Coll London, British Heart Fdn Ctr, Div Cardiovasc, St Thomas Hosp,Rayne Inst, London SE1 7EH, England.	metin.avkiran@kcl.ac.uk	Cuello, Friederike/A-9642-2016	Sadayappan, Sakthivel/0000-0003-2006-7678; Ehler, Elisabeth/0000-0001-5646-5964; Avkiran, Metin/0000-0003-2392-6343	British Heart Foundation; Medical Research Council; Centre of Research Excellence Award; MRC [G0800206, G0400153, G0001112] Funding Source: UKRI; Medical Research Council [G0400153, G0001112, G0800206] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Centre of Research Excellence Award; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the British Heart Foundation, including a Centre of Research Excellence Award, and the Medical Research Council.	Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Avkiran M, 2002, J AM COLL CARDIOL, V39, P747, DOI 10.1016/S0735-1097(02)01693-5; Avkiran M, 2008, CURR OPIN PHARMACOL, V8, P133, DOI 10.1016/j.coph.2007.12.007; Avkiran M, 2008, CIRC RES, V102, P157, DOI 10.1161/CIRCRESAHA.107.168211; Bardswell SC, 2010, J BIOL CHEM, V285, P5674, DOI 10.1074/jbc.M109.066456; Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; Bossuyt J, 2008, CIRC RES, V102, P695, DOI 10.1161/CIRCRESAHA.107.169755; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; Cheng H, 2010, CIRC RES, V106, P21, DOI 10.1161/CIRCRESAHA.109.206920; Cingolani HE, 2007, CIRCULATION, V115, P1090, DOI 10.1161/CIRCULATIONAHA.106.626929; Cuello F, 2007, MOL PHARMACOL, V71, P799, DOI 10.1124/mol.106.029900; Cuello F, 2007, CIRC RES, V100, P864, DOI 10.1161/01.RES.0000260809.15393.fa; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002; Dummler BA, 2005, J BIOL CHEM, V280, P13304, DOI 10.1074/jbc.M408194200; El-Armouche A, 2007, J MOL CELL CARDIOL, V43, P223, DOI 10.1016/j.yjmcc.2007.05.003; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Haworth RS, 2004, CIRC RES, V95, P1091, DOI 10.1161/01.RES.0000149299.34793.3c; Haworth RS, 2003, J BIOL CHEM, V278, P31676, DOI 10.1074/jbc.M304400200; Itoh S, 2006, CIRCULATION, V113, P1787, DOI 10.1161/CIRCULATIONAHA.105.578278; Itoh S, 2005, J BIOL CHEM, V280, P24135, DOI 10.1074/jbc.M413015200; Jacques AM, 2008, J MOL CELL CARDIOL, V45, P209, DOI 10.1016/j.yjmcc.2008.05.020; Kang SM, 2010, J CLIN INVEST, V120, P1165, DOI 10.1172/JCI40582; LEIGHTON IA, 1995, FEBS LETT, V375, P289, DOI 10.1016/0014-5793(95)01170-J; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Lu Z, 2008, CIRC RES, V103, P269, DOI 10.1161/CIRCRESAHA.107.166678; Maekawa N, 2006, CIRCULATION, V113, P2516, DOI 10.1161/CIRCULATIONAHA.105.563486; Pi YQ, 2002, CIRC RES, V90, P649, DOI 10.1161/01.RES.0000014080.82861.5F; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sadayappan S, 2009, CIRCULATION, V120, pS870; Sadayappan S, 2009, CIRCULATION, V119, P1253, DOI 10.1161/CIRCULATIONAHA.108.798983; Samarel AM, 2001, J MOL CELL CARDIOL, V33, P1637, DOI 10.1006/jmcc.2001.1427; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Sheffler DJ, 2006, P NATL ACAD SCI USA, V103, P4717, DOI 10.1073/pnas.0600585103; Smith JA, 2005, CANCER RES, V65, P1027; Snabaitis AK, 2000, CIRC RES, V86, P214, DOI 10.1161/01.RES.86.2.214; Snabaitis AK, 2005, CELL SIGNAL, V17, P655, DOI 10.1016/j.cellsig.2004.10.008; Snabaitis AK, 2002, CARDIOVASC RES, V53, P470, DOI 10.1016/S0008-6363(01)00464-3; Solaro RJ, 2008, J BIOL CHEM, V283, P26829, DOI 10.1074/jbc.R800037200; Takahashi E, 1997, CIRC RES, V81, P268, DOI 10.1161/01.RES.81.2.268; Takahashi E, 1999, J BIOL CHEM, V274, P20206, DOI 10.1074/jbc.274.29.20206; Takeishi Y, 1999, CIRC RES, V85, P1164; Takeishi Y, 2002, CARDIOVASC RES, V53, P131, DOI 10.1016/S0008-6363(01)00438-2; Tong CW, 2008, CIRC RES, V103, P974, DOI 10.1161/CIRCRESAHA.108.177683; van Dijk SJ, 2009, CIRCULATION, V119, P1473, DOI 10.1161/CIRCULATIONAHA.108.838672	48	39	39	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5300	5310		10.1074/jbc.M110.202713	http://dx.doi.org/10.1074/jbc.M110.202713			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148481	Green Published, hybrid			2022-12-27	WOS:000287230600038
J	de Vries, RP; de Vries, E; Moore, KS; Rigter, A; Rottier, PJM; de Haan, CAM				de Vries, Robert P.; de Vries, Erik; Moore, Karen S.; Rigter, Alan; Rottier, Peter J. M.; de Haan, Cornelis A. M.			Only Two Residues Are Responsible for the Dramatic Difference in Receptor Binding between Swine and New Pandemic H1 Hemagglutinin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY EPITHELIAL-CELLS; INFLUENZA-VIRUS; SWISS-MODEL; SIALIC-ACID; SPECIFICITY; GLYCOSYLATION; TRANSMISSION; ADAPTATION; MICROARRAY; PROTEINS	In view of its critical role in influenza A virus (IAV) tropism and pathogenesis, we evaluated the receptor binding properties of HA proteins of the closely related swine and new pandemic human IAVs. We generated recombinant soluble trimeric H1 ectodomains of several IAVs and analyzed their sialic acid binding properties using fetuin-binding and glycan array analysis. The results show that closely related swine and new pandemic H1 proteins differ dramatically in their ability to bind these receptors. Although new pandemic H1 protein exhibited hardly any binding, swine H1 bound efficiently to a number of alpha 2-6-linked sialyl glycans. The responsible amino acids were identified by analyzing chimeric H1 proteins and by performing systematic site-directed mutagenesis of swine and new pandemic human H1 proteins. The difference was found to map to residues at positions 200 and 227. Although substitution of either residue significantly affected the binding phenotype, substitution of both was found to act synergistically and reverse the phenotype almost completely. Modeling of the T200A and E227A substitutions into the crystal structure of the new pandemic human H1 protein revealed the loss of potential hydrogen bond formation with Gln(191), which is part of the 190-loop of the receptor binding site, and with the penultimate galactose, respectively. Thus, a residue not belonging to the receptor binding site may affect the interaction of HA with its receptor. Interestingly, whereas alanine at position 200 is found in most new pandemic human viruses, the residue at position 227 in these viruses is invariably a glutamic acid.	[de Vries, Robert P.; de Vries, Erik; Moore, Karen S.; Rigter, Alan; Rottier, Peter J. M.; de Haan, Cornelis A. M.] Univ Utrecht, Div Virol, Dept Infect Dis & Immunol, Fac Vet Med, NL-3584 CL Utrecht, Netherlands	Utrecht University	de Haan, CAM (corresponding author), Univ Utrecht, Div Virol, Dept Infect Dis & Immunol, Fac Vet Med, Yalelaan 1, NL-3584 CL Utrecht, Netherlands.	c.a.m.dehaan@uu.nl	de Vries, Robert/K-7212-2013	Moore, Kat/0000-0002-5746-4098; de Haan, Cornelis/0000-0002-4459-9874; de Vries, Robert/0000-0002-1586-4464	"Impulse Veterinary Avian Influenza Research" in the Netherlands	"Impulse Veterinary Avian Influenza Research" in the Netherlands	This work was supported by the program "Impulse Veterinary Avian Influenza Research" in the Netherlands.	BAENZIGER JU, 1979, J BIOL CHEM, V254, P789; Bateman AC, 2008, J VIROL, V82, P8204, DOI 10.1128/JVI.00718-08; Bateman AC, 2010, J BIOL CHEM, V285, P34016, DOI 10.1074/jbc.M110.115998; Baz M, 2007, ANTIVIR RES, V74, P159, DOI 10.1016/j.antiviral.2006.10.012; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bohne-Lang A, 2005, NUCLEIC ACIDS RES, V33, pW214, DOI 10.1093/nar/gki385; Chandrasekaran A, 2008, NAT BIOTECHNOL, V26, P107, DOI 10.1038/nbt1375; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Cornelissen LAHM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010645; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Vries RP, 2010, VIROLOGY, V403, P17, DOI 10.1016/j.virol.2010.03.047; Gambaryan A, 2005, VIROLOGY, V334, P276, DOI 10.1016/j.virol.2005.02.003; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Glaser L, 2005, J VIROL, V79, P11533, DOI 10.1128/JVI.79.17.11533-11536.2005; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Ilyushina NA, 2010, EMERG INFECT DIS, V16, P314, DOI 10.3201/eid1602.091141; Ito T, 1998, J VIROL, V72, P7367, DOI 10.1128/JVI.72.9.7367-7373.1998; Ma Wenjun, 2008, J Mol Genet Med, V3, P158; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; McKimm-Breschkin JL, 2000, ANTIVIR RES, V47, P1, DOI 10.1016/S0166-3542(00)00103-0; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; NAEVE CW, 1984, J VIROL, V51, P567, DOI 10.1128/JVI.51.2.567-569.1984; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; ROGERS GN, 1985, J BIOL CHEM, V260, P7362; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; SPIRO RG, 1974, J BIOL CHEM, V249, P5704; Steel J, 2010, J VIROL, V84, P21, DOI 10.1128/JVI.01732-09; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; Taubenberger JK, 2010, CELL HOST MICROBE, V7, P440, DOI 10.1016/j.chom.2010.05.009; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Xu R, 2010, SCIENCE, V328, P357, DOI 10.1126/science.1186430; Yang H., 2010, PLOS CURR, V22, P2	39	50	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5868	5875		10.1074/jbc.M110.193557	http://dx.doi.org/10.1074/jbc.M110.193557			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21173148	Green Published, hybrid			2022-12-27	WOS:000287230600095
J	Fang, JD; Chou, HC; Tung, HH; Huang, PY; Lee, SL				Fang, Jung-Da; Chou, Hsiao-Chin; Tung, Hsiu-Hui; Huang, Pao-Yi; Lee, Sheau-Ling			Endogenous Expression of Matriptase in Neural Progenitor Cells Promotes Cell Migration and Neuron Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE SERINE-PROTEASE; HEPATOCYTE GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; BREAST-CANCER CELLS; IN-VITRO; STEM-CELLS; ADULT NEUROGENESIS; BARRIER FUNCTION; ISCHEMIC BRAIN; TUBE CLOSURE	Recent studies show that type II transmembrane serine proteases play important roles in diverse cellular activities and pathological processes. Their expression and functions in the central nervous system, however, are largely unexplored. In this study, we show that the expression of one such member, matriptase (MTP), was cell type-restricted and primarily expressed in neural progenitor (NP) cells and neurons. Blocking MTP expression or MTP activity prevented NP cell traverse of reconstituted basement membrane, whereas overexpression of MTP promoted it. The NP cell mobilization induced by either vascular endothelial growth factor or hepatocyte growth factor was also impaired by knocking down MTP expression. MTP acts upstream of matrix metalloproteinase 2 in promoting NP cell mobility. In embryonic stem cell differentiation to neural cells, MTP knockdown had no effect on entry of embryonic stem cells into the neural lineage. High MTP expression or activity, however, shifts the population dynamics from NP cells toward neurons to favor neuronal differentiation. This is the first report to demonstrate the direct involvement of type II transmembrane serine protease in NP cell function.	[Fang, Jung-Da; Chou, Hsiao-Chin; Tung, Hsiu-Hui; Huang, Pao-Yi; Lee, Sheau-Ling] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan Town 35053, Miaoli County, Taiwan	National Health Research Institutes - Taiwan	Lee, SL (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan.	sllee@nhri.org.tw			National Health Research Institutes Taiwan, R.O.C. [CS-098-PP-09]	National Health Research Institutes Taiwan, R.O.C.(National Health Research Institutes - Taiwan)	This work was supported by National Health Research Institutes Grant CS-098-PP-09 (to S.-L.L.), Taiwan, R.O.C.	Aarum J, 2003, P NATL ACAD SCI USA, V100, P15983, DOI 10.1073/pnas.2237050100; Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Abrous DN, 2005, PHYSIOL REV, V85, P523, DOI 10.1152/physrev.00055.2003; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Belmadani A, 2006, J NEUROSCI, V26, P3182, DOI 10.1523/JNEUROSCI.0156-06.2006; Benaud CM, 2002, CLIN EXP METASTAS, V19, P639, DOI 10.1023/A:1020985632550; Bhatt AS, 2007, P NATL ACAD SCI USA, V104, P5771, DOI 10.1073/pnas.0606514104; Cacci E, 2003, J NEUROSCI RES, V74, P760, DOI 10.1002/jnr.10799; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Cheng HX, 2009, CANCER RES, V69, P1828, DOI 10.1158/0008-5472.CAN-08-3728; Cho EG, 2001, J BIOL CHEM, V276, P44581, DOI 10.1074/jbc.M107059200; Fukuda H, 2006, STEM CELLS, V24, P763, DOI 10.1634/stemcells.2005-0137; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Galtrey CM, 2007, BRAIN RES REV, V54, P1, DOI 10.1016/j.brainresrev.2006.09.006; Garzotto D, 2008, J NEUROSCI, V28, P5901, DOI 10.1523/JNEUROSCI.1083-08.2008; Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481; Guipponi M, 2002, HUM MOL GENET, V11, P2829, DOI 10.1093/hmg/11.23.2829; Ito Y, 2006, GLYCOBIOLOGY, V16, P368, DOI 10.1093/glycob/cwj084; Jin XL, 2006, CANCER SCI, V97, P1327, DOI 10.1111/j.1349-7006.2006.00328.x; Jin XL, 2005, J CELL BIOCHEM, V95, P632, DOI 10.1002/jcb.20418; Jung H, 2008, ONCOGENE, V27, P2635, DOI 10.1038/sj.onc.1210914; Kendall SE, 2008, STEM CELLS, V26, P1575, DOI 10.1634/stemcells.2007-0887; Kilpatrick LM, 2006, BLOOD, V108, P2616, DOI 10.1182/blood-2006-02-001073; Kim HJ, 2005, EXP NEUROL, V192, P60, DOI 10.1016/j.expneurol.2004.10.014; Kim MG, 1999, IMMUNOGENETICS, V49, P420, DOI 10.1007/s002510050515; Kiyomiya KI, 2006, AM J PHYSIOL-CELL PH, V291, pC40, DOI 10.1152/ajpcell.00351.2005; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; Lee SL, 2010, MECH DEVELOP, V127, P82, DOI 10.1016/j.mod.2009.10.004; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; List K, 2006, AM J PATHOL, V168, P1513, DOI 10.2353/ajpath.2006.051071; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Long YQ, 2001, BIOORG MED CHEM LETT, V11, P2515, DOI 10.1016/S0960-894X(01)00493-0; McQuibban GA, 2001, J BIOL CHEM, V276, P43503, DOI 10.1074/jbc.M107736200; Melchor JP, 2005, THROMB HAEMOSTASIS, V93, P655, DOI 10.1160/TH04-12-0838; MIGNATTI P, 1993, PHYSIOL REV, V73, P161, DOI 10.1152/physrev.1993.73.1.161; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Oberst M, 2001, AM J PATHOL, V158, P1301, DOI 10.1016/S0002-9440(10)64081-3; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Ohira K., 2010, CELL MOL LIFE SCI, P1; Parent JM, 1997, J NEUROSCI, V17, P3727; Paxinos G., 2001, MOUSE BRAIN ATLAS; Powell EM, 2001, NEURON, V30, P79, DOI 10.1016/S0896-6273(01)00264-1; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Sanders Andrew J, 2006, J Exp Ther Oncol, V6, P39; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Stallmach R, 2008, BIOCHEM J, V412, P81, DOI 10.1042/BJ20071432; Stumm R, 2007, J MOL ENDOCRINOL, V38, P377, DOI 10.1677/JME-06-0032; Szabo R, 2005, BIOCHEM J, V390, P231, DOI 10.1042/BJ20050299; Szabo R, 2003, THROMB HAEMOSTASIS, V90, P185, DOI 10.1160/TH03-02-0071; Szabo R, 2009, DEVELOPMENT, V136, P2653, DOI 10.1242/dev.038430; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Xu Q, 2007, CLIN EXP PHARMACOL P, V34, P624, DOI 10.1111/j.1440-1681.2007.04619.x; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yong VW, 2001, NAT REV NEUROSCI, V2, P502, DOI 10.1038/35081571; Zhang RL, 2005, NEUROSCIENTIST, V11, P408, DOI 10.1177/1073858405278865	58	18	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5667	5679		10.1074/jbc.M110.153866	http://dx.doi.org/10.1074/jbc.M110.153866			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21149451	hybrid, Green Published			2022-12-27	WOS:000287230600076
J	Tanaka, N; Morimoto, Y; Noguchi, Y; Tada, T; Waku, T; Kunugi, S; Morii, T; Lee, YF; Konno, T; Takahashi, N				Tanaka, Naoki; Morimoto, Yumi; Noguchi, Yurika; Tada, Tomoko; Waku, Tomonori; Kunugi, Shigeru; Morii, Takashi; Lee, Yin-Fai; Konno, Takashi; Takahashi, Nobuyuki			The Mechanism of Fibril Formation of a Non-inhibitory Serpin Ovalbumin Revealed by the Identification of Amyloidogenic Core Regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTIVE-CENTER LOOP; CRYSTAL-STRUCTURE; DISULFIDE BOND; AGGREGATION-PRONE; DENATURED STATE; MUTANT R339T; S-OVALBUMIN; IN-VITRO; POLYMERIZATION; PROTEINS	Ovalbumin (OVA), a non-inhibitory member of the serpin superfamily, forms fibrillar aggregates upon heat-induced denaturation. Recent studies suggested that OVA fibrils are generated by a mechanism similar to that of amyloid fibril formation, which is distinct from polymerization mechanisms proposed for other serpins. In this study, we provide new insights into the mechanism of OVA fibril formation through identification of amyloidogenic core regions using synthetic peptide fragments, site-directed mutagenesis, and limited proteolysis. OVA possesses a single disulfide bond between Cys(73) and Cys(120) in the N-terminal helical region of the protein. Heat treatment of disulfide-reduced OVA resulted in the formation of long straight fibrils that are distinct from the semi-flexible fibrils formed from OVA with an intact disulfide. Computer predictions suggest that helix B (hB) of the N-terminal region, strand 3A, and strands 4-5B are highly beta-aggregation- prone regions. These predictions were confirmed by the fact that synthetic peptides corresponding to these regions formed amyloid fibrils. Site-directed mutagenesis of OVA indicated that V41A substitution in hB interfered with the formation of fibrils. Co-incubation of a soluble peptide fragment of hB with the disulfide-intact full-length OVA consistently promoted formation of long straight fibrils. In addition, the N-terminal helical region of the heat-induced fibril of OVA was protected from limited proteolysis. These results indicate that the heat-induced fibril formation of OVA occurs by a mechanism involving transformation of the N-terminal helical region of the protein to beta-strands, thereby forming sequential intermolecular linkages.	[Tanaka, Naoki; Morimoto, Yumi; Noguchi, Yurika; Tada, Tomoko; Waku, Tomonori; Kunugi, Shigeru] Kyoto Inst Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan; [Morii, Takashi] Kyoto Univ, Inst Adv Energy, Kyoto 6110011, Japan; [Takahashi, Nobuyuki] Kyoto Univ, Grad Sch Agr, Kyoto 6110011, Japan; [Lee, Yin-Fai] Univ Leicester, Dept Canc Studies & Mol Med, Leicester LE1 9HN, Leics, England; [Konno, Takashi] Univ Fukui, Dept Mol Physiol & Biophys, Fukui 9101193, Japan	Kyoto Institute of Technology; Kyoto University; Kyoto University; University of Leicester; University of Fukui	Tanaka, N (corresponding author), Kyoto Inst Technol, Dept Biomol Engn, Sakyo Ku, Kyoto 6068585, Japan.	tanaka@kit.ac.jp	Morii, Takashi/AAL-1392-2020	Morii, Takashi/0000-0003-3663-3267	Japanese Ministry of Education, Culture, Sports, Science, and Technology [20550111, 21550154]	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Japanese Ministry of Education, Culture, Sports, Science, and Technology Grants-in-aid for Scientific Research 20550111 and 21550154.	Arii Y, 2002, BIOCHEM J, V363, P403, DOI 10.1042/0264-6021:3630403; Azakami H, 2005, J AGR FOOD CHEM, V53, P1254, DOI 10.1021/jf049325f; BAUMANN U, 1991, J MOL BIOL, V218, P595, DOI 10.1016/0022-2836(91)90704-A; Broersen K, 2007, BIOMACROMOLECULES, V8, P1648, DOI 10.1021/bm0612283; Chiti F, 2002, NAT STRUCT BIOL, V9, P137, DOI 10.1038/nsb752; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Davis RL, 1999, NATURE, V401, P376, DOI 10.1038/43897; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Ekeowa UI, 2010, P NATL ACAD SCI USA, V107, P17146, DOI 10.1073/pnas.1004785107; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Frare E, 2006, J MOL BIOL, V361, P551, DOI 10.1016/j.jmb.2006.06.055; Gozu M, 2003, J BIOCHEM, V133, P731, DOI 10.1093/jb/mvg094; Harrison PM, 1997, CURR OPIN STRUC BIOL, V7, P53, DOI 10.1016/S0959-440X(97)80007-3; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; HUNT LT, 1980, BIOCHEM BIOPH RES CO, V95, P864, DOI 10.1016/0006-291X(80)90867-0; Huntington JA, 1999, J MOL BIOL, V293, P449, DOI 10.1006/jmbi.1999.3184; Huntington JA, 2001, J CHROMATOGR B, V756, P189, DOI 10.1016/S0378-4347(01)00108-6; Huntington JA, 2009, PRION, V3, P12, DOI 10.4161/pri.3.1.8441; Kallberg Y, 2001, J BIOL CHEM, V276, P12945, DOI 10.1074/jbc.M010402200; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Knaupp AS, 2010, J MOL BIOL, V396, P375, DOI 10.1016/j.jmb.2009.11.048; Krysmann MJ, 2008, BIOCHEMISTRY-US, V47, P4597, DOI 10.1021/bi8000616; Kuroda Y, 2004, J PEPT SCI, V10, P8, DOI 10.1002/psc.485; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; NEMOTO N, 1993, BIOPOLYMERS, V33, P551, DOI 10.1002/bip.360330405; Onda M, 1997, J BIOL CHEM, V272, P3973, DOI 10.1074/jbc.272.7.3973; Onda M, 2003, J BIOL CHEM, V278, P23600, DOI 10.1074/jbc.M300295200; Onda M, 2008, J BIOL CHEM, V283, P17568, DOI 10.1074/jbc.M709262200; Padrick SB, 2002, BIOCHEMISTRY-US, V41, P4694, DOI 10.1021/bi0160462; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Pearce FG, 2007, J AGR FOOD CHEM, V55, P318, DOI 10.1021/jf062154p; Reches M, 2003, SCIENCE, V300, P625, DOI 10.1126/science.1082387; Rousseau F, 2006, J MOL BIOL, V355, P1037, DOI 10.1016/j.jmb.2005.11.035; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; SHARP HL, 1969, J LAB CLIN MED, V73, P934; Shirai N, 1997, J BIOCHEM-TOKYO, V121, P787; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; STEIN PE, 1995, NAT STRUCT BIOL, V2, P96, DOI 10.1038/nsb0295-96; STEIN PE, 1991, J MOL BIOL, V221, P941, DOI 10.1016/0022-2836(91)80185-W; STEIN PE, 1990, NATURE, V347, P99, DOI 10.1038/347099a0; TAKAHASHI N, 1995, GENE, V161, P211, DOI 10.1016/0378-1119(95)00234-W; Takahashi N, 2005, BIOSCI BIOTECH BIOCH, V69, P922, DOI 10.1271/bbb.69.922; TAKAHASHI N, 1992, J BIOL CHEM, V267, P11565; TAKAHASHI N, 1991, J BIOCHEM-TOKYO, V109, P846, DOI 10.1093/oxfordjournals.jbchem.a123469; Takahashi N, 2002, BBA-PROTEINS PROTEOM, V1601, P110, DOI 10.1016/S1570-9639(02)00435-1; Takehara S, 2010, J MOL BIOL, V403, P751, DOI 10.1016/j.jmb.2010.07.047; Takehara S, 2009, J MOL BIOL, V388, P11, DOI 10.1016/j.jmb.2009.03.007; Tanaka N, 2008, BIOCHEMISTRY-US, V47, P2961, DOI 10.1021/bi701823g; Tani F, 1997, PROTEIN SCI, V6, P1491, DOI 10.1002/pro.5560060713; Tani F, 2004, BIOSCI BIOTECH BIOCH, V68, P2466, DOI 10.1271/bbb.68.2466; TATSUMI E, 1994, J BIOL CHEM, V269, P28062; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Tjernberg LO, 1999, J BIOL CHEM, V274, P12619, DOI 10.1074/jbc.274.18.12619; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; Weijers M, 2003, PROTEIN SCI, V12, P2693, DOI 10.1110/ps.03242803; Weijers M, 2008, BIOMACROMOLECULES, V9, P3165, DOI 10.1021/bm800751e; Yamasaki M, 2003, J BIOL CHEM, V278, P35524, DOI 10.1074/jbc.M305926200; Yamasaki M, 2002, J MOL BIOL, V315, P113, DOI 10.1006/jmbi.2001.5056; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yamasaki M, 2010, J BIOL CHEM, V285, P30752, DOI 10.1074/jbc.M110.156042; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zhou A, 2004, J MOL BIOL, V342, P931, DOI 10.1016/j.jmb.2004.07.078	64	36	37	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5884	5894		10.1074/jbc.M110.176396	http://dx.doi.org/10.1074/jbc.M110.176396			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21156792	Green Published, hybrid			2022-12-27	WOS:000287230600097
J	Wang, WQ; Huang, J; Chen, JJ				Wang, Wenqi; Huang, Jun; Chen, Junjie			Angiomotin-like Proteins Associate with and Negatively Regulate YAP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PATHWAY; CELL CONTACT INHIBITION; ORGAN SIZE CONTROL; HIPPO PATHWAY; SIGNALING PATHWAY; BANTAM MICRORNA; GROWTH-CONTROL; COILED-COIL; DROSOPHILA; APOPTOSIS	In both Drosophila and mammalian systems, the Hippo pathway plays an important role in controlling organ size, mainly through its ability to regulate cell proliferation and apoptosis. The key component in the Hippo pathway is the Yes-associated protein YAP1, which localizes in nucleus, functions as a transcriptional coactivator, and regulates the expression of several proliferation-and apoptosis-related genes. The Hippo pathway negatively regulates YAP1 transcriptional activity by modulating its nuclear-cytoplasmic localization in a phosphorylation-dependent manner. Here, we describe the identification of several new PY motif-containing proteins, including angiomotin-like protein 1 (AMOTL1) and 2 (AMOTL2), as YAP1-associated proteins. We demonstrate that AMOTL1 and AMOTL2 can regulate YAP1 cytoplasm-to-nucleus translocation through direct protein-protein interaction, which can occur independent of YAP1 phosphorylation status. Moreover, down-regulation of AMOTL2 in MCF10A cells promotes epithelial-mesenchymal transition, a phenotype that is also observed in MCF10A cells with YAP1 overexpression. Together, these data support a new mechanism for YAP1 regulation, which is mediated via its direct interactions with angiomotin-like proteins.	[Huang, Jun] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Wang, Wenqi; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA	Zhejiang University; University of Texas System; UTMD Anderson Cancer Center	Huang, J (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	jhuang@zju.edu.cn; jchen8@mdanderson.org		Wang, Wenqi/0000-0003-4053-5088	Department of Defense (DOD) [W81XWH-09-1-0409, W81XWH-05-1-0470]; National Institutes of Health [CA016672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Department of Defense (DOD)(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Department of Defense (DOD) Era of Hope research scholar award (W81XWH-09-1-0409) (to J. C.) and an Era of Hope Scholar award from the Department of Defense (W81XWH-05-1-0470) (to J. C.).; We thank all colleagues in the Chen laboratory for insightful discussion and technical assistance. The M. D. Anderson Cancer Center was supported by National Institutes of Health Grant CA016672.	Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; Bratt A, 2005, J BIOL CHEM, V280, P34859, DOI 10.1074/jbc.M503915200; Bratt A, 2002, GENE, V298, P69, DOI 10.1016/S0378-1119(02)00928-9; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; Gagne V, 2009, CELL MOTIL CYTOSKEL, V66, P754, DOI 10.1002/cm.20405; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Huang HZ, 2007, DEVELOPMENT, V134, P979, DOI 10.1242/dev.02782; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; Nolo R, 2006, CURR BIOL, V16, P1895, DOI 10.1016/j.cub.2006.08.057; Okada T, 2007, TRENDS CELL BIOL, V17, P222, DOI 10.1016/j.tcb.2007.03.006; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Ren FF, 2010, DEV BIOL, V337, P303, DOI 10.1016/j.ydbio.2009.10.046; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zheng YJ, 2009, CIRC RES, V105, P260, DOI 10.1161/CIRCRESAHA.109.195156	28	193	197	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4364	4370		10.1074/jbc.C110.205401	http://dx.doi.org/10.1074/jbc.C110.205401			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21187284	Green Published, hybrid			2022-12-27	WOS:000286975700036
J	Marshall, MR; Clark, JP; Westenbroek, R; Yu, FH; Scheuer, T; Catterall, WA				Marshall, Misty R.; Clark, John Patrick, III; Westenbroek, Ruth; Yu, Frank H.; Scheuer, Todd; Catterall, William A.			Functional Roles of a C-terminal Signaling Complex of Ca(v)1 Channels and A-kinase Anchoring Protein 15 in Brain Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL SUBCELLULAR-LOCALIZATION; CALCIUM-ANTAGONIST RECEPTOR; SKELETAL-MUSCLE; GENE-EXPRESSION; CA2+ CHANNEL; HIPPOCAMPAL-NEURONS; NEUROTROPHIC FACTOR; ALPHA(1) SUBUNIT; PHOSPHORYLATION; TRANSCRIPTION	Regulation of Ca(V)1.2 channels in cardiac myocytes by the beta-adrenergic pathway requires a signaling complex in which the proteolytically processed distal C-terminal domain acts as an autoinhibitor of channel activity and mediates up-regulation by the beta-adrenergic receptor and PKA bound to A-kinase anchoring protein 15 (AKAP15). We examined the significance of this distal C-terminal signaling complex for Ca(V)1.2 and Ca(V)1.3 channels in neurons. AKAP15 co-immunoprecipitates with Ca(V)1.2 and Ca(V)1.3 channels. AKAP15 has overlapping localization with Ca(V)1.2 and Ca(V)1.3 channels in cell bodies and proximal dendrites and is closely co-localized with Ca(V)1.2 channels in punctate clusters. The neuronal AKAP MAP2B, which also interacts with Ca(V)1.2 and Ca(V)1.3 channels, has complementary localization to AKAP15, suggesting different functional roles in calcium channel regulation. Studies with mice that lack the distal C-terminal domain of Ca(V)1.2 channels (Ca(V)1.2 Delta DCT) reveal that AKAP15 interacts with neuronal Ca(V)1.2 channels via their C terminus in vivo and is co-localized in punctate clusters of Ca(V)1.2 channels via that interaction. Ca(V)1.2 Delta DCT neurons have reduced L-type calcium current, indicating that the distal C-terminal domain is required for normal functional expression in vivo. Deletion of the distal C-terminal domain impairs calcium- dependent signaling from Ca(V)1.2 channels to the nucleus, as shown by reduction in phosphorylation of the cAMP response element-binding protein. Our results define AKAP signaling complexes of Ca(V)1.2 and Ca(V)1.3 channels in brain and reveal three previously unrecognized functional roles for the distal C terminus of neuronal Ca(V)1.2 channels in vivo: increased functional expression, anchoring of AKAP15 and PKA, and initiation of excitation-transcription coupling.	[Marshall, Misty R.; Clark, John Patrick, III; Westenbroek, Ruth; Yu, Frank H.; Scheuer, Todd; Catterall, William A.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Catterall, WA (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA.	wcatt@uw.edu	Marshall, Misty R/E-5833-2016	Marshall, Misty R/0000-0002-1073-3131; Yu, Frank/0000-0001-9306-1731	National Institutes of Health [T32 GM07750, T3207332, P01 HL44948, R01 HL85372, R01 NS22625]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085372, P01HL044948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant Training Grants T32 GM07750 (to M. R. M.) and T3207332 (to J. P. C.) and Research Grants P01 HL44948, R01 HL85372, and R01 NS22625 (to W. A. C.).	Abel T, 1998, BRAIN RES REV, V26, P360, DOI 10.1016/S0165-0173(97)00050-7; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; CURTIS BM, 1984, BIOCHEMISTRY-US, V23, P2113, DOI 10.1021/bi00305a001; CURTIS BM, 1985, P NATL ACAD SCI USA, V82, P2528, DOI 10.1073/pnas.82.8.2528; Davare MA, 1999, J BIOL CHEM, V274, P30280, DOI 10.1074/jbc.274.42.30280; Davare MA, 2001, SCIENCE, V293, P98, DOI 10.1126/science.293.5527.98; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; DEJONGH KS, 1990, J BIOL CHEM, V265, P14738; DeJongh KS, 1996, BIOCHEMISTRY-US, V35, P10392, DOI 10.1021/bi953023c; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Endoh T, 2006, BRIT J PHARMACOL, V147, P391, DOI 10.1038/sj.bjp.0706623; Finkbeiner S, 1998, J NEUROBIOL, V37, P171, DOI 10.1002/(SICI)1097-4695(199810)37:1<171::AID-NEU13>3.0.CO;2-H; FLOCKERZI V, 1986, NATURE, V323, P66, DOI 10.1038/323066a0; Fraser IDC, 1998, EMBO J, V17, P2261, DOI 10.1093/emboj/17.8.2261; FU Y, 2011, J BIOL CHEM, P286; Gao TY, 2001, J BIOL CHEM, V276, P21089, DOI 10.1074/jbc.M008000200; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Gray PC, 1998, NEURON, V20, P1017, DOI 10.1016/S0896-6273(00)80482-1; Gray PC, 1997, J BIOL CHEM, V272, P6297, DOI 10.1074/jbc.272.10.6297; GRAY R, 1987, NATURE, V327, P620, DOI 10.1038/327620a0; GROSS RA, 1990, J PHYSIOL-LONDON, V429, P483, DOI 10.1113/jphysiol.1990.sp018268; Hall DD, 2007, BIOCHEMISTRY-US, V46, P1635, DOI 10.1021/bi062217x; HELL JW, 1993, J CELL BIOL, V123, P949, DOI 10.1083/jcb.123.4.949; HELL JW, 1993, J BIOL CHEM, V268, P19451; HOSEY MM, 1987, BIOCHEM BIOPH RES CO, V147, P1137; Hulme JT, 2006, J PHYSIOL-LONDON, V576, P87, DOI 10.1113/jphysiol.2006.111799; Hulme JT, 2005, P NATL ACAD SCI USA, V102, P5274, DOI 10.1073/pnas.0409885102; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; Hulme JT, 2002, J BIOL CHEM, V277, P4079, DOI 10.1074/jbc.M109814200; IMPEY S, 1994, MOL CELL BIOL, V14, P8272, DOI 10.1128/MCB.14.12.8272; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; KLOCKNER U, 1995, J BIOL CHEM, V270, P17306, DOI 10.1074/jbc.270.29.17306; MURPHY TH, 1991, J NEUROCHEM, V57, P1862, DOI 10.1111/j.1471-4159.1991.tb06396.x; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Pittenger C, 2002, NEURON, V34, P447, DOI 10.1016/S0896-6273(02)00684-0; Pizzorusso T, 2000, J NEUROSCI, V20, P2809; REUTER H, 1967, J PHYSIOL-LONDON, V192, P479, DOI 10.1113/jphysiol.1967.sp008310; REUTER H, 1979, ANNU REV PHYSIOL, V41, P413, DOI 10.1146/annurev.ph.41.030179.002213; Schroder E, 2009, CIRC RES, V104, P1373, DOI 10.1161/CIRCRESAHA.108.191387; SNUTCH TP, 1991, NEURON, V7, P45, DOI 10.1016/0896-6273(91)90073-9; TAKAHASHI M, 1987, P NATL ACAD SCI USA, V84, P5478, DOI 10.1073/pnas.84.15.5478; TSIEN RW, 1983, ANNU REV PHYSIOL, V45, P341, DOI 10.1146/annurev.ph.45.030183.002013; WEI XY, 1994, J BIOL CHEM, V269, P1635; Weick JP, 2003, J NEUROSCI, V23, P3446; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; WESTENBROEK RE, 1992, NEURON, V9, P1099, DOI 10.1016/0896-6273(92)90069-P; Westenbroek RE, 1998, J NEUROSCI, V18, P2321; Zhou J, 2005, NEUROENDOCRINOLOGY, V81, P294, DOI 10.1159/000088448	54	28	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.175257	http://dx.doi.org/10.1074/jbc.M110.175257			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21224388	Green Published, hybrid			2022-12-27	WOS:000289077500074
J	Hoek, M; Myers, MP; Stillman, B				Hoek, Maarten; Myers, Michael P.; Stillman, Bruce			An Analysis of CAF-1-interacting Proteins Reveals Dynamic and Direct Interactions with the KU Complex and 14-3-3 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMATIN ASSEMBLY FACTOR-1; DNA-REPLICATION; FACTOR-I; SACCHAROMYCES-CEREVISIAE; HISTONE CHAPERONE; HUMAN-CELLS; STRUCTURAL BASIS; P150 SUBUNIT; HUMAN ASF1; BINDING	CAF-1 is essential in human cells for the de novo deposition of histones H3 and H4 at the DNA replication fork. Depletion of CAF-1 from various cell lines causes replication fork arrest, activation of the intra-S phase checkpoint, and global defects in chromatin structure. CAF-1 is also involved in coordinating inheritance of states of gene expression and in chromatin assembly following DNA repair. In this study, we generated cell lines expressing RNAi-resistant versions of CAF-1 and showed that the N-terminal 296 amino acids are dispensable for essential CAF-1 function in vivo. N-terminally truncated CAF-1 p150 was deficient in proliferating cell nuclear antigen (PCNA) binding, reinforcing the existence of two PCNA binding sites in human CAF-1, but the defect in PCNA binding had no effect on the recruitment of CAF-1 to chromatin after DNA damage or to resistance to DNA-damaging agents. Tandem affinity purification of CAF-1-interacting proteins under mild conditions revealed that CAF-1 was directly associated with the KU70/80 complex, part of the DNA-dependent protein kinase, and the phosphoserine/threonine-binding protein 14-3-3 zeta. CAF-1 was a substrate for DNA-dependent protein kinase, and the 14-3-3 interaction in vitro is dependent on DNA-dependent protein kinase phosphorylation. These results highlight that CAF-1 has prominent interactions with theDNArepair machinery but that the N terminus is dispensable for the role of CAF-1 in DNA replication-and repair-coupled chromatin assembly.	[Hoek, Maarten; Myers, Michael P.; Stillman, Bruce] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Stillman, B (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	stillman@cshl.edu		Stillman, Bruce/0000-0002-9453-4091	National Institutes of Health, NCI [CA13016]; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA13016 from the NCI.	Ahmad A, 1999, J BIOL CHEM, V274, P16646, DOI 10.1074/jbc.274.23.16646; Alekseev OM, 2005, PROTEINS, V61, P1, DOI 10.1002/prot.20600; Arosio D, 2002, J BIOL CHEM, V277, P9741, DOI 10.1074/jbc.M111916200; Ben-Shahar TR, 2009, MOL CELL BIOL, V29, P6353, DOI 10.1128/MCB.01051-09; BRIDGES D, 2005, SCI STKE, pRE10, DOI DOI 10.1126/STKE.2962005RE10; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; di Fagagna FD, 2001, CURR BIOL, V11, P1192, DOI 10.1016/S0960-9822(01)00328-1; Ebrahimi H, 2008, GENE DEV, V22, P3363, DOI 10.1101/gad.486208; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Enomoto S, 1997, GENE DEV, V11, P358, DOI 10.1101/gad.11.3.358; Enomoto S, 1998, GENE DEV, V12, P219, DOI 10.1101/gad.12.2.219; Gerard A, 2006, EMBO REP, V7, P817, DOI 10.1038/sj.embor.7400750; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Hsu HL, 2000, GENE DEV, V14, P2807, DOI 10.1101/gad.844000; Jiao R, 2007, ONCOGENE, V26, P3811, DOI 10.1038/sj.onc.1210150; Jiao RJ, 2004, MOL CELL BIOL, V24, P4710, DOI 10.1128/MCB.24.11.4710-4719.2004; Jin J, 2004, CURR BIOL, V14, P1436, DOI 10.1016/j.cub.2004.07.051; Kaufman PD, 1997, GENE DEV, V11, P345, DOI 10.1101/gad.11.3.345; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Keller C, 2000, J BIOL CHEM, V275, P35512, DOI 10.1074/jbc.M003073200; KIM J, 1995, J BIOL CHEM, V270, P13620, DOI 10.1074/jbc.270.23.13620; Kim JA, 2009, P NATL ACAD SCI USA, V106, P1151, DOI 10.1073/pnas.0812578106; Krawitz DC, 2002, MOL CELL BIOL, V22, P614, DOI 10.1128/MCB.22.2.614-625.2002; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Linger J, 2005, GENETICS, V171, P1513, DOI 10.1534/genetics.105.043000; Lottersberger F, 2003, GENETICS, V165, P1717; Lottersberger F, 2007, MOL CELL BIOL, V27, P3266, DOI 10.1128/MCB.01767-06; Martini E, 1998, J CELL BIOL, V143, P563, DOI 10.1083/jcb.143.3.563; Meek K, 2004, IMMUNOL REV, V200, P132, DOI 10.1111/j.0105-2896.2004.00162.x; Meek SEM, 2004, J BIOL CHEM, V279, P32046, DOI 10.1074/jbc.M403044200; Mello JA, 2002, EMBO REP, V3, P329, DOI 10.1093/embo-reports/kvf068; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nabatiyan A, 2006, MOL CELL BIOL, V26, P1839, DOI 10.1128/MCB.26.5.1839-1849.2006; ONO M, 1994, NUCLEIC ACIDS RES, V22, P3918, DOI 10.1093/nar/22.19.3918; Patterson EE, 2008, GENETICS, V180, P771, DOI 10.1534/genetics.108.091710; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Polo SE, 2006, CELL, V127, P481, DOI 10.1016/j.cell.2006.08.049; Rampakakis E, 2008, J CELL SCI, V121, P590, DOI 10.1242/jcs.021352; Reese BE, 2003, MOL CELL BIOL, V23, P3226, DOI 10.1128/MCB.23.9.3226-3236.2003; Richardson RT, 2006, J BIOL CHEM, V281, P21526, DOI 10.1074/jbc.M603816200; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; SMITH S, 1991, J BIOL CHEM, V266, P12041; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Takami Y, 2007, MOL BIOL CELL, V18, P129, DOI 10.1091/mbc.E06-05-0426; Tamburini BA, 2006, GENETICS, V173, P599, DOI 10.1534/genetics.105.054783; Tang Y, 2006, NAT STRUCT MOL BIOL, V13, P921, DOI 10.1038/nsmb1147; Tie F, 2001, DEVELOPMENT, V128, P275; Usui T, 2007, P NATL ACAD SCI USA, V104, P2797, DOI 10.1073/pnas.0611259104; Vandre CL, 2008, GENETICS, V180, P1407, DOI 10.1534/genetics.108.094490; Verreault A, 1998, CURR BIOL, V8, P96, DOI 10.1016/S0960-9822(98)70040-5; Verreault A, 2000, GENE DEV, V14, P1430; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Ye XF, 2003, MOL CELL, V11, P341, DOI 10.1016/S1097-2765(03)00037-6; Yoo S, 1998, BIOCHEMISTRY-US, V37, P1336, DOI 10.1021/bi972100w; Zhang WZ, 2000, ANAL CHEM, V72, P2482, DOI 10.1021/ac991363o; Zhang ZG, 2000, NATURE, V408, P221, DOI 10.1038/35041601	64	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10876	10887		10.1074/jbc.M110.217075	http://dx.doi.org/10.1074/jbc.M110.217075			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21209461	Green Published, hybrid			2022-12-27	WOS:000288547000101
J	Harris, J; Hartman, M; Roche, C; Zeng, SJG; O'Shea, A; Sharp, FA; Lambe, EM; Creagh, EM; Golenbock, DT; Tschopp, J; Kornfeld, H; Fitzgerald, KA; Lavelle, EC				Harris, James; Hartman, Michelle; Roche, Caitrionna; Zeng, Shijuan G.; O'Shea, Amy; Sharp, Fiona A.; Lambe, Eimear M.; Creagh, Emma M.; Golenbock, Douglas T.; Tschopp, Jurg; Kornfeld, Hardy; Fitzgerald, Katherine A.; Lavelle, Ed C.			Autophagy Controls IL-1 beta Secretion by Targeting Pro-IL-1 beta for Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NALP3 INFLAMMASOME; NLRP3 INFLAMMASOME; DENDRITIC CELLS; CUTTING EDGE; ACTIVATION; RECOGNITION; MECHANISM; CYTOKINES; ADJUVANTS; CRYSTALS	Autophagy is a key regulator of cellular homeostasis that can be activated by pathogen-associated molecules and recently has been shown to influence IL-1 beta secretion by macrophages. However, the mechanisms behind this are unclear. Here, we describe a novel role for autophagy in regulating the production of IL-1 beta in antigen-presenting cells. After treatment of macrophages with Toll-like receptor ligands, pro-IL-1 beta was specifically sequestered into autophagosomes, whereas further activation of autophagy with rapamycin induced the degradation of pro-IL-1 beta and blocked secretion of the mature cytokine. Inhibition of autophagy promoted the processing and secretion of IL-1 beta by antigen-presenting cells in an NLRP3- and TRIF-dependent manner. This effect was reduced by inhibition of reactive oxygen species but was independent of NOX2. Induction of autophagy in mice in vivo with rapamycin reduced serum levels of IL-1 beta in response to challenge with LPS. These data demonstrate that autophagy controls the production of IL-1 beta through at least two separate mechanisms: by targeting pro-IL-1 beta for lysosomal degradation and by regulating activation of the NLRP3 inflammasome.	[Harris, James; Roche, Caitrionna; Zeng, Shijuan G.; O'Shea, Amy; Sharp, Fiona A.; Lambe, Eimear M.; Lavelle, Ed C.] Trinity Coll Dublin, Adjuvant Res Grp, Sch Biochem & Immunol, Dublin 2, Ireland; [Harris, James; Lavelle, Ed C.] Trinity Coll Dublin, Immunol Res Ctr, Sch Biochem & Immunol, Dublin 2, Ireland; [Creagh, Emma M.] Trinity Coll Dublin, Cytokine Res Grp, Sch Biochem & Immunol, Dublin 2, Ireland; [Hartman, Michelle; Golenbock, Douglas T.; Kornfeld, Hardy; Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA; [Tschopp, Jurg] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; University of Massachusetts System; University of Massachusetts Worcester; University of Lausanne	Harris, J (corresponding author), Trinity Coll Dublin, Adjuvant Res Grp, Sch Biochem & Immunol, Dublin 2, Ireland.	jaharris@tcd.ie	Fitzgerald, Katherine/ABE-6317-2020; Creagh, Emma/AAX-1064-2021; Kornfeld, Hardy/AAS-2903-2021	Creagh, Emma/0000-0001-7631-4370; Harris, James/0000-0002-5634-9637	Science Foundation of Ireland as part of the Immunology Research Centre, SFI Strategic Research Cluster [07/SRC/B1144]; National Institutes of Health [RO1 HL064884]; Irish Research Council for Science, Engineering and Technology (IRCSET); Science Foundation of Ireland [08/RFP/BMT1363, 07/RFP/BICF537]; Enterprise Ireland [IP 2007 0451]; Meningitis Research Foundation [0610.0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083713] Funding Source: NIH RePORTER	Science Foundation of Ireland as part of the Immunology Research Centre, SFI Strategic Research Cluster(Science Foundation Ireland); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irish Research Council for Science, Engineering and Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology); Science Foundation of Ireland(Science Foundation Ireland); Enterprise Ireland; Meningitis Research Foundation(Meningitis Research Foundation (MRF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Science Foundation of Ireland as part of the Immunology Research Centre, SFI Strategic Research Cluster (07/SRC/B1144). To whom correspondence should be addressed: Adjuvant Research Group, School of Biochemistry and Immunology, Trinity College Dublin, College Green, Dublin 2, Ireland. Tel.: 353-1-8963575; Fax: 353-1-6772400; E-mail: jaharris@tcd.ie.; Supported by National Institutes of Health Grant RO1 HL064884 (principal investigator, H. Kornfeld).; Supported by the Irish Research Council for Science, Engineering and Technology (IRCSET).; Supported by the Science Foundation of Ireland (08/RFP/BMT1363, 07/RFP/BICF537), Enterprise Ireland (IP 2007 0451), and the Meningitis Research Foundation (0610.0).	Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Deretic V, 2010, CURR OPIN CELL BIOL, V22, P252, DOI 10.1016/j.ceb.2009.12.009; Dinarello CA, 2010, EUR J IMMUNOL, V40, P599, DOI 10.1002/eji.201040319; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Harris J, 2010, CLIN EXP IMMUNOL, V161, P1, DOI 10.1111/j.1365-2249.2010.04146.x; Harris J, 2009, CURR PROTOC IMMUNOL; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Hewinson J, 2008, J IMMUNOL, V180, P8410, DOI 10.4049/jimmunol.180.12.8410; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kepp O, 2010, EUR J IMMUNOL, V40, P627, DOI 10.1002/eji.200940160; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Li HF, 2007, J IMMUNOL, V178, P5271, DOI 10.4049/jimmunol.178.8.5271; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Monastyrska Iryna, 2006, Molecular Aspects of Medicine, V27, P483, DOI 10.1016/j.mam.2006.08.004; Moreau K, 2010, CURR OPIN CELL BIOL, V22, P206, DOI 10.1016/j.ceb.2009.12.002; NAKAHIRA K, 2010, NAT IMMUNOL IN PRESS; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Prescott NJ, 2007, GASTROENTEROLOGY, V132, P1665, DOI 10.1053/j.gastro.2007.03.034; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Zhou R, 2010, NATURE	43	598	617	1	55	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9587	9597		10.1074/jbc.M110.202911	http://dx.doi.org/10.1074/jbc.M110.202911			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21228274	Green Published, hybrid			2022-12-27	WOS:000288247700084
J	Hooper, R; Churamani, D; Brailoiu, E; Taylor, CW; Patel, S				Hooper, Robert; Churamani, Dev; Brailoiu, Eugen; Taylor, Colin W.; Patel, Sandip			Membrane Topology of NAADP-sensitive Two-pore Channels and Their Regulation by N-linked Glycosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; INOSITOL TRISPHOSPHATE; CALCIUM-RELEASE; CA2+ SIGNALS; ACIDIC ORGANELLES; MOBILIZES CALCIUM; ION-CHANNEL; BETA-CELLS; RECEPTOR; MECHANISMS	Two-pore channels (TPCs) localize to the endolysosomal system and have recently emerged as targets for the Ca2+-mobilizing messenger, nicotinic acid adenine dinucleotide phosphate (NAADP). However, their membrane topology is unknown. Using fluorescence protease protection assays, we show that human TPC1 and TPC2 possess cytosolic N and C termini and therefore an even number of transmembrane regions. Fluorophores placed at position 225 or 347 in TPC1, or 339 in TPC2 were also cytosolic, whereas a fluorophore at position 628 in TPC1 was luminal. These data together with sequence similarity to voltage-gated Ca2+ and Na+ channels, and unbiased in silico predictions are consistent with a topology in which two homologous domains are present, each comprising 6 transmembrane regions and a re-entrant pore loop. Immunocytochemical analysis of selectively permeabilized cells using antipeptide antibodies confirmed that the C-terminal tails of recombinant TPCs are cytosolic and that residues 240-254 of TPC2 prior to putative pore 1 are luminal. Both TPC1 and TPC2 are N-glycosylated with residues 599, 611, and 616 contributing to glycosylation of TPC1. This confirms the luminal position of these residues, which immediately precede the putative pore loop of the second domain. Mutation of all three glycosylation sites in TPC1 enhances NAADP-evoked cytosolic Ca2+ signals. Our data establish essential features of the topology of two-pore channels.	[Hooper, Robert; Churamani, Dev; Patel, Sandip] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Brailoiu, Eugen] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of London; University College London; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Cambridge	Patel, S (corresponding author), UCL, Dept Cell & Dev Biol, Gower St, London WC1E 6BT, England.	patel.s@ucl.ac.uk	Taylor, Colin/G-2447-2010; Patel, Sandip/O-9591-2015	Taylor, Colin/0000-0001-7771-1044; Patel, Sandip/0000-0001-7247-2013	National Institutes of Health [HL90804]; Biotechnology and Biological Sciences Research Council [BB/G013721/1, BB/H009736/1]; Wellcome Trust [085295]; BBSRC [BB/H009736/1, BB/G013721/1] Funding Source: UKRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090804] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by Grants from the National Institutes of Health (HL90804, to E. B.), the Biotechnology and Biological Sciences Research Council (BB/G013721/1, to S. P., and BB/H009736/1, to C. W. T.) and the Wellcome Trust (085295, to C. W. T.).	Bennett ES, 2002, J PHYSIOL-LONDON, V538, P675, DOI 10.1113/jphysiol.2001.013285; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Brailoiu E, 2010, J BIOL CHEM, V285, P38511, DOI 10.1074/jbc.M110.162073; Brailoiu E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.C109.081943; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Cai XJ, 2010, MOL BIOL EVOL, V27, P2352, DOI 10.1093/molbev/msq122; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Churamani D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000797; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; CLAPPER DL, 1987, J BIOL CHEM, V262, P9561; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; Kim HJ, 2007, J BIOL CHEM, V282, P36138, DOI 10.1074/jbc.C700190200; Kiselyov K, 2005, J BIOL CHEM, V280, P43218, DOI 10.1074/jbc.M508210200; LEE HC, 1995, J BIOL CHEM, V270, P2152, DOI 10.1074/jbc.270.5.2152; Lee HC, 1997, PHYSIOL REV, V77, P1133, DOI 10.1152/physrev.1997.77.4.1133; Lorenz H, 2006, NAT PROTOC, V1, P276, DOI 10.1038/nprot.2006.42; Menteyne A, 2006, CURR BIOL, V16, P1931, DOI 10.1016/j.cub.2006.07.070; MICHIKAWA T, 1994, J BIOL CHEM, V269, P9184; Mitchell KJ, 2003, J BIOL CHEM, V278, P11057, DOI 10.1074/jbc.M210257200; Montpetit ML, 2009, P NATL ACAD SCI USA, V106, P16517, DOI 10.1073/pnas.0905414106; Noma K, 2009, J BIOL CHEM, V284, P33139, DOI 10.1074/jbc.M109.021519; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Patel S, 2010, TRENDS CELL BIOL, V20, P277, DOI 10.1016/j.tcb.2010.02.003; Petrecca K, 1999, J PHYSIOL-LONDON, V515, P41, DOI 10.1111/j.1469-7793.1999.041ad.x; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Satler CA, 1998, HUM GENET, V102, P265, DOI 10.1007/s004390050690; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; Wirkner K, 2005, NEUROREPORT, V16, P997, DOI 10.1097/00001756-200506210-00023; Yamasaki M, 2004, J BIOL CHEM, V279, P7234, DOI 10.1074/jbc.M311088200; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	40	48	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9141	9149		10.1074/jbc.M110.189985	http://dx.doi.org/10.1074/jbc.M110.189985			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21173144	hybrid, Green Published			2022-12-27	WOS:000288247700045
J	Lin, HV; Accili, D				Lin, Hua V.; Accili, Domenico			Reconstitution of Insulin Action in Muscle, White Adipose Tissue, and Brain of Insulin Receptor Knock-out Mice Fails to Rescue Diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; TRANSCRIPTION FACTOR FOXO1; HEPATIC GLUCOSE-PRODUCTION; FORKHEAD PROTEIN FOXO1; METABOLIC SYNDROME; OB/OB MICE; RESISTANCE; GLUT4; COMPENSATION; SENSITIVITY	Type 2 diabetes results from an impairment of insulin action. The first demonstrable abnormality of insulin signaling is a decrease of insulin-dependent glucose disposal followed by an increase in hepatic glucose production. In an attempt to dissect the relative importance of these two changes in disease progression, we have employed genetic knock-outs/knock-ins of the insulin receptor. Previously, we demonstrated that insulin receptor knock-out mice (Insr(-/-)) could be rescued from diabetes by reconstitution of insulin signaling in liver, brain, and pancreatic beta cells (L1 mice). In this study, we used a similar approach to reconstitute insulin signaling in tissues that display insulin-dependent glucose uptake. Using GLUT4-Cre mice, we restored InsR expression in muscle, fat, and brain of Insr(-/-) mice (GIRKI (Glut4-insulin receptor knock-in line 1) mice). Unlike L1 mice, GIRKI mice failed to thrive and developed diabetes, although their survival was modestly extended when compared with Insr(-/-). The data underscore the role of developmental factors in the presentation of murine diabetes. The broader implication of our findings is that diabetes treatment should not necessarily target the same tissues that are responsible for disease pathogenesis.	[Lin, Hua V.; Accili, Domenico] Columbia Univ, Dept Med, New York, NY 10032 USA	Columbia University	Accili, D (corresponding author), 1150 St Nicholas Ave,Rm 238, New York, NY 10032 USA.	da230@columbia.edu		Lin, Hua/0000-0001-5001-5567	National Institutes of Health [DK58282, DK57539]; Berrie Fellowship Award; Columbia University Diabetes and Endocrinology Research Center [DK63608]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK058282, P30DK063608, R01DK058282, R01DK057539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Berrie Fellowship Award; Columbia University Diabetes and Endocrinology Research Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK58282 and DK57539 (to D. A.). This work was also supported by the Berrie Fellowship Award (to H. V. L.) and by Grant DK63608 from the Columbia University Diabetes and Endocrinology Research Center.	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Accili D, 1996, NAT GENET, V12, P106, DOI 10.1038/ng0196-106; Biddinger SB, 2008, CELL METAB, V7, P125, DOI 10.1016/j.cmet.2007.11.013; Bluher M, 2002, DEV CELL, V3, P25, DOI 10.1016/S1534-5807(02)00199-5; Bruning JC, 1998, MOL CELL, V2, P559, DOI 10.1016/S1097-2765(00)80155-0; Buteau J, 2007, J BIOL CHEM, V282, P287, DOI 10.1074/jbc.M606118200; Cinti S, 1998, DIABETOLOGIA, V41, P171, DOI 10.1007/s001250050886; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; Joshi RL, 1996, EMBO J, V15, P1542, DOI 10.1002/j.1460-2075.1996.tb00498.x; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kido Y, 2002, J BIOL CHEM, V277, P36740, DOI 10.1074/jbc.M206314200; Kitamura T, 2004, J CLIN INVEST, V113, P209, DOI 10.1172/JCI200417810; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Konner AC, 2007, CELL METAB, V5, P438, DOI 10.1016/j.cmet.2007.05.004; Komori T, 2005, BRAIN RES, V1049, P34, DOI 10.1016/j.brainres.2005.04.079; Kotani K, 2004, J CLIN INVEST, V114, P1666, DOI 10.1172/JCI200421341; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Lauro D, 1998, NAT GENET, V20, P294, DOI 10.1038/3112; Lin HV, 2007, DIABETES, V56, P1969, DOI 10.2337/db07-0127; Lin HV, 2010, DIABETES, V59, P337, DOI 10.2337/db09-1303; LIN HV, 2011, DIABETES IN PRESS; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; MAHER F, 1994, FASEB J, V8, P1003, DOI 10.1096/fasebj.8.13.7926364; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; MOLLER DE, 1989, MOL ENDOCRINOL, V3, P1263, DOI 10.1210/mend-3-8-1263; Nakae J, 2001, ENDOCR REV, V22, P818, DOI 10.1210/edrv.22.6.0452; Nandi A, 2004, PHYSIOL REV, V84, P623, DOI 10.1152/physrev.00032.2003; Obici S, 2002, NAT NEUROSCI, V5, P566, DOI 10.1038/nn861; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Okamoto H, 2005, J CLIN INVEST, V115, P1314, DOI 10.1172/JCI200523096; Okamoto H, 2004, J CLIN INVEST, V114, P214, DOI 10.1172/JCI200421645; Okamoto H, 2003, J BIOL CHEM, V278, P28359, DOI 10.1074/jbc.R300009200; Okamoto H, 2006, J CLIN INVEST, V116, P775, DOI 10.1172/JCI24967; Pajvani UB, 2005, NAT MED, V11, P797, DOI 10.1038/nm1262; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Pocai A, 2005, NATURE, V434, P1026, DOI 10.1038/nature03439; Sankar R, 2002, MOL BRAIN RES, V107, P157, DOI 10.1016/S0169-328X(02)00487-4; SEINO S, 1989, BIOCHEM BIOPH RES CO, V159, P312, DOI 10.1016/0006-291X(89)92439-X; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; Vannucci SJ, 1998, BRAIN RES, V797, P1, DOI 10.1016/S0006-8993(98)00103-6; Xuan SH, 2010, J BIOL CHEM, V285, P41044, DOI 10.1074/jbc.M110.144790; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	46	12	14	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9797	9804		10.1074/jbc.M110.210807	http://dx.doi.org/10.1074/jbc.M110.210807			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21239487	Green Published, hybrid			2022-12-27	WOS:000288247700102
J	Mishra, NK; Peleg, Y; Cirri, E; Belogus, T; Lifshitz, Y; Voelker, DR; Apell, HJ; Garty, H; Karlish, SJD				Mishra, Neeraj Kumar; Peleg, Yoav; Cirri, Erica; Belogus, Talya; Lifshitz, Yael; Voelker, Dennis R.; Apell, Hans-Juergen; Garty, Haim; Karlish, Steven J. D.			FXYD Proteins Stabilize Na,K-ATPase AMPLIFICATION OF SPECIFIC PHOSPHATIDYLSERINE-PROTEIN INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA-K-ATPASE; PHOSPHOLEMMAN-LIKE PROTEIN; ION-TRANSPORT REGULATORS; SODIUM-POTASSIUM PUMP; GAMMA-SUBUNIT; PICHIA-PASTORIS; FUNCTIONAL INTERACTION; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI	FXYD proteins are a family of seven small regulatory proteins, expressed in a tissue-specific manner, that associate with Na,K-ATPase as subsidiary subunits and modulate kinetic properties. This study describes an additional property of FXYD proteins as stabilizers of Na, K-ATPase. FXYD1 (phospholemman), FXYD2 (gamma subunit), and FXYD4 (CHIF) have been expressed in Escherichia coli and purified. These FXYD proteins associate spontaneously in vitro with detergent-soluble purified recombinant human Na, K-ATPase (alpha 1 beta 1) to form alpha 1 beta 1FXYD complexes. Compared with the control (alpha 1 beta 1), all three FXYD proteins strongly protect Na, K-ATPase activity against inactivation by heating or excess detergent (C12E8), with effectiveness FXYD1 > FXYD2 >= FXYD4. Heating also inactivates E-1 <-> E-2 conformational changes and cation occlusion, and FXYD1 protects strongly. Incubation of alpha 1 beta 1 or alpha 1 beta 1FXYD complexes with guanidinium chloride (up to 6 M) causes protein unfolding, detected by changes in protein fluorescence, but FXYD proteins do not protect. Thus, general protein denaturation is not the cause of thermally mediated or detergent-mediated inactivation. By contrast, the experiments show that displacement of specifically bound phosphatidylserine is the primary cause of thermally mediated or detergent-mediated inactivation, and FXYD proteins stabilize phosphatidylserine-Na,K-ATPase interactions. Phosphatidylserine probably binds near trans-membrane segments M9 of the alpha subunit and the FXYD protein, which are in proximity. FXYD1, FXYD2, and FXYD4 co-expressed in HeLacells with rat alpha 1 protect strongly against thermal inactivation. Stabilization of Na, K-ATPase by three FXYD proteins in a mammalian cell membrane, as well the purified recombinant Na, K-ATPase, suggests that stabilization is a general property of FXYD proteins, consistent with a significant biological function.	[Mishra, Neeraj Kumar; Belogus, Talya; Lifshitz, Yael; Garty, Haim; Karlish, Steven J. D.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Peleg, Yoav] Weizmann Inst Sci, Israel Struct Prote Ctr, IL-76100 Rehovot, Israel; [Cirri, Erica; Apell, Hans-Juergen] Univ Konstanz, Dept Biol, D-78464 Constance, Germany; [Voelker, Dennis R.] Natl Jewish Med & Res Ctr, Dept Med, Denver, CO 80206 USA	Weizmann Institute of Science; Weizmann Institute of Science; University of Konstanz; National Jewish Health	Karlish, SJD (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	Steven.Karlish@weizmann.ac.il		Mishra, Neeraj/0000-0002-6762-1747	German-Israel Foundation [922-165.9]; National Institutes of Health [5R37-GM32453, GM081461]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032453, R01GM081461] Funding Source: NIH RePORTER	German-Israel Foundation(German-Israeli Foundation for Scientific Research and Development); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by German-Israel Foundation Grant 922-165.9 (to S. J. D. K., H. G., and H.-J. A.) and in part by National Institutes of Health Grants 5R37-GM32453 and GM081461 (to D. R. V.).	ARYSTARKHOVA E, 1995, J BIOL CHEM, V270, P8785, DOI 10.1074/jbc.270.15.8785; Arystarkhova E, 1999, J BIOL CHEM, V274, P33183, DOI 10.1074/jbc.274.47.33183; Arystarkhova E, 2007, AM J PHYSIOL-CELL PH, V292, pC1179, DOI 10.1152/ajpcell.00328.2006; ATTALI B, 1995, P NATL ACAD SCI USA, V92, P6092, DOI 10.1073/pnas.92.13.6092; Babavali M, 2009, BIOCHEMISTRY-US, V48, P9022, DOI 10.1021/bi901124j; Beguin P, 2002, EMBO J, V21, P3264, DOI 10.1093/emboj/cdf330; Beguin P, 2001, EMBO J, V20, P3993, DOI 10.1093/emboj/20.15.3993; Belogus T, 2009, J BIOL CHEM, V284, P31038, DOI 10.1074/jbc.M109.050054; Bibert S, 2008, J BIOL CHEM, V283, P476, DOI 10.1074/jbc.M705830200; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Blostein R, 2003, ANN NY ACAD SCI, V986, P420, DOI 10.1111/j.1749-6632.2003.tb07224.x; Bossuyt J, 2009, J BIOL CHEM, V284, P26749, DOI 10.1074/jbc.M109.047357; Cairo ER, 2009, J MEMBRANE BIOL, V231, P117, DOI 10.1007/s00232-009-9210-4; Capasso JM, 2003, ANN NY ACAD SCI, V986, P410, DOI 10.1111/j.1749-6632.2003.tb07222.x; Capasso JM, 2003, P NATL ACAD SCI USA, V100, P6428, DOI 10.1073/pnas.1130871100; Capasso JM, 2001, P NATL ACAD SCI USA, V98, P13414, DOI 10.1073/pnas.231309198; Capasso JM, 2006, AM J PHYSIOL-RENAL, V291, pF1142, DOI 10.1152/ajprenal.00077.2006; Cohen E, 2005, J BIOL CHEM, V280, P16610, DOI 10.1074/jbc.M414290200; Cornelius F, 2007, BIOCHEMISTRY-US, V46, P2371, DOI 10.1021/bi062239j; Crambert G, 2004, J BIOL CHEM, V279, P30888, DOI 10.1074/jbc.M313494200; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Dai LJ, 2001, PHYSIOL REV, V81, P51, DOI 10.1152/physrev.2001.81.1.51; DOWHAN W, 1974, J BIOL CHEM, V249, P3079; Garty H, 2002, AM J PHYSIOL-RENAL, V283, pF607, DOI 10.1152/ajprenal.00112.2002; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Geering K, 2006, AM J PHYSIOL-RENAL, V290, pF241, DOI 10.1152/ajprenal.00126.2005; Geering K, 2008, CURR OPIN NEPHROL HY, V17, P526, DOI 10.1097/MNH.0b013e3283036cbf; GOLDSHLEGER R, 1995, BIOCHEMISTRY-US, V34, P8668, DOI 10.1021/bi00027a016; Habeck M, 2009, BIOCHEMISTRY-US, V48, P9147, DOI 10.1021/bi901148k; Haviv H, 2007, BIOCHEMISTRY-US, V46, P12855, DOI 10.1021/bi701248y; Ino Y, 2002, P NATL ACAD SCI USA, V99, P365, DOI 10.1073/pnas.012425299; Jia LG, 2005, AM J PHYSIOL-HEART C, V288, pH1982, DOI 10.1152/ajpheart.00142.2004; Jones DH, 2005, J BIOL CHEM, V280, P19003, DOI 10.1074/jbc.M500697200; Jorgensen PL, 2003, ANNU REV PHYSIOL, V65, P817, DOI 10.1146/annurev.physiol.65.092101.142558; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Krebs MP, 2004, TRENDS BIOCHEM SCI, V29, P648, DOI 10.1016/j.tibs.2004.10.009; Li CM, 2005, P NATL ACAD SCI USA, V102, P12706, DOI 10.1073/pnas.0505980102; Li CM, 2004, J BIOL CHEM, V279, P38895, DOI 10.1074/jbc.M406697200; Lifshitz Y, 2007, BIOCHEMISTRY-US, V46, P14937, DOI 10.1021/bi701812c; Lifshitz Y, 2006, J BIOL CHEM, V281, P15790, DOI 10.1074/jbc.M601993200; Lindzen M, 2006, J BIOL CHEM, V281, P5947, DOI 10.1074/jbc.M512063200; Lindzen M, 2003, J BIOL CHEM, V278, P18738, DOI 10.1074/jbc.M213253200; Meij IC, 2000, NAT GENET, V26, P265, DOI 10.1038/81543; MERCER RW, 1993, J CELL BIOL, V121, P579, DOI 10.1083/jcb.121.3.579; MORRISON BW, 1995, J BIOL CHEM, V270, P2176, DOI 10.1074/jbc.270.5.2176; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; PALMER CJ, 1991, J BIOL CHEM, V266, P11126; Pedersen M, 2002, J MEMBRANE BIOL, V185, P221, DOI 10.1007/s00232-001-0125-y; Peleg Yoav, 2008, V426, P197, DOI 10.1007/978-1-60327-058-8_12; Pihakaski-Maunsbach K, 2006, AM J PHYSIOL-RENAL, V291, pF1033, DOI 10.1152/ajprenal.00086.2006; PRICE EM, 1988, BIOCHEMISTRY-US, V27, P8400, DOI 10.1021/bi00422a016; Pu HX, 2002, J BIOL CHEM, V277, P20270, DOI 10.1074/jbc.M201009200; Pu HX, 2001, J BIOL CHEM, V276, P20370, DOI 10.1074/jbc.M010836200; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Strugatsky D, 2003, J BIOL CHEM, V278, P46064, DOI 10.1074/jbc.M308303200; Sweadner KJ, 2003, ANN NY ACAD SCI, V986, P382, DOI 10.1111/j.1749-6632.2003.tb07218.x; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Therien AG, 1997, J BIOL CHEM, V272, P32628, DOI 10.1074/jbc.272.51.32628; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Wetzel RK, 2004, J BIOL CHEM, V279, P41750, DOI 10.1074/jbc.M405622200; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Yamaguchi F, 2001, MOL BRAIN RES, V86, P189, DOI 10.1016/S0169-328X(00)00213-8; Zouzoulas A, 2005, J MEMBRANE BIOL, V204, P49, DOI 10.1007/s00232-005-0746-7	63	66	69	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9699	9712		10.1074/jbc.M110.184234	http://dx.doi.org/10.1074/jbc.M110.184234			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21228272	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000288247700094
J	Rougier, JS; Albesa, M; Abriel, H; Viard, P				Rougier, Jean-Sebastien; Albesa, Maxime; Abriel, Hugues; Viard, Patricia			Neuronal Precursor Cell-expressed Developmentally Down-regulated 4-1 (NEDD4-1) Controls the Sorting of Newly Synthesized Ca(V)1.2 Calcium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI NETWORK; UBIQUITIN LIGASE; BETA-SUBUNIT; PLASMA-MEMBRANE; PROTEIN-KINASE; NA+ CHANNEL; ENDOCYTOSIS; SURFACE; MOUSE; TRAFFICKING	Neuronal precursor cell-expressed developmentally down-regulated 4 (Nedd4) proteins are ubiquitin ligases, which attach ubiquitin moieties to their target proteins, a post-translational modification that is most commonly associated with protein degradation. Nedd4 ubiquitin ligases have been shown to down-regulate both potassium and sodium channels. In this study, we investigated whether Nedd4 ubiquitin ligases also regulate Ca-v calcium channels. We expressed three Nedd4 family members, Nedd4-1, Nedd4-2, and WWP2, together with Ca(v)1.2 channels in tsA-201 cells. We found that Nedd4-1 dramatically decreased Ca-v whole-cell currents, whereas Nedd4-2 and WWP2 failed to regulate the current. Surface biotinylation assays revealed that Nedd4-1 decreased the number of channels inserted at the plasma membrane. Western blots also showed a concomitant decrease in the total expression of the channels. Surprisingly, however, neither the Ca-v pore-forming alpha 1 subunit nor the associated Ca-v beta and Ca-v alpha(2)delta subunits were ubiquitylated by Nedd4-1. The proteasome inhibitor MG132 prevented the degradation of Ca-v channels, whereas monodansylcadaverine and chloroquine partially antagonized the Nedd4-1-induced regulation of Ca-v currents. Remarkably, the effect of Nedd4-1 was fully prevented by brefeldin A. These data suggest that Nedd4-1 promotes the sorting of newly synthesized Ca-v channels for degradation by both the proteasome and the lysosome. Most importantly, Nedd4-1-induced regulation required the co-expression of Ca-v beta subunits, known to antagonize the retention of the channels in the endoplasmic reticulum. Altogether, our results suggest that Nedd4-1 interferes with the chaperon role of Ca-v beta at the endoplasmic reticulum/Golgi level to prevent the delivery of Ca-v channels at the plasma membrane.	[Rougier, Jean-Sebastien; Viard, Patricia] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Rougier, Jean-Sebastien; Albesa, Maxime; Abriel, Hugues] Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland	University of London; University College London; University of Bern	Viard, P (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	p.viard@ucl.ac.uk	Abriel, Hugues/B-9800-2009; Rougier, Jean-Sébastien/AAX-5038-2021	Abriel, Hugues/0000-0003-0465-5138; ROUGIER, Jean-Sebastien/0000-0002-8710-0260	Wellcome Trust; Swiss National Science Foundation [310030_120707]	Wellcome Trust(Wellcome TrustEuropean Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Wellcome Trust (to J.-S. R. and P. V.) and Swiss National Science Foundation Grant 310030_120707 (to H. A.).	Abriel H, 2005, PHYSIOLOGY, V20, P398, DOI 10.1152/physiol.00033.2005; Abriel H, 2000, FEBS LETT, V466, P377, DOI 10.1016/S0014-5793(00)01098-X; Beguin P, 2001, NATURE, V411, P701, DOI 10.1038/35079621; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chen H, 2003, P NATL ACAD SCI USA, V100, P14908, DOI 10.1073/pnas.2136625100; Chen YH, 2009, FEBS LETT, V583, P1969, DOI 10.1016/j.febslet.2009.05.001; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DAVIES PJA, 1980, NATURE, V283, P162, DOI 10.1038/283162a0; De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Dolphin AC, 2003, J BIOENERG BIOMEMBR, V35, P599, DOI 10.1023/B:JOBB.0000008026.37790.5a; Dolphin AC, 1999, J PHYSIOL-LONDON, V519, P35, DOI 10.1111/j.1469-7793.1999.0035o.x; Dolphin AC, 2009, CURR OPIN NEUROBIOL, V19, P237, DOI 10.1016/j.conb.2009.06.006; Doray B, 2002, SCIENCE, V297, P1700, DOI 10.1126/science.1075327; Dubel SJ, 2004, J BIOL CHEM, V279, P29263, DOI 10.1074/jbc.M313450200; Fitzgerald EM, 2002, J PHYSIOL-LONDON, V543, P425, DOI 10.1113/jphysiol.2002.022822; Gonzalez-Gutierrez G, 2007, J BIOL CHEM, V282, P2156, DOI 10.1074/jbc.M609071200; Henke G, 2004, J CELL PHYSIOL, V199, P194, DOI 10.1002/jcp.10430; Hryciw DH, 2004, J BIOL CHEM, V279, P54996, DOI 10.1074/jbc.M411491200; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kawaguchi M, 2006, J BIOL CHEM, V281, P13015, DOI 10.1074/jbc.M601228200; Luini A, 2008, HISTOCHEM CELL BIOL, V129, P153, DOI 10.1007/s00418-007-0365-8; Marionneau C, 2005, J PHYSIOL-LONDON, V562, P223, DOI 10.1113/jphysiol.2004.074047; MING Z, 1994, J MOL CELL CARDIOL, V26, P1133, DOI 10.1006/jmcc.1994.1132; Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X; Page KM, 2004, J NEUROSCI, V24, P5400, DOI 10.1523/JNEUROSCI.0553-04.2004; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Puri TS, 1997, BIOCHEMISTRY-US, V36, P9605, DOI 10.1021/bi970500d; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Rotin D, 2001, AM J PHYSIOL-RENAL, V281, pF391, DOI 10.1152/ajprenal.2001.281.3.F391; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Rougier JS, 2005, AM J PHYSIOL-CELL PH, V288, pC692, DOI 10.1152/ajpcell.00460.2004; Scott PM, 2004, NAT CELL BIOL, V6, P252, DOI 10.1038/ncb1107; Seisenberger C, 2000, J BIOL CHEM, V275, P39193, DOI 10.1074/jbc.M006467200; Takimoto K, 1997, J MOL CELL CARDIOL, V29, P3035, DOI 10.1006/jmcc.1997.0532; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Viard P, 2004, NAT NEUROSCI, V7, P939, DOI 10.1038/nn1300	41	43	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8829	8838		10.1074/jbc.M110.166520	http://dx.doi.org/10.1074/jbc.M110.166520			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21220429	hybrid, Green Published			2022-12-27	WOS:000288247700013
J	Spencer, NY; Yan, ZY; Boudreau, RL; Zhang, YL; Luo, MH; Li, QA; Tian, X; Shah, AM; Davisson, RL; Davidson, B; Banfi, B; Engelhardt, JF				Spencer, Netanya Y.; Yan, Ziying; Boudreau, Ryan L.; Zhang, Yulong; Luo, Meihui; Li, Qiang; Tian, Xin; Shah, Ajay M.; Davisson, Robin L.; Davidson, Beverly; Banfi, Botond; Engelhardt, John F.			Control of Hepatic Nuclear Superoxide Production by Glucose 6-Phosphate Dehydrogenase and NADPH Oxidase-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICED NOXO1 ISOFORMS; SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; SUBCELLULAR-LOCALIZATION; SIGNAL-TRANSDUCTION; HYDROGEN-PEROXIDE; LIVER NUCLEI; GENERATION; DEFICIENCY; ACTIVATION	Redox-regulated signal transduction is coordinated by spatially controlled production of reactive oxygen species within subcellular compartments. The nucleus has long been known to produce superoxide (O-2(radical anion)); however, the mechanisms that control this function remain largely unknown. We have characterized molecular features of a nuclear superoxide-producing system in the mouse liver. Using electron paramagnetic resonance, we investigated whether several NADPH oxidases (NOX1, 2, and 4) and known activators of NOX(Rac1, Rac2, p22(phox), and p47(phox)) contribute to nuclear O-2(radical anion) production in isolated hepatic nuclei. Our findings demonstrate that NOX4 most significantly contributes to hepatic nuclear O-2(radical anion) production that utilizes NADPH as an electron donor. Although NOX4 protein immunolocalized to both nuclear membranes and intranuclear inclusions, fluorescent detection of NADPH-dependent nuclear O-2(radical anion) predominantly localized to the perinuclear space. Interestingly, NADP(+) and G6P also induced nuclear O-2(radical anion) production, suggesting that intranuclear glucose-6-phosphate dehydrogenase (G6PD) can control NOX4 activity through nuclear NADPH production. Using G6PD mutant mice and G6PD shRNA, we confirmed that reductions in nuclear G6PD enzyme decrease the ability of hepatic nuclei to generate O-2(radical anion) in response to NADP(+) and G6P. NOX4 and G6PD protein were also observed in overlapping microdomains within the nucleus. These findings provide new insights on the metabolic pathways for substrate regulation of nuclear O-2(radical anion) production by NOX4.	[Spencer, Netanya Y.; Yan, Ziying; Zhang, Yulong; Luo, Meihui; Li, Qiang; Tian, Xin; Banfi, Botond; Engelhardt, John F.] Univ Iowa, Coll Med, Dept Anat & Cell Biol, Iowa City, IA 52242 USA; [Boudreau, Ryan L.; Davidson, Beverly; Banfi, Botond; Engelhardt, John F.] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Zhang, Yulong; Davidson, Beverly; Engelhardt, John F.] Univ Iowa, Coll Med, Ctr Gene Therapy Cyst Fibrosis & Other Genet Dis, Iowa City, IA 52242 USA; [Shah, Ajay M.] Kings Coll London, British Heart Fdn Ctr, London SE5 9NU, England; [Davisson, Robin L.] Cornell Univ, Dept Biomed Sci, Coll Vet Med & Cell & Dev Biol, Weill Cornell Med Coll, New York, NY 10065 USA	University of Iowa; University of Iowa; University of Iowa; University of London; King's College London; Cornell University	Engelhardt, JF (corresponding author), Univ Iowa, Coll Med, Dept Anat & Cell Biol, Rm 1-111 BSB,51 Newton Rd, Iowa City, IA 52242 USA.	john-engelhardt@uiowa.edu	Spencer, Netanya/AAS-7999-2020	Spencer, Netanya/0000-0003-1010-5458; Banfi, Botond/0000-0001-9273-1318; Yan, Ziying/0000-0001-8210-5567; Engelhardt, John/0000-0003-2389-9277; Shah, Ajay/0000-0002-6547-0631; Boudreau, Ryan/0000-0002-9800-5349	National Institutes of Health [R01 DK051315, K01 DK083429]; British Heart Foundation [RG/08/011/25922]; Center for Gene Therapy [P30 DK54759]; Roy J. Carver Chair in Molecular Medicine; University of Iowa ESR Facility; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007344, T32HL007121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051315, P30DK054759, K01DK083429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Center for Gene Therapy(Ohio State University); Roy J. Carver Chair in Molecular Medicine; University of Iowa ESR Facility; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK051315 and K01 DK083429. This work was also supported by British Heart Foundation Grant RG/08/011/25922 (to A. M. S.), the Vector Core funded through Center for Gene Therapy Grant P30 DK54759, and the Roy J. Carver Chair in Molecular Medicine.; We gratefully acknowledge the support of the University of Iowa ESR Facility and the advice from Dr. Garry Buettner. We thank Dr. David A. Williams for the kind gift of the Rac KO mice. We appreciate the help of Dr. Martin Fray at the Mary Lyon Centre (Medical Research Council, Harwell, UK) with the rederivation of the G6PD mutant mice from cryopreserved embryos. We appreciate the assistance of Jian Shao and Randy Nessler of the University of Iowa Central Microscopy Core for help with processing and imaging of TEM samples.	Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Anderson RD, 2000, GENE THER, V7, P1034, DOI 10.1038/sj.gt.3301197; Anilkumar N, 2008, ARTERIOSCL THROM VAS, V28, P1347, DOI 10.1161/ATVBAHA.108.164277; BARTOLI GM, 1977, BIOCHIM BIOPHYS ACTA, V497, P622, DOI 10.1016/0304-4165(77)90219-7; BEREZNEY R, 1970, BIOCHEM BIOPH RES CO, V38, P93, DOI 10.1016/0006-291X(70)91088-0; Block K, 2009, P NATL ACAD SCI USA, V106, P14385, DOI 10.1073/pnas.0906805106; Boudreau RL, 2008, RNA, V14, P1834, DOI 10.1261/rna.1062908; Chamulitrat W, 2003, ONCOGENE, V22, P6045, DOI 10.1038/sj.onc.1206654; Chen K, 2008, J CELL BIOL, V181, P1129, DOI 10.1083/jcb.200709049; Clempus RE, 2007, ARTERIOSCL THROM VAS, V27, P42, DOI 10.1161/01.ATV.0000251500.94478.18; de Mochel NSR, 2010, HEPATOLOGY, V52, P47, DOI 10.1002/hep.23671; DICKER E, 1991, BIOCHEM PHARMACOL, V42, P529, DOI 10.1016/0006-2952(91)90315-V; Dikalov SI, 2008, FREE RADICAL BIO MED, V45, P1340, DOI 10.1016/j.freeradbiomed.2008.08.013; Gavazzi G, 2006, FEBS LETT, V580, P497, DOI 10.1016/j.febslet.2005.12.049; Glogauer M, 2003, J IMMUNOL, V170, P5652, DOI 10.4049/jimmunol.170.11.5652; Gordillo G, 2010, ANTIOXID REDOX SIGN, V12, P933, DOI 10.1089/ars.2009.2917; Gorin Y, 2003, AM J PHYSIOL-RENAL, V285, pF219, DOI 10.1152/ajprenal.00414.2002; Goyal P, 2005, BIOCHEM BIOPH RES CO, V329, P32, DOI 10.1016/j.bbrc.2005.01.089; Gutierrez J, 2006, CIRC RES, V99, P924, DOI 10.1161/01.RES.0000248212.86638.e9; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Hawkins BJ, 2007, MOL BIOL CELL, V18, P2002, DOI 10.1091/mbc.E06-09-0830; Helmcke I, 2009, ANTIOXID REDOX SIGN, V11, P1279, DOI [10.1089/ars.2008.2383, 10.1089/ARS.2008.2383]; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Huang CK, 2000, J LEUKOCYTE BIOL, V67, P210, DOI 10.1002/jlb.67.2.210; Humbert JP, 1996, J BIOL CHEM, V271, P478, DOI 10.1074/jbc.271.1.478; Im JY, 2006, FREE RADICAL BIO MED, V41, P960, DOI 10.1016/j.freeradbiomed.2006.06.001; KRISHNA CM, 1992, ARCH BIOCHEM BIOPHYS, V294, P98, DOI 10.1016/0003-9861(92)90142-J; Kuroda J, 2005, GENES CELLS, V10, P1139, DOI 10.1111/j.1365-2443.2005.00907.x; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Lizotte E, 2005, ANAL BIOCHEM, V345, P47, DOI 10.1016/j.ab.2005.07.001; Longo L, 2002, EMBO J, V21, P4229, DOI 10.1093/emboj/cdf426; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; Mumbengegwi DR, 2008, MOL CELL BIOL, V28, P3700, DOI 10.1128/MCB.02038-07; Nakano Y, 2008, J CLIN INVEST, V118, P1176, DOI 10.1172/JCI33835; Opitz N, 2007, FREE RADICAL BIO MED, V42, P175, DOI 10.1016/j.freeradbiomed.2006.11.003; PATTON SE, 1980, MOL PHARMACOL, V18, P588; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P747, DOI [10.1089/ars.2008.2203, 10.1089/ARS.2008.2203]; Peterson JR, 2009, HYPERTENSION, V54, P1106, DOI 10.1161/HYPERTENSIONAHA.109.140087; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; PRETSCH W, 1988, BIOCHEM GENET, V26, P89, DOI 10.1007/BF00555491; PUNTARULO S, 1992, BIOCHIM BIOPHYS ACTA, V1116, P17, DOI 10.1016/0304-4165(92)90122-B; Roberts AW, 1999, IMMUNITY, V10, P183, DOI 10.1016/S1074-7613(00)80019-9; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Sanders S, 1997, MUTAT RES-FUND MOL M, V374, P79, DOI 10.1016/S0027-5107(96)00222-9; Serrander L, 2007, BIOCHEM J, V406, P105, DOI 10.1042/BJ20061903; TAKAHASHI T, 1978, BIOCHIM BIOPHYS ACTA, V524, P262, DOI 10.1016/0005-2744(78)90163-8; Terada LS, 2006, J CELL BIOL, V174, P615, DOI 10.1083/jcb.200605036; Ueyama T, 2007, FREE RADICAL BIO MED, V42, P180, DOI 10.1016/j.freeradbiomed.2006.08.024; Ushio-Fukai M, 2006, SCI STKE, V2006, pre8, DOI DOI 10.1126/STKE.3492006RE8; Van Buul JD, 2005, ANTIOXID REDOX SIGN, V7, P308, DOI 10.1089/ars.2005.7.308; VARTANYAN L S, 1989, Biokhimiya, V54, P1020; Venkataraman S, 2000, FREE RADICAL BIO MED, V29, P580, DOI 10.1016/S0891-5849(00)00404-4; Wang P, 2007, PHARMACOL RES, V55, P408, DOI 10.1016/j.phrs.2007.01.016; Wu RF, 2010, MOL CELL BIOL, V30, P3553, DOI 10.1128/MCB.01445-09; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783; YUSA T, 1984, BIOCHIM BIOPHYS ACTA, V798, P167, DOI 10.1016/0304-4165(84)90299-X; Zhao HT, 2005, P NATL ACAD SCI USA, V102, P5727, DOI 10.1073/pnas.0501719102; Zhao HT, 2001, FREE RADICAL BIO MED, V31, P599, DOI 10.1016/S0891-5849(01)00619-0; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473; Zwacka RM, 1998, HEPATOLOGY, V28, P1022, DOI 10.1002/hep.510280417	62	80	81	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8977	8987		10.1074/jbc.M110.193821	http://dx.doi.org/10.1074/jbc.M110.193821			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21212270	Green Published, hybrid			2022-12-27	WOS:000288247700029
J	Tiwari, M; Lopez-Cruzan, M; Morgan, WW; Herman, B				Tiwari, Meenakshi; Lopez-Cruzan, Marisa; Morgan, William W.; Herman, Brian			Loss of Caspase-2-dependent Apoptosis Induces Autophagy after Mitochondrial Oxidative Stress in Primary Cultures of Young Adult Cortical Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; PERMEABILITY TRANSITION; CYTOCHROME-C; CASPASE-2; SUPEROXIDE; PROTEINS; DYSFUNCTION; ACTIVATION; MECHANISMS; UPSTREAM	Mitochondrial dysfunctions have been associated with neuronal apoptosis and are characteristic of neurodegenerative conditions. Caspases play a central role in apoptosis; however, their involvement in mitochondrial dysfunction-induced neuronal apoptosis remains elusive. In the present report using rotenone, a complex I inhibitor that causes mitochondrial dysfunction, we determined the initiator caspase and its role in cell death in primary cultures of cortical neurons from young adult mice (1-2 months old). By pretreating the cells with a cell-permeable, biotinylated pan-caspase inhibitor that irreversibly binds to and traps the active caspase, we identified caspase-2 as an initiator caspase activated in rotenone-treated primary neurons. Loss of caspase-2 inhibited rotenone-induced apoptosis; however, these neurons underwent a delayed cell death by necrosis. We further found that caspase-2 acts upstream of mitochondria to mediate rotenone-induced apoptosis in neurons. The loss of caspase-2 significantly inhibited rotenone-induced activation of Bid and Bax and the release of cytochrome c and apoptosis inducing factor from mitochondria. Rotenone-induced down-stream activation of caspase-3 and caspase-9 were also inhibited in the neurons lacking caspase-2. Autophagy was enhanced in caspase-2 knock-out neurons after rotenone treatment, and this response was important in prolonging neuronal survival. In summary, the present study identifies a novel function of caspase-2 in mitochondrial oxidative stress-induced apoptosis in neurons cultured from young adult mice.	[Tiwari, Meenakshi; Lopez-Cruzan, Marisa; Morgan, William W.; Herman, Brian] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Herman, B (corresponding author), 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	hermanb@uthscsa.edu		Lopez-Cruzan, Marisa/0000-0003-0285-1012	National Institutes of Health [5 R37 AG007218-21, P30 CA54174, P30 AG013319, P01 AG19316]; University of Texas Health Science Center-San Antonio; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG007218, P30AG013319, P01AG019316] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Texas Health Science Center-San Antonio; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant 5 R37 AG007218-21.; We thank Dr. Junying Yuan of Harvard University and Dr. Carol Troy of Columbia University for providing the casp2<SUP>-/-</SUP> mice and Dr. Muniswamy Madesh of Temple University for providing bax<SUP>-/-</SUP>, bak<SUP>-/-</SUP>, and bax<SUP>-/-</SUP> bak<SUP>-/-</SUP> DKO MEFs. We thank Dr. Victoria Centonze-Frohlich for contributions and guidance on the microscopy experiments. Images were generated in the Core Optical Imaging Facility, which is supported by University of Texas Health Science Center-San Antonio and National Institutes of Health Grants P30 CA54174 (NCI; to the San Antonio Cancer Institute), P30 AG013319 (NIA; to the Nathan Shock Center), and P01 AG19316 (NIA). We also thank Dr. Christie Jones and Sonya Karbach for help in preparation of the manuscript and Michelle Bendele for assistance in mouse breeding.	Baliga BC, 2004, CELL DEATH DIFFER, V11, P1234, DOI 10.1038/sj.cdd.4401492; Bergeron L, 1998, GENE DEV, V12, P1304, DOI 10.1101/gad.12.9.1304; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Bonzon C, 2006, MOL BIOL CELL, V17, P2150, DOI 10.1091/mbc.E05-12-1107; Bouchier-Hayes L, 2010, J CELL MOL MED, V14, P1212, DOI 10.1111/j.1582-4934.2010.01037.x; Bredesen DE, 2006, NATURE, V443, P796, DOI 10.1038/nature05293; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Chauvier D, 2005, APOPTOSIS, V10, P1243, DOI 10.1007/s10495-005-1681-x; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Cregan SP, 2002, J CELL BIOL, V158, P507, DOI 10.1083/jcb.200202130; Daugas E, 2000, FASEB J, V14, P729, DOI 10.1096/fasebj.14.5.729; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; Guo Y, 2002, J BIOL CHEM, V277, P13430, DOI 10.1074/jbc.M108029200; Ho LH, 2008, ONCOGENE, V27, P3393, DOI 10.1038/sj.onc.1211005; Isenberg JS, 2000, TOXICOL SCI, V53, P340, DOI 10.1093/toxsci/53.2.340; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Keating DJ, 2008, J NEUROCHEM, V104, P298, DOI 10.1111/j.1471-4159.2007.04997.x; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; KUMAR S, 1994, GENE DEV, V8, P1613, DOI 10.1101/gad.8.14.1613; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Kumar S, 2009, NAT REV CANCER, V9, P897, DOI 10.1038/nrc2745; Kunchithapautham K, 2007, AUTOPHAGY, V3, P433, DOI 10.4161/auto.4294; Kuwana T, 2003, CURR OPIN CELL BIOL, V15, P691, DOI 10.1016/j.ceb.2003.10.004; Lamkanfi M, 2002, CELL DEATH DIFFER, V9, P358, DOI 10.1038/sj.cdd.4400989; Lassus P, 2002, SCIENCE, V297, P1352, DOI 10.1126/science.1074721; Lee JJ, 2008, BIOCHEM BIOPH RES CO, V371, P33, DOI 10.1016/j.bbrc.2008.03.149; Lee JA, 2009, BMB REP, V42, P324, DOI 10.5483/BMBRep.2009.42.6.324; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Lesuisse C, 2002, J CEREBR BLOOD F MET, V22, P935, DOI 10.1097/00004647-200208000-00005; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li NY, 2003, J BIOL CHEM, V278, P8516, DOI 10.1074/jbc.M210432200; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Luo S, 2010, CELL DEATH DIFFER, V17, P268, DOI 10.1038/cdd.2009.121; Madesh M, 2009, MOL CELL BIOL, V29, P3099, DOI 10.1128/MCB.01845-08; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Pei W, 2003, FASEB J, V17, P520, DOI 10.1096/fj.02-0653fje; Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798; Robertson GS, 2000, BRAIN PATHOL, V10, P283, DOI 10.1111/j.1750-3639.2000.tb00262.x; Robertson JD, 2002, J BIOL CHEM, V277, P29803, DOI 10.1074/jbc.M204185200; Schweizer A, 2003, J BIOL CHEM, V278, P42441, DOI 10.1074/jbc.M304895200; Shaw CA, 2008, NEUROMOL MED, V10, P1, DOI 10.1007/s12017-007-8016-8; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tamm C, 2008, APOPTOSIS, V13, P354, DOI 10.1007/s10495-007-0172-7; Tiwari M, 2008, CARCINOGENESIS, V29, P600, DOI 10.1093/carcin/bgm264; Troy CM, 1997, J NEUROSCI, V17, P1911; Troy CM, 2001, J NEUROSCI, V21, P5007, DOI 10.1523/JNEUROSCI.21-14-05007.2001; Troy CM, 2000, J NEUROSCI, V20, P1386; Trushina E, 2007, NEUROSCIENCE, V145, P1233, DOI 10.1016/j.neuroscience.2006.10.056; Tu S, 2006, NAT CELL BIOL, V8, P72, DOI 10.1038/ncb1340; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Yu L, 2008, AUTOPHAGY, V4, P567, DOI 10.4161/auto.5902; Zhang YP, 2007, MECH AGEING DEV, V128, P213, DOI 10.1016/j.mad.2006.11.030; Zheng TS, 2000, NAT MED, V6, P1241, DOI 10.1038/81343; Zhivotovsky B, 2005, BIOCHEM BIOPH RES CO, V331, P859, DOI 10.1016/j.bbrc.2005.03.191	63	54	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8493	8506		10.1074/jbc.M110.163824	http://dx.doi.org/10.1074/jbc.M110.163824			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21216964	Green Published, hybrid			2022-12-27	WOS:000288013300077
J	Lisboa, FA; Warren, J; Sulkowski, G; Aparicio, M; David, G; Zudaire, E; Dveksler, GS				Lisboa, Felipe A.; Warren, James; Sulkowski, Gisela; Aparicio, Marta; David, Guido; Zudaire, Enrique; Dveksler, Gabriela S.			Pregnancy-specific Glycoprotein 1 Induces Endothelial Tubulogenesis through Interaction with Cell Surface Proteoglycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; HERPES-SIMPLEX-VIRUS; ALTERNATIVE ACTIVATION; TROPHOBLAST CELLS; GROWTH-FACTOR; EXPRESSION; ANGIOGENESIS; MONOCYTES; MUTANTS; BINDING	Pregnancy-specific beta 1 glycoproteins (PSGs) are the most abundant fetal proteins in the maternal bloodstream in late pregnancy. They are secreted by the syncytiotrophoblast and are detected around day 14 postfertilization. There are 11 human PSG genes, which encode a family of proteins exhibiting significant conservation at the amino acid level. We and others have proposed that PSGs have an immune modulatory function. In addition, we recently postulated that they are proangiogenic due to their ability to induce the secretion of VEGF-A and the formation of tubes by endothelial cells. The cellular receptor(s) for human PSGs remain unknown. Therefore, we conducted these studies to identify the receptor for PSG1, the highest expressed member of the family. We show that removal of cell surface glycosaminoglycans (GAGs) by enzymatic or chemical treatment of cells or competition with heparin completely inhibited binding of PSG1. In addition, PSG1 did not bind to cells lacking heparan or chondroitin sulfate on their surface, and binding was restored upon transfection with all four syndecans and glypican-1. Importantly, the presence of GAGs on the surface of endothelial cells was required for the ability of PSG1 to induce tube formation. This finding indicates that the PSG1-GAG interaction mediates at least some of the PSG1 proposed functions.	[Lisboa, Felipe A.; Warren, James; Sulkowski, Gisela; Dveksler, Gabriela S.] Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20814 USA; [Aparicio, Marta; Zudaire, Enrique] NCI, Angiogenesis Core Facil, Radiat Oncol Branch, NIH,Adv Technol Ctr, Bethesda, MD 20892 USA; [David, Guido] Katholieke Univ Leuven, Dept Mol & Dev Genet, Vlaams Inst Biotechnol, B-3000 Louvain, Belgium	Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Flanders Institute for Biotechnology (VIB); KU Leuven	Dveksler, GS (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pathol, Rm B3096,4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	gdveksler@usuhs.mil			National Institutes of Health [R01HD035832]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035832] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant R01HD035832 (to G. S. D.).	Ball M, 2009, PLACENTA, V30, P649, DOI 10.1016/j.placenta.2009.05.001; BANFIELD BW, 1995, J VIROL, V69, P3290, DOI 10.1128/JVI.69.6.3290-3298.1995; Beauvais DM, 2009, J EXP MED, V206, P691, DOI 10.1084/jem.20081278; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bobardt MD, 2004, J VIROL, V78, P6567, DOI 10.1128/JVI.78.12.6567-6584.2004; Camolotto S, 2010, PLACENTA, V31, P312, DOI 10.1016/j.placenta.2010.01.004; Chen LG, 2004, J BIOL CHEM, V279, P15715, DOI 10.1074/jbc.C300430200; Chung JS, 2009, EUR J IMMUNOL, V39, P965, DOI 10.1002/eji.200838990; Crescimanno C, 1999, J PATHOL, V189, P600; den Dekker E, 2008, J IMMUNOL, V180, P3680, DOI 10.4049/jimmunol.180.6.3680; ESKO JD, 1986, J BIOL CHEM, V261, P5725; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; GRUENHEID S, 1993, J VIROL, V67, P93, DOI 10.1128/JVI.67.1.93-100.1993; Ha CT, 2008, AM J REPROD IMMUNOL, V59, P251, DOI 10.1111/j.1600-0897.2007.00573.x; Ha CT, 2010, BIOL REPROD, V83, P27, DOI 10.1095/biolreprod.109.082412; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Ishiguro K, 2000, DEV DYNAM, V219, P539, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1081>3.0.CO;2-K; Ishiguro K, 2001, J BIOL CHEM, V276, P47483, DOI 10.1074/jbc.M106268200; IU ST, 1970, B EKSP BIOL MED, V69, P66; Jokimaa VIS, 2000, AM J OBSTET GYNECOL, V183, P1495, DOI 10.1067/mob.2000.107320; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; LIN TM, 1974, J CLIN INVEST, V54, P576, DOI 10.1172/JCI107794; MARCUM JA, 1986, J BIOL CHEM, V261, P7507; McLellan AS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-4; MERTENS G, 1992, J BIOL CHEM, V267, P20435; MINGUELL JJ, 1992, EXP CELL RES, V201, P200, DOI 10.1016/0014-4827(92)90364-E; Motran CC, 2003, EUR J IMMUNOL, V33, P3007, DOI 10.1002/eji.200323993; Motran CC, 2002, J LEUKOCYTE BIOL, V72, P512; NADER HB, 1987, P NATL ACAD SCI USA, V84, P3565, DOI 10.1073/pnas.84.11.3565; Noguer O, 2009, EXP CELL RES, V315, P795, DOI 10.1016/j.yexcr.2008.11.016; Partovian C, 2008, MOL CELL, V32, P140, DOI 10.1016/j.molcel.2008.09.010; Pihl K, 2009, PRENATAL DIAG, V29, P1256, DOI 10.1002/pd.2408; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Robinson CJ, 2006, J BIOL CHEM, V281, P1731, DOI 10.1074/jbc.M510760200; RONNSTRAND L, 1992, EMBO J, V11, P3911, DOI 10.1002/j.1460-2075.1992.tb05484.x; Schaefer L, 2010, CELL TISSUE RES, V339, P237, DOI 10.1007/s00441-009-0821-y; Shao R, 2009, ONCOGENE, V28, P4456, DOI 10.1038/onc.2009.292; Snyder SK, 2001, AM J REPROD IMMUNOL, V45, P205, DOI 10.1111/j.8755-8920.2001.450403.x; THOMPSON J, 1990, BIOCHEM BIOPH RES CO, V167, P848, DOI 10.1016/0006-291X(90)92103-7; TOWLER CM, 1977, BRIT J OBSTET GYNAEC, V84, P258, DOI 10.1111/j.1471-0528.1977.tb12573.x; Uyama T, 2006, J BIOL CHEM, V281, P38668, DOI 10.1074/jbc.M609320200; Vanpouille C, 2007, J BIOL CHEM, V282, P24416, DOI 10.1074/jbc.M701835200; Waterhouse R, 2002, J EXP MED, V195, P277, DOI 10.1084/jem.20011741; Wessells J, 2000, EUR J IMMUNOL, V30, P1830, DOI 10.1002/1521-4141(200007)30:7&lt;1830::AID-IMMU1830&gt;3.0.CO;2-M; Wu JA, 2008, BIOL REPROD, V79, P1054, DOI 10.1095/biolreprod.108.070268; Wulff C, 2003, REPRODUCTION, V126, P569, DOI 10.1530/rep.0.1260569; Zhang Z, 2001, J BIOL CHEM, V276, P41921, DOI 10.1074/jbc.M106608200; Zhou GQ, 2001, BIOL REPROD, V64, P90, DOI 10.1095/biolreprod64.1.90	50	38	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7577	7586		10.1074/jbc.M110.161810	http://dx.doi.org/10.1074/jbc.M110.161810			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193412	Green Published, hybrid			2022-12-27	WOS:000287737300071
J	Baiet, B; Burel, C; Saint-Jean, B; Louvet, R; Menu-Bouaouiche, L; Kiefer-Meyer, MC; Mathieu-Rivet, E; Lefebvre, T; Castel, H; Carlier, A; Cadoret, JP; Lerouge, P; Bardor, M				Baiet, Berengere; Burel, Carole; Saint-Jean, Bruno; Louvet, Romain; Menu-Bouaouiche, Laurence; Kiefer-Meyer, Marie-Christine; Mathieu-Rivet, Elodie; Lefebvre, Thomas; Castel, Helene; Carlier, Aude; Cadoret, Jean-Paul; Lerouge, Patrice; Bardor, Muriel			N-Glycans of Phaeodactylum tricornutum Diatom and Functional Characterization of Its N-Acetylglucosaminyltransferase I Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-MANNOSIDASE-II; LOBES GENE ENCODES; ARABIDOPSIS-THALIANA; ENDOPLASMIC-RETICULUM; LINKED GLYCANS; LIQUID-CHROMATOGRAPHY; PHYLOGENETIC ANALYSIS; MOLECULAR-CLONING; GOLGI-APPARATUS; MARINE DIATOMS	N-Glycosylation, a major co- and post-translational event in the synthesis of proteins in eukaryotes, is unknown in aquatic photosynthetic microalgae. In this paper, we describe the N-glycosylation pathway in the diatom Phaeodactylum tricornutum. Bio-informatic analysis of its genome revealed the presence of a complete set of sequences potentially encoding for proteins involved in the synthesis of the lipid-linked Glc(3)Man(9)GlcNAc(2)-PP-dolichol N-glycan, some subunits of the oligosaccharyltransferase complex, as well as endoplasmic reticulum glucosidases and chaperones required for protein quality control and, finally, the alpha-mannosidase I involved in the trimming of the N-glycan precursor into Man-5 N-glycan. Moreover, one N-acetylglucosaminyltransferase I, a Golgi glycosyltransferase that initiates the synthesis of complex type N-glycans, was predicted in the P. tricornutum genome. We demonstrated that this gene encodes for an active N-acetylglucosaminyltransferase I, which is able to restore complex type N-glycans maturation in the Chinese hamster ovary Lec1 mutant, defective in its endogeneous N-acetylglucosaminyltransferase I. Consistent with these data, the structural analyses of N-linked glycans demonstrated that P. tricornutum proteins carry mainly high mannose type N-glycans ranging from Man-5 to Man-9. Although representing a minor glycan population, paucimannose N-glycans were also detected, suggesting the occurrence of an N-acetylglucosaminyltransferase I-dependent maturation of N-glycans in this diatom.	[Baiet, Berengere; Burel, Carole; Louvet, Romain; Menu-Bouaouiche, Laurence; Kiefer-Meyer, Marie-Christine; Mathieu-Rivet, Elodie; Lerouge, Patrice; Bardor, Muriel] Univ Rouen, Lab Glycobiol & Matrice Extracellulaire Vegetale, Fac Sci, F-76821 Mont St Aignan, France; [Saint-Jean, Bruno; Carlier, Aude; Cadoret, Jean-Paul] IFREMER, Ctr Nantes, Lab Physiol & Biotechnol Algues, F-44311 Nantes 03, France; [Lefebvre, Thomas; Castel, Helene] Univ Rouen, INSERM, Lab Differenciat & Commun Neuronale & Neuroendocr, Fac Sci,U982,IFRM23, F-76821 Mont St Aignan, France	Universite de Rouen Normandie; Ifremer; Nantes Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie	Bardor, M (corresponding author), ASTAR, Bioproc Technol Inst, 20 Biopolis Way,06-01, Singapore 138668, Singapore.		KIEFER-MEYER, Marie-Christine/AAQ-6467-2021; castel, helene/B-8675-2009	castel, helene/0000-0002-8972-5555; Saint-Jean, Bruno/0000-0003-3915-5440; Menu-Bouaouiche, Laurence/0000-0002-8214-5195; Cadoret, Jean-Paul/0000-0001-7542-5474	University of Rouen	University of Rouen	This work was supported by funds from the University of Rouen (to P. L. and M. B.).	ALTMANN F, 1995, J BIOL CHEM, V270, P17344, DOI 10.1074/jbc.270.29.17344; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bakker H, 2001, FEBS LETT, V507, P307, DOI 10.1016/S0014-5793(01)02999-4; Bakker H, 2001, P NATL ACAD SCI USA, V98, P2899, DOI 10.1073/pnas.031419998; Banerjee S, 2007, P NATL ACAD SCI USA, V104, P11676, DOI 10.1073/pnas.0704862104; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Bardor M, 2003, PLANT BIOTECHNOL J, V1, P451, DOI 10.1046/j.1467-7652.2003.00041.x; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; Bougaran GL, 2003, AQUAT LIVING RESOUR, V16, P389, DOI 10.1016/S0990-7440(03)00053-6; Breton C, 1999, CURR OPIN STRUC BIOL, V9, P563, DOI 10.1016/S0959-440X(99)00006-8; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; Chung CC, 2005, APPL ENVIRON MICROB, V71, P8744, DOI 10.1128/AEM.71.12.8744-8751.2005; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Fabini G, 2001, J BIOL CHEM, V276, P28058, DOI 10.1074/jbc.M100573200; Falciatore A, 1999, MAR BIOTECHNOL, V1, P239, DOI 10.1007/PL00011773; Falciatore A, 2002, ANNU REV PLANT BIOL, V53, P109, DOI 10.1146/annurev.arplant.53.091701.153921; FAYE L, 1993, ANAL BIOCHEM, V209, P104, DOI 10.1006/abio.1993.1088; FAYE L, 1985, ANAL BIOCHEM, V149, P218, DOI 10.1016/0003-2697(85)90498-1; Feng M, 2004, GLYCOBIOLOGY, V14, P909, DOI 10.1093/glycob/cwh110; Fitchette Anne-Catherine, 2007, V355, P317; Fitchette-Laine AC, 1998, METH BIOTEC, V3, P271; Frank J, 2008, PLANT PHYSIOL, V148, P1354, DOI 10.1104/pp.108.127027; Geisler C, 2008, J BIOL CHEM, V283, P11330, DOI 10.1074/jbc.M710279200; Gnanasambandam A, 2007, PLANT BIOTECHNOL J, V5, P290, DOI 10.1111/j.1467-7652.2007.00241.x; Gordon RD, 2006, J MOL BIOL, V360, P67, DOI 10.1016/j.jmb.2006.04.058; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HARA S, 1989, ANAL BIOCHEM, V179, P162, DOI 10.1016/0003-2697(89)90218-2; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Holmes EH, 2000, J BIOL CHEM, V275, P24237, DOI 10.1074/jbc.M000888200; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Kajiura H, 2010, GLYCOBIOLOGY, V20, P235, DOI 10.1093/glycob/cwp170; Kang JS, 2008, P NATL ACAD SCI USA, V105, P5933, DOI 10.1073/pnas.0800237105; Kang LK, 2009, J PHYCOL, V45, P864, DOI 10.1111/j.1529-8817.2009.00698.x; Klein A, 1997, GLYCOBIOLOGY, V7, P421, DOI 10.1093/glycob/7.3.421; KWIATKOWSKI BA, 1995, GENE, V165, P219, DOI 10.1016/0378-1119(95)00537-G; Leonard R, 2006, J BIOL CHEM, V281, P4867, DOI 10.1074/jbc.M511023200; Liebminger E, 2009, PLANT CELL, V21, P3850, DOI 10.1105/tpc.109.072363; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsushima R, 2003, PLANT J, V33, P493, DOI 10.1046/j.1365-313X.2003.01636.x; METZLER M, 1994, EMBO J, V13, P2056, DOI 10.1002/j.1460-2075.1994.tb06480.x; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Oriol R, 1999, GLYCOBIOLOGY, V9, P323, DOI 10.1093/glycob/9.4.323; Pagny S, 2003, PLANT CELL PHYSIOL, V44, P173, DOI 10.1093/pcp/pcg027; Pagny S, 2003, PLANT J, V33, P189, DOI 10.1046/j.0960-7412.2002.01604.x; Raven JA, 2004, NEW PHYTOL, V162, P45, DOI 10.1111/j.1469-8137.2004.01022.x; Salamov A., 2008, NATURE, V456, P239; Sarkar M, 2006, J BIOL CHEM, V281, P12776, DOI 10.1074/jbc.M512769200; Scala S, 2002, PLANT PHYSIOL, V129, P993, DOI 10.1104/pp.010713; Schachter H, 2009, CARBOHYD RES, V344, P1391, DOI 10.1016/j.carres.2009.04.028; Schoberer J, 2009, TRAFFIC, V10, P101, DOI 10.1111/j.1600-0854.2008.00841.x; Seveno M, 2008, ANAL BIOCHEM, V379, P66, DOI 10.1016/j.ab.2008.04.034; Siaut M, 2007, GENE, V406, P23, DOI 10.1016/j.gene.2007.05.022; STANLEY P, 1975, P NATL ACAD SCI USA, V72, P3323, DOI 10.1073/pnas.72.9.3323; Strasser R, 2006, PLANT J, V45, P789, DOI 10.1111/j.1365-313X.2005.02648.x; Strasser R, 2005, BIOCHEM J, V387, P385, DOI 10.1042/BJ20041686; Strasser R, 2000, FEBS LETT, V472, P105, DOI 10.1016/S0014-5793(00)01443-5; Tempel W, 2004, J BIOL CHEM, V279, P29774, DOI 10.1074/jbc.M403065200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRETTER V, 1991, EUR J BIOCHEM, V199, P647, DOI 10.1111/j.1432-1033.1991.tb16166.x; Unligil UM, 2000, EMBO J, V19, P5269, DOI 10.1093/emboj/19.20.5269; van den Elsen JMH, 2001, EMBO J, V20, P3008, DOI 10.1093/emboj/20.12.3008; Varki A, 2009, PROTEOMICS, V9, P5398, DOI 10.1002/pmic.200900708; VITALE A, 1984, J CELL BIOL, V99, P133, DOI 10.1083/jcb.99.1.133; von Schaewen A, 2008, PLANT SIGNAL BEHAV, V3, P871, DOI 10.4161/psb.3.10.6227; VONSCHAEWEN A, 1993, PLANT PHYSIOL, V102, P1109, DOI 10.1104/pp.102.4.1109; Walne P. R., 1966, Fishery Investigations London (2), V25, P1; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099; Wilkinson BM, 2006, J BIOL CHEM, V281, P6325, DOI 10.1074/jbc.M510455200; Wilson IBH, 2001, BBA-GEN SUBJECTS, V1527, P88, DOI 10.1016/S0304-4165(01)00151-9; Yan G, 2002, J BIOL CHEM, V277, P47692, DOI 10.1074/jbc.M208136200; Zhang WL, 2003, BIOCHEM J, V372, P53, DOI 10.1042/BJ20021931	76	51	54	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6152	6164		10.1074/jbc.M110.175711	http://dx.doi.org/10.1074/jbc.M110.175711			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21169367	Green Published, hybrid			2022-12-27	WOS:000287476400024
J	Frey, AG; Eide, DJ				Frey, Avery G.; Eide, David J.			Roles of Two Activation Domains in Zap1 in the Response to Zinc Deficiency in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATOR; GENE-EXPRESSION; DNA-BINDING; GLUCOCORTICOID-RECEPTOR; MUTATIONAL ANALYSIS; YEAST; PROTEIN; MULTIPLE; COMPLEX; GAL4	Previous studies suggested that the zinc-responsive Zap1 transcriptional activator directly regulates the expression of over 80 genes in Saccharomyces cerevisiae. Many of these genes play key roles to enhance the ability of yeast cells to grow under zinc-limiting conditions. Zap1 is unusual among transcriptional activators in that it contains two activation domains, designated AD1 and AD2, which are regulated independently by zinc. These two domains are evolutionarily conserved among Zap1 orthologs suggesting that they are both important for Zap1 function. In this study, we have examined the roles of AD1 and AD2 in low zinc growth and the regulation of Zap1 target gene expression. Using alleles that are specifically disrupted for either AD1 or AD2 function, we found that these domains are not redundant, and both are important for normal growth in low zinc. AD1 plays the primary role in zinc-responsive gene regulation, whereas AD2 is required for maximal expression of only a few target promoters. AD1 alone is capable of driving full expression of most Zap1 target genes and dictates the kinetics of Zap1 gene induction in response to zinc withdrawal. Surprisingly, we found that AD1 is less active in zinc-limited cells under heat stress and AD2 plays a more important role under those conditions. These results suggest that AD2 may contribute more to Zap1 function when zinc deficiency is combined with other environmental stresses. In the course of these studies, we also found that the heat shock response is induced under conditions of severe zinc deficiency.	[Frey, Avery G.; Eide, David J.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Eide, DJ (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	deide@wisc.edu			National Institutes of Health [RO1-GM056285, T32-DK007665]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-GM056285 and T32-DK007665.	Bird A, 2000, J BIOL CHEM, V275, P16160, DOI 10.1074/jbc.M000664200; Bird AJ, 2000, EMBO J, V19, P3704, DOI 10.1093/emboj/19.14.3704; Bird AJ, 2003, EMBO J, V22, P5137, DOI 10.1093/emboj/cdg484; Bird AJ, 2006, J BIOL CHEM, V281, P25326, DOI 10.1074/jbc.M600655200; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Cross FR, 1997, YEAST, V13, P647, DOI 10.1002/(SICI)1097-0061(19970615)13:7<647::AID-YEA115>3.0.CO;2-#; Ding WV, 1997, MOL CELL BIOL, V17, P2538, DOI 10.1128/MCB.17.5.2538; DOHRMANN PR, 1992, GENE DEV, V6, P93, DOI 10.1101/gad.6.1.93; DRYSDALE CM, 1995, MOL CELL BIOL, V15, P1220, DOI 10.1128/MCB.15.3.1220; Eastmond DL, 2006, J BIOL CHEM, V281, P32909, DOI 10.1074/jbc.M602454200; Eide DJ, 2009, J BIOL CHEM, V284, P18565, DOI 10.1074/jbc.R900014200; FALCHUK KH, 1975, J CELL SCI, V17, P57; Fan CY, 2005, J BIOL CHEM, V280, P695, DOI 10.1074/jbc.M410645200; Gao CY, 2000, BIOTECHNIQUES, V29, P1226, DOI 10.2144/00296st02; Gauci VJ, 2009, FEMS YEAST RES, V9, P1187, DOI 10.1111/j.1567-1364.2009.00557.x; GILL G, 1987, CELL, V51, P121, DOI 10.1016/0092-8674(87)90016-X; GILL G, 1988, NATURE, V334, P721, DOI 10.1038/334721a0; Gitan RS, 1998, J BIOL CHEM, V273, P28617, DOI 10.1074/jbc.273.44.28617; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Herbig A, 2005, MOL MICROBIOL, V57, P834, DOI 10.1111/j.1365-2958.2005.04734.x; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; JOHNSTON M, 1988, GENETICS, V120, P63; Kanin EI, 2007, P NATL ACAD SCI USA, V104, P5812, DOI 10.1073/pnas.0611505104; LOHR D, 1995, FASEB J, V9, P777, DOI 10.1096/fasebj.9.9.7601342; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; MULLERIMMERGLUCK MM, 1990, EMBO J, V9, P1625, DOI 10.1002/j.1460-2075.1990.tb08282.x; OTEIZA PI, 1995, J NUTR, V125, P823; RADTKE F, 1995, NUCLEIC ACIDS RES, V23, P2277, DOI 10.1093/nar/23.12.2277; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Rutherford JC, 2003, J BIOL CHEM, V278, P27636, DOI 10.1074/jbc.M300076200; Scannell DR, 2007, YEAST, V24, P929, DOI 10.1002/yea.1515; Stebbins JL, 2004, EUKARYOT CELL, V3, P339, DOI 10.1128/EC.3.2.339-347.2004; Wang ZH, 2006, J MOL BIOL, V357, P1167, DOI 10.1016/j.jmb.2006.01.010; Wu CY, 2007, J BIOL CHEM, V282, P2184, DOI 10.1074/jbc.M606639200; Wu CY, 2009, J BIOL CHEM, V284, P27544, DOI 10.1074/jbc.M109.042036; Wu CY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-370; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044	43	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6844	6854		10.1074/jbc.M110.203927	http://dx.doi.org/10.1074/jbc.M110.203927			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21177862	Green Published, hybrid			2022-12-27	WOS:000287476400091
J	Lim, SP; Sonntag, LS; Noble, C; Nilar, SH; Ng, RH; Zou, G; Monaghan, P; Chung, KY; Dong, HP; Liu, BP; Bodenreider, C; Lee, G; Ding, M; Chan, WL; Wang, G; Jian, YL; Chao, AT; Lescar, J; Yin, Z; Vedananda, TR; Keller, TH; Shi, PY				Lim, Siew Pheng; Sonntag, Louis Sebastian; Noble, Christian; Nilar, Shahul H.; Ng, Ru Hui; Zou, Gang; Monaghan, Paul; Chung, Ka Yan; Dong, Hongping; Liu, Boping; Bodenreider, Christophe; Lee, Gladys; Ding, Mei; Chan, Wai Ling; Wang, Gang; Jian, Yap Li; Chao, Alexander Theodore; Lescar, Julien; Yin, Zheng; Vedananda, T. R.; Keller, Thomas H.; Shi, Pei-Yong			Small Molecule Inhibitors That Selectively Block Dengue Virus Methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NS5; MECHANISM	Crystal structure analysis of Flavivirus methyltransferases uncovered a flavivirus-conserved cavity located next to the binding site for its cofactor, S-adenosyl-methionine (SAM). Chemical derivatization of S-adenosyl-homocysteine (SAH), the product inhibitor of the methylation reaction, with substituents that extend into the identified cavity, generated inhibitors that showed improved and selective activity against dengue virus methyltransferase (MTase), but not related human enzymes. Crystal structure of dengue virus MTase with a bound SAH derivative revealed that its N6-substituent bound in this cavity and induced conformation changes in residues lining the pocket. These findings demonstrate that one of the major hurdles for the development of methyltransferase-based therapeutics, namely selectivity for disease-related methyltransferases, can be overcome.	[Monaghan, Paul; Dong, Hongping; Liu, Boping; Bodenreider, Christophe; Lee, Gladys; Ding, Mei; Keller, Thomas H.; Shi, Pei-Yong] Novartis Inst Trop Dis, Singapore, Singapore; [Chung, Ka Yan; Jian, Yap Li; Lescar, Julien] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore; [Vedananda, T. R.] Novartis Inst BioMed Res, Cambridge, MA 02139 USA	Novartis; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Novartis		siew_pheng.lim@novartis.com; pei_yong.shi@novartis.com	Liu, Bo/HCG-9782-2022; Lim, Siew Pheng/P-8528-2016; Pheng, Lim Siew/AAG-4368-2021; Zou, Gang/J-1833-2014; LI, feng/HIR-1703-2022; yin, zheng/A-4825-2012	Liu, Bo/0000-0003-1685-7968; Pheng, Lim Siew/0000-0002-7377-5662; Zou, Gang/0000-0001-9607-7827; yin, zheng/0000-0002-7346-6325; Keller, Thomas/0000-0002-7553-6235	BMRC [06/1/22/19/447]	BMRC(Agency for Science Technology & Research (A*STAR))	This work was supported in part by BMRC Grant 06/1/22/19/447 (to J. L.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009; BORCHARDT RT, 1980, J MED CHEM, V23, P347, DOI 10.1021/jm00178a001; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chung KY, 2010, VIROLOGY, V402, P52, DOI 10.1016/j.virol.2010.03.011; Copeland RA, 2009, NAT REV DRUG DISCOV, V8, P724, DOI 10.1038/nrd2974; Dong HP, 2010, J BIOL CHEM, V285, P32586, DOI 10.1074/jbc.M110.129197; Dong HP, 2010, VIROLOGY, V405, P568, DOI 10.1016/j.virol.2010.06.039; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabrega C, 2004, MOL CELL, V13, P77, DOI 10.1016/S1097-2765(03)00522-7; FINNEY DJ, 1976, BIOMETRICS, V32, P721, DOI 10.2307/2529258; Geiss BJ, 2009, J MOL BIOL, V385, P1643, DOI 10.1016/j.jmb.2008.11.058; HASOBE M, 1989, ANTIMICROB AGENTS CH, V33, P828, DOI 10.1128/AAC.33.6.828; Hodel AE, 1996, CELL, V85, P247, DOI 10.1016/S0092-8674(00)81101-0; Kroschewski H, 2008, J BIOL CHEM, V283, P19410, DOI 10.1074/jbc.M800613200; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Lim SP, 2008, ANTIVIR RES, V80, P360, DOI 10.1016/j.antiviral.2008.08.005; Patnaik D, 2004, J BIOL CHEM, V279, P53248, DOI 10.1074/jbc.M409604200; Qing M, 2010, ANTIMICROB AGENTS CH, V54, P3686, DOI 10.1128/AAC.00561-10; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Saavedra OM, 2009, BIOORG MED CHEM LETT, V19, P2747, DOI 10.1016/j.bmcl.2009.03.113; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06	24	120	125	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6233	6240		10.1074/jbc.M110.179184	http://dx.doi.org/10.1074/jbc.M110.179184			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21147775	hybrid, Green Published			2022-12-27	WOS:000287476400033
J	Yu, C; Sonnen, AFP; George, R; Dessailly, BH; Stagg, LJ; Evans, EJ; Orengo, CA; Stuart, DI; Ladbury, JE; Ikemizu, S; Gilbert, RJC; Davis, SJ				Yu, Chao; Sonnen, Andreas F-P.; George, Roger; Dessailly, Benoit H.; Stagg, Loren J.; Evans, Edward J.; Orengo, Christine A.; Stuart, David I.; Ladbury, John E.; Ikemizu, Shinji; Gilbert, Robert J. C.; Davis, Simon J.			Rigid-body Ligand Recognition Drives Cytotoxic T-lymphocyte Antigen 4 (CTLA-4) Receptor Triggering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY ANALYSIS; CRYSTAL-STRUCTURE; CELL-SURFACE; PHOSPHATIDYLINOSITOL 3-KINASE; IMMUNOGLOBULIN SUPERFAMILY; STRUCTURAL GENOMICS; MOLECULAR-BASIS; BINDING DOMAIN; SOLUBLE FORM; PROTEIN	The inhibitory T-cell surface-expressed receptor, cytotoxic T lymphocyte-associated antigen-4 (CTLA-4), which belongs to the class of cell surface proteins phosphorylated by extrinsic tyrosine kinases that also includes antigen receptors, binds the related ligands, B7-1 and B7-2, expressed on antigen-presenting cells. Conformational changes are commonly invoked to explain ligand-induced "triggering" of this class of receptors. Crystal structures of ligand-bound CTLA-4 have been reported, but not the apo form, precluding analysis of the structural changes accompanying ligand binding. The 1.8-angstrom resolution structure of an apo human CTLA-4 homodimer emphasizes the shared evolutionary history of the CTLA-4/CD28 subgroup of the immunoglobulin superfamily and the antigen receptors. The ligand-bound and unbound forms of both CTLA-4 and B7-1 are remarkably similar, in marked contrast to B7-2, whose binding to CTLA-4 has elements of induced fit. Isothermal titration calorimetry reveals that ligand binding by CTLA-4 is enthalpically driven and accompanied by unfavorable entropic changes. The similarity of the thermodynamic parameters determined for the interactions of CTLA-4 with B7-1 and B7-2 suggests that the binding is not highly specific, but the conformational changes observed for B7-2 binding suggest some level of selectivity. The new structure establishes that rigid-body ligand interactions are capable of triggering CTLA-4 phosphorylation by extrinsic kinase(s).	[Yu, Chao; Evans, Edward J.; Davis, Simon J.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [Yu, Chao; Evans, Edward J.; Davis, Simon J.] Univ Oxford, John Radcliffe Hosp, MRC Human Immunol Unit, Oxford OX3 9DU, England; [Sonnen, Andreas F-P.; Stuart, David I.; Gilbert, Robert J. C.] Univ Oxford, Div Struct Biol, Oxford OX3 7BN, England; [George, Roger; Dessailly, Benoit H.; Orengo, Christine A.; Ladbury, John E.] UCL, Dept Struct & Mol Biol, London WC1E 6BT, England; [Stagg, Loren J.; Ladbury, John E.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Ikemizu, Shinji] Kumamoto Univ, Grad Sch Pharmaceut Sci, Div Struct Biol, Kumamoto 8620973, Japan	University of Oxford; University of Oxford; University of Oxford; University of London; University College London; University of Texas System; UTMD Anderson Cancer Center; Kumamoto University	Davis, SJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England.	simon.davis@ndm.ox.ac.uk		Gilbert, Robert/0000-0001-9336-5604; Ladbury, John/0000-0002-6328-7200; Stuart, David/0000-0002-3426-4210	United Kingdom Medical Research Council; Ministry of Education, Culture, Sports, Science and Technology of Japan; Royal Society; Wellcome Trust; Medical Research Council [G19/3, G1100525, G1000099] Funding Source: researchfish; MRC [G19/3, G1000099] Funding Source: UKRI	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by the United Kingdom Medical Research Council.; Supported by Grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan.; Supported by the Royal Society. To whom correspondence may be addressed. Tel.: 44-1865-287535; Fax: 44-1865-287547; E-mail: gilbert@strubi.ox.ac.uk.; Supported by the Wellcome Trust. To whom correspondence may be addressed. Tel.: 44-1865-221336; Fax: 44-1865-222737; E-mail: simon.davis@ndm.ox.ac.uk.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arold ST, 2001, J BIOL CHEM, V276, P17199, DOI 10.1074/jbc.M011185200; Beddoe T, 2009, IMMUNITY, V30, P777, DOI 10.1016/j.immuni.2009.03.018; Bhatia S, 2005, P NATL ACAD SCI USA, V102, P15569, DOI 10.1073/pnas.0507257102; Boggon TJ, 2004, ONCOGENE, V23, P7918, DOI 10.1038/sj.onc.1208081; Bradshaw JD, 1997, BIOCHEMISTRY-US, V36, P15975, DOI 10.1021/bi971762i; Chang CYY, 2000, ACTA CRYSTALLOGR D, V56, P1468, DOI 10.1107/S0907444900010738; Chang VT, 2007, STRUCTURE, V15, P267, DOI 10.1016/j.str.2007.01.011; CHOTHIA C, 1985, J MOL BIOL, V186, P651, DOI 10.1016/0022-2836(85)90137-8; Chuang E, 1999, J IMMUNOL, V162, P1270; Collins AV, 2002, IMMUNITY, V17, P201, DOI 10.1016/S1074-7613(02)00362-X; Compaan DM, 2005, J BIOL CHEM, V280, P39553, DOI 10.1074/jbc.M507629200; Cuff AL, 2009, NUCLEIC ACIDS RES, V37, pD310, DOI 10.1093/nar/gkn877; Daeron M, 2008, IMMUNOL REV, V224, P11, DOI 10.1111/j.1600-065X.2008.00666.x; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; DAVIS SJ, 1995, J BIOL CHEM, V270, P369, DOI 10.1074/jbc.270.1.369; DAVIS SJ, 1990, J BIOL CHEM, V265, P10410; DeLano W.L, PYMOL MOL GRAPHICS S; Dessailly BH, 2009, STRUCTURE, V17, P869, DOI 10.1016/j.str.2009.03.015; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans EJ, 2005, NAT IMMUNOL, V6, P271, DOI 10.1038/ni1170; Evans EJ, 2003, IMMUNITY, V19, P213, DOI 10.1016/S1074-7613(03)00198-5; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Hatherley D, 2008, MOL CELL, V31, P266, DOI 10.1016/j.molcel.2008.05.026; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; HOWARD TA, 1991, IMMUNOGENETICS, V33, P74, DOI 10.1007/BF00211698; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Jansson A, 2005, J IMMUNOL, V175, P1575, DOI 10.4049/jimmunol.175.3.1575; JOHNSON P, 1986, NATURE, V323, P74, DOI 10.1038/323074a0; Kolodny R, 2005, J MOL BIOL, V346, P1173, DOI 10.1016/j.jmb.2004.12.032; Ladbury JE, 1996, CHEM BIOL, V3, P973, DOI 10.1016/S1074-5521(96)90164-7; Ladbury JE, 1996, CHEM BIOL, V3, P791, DOI 10.1016/S1074-5521(96)90063-0; LAFAGEPOCHITALOFF M, 1990, IMMUNOGENETICS, V31, P198; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LEAHY DJ, 1992, CELL, V68, P1145, DOI 10.1016/0092-8674(92)90085-Q; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Lin DYW, 2008, P NATL ACAD SCI USA, V105, P3011, DOI 10.1073/pnas.0712278105; Linsley PS, 2009, IMMUNOL REV, V229, P307, DOI 10.1111/j.1600-065X.2009.00780.x; Long EO, 2008, IMMUNOL REV, V224, P70, DOI 10.1111/j.1600-065X.2008.00660.x; Marengere LEM, 1996, SCIENCE, V272, P1170, DOI 10.1126/science.272.5265.1170; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Metzler WJ, 1997, NAT STRUCT BIOL, V4, P527, DOI 10.1038/nsb0797-527; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nelson CA, 2008, J IMMUNOL, V180, P940, DOI 10.4049/jimmunol.180.2.940; O'Brien R, 2000, PROTEIN SCI, V9, P570; Orengo CA, 1996, METHOD ENZYMOL, V266, P617; Ostrov DA, 2000, SCIENCE, V290, P816, DOI 10.1126/science.290.5492.816; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paterson AM, 2010, NAT IMMUNOL, V11, P109, DOI 10.1038/ni0210-109; Peggs KS, 2008, IMMUNOL REV, V224, P141, DOI 10.1111/j.1600-065X.2008.00649.x; Pentcheva-Hoang T, 2004, IMMUNITY, V21, P401, DOI 10.1016/j.immuni.2004.06.017; PRASAD KVS, 1994, P NATL ACAD SCI USA, V91, P2834, DOI 10.1073/pnas.91.7.2834; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Schneider H, 1998, BIOCHEM BIOPH RES CO, V252, P14, DOI 10.1006/bbrc.1998.9559; Schonfeld D, 2009, P NATL ACAD SCI USA, V106, P8198, DOI 10.1073/pnas.0813399106; Schwartz JCD, 2001, NATURE, V410, P604, DOI 10.1038/35069112; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; Sonnen AFP, 2010, J MOL BIOL, V399, P207, DOI 10.1016/j.jmb.2010.04.011; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; TRUITT KE, 1994, J EXP MED, V179, P1071, DOI 10.1084/jem.179.3.1071; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Zhang XW, 2003, P NATL ACAD SCI USA, V100, P2586, DOI 10.1073/pnas.252771499; Zhang XW, 2002, PROTEIN EXPRES PURIF, V25, P105, DOI 10.1006/prep.2002.1616; Zhang Y, 1997, P NATL ACAD SCI USA, V94, P9273, DOI 10.1073/pnas.94.17.9273	75	28	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6685	6696		10.1074/jbc.M110.182394	http://dx.doi.org/10.1074/jbc.M110.182394			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21156796	Green Published, hybrid			2022-12-27	WOS:000287476400076
J	Zhuo, Y; Bellis, SL				Zhuo, Ya; Bellis, Susan L.			Emerging Role of alpha 2,6-Sialic Acid as a Negative Regulator of Galectin Binding and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BETA-GALACTOSIDE ALPHA-2,6-SIALYLTRANSFERASE; B-CELL LYMPHOMA; ALPHA-2-6-LINKED SIALIC ACIDS; MYELOID FIBRONECTIN RECEPTORS; MESSENGER-RNA LEVEL; N-GLYCANS; GALECTIN-3-INDUCED APOPTOSIS; SIALYLTRANSFERASE ACTIVITY; ST6GAL SIALYLTRANSFERASE; THERAPEUTIC TARGET	Galectins are beta-galactoside-binding lectins that regulate diverse cell behaviors, including adhesion, migration, proliferation, and apoptosis. Galectins can be expressed both intracellularly and extracellularly, and extracellular galectins mediate their effects by associating with cell-surface oligosaccharides. Despite intensive current interest in galectins, strikingly few studies have focused on a key enzyme that acts to inhibit galectin signaling, namely beta-galactoside alpha 2,6-sialyltransferase (ST6Gal-I). ST6Gal-I adds an alpha 2,6-linked sialic acid to the terminal galactose of N-linked glycans, and this modification blocks galectin binding to beta-galactosides. This minireview summarizes the evidence suggesting that ST6Gal-I activity serves as an "off switch" for galectin function.	[Zhuo, Ya; Bellis, Susan L.] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Bellis, SL (corresponding author), Univ Alabama Birmingham, Dept Physiol & Biophys, UAb Stn, Birmingham, AL 35294 USA.	bellis@uab.edu			National Institutes of Health from NCI [CA-84248]; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA084248] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-84248 from NCI. This work was also supported by a grant-in-aid from the American Heart Association. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	AASENG DA, 1995, BBA-GENE STRUCT EXPR, V1261, P166, DOI 10.1016/0167-4781(94)00250-7; Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Andre S, 2007, FEBS J, V274, P3233, DOI 10.1111/j.1742-4658.2007.05851.x; Baum LG, 1996, J BIOL CHEM, V271, P10793, DOI 10.1074/jbc.271.18.10793; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; BRESALIER RS, 1990, CANCER RES, V50, P1299; Brewer CF, 2002, GLYCOCONJUGATE J, V19, P459, DOI 10.1023/B:GLYC.0000014075.62724.d0; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Chen X, 2010, ACS CHEM BIOL, V5, P163, DOI 10.1021/cb900266r; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Collins BE, 2006, NAT IMMUNOL, V7, P199, DOI 10.1038/ni1283; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; Crespo HJ, 2009, IMMUNOLOGY, V128, pe621, DOI 10.1111/j.1365-2567.2009.03047.x; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Dall'Olio Fabio, 2000, Glycoconjugate Journal, V17, P669, DOI 10.1023/A:1011077000164; DALLOLIO F, 1989, INT J CANCER, V44, P434; DALLOLIO F, 1995, BIOCHEM BIOPH RES CO, V211, P554, DOI 10.1006/bbrc.1995.1849; Dalziel M, 2004, EUR J BIOCHEM, V271, P3623, DOI 10.1111/j.1432-1033.2004.04284.x; Dalziel M, 2001, GLYCOBIOLOGY, V11, P407, DOI 10.1093/glycob/11.5.407; de Melo FHM, 2007, J HISTOCHEM CYTOCHEM, V55, P1015, DOI 10.1369/jhc.7A7174.2007; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; Elola MT, 2007, CELL MOL LIFE SCI, V64, P1679, DOI 10.1007/s00018-007-7044-8; Fenteany FH, 2005, J BIOL CHEM, V280, P5423, DOI 10.1074/jbc.M412396200; Fukumori T, 2003, CANCER RES, V63, P8302; Fukushima K, 1998, CANCER RES, V58, P4301; Gagneux P, 2003, J BIOL CHEM, V278, P48245, DOI 10.1074/jbc.M309813200; Garner OB, 2008, BIOCHEM SOC T, V36, P1472, DOI 10.1042/BST0361472; GESSNER P, 1993, CANCER LETT, V75, P143, DOI 10.1016/0304-3835(93)90056-F; Ghosh S, 2006, INT IMMUNOL, V18, P603, DOI 10.1093/intimm/dxh402; Glinsky VV, 2009, CARBOHYD RES, V344, P1788, DOI 10.1016/j.carres.2008.08.038; Gretschel S, 2003, ONCOLOGY-BASEL, V65, P139, DOI 10.1159/000072339; Grigorian A, 2009, IMMUNOL REV, V230, P232, DOI 10.1111/j.1600-065X.2009.00796.x; Guo HB, 2007, J BIOL CHEM, V282, P22150, DOI 10.1074/jbc.M611518200; HARVEY BE, 1992, CANCER RES, V52, P1775; He JL, 2006, METHOD ENZYMOL, V417, P247, DOI 10.1016/S0076-6879(06)17017-2; Hedlund M, 2008, CANCER RES, V68, P388, DOI 10.1158/0008-5472.CAN-07-1340; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hsu DK, 2006, METHOD ENZYMOL, V417, P256, DOI 10.1016/S0076-6879(06)17018-4; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Jenner J, 2006, EXP HEMATOL, V34, P1212, DOI 10.1016/j.exphem.2006.04.016; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaneko Y, 1996, ACTA NEUROPATHOL, V91, P284, DOI 10.1007/s004010050427; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kitazume S, 2001, P NATL ACAD SCI USA, V98, P13554, DOI 10.1073/pnas.241509198; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; LEMARER N, 1995, GLYCOBIOLOGY, V5, P219, DOI 10.1093/glycob/5.2.219; Leppanen A, 2005, J BIOL CHEM, V280, P5549, DOI 10.1074/jbc.m412019200; Lin CL, 2009, MOL CANCER RES, V7, P1655, DOI 10.1158/1541-7786.MCR-09-0274; Lin SQ, 2002, EXP CELL RES, V276, P101, DOI 10.1006/excr.2002.5521; Lise M, 2000, HYBRIDOMA, V19, P281, DOI 10.1089/027245700429828; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Liu FT, 2002, BBA-GEN SUBJECTS, V1572, P263, DOI 10.1016/S0304-4165(02)00313-6; Liu FT, 2010, ANN NY ACAD SCI, V1183, P158, DOI 10.1111/j.1749-6632.2009.05131.x; Lopez-Morales D, 2009, INVEST CLIN, V50, P45; Marino JH, 2008, GLYCOBIOLOGY, V18, P719, DOI 10.1093/glycob/cwn051; Mondal S, 2010, LEUKEMIA RES, V34, P463, DOI 10.1016/j.leukres.2009.07.042; Nakahara S, 2006, METHOD ENZYMOL, V417, P273, DOI 10.1016/S0076-6879(06)17019-6; Nangia-Makker P, 2007, J BIOENERG BIOMEMBR, V39, P79, DOI 10.1007/s10863-006-9063-9; Nasirikenari M, 2006, BLOOD, V108, P3397, DOI 10.1182/blood-2006-04-014779; Nasirikenari M, 2010, J LEUKOCYTE BIOL, V87, P457, DOI 10.1189/jlb.1108704; Perillo NL, 1997, J EXP MED, V185, P1851, DOI 10.1084/jem.185.10.1851; Petretti T, 2000, GUT, V46, P359, DOI 10.1136/gut.46.3.359; POVEGLIANO LZ, 2011, J GASTROINT IN PRESS; Prieto VG, 2006, CLIN CANCER RES, V12, P6709, DOI 10.1158/1078-0432.CCR-06-0758; Rabinovich G, 1999, J EXP MED, V190, P385, DOI 10.1084/jem.190.3.385; Rabinovich GA, 2007, CURR OPIN STRUC BIOL, V17, P513, DOI 10.1016/j.sbi.2007.09.002; Recchi MA, 1998, GLYCOCONJUGATE J, V15, P19, DOI 10.1023/A:1006983214918; Sakaki M, 2010, J MED INVESTIG, V57, P152, DOI 10.2152/jmi.57.152; Salatino M, 2008, EXPERT OPIN BIOL TH, V8, P45, DOI 10.1517/14712598.8.1.45; SATA T, 1991, AM J PATHOL, V139, P1435; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Schutte M, 1997, CANCER RES, V57, P3126; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Semel AC, 2002, J BIOL CHEM, V277, P32830, DOI 10.1074/jbc.M202493200; Shah MH, 2008, GLYCOCONJUGATE J, V25, P279, DOI 10.1007/s10719-007-9086-4; Shaikh FM, 2008, EXP CELL RES, V314, P2941, DOI 10.1016/j.yexcr.2008.07.021; Song XZ, 2009, CHEM BIOL, V16, P36, DOI 10.1016/j.chembiol.2008.11.004; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Suzuki O, 2006, INT J ONCOL, V28, P155; Suzuki O, 1999, PATHOL INT, V49, P874, DOI 10.1046/j.1440-1827.1999.00960.x; Suzuki O, 2008, ONCOL REP, V19, P743; Taniguchi A, 2000, GLYCOBIOLOGY, V10, P623, DOI 10.1093/glycob/10.6.623; Taniguchi A, 1998, FEBS LETT, V441, P191, DOI 10.1016/S0014-5793(98)01548-8; Thijssen VLJL, 2007, BLOOD, V110, P2819, DOI 10.1182/blood-2007-03-077792; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Vespa GNR, 1999, J IMMUNOL, V162, P799; Videira PA, 2008, GLYCOCONJUGATE J, V25, P259, DOI 10.1007/s10719-007-9092-6; Wang PH, 2005, GYNECOL ONCOL, V99, P631, DOI 10.1016/j.ygyno.2005.07.016; WEN DX, 1992, J BIOL CHEM, V267, P2512; Woodard-Grice AV, 2008, J BIOL CHEM, V283, P26364, DOI 10.1074/jbc.M800836200; Wuensch SA, 2000, GLYCOBIOLOGY, V10, P67, DOI 10.1093/glycob/10.1.67; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Zhu YT, 2001, BBA-MOL BASIS DIS, V1536, P148, DOI 10.1016/S0925-4439(01)00044-8; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	99	123	126	1	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					5935	5941		10.1074/jbc.R110.191429	http://dx.doi.org/10.1074/jbc.R110.191429			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21173156	Green Published, hybrid			2022-12-27	WOS:000287476400001
J	Granneman, JG; Moore, HPH; Mottillo, EP; Zhu, ZX; Zhou, L				Granneman, James G.; Moore, Hsiao-Ping H.; Mottillo, Emilio P.; Zhu, Zhengxian; Zhou, Li			Interactions of Perilipin-5 (Plin5) with Adipose Triglyceride Lipase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHANARIN-DORFMAN-SYNDROME; HORMONE-SENSITIVE LIPASE; LIPID DROPLET PROTEIN; CGI-58; FAMILY; LIPOLYSIS; CELLS; ACCUMULATION; ADIPOCYTES; METABOLISM	Members of the perilipin family of lipid droplet scaffold proteins are thought to play important roles in tissue-specific regulation of triglyceride metabolism, but the mechanisms involved are not fully understood. Present results indicate that adipose triglyceride lipase (Atgl) interacts with perilipin-5 (Plin5) but not perilipin-1 (Plin1). Protein interaction assays in live cells and in situ binding experiments showed that Atgl and its protein activator, alpha-beta-hydrolase domain-containing 5 (Abhd5), each bind Plin5. Surprisingly, competition experiments indicated that individual Plin5 molecules bind Atgl or Abhd5 but not both simultaneously. Thus, the ability of Plin5 to concentrate these proteins at droplet surfaces involves binding to different Plin5 molecules, possibly in an oligomeric complex. The association of Plin5-Abhd5 complexes on lipid droplet surfaces was more stable than Plin5-Atgl complexes, and oleic acid treatment selectively promoted the interaction of Plin5 and Abhd5. Analysis of chimeric and mutant perilipin proteins demonstrated that amino acids 200-463 are necessary and sufficient to bind both Atgl and Abhd5 and that the C-terminal 64 amino acids of Plin5 are critical for the differential binding of Atgl to Plin5 and Plin1. Mutant Plin5 that binds Abhd5 but not Atgl was defective in preventing neutral lipid accumulation compared with wild type Plin5, indicating that the ability of Plin5 to concentrate these proteins on lipid droplets is critical to functional Atgl activity in cells.	[Granneman, James G.; Mottillo, Emilio P.; Zhu, Zhengxian; Zhou, Li] Wayne State Univ, Ctr Integrat Metab & Endocrine Res, Sch Med, Detroit, MI 48201 USA; [Moore, Hsiao-Ping H.] Lawrence Technol Univ, Southfield, MI 48075 USA	Wayne State University	Granneman, JG (corresponding author), Wayne State Univ, Ctr Integrat Metab & Endocrine Res, Sch Med, 550 E Canfield, Detroit, MI 48201 USA.	jgranne@med.wayne.edu			National Institutes of Health [DK62292, DK76629]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076629, R01DK062292, R56DK062292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK62292 and DK76629. This work was also supported by the Department of Veterans Affairs.	Bell M, 2008, DIABETES, V57, P2037, DOI 10.2337/db07-1383; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Caviglia JM, 2009, BBA-MOL CELL BIOL L, V1791, P198, DOI 10.1016/j.bbalip.2008.12.018; Ghosh AK, 2008, J BIOL CHEM, V283, P24525, DOI 10.1074/jbc.M801783200; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Granneman JG, 2009, J BIOL CHEM, V284, P34538, DOI 10.1074/jbc.M109.068478; Granneman JG, 2009, J BIOL CHEM, V284, P3049, DOI 10.1074/jbc.M808251200; Granneman JG, 2005, AM J PHYSIOL-ENDOC M, V289, pE608, DOI 10.1152/ajpendo.00009.2005; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Hickenbottom SJ, 2004, STRUCTURE, V12, P1199, DOI 10.1016/j.str.2004.04.021; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Moore HPH, 2005, J BIOL CHEM, V280, P43109, DOI 10.1074/jbc.M506336200; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Schoiswohl G, 2010, J LIPID RES, V51, P490, DOI 10.1194/jlr.M001073; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Subramanian V, 2004, J BIOL CHEM, V279, P42062, DOI 10.1074/jbc.M407462200; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wolins NE, 2006, DIABETES, V55, P3418, DOI 10.2337/db06-0399; Yamaguchi T, 2004, J BIOL CHEM, V279, P30490, DOI 10.1074/jbc.M403920200; Yamaguchi T, 2006, J BIOL CHEM, V281, P14232, DOI 10.1074/jbc.M601682200	24	146	153	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5126	5135		10.1074/jbc.M110.180711	http://dx.doi.org/10.1074/jbc.M110.180711			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148142	Green Published, hybrid			2022-12-27	WOS:000287230600020
J	Ong, HB; Sienkiewicz, N; Wyllie, S; Fairlamb, AH				Ong, Han B.; Sienkiewicz, Natasha; Wyllie, Susan; Fairlamb, Alan H.			Dissecting the Metabolic Roles of Pteridine Reductase 1 in Trypanosoma brucei and Leishmania major	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; PHENYLALANINE-HYDROXYLASE; DIHYDROFOLATE-REDUCTASE; TETRAHYDROBIOPTERIN BIOSYNTHESIS; METHOTREXATE RESISTANCE; THYMIDYLATE SYNTHASE; CYTOCHROME-C; ENZYME; OXIDATION; SYSTEM	Leishmania parasites are pteridine auxotrophs that use an NADPH-dependent pteridine reductase 1 (PTR1) and NADH-dependent quinonoid dihydropteridine reductase (QDPR) to salvage and maintain intracellular pools of tetrahydrobiopterin (H4B). However, the African trypanosome lacks a credible candidate-QDPR in its genome despite maintaining apparent QDPR activity. Here we provide evidence that the NADH-dependent activity previously reported by others is an assay artifact. Using an HPLC-based enzyme assay, we demonstrate that there is an NADPH-dependent QDPR activity associated with both TbPTR1 and LmPTR1. The kinetic properties of recombinant PTR1s are reported at physiological pH and ionic strength and compared with LmQDPR. Specificity constants (k(cat)/K-m) for LmPTR1 are similar with dihydrobiopterin (H2B) and quinonoid dihydrobiopterin (qH(2)B) as substrates and about 20-fold lower than LmQDPR with qH(2)B. In contrast, TbPTR1 shows a 10-fold higher k(cat)/K-m for H2B over qH(2)B. Analysis of Trypanosoma brucei isolated from infected rats revealed that H4B (430 nM, 98% of total biopterin) was the predominant intracellular pterin, consistent with a dual role in the salvage and regeneration of H4B. Gene knock-out experiments confirmed this: PTR1-nulls could only be obtained from lines overexpressing LmQDPR with H4B as a medium supplement. These cells grew normally with H4B, which spontaneously oxidizes to qH(2)B, but were unable to survive in the absence of pterin or with either biopterin or H2B in the medium. These findings establish that PTR1 has an essential and dual role in pterin metabolism in African trypanosomes and underline its potential as a drug target.	[Ong, Han B.; Sienkiewicz, Natasha; Wyllie, Susan; Fairlamb, Alan H.] Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland	University of Dundee	Fairlamb, AH (corresponding author), Univ Dundee, Div Biol Chem & Drug Discovery, Coll Life Sci, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland.	a.h.fairlamb@dundee.ac.uk	Fairlamb, Alan/A-5272-2009; Wyllie, Susan/AAI-4430-2021	Fairlamb, Alan/0000-0001-5134-0329; Wyllie, Susan/0000-0001-8810-5605; Ong, Han/0000-0003-3369-8196	Wellcome Trust [WT079838, WT083481]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust (WT079838 and WT083481).	BECK JT, 1990, MOL BIOCHEM PARASIT, V43, P221, DOI 10.1016/0166-6851(90)90147-E; BELLO AR, 1994, P NATL ACAD SCI USA, V91, P11442, DOI 10.1073/pnas.91.24.11442; BRUN R, 1979, ACTA TROP, V36, P289; Copeland R. A, 2005, EVALUATION ENZYME IN, P77; Crabtree MJ, 2009, J BIOL CHEM, V284, P28128, DOI 10.1074/jbc.M109.041483; Cunningham ML, 2001, SCIENCE, V292, P285, DOI 10.1126/science.1057740; CURTIUS HC, 1985, EUR J BIOCHEM, V148, P413, DOI 10.1111/j.1432-1033.1985.tb08855.x; DAVIS MD, 1988, EUR J BIOCHEM, V173, P345, DOI 10.1111/j.1432-1033.1988.tb14004.x; Dawson A, 2006, MOL MICROBIOL, V61, P1457, DOI 10.1111/j.1365-2958.2006.05332.x; FERSHT AR, 1974, PROC R SOC SER B-BIO, V187, P397, DOI 10.1098/rspb.1974.0084; FUKUSHIMA T, 1980, ANAL BIOCHEM, V102, P176, DOI 10.1016/0003-2697(80)90336-X; Gourley DG, 1999, ACTA CRYSTALLOGR D, V55, P1608, DOI 10.1107/S0907444999008999; Greig N, 2009, FEBS J, V276, P376, DOI 10.1111/j.1742-4658.2008.06788.x; HASEGAWA H, 1978, J BIOCHEM-TOKYO, V84, P499, DOI 10.1093/oxfordjournals.jbchem.a132153; HUANG CY, 1973, J BIOL CHEM, V248, P4242; JOCKERSSCHERUBL MC, 1989, EUR J BIOCHEM, V180, P267, DOI 10.1111/j.1432-1033.1989.tb14643.x; KAUFMAN S, 1967, J BIOL CHEM, V242, P3934; KAUFMAN S, 1961, J BIOL CHEM, V236, P804; KAUFMAN S, 1990, BIOCHIM BIOPHYS ACTA, V1040, P19, DOI 10.1016/0167-4838(90)90141-2; Keita M, 2000, EXP PARASITOL, V95, P19, DOI 10.1006/expr.2000.4505; KIDDER GW, 1958, J GEN MICROBIOL, V18, P621, DOI 10.1099/00221287-18-3-621; Kirsch M, 2003, J BIOL CHEM, V278, P24481, DOI 10.1074/jbc.M211779200; Kundig C, 1999, EMBO J, V18, P2342, DOI 10.1093/emboj/18.9.2342; KWON NS, 1989, J BIOL CHEM, V264, P20496; LANHAM SM, 1968, NATURE, V218, P1273, DOI 10.1038/2181273a0; LAZARUS RA, 1981, BIOCHEMISTRY-US, V20, P6834, DOI 10.1021/bi00527a015; LOVENBERG W, 1967, SCIENCE, V155, P217, DOI 10.1126/science.155.3759.217; Lye LF, 2002, J BIOL CHEM, V277, P38245, DOI 10.1074/jbc.M206543200; Lye LF, 2011, MOL BIOCHEM PARASIT, V175, P58, DOI 10.1016/j.molbiopara.2010.09.004; Ma DQ, 1996, BIOCHEM BIOPH RES CO, V227, P885, DOI 10.1006/bbrc.1996.1600; Mayer B, 1997, TRENDS BIOCHEM SCI, V22, P477, DOI 10.1016/S0968-0004(97)01147-X; Moreira W, 2009, FREE RADICAL BIO MED, V46, P367, DOI 10.1016/j.freeradbiomed.2008.10.034; Murr C, 2002, CURR DRUG METAB, V3, P175, DOI 10.2174/1389200024605082; NAGATSU T, 1964, J BIOL CHEM, V239, P2910; Nare B, 1997, J BIOL CHEM, V272, P13883, DOI 10.1074/jbc.272.21.13883; Nare B, 2009, CURR GENET, V55, P287, DOI 10.1007/s00294-009-0244-z; OPPERDOES FR, 1984, J CELL BIOL, V98, P1178, DOI 10.1083/jcb.98.4.1178; PFLEIDERER W, 1985, CHEM BIOCH PTERINS, P43; SCOTT DA, 1995, BIOCHEM J, V310, P789, DOI 10.1042/bj3100789; Shanks EJ, 2010, ANAL BIOCHEM, V396, P194, DOI 10.1016/j.ab.2009.09.003; SHIOTA T, 1964, J BIOL CHEM, V239, P2259; Sienkiewicz N, 2008, MOL MICROBIOL, V69, P520, DOI 10.1111/j.1365-2958.2008.06305.x; Sienkiewicz N, 2010, MOL MICROBIOL, V77, P658, DOI 10.1111/j.1365-2958.2010.07236.x; TAYEH MA, 1989, J BIOL CHEM, V264, P19654; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; TIETZ A, 1964, J BIOL CHEM, V239, P4081; Vickers TJ, 2006, J BIOL CHEM, V281, P38150, DOI 10.1074/jbc.M608387200; Wang JY, 1997, ARCH BIOCHEM BIOPHYS, V342, P197, DOI 10.1006/abbi.1997.0126; WERNER ER, 1990, J BIOL CHEM, V265, P3189; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yoshida S, 2001, RESPIRATION, V68, P299, DOI 10.1159/000050514	51	35	34	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10429	10438		10.1074/jbc.M110.209593	http://dx.doi.org/10.1074/jbc.M110.209593			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21239486	Green Published, hybrid			2022-12-27	WOS:000288547000059
J	Sattlegger, E; Barbosa, JARG; Moraes, MCS; Martins, RM; Hinnebusch, AG; Castilho, BA				Sattlegger, Evelyn; Barbosa, Joao A. R. G.; Moraes, Maria Carolina S.; Martins, Rafael M.; Hinnebusch, Alan G.; Castilho, Beatriz A.			Gcn1 and Actin Binding to Yih1 IMPLICATIONS FOR ACTIVATION OF THE eIF2 KINASE GCN2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR 1A; PROTEIN-KINASE GCN2; INTRINSICALLY UNSTRUCTURED PROTEIN; AMINO-ACID CONTROL; SACCHAROMYCES-CEREVISIAE; TRANSLATION ELONGATION; GI DOMAIN; GENE; ORGANIZATION; CYTOSKELETON	Yeast Yih1 protein and its mammalian ortholog IMPACT, abundant in neurons, are inhibitors of Gcn2, a kinase involved in amino acid homeostasis, stress response, and memory formation. Like Gcn2, Yih1/IMPACT harbors an N-terminal RWD domain that mediates binding to the Gcn2 activator Gcn1. Yih1 competes with Gcn2 for Gcn1 binding, thus inhibiting Gcn2. Yih1 also binds G-actin. Here, we show that Yih1-actin interaction is independent of Gcn1 and that Yih1-Gcn1 binding does not require actin. The Yih1 RWD (residues 1-132) was sufficient for Gcn2 inhibition and Gcn1 binding, but not for actin binding, showing that actin binding is dispensable for inhibiting Gcn2. Actin binding required Yih1 residues 68-258, encompassing part of the RWD and the C-terminal "ancient domain"; however, residues Asp-102 and Glu-106 in helix3 of the RWD were essential for Gcn1 binding and Gcn2 inhibition but dispensable for actin binding. Thus, the Gcn1- and actin-binding sites overlap in the RWD but have distinct binding determinants. Unexpectedly, Yih1 segment 68-258 was defective for inhibiting Gcn2 even though it binds Gcn1 at higher levels than does full-length Yih1. This and other results suggest that Yih1 binds with different requirements to distinct populations of Gcn1 molecules, and its ability to disrupt Gcn1-Gcn2 complexes is dependent on a complete RWD and hindered by actin binding. Modeling of the ancient domain on the bacterial protein YigZ showed peculiarities to the eukaryotic and prokaryotic lineages, suggesting binding sites for conserved cellular components. Our results support a role for Yih1 in a cross-talk between the cytoskeleton and translation.	[Sattlegger, Evelyn] Massey Univ, Inst Nat Sci, N Shore Mail Ctr, Auckland 0745, New Zealand; [Moraes, Maria Carolina S.; Martins, Rafael M.; Castilho, Beatriz A.] Univ Fed Sao Paulo, Dept Microbiol Imunol & Parasitol, BR-04023062 Sao Paulo, Brazil; [Sattlegger, Evelyn; Hinnebusch, Alan G.] NICHD, Lab Gene Regulat & Dev, NIH, Bethesda, MD 20892 USA; [Barbosa, Joao A. R. G.] Brazilian Synchrotron Light Lab, Ctr Struct Mol Biol, BR-13083970 Campinas, Brazil	Massey University; Universidade Federal de Sao Paulo (UNIFESP); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Laboratorio Nacional de Luz Sincrotron (LNLS)	Sattlegger, E (corresponding author), Massey Univ, Inst Nat Sci, N Shore Mail Ctr, Private Bag 102 904, Auckland 0745, New Zealand.	e.sattlegger@massey.ac.nz	Barbosa, João Alexandre/E-2261-2012; Moraes, Maria Carolina Strano/AAS-7557-2021; Barbosa, João/GVT-7916-2022; Castilho, Beatriz A/C-2503-2012	Barbosa, João Alexandre/0000-0002-0534-481X; Moraes, Maria Carolina Strano/0000-0003-4032-5101; Castilho, Beatriz A/0000-0003-4509-5237; miyazawa martins, rafael/0000-0001-7449-0696	National Institutes of Health; Health Research Council of New Zealand; Auckland Medical Research Foundation; Massey University; Maurice and Phyllis Paykel Trust; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health Research Council of New Zealand(Health Research Council of New Zealand); Auckland Medical Research Foundation; Massey University; Maurice and Phyllis Paykel Trust; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program. This work was also supported in part by the Health Research Council of New Zealand Emerging Researcher First Grant, Auckland Medical Research Foundation, Massey University Research and Technician's Fund, Maurice and Phyllis Paykel Trust (to E. S.), and a grant from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (to B. A. C.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Alves VS, 2005, BIOCHEM BIOPH RES CO, V332, P450, DOI 10.1016/j.bbrc.2005.04.151; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bittencourt S, 2008, J COMP NEUROL, V507, P1811, DOI 10.1002/cne.21652; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; CHEN YH, 1972, BIOCHEMISTRY-US, V11, P4120, DOI 10.1021/bi00772a015; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Cutler P, 1996, Methods Mol Biol, V59, P255; DEALDANA CRV, 1995, EMBO J, V14, P3184, DOI 10.1002/j.1460-2075.1995.tb07321.x; DeLano W.L, PYMOL MOL GRAPHICS S; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; DEVER TE, 1992, CELL, V68, P585, DOI 10.1016/0092-8674(92)90193-G; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; FOIANI M, 1991, MOL CELL BIOL, V11, P3203, DOI 10.1128/MCB.11.6.3203; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Gross SR, 2007, MOL CELL BIOL, V27, P1974, DOI 10.1128/MCB.00832-06; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hagiwara Y, 1997, P NATL ACAD SCI USA, V94, P9249, DOI 10.1073/pnas.94.17.9249; Hao SZ, 2005, SCIENCE, V307, P1776, DOI 10.1126/science.1104882; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; HOLM L, 1994, PROTEINS, V19, P165, DOI 10.1002/prot.340190302; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; Kandl KA, 2002, MOL GENET GENOMICS, V268, P10, DOI 10.1007/s00438-002-0726-x; Kang N, 2008, CELL MOL IMMUNOL, V5, P333, DOI 10.1038/cmi.2008.41; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kubota H, 2001, J BIOL CHEM, V276, P17591, DOI 10.1074/jbc.M011793200; Kubota H, 2000, J BIOL CHEM, V275, P20243, DOI 10.1074/jbc.C000262200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Marton MJ, 1997, MOL CELL BIOL, V17, P4474, DOI 10.1128/MCB.17.8.4474; MARTON MJ, 1993, MOL CELL BIOL, V13, P3541, DOI 10.1128/MCB.13.6.3541; Maurin AC, 2005, CELL METAB, V1, P273, DOI 10.1016/j.cmet.2005.03.004; MULHOLLAND J, 1994, J CELL BIOL, V125, P381, DOI 10.1083/jcb.125.2.381; MUNN A, 2009, AUST BIOCH, V40, P9; Munshi R, 2001, GENETICS, V157, P1425; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nameki N, 2004, PROTEIN SCI, V13, P2089, DOI 10.1110/ps.04751804; Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8; Park F, 2004, PROTEINS, V55, P775, DOI 10.1002/prot.20087; Pereira CM, 2005, J BIOL CHEM, V280, P28316, DOI 10.1074/jbc.M408571200; Pittman YR, 2009, J BIOL CHEM, V284, P4739, DOI 10.1074/jbc.M807945200; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sattlegger E, 2000, EMBO J, V19, P6622, DOI 10.1093/emboj/19.23.6622; Sattlegger E, 2005, J BIOL CHEM, V280, P16514, DOI 10.1074/jbc.M414566200; Sattlegger E, 2004, J BIOL CHEM, V279, P29952, DOI 10.1074/jbc.M404009200; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Wout PK, 2009, EUKARYOT CELL, V8, P1061, DOI 10.1128/EC.00356-08	53	24	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10341	10355		10.1074/jbc.M110.171587	http://dx.doi.org/10.1074/jbc.M110.171587			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21239490	hybrid, Green Published			2022-12-27	WOS:000288547000051
J	Yang, YK; Qu, H; Gao, D; Di, W; Chen, HW; Guo, X; Zhai, ZH; Chen, DY				Yang, Yong-Kang; Qu, Hong; Gao, Dong; Di, Wei; Chen, Hai-Wei; Guo, Xin; Zhai, Zhong-He; Chen, Dan-Ying			ARF-like Protein 16 (ARL16) Inhibits RIG-I by Binding with Its C-terminal Domain in a GTP-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEGATIVE FEEDBACK-REGULATION; E3 UBIQUITIN LIGASE; NF-KAPPA-B; ADAPTER PROTEIN; SWISS-MODEL; ENDOPLASMIC-RETICULUM; RNA HELICASE; FAMILY; RECOGNITION; REGULATOR	Retinoic acid-inducible gene I (RIG-I) recognizes RNA virus-derived nucleic acids, which leads to the production of type I interferon (IFN) in most cell types. Tight regulation of RIG-I activity is important to prevent ultra-immune responses. In this study, we identified an ARF-like (ARL) family member, ARL16, as a protein that interacts with RIG-I. Overexpression of ARL16, but not its homologous proteins ARL1 and ARF1, inhibited RIG-I-mediated downstream signaling and antiviral activity. Knockdown of endogenous ARL16 by RNAi potentiated Sendai virus-induced IFN-beta expression and vesicular stomatitis virus replication. ARL16 interacted with the C-terminal domain (CTD) of RIG-I to suppress the association between RIG-I and RNA. ARL16 (T37N) and ARL16 Delta 45-54, which were restricted to the GTP-disassociated form, did not interact with RIG-I and also lost the inhibitory function. Furthermore, we suggest that endogenous ARL16 changes to GTP binding status upon viral infection and binds with the RIG-I CTD to negatively control its signaling activity. These findings suggested a novel innate immune function for an ARL family member, and a GTP-dependent model in which RIG-I is regulated.	[Yang, Yong-Kang; Qu, Hong; Gao, Dong; Di, Wei; Chen, Hai-Wei; Zhai, Zhong-He; Chen, Dan-Ying] Peking Univ, Coll Life Sci, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China; [Guo, Xin] China Agr Univ, Key Lab Zoonosis, Minist Agr, Beijing 100083, Peoples R China	Peking University; China Agricultural University; Ministry of Agriculture & Rural Affairs	Chen, DY (corresponding author), Peking Univ, Coll Life Sci, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China.	dychen@pku.edu.cn	YANG, YONGKANG/AEP-2772-2022	YANG, YONGKANG/0000-0002-0333-7712; Gao, Dong/0000-0003-1821-2741	National Natural Science Foundation of China [30421004, 30871288]; China 973 Program [2010CB911801]; Foundation for Authors of National Excellent Doctoral Dissertations of PR China; National Key Technology RD Program [2008BAI64B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China 973 Program(National Basic Research Program of China); Foundation for Authors of National Excellent Doctoral Dissertations of PR China; National Key Technology RD Program(National Key Technology R&D Program)	This work was supported by the National Natural Science Foundation of China (30421004 and 30871288), the China 973 Program (2010CB911801), the Foundation for Authors of National Excellent Doctoral Dissertations of PR China, and the National Key Technology R&D Program (2008BAI64B01).	Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; Burd CG, 2004, TRENDS CELL BIOL, V14, P687, DOI 10.1016/j.tcb.2004.10.004; Chen R, 2010, CELL RES, V20, P802, DOI 10.1038/cr.2010.41; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; DASCHER C, 1994, J BIOL CHEM, V269, P1437; Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gack MU, 2010, J VIROL, V84, P3220, DOI 10.1128/JVI.02241-09; Gao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005760; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hofmann I, 2006, J CELL SCI, V119, P1494, DOI 10.1242/jcs.02958; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Kahn RA, 2005, BIOCHEM SOC T, V33, P1269, DOI 10.1042/BST0331269; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07; Klassen MP, 2010, NEURON, V66, P710, DOI 10.1016/j.neuron.2010.04.033; Li S, 2010, J BIOL CHEM, V285, P4291, DOI 10.1074/jbc.M109.074971; Li Y, 2009, P NATL ACAD SCI USA, V106, P7945, DOI 10.1073/pnas.0900818106; Li YJ, 2010, J CELL BIOL, V189, P1039, DOI 10.1083/jcb.200912001; Lin CY, 2000, J BIOL CHEM, V275, P37815, DOI 10.1074/jbc.M002470200; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Lu L, 2001, J CELL SCI, V114, P4543; Mankouri J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000778; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mi ZQ, 2010, PROTEIN CELL, V1, P275, DOI 10.1007/s13238-010-0030-1; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Munro S, 2005, BIOCHEM SOC T, V33, P601, DOI 10.1042/BST0330601; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Nistal-Villan E, 2010, J BIOL CHEM, V285, P20252, DOI 10.1074/jbc.M109.089912; O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044; Oshiumi H, 2009, J BIOL CHEM, V284, P807, DOI 10.1074/jbc.M804259200; Panic B, 2003, MOL CELL, V12, P863, DOI 10.1016/S1097-2765(03)00356-3; Pasqualato S, 2002, EMBO REP, V3, P1035, DOI 10.1093/embo-reports/kvf221; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Steinborn K, 2002, GENE DEV, V16, P959, DOI 10.1101/gad.221702; Sun ZG, 2011, J VIROL, V85, P1036, DOI 10.1128/JVI.01734-10; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Wang YY, 2004, FEBS LETT, V576, P86, DOI 10.1016/j.febslet.2004.08.071; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhang M, 2008, CELL RES, V18, P1096, DOI 10.1038/cr.2008.277; Zhang XX, 2000, MICROB PATHOGENESIS, V28, P267, DOI 10.1006/mpat.1999.0349; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong B, 2010, J IMMUNOL, V184, P6249, DOI 10.4049/jimmunol.0903748	65	18	18	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10568	10580		10.1074/jbc.M110.206896	http://dx.doi.org/10.1074/jbc.M110.206896			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21233210	Green Published, hybrid			2022-12-27	WOS:000288547000072
J	Song, QJ; Pallikkuth, S; Bossuyt, J; Bers, DM; Robia, SL				Song, Qiujing; Pallikkuth, Sandeep; Bossuyt, Julie; Bers, Donald M.; Robia, Seth L.			Phosphomimetic Mutations Enhance Oligomerization of Phospholemman and Modulate Its Interaction with the Na/K-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; FLUORESCENCE FLUCTUATION SPECTROSCOPY; BETA-ADRENERGIC STIMULATION; PHOTON-COUNTING HISTOGRAM; RAT CARDIAC MYOCYTES; PROTEIN-KINASE-C; PHOSPHOLAMBAN OLIGOMERIZATION; CONFORMATIONAL-CHANGES; PUMP REGULATION; LIVING CELLS	Na/K-ATPase (NKA) activity is dynamically regulated by an inhibitory interaction with a small transmembrane protein, phospholemman (PLM). Inhibition is relieved upon PLM phosphorylation. Phosphorylation may alter how PLM interacts with NKA and/or itself, but details of these interactions are unknown. To address this, we quantified FRET between PLM and its regulatory target NKA in live cells. Phosphorylation of PLM was mimicked by mutation S63E (PKC site), S68E (PKA/PKC site), or S63E/S68E. The dependence of FRET on protein expression in live cells yielded information about the structure and binding affinity of the PLM-NKA regulatory complex. PLM phosphomimetic mutations altered the quaternary structure of the regulatory complex and reduced the apparent affinity of the PLM-NKA interaction. The latter effect was likely due to increased oligomerization of PLM phosphomimetic mutants, as suggested by PLM-PLM FRET measurements. Distance constraints obtained by FRET suggest that phosphomimetic mutations slightly alter the oligomer quaternary conformation. Photon-counting histogram measurements revealed that the major PLM oligomeric species is a tetramer. We conclude that phosphorylation of PLM increases its oligomerization into tetramers, decreases its binding to NKA, and alters the structures of both the tetramer and NKA regulatory complex.	[Song, Qiujing; Pallikkuth, Sandeep; Robia, Seth L.] Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 60153 USA; [Bossuyt, Julie; Bers, Donald M.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA	Loyola University Chicago; University of California System; University of California Davis	Robia, SL (corresponding author), Loyola Univ Chicago, Dept Cell & Mol Physiol, 2160 S 1st Ave, Maywood, IL 60153 USA.	srobia@lumc.edu	Bers, Donald M/C-4507-2012	Bers, Donald/0000-0002-2237-9483; Bossuyt, Julie/0000-0001-8874-4765	National Institutes of Health [HL092321, EB006061]; American Heart Association [0720098Z]; McCormick Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL030077, R01HL092321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K01EB006061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); McCormick Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grants HL092321 and EB006061 (to S. L. R.). This work was also supported by American Heart Association Fellowship 0720098Z (to Q. S.) and the McCormick Foundation (to the Department of Cell and Molecular Physiology Multiphoton Imaging Facility).	Beevers AJ, 2006, PROTEIN SCI, V15, P1127, DOI 10.1110/ps.051899406; Beevers AJ, 2007, J BIOL CHEM, V282, P32742, DOI 10.1074/jbc.M703676200; Bell JR, 2008, AM J PHYSIOL-HEART C, V294, pH613, DOI 10.1152/ajpheart.01332.2007; BERS DM, 2002, EXCITATION CONTRACTI, P90; Bers DM, 2009, TRENDS CARDIOVAS MED, V19, P111, DOI 10.1016/j.tcm.2009.07.001; Bossuyt J, 2006, J BIOL CHEM, V281, P32765, DOI 10.1074/jbc.M606254200; Bossuyt J, 2009, J BIOL CHEM, V284, P26749, DOI 10.1074/jbc.M109.047357; Chen Y, 2003, P NATL ACAD SCI USA, V100, P15492, DOI 10.1073/pnas.2533045100; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; COLVIN RA, 1985, BIOCHIM BIOPHYS ACTA, V812, P601, DOI 10.1016/0005-2736(85)90253-6; Cornea RL, 1997, BIOCHEMISTRY-US, V36, P2960, DOI 10.1021/bi961955q; Cornelius F, 2003, ANN NY ACAD SCI, V986, P579, DOI 10.1111/j.1749-6632.2003.tb07256.x; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Despa S, 2005, CIRC RES, V97, P252, DOI 10.1161/01.RES.0000176532.97731.e5; Despa S, 2008, CIRCULATION, V117, P1849, DOI 10.1161/CIRCULATIONAHA.107.754051; Dobretsov M, 1998, J PHYSIOL-LONDON, V507, P527, DOI 10.1111/j.1469-7793.1998.527bt.x; Faller LD, 2008, ARCH BIOCHEM BIOPHYS, V476, P12, DOI 10.1016/j.abb.2008.05.017; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Franzin CM, 2007, J BIOENERG BIOMEMBR, V39, P379, DOI 10.1007/s10863-007-9105-y; Fuller W, 2009, AM J PHYSIOL-CELL PH, V296, pC1346, DOI 10.1152/ajpcell.00523.2008; Han F, 2006, CIRC RES, V99, P1376, DOI 10.1161/01.RES.0000251667.73461.fb; Hou ZJ, 2008, J BIOL CHEM, V283, P28996, DOI 10.1074/jbc.M804782200; Hou ZJ, 2010, J MOL BIOL, V402, P210, DOI 10.1016/j.jmb.2010.07.023; Karasawa A, 2005, J BIOL CHEM, V280, P41900, DOI 10.1074/jbc.M510795200; Kelly EM, 2008, J BIOL CHEM, V283, P12202, DOI 10.1074/jbc.M707590200; Li M, 1999, BIOPHYS J, V76, P2587, DOI 10.1016/S0006-3495(99)77411-4; Lingrel JB, 2010, ANNU REV PHYSIOL, V72, P395, DOI 10.1146/annurev-physiol-021909-135725; Marcaggi P, 2009, P NATL ACAD SCI USA, V106, P11388, DOI 10.1073/pnas.0901290106; Muller JD, 2000, BIOPHYS J, V78, P474, DOI 10.1016/S0006-3495(00)76610-0; Papadopoulos S, 2004, J BIOL CHEM, V279, P44046, DOI 10.1074/jbc.M405317200; Robia SL, 2005, BIOCHEMISTRY-US, V44, P4302, DOI 10.1021/bi0478446; Shattock MJ, 2009, CURR OPIN PHARMACOL, V9, P160, DOI 10.1016/j.coph.2008.12.015; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Teriete P, 2007, BIOCHEMISTRY-US, V46, P6774, DOI 10.1021/bi700391b; Teriete P, 2009, BBA-BIOMEMBRANES, V1788, P2462, DOI 10.1016/j.bbamem.2009.09.001; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Toyoshima C, 2003, P NATL ACAD SCI USA, V100, P467, DOI 10.1073/pnas.0237326100; Traaseth NJ, 2007, P NATL ACAD SCI USA, V104, P14676, DOI 10.1073/pnas.0701016104; Verdonck F, 2003, J MOL CELL CARDIOL, V35, P5, DOI 10.1016/S0022-2828(02)00280-8; Wong A, 2008, SOLID STATE NUCL MAG, V33, P72, DOI 10.1016/j.ssnmr.2008.04.003; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	41	26	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9120	9126		10.1074/jbc.M110.198036	http://dx.doi.org/10.1074/jbc.M110.198036			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21220422	Green Published, hybrid			2022-12-27	WOS:000288247700042
J	Britt, RL; Chitteni-Pattu, S; Page, AN; Cox, MM				Britt, Rachel L.; Chitteni-Pattu, Sindhu; Page, Asher N.; Cox, Michael M.			RecA K72R Filament Formation Defects Reveal an Oligomeric RecA Species Involved in Filament Extension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; DEPENDENT ATPASE ACTIVITY; ESCHERICHIA-COLI UVRB; DUPLEX DNA; NUCLEOSIDE TRIPHOSPHATE; STABLE COMPLEXES; IN-VIVO; PROTEIN; BINDING; HYDROLYSIS	Using an ensemble approach, we demonstrate that an oligomeric RecA species is required for the extension phase of RecA filament formation. The RecA K72R mutant protein can bind but not hydrolyze ATP or dATP. When mixed with other RecA variants, RecA K72R causes a drop in the rate of ATP hydrolysis and has been used to study disassembly of hydrolysis-proficient RecA protein filaments. RecA K72R filaments do not form in the presence of ATP but do so when dATP is provided. We demonstrate that in the presence of ATP, RecA K72R is defective for extension of RecA filaments on DNA. This defect is partially rescued when the mutant protein is mixed with sufficient levels of wild type RecA protein. Functional extension complexes form most readily when wild type RecA is in excess of RecA K72R. Thus, RecA K72R inhibits hydrolysis-proficient RecA proteins by interacting with them in solution and preventing the extension phase of filament assembly.	[Britt, Rachel L.; Chitteni-Pattu, Sindhu; Page, Asher N.; Cox, Michael M.] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Cox, MM (corresponding author), Univ Wisconsin, Dept Biochem, 433 Babcock Dr, Madison, WI 53706 USA.	cox@biochem.wisc.edu			National Institutes of Health [GM32335]; William R. and Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032335, U01GM032335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); William R. and Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM32335.; Supported in part by the William R. and Dorothy E. Sullivan Wisconsin Distinguished Graduate Fellowship.	Arenson TA, 1999, J MOL BIOL, V288, P391, DOI 10.1006/jmbi.1999.2705; Bindslev N., 2008, DRUG ACCEPTOR INTERA; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; Bork JM, 2001, J BIOL CHEM, V276, P45740, DOI 10.1074/jbc.M109247200; Brendel V, 1997, J MOL EVOL, V44, P528, DOI 10.1007/PL00006177; BRENNER SL, 1987, J BIOL CHEM, V262, P4011; Britt RL, 2010, J BIOL CHEM, V285, P3211, DOI 10.1074/jbc.M109.028951; Campbell MJ, 1999, J MOL BIOL, V286, P437, DOI 10.1006/jmbi.1998.2457; Campbell MJ, 1999, J MOL BIOL, V286, P417, DOI 10.1006/jmbi.1998.2456; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; Cox JM, 2006, J BIOL CHEM, V281, P12968, DOI 10.1074/jbc.M513736200; Cox JM, 2005, PLOS BIOL, V3, P231, DOI 10.1371/journal.pbio.0030052; Cox Michael M., 2005, P369; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; COX MM, 1981, P NATL ACAD SCI-BIOL, V78, P3433, DOI 10.1073/pnas.78.6.3433; COX MM, 1982, J BIOL CHEM, V257, P8523; CRAIG NL, 1981, J BIOL CHEM, V256, P8039; DOMBROSKI AJ, 1988, J BIOL CHEM, V263, P18802; Drees JC, 2004, MOL CELL, V15, P789, DOI 10.1016/j.molcel.2004.08.026; EGELMAN EH, 1986, J MOL BIOL, V191, P677, DOI 10.1016/0022-2836(86)90453-5; Eggler AL, 2003, J BIOL CHEM, V278, P16389, DOI 10.1074/jbc.M212920200; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Gruenig MC, 2008, MOL MICROBIOL, V69, P1165, DOI 10.1111/j.1365-2958.2008.06341.x; Haruta N, 2003, J BIOL CHEM, V278, P52710, DOI 10.1074/jbc.M308563200; HEUSER J, 1989, J MOL BIOL, V210, P473, DOI 10.1016/0022-2836(89)90124-1; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P97, DOI 10.1016/0022-2836(87)90630-9; KOWALCZYKOWSKI SC, 1987, P NATL ACAD SCI USA, V84, P3127, DOI 10.1073/pnas.84.10.3127; LAVERY PE, 1992, J BIOL CHEM, V267, P20648; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; LOHMAN TM, 1986, BIOCHEMISTRY-US, V25, P21, DOI 10.1021/bi00349a004; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Lusetti SL, 2003, J BIOL CHEM, V278, P16372, DOI 10.1074/jbc.M212917200; MENETSKI JP, 1989, BIOCHEMISTRY-US, V28, P5871, DOI 10.1021/bi00440a025; MENETSKI JP, 1985, J MOL BIOL, V181, P281, DOI 10.1016/0022-2836(85)90092-0; MENETSKI JP, 1987, J BIOL CHEM, V262, P2093; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; MYLES GM, 1991, BIOCHEMISTRY-US, V30, P3824, DOI 10.1021/bi00230a004; OGAWA T, 1993, SCIENCE, V259, P1896, DOI 10.1126/science.8456314; Petrova V, 2009, MOL CELL, V36, P121, DOI 10.1016/j.molcel.2009.07.026; PUGH BF, 1988, J MOL BIOL, V203, P479, DOI 10.1016/0022-2836(88)90014-9; PUGH BF, 1987, J BIOL CHEM, V262, P1326; REGISTER JC, 1985, J BIOL CHEM, V260, P2308; REHRAUER WM, 1993, J BIOL CHEM, V268, P1292; Renzette N, 2008, MOL MICROBIOL, V67, P1347, DOI 10.1111/j.1365-2958.2008.06130.x; Roca AI, 1997, PROG NUCLEIC ACID RE, V56, P129, DOI 10.1016/S0079-6603(08)61005-3; SEELEY TW, 1990, J BIOL CHEM, V265, P7158; SEELEY TW, 1989, P NATL ACAD SCI USA, V86, P6577, DOI 10.1073/pnas.86.17.6577; Seitz EM, 1998, GENE DEV, V12, P1248, DOI 10.1101/gad.12.9.1248; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; Shan Q, 1997, J BIOL CHEM, V272, P11063; Shan Q, 1996, J BIOL CHEM, V271, P5712, DOI 10.1074/jbc.271.10.5712; Shan Q, 1996, J MOL BIOL, V257, P756, DOI 10.1006/jmbi.1996.0200; Shinohara A, 1997, GENES CELLS, V2, P615, DOI 10.1046/j.1365-2443.1997.1480347.x; STASIAK A, 1981, J MOL BIOL, V151, P557, DOI 10.1016/0022-2836(81)90010-3; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; SUNG P, 1988, EMBO J, V7, P3263, DOI 10.1002/j.1460-2075.1988.tb03193.x; TAKAHASHI M, 1989, J BIOL CHEM, V264, P288; THRESHER RJ, 1988, J MOL BIOL, V201, P101, DOI 10.1016/0022-2836(88)90442-1; van Loenhout MTJ, 2009, NUCLEIC ACIDS RES, V37, P4089, DOI 10.1093/nar/gkp326; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WITKIN EM, 1982, MOL GEN GENET, V185, P43, DOI 10.1007/BF00333788	65	9	9	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7830	7840		10.1074/jbc.M110.194407	http://dx.doi.org/10.1074/jbc.M110.194407			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21193798	Green Published, hybrid			2022-12-27	WOS:000288013300014
J	Hassan, BH; Cronan, JE				Hassan, Bachar H.; Cronan, John E.			Protein-Protein Interactions in Assembly of Lipoic Acid on the 2-Oxoacid Dehydrogenases of Aerobic Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; MULTI-ENZYME COMPLEX; ESCHERICHIA-COLI; POSTTRANSLATIONAL MODIFICATION; THERMOPLASMA-ACIDOPHILUM; MULTIENZYME COMPLEXES; OCTANOYL SUBSTRATE; REACTION-MECHANISM; MOLECULAR-CLONING; ELEMENTARY STEPS	Lipoic acid is a covalently attached cofactor essential for the activity of 2-oxoacid dehydrogenases and the glycine cleavage system. In the absence of lipoic acid modification, the dehydrogenases are inactive, and aerobic metabolism is blocked. In Escherichia coli, two pathways for the attachment of lipoic acid exist, a de novo biosynthetic pathway dependent on the activities of the LipB and LipA proteins and a lipoic acid scavenging pathway catalyzed by the LplA protein. LipB is responsible for octanoylation of the E2 components of 2-oxoacid dehydrogenases to provide the substrates of LipA, an S-adenosyl-L-methionine radical enzyme that inserts two sulfur atoms into the octanoyl moiety to give the active lipoylated dehydrogenase complexes. We report that the intact pyruvate and 2-oxoglutarate dehydrogenase complexes specifically copurify with both LipB and LipA. Proteomic, genetic, and dehydrogenase activity data indicate that all of the 2-oxoacid dehydrogenase components are present. In contrast, LplA, the lipoate protein ligase enzyme of lipoate salvage, shows no interaction with the 2-oxoacid dehydrogenases. The interaction is specific to the dehydrogenases in that the third lipoic acid-requiring enzyme of Escherichia coli, the glycine cleavage system H protein, does not copurify with either LipA or LipB. Studies of LipB interaction with engineered variants of the E2 subunit of 2-oxoglutarate dehydrogenase indicate that binding sites for LipB reside both in the lipoyl domain and catalytic core sequences. We also report that LipB forms a very tight, albeit noncovalent, complex with acyl carrier protein. These results indicate that lipoic acid is not only assembled on the dehydrogenase lipoyl domains but that the enzymes that catalyze the assembly are also present "on site."	[Cronan, John E.] Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, Urbana, IL 61801 USA; [Hassan, Bachar H.; Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, Chem & Life Sci Lab B103, 601 S Goodwin Ave, Urbana, IL 61801 USA.	j-cronan@life.uiuc.edu	Cronan, John/V-6626-2019		National Institutes of Health, NIAID [AI15650]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI015650, R01AI015650] Funding Source: NIH RePORTER	National Institutes of Health, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI15650 from the NIAID.	AKIYAMA SK, 1980, BIOCHEMISTRY-US, V19, P4208, DOI 10.1021/bi00559a011; AKIYAMA SK, 1981, BIOCHEMISTRY-US, V20, P1491, DOI 10.1021/bi00509a013; ALI ST, 1990, MOL MICROBIOL, V4, P943, DOI 10.1111/j.1365-2958.1990.tb00667.x; ALI ST, 1990, BIOCHEM J, V271, P139, DOI 10.1042/bj2710139; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bryant P, 2006, ANAL BIOCHEM, V351, P44, DOI 10.1016/j.ab.2006.01.023; Busby RW, 1999, J AM CHEM SOC, V121, P4706, DOI 10.1021/ja990134g; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; CHANG YY, 1988, J BACTERIOL, V170, P3937, DOI 10.1128/jb.170.9.3937-3945.1988; Christensen QH, 2010, BIOCHEMISTRY-US, V49, P10024, DOI 10.1021/bi101215f; Christensen QH, 2009, J BIOL CHEM, V284, P21317, DOI 10.1074/jbc.M109.015016; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; Cicchillo RM, 2005, J AM CHEM SOC, V127, P2860, DOI 10.1021/ja042428u; Dennis JJ, 1998, BIOTECHNIQUES, V25, P772, DOI 10.2144/98255bm04; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; Douglas P, 2006, ANGEW CHEM INT EDIT, V45, P5197, DOI 10.1002/anie.200601910; GREEN DE, 1995, BIOCHEM J, V309, P853, DOI 10.1042/bj3090853; GUEST JR, 1973, J GEN MICROBIOL, V75, P197, DOI 10.1099/00221287-75-1-197; GUEST JR, 1985, J MOL BIOL, V185, P743, DOI 10.1016/0022-2836(85)90059-2; Iram SH, 2006, J BACTERIOL, V188, P599, DOI 10.1128/JB.188.2.599-608.2006; Jordan SW, 1997, METHOD ENZYMOL, V279, P176; Jordan SW, 1997, J BIOL CHEM, V272, P17903, DOI 10.1074/jbc.272.29.17903; Lengyel JS, 2008, STRUCTURE, V16, P93, DOI 10.1016/j.str.2007.10.017; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Ma QJ, 2006, P NATL ACAD SCI USA, V103, P8662, DOI 10.1073/pnas.0510436103; McManus E, 2006, J MOL BIOL, V356, P625, DOI 10.1016/j.jmb.2005.11.057; Miller JR, 2000, BIOCHEMISTRY-US, V39, P15166, DOI 10.1021/bi002060n; MORRIS TW, 1995, J BACTERIOL, V177, P1; MORRIS TW, 1994, J BIOL CHEM, V269, P16091; Nesbitt NM, 2005, PROTEIN EXPRES PURIF, V39, P269, DOI 10.1016/j.pep.2004.10.021; PACKMAN LC, 1991, BIOCHEM J, V277, P153, DOI 10.1042/bj2770153; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; PERHAM RN, 1991, BIOCHEMISTRY-US, V30, P8501, DOI 10.1021/bi00099a001; Phillips GJ, 2000, BIOTECHNIQUES, V28, P400, DOI 10.2144/00283bm02; PRATT KJ, 1989, BIOCHEM J, V258, P749, DOI 10.1042/bj2580749; REED KE, 1993, J BACTERIOL, V175, P1325, DOI 10.1128/JB.175.5.1325-1336.1993; SMITH MW, 1983, J BACTERIOL, V156, P81, DOI 10.1128/JB.156.1.81-88.1983; Stadtman E., 1954, MECHANISM ENZYME ACT, P581; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; VANAMAN TC, 1968, J BIOL CHEM, V243, P6409; VANAMAN TC, 1968, J BIOL CHEM, V243, P6420; VANDENBOOM TJ, 1991, J BACTERIOL, V173, P6411, DOI 10.1128/jb.173.20.6411-6420.1991; Worrall JAR, 2008, J MOL BIOL, V382, P870, DOI 10.1016/j.jmb.2008.07.059; Wycuff DR, 2000, ANAL BIOCHEM, V277, P67, DOI 10.1006/abio.1999.4385; Zhao X, 2005, BIOCHEMISTRY-US, V44, P16737, DOI 10.1021/bi051865y; Zhao X, 2003, CHEM BIOL, V10, P1293, DOI 10.1016/j.chembiol.2003.11.016	46	20	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8263	8276		10.1074/jbc.M110.194191	http://dx.doi.org/10.1074/jbc.M110.194191			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21209092	Green Published, hybrid			2022-12-27	WOS:000288013300056
J	Jrad-Lamine, A; Henry-Berger, J; Gourbeyre, P; Damon-Soubeyrand, C; Lenoir, A; Combaret, L; Saez, F; Kocer, A; Tone, S; Fuchs, D; Zhu, WT; Oefner, PJ; Munn, DH; Mellor, AL; Gharbi, N; Cadet, R; Aitken, RJ; Drevet, JR				Jrad-Lamine, Aicha; Henry-Berger, Joelle; Gourbeyre, Pascal; Damon-Soubeyrand, Christelle; Lenoir, Alain; Combaret, Lydie; Saez, Fabrice; Kocer, Ayhan; Tone, Shigenobu; Fuchs, Dietmar; Zhu, Wentao; Oefner, Peter J.; Munn, David H.; Mellor, Andrew L.; Gharbi, Najoua; Cadet, Remi; Aitken, R. John; Drevet, Joel R.			Deficient Tryptophan Catabolism along the Kynurenine Pathway Reveals That the Epididymis Is in a Unique Tolerogenic State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDOLEAMINE 2,3-DIOXYGENASE; DENDRITIC CELLS; DEPENDENT PROTEOLYSIS; UBIQUITIN-PROTEASOME; EXPRESSION; INHIBITION; IDO; DEGRADATION; SUPPRESSION; TOLERANCE	Indoleamine 2,3-dioxygenase (IDO) is the first and rate-limiting enzyme of tryptophan catabolism through the kynurenine pathway. Intriguingly, IDO is constitutively and highly expressed in the mammalian epididymis in contrast to most other tissues where IDO is induced by proinflammatory cytokines, such as interferons. To gain insight into the role of IDO in the physiology of the mammalian epididymis, we studied both wild type and Ido1(-/-)-deficient mice. In the caput epididymis of Ido1(-/-) animals, the lack of IDO activity was not compensated by other tryptophan-catabolizing enzymes and led to the loss of kynurenine production. The absence of IDO generated an inflammatory state in the caput epididymis as revealed by an increased accumulation of various inflammation markers. The absence of IDO also increased the tryptophan content of the caput epididymis and generated a parallel increase in caput epididymal protein content as a consequence of deficient proteasomal activity. Surprisingly, the lack of IDO expression had no noticeable impact on overall male fertility but did induce highly significant increases in both the number and the percentage of abnormal spermatozoa. These changes coincided with a significant decrease in white blood cell count in epididymal fluid compared with wild type mice. These data provide support for IDO playing a hitherto unsuspected role in sperm quality control in the epididymis involving the ubiquitination of defective spermatozoa and their subsequent removal.	[Jrad-Lamine, Aicha; Henry-Berger, Joelle; Damon-Soubeyrand, Christelle; Lenoir, Alain; Saez, Fabrice; Kocer, Ayhan; Cadet, Remi; Drevet, Joel R.] Clermont Univ, CNRS UMR 6247, INSERM U931, GReD, F-63171 Aubiere, France; [Gourbeyre, Pascal] INRA, Biopolymeres Interact Assemblages, F-44316 Nantes, France; [Combaret, Lydie] Univ Clermont Ferrand 2, Unite Nutr Humaine, F-63000 Clermont Ferrand, France; [Combaret, Lydie] CRNH Auvergne, UNH, UMR 1019, Inst Natl Rech Agron, F-63000 Clermont Ferrand, France; [Tone, Shigenobu] Kawasaki Med Sch, Dept Biochem, Okayama 7010192, Japan; [Fuchs, Dietmar] Innsbruck Med Univ, Bioctr, Div Biol Chem, A-6020 Innsbruck, Austria; [Zhu, Wentao; Oefner, Peter J.] Univ Regensburg, Inst Funct Genom, D-93053 Regensburg, Germany; [Munn, David H.; Mellor, Andrew L.] Med Coll Georgia, Immunotherapy Ctr, Augusta, GA 30912 USA; [Munn, David H.] Med Coll Georgia, Dept Pediat, Augusta, GA 30912 USA; [Mellor, Andrew L.] Med Coll Georgia, Dept Med, Augusta, GA 30912 USA; [Gharbi, Najoua] Univ Tunis El Manar, Dept Biol, Fac Sci Tunis, Tunis 1060, Tunisia; [Aitken, R. John] Univ Newcastle, Sch Environm & Life Sci, Australian Res Council Ctr Excellence Biotechnol, Callaghan, NSW 2308, Australia	Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Universite Clermont Auvergne (UCA); INRAE; Kawasaki Medical School; Medical University of Innsbruck; University of Regensburg; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); University of Newcastle	Drevet, JR (corresponding author), Clermont Univ, CNRS UMR 6247, INSERM U931, GReD, 24 Ave Landais,BP 80026, F-63171 Aubiere, France.	joel.drevet@univ-bpclermont.fr	Fuchs, Dietmar/AAL-8011-2021; Aitken, Robert John/AAY-8238-2020; Kocer, Ayhan/N-7927-2014; Zhu, Wentao/O-8964-2019; Drevet, Joël/W-2692-2019; Tone, Shigenobu/L-2694-2019	Fuchs, Dietmar/0000-0003-1627-9563; Aitken, Robert John/0000-0002-9152-156X; Zhu, Wentao/0000-0001-6371-7998; Drevet, Joël/0000-0003-3077-6558; Combaret, Lydie/0000-0001-6550-8700; Munn, David/0000-0002-7711-2858	French Ministry of Higher Education; CNRS; INSERM; BayGene; Australian Research Council	French Ministry of Higher Education; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); BayGene; Australian Research Council(Australian Research Council)	This work was supported by grants from the French Ministry of Higher Education, CNRS, and INSERM (to J. R. D.). This work was also supported by grants from BayGene (to P. J. O.) and the Australian Research Council (to R. J. A.).	Avruch J, 2001, Prog Mol Subcell Biol, V26, P115; Axner E, 2006, THERIOGENOLOGY, V66, P14, DOI 10.1016/j.theriogenology.2006.03.022; Baban B, 2004, J REPROD IMMUNOL, V61, P67, DOI 10.1016/j.jri.2003.11.003; Ball HJ, 2009, INT J BIOCHEM CELL B, V41, P467, DOI 10.1016/j.biocel.2008.01.005; Ball HJ, 2007, GENE, V396, P203, DOI 10.1016/j.gene.2007.04.010; Baska KM, 2008, J CELL PHYSIOL, V215, P684, DOI 10.1002/jcp.21349; Belladonna ML, 2009, TRENDS MOL MED, V15, P41, DOI 10.1016/j.molmed.2008.11.006; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Beutelspacher SC, 2006, AM J TRANSPLANT, V6, P1320, DOI 10.1111/j.1600-6143.2006.01324.x; Britan A, 2006, CELL TISSUE RES, V324, P301, DOI 10.1007/s00441-005-0151-7; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Combaret L, 2005, J PHYSIOL-LONDON, V569, P489, DOI 10.1113/jphysiol.2005.098004; Deretic V, 2006, CURR OPIN IMMUNOL, V18, P375, DOI 10.1016/j.coi.2006.05.019; Dominguez K, 2009, SYST BIOL REPROD MED, V55, P193, DOI 10.3109/19396360903234052; Dufaure JP, 1996, CR ACAD SCI III-VIE, V319, P559; Favre D., 2010, TRANSL MED, V32, P32; Fissolo N, 2008, EUR J IMMUNOL, V38, P2401, DOI 10.1002/eji.200838413; Hamel FG, 2003, METABOLISM, V52, P810, DOI 10.1016/S0026-0495(03)00094-5; Hariri M, 2000, MOL BIOL CELL, V11, P255, DOI 10.1091/mbc.11.1.255; Hwu P, 2000, J IMMUNOL, V164, P3596, DOI 10.4049/jimmunol.164.7.3596; Itoh M, 2005, J REPROD IMMUNOL, V67, P57, DOI 10.1016/j.jri.2005.06.007; Jalili RB, 2007, IRAN J ALLERGY ASTHM, V6, P167; Jenny M, 2009, J NEUROIMMUNOL, V207, P75, DOI 10.1016/j.jneuroim.2008.12.004; Johnston DS, 2005, BIOL REPROD, V73, P404, DOI 10.1095/biolreprod.105.039719; Jones R, 2004, BIOL REPROD, V71, P1405, DOI 10.1095/biolreprod.104.031252; Kimball S R, 2001, Prog Mol Subcell Biol, V26, P155; King NJC, 2007, INT J BIOCHEM CELL B, V39, P2167, DOI 10.1016/j.biocel.2007.01.004; Korolchuk VI, 2010, FEBS LETT, V584, P1393, DOI 10.1016/j.febslet.2009.12.047; LEFRANCOIS AM, 1993, INT J ANDROL, V16, P147, DOI 10.1111/j.1365-2605.1993.tb01168.x; Levine SJ, 2005, AM J PHYSIOL-LUNG C, V289, pL233, DOI 10.1152/ajplung.00469.2004; Liu XQ, 2009, CHINESE MED J-PEKING, V122, P3072, DOI 10.3760/cma.j.issn.0366-6999.2009.24.030; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mellor AL, 2008, NAT REV IMMUNOL, V8, P74, DOI 10.1038/nri2233; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; Rajapurohitam V, 2002, AM J PHYSIOL-ENDOC M, V282, pE739, DOI 10.1152/ajpendo.00511.2001; Saito S, 2010, AM J REPROD IMMUNOL, V63, P601, DOI 10.1111/j.1600-0897.2010.00852.x; Sutovsky P, 2003, MICROSC RES TECHNIQ, V61, P88, DOI 10.1002/jemt.10319; Takikawa O, 1999, ADV EXP MED BIOL, V467, P553; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; Vazeille E, 2008, AM J PHYSIOL-ENDOC M, V295, pE1181, DOI 10.1152/ajpendo.90532.2008; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Wang YT, 2010, NAT MED, V16, P279, DOI 10.1038/nm.2092; Xu H, 2008, IMMUNOL LETT, V121, P1, DOI 10.1016/j.imlet.2008.08.008; YOSHIDA R, 1980, ARCH BIOCHEM BIOPHYS, V203, P343, DOI 10.1016/0003-9861(80)90185-X; Zhu BT, 2010, INT J MOL MED, V25, P831, DOI 10.3892/ijmm_00000411	48	42	42	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8030	8042		10.1074/jbc.M110.172114	http://dx.doi.org/10.1074/jbc.M110.172114			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21189261	hybrid, Green Published			2022-12-27	WOS:000288013300034
J	Kouchi, Z; Igarashi, T; Shibayama, N; Inanobe, S; Sakurai, K; Yamaguchi, H; Fukuda, T; Yanagi, S; Nakamura, Y; Fukami, K				Kouchi, Zen; Igarashi, Takahiro; Shibayama, Nami; Inanobe, Shunichi; Sakurai, Kazuyuki; Yamaguchi, Hideki; Fukuda, Toshifumi; Yanagi, Shigeru; Nakamura, Yoshikazu; Fukami, Kiyoko			Phospholipase C delta 3 Regulates RhoA/Rho Kinase Signaling and Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICAL NEURONAL MIGRATION; CEREBELLAR GRANULE CELLS; RHO-ASSOCIATED KINASE; ACROSOME REACTION; C-DELTA; POLARITY; PROTEIN; UBIQUITINATION; ESTABLISHMENT; REQUIREMENT	Phospholipase C delta 3 (PLC delta 3) is a key enzyme regulating phosphoinositide metabolism; however, its physiological function remains unknown. Because PLC delta 3 is highly enriched in the cerebellum and cerebral cortex, we examined the role of PLC delta 3 in neuronal migration and outgrowth. PLC delta 3 knockdown (KD) inhibits neurite formation of cerebellar granule cells, and application of PLC delta 3KD using in utero electroporation in the developing brain results in the retardation of the radial migration of neurons in the cerebral cortex. In addition, PLC delta 3KD inhibits axon and dendrite outgrowth in primary cortical neurons. PLC delta 3KD also suppresses neurite formation of Neuro2a neuroblastoma cells induced by serum withdrawal or treatment with retinoic acid. This inhibition is released by the reintroduction of wild-type PLC delta 3. Interestingly, the H393A mutant lacking phosphatidylinositol 4,5-bisphosphate hydrolyzing activity generates supernumerary protrusions, and a constitutively active mutant promotes extensive neurite outgrowth, indicating that PLC activity is important for normal neurite outgrowth. The introduction of dominant negative RhoA (RhoA-DN) or treatment with Y-27632, a Rho kinase-specific inhibitor, rescues the neurite extension in PLC delta 3KD Neuro2a cells. Similar effects were also detected in primary cortical neurons. Furthermore, the RhoA expression level was significantly decreased by serum withdrawal or retinoic acid in control cells, although this decrease was not observed in PLC delta 3KD cells. We also found that exogenous expression of PLC delta 3 down-regulated RhoA protein, and constitutively active PLC delta 3 promotes the RhoA down-regulation more significantly than PLC delta 3 upon differentiation. These results indicate that PLC delta 3 negatively regulates RhoA expression, inhibits RhoA/Rho kinase signaling, and thereby promotes neurite extension.	[Kouchi, Zen; Igarashi, Takahiro; Shibayama, Nami; Inanobe, Shunichi; Sakurai, Kazuyuki; Yamaguchi, Hideki; Nakamura, Yoshikazu; Fukami, Kiyoko] Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignal, Tokyo 1920392, Japan; [Yamaguchi, Hideki] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Fukuda, Toshifumi; Yanagi, Shigeru] Tokyo Univ Pharm & Life Sci, Lab Mol Biochem, Tokyo 1920392, Japan	Tokyo University of Pharmacy & Life Sciences; Japan Science & Technology Agency (JST); Tokyo University of Pharmacy & Life Sciences	Fukami, K (corresponding author), Tokyo Univ Pharm & Life Sci, Lab Genome & Biosignal, 1432-1 Horinouchi, Tokyo 1920392, Japan.	kfukami@ls.toyaku.ac.jp	Yanagi, Shigeru/AAU-9513-2020; Yamaguchi, Hideki/AAP-1767-2021	Yanagi, Shigeru/0000-0002-1392-8663; Yamaguchi, Hideki/0000-0003-2125-9655; Nakamura, Yoshikazu/0000-0001-8355-1091	Japan Ministry of Education, Culture, Sports, Science and Technology	Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for young scientists (Category B to Z. K.) and for general scientific research (to K. F.) and a High-Tech Research Center Project for Private Universities matching the fund subsidy from the Japan Ministry of Education, Culture, Sports, Science and Technology.	Ahmed Z, 2009, MOL CELL NEUROSCI, V42, P128, DOI 10.1016/j.mcn.2009.06.005; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Bito H, 2000, NEURON, V26, P431, DOI 10.1016/S0896-6273(00)81175-7; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bryan B, 2005, FEBS LETT, V579, P1015, DOI 10.1016/j.febslet.2004.12.074; Choi JY, 2004, AM J PHYSIOL-CELL PH, V287, pC971, DOI 10.1152/ajpcell.00571.2003; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Cooper JA, 2008, TRENDS NEUROSCI, V31, P113, DOI 10.1016/j.tins.2007.12.003; Fukami K, 2003, J CELL BIOL, V161, P79, DOI 10.1083/jcb.200210057; Fukami K, 2001, SCIENCE, V292, P920, DOI 10.1126/science.1059042; Fukami K, 2010, PROG LIPID RES, V49, P429, DOI 10.1016/j.plipres.2010.06.001; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Ge WH, 2006, P NATL ACAD SCI USA, V103, P1319, DOI 10.1073/pnas.0510419103; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Hama H, 2004, NEURON, V41, P405, DOI 10.1016/S0896-6273(04)00007-8; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Ichinohe M, 2007, BIOCHEM BIOPH RES CO, V356, P912, DOI 10.1016/j.bbrc.2007.03.082; Irino Y, 2004, BIOCHEM BIOPH RES CO, V320, P537, DOI 10.1016/j.bbrc.2004.05.206; Kawauchi T, 2006, NAT CELL BIOL, V8, P17, DOI 10.1038/ncb1338; Kawauchi T, 2003, EMBO J, V22, P4190, DOI 10.1093/emboj/cdg413; Kouchi Z, 2005, J BIOL CHEM, V280, P21015, DOI 10.1074/jbc.M412123200; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Moon SY, 2003, J BIOL CHEM, V278, P4151, DOI 10.1074/jbc.M207789200; Nakamura Y, 2003, EMBO J, V22, P2981, DOI 10.1093/emboj/cdg302; Nakamura Y, 2008, FASEB J, V22, P841, DOI 10.1096/fj.07-9239com; Nakanishi S, 2006, J PHYSIOL-LONDON, V575, P389, DOI 10.1113/jphysiol.2006.113340; Santarius M, 2006, BIOCHEM J, V398, P1, DOI 10.1042/BJ20060565; Sato M, 2005, P NATL ACAD SCI USA, V102, P5874, DOI 10.1073/pnas.0501972102; Schwamborn JC, 2007, EMBO J, V26, P1410, DOI 10.1038/sj.emboj.7601580; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; Xie Y, 2006, J BIOL CHEM, V281, P2605, DOI 10.1074/jbc.M512767200; Yagisawa H, 2006, BBA-MOL CELL BIOL L, V1761, P522, DOI 10.1016/j.bbalip.2006.02.016; Yamazaki M, 2002, J BIOL CHEM, V277, P17226, DOI 10.1074/jbc.M109795200; Zhang Z, 2006, CELL MOL BIOL LETT, V11, P12, DOI 10.2478/s11658-006-0002-x; Zhao CT, 2009, P NATL ACAD SCI USA, V106, P21353, DOI 10.1073/pnas.0812872106	38	29	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8459	8471		10.1074/jbc.M110.171223	http://dx.doi.org/10.1074/jbc.M110.171223			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21187285	hybrid, Green Published			2022-12-27	WOS:000288013300074
J	Manickam, B; Jha, P; Matta, B; Liu, JA; Bora, PS; Bora, NS				Manickam, Balasubramanian; Jha, Purushottam; Matta, Bharati; Liu, Juan; Bora, Puran S.; Bora, Nalini S.			Inhibition of Complement Alternative Pathway Suppresses Experimental Autoimmune Anterior Uveitis by Modulating T Cell Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MELANIN-ASSOCIATED ANTIGEN; INDUCED CHOROIDAL NEOVASCULARIZATION; COLLAGEN-INDUCED ARTHRITIS; ISCHEMIA/REPERFUSION INJURY; REGULATORY PROTEINS; ADAPTIVE IMMUNITY; PRESENTING CELLS; FACTOR-B; ACTIVATION; INDUCTION	The objective of the current study was to delineate the pathway of complement activation that is crucial for the induction of experimental autoimmune anterior uveitis (EAAU). We studied the development of EAAU in melanin-associated antigen (MAA)-sensitized Lewis rats treated with antibody against C4 or factor B. Control animals received isotype IgG control. Antibody against C4 had no effect on EAAU, and all of the animals developed EAAU similar to those injected with control IgG. In contrast, EAAU was completely inhibited in all MAA-sensitized Lewis rats injected with factor B antibody. Treatment with anti-factor B antibody resulted in suppression of ocular complement activation. Adoptive transfer of T lymphocytes harvested from draining lymph nodes of donor animals treated with anti-factor B did not transfer EAAU to naive syngenic rats. Anti-factor B antibody inhibited the ability of MAA-specific CD4(+) T cells to proliferate (in vitro) in response to MAA in a dose-dependent manner. Level of TNF-alpha and IFN-gamma decreased in the presence of anti-factor B. Collectively, our results provide the novel finding that complement activation via the alternative pathway contributes to intraocular inflammation in EAAU, and anti-factor B-mediated inhibition of EAAU is due to diminished antigen-specific CD4(+) T cell responses to MAA. Our findings explain the interactions between the complement system and T cells that are critical for the induction of EAAU and may lead to the development of therapy for idiopathic anterior uveitis based on selective blockade of the alternative pathway.	[Manickam, Balasubramanian; Jha, Purushottam; Matta, Bharati; Liu, Juan; Bora, Puran S.; Bora, Nalini S.] Univ Arkansas Med Sci, Jones Eye Inst, Pat & Willard Walker Eye Res Ctr, Dept Ophthalmol, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Bora, NS (corresponding author), Univ Arkansas Med Sci, Jones Eye Inst, Pat & Willard Walker Eye Res Ctr, Dept Ophthalmol, 4301 W Markham,Mail Slot 523, Little Rock, AR 72205 USA.	nbora@uams.edu		Bora, Puran/0000-0003-4781-1217	National Institutes of Health [EY018812, EY014623]; Pat and Willard Walker Eye Research Center (Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR); NATIONAL EYE INSTITUTE [R01EY018812, R01EY014623] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pat and Willard Walker Eye Research Center (Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants EY018812 and EY014623. This work was also supported by grants from the Pat and Willard Walker Eye Research Center (Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, AR).	Abbas AK, 2003, CELLULAR MOL IMMUNOL; An FQ, 2009, INVEST OPHTH VIS SCI, V50, P3778, DOI 10.1167/iovs.08-3264; Banda NK, 2006, J IMMUNOL, V177, P1904, DOI 10.4049/jimmunol.177.3.1904; Banda NK, 2009, J IMMUNOL, V183, P5928, DOI 10.4049/jimmunol.0901826; BLOCHMICHEL E, 1987, AM J OPHTHALMOL, V103, P234, DOI 10.1016/S0002-9394(14)74235-7; Bora NS, 2008, SEMIN IMMUNOPATHOL, V30, P85, DOI 10.1007/s00281-008-0110-y; Bora Nalini S, 2007, Chem Immunol Allergy, V92, P213, DOI 10.1159/000099272; Bora NS, 2006, J IMMUNOL, V177, P1872, DOI 10.4049/jimmunol.177.3.1872; Bora NS, 2004, J IMMUNOL, V172, P7086, DOI 10.4049/jimmunol.172.11.7086; Bora NS, 1997, INVEST OPHTH VIS SCI, V38, P2171; BORA NS, 1995, INVEST OPHTH VIS SCI, V36, P1056; Bora PS, 2005, J IMMUNOL, V174, P491, DOI 10.4049/jimmunol.174.1.491; BROEKHUYSE RM, 1991, EXP EYE RES, V52, P465, DOI 10.1016/0014-4835(91)90044-F; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Chen M, 2010, J AUTOIMMUN, V34, pJ276, DOI 10.1016/j.jaut.2009.11.014; Clark A, 2008, MOL IMMUNOL, V45, P3125, DOI 10.1016/j.molimm.2008.03.008; Copland DA, 2010, CLIN EXP IMMUNOL, V159, P303, DOI 10.1111/j.1365-2249.2009.04070.x; Dunkelberger JR, 2010, MOL IMMUNOL, V47, P2176, DOI 10.1016/j.molimm.2010.05.008; GAEDE KI, 1995, INFECT IMMUN, V63, P3697, DOI 10.1128/IAI.63.9.3697-3701.1995; Gritz DC, 2004, OPHTHALMOLOGY, V111, P491, DOI 10.1016/j.ophtha.2003.06.014; Hietala MA, 2002, J IMMUNOL, V169, P454, DOI 10.4049/jimmunol.169.1.454; Huang YX, 2008, J IMMUNOL, V181, P8068, DOI 10.4049/jimmunol.181.11.8068; JACQUIERSARLIN MR, 1995, IMMUNOLOGY, V84, P164; Jha P, 2006, INVEST OPHTH VIS SCI, V47, P1030, DOI 10.1167/iovs.05-1062; Jha P, 2007, MOL IMMUNOL, V44, P3901, DOI 10.1016/j.molimm.2007.06.145; Jha P, 2007, INVEST OPHTH VIS SCI, V48, P5091, DOI 10.1167/iovs.07-0651; Jha P, 2006, J IMMUNOL, V176, P7221, DOI 10.4049/jimmunol.176.12.7221; Jha P, 2009, J BIOL CHEM, V284, P31401, DOI 10.1074/jbc.M109.033381; Kaya Z, 2001, NAT IMMUNOL, V2, P739, DOI 10.1038/90686; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Kerekes K, 1998, INT IMMUNOL, V10, P1923, DOI 10.1093/intimm/10.12.1923; KIM MC, 1995, CURR EYE RES, V14, P703, DOI 10.3109/02713689508998498; Manickam B, 2010, MOL IMMUNOL, V48, P231, DOI 10.1016/j.molimm.2010.08.006; Matta B, 2008, AM J PATHOL, V173, P1440, DOI 10.2353/ajpath.2008.080150; Matta B, 2010, IMMUNOL CELL BIOL, V88, P187, DOI 10.1038/icb.2009.83; Mihai S, 2007, J IMMUNOL, V178, P6514, DOI 10.4049/jimmunol.178.10.6514; MORGAN BP, 1995, CRIT REV CL LAB SCI, V32, P265, DOI 10.3109/10408369509084686; Morgan BP., 1999, COMPLEMENT REGULATOR; Pasinetti GM, 1996, NEUROBIOL AGING, V17, P707, DOI 10.1016/0197-4580(96)00113-3; Romagnani S, 2000, ANN ALLERG ASTHMA IM, V85, P9, DOI 10.1016/S1081-1206(10)62426-X; Singhrao SK, 1999, EXP NEUROL, V159, P362, DOI 10.1006/exnr.1999.7170; Sohn JH, 2003, NAT MED, V9, P206, DOI 10.1038/nm814; Sohn JH, 2000, INVEST OPHTH VIS SCI, V41, P3492; Thurman JM, 2006, J AM SOC NEPHROL, V17, P707, DOI 10.1681/ASN.2005070698; Tran GT, 2002, J IMMUNOL, V168, P4293, DOI 10.4049/jimmunol.168.9.4293; Tsokos G. C., 2004, COMPLEMENT AUTOIMMUN; Unanue ER, 2002, IMMUNOL REV, V185, P86, DOI 10.1034/j.1600-065X.2002.18510.x; Vriesendorp FJ, 1998, ACTA NEUROPATHOL, V95, P297, DOI 10.1007/s004010050801; Yalcindag A, 2006, J ALLERGY CLIN IMMUN, V117, P1455, DOI 10.1016/j.jaci.2006.01.048	49	17	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8472	8480		10.1074/jbc.M110.197616	http://dx.doi.org/10.1074/jbc.M110.197616			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21216963	hybrid, Green Published			2022-12-27	WOS:000288013300075
J	Sharma, AK; Ye, LW; Baer, CE; Shanmugasundaram, K; Alber, T; Alper, SL; Rigby, AC				Sharma, Alok K.; Ye, Liwen; Baer, Christina E.; Shanmugasundaram, Kumaran; Alber, Tom; Alper, Seth L.; Rigby, Alan C.			Solution Structure of the Guanine Nucleotide-binding STAS Domain of SLC26-related SulP Protein Rv1739c from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACYL CARRIER PROTEIN; PUTATIVE SULFATE TRANSPORTER; ANION-EXCHANGER SLC26A6; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURES; MOTOR PROTEIN; IN-VIVO; NMR; MUTATIONS; SECRETION	The structure and intrinsic activities of conserved STAS domains of the ubiquitous SulP/SLC26 anion transporter superfamily have until recently remained unknown. Here we report the heteronuclear, multidimensional NMR spectroscopy solution structure of the STAS domain from the SulP/SLC26 putative anion transporter Rv1739c of Mycobacterium tuberculosis. The 0.87-angstrom root mean square deviation structure revealed a four-stranded beta-sheet with five interspersed alpha-helices, resembling the anti-sigma factor antagonist fold. Rv1739c STAS was shown to be a guanine nucleotide-binding protein, as revealed by nucleotide-dependent quench of intrinsic STAS fluorescence and photoaffinity labeling. NMR chemical shift perturbation analysis partnered with in silico docking calculations identified solvent-exposed STAS residues involved in nucleotide binding. Rv1739c STAS was not an in vitro substrate of mycobacterial kinases or anti-sigma factors. These results demonstrate that Rv1739c STAS binds guanine nucleotides at physiological concentrations and undergoes a ligand-induced conformational change but, unlike anti-sigma factor antagonists, may not mediate signals via phosphorylation.	[Sharma, Alok K.; Shanmugasundaram, Kumaran; Alper, Seth L.; Rigby, Alan C.] Beth Israel Deaconess Med Ctr, Div Mol & Vasc Med, Boston, MA 02215 USA; [Ye, Liwen; Alper, Seth L.] Beth Israel Deaconess Med Ctr, Div Renal, Boston, MA 02215 USA; [Sharma, Alok K.; Ye, Liwen; Shanmugasundaram, Kumaran; Alper, Seth L.; Rigby, Alan C.] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Sharma, Alok K.; Ye, Liwen; Shanmugasundaram, Kumaran; Alper, Seth L.; Rigby, Alan C.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Baer, Christina E.; Alber, Tom] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of California System; University of California Berkeley	Alper, SL (corresponding author), 99 Brookline Ave,RN 380F, Boston, MA 02215 USA.	salper@bidmc.harvard.edu		Baer, Christina/0000-0002-8909-2583	National Institutes of Health [R01 DK43495, P30 DK34854, P01 AI68135]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854, R01DK043495, R37DK043495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 DK43495 (to S. L. A.), P30 DK34854 (Harvard Digestive Diseases Center to S. L. A.), and P01 AI68135 (TB Structural Genomics Consortium to T. A.).	Alvarez BV, 2005, EMBO J, V24, P2499, DOI 10.1038/sj.emboj.7600736; Aravind L, 2000, CURR BIOL, V10, pR53, DOI 10.1016/S0960-9822(00)00335-3; Avila-Perez M, 2009, J BIOL CHEM, V284, P24958, DOI 10.1074/jbc.M109.033316; Babu M, 2010, STRUCTURE, V18, P1450, DOI 10.1016/j.str.2010.08.015; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bergbrede T, 2005, J STRUCT BIOL, V152, P235, DOI 10.1016/j.jsb.2005.10.001; Bergbrede T, 2009, J BIOL CHEM, V284, P2628, DOI 10.1074/jbc.M806003200; Buttani V, 2006, FEBS LETT, V580, P3818, DOI 10.1016/j.febslet.2006.06.007; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Chang MH, 2009, J BIOL CHEM, V284, P28306, DOI 10.1074/jbc.M109.001669; Clarkson J, 2003, BIOCHEM J, V372, P113, DOI 10.1042/BJ20021748; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dawson PA, 2010, J CLIN INVEST, V120, P706, DOI 10.1172/JCI31474; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-349; Dorwart MR, 2008, PHYSIOLOGY, V23, P104, DOI 10.1152/physiol.00037.2007; Dorwart MR, 2008, J BIOL CHEM, V283, P8711, DOI 10.1074/jbc.M704328200; Etezady-Esfarjani T, 2006, MAGN RESON CHEM, V44, pS61, DOI 10.1002/mrc.1831; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; Greenstein AE, 2007, PLOS PATHOG, V3, P475, DOI 10.1371/journal.ppat.0030049; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hassan HA, 2007, AM J PHYSIOL-CELL PH, V292, pC1485, DOI 10.1152/ajpcell.00447.2006; HASTBACKA J, 1994, CELL, V78, P1073, DOI 10.1016/0092-8674(94)90281-X; Hoglund P, 1996, NAT GENET, V14, P316, DOI 10.1038/ng1196-316; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ishiguro H, 2007, AM J PHYSIOL-GASTR L, V292, pG447, DOI 10.1152/ajpgi.00286.2006; Jiang ZR, 2006, NAT GENET, V38, P474, DOI 10.1038/ng1762; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kovacs H, 1998, P NATL ACAD SCI USA, V95, P5067, DOI 10.1073/pnas.95.9.5067; KRAULIS PJ, 1994, BIOCHEMISTRY-US, V33, P3515, DOI 10.1021/bi00178a008; Kuo S, 2008, J BACTERIOL, V190, P6625, DOI 10.1128/JB.00799-08; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Liu A, 2010, ANTIMICROB AGENTS CH, V54, P1393, DOI 10.1128/AAC.00906-09; Liu XZ, 2003, HUM MOL GENET, V12, P1155, DOI 10.1093/hmg/ddg127; Masuda S, 2004, J MOL BIOL, V340, P941, DOI 10.1016/j.jmb.2004.05.040; Mazhab-Jafari MT, 2010, J BIOL CHEM, V285, P5132, DOI 10.1074/jbc.C109.064766; MUHANDIRAM DR, 1993, J MAGN RESON SER B, V102, P317, DOI 10.1006/jmrb.1993.1102; Murphy DJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-84; Najafi SMA, 1996, J BACTERIOL, V178, P6632, DOI 10.1128/jb.178.22.6632-6634.1996; Niederweis M, 2008, MICROBIOL-SGM, V154, P679, DOI 10.1099/mic.0.2007/012872-0; Pasqualetto E, 2010, J MOL BIOL, V400, P448, DOI 10.1016/j.jmb.2010.05.013; Price GD, 2004, P NATL ACAD SCI USA, V101, P18228, DOI 10.1073/pnas.0405211101; Quin M, 2008, ACTA CRYSTALLOGR F, V64, P196, DOI 10.1107/S1744309108003849; RAO A, 1979, BIOCHEMISTRY-US, V18, P4505, DOI 10.1021/bi00588a008; Riordan JT, 2010, MICROBIOL-SGM, V156, P719, DOI 10.1099/mic.0.032631-0; Seavers PR, 2001, STRUCTURE, V9, P605, DOI 10.1016/S0969-2126(01)00623-2; Serrano P, 2010, ACTA CRYSTALLOGR F, V66, P1393, DOI 10.1107/S1744309110033658; Sharma AK, 2009, BIOMOL NMR ASSIGN, V3, P99, DOI 10.1007/s12104-009-9150-z; Sharma AK, 2006, BIOCHEMISTRY-US, V45, P6904, DOI 10.1021/bi060368u; Shelden MC, 2010, MOL MEMBR BIOL, V27, P11, DOI 10.3109/09687680903400120; Sherman T, 2005, AM J PHYSIOL-CELL PH, V289, pC341, DOI 10.1152/ajpcell.00071.2005; Shibagaki N, 2010, J BIOL CHEM, V285, P25094, DOI 10.1074/jbc.M110.126888; Tang YF, 2010, PHOTOCH PHOTOBIO SCI, V9, P47, DOI 10.1039/b9pp00075e; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Tuo BG, 2006, GASTROENTEROLOGY, V130, P349, DOI 10.1053/j.gastro.2005.10.017; Wang YX, 2006, EMBO J, V25, P5049, DOI 10.1038/sj.emboj.7601387; Wooff E, 2002, MOL MICROBIOL, V43, P653, DOI 10.1046/j.1365-2958.2002.02771.x; Xu J, 2009, J BIOL CHEM, V284, P29470, DOI 10.1074/jbc.M109.044396; Xu J, 2008, P NATL ACAD SCI USA, V105, P17955, DOI 10.1073/pnas.0800616105; Zolotarev AS, 2008, COMP BIOCHEM PHYS A, V149, P255, DOI 10.1016/j.cbpa.2007.12.005	62	32	32	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8534	8544		10.1074/jbc.M110.165449	http://dx.doi.org/10.1074/jbc.M110.165449			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21190940	Green Published, hybrid			2022-12-27	WOS:000288013300080
J	Xiong, YB; Qiu, F; Piao, WJ; Song, C; Wahl, LM; Medvedev, AE				Xiong, Yanbao; Qiu, Fu; Piao, Wenji; Song, Chang; Wahl, Larry M.; Medvedev, Andrei E.			Endotoxin Tolerance Impairs IL-1 Receptor-Associated Kinase (IRAK) 4 and TGF-beta-activated Kinase 1 Activation, K63-linked Polyubiquitination and Assembly of IRAK1, TNF Receptor-associated Factor 6, and I kappa B Kinase gamma and Increases A20 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE-RECEPTOR; TUMOR-NECROSIS-FACTOR; INTESTINAL EPITHELIAL-CELLS; SIGNALING PATHWAY; NEGATIVE REGULATOR; INNATE IMMUNITY; LYS63-LINKED POLYUBIQUITINATION; COMPLEX-FORMATION; GENE-EXPRESSION; DOWN-REGULATION	Endotoxin tolerance reprograms Toll-like receptor 4 responses by impairing LPS-elicited production of pro-inflammatory cytokines without inhibiting expression of anti-inflammatory or anti-microbial mediators. In septic patients, Toll-like receptor tolerance is thought to underlie decreased pro-inflammatory cytokine expression in response to LPS and increased incidence of microbial infections. The impact of endotoxin tolerance on recruitment, post-translational modifications and signalosome assembly of IL-1 receptor-associated kinase (IRAK) 4, IRAK1, TNF receptor-associated factor (TRAF) 6, TGF-beta-activated kinase (TAK) 1, and I kappa B kinase (IKK) gamma is largely unknown. We report that endotoxin tolerization of THP1 cells and human monocytes impairs LPS-mediated receptor recruitment and activation of IRAK4, ablates K63-linked polyubiquitination of IRAK1 and TRAF6, compromises assembly of IRAK1-TRAF6 and IRAK1-IKK gamma platforms, and inhibits TAK1 activation. Deficiencies in these signaling events in LPS-tolerant cells coincided with increased expression of A20, an essential deubiquitination enzyme, and sustained A20-IRAK1 associations. Overexpression of A20 inhibited LPS-induced activation of NF-kappa B and ablated NF-kappa B reporter activation driven by ectopic expression of MyD88, IRAK1, IRAK2, TRAF6, and TAK1/TAB1, while not affecting the responses induced by IKK beta and p65. A20 shRNA knockdown abolished LPS tolerization of THP1 cells, mechanistically linking A20 and endotoxin tolerance. Thus, deficient LPS-induced activation of IRAK4 and TAK1, K63-linked polyubiquitination of IRAK1 and TRAF6, and disrupted IRAK1-TRAF6 and IRAK1-IKK gamma assembly associated with increased A20 expression and A20-IRAK1 interactions are new determinants of endotoxin tolerance.	[Xiong, Yanbao; Qiu, Fu; Piao, Wenji; Song, Chang; Medvedev, Andrei E.] Univ Maryland, Dept Microbiol & Immunol, Sch Med, Baltimore, MD 21201 USA; [Wahl, Larry M.] NIDCR, NIH, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Medvedev, AE (corresponding author), Univ Maryland, Dept Microbiol & Immunol, Sch Med, 685 W Baltimore St,HSF-1 Bldg,Rm 380, Baltimore, MD 21201 USA.	amedvedev@som.umaryland.edu			National Institutes of Health [AI-059524]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000456] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant AI-059524 (to A. E. M.).	Abbott DW, 2007, MOL CELL BIOL, V27, P6012, DOI 10.1128/MCB.00270-07; Berglund M, 2008, SCAND J IMMUNOL, V67, P473, DOI 10.1111/j.1365-3083.2008.02096.x; Beutler B, 2009, IMMUNOL REV, V227, P248, DOI 10.1111/j.1600-065X.2008.00733.x; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Cheng H, 2007, BIOCHEM BIOPH RES CO, V352, P609, DOI 10.1016/j.bbrc.2006.11.068; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; De Nardo D, 2009, CELL SIGNAL, V21, P246, DOI 10.1016/j.cellsig.2008.10.009; Dobrovolskaia MA, 2003, J IMMUNOL, V170, P508, DOI 10.4049/jimmunol.170.1.508; Dong W, 2006, J BIOL CHEM, V281, P26029, DOI 10.1074/jbc.M513057200; Ea CK, 2004, P NATL ACAD SCI USA, V101, P15318, DOI 10.1073/pnas.0404132101; El Gazzar M, 2007, J BIOL CHEM, V282, P26857, DOI 10.1074/jbc.M704584200; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Geleziunas R, 1998, MOL CELL BIOL, V18, P5157, DOI 10.1128/MCB.18.9.5157; Heyninck K, 1999, FEBS LETT, V442, P147, DOI 10.1016/S0014-5793(98)01645-7; Hu J, 2002, J IMMUNOL, V168, P3910, DOI 10.4049/jimmunol.168.8.3910; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kajino T, 2006, J BIOL CHEM, V281, P39891, DOI 10.1074/jbc.M608155200; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Keating SE, 2007, J BIOL CHEM, V282, P33435, DOI 10.1074/jbc.M705266200; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Kim YH, 2007, J EXP MED, V204, P2063, DOI 10.1084/jem.20070868; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kollewe C, 2004, J BIOL CHEM, V279, P5227, DOI 10.1074/jbc.M309251200; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Li CH, 2006, J LEUKOCYTE BIOL, V79, P867, DOI 10.1189/jlb.0905505; Li LW, 2000, J BIOL CHEM, V275, P23340, DOI 10.1074/jbc.M001950200; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Li XX, 2001, P NATL ACAD SCI USA, V98, P4461, DOI 10.1073/pnas.071054198; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin M, 2001, J IMMUNOL, V167, P5278, DOI 10.4049/jimmunol.167.9.5278; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; McCall CE, 2007, AM J RESP CRIT CARE, V175, P763, DOI 10.1164/rccm.200610-1436CP; Medvedev AE, 2005, J IMMUNOL, V174, P6587, DOI 10.4049/jimmunol.174.11.6587; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Medvedev AE, 2002, J IMMUNOL, V169, P5209, DOI 10.4049/jimmunol.169.9.5209; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Medvedev AE, 2006, J ENDOTOXIN RES, V12, P133, DOI 10.1179/096805106X102255; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oshima N, 2010, CLIN EXP IMMUNOL, V159, P185, DOI 10.1111/j.1365-2249.2009.04048.x; Piao W, 2008, J BIOL CHEM, V283, P3109, DOI 10.1074/jbc.M707400200; Piao W, 2009, J LEUKOCYTE BIOL, V86, P863, DOI 10.1189/jlb.0309189; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Qin JZ, 2006, J BIOL CHEM, V281, P21013, DOI 10.1074/jbc.M512908200; Qin JZ, 2004, J BIOL CHEM, V279, P26748, DOI 10.1074/jbc.M400785200; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Sato S, 2002, INT IMMUNOL, V14, P783, DOI 10.1093/intimm/dxf046; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Shnyra A, 1998, J IMMUNOL, V160, P3729; Skaug B, 2009, ANNU REV BIOCHEM, V78, P769, DOI 10.1146/annurev.biochem.78.070907.102750; Sly LM, 2004, IMMUNITY, V21, P227, DOI 10.1016/j.immuni.2004.07.010; Sun J, 2007, AM J PHYSIOL-GASTR L, V292, pG767, DOI 10.1152/ajpgi.00447.2006; Takaesu G, 2001, MOL CELL BIOL, V21, P2475, DOI 10.1128/MCB.21.7.2475-2484.2001; van 't Veer C, 2007, J IMMUNOL, V179, P7110, DOI 10.4049/jimmunol.179.10.7110; Wang J, 2009, J IMMUNOL, V183, P1384, DOI 10.4049/jimmunol.0803987; Windheim M, 2008, MOL CELL BIOL, V28, P1783, DOI 10.1128/MCB.02380-06; Xiao H, 2008, J BIOL CHEM, V283, P14654, DOI 10.1074/jbc.M706931200; Yang K, 2004, BIOCHEM BIOPH RES CO, V324, P432, DOI 10.1016/j.bbrc.2004.09.070; Yao JH, 2007, J BIOL CHEM, V282, P6075, DOI 10.1074/jbc.M609039200; Zetoune FS, 2001, CYTOKINE, V15, P282, DOI 10.1006/cyto.2001.0921; ZIEGLERHEITBROCK HWL, 1994, J BIOL CHEM, V269, P17001	75	68	70	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7905	7916		10.1074/jbc.M110.182873	http://dx.doi.org/10.1074/jbc.M110.182873			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21220427	hybrid, Green Published			2022-12-27	WOS:000288013300021
J	Dai, CS; Wen, XY; He, WC; Liu, YH				Dai, Chunsun; Wen, Xiaoyan; He, Weichun; Liu, Youhua			Inhibition of Proinflammatory RANTES Expression by TGF-beta 1 Is Mediated by Glycogen Synthase Kinase-3 beta-dependent beta-Catenin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GROWTH-FACTOR-BETA; CHEMOKINE RECEPTORS; RENAL INFLAMMATION; ACTIVATION; ALPHA; PROGRESSION; KINASE; FIBROBLASTS; INDUCTION	TGF-beta 1 is a pleiotropic cytokine with potent anti-inflammation property. However, the mechanisms underlying TGF-beta 1 suppression of inflammation remain largely unexplored. In this study, we demonstrated that TGF-beta 1 inhibited TNF-alpha-or IL-1-induced RANTES expression in human kidney tubular epithelial cells (HKC-8). To delineate the mechanism by which TGF-beta 1 inhibits RANTES expression, we examined the potential signal pathway activated by TGF-beta 1 in suppressing NF-kappa B signaling. TGF-beta 1 affected neither TNF-beta-induced I kappa B alpha phosphorylation and subsequent degradation, nor p65 NF-kappa B phosphorylation and its nuclear translocation. However, TGF-beta 1 could inhibit p65 and p50 binding to the kappa B site in human RANTES promoter as revealed by chromatin immunoprecipitation assay and protein-DNA binding assay. We found that TGF-beta 1 induced glycogen synthase kinase-3 beta (GSK-3 beta) phosphorylation on Ser-9 in HKC-8 cells, leading to its inactivation. Knockdown of GSK-3 beta mimicked TGF-beta 1 and inhibited RANTES induction, whereas overexpression of GSK-3 beta abolished the inhibitory effect of TGF-beta 1 and completely restored RANTES expression. Furthermore, TGF-beta 1 induced the dephosphorylation and activation of beta-catenin, a major downstream target of GSK-3 beta. Ectopic expression of constitutively active beta-catenin mimicked the TGF-beta 1 effect and completely suppressed RANTES expression induced by TNF-alpha. Interestingly, TGF-beta 1 induced a physical interaction between beta-catenin and p65 NF-kappa B, which prevented p65 binding to the kappa B site, sequestered its trans-activating activity, and repressed p65-mediated gene transcription. We conclude that TGF-beta 1 inhibition of proinflammatory RANTES expression is mediated by beta-catenin-triggered blockade of NF-kappa B signaling.	[Dai, Chunsun; Wen, Xiaoyan; He, Weichun; Liu, Youhua] Univ Pittsburgh, Dept Pathol, Sch Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Liu, YH (corresponding author), Univ Pittsburgh, Dept Pathol, Sch Med, S-405 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	liuy@upmc.edu		Liu, Youhua/0000-0002-4740-805X	National Institutes of Health [DK061408, DK064005, DK071040]; American Heart Association [0865392D]; University of Pittsburgh Medical Center Health System; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061408, R01DK064005, R01DK071040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Pittsburgh Medical Center Health System; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK061408, DK064005, and DK071040.; Supported by American Heart Association beginning Grant-in-aid 0865392D and the University of Pittsburgh Medical Center Health System Competitive Medical Research Fund.	Anders HJ, 2004, J AM SOC NEPHROL, V15, P1504, DOI 10.1097/01.ASN.0000130082.67775.60; Anders HJ, 2003, KIDNEY INT, V63, P401, DOI 10.1046/j.1523-1755.2003.00750.x; BOIVIN GP, 1995, AM J PATHOL, V146, P276; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Cho ML, 2006, IMMUNOL LETT, V105, P159, DOI 10.1016/j.imlet.2006.02.003; Dai CS, 2006, J AM SOC NEPHROL, V17, P2164, DOI 10.1681/ASN.2006010033; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Dai CS, 2004, J AM SOC NEPHROL, V15, P1402, DOI 10.1097/01.ASN.0000130568.53923.FD; Deng JO, 2002, CANCER CELL, V2, P323, DOI 10.1016/S1535-6108(02)00154-X; Du Q, 2009, CANCER RES, V69, P3764, DOI 10.1158/0008-5472.CAN-09-0014; Fan WQ, 2005, ENDOCRINOLOGY, V146, P85, DOI 10.1210/en.2004-1046; Ghafoori P, 2009, FASEB J, V23, P2226, DOI 10.1096/fj.08-124545; Giannopoulou M, 2008, AM J PATHOL, V173, P30, DOI 10.2353/ajpath.2008.070583; Gong RJ, 2008, J BIOL CHEM, V283, P7401, DOI 10.1074/jbc.M710396200; Hao S, 2010, AM J PATHOL, V177, P1164, DOI 10.2353/ajpath.2010.091269; He WC, 2010, J BIOL CHEM, V285, P24665, DOI 10.1074/jbc.M109.091256; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Ishinaga H, 2009, BIOCHEM J, V417, P583, DOI 10.1042/BJ20080781; Krensky AM, 2007, NAT CLIN PRACT NEPHR, V3, P164, DOI 10.1038/ncpneph0418; KULKARNI AB, 1995, AM J PATHOL, V146, P264; Lan HY, 2008, FRONT BIOSCI-LANDMRK, V13, P4984, DOI 10.2741/3057; Li YJ, 2007, J AM SOC NEPHROL, V18, P449, DOI 10.1681/ASN.2006030236; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; Liu Y, 2010, STRUCT CHEM, V21, P21, DOI 10.1007/s11224-009-9519-8; Lu T, 2007, P NATL ACAD SCI USA, V104, P4365, DOI 10.1073/pnas.0700118104; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Monteleone G, 2004, J BIOL CHEM, V279, P3925, DOI 10.1074/jbc.M303654200; PEREZ DL, 2001, J AM SOC NEPHROL, V12, P1369; Rangan G, 2009, FRONT BIOSCI-LANDMRK, V14, P3496, DOI 10.2741/3467; Ruster C, 2008, FRONT BIOSCI-LANDMRK, V13, P944, DOI 10.2741/2734; Schmid JA, 2000, J BIOL CHEM, V275, P17035, DOI 10.1074/jbc.M000291200; Schnaper HW, 2009, FRONT BIOSCI-LANDMRK, V14, P2448, DOI 10.2741/3389; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Tan RY, 2007, J AM SOC NEPHROL, V18, P2340, DOI 10.1681/ASN.2007010128; Tan XY, 2008, J AM SOC NEPHROL, V19, P1741, DOI 10.1681/ASN.2007060666; Vielhauer Volker, 2009, Front Biosci (Schol Ed), V1, P1; Wang WS, 2005, J AM SOC NEPHROL, V16, P1371, DOI 10.1681/ASN.2004121070; Xiao YQ, 2006, J IMMUNOL, V176, P1209, DOI 10.4049/jimmunol.176.2.1209; Yang JW, 2003, AM J PATHOL, V163, P621, DOI 10.1016/S0002-9440(10)63689-9; Yang JW, 2001, AM J PATHOL, V159, P1465, DOI 10.1016/S0002-9440(10)62533-3	40	25	26	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7052	7059		10.1074/jbc.M110.174821	http://dx.doi.org/10.1074/jbc.M110.174821			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21189258	Green Published, hybrid			2022-12-27	WOS:000287737300022
J	Danielson, SR; Held, JM; Oo, M; Riley, R; Gibson, BW; Andersen, JK				Danielson, Steven R.; Held, Jason M.; Oo, May; Riley, Rebeccah; Gibson, Bradford W.; Andersen, Julie K.			Quantitative Mapping of Reversible Mitochondrial Complex I Cysteine Oxidation in a Parkinson Disease Mouse Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE DEPLETION; MASS-SPECTROMETRY; DIFFERENTIAL ALKYLATION; HEART-MITOCHONDRIA; INHIBITION; PROTEINS; ASSAYS; IDENTIFICATION; DEHYDROGENASE; NITROSATION	Differential cysteine oxidation within mitochondrial Complex I has been quantified in an in vivo oxidative stress model of Parkinson disease. We developed a strategy that incorporates rapid and efficient immunoaffinity purification of Complex I followed by differential alkylation and quantitative detection using sensitive mass spectrometry techniques. This method allowed us to quantify the reversible cysteine oxidation status of 34 distinct cysteine residues out of a total 130 present in murine Complex I. Six Complex I cysteine residues were found to display an increase in oxidation relative to controls in brains from mice undergoing in vivo glutathione depletion. Three of these residues were found to reside within iron-sulfur clusters of Complex I, suggesting that their redox state may affect electron transport function.	[Danielson, Steven R.; Held, Jason M.; Oo, May; Riley, Rebeccah; Gibson, Bradford W.; Andersen, Julie K.] Buck Inst Age Res, Novato, CA 94945 USA	Buck Institute for Research on Aging	Gibson, BW (corresponding author), Buck Inst Age Res, 8001 Redwood Blvd, Novato, CA 94945 USA.	bgibson@buckinstitute.org; jandersen@buckinstitute.org		Andersen, Julie/0000-0003-1324-4875; Held, Jason/0000-0001-8024-2736	National Institutes of Health [P01AG025901, PL1AG032118, S10RR024615, S10RR0021222]; W. M. Keck Foundation; NATIONAL CANCER INSTITUTE [R21CA138308] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024615, S10RR021222] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG025901, PL1AG032118] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants P01AG025901(to J. K. A.), PL1AG032118(to B. W. G.), S10RR024615(to B. W. G.), and S10RR0021222 (to B. W. G.). This work was also supported by a grant from the W. M. Keck Foundation (to J. K. A. and B. W. G.).	Andersen JK, 1996, J NEUROCHEM, V67, P2164; Anderson L, 2006, MOL CELL PROTEOMICS, V5, P573, DOI 10.1074/mcp.M500331-MCP200; Burwell LS, 2006, BIOCHEM J, V394, P627, DOI 10.1042/BJ20051435; Chinta SJ, 2007, J NEUROSCI, V27, P13997, DOI 10.1523/JNEUROSCI.3885-07.2007; Chinta SJ, 2006, FREE RADICAL BIO MED, V41, P1442, DOI 10.1016/j.freeradbiomed.2006.08.002; Chinta SJ, 2006, FREE RADICAL BIO MED, V40, P1557, DOI 10.1016/j.freeradbiomed.2005.12.023; Danielson SR, 2009, ANAL CHEM, V81, P7823, DOI 10.1021/ac901176t; Di Simplicio P, 2003, AMINO ACIDS, V25, P323, DOI 10.1007/s00726-003-0020-1; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Giles NM, 2003, CHEM BIOL, V10, P677, DOI 10.1016/S1074-5521(03)00174-1; HEIKKILA RE, 1985, NEUROSCI LETT, V62, P389, DOI 10.1016/0304-3940(85)90580-4; Held JM, 2010, MOL CELL PROTEOMICS, V9, P1400, DOI 10.1074/mcp.M900643-MCP200; Hinchliffe P, 2005, SCIENCE, V309, P771, DOI 10.1126/science.1113988; Hsu M, 2005, J NEUROCHEM, V92, P1091, DOI 10.1111/j.1471-4159.2004.02929.x; Hurd TR, 2008, J BIOL CHEM, V283, P24801, DOI 10.1074/jbc.M803432200; JENNER P, 1993, ACTA NEUROL SCAND, V87, P6; Jha N, 2000, J BIOL CHEM, V275, P26096, DOI 10.1074/jbc.M000120200; Keshishian H, 2007, MOL CELL PROTEOMICS, V6, P2212, DOI 10.1074/mcp.M700354-MCP200; Ladha JS, 2005, CELL DEATH DIFFER, V12, P1417, DOI 10.1038/sj.cdd.4401668; Lee MS, 1999, MASS SPECTROM REV, V18, P187, DOI 10.1002/(SICI)1098-2787(1999)18:3/4<187::AID-MAS2>3.0.CO;2-K; Nadanaciva S, 2007, TOXICOL APPL PHARM, V223, P277, DOI 10.1016/j.taap.2007.06.003; NICKLAS WJ, 1985, LIFE SCI, V36, P2503, DOI 10.1016/0024-3205(85)90146-8; Perdivara I, 2010, J AM SOC MASS SPECTR, V21, P1114, DOI 10.1016/j.jasms.2010.02.016; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; PERRY TL, 1986, NEUROSCI LETT, V67, P269, DOI 10.1016/0304-3940(86)90320-4; PERRY TL, 1982, NEUROSCI LETT, V33, P305, DOI 10.1016/0304-3940(82)90390-1; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; SCHAPIRA AHV, 1989, LANCET, V1, P1269, DOI 10.1016/S0140-6736(89)92366-0; Schilling B, 2006, BBA-MOL BASIS DIS, V1762, P213, DOI 10.1016/j.bbadis.2005.07.003; Schilling B, 2005, MOL CELL PROTEOMICS, V4, P84, DOI 10.1074/mcp.M400143-MCP200; Schilling B, 2004, INT J MASS SPECTROM, V236, P117, DOI 10.1016/j.ijms.2004.06.004; Sethuraman M, 2004, J PROTEOME RES, V3, P1228, DOI 10.1021/pr049887e; Taylor FR, 2006, ANAL BIOCHEM, V353, P204, DOI 10.1016/j.ab.2006.02.022; Tiller R, 1997, J CHROMATOGR A, V771, P119, DOI 10.1016/S0021-9673(97)00147-7; Trounce I A, 1996, Methods Enzymol, V264, P484, DOI 10.1016/S0076-6879(96)64044-0; Willis JH, 2009, BBA-BIOENERGETICS, V1787, P533, DOI 10.1016/j.bbabio.2008.10.009	37	46	47	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7601	7608		10.1074/jbc.M110.190108	http://dx.doi.org/10.1074/jbc.M110.190108			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21196577	Green Published, hybrid			2022-12-27	WOS:000287737300073
J	Kurita, T; Noda, Y; Takagi, T; Osumi, M; Yoda, K				Kurita, Tomokazu; Noda, Yoichi; Takagi, Tomoko; Osumi, Masako; Yoda, Koji			Kre6 Protein Essential for Yeast Cell Wall beta-1,6-Glucan Synthesis Accumulates at Sites of Polarized Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICAL ER INHERITANCE; BETA-GLUCAN SYNTHESIS; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; SCHIZOSACCHAROMYCES-POMBE; ACTIN CYTOSKELETON; ELECTRON-MICROSCOPY; MEMBRANE-PROTEINS; PLASMA-MEMBRANE; IN-VITRO	Saccharomyces cerevisiae Kre6 is a type II membrane protein with amino acid sequence homology with glycoside hydrolase and is essential for beta-1,6-glucan synthesis as revealed by the mutant phenotype, but its biochemical function is still unknown. The localization of Kre6, determined by epitope tagging, is a matter of debate. We raised anti-Kre6 rabbit antiserum and examined the localization of Kre6 and its tagged protein by immunofluorescence microscopy, subcellular fractionation in sucrose density gradients, and immunoelectron microscopy. Integration of the results indicates that the majority of Kre6 is in the endoplasmic reticulum; however, a small but significant portion is also present in the secretory vesicle-like compartments and plasma membrane. Kre6 in the latter compartments is observed as strong signals that accumulate at the sites of polarized growth by immunofluorescence. The truncated Kre6 without the N-terminal 230-amino acid cytoplasmic region did not show this polarized accumulation and had a severe defect in beta-1,6-glucan synthesis. This is the first evidence of a beta-1,6-glucan-related protein showing the polarized membrane localization that correlates with its biological function.	[Kurita, Tomokazu; Noda, Yoichi; Yoda, Koji] Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; [Takagi, Tomoko; Osumi, Masako] Japan Womens Univ, Lab Electron Microscopy, Bio Imaging Ctr, Bunkyo Ku, Tokyo 1128681, Japan; [Osumi, Masako] Integrated Imaging Res Support, Chiyoda Ku, Tokyo 1020093, Japan	University of Tokyo; Japan Womens University	Yoda, K (corresponding author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan.	asdfg@mail.ecc.u-tokyo.ac.jp	Kurita, Tomokazu/E-6346-2012		Japan Society for the Promotion of Science; Noda Institute of Scientific Research; Grants-in-Aid for Scientific Research [21380058] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Noda Institute of Scientific Research(Noda Institute for Scientific Research); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for Scientific Research from the Japan Society for the Promotion of Science (to Y.N. and K.Y.) and a grant from the Noda Institute of Scientific Research (to Y.N.).	Aimanianda V, 2009, J BIOL CHEM, V284, P13401, DOI 10.1074/jbc.M807667200; AMBERG DC, 2005, METHODS YEAST GENETI, P165; Arai S, 2008, CURR BIOL, V18, P987, DOI 10.1016/j.cub.2008.06.028; Ayscough KR, 1999, MOL BIOL CELL, V10, P1061, DOI 10.1091/mbc.10.4.1061; Du YR, 2006, EMBO J, V25, P4413, DOI 10.1038/sj.emboj.7601319; Epping EA, 2002, J BIOL CHEM, V277, P34860, DOI 10.1074/jbc.M202987200; Estrada P, 2003, J CELL BIOL, V163, P1255, DOI 10.1083/jcb.200304030; Fehrenbacher KL, 2002, MOL BIOL CELL, V13, P854, DOI 10.1091/mbc.01-04-0184; Fujimoto K, 1997, HISTOCHEM CELL BIOL, V107, P87, DOI 10.1007/s004180050092; Gurunathan S, 2000, MOL BIOL CELL, V11, P3629, DOI 10.1091/mbc.11.10.3629; Hosomi A, 2010, J BIOL CHEM, V285, P24324, DOI 10.1074/jbc.M109.095919; Humbel BM, 2001, YEAST, V18, P433, DOI 10.1002/yea.694; Imai K, 2005, J BIOL CHEM, V280, P8275, DOI 10.1074/jbc.M409428200; Konomi M, 2003, YEAST, V20, P427, DOI 10.1002/yea.974; KONOMI M, 2000, PLANT MORPHOL, V12, P20; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Levinson JN, 2002, YEAST, V19, P1243, DOI 10.1002/yea.908; Lewis MJ, 2000, MOL BIOL CELL, V11, P23, DOI 10.1091/mbc.11.1.23; Li HJ, 2002, YEAST, V19, P1097, DOI 10.1002/yea.904; Montijn RC, 1999, J BACTERIOL, V181, P7414, DOI 10.1128/JB.181.24.7414-7420.1999; Nakamata K, 2007, J BIOL CHEM, V282, P34315, DOI 10.1074/jbc.M706486200; Page N, 2003, GENETICS, V163, P875; Powers J, 1998, J CELL BIOL, V142, P1209, DOI 10.1083/jcb.142.5.1209; ROEMER T, 1994, J CELL BIOL, V127, P567, DOI 10.1083/jcb.127.2.567; ROEMER T, 1993, MOL CELL BIOL, V13, P4039, DOI 10.1128/MCB.13.7.4039; ROEMER T, 1991, P NATL ACAD SCI USA, V88, P11295, DOI 10.1073/pnas.88.24.11295; Sato K, 2007, MOL BIOL CELL, V18, P3472, DOI 10.1091/mbc.E07-03-0258; Sato K, 2009, MOL BIOL CELL, V20, P4444, DOI 10.1091/mbc.E09-03-0235; Shahinian S, 2000, MOL MICROBIOL, V35, P477, DOI 10.1046/j.1365-2958.2000.01713.x; Takagi T, 2003, J ELECTRON MICROSC, V52, P161, DOI 10.1093/jmicro/52.2.161; Takeuchi M, 2008, MOL BIOL CELL, V19, P3514, DOI 10.1091/mbc.E07-12-1289; Tang HY, 2000, MOL CELL BIOL, V20, P12, DOI 10.1128/MCB.20.1.12-25.2000; Valdez-Taubas J, 2003, CURR BIOL, V13, P1636, DOI 10.1016/j.cub.2003.09.001; Valdivia RH, 2003, P NATL ACAD SCI USA, V100, P10287, DOI 10.1073/pnas.1834246100; Vink E, 2004, YEAST, V21, P1121, DOI 10.1002/yea.1156	35	21	21	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7429	7438		10.1074/jbc.M110.174060	http://dx.doi.org/10.1074/jbc.M110.174060			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193403	Green Published, hybrid			2022-12-27	WOS:000287737300058
J	Collier, DM; Snyder, PM				Collier, Daniel M.; Snyder, Peter M.			Identification of Epithelial Na+ Channel (ENaC) Intersubunit Cl- Inhibitory Residues Suggests a Trimeric alpha gamma beta Channel Architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELF-INHIBITION; SODIUM-CHANNEL; BINDING SITE; X-RAY; ACTIVATION; RESOLUTION; SUBUNIT; EXPRESSION; PROTEASES; CLONING	The extracellular domain of the epithelial Na+ channel (ENaC) is exposed to a wide range of anion concentrations in the kidney. We have previously demonstrated that extracellular Cl- inhibits ENaC activity. To identify sites involved in Cl- inhibition, we mutated residues in the extracellular domain of alpha-, beta-, and gamma ENaC that are homologous to the Cl- binding site in acid-sensing ion channel 1a and tested the effect of Cl- on the activity of ENaC expressed in Xenopus oocytes. We identified two Cl- inhibitory sites in ENaC. One is formed by residues in the thumb domain of alpha ENaC and the palm domain of beta ENaC. Mutation of residues at this interface decreased Cl- inhibition and decreased Na+ self-inhibition. The second site is formed by residues at the interface of the thumb domain of beta ENaC and the palm domain of gamma ENaC. Mutation of these residues also decreased Cl- inhibition yet had no effect on Na+ self-inhibition. In contrast, mutations in the thumb domain of gamma ENaC and palm of alpha ENaC had little or no effect on Cl- inhibition or Na+ self-inhibition. The data demonstrate that Cl- inhibits ENaC activity by two distinct Na+-dependent and Na+-independent mechanisms that correspond to the two functional Cl- inhibitory sites. Furthermore, based on the effects of mutagenesis on Cl- inhibition, the additive nature of mutations, and on differences in the mechanisms of Cl- inhibition, the data support a model in which ENaC subunits assemble in an alpha gamma beta orientation (listed clockwise when viewed from the top).	[Snyder, Peter M.] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Snyder, PM (corresponding author), Univ Iowa, Carver Coll Med, Dept Internal Med, 371 EMRB, Iowa City, IA 52242 USA.	peter-snyder@uiowa.edu	Collier, Daniel/GVU-0199-2022		American Heart Association; National Institutes of Health [HL072256]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072256] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by a predoctoral fellowship grant from the American Heart Association.; Supported by National Institutes of Health Grant HL072256. To whom correspondence should be addressed: 371 EMRB, University of Iowa, Iowa City, IA 52242. E-mail: peter-snyder@uiowa.edu.	BOUCHER RC, 1986, J CLIN INVEST, V78, P1245, DOI 10.1172/JCI112708; Burkhard P, 2000, J MOL BIOL, V303, P279, DOI 10.1006/jmbi.2000.4109; Carattino MD, 2008, J BIOL CHEM, V283, P25290, DOI 10.1074/jbc.M803931200; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Gonzales EB, 2009, NATURE, V460, P599, DOI 10.1038/nature08218; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kashlan OB, 2011, J BIOL CHEM, V286, P649, DOI 10.1074/jbc.M110.167098; KAVANAUGH JS, 1992, BIOCHEMISTRY-US, V31, P4111, DOI 10.1021/bi00131a030; Kusama N, 2010, J BIOL CHEM, V285, P17425, DOI 10.1074/jbc.M109.091561; Lifton RP, 1996, SCIENCE, V272, P676, DOI 10.1126/science.272.5262.676; MCDONALD FJ, 1994, AM J PHYSIOL, V266, pL728, DOI 10.1152/ajplung.1994.266.6.L728; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Rose B. D., 1984, CLIN PHYSL ACID BASE, P274; Schild L, 2004, REV PHYSIOL BIOCH P, V151, P93, DOI 10.1007/s10254-004-0023-7; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Snyder PM, 2005, ENDOCRINOLOGY, V146, P5079, DOI 10.1210/en.2005-0894; Snyder PM, 1999, J BIOL CHEM, V274, P28484, DOI 10.1074/jbc.274.40.28484; Snyder PM, 2000, J GEN PHYSIOL, V116, P781, DOI 10.1085/jgp.116.6.781; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329	25	40	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6027	6032		10.1074/jbc.M110.198127	http://dx.doi.org/10.1074/jbc.M110.198127			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21149458	hybrid, Green Published			2022-12-27	WOS:000287476400010
J	Guan, L; Nurva, S; Ankeshwarapu, SP				Guan, Lan; Nurva, Shailika; Ankeshwarapu, Siva P.			Mechanism of Melibiose/Cation Symport of the Melibiose Permease of Salmonella typhimurium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CONFORMATIONAL-CHANGES; RESONANCE ENERGY-TRANSFER; MEMBRANE-SPANNING SEGMENTS; ESCHERICHIA-COLI; SUGAR BINDING; ACTIVE-TRANSPORT; LACTOSE PERMEASE; KLEBSIELLA-PNEUMONIAE; DEPENDENT BINDING; CHARGED RESIDUES	The MelB permease of Salmonella typhimurium (MelB-ST) catalyzes the coupled symport of melibiose and Na+, Li+, or H+. In right-side-out membrane vesicles, melibiose efflux is inhibited by an inwardly directed gradient of Na+ or Li+ and stimulated by equimolar concentrations of internal and external Na+ or Li+. Melibiose exchange is faster than efflux in the presence of H+ or Na+ and stimulated by an inwardly directed Na+ gradient. Thus, sugar is released from MelB-ST externally prior to the release of cation in agreement with current models proposed for MelB of Escherichia coli (MelB-EC) and LacY. Although Li+ stimulates efflux, and an outwardly directed Li+ gradient increases exchange, it is striking that internal and external Li+ with no gradient inhibits exchange. Furthermore, Trp -> dansyl FRET measurements with a fluorescent sugar (2'-(N-dansyl) aminoalkyl-1-thio-beta-D-galactopyranoside) demonstrate that MelB-ST, in the presence of Na+ or Li+, exhibits K-app(d) values of similar to 1 mM for melibiose. Na+ and Li+ compete for a common binding pocket with activation constants for FRET of similar to 1 mM, whereas Rb+ or Cs+ exhibits little or no effect. Taken together, the findings indicate that MelB-ST utilizes H+ in addition to Na+ and Li+. FRET studies also show symmetrical emission maximum at similar to 500 nm with MelB-ST in the presence of 2'-(N-dansyl) aminoalkyl-1-thio-beta-D-galactopyranoside and Na+, Li+, or H+, which implies a relatively homogeneous distribution of conformers of MelB-ST ternary complexes in the membrane.	[Guan, Lan; Nurva, Shailika; Ankeshwarapu, Siva P.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Ctr Membrane Prot Res, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Guan, L (corresponding author), 3601 4th St,5A163,STOP 6551, Lubbock, TX 79430 USA.	Lan.Guan@ttuhsc.edu			National Institutes of Health [R21HL087895, R01GM095538]; Texas Norman Hackerman Advanced Research Program [010674-0034-2009]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL087895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095538] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Norman Hackerman Advanced Research Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R21HL087895 and R01GM095538 (to L. G.). This work was also supported by Texas Norman Hackerman Advanced Research Program Grant 010674-0034-2009 (to L. G.).	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; BASSILANA M, 1988, J BIOL CHEM, V263, P9663; BASSILANA M, 1987, J BIOL CHEM, V262, P16865; BOTFIELD MC, 1992, J BIOL CHEM, V267, P1818; Cordat E, 1998, J BIOL CHEM, V273, P33198, DOI 10.1074/jbc.273.50.33198; DAMIANOFORANO E, 1986, J BIOL CHEM, V261, P6893; Dayem MA, 2003, J BIOL CHEM, V278, P1518, DOI 10.1074/jbc.M210053200; Ding PZ, 2001, BIOCHEM BIOPH RES CO, V285, P348, DOI 10.1006/bbrc.2001.5200; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Franco PJ, 1999, J BACTERIOL, V181, P6377, DOI 10.1128/JB.181.20.6377-6386.1999; Franco PJ, 2001, BBA-BIOMEMBRANES, V1510, P231, DOI 10.1016/S0005-2736(00)00353-9; Ganea C, 2001, BIOCHEMISTRY-US, V40, P13744, DOI 10.1021/bi011223k; Garcia-Celma JJ, 2008, LANGMUIR, V24, P8119, DOI 10.1021/la800428h; Garcia-Celma JJ, 2010, BIOCHEMISTRY-US, V49, P6115, DOI 10.1021/bi100492p; Guan L, 2007, P NATL ACAD SCI USA, V104, P15294, DOI 10.1073/pnas.0707688104; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Guan L, 2009, BIOCHEMISTRY-US, V48, P9250, DOI 10.1021/bi9014067; Gwizdek C, 1997, BIOCHEMISTRY-US, V36, P8522, DOI 10.1021/bi970312n; Hacksell I, 2002, EMBO J, V21, P3569, DOI 10.1093/emboj/cdf378; HAMA H, 1994, J BIOL CHEM, V269, P1063; HAMA H, 1993, J BIOL CHEM, V268, P10060; Hirayama BA, 1997, J BIOL CHEM, V272, P2110; Kaback H R, 1974, Methods Enzymol, V31, P698; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; KACZOROWSKI GJ, 1979, BIOCHEMISTRY-US, V18, P3691, DOI 10.1021/bi00584a009; KONINGS WN, 1971, J BIOL CHEM, V246, P5857; Leon X, 2005, BIOCHEMISTRY-US, V44, P3506, DOI 10.1021/bi048301z; Leon X, 2006, BIOPHYS J, V91, P4440, DOI 10.1529/biophysj.106.090241; Leon X, 2009, BIOPHYS J, V96, P4877, DOI 10.1016/j.bpj.2009.03.025; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; LOPILATO J, 1978, J BACTERIOL, V134, P147, DOI 10.1128/JB.134.1.147-156.1978; Maehrel C, 1998, J BIOL CHEM, V273, P33192, DOI 10.1074/jbc.273.50.33192; Matsuzaki S, 1999, BBA-BIOMEMBRANES, V1420, P63, DOI 10.1016/S0005-2736(99)00087-5; Meyer-Lipp K, 2006, J BIOL CHEM, V281, P25882, DOI 10.1074/jbc.M601259200; Mirza O, 2006, EMBO J, V25, P1177, DOI 10.1038/sj.emboj.7601028; MIZUSHIMA K, 1992, MOL GEN GENET, V234, P74, DOI 10.1007/BF00272347; MUSVETEAU I, 1995, BIOCHEMISTRY-US, V34, P6775, DOI 10.1021/bi00020a024; NIIYA S, 1980, J BACTERIOL, V144, P192, DOI 10.1128/JB.144.1.192-199.1980; POURCHER T, 1991, BIOCHEM BIOPH RES CO, V178, P1176, DOI 10.1016/0006-291X(91)91016-6; POURCHER T, 1993, J BIOL CHEM, V268, P3209; POURCHER T, 1995, BIOCHEMISTRY-US, V34, P4412, DOI 10.1021/bi00013a033; Pourcher T, 1996, BIOCHEMISTRY-US, V35, P4161, DOI 10.1021/bi9527496; Purhonen P, 2005, J STRUCT BIOL, V152, P76, DOI 10.1016/j.jsb.2005.07.003; Saier MH, 2000, MOL MICROBIOL, V35, P699, DOI 10.1046/j.1365-2958.2000.01759.x; SCHULDINER S, 1975, J BIOL CHEM, V250, P1361; SCHULDINER S, 1978, BIOCHEMISTRY-US, V17, P706, DOI 10.1021/bi00597a023; SCHULDINER S, 1975, BIOCHEMISTRY-US, V14, P5451, DOI 10.1021/bi00696a011; SHORT SA, 1974, P NATL ACAD SCI USA, V71, P1461, DOI 10.1073/pnas.71.4.1461; Smirnova IN, 2006, BIOCHEMISTRY-US, V45, P15279, DOI 10.1021/bi061632m; Smith KM, 2005, J BIOL CHEM, V280, P25436, DOI 10.1074/jbc.M409454200; TOKUDA H, 1978, BIOCHEMISTRY-US, V17, P698, DOI 10.1021/bi00597a022; TOKUDA H, 1977, BIOCHEMISTRY-US, V16, P2130, DOI 10.1021/bi00629a013; TSUCHIYA T, 1978, MEMBRANE BIOCHEM, V2, P63, DOI 10.3109/09687687809063858; TSUCHIYA T, 1977, BIOCHEM BIOPH RES CO, V76, P26, DOI 10.1016/0006-291X(77)91663-1; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; WEST IC, 1974, BIOCHEM J, V144, P87, DOI 10.1042/bj1440087; WILSON DM, 1987, BIOCHIM BIOPHYS ACTA, V904, P191, DOI 10.1016/0005-2736(87)90368-3; Wilson TH, 2001, BBA-BIOENERGETICS, V1505, P121, DOI 10.1016/S0005-2728(00)00282-6; Yousef MS, 2009, P NATL ACAD SCI USA, V106, P15291, DOI 10.1073/pnas.0905516106; ZANI ML, 1993, J BIOL CHEM, V268, P3216; ZANI ML, 1994, J BIOL CHEM, V269, P24883	62	51	51	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6367	6374		10.1074/jbc.M110.206227	http://dx.doi.org/10.1074/jbc.M110.206227			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21148559	hybrid, Green Published			2022-12-27	WOS:000287476400047
J	Kurooka, T; Yamamoto, Y; Takai, Y; Sakisaka, T				Kurooka, Takao; Yamamoto, Yasunori; Takai, Yoshimi; Sakisaka, Toshiaki			Dual Regulation of RA-RhoGAP Activity by Phosphatidic Acid and Rap1 during Neurite Outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM POTENTIATION; HIPPOCAMPAL-NEURONS; DENDRITIC SPINES; LYSOPHOSPHATIDIC ACID; ACTIN CYTOSKELETON; MEMBRANE CURVATURE; BINDING PROTEINS; NERVE GROWTH; PC12 CELLS	During neurite outgrowth, Rho small G protein activity is spatiotemporally regulated to organize the neurite sprouting, extension, and branching. We have previously identified a potent Rho GTPase-activating protein (GAP), RA-RhoGAP, as a direct downstream target of Rap1 small G protein in the neurite outgrowth. In addition to the Ras-associating (RA) domain for Rap1 binding, RA-RhoGAP has the pleckstrin homology (PH) domain for lipid binding. Here, we showed that phosphatidic acid (PA) bound to the PH domain and enhanced GAP activity for Rho. RA-RhoGAP induced extension of neurite in a diacylglycerol kinase-mediated synthesis of the PA-dependent manner. Knockdown of RA-RhoGAP reduced the diacylglycerol kinase-induced neurite extension. In contrast to the effect of the RA domain, the PH domain was specifically involved in the neurite extension, not in the sprouting and branching. These results indicate that PA and Rap1 cooperatively regulate RA-RhoGAP activity for promoting neurite outgrowth.	Kobe Univ, Grad Sch Med, Div Membrane Dynam, Dept Physiol & Cell Biol, Kobe, Hyogo 6500017, Japan; [Takai, Yoshimi] Kobe Univ, Grad Sch Med, Div Mol & Cellular Biol, Dept Biochem & Mol Biol, Kobe, Hyogo 6500017, Japan	Kobe University; Kobe University		sakisaka@med.kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology; The Japan Epilepsy Research Foundation; Hyogo Science and Technology Association	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); The Japan Epilepsy Research Foundation; Hyogo Science and Technology Association	This work was supported by grants-in-aid for scientific research and for the Global COE Program F11 from the Ministry of Education, Culture, Sports, Science, and Technology, by a grant provided by The Japan Epilepsy Research Foundation, and by the grant provided by Hyogo Science and Technology Association.	Anwyl R, 2009, NEUROPHARMACOLOGY, V56, P735, DOI 10.1016/j.neuropharm.2009.01.002; Aoki K, 2005, MOL BIOL CELL, V16, P2207, DOI 10.1091/mbc.e04-10-0904; Bellone C, 2008, CELL MOL LIFE SCI, V65, P2913, DOI 10.1007/s00018-008-8263-3; Bradke F, 2000, CURR BIOL, V10, P1467, DOI 10.1016/S0960-9822(00)00807-1; Cai JJ, 2009, BBA-MOL CELL BIOL L, V1791, P942, DOI 10.1016/j.bbalip.2009.02.010; Cazzolli R, 2006, IUBMB LIFE, V58, P457, DOI 10.1080/15216540600871142; Chen YC, 2005, MOL CELL NEUROSCI, V28, P215, DOI 10.1016/j.mcn.2004.08.012; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Da Silva JS, 2003, J CELL BIOL, V162, P1267, DOI 10.1083/jcb.200304021; Da Silva JS, 2002, NAT REV NEUROSCI, V3, P694, DOI 10.1038/nrn918; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015; Fukui K, 1997, J BIOL CHEM, V272, P4655, DOI 10.1074/jbc.272.8.4655; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Haubert D, 2007, EMBO J, V26, P3308, DOI 10.1038/sj.emboj.7601778; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; Hisata S, 2007, J CELL BIOL, V178, P843, DOI 10.1083/jcb.200610073; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Hozumi Y, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-99; Itoh T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000393; Jackson SG, 2006, ACTA CRYSTALLOGR D, V62, P324, DOI 10.1107/S0907444905043179; JALINK K, 1993, CELL GROWTH DIFFER, V4, P247; Kanaho Y, 2009, BBA-MOL CELL BIOL L, V1791, P898, DOI 10.1016/j.bbalip.2009.03.010; Kooijman EE, 2003, TRAFFIC, V4, P162, DOI 10.1034/j.1600-0854.2003.00086.x; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Liao YH, 2001, J BIOL CHEM, V276, P28478, DOI 10.1074/jbc.M101737200; Liu C, 2008, MOL CELL BIOL, V28, P7109, DOI 10.1128/MCB.01060-08; Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; MITCHISON T, 1988, NEURON, V1, P761, DOI 10.1016/0896-6273(88)90124-9; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Picard M, 2009, CELL SIGNAL, V21, P1961, DOI 10.1016/j.cellsig.2009.09.004; Sakane F, 2007, BBA-MOL CELL BIOL L, V1771, P793, DOI 10.1016/j.bbalip.2007.04.006; Sakisaka T, 2004, J CELL BIOL, V166, P17, DOI 10.1083/jcb.200405002; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Sebok A, 1999, J NEUROCHEM, V73, P949, DOI 10.1046/j.1471-4159.1999.0730949.x; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shirai Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011602; Song C, 2001, J BIOL CHEM, V276, P2752, DOI 10.1074/jbc.M008324200; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Umikawa M, 1999, J BIOL CHEM, V274, P25197, DOI 10.1074/jbc.274.36.25197; Vanderklish PW, 2002, P NATL ACAD SCI USA, V99, P1639, DOI 10.1073/pnas.032681099; Vetter IR, 1999, FEBS LETT, V451, P175, DOI 10.1016/S0014-5793(99)00555-4; Wakamatsu I, 2006, MOL CELL BIOCHEM, V293, P137, DOI 10.1007/s11010-006-9236-1; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Yamada T, 2005, J BIOL CHEM, V280, P33026, DOI 10.1074/jbc.M504587200; Yang YL, 2008, J NEUROSCI, V28, P5740, DOI 10.1523/JNEUROSCI.3998-07.2008; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594; Zito K, 2002, NEURON, V35, P1015, DOI 10.1016/S0896-6273(02)00903-0	63	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6832	6843		10.1074/jbc.M110.183772	http://dx.doi.org/10.1074/jbc.M110.183772			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21169361	Green Published, hybrid			2022-12-27	WOS:000287476400090
J	Teupser, D; Weber, O; Rao, TN; Sass, K; Thiery, J; Fehling, HJ				Teupser, Daniel; Weber, Odile; Rao, Tata Nageswara; Sass, Kristina; Thiery, Joachim; Fehling, Hans Joerg			No Reduction of Atherosclerosis in C-reactive Protein (CRP)-deficient Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONARY-HEART-DISEASE; APOLIPOPROTEIN-E GENE; E-DEFICIENT MICE; BRACHIOCEPHALIC ARTERY; TRANSGENIC MICE; KNOCKOUT MICE; MOUSE MODELS; AORTIC ROOT; HYPERCHOLESTEROLEMIA; MODIFIERS	C-reactive protein (CRP), a phylogenetically highly conserved plasma protein, is the classical acute phase reactant in humans. Upon infection, inflammation, or tissue damage, its plasma level can rise within hours > 1000-fold, providing an early, nonspecific disease indicator of prime clinical importance. In recent years, another aspect of CRP expression has attracted much scientific and public attention. Apart from transient, acute phase-associated spikes in plasma concentration, highly sensitive measurements have revealed stable interindividual differences of baseline CRP values in healthy persons. Strikingly, even modest elevations in stable baseline CRP plasma levels have been found to correlate with a significantly increased risk of future cardiovascular disease. These observations have triggered intense controversies about potential atherosclerosis-promoting properties of CRP. To directly assess potential effects of CRP on atherogenesis, we have generated CRP-deficient mice via gene targeting and introduced the inactivated allele into atherosclerosis-susceptible ApoE(-/-) and LDLR-/- mice, two well established mouse models of atherogenesis. Morphometric analyses of atherosclerotic plaques in CRP-deficient animals revealed equivalent or increased atherosclerotic lesions compared with controls, an experimental result, which does not support a proatherogenic role of CRP. In fact, our data suggest that mouse CRP may even mediate atheroprotective effects, adding a cautionary note to the idea of targeting CRP as therapeutic intervention against progressive cardiovascular disease.	Univ Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, D-04103 Leipzig, Germany; [Teupser, Daniel; Sass, Kristina; Thiery, Joachim] Univ Leipzig, Leipzig Res Ctr Civilizat Dis, D-04103 Leipzig, Germany; [Weber, Odile; Rao, Tata Nageswara; Fehling, Hans Joerg] Univ Clin Ulm, Inst Immunol, D-89081 Ulm, Germany	Leipzig University; Leipzig University; Ulm University	Fehling, HJ (corresponding author), Albert Einstein Allee 11, D-89081 Ulm, Germany.	Joerg.fehling@uni-ulm.de		Tata, Nageswara Rao/0000-0002-9928-5944; Fehling, Hans Joerg/0000-0002-4580-1990	Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes, and Environment at the Universitat Leipzig; European Union; European Regional Development Fund; Free State of Saxony;  [SFB451-Teilprojekt B12]	Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes, and Environment at the Universitat Leipzig; European Union(European Commission); European Regional Development Fund(European Commission); Free State of Saxony; 	This work was supported by SFB451-Teilprojekt B12 and by the Leipzig Interdisciplinary Research Cluster of Genetic Factors, Clinical Phenotypes, and Environment at the Universitat Leipzig. LIFE is funded by the European Union, the European Regional Development Fund, and the Free State of Saxony within the framework of the excellence initiative.	Black S, 2004, J BIOL CHEM, V279, P48487, DOI 10.1074/jbc.R400025200; Breslow JL, 1996, SCIENCE, V272, P685, DOI 10.1126/science.272.5262.685; Casas JP, 2008, J INTERN MED, V264, P295, DOI 10.1111/j.1365-2796.2008.02015.x; Dansky HM, 1999, ARTERIOSCL THROM VAS, V19, P1960, DOI 10.1161/01.ATV.19.8.1960; Davignon J, 2005, ARTERIOSCL THROM VAS, V25, P267, DOI 10.1161/01.ATV.0000154570.50696.2c; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hirschfield GM, 2005, P NATL ACAD SCI USA, V102, P8309, DOI 10.1073/pnas.0503202102; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Knowles JW, 2000, ARTERIOSCL THROM VAS, V20, P2336, DOI 10.1161/01.ATV.20.11.2336; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Kovacs A, 2007, P NATL ACAD SCI USA, V104, P13768, DOI 10.1073/pnas.0706027104; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Nilsson J, 2005, ARTERIOSCL THROM VAS, V25, P1527, DOI 10.1161/01.ATV.0000174796.81443.3f; Paffen E, 2006, CARDIOVASC RES, V71, P30, DOI 10.1016/j.cardiores.2006.03.004; Paul A, 2004, CIRCULATION, V109, P647, DOI 10.1161/01.CIR.0000114526.50618.24; Pepys MB, 2008, NAT CLIN PRACT NEPHR, V4, P234, DOI 10.1038/ncpneph0778; PEPYS MB, 1979, IMMUNOLOGY, V37, P637; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Reifenberg K, 2005, ARTERIOSCL THROM VAS, V25, P1641, DOI 10.1161/01.ATV.0000171983.95612.90; Schwedler SB, 2005, CIRCULATION, V112, P1016, DOI 10.1161/CIRCULATIONAHA.105.556530; Scirica BM, 2006, CIRCULATION, V113, P2128, DOI 10.1161/CIRCULATIONAHA.105.611350; Smith Jonathan D, 2006, Expert Rev Cardiovasc Ther, V4, P703, DOI 10.1586/14779072.4.5.703; Su ZG, 2006, GENETICS, V172, P1799, DOI 10.1534/genetics.105.051912; Tennent GA, 2008, ATHEROSCLEROSIS, V196, P248, DOI 10.1016/j.atherosclerosis.2007.05.010; Teupser D, 2004, P NATL ACAD SCI USA, V101, P17795, DOI 10.1073/pnas.0408096101; Teupser D, 2003, ARTERIOSCL THROM VAS, V23, P1907, DOI 10.1161/01.ATV.0000090126.34881.B1; Torzewski M, 2008, THROMB HAEMOSTASIS, V99, P196, DOI 10.1160/TH07-10-0595; Trion A, 2005, ARTERIOSCL THROM VAS, V25, P1635, DOI 10.1161/01.ATV.0000171992.36710.1e; Verma S, 2006, CIRCULATION, V113, P2135; Verma S, 2005, NAT CLIN PRACT CARD, V2, P29, DOI 10.1038/ncpcardio0074; Wouters K, 2005, CLIN CHEM LAB MED, V43, P470, DOI 10.1515/CCLM.2005.085; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	38	61	68	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6272	6279		10.1074/jbc.M110.161414	http://dx.doi.org/10.1074/jbc.M110.161414			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21149301	hybrid, Green Published			2022-12-27	WOS:000287476400037
J	Bansal, K; Balaji, KN				Bansal, Kushagra; Balaji, Kithiganahalli N.			Intracellular Pathogen Sensor NOD2 Programs Macrophages to Trigger Notch1 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROHNS-DISEASE; NITRIC-OXIDE; SOCS3 EXPRESSION; DENDRITIC CELLS; INNATE IMMUNITY; UP-REGULATION; MOUSE MODEL; INFLAMMATION; RECOGNITION; CYCLOOXYGENASE-2	Intracellular pathogen sensor, NOD2, has been implicated in regulation of wide range of anti-inflammatory responses critical during development of a diverse array of inflammatory diseases; however, underlying molecular details are still imprecisely understood. In this study, we demonstrate that NOD2 programs macrophages to trigger Notch1 signaling. Signaling perturbations or genetic approaches suggest signaling integration through cross-talk between Notch1-PI3K during the NOD2-triggered expression of a multitude of immunological parameters including COX-2/PGE(2) and IL-10. NOD2 stimulation enhanced active recruitment of CSL/RBP-Jk on the COX-2 promoter in vivo. Intriguingly, nitric oxide assumes critical importance in NOD2-mediated activation of Notch1 signaling as iNOS(-/-) macrophages exhibited compromised ability to execute NOD2-triggered Notch1 signaling responses. Correlative evidence demonstrates that this mechanism operates in vivo in brain and splenocytes derived from wild type, but not from iNOS(-/-) mice. Importantly, NOD2-driven activation of the Notch1-PI3K signaling axis contributes to its capacity to impart survival of macrophages against TNF-alpha or IFN-gamma-mediated apoptosis and resolution of inflammation. Current investigation identifies Notch1-PI3K as signaling cohorts involved in the NOD2-triggered expression of a battery of genes associated with anti-inflammatory functions. These findings serve as a paradigm to understand the pathogenesis of NOD2-associated inflammatory diseases and clearly pave a way toward development of novel therapeutics.	[Bansal, Kushagra; Balaji, Kithiganahalli N.] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Balaji, KN (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	balaji@mcbl.iisc.ernet.in			Indian Council of Medical Research (ICMR); Department of Biotechnology (DBT); VINNOVA (The Swedish Governmental Agency for Innovation Systems); DBT, India; Department of Science and Technology (DST); Council for Scientific and Industrial Research; Indian Institute of Science, Bangalore, India	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); VINNOVA (The Swedish Governmental Agency for Innovation Systems)(Vinnova); DBT, India(Department of Biotechnology (DBT) India); Department of Science and Technology (DST)(Department of Science & Technology (India)); Council for Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Indian Institute of Science, Bangalore, India	This work was supported by funds from the Indian Council of Medical Research (ICMR), the Department of Biotechnology (DBT); a collaborative grant (to the Indian Institute of Science and Karolinska Institute) from VINNOVA (The Swedish Governmental Agency for Innovation Systems) and DBT, India; the Department of Science and Technology (DST); and the Council for Scientific and Industrial Research (to K.N.B.) and by infrastructure support from ICMR (Center for Advanced Study in Molecular Medicine), DST (Fund for Improvement of Science and Technology Infrastructure in Universities and Higher Educational Institutions), and University Grants Commission (special assistance).; Supported by a fellowship from the Indian Institute of Science, Bangalore, India.	Bansal K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004911; Bansal K, 2009, J LEUKOCYTE BIOL, V85, P804, DOI 10.1189/jlb.0908561; BETZ M, 1991, J IMMUNOL, V146, P108; Beverly LJ, 2005, CANCER RES, V65, P7159, DOI 10.1158/0008-5472.CAN-05-1664; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Butler M, 2007, J CROHNS COLITIS, V1, P106, DOI 10.1016/j.crohns.2007.08.006; Chen C, 2010, NAT CHEM BIOL, V6, P401, DOI 10.1038/nchembio.375; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240; Dumont E, 2000, ONCOGENE, V19, P556, DOI 10.1038/sj.onc.1203352; Eckmann L, 2005, IMMUNITY, V22, P661, DOI 10.1016/j.immuni.2005.06.004; EHEBAUER M, 2006, SCI STKE, pCM7, DOI DOI 10.1126/STKE.3642006CM7; Franchi L, 2008, CELL MICROBIOL, V10, P1, DOI 10.1111/j.1462-5822.2007.01059.x; Fung E, 2007, CIRCULATION, V115, P2948, DOI 10.1161/CIRCULATIONAHA.106.675462; Gilroy DW, 1999, NAT MED, V5, P698, DOI 10.1038/9550; Goralski KB, 2005, AM J PHYSIOL-GASTR L, V289, pG434, DOI 10.1152/ajpgi.00562.2004; Groeger AL, 2010, NAT CHEM BIOL, V6, P433, DOI 10.1038/nchembio.367; Gutierrez A, 2007, CANCER CELL, V12, P411, DOI 10.1016/j.ccr.2007.10.027; Harizi H, 2006, CELL MOL IMMUNOL, V3, P271; Henckaerts L, 2007, INFLAMM BOWEL DIS, V13, P235, DOI 10.1002/ibd.20066; Hori K, 2008, GENE DEV, V22, P166, DOI 10.1101/gad.1628008; Ishimura N, 2005, GASTROENTEROLOGY, V128, P1354, DOI 10.1053/j.gastro.2005.01.055; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kimura M, 2003, CELL DEATH DIFFER, V10, P718, DOI 10.1038/sj.cdd.4401219; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Magalhaes JG, 2008, J IMMUNOL, V181, P7925, DOI 10.4049/jimmunol.181.11.7925; Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Masek KS, 2006, J CELL SCI, V119, P4565, DOI 10.1242/jcs.03206; Monsalve E, 2006, J IMMUNOL, V176, P5362, DOI 10.4049/jimmunol.176.9.5362; Nakhai H, 2008, DEVELOPMENT, V135, P2757, DOI 10.1242/dev.013722; Narayana Y, 2008, J BIOL CHEM, V283, P12501, DOI 10.1074/jbc.M709960200; Narayana Y, 2009, MOL IMMUNOL, V46, P2947, DOI 10.1016/j.molimm.2009.06.019; NIEUWENHUIJZEN GAP, 1993, ANN SURG, V218, P791, DOI 10.1097/00000658-199312000-00014; Philpott DJ, 2009, NAT IMMUNOL, V10, P455, DOI 10.1038/ni0509-455; Rahman MK, 2010, J IMMUNOL, V184, P7247, DOI 10.4049/jimmunol.0901479; Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104; Sade H, 2004, J BIOL CHEM, V279, P2937, DOI 10.1074/jbc.M309924200; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schroeder T, 2003, J IMMUNOL, V170, P5538, DOI 10.4049/jimmunol.170.11.5538; Seibert K, 1999, NAT MED, V5, P621, DOI 10.1038/9465; Sharma VM, 2006, MOL CELL BIOL, V26, P8022, DOI 10.1128/MCB.01091-06; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; Totemeyer S, 2006, J IMMUNOL, V176, P4804, DOI 10.4049/jimmunol.176.8.4804; Watanabe J, 2010, AM J PHYSIOL-GASTR L, V298, pG842, DOI 10.1152/ajpgi.00468.2009; Windheim M, 2007, BIOCHEM J, V404, P179, DOI 10.1042/BJ20061704; Zhang X, 2008, J PATHOL, V214, P161, DOI 10.1002/path.2284	50	28	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5823	5835		10.1074/jbc.M110.192393	http://dx.doi.org/10.1074/jbc.M110.192393			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21156799	Green Published, hybrid			2022-12-27	WOS:000287230600091
J	Disse, J; Petersen, HH; Larsen, KS; Persson, E; Esmon, N; Esmon, CT; Teyton, L; Petersen, LC; Ruf, W				Disse, Jennifer; Petersen, Helle Heibroch; Larsen, Katrine S.; Persson, Egon; Esmon, Naomi; Esmon, Charles T.; Teyton, Luc; Petersen, Lars C.; Ruf, Wolfram			The Endothelial Protein C Receptor Supports Tissue Factor Ternary Coagulation Initiation Complex Signaling through Protease-activated Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; FACTOR CYTOPLASMIC DOMAIN; FACTOR VIIA; FACTOR-XA; GROWTH-FACTOR; GLA DOMAIN; DISULFIDE-ISOMERASE; CRYSTAL-STRUCTURE; FACTOR EXPRESSION; BINDING	Protease-activated receptor (PAR) signaling is closely linked to the cellular activation of the pro- and anticoagulant pathways. The endothelial protein C receptor (EPCR) is crucial for signaling by activated protein C through PAR1, but EPCR may have additional roles by interacting with the 4-carboxyglutamic acid domains of procoagulant coagulation factors VII (FVII) and X (FX). Here we show that soluble EPCR regulates the interaction of FX with human or mouse tissue factor (TF)-FVIIa complexes. Mutagenesis of the FVIIa 4-carboxyglutamic acid domain and dose titrations with FX showed that EPCR interacted primarily with FX to attenuate FX activation in lipid-free assay systems. In human cell models of TF signaling, antibody inhibition of EPCR selectively blocked PAR activation by the ternary TF-FVIIa-FXa complex but not by the non-coagulant TF-FVIIa binary complex. Heterologous expression of EPCR promoted PAR1 and PAR2 cleavage by FXa in the ternary complex but did not alter PAR2 cleavage by TF-FVIIa. In murine smooth muscle cells that constitutively express EPCR and TF, thrombin and FVIIa/FX but not FVIIa alone induced PAR1-dependent signaling. Although thrombin signaling was unchanged, cells with genetically reduced levels of EPCR no longer showed a signaling response to the ternary complex. These results demonstrate that EPCR interacts with the ternary TF coagulation initiation complex to enable PAR signaling and suggest that EPCR may play a role in regulating the biology of TF-expressing extravascular and vessel wall cells that are exposed to limited concentrations of FVIIa and FX provided by ectopic synthesis or vascular leakage.	[Disse, Jennifer; Petersen, Helle Heibroch; Larsen, Katrine S.; Teyton, Luc; Ruf, Wolfram] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Petersen, Helle Heibroch; Larsen, Katrine S.; Persson, Egon; Petersen, Lars C.] Novo Nordisk, Dept Haemostasis Biol, DK-2760 Malov, Denmark; [Esmon, Naomi; Esmon, Charles T.] Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Esmon, Charles T.] Howard Hughes Med Inst, Oklahoma City, OK 73104 USA	Scripps Research Institute; Novo Nordisk; Oklahoma Medical Research Foundation; Howard Hughes Medical Institute	Ruf, W (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ruf@scripps.edu		Persson, Egon/0000-0003-3005-4926	National Institutes of Health, NHLBI [HL077753, HL100115]; NHLBI [HL100115]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100115, R01HL077753] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL077753 and HL100115 from the NHLBI.	Ahamed J, 2004, J BIOL CHEM, V279, P23038, DOI 10.1074/jbc.M401376200; Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; Albrektsen T, 2007, J THROMB HAEMOST, V5, P1588, DOI 10.1111/j.1538-7836.2007.02603.x; Bae JS, 2007, BLOOD, V110, p520A; Bae JS, 2007, P NATL ACAD SCI USA, V104, P2867, DOI 10.1073/pnas.0611493104; Bajaj SP, 2006, J BIOL CHEM, V281, P24873, DOI 10.1074/jbc.M509971200; Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Bergum PW, 2001, J BIOL CHEM, V276, P10063, DOI 10.1074/jbc.M009116200; Bretschneider E, 2007, CIRC RES, V100, P255, DOI 10.1161/01.RES.0000255685.06922.c7; Camerer E, 2000, P NATL ACAD SCI USA, V97, P5255, DOI 10.1073/pnas.97.10.5255; Camerer E, 2000, J BIOL CHEM, V275, P6580, DOI 10.1074/jbc.275.9.6580; Camerer E, 2002, J BIOL CHEM, V277, P16081, DOI 10.1074/jbc.M108555200; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Cao CZ, 2010, J CLIN INVEST, V120, P1971, DOI 10.1172/JCI40380; Castellino FJ, 2002, THROMB HAEMOSTASIS, V88, P462; Centelles MN, 2010, THROMB HAEMOSTASIS, V103, P1239, DOI 10.1160/TH09-11-0750; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Damiano BP, 1999, J PHARMACOL EXP THER, V288, P671; Demetz G, 2010, ATHEROSCLEROSIS, V212, P466, DOI 10.1016/j.atherosclerosis.2010.07.017; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Elphick GF, 2009, BLOOD, V113, P4078, DOI 10.1182/blood-2008-09-180968; Esmon CT, 2006, CURR OPIN HEMATOL, V13, P382, DOI 10.1097/01.moh.0000239712.93662.35; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Feistritzer C, 2006, J BIOL CHEM, V281, P20077, DOI 10.1074/jbc.M600506200; GASIC GP, 1992, P NATL ACAD SCI USA, V89, P2317, DOI 10.1073/pnas.89.6.2317; Ghosh S, 2007, J BIOL CHEM, V282, P11849, DOI 10.1074/jbc.M609283200; Gopalakrishnan R, 2010, J THROMB HAEMOST, V8, P301, DOI 10.1111/j.1538-7836.2009.03696.x; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Hoffman M, 2007, J THROMB HAEMOST, V5, P1403, DOI 10.1111/j.1538-7836.2007.02576.x; Kerschen E, 2010, J CLIN INVEST, V120, P3167, DOI 10.1172/JCI42629; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Koo BH, 2002, FEBS LETT, V523, P85, DOI 10.1016/S0014-5793(02)02948-4; Larsen KS, 2010, J BIOL CHEM, V285, P19959, DOI 10.1074/jbc.M110.101030; Li WH, 2005, BLOOD, V106, P2716, DOI 10.1182/blood-2005-01-0406; Liaw PCY, 2001, J BIOL CHEM, V276, P8364, DOI 10.1074/jbc.M010572200; Lopez-Sagaseta J, 2007, J THROMB HAEMOST, V5, P1817, DOI 10.1111/j.1538-7836.2007.02648.x; Lopez-Sagaseta J, 2009, PROTEIN EXPRES PURIF, V64, P194, DOI 10.1016/j.pep.2008.11.002; Luther T, 1996, AM J PATHOL, V149, P101; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Mueller BM, 1998, J CLIN INVEST, V101, P1372, DOI 10.1172/JCI930; Nayak RC, 2009, BLOOD, V114, P1974, DOI 10.1182/blood-2009-03-208900; O'Brien PJ, 2000, J BIOL CHEM, V275, P13502, DOI 10.1074/jbc.275.18.13502; Oganesyan V, 2002, J BIOL CHEM, V277, P24851, DOI 10.1074/jbc.C200163200; Pendurthi UR, 2000, J BIOL CHEM, V275, P14632, DOI 10.1074/jbc.275.19.14632; Persson E, 2007, J THROMB HAEMOST, V5, P1977, DOI 10.1111/j.1538-7836.2007.02661.x; Persson E, 2001, P NATL ACAD SCI USA, V98, P13583, DOI 10.1073/pnas.241339498; Persson E, 2008, THROMB RES, V123, P171, DOI 10.1016/j.thromres.2008.04.012; Petersen LC, 2005, THROMB RES, V116, P75, DOI 10.1016/j.thromres.2004.11.003; Preston RJS, 2006, J BIOL CHEM, V281, P28850, DOI 10.1074/jbc.M604966200; Puy C, 2010, BRIT J HAEMATOL, V149, P111, DOI 10.1111/j.1365-2141.2009.08060.x; Riewald M, 2005, J BIOL CHEM, V280, P19808, DOI 10.1074/jbc.M500747200; Riewald M, 2002, SCIENCE, V296, P1880, DOI 10.1126/science.1071699; Riewald M, 2001, P NATL ACAD SCI USA, V98, P7742, DOI 10.1073/pnas.141126698; Riewald M, 2001, BLOOD, V97, P3109, DOI 10.1182/blood.V97.10.3109; Ruf W, 2003, J THROMB HAEMOST, V1, P1495, DOI 10.1046/j.1538-7836.2003.00300.x; Ruf W, 1998, TRENDS CARDIOVAS MED, V8, P350, DOI 10.1016/S1050-1738(98)00031-0; Russo A, 2009, P NATL ACAD SCI USA, V106, P6393, DOI 10.1073/pnas.0810687106; Schaffner F, 2010, BLOOD, V116, P6106, DOI 10.1182/blood-2010-06-289314; Schecter AD, 1997, J CLIN INVEST, V100, P2276, DOI 10.1172/JCI119765; Schuepbach RA, 2010, J THROMB HAEMOST, V8, P379, DOI 10.1111/j.1538-7836.2009.03682.x; Scotton CJ, 2009, J CLIN INVEST, V119, P2550, DOI 10.1172/JCI33288; Sen P, 2010, J BIOL CHEM, V285, P20410, DOI 10.1074/jbc.M110.111575; Shikamoto Y, 2003, J BIOL CHEM, V278, P24090, DOI 10.1074/jbc.M300650200; Shinagawa K, 2007, AM J RESP CRIT CARE, V175, P136, DOI 10.1164/rccm.200608-1097OC; Siegbahn A, 2000, BLOOD, V96, P3452, DOI 10.1182/blood.V96.10.3452.h8003452_3452_3458; Stanssens P, 1996, P NATL ACAD SCI USA, V93, P2149, DOI 10.1073/pnas.93.5.2149; STONE MJ, 1995, BIOCHEM J, V310, P605, DOI 10.1042/bj3100605; Versteeg HH, 2008, BLOOD, V111, P190, DOI 10.1182/blood-2007-07-101048; Versteeg HH, 2007, J BIOL CHEM, V282, P25416, DOI 10.1074/jbc.M702410200; Xu J, 2009, J THROMB HAEMOST, V7, P851, DOI 10.1111/j.1538-7836.2009.03333.x; Xue ML, 2007, J BIOL CHEM, V282, P13610, DOI 10.1074/jbc.M610740200; Xue ML, 2005, J INVEST DERMATOL, V125, P1279, DOI 10.1111/j.0022-202X.2005.23952.x; Yang XV, 2009, P NATL ACAD SCI USA, V106, P274, DOI 10.1073/pnas.0807594106; Zhang Q, 2009, PROTEINS, V77, P559, DOI 10.1002/prot.22468; Zheng X, 2007, J THROMB HAEMOST, V5, P1394, DOI 10.1111/j.1538-7836.2007.02592.x	75	79	81	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5756	5767		10.1074/jbc.M110.201228	http://dx.doi.org/10.1074/jbc.M110.201228			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21149441	Green Published, hybrid			2022-12-27	WOS:000287230600084
J	Wang, YQ; Buell, AK; Wang, XY; Welland, ME; Dobson, CM; Knowles, TPJ; Perrett, S				Wang, Yi-Qian; Buell, Alexander K.; Wang, Xin-Yu; Welland, Mark E.; Dobson, Christopher M.; Knowles, Tuomas P. J.; Perrett, Sarah			Relationship between Prion Propensity and the Rates of Individual Molecular Steps of Fibril Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMATION IN-VITRO; SACCHAROMYCES-CEREVISIAE; AMYLOID FIBRILS; PROTEIN URE2; YEAST URE2P; SEEDING SPECIFICITY; ALZHEIMERS-DISEASE; SPECIES BARRIERS; NUCLEATION; DOMAIN	Peptides and proteins possess an inherent propensity to self-assemble into generic fibrillar nanostructures known as amyloid fibrils, some of which are involved in medical conditions such as Alzheimer disease. In certain cases, such structures can self-propagate in living systems as prions and transmit characteristic traits to the host organism. The mechanisms that allow certain amyloid species but not others to function as prions are not fully understood. Much progress in understanding the prion phenomenon has been achieved through the study of prions in yeast as this system has proved to be experimentally highly tractable; but quantitative understanding of the biophysics and kinetics of the assembly process has remained challenging. Here, we explore the assembly of two closely related homologues of the Ure2p protein from Saccharomyces cerevisiae and Saccharomyces paradoxus, and by using a combination of kinetic theory with solution and biosensor assays, we are able to compare the rates of the individual microscopic steps of prion fibril assembly. We find that for these proteins the fragmentation rate is encoded in the structure of the seed fibrils, whereas the elongation rate is principally determined by the nature of the soluble precursor protein. Our results further reveal that fibrils that elongate faster but fracture less frequently can lose their ability to propagate as prions. These findings illuminate the connections between the in vitro aggregation of proteins and the in vivo proliferation of prions, and provide a framework for the quantitative understanding of the parameters governing the behavior of amyloid fibrils in normal and aberrant biological pathways.	[Buell, Alexander K.; Welland, Mark E.; Knowles, Tuomas P. J.] Univ Cambridge, Nanosci Ctr, Cambridge CB3 0FF, England; [Wang, Yi-Qian; Wang, Xin-Yu; Perrett, Sarah] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Wang, Xin-Yu] Nankai Univ, Sch Phys, Tianjin 300071, Peoples R China; [Dobson, Christopher M.; Knowles, Tuomas P. J.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Wang, Yi-Qian] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	University of Cambridge; Chinese Academy of Sciences; Institute of Biophysics, CAS; Nankai University; University of Cambridge; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Knowles, TPJ (corresponding author), Univ Cambridge, Nanosci Ctr, Cambridge CB3 0FF, England.	tpjk2@cam.ac.uk; sarah.perrett@cantab.net	Knowles, Tuomas/C-6663-2009; Buell, Alexander/B-4155-2013; 王, 新宇/B-1043-2012; Wang, Xin/AAN-8435-2021; Perrett, Sarah/AAS-9483-2020	Knowles, Tuomas/0000-0002-7879-0140; Buell, Alexander/0000-0003-1161-3622; 王, 新宇/0000-0002-2681-4614; Wang, Xin/0000-0002-4457-7376; Perrett, Sarah/0000-0003-0137-0997	National Natural Science Foundation of China [30620130109, 30670428, 30870482, 31070656]; Chinese Ministry of Science and Technology [2006CB500703, 2006CB910903]; Chinese Academy of Sciences [KSCX2-YW-R-119, KSCX2-YW-R-256]; IRC in Nanotechnology; Wellcome and Leverhulme Trusts; St John's College, Cambridge; Science and Innovation Section of the Foreign & Commonwealth Office; Royal Society; MRC [MC_G1000734] Funding Source: UKRI; Medical Research Council [MC_G1000734] Funding Source: researchfish	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); IRC in Nanotechnology; Wellcome and Leverhulme Trusts; St John's College, Cambridge; Science and Innovation Section of the Foreign & Commonwealth Office; Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by grants from the National Natural Science Foundation of China (30620130109, 30670428, 30870482, 31070656), the Chinese Ministry of Science and Technology (2006CB500703, 2006CB910903) and the Chinese Academy of Sciences (KSCX2-YW-R-119, KSCX2-YW-R-256) (to S. P.), as well as support from the IRC in Nanotechnology (to M. E. W. and A. K. B.), the Wellcome and Leverhulme Trusts (to C. M. D.), and St John's College, Cambridge (to T. P. J. K.). The initial stages of this work were supported by a "UK China Partners in Science II"' fund award from the Science and Innovation Section of the Foreign & Commonwealth Office (to T. P. J. K.). This work was facilitated by a Royal Society International Joint Project Grant (to Laura Itzhaki and S. P.).	Aguzzi A, 2003, SCIENCE, V302, P814, DOI 10.1126/science.1087348; Bai M, 2004, J BIOL CHEM, V279, P50025, DOI 10.1074/jbc.M406612200; Baudin-Baillieu A, 2003, MOL BIOL CELL, V14, P3449, DOI 10.1091/mbc.e03-01-0007; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chien P, 2001, NATURE, V410, P223, DOI 10.1038/35065632; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Cooper TG, 2002, FEMS MICROBIOL REV, V26, P223, DOI 10.1111/j.1574-6976.2002.tb00612.x; COSCHIGANO PW, 1991, MOL CELL BIOL, V11, P822, DOI 10.1128/MCB.11.2.822; Crapeau M, 2009, MOL BIOL CELL, V20, P2286, DOI 10.1091/mbc.E08-11-1097; DePace AH, 2002, NAT STRUCT BIOL, V9, P389, DOI 10.1038/nsb786; Devlin GL, 2006, J MOL BIOL, V360, P497, DOI 10.1016/j.jmb.2006.05.007; Edskes HK, 2009, GENETICS, V181, P1159, DOI 10.1534/genetics.108.099929; Edskes HK, 2002, P NATL ACAD SCI USA, V99, P16384, DOI 10.1073/pnas.162349599; Fay N, 2003, J BIOL CHEM, V278, P30199, DOI 10.1074/jbc.M303000200; Hall D, 2004, J MOL BIOL, V336, P775, DOI 10.1016/j.jmb.2003.12.004; Hovgaard MB, 2007, BIOPHYS J, V93, P2162, DOI 10.1529/biophysj.107.109686; Immel F, 2007, J BIOL CHEM, V282, P7912, DOI 10.1074/jbc.M608652200; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jiang Y, 2004, J BIOL CHEM, V279, P3361, DOI 10.1074/jbc.M310494200; Jones EM, 2005, CELL, V121, P63, DOI 10.1016/j.cell.2005.01.034; Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057; Knowles TPJ, 2007, P NATL ACAD SCI USA, V104, P10016, DOI 10.1073/pnas.0610659104; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679; Kunes KC, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051915; Lian HY, 2006, BBA-PROTEINS PROTEOM, V1764, P535, DOI 10.1016/j.bbapap.2005.11.016; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Masel J, 2004, BIOPHYS J, V87, P728, DOI 10.1529/biophysj.104.039867; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Perrett S, 1999, J MOL BIOL, V290, P331, DOI 10.1006/jmbi.1999.2872; Perrett S, 2008, CURR OPIN STRUC BIOL, V18, P52, DOI 10.1016/j.sbi.2007.12.005; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Poschel T, 2003, BIOPHYS J, V85, P3460, DOI 10.1016/S0006-3495(03)74767-5; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saupe SJ, 2007, PRION, V1, P110, DOI 10.4161/pri.1.2.4666; Schlumpberger M, 2000, PROTEIN SCI, V9, P440; Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103; Stohr J, 2008, P NATL ACAD SCI USA, V105, P2409, DOI 10.1073/pnas.0712036105; Talarek N, 2005, GENETICS, V171, P23, DOI 10.1534/genetics.105.043489; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; Tessier PM, 2009, NAT STRUCT MOL BIOL, V16, P598, DOI 10.1038/nsmb.1617; Thual C, 2001, BIOCHEMISTRY-US, V40, P1764, DOI 10.1021/bi001916l; Watzky MA, 2008, BIOCHEMISTRY-US, V47, P10790, DOI 10.1021/bi800726m; White DA, 2009, FEBS LETT, V583, P2587, DOI 10.1016/j.febslet.2009.06.008; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Zhang ZR, 2009, J BIOL CHEM, V284, P14058, DOI 10.1074/jbc.M901189200; Zhang ZR, 2008, J MOL BIOL, V384, P641, DOI 10.1016/j.jmb.2008.09.047; Zhu L, 2003, J MOL BIOL, V328, P235, DOI 10.1016/S0022-2836(03)00249-3	56	27	28	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.208934	http://dx.doi.org/10.1074/jbc.M110.208934			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21233211	Green Published, hybrid			2022-12-27	WOS:000289077500025
J	Huang, M; Whang, P; Chodaparambil, JV; Pollyea, DA; Kusler, B; Xu, LW; Felsher, DW; Mitchell, BS				Huang, Min; Whang, Patrick; Chodaparambil, Jayanth V.; Pollyea, Daniel A.; Kusler, Brenda; Xu, Liwen; Felsher, Dean W.; Mitchell, Beverly S.			Reactive Oxygen Species Regulate Nucleostemin Oligomerization and Protein Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; REDOX REGULATION; C-MYC; DNA-DAMAGE; GENETIC INSTABILITY; OXIDATIVE STRESS; MOLECULAR-BASIS; ROS PRODUCTION; MECHANISM; PROGRESSION	Nucleostemin (NS) is a nucleolar-nucleoplasmic shuttle protein that regulates cell proliferation, binds p53 and Mdm2, and is highly expressed in tumor cells. We have identified NS as a target of oxidative regulation in transformed hematopoietic cells. NS oligomerization occurs in HL-60 leukemic cells and Raji B lymphoblasts that express high levels of c-Myc and have high intrinsic levels of reactive oxygen species (ROS); reducing agents dissociate NS into monomers and dimers. Exposure of U2OS osteosarcoma cells with low levels of intrinsic ROS to hydrogen peroxide (H2O2) induces thiol-reversible disulfide bond-mediated oligomerization of NS. Increased exposure to H2O2 impairs NS degradation, immobilizes the protein within the nucleolus, and results in detergent-insoluble NS. The regulation of NS by ROS was validated in a murine lymphoma tumor model in which c-Myc is overexpressed and in CD34+ cells from patients with chronic myelogenous leukemia in blast crisis. In both instances, increased ROS levels were associated with markedly increased expression of NS protein and thiol-reversible oligomerization. Site-directed mutagenesis of critical cysteine-containing regions of nucleostemin altered both its intracellular localization and its stability. MG132, a potent proteasome inhibitor and activator of ROS, markedly decreased degradation and increased nucleolar retention of NS mutants, whereas N-acetyl-L-cysteine largely prevented the effects of MG132. These results indicate that NS is a highly redox-sensitive protein. Increased intracellular ROS levels, such as those that result from oncogenic transformation in hematopoietic malignancies, regulate the ability of NS to oligomerize, prevent its degradation, and may alter its ability to regulate cell proliferation.	[Huang, Min; Whang, Patrick; Pollyea, Daniel A.; Kusler, Brenda; Xu, Liwen; Felsher, Dean W.; Mitchell, Beverly S.] Stanford Univ, Sch Med, Stanford Canc Ctr, Stanford, CA 94305 USA; [Huang, Min; Whang, Patrick; Pollyea, Daniel A.; Kusler, Brenda; Xu, Liwen; Felsher, Dean W.; Mitchell, Beverly S.] Stanford Univ, Sch Med, Dept Med, Div Oncol, Stanford, CA 94305 USA; [Huang, Min; Whang, Patrick; Pollyea, Daniel A.; Kusler, Brenda; Xu, Liwen; Felsher, Dean W.; Mitchell, Beverly S.] Stanford Univ, Sch Med, Dept Med, Div Hematol, Stanford, CA 94305 USA; [Chodaparambil, Jayanth V.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford Cancer Institute; Stanford University; Stanford University; Stanford University; Stanford University	Mitchell, BS (corresponding author), Stanford Univ, Sch Med, Stanford Canc Ctr, LLSC Res Bldg SIM1,Rm 2167,265 Campus Dr, Stanford, CA 94305 USA.	bmitchell@stanford.edu	Chodaparambil, Jayanth V/F-3229-2015	Chodaparambil, Jayanth/0000-0002-4217-8355	Leukemia and Lymphoma Society; American Heart Association	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Heart Association(American Heart Association)	This work was supported by a SCOR Award and a Translational Award from the Leukemia and Lymphoma Society. This work was also supported by a Western States Postdoctoral Fellowship from the American Heart Association (to J. V. C.).	Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; Ben-Yosef T, 1998, ONCOGENE, V17, P165, DOI 10.1038/sj.onc.1201939; Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5; Cerimele F, 2005, P NATL ACAD SCI USA, V102, P175, DOI 10.1073/pnas.0408381102; Chandra J, 2009, ANTIOXID REDOX SIGN, V11, P1123, DOI [10.1089/ars.2008.2302, 10.1089/ARS.2008.2302]; Chiarugi P, 2003, TRENDS BIOCHEM SCI, V28, P509, DOI 10.1016/S0968-0004(03)00174-9; Ciani B, 2010, P NATL ACAD SCI USA, V107, P19850, DOI 10.1073/pnas.1008502107; Dai MS, 2008, MOL CELL BIOL, V28, P4365, DOI 10.1128/MCB.01662-07; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Dang CV, 2005, CELL CYCLE, V4, P1465, DOI 10.4161/cc.4.11.2121; Egler RA, 2005, ONCOGENE, V24, P8038, DOI 10.1038/sj.onc.1208821; Esteves AR, 2009, ANTIOXID REDOX SIGN, V11, P439, DOI [10.1089/ars.2008.2247, 10.1089/ARS.2008.2247]; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Gopalakrishna R, 2008, J BIOL CHEM, V283, P14430, DOI 10.1074/jbc.M801519200; Graves JA, 2009, J BIOL CHEM, V284, P6520, DOI 10.1074/jbc.M807564200; Herrera JE, 1996, BIOCHEMISTRY-US, V35, P2668, DOI 10.1021/bi9523320; Herrmann JM, 2008, BBA-MOL CELL RES, V1783, P519, DOI 10.1016/j.bbamcr.2008.03.002; Huang M, 2008, LEUKEMIA RES, V32, P131, DOI 10.1016/j.leukres.2007.03.025; Huang M, 2009, CANCER RES, V69, P3004, DOI 10.1158/0008-5472.CAN-08-3413; Hussain SP, 2003, NAT REV CANCER, V3, P276, DOI 10.1038/nrc1046; Kopnin PB, 2007, CANCER RES, V67, P4671, DOI 10.1158/0008-5472.CAN-06-2466; Koptyra M, 2006, BLOOD, V108, P319, DOI 10.1182/blood-2005-07-2815; Ma HH, 2007, MOL BIOL CELL, V18, P2630, DOI 10.1091/mbc.E07-03-0244; Meng LJ, 2007, MOL CELL BIOL, V27, P8670, DOI 10.1128/MCB.00635-07; Meng LJ, 2006, J CELL SCI, V119, P5124, DOI 10.1242/jcs.03292; Meng LJ, 2008, J CELL SCI, V121, P4037, DOI 10.1242/jcs.037952; Naughton R, 2009, LEUKEMIA, V23, P1432, DOI 10.1038/leu.2009.49; Nikpour P, 2009, CELL PROLIFERAT, V42, P762, DOI 10.1111/j.1365-2184.2009.00635.x; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Okuwaki M, 2008, J BIOCHEM, V143, P441, DOI 10.1093/jb/mvm222; Rodrigues MS, 2008, ANTIOXID REDOX SIGN, V10, P1813, DOI 10.1089/ars.2008.2071; Romanova L, 2009, J BIOL CHEM, V284, P26685, DOI 10.1074/jbc.M109.013342; Romanova L, 2009, J BIOL CHEM, V284, P4968, DOI 10.1074/jbc.M804594200; Sallmyr A, 2008, BLOOD, V111, P3173, DOI 10.1182/blood-2007-05-092510; Sattler M, 2000, J BIOL CHEM, V275, P24273, DOI 10.1074/jbc.M002094200; Sijin L, 2004, J EXP CLIN CANC RES, V23, P529; Singh Raj K, 2009, Hematol Oncol Stem Cell Ther, V2, P285; Storz P, 2005, FRONT BIOSCI-LANDMRK, V10, P1881, DOI 10.2741/1667; Tsai RYL, 2009, INT J BIOCHEM CELL B, V41, P2122, DOI 10.1016/j.biocel.2009.05.020; Tsai RYL, 2002, GENE DEV, V16, P2991, DOI 10.1101/gad.55671; Tsai RYL, 2005, J CELL BIOL, V168, P179, DOI 10.1083/jcb.200409053; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; van Reyk DM, 2001, FREE RADICAL BIO MED, V30, P82, DOI 10.1016/S0891-5849(00)00449-4; VONHOFF DD, 1988, P NATL ACAD SCI USA, V85, P4804; Wu CH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000090; Wu CH, 2007, P NATL ACAD SCI USA, V104, P13028, DOI 10.1073/pnas.0701953104; Xu Z, 2008, FASEB J, V22, P127, DOI 10.1096/fj.06-7871com; Zhu QB, 2006, MOL CELL BIOL, V26, P9279, DOI 10.1128/MCB.00724-06	49	12	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11035	11046		10.1074/jbc.M110.208470	http://dx.doi.org/10.1074/jbc.M110.208470			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21242306	hybrid, Green Published			2022-12-27	WOS:000288797100015
J	Chen, S; Evans, HG; Evans, DR				Chen, Song; Evans, Hedeel Guy; Evans, David R.			FAM129B/MINERVA, a Novel Adherens Junction-associated Protein, Suppresses Apoptosis in HeLa Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL CARCINOGENESIS; SIGNALING PATHWAYS; DRUG-RESISTANCE; ALPHA-CATENIN; BETA-CATENIN; E-CADHERIN; EXPRESSION; MELANOMA; CLEAVAGE; CANCER	Arecent proteomics study identified FAM129B or MINERVA as a target of the MAP kinase (Erk1/2) signaling cascade in human melanoma cells. Phosphorylation of the protein was found to promote cell invasion and the dissociation of the protein from the cell-cell junctions. Suppression of apoptosis during metastasis is a prerequisite for the survival and spread of cancer cells. During apoptosis, the adherens junctions are disassembled as the dying cell retracts, and new contacts are formed between normal neighboring cells. In this study, we show that FAM129B was cytosolic in exponentially growing HeLa cells but was translocated to the adherens junctions where it colocalized with beta-catenin whenever contact between two or more cells was established. Silencing the FAM129B gene expression by specific siRNAs did not induce apoptosis or inhibit the growth of HeLa cells. However, when apoptosis was induced by exposure to TNF alpha/cycloheximide or other apoptotic signaling molecules, the onset of apoptosis was accelerated 3-4-fold when FAM129B was depleted. Annexin V binding, the inactivation of the DNA repair enzyme, poly(ADP-ribose) polymerase, and the activation of the caspases occurred more rapidly in the cells lacking FAM129B. The rapid induction of apoptosis in FAM129B knockdown cells was reversed by co-transfection with recombinant FAM129B, indicating that its effect on apoptosis was specific. As apoptosis proceeded, FAM129B was degraded and disappeared from the plasma membrane. Thus, one crucial facet of the mechanism by which FAM129B promotes cancer cell invasion is likely to be the suppression of apoptosis.	[Evans, Hedeel Guy] Eastern Michigan Univ, Dept Chem, Ypsilanti, MI 48197 USA; [Chen, Song; Evans, Hedeel Guy; Evans, David R.] Wayne State Univ, Dept Biochem & Mol Biol, Sch Med, Detroit, MI 48201 USA	Eastern Michigan University; Wayne State University	Evans, HG (corresponding author), Eastern Michigan Univ, Dept Chem, 225 Mark, Ypsilanti, MI 48197 USA.	hevans@emich.edu			National Institutes of Health [GM/CA60371, P30CA22453]; Office of the Provost (Wayne State University); NATIONAL CANCER INSTITUTE [P30CA022453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of the Provost (Wayne State University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant GM/CA60371. This work was also supported by internal funds from the Office of the Provost (Wayne State University). The Microscopy, Imaging and Cytometry Resource Core is supported in part by NIH Center Grant P30CA22453 to the Karmanos Cancer Institute, Wayne State University, and the Perinatology Research Branch of the National Institutes of Child Health and Development, Wayne State University.	Adachi H, 2004, ONCOGENE, V23, P3495, DOI 10.1038/sj.onc.1207468; Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Antonsson A, 2009, ANTICANCER RES, V29, P2893; Boyd RS, 2003, LEUKEMIA, V17, P1605, DOI 10.1038/sj.leu.2402993; Brancolini C, 1997, J CELL BIOL, V139, P759, DOI 10.1083/jcb.139.3.759; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Green DR, 2000, METHOD ENZYMOL, V322, P15; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; Grossman D, 2001, CANCER METAST REV, V20, P3, DOI 10.1023/A:1013123532723; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; HAGUE A, 1994, ONCOGENE, V9, P3367; HOFFMAN B, 1994, ONCOGENE, V9, P1807; KERR JFR, 1994, CANCER-AM CANCER SOC, V73, P2013, DOI 10.1002/1097-0142(19940415)73:8<2013::AID-CNCR2820730802>3.0.CO;2-J; Kim HA, 2003, J RHEUMATOL, V30, P550; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Majima S, 2000, JPN J CANCER RES, V91, P869, DOI 10.1111/j.1349-7006.2000.tb01027.x; Matsumoto F, 2006, HUM PATHOL, V37, P1592, DOI 10.1016/j.humpath.2006.06.022; MCDONNELL TJ, 1992, CANCER RES, V52, P6940; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Old WM, 2009, MOL CELL, V34, P115, DOI 10.1016/j.molcel.2009.03.007; Pokutta S, 2008, BIOCHEM SOC T, V36, P141, DOI 10.1042/BST0360141; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Schmitt CA, 1999, J PATHOL, V187, P127; Simbulan-Rosenthal CM, 1999, MOL CELL BIOCHEM, V193, P137, DOI 10.1023/A:1006988832729; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Steinhusen U, 2001, J BIOL CHEM, V276, P4972, DOI 10.1074/jbc.M006102200; Suzanne Magali, 2009, Journal of Biology (London), V8, P49, DOI 10.1186/jbiol152; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Townson JL, 2003, CURR MOL MED, V3, P631, DOI 10.2174/1566524033479483; Wajant H, 2002, SCIENCE, V296, P1635, DOI 10.1126/science.1071553; Widmann C, 1998, J BIOL CHEM, V273, P7141, DOI 10.1074/jbc.273.12.7141; Wyllie A H, 1980, Int Rev Cytol, V68, P251	37	26	29	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10201	10209		10.1074/jbc.M110.175273	http://dx.doi.org/10.1074/jbc.M110.175273			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21148485	Green Published, hybrid			2022-12-27	WOS:000288547000036
J	Haneburger, I; Eichinger, A; Skerra, A; Jung, K				Haneburger, Ina; Eichinger, Andreas; Skerra, Arne; Jung, Kirsten			New Insights into the Signaling Mechanism of the pH-responsive, Membrane-integrated Transcriptional Activator CadC of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSINE DECARBOXYLASE; ACID INDUCTION; HOST STRAINS; PROTEIN; OPERON; DOMAIN; APOPTOSIS; GENE; DISSOCIATION; POLYMERASE	The membrane-integrated transcriptional regulator CadC of Escherichia coli activates expression of the cadBA operon at low external pH with concomitantly available lysine, providing adaptation to mild acidic stress. CadC is a representative of the ToxR-like proteins that combine sensory, signal transduction, and DNA-binding activities within a single polypeptide. Although several ToxR-like regulators such as CadC, as well as the main regulator of Vibrio cholerae virulence, ToxR itself, which activate gene expression at acidic pH, have been intensively investigated, their molecular activation mechanism is still unclear. In this study, a structure-guided mutational analysis was performed to elucidate the mechanism by which CadC detects acidification of the external milieu. Thus, a cluster of negatively charged amino acids (Asp-198, Asp-200, Glu-461, Glu-468, and Asp-471) was found to be crucial for pH detection. These amino acids form a negatively charged patch on the surface of the periplasmic domain of CadC that stretches across its two subdomains. The results of different combinations of amino acid replacements within this patch indicated that the N-terminal subdomain integrates and transduces the signals coming from both subdomains to the transmembrane domain. Alterations in the phospholipid composition did not influence pH-dependent cadBA expression, and therefore, interplay of the acidic surface patch with the negatively charged headgroups is unlikely. Models are discussed according to which protonation of these acidic amino acid side chains reduces repulsive forces between the two subdomains and/or between two monomers within a CadC dimer and thereby enables receptor activation upon lowering of the environmental pH.	[Jung, Kirsten] Univ Munich, Dept Biol 1, Biozentrum, Ctr Integrated Prot Sci Munich, D-82152 Martinsried, Germany; [Haneburger, Ina; Jung, Kirsten] Univ Munich, Dept Microbiol, D-82152 Martinsried, Germany; [Eichinger, Andreas; Skerra, Arne] Tech Univ Munich, Lehrstuhl Biol Chem, D-85350 Freising Weihenstephan, Germany	University of Munich; University of Munich; Technical University of Munich	Jung, K (corresponding author), Univ Munich, Dept Biol 1, Biozentrum, Ctr Integrated Prot Sci Munich, Grosshadernerstr 2-4, D-82152 Martinsried, Germany.	jung@lmu.de	Skerra, Arne/A-2269-2013	Skerra, Arne/0000-0002-5717-498X	Deutsche Forschungsgemeinschaft [JU270/5-1, Exc114/1]; Elitenetzwerk Bayern research scholarship (BayEFG)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Elitenetzwerk Bayern research scholarship (BayEFG)	This work was supported by Deutsche Forschungsgemeinschaft Grants JU270/5-1 and Exc114/1 and by an Elitenetzwerk Bayern research scholarship (BayEFG) (to I.H.).	AUGER EA, 1989, MOL MICROBIOL, V3, P609, DOI 10.1111/j.1365-2958.1989.tb00208.x; Bearson S, 1997, FEMS MICROBIOL LETT, V147, P173, DOI 10.1016/S0378-1097(96)00503-4; Cho US, 2006, J MOL BIOL, V356, P1193, DOI 10.1016/j.jmb.2005.12.032; Damaghi M, 2010, J MOL BIOL, V397, P878, DOI 10.1016/j.jmb.2010.02.023; Dawson JE, 2009, P NATL ACAD SCI USA, V106, P8543, DOI 10.1073/pnas.0809138106; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; DeLano WL., 2020, PYMOL MOL GRAPHICS S; DELL CL, 1994, MOL MICROBIOL, V14, P7, DOI 10.1111/j.1365-2958.1994.tb01262.x; EICHINGER A, 2011, PROTEIN SCI IN PRESS; EPSTEIN W, 1971, J BACTERIOL, V108, P639, DOI 10.1128/JB.108.2.639-644.1971; Fritz G, 2009, J MOL BIOL, V393, P272, DOI 10.1016/j.jmb.2009.08.037; HEACOCK PN, 1989, J BIOL CHEM, V264, P14972; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058; Kuper C, 2005, J MOL MICROB BIOTECH, V10, P26, DOI 10.1159/000090346; Lagadic-Gossmann D, 2004, CELL DEATH DIFFER, V11, P953, DOI 10.1038/sj.cdd.4401466; Lemonnier M, 1998, MICROBIOL-SGM, V144, P751, DOI 10.1099/00221287-144-3-751; Liechti LA, 2010, J BIOL CHEM, V285, P16315, DOI 10.1074/jbc.M109.092015; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; MENG SY, 1992, J BACTERIOL, V174, P2670, DOI 10.1128/jb.174.8.2670-2678.1992; Miller JH., 1992, EXPT MOL GENETICS; MILLER VL, 1987, CELL, V48, P271, DOI 10.1016/0092-8674(87)90430-2; Muller S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006930; NEELY MN, 1994, J BACTERIOL, V176, P3278, DOI 10.1128/jb.176.11.3278-3285.1994; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; NOZAKI Y, 1967, J BIOL CHEM, V242, P4731; Nyarko A, 2005, BIOCHEMISTRY-US, V44, P14248, DOI 10.1021/bi0512694; Perier A, 2007, J BIOL CHEM, V282, P24239, DOI 10.1074/jbc.M703392200; PHAN APH, 1982, ANAL BIOCHEM, V120, P193, DOI 10.1016/0003-2697(82)90336-0; Prost LR, 2007, MOL CELL, V26, P165, DOI 10.1016/j.molcel.2007.03.008; Sambrook J, 1989, MOL CLONING LABORATO; Soksawatmaekhin W, 2004, MOL MICROBIOL, V51, P1401, DOI 10.1046/j.1365-2958.2003.03913.x; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TAYLOR RG, 1993, NUCLEIC ACIDS RES, V21, P1677, DOI 10.1093/nar/21.7.1677; Tetsch L, 2008, MOL MICROBIOL, V67, P570, DOI 10.1111/j.1365-2958.2007.06070.x; Thompson AN, 2008, P NATL ACAD SCI USA, V105, P6900, DOI 10.1073/pnas.0800873105; Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; WATSON N, 1992, J BACTERIOL, V174, P530, DOI 10.1128/jb.174.2.530-540.1992; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Yu JY, 2001, CIRC RES, V89, P1161, DOI 10.1161/hh2401.101909	41	42	42	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10681	10689		10.1074/jbc.M110.196923	http://dx.doi.org/10.1074/jbc.M110.196923			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21216950	Green Published, hybrid			2022-12-27	WOS:000288547000082
J	Sakami, S; Maeda, T; Bereta, G; Okano, K; Golczak, M; Sumaroka, A; Roman, AJ; Cideciyan, AV; Jacobson, SG; Palczewski, K				Sakami, Sanae; Maeda, Tadao; Bereta, Grzegorz; Okano, Kiichiro; Golczak, Marcin; Sumaroka, Alexander; Roman, Alejandro J.; Cideciyan, Artur V.; Jacobson, Samuel G.; Palczewski, Krzysztof			Probing Mechanisms of Photoreceptor Degeneration in a New Mouse Model of the Common Form of Autosomal Dominant Retinitis Pigmentosa due to P23H Opsin Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENIC RAT MODEL; XENOPUS-LAEVIS MODEL; LIGHT-INDUCED DAMAGE; RETINAL DEGENERATION; RHODOPSIN MUTATIONS; DISK MORPHOGENESIS; OUTER SEGMENT; MONOCLONAL-ANTIBODIES; DISEASE PROGRESSION; MOLECULAR-GENETICS	Rhodopsin, the visual pigment mediating vision under dim light, is composed of the apoprotein opsin and the chromophore ligand 11-cis-retinal. A P23H mutation in the opsin gene is one of the most prevalent causes of the human blinding disease, autosomal dominant retinitis pigmentosa. Although P23H cultured cell and transgenic animal models have been developed, there remains controversy over whether they fully mimic the human phenotype; and the exact mechanism by which this mutation leads to photoreceptor cell degeneration remains unknown. By generating P23H opsin knock-in mice, we found that the P23H protein was inadequately glycosylated with levels 1-10% that of wild type opsin. Moreover, the P23H protein failed to accumulate in rod photoreceptor cell endoplasmic reticulum but instead disrupted rod photoreceptor disks. Genetically engineered P23H mice lacking the chromophore showed accelerated photoreceptor cell degeneration. These results indicate that most synthesized P23H protein is degraded, and its retinal cytotoxicity is enhanced by lack of the 11-cis-retinal chromophore during rod outer segment development.	[Palczewski, Krzysztof] Case Western Reserve Univ, Dept Pharmacol, Sch Med, Cleveland, OH 44106 USA; [Maeda, Tadao] Case Western Reserve Univ, Dept Ophthalmol & Vis Sci, Cleveland, OH 44106 USA; [Sumaroka, Alexander; Roman, Alejandro J.; Cideciyan, Artur V.; Jacobson, Samuel G.] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Philadelphia, PA 19104 USA	Case Western Reserve University; Case Western Reserve University; University of Pennsylvania; Pennsylvania Medicine	Palczewski, K (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Sch Med, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu	Cideciyan, Artur V/A-1075-2007	Cideciyan, Artur V/0000-0002-2018-0905; Imanishi, Sanae/0000-0001-9884-2123; Jacobson, Samuel/0000-0003-2122-169X	National Institutes of Health [K08EY019880, EY019031, EY009339, R24 EY021126, P30 EY11373]; Foundation Fighting Blindness; NATIONAL EYE INSTITUTE [R01EY009339, P30EY011373, K08EY019031, K08EY019880, R24EY021126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation Fighting Blindness(European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants K08EY019880, K08EY019880, EY019031, EY009339, R24 EY021126, and P30 EY11373. This work was also supported by the Foundation Fighting Blindness.	ADAMUS G, 1991, VISION RES, V31, P17, DOI 10.1016/0042-6989(91)90069-H; Aleman TS, 2008, INVEST OPHTH VIS SCI, V49, P1580, DOI 10.1167/iovs.07-1110; BARTHEL LK, 1990, J HISTOCHEM CYTOCHEM, V38, P1383, DOI 10.1177/38.9.2201738; Batten ML, 2005, PLOS MED, V2, P1177, DOI 10.1371/journal.pmed.0020333; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; BERSON EL, 1991, ARCH OPHTHALMOL-CHIC, V109, P92, DOI 10.1001/archopht.1991.01080010094039; Berson EL, 2002, INVEST OPHTH VIS SCI, V43, P3027; BERSON EL, 1985, AM J OPHTHALMOL, V99, P240, DOI 10.1016/0002-9394(85)90351-4; Birch DG, 1999, OPHTHALMOLOGY, V106, P258, DOI 10.1016/S0161-6420(99)90064-7; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P263, DOI 10.1002/cne.901880205; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Chan F, 2004, P NATL ACAD SCI USA, V101, P9109, DOI 10.1073/pnas.0403149101; Chapple JP, 2003, J BIOL CHEM, V278, P19087, DOI 10.1074/jbc.M212349200; Cideciyan AV, 2009, HUM MOL GENET, V18, P931, DOI 10.1093/hmg/ddn421; Cideciyan AV, 1998, P NATL ACAD SCI USA, V95, P7103, DOI 10.1073/pnas.95.12.7103; Cideciyan AV, 2005, P NATL ACAD SCI USA, V102, P5233, DOI 10.1073/pnas.0408892102; CLEMENTI E, 1992, EUR J NEUROSCI, V4, P944, DOI 10.1111/j.1460-9568.1992.tb00121.x; COHEN AI, 1960, AM J ANAT, V107, P23, DOI 10.1002/aja.1001070103; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; deTorres C, 1997, NEUROSCI LETT, V230, P1, DOI 10.1016/S0304-3940(97)00445-X; Dryja TP, 2000, INVEST OPHTH VIS SCI, V41, P3124; DRYJA TP, 1990, NATURE, V343, P364, DOI 10.1038/343364a0; DRYJA TP, 1995, HUM MOL GENET, V4, P1739, DOI 10.1093/hmg/4.suppl_1.1739; Farrar GJ, 2002, EMBO J, V21, P857, DOI 10.1093/emboj/21.5.857; Green ES, 2000, INVEST OPHTH VIS SCI, V41, P1546; Hao WS, 2002, NAT GENET, V32, P254, DOI 10.1038/ng984; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HECKENLIVELY JR, 1991, ARCH OPHTHALMOL-CHIC, V109, P84, DOI 10.1001/archopht.1991.01080010086038; Herrera W, 2008, INVEST OPHTH VIS SCI, V49, P2651, DOI 10.1167/iovs.07-1505; HODGES RS, 1988, J BIOL CHEM, V263, P11768; Iannaccone A, 2004, INVEST OPHTH VIS SCI, V45, P784, DOI 10.1167/iovs.03-0906; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Imanishi Y, 2008, J BIOL CHEM, V283, P25091, DOI 10.1074/jbc.M802981200; Jacobson SG, 2010, INVEST OPHTH VIS SCI, V51, P1079, DOI 10.1167/iovs.09-4372; Jacobson SG, 2009, INVEST OPHTH VIS SCI, V50, P1886, DOI 10.1167/iovs.08-3122; JACOBSON SG, 1991, AM J OPHTHALMOL, V112, P256, DOI 10.1016/S0002-9394(14)76726-1; JACOBSON SG, 1989, EXP EYE RES, V48, P679, DOI 10.1016/0014-4835(89)90009-2; Jacobson SG, 2000, INVEST OPHTH VIS SCI, V41, P1898; John SK, 2000, MOL VIS, V6, P204; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; KEMP CM, 1992, AM J OPHTHALMOL, V113, P165, DOI 10.1016/S0002-9394(14)71529-6; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; KOLB H, 1974, INVEST OPHTH VISUAL, V13, P487; LaVail MM, 2000, P NATL ACAD SCI USA, V97, P11488, DOI 10.1073/pnas.210319397; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Liu X, 1996, P NATL ACAD SCI USA, V93, P4554, DOI 10.1073/pnas.93.10.4554; Liu XR, 1997, J CELL SCI, V110, P2589; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda T, 2005, INVEST OPHTH VIS SCI, V46, P4320, DOI 10.1167/iovs.05-0478; Maeda T, 2009, HUM MOL GENET, V18, P2277, DOI 10.1093/hmg/ddp163; MASSOF R, 1987, 2 STAGE HYPOTHESIS N, V62, P29; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; NAASH MI, 1993, P NATL ACAD SCI USA, V90, P5499, DOI 10.1073/pnas.90.12.5499; Naash ML, 1996, INVEST OPHTH VIS SCI, V37, P775; Noorwez SM, 2004, J BIOL CHEM, V279, P16278, DOI 10.1074/jbc.M312101200; Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200; OBATA S, 1992, CELL TISSUE RES, V269, P39, DOI 10.1007/BF00384724; Oh KT, 2003, AM J OPHTHALMOL, V136, P306, DOI 10.1016/S0002-9394(03)00206-X; OLSSON JE, 1992, NEURON, V9, P815, DOI 10.1016/0896-6273(92)90236-7; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Palczewski K, 2010, TRENDS PHARMACOL SCI, V31, P284, DOI 10.1016/j.tips.2010.03.001; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; Rajan RS, 2005, J BIOL CHEM, V280, P1284, DOI 10.1074/jbc.M406448200; Rajan RS, 2001, P NATL ACAD SCI USA, V98, P13060, DOI 10.1073/pnas.181479798; Ranchon I, 2003, J NEUROSCI, V23, P6050, DOI 10.1523/JNEUROSCI.23-14-06050.2003; Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89; Roman AJ, 2005, EXP EYE RES, V80, P259, DOI 10.1016/j.exer.2004.09.008; ROOF DJ, 1994, INVEST OPHTH VIS SCI, V35, P4049; Sakami S, 2008, MECH DEVELOP, V125, P106, DOI 10.1016/j.mod.2007.10.001; Saliba RS, 2002, J CELL SCI, V115, P2907; Seyedahmadia BJ, 2004, EXP EYE RES, V79, P167, DOI 10.1016/j.exer.2004.03.005; Sohocki MM, 2001, HUM MUTAT, V17, P42, DOI 10.1002/1098-1004(2001)17:1<42::AID-HUMU5>3.0.CO;2-K; Srinivasan VJ, 2008, INVEST OPHTH VIS SCI, V49, P1571, DOI 10.1167/iovs.07-0838; STONE EM, 1991, OPHTHALMOLOGY, V98, P1806; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P6481, DOI 10.1073/pnas.88.15.6481; SUNG CH, 1991, P NATL ACAD SCI USA, V88, P8840, DOI 10.1073/pnas.88.19.8840; SZEL A, 1993, INVEST OPHTH VIS SCI, V34, P3641; Tam BM, 2007, J NEUROSCI, V27, P9043, DOI 10.1523/JNEUROSCI.2245-07.2007; Tam BM, 2006, INVEST OPHTH VIS SCI, V47, P3234, DOI 10.1167/iovs.06-0213; Tam BM, 2010, INVEST OPHTH VIS SCI, V51, P1327, DOI 10.1167/iovs.09-4123; To K, 2002, AM J OPHTHALMOL, V134, P290, DOI 10.1016/S0002-9394(02)01545-3; VAUGHAN DK, 1989, INVEST OPHTH VIS SCI, V30, P339; Vaughan DK, 2003, INVEST OPHTH VIS SCI, V44, P848, DOI 10.1167/iovs.02-0709; von Lintig J, 2010, TRENDS BIOCHEM SCI, V35, P400, DOI 10.1016/j.tibs.2010.01.005; Walsh N, 2004, BRAIN RES, V1013, P194, DOI 10.1016/j.brainres.2004.04.030; White DA, 2007, INVEST OPHTH VIS SCI, V48, P1942, DOI 10.1167/iovs.06-1131; Yang ZL, 2008, J CLIN INVEST, V118, P2908, DOI 10.1172/JCI35891; Zhang Y, 2009, J CELL SCI, V122, P1192, DOI 10.1242/jcs.042531	92	173	184	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10551	10567		10.1074/jbc.M110.209759	http://dx.doi.org/10.1074/jbc.M110.209759			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21224384	Green Published, hybrid			2022-12-27	WOS:000288547000071
J	Chen, S; Wei, HM; Lv, WW; Wang, DL; Sun, FL				Chen, Su; Wei, Hui-Min; Lv, Wen-Wen; Wang, Da-Liang; Sun, Fang-Lin			E2 Ligase dRad6 Regulates DMP53 Turnover in Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-CONJUGATING ENZYME; TUMOR-SUPPRESSOR P53; HISTONE H2B MONOUBIQUITINATION; DAMAGE-INDUCED RESPONSE; DNA-BINDING PROTEIN; REPAIR GENE RAD6; ACTIVITY IN-VIVO; YEAST RAD6; SACCHAROMYCES-CEREVISIAE; COMPLEX-FORMATION	The turnover of tumor suppressor p53 is critical for its role in various cellular events. However, the pathway that regulates the turnover of the Drosophila melanogaster DMP53 is largely unknown. Here, we provide evidence for the first time that the E2 ligase, Drosophila homolog of Rad6 (dRad6/Dhr6), plays an important role in the regulation of DMP53 turnover. Depletion of dRad6 results in DMP53 accumulation, whereas overexpression of dRad6 causes enhanced DMP53 degradation. We show that dRad6 specifically interacts with DMP53 at the transcriptional activation domain and regulates DMP53 ubiquitination. Loss of dRad6 function in transgenic flies leads to lethalities and altered morphogenesis. The dRad6-induced defects in cell proliferation and apoptosis are found to be DMP53-dependent. The loss of dRad6 induces an accumulation of DMP53 that enhances the activation of apoptotic genes and leads to apoptosis in the presence of stress stimuli. In contrast to that, the E3 ligase is the primary factor that regulates p53 turnover in mammals, and this work demonstrates that the E2 ligase dRad6 is critical for the control of DMP53 degradation in Drosophila.	[Chen, Su; Wei, Hui-Min; Lv, Wen-Wen; Wang, Da-Liang; Sun, Fang-Lin] Tsinghua Univ, Inst Epigenet & Canc Res, Sch Med, Beijing 100084, Peoples R China; [Sun, Fang-Lin] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University	Sun, FL (corresponding author), Tsinghua Univ, Inst Epigenet & Canc Res, Sch Med, Med Sci Bldg C-315, Beijing 100084, Peoples R China.	sfl@tsinghua.edu.cn	Chen, Su/J-5130-2012		Chinese National Science Foundation [30625017]; Ministry of Science and Technology [2011CB965300, 2007CB948101, 2009CB825603]; Yu-Yuan Foundation; Wu-Shun-De Foundation of Tsinghua University	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Yu-Yuan Foundation; Wu-Shun-De Foundation of Tsinghua University	This work was supported by National Grant "Jie-Chu-Qing-Nian-Ke-Xue Fund" from the Chinese National Science Foundation 30625017, National "973" Grants from the Ministry of Science and Technology 2011CB965300, 2007CB948101, and 2009CB825603, and a start-up grant from the Yu-Yuan Foundation and the Wu-Shun-De Foundation of Tsinghua University.	Abrams JM, 1999, TRENDS CELL BIOL, V9, P435, DOI 10.1016/S0962-8924(99)01646-3; Allton K, 2009, P NATL ACAD SCI USA, V106, P11612, DOI 10.1073/pnas.0813177106; Arama E, 2006, NAT PROTOC, V1, P1725, DOI 10.1038/nprot.2006.235; Baarends WM, 2003, MOL CELL BIOL, V23, P1151, DOI 10.1128/MCB.23.4.1151-1162.2003; Bailly V, 1997, MOL CELL BIOL, V17, P4536, DOI 10.1128/MCB.17.8.4536; BAILLY V, 1994, GENE DEV, V8, P811, DOI 10.1101/gad.8.7.811; Bailly V, 1997, J BIOL CHEM, V272, P23360, DOI 10.1074/jbc.272.37.23360; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BARGONETTI J, 1991, CELL, V65, P1083, DOI 10.1016/0092-8674(91)90560-L; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Brooks CL, 2004, CELL CYCLE, V3, P895; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Cain C, 2000, J BIOL CHEM, V275, P39944, DOI 10.1074/jbc.M002509200; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; Giet R, 2001, J CELL BIOL, V152, P669, DOI 10.1083/jcb.152.4.669; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; KASTAN MB, 1991, CANCER RES, V51, P4279; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; Kim E, 1999, ONCOGENE, V18, P7310, DOI 10.1038/sj.onc.1203139; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kim J, 2009, J BIOL CHEM, V284, P20582, DOI 10.1074/jbc.M109.017442; KOKEN M, 1991, P NATL ACAD SCI USA, V88, P3832, DOI 10.1073/pnas.88.9.3832; KOKEN MHM, 1991, P NATL ACAD SCI USA, V88, P8865, DOI 10.1073/pnas.88.20.8865; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lane David P., 1992, Current Biology, V2, P581, DOI 10.1016/0960-9822(92)90154-3; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lee KY, 2008, MOL CELLS, V26, P5; Leng RP, 2003, CELL, V112, P779, DOI 10.1016/S0092-8674(03)00193-4; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Liu LP, 2005, NAT GENET, V37, P1361, DOI 10.1038/ng1662; Liu XG, 2004, CANCER RES, V64, P5078, DOI 10.1158/0008-5472.CAN-04-1195; Lu X, 2005, CURR OPIN GENET DEV, V15, P27, DOI 10.1016/j.gde.2004.12.008; Lyakhovich A, 2004, ONCOGENE, V23, P3097, DOI 10.1038/sj.onc.1207449; Lyakhovich A, 2003, MOL CELL BIOL, V23, P2463, DOI 10.1128/MCB.23.7.2463-2475.2003; Mackay AM, 1998, J CELL BIOL, V140, P991, DOI 10.1083/jcb.140.5.991; May P, 1999, ONCOGENE, V18, P7621, DOI 10.1038/sj.onc.1203285; McCall K, 1997, TRENDS GENET, V13, P222, DOI 10.1016/S0168-9525(97)01126-8; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Ni JQ, 2006, GENE DEV, V20, P1959, DOI 10.1101/gad.390106; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Nordstrom W, 2000, CELL DEATH DIFFER, V7, P1035, DOI 10.1038/sj.cdd.4400766; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Ringshausen I, 2006, CANCER CELL, V10, P501, DOI 10.1016/j.ccr.2006.10.010; Roest HP, 2004, MOL CELL BIOL, V24, P5485, DOI 10.1128/MCB.24.12.5485-5495.2004; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Shekhar MPV, 2008, CANCER RES, V68, P1741, DOI 10.1158/0008-5472.CAN-07-2111; Shekhar MPV, 2002, CANCER RES, V62, P2115; Shema E, 2008, GENE DEV, V22, P2664, DOI 10.1101/gad.1703008; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sogame N, 2003, P NATL ACAD SCI USA, V100, P4696, DOI 10.1073/pnas.0736384100; Srinivasula SM, 2002, CURR BIOL, V12, P125, DOI 10.1016/S0960-9822(01)00657-1; Steller H, 2000, NAT CELL BIOL, V2, pE100, DOI 10.1038/35014093; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; SUNG P, 1991, EMBO J, V10, P2187, DOI 10.1002/j.1460-2075.1991.tb07754.x; Szak ST, 2001, MOL CELL BIOL, V21, P3375, DOI 10.1128/MCB.21.10.3375-3386.2001; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; WATKINS JF, 1993, GENE DEV, V7, P250, DOI 10.1101/gad.7.2.250; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Wood A, 2005, MOL CELL, V20, P589, DOI 10.1016/j.molcel.2005.09.010; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Yamashita K, 2004, P NATL ACAD SCI USA, V101, P11380, DOI 10.1073/pnas.0400078101; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	81	14	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9020	9030		10.1074/jbc.M110.190314	http://dx.doi.org/10.1074/jbc.M110.190314			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21205821	Green Published, hybrid			2022-12-27	WOS:000288247700033
J	Cuomo, ME; Platt, GM; Pearl, LH; Mittnacht, S				Cuomo, Maria Emanuela; Platt, Georgina M.; Pearl, Laurence H.; Mittnacht, Sibylle			Cyclin-Cyclin-dependent Kinase Regulatory Response Is Linked to Substrate Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARCOMA-ASSOCIATED HERPESVIRUS; 68 V-CYCLIN; STRUCTURAL BASIS; CELL-CYCLE; CDK INHIBITOR; CRYSTAL-STRUCTURE; RETINOBLASTOMA PROTEIN; RECRUITMENT PEPTIDES; INK4 INHIBITORS; VIRAL CYCLIN	Cyclin/cyclin-dependent kinase (CDK) complexes are critical regulators of cellular proliferation. A complex network of regulatory mechanisms has evolved to control their activity, including activating and inactivating phosphorylation of the catalytic CDK subunit and inhibition through specific regulatory proteins. Primate herpesviruses, including the oncogenic Kaposi sarcoma herpesvirus, encode cyclin D homologues. Viral cyclins have diverged from their cellular progenitor in that they elicit holoenzyme activity independent of activating phosphorylation by the CDK-activating kinase and resistant to inhibition by CDK inhibitors. Using sequence comparison and site-directed mutagenesis, we performed molecular analysis of the cellular cyclin D and the Kaposi sarcoma herpesvirus-cyclin to delineate the molecular mechanisms behind their different behavior. This provides evidence that a surface recognized for its involvement in the docking of CIP/KIP inhibitors is required and sufficient to modulate cyclin-CDK response to a range of regulatory cues, including INK4 sensitivity and CDK-activating kinase dependence. Importantly, amino acids in this region are critically linked to substrate selection, suggesting that a mutational drift in this surface simultaneously affects function and regulation. Together our work provides novel insight into the molecular mechanisms governing cyclin-CDK function and regulation and defines the biological forces that may have driven evolution of viral cyclins.	[Cuomo, Maria Emanuela; Platt, Georgina M.; Mittnacht, Sibylle] Inst Canc Res, Sect Cell & Mol Biol, London SW3 6JB, England; [Pearl, Laurence H.] Inst Canc Res, Sect Struct Biol, London SW3 6JB, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Cuomo, ME (corresponding author), UCL Canc Inst, 72 Huntley St, London WC1E 6BT, England.	m.cuomo@ucl.ac.uk		Pearl, Laurence/0000-0002-6910-1809	Cancer Research UK; Institute of Cancer Research	Cancer Research UK(Cancer Research UK); Institute of Cancer Research	This work was supported by Cancer Research UK (to S. M. and G. M. P.).; Recipient of an Institute of Cancer Research Ph.D. scholarship. To whom correspondence should be addressed: UCL Cancer Institute, 72 Huntley St., WC1E 6BT London, United Kingdom. Tel.: 44-207-1535140; Fax: 44-207-6796817; E-mail: m.cuomo@ucl.ac.uk.	Adams PD, 1996, MOL CELL BIOL, V16, P6623; Alba MM, 2001, GENOME RES, V11, P43, DOI 10.1101/gr.149801; Archambault V, 2005, CELL CYCLE, V4, P125, DOI 10.4161/cc.4.1.1402; Blain SW, 1997, J BIOL CHEM, V272, P25863, DOI 10.1074/jbc.272.41.25863; Brotherton DH, 1998, NATURE, V395, P244, DOI 10.1038/26164; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Chew YP, 1998, ONCOGENE, V17, P2177, DOI 10.1038/sj.onc.1202443; Cross FR, 2000, MOL CELL BIOL, V20, P4782, DOI 10.1128/MCB.20.13.4782-4790.2000; Cuomo ME, 2008, NAT CELL BIOL, V10, P723, DOI 10.1038/ncb1735; Cuomo ME, 2005, J BIOL CHEM, V280, P35844, DOI 10.1074/jbc.M503877200; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Echalier A, 2010, BBA-PROTEINS PROTEOM, V1804, P511, DOI 10.1016/j.bbapap.2009.10.002; Ellis M, 1999, EMBO J, V18, P644, DOI 10.1093/emboj/18.3.644; Endicott JA, 1999, CURR OPIN STRUC BIOL, V9, P738, DOI 10.1016/S0959-440X(99)00038-X; Ferrer JL, 2006, CELL CYCLE, V5, P2760, DOI 10.4161/cc.5.23.3506; GoddenKent D, 1997, J VIROL, V71, P4193, DOI 10.1128/JVI.71.6.4193-4198.1997; Hoge AT, 2000, J VIROL, V74, P7016, DOI 10.1128/JVI.74.15.7016-7023.2000; James MK, 2008, MOL CELL BIOL, V28, P498, DOI 10.1128/MCB.02171-06; Jarviluoma A, 2006, MOL CELL BIOL, V26, P2430, DOI 10.1128/MCB.26.6.2430-2440.2006; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jeffrey PD, 2000, GENE DEV, V14, P3115, DOI 10.1101/gad.851100; Kaldis P, 1999, CELL MOL LIFE SCI, V55, P284, DOI 10.1007/s000180050290; Kaldis P, 2001, MOL BIOL CELL, V12, P3987, DOI 10.1091/mbc.12.12.3987; Knebel A, 2001, EMBO J, V20, P4360, DOI 10.1093/emboj/20.16.4360; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lacy ER, 2005, J MOL BIOL, V349, P764, DOI 10.1016/j.jmb.2005.04.019; Lacy ER, 2004, NAT STRUCT MOL BIOL, V11, P358, DOI 10.1038/nsmb746; Lairmore MD, 2000, P NATL ACAD SCI USA, V97, P6114, DOI 10.1073/pnas.110024497; Laman H, 2001, EXP CELL RES, V271, P230, DOI 10.1006/excr.2001.5360; Laman H, 2000, CURR OPIN GENET DEV, V10, P70, DOI 10.1016/S0959-437X(99)00045-3; Lowe ED, 2002, BIOCHEMISTRY-US, V41, P15625, DOI 10.1021/bi0268910; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mann DJ, 1999, EMBO J, V18, P654, DOI 10.1093/emboj/18.3.654; Mittnacht S, 2000, REV MED VIROL, V10, P175, DOI 10.1002/(SICI)1099-1654(200005/06)10:3<175::AID-RMV283>3.0.CO;2-F; Moore PS, 1998, TRENDS GENET, V14, P144, DOI 10.1016/S0168-9525(98)01408-5; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Ojala PM, 2000, NAT CELL BIOL, V2, P819, DOI 10.1038/35041064; Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640; Pines J, 1999, NAT CELL BIOL, V1, pE73, DOI 10.1038/11041; Platt GM, 2000, VIROLOGY, V272, P257, DOI 10.1006/viro.2000.0343; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Russo AA, 1996, NATURE, V382, P325, DOI 10.1038/382325a0; Russo AA, 1998, NATURE, V395, P237, DOI 10.1038/26155; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Schulze-Gahmen U, 2002, NAT STRUCT BIOL, V9, P177, DOI 10.1038/nsb756; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Swanton C, 1997, NATURE, V390, P184, DOI 10.1038/36606; Takaki T, 2009, P NATL ACAD SCI USA, V106, P4171, DOI 10.1073/pnas.0809674106; van Dyk LF, 2000, J VIROL, V74, P7451, DOI 10.1128/JVI.74.16.7451-7461.2000; Van Dyk LF, 1999, J VIROL, V73, P5110, DOI 10.1128/JVI.73.6.5110-5122.1999; Verschuren EW, 2004, CANCER RES, V64, P581, DOI 10.1158/0008-5472.CAN-03-1863; Verschuren EW, 2002, CANCER CELL, V2, P229, DOI 10.1016/S1535-6108(02)00123-X; Zarkowska T, 1997, J BIOL CHEM, V272, P12738, DOI 10.1074/jbc.272.19.12738	59	1	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9713	9725		10.1074/jbc.M110.173872	http://dx.doi.org/10.1074/jbc.M110.173872			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21233209	Green Published, hybrid			2022-12-27	WOS:000288247700095
J	Hussack, G; Arbabi-Ghahroudi, M; van Faassen, H; Songer, JG; Ng, KKS; MacKenzie, R; Tanha, J				Hussack, Greg; Arbabi-Ghahroudi, Mehdi; van Faassen, Henk; Songer, J. Glenn; Ng, Kenneth K. -S.; MacKenzie, Roger; Tanha, Jamshid			Neutralization of Clostridium difficile Toxin A with Single-domain Antibodies Targeting the Cell Receptor Binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE IMMUNOGLOBULIN CONCENTRATE; HEAVY-CHAIN ANTIBODIES; MOUSE MONOCLONAL-ANTIBODIES; PHAGE-DISPLAY LIBRARIES; INTRAVENOUS IMMUNOGLOBULIN; PASSIVE-IMMUNIZATION; NONSPECIFIC-BINDING; CRYSTAL-STRUCTURE; IN-VIVO; FRAGMENTS	Clostridium difficile is a leading cause of nosocomial infection in North America and a considerable challenge to healthcare professionals in hospitals and nursing homes. The Gram-positive bacterium produces two high molecular weight exotoxins, toxin A (TcdA) and toxin B (TcdB), which are the major virulence factors responsible for C. difficile-associated disease and are targets for C. difficile-associated disease therapy. Here, recombinant single-domain antibody fragments (V(H)Hs), which specifically target the cell receptor binding domains of TcdA or TcdB, were isolated from an immune llama phage display library and characterized. Four V(H)Hs (A4.2, A5.1, A20.1, and A26.8), all shown to recognize conformational epitopes, were potent neutralizers of the cytopathic effects of toxin A on fibroblast cells in an in vitro assay. The neutralizing potency was further enhanced when V(H)Hs were administered in paired or triplet combinations at the same overall VHH concentration, suggesting recognition of nonoverlapping TcdA epitopes. Biacore epitope mapping experiments revealed that some synergistic combinations consisted of V(H)Hs recognizing overlapping epitopes, an indication that factors other than mere epitope blocking are responsible for the increased neutralization. Further binding assays revealed TcdA-specific V(H)Hs neutralized toxin A by binding to sites other than the carbohydrate binding pocket of the toxin. With favorable characteristics such as high production yield, potent toxin neutralization, and intrinsic stability, these V(H)Hs are attractive systemic therapeutics but are more so as oral therapeutics in the destabilizing environment of the gastrointestinal tract.	[Hussack, Greg; Arbabi-Ghahroudi, Mehdi; van Faassen, Henk; MacKenzie, Roger; Tanha, Jamshid] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Hussack, Greg; Tanha, Jamshid] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Arbabi-Ghahroudi, Mehdi] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Songer, J. Glenn] Univ Arizona, Dept Vet Sci & Microbiol, Tucson, AZ 85721 USA; [Ng, Kenneth K. -S.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Ng, Kenneth K. -S.] Univ Calgary, Alberta Ingenu Ctr Carbohydrate Sci, Calgary, AB T2N 1N4, Canada; [MacKenzie, Roger; Tanha, Jamshid] Univ Guelph, Dept Environm Sci, Guelph, ON N1G 2W1, Canada	National Research Council Canada; University of Ottawa; Carleton University; University of Arizona; University of Calgary; University of Calgary; University of Guelph	Tanha, J (corresponding author), Natl Res Council Canada, Inst Biol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	Jamshid.Tanha@nrc-cnrc.gc.ca		Ng, Kenneth K.S./0000-0001-7280-8445	Dow Agro Sciences	Dow Agro Sciences	This work was supported by Dow Agro Sciences. This is National Research Council Canada Publication Number 50010.	Anderson GP, 2008, ANAL CHEM, V80, P9604, DOI 10.1021/ac8019398; Arbabi-Ghahroudi M, 2005, CANCER METAST REV, V24, P501, DOI 10.1007/s10555-005-6193-1; Arbabi-Ghahroudi M, 2009, PROTEIN ENG DES SEL, V22, P59, DOI 10.1093/protein/gzn071; Arbabi-Ghahroudi Mehdi, 2009, V525, P187, DOI 10.1007/978-1-59745-554-1_10; Arbabi-Ghahroudi Mehdi, 2009, V502, P341, DOI 10.1007/978-1-60327-565-1_20; Babcock GJ, 2006, INFECT IMMUN, V74, P6339, DOI 10.1128/IAI.00982-06; BARROSO LA, 1994, MICROB PATHOGENESIS, V16, P297, DOI 10.1006/mpat.1994.1030; Cooke DL, 1998, INFECT IMMUN, V66, P1981, DOI 10.1128/IAI.66.5.1981-1984.1998; CORTHIER G, 1991, INFECT IMMUN, V59, P1192, DOI 10.1128/IAI.59.3.1192-1195.1991; De Genst E, 2006, P NATL ACAD SCI USA, V103, P4586, DOI 10.1073/pnas.0505379103; DEMAREST SJ, 2010, MABS, V2, P1; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; Dingle T, 2008, GLYCOBIOLOGY, V18, P698, DOI 10.1093/glycob/cwn048; Doyle PJ, 2008, MOL IMMUNOL, V45, P3703, DOI 10.1016/j.molimm.2008.06.005; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; FLORIN I, 1983, BIOCHIM BIOPHYS ACTA, V763, P383, DOI 10.1016/0167-4889(83)90100-3; Forsman A, 2008, J VIROL, V82, P12069, DOI 10.1128/JVI.01379-08; Garaicoechea L, 2008, J VIROL, V82, P9753, DOI 10.1128/JVI.00436-08; Gardiner DF, 2009, VACCINE, V27, P3598, DOI 10.1016/j.vaccine.2009.03.058; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Giannasca PJ, 1999, INFECT IMMUN, V67, P527, DOI 10.1128/IAI.67.2.527-538.1999; Goldman ER, 2008, ANAL CHEM, V80, P8583, DOI 10.1021/ac8014774; Goldman ER, 2006, ANAL CHEM, V78, P8245, DOI 10.1021/ac0610053; Greco A, 2006, NAT STRUCT MOL BIOL, V13, P460, DOI 10.1038/nsmb1084; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Harmsen MM, 2006, APPL MICROBIOL BIOT, V72, P544, DOI 10.1007/s00253-005-0300-7; Harmsen MM, 2009, APPL MICROBIOL BIOT, V84, P1087, DOI 10.1007/s00253-009-2029-1; Harmsen MM, 2009, VACCINE, V27, P1904, DOI 10.1016/j.vaccine.2009.01.110; Hassoun Ali, 2007, Am J Geriatr Pharmacother, V5, P48, DOI 10.1016/j.amjopharm.2007.03.001; Hmila I, 2008, MOL IMMUNOL, V45, P3847, DOI 10.1016/j.molimm.2008.04.011; Hmila I, 2010, FASEB J, V24, P3479, DOI 10.1096/fj.09-148213; Ho JGS, 2005, P NATL ACAD SCI USA, V102, P18373, DOI 10.1073/pnas.0506391102; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; Hussack G, 2010, TOXINS, V2, P998, DOI 10.3390/toxins2050998; Hussack G, 2009, SENSORS-BASEL, V9, P5351, DOI 10.3390/s90705351; Jank T, 2008, TRENDS MICROBIOL, V16, P222, DOI 10.1016/j.tim.2008.01.011; Jank T, 2007, GLYCOBIOLOGY, V17, p15R, DOI 10.1093/glycob/cwm004; Johal SS, 2004, J CLIN PATHOL, V57, P973, DOI 10.1136/jcp.2003.015875; Johnson S, 2009, J INFECTION, V58, P403, DOI 10.1016/j.jinf.2009.03.010; Juang P, 2007, AM J INFECT CONTROL, V35, P131, DOI 10.1016/j.ajic.2006.06.007; Katchar K, 2007, CLIN GASTROENTEROL H, V5, P707, DOI 10.1016/j.cgh.2007.02.025; Keel MK, 2007, VET PATHOL, V44, P814, DOI 10.1354/vp.44-6-814; Kelly CP, 1997, ANTIMICROB AGENTS CH, V41, P236, DOI 10.1128/AAC.41.2.236; KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406; Kelly CP, 1996, ANTIMICROB AGENTS CH, V40, P373, DOI 10.1128/AAC.40.2.373; KELLY CP, 1992, GASTROENTEROLOGY, V102, P35, DOI 10.1016/0016-5085(92)91781-X; Kink JA, 1998, INFECT IMMUN, V66, P2018, DOI 10.1128/IAI.66.5.2018-2025.1998; Koch-Nolte F, 2007, FASEB J, V21, P3490, DOI 10.1096/fj.07-8661com; Koide A, 2007, J MOL BIOL, V373, P941, DOI 10.1016/j.jmb.2007.08.027; Kuehne SA, 2010, NATURE, V467, P711, DOI 10.1038/nature09397; Kyne L, 2000, NEW ENGL J MED, V342, P390, DOI 10.1056/NEJM200002103420604; Kyne L, 2001, LANCET, V357, P189, DOI 10.1016/S0140-6736(00)03592-3; Kyne L, 2002, CLIN INFECT DIS, V34, P346, DOI 10.1086/338260; Ledeboer AM, 2002, J DAIRY SCI, V85, P1376, DOI 10.3168/jds.S0022-0302(02)74204-5; Leffler DA, 2009, GASTROENTEROLOGY, V136, P1899, DOI 10.1053/j.gastro.2008.12.070; LEUNG DYM, 1991, J PEDIATR-US, V118, P633, DOI 10.1016/S0022-3476(05)83393-1; Liu JL, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-78; Liu TM, 2000, J BIOL CHEM, V275, P32832, DOI 10.1074/jbc.C000573200; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; LYERLY DM, 1989, CURR MICROBIOL, V19, P303, DOI 10.1007/BF01570105; LYERLY DM, 1991, INFECT IMMUN, V59, P2215, DOI 10.1128/IAI.59.6.2215-2218.1991; LYERLY DM, 1990, CURR MICROBIOL, V21, P29, DOI 10.1007/BF02090096; LYERLY DM, 1986, INFECT IMMUN, V54, P70, DOI 10.1128/IAI.54.1.70-76.1986; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; McPherson S, 2006, DIS COLON RECTUM, V49, P640, DOI 10.1007/s10350-006-0511-8; Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899; O'Connor JR, 2009, GASTROENTEROLOGY, V136, P1913, DOI 10.1053/j.gastro.2009.02.073; Ochsner UA, 2009, J ANTIMICROB CHEMOTH, V63, P964, DOI 10.1093/jac/dkp042; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pepin J, 2005, CAN MED ASSOC J, V173, P1037, DOI 10.1503/cmaj.050978; Pruitt RN, 2010, P NATL ACAD SCI USA, V107, P13467, DOI 10.1073/pnas.1002199107; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Salcedo J, 1997, GUT, V41, P366, DOI 10.1136/gut.41.3.366; Salnikova MS, 2008, J PHARM SCI-US, V97, P3735, DOI 10.1002/jps.21261; Songer J. Glenn, 2004, Animal Health Research Reviews, V5, P321, DOI 10.1079/AHR200492; Stewart CS, 2007, TOXICON, V49, P699, DOI 10.1016/j.toxicon.2006.11.023; Stone E, 2007, MOL IMMUNOL, V44, P2487, DOI 10.1016/j.molimm.2006.10.020; Tanha Jamshid, 2003, Methods Mol Med, V89, P435; Teh YHA, 2010, TRANSGENIC RES, V19, P575, DOI 10.1007/s11248-009-9338-0; Thomassen YE, 2005, J BIOTECHNOL, V118, P270, DOI 10.1016/j.jbiotec.2005.05.010; TJELLSTROM B, 1993, LANCET, V341, P701, DOI 10.1016/0140-6736(93)90477-X; To R, 2005, J BIOL CHEM, V280, P41395, DOI 10.1074/jbc.M509900200; TUCKER KD, 1991, INFECT IMMUN, V59, P73, DOI 10.1128/IAI.59.1.73-78.1991; van der Linden RHJ, 1999, BBA-PROTEIN STRUCT M, V1431, P37, DOI 10.1016/S0167-4838(99)00030-8; van der Vaart JM, 2006, VACCINE, V24, P4130, DOI 10.1016/j.vaccine.2006.02.045; VISCIDI R, 1983, J INFECT DIS, V148, P93, DOI 10.1093/infdis/148.1.93; Vu KB, 1997, MOL IMMUNOL, V34, P1121, DOI 10.1016/S0161-5890(97)00146-6; Ward SJ, 1999, INFECT IMMUN, V67, P5124, DOI 10.1128/IAI.67.10.5124-5132.1999; Warny M, 1999, GUT, V44, P212, DOI 10.1136/gut.44.2.212; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; WARNY M, 1994, INFECT IMMUN, V62, P384, DOI 10.1128/IAI.62.2.384-389.1994; Wesolowski J, 2009, MED MICROBIOL IMMUN, V198, P157, DOI 10.1007/s00430-009-0116-7; Wilcox MH, 2004, J ANTIMICROB CHEMOTH, V53, P882, DOI 10.1093/jac/dkh176; Wilkins TD, 2003, J CLIN MICROBIOL, V41, P531, DOI 10.1128/JCM.41.2.531-534.2003; Zhang Jianbing, 2009, V525, P323, DOI 10.1007/978-1-59745-554-1_17	97	94	119	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8961	8976		10.1074/jbc.M110.198754	http://dx.doi.org/10.1074/jbc.M110.198754			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21216961	hybrid, Green Published			2022-12-27	WOS:000288247700028
J	An, S; Yeo, KJ; Jeon, YH; Song, JJ				An, Sojin; Yeo, Kwon Joo; Jeon, Young Ho; Song, Ji-Joon			Crystal Structure of the Human Histone Methyltransferase ASH1L Catalytic Domain and Its Implications for the Regulatory Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRITHORAX-GROUP PROTEIN; SET DOMAIN; METHYLATION; KINASE; GENES; PRODUCT; REGION; H3	Absent, small, or homeotic disc1 (Ash1) is a trithorax group histone methyltransferase that is involved in gene activation. Although there are many known histone methyltransferases, their regulatory mechanisms are poorly understood. Here, we present the crystal structure of the human ASH1L catalytic domain, showing its substrate binding pocket blocked by a loop from the post-SET domain. In this configuration, the loop limits substrate access to the active site. Mutagenesis of the loop stimulates ASH1L histone methyltransferase activity, suggesting that ASH1L activity may be regulated through the loop from the post-SET domain. In addition, we show that human ASH1L specifically methylates histone H3 Lys-36. Our data implicate that there may be a regulatory mechanism of ASH1L histone methyltransferases.	[An, Sojin; Song, Ji-Joon] World Class Univ, Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, KI BioCentury,Dept Biol Sci,Struct Biol Lab Epige, Taejon 305701, South Korea; [Yeo, Kwon Joo; Jeon, Young Ho] KBSI, Div Magnet Resonance, Ochang 363883, Chungbuk, South Korea; [Yeo, Kwon Joo; Jeon, Young Ho] Univ Sci & Technol, Ochang 363883, Chungbuk, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Basic Science Institute (KBSI)	Song, JJ (corresponding author), World Class Univ, Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol, KI BioCentury,Dept Biol Sci,Struct Biol Lab Epige, 335 Gwahangno, Taejon 305701, South Korea.	songj@kaist.ac.kr	Jeon, Young Ho/F-4483-2011; Song, Ji-Joon/C-1721-2011	Song, Ji-Joon/0000-0001-7120-6311	Korea Ministry of Education, Science and Technology; World Class University (WCU) [R31-2008-000-10071-0]; Ministry of Health, Welfare and Family Affairs [A100525]; Ministry of Education, Science and Technology;  [KRF-2010-007869];  [KRF-2010-0016263]	Korea Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); World Class University (WCU); Ministry of Health, Welfare and Family Affairs(Ministry of Health & Welfare (MOHW), Republic of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); ; 	This work was supported by the Brain Korea 21 (BK21) program from the Korea Ministry of Education, Science and Technology (to S. A.). This work was partially supported by the World Class University (WCU) program Grant R31-2008-000-10071-0 (to J.-J. S.), a grant from the Korea Healthcare Technology R&D project of the Ministry of Health, Welfare and Family Affairs (Grant A100525) and Grants KRF-2010-007869 and KRF-2010-0016263 (to J.-J. S.), and a grant from the High Field NMR Research Program (to Y. H. J.) awarded through the National Research Foundation of Korea and funded by the Ministry of Education, Science and Technology.	Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Byrd KN, 2003, P NATL ACAD SCI USA, V100, P11535, DOI 10.1073/pnas.1933593100; Chen L, 2009, NATURE, V459, P1146, DOI 10.1038/nature08075; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Couture JF, 2008, P NATL ACAD SCI USA, V105, P20659, DOI 10.1073/pnas.0806712105; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Gould A, 1997, CURR OPIN GENET DEV, V7, P488, DOI 10.1016/S0959-437X(97)80075-5; Gregory GD, 2007, MOL CELL BIOL, V27, P8466, DOI 10.1128/MCB.00993-07; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; LAJEUNESSE D, 1995, MECH DEVELOP, V53, P123, DOI 10.1016/0925-4773(95)00430-0; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Luger K, 1999, METH MOL B, V119, P1; OwenHughes T, 1996, EMBO J, V15, P4702, DOI 10.1002/j.1460-2075.1996.tb00847.x; Qiao Q, 2011, J BIOL CHEM, V286, P8361, DOI 10.1074/jbc.M110.204115; Rozovskaia T, 1999, MOL CELL BIOL, V19, P6441; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Simpson R. J., 2006, COLD SPRING HARB PRO; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tanaka Y, 2007, GENE, V397, P161, DOI 10.1016/j.gene.2007.04.027; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Tripoulas N, 1996, GENETICS, V143, P913; Yokoyama N, 2005, J BIOL CHEM, V280, P8893, DOI 10.1074/jbc.M412623200	25	89	95	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8369	8374		10.1074/jbc.M110.203380	http://dx.doi.org/10.1074/jbc.M110.203380			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21239497	Green Published, hybrid			2022-12-27	WOS:000288013300065
J	Bradley, HJ; Baldwin, JM; Goli, GR; Johnson, B; Zou, J; Sivaprasadarao, A; Baldwin, SA; Jiang, LH				Bradley, Helen J.; Baldwin, Jocelyn M.; Goli, G. Ranjan; Johnson, Brian; Zou, Jie; Sivaprasadarao, Asipu; Baldwin, Stephen A.; Jiang, Lin-Hua			Residues 155 and 348 Contribute to the Determination of P2X(7) Receptor Function via Distinct Mechanisms Revealed by Single-nucleotide Polymorphisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; AMINO-ACID-RESIDUES; GAIN-OF-FUNCTION; P2X7 RECEPTOR; MICROGLIAL ACTIVATION; PURINERGIC RECEPTOR; ALA POLYMORPHISM; HUMAN MONOCYTES; ATP RECEPTOR; ION-CHANNEL	P2X(7) receptors are important in mediating the physiological functions of extracellular ATP, and altered receptor expression and function have a causative role in the disease pathogenesis. Here, we investigated the mechanisms determining the P2X(7) receptor function by following two human single-nucleotide polymorphism (SNP) mutations that replace His-155 and Ala-348 in the human (h) P2X(7) receptor with the corresponding residues, Tyr-155 and Thr-348, in the rat (r) P2X(7) receptor. H155Y and A348T mutations in the hP2X(7) receptor increased ATP-induced currents, whereas the reciprocal mutations, Y155H and T348A, in the rP2X(7) receptor caused the opposite effects. Such a functional switch is a compelling indication that these residues are critical for P2X(7) receptor function. Additional mutations of His-155 and Ala-348 in the hP2X(7) receptor to residues with diverse side chains revealed a different dependence on the side chain properties, supporting the specificity of these two residues. Substitutions of the residues surrounding His-155 and Ala-348 in the hP2X(7) receptor with the equivalent ones in the rP2X(7) receptor also affected ATP-induced currents but were not fully reminiscent of the H155Y and A348T effects. Immunofluorescence imaging and biotin labeling assays showed that H155Y in the hP2X(7) receptor increased and Y155H in the rP2X(7) receptor decreased cell-surface expression. Such contrasting effects were not obvious with the reciprocal mutations of residue 348. Taken together, our results suggest that residues at positions 155 and 348 contribute to P2X(7) receptor function via determining the surface expression and the single-channel function, respectively. Such interpretations are consistent with the locations of the residues in the structural model of the hP2X(7) receptor.	[Bradley, Helen J.; Baldwin, Jocelyn M.; Goli, G. Ranjan; Johnson, Brian; Zou, Jie; Sivaprasadarao, Asipu; Baldwin, Stephen A.; Jiang, Lin-Hua] Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Jiang, LH (corresponding author), Univ Leeds, Fac Biol Sci, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England.	l.h.jiang@leeds.ac.uk	Jiang, Lin-Hua/AAU-1078-2020; Jiang, Lin-Hua/D-2030-2010	Jiang, Lin-Hua/0000-0001-6398-0411; Jiang, Lin-Hua/0000-0001-6398-0411; Sivaprasadarao, Asipu/0000-0002-6755-3502	Biotechnology and Biological Science Research Council; BBSRC [BB/C517317/1, BB/D524875/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C517317/1, BB/D524875/1] Funding Source: researchfish	Biotechnology and Biological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the Biotechnology and Biological Science Research Council.	Adinolfi E, 2005, MOL BIOL CELL, V16, P3260, DOI 10.1091/mbc.E04-11-1025; Adinolfi E, 2002, BLOOD, V99, P706, DOI 10.1182/blood.V99.2.706; Adriouch S, 2002, J IMMUNOL, V169, P4108, DOI 10.4049/jimmunol.169.8.4108; Adriouch S, 2009, PURINERG SIGNAL, V5, P151, DOI 10.1007/s11302-009-9134-6; Barden N, 2006, AM J MED GENET B, V141B, P374, DOI 10.1002/ajmg.b.30303; Basso AM, 2009, BEHAV BRAIN RES, V198, P83, DOI 10.1016/j.bbr.2008.10.018; Brough D, 2002, MOL CELL NEUROSCI, V19, P272, DOI 10.1006/mcne.2001.1054; Browne LE, 2010, TRENDS PHARMACOL SCI, V31, P229, DOI 10.1016/j.tips.2010.02.004; Cabrini G, 2005, J IMMUNOL, V175, P82, DOI 10.4049/jimmunol.175.1.82; Chen Y, 2008, P NATL ACAD SCI USA, V105, P16773, DOI 10.1073/pnas.0801793105; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Chessell IP, 1998, FEBS LETT, V439, P26, DOI 10.1016/S0014-5793(98)01332-5; Choi HB, 2007, J NEUROSCI, V27, P4957, DOI 10.1523/JNEUROSCI.5417-06.2007; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Denlinger LC, 2003, J IMMUNOL, V171, P1304, DOI 10.4049/jimmunol.171.3.1304; Di Virgilio F, 2007, TRENDS PHARMACOL SCI, V28, P465, DOI 10.1016/j.tips.2007.07.002; Diaz-Hernandez M, 2009, FASEB J, V23, P1893, DOI 10.1096/fj.08-122275; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; Donnelly-Roberts DL, 2009, BRIT J PHARMACOL, V157, P1203, DOI 10.1111/j.1476-5381.2009.00233.x; Duan SM, 2003, J NEUROSCI, V23, P1320, DOI 10.1523/JNEUROSCI.23-04-01320.2003; Erhardt A, 2007, J AFFECT DISORDERS, V101, P159, DOI 10.1016/j.jad.2006.11.016; Feng YH, 2006, J BIOL CHEM, V281, P17228, DOI 10.1074/jbc.M602999200; Fiser A, 2003, BIOINFORMATICS, V19, P2500, DOI 10.1093/bioinformatics/btg362; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Glas R, 2009, DIABETOLOGIA, V52, P1579, DOI 10.1007/s00125-009-1349-0; Gorodeski GI, 2009, EXPERT OPIN THER TAR, V13, P1313, DOI 10.1517/14728220903277249; Gu BJ, 2004, J BIOL CHEM, V279, P31287, DOI 10.1074/jbc.M313902200; Gu BJ, 2001, J BIOL CHEM, V276, P11135, DOI 10.1074/jbc.M010353200; Gunosewoyo H, 2010, EXPERT OPIN THER PAT, V20, P625, DOI 10.1517/13543771003702424; Hibell AD, 2000, BRIT J PHARMACOL, V130, P167, DOI 10.1038/sj.bjp.0703302; Hille B., 1992, IONIC CHANNELS EXCIT; Humphreys BD, 1998, MOL PHARMACOL, V54, P22, DOI 10.1124/mol.54.1.22; Jiang LH, 2000, MOL PHARMACOL, V58, P82, DOI 10.1124/mol.58.1.82; Jiang LH, 2005, AM J PHYSIOL-CELL PH, V289, pC1295, DOI 10.1152/ajpcell.00253.2005; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Ke HZ, 2003, MOL ENDOCRINOL, V17, P1356, DOI 10.1210/me.2003-0021; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Kim M, 2001, EMBO J, V20, P6347, DOI 10.1093/emboj/20.22.6347; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Le Stunff H, 2004, J BIOL CHEM, V279, P16918, DOI 10.1074/jbc.M313064200; Li MF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1048; Liu X, 2009, BRIT J PHARMACOL, V156, P135, DOI 10.1111/j.1476-5381.2008.00002.x; Liu X, 2008, MOL PHARMACOL, V73, P252, DOI 10.1124/mol.107.039651; Lucae S, 2006, HUM MOL GENET, V15, P2438, DOI 10.1093/hmg/ddl166; Matute C, 2007, J NEUROSCI, V27, P9525, DOI 10.1523/JNEUROSCI.0579-07.2007; McLarnon JG, 2006, J NEUROPATH EXP NEUR, V65, P1090, DOI 10.1097/01.jnen.0000240470.97295.d3; Mei ZZ, 2006, J BIOL CHEM, V281, P38748, DOI 10.1074/jbc.M607591200; Monif M, 2009, J NEUROSCI, V29, P3781, DOI 10.1523/JNEUROSCI.5512-08.2009; Moore SF, 2008, BIOCHEM PHARMACOL, V76, P1740, DOI 10.1016/j.bcp.2008.09.015; Nakamoto T, 2009, J BIOL CHEM, V284, P4815, DOI 10.1074/jbc.M808597200; Nicke A, 2008, BIOCHEM BIOPH RES CO, V377, P803, DOI 10.1016/j.bbrc.2008.10.042; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Parvathenani LK, 2003, J BIOL CHEM, V278, P13309, DOI 10.1074/jbc.M209478200; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rassendren F, 1997, J BIOL CHEM, V272, P5482, DOI 10.1074/jbc.272.9.5482; Roger B, 2008, J NEUROSCI, V28, P6393, DOI 10.1523/JNEUROSCI.0696-08.2008; Roger S, 2010, J PSYCHIATR RES, V44, P347, DOI 10.1016/j.jpsychires.2009.10.005; Sanz JM, 2009, J IMMUNOL, V182, P4378, DOI 10.4049/jimmunol.0803612; Saunders BM, 2003, J IMMUNOL, V171, P5442, DOI 10.4049/jimmunol.171.10.5442; Shemon AN, 2006, J BIOL CHEM, V281, P2079, DOI 10.1074/jbc.M507816200; Skaper SD, 2010, FASEB J, V24, P337, DOI 10.1096/fj.09-138883; Sluyter R, 2004, GENES IMMUN, V5, P588, DOI 10.1038/sj.gene.6364127; Sluyter R, 2004, J IMMUNOL, V172, P3399, DOI 10.4049/jimmunol.172.6.3399; Sluyter R, 2007, AM J PHYSIOL-REG I, V293, pR2090, DOI 10.1152/ajpregu.00166.2007; Solini A, 2008, ENDOCRINOLOGY, V149, P389, DOI 10.1210/en.2007-1223; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Stokes L, 2006, BRIT J PHARMACOL, V149, P880, DOI 10.1038/sj.bjp.0706933; Stokes L, 2010, FASEB J, V24, P2916, DOI 10.1096/fj.09-150862; Sun CQ, 2010, PURINERG SIGNAL, V6, P31, DOI 10.1007/s11302-009-9168-9; Surprenant A, 1996, SCIENCE, V272, P735, DOI 10.1126/science.272.5262.735; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Thunberg U, 2002, LANCET, V360, P1935, DOI 10.1016/S0140-6736(02)11917-9; Vial C, 2004, TRENDS PHARMACOL SCI, V25, P487, DOI 10.1016/j.tips.2004.07.008; Wiley JS, 2003, J BIOL CHEM, V278, P17108, DOI 10.1074/jbc.M212759200; Wiley JS, 2002, LANCET, V359, P1114, DOI 10.1016/S0140-6736(02)08156-4; Wilkinson WJ, 2006, MOL PHARMACOL, V70, P1159, DOI 10.1124/mol.106.026658; Worthington RA, 2002, FEBS LETT, V512, P43, DOI 10.1016/S0014-5793(01)03311-7; Xia R, 2008, J BIOL CHEM, V283, P27426, DOI 10.1074/jbc.M801049200; Yiangou Y, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-12; Young MT, 2006, BRIT J PHARMACOL, V149, P261, DOI 10.1038/sj.bjp.0706880; Young MT, 2007, MOL PHARMACOL, V71, P92, DOI 10.1124/mol.106.030163; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3; Zhang X, 2007, P NATL ACAD SCI USA, V104, P9864, DOI 10.1073/pnas.0611048104; Zhou LY, 2008, J BIOL CHEM, V283, P28274, DOI 10.1074/jbc.M802663200	84	39	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8176	8187		10.1074/jbc.M110.211284	http://dx.doi.org/10.1074/jbc.M110.211284			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21205829	hybrid, Green Published			2022-12-27	WOS:000288013300048
J	Aflaki, E; Radovic, B; Chandak, PG; Kolb, D; Eisenberg, T; Ring, J; Fertschai, I; Uellen, A; Wolinski, H; Kohlwein, SD; Zechner, R; Levak-Frank, S; Sattler, W; Graier, WF; Malli, R; Madeo, F; Kratky, D				Aflaki, Elma; Radovic, Branislav; Chandak, Prakash G.; Kolb, Dagmar; Eisenberg, Tobias; Ring, Julia; Fertschai, Ismene; Uellen, Andreas; Wolinski, Heimo; Kohlwein, Sepp-Dieter; Zechner, Rudolf; Levak-Frank, Sanja; Sattler, Wolfgang; Graier, Wolfgang F.; Malli, Roland; Madeo, Frank; Kratky, Dagmar			Triacylglycerol Accumulation Activates the Mitochondrial Apoptosis Pathway in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE TRIGLYCERIDE LIPASE; LOW-DENSITY-LIPOPROTEIN; LIPID STORAGE DISEASE; CYTOPLASMIC CHOLESTERYL ESTERS; CELL-DEATH; PATATIN DOMAIN; FOAM CELLS; MICE; RECEPTOR; METABOLISM	Programmed cell death of lipid-laden macrophages is a prominent feature of atherosclerotic lesions and mostly ascribed to accumulation of excess intracellular cholesterol. The present in vitro study investigated whether intracellular triacylglycerol (TG) accumulation could activate a similar apoptotic response in macrophages. To address this question, we utilized peritoneal macrophages isolated from mice lacking adipose triglyceride lipase (ATGL), the major enzyme responsible for TG hydrolysis in multiple tissues. In Atgl(-/-) macrophages, we observed elevated levels of cytosolic Ca2+ and reactive oxygen species, stimulated cytochrome c release, and nuclear localization of apoptosis-inducing factor. Fragmented mitochondria prior to cell death were indicative of the mitochondrial apoptosis pathway being triggered as a consequence of defective lipolysis. Other typical markers of apoptosis, such as externalization of phosphatidylserine in the plasma membrane, caspase 3 and poly(ADP-ribose) polymerase cleavage, were increased in Atgl(-/-) macrophages. An artificial increase of cellular TG levels by incubating wild-type macrophages with very low density lipoprotein closely mimicked the apoptotic phenotype observed in Atgl(-/-) macrophages. Results obtained during the present study define a novel pathway linking intracellular TG accumulation to mitochondrial dysfunction and programmed cell death in macrophages.	[Aflaki, Elma; Radovic, Branislav; Chandak, Prakash G.; Kolb, Dagmar; Fertschai, Ismene; Uellen, Andreas; Levak-Frank, Sanja; Sattler, Wolfgang; Graier, Wolfgang F.; Malli, Roland; Kratky, Dagmar] Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, A-8010 Graz, Austria; [Kolb, Dagmar; Eisenberg, Tobias; Ring, Julia; Wolinski, Heimo; Kohlwein, Sepp-Dieter; Zechner, Rudolf; Madeo, Frank] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	Medical University of Graz; University of Graz	Kratky, D (corresponding author), Med Univ Graz, Ctr Mol Med, Inst Mol Biol & Biochem, Harrachgasse 21, A-8010 Graz, Austria.	dagmar.kratky@medunigraz.at	Graier, Wolfgang F./B-7052-2008; Eisenberg, Tobias/AAV-7806-2021; Kratky, Dagmar/ABF-5699-2021	Graier, Wolfgang F./0000-0003-1871-3298; Eisenberg, Tobias/0000-0003-3559-1130; Zechner, Rudolf/0000-0001-5483-1182; Ring, Julia/0000-0003-4991-9328; Kohlwein, Sepp Dieter/0000-0002-1030-0598; Wolinski, Heimo/0000-0002-1583-6092; Malli, Roland/0000-0001-6327-8729; Kratky, Dagmar/0000-0003-1357-7573; Madeo, Frank/0000-0002-5070-1329	Medical University of Graz; Austrian Science Fund FWF [SFB-LIPOTOX F30, P19186]; Austrian Federal Ministry of Science and Research; Austrian Science Fund (FWF) [F 3002, Z 136, F 3007, F 3005, F 3004] Funding Source: researchfish	Medical University of Graz; Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Federal Ministry of Science and Research; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Medical University of Graz (Ph.D. Program "Molecular Medicine"), the Austrian Science Fund FWF (SFB-LIPOTOX F30 and P19186), and the Austrian Federal Ministry of Science and Research (GEN-AU project Genomics of Lipid-associated Disorders).	Akiyama M, 2007, MUSCLE NERVE, V36, P856, DOI 10.1002/mus.20869; Arnould T, 2002, EMBO J, V21, P53, DOI 10.1093/emboj/21.1.53; Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; BROWN MS, 1980, J BIOL CHEM, V255, P9344; Chandak PG, 2010, J BIOL CHEM, V285, P20192, DOI 10.1074/jbc.M110.107854; DeVries-Seimon T, 2005, J CELL BIOL, V171, P61, DOI 10.1083/jcb.200502078; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Haemmerle G, 2002, J BIOL CHEM, V277, P4806, DOI 10.1074/jbc.M110355200; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Heiskanen KM, 1999, J BIOL CHEM, V274, P5654, DOI 10.1074/jbc.274.9.5654; Hirano K, 2008, NEW ENGL J MED, V359, P2396, DOI 10.1056/NEJMc0805305; HO YK, 1980, J LIPID RES, V21, P391; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Karlsson M, 2010, BIOCHEM J, V428, P183, DOI 10.1042/BJ20100208; Kellner-Weibel G, 1998, ARTERIOSCL THROM VAS, V18, P423, DOI 10.1161/01.ATV.18.3.423; Kobayashi K, 2008, J CLIN ENDOCR METAB, V93, P2877, DOI 10.1210/jc.2007-2247; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Lammers B, 2011, ARTERIOSCL THROM VAS, V31, P67, DOI 10.1161/ATVBAHA.110.215814; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; Liu J, 2005, ARTERIOSCL THROM VAS, V25, P174, DOI 10.1161/01.ATV.0000148548.47755.22; Lutgens E, 1999, CARDIOVASC RES, V41, P473, DOI 10.1016/S0008-6363(98)00311-3; Norberg E, 2008, CELL DEATH DIFFER, V15, P1857, DOI 10.1038/cdd.2008.123; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Thorp E, 2008, ARTERIOSCL THROM VAS, V28, P1421, DOI 10.1161/ATVBAHA.108.167197; Thorp E, 2009, ARTERIOSCL THROM VAS, V29, P169, DOI 10.1161/ATVBAHA.108.176495; Timmins JM, 2009, J CLIN INVEST, V119, P2925, DOI 10.1172/JCI38857; Ullery-Ricewick JC, 2009, J LIPID RES, V50, P2014, DOI 10.1194/jlr.M800659-JLR200; Vander Heiden MG, 1999, MOL CELL, V3, P159; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; WARNER GJ, 1995, J BIOL CHEM, V270, P5772, DOI 10.1074/jbc.270.11.5772; Yao PM, 2000, J BIOL CHEM, V275, P23807, DOI 10.1074/jbc.M002087200; Yao PM, 2001, J BIOL CHEM, V276, P42468, DOI 10.1074/jbc.M101419200; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zhang KZ, 2003, NAT CELL BIOL, V5, P769, DOI 10.1038/ncb0903-769; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	41	54	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7418	7428		10.1074/jbc.M110.175703	http://dx.doi.org/10.1074/jbc.M110.175703			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21196579	Green Published, hybrid			2022-12-27	WOS:000287737300057
J	Jiang, LY; Rong, R; Sheikh, MS; Huang, Y				Jiang, Lingyan; Rong, Rong; Sheikh, M. Saeed; Huang, Ying			Cullin-4A.DNA Damage-binding Protein 1 E3 Ligase Complex Targets Tumor Suppressor RASSF1A for Degradation during Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-CHROMOSOME 3P21.3; CELL-CYCLE; EPIGENETIC INACTIVATION; UBIQUITIN LIGASE; MICROTUBULE STABILITY; DNA-REPLICATION; BREAST CANCERS; CDK INHIBITOR; GENE; LUNG	Tumor suppressor RASSF1A (RAS association domain family 1, isoform A) is known to play an important role in regulation of mitosis; however, little is known about how RASSF1A is regulated during the mitotic phase of the cell cycle. In the present study, we have identified Cullin-4A (CUL4A) as a novel E3 ligase for RASSF1A. Our results demonstrate that DNA damage-binding protein 1 (DDB1) functions as a substrate adaptor that directly interacts with RASSF1A and bridges RASSF1A to the CUL4A E3 ligase complex. Depletion of DDB1 also diminishes intracellular interactions between RASSF1A and CUL4A. Our results also show that RASSF1A interacts with DDB1 via a region containing amino acids 165-200, and deletion of this region abolishes RASSF1A and DDB1 interactions. We have found that CUL4A depletion results in increased levels of RASSF1A protein due to increased half-life; whereas overexpression of CUL4A and DDB1 markedly enhances RASSF1A protein ubiquitination resulting in reduced RASSF1A levels. We further show that CUL4A-mediated RASSF1A degradation occurs during mitosis, and depletion of CUL4A markedly reverses mitotic-phase-stimulated RASSF1A degradation. We also note that overexpression of CUL4A antagonizes the ability of RASSF1A to induce M-phase cell cycle arrest. Thus, our present study demonstrates that the CUL4A.DDB1 E3 complex is important for regulation of RASSF1A during mitosis, and it may contribute to inactivation of RASSF1A and promoting cell cycle progression.	[Jiang, Lingyan; Rong, Rong; Sheikh, M. Saeed; Huang, Ying] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Huang, Y (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, 750 E Adams St, Syracuse, NY 13210 USA.	huangy@upstate.edu			National Institutes of Health [CA113868, CA128096]; U.S. Department of Defense [BC073479]; NATIONAL CANCER INSTITUTE [R03CA128096, R21CA113868] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grants CA113868 and CA128096 (to Y. H.).; Supported by a predoctoral fellowship (BC073479) from the U.S. Department of Defense.	Agathanggelou A, 2001, ONCOGENE, V20, P1509, DOI 10.1038/sj.onc.1204175; Bondar T, 2006, MOL CELL BIOL, V26, P2531, DOI 10.1128/MCB.26.7.2531-2539.2006; Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691; Chan MWY, 2003, INT J CANCER, V104, P611, DOI 10.1002/ijc.10971; Chen LC, 1998, CANCER RES, V58, P3677; Dallol A, 2004, CANCER RES, V64, P4112, DOI 10.1158/0008-5472.CAN-04-0267; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Dreijerink K, 2001, P NATL ACAD SCI USA, V98, P7504, DOI 10.1073/pnas.131216298; Furstenthal L, 2001, NAT CELL BIOL, V3, P715, DOI 10.1038/35087026; Higa LA, 2006, CELL CYCLE, V5, P71, DOI 10.4161/cc.5.1.2266; Jackson S, 2009, TRENDS BIOCHEM SCI, V34, P562, DOI 10.1016/j.tibs.2009.07.002; Kim Y, 2007, MOL CELL BIOL, V27, P1394, DOI 10.1128/MCB.00736-06; Kopanja D, 2009, ONCOGENE, V28, P2456, DOI 10.1038/onc.2009.86; Kuzmin I, 2002, CANCER RES, V62, P3498; Lerman MI, 2000, CANCER RES, V60, P6116; Li BH, 2006, BLOOD, V107, P4291, DOI 10.1182/blood-2005-08-3349; Liu LM, 2003, ONCOGENE, V22, P8125, DOI 10.1038/sj.onc.1206984; Matsuda N, 2005, DNA REPAIR, V4, P537, DOI 10.1016/j.dnarep.2004.12.012; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Rong R, 2007, ONCOGENE, V26, P7700, DOI 10.1038/sj.onc.1210575; Rong R, 2004, ONCOGENE, V23, P8216, DOI 10.1038/sj.onc.1207901; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shivakumar L, 2002, MOL CELL BIOL, V22, P4309, DOI 10.1128/MCB.22.12.4309-4318.2002; Song MS, 2008, ONCOGENE, V27, P3176, DOI 10.1038/sj.onc.1210971; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Song SJ, 2009, CANCER RES, V69, P8540, DOI 10.1158/0008-5472.CAN-09-1554; Suzuki H, 1999, BIOCHEM BIOPH RES CO, V256, P127, DOI 10.1006/bbrc.1999.0289; Tomizawa Y, 2002, CLIN CANCER RES, V8, P2362; van der Weyden L, 2005, MOL CELL BIOL, V25, P8356, DOI 10.1128/MCB.25.18.8356-8367.2005; Verma SK, 2008, FEBS LETT, V582, P2270, DOI 10.1016/j.febslet.2008.05.028; Vichalkovski A, 2008, CURR BIOL, V18, P1889, DOI 10.1016/j.cub.2008.10.060; Vos MD, 2004, CANCER RES, V64, P4244, DOI 10.1158/0008-5472.CAN-04-0339; Wang W, 2005, BIOCHEMISTRY-US, V44, P14553, DOI 10.1021/bi051071j; Wertz IE, 2004, SCIENCE, V303, P1371, DOI 10.1126/science.1093549; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Yasui K, 2002, HEPATOLOGY, V35, P1476, DOI 10.1053/jhep.2002.33683; Yu MY, 2003, INT J CANCER, V105, P204, DOI 10.1002/ijc.11051; Zhong WW, 2003, NATURE, V423, P885, DOI 10.1038/nature01747	42	26	27	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6971	6978		10.1074/jbc.M110.186494	http://dx.doi.org/10.1074/jbc.M110.186494			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21205828	Green Published, hybrid			2022-12-27	WOS:000287737300013
J	Mao, GH; Wang, RG; Guan, YF; Liu, YD; Zhang, SQ				Mao, Guohong; Wang, Ruigang; Guan, Yuefeng; Liu, Yidong; Zhang, Shuqun			Sulfurtransferases 1 and 2 Play Essential Roles in Embryo and Seed Development in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MERCAPTOPYRUVATE SULFURTRANSFERASE; CYANIDE DETOXIFICATION; ETHYLENE BIOSYNTHESIS; LEAFY COTYLEDON2; AUXIN GRADIENTS; EMBRYOGENESIS; SENESCENCE; GENES; EXPRESSION; RHODANESE	Sulfurtransferases (STRs) catalyze the transfer of a sulfur atom from a donor to a suitable acceptor molecule. The Arabidopsis thaliana genome encodes 20 putative STR proteins. The biological functions of most are unclear. We found that STR1 and STR2 play important roles in embryo/seed development. Mutation of STR1 alone resulted in a shrunken seed phenotype, although growth and development of vegetative and reproductive organs were not affected. The shrunken seed phenotype was associated with the delayed/arrested embryo development, in most cases, at the heart stage. The embryo defect of str1 mutant is not fully penetrant. Approximately 12.5% of embryos developed further and formed normal looking seeds. In severely shrunken seeds, no embryo could be identified after seed collection. Partially shrunken seeds that contained viable embryos could still germinate. However, cotyledons of the seedlings from such seeds were abnormal. An STR1-GUS fusion reporter revealed that the STR1 gene was universally expressed, with high levels of expression in specific tissues/organs including embryos. The incomplete penetrance of str1 embryo/seed phenotype is a result of functional STR2. Single str2 mutant had no phenotype. However, no str1(-/-)/str2(-/-) double mutant embryos were able to develop past the heart stage. Furthermore, STR2 is haplo-insufficient in str1 mutant background, and str1(-/-)/str2(+/-) embryos were 100% lethal. These data provide new insights into the biological functions of the ubiquitous sulfurtransferase in Arabidopsis embryogenesis and seed development.	[Zhang, Shuqun] Univ Missouri, Div Biochem, Bond Life Sci Ctr 371G, Interdisciplinary Plant Grp, Columbia, MO 65211 USA; [Mao, Guohong; Guan, Yuefeng; Liu, Yidong; Zhang, Shuqun] Univ Missouri, Christopher S Bond Life Sci Ctr, Columbia, MO 65211 USA; [Wang, Ruigang] Inner Mongolia Agr Univ, Coll Life Sci, Hohhot 010018, Inner Mongolia, Peoples R China	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Inner Mongolia Agricultural University	Zhang, SQ (corresponding author), Univ Missouri, Div Biochem, Bond Life Sci Ctr 371G, Interdisciplinary Plant Grp, Columbia, MO 65211 USA.	zhangsh@missouri.edu	Guan, Yuefeng/B-5733-2011; Zhang, Shuqun/X-6343-2019	Guan, Yuefeng/0000-0002-1436-3828	National Science Foundation [IOS-0743957]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant IOS-0743957 (to S. Z.).	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bartels A, 2007, PLANT PHYSIOL BIOCH, V45, P178, DOI 10.1016/j.plaphy.2007.02.005; BAUD S, 2008, ARABIDOPSIS BOOK, P1; Baud S, 2007, PLANT J, V50, P825, DOI 10.1111/j.1365-313X.2007.03092.x; Bauer M, 2004, PLANT PHYSIOL, V135, P916, DOI 10.1104/pp.104.040121; Berger F, 2006, CURR OPIN PLANT BIOL, V9, P664, DOI 10.1016/j.pbi.2006.09.015; Berleth T, 1998, PLANT PHYSIOL BIOCH, V36, P69, DOI 10.1016/S0981-9428(98)80092-2; Billaut-Laden I, 2006, TOXICOL LETT, V165, P101, DOI 10.1016/j.toxlet.2006.02.002; BONOMI F, 1977, EUR J BIOCHEM, V72, P17, DOI 10.1111/j.1432-1033.1977.tb11219.x; Braybrook SA, 2006, P NATL ACAD SCI USA, V103, P3468, DOI 10.1073/pnas.0511331103; CAPRON A, 2008, ARABIDOPSIS BOOK, P1; CERLETTI P, 1986, TRENDS BIOCHEM SCI, V11, P369, DOI 10.1016/0968-0004(86)90206-9; Cernac A, 2004, PLANT J, V40, P575, DOI 10.1111/j.1365-313X.2004.02235.x; Chung BC, 1997, J PLANT PHYSIOL, V151, P339, DOI 10.1016/S0176-1617(97)80262-3; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Smet I, 2010, PLANT J, V61, P959, DOI 10.1111/j.1365-313X.2010.04143.x; DONADIO S, 1990, J BACTERIOL, V172, P350, DOI 10.1128/JB.172.1.350-360.1990; Focks N, 1998, PLANT PHYSIOL, V118, P91, DOI 10.1104/pp.118.1.91; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Fujiki Y, 2001, PHYSIOL PLANTARUM, V111, P345, DOI 10.1034/j.1399-3054.2001.1110312.x; Grossmann K, 1996, PHYSIOL PLANTARUM, V97, P772, DOI 10.1111/j.1399-3054.1996.tb00543.x; Hatzfeld Y, 2000, FEBS LETT, V470, P147, DOI 10.1016/S0014-5793(00)01311-9; Iannetta PPM, 2006, PHYSIOL PLANTARUM, V127, P247, DOI 10.1111/j.1399-3054.2006.00656.x; Jenik PD, 2007, ANNU REV CELL DEV BI, V23, P207, DOI 10.1146/annurev.cellbio.22.011105.102609; Jurgens G, 2001, EMBO J, V20, P3609, DOI 10.1093/emboj/20.14.3609; Kamada H, 2005, PLANT BIOTECHNOL, V22, P253, DOI DOI 10.5511/plantbiotechnology.22.253; Liu CM, 1998, PLANT J, V16, P21, DOI 10.1046/j.1365-313x.1998.00268.x; Liu YD, 2004, PLANT CELL, V16, P3386, DOI 10.1105/tpc.104.026609; Meyer T, 2003, PLANTA, V217, P1, DOI 10.1007/s00425-002-0964-5; Mezard C, 2006, BIOCHEM SOC T, V34, P531, DOI 10.1042/BST0340531; Michniewicz Marta, 2007, Arabidopsis Book, V5, pe0108, DOI 10.1199/tab.0108; Nagahara N, 2006, CURR MED CHEM, V13, P1219, DOI 10.2174/092986706776360914; Nagahara N, 1999, HISTOL HISTOPATHOL, V14, P1277, DOI 10.14670/HH-14.1277; Nakamura T, 2000, EUR J BIOCHEM, V267, P5621, DOI 10.1046/j.1432-1327.2000.01633.x; Olsen OA, 2001, ANNU REV PLANT PHYS, V52, P233, DOI 10.1146/annurev.arplant.52.1.233; Papenbrock J, 2000, EUR J BIOCHEM, V267, P5571, DOI 10.1046/j.1432-1327.2000.01623.x; Ramasamy S, 2006, AM J PHYSIOL-GASTR L, V291, pG288, DOI 10.1152/ajpgi.00324.2005; Roeder S, 2009, PLANT MOL BIOL, V70, P535, DOI 10.1007/s11103-009-9490-1; Sabatini S, 1999, CELL, V99, P463, DOI 10.1016/S0092-8674(00)81535-4; Schenk PM, 2005, PLANT PHYSIOL BIOCH, V43, P997, DOI 10.1016/j.plaphy.2005.09.002; SCHERES B, 2002, ARABIDOPSIS BOOK, P1, DOI DOI 10.1199/TAB.0101; SCHWARTZ B, 1997, DEV SUSPENSOR DIFFER, P53; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Solomonson LP, 1981, CYANIDE BIOL, P11; Song SK, 2008, DEV CELL, V15, P98, DOI 10.1016/j.devcel.2008.05.008; Spencer MWB, 2007, PLANT PHYSIOL, V143, P924, DOI 10.1104/pp.106.087668; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; Tzafrir I, 2003, NUCLEIC ACIDS RES, V31, P90, DOI 10.1093/nar/gkg028; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; VENNESLAND B, 1982, FED PROC, V41, P2639; Weaver LM, 1998, PLANT MOL BIOL, V37, P455, DOI 10.1023/A:1005934428906; WISLER JA, 1991, TOXICOL LETT, V56, P275, DOI 10.1016/0378-4274(91)90156-Z; Xiao WY, 2006, PLANT CELL, V18, P805, DOI 10.1105/tpc.105.038836; Zhao YD, 2003, SCIENCE, V301, P1107, DOI 10.1126/science.1084161	56	21	23	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7548	7557		10.1074/jbc.M110.182865	http://dx.doi.org/10.1074/jbc.M110.182865			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21189252	Green Published, hybrid			2022-12-27	WOS:000287737300068
J	Sengupta, A; Molkentin, JD; Paik, JH; DePinho, RA; Yutzey, KE				Sengupta, Arunima; Molkentin, Jeffery D.; Paik, Ji-Hye; DePinho, Ronald A.; Yutzey, Katherine E.			FoxO Transcription Factors Promote Cardiomyocyte Survival upon Induction of Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CELL-DEATH; APOPTOSIS; HEART; HYPERTROPHY; INJURY; PROLIFERATION; RESPONSES; REVEALS; TBX20	Transcriptional regulatory mechanisms of cardiac oxidative stress resistance are not well defined. FoxO transcription factors are critical mediators of oxidative stress resistance in multiple cell types, but cardioprotective functions have not been reported previously. FoxO function in oxidative stress resistance was investigated in cultured cardiomyocytes and in mice with cardiomyocyte-specific combined deficiency of FoxO1 and FoxO3 subjected to myocardial infarction (MI) or acute ischemia/reperfusion (I/R) injury. Induction of oxidative stress in cardiomyocytes promotes FoxO1 and FoxO3 nuclear localization and target gene activation. Infection of cardiomyocytes with a dominant-negative FoxO1(Delta 256) adenovirus results in a significant increase in reactive oxygen species and cell death, whereas increased FoxO1 or FoxO3 expression reduces reactive oxygen species and cell death. Mice generated with combined conditional deletion of FoxO1 and FoxO3 specifically in cardiomyocytes were subjected to I/R or MI. Loss of FoxO1 and FoxO3 in cardiomyocytes results in a significant increase in infarct area with decreased expression of the antiapoptotic molecules, PTEN-induced kinase1 (PINK1) and CBP/P300-interacting transactivator (CITED2). Expressions of the antioxidants catalase and manganese superoxide dismutase-2 (SOD2) and the autophagy-related proteins LC3II and Gabarapl1 also are decreased following I/R compared with controls. Mice with cardiomyocyte-specific FoxO deficiency subjected to MI have reduced cardiac function, increased scar formation, induction of stress-responsive signaling, and increased apoptotic cell death relative to controls. These data support a critical role for FoxOs in promoting cardiomyocyte survival during conditions of oxidative stress through induction of antioxidants and cell survival pathways.	[Sengupta, Arunima; Molkentin, Jeffery D.; Yutzey, Katherine E.] Cincinnati Childrens Med Ctr, Div Mol Cardiovasc Biol, Inst Heart, Cincinnati, OH 45229 USA; [Paik, Ji-Hye; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Belfer Inst Appl Canc Sci,Dept Med Oncol, Boston, MA 02115 USA; [Paik, Ji-Hye; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Belfer Inst Appl Canc Sci,Dept Med, Boston, MA 02115 USA; [Paik, Ji-Hye; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Belfer Inst Appl Canc Sci,Dept Genet, Boston, MA 02115 USA	Cincinnati Children's Hospital Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Yutzey, KE (corresponding author), Cincinnati Childrens Med Ctr ML 7020, Div Mol Cardiovasc Biol, 240 Albert Sabin Way, Cincinnati, OH 45229 USA.	katherine.yutzey@cchmc.org		Yutzey, Katherine/0000-0002-1444-7124; DePinho, Ronald/0000-0002-5625-577X; Molkentin, Jeffery/0000-0002-3558-6529	National Institutes of Health [PO1 HL069779]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL069779] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 HL069779 (to K. E. Y. and J. D. M.).	Alcendor RR, 2007, CIRC RES, V100, P1512, DOI 10.1161/01.RES.0000267723.65696.4a; Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chen ZY, 2001, AM J PHYSIOL-HEART C, V280, pH2313, DOI 10.1152/ajpheart.2001.280.5.H2313; De Windt LJ, 2000, J BIOL CHEM, V275, P13571, DOI 10.1074/jbc.275.18.13571; De Windt LJ, 2000, CIRC RES, V86, P255, DOI 10.1161/01.RES.86.3.255; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Edwards MG, 2003, PHYSIOL GENOMICS, V13, P119, DOI 10.1152/physiolgenomics.00172.2002; Evans-Anderson HJ, 2008, CIRC RES, V102, P686, DOI 10.1161/CIRCRESAHA.107.163428; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Hochhauser E, 2003, AM J PHYSIOL-HEART C, V284, pH2351, DOI 10.1152/ajpheart.00783.2002; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Huang CQ, 2010, J CARDIOVASC TRANSL, V3, P365, DOI 10.1007/s12265-010-9189-3; Jin ZQ, 2005, AM J PHYSIOL-HEART C, V288, pH2986, DOI 10.1152/ajpheart.01144.2004; Kaiser RA, 2004, J BIOL CHEM, V279, P15524, DOI 10.1074/jbc.M313717200; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Li XN, 2009, DIABETES, V58, P2246, DOI 10.2337/db08-1512; Maillet M, 2009, J CLIN INVEST, V119, P3079, DOI 10.1172/JCI37694; Mandel EM, 2010, DEVELOPMENT, V137, P1919, DOI 10.1242/dev.043588; Mei Y, 2009, P NATL ACAD SCI USA, V106, P5153, DOI 10.1073/pnas.0901104106; MURPHY E, 2008, NATURE, V88, P239; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Parsons SA, 2004, J BIOL CHEM, V279, P26192, DOI 10.1074/jbc.M313800200; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Russell RR, 2004, J CLIN INVEST, V114, P495, DOI 10.1172/JCI200419297; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; Shelton EL, 2007, DEV BIOL, V302, P376, DOI 10.1016/j.ydbio.2006.09.047; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Tan WQ, 2008, J BIOL CHEM, V283, P29730, DOI 10.1074/jbc.M805514200; Tokudome S, 2009, J CLIN INVEST, V119, P1477, DOI 10.1172/JCI37413; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Wang YJ, 2009, CIRCULATION, V119, P835, DOI 10.1161/CIRCULATIONAHA.108.815043; Wu CG, 2009, AM J PHYSIOL-CELL PH, V297, pC928, DOI 10.1152/ajpcell.00045.2009; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	42	238	254	0	38	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7468	7478		10.1074/jbc.M110.179242	http://dx.doi.org/10.1074/jbc.M110.179242			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21159781	Green Published, hybrid			2022-12-27	WOS:000287737300061
J	Seong, HA; Manoharan, R; Ha, H				Seong, Hyun-A; Manoharan, Ravi; Ha, Hyunjung			B-MYB Positively Regulates Serine-Threonine Kinase Receptor-associated Protein (STRAP) Activity through Direct Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIGRATION INHIBITORY FACTOR; TUMOR-SUPPRESSOR; TRANSCRIPTION FACTOR; PHYSICAL INTERACTION; CELL-LINES; APOPTOSIS; GENE; P53; CANCER; PROLIFERATION	Serine-threonine kinase receptor-associated protein (STRAP) functions as a regulator of both TGF-beta and p53 signaling. However, the regulatory mechanism of STRAP activity is not understood. In this study, we report that B-MYB is a new STRAP-interacting protein, and that an amino-terminal DNA-binding domain and an area (amino acids 373-468) between the acidic and conserved regions of B-MYB mediate the B-MYB.STRAP interaction. Functionally, B-MYB enhances STRAP-mediated inhibition of TGF-beta signaling pathways, such as apoptosis and growth inhibition, by modulating complex formation between the TGF-beta receptor and SMAD3 or SMAD7. Furthermore, coexpression of B-MYB results in a dose-dependent increase in STRAP-mediated stimulation of p53-induced apoptosis and cell cycle arrest via direct interaction. Confocal microscopy showed that B-MYB prevents the normal translocation of SMAD3 in response to TGF-beta 1 and stimulates p53 nuclear translocation. These results suggest that B-MYB acts as a positive regulator of STRAP.	[Seong, Hyun-A; Manoharan, Ravi; Ha, Hyunjung] Chungbuk Natl Univ, Sch Life Sci, Dept Biochem, Cheongju 361763, South Korea	Chungbuk National University	Ha, H (corresponding author), Chungbuk Natl Univ, Sch Life Sci, Dept Biochem, Cheongju 361763, South Korea.	hyunha@chungbuk.ac.kr	Manoharan, Ravi/AAI-4139-2021	Manoharan, Ravi/0000-0002-3494-2173	National Research Foundation (NRF) of Korea [R0A-2007-000-20006-0]	National Research Foundation (NRF) of Korea(National Research Foundation of Korea)	This work was supported by National Research Foundation (NRF) of Korea Grant R0A-2007-000-20006-0.	Anumanthan G, 2006, CANCER RES, V66, P10824, DOI 10.1158/0008-5472.CAN-06-1599; ARSURA M, 1992, BLOOD, V79, P2708; BIES J, 1995, CANCER RES, V55, P501; Chang H, 1999, DEVELOPMENT, V126, P1631; Chen WSV, 2004, NAT GENET, V36, P304, DOI 10.1038/ng1306; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Datta PK, 2000, MOL CELL BIOL, V20, P3157, DOI 10.1128/MCB.20.9.3157-3167.2000; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Haider SK, 2006, CANCER RES, V66, P6156, DOI 10.1158/0008-5472.CAN-05-3261; Joaquin M, 2003, CELL MOL LIFE SCI, V60, P2389, DOI 10.1007/s00018-003-3037-4; Jung HY, 2008, J BIOL CHEM, V283, P20383, DOI 10.1074/jbc.M800050200; Jung HY, 2007, J BIOL CHEM, V282, P35293, DOI 10.1074/jbc.M705181200; Jung HY, 2010, J BIOL CHEM, V285, P54, DOI 10.1074/jbc.M109.045229; Jung H, 2008, J BIOL CHEM, V283, P34541, DOI 10.1074/jbc.M807219200; Kim T, 1999, FEBS LETT, V460, P363, DOI 10.1016/S0014-5793(99)01375-7; Lang G, 2005, IMMUNOLOGY, V114, P25, DOI 10.1111/j.1365-2567.2004.02073.x; Lechleider RJ, 2001, DEV BIOL, V240, P157, DOI 10.1006/dbio.2001.0469; LIN D, 1994, P NATL ACAD SCI USA, V91, P10079, DOI 10.1073/pnas.91.21.10079; Lipsick JS, 1996, ONCOGENE, V13, P223; Liu DX, 2004, J NEUROSCI, V24, P8720, DOI 10.1523/JNEUROSCI.1821-04.2004; LOTEM J, 1990, BLOOD, V76, P1315; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; RASCHELLA G, 1995, J BIOL CHEM, V270, P8540, DOI 10.1074/jbc.270.15.8540; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Sala A, 2005, EUR J CANCER, V41, P2479, DOI 10.1016/j.ejca.2005.08.004; SALA A, 1992, P NATL ACAD SCI USA, V89, P10415, DOI 10.1073/pnas.89.21.10415; Sala A, 1996, J BIOL CHEM, V271, P9363, DOI 10.1074/jbc.271.16.9363; Santilli G, 2005, J BIOL CHEM, V280, P15628, DOI 10.1074/jbc.M411747200; SELVAKUMARAN M, 1994, MOL CELL BIOL, V14, P2352, DOI 10.1128/MCB.14.4.2352; Seong HA, 2005, J BIOL CHEM, V280, P42897, DOI 10.1074/jbc.M507539200; Seong HA, 2003, J BIOL CHEM, V278, P9655, DOI 10.1074/jbc.M207478200; Seong HA, 2007, J BIOL CHEM, V282, P12272, DOI 10.1074/jbc.M609279200; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; Tanaka Y, 1999, J BIOL CHEM, V274, P28067, DOI 10.1074/jbc.274.40.28067; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Yao KS, 2005, CLIN CANCER RES, V11, P7264, DOI 10.1158/1078-0432.CCR-05-0135; Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4	37	13	15	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7439	7456		10.1074/jbc.M110.184382	http://dx.doi.org/10.1074/jbc.M110.184382			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21148321	hybrid, Green Published			2022-12-27	WOS:000287737300059
J	Stitham, J; Arehart, E; Elderon, L; Gleim, SR; Douville, K; Kasza, Z; Fetalvero, K; MacKenzie, T; Robb, J; Martin, KA; Hwa, J				Stitham, Jeremiah; Arehart, Eric; Elderon, Larkin; Gleim, Scott R.; Douville, Karen; Kasza, Zsolt; Fetalvero, Kristina; MacKenzie, Todd; Robb, John; Martin, Kathleen A.; Hwa, John			Comprehensive Biochemical Analysis of Rare Prostacyclin Receptor Variants STUDY OF ASSOCIATION OF SIGNALING WITH CORONARY ARTERY OBSTRUCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; NEPHROGENIC DIABETES-INSIPIDUS; VASCULAR SMOOTH-MUSCLE; CARDIOVASCULAR-DISEASE; RETINITIS-PIGMENTOSA; SYNTHETIC MUTATIONS; MICE LACKING; POLYMORPHISMS; GENE; RHODOPSIN	Currently, pharmacogenetic studies are at an impasse as the low prevalence (<2%) of most variants hinder their pharmacogenetic analysis with population sizes often inadequate for sufficiently powered studies. Grouping rare mutations by functional phenotype rather than mutation site can potentially increase sample size. Using human population-based studies (n = 1,761) to search for dysfunctional human prostacyclin receptor (hIP) variants, we recently discovered 18 non-synonymous mutations, all with frequencies less than 2% in our study cohort. Eight of the 18 had defects in binding, activation, and/or protein stability/folding. Mutations (M113T, L104R, and R279C) in three highly conserved positions demonstrated severe misfolding manifested by impaired binding and activation of cell surface receptors. To assess for association with coronary artery disease, we performed a case-control study comparing coronary angiographic results from patients with reduced cAMP production arising from the non-synonymous mutations (n = 23) with patients with non-synonymous mutations that had no reduction in cAMP (n = 17). Major coronary artery obstruction was significantly increased in the dysfunctional mutation group in comparison with the silent mutations. We then compared the 23 dysfunctional receptor patients with 69 age-and risk factor-matched controls (1:3). This verified the significantly increased coronary disease in the non-synonymous dysfunctional variant cohort. This study demonstrates the potential utility of in vitro functional characterization in predicting clinical phenotypes and represents the most comprehensive characterization of human prostacyclin receptor genetic variants to date.	[Fetalvero, Kristina; Martin, Kathleen A.; Hwa, John] Dartmouth Med Sch, Dept Pharmacol & Toxicol, Hanover, NH 03755 USA; [MacKenzie, Todd; Robb, John; Hwa, John] Dartmouth Med Sch, Dept Med Cardiol, Hanover, NH 03755 USA; [Martin, Kathleen A.] Dartmouth Med Sch, Dept Vasc Surg, Hanover, NH 03755 USA; [Stitham, Jeremiah; Gleim, Scott R.; Martin, Kathleen A.; Hwa, John] Yale Univ, Sch Med, Sect Cardiovasc Med, Dept Internal Med, New Haven, CT 06520 USA	Dartmouth College; Dartmouth College; Dartmouth College; Yale University	Hwa, J (corresponding author), Cardiovasc Res Ctr, 300 George St,759H, New Haven, CT 06511 USA.	john.hwa@yale.edu	Robb, John/AAI-9306-2021	Elderon, Larkin/0000-0002-9620-7756; Martin, Kathleen/0000-0002-1748-0034	National Institutes of Health, NHLBI [RO1 HL074190]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074190] Funding Source: NIH RePORTER	National Institutes of Health, NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HL074190 from the NHLBI (to J. H.). This work was also supported by grants from the American Heart Association (to J. H. and J. S.).	Abraham J, 2006, BBA-REV CANCER, V1766, P168, DOI 10.1016/j.bbcan.2006.10.003; [Anonymous], 2015, AM J CRIT CARE, V24, P156; Arehart E, 2007, CURR MED CHEM, V14, P2161; Arehart E, 2008, CIRC RES, V102, P986, DOI 10.1161/CIRCRESAHA.107.165936; Bengtsson K, 2001, CIRCULATION, V104, P187, DOI 10.1161/01.CIR.104.2.187; Berndt SI, 2007, INT J CANCER, V120, P1548, DOI 10.1002/ijc.22510; BOIE Y, 1994, J BIOL CHEM, V269, P12173; Cheng Y, 2002, SCIENCE, V296, P539, DOI 10.1126/science.1068711; Cravchik A, 1996, J BIOL CHEM, V271, P26013, DOI 10.1074/jbc.271.42.26013; Dudbridge F, 2004, AM J HUM GENET, V75, P424, DOI 10.1086/423738; Egan KM, 2004, SCIENCE, V306, P1954, DOI 10.1126/science.1103333; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fetalvero KM, 2007, PROSTAG OTH LIPID M, V82, P109, DOI 10.1016/j.prostaglandins.2006.05.011; FitzGerald GA, 2004, NEW ENGL J MED, V351, P1709, DOI 10.1056/NEJMp048288; Glynn RJ, 2007, CIRCULATION, V116, P1497, DOI 10.1161/CIRCULATIONAHA.107.716407; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hiratsuka M, 2001, MOL GENET METAB, V73, P298, DOI 10.1006/mgme.2001.3204; Hwa J, 1997, P NATL ACAD SCI USA, V94, P10571, DOI 10.1073/pnas.94.20.10571; Ibrahim S, 2010, ARTERIOSCL THROM VAS, V30, P1802, DOI 10.1161/ATVBAHA.110.208900; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Kimchi-Sarfaty C, 2007, PHARMACOGENOMICS, V8, P29, DOI 10.2217/14622416.8.1.29; Liggett SB, 1998, J CLIN INVEST, V102, P1534, DOI 10.1172/JCI4059; Liu ISC, 1996, AM J MED GENET, V61, P277, DOI 10.1002/(SICI)1096-8628(19960122)61:3<277::AID-AJMG14>3.3.CO;2-5; Martin KA, 2004, AM J PHYSIOL-CELL PH, V286, pC507, DOI 10.1152/ajpcell.00201.2003; Murata T, 1997, NATURE, V388, P678, DOI 10.1038/41780; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; O'Keeffe MB, 2008, BBA-MOL CELL RES, V1783, P1914, DOI 10.1016/j.bbamcr.2008.04.010; OGAWA Y, 1995, GENOMICS, V27, P142, DOI 10.1006/geno.1995.1016; Oksche A, 1998, J MOL MED, V76, P326, DOI 10.1007/s001090050224; Patrignani P, 2008, PHARMACOGENET GENOM, V18, P611, DOI 10.1097/FPC.0b013e328301a774; Rana BK, 2001, ANNU REV PHARMACOL, V41, P593, DOI 10.1146/annurev.pharmtox.41.1.593; ROSENTHAL W, 1994, CELL MOL BIOL, V40, P429; ROSOLOWSKY M, 1993, AM J PHYSIOL, V264, pH327, DOI 10.1152/ajpheart.1993.264.2.H327; Saito S, 2003, J HUM GENET, V48, P461, DOI 10.1007/s10038-003-0062-y; Stitham J, 2007, BRIT J PHARMACOL, V152, P513, DOI 10.1038/sj.bjp.0707413; Stitham J, 2004, BIOCHEMISTRY-US, V43, P8974, DOI 10.1021/bi0496788; Stitham J, 2003, J BIOL CHEM, V278, P4250, DOI 10.1074/jbc.M207420200; Stitham J, 2002, MOL PHARMACOL, V61, P1202, DOI 10.1124/mol.61.5.1202; Stitham J, 2007, GENE, V396, P180, DOI 10.1016/j.gene.2007.03.016; Stitham J, 2007, PROSTAG OTH LIPID M, V82, P95, DOI 10.1016/j.prostaglandins.2006.05.010; Stitham J, 2006, J BIOL CHEM, V281, P37227, DOI 10.1074/jbc.M604042200; Stojanovic A, 2004, J BIOL CHEM, V279, P35932, DOI 10.1074/jbc.M403821200; Stojanovic A, 2003, J BIOL CHEM, V278, P39020, DOI 10.1074/jbc.M303625200; Stojanovic A, 2002, RECEPTOR CHANNEL, V8, P33, DOI 10.1080/10606820212137; Stoneking M, 2001, NATURE, V409, P821, DOI 10.1038/35057279; Tanaka H, 1998, J BIOL CHEM, V273, P11378, DOI 10.1074/jbc.273.18.11378; Taylor DR, 2000, THORAX, V55, P762, DOI 10.1136/thorax.55.9.762; Trompet S, 2007, ANN NY ACAD SCI, V1100, P189, DOI 10.1196/annals.1395.018; Wise H, 1996, TRENDS PHARMACOL SCI, V17, P17, DOI 10.1016/0165-6147(96)81565-3; Xiao CY, 2001, CIRCULATION, V104, P2210, DOI 10.1161/hc4301.098058	50	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7060	7069		10.1074/jbc.M110.124933	http://dx.doi.org/10.1074/jbc.M110.124933			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21189259	Green Published, hybrid			2022-12-27	WOS:000287737300023
J	Biegel, E; Muller, V				Biegel, Eva; Mueller, Volker			A Na+-translocating Pyrophosphatase in the Acetogenic Bacterium Acetobacterium woodii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-BOUND PYROPHOSPHATASE; POTENTIAL COUPLING SITE; ENERGY-CONSERVATION; INORGANIC PYROPHOSPHATASE; PHOTOTROPHIC BACTERIA; CAFFEATE REDUCTION; ATP SYNTHESIS; SODIUM; PROTON; ION	The anaerobic acetogenic bacterium Acetobacterium woodii employs a novel type of Na+-motive anaerobic respiration, caffeate respiration. However, this respiration is at the thermodynamic limit of energy conservation, and even worse, in the first step, caffeate is activated by caffeyl-CoA synthetase, which hydrolyzes ATP to AMP and pyrophosphate. Here, we have addressed whether or not the energy stored in the anhydride bond of pyrophosphate is conserved by A. woodii. Inverted membrane vesicles of A. woodii have a membrane-bound pyrophosphatase that catalyzes pyrophosphate hydrolysis at a rate of 70-120 milliunits/mg of protein. Pyrophosphatase activity was dependent on the divalent cation Mg2+. In addition, activity was strictly dependent on Na+ with a Km of 1.1 mM. Hydrolysis of pyrophosphate was accompanied by Na-22(+) transport into the lumen of the inverted membrane vesicles. Inhibitor studies revealed that Na-22(+) transport was primary and electrogenic. Next to the Na+-motive ferredoxin: NAD(+) oxidoreductase (Fno or Rnf), the Na+-pyrophosphatase is the second primary Na+-translocating enzyme in A. woodii.	[Biegel, Eva; Mueller, Volker] Goethe Univ Frankfurt, Dept Mol Microbiol & Bioenerget, Inst Mol Biosci, D-60438 Frankfurt, Germany	Goethe University Frankfurt	Muller, V (corresponding author), Goethe Univ Frankfurt, Dept Mol Microbiol & Bioenerget, Inst Mol Biosci, Max von Laue Str 9, D-60438 Frankfurt, Germany.	vmueller@bio.uni-frankfurt.de	Mueller, Volker/ABE-4305-2021	Mueller, Volker/0000-0001-7955-5508	Deutsche Forschungsgemeinschaft [SFB 807]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (SFB 807).	Baltscheffsky M, 1999, FEBS LETT, V457, P525, DOI 10.1016/S0014-5793(99)00914-X; Belogurov GA, 2005, BIOCHEMISTRY-US, V44, P2088, DOI 10.1021/bi048429g; Biegel E, 2011, CELL MOL LIFE SCI, V68, P613, DOI 10.1007/s00018-010-0555-8; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; Fritz M, 2007, FEBS J, V274, P3421, DOI 10.1111/j.1742-4658.2007.05874.x; HEINONEN JK, 1981, ANAL BIOCHEM, V113, P313, DOI 10.1016/0003-2697(81)90082-8; HEISE R, 1993, FEMS MICROBIOL LETT, V112, P261, DOI 10.1111/j.1574-6968.1993.tb06460.x; HEISE R, 1989, J BACTERIOL, V171, P5473, DOI 10.1128/jb.171.10.5473-5478.1989; HEISE R, 1992, EUR J BIOCHEM, V206, P553, DOI 10.1111/j.1432-1033.1992.tb16959.x; Herrmann G, 2008, J BACTERIOL, V190, P784, DOI 10.1128/JB.01422-07; Hess V., 2011, J BACTERIOL IN PRESS; Imkamp F, 2002, J BACTERIOL, V184, P1947, DOI 10.1128/JB.184.7.1947-1951.2002; Imkamp F, 2007, J BACTERIOL, V189, P8145, DOI 10.1128/JB.01017-07; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; MAESHIMA M, 1989, J BIOL CHEM, V264, P20068; Malinen AM, 2007, BIOCHEMISTRY-US, V46, P8872, DOI 10.1021/bi700564b; Malinen AM, 2008, BIOCHEMISTRY-US, V47, P13447, DOI 10.1021/bi801803b; Muller V, 2008, ANN NY ACAD SCI, V1125, P137, DOI 10.1196/annals.1419.011; Muller V, 1995, ARCH MICROBIOL, V164, P363, DOI 10.1007/s002030050276; Muller V, 2004, STRICT AND FACULTATIVE ANAEROBES: MEDICAL AND ENVIRONMENTAL ASPECTS, P251; Muller V, 2003, APPL ENVIRON MICROB, V69, P6345, DOI 10.1128/AEM.69.11.6345-6353.2003; Muller V, 2001, BBA-BIOENERGETICS, V1505, P108, DOI 10.1016/S0005-2728(00)00281-4; NAKAMURA T, 1986, J BIOL CHEM, V261, P678; NORE BF, 1990, PHOTOSYNTH RES, V24, P75, DOI 10.1007/BF00032646; NYREN P, 1991, FEMS MICROBIOL LETT, V77, P265, DOI 10.1016/0378-1097(91)90563-P; Pisa KY, 2007, FEBS J, V274, P3928, DOI 10.1111/j.1742-4658.2007.05925.x; REA PA, 1993, ANNU REV PLANT PHYS, V44, P157, DOI 10.1146/annurev.pp.44.060193.001105; Schmidt S, 2009, BBA-BIOENERGETICS, V1787, P691, DOI 10.1016/j.bbabio.2008.12.015; Schocke L, 1998, EUR J BIOCHEM, V256, P589, DOI 10.1046/j.1432-1327.1998.2560589.x; Serrano A, 2004, J BIOENERG BIOMEMBR, V36, P127, DOI 10.1023/B:JOBB.0000019604.49875.b3; SKULACHEV VP, 1977, FEBS LETT, V74, P1, DOI 10.1016/0014-5793(77)80739-4; SOSA A, 1992, BIOCHEM J, V283, P561, DOI 10.1042/bj2830561	34	20	21	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6080	6084		10.1074/jbc.M110.192823	http://dx.doi.org/10.1074/jbc.M110.192823			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21173152	Green Published, hybrid			2022-12-27	WOS:000287476400016
J	Carew, JS; Espitia, CM; Esquivel, JA; Mahalingam, D; Kelly, KR; Reddy, G; Giles, FJ; Nawrocki, ST				Carew, Jennifer S.; Espitia, Claudia M.; Esquivel, Juan A., II; Mahalingam, Devalingam; Kelly, Kevin R.; Reddy, Guru; Giles, Francis J.; Nawrocki, Steffan T.			Lucanthone Is a Novel Inhibitor of Autophagy That Induces Cathepsin D-mediated Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOSOMAL MEMBRANE PERMEABILIZATION; MALIGNANT GLIOMA-CELLS; BREAST-CANCER CELLS; DEATH; CHLOROQUINE; INDUCTION; DRUG; TUMORIGENESIS; DEGRADATION; SUPPRESSION	Cellular stress induced by nutrient deprivation, hypoxia, and exposure to many chemotherapeutic agents activates an evolutionarily conserved cell survival pathway termed autophagy. This pathway enables cancer cells to undergo self-digestion to generate ATP and other essential biosynthetic molecules to temporarily avoid cell death. Therefore, disruption of autophagy may sensitize cancer cells to cell death and augment chemotherapy-induced apoptosis. Chloroquine and its analog hydroxychloroquine are the only clinically relevant autophagy inhibitors. Because both of these agents induce ocular toxicity, novel inhibitors of autophagy with a better therapeutic index are needed. Here we demonstrate that the small molecule lucanthone inhibits autophagy, induces lysosomal membrane permeabilization, and possesses significantly more potent activity in breast cancer models compared with chloroquine. Exposure to lucanthone resulted in processing and recruitment of microtubule-associated protein 1 light chain 3 (LC3) to autophagosomes, but impaired autophagic degradation as revealed by transmission electron microscopy and the accumulation of p62/SQSTM1. Microarray analysis, qRT-PCR, and immunoblotting determined that lucanthone stimulated a large induction in cathepsin D, which correlated with cell death. Accordingly, knockdown of cathepsin D reduced lucanthone-mediated apoptosis. Subsequent studies using p53(+/+) and p53(-/-) HCT116 cells established that lucanthone induced cathepsin D expression and reduced cancer cell viability independently of p53 status. In addition, lucanthone enhanced the anticancer activity of the histone deacetylase inhibitor vorinostat. Collectively, our results demonstrate that lucanthone is a novel autophagic inhibitor that induces apoptosis via cathepsin D accumulation and enhances vorinostat-mediated cell death in breast cancer models.	[Carew, Jennifer S.; Espitia, Claudia M.; Esquivel, Juan A., II; Mahalingam, Devalingam; Kelly, Kevin R.; Giles, Francis J.; Nawrocki, Steffan T.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Inst Drug Dev, Canc Therapy & Res Ctr, San Antonio, TX 78245 USA; [Reddy, Guru] Spectrum Pharmaceut, Irvine, CA 92618 USA	Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio	Nawrocki, ST (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Inst Drug Dev, Canc Therapy & Res Ctr, 14960 Omicron Dr, San Antonio, TX 78245 USA.	Nawrocki@uthscsa.edu			San Antonio Area Foundation; Spectrum Pharmaceuticals	San Antonio Area Foundation; Spectrum Pharmaceuticals	This work was supported by a grant from the Martha and Frank Herberth Memorial Fund and Beta and Melvin Leazar Memorial Fund and Robert F. and Anna M. Harper Memorial Fund of the San Antonio Area Foundation and funds provided by Spectrum Pharmaceuticals. G. R. is employed at Spectrum Pharmaceuticals. This study was funded in part by Spectrum Pharmaceuticals.	Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Apel A, 2009, INT J CANCER, V125, P991, DOI 10.1002/ijc.24500; Beaujouin M, 2006, ONCOGENE, V25, P1967, DOI 10.1038/sj.onc.1209221; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; Carew JS, 2007, AUTOPHAGY, V3, P464, DOI 10.4161/auto.4311; Carew JS, 2007, BLOOD, V110, P313, DOI 10.1182/blood-2006-10-050260; Carew Jennifer S, 2008, Biologics, V2, P201; Carew JS, 2010, J CELL MOL MED, V14, P2448, DOI 10.1111/j.1582-4934.2009.00832.x; CLARKSON J, 1984, J HELMINTHOL, V58, P59, DOI 10.1017/S0022149X00028066; Dassonneville L, 1999, BIOCHEM PHARMACOL, V58, P1307, DOI 10.1016/S0006-2952(99)00221-X; Ding WX, 2009, MOL CANCER THER, V8, P2036, DOI 10.1158/1535-7163.MCT-08-1169; Emert-Sedlak L, 2005, MOL CANCER THER, V4, P733, DOI 10.1158/1535-7163.MCT-04-0301; Erdal H, 2005, P NATL ACAD SCI USA, V102, P192, DOI 10.1073/pnas.0408592102; Fehrenbacher N, 2005, CANCER RES, V65, P2993, DOI 10.1158/0008-5472.CAN-05-0476; GLAUMANN H, 1987, EXP MOL PATHOL, V47, P346, DOI 10.1016/0014-4800(87)90018-9; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hippert MM, 2006, CANCER RES, V66, P9349, DOI 10.1158/0008-5472.CAN-06-1597; Hoang B, 2009, MOL CANCER THER, V8, P1974, DOI 10.1158/1535-7163.MCT-08-1177; Kanzawa T, 2003, CANCER RES, V63, P2103; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Khraishi MM, 1996, LUPUS, V5, pS41, DOI 10.1177/096120339600500110; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Liaudet-Coopman E, 2006, CANCER LETT, V237, P167, DOI 10.1016/j.canlet.2005.06.007; Lin XJ, 2001, CANCER RES, V61, P1508; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; Luo MH, 2004, ANTICANCER RES, V24, P2127; Mahalingam D, 2010, CLIN CANCER RES, V16, P141, DOI 10.1158/1078-0432.CCR-09-1385; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Milani M, 2009, CANCER RES, V69, P4415, DOI 10.1158/0008-5472.CAN-08-2839; MILLIGAN AJ, 1978, J NATL CANCER I, V60, P1023, DOI 10.1093/jnci/60.5.1023; Myint HY, 2004, T ROY SOC TROP MED H, V98, P73, DOI 10.1016/S0035-9203(03)00014-2; Nawrocki ST, 2008, BLOOD, V112, P2917, DOI 10.1182/blood-2007-12-130823; Paglin S, 2001, CANCER RES, V61, P439; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POOLE B, 1981, J CELL BIOL, V90, P665, DOI 10.1083/jcb.90.3.665; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Romanelli F, 2004, CURR PHARM DESIGN, V10, P2643, DOI 10.2174/1381612043383791; Savarino A, 2006, LANCET ONCOL, V7, P792, DOI 10.1016/S1470-2045(06)70875-0; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Solomon VR, 2009, EUR J PHARMACOL, V625, P220, DOI 10.1016/j.ejphar.2009.06.063; Sotelo J, 2006, ANN INTERN MED, V144, P337, DOI 10.7326/0003-4819-144-5-200603070-00008; Takeuchi H, 2005, CANCER RES, V65, P3336, DOI 10.1158/0008-5472.CAN-04-3640; Tehrani Rodney, 2008, Semin Ophthalmol, V23, P201, DOI 10.1080/08820530802049962; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765	52	108	108	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6602	6613		10.1074/jbc.M110.151324	http://dx.doi.org/10.1074/jbc.M110.151324			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21148553	Green Published, hybrid			2022-12-27	WOS:000287476400069
J	Fatrai, S; van Gosliga, D; Han, LN; Daenen, SMGJ; Vellenga, E; Schuringa, JJ				Fatrai, Szabolcs; van Gosliga, Djoke; Han, Lina; Daenen, Simon M. G. J.; Vellenga, Edo; Schuringa, Jan Jacob			KRAS(G12V) Enhances Proliferation and Initiates Myelomonocytic Differentiation in Human Stem/Progenitor Cells via Intrinsic and Extrinsic Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC STEM-CELLS; ONCOGENIC K-RAS; EX-VIVO EXPANSION; N-RAS; ERYTHROID-DIFFERENTIATION; MYELOID DIFFERENTIATION; PROGENITOR CELLS; MOUSE; GENE; EXPRESSION	In human hematopoietic malignancies, RAS mutations are frequently observed. Yet, little is known about signal transduction pathways that mediate KRAS-induced phenotypes in human CD34(+) stem/progenitor cells. When cultured on bone marrow stroma, we observed that KRAS(G12V)-transduced cord blood (CB) CD34(+) cells displayed a strong proliferative advantage over control cells, which coincided with increased early cobblestone (CAFC) formation and induction of myelomonocytic differentiation. However, the KRAS(G12V)-induced proliferative advantage was transient. By week three no progenitors remained in KRAS(G12V)-transduced cultures and cells were all terminally differentiated into monocytes/macrophages. In line with these results, LTC-IC frequencies were strongly reduced. Both the ERK and p38 MAPK pathways, but not JNK, were activated by KRAS(G12V) and we observed that proliferation and CAFC formation were mediated via ERK, while differentiation was predominantly mediated via p38. Interestingly, we observed that KRAS(G12V)-induced proliferation and CAFC formation, but not differentiation, were largely mediated via secreted factors, since these phenotypes could be recapitulated by treating non-transduced cells with conditioned medium harvested from KRAS(G12V)-transduced cultures. Multiplex cytokine arrays and genome-wide gene expression profiling were performed to gain further insight into the mechanisms by which oncogenic KRAS(G12V) can contribute to the process of leukemic transformation. Thus, angiopoietin-like 6 (ANGPTL6) was identified as an important factor in the KRAS(G12V) secretome that enhanced proliferation of human CB CD34(+) cells.	[Fatrai, Szabolcs; van Gosliga, Djoke; Han, Lina; Daenen, Simon M. G. J.; Vellenga, Edo; Schuringa, Jan Jacob] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, NL-9700 RB Groningen, Netherlands	University of Groningen	Schuringa, JJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, Hanzepl 1,Z2-66 DA13, NL-9700 RB Groningen, Netherlands.	j.schuringa@int.umcg.nl	Han, Lina/J-5119-2015	Han, Lina/0000-0003-1538-1734	NWO-VENI; NWO-VIDI; KWF [RUG 2009-4275]	NWO-VENI(Netherlands Organization for Scientific Research (NWO)); NWO-VIDI(Netherlands Organization for Scientific Research (NWO)); KWF	This work was supported by grants from the NWO-VENI (2004), NWO-VIDI (2008), and KWF (RUG 2009-4275).	ALMOGUERA C, 1988, CELL, V53, P549, DOI 10.1016/0092-8674(88)90571-5; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BOS JL, 1987, BLOOD, V69, P1237; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Braun BS, 2004, P NATL ACAD SCI USA, V101, P597, DOI 10.1073/pnas.0307203101; BREIVIK J, 1994, BRIT J CANCER, V69, P367, DOI 10.1038/bjc.1994.67; Chan IT, 2006, BLOOD, V108, P1708, DOI 10.1182/blood-2006-04-015040; Chan IT, 2004, J CLIN INVEST, V113, P528, DOI 10.1172/JCI200420476; Darley RL, 1997, J EXP MED, V185, P1337, DOI 10.1084/jem.185.7.1337; Deneault E, 2009, CELL, V137, P369, DOI 10.1016/j.cell.2009.03.026; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; Geest CR, 2009, BLOOD, V114, P3402, DOI 10.1182/blood-2008-08-175141; Hato T, 2008, TRENDS CARDIOVAS MED, V18, P6, DOI 10.1016/j.tcm.2007.10.003; Hole PS, 2010, BLOOD, V115, P1238, DOI 10.1182/blood-2009-06-222869; HRUBAN RH, 1993, AM J PATHOL, V143, P545; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; KALRA R, 1994, BLOOD, V84, P3435; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; LEMOINE NR, 1988, CANCER RES, V48, P4459; LI SR, 1994, LUNG CANCER-J IASLC, V11, P19, DOI 10.1016/0169-5002(94)90279-8; MILLS NE, 1995, CANCER RES, V55, P1444; Monticone M, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-92; O'Hayer KM, 2009, CARCINOGENESIS, V30, P1841, DOI 10.1093/carcin/bgp198; Oike Y, 2005, NAT MED, V11, P400, DOI 10.1038/nm1214; Oike Y, 2003, P NATL ACAD SCI USA, V100, P9494, DOI 10.1073/pnas.1531901100; Onida F, 2002, BLOOD, V99, P840, DOI 10.1182/blood.V99.3.840; Parikh C, 2007, CANCER RES, V67, P7139, DOI 10.1158/0008-5472.CAN-07-0778; PIERCEALL WE, 1991, MOL CARCINOGEN, V4, P196, DOI 10.1002/mc.2940040306; Sabnis AJ, 2009, PLOS BIOL, V7, P537, DOI 10.1371/journal.pbio.1000059; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shen SW, 2004, EXP HEMATOL, V32, P852, DOI 10.1016/j.exphem.2004.06.001; Shen S, 2007, EXP HEMATOL, V35, P908, DOI 10.1016/j.exphem.2007.02.011; Van Meter MEM, 2007, BLOOD, V109, P3945, DOI 10.1182/blood-2006-09-047530; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479; Zhang J, 2007, BLOOD, V109, P5238, DOI 10.1182/blood-2006-09-047050; Zhang J, 2009, BLOOD, V113, P1304, DOI 10.1182/blood-2008-01-134262	41	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6061	6070		10.1074/jbc.M110.201848	http://dx.doi.org/10.1074/jbc.M110.201848			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21169357	Green Published, hybrid			2022-12-27	WOS:000287476400014
J	Inoue, Y; Iemura, SI; Natsume, T; Miyazawa, K; Imamura, T				Inoue, Yasumichi; Iemura, Shun-ichiro; Natsume, Tohru; Miyazawa, Keiji; Imamura, Takeshi			Suppression of p53 Activity through the Cooperative Action of Ski and Histone Deacetylase SIRT1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA; C-SKI; TUMOR-SUPPRESSOR; HUMAN CANCER; DUAL ROLE; GROWTH; PROTEIN; ACETYLATION; SNON; GENE	Ski was originally identified as an oncogene based on the fact that Ski overexpression transformed chicken and quail embryo fibroblasts. Consistent with these proposed oncogenic roles, Ski is overexpressed in various human tumors. However, whether and how Ski functions in mammalian tumorigenesis has not been fully investigated. Here, we show that Ski interacts with p53 and attenuates the biological functions of p53. Ski overexpression attenuated p53-dependent transactivation, whereas Ski knockdown enhanced the transcriptional activity of p53. Interestingly, Ski bound to the histone deacetylase SIRT1 and stabilized p53-SIRT1 interaction to promote p53 deacetylation, which subsequently decreased the DNA binding activity of p53. Consistent with the ability of Ski to inactivate p53, overexpressing Ski desensitized cells to genotoxic drugs and Nutlin-3, a small-molecule antagonist of Mdm2 that stabilizes p53 and activates the p53 pathway, whereas knocking down Ski increased the cellular sensitivity to these agents. These results indicate that Ski negatively regulates p53 and suggest that the p53-Ski-SIRT1 axis is an attractive target for cancer therapy.	[Inoue, Yasumichi; Imamura, Takeshi] Japan Sci & Technol Agcy, Koto Ku, Tokyo 1358550, Japan; Japanese Fdn Canc Res, Inst Canc, Div Biochem, Koto Ku, Tokyo 1358550, Japan; [Imamura, Takeshi] Ehime Univ, Grad Sch Med, Dept Mol Med Pathogenesis, Toon, Ehime 7910295, Japan; [Iemura, Shun-ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Biol Syst Control Team, Koto Ku, Tokyo 1350064, Japan; [Miyazawa, Keiji] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Biochem, Chuo Ku, Yamanashi 4093898, Japan	Japan Science & Technology Agency (JST); Japanese Foundation for Cancer Research; Ehime University; National Institute of Advanced Industrial Science & Technology (AIST); University of Yamanashi	Imamura, T (corresponding author), Japan Sci & Technol Agcy, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	timamura-ind@umin.ac.jp	Natsume, Tohru/M-7627-2018; MIYAZAWA, KEIJI/I-9713-2014	Natsume, Tohru/0000-0002-1510-2582; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22113004, 21025036, 20058038]; Japan Society for the Promotion of Science (JSPS) [20390407, 22700890]; Vehicle Racing Commemorative Foundation; Takeda Science Foundation; Naito Foundation	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Vehicle Racing Commemorative Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation)	This work was supported by Grant-in-aid for Scientific Research on Innovative Areas 22113004, "Fluorescence Live Imaging," and Grants-in-aid for Scientific Research on Priority Areas 21025036 and 20058038 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and by Grant-in-aid for Scientific Research (B) 20390407 and Grant-in-aid for Young Scientists (B) 22700890 from the Japan Society for the Promotion of Science (JSPS).; Supported by the Vehicle Racing Commemorative Foundation, the Takeda Science Foundation, and the Naito Foundation.	Akiyoshi S, 1999, J BIOL CHEM, V274, P35269, DOI 10.1074/jbc.274.49.35269; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Brooks CL, 2003, CURR OPIN CELL BIOL, V15, P164, DOI 10.1016/S0955-0674(03)00003-6; Buess M, 2004, NEOPLASIA, V6, P207, DOI 10.1593/neo.03442; Chen DH, 2009, PIGM CELL MELANOMA R, V22, P761, DOI 10.1111/j.1755-148X.2009.00603.x; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Fukuchi M, 2004, INT J CANCER, V108, P818, DOI 10.1002/ijc.11651; Fukunaga E, 2008, J BIOL CHEM, V283, P35660, DOI 10.1074/jbc.M710496200; Gilkes DM, 2006, EMBO J, V25, P5614, DOI 10.1038/sj.emboj.7601424; Hainaut P, 2000, ADV CANCER RES, V77, P81; Heider TR, 2007, ANN SURG, V246, P61, DOI 10.1097/SLA.0b013e318070cafa; Inoue Y, 2007, EMBO J, V26, P2083, DOI 10.1038/sj.emboj.7601652; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kitagawa M, 2008, MOL CELL, V29, P217, DOI 10.1016/j.molcel.2007.11.036; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Le Scolan E, 2008, CANCER RES, V68, P3277, DOI 10.1158/0008-5472.CAN-07-6793; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LI Y, 1986, J VIROL, V57, P1065, DOI 10.1128/JVI.57.3.1065-1072.1986; Lohrum MAE, 2003, CANCER CELL, V3, P577, DOI 10.1016/S1535-6108(03)00134-X; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Medrano EE, 2003, ONCOGENE, V22, P3123, DOI 10.1038/sj.onc.1206452; Miyazono K, 2003, CANCER SCI, V94, P230, DOI 10.1111/j.1349-7006.2003.tb01425.x; Nagano Y, 2007, J BIOL CHEM, V282, P20492, DOI 10.1074/jbc.M701294200; Nagano Y, 2010, J BIOCHEM, V147, P545, DOI 10.1093/jb/mvp202; Nanjundan M, 2008, MOL ONCOL, V2, P164, DOI 10.1016/j.molonc.2008.05.001; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Oren M, 2003, CELL DEATH DIFFER, V10, P431, DOI 10.1038/sj.cdd.4401183; Pan D, 2009, EMBO J, V28, P3500, DOI 10.1038/emboj.2009.250; Prives C, 1999, J PATHOL, V187, P112; Ritter M, 2006, LEUKEMIA, V20, P437, DOI 10.1038/sj.leu.2404093; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Shinagawa T, 2000, EMBO J, V19, P2280, DOI 10.1093/emboj/19.10.2280; Shinagawa T, 2001, ONCOGENE, V20, P8100, DOI 10.1038/sj.onc.1204987; STAVNEZER E, 1989, MOL CELL BIOL, V9, P4038, DOI 10.1128/MCB.9.9.4038; Takahata M, 2009, J BIOL CHEM, V284, P3334, DOI 10.1074/jbc.M808989200; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wang P, 2009, CARCINOGENESIS, V30, P1497, DOI 10.1093/carcin/bgp154; Wu JW, 2002, CELL, V111, P357, DOI 10.1016/S0092-8674(02)01006-1; Zhang YP, 2003, MOL CELL BIOL, V23, P8902, DOI 10.1128/MCB.23.23.8902-8912.2003; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zheng GX, 1997, ONCOGENE, V15, P459, DOI 10.1038/sj.onc.1201205; Zhu QW, 2007, MOL CELL BIOL, V27, P324, DOI 10.1128/MCB.01394-06	50	18	21	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6311	6320		10.1074/jbc.M110.177683	http://dx.doi.org/10.1074/jbc.M110.177683			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21149449	hybrid, Green Published			2022-12-27	WOS:000287476400041
J	Johnson, JL; Hong, H; Monfregola, J; Kiosses, WB; Catz, SD				Johnson, Jennifer L.; Hong, Hong; Monfregola, Jlenia; Kiosses, William B.; Catz, Sergio D.			Munc13-4 Restricts Motility of Rab27a-expressing Vesicles to Facilitate Lipopolysaccharide-induced Priming of Exocytosis in Neutrophils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; GRANULE SECRETION; RAB27A; MECHANISMS; MEMBRANE; EFFECTOR; CELLS; EXPRESSION; PROTEASES; FUSION	LPS is an efficient sensitizer of the neutrophil exocytic response to a second stimulus. Although neutrophil exocytosis in response to pathogen-derived molecules plays an important role in the innate immune response to infections, the molecular mechanism underlying LPS-dependent regulation of neutrophil exocytosis is currently unknown. The small GTPase Rab27a and its effector Munc13-4 regulate exocytosis in hematopoietic cells. Whether Rab27a and Munc13-4 modulate discrete steps or the same steps during exocytosis also remains unknown. Here, using Munc13-4- and Rab27a-deficient neutrophils, we analyzed the mechanism of lipopolysaccharide-dependent vesicular priming to amplify exocytosis of azurophilic granules. We found that both Munc13-4 and Rab27a are necessary to mediate LPS-dependent priming of exocytosis. However, we show that LPS-induced mobilization of a small population of readily releasable vesicles is a Munc13-4-dependent but Rab27a-independent process. LPS-induced priming regulation could not be fully explained by secretory organelle maturation as the redistribution of the secretory proteins Rab27a or Munc13-4 in response to LPS treatment was minimal. Using total internal reflection fluorescence microscopy and a novel mouse model expressing EGFP-Rab27a under the endogenous Rab27a promoter but lacking Munc13-4, we demonstrate that Munc13-4 is essential for the mechanism of LPS-dependent exocytosis in neutrophils and unraveled a novel mechanism of vesicular dynamics in which Munc13-4 restricts motility of Rab27a-expressing vesicles to facilitate lipopolysaccharide-induced priming of exocytosis.	[Johnson, Jennifer L.; Hong, Hong; Monfregola, Jlenia; Catz, Sergio D.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Kiosses, William B.] Scripps Res Inst, Core Microscopy Facil, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Catz, SD (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	scatz@scripps.edu	Monfregola, Jlenia/AAW-9055-2021	Hong, Hong/0000-0002-1009-3621; Catz, Sergio/0000-0002-1873-0277	U. S. Public Health Service [HL088256]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088256] Funding Source: NIH RePORTER	U. S. Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL088256 from the U. S. Public Health Service (to S. D. C.).	BAINTON DF, 1987, J EXP MED, V166, P1641, DOI 10.1084/jem.166.6.1641; Barral DC, 2002, J CLIN INVEST, V110, P247, DOI 10.1172/JCI200215058; Brovkovych V, 2008, AM J PHYSIOL-LUNG C, V295, pL96, DOI 10.1152/ajplung.00450.2007; Brzezinska AA, 2008, TRAFFIC, V9, P2151, DOI 10.1111/j.1600-0854.2008.00838.x; Brzezinska AA, 2009, IMMUNOLOGY, V127, P386, DOI 10.1111/j.1365-2567.2008.02980.x; Condliffe AM, 1998, CLIN SCI, V94, P461, DOI 10.1042/cs0940461; Crozat K, 2007, J EXP MED, V204, P853, DOI 10.1084/jem.20062447; Degtyar VE, 2007, P NATL ACAD SCI USA, V104, P15929, DOI 10.1073/pnas.0705406104; Feldmann J, 2003, CELL, V115, P461, DOI 10.1016/S0092-8674(03)00855-9; Fukuda M, 2005, J BIOCHEM, V137, P9, DOI 10.1093/jb/mvi002; Gomi H, 2007, MOL BIOL CELL, V18, P4377, DOI 10.1091/mbc.E07-05-0409; GRISCELLI C, 1978, AM J MED, V65, P691, DOI 10.1016/0002-9343(78)90858-6; Johnson JL, 2010, TRAFFIC, V11, P533, DOI 10.1111/j.1600-0854.2009.01029.x; KUIJPERS TW, 1991, BLOOD, V78, P1105; Menager MM, 2007, NAT IMMUNOL, V8, P257, DOI 10.1038/ni1431; Mortier A, 2010, J BIOL CHEM, V285, P29750, DOI 10.1074/jbc.M110.119388; Munafo DB, 2007, BIOCHEM J, V402, P229, DOI 10.1042/BJ20060950; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Neeft M, 2005, MOL BIOL CELL, V16, P731, DOI 10.1091/mbc.E04-10-0923; Pivot-Pajot C, 2008, J IMMUNOL, V180, P6786, DOI 10.4049/jimmunol.180.10.6786; Ren QS, 2010, BLOOD, V116, P869, DOI 10.1182/blood-2010-02-270934; SHAHIN RD, 1987, J IMMUNOL, V138, P3475; Shirakawa R, 2004, J BIOL CHEM, V279, P10730, DOI 10.1074/jbc.M309426200; Standish AJ, 2009, J IMMUNOL, V183, P2602, DOI 10.4049/jimmunol.0900688; Stinchcombe JC, 2001, J CELL BIOL, V152, P825, DOI 10.1083/jcb.152.4.825; Tolmachova T, 2004, MOL BIOL CELL, V15, P332, DOI 10.1091/mbc.e03-07-0452; Ward RA, 2000, J BIOL CHEM, V275, P36713, DOI 10.1074/jbc.M003017200; Wilson SM, 2000, P NATL ACAD SCI USA, V97, P7933, DOI 10.1073/pnas.140212797; Wood SM, 2009, BLOOD, V114, P4117, DOI 10.1182/blood-2009-06-225359	29	38	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5647	5656		10.1074/jbc.M110.184762	http://dx.doi.org/10.1074/jbc.M110.184762			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148308	Green Published, hybrid			2022-12-27	WOS:000287230600074
J	Nozoye, T; Nagasaka, S; Kobayashi, T; Takahashi, M; Sato, Y; Sato, Y; Uozumi, N; Nakanishi, H; Nishizawa, NK				Nozoye, Tomoko; Nagasaka, Seiji; Kobayashi, Takanori; Takahashi, Michiko; Sato, Yuki; Sato, Yoko; Uozumi, Nobuyuki; Nakanishi, Hiromi; Nishizawa, Naoko K.			Phytosiderophore Efflux Transporters Are Crucial for Iron Acquisition in Graminaceous Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR FACILITATOR SUPERFAMILY; NICOTIANAMINE SYNTHASE GENES; TRANSCRIPTION FACTOR; ENHANCED TOLERANCE; DEFICIENT BARLEY; MUGINEIC ACID; RICE; BIOSYNTHESIS; EXPRESSION; PROTEIN	Eukaryotic organisms have developed diverse mechanisms for the acquisition of iron, which is required for their survival. Graminaceous plants use a chelation strategy. They secrete phytosiderophore compounds, which solubilize iron in the soil, and then take up the resulting iron-phytosiderophore complexes. Bacteria and mammals also secrete siderophores to acquire iron. Although phytosiderophore secretion is crucial for plant growth, its molecular mechanism remains unknown. Here, we show that the efflux of deoxymugineic acid, the primary phytosiderophore from rice and barley, involves the TOM1 and HvTOM1 genes, respectively. Xenopus laevis oocytes expressing TOM1 or HvTOM1 released C-14-labeled deoxymugineic acid but not C-14-labeled nicotianamine, a structural analog and biosynthetic precursor of deoxymugineic acid, indicating that the TOM1 and HvTOM1 proteins are the phytosiderophore efflux transporters. Under conditions of iron deficiency, rice and barley roots express high levels of TOM1 and HvTOM1, respectively, and the overexpression of these genes increased tolerance to iron deficiency. In rice roots, the efficiency of deoxymugineic acid secretion was enhanced by overexpression of TOM1 and decreased by its repression, providing further evidence that TOM1 encodes the efflux transporter of deoxymugineic acid. We have also identified two genes encoding efflux transporters of nicotianamine, ENA1 and ENA2. Our identification of phytosiderophore efflux transporters has revealed the final piece in the molecular machinery of iron acquisition in graminaceous plants.	[Nozoye, Tomoko; Nagasaka, Seiji; Kobayashi, Takanori; Takahashi, Michiko; Nakanishi, Hiromi; Nishizawa, Naoko K.] Univ Tokyo, Dept Global Agr Sci, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Sato, Yuki; Sato, Yoko; Uozumi, Nobuyuki] Tohoku Univ, Dept Biomol Engn, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Nishizawa, Naoko K.] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan	University of Tokyo; Tohoku University; Ishikawa Prefecture University	Nishizawa, NK (corresponding author), Univ Tokyo, Dept Global Agr Sci, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	annaoko@mail.ecc.u-tokyo.ac.jp	Uozumi, Nobuyuki/AAG-3252-2019; Nakanishi, Hiromi/C-6461-2015	Uozumi, Nobuyuki/0000-0003-4268-1126; Nakanishi, Hiromi/0000-0001-5556-5058	CREST from Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science, and Technology of Japan	CREST from Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a research grant of CREST from Japan Science and Technology Agency (to N. K. N.) and by a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to N. K. N. and N. U.).	Aoyama T, 2009, PLANT MOL BIOL, V70, P681, DOI 10.1007/s11103-009-9500-3; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; Bashir K, 2006, J BIOL CHEM, V281, P32395, DOI 10.1074/jbc.M604133200; Curie C, 2001, NATURE, V409, P346, DOI 10.1038/35053080; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Furrer JL, 2002, MOL MICROBIOL, V44, P1225, DOI 10.1046/j.1365-2958.2002.02885.x; Haydon MJ, 2007, PLANT PHYSIOL, V143, P1705, DOI 10.1104/pp.106.092015; Hell R, 2003, PLANTA, V216, P541, DOI 10.1007/s00425-002-0920-4; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Higuchi K, 1999, PLANT PHYSIOL, V119, P471, DOI 10.1104/pp.119.2.471; Huang CF, 2009, PLANT CELL, V21, P655, DOI 10.1105/tpc.108.064543; Inoue H, 2003, PLANT J, V36, P366, DOI 10.1046/j.1365-313X.2003.01878.x; Inoue H, 2009, J BIOL CHEM, V284, P3470, DOI 10.1074/jbc.M806042200; Inoue H, 2008, PLANT MOL BIOL, V66, P193, DOI 10.1007/s11103-007-9262-8; Ishimaru Y, 2007, P NATL ACAD SCI USA, V104, P7373, DOI 10.1073/pnas.0610555104; Kakei Y, 2009, PLANT CELL PHYSIOL, V50, P1988, DOI 10.1093/pcp/pcp141; Kato Y, 2001, P NATL ACAD SCI USA, V98, P6488, DOI 10.1073/pnas.101556598; Kawai S, 2001, SOIL SCI PLANT NUTR, V47, P265, DOI 10.1080/00380768.2001.10408390; Kobayashi T, 2007, P NATL ACAD SCI USA, V104, P19150, DOI 10.1073/pnas.0707010104; Kobayashi T, 2008, RICE, V1, P144, DOI 10.1007/s12284-008-9011-x; Miethke M, 2007, MICROBIOL MOL BIOL R, V71, P413, DOI 10.1128/MMBR.00012-07; Mori S, 1999, CURR OPIN PLANT BIOL, V2, P250, DOI 10.1016/S1369-5266(99)80043-0; MORI S, 1987, PLANT CELL PHYSIOL, V28, P1081; MORI S, 1991, PLANT SOIL, V130, P143, DOI 10.1007/BF00011869; Nagasaka S, 2009, PLANT MOL BIOL, V69, P621, DOI 10.1007/s11103-008-9443-0; NAKANISHI H, 1993, PLANT CELL PHYSIOL, V34, P401; NOMOTO K, 1982, J SYN ORG CHEM JPN, V40, P401, DOI 10.5059/yukigoseikyokaishi.40.401; Nozoye T, 2004, SOIL SCI PLANT NUTR, V50, P1125, DOI 10.1080/00380768.2004.10408585; Nozoye T, 2007, PLANT MOL BIOL, V64, P35, DOI 10.1007/s11103-007-9132-4; Ogo Y, 2008, J BIOL CHEM, V283, P13407, DOI 10.1074/jbc.M708732200; Ogo Y, 2007, PLANT J, V51, P366, DOI 10.1111/j.1365-313X.2007.03149.x; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; SHOJIMA S, 1990, PLANT PHYSIOL, V93, P1497, DOI 10.1104/pp.93.4.1497; SHOJIMA S, 1989, PLANT CELL PHYSIOL, V30, P673; Suzuki M, 2008, SOIL SCI PLANT NUTR, V54, P77, DOI 10.1111/j.1747-0765.2007.00205.x; Suzuki M, 2006, PLANT J, V48, P85, DOI 10.1111/j.1365-313X.2006.02853.x; TAKAGI S, 1984, J PLANT NUTR, V7, P469, DOI 10.1080/01904168409363213; Takagi S., 1976, SOIL SCI PLANT NUTR, V45, P993; Takahashi M, 1999, PLANT PHYSIOL, V121, P947, DOI 10.1104/pp.121.3.947; Takahashi M, 2003, PLANT CELL, V15, P1263, DOI 10.1105/tpc.010256; Takahashi M, 2001, NAT BIOTECHNOL, V19, P466, DOI 10.1038/88143; Takahashi M, 2009, PLANT SOIL, V325, P39, DOI 10.1007/s11104-009-0045-7; Welch RM, 2004, J EXP BOT, V55, P353, DOI 10.1093/jxb/erh064	44	298	314	4	80	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5446	5454		10.1074/jbc.M110.180026	http://dx.doi.org/10.1074/jbc.M110.180026			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21156806	Green Published, hybrid			2022-12-27	WOS:000287230600053
J	Oakley, RH; Cidlowski, JA				Oakley, Robert H.; Cidlowski, John A.			Cellular Processing of the Glucocorticoid Receptor Gene and Protein: New Mechanisms for Generating Tissue-specific Actions of Glucocorticoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PRE-MESSENGER-RNA; BETA-ISOFORM; BINDING DOMAIN; EXPRESSION; PHOSPHORYLATION; ALPHA; TRANSACTIVATION; CELLS; REPRESSION; INHIBITION	Glucocorticoids regulate numerous physiological processes and are mainstays in the treatment of inflammation, autoimmune disease, and cancer. The traditional view that glucocorticoids act through a single glucocorticoid receptor (GR) protein has changed in recent years with the discovery of a large cohort of receptor subtypes arising from alternative processing of the GR gene. These isoforms differ in their expression, gene regulatory, and functional profiles. Post-translational modification of these proteins further expands GR diversity. Here, we discuss the origin and molecular properties of the GR isoforms and their contribution to the sensitivity and specificity of the glucocorticoid response.	[Oakley, Robert H.; Cidlowski, John A.] NIEHS, Lab Signal Transduct, NIH, Dept Hlth & Human Serv, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cidlowski, JA (corresponding author), NIEHS, Lab Signal Transduct, NIH, Dept Hlth & Human Serv, POB 12233, Res Triangle Pk, NC 27709 USA.	cidlows1@niehs.nih.gov	Cidlowski, John A/G-2548-2019	Cidlowski, John A/0000-0003-1420-0516	NIEHS, National Institutes of Health; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090057] Funding Source: NIH RePORTER	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the NIEHS Intramural Research Program of the National Institutes of Health. This is the fourth article in the Thematic Minireview Series on Nuclear Receptors in Biology and Diseases. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Avenant C, 2010, MOL CELL ENDOCRINOL, V327, P72, DOI 10.1016/j.mce.2010.06.007; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; Barraille P, 1999, BIOCHEM BIOPH RES CO, V257, P84, DOI 10.1006/bbrc.1999.0334; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Beger C, 2003, BRIT J HAEMATOL, V122, P245, DOI 10.1046/j.1365-2141.2003.04426.x; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Blind RD, 2008, J STEROID BIOCHEM, V109, P150, DOI 10.1016/j.jsbmb.2008.01.002; Chen WW, 2008, MOL ENDOCRINOL, V22, P1754, DOI 10.1210/me.2007-0219; Chrousos George P, 2005, Sci STKE, V2005, ppe48, DOI 10.1126/stke.3042005pe48; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Davies L, 2008, MOL ENDOCRINOL, V22, P1331, DOI 10.1210/me.2007-0360; de Lange P, 2001, CANCER RES, V61, P3937; Derijk RH, 2001, J RHEUMATOL, V28, P2383; Deroo BJ, 2002, MOL CELL BIOL, V22, P4113, DOI 10.1128/MCB.22.12.4113-4123.2002; Dostert A, 2004, CURR PHARM DESIGN, V10, P2807; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FREEDMAN LP, 1992, ENDOCR REV, V13, P129, DOI 10.1210/er.13.2.129; Freedman ND, 2004, MOL BIOL CELL, V15, P2276, DOI 10.1091/mbc.E03-11-0839; GAITAN D, 1995, MOL ENDOCRINOL, V9, P1193, DOI 10.1210/me.9.9.1193; Galliher-Beckley AJ, 2009, IUBMB LIFE, V61, P979, DOI 10.1002/iub.245; Galliher-Beckley AJ, 2008, MOL CELL BIOL, V28, P7309, DOI 10.1128/MCB.00808-08; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; Goecke IA, 2007, MOL IMMUNOL, V44, P2115, DOI 10.1016/j.molimm.2006.07.303; GOROVITS R, 1994, P NATL ACAD SCI USA, V91, P4786, DOI 10.1073/pnas.91.11.4786; Grad W, 2007, MOL CELL ENDOCRINOL, V275, P2, DOI 10.1016/j.mce.2007.05.018; Hauk PJ, 2000, J ALLERGY CLIN IMMUN, V105, P782, DOI 10.1067/mai.2000.105807; Hinds TD, 2010, MOL ENDOCRINOL, V24, P1715, DOI 10.1210/me.2009-0411; Holmstrom S, 2003, P NATL ACAD SCI USA, V100, P15758, DOI 10.1073/pnas.2136933100; Holmstrom SR, 2008, MOL ENDOCRINOL, V22, P2061, DOI 10.1210/me.2007-0581; HSU SC, 1995, J BIOL CHEM, V270, P3359, DOI 10.1074/jbc.270.7.3359; Iniguez-Lluhi JA, 2000, MOL CELL BIOL, V20, P6040, DOI 10.1128/MCB.20.16.6040-6050.2000; Ismaili N, 2005, J BIOL CHEM, V280, P11120, DOI 10.1074/jbc.M500059200; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Itoh M, 2002, MOL ENDOCRINOL, V16, P2382, DOI 10.1210/me.2002-0144; Jenkins BD, 2001, TRENDS ENDOCRIN MET, V12, P122, DOI 10.1016/S1043-2760(00)00357-X; Kelly A, 2008, J ALLERGY CLIN IMMUN, V121, P203, DOI 10.1016/j.jaci.2007.09.010; Kim SH, 2009, EXP MOL MED, V41, P297, DOI 10.3858/emm.2009.41.5.033; Kino T, 2003, J STEROID BIOCHEM, V85, P457, DOI 10.1016/S0960-0760(03)00218-8; Kino T, 2009, CELL MOL LIFE SCI, V66, P3435, DOI 10.1007/s00018-009-0098-z; Kino T, 2009, BIOCHEM BIOPH RES CO, V381, P671, DOI 10.1016/j.bbrc.2009.02.110; KRETT NL, 1995, CANCER RES, V55, P2727; Kumar R, 2005, J STEROID BIOCHEM, V94, P383, DOI 10.1016/j.jsbmb.2004.12.046; Kumar R, 2008, BIOL-TARGETS THER, V2, P845; Lamberts SWJ, 1996, STEROIDS, V61, P157, DOI 10.1016/0039-128X(96)00005-0; LE DY, 2002, ENDOCRINOLOGY, V143, P3482; Lewis-Tuffin LJ, 2007, MOL CELL BIOL, V27, P2266, DOI 10.1128/MCB.01439-06; Lewis-Tuffin LJ, 2006, ANN NY ACAD SCI, V1069, P1, DOI 10.1196/annals.1351.001; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lonard DM, 2005, TRENDS BIOCHEM SCI, V30, P126, DOI 10.1016/j.tibs.2005.01.001; Lu NZ, 2007, MOL CELL BIOL, V27, P7143, DOI 10.1128/MCB.00253-07; Lu NZ, 2005, MOL CELL, V18, P331, DOI 10.1016/j.molcel.2005.03.025; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; Miller AL, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-3; Miller AL, 2005, MOL ENDOCRINOL, V19, P1569, DOI 10.1210/me.2004-0528; Miner JN, 2005, EXPERT OPIN INV DRUG, V14, P1527, DOI 10.1517/13543784.14.12.1527; MOALLI PA, 1993, CANCER RES, V53, P3877; Necela Brian M, 2004, Proc Am Thorac Soc, V1, P239, DOI 10.1513/pats.200402-005MS; Nehme A, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-58; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Otto C, 1997, J BIOL CHEM, V272, P26665, DOI 10.1074/jbc.272.42.26665; Pascual-Le Tallec L, 2005, MOL ENDOCRINOL, V19, P2211, DOI 10.1210/me.2005-0089; Pedersen KB, 2004, BIOCHEMISTRY-US, V43, P10851, DOI 10.1021/bi049458u; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Ray DW, 1996, CANCER RES, V56, P3276; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rivers C, 1999, J CLIN ENDOCR METAB, V84, P4283, DOI 10.1210/jc.84.11.4283; Rogatsky I, 2006, TISSUE ANTIGENS, V68, P1, DOI 10.1111/j.1399-0039.2006.00599.x; Ronacher K, 2009, MOL CELL ENDOCRINOL, V299, P219, DOI 10.1016/j.mce.2008.10.008; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Russcher H, 2005, MOL ENDOCRINOL, V19, P1687, DOI 10.1210/me.2004-0467; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schaaf MJM, 2008, ENDOCRINOLOGY, V149, P1591, DOI 10.1210/en.2007-1364; Schaaf MJM, 2002, STEROIDS, V67, P627, DOI 10.1016/S0039-128X(02)00015-6; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Sinclair D, 2011, MOL PSYCHIATR, V16, P504, DOI 10.1038/mp.2010.28; Song IH, 2006, MOL CELL ENDOCRINOL, V246, P142, DOI 10.1016/j.mce.2005.11.012; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Syed AA, 2006, OBESITY, V14, P759, DOI 10.1038/oby.2006.86; Tian S, 2002, BIOCHEM J, V367, P907, DOI 10.1042/BJ20021085; Tliba O, 2006, MOL PHARMACOL, V69, P588, DOI 10.1124/mol.105.019679; van den Akker ELT, 2008, ARCH INTERN MED, V168, P33, DOI 10.1001/archinternmed.2007.41; Viegas LR, 2008, J STEROID BIOCHEM, V109, P273, DOI 10.1016/j.jsbmb.2008.03.007; Wallace AD, 2001, J BIOL CHEM, V276, P42714, DOI 10.1074/jbc.M106033200; Walsh CT, 2005, ANGEW CHEM INT EDIT, V44, P7342, DOI 10.1002/anie.200501023; Wang SCM, 2010, MOL CELL ENDOCRINOL, V315, P146, DOI 10.1016/j.mce.2009.07.012; Wang XJ, 2005, MOL ENDOCRINOL, V19, P1474, DOI 10.1210/me.2004-0383; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200; Webster JC, 2001, P NATL ACAD SCI USA, V98, P6865, DOI 10.1073/pnas.121455098; Webster JC, 1997, J BIOL CHEM, V272, P9287; WILSON CM, 1994, P NATL ACAD SCI USA, V91, P1234, DOI 10.1073/pnas.91.4.1234; Xu Q, 2003, J BIOL CHEM, V278, P27112, DOI 10.1074/jbc.M300824200; Yudt MR, 2003, MOL CELL BIOL, V23, P4319, DOI 10.1128/MCB.23.12.4319-4330.2003; Yudt MR, 2001, MOL ENDOCRINOL, V15, P1093, DOI 10.1210/me.15.7.1093; Zhang Y, 2009, J BIOL CHEM, V284, P24542, DOI 10.1074/jbc.M109.021469; Zhu J, 2007, BBA-MOL CELL RES, V1773, P1087, DOI 10.1016/j.bbamcr.2007.04.016	98	261	270	3	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 4	2011	286	5					3177	3184		10.1074/jbc.R110.179325	http://dx.doi.org/10.1074/jbc.R110.179325			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	712GE	21149445	Green Published, hybrid			2022-12-27	WOS:000286653200001
J	Broadhead, GK; Mun, HC; Avlani, VA; Jourdon, O; Church, WB; Christopoulos, A; Delbridge, L; Conigrave, AD				Broadhead, Geoffrey K.; Mun, Hee-chang; Avlani, Vimesh A.; Jourdon, Orane; Church, W. Bret; Christopoulos, Arthur; Delbridge, Leigh; Conigrave, Arthur D.			Allosteric Modulation of the Calcium-sensing Receptor by gamma-Glutamyl Peptides INHIBITION OF PTH SECRETION, SUPPRESSION OF INTRACELLULAR cAMP LEVELS, AND A COMMON MECHANISM OF ACTION WITH L-AMINO ACIDS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR CA2+-SENSING RECEPTOR; PROTEIN-COUPLED RECEPTORS; PHYSIOLOGICAL SIGNIFICANCE; CALCIMIMETIC COMPOUND; SIGNAL-TRANSDUCTION; CA2+ OSCILLATIONS; RAT-BRAIN; GLUTATHIONE; DOMAIN; ACTIVATION	gamma-Glutamyl peptides were identified previously as novel positive allosteric modulators of Ca2+ (o)-dependent intracellular Ca2+ mobilization in HEK-293 cells that bind in the calcium-sensing receptor VFT domain. In the current study, we investigated whether gamma-glutamyl-tripeptides including gamma-Glu-Cys-Gly (glutathione) and its analogs S-methylglutathione and S-propylglutathione, or dipeptides including gamma-Glu-Ala and gamma-Glu-Cys are positive allosteric modulators of Ca2+ (o)-dependent Ca2+ (i) mobilization and PTH secretion from normal human parathyroid cells as well as Ca2+ (o)-dependent suppression of intracellular cAMP levels in calcium-sensing receptor (CaR)-expressing HEK-293 cells. In addition, we compared the effects of the potent gamma-glutamyl peptide S-methylglutathione, and the amino acid L-Phe on HEK-293 cells that stably expressed either the wild-type CaR or the double mutant T145A/S170T, which exhibits selectively impaired responses to L-amino acids. We find that gamma-glutamyl peptides are potent positive allosteric modulators of the CaR that promote Ca2+ (o)-dependent Ca2+ (i) mobilization, suppress intracellular cAMP levels and inhibit PTH secretion from normal human parathyroid cells. Furthermore, we find that the double mutant T145A/S170T exhibits markedly impaired Ca2+ (i) mobilization and cAMP suppression responses to S-methylglutathione as well as L-Phe indicating that gamma-glutamyl peptides and L-amino acids activate the CaR via a common mechanism.	[Broadhead, Geoffrey K.; Mun, Hee-chang; Avlani, Vimesh A.; Jourdon, Orane; Conigrave, Arthur D.] Univ Sydney, Sch Mol Biosci G08, Sydney, NSW 2006, Australia; [Church, W. Bret] Univ Sydney, Fac Pharm, Sydney, NSW 2006, Australia; [Christopoulos, Arthur] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Christopoulos, Arthur] Monash Univ, Dept Pharmacol, Parkville, Vic 3052, Australia; [Delbridge, Leigh] Univ Sydney, Royal N Shore Hosp, Endocrine Surg Unit, St Leonards, NSW 2065, Australia	University of Sydney; University of Sydney; Monash University; Monash University; Royal North Shore Hospital; University of Sydney	Conigrave, AD (corresponding author), Univ Sydney, Sch Mol Biosci G08, Sydney, NSW 2006, Australia.	arthur.conigrave@sydney.edu.au	Centeno, Patricia Pacios/O-8368-2016; Church, William/H-6040-2013; Christopoulos, Arthur/B-6207-2013	Church, William/0000-0002-8033-5518; Christopoulos, Arthur/0000-0003-4442-3294; Delbridge, leigh/0000-0001-8281-8831; Conigrave, Arthur/0000-0002-7232-3891	NHMRC of Australia	NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the NHMRC of Australia for Fellowship and Project Grant funding (to A. C. and A. D. C.).	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Brennan SC, 2009, CURR PHARM BIOTECHNO, V10, P270, DOI 10.2174/138920109787847484; BROWN EM, 1976, ENDOCRINOLOGY, V99, P1582, DOI 10.1210/endo-99-6-1582; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Chang WH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159945; Conigrave AD, 2007, BIOCHEM SOC T, V35, P1195, DOI 10.1042/BST0351195; Conigrave AD, 2000, TRENDS PHARMACOL SCI, V21, P401, DOI 10.1016/S0165-6147(00)01546-7; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; Conigrave AD, 2006, TRENDS ENDOCRIN MET, V17, P398, DOI 10.1016/j.tem.2006.10.012; Conigrave AD, 2006, AM J PHYSIOL-GASTR L, V291, pG753, DOI 10.1152/ajpgi.00189.2006; Conigrave AD, 2010, PHARMACOL THERAPEUT, V127, P252, DOI 10.1016/j.pharmthera.2010.04.007; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Feng JY, 2010, P NATL ACAD SCI USA, V107, P17791, DOI 10.1073/pnas.1009078107; Ferry S, 2000, EUR J NEUROSCI, V12, P872, DOI 10.1046/j.1460-9568.2000.00980.x; Finney BA, 2008, J PHYSIOL-LONDON, V586, P6007, DOI 10.1113/jphysiol.2008.161687; Geibel JP, 2009, ANNU REV PHYSIOL, V71, P205, DOI 10.1146/annurev.physiol.010908.163128; Gerbino A, 2005, J CELL BIOL, V171, P303, DOI 10.1083/jcb.200507054; Hauache OM, 2000, ENDOCRINOLOGY, V141, P4156, DOI 10.1210/en.141.11.4156; HO C, 1995, NAT GENET, V11, P389, DOI 10.1038/ng1295-389; Huang Y, 2009, BIOCHEMISTRY-US, V48, P388, DOI 10.1021/bi8014604; Janaky R, 1999, J NEUROCHEM, V73, P889, DOI 10.1046/j.1471-4159.1999.0730889.x; Jenei Z, 1998, NEUROCHEM RES, V23, P1085, DOI 10.1023/A:1020712203611; Khan MA, 2010, BRIT J PHARMACOL, V159, P1039, DOI 10.1111/j.1476-5381.2009.00603.x; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Lee HJ, 2007, BIOCHEM J, V404, P141, DOI 10.1042/BJ20061826; Lu WY, 1998, J PHYSIOL-LONDON, V512, P29, DOI 10.1111/j.1469-7793.1998.029bf.x; Mun HC, 2009, J CLIN ENDOCR METAB, V94, P3567, DOI 10.1210/jc.2008-2714; Mun HC, 2005, J BIOL CHEM, V280, P29067, DOI 10.1074/jbc.M500002200; Mun HC, 2004, J BIOL CHEM, V279, P51739, DOI 10.1074/jbc.M406164/200; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Ohsu T, 2010, J BIOL CHEM, V285, P1016, DOI 10.1074/jbc.M109.029165; Phillips CG, 2008, J NEUROSCI, V28, P12062, DOI 10.1523/JNEUROSCI.4134-08.2008; Pope SAS, 2008, NEUROCHEM RES, V33, P1410, DOI 10.1007/s11064-008-9602-3; QUINN SJ, 2003, ENDOCRIN UPDAT SER, V19, P203; Ray K, 2002, J BIOL CHEM, V277, P18908, DOI 10.1074/jbc.M202113200; Rey O, 2005, J BIOL CHEM, V280, P22875, DOI 10.1074/jbc.M503455200; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; Varga V, 1997, NEUROCHEM RES, V22, P1165, DOI 10.1023/A:1027377605054; Vizard TN, 2008, NAT NEUROSCI, V11, P285, DOI 10.1038/nn2044; Wang MH, 2006, J BIOL CHEM, V281, P8864, DOI 10.1074/jbc.M512865200; Wang MH, 2006, BIOORGAN MED CHEM, V14, P2032, DOI 10.1016/j.bmc.2005.10.052; Ward DT, 2004, CELL CALCIUM, V35, P217, DOI 10.1016/j.ceca.2003.10.017; Watts VJ, 2005, PHARMACOL THERAPEUT, V106, P405, DOI 10.1016/j.pharmthera.2004.12.005; Wellendorph P, 2009, BRIT J PHARMACOL, V156, P869, DOI 10.1111/j.1476-5381.2008.00078.x; YANG CS, 1994, J CHROMATOGR B, V661, P231, DOI 10.1016/S0378-4347(94)80050-2; Young SH, 2002, AM J PHYSIOL-CELL PH, V282, pC1414, DOI 10.1152/ajpcell.00432.2001	46	68	71	3	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8786	8797		10.1074/jbc.M110.149724	http://dx.doi.org/10.1074/jbc.M110.149724			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21187282	Green Published, hybrid			2022-12-27	WOS:000288247700009
J	Huang, X; Rezaie, AR; Broze, GJ; Olson, ST				Huang, Xin; Rezaie, Alireza R.; Broze, George J., Jr.; Olson, Steven T.			Heparin Is a Major Activator of the Anticoagulant Serpin, Protein Z-dependent Protease Inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTITHROMBIN-FACTOR XA; KINETIC CHARACTERIZATION; PROTHROMBOTIC PHENOTYPE; Z DEFICIENCY; COFACTOR-II; THROMBIN; BINDING; ACCELERATION; MECHANISM; SULFATE	Protein Z-dependent protease inhibitor (ZPI) is a recently identified member of the serpin superfamily that functions as a cofactor-dependent regulator of blood coagulation factors Xa and XIa. Here we provide evidence that, in addition to the established cofactors, protein Z, lipid, and calcium, heparin is an important cofactor of ZPI anticoagulant function. Heparin produced 20-100-fold accelerations of ZPI reactions with factor Xa and factor XIa to yield second order rate constants approaching the physiologically significant diffusion limit (k(a) = 10(6) to 10(7) M-1 s(-1)). The dependence of heparin accelerating effects on heparin concentration was bell-shaped for ZPI reactions with both factors Xa and XIa, consistent with a template-bridging mechanism of heparin rate enhancement. Maximal accelerations of ZPI-factor Xa reactions required calcium, which augmented the heparin acceleration by relieving Gla domain inhibition as previously shown for heparin bridging of the antithrombin-factor Xa reaction. Heparin acceleration of both ZPI-protease reactions was optimal at heparin concentrations and heparin chain lengths comparable with those that produce physiologically significant rate enhancements of other serpin-protease reactions. Protein Z binding to ZPI minimally affected heparin rate enhancements, indicating that heparin binds to a distinct site on ZPI and activates ZPI in its physiologically relevant complex with protein Z. Taken together, these results suggest that whereas protein Z, lipid, and calcium cofactors promote ZPI inhibition of membrane-associated factor Xa, heparin activates ZPI to inhibit free factor Xa as well as factor XIa and therefore may play a physiologically and pharmacologically important role in ZPI anticoagulant function.	[Huang, Xin; Olson, Steven T.] Univ Illinois, Ctr Mol Biol Oral Dis, Chicago, IL 60612 USA; [Rezaie, Alireza R.] St Louis Univ, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Broze, George J., Jr.] Washington Univ, Med Ctr, Barnes Jewish Hosp, Div Hematol, St Louis, MO 63110 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Saint Louis University; Barnes-Jewish Hospital; Washington University (WUSTL)	Olson, ST (corresponding author), Univ Illinois, Ctr Mol Biol Oral Dis, 801 S Paulina St,Rm 530C, Chicago, IL 60612 USA.	stolson@uic.edu		Huang, Xin/0000-0002-4730-9318	National Institutes of Health [HL78827, HL39888, HL-62565]; American Heart Association [0920029G]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL039888, R29HL039888, R01HL078827, R01HL039888, R01HL062565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL78827 and HL39888 (to S. T. O.) and HL-62565 (to A. R. R.). This work was also supported by American Heart Association Fellowship 0920029G (to X. H.).	BOYD J, 1980, J MOL BIOL, V137, P175, DOI 10.1016/0022-2836(80)90324-1; Church F. C., 2007, MOL CELLULAR ASPECTS, P509; Gettins P.G.W., 1996, SERPINS STRUCTURE FU; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; HajMohammadi S, 2003, J CLIN INVEST, V111, P989, DOI 10.1172/JCI200315809; Han X, 1999, BIOCHEMISTRY-US, V38, P11073, DOI 10.1021/bi990641a; Han X, 2000, BLOOD, V96, P3049; Han X, 1998, P NATL ACAD SCI USA, V95, P9250, DOI 10.1073/pnas.95.16.9250; Huang X, 2008, J BIOL CHEM, V283, P29770, DOI 10.1074/jbc.M805214200; Huang X, 2010, J BIOL CHEM, V285, P20399, DOI 10.1074/jbc.M110.112748; HURST RE, 1983, J CLIN INVEST, V72, P1042, DOI 10.1172/JCI111028; Kemkes-Matthes B, 2002, THROMB RES, V106, P183, DOI 10.1016/S0049-3848(02)00181-0; KUSCHE M, 1990, J BIOL CHEM, V265, P7292; Lin PH, 2001, BBA-GEN SUBJECTS, V1526, P105, DOI 10.1016/S0304-4165(01)00117-9; MARCUM JA, 1986, J BIOL CHEM, V261, P7507; OLSON ST, 1992, J BIOL CHEM, V267, P12528; OLSON ST, 1991, J BIOL CHEM, V266, P6342; Olson ST, 2004, THROMB HAEMOSTASIS, V92, P929, DOI 10.1160/TH04-06-0384; OLSON ST, 1991, J BIOL CHEM, V266, P6353; OLSON ST, 1988, J BIOL CHEM, V263, P1698; OLSON ST, 1993, METHOD ENZYMOL, V222, P525; Rezaie AR, 2008, J BIOL CHEM, V283, P19922, DOI 10.1074/jbc.M802639200; Rezaie AR, 1998, J BIOL CHEM, V273, P16824, DOI 10.1074/jbc.273.27.16824; Rezaie AR, 2000, BIOCHEMISTRY-US, V39, P12083, DOI 10.1021/bi0011126; Rezaie AR, 2005, J BIOL CHEM, V280, P32722, DOI 10.1074/jbc.M505517200; Riewald M, 2002, TRENDS CARDIOVAS MED, V12, P149, DOI 10.1016/S1050-1738(02)00153-6; SCULLY MF, 1988, FEBS LETT, V241, P11, DOI 10.1016/0014-5793(88)81020-2; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; Sofi F, 2009, J THROMB HAEMOST, V7, P731, DOI 10.1111/j.1538-7836.2009.03325.x; STREUSAND VJ, 1995, J BIOL CHEM, V270, P9043, DOI 10.1074/jbc.270.16.9043; Tabatabai A, 2001, THROMB HAEMOSTASIS, V85, P655, DOI 10.1055/s-0037-1615649; TOLLEFSEN DM, 2006, HEMOSTASIS THROMBOSI, P271; Verhamme IM, 2004, J BIOL CHEM, V279, P9785, DOI 10.1074/jbc.M313962200; Wei ZQ, 2009, BLOOD, V114, P3662, DOI 10.1182/blood-2009-04-210021; Yang LK, 2009, BIOCHEMISTRY-US, V48, P1517, DOI 10.1021/bi802298r; Yin ZF, 2000, P NATL ACAD SCI USA, V97, P6734, DOI 10.1073/pnas.120081897; Zhang J, 2008, BLOOD, V111, P4973, DOI 10.1182/blood-2007-12-126391	37	38	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8740	8751		10.1074/jbc.M110.188375	http://dx.doi.org/10.1074/jbc.M110.188375			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21220417	Green Published, hybrid			2022-12-27	WOS:000288247700005
J	Iyer, AS; Morales, JL; Huang, WS; Ojo, F; Ning, G; Wills, E; Baines, JD; August, A				Iyer, Archana S.; Morales, J. Luis; Huang, Weishan; Ojo, Folake; Ning, Gang; Wills, Elizabeth; Baines, Joel D.; August, Avery			Absence of Tec Family Kinases Interleukin-2 Inducible T cell Kinase (Itk) and Bruton's Tyrosine Kinase (Btk) Severely Impairs Fc epsilon RI-dependent Mast Cell Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED AGAMMAGLOBULINEMIA; ACTIVATION; INHIBITOR; DEGRANULATION; MODELS	Mast cells are critical effector cells in the pathophysiology of allergic asthma and other IgE-mediated diseases. The Tec family of tyrosine kinases Itk and Btk serve as critical signal amplifiers downstream of antigen receptors. Although both kinases are expressed and activated in mast cells following Fc epsilon RI stimulation, their individual contributions are not clear. To determine whether these kinases play unique and/or complementary roles in Fc epsilon RI signaling and mast cell function, we generated Itk and Btk double knock-out mice. Analyses of these mice show decreased mast cell granularity and impaired passive systemic anaphylaxis responses. This impaired response is accompanied by a significant elevation in serum IgE in Itk/Btk double knockout mice. In vitro analyses of bone marrow-derived mast cells (BMMCs) indicated that Itk/Btk double knock-out BMMCs are defective in degranulation and cytokine secretion responses downstream to Fc epsilon RI activation. These responses were accompanied by a significant reduction in PLC gamma 2 phosphorylation and severely impaired calcium responses in these cells. This defect also results in altered NFAT1 nuclear localization in double knock-out BMMCs. Network analysis suggests that although they may share substrates, Itk plays both positive and negative roles, while Btk primarily plays a positive role in mast cell Fc epsilon RI-induced cytokine secretion.	[August, Avery] Cornell Univ, Dept Microbiol & Immunol, Coll Vet Med, Ithaca, NY 14853 USA; [Iyer, Archana S.; Morales, J. Luis; Huang, Weishan; Ojo, Folake; August, Avery] Penn State Univ, Ctr Mol Immunol & Infect Dis, University Pk, PA 16802 USA; [Iyer, Archana S.; Morales, J. Luis; Huang, Weishan; Ojo, Folake; August, Avery] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Iyer, Archana S.] Penn State Univ, Immunol & Infect Dis Grad Program, University Pk, PA 16802 USA; [Ning, Gang] Penn State Univ, Electron Microscopy Facil, Huck Inst Life Sci, University Pk, PA 16802 USA	Cornell University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	August, A (corresponding author), Cornell Univ, Dept Microbiol & Immunol, Coll Vet Med, C5 117 VMC, Ithaca, NY 14853 USA.	averyaugust@cornell.edu	Huang, Weishan/J-3127-2014	Huang, Weishan/0000-0002-1330-1131	National Institutes of Health [AI051626, AI065566, AI051626-S1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065566, R01AI051626, R01AI052341, R56AI065566] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI051626 and AI065566 (to A. A.), and AI051626-S1 (to A. A.) (for J. L. M.).	Albert I, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-16; Chaves M, 2005, J THEOR BIOL, V235, P431, DOI 10.1016/j.jtbi.2005.01.023; Denyer J, 2009, DRUG NEWS PERSPECT, V22, P146, DOI 10.1358/dnp.2009.22.3.1354124; Dvorak AM, 2005, J HISTOCHEM CYTOCHEM, V53, P1043, DOI 10.1369/jhc.5R6647.2005; Felices M, 2009, P NATL ACAD SCI USA, V106, P8308, DOI 10.1073/pnas.0808459106; Ferrell JE, 2009, MOL CELL, V36, P724, DOI 10.1016/j.molcel.2009.11.032; Forssell J, 2005, AM J RESP CELL MOL, V32, P511, DOI 10.1165/rcmb.2004-0348OC; Hata D, 1998, J BIOL CHEM, V273, P10979, DOI 10.1074/jbc.273.18.10979; Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; Iwaki S, 2005, J BIOL CHEM, V280, P40261, DOI 10.1074/jbc.M506063200; Iyer AS, 2008, J IMMUNOL, V180, P7869, DOI 10.4049/jimmunol.180.12.7869; Kawakami Y, 2006, P NATL ACAD SCI USA, V103, P153, DOI 10.1073/pnas.0509784103; Kawakami Y, 1999, P NATL ACAD SCI USA, V96, P2227, DOI 10.1073/pnas.96.5.2227; Kawakami Y, 2000, J IMMUNOL, V165, P1210, DOI 10.4049/jimmunol.165.3.1210; KAWAKAMI Y, 1995, J IMMUNOL, V155, P3556; KAWAKAMI Y, 1994, MOL CELL BIOL, V14, P5108, DOI 10.1128/MCB.14.8.5108; Kawakami Y, 1997, P NATL ACAD SCI USA, V94, P3938, DOI 10.1073/pnas.94.8.3938; KERNER JD, 1995, IMMUNITY, V3, P301, DOI 10.1016/1074-7613(95)90115-9; KHAN WN, 1995, IMMUNITY, V3, P283, DOI 10.1016/1074-7613(95)90114-0; Koranteng RD, 2004, CLIN EXP IMMUNOL, V137, P81, DOI 10.1111/j.1365-2249.2004.02510.x; Kovarova M, 2004, CURR MED CHEM, V11, P2083, DOI 10.2174/0929867043364801; Logan MR, 2003, J ALLERGY CLIN IMMUN, V111, P923, DOI 10.1067/mai.2003.1573; Qi Q, 2009, BLOOD, V114, P564, DOI 10.1182/blood-2008-12-196345; Rossi AB, 2006, J ALLERGY CLIN IMMUN, V118, P749, DOI 10.1016/j.jaci.2006.05.023; Schmidt U, 2009, EUR J IMMUNOL, V39, P3228, DOI 10.1002/eji.200838839; Setoguchi R, 1998, IMMUNOL LETT, V64, P109, DOI 10.1016/S0165-2478(98)00086-8; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Thakar J, 2007, PLOS COMPUT BIOL, V3, P1022, DOI 10.1371/journal.pcbi.0030109; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; Vihinen M, 2000, FRONT BIOSCI-LANDMRK, V5, pD917, DOI 10.2741/vihinen	30	38	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9503	9513		10.1074/jbc.M110.165613	http://dx.doi.org/10.1074/jbc.M110.165613			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21212279	hybrid, Green Published			2022-12-27	WOS:000288247700077
J	Wang, F; Yamauchi, M; Muramatsu, M; Osawa, T; Tsuchida, R; Shibuya, M				Wang, Feng; Yamauchi, Mai; Muramatsu, Masashi; Osawa, Tsuyoshi; Tsuchida, Rika; Shibuya, Masabumi			RACK1 Regulates VEGF/Flt1-mediated Cell Migration via Activation of a PI3K/Akt Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROTEIN-KINASE-C; RECEPTOR-INTERACTING PROTEIN; TYROSINE KINASE; SIGNAL-TRANSDUCTION; BONE-MARROW; VASCULAR DEVELOPMENT; HUMAN MONOCYTES; VEGF RECEPTORS; BINDING-SITE	Vascular endothelial growth factor (VEGF) is vital to physiological as well as pathological angiogenesis, and regulates a variety of cellular functions, largely by activating its 2 receptors, fms-like tyrosine kinase (Flt1) and kinase domain receptor (KDR). KDR plays a critical role in the proliferation of endothelial cells by controlling VEGF-induced phospholipase C gamma-protein kinase C (PLC gamma-PKC) signaling. The function of Flt1, however, remains to be clarified. Recent evidence has indicated that Flt1 regulates the VEGF-triggered migration of endothelial cells and macrophages. Here, we show that RACK1, a ubiquitously expressed scaffolding protein, functions as an important regulator of this process. We found that RACK1 (receptor for activated protein kinase C 1) binds to Flt1 in vitro. When the endogenous expression of RACK1 was attenuated by RNA interference, the VEGF-driven migration was remarkably suppressed whereas the proliferation was unaffected in a stable Flt1-expressing cell line, AG1-G1-Flt1. Further, we demonstrated that the VEGF/Flt-mediated migration of AG1-G1-Flt1 cells occurred mainly via the activation of the PI3 kinase (PI3K)/Akt and Rac1 pathways, and that RACK1 plays a crucial regulatory role in promoting PI3K/Akt-Rac1 activation.	[Wang, Feng; Muramatsu, Masashi; Osawa, Tsuyoshi; Tsuchida, Rika; Shibuya, Masabumi] Tokyo Med & Dent Univ, Dept Mol Oncol, Grad Sch Med & Dent, Bunkyo Ku, Tokyo 1138519, Japan; [Yamauchi, Mai] Univ Tokyo, Div Syst Biomed Technol, Inst Med Sci, Minato Ku, Tokyo 1080071, Japan	Tokyo Medical & Dental University (TMDU); University of Tokyo	Shibuya, M (corresponding author), Tokyo Med & Dent Univ, Dept Mol Oncol, Grad Sch Med & Dent, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	shibuya@ims.u-tokyo.ac.jp	Wang, Feng/Q-7386-2017		Ministry of Education, Culture, Sports, Science and Technology of Japan [17014020]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-aid Special Project Research on Cancer-Bioscience 17014020 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Banerjee S, 2008, BIOCHEMISTRY-US, V47, P3345, DOI 10.1021/bi8000352; Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336; Besson A, 2002, J BIOL CHEM, V277, P22073, DOI 10.1074/jbc.M111644200; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; Cox EA, 2003, MOL BIOL CELL, V14, P658, DOI 10.1091/mbc.E02-03-0142; CUNNINGHAM SA, 1995, J BIOL CHEM, V270, P20254, DOI 10.1074/jbc.270.35.20254; DavisSmyth T, 1996, EMBO J, V15, P4919, DOI 10.1002/j.1460-2075.1996.tb00872.x; del Valle-Perez B, 2010, J BIOL CHEM, V285, P10748, DOI 10.1074/jbc.M109.062984; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Fuh G, 1998, J BIOL CHEM, V273, P11197, DOI 10.1074/jbc.273.18.11197; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Hermanto U, 2002, MOL CELL BIOL, V22, P2345, DOI 10.1128/MCB.22.7.2345-2365.2002; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Hiratsuka S, 2002, CANCER CELL, V2, P289, DOI 10.1016/S1535-6108(02)00153-8; Ishizaki H, 2006, CLIN CANCER RES, V12, P5841, DOI 10.1158/1078-0432.CCR-06-0750; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kearney JB, 2004, BLOOD, V103, P4527, DOI 10.1182/blood-2003-07-2315; Kerber M, 2008, CANCER RES, V68, P7342, DOI 10.1158/0008-5472.CAN-07-6241; Kiely PA, 2002, J BIOL CHEM, V277, P22581, DOI 10.1074/jbc.M201758200; Krysiak O, 2005, CIRC RES, V97, P1253, DOI 10.1161/01.RES.0000194324.29363.82; Lee TH, 2007, PLOS MED, V4, P1101, DOI 10.1371/journal.pmed.0040186; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Muramatsu M, 2010, CANCER RES, V70, P8211, DOI 10.1158/0008-5472.CAN-10-0202; Orlichenko L, 2010, J BIOL CHEM, V285, P19153, DOI 10.1074/jbc.M109.099382; Podar K, 2004, BLOOD, V103, P3474, DOI 10.1182/blood-2003-10-3527; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RON D, 1994, J BIOL CHEM, V269, P21395; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Sawano A, 1996, CELL GROWTH DIFFER, V7, P213; Sawano A, 1997, BIOCHEM BIOPH RES CO, V238, P487, DOI 10.1006/bbrc.1997.7327; SEETHARAM L, 1995, ONCOGENE, V10, P135; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; SHIBUYA M, 1990, ONCOGENE, V5, P519; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; Suzuma K, 2000, J BIOL CHEM, V275, P40725, DOI 10.1074/jbc.M006509200; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tan WF, 2008, FASEB J, V22, P1829, DOI 10.1096/fj.07-096438; Tchaikovski V, 2008, ARTERIOSCL THROM VAS, V28, P322, DOI 10.1161/ATVBAHA.107.158022; TERMAN BI, 1991, ONCOGENE, V6, P1677; Wu LW, 2000, J BIOL CHEM, V275, P5096, DOI 10.1074/jbc.275.7.5096; Wu Y, 2006, INT J CANCER, V119, P1519, DOI 10.1002/ijc.21865; Xia P, 1996, J CLIN INVEST, V98, P2018, DOI 10.1172/JCI119006	48	81	87	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9097	9106		10.1074/jbc.M110.165605	http://dx.doi.org/10.1074/jbc.M110.165605			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21212275	Green Published, hybrid			2022-12-27	WOS:000288247700040
J	Acevedo, KM; Hung, YH; Dalziel, AH; Li, QX; Laughton, K; Wikhe, K; Rembach, A; Roberts, B; Masters, CL; Bush, AI; Camakaris, J				Acevedo, Karla M.; Hung, Ya Hui; Dalziel, Andrew H.; Li, Qiao-Xin; Laughton, Katrina; Wikhe, Krutika; Rembach, Alan; Roberts, Blaine; Masters, Colin L.; Bush, Ashley I.; Camakaris, James			Copper Promotes the Trafficking of the Amyloid Precursor Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-TYPE ATPASE; TRANS-GOLGI NETWORK; TARGETING A-BETA; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; PLASMA-MEMBRANE; REGULATED TRANSPORT; SECRETASE CLEAVAGE; AGGREGATION STATE; REDOX CHEMISTRY	Accumulation of the amyloid beta peptide in the cortical and hippocampal regions of the brain is a major pathological feature of Alzheimer disease. Amyloid beta peptide is generated from the sequential protease cleavage of the amyloid precursor protein (APP). We reported previously that copper increases the level of APP at the cell surface. Here we report that copper, but not iron or zinc, promotes APP trafficking in cultured polarized epithelial cells and neuronal cells. In SH-SY5Y neuronal cells and primary cortical neurons, copper promoted a redistribution of APP from a perinuclear localization to a wider distribution, including neurites. Importantly, a change in APP localization was not attributed to an up-regulation of APP protein synthesis. Using live cell imaging and endocytosis assays, we found that copper promotes an increase in cell surface APP by increasing its exocytosis and reducing its endocytosis, respectively. This study identifies a novel mechanism by which copper regulates the localization and presumably the function of APP, which is of major significance for understanding the role of APP in copper homeostasis and the role of copper in Alzheimer disease.	[Acevedo, Karla M.; Dalziel, Andrew H.; Camakaris, James] Univ Melbourne, Dept Genet, Melbourne, Vic 3010, Australia; [Li, Qiao-Xin; Laughton, Katrina] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Hung, Ya Hui; Masters, Colin L.] Univ Melbourne, Ctr Neurosci, Melbourne, Vic 3010, Australia; [Hung, Ya Hui; Li, Qiao-Xin; Laughton, Katrina; Wikhe, Krutika; Rembach, Alan; Roberts, Blaine; Masters, Colin L.; Bush, Ashley I.] Univ Melbourne, Mental Hlth Res Inst, Melbourne, Vic 3010, Australia; [Rembach, Alan] Commonwealth Sci & Res Org CSIRO Mol & Hlth Techn, Parkville, Vic 3052, Australia	University of Melbourne; University of Melbourne; University of Melbourne; University of Melbourne; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Camakaris, J (corresponding author), Univ Melbourne, Dept Genet, Melbourne, Vic 3010, Australia.	j.camakaris@unimelb.edu.au	Hung, Ya Hui/F-1951-2010; Bush, Ashley/Y-2457-2019; Bush, Ashley I/A-1186-2007	Hung, Ya Hui/0000-0002-5440-2764; Bush, Ashley/0000-0001-8259-9069; Bush, Ashley I/0000-0001-8259-9069; Roberts, Blaine/0000-0001-5466-0053; Acevedo, Karla/0000-0002-7996-3445	National Health and Medical Research Council; Rowden White Foundation; Australian Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Rowden White Foundation; Australian Research Council(Australian Research Council)	This work was supported by grants from the National Health and Medical Research Council (to J. C. and A. I. B.). The FV1000 Olympus confocal microscope used for this work was co-funded by the Rowden White Foundation.; Supported by the Australian Research Council.	Adlard PA, 2008, NEURON, V59, P43, DOI 10.1016/j.neuron.2008.06.018; Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Armendariz AD, 2004, PHYSIOL GENOMICS, V20, P45, DOI 10.1152/physiolgenomics.00196.2003; Atwood CS, 2004, BIOCHEMISTRY-US, V43, P560, DOI 10.1021/bi0358824; Bayer TA, 2003, P NATL ACAD SCI USA, V100, P14187, DOI 10.1073/pnas.2332818100; Bellingham SA, 2004, J BIOL CHEM, V279, P20378, DOI 10.1074/jbc.M400805200; Bellingham SA, 2004, J NEUROCHEM, V91, P423, DOI 10.1111/j.1471-4159.2004.02731.x; Birkaya B, 2005, J NEUROBIOL, V63, P49, DOI 10.1002/neu.20114; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Borchardt T, 1999, BIOCHEM J, V344, P461, DOI 10.1042/0264-6021:3440461; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Buhl ES, 2001, DIABETES, V50, P12, DOI 10.2337/diabetes.50.1.12; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; BUSH AI, 1993, J BIOL CHEM, V268, P16109; CAMAKARIS J, 1995, HUM MOL GENET, V4, P2117, DOI 10.1093/hmg/4.11.2117; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; Cater MA, 2008, BIOCHEM J, V412, P141, DOI 10.1042/BJ20080103; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; Crouch PJ, 2009, P NATL ACAD SCI USA, V106, P381, DOI 10.1073/pnas.0809057106; Crouch PJ, 2005, J NEUROSCI, V25, P672, DOI 10.1523/JNEUROSCI.4276-04.2005; Deibel MA, 1996, J NEUROL SCI, V143, P137, DOI 10.1016/S0022-510X(96)00203-1; Ding WQ, 2009, IUBMB LIFE, V61, P1013, DOI 10.1002/iub.253; Donnelly PS, 2008, J BIOL CHEM, V283, P4568, DOI 10.1074/jbc.M705957200; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; Ermolieff J, 2000, BIOCHEMISTRY-US, V39, P12450, DOI 10.1021/bi001494f; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Greenough M, 2004, AM J PHYSIOL-CELL PH, V287, pC1463, DOI 10.1152/ajpcell.00179.2004; Guilloreau L, 2007, CHEMBIOCHEM, V8, P1317, DOI 10.1002/cbic.200700111; Ha C, 2007, BIOCHEMISTRY-US, V46, P6118, DOI 10.1021/bi7000032; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hou JCQ, 2007, CURR OPIN CELL BIOL, V19, P466, DOI 10.1016/j.ceb.2007.04.018; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Hung YH, 2009, J BIOL CHEM, V284, P21899, DOI 10.1074/jbc.M109.019521; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Jiang DL, 2007, BIOCHEMISTRY-US, V46, P9270, DOI 10.1021/bi700508n; Jiang DL, 2009, BIOCHEMISTRY-US, V48, P7939, DOI 10.1021/bi900907a; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lannfelt L, 2008, LANCET NEUROL, V7, P779, DOI 10.1016/S1474-4422(08)70167-4; Lee HW, 2008, NEUROSCI LETT, V436, P245, DOI 10.1016/j.neulet.2008.03.038; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Magaki S, 2007, NEUROSCI LETT, V418, P72, DOI 10.1016/j.neulet.2007.02.077; Maynard CJ, 2002, J BIOL CHEM, V277, P44670, DOI 10.1074/jbc.M204379200; MCGEER EG, 1990, J NEUROSCI RES, V27, P612, DOI 10.1002/jnr.490270422; Miller LM, 2006, J STRUCT BIOL, V155, P30, DOI 10.1016/j.jsb.2005.09.004; Neumann S, 2006, J BIOL CHEM, V281, P7583, DOI 10.1074/jbc.M508340200; Nyasae L, 2007, AM J PHYSIOL-GASTR L, V292, pG1181, DOI 10.1152/ajpgi.00472.2006; Opazo C, 2000, BIOL RES, V33, P125; Opazo C, 2002, J BIOL CHEM, V277, P40302, DOI 10.1074/jbc.M206428200; Ostrakhovitch EA, 2002, ARCH BIOCHEM BIOPHYS, V397, P232, DOI 10.1006/abbi.2001.2559; Pase L, 2004, BIOCHEM J, V378, P1031, DOI 10.1042/BJ20031181; Pessin JE, 1999, J BIOL CHEM, V274, P2593, DOI 10.1074/jbc.274.5.2593; Petris MJ, 1999, HUM MOL GENET, V8, P2107, DOI 10.1093/hmg/8.11.2107; Petris MJ, 1996, EMBO J, V15, P6084, DOI 10.1002/j.1460-2075.1996.tb00997.x; Pinnix I, 2001, J BIOL CHEM, V276, P481, DOI 10.1074/jbc.M005968200; Religa D, 2006, NEUROLOGY, V67, P69, DOI 10.1212/01.wnl.0000223644.08653.b5; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; Sabo SL, 2003, J NEUROSCI, V23, P5407; Sabo SL, 2001, J CELL BIOL, V153, P1403, DOI 10.1083/jcb.153.7.1403; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Smith DG, 2007, BBA-BIOMEMBRANES, V1768, P1976, DOI 10.1016/j.bbamem.2007.02.002; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Tougu V, 2009, J NEUROCHEM, V110, P1784, DOI 10.1111/j.1471-4159.2009.06269.x; Treiber C, 2004, J BIOL CHEM, V279, P51958, DOI 10.1074/jbc.M407410200; Veldhuis NA, 2009, INT J BIOCHEM CELL B, V41, P2403, DOI 10.1016/j.biocel.2009.06.008; Vetrivel KS, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/01.wnl.0000192107.17175.39; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; White AR, 1999, J NEUROSCI, V19, P9170; White AR, 1998, J NEUROSCI, V18, P6207; Winckler B, 1999, NEURON, V23, P637, DOI 10.1016/S0896-6273(01)80021-0; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748	73	81	81	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8252	8262		10.1074/jbc.M110.128512	http://dx.doi.org/10.1074/jbc.M110.128512			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21177866	hybrid, Green Published			2022-12-27	WOS:000288013300055
J	How, PC; Shields, D				How, Poh Choo; Shields, Dennis			Tethering Function of the Caspase Cleavage Fragment of Golgi Protein p115 Promotes Apoptosis via a p53-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; ENDOPLASMIC-RETICULUM; MITOTIC PHOSPHORYLATION; MEDIATED CLEAVAGE; GENE-EXPRESSION; REGULATES GOLGI; P53 ACTIVATION; KINASE; GRASP65; GM130	The Golgi apparatus undergoes extensive fragmentation during apoptosis due in part to caspase-mediated cleavage of its structural proteins. Significantly, the Golgi-vesicle-tethering protein p115 is cleaved at Asp(757) early during apoptosis and the nuclear translocation of its 205 amino acid C-terminal fragment (CTF) precedes observable Golgi fragmentation. Nuclear localization of the p115 CTF induces apoptosis. The regulation of CTF nuclear translocation and the mechanism of its apoptotic activity however, remain unknown. Here, we demonstrate that nuclear translocation of the CTF is regulated by SUMOylation. CTF-induced apoptosis is transcription dependent and mediated by the tumor suppressor, p53. Expression of the CTF led to the phosphorylation and stabilization of p53 and results in the expression of PUMA, a pro-apoptotic target of p53. CTF-induced stabilization of p53 is sensitive to the MEK/ERK inhibitor U0126. Co-immunoprecipitation studies indicate that the p115 CTF can bind to both p53 and ERK1. The CTF is also able to form dimers and its dimerization is dependent on residues 859-884, previously determined to be required for apoptosis. Indeed, CTF expression promotes p53-ERK interaction, which is diminished upon deletion of residues 859-884. Together, our results indicate a conserved tethering function of the Golgi protein p115 CTF which promotes p53-ERK interaction for the amplification of the apoptotic signal.	[How, Poh Choo; Shields, Dennis] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA; [Shields, Dennis] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	How, PC (corresponding author), Chanin 501,1300 Morris Pk Ave, Bronx, NY 10461 USA.	pohchoo.how@med.einstein.yu.edu			National Institutes of Health [DK21860]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK021860, R01DK021860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK21860 (to D. S.).	Acharya U, 1998, CELL, V92, P183, DOI 10.1016/S0092-8674(00)80913-7; Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Beard M, 2005, J BIOL CHEM, V280, P25840, DOI 10.1074/jbc.M503925200; Bisel B, 2008, J CELL BIOL, V182, P837, DOI 10.1083/jcb.200805045; Brantley-Finley C, 2003, BIOCHEM PHARMACOL, V66, P459, DOI 10.1016/S0006-2952(03)00255-7; Brown L, 2006, J BIOL CHEM, V281, P3832, DOI 10.1074/jbc.M507951200; Chipuk JE, 2009, CELL CYCLE, V8, P2692, DOI 10.4161/cc.8.17.9412; Chiu R, 2002, J CELL BIOL, V159, P637, DOI 10.1083/jcb.200208013; Diao A, 2008, J BIOL CHEM, V283, P6957, DOI 10.1074/jbc.M708401200; Dirac-Svejstrup AB, 2000, J CELL BIOL, V150, P475, DOI 10.1083/jcb.150.3.475; Foo RSY, 2007, P NATL ACAD SCI USA, V104, P20826, DOI 10.1073/pnas.0710017104; Garrison SP, 2008, MOL CELL BIOL, V28, P5391, DOI 10.1128/MCB.00907-07; Giono LE, 2007, MOL CELL BIOL, V27, P4166, DOI 10.1128/MCB.01967-06; Guo YS, 2008, MOL BIOL CELL, V19, P2830, DOI 10.1091/mbc.E07-12-1236; Hicks SW, 2002, J BIOL CHEM, V277, P35833, DOI 10.1074/jbc.M206280200; Jesch SA, 2001, MOL BIOL CELL, V12, P1811, DOI 10.1091/mbc.12.6.1811; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lane JD, 2002, J CELL BIOL, V156, P495, DOI 10.1083/jcb.200110007; Li DWC, 2005, MOL BIOL CELL, V16, P4437, DOI 10.1091/mbc.E05-01-0010; Li MQ, 2000, MOL CELL BIOL, V20, P5096, DOI 10.1128/MCB.20.14.5096-5106.2000; Lin CY, 2000, P NATL ACAD SCI USA, V97, P12589, DOI 10.1073/pnas.220423497; Linstedt AD, 2000, J BIOL CHEM, V275, P10196, DOI 10.1074/jbc.275.14.10196; Liu JH, 2008, AM J PHYSIOL-HEART C, V295, pH1956, DOI 10.1152/ajpheart.00407.2008; Lowe M, 2000, J CELL BIOL, V149, P341, DOI 10.1083/jcb.149.2.341; Lowe M, 2004, J CELL SCI, V117, P1139, DOI 10.1242/jcs.00950; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; Maag RS, 2005, MOL BIOL CELL, V16, P3019, DOI 10.1091/mbc.E04-11-0971; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; Mukherjee S, 2007, TRAFFIC, V8, P369, DOI 10.1111/j.1600-0854.2007.00542.x; Mukherjee S, 2009, J BIOL CHEM, V284, P1709, DOI 10.1074/jbc.M807263200; Nelson DS, 1998, J CELL BIOL, V143, P319, DOI 10.1083/jcb.143.2.319; Novakovic P, 2006, CARCINOGENESIS, V27, P916, DOI 10.1093/carcin/bgi312; Persons DL, 2000, J BIOL CHEM, V275, P35778, DOI 10.1074/jbc.M004267200; Ploner C, 2008, ONCOGENE, V27, pS84, DOI 10.1038/onc.2009.46; Preisinger C, 2005, EMBO J, V24, P753, DOI 10.1038/sj.emboj.7600569; Puthenveedu MA, 2004, P NATL ACAD SCI USA, V101, P1253, DOI 10.1073/pnas.0306373101; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sablina AA, 2001, ONCOGENE, V20, P899, DOI 10.1038/sj.onc.1204156; Salinas S, 2004, J CELL BIOL, V165, P767, DOI 10.1083/jcb.200310136; SAPPERSTEIN SK, 1995, P NATL ACAD SCI USA, V92, P522, DOI 10.1073/pnas.92.2.522; Sbodio JI, 2006, J BIOL CHEM, V281, P27924, DOI 10.1074/jbc.M603276200; Shaul YD, 2006, J CELL BIOL, V172, P885, DOI 10.1083/jcb.200509063; Shaul YD, 2009, GENE DEV, V23, P1779, DOI 10.1101/gad.523909; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; Shorter J, 2002, J CELL BIOL, V157, P45, DOI 10.1083/jcb.200112127; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Sohda M, 2007, TRAFFIC, V8, P270, DOI 10.1111/j.1600-0854.2006.00530.x; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Warren G, 1998, CURR OPIN CELL BIOL, V10, P493, DOI 10.1016/S0955-0674(98)80064-1; Wei Jen-Hsuan, 2009, Commun Integr Biol, V2, P35; Wiencke JK, 2005, CANCER EPIDEM BIOMAR, V14, P1774, DOI 10.1158/1055-9965.EPI-05-0089; Yang T, 2001, J BIOL CHEM, V276, P39569, DOI 10.1074/jbc.M102961200; Yu J, 2005, BIOCHEM BIOPH RES CO, V331, P851, DOI 10.1016/j.bbrc.2005.03.189	54	20	22	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8565	8576		10.1074/jbc.M110.175174	http://dx.doi.org/10.1074/jbc.M110.175174			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21147777	Green Published, hybrid			2022-12-27	WOS:000288013300083
J	Chan, SW; Lim, CJ; Chong, YF; Pobbati, AV; Huang, CX; Hong, WJ				Chan, Siew Wee; Lim, Chun Jye; Chong, Yaan Fun; Pobbati, Ajaybabu V.; Huang, Caixia; Hong, Wanjin			Hippo Pathway-independent Restriction of TAZ and YAP by Angiomotin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YES-ASSOCIATED PROTEIN; EPITHELIAL-MESENCHYMAL TRANSITION; CELL CONTACT INHIBITION; ORGAN SIZE CONTROL; WW DOMAIN; ONCOGENIC TRANSFORMATION; GROWTH-CONTROL; TRANSCRIPTION; BINDING; CANCER	The Hippo pathway restricts the activity of transcriptional co-activators TAZ and YAP by phosphorylating them for cytoplasmic sequestration or degradation. In this report, we describe an independent mechanism for the cell to restrict the activity of TAZ and YAP through interaction with angiomotin (Amot) and angiomotin-like 1 (AmotL1). Amot and AmotL1 were robustly co-immunoprecipitated with FLAG-tagged TAZ, and their interaction is dependent on the WW domain of TAZ and the PPXY motif in the N terminus of Amot. Amot and AmotL1 also interact with YAP via the first WW domain of YAP. Overexpression of Amot and AmotL1 caused cytoplasmic retention of TAZ and suppressed its transcriptional outcome such as the expression of CTGF and Cyr61. Hippo refractory TAZ mutant (S89A) is also negatively regulated by Amot and AmotL1. HEK293 cells express the highest level of Amot and AmotL1 among nine cell lines examined, and silencing the expression of endogenous Amot increased the expression of CTGF and Cyr61 either at basal levels or upon overexpression of exogenous S89A. These results reveal a novel mechanism to restrict the activity of TAZ and YAP through physical interaction with Amot and AmotL1.	[Chan, Siew Wee; Lim, Chun Jye; Chong, Yaan Fun; Pobbati, Ajaybabu V.; Huang, Caixia; Hong, Wanjin] Inst Mol & Cell Biol, Canc & Dev Cell Biol Div, Singapore 138673, Singapore; [Hong, Wanjin] Natl Univ Singapore, Dept Biochem, Singapore 119077, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore	Hong, WJ (corresponding author), 61 Biopolis Dr, Singapore 138673, Singapore.	mcbhwj@imcb.a-star.edu.sg	HONG, Wanjin/E-9927-2010		Agency for Science, Technology and Research (A*STAR), Singapore	Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by a grant from the Agency for Science, Technology and Research (A*STAR), Singapore.	Badouel C, 2009, DEV CELL, V16, P411, DOI 10.1016/j.devcel.2009.01.010; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Bratt A, 2005, J BIOL CHEM, V280, P34859, DOI 10.1074/jbc.M503915200; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chan SW, 2011, J CELL PHYSIOL, V226, P928, DOI 10.1002/jcp.22435; Chan SW, 2009, J BIOL CHEM, V284, P14347, DOI 10.1074/jbc.M901568200; CHAN SW, 2010, ONCOGENE        1025, DOI DOI 10.1038/ONC.2010.438; Chen LM, 2010, GENE DEV, V24, P290, DOI 10.1101/gad.1865310; Ernkvist M, 2006, FEBS J, V273, P2000, DOI 10.1111/j.1742-4658.2006.05216.x; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kang HS, 2009, MOL CELL BIOL, V29, P2556, DOI 10.1128/MCB.01620-08; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Murakami M, 2006, BIOCHEM BIOPH RES CO, V339, P533, DOI 10.1016/j.bbrc.2005.10.214; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Park KS, 2004, J BIOL CHEM, V279, P17384, DOI 10.1074/jbc.M312569200; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Sugihara-Mizuno Y, 2007, GENES CELLS, V12, P473, DOI 10.1111/j.1365-2443.2007.01066.x; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Vitolol MI, 2007, CANCER BIOL THER, V6, P856, DOI 10.4161/cbt.6.6.4241; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; XU MZ, 2010, ONCOGENE        1115, DOI DOI 10.1038/ONC.2010.518; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhao B, 2009, CANCER RES, V69, P1089, DOI 10.1158/0008-5472.CAN-08-2997	36	285	290	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7018	7026		10.1074/jbc.C110.212621	http://dx.doi.org/10.1074/jbc.C110.212621			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21224387	Green Published, hybrid			2022-12-27	WOS:000287737300018
J	Rauner, C; Kohr, G				Rauner, Claudia; Koehr, Georg			Triheteromeric NR1/NR2A/NR2B Receptors Constitute the Major N-Methyl-D-aspartate Receptor Population in Adult Hippocampal Synapses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC NMDA RECEPTORS; LONG-TERM POTENTIATION; SUBUNIT COMPOSITION; FUNCTIONAL-PROPERTIES; DIFFERENTIAL ROLES; NR2D SUBUNITS; MICE LACKING; RAT-BRAIN; IN-VITRO; LTP	NMDA receptors (NMDARs), fundamental to learning and memory and implicated in certain neurological disorders, are heterotetrameric complexes composed of two NR1 and two NR2 subunits. The function of synaptic NMDARs in postnatal principal forebrain neurons is typically attributed to diheteromeric NR1/NR2A and NR1/NR2B receptors, despite compelling evidence for triheteromeric NR1/NR2A/NR2B receptors. In synapses, the properties of triheteromeric NMDARs could thus far not be distinguished from those of mixtures of diheteromeric NMDARs. To find a signature of NR1/NR2A/NR2B receptors, we have employed two gene-targeted mouse lines, expressing either NR1/NR2A or NR1/NR2B receptors without NR1/NR2A/NR2B receptors, and compared their synaptic properties with those of wild type. In acute hippocampal slices of mutants older than 4 weeks we found a distinct voltage dependence of NMDA R-mediated excitatory postsynaptic current (NMDA EPSC) decay time for the two diheteromeric NMDARs. In wild-type mice, NMDA EPSCs unveiled the NR1/NR2A characteristic for this voltage-dependent deactivation exclusively, indicating that the contribution of NR1/NR2B receptors to evoked NMDA EPSCs is negligible in adult CA3-to-CA1 synapses. The presence of NR1/NR2A/NR2B receptors was obvious from properties that could not be explained by a mixture of diheteromeric NR1/NR2A and NR1/NR2B receptors or by the presence of NR1/NR2A receptors alone. The decay time for NMDA EPSCs in wild type was slower than that for NR1/NR2A receptors, and the sensitivity of NMDA EPSCs to NR2B-directed NMDAR antagonists was 50%. Thus, NR2B is prominent in adult hippocampal synapses as an integral part of NR1/NR2A/NR2B receptors.	[Rauner, Claudia; Koehr, Georg] Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany	Max Planck Society	Kohr, G (corresponding author), Max Planck Inst Med Res, Dept Mol Neurobiol, Jahnstr 29, D-69120 Heidelberg, Germany.	kohr@mpimf-heidelberg.mpg.de						Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Berberich S, 2007, NEUROPHARMACOLOGY, V52, P77, DOI 10.1016/j.neuropharm.2006.07.016; Brickley SG, 2003, J NEUROSCI, V23, P4958; Brimecombe JC, 1997, P NATL ACAD SCI USA, V94, P11019, DOI 10.1073/pnas.94.20.11019; Brothwell SLC, 2008, J PHYSIOL-LONDON, V586, P739, DOI 10.1113/jphysiol.2007.144618; Chazot PL, 2002, NEUROPHARMACOLOGY, V42, P319, DOI 10.1016/S0028-3908(01)00191-5; CHAZOT PL, 1994, J BIOL CHEM, V269, P24403; Clarke RJ, 2008, J PHYSIOL-LONDON, V586, P5727, DOI 10.1113/jphysiol.2008.160622; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Costa BM, 2009, J PHARMACOL EXP THER, V331, P618, DOI 10.1124/jpet.109.156752; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; de Armentia ML, 2003, J NEUROSCI, V23, P6876; de Marchena J, 2008, J NEUROPHYSIOL, V100, P1936, DOI 10.1152/jn.90290.2008; Dingledine R, 1999, PHARMACOL REV, V51, P7; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; Goebel-Goody SM, 2009, NEUROSCIENCE, V158, P1446, DOI 10.1016/j.neuroscience.2008.11.006; Harney SC, 2008, J NEUROSCI, V28, P11685, DOI 10.1523/JNEUROSCI.3035-08.2008; Hatton CJ, 2005, NEURON, V46, P261, DOI 10.1016/j.neuron.2005.03.005; Hawkins LM, 1999, J BIOL CHEM, V274, P27211, DOI 10.1074/jbc.274.38.27211; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Kawakami R, 2003, SCIENCE, V300, P990, DOI 10.1126/science.1082609; Kawakami R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001945; Kew JNC, 1998, J NEUROSCI, V18, P1935; Kew JNC, 1998, J PHYSIOL-LONDON, V512, P17, DOI 10.1111/j.1469-7793.1998.017bf.x; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Kirson ED, 1996, J PHYSIOL-LONDON, V497, P437, DOI 10.1113/jphysiol.1996.sp021779; Kiyama Y, 1998, J NEUROSCI, V18, P6704; Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6; Kohr G, 2003, J NEUROSCI, V23, P10791; KONNERTH A, 1990, EXP BRAIN RES, V81, P209; Krapivinsky G, 2003, NEURON, V40, P775, DOI 10.1016/S0896-6273(03)00645-7; Kuner T, 1996, J NEUROSCI, V16, P3549; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Lozovaya NA, 2004, J PHYSIOL-LONDON, V558, P451, DOI 10.1113/jphysiol.2004.063792; Luo JH, 1997, MOL PHARMACOL, V51, P79, DOI 10.1124/mol.51.1.79; Martel MA, 2009, NEUROSCIENCE, V158, P334, DOI 10.1016/j.neuroscience.2008.01.080; Martina M, 2005, J PHYSIOL-LONDON, V563, P777, DOI 10.1113/jphysiol.2004.080655; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; Mott DD, 1998, NAT NEUROSCI, V1, P659, DOI 10.1038/3661; Nakazawa K, 2004, NAT REV NEUROSCI, V5, P361, DOI 10.1038/nrn1385; Petralia RS, 2010, NEUROSCIENCE, V167, P68, DOI 10.1016/j.neuroscience.2010.01.022; Rambhadran A, 2010, J BIOL CHEM, V285, P15296, DOI 10.1074/jbc.M109.085035; ROTHMAN SM, 1995, TRENDS NEUROSCI, V18, P57; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Scimemi A, 2004, J NEUROSCI, V24, P4767, DOI 10.1523/JNEUROSCI.0364-04.2004; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shinohara Y, 2008, P NATL ACAD SCI USA, V105, P19498, DOI 10.1073/pnas.0807461105; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Tang TTT, 2010, J BIOL CHEM, V285, P20975, DOI 10.1074/jbc.M110.102210; Tang TTT, 2009, P NATL ACAD SCI USA, V106, P21395, DOI 10.1073/pnas.0910499106; Tovar KR, 1999, J NEUROSCI, V19, P4180; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; von Engelhardt J, 2007, NEUROPHARMACOLOGY, V53, P10, DOI 10.1016/j.neuropharm.2007.04.015; von Engelhardt J, 2008, NEURON, V60, P846, DOI 10.1016/j.neuron.2008.09.039; WATANABE M, 1993, J COMP NEUROL, V338, P377, DOI 10.1002/cne.903380305; Wenzel A, 1997, J NEUROCHEM, V68, P469; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046; Zhang W, 2008, NAT NEUROSCI, V11, P1373, DOI 10.1038/nn.2214; Zhou Y, 2007, J NEUROSCI, V27, P13843, DOI 10.1523/JNEUROSCI.4486-07.2007	68	183	186	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7558	7566		10.1074/jbc.M110.182600	http://dx.doi.org/10.1074/jbc.M110.182600			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21190942	Green Published, hybrid			2022-12-27	WOS:000287737300069
J	Yang, GY; Liang, B; Zhu, J; Luo, ZG				Yang, Guo-Ying; Liang, Bin; Zhu, Ji; Luo, Zhen-Ge			Calpain Activation by Wingless-type Murine Mammary Tumor Virus Integration Site Family, Member 5A (Wnt5a) Promotes Axonal Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; BETA-CATENIN; NEURONAL POLARIZATION; PROTEOLYTIC ACTIVITY; MEMBRANE PROTRUSION; FRIZZLED HOMOLOGS; SIGNALING PATHWAY; MAMMALIAN CORTEX; CELL-MIGRATION; CONE FORMATION	Axon development involves spatial-temporal cytoskeletal reorganization. However, how the cytoskeleton remodeling is modulated by extracellular cues is unclear. Here, we report a role of Wnt/Ca2+ signaling in regulating actin and growth cone dynamics. We found that treatment of cultured cortical neurons with Wnt5a, a non-canonical Wnt, either globally or locally, caused an increase in the activity of calpain, a calcium-dependent protease responsible for the cleavage of several actin binding proteins, including spectrin. Treatment with Wnt5a promoted growth cone advance, as well as axonal growth, and these effects were prevented by chelating intracellular calcium, inhibition or down-regulation of calpain, or blockade of spectrin cleavage by competitive peptides. Interestingly, both Wnt5a and activated calpain were found to be mainly distributed in the axon-rich intermediate zone of neocortex. Down-regulating calpain expression interfered with the growth of callosal axons in vivo. Thus, Wnt5a serves as a physiological cue to stimulate localized calpain activity, which in turn promotes growth cone advance and axonal growth.	[Yang, Guo-Ying; Liang, Bin; Zhu, Ji; Luo, Zhen-Ge] Chinese Acad Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Luo, ZG (corresponding author), Chinese Acad Sci, Inst Neurosci, State Key Lab Neurosci, Shanghai Inst Biol Sci, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	zgluo@ion.ac.cn	Luo, Zhen-Ge/GNM-7635-2022	Luo, Zhen-Ge/0000-0001-5037-0542	National Natural Science Foundation of China [31021063, 30825013]; National Basic Research Program [2011CBA00403]; Chinese Academy of Sciences [KSCX2-YW-R-102]; Program of Shanghai Subject Chief Scientist [08XD14050]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences); Program of Shanghai Subject Chief Scientist	This work was supported by National Natural Science Foundation of China Grants 31021063 and 30825013, National Basic Research Program Grant 2011CBA00403, Chinese Academy of Sciences Grant KSCX2-YW-R-102, and Program of Shanghai Subject Chief Scientist Grant 08XD14050.	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Bradke F, 2000, CURR BIOL, V10, P1467, DOI 10.1016/S0960-9822(00)00807-1; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Carragher NO, 2002, INT J BIOCHEM CELL B, V34, P1539, DOI 10.1016/S1357-2725(02)00069-9; Chen YM, 2006, P NATL ACAD SCI USA, V103, P8534, DOI 10.1073/pnas.0509955103; Ciani L, 2004, J CELL BIOL, V164, P243, DOI 10.1083/jcb.200309096; Ciani L, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-27; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; FORSCHER P, 1988, J CELL BIOL, V107, P1505, DOI 10.1083/jcb.107.4.1505; Franco S, 2004, EXP CELL RES, V299, P179, DOI 10.1016/j.yexcr.2004.05.021; Franco SJ, 2005, J CELL SCI, V118, P3829, DOI 10.1242/jcs.02562; Gitler D, 1998, NEURON, V20, P1123, DOI 10.1016/S0896-6273(00)80494-8; Glading A, 2004, MOL CELL BIOL, V24, P2499, DOI 10.1128/MCB.24.6.2499-2512.2004; Glading A, 2001, J BIOL CHEM, V276, P23341, DOI 10.1074/jbc.M008847200; Gomez TM, 2006, NAT REV NEUROSCI, V7, P115, DOI 10.1038/nrn1844; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; He X, 2003, DEV CELL, V4, P791, DOI 10.1016/S1534-5807(03)00165-5; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Ishikawa R, 2007, J PHARMACOL SCI, V105, P6, DOI 10.1254/jphs.CP0070071; KATER SB, 1988, TRENDS NEUROSCI, V11, P315, DOI 10.1016/0166-2236(88)90094-X; Kohn AD, 2005, CELL CALCIUM, V38, P439, DOI 10.1016/j.ceca.2005.06.022; Krylova O, 2000, J CELL BIOL, V151, P83, DOI 10.1083/jcb.151.1.83; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Kunda P, 2001, J NEUROSCI, V21, P2361, DOI 10.1523/JNEUROSCI.21-07-02361.2001; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; Li L, 2009, J NEUROSCI, V29, P5873, DOI 10.1523/JNEUROSCI.0183-09.2009; Lipton P, 1999, PHYSIOL REV, V79, P1431, DOI 10.1152/physrev.1999.79.4.1431; LYNCH G, 1984, SCIENCE, V224, P1057, DOI 10.1126/science.6144182; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Nixon RA, 2000, ANN NY ACAD SCI, V924, P117; NIXON RA, 1986, J NEUROSCI, V6, P1264; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; OLEARY DDM, 1993, NEURON, V10, P991, DOI 10.1016/0896-6273(93)90049-W; OLEARY DDM, 1994, ANNU REV NEUROSCI, V17, P419, DOI 10.1146/annurev.neuro.17.1.419; Pan CL, 2006, DEV CELL, V10, P367, DOI 10.1016/j.devcel.2006.02.010; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Perrin BJ, 2006, MOL BIOL CELL, V17, P239, DOI 10.1091/mbc.e05-06-0488; Potter DA, 1998, J CELL BIOL, V141, P647, DOI 10.1083/jcb.141.3.647; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; SEUBERT P, 1988, BRAIN RES, V460, P189, DOI 10.1016/0006-8993(88)91222-X; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shimizu K, 2007, CELL, V128, P1219, DOI 10.1016/j.cell.2006.12.047; Shiraha H, 2002, MOL CELL BIOL, V22, P2716, DOI 10.1128/MCB.22.8.2716-2727.2002; SIKORSKI AF, 1991, J CELL BIOL, V114, P313, DOI 10.1083/jcb.114.2.313; SIMAN R, 1989, J NEUROSCI, V9, P1579; SIMAN R, 1984, P NATL ACAD SCI-BIOL, V81, P3572, DOI 10.1073/pnas.81.11.3572; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; VANDERKLISH P, 1995, MOL BRAIN RES, V32, P25, DOI 10.1016/0169-328X(95)00057-Y; Vanderklish PW, 2000, P NATL ACAD SCI USA, V97, P2253, DOI 10.1073/pnas.040565597; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; Xu W, 2007, NEURON, V53, P399, DOI 10.1016/j.neuron.2006.12.020; Yamashima T, 2003, HIPPOCAMPUS, V13, P791, DOI 10.1002/hipo.10127; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Zadran S, 2010, J NEUROSCI, V30, P1086, DOI 10.1523/JNEUROSCI.5120-09.2010; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221; Ziv NE, 1997, J NEUROSCI, V17, P3568; Ziv NE, 1998, J CELL BIOL, V140, P223, DOI 10.1083/jcb.140.1.223	68	7	9	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6566	6576		10.1074/jbc.M110.196568	http://dx.doi.org/10.1074/jbc.M110.196568			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21177867	Green Published, hybrid			2022-12-27	WOS:000287476400066
J	Ozaki, Y; Matsui, H; Nagamachi, A; Asou, H; Aki, D; Inaba, T				Ozaki, Yuko; Matsui, Hirotaka; Nagamachi, Akiko; Asou, Hiroya; Aki, Daisuke; Inaba, Toshiya			The Dynactin Complex Maintains the Integrity of Metaphasic Centrosomes to Ensure Transition to Anaphase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; MOLECULAR CHARACTERIZATION; HEMATOPOIETIC PROGENITORS; CYTOPLASMIC DYNEIN; RETROVIRAL VECTORS; HIGH-TITER; P150(GLUED); SUBUNIT; CELLS; MAINTENANCE	The dynactin complex is required for activation of the dynein motor complex, which plays a critical role in various cell functions including mitosis. During metaphase, the dynein-dynactin complex removes spindle checkpoint proteins from kinetochores to facilitate the transition to anaphase. Three components (p150(Glued), dynamitin, and p24) compose a key portion of the dynactin complex, termed the projecting arm. To investigate the roles of the dynactin complex in mitosis, we used RNA interference to down-regulate p24 and p150(Glued) in human cells. In response to p24 down-regulation, we observed cells with delayed metaphase in which chromosomes frequently align abnormally to resemble a "figure eight," resulting in cell death. We attribute the figure eight chromosome alignment to impaired metaphasic centrosomes that lack spindle tension. Like p24, RNA interference of p150(Glued) also induces prometaphase and metaphase delays; however, most of these cells eventually enter anaphase and complete mitosis. Our findings suggest that although both p24 and p150(Glued) components of the dynactin complex contribute to mitotic progression, p24 also appears to play a role in metaphase centrosome integrity, helping to ensure the transition to anaphase.	Hiroshima Univ, Dept Mol Oncol, Res Inst Radiat Biol & Med, Hiroshima 7348553, Japan; Hiroshima Univ, Leukemia Program Project, Res Inst Radiat Biol & Med, Hiroshima 7348553, Japan	Hiroshima University; Hiroshima University	Inaba, T (corresponding author), 1-2-3 Kasumi,Minami Ku, Hiroshima 7348553, Japan.	tinaba@hiroshima-u.ac.jp	Matsui, Hirotaka/AED-6669-2022	Matsui, Hirotaka/0000-0002-6266-3227	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Amaro IA, 2008, GENETICS, V178, P703, DOI 10.1534/genetics.107.079103; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; BURNS JC, 1993, P NATL ACAD SCI USA, V90, P8033, DOI 10.1073/pnas.90.17.8033; Cheung PY, 2004, J BIOL CHEM, V279, P45308, DOI 10.1074/jbc.C400333200; Dixit R, 2008, J BIOL CHEM, V283, P33611, DOI 10.1074/jbc.M804840200; Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617; Eckley DM, 2003, MOL BIOL CELL, V14, P2645, DOI 10.1091/mbc.E03-01-0049; Karki S, 1998, J CELL BIOL, V142, P1023, DOI 10.1083/jcb.142.4.1023; Katsuno M, 2006, J NEUROSCI, V26, P12106, DOI 10.1523/JNEUROSCI.3032-06.2006; Kuribara R, 2004, MOL CELL BIOL, V24, P6172, DOI 10.1128/MCB.24.14.6172-6183.2004; Kuribara R, 1999, MOL CELL BIOL, V19, P2754; Lu YJ, 2009, CELL STRUCT FUNCT, V34, P31, DOI 10.1247/csf.08040; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Oshimori N, 2006, NAT CELL BIOL, V8, P1095, DOI 10.1038/ncb1474; Pfister KK, 1998, CELL MOTIL CYTOSKEL, V41, P154, DOI 10.1002/(SICI)1097-0169(1998)41:2<154::AID-CM6>3.0.CO;2-E; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Shinjyo T, 2001, MOL CELL BIOL, V21, P854, DOI 10.1128/MCB.21.3.854-864.2001; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Tokai-Nishizumi N, 2005, MOL BIOL CELL, V16, P5455, DOI 10.1091/mbc.E05-03-0244; Whyte J, 2008, J CELL BIOL, V183, P819, DOI 10.1083/jcb.200804114	21	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5589	5598		10.1074/jbc.M110.167742	http://dx.doi.org/10.1074/jbc.M110.167742			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21163948	Green Published, hybrid			2022-12-27	WOS:000287230600068
J	Poburko, D; Santo-Domingo, J; Demaurex, N				Poburko, Damon; Santo-Domingo, Jaime; Demaurex, Nicolas			Dynamic Regulation of the Mitochondrial Proton Gradient during Cytosolic Calcium Elevations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT-LIVER MITOCHONDRIA; PERMEABILITY TRANSITION PORE; FLUORESCENT PROTEIN MUTANT; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; ELECTROCHEMICAL GRADIENT; ADENOSINE-TRIPHOSPHATASE; BUFFERING POWER; INNER MEMBRANE; PH DIFFERENCE	Mitochondria extrude protons across their inner membrane to generate the mitochondrial membrane potential (Delta Psi(m)) and pH gradient (Delta pH(m)) that both power ATP synthesis. Mitochondrial uptake and efflux of many ions and metabolites are driven exclusively by Delta pH(m), whose in situ regulation is poorly characterized. Here, we report the first dynamic measurements of Delta pH(m) in living cells, using a mitochondrially targeted, pH-sensitive YFP (SypHer) combined with a cytosolic pH indicator (5-(and 6)-carboxy-SNARF-1). The resting matrix pH (similar to 7.6) and Delta pH(m) (similar to 0.45) of HeLa cells at 37 degrees C were lower than previously reported. Unexpectedly, mitochondrial pH and Delta pH(m) decreased during cytosolic Ca2+ elevations. The drop in matrix pH was due to cytosolic acid generated by plasma membrane Ca2+-ATPases and transmitted to mitochondria by P-i/H+ symport and K+/H+ exchange, whereas the decrease in Delta pH(m) reflected the low H+-buffering power of mitochondria (similar to 5mM, pH 7.8) compared with the cytosol (similar to 20 mM, pH 7.4). Upon agonist washout and restoration of cytosolic Ca2+ and pH, mitochondria alkalinized and Delta pH(m) increased. In permeabilized cells, a decrease in bath pH from 7.4 to 7.2 rapidly decreased mitochondrial pH, whereas the addition of 10 mu M Ca2+ caused a delayed and smaller alkalinization. These findings indicate that the mitochondrial matrix pH and Delta pH(m) are regulated by opposing Ca2+-dependent processes of stimulated mitochondrial respiration and cytosolic acidification.	[Poburko, Damon; Santo-Domingo, Jaime; Demaurex, Nicolas] Univ Geneva, Sch Med, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland	University of Geneva	Demaurex, N (corresponding author), Univ Geneva, Sch Med, Dept Cell Physiol & Metab, 1 Michel Servet, CH-1211 Geneva 4, Switzerland.	Nicolas.Demaurex@unige.ch	Domingo, Jaime Santo/AAA-4995-2020	Domingo, Jaime Santo/0000-0001-5501-0482; Demaurex, Nicolas/0000-0002-9933-6772	Swiss National Foundation [31-068317]; Canadian Natural Sciences and Engineering Research Council	Swiss National Foundation(Swiss National Science Foundation (SNSF)); Canadian Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by Swiss National Foundation Grant 31-068317 (to N. D.).; Supported in part by the Canadian Natural Sciences and Engineering Research Council.	Abad MFC, 2004, J BIOL CHEM, V279, P11521, DOI 10.1074/jbc.M306766200; Arnaudeau S, 2001, J BIOL CHEM, V276, P29430, DOI 10.1074/jbc.M103274200; Bednarczyk P, 2008, BBA-BIOENERGETICS, V1777, P540, DOI 10.1016/j.bbabio.2008.04.018; Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; BERNARDI P, 1992, J BIOL CHEM, V267, P2934; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; BERNARDI P, 1983, EUR J BIOCHEM, V134, P377, DOI 10.1111/j.1432-1033.1983.tb07578.x; Bolshakov AP, 2008, CELL CALCIUM, V43, P602, DOI 10.1016/j.ceca.2007.10.005; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; BRAND MD, 1984, BIOCHEM J, V217, P453, DOI 10.1042/bj2170453; Brini M, 2009, PHYSIOL REV, V89, P1341, DOI 10.1152/physrev.00032.2008; CARAFOLI E, 1992, J BIOL CHEM, V267, P2115; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; CHEN LB, 1988, ANNU REV CELL BIOL, V4, P155, DOI 10.1146/annurev.cb.04.110188.001103; Contreras L, 2007, J BIOL CHEM, V282, P7098, DOI 10.1074/jbc.M610491200; Dash RK, 2008, J PHYSIOL-LONDON, V586, P3267, DOI 10.1113/jphysiol.2008.151977; De Marchi U, 2004, J BIOL CHEM, V279, P37415, DOI 10.1074/jbc.M314093200; Demaurex N, 2009, BBA-BIOENERGETICS, V1787, P1383, DOI 10.1016/j.bbabio.2008.12.012; Durand T, 1999, CRYOBIOLOGY, V38, P68, DOI 10.1006/cryo.1999.2152; Frieden M, 2005, J BIOL CHEM, V280, P43198, DOI 10.1074/jbc.M510279200; Frieden M, 2004, J BIOL CHEM, V279, P22704, DOI 10.1074/jbc.M312366200; Gover TD, 2007, CELL CALCIUM, V41, P389, DOI 10.1016/j.ceca.2006.08.014; HAJNOCZKY G, 1995, CELL, V82, P415, DOI 10.1016/0092-8674(95)90430-1; Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1402, DOI 10.1016/j.bbabio.2008.12.017; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; HOEK JB, 1980, J BIOL CHEM, V255, P1458; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; Jousset H, 2007, J BIOL CHEM, V282, P11456, DOI 10.1074/jbc.M609551200; Kristian T, 2001, J NEUROTRAUM, V18, P1059, DOI 10.1089/08977150152693755; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lambert AJ, 2004, BIOCHEM J, V382, P511, DOI 10.1042/BJ20040485; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Malli R, 2003, J BIOL CHEM, V278, P10807, DOI 10.1074/jbc.M212971200; Malli R, 2003, J BIOL CHEM, V278, P44769, DOI 10.1074/jbc.M302511200; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; MITCHELL P, 1961, NATURE, V191, P144, DOI 10.1038/191144a0; MITCHELL P, 1969, EUR J BIOCHEM, V7, P471, DOI 10.1111/j.1432-1033.1969.tb19633.x; MITCHELL P, 1965, NATURE, V208, P147, DOI 10.1038/208147a0; Nicholls DG, 2008, BBA-BIOENERGETICS, V1777, P550, DOI 10.1016/j.bbabio.2008.03.014; NICHOLLS DG, 1974, EUR J BIOCHEM, V50, P305, DOI 10.1111/j.1432-1033.1974.tb03899.x; Nicholls DG, 2004, J BIOENERG BIOMEMBR, V36, P277, DOI 10.1023/B:JOBB.0000041753.52832.f3; NIGGLI V, 1982, J BIOL CHEM, V257, P2350; Niggli V, 2008, TRENDS BIOCHEM SCI, V33, P156, DOI 10.1016/j.tibs.2007.12.005; Nowikovsky K, 2004, J BIOL CHEM, V279, P30307, DOI 10.1074/jbc.M403607200; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; PETRONILLI V, 1993, J BIOL CHEM, V268, P1011; Porcelli AM, 2005, BIOCHEM BIOPH RES CO, V326, P799, DOI 10.1016/j.bbrc.2004.11.105; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; ROTTENBERG H, 1974, BIOCHEMISTRY-US, V13, P4811, DOI 10.1021/bi00720a020; Santo-Domingo J, 2010, BBA-BIOENERGETICS, V1797, P907, DOI 10.1016/j.bbabio.2010.01.005; Satrustegui J, 2007, PHYSIOL REV, V87, P29, DOI 10.1152/physrev.00005.2006; Scaduto RC, 1999, BIOPHYS J, V76, P469, DOI 10.1016/S0006-3495(99)77214-0; SCARPA A, 1970, EUR J BIOCHEM, V12, P328, DOI 10.1111/j.1432-1033.1970.tb00854.x; Selivanov VA, 2008, J BIOL CHEM, V283, P29292, DOI 10.1074/jbc.M801019200; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Talbot J, 2007, J PHYSIOL-LONDON, V579, P783, DOI 10.1113/jphysiol.2006.126383; Thomas RC, 2009, J PHYSIOL-LONDON, V587, P315, DOI 10.1113/jphysiol.2008.162453; Trenker M, 2007, NAT CELL BIOL, V9, P445, DOI 10.1038/ncb1556; Vale-Gonzalez C, 2006, J NEUROSCI RES, V84, P326, DOI 10.1002/jnr.20878; VAUGHANJONES RD, 1990, J PHYSIOL-LONDON, V425, P429, DOI 10.1113/jphysiol.1990.sp018112; von Ballmoos C, 2009, ANNU REV BIOCHEM, V78, P649, DOI 10.1146/annurev.biochem.78.081307.104803; Wiedenmann A, 2008, BBA-BIOENERGETICS, V1777, P1301, DOI 10.1016/j.bbabio.2008.06.008; Wiederkehr A, 2009, EMBO J, V28, P417, DOI 10.1038/emboj.2008.302; WINGROVE DE, 1984, J BIOL CHEM, V259, P9390; Zotova L, 2010, J BIOL CHEM, V285, P14399, DOI 10.1074/jbc.M109.059956	68	231	232	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11672	11684		10.1074/jbc.M110.159962	http://dx.doi.org/10.1074/jbc.M110.159962			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21224385	hybrid, Green Published			2022-12-27	WOS:000288797100075
J	Imamura, J; Suzuki, Y; Gonda, K; Roy, CN; Gatanaga, H; Ohuchi, N; Higuchi, H				Imamura, Junji; Suzuki, Yasuhiro; Gonda, Kohsuke; Roy, Chandra Nath; Gatanaga, Hiroyuki; Ohuchi, Noriaki; Higuchi, Hideo			Single Particle Tracking Confirms That Multivalent Tat Protein Transduction Domain-induced Heparan Sulfate Proteoglycan Cross-linkage Activates Rac1 for Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-1 TAT; QUANTUM DOTS; LIVING CELLS; VESICLE TRANSPORT; BINDING MECHANISM; MOLECULE TRACKING; PLASMA-MEMBRANE; FUSION PROTEINS; GROWTH-FACTOR	The mechanism by which HIV-1-Tat protein transduction domain (TatP) enters the cell remains unclear because of an insufficient understanding of the initial kinetics of peptide entry. Here, we report the successful visualization and tracking of TatP molecular kinetics on the cell surface with 7-nm spatial precision using quantum dots. Strong cell binding was only observed with a TatP valence of >= 8, whereas monovalent TatP binding was negligible. The requirement of the cell-surface heparan sulfate (HS) chains of HS proteoglycans (HSPGs) for TatP binding and intracellular transport was demonstrated by the enzymatic removal of HS and simultaneous observation of two individual particles. Multivalent TatP induces HSPG cross-linking, recruiting activated Rac1 to adjacent lipid rafts and thereby enhancing the recruitment of TatP/HSPG to actin-associated microdomains and its internalization by macropinocytosis. These findings clarify the initial binding mechanism of TatP to the cell surface and demonstrate the importance of TatP valence for strong surface binding and signal transduction. Our data also shed light on the ability of TatP to exploit the machinery of living cells, using HSPG signaling to activate Rac1 and alter TatP mobility and internalization. This work should guide the future design of TatP-based peptides as therapeutic nano-carriers with efficient transduction.	[Imamura, Junji; Suzuki, Yasuhiro; Roy, Chandra Nath] Tohoku Univ, Grad Sch Med, Dept Emerging Infect Dis, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Gonda, Kohsuke; Ohuchi, Noriaki] Tohoku Univ, Grad Sch Med, Dept Nanomed Sci, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Gatanaga, Hiroyuki] Int Med Ctr Japan, AIDS Clin Ctr, Shinjuku Ku, Tokyo 1628655, Japan; [Ohuchi, Noriaki] Tohoku Univ, Dept Surg Oncol, Grad Sch Med, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Higuchi, Hideo] Univ Tokyo, Dept Phys, Grad Sch Sci, Hongo Bunkyou Ku, Tokyo 1138654, Japan	Tohoku University; Tohoku University; National Center for Global Health & Medicine - Japan; Tohoku University; University of Tokyo	Suzuki, Y (corresponding author), Tohoku Univ, Grad Sch Med, Dept Emerging Infect Dis, Aoba Ku, Seiryo Machi, Sendai, Miyagi 9808575, Japan.	suzukiy39@med.tohoku.ac.jp	Roy, Chandra Nath/X-5769-2019; Roy, Chandra Nath/E-8710-2010	Roy, Chandra Nath/0000-0001-6667-1550; 	Ministry of Health, Labor, and Welfare of Japan; Japanese Foundation for AIDS Prevention	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japanese Foundation for AIDS Prevention	This work was supported by a grant-in-aid for AIDS research from the Ministry of Health, Labor, and Welfare of Japan and by the Japanese Foundation for AIDS Prevention (to Y. S.).	Albini A, 1996, NAT MED, V2, P1371, DOI 10.1038/nm1296-1371; BARILLARI G, 1993, P NATL ACAD SCI USA, V90, P7941, DOI 10.1073/pnas.90.17.7941; BARTHOLOMEW JS, 1985, BIOCHEM J, V227, P429, DOI 10.1042/bj2270429; Chauhan A, 2007, J CONTROL RELEASE, V117, P148, DOI 10.1016/j.jconrel.2006.10.031; Dathe M, 1996, BIOCHEMISTRY-US, V35, P12612, DOI 10.1021/bi960835f; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Gomez-Mouton C, 2004, J CELL BIOL, V164, P759, DOI 10.1083/jcb.200309101; Gonda K, 2010, J BIOL CHEM, V285, P2750, DOI 10.1074/jbc.M109.075374; Grande-Garcia A, 2005, BIOCHEM SOC T, V33, P609, DOI 10.1042/BST0330609; GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0; Grimmer S, 2002, J CELL SCI, V115, P2953; Gump JM, 2010, J BIOL CHEM, V285, P1500, DOI 10.1074/jbc.M109.021964; Hall A, 2005, BIOCHEM SOC T, V33, P891, DOI 10.1042/BST0330891; Hikage M, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/18/185103; Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt767; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lidke DS, 2005, J CELL BIOL, V170, P619, DOI 10.1083/jcb.200503140; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Mishra A, 2008, ANGEW CHEM INT EDIT, V47, P2986, DOI 10.1002/anie.200704444; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nguyen VT, 2003, EMBO J, V22, P4968, DOI 10.1093/emboj/cdg498; Pinon JD, 2003, J VIROL, V77, P9922, DOI 10.1128/JVI.77.18.9922-9930.2003; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Ruan G, 2007, J AM CHEM SOC, V129, P14759, DOI 10.1021/ja074936k; Rusnati M, 1997, J BIOL CHEM, V272, P11313, DOI 10.1074/jbc.272.17.11313; Sandgren S, 2002, J BIOL CHEM, V277, P38877, DOI 10.1074/jbc.M205395200; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; SODROSKI J, 1985, SCIENCE, V229, P74, DOI 10.1126/science.2990041; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Suzuki T, 2002, J BIOL CHEM, V277, P2437, DOI 10.1074/jbc.M110017200; Suzuki Y, 2001, J IMMUNOL, V167, P3064, DOI 10.4049/jimmunol.167.6.3064; Tada H, 2007, CANCER RES, V67, P1138, DOI 10.1158/0008-5472.CAN-06-1185; Toschi E, 2006, MOL BIOL CELL, V17, P1985, DOI 10.1091/mbc.E05-08-0717; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; Watanabe TM, 2007, BIOPHYS J, V92, P4109, DOI 10.1529/biophysj.106.094649; Watanabe TM, 2007, BIOCHEM BIOPH RES CO, V359, P1, DOI 10.1016/j.bbrc.2007.04.168; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Ziegler A, 2004, BIOPHYS J, V86, P254, DOI 10.1016/S0006-3495(04)74101-6; Ziegler A, 2003, BIOCHEMISTRY-US, V42, P9185, DOI 10.1021/bi0346805	49	31	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10581	10592		10.1074/jbc.M110.187450	http://dx.doi.org/10.1074/jbc.M110.187450			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21199870	Green Published, hybrid			2022-12-27	WOS:000288547000073
J	Zhang, ZY; Kelemen, O; van Santen, MA; Yelton, SM; Wendlandt, AE; Sviripa, VM; Bollen, M; Beullens, M; Urlaub, H; Luhrmann, R; Watt, DS; Stamm, S				Zhang, Zhaiyi; Kelemen, Olga; van Santen, Maria A.; Yelton, Sharon M.; Wendlandt, Alison E.; Sviripa, Vitaliy M.; Bollen, Mathieu; Beullens, Monique; Urlaub, Henning; Luehrmann, Reinhard; Watt, David S.; Stamm, Stefan			Synthesis and Characterization of Pseudocantharidins, Novel Phosphatase Modulators That Promote the Inclusion of Exon 7 into the SMN (Survival of Motoneuron) pre-mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL MUSCULAR-ATROPHY; PROTEIN PHOSPHATASE-1; NORCANTHARIDIN ANALOGS; ANTICANCER ACTIVITY; CANTHARIDIN ANALOGS; CELL LINES; CERAMIDE; RECOGNITION; INHIBITION; COMPLEXES	Alternative pre-mRNA splicing is a central element of eukaryotic gene expression. Its deregulation can lead to disease, and methods to change splice site selection are developed as potential therapies. Spinal muscular atrophy is caused by the loss of the SMN1 (survival of motoneuron 1) gene. A therapeutic avenue for spinal muscular atrophy treatment is to promote exon 7 inclusion of the almost identical SMN2 (survival of motoneuron 2) gene. The splicing factor tra2-beta1 promotes inclusion of this exon and is antagonized by protein phosphatase (PP) 1. To identify new compounds that promote exon 7 inclusion, we synthesized analogs of cantharidin, an inhibitor of PP1, and PP2A. Three classes of compounds emerged from these studies. The first class blocks PP1 and PP2A activity, blocks constitutive splicing in vitro, and promotes exon 7 inclusion in vivo. The second class has no measurable effect on PP1 activity but activates PP2A. This class represents the first compounds described with these properties. These compounds cause a dephosphorylation of Thr-33 of tra2-beta1, which promotes exon 7 inclusion. The third class had no detectable effect on phosphatase activity and could promote exon 7 via allosteric effects. Our data show that subtle changes in similar compounds can turn a phosphatase inhibitor into an activator. These chemically related compounds influence alternative splicing by distinct mechanisms.	[Zhang, Zhaiyi; Kelemen, Olga; Yelton, Sharon M.; Wendlandt, Alison E.; Sviripa, Vitaliy M.; Watt, David S.; Stamm, Stefan] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [van Santen, Maria A.; Urlaub, Henning; Luehrmann, Reinhard] Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany; [Bollen, Mathieu; Beullens, Monique] Catholic Univ Louvain, Dept Mol Cell Biol, Lab Biosignaling & Therapeut, B-3000 Louvain, Belgium	University of Kentucky; Max Planck Society; Universite Catholique Louvain	Stamm, S (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, B283 Biomed Biol Sci Res Bldg,741 S Limestone, Lexington, KY 40536 USA.	stefan@stamms-lab.net		Sviripa, Vitaliy/0000-0002-7272-373X	National Institutes of Health [P20 RR020171]; Center of Biomedical Research Excellence in the Molecular Basis of Human Disease [P20 RR020171]; Muscular Dystrophy Association; EURASNET; Office of the Vice President for Research of the University of Kentucky; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center of Biomedical Research Excellence in the Molecular Basis of Human Disease; Muscular Dystrophy Association(Muscular Dystrophy Association); EURASNET; Office of the Vice President for Research of the University of Kentucky; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Research Resources Grant P20 RR020171 (to the University of Kentucky Center for Structural Biology Protein Core Facility) and Center of Biomedical Research Excellence in the Molecular Basis of Human Disease Grant P20 RR020171 (to the Organic Synthesis Core Facility). This work was also supported by the Muscular Dystrophy Association and EURASNET.; Supported by the Office of the Vice President for Research of the University of Kentucky.	Baba Y, 2003, J AM CHEM SOC, V125, P9740, DOI 10.1021/ja034694y; BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; BEULLENS M, 1992, J BIOL CHEM, V267, P16538; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; BOCKSTAHLER ER, 1966, Patent No. 3261845; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Chalfant CE, 2002, J BIOL CHEM, V277, P12587, DOI 10.1074/jbc.M112010200; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Chalfant CE, 2004, J LIPID RES, V45, P496, DOI 10.1194/jlr.M300347-JLR200; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Das R, 1999, RNA, V5, P1504, DOI 10.1017/S1355838299991501; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Galadari S, 1998, BIOCHEMISTRY-US, V37, P11232, DOI 10.1021/bi980911+; Hart ME, 2004, BIOORG MED CHEM LETT, V14, P1969, DOI 10.1016/j.bmcl.2004.01.093; Hill TA, 2007, BIOORGAN MED CHEM, V15, P6126, DOI 10.1016/j.bmc.2007.06.034; Hill TA, 2007, BIOORG MED CHEM LETT, V17, P3392, DOI 10.1016/j.bmcl.2007.03.093; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; JOLIVET J, 1960, ANN CHIM, V5, P1165; Kok SHL, 2006, INT J MOL MED, V17, P945; Kok SHL, 2006, INT J MOL MED, V17, P151; Kok SHL, 2007, BIOORG MED CHEM LETT, V17, P1155, DOI 10.1016/j.bmcl.2006.12.039; Kok SHL, 2006, INT J MOL MED, V18, P1217; Leoni LM, 1998, BIOCHEM PHARMACOL, V55, P1105, DOI 10.1016/S0006-2952(97)00685-0; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lunn MR, 2008, LANCET, V371, P2120, DOI 10.1016/S0140-6736(08)60921-6; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; McCluskey A, 2003, BIOORG CHEM, V31, P68, DOI 10.1016/S0045-2068(02)00524-2; MERMOUD JE, 1992, NUCLEIC ACIDS RES, V20, P5263, DOI 10.1093/nar/20.20.5263; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakatani T, 2004, CHEM PHARM BULL, V52, P807, DOI 10.1248/cpb.52.807; Novoyatleva T, 2008, HUM MOL GENET, V17, P52, DOI 10.1093/hmg/ddm284; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pang SK, 2007, BIOCHEM BIOPH RES CO, V363, P235, DOI 10.1016/j.bbrc.2007.08.172; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Politis JK, 2001, J AM CHEM SOC, V123, P2537, DOI 10.1021/ja003588i; Shi YS, 2006, MOL CELL, V23, P819, DOI 10.1016/j.molcel.2006.07.022; Shin C, 2004, NAT REV MOL CELL BIO, V5, P727, DOI 10.1038/nrm1467; Singh NN, 2009, RNA BIOL, V6, P341, DOI 10.4161/rna.6.3.8723; Singh NN, 2004, CRIT REV EUKAR GENE, V14, P271, DOI 10.1615/CritRevEukaryotGeneExpr.v14.i4.30; Singh RN, 2007, RNA BIOL, V4, P7, DOI 10.4161/rna.4.1.4535; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Stewart SG, 2007, BIOORGAN MED CHEM, V15, P7301, DOI 10.1016/j.bmc.2007.08.028; Sumanasekera C, 2008, BIOCHEM SOC T, V36, P483, DOI 10.1042/BST0360483; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; ZILLMANN M, 1988, MOL CELL BIOL, V8, P814, DOI 10.1128/MCB.8.2.814	51	23	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10126	10136		10.1074/jbc.M110.183970	http://dx.doi.org/10.1074/jbc.M110.183970			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21220421	Green Published, hybrid			2022-12-27	WOS:000288547000027
J	Hou, H; Wang, FS; Zhang, WC; Wang, DM; Li, XM; Bartlam, M; Yao, XB; Rao, ZH				Hou, Hai; Wang, Fengsong; Zhang, Wenchi; Wang, Dongmei; Li, Xuemei; Bartlam, Mark; Yao, Xuebiao; Rao, Zihe			Structure-Functional Analyses of CRHSP-24 Plasticity and Dynamics in Oxidative Stress Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLD-SHOCK PROTEIN; RNA-BINDING PROTEIN; MESSENGER-RNA; DNA-BINDING; PHYSIOLOGICAL SUBSTRATE; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; GENE-EXPRESSION; RAT-BRAIN; GRANULES	The cold shock domain (CSD) is an evolutionarily conserved nucleic acid binding domain that exhibits binding activity to RNA, ssDNA, and dsDNA. Mammalian CRHSP-24 contains CSD, but its structure-functional relationship has remained elusive. Here we report the crystal structure of human CRHSP-24 and characterization of the molecular trafficking of CRHSP-24 between stress granules and processing bodies in response to oxidative stress. The structure of CRHSP-24 determined by single-wavelength anomalous dispersion exhibits an alpha-helix and a compact beta-barrel formed by five curved anti-parallel beta strands. Ligand binding activity of the CSD is orchestrated by residues Ser(41) to Leu(43). Interestingly, a phosphomimetic S41D mutant abolishes the ssDNA binding in vitro and causes CRHSP-24 liberated from stress granules in vivo without apparent alternation of its localization to the processing bodies. This new class of phosphorylation-regulated interaction between the CSD and nucleic acids is unique in stress granule plasticity. Importantly, the association of CRHSP-24 with stress granules is blocked by PP4/PP2A inhibitor calyculin A as PP2A catalyzes the dephosphorylation of Ser(41) of CRHSP-24. Therefore, we speculate that CRHSP-24 participates in oxidative stress response via a dynamic and temporal association between stress granules and processing bodies.	[Wang, Fengsong; Wang, Dongmei; Yao, Xuebiao] Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China; [Wang, Fengsong; Wang, Dongmei; Yao, Xuebiao] Hefei Natl Lab Phys Sci Nanoscale, Hefei 230027, Peoples R China; [Hou, Hai; Zhang, Wenchi; Li, Xuemei; Rao, Zihe] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Bartlam, Mark; Rao, Zihe] Nankai Univ, Coll Life Sci, Tianjin Key Lab Prot Sci, Tianjin 300071, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Nankai University	Yao, XB (corresponding author), Anhui Key Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China.	yaoxb@ustc.edu.cn; raozh@xtal.tsinghua.edu.cn	Yao, Xuebiao/P-5771-2014; Rao, Zihe/HCH-6944-2022; Zhang, Wenchi/E-3389-2015	Bartlam, Mark/0000-0001-5173-5080	Chinese Natural Science Foundation [30900497, 90913016]; Chinese Academy of Science [KSCX1-YW-R-65, KSCX2-YW-H-10, KSCX2-YW-R-195]; Chinese 973 Project [2007CB914503, 2010CB912103, 2007CB914304, 2009ZX10603]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER	Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Science(Chinese Academy of Sciences); Chinese 973 Project(National Basic Research Program of China); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by Chinese Natural Science Foundation Grants 30900497 (to F. W.) and 90913016 (to X. Y.), Chinese Academy of Science Grants KSCX1-YW-R-65, KSCX2-YW-H-10, and KSCX2-YW-R-195, and Chinese 973 Project Grants 2007CB914503 and 2010CB912103 (to X. Y.), 2007CB914304 (to Z. R.), and 2009ZX10603 (to Z. R.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Auld GC, 2005, BIOCHEM J, V389, P775, DOI 10.1042/BJ20050733; Bae WH, 2000, P NATL ACAD SCI USA, V97, P7784, DOI 10.1073/pnas.97.14.7784; Bono E, 2007, ENDOCRINOLOGY, V148, P252, DOI 10.1210/en.2006-0660; Castiglia D, 1996, BIOCHEM BIOPH RES CO, V218, P390, DOI 10.1006/bbrc.1996.0068; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Davies HG, 2000, DEV BIOL, V221, P87, DOI 10.1006/dbio.2000.9658; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Evdokimova V, 2001, EMBO J, V20, P5491, DOI 10.1093/emboj/20.19.5491; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Graumann P, 1996, BIOESSAYS, V18, P309, DOI 10.1002/bies.950180409; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; Groblewski GE, 1998, J BIOL CHEM, V273, P22738, DOI 10.1074/jbc.273.35.22738; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; Hua YM, 2004, FEBS LETT, V572, P69, DOI 10.1016/j.febslet.2004.07.010; Jiang WN, 1997, J BIOL CHEM, V272, P196; JONSSON U, 1991, BIOTECHNIQUES, V11, P620; Jurchott K, 2003, J BIOL CHEM, V278, P27988, DOI 10.1074/jbc.M212966200; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kloks CPAM, 2002, J MOL BIOL, V316, P317, DOI 10.1006/jmbi.2001.5334; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee SH, 2009, BIOCHEM BIOPH RES CO, V385, P413, DOI 10.1016/j.bbrc.2009.05.096; Lopez MM, 1999, J BIOL CHEM, V274, P33601, DOI 10.1074/jbc.274.47.33601; Lorkovic ZJ, 2002, NUCLEIC ACIDS RES, V30, P623, DOI 10.1093/nar/30.3.623; Lu ZH, 2005, MOL CELL BIOL, V25, P4625, DOI 10.1128/MCB.25.11.4625-4637.2005; Max KEA, 2006, J MOL BIOL, V360, P702, DOI 10.1016/j.jmb.2006.05.044; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Nastasi T, 2000, NEUROREPORT, V11, P2233, DOI 10.1097/00001756-200007140-00034; Nastasi T, 1999, J BIOL CHEM, V274, P24087, DOI 10.1074/jbc.274.34.24087; Nekrasov MP, 2003, J BIOL CHEM, V278, P13936, DOI 10.1074/jbc.M209145200; Pfeiffer JR, 2011, MOL CELL BIOL, V31, P277, DOI 10.1128/MCB.00775-10; Schafer C, 2003, AM J PHYSIOL-GASTR L, V285, pG726, DOI 10.1152/ajpgi.00111.2003; Schumacher MA, 2006, CELL, V126, P701, DOI 10.1016/j.cell.2006.06.047; Sorokin AV, 2005, EMBO J, V24, P3602, DOI 10.1038/sj.emboj.7600830; TAFURI SR, 1992, NEW BIOL, V4, P349; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Wishart MJ, 2002, P NATL ACAD SCI USA, V99, P2112, DOI 10.1073/pnas.251686198; Yang WH, 2007, RNA, V13, P704, DOI 10.1261/rna.411907; Yao XB, 2000, NAT CELL BIOL, V2, P484, DOI 10.1038/35019518; Zeeb M, 2003, PROTEIN SCI, V12, P112, DOI 10.1110/ps.0219703	44	21	22	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9623	9635		10.1074/jbc.M110.177436	http://dx.doi.org/10.1074/jbc.M110.177436			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21177848	hybrid, Green Published			2022-12-27	WOS:000288247700087
J	Waithe, D; Ferron, L; Page, KM; Chaggar, K; Dolphin, AC				Waithe, Dominic; Ferron, Laurent; Page, Karen M.; Chaggar, Kanchan; Dolphin, Annette C.			beta-Subunits Promote the Expression of Ca(V)2.2 Channels by Reducing Their Proteasomal Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CALCIUM-CHANNEL; GATED CA2+ CHANNELS; RAT TAIL ARTERY; I-II LINKER; ENDOPLASMIC-RETICULUM; PROTEIN-SYNTHESIS; NORADRENALINE RELEASE; TRUNCATED CONSTRUCTS; SYMPATHETIC NEURONS; NEUROPATHIC PAIN	The beta-subunits of voltage-gated calcium channels regulate their functional expression and properties. Two mechanisms have been proposed for this, an effect on gating and an enhancement of expression. With respect to the effect on expression, beta-subunits have been suggested to enhance trafficking by masking an unidentified endoplasmic reticulum (ER) retention signal. Here we have investigated whether, and how, beta-subunits affect the level of Ca(V)2.2 channels within somata and neurites of cultured sympathetic neurons. We have used YFP-Ca(V)2.2 containing a mutation (W391A), that prevents binding of beta-subunits to its I-II linker and found that expression of this channel was much reduced compared with WT CFP-Ca(V)2.2 when both were expressed in the same neuron. This effect was particularly evident in neurites and growth cones. The difference between the levels of YFP-Ca(V)2.2(W391A) and CFP-Ca(V)2.2(WT) was lost in the absence of co-expressed beta-subunits. Furthermore, the relative reduction of expression of Ca(V)2.2(W391A) compared with the WT channel was reversed by exposure to two proteasome inhibitors, MG132 and lactacystin, particularly in the somata. In further experiments in tsA-201 cells, we found that proteasome inhibition did not augment the cell surface Ca(V)2.2(W391A) level but resulted in the observation of increased ubiquitination, particularly of mutant channels. In contrast, we found no evidence for selective retention of Ca(V)2.2(W391A) in the ER, in either the soma or growth cones. In conclusion, there is a marked effect of beta-subunits on Ca(V)2.2 expression, particularly in neurites, but our results point to protection from proteasomal degradation rather than masking of an ER retention signal.	[Waithe, Dominic; Ferron, Laurent; Page, Karen M.; Chaggar, Kanchan; Dolphin, Annette C.] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of London; University College London	Dolphin, AC (corresponding author), UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England.	a.dolphin@ucl.ac.uk	Dolphin, Annette C/F-7416-2010	Dolphin, Annette C/0000-0003-4626-4856; Waithe, Dominic/0000-0003-2685-4226	British Heart Foundation; Wellcome Trust [077883]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI077883] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a British Heart Foundation Ph.D. studentship (to D. W.) and Wellcome Trust Grant 077883.	Altier C, 2002, J BIOL CHEM, V277, P33598, DOI 10.1074/jbc.M202476200; ALTIER C, 2009, SOC NEUR ABS; Bauer CS, 2009, J NEUROSCI, V29, P4076, DOI 10.1523/JNEUROSCI.0356-09.2009; Berrou L, 2002, BIOPHYS J, V83, P1429, DOI 10.1016/S0006-3495(02)73914-3; Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; Bowersox SS, 1996, J PHARMACOL EXP THER, V279, P1243; Brice NL, 1997, EUR J NEUROSCI, V9, P749, DOI 10.1111/j.1460-9568.1997.tb01423.x; Brock JA, 1999, BRIT J PHARMACOL, V126, P11, DOI 10.1038/sj.bjp.0702256; Campbell DS, 2001, NEURON, V32, P1013, DOI 10.1016/S0896-6273(01)00551-7; Canti C, 2001, BIOPHYS J, V81, P1439, DOI 10.1016/S0006-3495(01)75799-2; Canti C, 1999, J NEUROSCI, V19, P6855, DOI 10.1523/JNEUROSCI.19-16-06855.1999; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; CLASBRUMMEL B, 1989, BRIT J PHARMACOL, V96, P101, DOI 10.1111/j.1476-5381.1989.tb11789.x; Cohen RM, 2005, AM J PHYSIOL-HEART C, V288, pH2363, DOI 10.1152/ajpheart.00348.2004; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cornet V, 2002, EUR J NEUROSCI, V16, P883, DOI 10.1046/j.1460-9568.2002.02168.x; Ding QX, 2006, FASEB J, V20, P1055, DOI 10.1096/fj.05-5495com; Dolphin AC, 2006, BRIT J PHARMACOL, V147, pS56, DOI 10.1038/sj.bjp.0706442; Drinjakovic J, 2010, NEURON, V65, P341, DOI 10.1016/j.neuron.2010.01.017; Drisaldi B, 2003, J BIOL CHEM, V278, P21732, DOI 10.1074/jbc.M213247200; Ferron L, 2008, J NEUROSCI, V28, P10604, DOI 10.1523/JNEUROSCI.2709-08.2008; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; HIRNING LD, 1988, SCIENCE, V239, P57, DOI 10.1126/science.2447647; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Josephson IR, 1996, BIOPHYS J, V70, P1285, DOI 10.1016/S0006-3495(96)79685-6; Kamp TJ, 1996, J PHYSIOL-LONDON, V492, P89, DOI 10.1113/jphysiol.1996.sp021291; Kucharz K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005250; Laser H, 2003, J NEUROSCI RES, V74, P906, DOI 10.1002/jnr.10806; Leroy J, 2005, J NEUROSCI, V25, P6984, DOI 10.1523/JNEUROSCI.1137-05.2005; LIPSCOMBE D, 1988, P NATL ACAD SCI USA, V85, P2398, DOI 10.1073/pnas.85.7.2398; Maltez JM, 2005, NAT STRUCT MOL BIOL, V12, P372, DOI 10.1038/nsmb909; Matsuyama Z, 1999, J Neurosci, V19, pRC14; Maximov A, 2002, J NEUROSCI, V22, P6939; Meir A, 2000, BIOPHYS J, V79, P731, DOI 10.1016/S0006-3495(00)76331-4; Murakami M, 2007, BRAIN RES, V1160, P102, DOI 10.1016/j.brainres.2007.05.041; Neely A, 2004, J BIOL CHEM, V279, P21689, DOI 10.1074/jbc.M312675200; NEELY A, 1993, SCIENCE, V262, P575, DOI 10.1126/science.8211185; Obermair GJ, 2010, J BIOL CHEM, V285, P5776, DOI 10.1074/jbc.M109.044271; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Page KM, 2010, J BIOL CHEM, V285, P835, DOI 10.1074/jbc.M109.065045; Page KM, 2004, J NEUROSCI, V24, P5400, DOI 10.1523/JNEUROSCI.0553-04.2004; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; PRAGNELL M, 1994, NATURE, V368, P67, DOI 10.1038/368067a0; Raghib A, 2001, J NEUROSCI, V21, P8495, DOI 10.1523/JNEUROSCI.21-21-08495.2001; Richards MW, 2004, TRENDS PHARMACOL SCI, V25, P626, DOI 10.1016/j.tips.2004.10.008; Snutch Terrance P, 2005, NeuroRx, V2, P662, DOI 10.1602/neurorx.2.4.662; Tran-Van-Minh A, 2010, J NEUROSCI, V30, P12856, DOI 10.1523/JNEUROSCI.2700-10.2010; TSUBUKI S, 1993, BIOCHEM BIOPH RES CO, V196, P1195, DOI 10.1006/bbrc.1993.2378; TURNER TJ, 1993, P NATL ACAD SCI USA, V90, P9518, DOI 10.1073/pnas.90.20.9518; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Verma P, 2005, J NEUROSCI, V25, P331, DOI 10.1523/JNEUROSCI.3073-04.2005; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	54	84	84	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9598	9611		10.1074/jbc.M110.195909	http://dx.doi.org/10.1074/jbc.M110.195909			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21233207	Green Published, hybrid			2022-12-27	WOS:000288247700085
J	Yamashita, M; Somasundaram, A; Prakriya, M				Yamashita, Megumi; Somasundaram, Agila; Prakriya, Murali			Competitive Modulation of Ca2+ Release-activated Ca2+ Channel Gating by STIM1 and 2-Aminoethyldiphenyl Borate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAST CA2+-DEPENDENT INACTIVATION; CRAC CHANNELS; 2-AMINOETHOXYDIPHENYL BORATE; CALCIUM-CHANNELS; PLASMA-MEMBRANE; ORAI CHANNELS; MOLECULAR DETERMINANTS; ENTRY; DOMAIN; CELLS	Activation of Ca2+ release-activated Ca2+ channels by depletion of intracellular Ca2+ stores involves physical interactions between the endoplasmic reticulum Ca2+ sensor, STIM1, and the channels composed of Orai subunits. Recent studies indicate that the Orai3 subtype, in addition to being store-operated, is also activated in a store-independent manner by 2-aminoethyldiphenyl borate (2-APB), a small molecule with complex pharmacology. However, it is unknown whether the store-dependent and -independent activation modes of Orai3 channels operate independently or whether there is cross-talk between these activation states. Here we report that in addition to causing direct activation, 2-APB also regulates store-operated gating of Orai3 channels, causing potentiation at low doses and inhibition at high doses. Inhibition of store-operated gating by 2-APB was accompanied by the suppression of several modes of Orai3 channel regulation that depend on STIM1, suggesting that high doses of 2-APB interrupt STIM1-Orai3 coupling. Conversely, STIM1-bound Orai3 (and Orai1) channels resisted direct gating by high doses of 2-APB. The rate of direct 2-APB activation of Orai3 channels increased linearly with the degree of STIM1-Orai3 uncoupling, suggesting that 2-APB has to first disengage STIM1 before it can directly gate Orai3 channels. Collectively, our results indicate that the store-dependent and -independent modes of Ca2+ release-activated Ca2+ channel activation are mutually exclusive: channels bound to STIM1 resist 2-APB gating, whereas 2-APB antagonizes STIM1 gating.	[Yamashita, Megumi; Somasundaram, Agila; Prakriya, Murali] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Prakriya, M (corresponding author), Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Sch Med, 303 E Chicago Ave,Ward 8-296, Chicago, IL 60611 USA.	m-prakriya@northwestern.edu		Prakriya, Murali/0000-0003-0781-4480; Yamashita, Megumi/0000-0003-0196-0428	National Institutes of Health [NS057499, GM082133]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057499, R56NS057499] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS057499 and GM082133 (to M.P.).	BOLAND LM, 1993, J NEUROSCI, V13, P516; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Covington ED, 2010, MOL BIOL CELL, V21, P1897, DOI 10.1091/mbc.E10-02-0145; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; DeHaven WI, 2007, J BIOL CHEM, V282, P17548, DOI 10.1074/jbc.M611374200; Derler I, 2009, J BIOL CHEM, V284, P24933, DOI 10.1074/jbc.C109.024083; Fahmer M, 2009, IMMUNOL REV, V231, P99, DOI 10.1111/j.1600-065X.2009.00815.x; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2010, PFLUG ARCH EUR J PHY, V460, P417, DOI 10.1007/s00424-009-0777-5; Feske S, 2009, IMMUNOL REV, V231, P189, DOI 10.1111/j.1600-065X.2009.00818.x; Fierro L, 1999, J MEMBRANE BIOL, V168, P9, DOI 10.1007/s002329900493; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; Goto J, 2010, CELL CALCIUM, V47, P1, DOI 10.1016/j.ceca.2009.10.004; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Ikeda SR, 1999, ADV SEC MESS PHOSPH, V33, P131; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Lee KP, 2009, P NATL ACAD SCI USA, V106, P14687, DOI 10.1073/pnas.0904664106; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Ma HT, 2002, J BIOL CHEM, V277, P6915, DOI 10.1074/jbc.M107755200; Madl J, 2010, J BIOL CHEM, V285, P41135, DOI 10.1074/jbc.M110.177881; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Motiani RK, 2010, J BIOL CHEM, V285, P19173, DOI 10.1074/jbc.M110.102582; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prakriya M, 2006, J GEN PHYSIOL, V128, P373, DOI 10.1085/jgp.200609588; Putney JW, 2010, MOL INTERV, V10, P209, DOI 10.1124/mi.10.4.4; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; Schindl R, 2008, J BIOL CHEM, V283, P20261, DOI 10.1074/jbc.M803101200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wang YJ, 2009, P NATL ACAD SCI USA, V106, P7391, DOI 10.1073/pnas.0900293106; Wu MM, 2007, CELL CALCIUM, V42, P163, DOI 10.1016/j.ceca.2007.03.003; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209	48	46	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9429	9442		10.1074/jbc.M110.189035	http://dx.doi.org/10.1074/jbc.M110.189035			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21193399	Green Published, hybrid			2022-12-27	WOS:000288247700071
J	Frischauf, I; Schindl, R; Bergsmann, J; Derler, I; Fahrner, M; Muik, M; Fritsch, R; Lackner, B; Groschner, K; Romanin, C				Frischauf, Irene; Schindl, Rainer; Bergsmann, Judith; Derler, Isabella; Fahrner, Marc; Muik, Martin; Fritsch, Reinhard; Lackner, Barbara; Groschner, Klaus; Romanin, Christoph			Cooperativeness of Orai Cytosolic Domains Tunes Subtype-specific Gating	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAST CA2+-DEPENDENT INACTIVATION; CRAC CHANNELS; MOLECULAR DETERMINANTS; CA2+ CHANNELS; STIM1; SELECTIVITY; CALMODULIN; ACTIVATION	Activation of immune cells is triggered by the Ca2+ release-activated Ca2+ current, which is mediated via channels of the Orai protein family. A key gating process of the three Orai channel isoforms to prevent Ca2+ overload is fast inactivation, most pronounced in Orai3. A subsequent reactivation is a unique gating characteristic of Orai1 channels, whereas Orai2 and Orai3 currents display a second, slow inactivation phase. Employing a chimeric approach by sequential swapping of respective intra- and extracellular regions between Orai1 and Orai3, we show here that Orai1 specific proline/arginine-rich domains in the N terminus mediate reactivation, whereas the second, intracellular loop modulates fast and slow gating processes. Swapping C-terminal strands lacks a significant impact. However, simultaneous transfer of Orai3 N terminus and its second loop or C terminus in an Orai1 chimera substantially increases fast inactivation centered between wild-type channels. Concomitant swap of all three cytosolic strands from Orai3 onto Orai1 fully conveys Orai3-like gating characteristics, in a strongly cooperative manner. In conclusion, Orai subtype-specific gating requires a cooperative interplay of all three cytosolic domains.	[Frischauf, Irene; Schindl, Rainer; Bergsmann, Judith; Derler, Isabella; Fahrner, Marc; Muik, Martin; Fritsch, Reinhard; Lackner, Barbara; Romanin, Christoph] Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Groschner, Klaus] Graz Univ, Dept Pharmaceut Sci Pharmacol & Toxicol, A-8010 Graz, Austria	Johannes Kepler University Linz; University of Graz	Schindl, R (corresponding author), Univ Linz, Inst Biophys, Altenbergerstr 69, A-4040 Linz, Austria.	rainer.schindl@jku.at; christoph.romanin@jku.at	Fahrner, Marc/AAI-7927-2021; Schindl, Rainer/V-4205-2019; Romanin, Christoph/D-5399-2009; Derler, Isabella/B-7871-2019; Groschner, Klaus/A-2550-2010; Schindl, Rainer/E-3959-2013; Frischauf, Irene/AAG-2007-2019	Romanin, Christoph/0000-0003-3756-4136; Derler, Isabella/0000-0002-4768-146X; Groschner, Klaus/0000-0002-8659-377X; Schindl, Rainer/0000-0003-0896-8887; Frischauf, Irene/0000-0003-0661-2932; Fahrner, Marc/0000-0002-2689-0158	Austrian Science Foundation (FWF) [P22747, P211925, P21118]; Hertha-Firnberg Scholarship [T442, T466]; Austrian Academy of Sciences; Austrian Science Fund (FWF) [P 22747, P 21925] Funding Source: researchfish	Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Hertha-Firnberg Scholarship(Austrian Science Fund (FWF)); Austrian Academy of Sciences; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported in part by Austrian Science Foundation (FWF) Projects P22747 (to R. S.), P211925 (to K. G.), and P21118 (to C. R.).; Recipient of Hertha-Firnberg Scholarship T442.; Recipient of a scholarship from the Austrian Academy of Sciences.; Recipient of Hertha-Firnberg Scholarship T466.	Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Derler I, 2009, J BIOL CHEM, V284, P24933, DOI 10.1074/jbc.C109.024083; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; Lee KP, 2009, P NATL ACAD SCI USA, V106, P14687, DOI 10.1073/pnas.0904664106; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schindl R, 2008, J BIOL CHEM, V283, P20261, DOI 10.1074/jbc.M803101200; Schindl R, 2009, P NATL ACAD SCI USA, V106, P19623, DOI 10.1073/pnas.0907714106; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Srikanth S, 2010, J BIOL CHEM, V285, P5066, DOI 10.1074/jbc.M109.072736; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842	21	43	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8577	8584		10.1074/jbc.M110.187179	http://dx.doi.org/10.1074/jbc.M110.187179			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21220423	hybrid, Green Published			2022-12-27	WOS:000288013300084
J	Kinnunen, AI; Sormunen, R; Elamaa, H; Seppinen, L; Miller, RT; Ninomiya, Y; Janmey, PA; Pihlajaniemi, T				Kinnunen, Aino I.; Sormunen, Raija; Elamaa, Harri; Seppinen, Lotta; Miller, R. Tyler; Ninomiya, Yoshifumi; Janmey, Paul A.; Pihlajaniemi, Taina			Lack of Collagen XVIII Long Isoforms Affects Kidney Podocytes, whereas the Short Form Is Needed in the Proximal Tubular Basement Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; PRESSURE FROZEN SAMPLES; ENDOTHELIAL-CELLS; EXTRACELLULAR MATRICES; ENDOGENOUS INHIBITOR; KNOBLOCH-SYNDROME; TUMOR-GROWTH; TISSUE; ENDOSTATIN; EXPRESSION	Collagen XVIII is characterized by three variant N termini, an interrupted collagenous domain, and a C-terminal antiangiogenic domain known as endostatin. We studied here the roles of this collagen type and its variant isoforms in the mouse kidney. Collagen XVIII appeared to be in a polarized orientation in the tubular basement membranes (BMs), the endostatin domain embedded in the BM, and the N terminus residing at the BM-fibrillar matrix interface. In the case of the glomerular BM (GBM), collagen XVIII was expressed in different isoforms depending on the side of the GBM. The orientation appeared polarized here, too, both the endothelial promoter 1-derived short variant of collagen XVIII and the epithelial promoter 2-derived longer variants having their C-terminal endostatin domains embedded in the BM and the N termini at the respective BM-cell interfaces. In addition to loosening of the proximal tubular BM structure, the Col18a1(-/-) mice showed effacement of the glomerular podocyte foot processes, and microindentation studies showed changes in the mechanical properties of the glomeruli, the Col18a1(-/-) glomeruli being similar to 30% softer than the wild-type. Analysis of promoter-specific knockouts (Col18a1(P1/P1) and Col18a1(P2/P2)) indicated that tubular BM loosening is due to a lack of the shortest isoform, whereas the glomerular podocyte effacement was due to a lack of the longer isoforms. We suggest that lack of collagen XVIII may also have disparate effects on kidney function in man, but considering the mild physiological findings in the mutant mice, such effects may manifest themselves only late in life or require other compounding molecular changes.	[Kinnunen, Aino I.; Elamaa, Harri; Seppinen, Lotta; Pihlajaniemi, Taina] Univ Oulu, Dept Med Biochem & Mol Biol, Oulu Ctr Cell Matrix Res, Oulu 90014, Finland; [Sormunen, Raija] Univ Oulu, Dept Pathol, Bioctr Oulu, Oulu 90014, Finland; [Miller, R. Tyler] Case Western Reserve Univ, Louis Stokes Vet Affairs Med Ctr, Dept Med, Cleveland, OH 44106 USA; [Miller, R. Tyler] Case Western Reserve Univ, Louis Stokes Vet Affairs Med Ctr, Dept Physiol, Cleveland, OH 44106 USA; [Miller, R. Tyler] Case Western Reserve Univ, Rammelkamp Ctr Res & Educ, Cleveland, OH 44106 USA; [Ninomiya, Yoshifumi] Okayama Univ, Dept Mol Biol & Biochem, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan; [Janmey, Paul A.] Univ Penn, Inst Med & Engn, Philadelphia, PA 19104 USA	University of Oulu; University of Oulu; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Okayama University; University of Pennsylvania; Pennsylvania Medicine	Pihlajaniemi, T (corresponding author), Univ Oulu, Dept Med Biochem & Mol Biol, Oulu Ctr Cell Matrix Res, Aapistie 7, Oulu 90014, Finland.	taina.pihlajaniemi@oulu.fi		Pihlajaniemi, Taina/0000-0002-1664-9045	Research Council for Health of the Academy of Finland [115237]; Sigrid Juselius Foundation; Grants-in-Aid for Scientific Research [23390348] Funding Source: KAKEN; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083592] Funding Source: NIH RePORTER	Research Council for Health of the Academy of Finland; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Research Council for Health of the Academy of Finland (Grant 115237) and the Sigrid Juselius Foundation.	Abrahamson DR, 2009, ORGANOGENESIS, V5, P275; Abrahamson DR, 2009, J AM SOC NEPHROL, V20, P1471, DOI 10.1681/ASN.2008101086; ABRAHAMSON DR, 1987, AM J PHYSIOL, V253, pF783, DOI 10.1152/ajprenal.1987.253.5.F783; ADLER S, 1992, AM J PATHOL, V141, P571; Breitkreutz D, 2009, HISTOCHEM CELL BIOL, V132, P1, DOI 10.1007/s00418-009-0586-0; Cortes P, 1996, AM J PHYSIOL-RENAL, V270, pF356, DOI 10.1152/ajprenal.1996.270.2.F356; CYBULSKY AV, 1992, KIDNEY INT, V42, P1099, DOI 10.1038/ki.1992.393; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Elamaa H, 2005, AM J PATHOL, V166, P221, DOI 10.1016/S0002-9440(10)62246-8; Elamaa H, 2003, MATRIX BIOL, V22, P427, DOI 10.1016/S0945-053X(03)00073-8; Erickson AC, 2000, J HISTOCHEM CYTOCHEM, V48, P1291, DOI 10.1177/002215540004801001; Faye C, 2009, J BIOL CHEM, V284, P22029, DOI 10.1074/jbc.M109.002840; Fukai N, 2002, EMBO J, V21, P1535, DOI 10.1093/emboj/21.7.1535; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Gubler MC, 2008, NAT CLIN PRACT NEPHR, V4, P24, DOI 10.1038/ncpneph0671; Halfter W, 1998, J BIOL CHEM, V273, P25404, DOI 10.1074/jbc.273.39.25404; Hamano Y, 2010, J AM SOC NEPHROL, V21, P1445, DOI 10.1681/ASN.2009050492; Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3; Kanasaki K, 2008, DEV BIOL, V313, P584, DOI 10.1016/j.ydbio.2007.10.047; Kawashima H, 2003, J BIOL CHEM, V278, P13069, DOI 10.1074/jbc.M212244200; Kojima K, 2004, J AM SOC NEPHROL, V15, P2079, DOI 10.1097/01.ASN.0000133531.43177.21; Kretzler M, 2002, MICROSC RES TECHNIQ, V57, P247, DOI 10.1002/jemt.10083; Kyriakides TR, 2009, J CELL COMMUN SIGNAL, V3, P215, DOI 10.1007/s12079-009-0077-z; Levental I, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194120; Marneros AG, 2004, EMBO J, V23, P89, DOI 10.1038/sj.emboj.7600014; Marneros AG, 2003, INVEST OPHTH VIS SCI, V44, P2367, DOI 10.1167/iovs.02-1180; McCarthy KJ, 1997, MICROSC RES TECHNIQ, V39, P233, DOI 10.1002/(SICI)1097-0029(19971101)39:3<233::AID-JEMT4>3.0.CO;2-L; McMillan JR, 2003, J HISTOCHEM CYTOCHEM, V51, P1299, DOI 10.1177/002215540305101007; MUNDEL P, 1995, ANAT EMBRYOL, V192, P387; MURAGAKI Y, 1995, P NATL ACAD SCI USA, V92, P8763, DOI 10.1073/pnas.92.19.8763; NINOMIYA Y, 1995, J CELL BIOL, V130, P1219, DOI 10.1083/jcb.130.5.1219; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Quelard D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001878; Raats CJI, 2000, AM J PATHOL, V156, P1749, DOI 10.1016/S0002-9440(10)65046-8; Regele HM, 2000, J AM SOC NEPHROL, V11, P403, DOI 10.1681/ASN.V113403; Rehn M, 1996, GENOMICS, V32, P436, DOI 10.1006/geno.1996.0139; REHN M, 1995, J BIOL CHEM, V270, P4705, DOI 10.1074/jbc.270.9.4705; REHN M, 1994, P NATL ACAD SCI USA, V91, P4234, DOI 10.1073/pnas.91.10.4234; Saarela J, 1998, AM J PATHOL, V153, P611, DOI 10.1016/S0002-9440(10)65603-9; Sasaki T, 1998, EMBO J, V17, P4249, DOI 10.1093/emboj/17.15.4249; SCHURER JW, 1978, J HISTOCHEM CYTOCHEM, V26, P688, DOI 10.1177/26.8.690407; Sertie AL, 2000, HUM MOL GENET, V9, P2051, DOI 10.1093/hmg/9.13.2051; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; Studer D, 2008, HISTOCHEM CELL BIOL, V130, P877, DOI 10.1007/s00418-008-0500-1; Suzuki OT, 2002, AM J HUM GENET, V71, P1320, DOI 10.1086/344695; Tandon R, 2007, AM J PHYSIOL-RENAL, V292, pF701, DOI 10.1152/ajprenal.00246.2006; Utriainen A, 2004, HUM MOL GENET, V13, P2089, DOI 10.1093/hmg/ddh213; van Donselaar E, 2007, TRAFFIC, V8, P471, DOI 10.1111/j.1600-0854.2007.00552.x; Walther P, 2002, J MICROSC-OXFORD, V208, P3, DOI 10.1046/j.1365-2818.2002.01064.x; Wickstrom SA, 2004, J BIOL CHEM, V279, P20178, DOI 10.1074/jbc.M312921200; Wickstrom SA, 2002, CANCER RES, V62, P5580; Ylikarppa R, 2003, FASEB J, V17, P2257, DOI 10.1096/fj.02-1001fje; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006	55	27	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7755	7764		10.1074/jbc.M110.166132	http://dx.doi.org/10.1074/jbc.M110.166132			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21193414	Green Published, hybrid			2022-12-27	WOS:000288013300007
J	Rossi, M; Colecchia, D; Iavarone, C; Strambi, A; Piccioni, F; di Pianella, AV; Chiariello, M				Rossi, Matteo; Colecchia, David; Iavarone, Carlo; Strambi, Angela; Piccioni, Federica; di Pianella, Arturo Verrotti; Chiariello, Mario			Extracellular Signal-regulated Kinase 8 (ERK8) Controls Estrogen-related Receptor alpha (ERR alpha) Cellular Localization and Inhibits Its Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; ORPHAN NUCLEAR RECEPTORS; ACTIVATED PROTEIN-KINASES; STEROID-HORMONE RECEPTORS; C-JUN PROMOTER; LIVING CELLS; MITOCHONDRIAL BIOGENESIS; GLUCOCORTICOID-RECEPTOR; ANDROGEN RECEPTOR; DNA-SYNTHESIS	ERK8 (MAPK15) is a large MAP kinase already implicated in the regulation of the functions of different nuclear receptors and in cellular proliferation and transformation. Here, we identify ERR alpha as a novel ERK8-interacting protein. As a consequence of such interaction, ERK8 induces CRM1-dependent translocation of ERR alpha to the cytoplasm and inhibits its transcriptional activity. Also, we identify in ERK8 two LXXLL motifs, typical of agonist-bound nuclear receptor corepressors, as necessary features for this MAP kinase to interact with ERR alpha and to regulate its cellular localization and transcriptional activity. Ultimately, we demonstrate that ERK8 is able to counteract, in immortalized human mammary cells, ERR alpha activation induced by the EGF receptor pathway, often deregulated in breast cancer. Altogether, these results reveal a novel function for ERK8 as a bona fide ERR alpha corepressor, involved in control of its cellular localization by nuclear exclusion, and suggest a key role for this MAP kinase in the regulation of the biological activities of this nuclear receptor.	[Rossi, Matteo; Colecchia, David; Strambi, Angela; Chiariello, Mario] Ist Toscano Tumori, Core Res Lab, Signal Transduct Unit, I-53100 Siena, Italy; [Rossi, Matteo; Colecchia, David] Univ Siena, Naples, Italy; [Iavarone, Carlo; Chiariello, Mario] CNR, Ist Endocrinol & Oncol Sperimentale, I-80125 Naples, Italy; [Piccioni, Federica; di Pianella, Arturo Verrotti] CEINGE Biotecnol Avanzate, Naples, Italy; [di Pianella, Arturo Verrotti] Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, Naples, Italy; [Chiariello, Mario] CNR, Ist Fisiol Clin, Siena, Italy	ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; University of Siena; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); CEINGE Biotecnologie Avanzate; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR)	Chiariello, M (corresponding author), Ist Toscano Tumori, Core Res Lab, Signal Transduct Unit, Via Fiorentina 1, I-53100 Siena, Italy.	mario.chiariello@ittumori.it	Colecchia, David/J-8361-2016; Colecchia, David/AAS-8110-2021; Chiariello, Mario/O-3642-2014	Colecchia, David/0000-0002-0364-8924; Chiariello, Mario/0000-0001-8434-5177	Regione Toscana; Italian Association for Cancer Research	Regione Toscana(Regione Toscana); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	This work was supported by a "Start-up grant" from Regione Toscana and by a grant from the Italian Association for Cancer Research (to M.C.).	Abe MK, 2002, J BIOL CHEM, V277, P16733, DOI 10.1074/jbc.M112483200; Ariazi EA, 2002, CANCER RES, V62, P6510; Ariazi EA, 2007, MOL CANCER RES, V5, P71, DOI 10.1158/1541-7786.MCR-06-0227; Augereau P, 2006, J STEROID BIOCHEM, V102, P51, DOI 10.1016/j.jsbmb.2006.09.005; Barry JB, 2005, CANCER RES, V65, P6120, DOI 10.1158/0008-5472.CAN-05-0922; Bartholome B, 2004, FASEB J, V18, P70, DOI 10.1096/fj.03-0328com; Bianco S, 2009, J BIOL CHEM, V284, P23286, DOI 10.1074/jbc.M109.028191; Bin Cho K, 2010, CANCER LETT, V293, P230, DOI 10.1016/j.canlet.2010.01.013; Black BE, 2001, CURR BIOL, V11, P1749, DOI 10.1016/S0960-9822(01)00537-1; Bogoyevitch MA, 2004, CELL SIGNAL, V16, P1345, DOI 10.1016/j.cellsig.2004.05.004; Bonnelye E, 1997, MOL ENDOCRINOL, V11, P905, DOI 10.1210/me.11.7.905; Boonyaratanakornkit V, 2004, ESSAYS BIOCHEM, V40, P105, DOI 10.1042/bse0400105; Castoria G, 1999, EMBO J, V18, P2500, DOI 10.1093/emboj/18.9.2500; Castoria G, 2004, MOL CELL BIOL, V24, P7643, DOI 10.1128/MCB.24.17.7643-7653.2004; Cheung CP, 2005, J CLIN ENDOCR METAB, V90, P1830, DOI 10.1210/jc.2004-1421; Chiariello M, 2000, MOL CELL BIOL, V20, P1747, DOI 10.1128/MCB.20.5.1747-1758.2000; Cicek MS, 2005, CANCER EPIDEM BIOMAR, V14, P2173, DOI 10.1158/1055-9965.EPI-05-0215; DeFranco DB, 2002, MOL ENDOCRINOL, V16, P1449, DOI 10.1210/me.16.7.1449; Duellman SJ, 2010, BIOCHEM PHARMACOL, V80, P819, DOI 10.1016/j.bcp.2010.05.024; Feige JN, 2007, TRENDS CELL BIOL, V17, P292, DOI 10.1016/j.tcb.2007.04.001; Fejes-Toth G, 1998, P NATL ACAD SCI USA, V95, P2973, DOI 10.1073/pnas.95.6.2973; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Groehler AL, 2010, J CELL BIOL, V190, P575, DOI 10.1083/jcb.201002124; Gurevich I, 2007, TOXICOL APPL PHARM, V223, P288, DOI 10.1016/j.taap.2007.05.019; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hatzoglou A, 2005, J CLIN ENDOCR METAB, V90, P893, DOI 10.1210/jc.2004-0801; Heard DJ, 2000, MOL ENDOCRINOL, V14, P382, DOI 10.1210/me.14.3.382; Henrich LM, 2003, MOL CELL BIOL, V23, P5979, DOI 10.1128/MCB.23.17.5979-5988.2003; Horard B, 2003, J MOL ENDOCRINOL, V31, P349, DOI 10.1677/jme.0.0310349; Htun H, 1999, MOL BIOL CELL, V10, P471, DOI 10.1091/mbc.10.2.471; Htun H, 1996, P NATL ACAD SCI USA, V93, P4845, DOI 10.1073/pnas.93.10.4845; Hu X, 1999, NATURE, V402, P93, DOI 10.1038/47069; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Iavarone C, 2006, J BIOL CHEM, V281, P10567, DOI 10.1074/jbc.M513397200; Johnston SD, 1997, MOL ENDOCRINOL, V11, P342, DOI 10.1210/me.11.3.342; Kadota M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009201; Kallen J, 2004, J BIOL CHEM, V279, P49330, DOI 10.1074/jbc.M407999200; Klevernic IV, 2006, BIOCHEM J, V394, P365, DOI 10.1042/BJ20051288; Klevernic IV, 2009, FEBS LETT, V583, P680, DOI 10.1016/j.febslet.2009.01.011; Kousidou OC, 2008, MOL ONCOL, V2, P223, DOI 10.1016/j.molonc.2008.06.002; Kraus RJ, 2002, J BIOL CHEM, V277, P24826, DOI 10.1074/jbc.M202952200; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kumar R, 2002, NATURE, V418, P654, DOI 10.1038/nature00889; Lanvin O, 2007, J BIOL CHEM, V282, P28328, DOI 10.1074/jbc.M704295200; Lim CS, 1999, MOL ENDOCRINOL, V13, P366, DOI 10.1210/me.13.3.366; Lombardi M, 2008, J CELL BIOL, V182, P327, DOI 10.1083/jcb.200712125; Lu DS, 2001, CANCER RES, V61, P6755; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; McKenna NJ, 2010, CELL, V142, DOI 10.1016/j.cell.2010.08.026; Nonclercq D, 2007, J MOL ENDOCRINOL, V39, P105, DOI 10.1677/JME-07-0040; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Perissi V, 1999, GENE DEV, V13, P3198, DOI 10.1101/gad.13.24.3198; Rimawi MF, 2010, CANCER-AM CANCER SOC, V116, P1234, DOI 10.1002/cncr.24816; Saelzler MP, 2006, J BIOL CHEM, V281, P16821, DOI 10.1074/jbc.M512418200; Savkur RS, 2004, J PEPT RES, V63, P207, DOI 10.1111/j.1399-3011.2004.00126.x; Scheller K, 2003, INT REV CYTOL, V222, P1; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Sebastian T, 2004, MOL CELL BIOCHEM, V260, P91, DOI 10.1023/B:MCBI.0000026060.81570.35; St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200; Stein RA, 2008, CANCER RES, V68, P8805, DOI 10.1158/0008-5472.CAN-08-1594; Stenoien DL, 2000, MOL ENDOCRINOL, V14, P518, DOI 10.1210/me.14.4.518; Sun PM, 2005, J MOL MED, V83, P457, DOI 10.1007/s00109-005-0639-3; Suzuki T, 2004, CANCER RES, V64, P4670, DOI 10.1158/0008-5472.CAN-04-0250; Terry K, 2010, GYNECOL ONCOL, V117, P255, DOI 10.1016/j.ygyno.2010.02.002; Teyssier C, 2008, NUCLEIC ACIDS RES, V36, P5350, DOI 10.1093/nar/gkn520; Tyagi RK, 2000, MOL ENDOCRINOL, V14, P1162, DOI 10.1210/me.14.8.1162; Vanacker JM, 1998, CELL GROWTH DIFFER, V9, P1007; Vanacker JM, 1999, EMBO J, V18, P4270, DOI 10.1093/emboj/18.15.4270; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; WEISZ A, 1988, MOL ENDOCRINOL, V2, P816, DOI 10.1210/mend-2-9-816; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xu YM, 2010, CANCER RES, V70, P3218, DOI 10.1158/0008-5472.CAN-09-4306; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101; Zheng W, 2004, CANCER EPIDEM BIOMAR, V13, P709	78	31	33	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8507	8522		10.1074/jbc.M110.179523	http://dx.doi.org/10.1074/jbc.M110.179523			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21190936	Green Published, hybrid			2022-12-27	WOS:000288013300078
J	Vina-Vilaseca, A; Bender-Sigel, J; Sorkina, T; Closs, EI; Sorkin, A				Vina-Vilaseca, Arnau; Bender-Sigel, Julia; Sorkina, Tatiana; Closs, Ellen Ildicho; Sorkin, Alexander			Protein Kinase C-dependent Ubiquitination and Clathrin-mediated Endocytosis of the Cationic Amino Acid Transporter CAT-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOPAMINE TRANSPORTER; LIGASE NEDD4-2; POSTTRANSLATIONAL REGULATION; NOREPINEPHRINE TRANSPORTER; ARGININE UPTAKE; PHOSPHORYLATION; ACTIVATION; INTERNALIZATION; MEMBRANE; DEGRADATION	Cationic amino acid transporter 1 (CAT-1) is responsible for the bulk of the uptake of cationic amino acids in most mammalian cells. Activation of protein kinase C (PKC) leads to down-regulation of the cell surface CAT-1. To examine the mechanisms of PKC-induced down-regulation of CAT-1, a functional mutant of CAT-1 (CAT-1-HA-GFP) was generated in which a hemagglutinin antigen (HA) epitope tag was introduced into the second extracellular loop and GFP was attached to the carboxyl terminus. CAT-1-HA-GFP was stably expressed in porcine aorthic endothelial and human epithelial kidney (HEK) 293 cells. Using the HA antibody internalization assay we have demonstrated that PKC-dependent endocytosis was strongly inhibited by siRNA depletion of clathrin heavy chain, indicating that CAT-1-HA-GFP internalization requires clathrin-coated pits. Internalized CAT-1-HA-GFP was accumulated in early, recycling, and late endosomes. PKC activation also resulted in ubiquitination of CAT-1. CAT-1 ubiquitination and endocytosis in phorbol ester-stimulated porcine aorthic endothelial and HEK293 cells were inhibited by siRNA knockdown of NEDD4-2 and NEDD4-1 E3 ubiquitin ligases, respectively. In contrast, ubiquitination and endocytosis of the dopamine transporter was dependent on NEDD4-2 in all cell types tested. Altogether, our data suggest that ubiquitination mediated by NEDD4-2 or NEDD4-1 leading to clathrin-mediated endocytosis is the common mode of regulation of various transporter proteins by PKC.	[Sorkina, Tatiana; Sorkin, Alexander] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Vina-Vilaseca, Arnau; Sorkin, Alexander] Univ Colorado Denver, Dept Pharmacol, Anschutz Med Ctr, Aurora, CO 80010 USA; [Bender-Sigel, Julia; Closs, Ellen Ildicho] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Pharmacol, D-55101 Mainz, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Johannes Gutenberg University of Mainz	Sorkin, A (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, S368 Biomed Sci Tower S,3500 Terrace St, Pittsburgh, PA 15261 USA.	sorkin@pitt.edu	Closs, Ellen/ABD-5217-2020; Vina-Vilaseca, Arnau/O-1779-2015	Closs, Ellen/0000-0002-9505-2289; Vina-Vilaseca, Arnau/0000-0003-0447-5268; Sorkin, Alexander/0000-0002-4446-1920	National Institutes of Health from NIDA [DA014204]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014204] Funding Source: NIH RePORTER	National Institutes of Health from NIDA; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA014204 from the NIDA.	Abe F, 2003, MOL CELL BIOL, V23, P7566, DOI 10.1128/MCB.23.21.7566-7584.2003; Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Alvarez CE, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-222; Boehmer C, 2006, J NEUROCHEM, V97, P911, DOI 10.1111/j.1471-4159.2006.03629.x; Boehmer C, 2003, J NEUROCHEM, V86, P1181, DOI 10.1046/j.1471-4159.2003.01937.x; Chan W, 2009, J BIOL CHEM, V284, P8185, DOI 10.1074/jbc.M806877200; Chang MY, 2001, J NEUROCHEM, V77, P754, DOI 10.1046/j.1471-4159.2001.00284.x; Closs EI, 2006, J MEMBRANE BIOL, V213, P67, DOI 10.1007/s00232-006-0875-7; Closs EI, 2002, CURR OPIN NEPHROL HY, V11, P99, DOI 10.1097/00041552-200201000-00015; Cui ZQ, 2005, GENOMICS, V85, P352, DOI 10.1016/j.ygeno.2004.11.006; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; Draheim KM, 2010, ONCOGENE, V29, P5032, DOI 10.1038/onc.2010.250; Fernandez-Sanchez E, 2009, J BIOL CHEM, V284, P19482, DOI 10.1074/jbc.M109.005165; Fotia AB, 2002, FASEB J, V16, P70, DOI 10.1096/fj.02-0497fje; Graf P, 2001, BRIT J PHARMACOL, V132, P1193, DOI 10.1038/sj.bjp.0703921; Granas C, 2003, J BIOL CHEM, V278, P4990, DOI 10.1074/jbc.M205058200; Hatanaka T, 2006, J BIOL CHEM, V281, P35922, DOI 10.1074/jbc.M606577200; Jayanthi LD, 2006, J BIOL CHEM, V281, P23326, DOI 10.1074/jbc.M601156200; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; Jespersen T, 2007, CARDIOVASC RES, V74, P64, DOI 10.1016/j.cardiores.2007.01.008; Kanelis V, 1998, BIOCHEM CELL BIOL, V76, P341, DOI 10.1139/bcb-76-2-3-341; Kizhatil K, 2002, AM J PHYSIOL-CELL PH, V283, pC1784, DOI 10.1152/ajpcell.00061.2002; Konstas AA, 2002, J BIOL CHEM, V277, P29406, DOI 10.1074/jbc.M203018200; Krotova KY, 2003, AM J PHYSIOL-LUNG C, V284, pL1037, DOI 10.1152/ajplung.00308.2002; Lee SY, 1999, J VIROL, V73, P5994, DOI 10.1128/JVI.73.7.5994-6005.1999; Lin CH, 2008, CELL, V135, P714, DOI 10.1016/j.cell.2008.09.025; Lu XB, 2002, J VIROL, V76, P6701, DOI 10.1128/JVI.76.13.6701-6709.2002; McDonald KK, 1997, J BIOL CHEM, V272, P31213, DOI 10.1074/jbc.272.50.31213; Melikian HE, 2004, PHARMACOL THERAPEUT, V104, P17, DOI 10.1016/j.pharmthera.2004.07.006; Melikian HE, 1999, J NEUROSCI, V19, P7699; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; Miranda M, 2007, MOL INTERV, V7, P157, DOI 10.1124/mi.7.3.7; Nabhan JF, 2010, EMBO REP, V11, P605, DOI 10.1038/embor.2010.80; Nikko E, 2009, TRAFFIC, V10, P1856, DOI 10.1111/j.1600-0854.2009.00990.x; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Palmada M, 2004, AM J PHYSIOL-GASTR L, V287, pG143, DOI 10.1152/ajpgi.00121.2003; Perkins CP, 1997, GENE DEV, V11, P914, DOI 10.1101/gad.11.7.914; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Qian Y, 1997, J NEUROSCI, V17, P45, DOI 10.1523/JNEUROSCI.17-01-00045.1997; Racke K, 1998, J PHYSIOL-LONDON, V511, P813, DOI 10.1111/j.1469-7793.1998.813bg.x; Ramamoorthy S, 1998, J BIOL CHEM, V273, P2458, DOI 10.1074/jbc.273.4.2458; Reshef R, 2008, AM J PHYSIOL-HEART C, V294, pH1156, DOI 10.1152/ajpheart.01051.2007; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Rotmann A, 2006, BIOCHEM J, V395, P117, DOI 10.1042/BJ20051558; Rotmann A, 2004, J BIOL CHEM, V279, P54185, DOI 10.1074/jbc.M409556200; Schwartz IF, 2007, ATHEROSCLEROSIS, V194, P357, DOI 10.1016/j.atherosclerosis.2006.10.039; Sorkina T, 2005, TRAFFIC, V6, P157, DOI 10.1111/j.1600-0854.2005.00259.x; Sorkina T, 2006, J NEUROSCI, V26, P8195, DOI 10.1523/JNEUROSCI.1301-06.2006; Sorkina T, 2009, J NEUROSCI, V29, P1361, DOI 10.1523/JNEUROSCI.3250-08.2009; Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253; Sullivan JA, 2007, MOL BIOL CELL, V18, P2429, DOI 10.1091/mbc.e07-01-0011; Turiault M, 2007, FEBS J, V274, P3568, DOI 10.1111/j.1742-4658.2007.05886.x; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Vina-Vilaseca A, 2010, J BIOL CHEM, V285, P7645, DOI 10.1074/jbc.M109.058990; Zeng FH, 2009, FASEB J, V23, P1935, DOI 10.1096/fj.08-121947	56	48	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8697	8706		10.1074/jbc.M110.186858	http://dx.doi.org/10.1074/jbc.M110.186858			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21212261	Green Published, hybrid			2022-12-27	WOS:000288013300095
J	Filomatori, CV; Iglesias, NG; Villordo, SM; Alvarez, DE; Gamarnik, AV				Filomatori, Claudia V.; Iglesias, Nestor G.; Villordo, Sergio M.; Alvarez, Diego E.; Gamarnik, Andrea V.			RNA Sequences and Structures Required for the Recruitment and Activity of the Dengue Virus Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WEST-NILE-VIRUS; MINUS-STRAND SYNTHESIS; LA PROTEIN BINDS; 3'-UNTRANSLATED REGION; FUNCTIONAL-ANALYSIS; CYCLIZATION SEQUENCES; UNTRANSLATED REGION; GENOME CYCLIZATION; NONCODING REGION; MOSQUITO-BORNE	Dengue virus RNA-dependent RNA polymerase specifically binds to the viral genome by interacting with a promoter element known as stem-loop A (SLA). Although a great deal has been learned in recent years about the function of this promoter in dengue virus-infected cells, the molecular details that explain how the SLA interacts with the polymerase to promote viral RNA synthesis remain poorly understood. Using RNA binding and polymerase activity assays, we defined two elements of the SLA that are involved in polymerase interaction and RNA synthesis. Mutations at the top of the SLA resulted in RNAs that retained the ability to bind the polymerase but impaired promoter-dependent RNA synthesis. These results indicate that protein binding to the SLA is not sufficient to induce polymerase activity and that specific nucleotides of the SLA are necessary to render an active polymerase-promoter complex for RNA synthesis. We also report that protein binding to the viral RNA induces conformational changes downstream of the promoter element. Furthermore, we found that structured RNA elements at the 3' end of the template repress dengue virus polymerase activity in the context of a fully active SLA promoter. Using assays to evaluate initiation of RNA synthesis at the viral 3'-UTR, we found that the RNA-RNA interaction mediated by 5'-3'-hybridization was able to release the silencing effect of the 3'-stem-loop structure. We propose that the long range RNA-RNA interactions in the viral genome play multiple roles during RNA synthesis. Together, we provide new molecular details about the promoter-dependent dengue virus RNA polymerase activity.	[Filomatori, Claudia V.; Iglesias, Nestor G.; Villordo, Sergio M.; Alvarez, Diego E.; Gamarnik, Andrea V.] Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, RA-1405 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Gamarnik, AV (corresponding author), Consejo Nacl Invest Cient & Tecn, Fdn Inst Leloir, Avenida Patricias Argentinas 435, RA-1405 Buenos Aires, DF, Argentina.	agamarnik@leloir.org.ar	FILOMATORI, Claudia/W-9924-2019	Villordo, Sergio/0000-0003-4434-7930	Howard Hughes Medical Institute; L'Oreal-UNESCO-CONICET; CONICET	Howard Hughes Medical Institute(Howard Hughes Medical Institute); L'Oreal-UNESCO-CONICET; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from the Howard Hughes Medical Institute and L'Oreal-UNESCO-CONICET (to A. V. G.) and by CONICET fellowships (to C. V. F., N. G. I., S. M. V., and D. E. A.).	Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009; Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005; Alvarez DE, 2008, VIROLOGY, V375, P223, DOI 10.1016/j.virol.2008.01.014; Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997; BRINTON MA, 1988, VIROLOGY, V162, P290, DOI 10.1016/0042-6822(88)90468-0; CAHOUR A, 1995, VIROLOGY, V207, P68, DOI 10.1006/viro.1995.1052; Corver J, 2003, J VIROL, V77, P2265, DOI 10.1128/JVI.77.3.2265-2270.2003; De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407; Dong HP, 2008, VIROLOGY, V381, P123, DOI 10.1016/j.virol.2008.07.040; Dong HP, 2010, VIROLOGY, V405, P568, DOI 10.1016/j.virol.2010.06.039; Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206; Gamarnik A, 2010, FRONTIERS IN DENGUE VIRUS RESEARCH, P55; Garcia-Montalvo BM, 2004, VIRUS RES, V102, P141, DOI 10.1016/j.virusres.2004.01.024; Gritsun TS, 2007, VIROLOGY, V366, P8, DOI 10.1016/j.virol.2007.04.011; Gubler D.J., 2007, FIELDS VIROLOGY, VVolume 1; HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4; Khromykh AA, 2003, J VIROL, V77, P10623, DOI 10.1128/JVI.77.19.10623-10629.2003; Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001; Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500; Kofler RM, 2006, J VIROL, V80, P4099, DOI 10.1128/JVI.80.8.4099-4113.2006; Leyssen P, 2002, VIROLOGY, V293, P125, DOI 10.1006/viro.2001.1241; Li XF, 2010, J GEN VIROL, V91, P1218, DOI 10.1099/vir.0.013854-0; Lo MK, 2003, J VIROL, V77, P10004, DOI 10.1128/JVI.77.18.10004-10014.2003; Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08; Markoff L, 2003, ADV VIRUS RES, V59, P177, DOI 10.1016/S0065-3527(03)59006-6; Men RH, 1996, J VIROL, V70, P3930, DOI 10.1128/JVI.70.6.3930-3937.1996; Olsthoorn RCL, 1999, EMBO J, V18, P4856, DOI 10.1093/emboj/18.17.4856; Paranjape SM, 2007, J BIOL CHEM, V282, P30497, DOI 10.1074/jbc.M705755200; Pogany J, 2003, EMBO J, V22, P5602, DOI 10.1093/emboj/cdg523; Polacek C, 2009, J VIROL, V83, P1161, DOI 10.1128/JVI.01362-08; Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06; Teramoto T, 2008, RNA, V14, P2645, DOI 10.1261/rna.1051208; Thurner C, 2004, J GEN VIROL, V85, P1113, DOI 10.1099/vir.0.19462-0; Tilgner M, 2005, VIROLOGY, V331, P375, DOI 10.1016/j.virol.2004.07.022; Tilgner M, 2004, J VIROL, V78, P8159, DOI 10.1128/JVI.78.15.8159-8171.2004; TIRADO MGG, 1980, REV CUBA MED TROP, V32, P123; Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; Yocupicio-Monroy M, 2007, VIROLOGY, V357, P29, DOI 10.1016/j.virol.2006.07.042; You S, 1999, J BIOL CHEM, V274, P33714, DOI 10.1074/jbc.274.47.33714; You SY, 2001, J BIOL CHEM, V276, P15581, DOI 10.1074/jbc.M010923200; Yu L, 2005, J VIROL, V79, P2309, DOI 10.1128/JVI.79.4.2309-2324.2005; Yu L, 2008, VIROLOGY, V374, P170, DOI 10.1016/j.virol.2007.12.035; Zhang B, 2008, VIROLOGY, V373, P1, DOI 10.1016/j.virol.2008.01.016; Zhang GH, 2006, RNA, V12, P147, DOI 10.1261/rna.2166706; Zhang GH, 2004, J VIROL, V78, P7619, DOI 10.1128/JVI.78.14.7619-7633.2004	46	83	85	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6929	6939		10.1074/jbc.M110.162289	http://dx.doi.org/10.1074/jbc.M110.162289			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21183683	hybrid, Green Published			2022-12-27	WOS:000287737300008
J	Seguin, A; Santos, R; Pain, D; Dancis, A; Camadro, JM; Lesuisse, E				Seguin, Alexandra; Santos, Renata; Pain, Debkumar; Dancis, Andrew; Camadro, Jean-Michel; Lesuisse, Emmanuel			Co-precipitation of Phosphate and Iron Limits Mitochondrial Phosphate Availability in Saccharomyces cerevisiae Lacking the Yeast Frataxin Homologue (YFH1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRIEDREICHS-ATAXIA; CLUSTER SYNTHESIS; OXIDATIVE STRESS; TRANSPORT; CARRIER; BIOGENESIS; CONVERSION; MEMBRANE; PROTEIN; STORAGE	Saccharomyces cerevisiae cells lacking the yeast frataxin homologue (Delta yfh1) accumulate iron in the mitochondria in the form of nanoparticles of ferric phosphate. The phosphate content of Delta yfh1 mitochondria was higher than that of wild-type mitochondria, but the proportion of mitochondrial phosphate that was soluble was much lower in Delta yfh1 cells. The rates of phosphate and iron uptake in vitro by isolated mitochondria were higher for Delta yfh1 than wild-type mitochondria, and a significant proportion of the phosphate and iron rapidly became insoluble in the mitochondrial matrix, suggesting co-precipitation of these species after oxidation of iron by oxygen. Increasing the amount of phosphate in the medium decreased the amount of iron accumulated by Delta yfh1 cells and improved their growth in an iron-dependent manner, and this effect was mostly transcriptional. Overexpressing the major mitochondrial phosphate carrier, MIR1, slightly increased the concentration of soluble mitochondrial phosphate and significantly improved various mitochondrial functions (cytochromes, [Fe-S] clusters, and respiration) in Delta yfh1 cells. We conclude that in Delta yfh1 cells, soluble phosphate is limiting, due to its co-precipitation with iron.	[Lesuisse, Emmanuel] Univ Paris Diderot, CNRS, Inst Jacques Monod, Lab Mitochondria Met & Oxidat Stress, F-75205 Paris 13, France; [Pain, Debkumar] Univ Med & Dent New Jersey, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; [Dancis, Andrew] Univ Penn, Dept Med, Philadelphia, PA 19104 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Pennsylvania	Lesuisse, E (corresponding author), Univ Paris Diderot, CNRS, Inst Jacques Monod, Lab Mitochondria Met & Oxidat Stress, Batiment Buffon,15 Rue Helene Brion, F-75205 Paris 13, France.	lesuisse.emmanuel@ijm.univ-paris-diderot.fr		Camadro, Jean-Michel/0000-0002-8549-2707; Santos, Renata/0000-0002-3085-5128	NIA, National Institutes of Health [AG030504]; AFAF (Association Francaise Ataxie de Friedreich); Agence Nationale de la Recherche (ANR Maladies Rares) [ANR-06-MRAR-025-01]; NATIONAL INSTITUTE ON AGING [R01AG030504] Funding Source: NIH RePORTER	NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AFAF (Association Francaise Ataxie de Friedreich); Agence Nationale de la Recherche (ANR Maladies Rares)(French National Research Agency (ANR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by NIA, National Institutes of Health Grant AG030504 (to D. P.). This work was also supported by the AFAF (Association Francaise Ataxie de Friedreich), the "Agence Nationale de la Recherche" ("ANR Maladies Rares, ANR-06-MRAR-025-01") (to A. S., R. S., J.-M. C., and E. L.).	Amutha B, 2008, J BIOL CHEM, V283, P1362, DOI 10.1074/jbc.M706808200; Armstrong JS, 2010, FASEB J, V24, P2152, DOI 10.1096/fj.09-143222; Auchere F, 2008, HUM MOL GENET, V17, P2790, DOI 10.1093/hmg/ddn178; Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Chantrel-Groussard K, 2001, HUM MOL GENET, V10, P2061, DOI 10.1093/hmg/10.19.2061; Foury F, 2002, J BIOL CHEM, V277, P24475, DOI 10.1074/jbc.M111789200; Froschauer EM, 2009, BBA-BIOMEMBRANES, V1788, P1044, DOI 10.1016/j.bbamem.2009.03.004; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; Hamel P, 2004, MOL MICROBIOL, V51, P307, DOI 10.1046/j.1365-2958.2003.03810.x; Labbe P, 1969, Bull Soc Chim Biol (Paris), V51, P1642; LABBE P, 1971, ANAL BIOCHEM, V39, P322, DOI 10.1016/0003-2697(71)90421-0; Lesuisse E, 2003, HUM MOL GENET, V12, P879, DOI 10.1093/hmg/ddg096; Li HQ, 2009, J BIOL CHEM, V284, P21971, DOI 10.1074/jbc.M109.011197; Li LT, 1997, J BIOL CHEM, V272, P28485, DOI 10.1074/jbc.272.45.28485; Martin H, 1998, ANAL BIOCHEM, V265, P123, DOI 10.1006/abio.1998.2863; Miao R, 2008, BIOCHEMISTRY-US, V47, P9888, DOI 10.1021/bi801047q; Miao R, 2009, BIOCHEMISTRY-US, V48, P9556, DOI 10.1021/bi901110n; Muhlenhoff U, 2003, J BIOL CHEM, V278, P40612, DOI 10.1074/jbc.M307847200; MURAKAMI H, 1990, NATURE, V347, P488, DOI 10.1038/347488a0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; RAGUZZI F, 1988, FEBS LETT, V231, P253, DOI 10.1016/0014-5793(88)80742-7; Reddi AR, 2009, FREE RADICAL BIO MED, V46, P154, DOI 10.1016/j.freeradbiomed.2008.09.032; Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797; Rosenfeld L, 2010, J BIOL INORG CHEM, V15, P1051, DOI 10.1007/s00775-010-0664-8; Santos MM, 2001, HUM MOL GENET, V10, P1935, DOI 10.1093/hmg/10.18.1935; Santos R, 2010, ANTIOXID REDOX SIGN, V13, P651, DOI 10.1089/ars.2009.3015; Schroers A, 1997, J BIOL CHEM, V272, P10558; Seguin A, 2010, BBA-MOL BASIS DIS, V1802, P531, DOI 10.1016/j.bbadis.2010.03.008; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; Takabatake R, 2001, J BIOCHEM, V129, P827, DOI 10.1093/oxfordjournals.jbchem.a002926; Vozza A, 2004, J BIOL CHEM, V279, P20850, DOI 10.1074/jbc.M313610200; Yoon T, 2004, J BIOL CHEM, V279, P25943, DOI 10.1074/jbc.C400107200; Zara V, 1996, MOL CELL BIOL, V16, P6524; Zhang Y, 2006, J BIOL CHEM, V281, P22493, DOI 10.1074/jbc.M604246200	37	16	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6071	6079		10.1074/jbc.M110.163253	http://dx.doi.org/10.1074/jbc.M110.163253			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21189251	Green Published, hybrid			2022-12-27	WOS:000287476400015
J	Song, QA; Cannistraro, VJ; Taylor, JS				Song, Qian; Cannistraro, Vincent J.; Taylor, John-Stephen			Rotational Position of a 5-Methylcytosine-containing Cyclobutane Pyrimidine Dimer in a Nucleosome Greatly Affects Its Deamination Rate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; DNA-POLYMERASE-ETA; GLUCOCORTICOID RESPONSE ELEMENT; SYN THYMINE DIMER; CIS-SYN; UV PHOTOPRODUCT; SKIN-CANCER; IN-VIVO; RECONSTITUTED NUCLEOSOMES; HYDROLYTIC DEAMINATION	C to T mutation hotspots in skin cancers occur primarily at methylated CpG sites that coincide with sites of UV-induced cyclobutane pyrimidine dimer (CPD) formation. These mutations are proposed to arise from the insertion of A by DNA polymerase eta opposite the T that results from deamination of the methylC (C-m) within the CPD. Although the frequency of CPD formation and repair is modestly modulated by its rotational position within a nucleosome, the effect of position on the rate of C-m deamination in a CPD has not been previously studied. We now report that deamination of a (TC)-C-m CPD whose sugar phosphate backbone is positioned against the histone core surface decreases by a factor of 4.7, whereas that of a (TC)-C-m CPD positioned away from the surface increases by a factor of 8.9 when compared with unbound DNA. Because the Cs-m undergoing deamination are in similar steric environments, the difference in rate appears to be a consequence of a difference in the flexibility and compression of the two sites due to DNA bending. Considering that formation of the CPD positioned away from the surface is also enhanced by a factor of two, a T(m)CG site in this position might be expected to have up to an 84-fold higher probability of resulting in a UV-induced C-m to T mutation than one positioned against the surface. These results indicate that rotational position may play an important role in the formation of UV-induced C to T mutation hotspots, as well as in the mutagenic mechanism of other DNA lesions.	[Song, Qian; Cannistraro, Vincent J.; Taylor, John-Stephen] Washington Univ, Dept Chem, St Louis, MO 63130 USA	Washington University (WUSTL)	Taylor, JS (corresponding author), Washington Univ, Dept Chem, St Louis, MO 63130 USA.	taylor@wustl.edu	Taylor, John-Stephen/AAA-3218-2020	Taylor, John-Stephen/0000-0002-8615-7257	National Institutes of Health [CA40463]; NATIONAL CANCER INSTITUTE [R37CA040463, R01CA040463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA40463 (to J.-S. T.).	Balasubramanian B, 1998, P NATL ACAD SCI USA, V95, P9738, DOI 10.1073/pnas.95.17.9738; BECKER MM, 1989, J MOL BIOL, V210, P429, DOI 10.1016/0022-2836(89)90120-4; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Cannistraro VJ, 2010, NUCLEIC ACIDS RES, V38, P6943, DOI 10.1093/nar/gkq582; Cannistraro VJ, 2009, J MOL BIOL, V392, P1145, DOI 10.1016/j.jmb.2009.07.048; Carpenter M, 2006, NUCLEIC ACIDS RES, V34, P3762, DOI 10.1093/nar/gkl545; Celewicz L, 2005, PHOTOCHEM PHOTOBIOL, V81, P404, DOI 10.1562/2004-06-15-RA-201.1; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; DOUKI T, 1994, BIOCHEMISTRY-US, V33, P11942, DOI 10.1021/bi00205a033; Douki T, 2001, BIOCHEMISTRY-US, V40, P2495, DOI 10.1021/bi0022543; Drouin R, 1997, PHOTOCHEM PHOTOBIOL, V66, P719, DOI 10.1111/j.1751-1097.1997.tb03213.x; FIX D, 1981, MOL GEN GENET, V182, P7, DOI 10.1007/BF00422759; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; GALE JM, 1987, P NATL ACAD SCI USA, V84, P6644, DOI 10.1073/pnas.84.19.6644; Giglia-Mari G, 2003, HUM MUTAT, V21, P217, DOI 10.1002/humu.10179; Hara R, 2003, MOL CELL BIOL, V23, P4121, DOI 10.1128/MCB.23.12.4121-4125.2003; JIANG N, 1993, BIOCHEMISTRY-US, V32, P472, DOI 10.1021/bi00053a011; Jing YQ, 1998, NUCLEIC ACIDS RES, V26, P3845, DOI 10.1093/nar/26.16.3845; Kosmoski JV, 2001, P NATL ACAD SCI USA, V98, P10113, DOI 10.1073/pnas.181073398; Kosmoski JV, 1999, BIOCHEMISTRY-US, V38, P9485, DOI 10.1021/bi990297h; Kreutzer DA, 1998, P NATL ACAD SCI USA, V95, P3578, DOI 10.1073/pnas.95.7.3578; Lee DH, 2003, J BIOL CHEM, V278, P10314, DOI 10.1074/jbc.M212696200; LEMAIRE DGE, 1993, BIOCHEMISTRY-US, V32, P2525, DOI 10.1021/bi00061a009; LI Q, 1993, GENE DEV, V7, P2471, DOI 10.1101/gad.7.12a.2471; LI Q, 1995, MOL CELL BIOL, V15, P4375; Liu XQ, 2000, J BIOL CHEM, V275, P23729, DOI 10.1074/jbc.M002206200; Luger K, 2006, CHROMOSOME RES, V14, P5, DOI 10.1007/s10577-005-1026-1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; McCulloch SD, 2004, NATURE, V428, P97, DOI 10.1038/nature02352; Mu D, 1997, MOL CELL BIOL, V17, P760, DOI 10.1128/MCB.17.2.760; Ober M, 2007, J AM CHEM SOC, V129, P6278, DOI 10.1021/ja0706145; Park H, 2002, P NATL ACAD SCI USA, V99, P15965, DOI 10.1073/pnas.242422699; PEHRSON JR, 1989, P NATL ACAD SCI USA, V86, P9149, DOI 10.1073/pnas.86.23.9149; PEHRSON JR, 1992, NUCLEIC ACIDS RES, V20, P1321, DOI 10.1093/nar/20.6.1321; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Pfeifer GP, 1997, PHOTOCHEM PHOTOBIOL, V65, P270, DOI 10.1111/j.1751-1097.1997.tb08560.x; SETLOW RB, 1966, SCIENCE, V153, P379, DOI 10.1126/science.153.3734.379; SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972; Sohail A, 2002, BIOCHEMISTRY-US, V41, P11325, DOI 10.1021/bi026332t; Sugasawa K, 2001, GENE DEV, V15, P507, DOI 10.1101/gad.866301; SUQUET C, 1993, J BIOL CHEM, V268, P23755; Svedruzic ZM, 2005, J BIOL CHEM, V280, P40051, DOI 10.1074/jbc.M509478200; TAYLOR JS, 1990, BIOCHEMISTRY-US, V29, P1624, DOI 10.1021/bi00458a038; Thoma F, 2005, DNA REPAIR, V4, P855, DOI 10.1016/j.dnarep.2005.04.005; Tommasi S, 1997, CANCER RES, V57, P4727; Tu YQ, 1998, J MOL BIOL, V284, P297, DOI 10.1006/jmbi.1998.2176; Vu B, 2006, BIOCHEMISTRY-US, V45, P9327, DOI 10.1021/bi0602009; WANG ZG, 1991, J BIOL CHEM, V266, P22472; Washington MT, 2000, P NATL ACAD SCI USA, V97, P3094, DOI 10.1073/pnas.050491997; Yoon JH, 2000, J MOL BIOL, V299, P681, DOI 10.1006/jmbi.2000.3771; You HY, 2000, CARCINOGENESIS, V21, P2113, DOI 10.1093/carcin/21.11.2113; You YH, 1999, J MOL BIOL, V293, P493, DOI 10.1006/jmbi.1999.3174; You YH, 2001, J BIOL CHEM, V276, P44688, DOI 10.1074/jbc.M107696200; You YH, 2001, J MOL BIOL, V305, P389, DOI 10.1006/jmbi.2000.4322; Yu SL, 2001, MOL CELL BIOL, V21, P185, DOI 10.1128/MCB.21.1.185-188.2001; ZIEGLER A, 1993, P NATL ACAD SCI USA, V90, P4216, DOI 10.1073/pnas.90.9.4216	57	18	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6329	6335		10.1074/jbc.M110.183178	http://dx.doi.org/10.1074/jbc.M110.183178			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21160086	Green Published, hybrid			2022-12-27	WOS:000287476400043
J	Chernev, P; Zaharieva, I; Dau, H; Haumann, M				Chernev, Petko; Zaharieva, Ivelina; Dau, Holger; Haumann, Michael			Carboxylate Shifts Steer Interquinone Electron Transfer in Photosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY-ABSORPTION SPECTROSCOPY; INDUCED STRUCTURAL-CHANGES; IRON-QUINONE COMPLEX; NON-HEME IRON; PHOTOSYSTEM-II; REACTION CENTERS; RHODOBACTER-SPHAEROIDES; RHODOPSEUDOMONAS-VIRIDIS; PROTON UPTAKE; THERMOSYNECHOCOCCUS-ELONGATUS	Understanding the mechanisms of electron transfer (ET) in photosynthetic reaction centers (RCs) may inspire novel catalysts for sunlight-driven fuel production. The electron exit pathway of type II RCs comprises two quinone molecules working in series and in between a non-heme iron atom with a carboxyl ligand (bicarbonate in photosystem II (PSII), glutamate in bacterial RCs). For decades, the functional role of the iron has remained enigmatic. We tracked the iron site using microsecond-resolution x-ray absorption spectroscopy after laser-flash excitation of PSII. After formation of the reduced primary quinone, Q (A) over bar, the x-ray spectral changes revealed a transition (t(1/2) approximate to 150 mu s) from a bidentate to a monodentate coordination of the bicarbonate at the Fe(II) (carboxylate shift), which reverted concomitantly with the slower ET to the secondary quinone QB. A redox change of the iron during the ET was excluded. Density-functional theory calculations corroborated the carboxylate shift both in PSII and bacterial RCs and disclosed underlying changes in electronic configuration. We propose that the iron-carboxyl complex facilitates the first interquinone ET by optimizing charge distribution and hydrogen bonding within the Q(A)FeQ(B) triad for high yield Q(B) reduction. Formation of a specific priming intermediate by nuclear rearrangements, setting the stage for subsequent ET, may be a common motif in reactions of biological redox cofactors.	[Haumann, Michael] Free Univ Berlin, FB Phys, Inst Expt Phys, D-14195 Berlin, Germany	Free University of Berlin	Haumann, M (corresponding author), Free Univ Berlin, FB Phys, Inst Expt Phys, Arnimallee 14, D-14195 Berlin, Germany.	michael.haumann@fu-berlin.de	MIchael, Haumann/A-7087-2013; Chernev, Petko/F-9964-2018; Zaharieva, Ivelina S/H-6119-2012	Chernev, Petko/0000-0002-2836-838X; Zaharieva, Ivelina S/0000-0002-4745-5307; Dau, Holger/0000-0001-6482-7494	Deutsche Forschungsgemeinschaft [Ha3265/3-1]; Unicat (Berlin Cluster of Excellence); European Union; Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Unicat (Berlin Cluster of Excellence); European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Grant Ha3265/3-1 to M. H. and Unicat (Berlin Cluster of Excellence)) and European Union FP7 program (SolarH2 Consortium).; Supported by a Heisenberg fellowship from the Deutsche Forschungsgemeinschaft. To whom correspondence should be addressed: Freie Universitat Berlin, FB Physik, Arnimallee 14, 14195 Berlin, Germany. Fax: 49-30-8385-6299; E-mail: michael. haumann@fu-berlin.de.	Barber J, 2009, CHEM SOC REV, V38, P185, DOI 10.1039/b802262n; Berthomieu C, 2001, BIOCHEMISTRY-US, V40, P4044, DOI 10.1021/bi002236l; Chen LX, 2005, ANNU REV PHYS CHEM, V56, P221, DOI 10.1146/annurev.physchem.56.092503.141310; Cohen AJ, 2008, SCIENCE, V321, P792, DOI 10.1126/science.1158722; Cramer CJ, 2009, PHYS CHEM CHEM PHYS, V11, P10757, DOI 10.1039/b907148b; Dau H, 2008, COORDIN CHEM REV, V252, P273, DOI 10.1016/j.ccr.2007.09.001; de Wijn R, 2001, BIOCHEMISTRY-US, V40, P11912, DOI 10.1021/bi010852r; DEBUS RJ, 1986, BIOCHEMISTRY-US, V25, P2276, DOI 10.1021/bi00356a064; DEISENHOFER J, 1989, SCIENCE, V245, P1463, DOI 10.1126/science.245.4925.1463; DINER BA, 1987, BIOCHIM BIOPHYS ACTA, V895, P107, DOI 10.1016/S0304-4173(87)80010-1; Diner BA, 2002, ANNU REV PLANT BIOL, V53, P551, DOI 10.1146/annurev.arplant.53.100301.135238; DISMUKES GC, 1984, BIOCHIM BIOPHYS ACTA, V764, P253, DOI 10.1016/0005-2728(84)90096-3; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Fufezan C, 2005, BIOCHEMISTRY-US, V44, P12780, DOI 10.1021/bi051000k; Goussias C, 2002, BIOCHEMISTRY-US, V41, P15212, DOI 10.1021/bi026223e; Gunner MR, 2008, J BIOENERG BIOMEMBR, V40, P509, DOI 10.1007/s10863-008-9179-1; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; GUST D, 1989, SCIENCE, V244, P35, DOI 10.1126/science.244.4900.35; Haumann M, 2005, SCIENCE, V310, P1019, DOI 10.1126/science.1117551; HAUMANN M, 1994, FEBS LETT, V347, P45, DOI 10.1016/0014-5793(94)00495-1; Haumann M, 2008, P NATL ACAD SCI USA, V105, P17384, DOI 10.1073/pnas.0802596105; Hermes S, 2006, BIOCHEMISTRY-US, V45, P353, DOI 10.1021/bi0515725; Hienerwadel R, 1995, BIOCHEMISTRY-US, V34, P16288, DOI 10.1021/bi00050a008; Ishikita H, 2007, BBA-BIOENERGETICS, V1767, P1300, DOI 10.1016/j.bbabio.2007.08.004; Iwata T, 2009, BIOCHEMISTRY-US, V48, P1220, DOI 10.1021/bi801990s; Kalyanasundaram K, 2010, CURR OPIN BIOTECH, V21, P298, DOI 10.1016/j.copbio.2010.03.021; Kaminskaya O, 2003, BIOCHEMISTRY-US, V42, P8119, DOI 10.1021/bi020606v; Kirchner B, 2007, CURR OPIN CHEM BIOL, V11, P134, DOI 10.1016/j.cbpa.2007.02.026; KIRMAIER C, 1986, P NATL ACAD SCI USA, V83, P6407, DOI 10.1073/pnas.83.17.6407; Kleifeld O, 2003, NAT STRUCT BIOL, V10, P98, DOI 10.1038/nsb889; KLEINFELD D, 1984, BIOCHEMISTRY-US, V23, P5780, DOI 10.1021/bi00319a017; Koepke J, 2007, J MOL BIOL, V371, P396, DOI 10.1016/j.jmb.2007.04.082; Krivanek R, 2007, BBA-BIOENERGETICS, V1767, P520, DOI 10.1016/j.bbabio.2007.02.013; Kurreck J, 1996, FEBS LETT, V381, P53, DOI 10.1016/0014-5793(96)00061-0; Lancaster CRD, 2000, J BIOL CHEM, V275, P39364, DOI 10.1074/jbc.M008225200; Lemercier G, 2004, INORG CHEM, V43, P2105, DOI 10.1021/ic034907k; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Loscher S, 2007, INORG CHEM, V46, P11094, DOI 10.1021/ic701255p; McConnell I, 2010, CHEM BIOL, V17, P434, DOI 10.1016/j.chembiol.2010.05.005; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; MOSER CC, 1992, NATURE, V355, P796, DOI 10.1038/355796a0; Nabedryk E, 2008, BBA-BIOENERGETICS, V1777, P1229, DOI 10.1016/j.bbabio.2008.06.012; Neese F., 2007, ORCA AB INITIO DENSI; Noodleman L, 2006, J BIOL INORG CHEM, V11, P674, DOI 10.1007/s00775-006-0136-3; OKAMURA MY, 1992, ANNU REV BIOCHEM, V61, P861; Palazzo G, 2008, J AM CHEM SOC, V130, P9353, DOI 10.1021/ja801963a; PARSON WW, 1974, ANNU REV MICROBIOL, V28, P41, DOI 10.1146/annurev.mi.28.100174.000353; Peluso A, 2000, J THEOR BIOL, V207, P101, DOI 10.1006/jtbi.2000.2159; PETROULEAS V, 1994, BBA-BIOENERGETICS, V1188, P271, DOI 10.1016/0005-2728(94)90045-0; RARDIN RL, 1991, NEW J CHEM, V15, P417; Reifarth F, 1998, FEBS LETT, V428, P123, DOI 10.1016/S0014-5793(98)00491-8; Remy A, 2003, NAT STRUCT BIOL, V10, P637, DOI 10.1038/nsb954; Renger G, 2008, PHOTOSYNTH RES, V98, P53, DOI 10.1007/s11120-008-9345-7; Shen JR, 2011, METHODS MOL BIOL, V684, P41, DOI [10.1007/978.1.60761.925.3_5, 10.1007/978-1-60761-925-3_5]; Sinnecker S, 2006, J PHYS CHEM A, V110, P2235, DOI 10.1021/jp056016z; Stewart DH, 1998, BBA-BIOENERGETICS, V1367, P63, DOI 10.1016/S0005-2728(98)00139-X; Takahashi R, 2009, BIOCHEMISTRY-US, V48, P8994, DOI 10.1021/bi901195e; Veronesi G, 2008, BIOPHYS J, V95, P814, DOI 10.1529/biophysj.108.132654; Wastl J, 2000, J BIOL CHEM, V275, P30058, DOI 10.1074/jbc.M004629200; Westre TE, 1997, J AM CHEM SOC, V119, P6297, DOI 10.1021/ja964352a; Wohri AB, 2010, SCIENCE, V328, P630, DOI 10.1126/science.1186159; Woodbury NW, 1995, ANOXYGENIC PHOTOSYNT, P527, DOI [DOI 10.1007/0-306-47954-0_24, 10.1007/0-306-47954-0_24]; Wraight CA, 2004, FRONT BIOSCI-LANDMRK, V9, P309, DOI 10.2741/1236; Xu Q, 2004, STRUCTURE, V12, P703, DOI 10.1016/j.str.2004.03.001; Zhu ZY, 2005, BIOCHEMISTRY-US, V44, P82, DOI 10.1021/bi048348k	65	28	28	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5368	5374		10.1074/jbc.M110.202879	http://dx.doi.org/10.1074/jbc.M110.202879			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21169354	Green Published, hybrid			2022-12-27	WOS:000287230600045
J	Figiel, M; Chon, H; Cerritelli, SM; Cybulska, M; Crouch, RJ; Nowotny, M				Figiel, Malgorzata; Chon, Hyongi; Cerritelli, Susana M.; Cybulska, Magdalena; Crouch, Robert J.; Nowotny, Marcin			The Structural and Biochemical Characterization of Human RNase H2 Complex Reveals the Molecular Basis for Substrate Recognition and Aicardi-Goutieres Syndrome Defects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; RIBONUCLEASE-H; HII; TYPE-2; MUTATIONS; MECHANISM; SUBUNITS; REMOVAL; HOMOLOG	RNase H2 cleaves RNA sequences that are part of RNA/DNA hybrids or that are incorporated into DNA, thus, preventing genomic instability and the accumulation of aberrant nucleic acid, which in humans induces Aicardi-Goutieres syndrome, a severe autoimmune disorder. The 3.1 angstrom crystal structure of human RNase H2 presented here allowed us to map the positions of all 29 mutations found in Aicardi-Goutieres syndrome patients, several of which were not visible in the previously reported mouse RNase H2. We propose the possible effects of these mutations on the protein stability and function. Bacterial and eukaryotic RNases H2 differ in composition and substrate specificity. Bacterial RNases H2 are monomeric proteins and homologs of the eukaryotic RNases H2 catalytic subunit, which in addition possesses two accessory proteins. The eukaryotic RNase H2 heterotrimeric complex recognizes RNA/DNA hybrids and (5') RNA-DNA(3')/DNA junction hybrids as substrates with similar efficiency, whereas bacterial RNases H2 are highly specialized in the recognition of the (5') RNA-DNA(3') junction and very poorly cleave RNA/DNA hybrids in the presence of Mg2+ ions. Using the crystal structure of the Thermotoga maritima RNase H2-substrate complex, we modeled the human RNase H2-substrate complex and verified the model by mutational analysis. Our model indicates that the difference in substrate preference stems from the different position of the crucial tyrosine residue involved in substrate binding and recognition.	[Figiel, Malgorzata; Cybulska, Magdalena; Nowotny, Marcin] Int Inst Mol & Cell Biol, Lab Prot Struct, PL-02109 Warsaw, Poland; [Chon, Hyongi; Cerritelli, Susana M.; Crouch, Robert J.] Eunice Kennedy Shriver NICHD, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA	Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Nowotny, M (corresponding author), 4 Trojdena St, PL-02109 Warsaw, Poland.	mnowotny@iimcb.gov.pl	Figiel, Małgorzata/ABF-9197-2020	Nowotny, Marcin/0000-0001-8632-0977; Figiel, Malgorzata/0000-0002-2211-0425	National Institutes of Health, Eunice Kennedy Shriver NICHD; Wellcome Trust [081760]; Polish Ministry of Science and Higher Education [ESRF/73/2006]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000068] Funding Source: NIH RePORTER	National Institutes of Health, Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the Eunice Kennedy Shriver NICHD. This work was also supported by Wellcome Trust International Senior Fellowship 081760. The access to the European Synchrotron Radiation Facility was financed by the Polish Ministry of Science and Higher Education (Project ESRF/73/2006).	Afonine PV, 2005, CCP4 NEWSL, V42; Arudchandran A, 2000, GENES CELLS, V5, P789, DOI 10.1046/j.1365-2443.2000.00373.x; Chai Q, 2001, BIOCHEM BIOPH RES CO, V286, P1073, DOI 10.1006/bbrc.2001.5523; Chapados BR, 2001, J MOL BIOL, V307, P541, DOI 10.1006/jmbi.2001.4494; Chon HG, 2009, NUCLEIC ACIDS RES, V37, P96, DOI 10.1093/nar/gkn913; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; EDER PS, 1991, J BIOL CHEM, V266, P6472; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frank P, 1998, P NATL ACAD SCI USA, V95, P12872, DOI 10.1073/pnas.95.22.12872; Gaidamakov SA, 2005, NUCLEIC ACIDS RES, V33, P2166, DOI 10.1093/nar/gki510; Jeong HS, 2004, NUCLEIC ACIDS RES, V32, P407, DOI 10.1093/nar/gkh209; Lai LH, 2000, STRUCTURE, V8, P897, DOI 10.1016/S0969-2126(00)00179-9; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Muroya A, 2001, PROTEIN SCI, V10, P707, DOI 10.1110/ps.48001; Nettleship Joanne E., 2008, V426, P299, DOI 10.1007/978-1-60327-058-8_19; Nowotny M, 2009, EMBO REP, V10, P144, DOI 10.1038/embor.2008.256; Ohtani N, 1999, BIOCHEMISTRY-US, V38, P605, DOI 10.1021/bi982207z; Ohtani N, 2008, FEBS J, V275, P5444, DOI 10.1111/j.1742-4658.2008.06673.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrino FW, 2009, J MOL MED-JMM, V87, P25, DOI 10.1007/s00109-008-0422-3; Qiu JZ, 1999, MOL CELL BIOL, V19, P8361, DOI 10.1128/mcb.19.12.8361; Ramantani G, 2010, ARTHRITIS RHEUM-US, V62, P1469, DOI 10.1002/art.27367; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rohman MS, 2008, FEBS J, V275, P4836, DOI 10.1111/j.1742-4658.2008.06622.x; Rychlik MP, 2010, MOL CELL, V40, P658, DOI 10.1016/j.molcel.2010.11.001; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; Shaban NM, 2010, J BIOL CHEM, V285, P3617, DOI 10.1074/jbc.M109.059048; Tadokoro T, 2009, FEBS J, V276, P1482, DOI 10.1111/j.1742-4658.2009.06907.x	29	47	50	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10540	10550		10.1074/jbc.M110.181974	http://dx.doi.org/10.1074/jbc.M110.181974			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21177858	Green Published, hybrid			2022-12-27	WOS:000288547000070
J	Hisa, I; Inoue, Y; Hendy, GN; Canaff, L; Kitazawa, R; Kitazawa, S; Komori, T; Sugimoto, T; Seino, S; Kaji, H				Hisa, Itoko; Inoue, Yoshifumi; Hendy, Geoffrey N.; Canaff, Lucie; Kitazawa, Riko; Kitazawa, Sohei; Komori, Toshihisa; Sugimoto, Toshitsugu; Seino, Susumu; Kaji, Hiroshi			Parathyroid Hormone-responsive Smad3-related Factor, Tmem119, Promotes Osteoblast Differentiation and Interacts with the Bone Morphogenetic Protein-Runx2 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; ALKALINE-PHOSPHATASE ACTIVITY; TRANSCRIPTION FACTOR; CLEIDOCRANIAL DYSPLASIA; GENE-EXPRESSION; ANABOLIC ACTION; MC3T3-E1 CELLS; CBFA1; SMAD3; RUNX2	The mechanisms whereby the parathyroid hormone (PTH) exerts its anabolic action on bone are incompletely understood. We previously showed that inhibition of ERK1/2 enhanced Smad3-induced bone anabolic action in osteoblasts. These findings suggested the hypothesis that changes in gene expression associated with the altered Smad3-induced signaling brought about by an ERK1/2 inhibitor would identify novel bone anabolic factors in osteoblasts. We therefore performed a comparative DNA microarray analysis between empty vector-transfected mouse osteoblastic MC3T3-E1 cells and PD98059-treated stable Smad3-overexpressing MC3T3-E1 cells. Among the novel factors, Tmem119 was selected on the basis of its rapid induction by PTH independent of later increases in endogenous TGF-beta. The levels of Tmem119 increased with time in cultures of MC3T3-E1 cells and mouse mesenchymal ST-2 cells committed to the osteoblast lineage by BMP-2. PTH stimulated Tmem119 levels within 1 h as determined by Western blot analysis and immunocytochemistry in MC3T3-E1 cells. MC3T3-E1 cells stably overexpressing Tmem119 exhibited elevated levels of Runx2, osteocalcin, alkaline phosphatase, and beta-catenin, whereas Tmem119 augmented BMP-2-induced Runx2 levels in mesenchymal cells. Tmem119 interacted with Runx2, Smad1, and Smad5 in C2C12 cells. In conclusion, we identified a Smad3-related factor, Tmem119, that is induced by PTH and promotes differentiation in mouse osteoblastic cells. Tmem119 is an important molecule in the pathway downstream of PTH and Smad3 signaling in osteoblasts.	[Hisa, Itoko; Inoue, Yoshifumi; Seino, Susumu; Kaji, Hiroshi] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet & Endocrinol,Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan; [Hendy, Geoffrey N.; Canaff, Lucie] McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada; [Hendy, Geoffrey N.; Canaff, Lucie] McGill Univ, Dept Physiol, Montreal, PQ H3A 1A1, Canada; [Hendy, Geoffrey N.; Canaff, Lucie] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1A1, Canada; [Hendy, Geoffrey N.; Canaff, Lucie] Royal Victoria Hosp, Calcium Res Lab, Montreal, PQ H3A 1A1, Canada; [Hendy, Geoffrey N.; Canaff, Lucie] Royal Victoria Hosp, Hormones & Canc Res Unit, Montreal, PQ H3A 1A1, Canada; [Kitazawa, Riko; Kitazawa, Sohei] Kobe Univ, Grad Sch Med, Div Diagnost Mol Pathol, Kobe, Hyogo 6500017, Japan; [Komori, Toshihisa] Nagasaki Univ, Grad Sch Biomed Sci, Dept Cell Biol, Unit Basic Med Sci, Nagasaki 852, Japan; [Sugimoto, Toshitsugu] Shimane Univ, Fac Med, Dept Internal Med 1, Izumo, Shimane, Japan; [Seino, Susumu; Kaji, Hiroshi] Kobe Univ, Grad Sch Med, Dept Physiol & Cellular Biol, Div Cellular & Mol Med, Kobe, Hyogo 6500017, Japan	Kobe University; McGill University; McGill University; McGill University; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital; Kobe University; Nagasaki University; Shimane University; Kobe University	Kaji, H (corresponding author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet & Endocrinol,Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	hiroshik@med.kobe-u.ac.jp	Kitazawa, Sohei/E-5602-2010; Kaji, Hiroshi/AAI-5628-2020	Kitazawa, Sohei/0000-0002-7466-7356; 	Mitsui Life Social Welfare Foundation; Ministry of Science, Education, and Culture of Japan [17590961, 21591179]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Canadian Institutes of Health Research [MOP-9315]; Kidney Foundation of Canada; Research Institute of the McGill University Health Centre; Grants-in-Aid for Scientific Research [21591179] Funding Source: KAKEN	Mitsui Life Social Welfare Foundation; Ministry of Science, Education, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Kidney Foundation of Canada; Research Institute of the McGill University Health Centre; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant from Mitsui Life Social Welfare Foundation (to H. K.), Grants-in-aid 17590961 and 21591179 from the Ministry of Science, Education, and Culture of Japan (to H. K.), the Global COE Program F11 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and Canadian Institutes of Health Research Grant MOP-9315 (to G. N. H.).r Supported by a Kidney Foundation of Canada Biomedical Fellowship and a fellowship from the Research Institute of the McGill University Health Centre.	Alford AI, 2006, BONE, V38, P749, DOI 10.1016/j.bone.2005.11.017; Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200; Borton AJ, 2001, J BONE MINER RES, V16, P1754, DOI 10.1359/jbmr.2001.16.10.1754; D'Alonzo RC, 2002, J BIOL CHEM, V277, P24788, DOI 10.1074/jbc.M202604200; DEMPSTER DW, 1993, ENDOCR REV, V14, P690, DOI 10.1210/er.14.6.690; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; Hecht J, 2007, GENE EXPR PATTERNS, V7, P102, DOI 10.1016/j.modgep.2006.05.014; Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006; Inoue Y, 2009, J CELL BIOCHEM, V108, P285, DOI 10.1002/jcb.22252; Ishizuya T, 1997, J CLIN INVEST, V99, P2961, DOI 10.1172/JCI119491; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Kaji H, 1999, CANCER RES, V59, P5097; Kaji H, 2006, HORM METAB RES, V38, P740, DOI 10.1055/s-2006-955085; Kaji H, 2001, P NATL ACAD SCI USA, V98, P3837, DOI 10.1073/pnas.061358098; Kalajzic I, 2005, J BIOL CHEM, V280, P24618, DOI 10.1074/jbc.M413834200; Kanamoto T, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-70; Komori T, 2002, J CELL BIOCHEM, V87, P1, DOI 10.1002/jcb.10276; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kramer I, 2010, J BONE MINER RES, V25, P178, DOI 10.1359/jbmr.090730; Krishnan V, 2003, MOL ENDOCRINOL, V17, P423, DOI 10.1210/me.2002-0225; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Ogata N, 2007, J BIOL CHEM, V282, P35757, DOI 10.1074/jbc.M611902200; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Rajaram S, 1997, ENDOCR REV, V18, P801, DOI 10.1210/er.18.6.801; Roberts S, 2007, J BONE MINER RES, V22, P617, DOI 10.1359/JBMR.070108; Rosen CJ, 2001, J CLIN ENDOCR METAB, V86, P957, DOI 10.1210/jc.86.3.957; Sowa H, 2002, J BONE MINER RES, V17, P1190, DOI 10.1359/jbmr.2002.17.7.1190; Sowa H, 2004, J BIOL CHEM, V279, P40267, DOI 10.1074/jbc.M401312200; Sowa H, 2003, J BIOL CHEM, V278, P52240, DOI 10.1074/jbc.M302566200; Sowa H, 2003, J BIOL CHEM, V278, P21058, DOI 10.1074/jbc.M302044200; Sowa H, 2002, J BIOL CHEM, V277, P36024, DOI 10.1074/jbc.M206030200; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; Tobimatsu T, 2006, ENDOCRINOLOGY, V147, P2583, DOI 10.1210/en.2005-1627; Westendorf JJ, 2004, GENE, V341, P19, DOI 10.1016/j.gene.2004.06.044; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393	40	52	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9787	9796		10.1074/jbc.M110.179127	http://dx.doi.org/10.1074/jbc.M110.179127			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21239498	hybrid, Green Published			2022-12-27	WOS:000288247700101
J	Lelouvier, B; Puertollano, R				Lelouvier, Benjamin; Puertollano, Rosa			Mucolipin-3 Regulates Luminal Calcium, Acidification, and Membrane Fusion in the Endosomal Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VARITINT-WADDLER PHENOTYPE; CONSTITUTIVE ACTIVITY; MUTATION; MOUSE; MICE; ORGANELLES; DEAFNESS; LEADS; CA2+	Mucolipin-3 (MCOLN3) is a pH-regulated Ca2+ channel that localizes to the endosomal pathway. Gain-of-function mutation in MCOLN3 causes the varitint-waddler (Va) phenotype in mice, which is characterized by hearing loss, vestibular dysfunction, and coat color dilution. The Va phenotype results from a punctual mutation (A419P) in the pore region of MCOLN3 that locks the channel in an open conformation causing massive entry of Ca2+ inside cells and inducing cell death by apoptosis. Overexpression of wild-type MCOLN3 produces severe alterations of the endosomal pathway, including enlargement and clustering of endosomes, delayed EGF receptor degradation, and impaired autophagosome maturation, thus suggesting that MCOLN3 plays an important role in the regulation of endosomal function. To understand better the physiological role of MCOLN3, we inhibited MCOLN3 function by expression of a channel-dead dominant negative mutant (458DD/KK) or by knockdown of endogenous MCOLN3. Remarkably, we found that impairment of MCOLN3 activity caused a significant accumulation of luminal Ca2+ in endosomes. This accumulation led to severe defects in endosomal acidification as well as to increased endosomal fusion. Our findings reveal a prominent role for MCOLN3 in regulating Ca2+ homeostasis at the endosomal pathway and confirm the importance of luminal Ca2+ for proper acidification and membrane fusion.	[Lelouvier, Benjamin; Puertollano, Rosa] NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Puertollano, R (corresponding author), NHLBI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA.	puertolr@mail.nih.gov			NHLBI, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006075] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Intramural Research Program of the NHLBI, National Institutes of Health.	Bach G, 2001, MOL GENET METAB, V73, P197, DOI 10.1006/mgme.2001.3195; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cuajungco MP, 2008, PFLUG ARCH EUR J PHY, V457, P463, DOI 10.1007/s00424-008-0523-4; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Dunn Kenneth, 2003, Methods Cell Biol, V72, P389, DOI 10.1016/S0091-679X(03)72019-6; Gerasimenko JV, 1998, CURR BIOL, V8, P1335, DOI 10.1016/S0960-9822(07)00565-9; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; Karacsonyi C, 2007, TRAFFIC, V8, P1404, DOI 10.1111/j.1600-0854.2007.00619.x; Kim HS, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-8; Kim HJ, 2008, EMBO J, V27, P1197, DOI 10.1038/emboj.2008.56; Kim HJ, 2007, J BIOL CHEM, V282, P36138, DOI 10.1074/jbc.C700190200; Lev S, 2010, J BIOL CHEM, V285, P2771, DOI 10.1074/jbc.M109.046508; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Martina JA, 2009, TRAFFIC, V10, P1143, DOI 10.1111/j.1600-0854.2009.00935.x; Piper RC, 2004, TRENDS CELL BIOL, V14, P471, DOI 10.1016/j.tcb.2004.07.010; Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; Samie MA, 2009, PFLUG ARCH EUR J PHY, V459, P79, DOI 10.1007/s00424-009-0716-5; van Aken AFJ, 2008, J PHYSIOL-LONDON, V586, P5403, DOI 10.1113/jphysiol.2008.156992; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Yan Q, 2004, J BIOL CHEM, V279, P18270, DOI 10.1074/jbc.M400093200; Zeevi DA, 2009, J PATHOL, V219, P153, DOI 10.1002/path.2587	24	55	55	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9826	9832		10.1074/jbc.M110.169185	http://dx.doi.org/10.1074/jbc.M110.169185			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21245134	hybrid, Green Published			2022-12-27	WOS:000288247700105
J	Liu, TF; Yoza, BK; El Gazzar, M; Vachharajani, VT; Mccall, CE				Liu, Tie Fu; Yoza, Barbara K.; El Gazzar, Mohamed; Vachharajani, Vidula T.; Mccall, Charles E.			NAD(+)-dependent SIRT1 Deacetylase Participates in Epigenetic Reprogramming during Endotoxin Tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL BIOGENESIS; CHROMATIN; HISTONE; ACTIVATION; INDUCTION; ALPHA; TRANSCRIPTION; METABOLISM; MODULATION; EXPRESSION	Gene-selective epigenetic reprogramming and shifts in cellular bioenergetics develop when Toll-like receptors (TLR) recognize and respond to systemic life-threatening infections. Using a human monocyte cell model of endotoxin tolerance and human leukocytes from acute systemic inflammation with sepsis, we report that energy sensor sirtuin 1 (SIRT1) coordinates the epigenetic and bioenergy shifts. After TLR4 signaling, SIRT1 rapidly accumulated at the promoters of TNF-alpha and IL-beta, but not I kappa B alpha; SIRT1 promoter binding was dependent on its co-factor, NAD(+). During this initial process, SIRT1 deacetylated RelA/p65 lysine 310 and nucleosomal histone H4 lysine 16 to promote termination of NF kappa B-dependent transcription. SIRT1 then remained promoter bound and recruited de novo induced RelB, which directed assembly of the mature transcription repressor complex that generates endotoxin tolerance. SIRT1 also promoted de novo expression of RelB. During sustained endotoxin tolerance, nicotinamide phosphoribosyltransferase (Nampt), the rate-limiting enzyme for endogenous production of NAD(+), and SIRT1 expression increased. The elevation of SIRT1 required protein stabilization and enhanced translation. To support the coordination of bioenergetics in human sepsis, we observed elevated NAD(+) levels concomitant with SIRT1 and RelB accumulation at the TNF-alpha promoter of endotoxin tolerant sepsis blood leukocytes. We conclude that TLR4 stimulation and human sepsis activate pathways that couple NAD(+) and its sensor SIRT1 with epigenetic reprogramming.	[Liu, Tie Fu; Yoza, Barbara K.; El Gazzar, Mohamed; Mccall, Charles E.] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA; [Yoza, Barbara K.] Wake Forest Univ, Bowman Gray Sch Med, Dept Surg, Winston Salem, NC 27157 USA; [Vachharajani, Vidula T.] Wake Forest Univ, Bowman Gray Sch Med, Dept Anesthesiol, Winston Salem, NC 27157 USA; [Mccall, Charles E.] Wake Forest Univ, Bowman Gray Sch Med, Translat Sci Inst, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Liu, TF (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Mol Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.	tliu@wfubmc.edu; chmccall@wfubmc.edu	Vachharajani, Vidula/AAX-3640-2021	Vachharajani, Vidula/0000-0002-0892-7084	National Institutes of Health [RO1 AI-065791, R01 AI-079144]; Wake Forest University General Clinical Research Center [MO-1RR 007122]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR007122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079144, R01AI065791] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wake Forest University General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AI-065791 (to C. E. M.), R01 AI-079144 (to C. E. M.), and MO-1RR 007122 (Wake Forest University General Clinical Research Center). The research on human participants was endorsed by Wake Forest University IRB Protocol BG174.	AGWU DE, 1991, J CLIN INVEST, V88, P531, DOI 10.1172/JCI115336; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Carre JE, 2010, AM J RESP CRIT CARE, V182, P745, DOI 10.1164/rccm.201003-0326OC; Chan C, 2005, J IMMUNOL, V175, P461, DOI 10.4049/jimmunol.175.1.461; Chen XP, 2009, J BIOL CHEM, V284, P27857, DOI 10.1074/jbc.M109.000950; Chen XP, 2009, CLIN VACCINE IMMUNOL, V16, P104, DOI 10.1128/CVI.00320-08; El Gazzar M, 2008, J BIOL CHEM, V283, P32198, DOI 10.1074/jbc.M803446200; El Gazzar M, 2007, J BIOL CHEM, V282, P26857, DOI 10.1074/jbc.M704584200; El Gazzar M, 2010, J BIOL CHEM, V285, P1259, DOI 10.1074/jbc.M109.067330; El Gazzar M, 2009, MOL CELL BIOL, V29, P1959, DOI 10.1128/MCB.01862-08; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Guarente L, 2007, COLD SPRING HARB SYM, V72, P483, DOI 10.1101/sqb.2007.72.024; Haden DW, 2007, AM J RESP CRIT CARE, V176, P768, DOI 10.1164/rccm.200701-161OC; Hasmann M, 2003, CANCER RES, V63, P7436; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Imai S, 2000, COLD SPRING HARB SYM, V65, P297, DOI 10.1101/sqb.2000.65.297; Imai S, 2009, CELL BIOCHEM BIOPHYS, V53, P65, DOI 10.1007/s12013-008-9041-4; Irizar A, 2010, NUCLEIC ACIDS RES, V38, P4675, DOI 10.1093/nar/gkq242; Learn CA, 2000, J BIOL CHEM, V275, P12185, DOI 10.1074/jbc.275.16.12185; McCall CE, 2007, AM J RESP CRIT CARE, V175, P763, DOI 10.1164/rccm.200610-1436CP; McCall CE, 2010, J INNATE IMMUN, V2, P395, DOI 10.1159/000314077; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Saccani S, 2003, MOL CELL, V11, P1563, DOI 10.1016/S1097-2765(03)00227-2; Sasaki T, 2010, ENDOCRINOLOGY, V151, P2556, DOI 10.1210/en.2009-1319; Schreiber J, 2006, P NATL ACAD SCI USA, V103, P5899, DOI 10.1073/pnas.0510996103; Singer M, 2008, CLIN CHEST MED, V29, P655, DOI 10.1016/j.ccm.2008.06.003; Suliman HB, 2005, FASEB J, V19, P1531, DOI 10.1096/fj.04-3500fje; Suliman HB, 2003, J BIOL CHEM, V278, P41510, DOI 10.1074/jbc.M304719200; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoza BK, 2006, J IMMUNOL, V177, P4080, DOI 10.4049/jimmunol.177.6.4080; Yoza BK, 2011, CYTOKINE, V53, P145, DOI 10.1016/j.cyto.2010.10.007; Zhang ZY, 2010, J BIOL CHEM, V285, P41391, DOI 10.1074/jbc.M110.174482	36	178	185	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9856	9864		10.1074/jbc.M110.196790	http://dx.doi.org/10.1074/jbc.M110.196790			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21245135	Green Published, hybrid			2022-12-27	WOS:000288247700109
J	Marion, V; Sankaranarayanan, S; de Theije, C; van Dijk, P; Lindsey, P; Lamers, MC; Harding, HP; Ron, D; Lamers, WH; Kohler, SE				Marion, Vincent; Sankaranarayanan, Selvakumari; de Theije, Chiel; van Dijk, Paul; Lindsey, Patrick; Lamers, Marinus C.; Harding, Heather P.; Ron, David; Lamers, Wouter H.; Kohler, S. Eleonore			Arginine Deficiency Causes Runting in the Suckling Period by Selectively Activating the Stress Kinase GCN2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-I; TRANSLATIONAL CONTROL; SKELETAL-MUSCLE; IGF-I; MOLECULAR-MECHANISMS; INSULIN-SECRETION; SIGNALING PATHWAY; PROTEIN-SYNTHESIS; MOUSE INTESTINE; GENE-EXPRESSION	Suckling "F/A2" mice, which overexpress arginase-I in their enterocytes, develop a syndrome (hypoargininemia, reduced hair and muscle growth, impaired B-cell maturation) that resembles IGF1 deficiency. The syndrome may result from an impaired function of the GH-IGF1 axis, activation of the stress-kinase GCN2, and/or blocking of the mTORC1-signaling pathway. Arginine deficiency inhibited GH secretion and decreased liver Igf1 mRNA and plasma IGF1 concentration, but did not change muscle IGF1 concentration. GH supplementation induced Igf1 mRNA synthesis, but did not restore growth, ruling out direct involvement of the GH-IGF1 axis. In C2C12 muscle cells, arginine withdrawal activated GCN2 signaling, without impacting mTORC1 signaling. In F/A2 mice, the reduction of plasma and tissue arginine concentrations to similar to 25% of wild-type values activated GCN2 signaling, but mTORC1-mediated signaling remained unaffected. Gcn2-deficient F/A2 mice suffered from hypoglycemia and died shortly after birth. Because common targets of all stress kinases (eIF2 alpha phosphorylation, Chop mRNA expression) were not increased in these mice, the effects of arginine deficiency were solely mediated by GCN2.	[Marion, Vincent; Sankaranarayanan, Selvakumari; de Theije, Chiel; van Dijk, Paul; Lamers, Wouter H.; Kohler, S. Eleonore] Maastricht Univ, Dept Anat & Embryol, NL-6200 MD Maastricht, Netherlands; [Marion, Vincent; Sankaranarayanan, Selvakumari; de Theije, Chiel; van Dijk, Paul; Lamers, Wouter H.; Kohler, S. Eleonore] Maastricht Univ, NUTRIM Sch Nutr Toxicol & Metab, NL-6200 MD Maastricht, Netherlands; [Lindsey, Patrick] Maastricht Univ, Dept Populat Genet Genom & Bioinformat, NL-6200 MD Maastricht, Netherlands; [Lamers, Marinus C.] Max Planck Inst Immunobiol, D-79011 Freiburg, Germany; [Harding, Heather P.; Ron, David] Univ Cambridge, Inst Metab Sci, Cambridge CB2 0QQ, England; [Lamers, Marinus C.] Univ Amsterdam, Acad Med Ctr, AMC Liver Ctr, NL-1100 DD Amsterdam, Netherlands	Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University; Max Planck Society; University of Cambridge; University of Amsterdam; Academic Medical Center Amsterdam	Kohler, SE (corresponding author), Maastricht Univ, Dept Anat & Embryol, POB 616, NL-6200 MD Maastricht, Netherlands.	leo.koehler@maastrichtuniversity.nl	Lindsey, Patrick/AAD-8100-2021; Marion, Vincent/H-9730-2016; Lamers, Wouter H./D-2965-2012; Köhler, Eleonore/D-2915-2012	Köhler, Eleonore/0000-0003-1977-9977; Harding, Heather P/0000-0002-7359-7974; Marion, Vincent/0000-0002-8271-7376; Ron, David/0000-0002-3014-5636	graduate school NUTRIM; Medical Research Council [G0600717B] Funding Source: researchfish	graduate school NUTRIM; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was supported by the graduate school NUTRIM.	Adriao M, 2004, NEUROENDOCRINOLOGY, V79, P26, DOI 10.1159/000076043; Akaike H., 1973, 2 INT S INF THEOR AK; ALBAROTH J, 1988, J CLIN ENDOCR METAB, V67, P1186, DOI 10.1210/jcem-67-6-1186; Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Anthony TG, 2004, J BIOL CHEM, V279, P36553, DOI 10.1074/jbc.M404559200; Averous J, 2004, J BIOL CHEM, V279, P5288, DOI 10.1074/jbc.M311862200; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Barbosa TD, 2009, ENDOCRINOLOGY, V150, P2080, DOI 10.1210/en.2008-1487; Bertolo RFP, 2003, AM J PHYSIOL-ENDOC M, V284, pE915, DOI 10.1152/ajpendo.00269.2002; DAVIS TA, 1993, J NUTR, V123, P947, DOI 10.1093/jn/123.5.947; de Jonge WJ, 2002, AM J CLIN NUTR, V76, P128, DOI 10.1093/ajcn/76.1.128; de Jonge WJ, 2002, J CLIN INVEST, V110, P1539, DOI [10.1172/JCI200216143, 10.1172/JCI0216143]; De Jonge WJ, 1998, PEDIATR RES, V43, P442, DOI 10.1203/00006450-199804000-00002; de Jonge WJ, 2001, J NUTR, V131, P2732, DOI 10.1093/jn/131.10.2732; Deldicque L, 2008, AMINO ACIDS, V35, P147, DOI 10.1007/s00726-007-0607-z; Deval C, 2008, BIOCHIMIE, V90, P1716, DOI 10.1016/j.biochi.2008.07.004; Drummond MJ, 2008, CURR OPIN CLIN NUTR, V11, P222, DOI 10.1097/MCO.0b013e3282fa17fb; Fernandez J, 2002, J BIOL CHEM, V277, P19198, DOI 10.1074/jbc.M201052200; Foulstone EJ, 2004, EXP CELL RES, V294, P223, DOI 10.1016/j.yexcr.2003.10.034; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; HURWITZ R, 1986, AM J PHYSIOL, V251, pG103, DOI 10.1152/ajpgi.1986.251.1.G103; Illnerova H, 1965, Biol Neonat, V9, P197; Kilberg MS, 2009, TRENDS ENDOCRIN MET, V20, P436, DOI 10.1016/j.tem.2009.05.008; Kim H, 2005, ENDOCRINOLOGY, V146, P1772, DOI 10.1210/en.2004-0906; Kwikkers KL, 2005, BRIT J NUTR, V93, P183, DOI 10.1079/BJN20051334; LANDRETH KS, 1992, BLOOD, V80, P1207; LARON Z, 1995, DRUGS, V50, P595, DOI 10.2165/00003495-199550040-00002; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Le Roith D, 2001, ENDOCR REV, V22, P53, DOI 10.1210/er.22.1.53; Liu JL, 2000, ENDOCRINOLOGY, V141, P4436, DOI 10.1210/en.141.12.4436; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Liu Ya-Li, 2005, Shengli Xuebao, V57, P254; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Nakajo T, 2005, BIOCHEM BIOPH RES CO, V326, P174, DOI 10.1016/j.bbrc.2004.11.015; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; RIBY JE, 1990, PEDIATR RES, V28, P261, DOI 10.1203/00006450-199009000-00022; Rodriguez S, 2007, HUM GENET, V122, P1, DOI 10.1007/s00439-007-0378-3; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; Rosati B, 2000, FASEB J, V14, P2601, DOI 10.1096/fj.00-0077com; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruijter JM, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-2; Sakuma K, 2000, ACTA NEUROPATHOL, V99, P169, DOI 10.1007/PL00007421; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Shaw RJ, 2008, TRENDS BIOCHEM SCI, V33, P565, DOI 10.1016/j.tibs.2008.09.005; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Soulard A, 2007, CELL, V129, P434, DOI 10.1016/j.cell.2007.04.010; Sumita K, 2005, J PHARMACOL SCI, V97, P408, DOI 10.1254/jphs.FPJ04054X; Tsutsui M, 2006, J PHARMACOL SCI, V102, P147, DOI 10.1254/jphs.CPJ06015X; van Straaten HWM, 2006, BIOCHEM CELL BIOL, V84, P215, DOI 10.1139/O05-170; VANEIJK HMH, 1993, J CHROMATOGR-BIOMED, V620, P143, DOI 10.1016/0378-4347(93)80062-9; VANHAEFTEN TW, 1988, DIABETES RES CLIN EX, V9, P187; VELLEKAMP G, 1985, J BIOL CHEM, V260, P9843; VISEK WJ, 1986, J NUTR, V116, P36, DOI 10.1093/jn/116.1.36; Weger N, 2005, J INVEST DERMATOL, V125, P873, DOI 10.1111/j.0022-202X.2005.23946.x; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; WINDMUELLER HG, 1982, ADV ENZYMOL RAMB, V53, P201; Wu GY, 1997, AM J PHYSIOL-GASTR L, V272, pG1382, DOI 10.1152/ajpgi.1997.272.6.G1382; Wu GY, 2004, J NUTR BIOCHEM, V15, P442, DOI 10.1016/j.jnutbio.2003.11.010; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Yao K, 2008, J NUTR, V138, P867, DOI 10.1093/jn/138.5.867; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002	66	10	10	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8866	8874		10.1074/jbc.M110.216119	http://dx.doi.org/10.1074/jbc.M110.216119			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21239484	Green Published, hybrid			2022-12-27	WOS:000288247700017
J	Cariolato, L; Cavin, S; Diviani, D				Cariolato, Luca; Cavin, Sabrina; Diviani, Dario			A-Kinase Anchoring Protein (AKAP)-Lbc Anchors a PKN-based Signaling Complex Involved in alpha(1)-Adrenergic Receptor-induced p38 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTORS; CARDIAC-HYPERTROPHY; DBL FAMILY; RHO; SCAFFOLD; PATHWAYS; PHOSPHORYLATION; EXPRESSION; INDUCTION; APOPTOSIS	The mitogen-activated protein kinases (MAPKs) pathways are highly organized signaling systems that transduce extracellular signals into a variety of intracellular responses. In this context, it is currently poorly understood how kinases constituting these signaling cascades are assembled and activated in response to receptor stimulation to generate specific cellular responses. Here, we show that AKAP-Lbc, an A-kinase anchoring protein (AKAP) with an intrinsic Rho-specific guanine nucleotide exchange factor activity, is critically involved in the activation of the p38 alpha MAPK downstream of alpha(1b)-adrenergic receptors (alpha(1b)-ARs). Our results indicate that AKAP-Lbc can assemble a novel transduction complex containing the RhoA effector PKN alpha, MLTK, MKK3, and p38 alpha, which integrates signals from alpha(1b)-ARs to promote RhoA-dependent activation of p38 alpha. In particular, silencing of AKAP-Lbc expression or disrupting the formation of the AKAP-Lbc.p38 alpha signaling complex specifically reduces alpha(1)-AR-mediated p38 alpha activation without affecting receptor-mediated activation of other MAPK pathways. These findings provide a novel mechanistic hypothesis explaining how assembly of macromolecular complexes can specify MAPK signaling downstream of alpha(1)-ARs.	[Cariolato, Luca; Cavin, Sabrina; Diviani, Dario] Univ Lausanne, Dept Pharmacol & Toxicol, Fac Biol & Med, CH-1005 Lausanne, Switzerland	University of Lausanne	Diviani, D (corresponding author), Rue Bugnon 27, CH-1005 Lausanne, Switzerland.	Dario.diviani@unil.ch	Cavin, Sabrina/AAE-9866-2019	Diviani, Dario/0000-0003-4375-3718	Fonds National Suisse de la Recherche Scientifique [3100A0-122020]	Fonds National Suisse de la Recherche Scientifique	This work was supported by Grant 3100A0-122020 of the Fonds National Suisse de la Recherche Scientifique (to D. D.).	Appert-Collin A, 2007, P NATL ACAD SCI USA, V104, P10140, DOI 10.1073/pnas.0701099104; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Brown JH, 2006, CIRC RES, V98, P730, DOI 10.1161/01.RES.0000216039.75913.9e; Buchsbaum RJ, 2002, MOL CELL BIOL, V22, P4073, DOI 10.1128/MCB.22.12.4073-4085.2002; Cerione RA, 1996, CURR OPIN CELL BIOL, V8, P216, DOI 10.1016/S0955-0674(96)80068-8; Charron F, 2001, GENE DEV, V15, P2702, DOI 10.1101/gad.915701; Clerk A, 1999, AM J CARDIOL, V83, p64H; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Diviani D, 2001, J BIOL CHEM, V276, P44247, DOI 10.1074/jbc.M106629200; Diviani D, 2004, EMBO J, V23, P2811, DOI 10.1038/sj.emboj.7600287; Erami C, 2005, AM J PHYSIOL-HEART C, V289, pH744, DOI 10.1152/ajpheart.00129.2005; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Jaffe AB, 2005, CURR BIOL, V15, P405, DOI 10.1016/j.cub.2004.12.082; Kang JS, 2008, J CELL BIOL, V182, P497, DOI 10.1083/jcb.200801119; Kelkar N, 2005, MOL CELL BIOL, V25, P2733, DOI 10.1128/MCB.25.7.2733-2743.2005; Kino T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000081; KNOWLTON KU, 1995, J CLIN INVEST, V96, P1311, DOI 10.1172/JCI118166; Lu M, 2010, P NATL ACAD SCI USA, V107, P4212, DOI 10.1073/pnas.0908883107; Marinissen MT, 2001, GENE DEV, V15, P535, DOI 10.1101/gad.855801; Maruyama Y, 2002, CIRC RES, V91, P961, DOI 10.1161/01.RES.0000043282.39776.7C; MILANO CA, 1994, P NATL ACAD SCI USA, V91, P10109, DOI 10.1073/pnas.91.21.10109; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; O'Connell TD, 2003, J CLIN INVEST, V111, P1783, DOI 10.1172/JCI200316100; Philipp M, 2004, PHARMACOL THERAPEUT, V101, P65, DOI 10.1016/j.pharmthera.2003.10.004; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Srinivasan R, 2008, AM J PHYSIOL-HEART C, V294, pH961, DOI 10.1152/ajpheart.00939.2007; Takahashi M, 2003, J BIOCHEM, V133, P181, DOI 10.1093/jb/mvg022; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Xing HM, 2000, EMBO J, V19, P349, DOI 10.1093/emboj/19.3.349; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang H, 2004, CIRC RES, V95, P989, DOI 10.1161/01.RES.0000147962.01036.bb; Zhang H, 2001, CIRC RES, V89, P815, DOI 10.1161/hh2101.098379; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511; Zhang SS, 2003, CIRC RES, V93, P1026, DOI 10.1161/01.RES.0000104084.88317.91; Zheng Y, 2001, TRENDS BIOCHEM SCI, V26, P724, DOI 10.1016/S0968-0004(01)01973-9	40	44	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7925	7937		10.1074/jbc.M110.185645	http://dx.doi.org/10.1074/jbc.M110.185645			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21224381	Green Published, hybrid			2022-12-27	WOS:000288013300023
J	Gazi, U; Rosas, M; Singh, S; Heinsbroek, S; Haq, I; Johnson, S; Brown, GD; Williams, DL; Taylor, PR; Martinez-Pomares, L				Gazi, Umut; Rosas, Marcela; Singh, Sonali; Heinsbroek, Sigrid; Haq, Imran; Johnson, Simon; Brown, Gordon D.; Williams, David L.; Taylor, Philip R.; Martinez-Pomares, Luisa			Fungal Recognition Enhances Mannose Receptor Shedding through Dectin-1 Engagement	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN DENDRITIC CELLS; BETA-GLUCAN RECEPTOR; CYSTEINE-RICH DOMAIN; PHOSPHATIDYLINOSITOL-3 KINASE; CRYPTOCOCCUS-NEOFORMANS; INFLAMMATORY RESPONSES; ANTIFUNGAL IMMUNITY; MURINE MACROPHAGES; SOLUBLE FORM	The mannose receptor (MR) is an endocytic type I membrane molecule with a broad ligand specificity that is involved in both hemostasis and pathogen recognition. Membrane-anchored MR is cleaved by a metalloproteinase into functional soluble MR (sMR) composed of the extracellular domains of intact MR. Although sMR production was initially considered a constitutive process, enhanced MR shedding has been observed in response to the fungal pathogen Pneumocystis carinii. In this work, we have investigated the mechanism mediating enhanced MR shedding in response to fungi. We show that other fungal species, including Candida albicans and Aspergillus fumigatus, together with zymosan, a preparation of the cell wall of Saccharomyces cerevisiae, mimic the effect of P. carinii on sMR production and that this effect takes place mainly through beta-glucan recognition. Additionally, we demonstrate that MR cleavage in response to C. albicans and bioactive particulate beta-glucan requires expression of dectin-1. Our data, obtained using specific inhibitors, are consistent with the canonical Syk-mediated pathway triggered by dectin-1 being mainly responsible for inducing MR shedding, with Raf-1 being partially involved. As in the case of steady-state conditions, MR shedding in response to C. albicans and beta-glucan particles requires metalloprotease activity. The induction of MR shedding by dectin-1 has clear implications for the role of MR in fungal recognition, as sMR was previously shown to retain the ability to bind fungal pathogens and can interact with numerous host molecules, including lysosomal hydrolases. Thus, MR cleavage could also impact on the magnitude of inflammation during fungal infection.	[Gazi, Umut; Singh, Sonali; Martinez-Pomares, Luisa] Univ Nottingham, Queens Med Ctr, Sch Mol Med Sci, Nottingham NG7 2UH, England; [Haq, Imran; Johnson, Simon] Univ Nottingham, Queens Med Ctr, Div Therapeut & Mol Med, Nottingham NG7 2UH, England; [Gazi, Umut; Singh, Sonali; Haq, Imran; Johnson, Simon; Martinez-Pomares, Luisa] Univ Nottingham, Queens Med Ctr, Resp Biomed Res Unit, Nottingham NG7 2UH, England; [Rosas, Marcela; Taylor, Philip R.] Cardiff Univ, Sch Med, Dept Infect Immun & Biochem, Cardiff CF14 4XN, S Glam, Wales; [Heinsbroek, Sigrid] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol, NL-1105 AZ Amsterdam, Netherlands; [Brown, Gordon D.] Univ Aberdeen, Inst Med Sci, Aberdeen Fungal Grp, Aberdeen AB24 3FX, Scotland; [Williams, David L.] E Tennessee State Univ, Quillen Coll Med, Dept Surg, Johnson City, TN 37614 USA	University of Nottingham; University of Nottingham; University of Nottingham; Cardiff University; University of Amsterdam; Academic Medical Center Amsterdam; University of Aberdeen; East Tennessee State University	Martinez-Pomares, L (corresponding author), Univ Nottingham, Queens Med Ctr, Sch Mol Med Sci, Nottingham NG7 2UH, England.	luisa.martinez-pomares@nottingham.ac.uk	Rosas Nexticapa, Marcela/HGU-1088-2022; brown, gordon/B-4249-2012	Taylor, Philip/0000-0003-0163-1421; brown, gordon/0000-0002-0287-5383; Johnson, Simon/0000-0002-9837-2763; Martinez-Pomares, Luisa/0000-0002-2331-127X; Singh, Sonali/0000-0003-0600-9084	Mizutani Foundation for Glycoscience (Japan); Cancer Research UK; Medical Research Council; MRC [G0601617] Funding Source: UKRI; Medical Research Council [G0601617] Funding Source: researchfish	Mizutani Foundation for Glycoscience (Japan); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the Mizutani Foundation for Glycoscience (Japan) and Cancer Research UK.; Recipient of a Medical Research Council Doctoral Training Account Ph.D. fellowship.	Adams EL, 2008, J PHARMACOL EXP THER, V325, P115, DOI 10.1124/jpet.107.133124; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Dan JM, 2008, INFECT IMMUN, V76, P2362, DOI 10.1128/IAI.00095-08; Dennehy KM, 2008, EUR J IMMUNOL, V38, P500, DOI 10.1002/eji.200737741; Deslee G, 2002, J ALLERGY CLIN IMMUN, V110, P763, DOI 10.1067/mai.2002.129121; Fiete D, 2007, J BIOL CHEM, V282, P1873, DOI 10.1074/jbc.M606455200; Fraser IP, 2000, MICROBES INFECT, V2, P1305, DOI 10.1016/S1286-4579(00)01283-1; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Gringhuis SI, 2009, NAT IMMUNOL, V10, P203, DOI 10.1038/ni.1692; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Hagemann C, 1999, EXP CELL RES, V253, P34, DOI 10.1006/excr.1999.4689; Heinsbroek SEM, 2006, J IMMUNOL, V176, P5513, DOI 10.4049/jimmunol.176.9.5513; Heinsbroek SEM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000218; Hernanz-Falcon P, 2009, EUR J IMMUNOL, V39, P507, DOI 10.1002/eji.200838687; Hiller G, 2000, BBA-MOL CELL BIOL L, V1485, P163, DOI 10.1016/S1388-1981(00)00037-8; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Jordens R, 1999, INT IMMUNOL, V11, P1775, DOI 10.1093/intimm/11.11.1775; Koyasu S, 2003, NAT IMMUNOL, V4, P313, DOI 10.1038/ni0403-313; Lee JY, 2008, J MICROBIOL BIOTECHN, V18, P355; Linehan SA, 1999, J EXP MED, V189, P1961, DOI 10.1084/jem.189.12.1961; Martin M, 2003, J IMMUNOL, V171, P717, DOI 10.4049/jimmunol.171.2.717; Martinez-Pomares L, 2006, EUR J IMMUNOL, V36, P1074, DOI 10.1002/eji.200535685; Martinez-Pomares L, 1999, J BIOL CHEM, V274, P35211, DOI 10.1074/jbc.274.49.35211; Martinez-Pomares L, 1998, J BIOL CHEM, V273, P23376, DOI 10.1074/jbc.273.36.23376; MartinezPomares L, 1996, J EXP MED, V184, P1927, DOI 10.1084/jem.184.5.1927; McCann F, 2005, INFECT IMMUN, V73, P6340, DOI 10.1128/IAI.73.10.6340-6349.2005; Nakamura K, 2007, MICROBIOL IMMUNOL, V51, P1115, DOI 10.1111/j.1348-0421.2007.tb04007.x; Netea MG, 2010, TRENDS IMMUNOL, V31, P346, DOI 10.1016/j.it.2010.06.007; Olsson Sandra, 2006, J Inflamm (Lond), V3, P8, DOI 10.1186/1476-9255-3-8; Olsson S, 2007, MOL IMMUNOL, V44, P1509, DOI 10.1016/j.molimm.2006.09.004; Polumuri SK, 2007, J IMMUNOL, V179, P236, DOI 10.4049/jimmunol.179.1.236; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Rosas M, 2008, J IMMUNOL, V181, P3549, DOI 10.4049/jimmunol.181.5.3549; Ruiz-Herrera J, 2006, FEMS YEAST RES, V6, P14, DOI 10.1111/j.1567-1364.2005.00017.x; Scheid MP, 2000, CURR BIOL, V10, pR191, DOI 10.1016/S0960-9822(00)00349-3; Shah VB, 2009, MOL IMMUNOL, V46, P1845, DOI 10.1016/j.molimm.2009.01.014; Stamenkovic I, 2009, J INVEST DERMATOL, V129, P1321, DOI 10.1038/jid.2009.13; Sutor SL, 1999, J BIOL CHEM, V274, P7002, DOI 10.1074/jbc.274.11.7002; Swain SD, 2003, INFECT IMMUN, V71, P6213, DOI 10.1128/IAI.71.11.6213-6221.2003; Tachado SD, 2007, J LEUKOCYTE BIOL, V81, P205, DOI 10.1189/jlb.1005580; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Taylor PR, 2005, TRENDS IMMUNOL, V26, P104, DOI 10.1016/j.it.2004.12.001; Underhill DM, 2005, BLOOD, V106, P2543, DOI 10.1182/blood-2005-03-1239; Wang CC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.4; Weichhart T, 2008, ANN RHEUM DIS, V67, P70, DOI 10.1136/ard.2008.098459; Wennstrom S, 1999, MOL CELL BIOL, V19, P4279; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; Willment JA, 2008, TRENDS MICROBIOL, V16, P27, DOI 10.1016/j.tim.2007.10.012; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yart A, 2002, BBA-MOL CELL BIOL L, V1582, P107, DOI 10.1016/S1388-1981(02)00144-0; Zhang JM, 2004, INFECT IMMUN, V72, P3147, DOI 10.1128/IAI.72.6.3147-3160.2004	53	43	49	4	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7822	7829		10.1074/jbc.M110.185025	http://dx.doi.org/10.1074/jbc.M110.185025			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21205820	Green Published, hybrid			2022-12-27	WOS:000288013300013
J	Li, WW; Li, H; Sanders, PN; Mohler, PJ; Backs, J; Olson, EN; Anderson, ME; Grumbach, IM				Li, Weiwei; Li, Hui; Sanders, Philip N.; Mohler, Peter J.; Backs, Johannes; Olson, Eric N.; Anderson, Mark E.; Grumbach, Isabella M.			The Multifunctional Ca2+/Calmodulin-dependent Kinase II delta (CaMKII delta) Controls Neointima Formation after Carotid Ligation and Vascular Smooth Muscle Cell Proliferation through Cell Cycle Regulation by p21	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; ANGIOTENSIN-II; CARDIAC-HYPERTROPHY; ISOFORM REGULATION; PRESSURE-OVERLOAD; DOWN-REGULATION; NIH 3T3-CELLS; C-JUN; ACTIVATION; PATHWAY	The multifunctional Ca2+/calmodulin-dependent protein kinase II (CaMKII) promotes vascular smooth muscle (VSMC) proliferation. However, the signaling pathways mediating CAMKII-dependent proliferative effects in vivo are poorly understood. This study tested the hypothesis that CaMKII delta mediates neointimal proliferation after carotid artery ligation by regulating expression and activity of cell cycle regulators, particularly at the G1/S checkpoint. Data herein indicate that 14 days after carotid ligation, C57Bl/6 mice developed a marked neointima with robust CaMKII protein expression. In particular, only the CaMKII isoform delta was increased as demonstrated by quantitative RT-PCR. Genetic deletion of CaMKII delta prevented injury-induced neointimal hyperplasia and cell proliferation in the intima and media. In ligated carotids of control mice, the proliferative cell cycle markers cdk2, cyclin E, and cyclin D1 were activated. In contrast, in CaMKII delta(-/-) mice, we detected a reduction in proliferative cell cycle regulators as well as an increase in the cell cycle inhibitor p21. This expression profile was confirmed in cultured CaMKII delta(-/-) VSMC, in which cdk2 and cdk4 activity was decreased. Toward understanding how CAMKII delta affects p53, a transcriptional regulator of p21, we examined p53 pathway components. Our data indicate that p53 is elevated in CAMKII delta(-/-) VSMC, whereas phosphorylation of the p53-specific E3 ligase, Mdm2, was decreased. In conclusion, CaMKII stimulates neointima proliferation after vascular injury by regulating cell proliferation through inhibition of p21 and induction of Mdm-2-mediated degradation of p53.	[Li, Weiwei; Li, Hui; Sanders, Philip N.; Mohler, Peter J.; Anderson, Mark E.; Grumbach, Isabella M.] Univ Iowa, Carver Coll Med, Div Cardiovasc Med, Dept Med, Iowa City, IA 52242 USA; [Grumbach, Isabella M.] Iowa City VA Med Ctr, Iowa City, IA 52242 USA; [Backs, Johannes] Univ Heidelberg, Dept Internal Med 3, D-69120 Heidelberg, Germany; [Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; Ruprecht Karls University Heidelberg; University of Texas System; University of Texas Southwestern Medical Center Dallas	Grumbach, IM (corresponding author), Univ Iowa, Carver Coll Med, Div Cardiovasc Med, Dept Med, 2270-A CBRB,285 Newton Rd, Iowa City, IA 52242 USA.	isabella-grumbach@uiowa.edu		Grumbach, Isabella/0000-0002-2285-3157	National Institutes of Health [HL 079031, R01 HL 70250, R01 HL 084583, R01 HL 083422]; Pew Scholars Trust; American Heart Association; Office of Research and Development, Dept. of Veterans Affairs; Carver Trust Medical Research Initiative; University of Iowa Cardiovascular Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113001, R01HL084583, R01HL079031, R01HL070250, R01HL083422, R01HL096652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Scholars Trust; American Heart Association(American Heart Association); Office of Research and Development, Dept. of Veterans Affairs(US Department of Veterans Affairs); Carver Trust Medical Research Initiative; University of Iowa Cardiovascular Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 079031, and R01 HL 70250 (to M. E. A.); National Institutes of Health Grants R01 HL 084583 and R01 HL 083422, and Pew Scholars Trust (to P. J. M.). This work was also supported in part by funding from the following grants: an American Heart Association Scientist Development Grant, a VA Merit grant by the Office of Research and Development, Dept. of Veterans Affairs and a Carver Trust Medical Research Initiative Grant (to I. M. G.), and the University of Iowa Cardiovascular Center Interdisciplinary Research Fellowship (to W. L.).	Backs J, 2010, P NATL ACAD SCI USA, V107, P81, DOI 10.1073/pnas.0912658106; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Chen DH, 1997, J CLIN INVEST, V99, P2334, DOI 10.1172/JCI119414; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Gordon JW, 2009, J BIOL CHEM, V284, P19027, DOI 10.1074/jbc.M109.000539; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; House SJ, 2008, ARTERIOSCL THROM VAS, V28, P441, DOI 10.1161/ATVBAHA.107.156810; House SJ, 2007, AM J PHYSIOL-CELL PH, V292, pC2276, DOI 10.1152/ajpcell.00606.2006; Ishiguro K, 2006, MOL CELL BIOL, V26, P5497, DOI 10.1128/MCB.02469-05; Kim I, 2000, J PHYSIOL-LONDON, V526, P367, DOI 10.1111/j.1469-7793.2000.00367.x; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Li F, 2005, AM J PHYSIOL-HEART C, V288, pH2306, DOI 10.1152/ajpheart.00571.2004; Li H, 2010, AM J PHYSIOL-HEART C, V298, pH688, DOI 10.1152/ajpheart.01014.2009; Li N, 2009, J BIOL CHEM, V284, P3021, DOI 10.1074/jbc.M805483200; Li YX, 2009, CIRCULATION, V119, P2686, DOI 10.1161/CIRCULATIONAHA.108.790485; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Lu X, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000984; Ma SL, 2009, J BIOL CHEM, V284, P24773, DOI 10.1074/jbc.M109.028621; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mercure MZ, 2008, AM J PHYSIOL-CELL PH, V294, pC1465, DOI 10.1152/ajpcell.90638.2007; MORISHITA R, 1994, J CLIN INVEST, V93, P1458, DOI 10.1172/JCI117123; Morris TA, 1998, EXP CELL RES, V240, P218, DOI 10.1006/excr.1997.3925; Muthalif MM, 2002, HYPERTENSION, V39, P704, DOI 10.1161/hy0202.103823; Ray Jenna Lynn, 2001, Methods in Cell Science, V23, P185; Rezazadeh S, 2006, J PHARMACOL EXP THER, V317, P292, DOI 10.1124/jpet.105.097618; Rousseau D, 1999, ONCOGENE, V18, P4313, DOI 10.1038/sj.onc.1202686; SCHWORER CM, 1993, J BIOL CHEM, V268, P14443; Singh MV, 2009, J CLIN INVEST, V119, P986, DOI 10.1172/JCI35814; Stabile E, 2003, CIRC RES, V93, P1059, DOI 10.1161/01.RES.0000105086.31909.1B; Tanner FC, 2000, CIRCULATION, V101, P2022, DOI 10.1161/01.CIR.101.17.2022; TOMBES RM, 1995, CELL GROWTH DIFFER, V6, P1063; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; Wu YJ, 2002, CIRCULATION, V106, P1288, DOI 10.1161/01.CIR.0000027583.73268.E7; Yuan KY, 2007, LAB INVEST, V87, P938, DOI 10.1038/labinvest.3700658; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; ZHOU ZHL, 1994, BIOCHEM J, V299, P489, DOI 10.1042/bj2990489	40	46	51	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7990	7999		10.1074/jbc.M110.163006	http://dx.doi.org/10.1074/jbc.M110.163006			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21193397	Green Published, hybrid			2022-12-27	WOS:000288013300030
J	Luo, SS; Blom, AM; Rupp, S; Hipler, UC; Hube, B; Skerka, C; Zipfel, PF				Luo, Shanshan; Blom, Anna M.; Rupp, Steffen; Hipler, Uta-Christina; Hube, Bernhard; Skerka, Christine; Zipfel, Peter F.			The pH-regulated Antigen 1 of Candida albicans Binds the Human Complement Inhibitor C4b-binding Protein and Mediates Fungal Complement Evasion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-H; SERUM RESISTANCE; STREPTOCOCCUS-PNEUMONIAE; NEISSERIA-GONORRHOEAE; SURFACE-PROTEINS; MOLECULAR-MECHANISM; ALTERNATIVE PATHWAY; ALPHA-CHAIN; FLUID-PHASE; C4BP	Candida albicans binds and utilizes human complement inhibitors, such as C4b-binding protein (C4BP), Factor H, and FHL-1 for immune evasion. Here, we identify Candida pH-regulated antigen 1 (Pra1) as the first fungal C4BP-binding protein. Recombinant Pra1 binds C4BP, as shown by ELISA and isothermal titration calorimetry, and the Pra1-C4BP interaction is ionic in nature. The Pra1 binding domains within C4BP were localized to the complement control protein domain 4 (CCP4), CCP7, and CCP8. C4BP bound to Pra1 maintains complement-inhibitory activity. C4BP and Factor H bind simultaneously to Candida Pra1 and do not compete for binding at physiological levels. A Pra1-overexpressing C. albicans strain, which had about 2-fold Pra1 levels at the surface acquired also about 2-fold C4BP to the surface, compared with the wild type strain CAI4. A Pra1 knock-out strain showed similar to 22% reduced C4BP binding. C4BP captured by C. albicans from human serum inhibits C4b and C3b surface deposition and also maintains cofactor activity. In summary, Candida Pra1 represents the first fungal C4BP-binding surface protein. Pra1, via binding to C4BP, mediates human complement control, thereby favoring the immune and complement evasion of C. albicans.	[Luo, Shanshan; Skerka, Christine; Zipfel, Peter F.] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, D-07745 Jena, Germany; [Hube, Bernhard] Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Microbial Pathogenic Mech, D-07745 Jena, Germany; [Blom, Anna M.] Lund Univ, Dept Lab Med, Sect Med Prot Chem, S-20502 Malmo, Sweden; [Rupp, Steffen] Fraunhofer Inst Interfacial Engn, D-70569 Stuttgart, Germany; [Hipler, Uta-Christina] Univ Jena, Dermatol Clin, D-07743 Jena, Germany; [Zipfel, Peter F.] Univ Jena, Dept Infect Biol, D-07743 Jena, Germany	Hans Knoll Institute (HKI); Hans Knoll Institute (HKI); Lund University; Fraunhofer Gesellschaft; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Zipfel, PF (corresponding author), Hans Knoell Inst, Leibniz Inst Nat Prod Res & Infect Biol, Dept Infect Biol, Beutenberg Str 11A, D-07745 Jena, Germany.	peter.zipfel@hki-jena.de	Blom, Anna/AFS-7369-2022; Blom, Anna/B-9607-2009	Blom, Anna/0000-0002-1348-1734; Hube, Bernhard/0000-0002-6028-0425	International Leibniz Research School for Microbial and Biomolecular Interactions Jena and the Jena School for Microbial Communication; Deutsche Forschungsgemeinschaft [Zi 432, Ru 608]; Zi 432, Ru 608), and the Swedish Research Council; Swedish Foundation for Strategic Research; Foundation of Osterlund; Foundation of King Gustav V's 80th Anniversary; Foundation of Greta and Johan Kock; Foundation of Knut and Alice Wallenberg; Foundation of Inga-Britt and Arne Lundberg	International Leibniz Research School for Microbial and Biomolecular Interactions Jena and the Jena School for Microbial Communication; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Zi 432, Ru 608), and the Swedish Research Council; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Foundation of Osterlund; Foundation of King Gustav V's 80th Anniversary; Foundation of Greta and Johan Kock; Foundation of Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); Foundation of Inga-Britt and Arne Lundberg	This work was supported by the International Leibniz Research School for Microbial and Biomolecular Interactions Jena and the Jena School for Microbial Communication, Priority Program 1160 of the Deutsche Forschungsgemeinschaft (Zi 432, Ru 608), and the Swedish Research Council, Swedish Foundation for Strategic Research, and Foundations of Osterlund, King Gustav V's 80th Anniversary, Greta and Johan Kock, Knut and Alice Wallenberg, and Inga-Britt and Arne Lundberg. The data for this work were presented in part at the XXIII International Complement Workshop in New York in 2010.	Agarwal V, 2010, J BIOL CHEM, V285, P23484, DOI 10.1074/jbc.M110.142703; Alonso-Valle H, 2003, EUR J CLIN MICROBIOL, V22, P254, DOI 10.1007/s10096-003-0890-x; Behnsen J, 2008, INFECT IMMUN, V76, P820, DOI 10.1128/IAI.01037-07; Berggard K, 1997, INFECT IMMUN, V65, P3638; Blackmore TK, 1998, INFECT IMMUN, V66, P1427, DOI 10.1128/IAI.66.4.1427-1431.1998; Blom AM, 2009, ANN RHEUM DIS, V68, P136, DOI 10.1136/ard.2007.085753; Blom AM, 2000, MOL IMMUNOL, V37, P445, DOI 10.1016/S0161-5890(00)00059-6; Blom AM, 2000, J IMMUNOL, V164, P5328, DOI 10.4049/jimmunol.164.10.5328; Blom AM, 2004, MOL IMMUNOL, V40, P1333, DOI 10.1016/j.molimm.2003.12.002; Blom AM, 2003, MOL IMMUNOL, V39, P547, DOI 10.1016/S0161-5890(02)00213-4; Blom AM, 2001, J BIOL CHEM, V276, P27136, DOI 10.1074/jbc.M102445200; CASANOVA M, 1992, INFECT IMMUN, V60, P4221, DOI 10.1128/IAI.60.10.4221-4229.1992; Dieudonne-Vatran A, 2009, J IMMUNOL, V182, P7865, DOI 10.4049/jimmunol.0802376; FONZI WA, 1993, GENETICS, V134, P717; Friese MA, 1999, MOL IMMUNOL, V36, P809, DOI 10.1016/S0161-5890(99)00101-7; Garred P, 2009, MOL IMMUNOL, V46, P2737, DOI 10.1016/j.molimm.2009.05.005; GIGLI I, 1985, J IMMUNOL, V135, P440; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Hallstrom T, 2008, J IMMUNOL, V181, P537, DOI 10.4049/jimmunol.181.1.537; Hallstrom T, 2007, J IMMUNOL, V178, P6359, DOI 10.4049/jimmunol.178.10.6359; Hallstrom T, 2006, J IMMUNOL, V177, P430, DOI 10.4049/jimmunol.177.1.430; Hammerschmidt S, 2007, J IMMUNOL, V178, P5848, DOI 10.4049/jimmunol.178.9.5848; Janulczyk R, 2000, J BIOL CHEM, V275, P37257, DOI 10.1074/jbc.M004572200; Jarva H, 2007, J IMMUNOL, V179, P540, DOI 10.4049/jimmunol.179.1.540; Jenkins HT, 2006, J BIOL CHEM, V281, P3690, DOI 10.1074/jbc.M511563200; Jong AY, 2001, INFECT IMMUN, V69, P4536, DOI 10.1128/IAI.69.7.4536-4544.2001; Jozsi M, 2008, BLOOD, V111, P1512, DOI 10.1182/blood-2007-09-109876; Kraiczy P, 2001, EUR J IMMUNOL, V31, P1674, DOI 10.1002/1521-4141(200106)31:6&lt;1674::AID-IMMU1674&gt;3.0.CO;2-2; Luo SS, 2010, J IMMUNOL, V185, P2164, DOI 10.4049/jimmunol.1001011; Luo SS, 2009, MOL IMMUNOL, V47, P541, DOI 10.1016/j.molimm.2009.07.017; Marcil A, 2008, INFECT IMMUN, V76, P4345, DOI 10.1128/IAI.00588-07; Meri T, 2004, INFECT IMMUN, V72, P6633, DOI 10.1128/IAI.72.11.6633-6641.2004; Mihlan M, 2009, CELL DEATH DIFFER, V16, P1630, DOI 10.1038/cdd.2009.103; Nordstrom T, 2004, J IMMUNOL, V173, P4598, DOI 10.4049/jimmunol.173.7.4598; Pappas PG, 2003, CLIN INFECT DIS, V37, P634, DOI 10.1086/376906; PEREZCASAL J, 1995, MOL MICROBIOL, V15, P907, DOI 10.1111/j.1365-2958.1995.tb02360.x; Pietikainen J, 2010, MOL IMMUNOL, V47, P1299, DOI 10.1016/j.molimm.2009.11.028; Poltermann S, 2007, J BIOL CHEM, V282, P37537, DOI 10.1074/jbc.M707280200; Prasadarao NV, 2002, J IMMUNOL, V169, P6352, DOI 10.4049/jimmunol.169.11.6352; Ram S, 1998, J EXP MED, V188, P671, DOI 10.1084/jem.188.4.671; Ram S, 2001, J EXP MED, V193, P281, DOI 10.1084/jem.193.3.281; SCHARFSTEIN J, 1978, J EXP MED, V148, P207, DOI 10.1084/jem.148.1.207; Sentandreu M, 1998, J BACTERIOL, V180, P282, DOI 10.1128/JB.180.2.282-289.1998; SEPULVEDA P, 1995, INFECT IMMUN, V63, P2173; Soloviev DA, 2007, J IMMUNOL, V178, P2038, DOI 10.4049/jimmunol.178.4.2038; THERN A, 1995, J IMMUNOL, V154, P375; Zhang MX, 1998, INFECT IMMUN, V66, P4845, DOI 10.1128/IAI.66.10.4845-4850.1998; Zipfel PF, 2007, MOL IMMUNOL, V44, P3850, DOI 10.1016/j.molimm.2007.06.149; Zipfel PF, 2007, ADV EXP MED BIOL, V598, P80; Zipfel PF, 2009, IMMUNOL LETT, V126, P1, DOI 10.1016/j.imlet.2009.07.005; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620; Zipfel PF, 2006, MOL IMMUNOL, V43, P97, DOI 10.1016/j.molimm.2005.06.015; Zipfel PF, 2002, BIOCHEM SOC T, V30, P971, DOI 10.1042/bst0300971; Zipfel PF, 1999, MOL IMMUNOL, V36, P241, DOI 10.1016/S0161-5890(99)00038-3; Zipfel PF, 1999, IMMUNOPHARMACOLOGY, V42, P53, DOI 10.1016/S0162-3109(99)00015-6	56	42	44	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8021	8029		10.1074/jbc.M110.130138	http://dx.doi.org/10.1074/jbc.M110.130138			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21212281	Green Published, hybrid			2022-12-27	WOS:000288013300033
J	Ma, L; Kaufman, Y; Zhang, JH; Washington, I				Ma, Li; Kaufman, Yardana; Zhang, Junhua; Washington, Ilyas			C20-D-3-vitamin A Slows Lipofuscin Accumulation and Electrophysiological Retinal Degeneration in a Mouse Model of Stargardt Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PIGMENT EPITHELIAL-CELLS; AGE-RELATED-CHANGES; VISUAL-ACUITY LOSS; MACULAR DEGENERATION; FUNDUS AUTOFLUORESCENCE; COMPLEMENT-SYSTEM; ANIMAL-MODEL; A2E; ABCR; MUTATIONS	Stargardt disease, also known as juvenile macular degeneration, occurs in approximately one in 10,000 people and results from genetic defects in the ABCA4 gene. The disease is characterized by premature accumulation of lipofuscin in the retinal pigment epithelium (RPE) of the eye and by vision loss. No cure or treatment is available. Although lipofuscin is considered a hallmark of Stargardt disease, its mechanism of formation and its role in disease pathogenesis are poorly understood. In this work we investigated the effects of long-term administration of deuterium-enriched vitamin A, C20-D-3-vitamin A, on RPE lipofuscin deposition and eye function in a mouse model of Stargardt's disease. Results support the notion that lipofuscin forms partly as a result of the aberrant reactivity of vitamin A through the formation of vitamin A dimers, provide evidence that preventing vitamin A dimerization may slow disease related, retinal physiological changes and perhaps vision loss and suggest that administration of C20-D-3-vitamin A may be a potential clinical strategy to ameliorate clinical symptoms resulting from ABCA4 genetic defects.	[Ma, Li; Kaufman, Yardana; Zhang, Junhua; Washington, Ilyas] Columbia Univ, Med Ctr, Dept Ophthalmol, New York, NY 10032 USA	Columbia University	Washington, I (corresponding author), Columbia Univ, Med Ctr, Dept Ophthalmol, New York, NY 10032 USA.	iw2101@columbia.edu		W, I/0000-0002-2238-7918	International Retinal Research Foundation; NATIONAL EYE INSTITUTE [R01EY021207] Funding Source: NIH RePORTER	International Retinal Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the International Retinal Research Foundation.	Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Anderson DH, 2010, PROG RETIN EYE RES, V29, P95, DOI 10.1016/j.preteyeres.2009.11.003; Bakall B, 2007, EXP EYE RES, V85, P34, DOI 10.1016/j.exer.2007.02.018; Bayer AU, 2001, INVEST OPHTH VIS SCI, V42, P1258; Ben-Shabat S, 2002, ANGEW CHEM INT EDIT, V41, P814, DOI 10.1002/1521-3773(20020301)41:5<814::AID-ANIE814>3.0.CO;2-2; BERGEN HR, 1988, J LABELLED COMPD RAD, V25, P11; Burns R P, 1980, Trans Am Ophthalmol Soc, V78, P206; Chan CC, 2008, OPHTHALMIC RES, V40, P124, DOI 10.1159/000119862; Chen HY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002339; Chen M, 2010, INVEST OPHTH VIS SCI, V51, P5888, DOI 10.1167/iovs.09-5103; Davies S, 2001, FREE RADICAL BIO MED, V31, P256, DOI 10.1016/S0891-5849(01)00582-2; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; De S, 2002, J GEN PHYSIOL, V120, P147, DOI 10.1085/jgp.20028566; Donoso LA, 2006, SURV OPHTHALMOL, V51, P137, DOI 10.1016/j.survophthal.2005.12.001; Dontsov A E, 2005, Dokl Biochem Biophys, V405, P458, DOI 10.1007/s10628-005-0139-y; ELDRED GE, 1993, NATURE, V361, P724, DOI 10.1038/361724a0; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Fishkin NE, 2005, P NATL ACAD SCI USA, V102, P7091, DOI 10.1073/pnas.0501266102; FISHMAN GA, 1987, OPHTHALMOLOGY, V94, P809, DOI 10.1016/s0161-6420(87)33533-x; Furr HC, 2005, PUBLIC HEALTH NUTR, V8, P596, DOI 10.1079/PHN2004715; GAILLARD ER, 1995, PHOTOCHEM PHOTOBIOL, V61, P448, DOI 10.1111/j.1751-1097.1995.tb02343.x; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; Gomes NL, 2009, INVEST OPHTH VIS SCI, V50, P3953, DOI 10.1167/iovs.08-2657; Gouras P, 2008, GRAEF ARCH CLIN EXP, V246, P1403, DOI 10.1007/s00417-008-0911-7; Gresh J, 2003, VISUAL NEUROSCI, V20, P211, DOI 10.1017/S0952523803202108; GROENENDIJK GWT, 1980, EUR J BIOCHEM, V106, P119; HENBEST HB, 1957, J CHEM SOC, P4909, DOI 10.1039/jr9570004909; Iriyama A, 2008, J BIOL CHEM, V283, P11947, DOI 10.1074/jbc.M708989200; ISHIBASHI T, 1986, INVEST OPHTH VIS SCI, V27, P184; ISLER O, 1949, HELV CHIM ACTA, V32, P489, DOI 10.1002/hlca.19490320218; Jaakson K, 2003, HUM MUTAT, V22, P395, DOI 10.1002/humu.10263; Karan G, 2005, P NATL ACAD SCI USA, V102, P4164, DOI 10.1073/pnas.0407698102; KATZ ML, 1986, MECH AGEING DEV, V35, P291, DOI 10.1016/0047-6374(86)90131-4; Katz ML, 2001, INVEST OPHTH VIS SCI, V42, P3023; KATZ ML, 1987, MECH AGEING DEV, V39, P81, DOI 10.1016/0047-6374(87)90088-1; Kaufman Y, 2011, J BIOL CHEM, V286, P7958, DOI 10.1074/jbc.M110.178640; Kennedy CJ, 1995, EYE, V9, P763, DOI 10.1038/eye.1995.192; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Klevering BJ, 2005, GRAEF ARCH CLIN EXP, V243, P90, DOI 10.1007/s00417-004-1079-4; Koenekoop Robert K, 2003, Ophthalmic Genet, V24, P75, DOI 10.1076/opge.24.2.75.13996; Lakkaraju A, 2007, P NATL ACAD SCI USA, V104, P11026, DOI 10.1073/pnas.0702504104; Lamb LE, 2004, PHOTOCHEM PHOTOBIOL, V79, P127, DOI 10.1562/0031-8655(2004)079<0127:AACOOL>2.0.CO;2; Lei B, 2003, INVEST OPHTH VIS SCI, V44, pU304; Li CB, 2001, OPTOMETRY VISION SCI, V78, P425, DOI 10.1097/00006324-200106000-00015; Lorenz B, 2004, OPHTHALMOLOGY, V111, P1585, DOI 10.1016/j.ophtha.2004.01.033; Maeda A, 2009, INVEST OPHTH VIS SCI, V50, P5435, DOI 10.1167/iovs.09-3944; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Maiti P, 2006, BIOCHEMISTRY-US, V45, P852, DOI 10.1021/bi0518545; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; Mata NL, 2001, INVEST OPHTH VIS SCI, V42, P1685; Maugeri A, 1999, AM J HUM GENET, V64, P1024, DOI 10.1086/302323; MISHIMA H, 1981, A GRAEF ARCH KLIN EX, V216, P209, DOI 10.1007/BF00408162; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Olson EN, 1996, CELL, V85, P1, DOI 10.1016/S0092-8674(00)81073-9; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Pawar AS, 2008, INVEST OPHTH VIS SCI, V49, P2743, DOI 10.1167/iovs.07-1499; Radu RA, 2005, INVEST OPHTH VIS SCI, V46, P4393, DOI 10.1167/iovs.05-0820; Radu RA, 2003, P NATL ACAD SCI USA, V100, P4742, DOI 10.1073/pnas.0737855100; RANDO RR, 1982, BIOCHEM BIOPH RES CO, V104, P430, DOI 10.1016/0006-291X(82)90655-6; Rotenstreich Y, 2003, OPHTHALMOLOGY, V110, P1151, DOI 10.1016/S0161-6420(03)00333-6; Rozanowska M, 2004, INVEST OPHTH VIS SCI, V45, P1052, DOI 10.1167/iovs.03-0277; Sigmund CD, 2000, ARTERIOSCL THROM VAS, V20, P1425, DOI 10.1161/01.ATV.20.6.1425; Sivaprasad S, 2006, EYE, V20, P867, DOI 10.1038/sj.eye.6702176; Sparrow JR, 2010, INVEST OPHTH VIS SCI, V51, P4351, DOI 10.1167/iovs.10-5852; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Sparrow JR, 2003, VISION RES, V43, P2983, DOI 10.1016/S0042-6989(03)00475-9; Sparrow JR, 2003, J BIOL CHEM, V278, P18207, DOI 10.1074/jbc.M300457200; Sparrow JR, 2003, INVEST OPHTH VIS SCI, V44, P2245, DOI 10.1167/iovs.02-0746; SPENCER W H, 1965, Trans Am Acad Ophthalmol Otolaryngol, V69, P662; Washington I, 2005, ANGEW CHEM INT EDIT, V44, P7097, DOI 10.1002/anie.200501346; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wielgus AR, 2010, PHOTOCHEM PHOTOBIOL, V86, P781, DOI 10.1111/j.1751-1097.2010.00750.x; Wingerath T, 1997, ANAL CHEM, V69, P3855, DOI 10.1021/ac970463w; Wu L, 2010, ADV EXP MED BIOL, V664, P533, DOI 10.1007/978-1-4419-1399-9_61; Yatsenko AN, 2001, HUM GENET, V108, P346, DOI 10.1007/s004390100493; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	77	50	52	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7966	7974		10.1074/jbc.M110.178657	http://dx.doi.org/10.1074/jbc.M110.178657			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21156790	Green Published, hybrid			2022-12-27	WOS:000288013300027
J	Tebbi, A; Guittet, O; Cottet, MH; Vesin, MF; Lepoivre, M				Tebbi, Ali; Guittet, Olivier; Cottet, Marie-Helene; Vesin, Marie-Francoise; Lepoivre, Michel			TAp73 Induction by Nitric Oxide REGULATION BY CHECKPOINT KINASE 1 (CHK1) AND PROTECTION AGAINST APOPTOSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR FUNCTIONS; EXPRESSING WILD-TYPE; DNA-DAMAGE; RIBONUCLEOTIDE REDUCTASE; UP-REGULATION; P53 FAMILY; IN-VIVO; RADIOSENSITIZING AGENT; ANTIOXIDANT FUNCTION; SYNTHASE EXPRESSION	Nitric oxide (NO) is a potent activator of the p53 tumor suppressor protein, thereby inducing cell cycle arrest and apoptosis. However, little is known about the regulation of the two other p53-family members, p63 and p73, by nitrogen oxides. We report here an up-regulation of p73 by NO in p53-null K-562 leukemia cells. Chemical NO prodrugs or macrophage iNOS activity induced an accumulation of the TAp73 alpha isoform in these cells, whereas macrophages from iNOS(-/-) mice did not. NO also up-regulated TAp73 mRNA expression, suggesting a transcriptional regulation. The checkpoint kinases Chk1 and Chk2 can regulate TAp73 induction after DNA damage. We show that these kinases were rapidly phosphorylated upon NO treatment. Genetic silencing or pharmacological inhibition of Chk1 impaired NO-mediated accumulation of TAp73 alpha. Because NO is known to block DNA synthesis through ribonucleotide reductase inhibition, the up-regulation of TAp73 alpha might be caused by DNA damage induced by an arrest of DNA replication forks. In support of this hypothesis, DNA replication inhibitors such as hydroxyurea and aphidicolin similarly enhanced TAp73 alpha expression and Chk1 phosphorylation. Moreover, inhibition of Chk1 also prevented TAp73 alpha accumulation in response to replication inhibitors. The knockdown of TAp73 with siRNA sensitized K-562 cells to apoptosis induced by a nitrosative (NO) or oxidative (H2O2) injury. Therefore, TAp73 alpha has an unusual cytoprotective role in K-562 cells, contrasting with its pro-apoptotic functions in many other cell models. In conclusion, NO upregulates several p53 family members displaying pro-and anti-apoptotic effects, suggesting a complex network of interactions and cross-regulations between NO production and p53-related proteins.	[Tebbi, Ali; Guittet, Olivier; Cottet, Marie-Helene; Vesin, Marie-Francoise; Lepoivre, Michel] Univ Paris 11, Inst Mol & Cellular Biochem & Biophys, UMR 8619, F-91405 Orsay, France; [Tebbi, Ali; Guittet, Olivier; Cottet, Marie-Helene; Vesin, Marie-Francoise; Lepoivre, Michel] CNRS, F-91405 Orsay, France; [Tebbi, Ali] Univ Utah, Sch Med, Dept Mol Med, Div Endocrinol Diabet & Metab, Salt Lake City, UT 84112 USA	UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Utah System of Higher Education; University of Utah	Lepoivre, M (corresponding author), Univ Paris 11, UMR CNRS 8619, IBBMC, F-91405 Orsay, France.	michel.lepoivre@u-psud.fr	Lepoivre, Michel/J-8578-2013; Guittet, Olivier/J-8642-2013		Groupement des Entreprises Francaises dans la Lutte contre le Cancer Paris-Ile de France; l'Association pour la Recherche sur le Cancer	Groupement des Entreprises Francaises dans la Lutte contre le Cancer Paris-Ile de France; l'Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer)	This work was supported in part by a grant from the Groupement des Entreprises Francaises dans la Lutte contre le Cancer Paris-Ile de France (to M. L.).; Supported by a fellowship from l'Association pour la Recherche sur le Cancer.	Akaike T, 2000, FASEB J, V14, P1447, DOI 10.1096/fj.14.10.1447; Ambs S, 1998, P NATL ACAD SCI USA, V95, P8823, DOI 10.1073/pnas.95.15.8823; Banki K, 1996, J BIOL CHEM, V271, P32994, DOI 10.1074/jbc.271.51.32994; Benard J, 2003, HUM MUTAT, V21, P182, DOI 10.1002/humu.10172; Berendji D, 1999, FREE RADICAL BIO MED, V27, P773, DOI 10.1016/S0891-5849(99)00123-9; Brune B, 2007, CARDIOVASC RES, V75, P275, DOI 10.1016/j.cardiores.2007.03.005; Burney S, 1999, MUTAT RES-FUND MOL M, V424, P37, DOI 10.1016/S0027-5107(99)00006-8; Busby EC, 2000, CANCER RES, V60, P2108; Cano CE, 2009, CANCER RES, V69, P219, DOI 10.1158/0008-5472.CAN-08-2320; Collavin L, 2010, CELL DEATH DIFFER, V17, P901, DOI 10.1038/cdd.2010.35; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Dominguez G, 2006, J CLIN ONCOL, V24, P805, DOI 10.1200/JCO.2005.02.2350; FIELD L, 1978, J CHEM SOC CHEM COMM, P249, DOI 10.1039/c39780000249; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Fontecave M, 1998, FEBS LETT, V421, P277, DOI 10.1016/S0014-5793(97)01572-X; Fontemaggi G, 2002, J BIOL CHEM, V277, P43359, DOI 10.1074/jbc.M205573200; Forrester K, 1996, P NATL ACAD SCI USA, V93, P2442, DOI 10.1073/pnas.93.6.2442; Girard PM, 2008, DNA REPAIR, V7, P1500, DOI 10.1016/j.dnarep.2008.05.004; Glockzin S, 1999, J BIOL CHEM, V274, P19581, DOI 10.1074/jbc.274.28.19581; Gonzalez S, 2005, CANCER RES, V65, P2186, DOI 10.1158/0008-5472.CAN-04-3047; Guittet O, 2008, NITRIC OXIDE-BIOL CH, V19, P84, DOI 10.1016/j.niox.2008.04.011; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Hofseth LJ, 2003, P NATL ACAD SCI USA, V100, P143, DOI 10.1073/pnas.0237083100; JENKINS DC, 1995, P NATL ACAD SCI USA, V92, P4392, DOI 10.1073/pnas.92.10.4392; Jordheim LP, 2005, MOL CANCER THER, V4, P1268, DOI 10.1158/1535-7163.MCT-05-0121; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Jungas T, 2002, J BIOL CHEM, V277, P27912, DOI 10.1074/jbc.M110288200; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kim SJ, 2002, J BIOL CHEM, V277, P33501, DOI 10.1074/jbc.M202862200; Lee CW, 1999, ONCOGENE, V18, P4171, DOI 10.1038/sj.onc.1202793; Lefkimmiatis K, 2009, CANCER RES, V69, P8563, DOI 10.1158/0008-5472.CAN-09-0259; Li CQ, 2002, P NATL ACAD SCI USA, V99, P10364, DOI 10.1073/pnas.162356399; MACMICKING JD, 1995, CELL, V81, P641, DOI 10.1016/0092-8674(95)90085-3; MESSMER UK, 1994, FEBS LETT, V355, P23; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Muller M, 2006, DRUG RESIST UPDATE, V9, P288, DOI 10.1016/j.drup.2007.01.001; Nyman U, 2005, J BIOL CHEM, V280, P34159, DOI 10.1074/jbc.M500394200; Ozaki T, 1999, CANCER RES, V59, P5902; Petit JF, 1996, BIOCHEM PHARMACOL, V52, P205, DOI 10.1016/0006-2952(96)00177-3; POTSCH S, 1994, MOL PHARMACOL, V45, P792; Roy B, 2004, FREE RADICAL BIO MED, V36, P507, DOI 10.1016/j.freeradbiomed.2003.11.028; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; SAH VP, 1995, NAT GENET, V10, P175, DOI 10.1038/ng0695-175; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sarkaria JN, 1999, CANCER RES, V59, P4375; Stiewe T, 2003, J BIOL CHEM, V278, P14230, DOI 10.1074/jbc.M300357200; Tao YG, 2009, CELL CYCLE, V8, P1196, DOI 10.4161/cc.8.8.8203; Thomas DD, 2008, FREE RADICAL BIO MED, V45, P18, DOI 10.1016/j.freeradbiomed.2008.03.020; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; Urist M, 2004, GENE DEV, V18, P3041, DOI 10.1101/gad.1221004; Vilgelm A, 2008, DRUG RESIST UPDATE, V11, P152, DOI 10.1016/j.drup.2008.08.001; Wang XJ, 2002, J BIOL CHEM, V277, P15697, DOI 10.1074/jbc.M112068200; Wilhelm MT, 2010, GENE DEV, V24, P549, DOI 10.1101/gad.1873910; Yang A, 2000, NATURE, V404, P99, DOI 10.1038/35003607; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	58	11	11	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7873	7884		10.1074/jbc.M110.184879	http://dx.doi.org/10.1074/jbc.M110.184879			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21212274	hybrid, Green Published			2022-12-27	WOS:000288013300018
J	Cotter, DG; d'Avignon, DA; Wentz, AE; Weber, ML; Crawford, PA				Cotter, David G.; d'Avignon, D. Andre; Wentz, Anna E.; Weber, Mary L.; Crawford, Peter A.			Obligate Role for Ketone Body Oxidation in Neonatal Metabolic Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COA TRANSFERASE SCOT; RAT-LIVER MITOCHONDRIA; FATTY-ACID OXIDATION; KETOGENIC DIET; SUCCINYL-COA; ENERGY-METABOLISM; PIG-HEART; AUTOPHAGY; INSULIN; BRAIN	To compensate for the energetic deficit elicited by reduced carbohydrate intake, mammals convert energy stored in ketone bodies to high energy phosphates. Ketone bodies provide fuel particularly to brain, heart, and skeletal muscle in states that include starvation, adherence to low carbohydrate diets, and the neonatal period. Here, we use novel Oxct1(-/-) mice, which lack the ketolytic enzyme succinyl-CoA:3-oxo-acid CoA-transferase (SCOT), to demonstrate that ketone body oxidation is required for postnatal survival in mice. Although Oxct1(-/-) mice exhibit normal prenatal development, all develop ketoacidosis, hypoglycemia, and reduced plasma lactate concentrations within the first 48 h of birth. In vivo oxidation of C-13-labeled beta-hydroxybutyrate in neonatal Oxct1(-/-) mice, measured using NMR, reveals intact oxidation to acetoacetate but no contribution of ketone bodies to the tricarboxylic acid cycle. Accumulation of acetoacetate yields a markedly reduced beta-hydroxybutyrate:acetoacetate ratio of 1:3, compared with 3:1 in Oxct1(+) littermates. Frequent exogenous glucose administration to actively suckling Oxct1(-/-) mice delayed, but could not prevent, lethality. Brains of newborn SCOT-deficient mice demonstrate evidence of adaptive energy acquisition, with increased phosphorylation of AMP-activated protein kinase alpha, increased autophagy, and 2.4-fold increased in vivo oxidative metabolism of [C-13] glucose. Furthermore, [C-13] lactate oxidation is increased 1.7-fold in skeletal muscle of Oxct1(-/-) mice but not in brain. These results indicate the critical metabolic roles of ketone bodies in neonatal metabolism and suggest that distinct tissues exhibit specific metabolic responses to loss of ketone body oxidation.	[Cotter, David G.; Wentz, Anna E.; Weber, Mary L.; Crawford, Peter A.] Washington Univ, Dept Med, Sch Med, St Louis, MO 63110 USA; [d'Avignon, D. Andre] Washington Univ, Dept Chem, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Crawford, PA (corresponding author), Washington Univ, Dept Med, Sch Med, Campus Box 8086,660 S Euclid Ave, St Louis, MO 63110 USA.	pcrawford@wustl.edu		Crawford, Peter/0000-0001-8597-4426; Wentz, Anna/0000-0002-3585-8379	National Institutes of Health [DK020579, DK073282]; Diabetic Cardiovascular Disease Center at Washington University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK073282, R01DK091538, P30DK020579, P60DK020579] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetic Cardiovascular Disease Center at Washington University; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK020579 and DK073282. This work was also supported by a pilot and feasibility grant from the Diabetic Cardiovascular Disease Center at Washington University.	AFIFI AK, 2005, FUNCTIONAL NEUROANAT, P326; Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; ALLEN JC, 1991, AM J CLIN NUTR, V54, P69, DOI 10.1093/ajcn/54.1.69; BARNETT SA, 1971, J REPROD FERTIL, V26, P39, DOI 10.1530/jrf.0.0260039; Barth S, 2010, J PATHOL, V221, P117, DOI 10.1002/path.2694; Bateman KS, 2002, BIOCHEMISTRY-US, V41, P14455, DOI 10.1021/bi020568f; Berry GT, 2001, J INHERIT METAB DIS, V24, P587, DOI 10.1023/A:1012419911789; Best TH, 2000, NEUROLOGY, V54, P2328, DOI 10.1212/WNL.54.12.2328; BOUGNERES PF, 1986, J CLIN INVEST, V77, P42, DOI 10.1172/JCI112299; Burgess SC, 2006, J BIOL CHEM, V281, P19000, DOI 10.1074/jbc.M600050200; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; CAHILL GF, 1966, J CLIN INVEST, V45, P1751, DOI 10.1172/JCI105481; CHAUSSAIN JL, 1977, J PEDIATR-US, V91, P711, DOI 10.1016/S0022-3476(77)81020-2; Chen TY, 2006, LANCET, V367, P958, DOI 10.1016/S0140-6736(06)68394-3; Crawford PA, 2009, P NATL ACAD SCI USA, V106, P11276, DOI 10.1073/pnas.0902366106; DENNE SC, 1986, AM J PHYSIOL, V251, pE71, DOI 10.1152/ajpendo.1986.251.1.E71; EDMOND J, 1987, J NEUROSCI RES, V18, P551, DOI 10.1002/jnr.490180407; FERRE P, 1978, BIOCHEM J, V176, P759, DOI 10.1042/bj1760759; Fukao T, 2004, PROSTAG LEUKOTR ESS, V70, P243, DOI 10.1016/j.plefa.2003.11.001; Fukao T, 2000, GENOMICS, V68, P144, DOI 10.1006/geno.2000.6282; Fukao T, 2006, MOL GENET METAB, V89, P280, DOI 10.1016/j.ymgme.2006.04.014; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; GIRARD JR, 1973, J CLIN INVEST, V52, P3190, DOI 10.1172/JCI107519; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Hagberg H, 2002, MENT RETARD DEV D R, V8, P30, DOI 10.1002/mrdd.10007; Hasan NM, 2010, ARCH BIOCHEM BIOPHYS, V499, P62, DOI 10.1016/j.abb.2010.05.007; HAWDON JM, 1992, ARCH DIS CHILD-FETAL, V67, P357, DOI 10.1136/adc.67.4_Spec_No.357; Hertz L, 2002, INT REV NEUROBIOL, V51, P1, DOI 10.1016/S0074-7742(02)51003-5; Hew KW, 2003, BIRTH DEFECTS RES B, V68, P309, DOI 10.1002/bdrb.10034; Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001; Ibanez L, 2008, J CLIN ENDOCR METAB, V93, P2774, DOI 10.1210/jc.2008-0526; JENNESS R, 1979, SEMIN PERINATOL, V3, P225; Jones JG, 1997, ANAL BIOCHEM, V249, P201, DOI 10.1006/abio.1997.2172; KassovskaBratinova S, 1996, AM J HUM GENET, V59, P519; Kayer Michael A, 2006, Mol Genet Metab, V87, P281; KREBS H. A., 1967, NAT CANCER INST MONGR, V27, P331; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Longo N, 2004, J INHERIT METAB DIS, V27, P691, DOI 10.1023/B:BOLI.0000043023.57321.18; MacDonald MJ, 2008, AM J PHYSIOL-CELL PH, V294, pC442, DOI 10.1152/ajpcell.00368.2007; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; MCGARRY JD, 1977, ARCH INTERN MED, V137, P495, DOI 10.1001/archinte.137.4.495; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; MITCHELL GA, 2000, ONLINE METABOLIC MOL; Morris AAM, 2005, J INHERIT METAB DIS, V28, P109, DOI 10.1007/s10545-005-5518-0; Nehlig A, 1999, EPILEPSY RES, V37, P211, DOI 10.1016/S0920-1211(99)00073-X; Orii KE, 2008, TOHOKU J EXP MED, V215, P227, DOI 10.1620/tjem.215.227; Owen D, 2008, INTENS CARE MED, V34, P971, DOI 10.1007/s00134-007-0950-2; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; Platt MW, 2005, SEMIN FETAL NEONAT M, V10, P341, DOI 10.1016/j.siny.2005.04.001; QUANT PA, 1991, EUR J BIOCHEM, V195, P449, DOI 10.1111/j.1432-1033.1991.tb15724.x; QUANT PA, 1989, BIOCHEM SOC T, V17, P1089, DOI 10.1042/bst0171089; QUANT PA, 1993, BIOCHIM BIOPHYS ACTA, V1156, P135, DOI 10.1016/0304-4165(93)90128-U; REICHARD GA, 1979, J CLIN INVEST, V63, P619, DOI 10.1172/JCI109344; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; SATO K, 1995, FASEB J, V9, P651, DOI 10.1096/fasebj.9.8.7768357; SAUDUBRAY JM, 1987, ENZYME, V38, P80, DOI 10.1159/000469194; Soeters MR, 2009, OBESITY, V17, P1326, DOI 10.1038/oby.2008.678; Takahashi M, 1997, J LAB CLIN MED, V129, P72, DOI 10.1016/S0022-2143(97)90163-3; Tammam SD, 2007, BIOCHEMISTRY-US, V46, P10852, DOI 10.1021/bi700828h; TILDON JT, 1972, J CLIN INVEST, V51, P493, DOI 10.1172/JCI106837; Veech RL, 2004, PROSTAG LEUKOTR ESS, V70, P309, DOI 10.1016/j.plefa.2003.09.007; Wentz AE, 2010, J BIOL CHEM, V285, P24447, DOI 10.1074/jbc.M110.100651; YANG SY, 1987, J BIOL CHEM, V262, P13027; Yu L, 2010, NATURE, V465, P942, DOI 10.1038/nature09076	64	72	73	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6902	6910		10.1074/jbc.M110.192369	http://dx.doi.org/10.1074/jbc.M110.192369			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21209089	hybrid, Green Published			2022-12-27	WOS:000287737300005
J	Donohue, E; Tovey, A; Vogl, AW; Arns, S; Sternberg, E; Young, RN; Roberge, M				Donohue, Elizabeth; Tovey, Andrew; Vogl, A. Wayne; Arns, Steve; Sternberg, Ethan; Young, Robert N.; Roberge, Michel			Inhibition of Autophagosome Formation by the Benzoporphyrin Derivative Verteporfin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALIGNANT GLIOMA-CELLS; PROTEIN-DEGRADATION; CANCER-CELLS; NUTRIENT DEPRIVATION; MAMMALIAN-CELLS; TUMOR-CELLS; TUMORIGENESIS; TAMOXIFEN; THERAPY; TARGET	Autophagy enables cells to degrade and recycle cytoplasmic materials both as a housekeeping mechanism and in response to extracellular stress such as nutrient deprivation. Recent studies indicate that autophagy also functions as a protective mechanism in response to several cancer therapy agents, making it a prospective therapeutic target. Few pharmacological inhibitors suitable for testing the therapeutic potential of autophagy inhibition in vivo are known. An automated microscopy assay was used to screen > 3,500 drugs and pharmacological agents and identified one drug, verteporfin, as an inhibitor of autophagosome accumulation. Verteporfin is a benzoporphyrin derivative used in photodynamic therapy, but it inhibits autophagy without light activation. Verteporfin did not inhibit LC3/Atg8 processing or membrane recruitment in response to autophagic stimuli, but it inhibited drug-and starvation-induced autophagic degradation and the sequestration of cytoplasmic materials into autophagosomes. Transient exposure to verteporfin in starvation conditions reduced cell viability whereas cells in nutrient-rich medium were unaffected by drug treatment. Analysis of structural analogs indicated that the activity of verteporfin requires the presence of a substituted cyclohexadiene at ring A of the porphyrin core but that it can tolerate a number of large substituents at rings C and D. The existence of an autophagy inhibitor among FDA-approved drugs should facilitate the investigation of the therapeutic potential of autophagy inhibition in vivo.	[Donohue, Elizabeth; Roberge, Michel] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Tovey, Andrew; Sternberg, Ethan] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z3, Canada; [Vogl, A. Wayne] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Arns, Steve; Young, Robert N.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada	University of British Columbia; University of British Columbia; University of British Columbia; Simon Fraser University	Roberge, M (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	michelr@interchange.ubc.ca		Young, Robert/0000-0002-8235-6080	Canadian Breast Cancer Foundation	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS))	This work was supported by the Canadian Breast Cancer Foundation.	Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Bauvy C, 2009, METHOD ENZYMOL, V452, P47, DOI 10.1016/S0076-6879(08)03604-5; Belzacq AS, 2001, CANCER RES, V61, P1260; Bilir A, 2001, PATHOBIOLOGY, V69, P120, DOI 10.1159/000048766; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Bursch W, 1996, CARCINOGENESIS, V17, P1595, DOI 10.1093/carcin/17.8.1595; CARO LHP, 1988, EUR J BIOCHEM, V175, P325, DOI 10.1111/j.1432-1033.1988.tb14200.x; Chen B, 2005, INT J RADIAT ONCOL, V61, P1216, DOI 10.1016/j.ijrobp.2004.08.006; Curman D, 2001, J BIOL CHEM, V276, P17914, DOI 10.1074/jbc.M100728200; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Ertmer A, 2007, LEUKEMIA, V21, P936, DOI 10.1038/sj.leu.2404606; Eskelinen EL, 2008, AUTOPHAGY, V4, P257, DOI 10.4161/auto.5179; Furuya N, 2005, AUTOPHAGY, V1, P46, DOI 10.4161/auto.1.1.1542; Granville D J, 2000, Curr Opin Drug Discov Devel, V3, P232; Hariri M, 2000, MOL BIOL CELL, V11, P255, DOI 10.1091/mbc.11.1.255; Izuishi K, 2000, CANCER RES, V60, P6201; Jin SK, 2006, AUTOPHAGY, V2, P80, DOI 10.4161/auto.2.2.2460; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Katayama M, 2007, CELL DEATH DIFFER, V14, P548, DOI 10.1038/sj.cdd.4402030; Kawai A, 2007, AUTOPHAGY, V3, P154, DOI 10.4161/auto.3634; Kimura N, 2007, PATHOBIOLOGY, V74, P169, DOI 10.1159/000103376; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Klionsky DJ, 2007, AUTOPHAGY, V3, P181, DOI 10.4161/auto.3678; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Levine B, 2005, CELL, V120, P159, DOI 10.1016/j.cell.2005.01.005; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Mari M, 2007, NAT CELL BIOL, V9, P1125, DOI 10.1038/ncb1007-1125; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Michels S, 2001, Semin Ophthalmol, V16, P201, DOI 10.1076/soph.16.4.201.10298; Ogier-Denis E, 2003, BBA-REV CANCER, V1603, P113, DOI 10.1016/S0304-419X(03)00004-0; Paglin S, 2001, CANCER RES, V61, P439; Qadir MA, 2008, BREAST CANCER RES TR, V112, P389, DOI 10.1007/s10549-007-9873-4; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; RICHTER AM, 1990, J PHOTOCH PHOTOBIO B, V5, P231, DOI 10.1016/1011-1344(90)80008-L; RICHTER AM, 1987, J NATL CANCER I, V79, P1327; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Schneider P, 1997, MICROSC RES TECHNIQ, V36, P253; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; TOVEY A, 1994, THESIS U BRIT COLUMB; WIBO M, 1974, J CELL BIOL, V63, P430, DOI 10.1083/jcb.63.2.430	47	96	97	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7290	7300		10.1074/jbc.M110.139915	http://dx.doi.org/10.1074/jbc.M110.139915			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193398	Green Published, hybrid			2022-12-27	WOS:000287737300045
J	Li, M; Hou, YF; Wang, JS; Chen, XY; Shao, ZM; Yin, XM				Li, Min; Hou, Yifeng; Wang, Jinsong; Chen, Xiaoyun; Shao, Zhi-Ming; Yin, Xiao-Ming			Kinetics Comparisons of Mammalian Atg4 Homologues Indicate Selective Preferences toward Diverse Atg8 Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-ASSOCIATED PROTEIN; CRYSTAL-STRUCTURE; AUTOPHAGOSOME FORMATION; TRANSPORT MODULATOR; LC3; GABARAP; GATE-16; LIPIDATION; YEAST; MICE	The Atg4 cysteine proteases are required for processing Atg8 for the latter to be conjugated to phosphatidylethanolamine on autophagosomal membranes, a key step in autophagosome biogenesis. Notably, whereas there are only one atg4 and one atg8 gene in the yeast, the mammals have four Atg4 homologues and six Atg8 homologues. The Atg8 homologues seem to play different roles in autophagosome biogenesis, and previous studies had indicated that they could be differentially processed by Atg4 homologues. The present study provided the first detailed kinetics analysis of all four Atg4 homologues against four representative Atg8 homologues. The data indicated that Atg4B possessed the broadest spectrum against all substrates, followed by Atg4A, whereas Atg4C and Atg4D had minimal activities as did the catalytic mutant of Atg4B (C74S). On the other hand, GATE-16 seemed to be the overall best substrate for Atg4 proteases. The kinetics parameters of Atg4B were also affected by its structure and that of the substrates, indicating a process of induced fit. The determination of the kinetics parameters of the various Atg4-Atg8 pairs provides a base for the understanding of the potential selective impact of the reaction on autophagosome biogenesis.	[Li, Min; Chen, Xiaoyun; Yin, Xiao-Ming] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Hou, Yifeng; Wang, Jinsong; Shao, Zhi-Ming] Fudan Univ, Canc Hosp, Dept Surg, Shanghai 200032, Peoples R China	Indiana University System; Indiana University Bloomington; Fudan University	Yin, XM (corresponding author), Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA.	xmyin@iupui.edu	Li, Min/B-1281-2011	li, min/0000-0002-5657-8675	National Institutes of Health [R01CA 83817, R01 CA111456]; NATIONAL CANCER INSTITUTE [R01CA111456, R01CA083817] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA 83817 and R01 CA111456 (to X.-M. Y.).	Betin VMS, 2009, J CELL SCI, V122, P2554, DOI 10.1242/jcs.046250; Cann GM, 2008, DEV DYNAM, V237, P187, DOI 10.1002/dvdy.21392; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Hemelaar J, 2003, J BIOL CHEM, V278, P51841, DOI 10.1074/jbc.M308762200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Knight D, 2002, J BIOL CHEM, V277, P5556, DOI 10.1074/jbc.M109753200; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kouno T, 2005, J BIOL CHEM, V280, P24610, DOI 10.1074/jbc.M413565200; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kumanomidou T, 2006, J MOL BIOL, V355, P612, DOI 10.1016/j.jmb.2005.11.018; Marino G, 2003, J BIOL CHEM, V278, P3671, DOI 10.1074/jbc.M208247200; Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200; Marino G, 2010, J CLIN INVEST, V120, P2331, DOI 10.1172/JCI42601; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nakatogawa H, 2007, CELL, V130, P165, DOI 10.1016/j.cell.2007.05.021; Oh-Oka K, 2008, J BIOL CHEM, V283, P21847, DOI 10.1074/jbc.M801836200; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; Paz Y, 2000, J BIOL CHEM, V275, P25445, DOI 10.1074/jbc.C000307200; READ R, 2011, VET PATHOL IN PRESS; Satoo K, 2009, EMBO J, V28, P1341, DOI 10.1038/emboj.2009.80; Scherz-Shouval R, 2003, J BIOL CHEM, V278, P14053, DOI 10.1074/jbc.M212108200; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Shu CW, 2010, AUTOPHAGY, V6, P936, DOI 10.4161/auto.6.7.13075; Stangler T, 2002, J BIOL CHEM, V277, P13363, DOI 10.1074/jbc.C200050200; Sugawara K, 2005, J BIOL CHEM, V280, P40058, DOI 10.1074/jbc.M509158200; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2003, BIOCHEM BIOPH RES CO, V300, P637, DOI 10.1016/S0006-291X(02)02907-8; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tanida I, 2006, FEBS J, V273, P2553, DOI 10.1111/j.1742-4658.2006.05260.x; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292	38	168	181	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7327	7338		10.1074/jbc.M110.199059	http://dx.doi.org/10.1074/jbc.M110.199059			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177865	Green Published, hybrid			2022-12-27	WOS:000287737300049
J	Bulut, GB; Sulahian, R; Ma, Y; Chi, NW; Huang, LJS				Bulut, Gamze Betul; Sulahian, Rita; Ma, Yue; Chi, Nai-wen; Huang, Lily Jun-shen			Ubiquitination Regulates the Internalization, Endolysosomal Sorting, and Signaling of the Erythropoietin Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE EXPRESSION; DEGRADATION; TRANSDUCTION; JAK2; ENDOCYTOSIS; ACTIVATION; MEMBRANE; REGION; DOMAIN	Ubiquitination is a common mechanism of down-regulation of mitogenic receptors. Here, we show that ubiquitination of the erythropoietin receptor (EpoR) at Lys(256) is necessary and sufficient for efficient Epo-induced receptor internalization, whereas ubiquitination at Lys(428) promotes trafficking of activated receptors to the lysosomes for degradation. Interestingly, EpoR that cannot be ubiquitinated has reduced mitogenic activities and ability to stimulate the STAT5, Ras/MAPK, and PI3K/AKT signaling pathways. We therefore propose that ubiquitination of the EpoR critically controls both receptor down-regulation and downstream signaling.	[Huang, Lily Jun-shen] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Chi, Nai-wen] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Diego	Huang, LJS (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Lily.Huang@utsouthwestern.edu			National Institutes of Health [R01 HL089966]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089966] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL089966.	Barriere H, 2007, MOL BIOL CELL, V18, P3952, DOI 10.1091/mbc.E07-07-0678; Constantinescu SN, 1999, TRENDS ENDOCRIN MET, V10, P18, DOI 10.1016/S1043-2760(98)00101-5; dos Santos GMA, 2001, J BIOL CHEM, V276, P32635, DOI 10.1074/jbc.M103583200; Fehrenbacher N, 2009, MOL ONCOL, V3, P297, DOI 10.1016/j.molonc.2009.06.004; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Hitchcock IS, 2008, BLOOD, V112, P2222, DOI 10.1182/blood-2008-01-134049; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Kim HJ, 2007, CURR BIOL, V17, P455, DOI 10.1016/j.cub.2007.01.059; Kumar KGS, 2003, EMBO J, V22, P5480; Meyer L, 2007, BLOOD, V109, P5215, DOI 10.1182/blood-2006-10-055350; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; NEUMANN D, 1993, J BIOL CHEM, V268, P13639; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Richmond TD, 2005, TRENDS CELL BIOL, V15, P146, DOI 10.1016/j.tcb.2005.01.007; Saur SJ, 2010, BLOOD, V115, P1254, DOI 10.1182/blood-2009-06-227033; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Sulahian R, 2009, BLOOD, V113, P5287, DOI 10.1182/blood-2008-09-179572; Suzuki N, 2002, BLOOD, V100, P2279, DOI 10.1182/blood-2002-01-0124; Swaminathan G, 2008, J ENDOCRINOL, V196, pR1, DOI 10.1677/JOE-07-0554; Tanaka Y, 2008, MOL CELL BIOL, V28, P4805, DOI 10.1128/MCB.01784-07; Teis D, 2003, CELL MOL LIFE SCI, V60, P2020, DOI 10.1007/s00018-003-3010-2; Teis D, 2006, J CELL BIOL, V175, P861, DOI 10.1083/jcb.200607025; Tong W, 2006, J BIOL CHEM, V281, P38930, DOI 10.1074/jbc.M607524200; van Kerkhof P, 2001, MOL BIOL CELL, V12, P2556, DOI 10.1091/mbc.12.8.2556; Varghese B, 2008, MOL CELL BIOL, V28, P5275, DOI 10.1128/MCB.00350-08; Walrafen P, 2005, BLOOD, V105, P600, DOI 10.1182/blood-2004-03-1216; Walz HA, 2010, J BIOL CHEM, V285, P14101, DOI 10.1074/jbc.M110.110536; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Yen CH, 2000, J IMMUNOL, V165, P6372, DOI 10.4049/jimmunol.165.11.6372; Zang HS, 2001, EMBO J, V20, P3156, DOI 10.1093/emboj/20.12.3156	31	21	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6449	6457		10.1074/jbc.M110.186890	http://dx.doi.org/10.1074/jbc.M110.186890			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21183685	Green Published, hybrid			2022-12-27	WOS:000287476400055
J	Fujita, M; Tsuchida, A; Hirata, A; Kobayashi, N; Goto, K; Osumi, K; Hirose, Y; Nakayama, J; Yamanoi, T; Ashida, H; Mizuno, M				Fujita, Masaya; Tsuchida, Akiko; Hirata, Akiko; Kobayashi, Natsumi; Goto, Kohtaro; Osumi, Kenji; Hirose, Yuriko; Nakayama, Jun; Yamanoi, Takashi; Ashida, Hisashi; Mizuno, Mamoru			Glycoside Hydrolase Family 89 alpha-N-acetylglucosaminidase from Clostridium perfringens Specifically Acts on GlcNAc alpha 1,4Gal beta 1R at the Non-reducing Terminus of O-Glycans in Gastric Mucin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDO-BETA-GALACTOSIDASE; HELICOBACTER-PYLORI INFECTION; CARBOHYDRATE-BINDING MODULES; CELL-TYPE MUCIN; BIFIDOBACTERIUM-LONGUM; MILK OLIGOSACCHARIDES; MONOCLONAL-ANTIBODY; EXPRESSION CLONING; MOLECULAR-CLONING; ADENOMA MALIGNUM	In mammals, alpha-linked GlcNAc is primarily found in heparan sulfate/heparin and gastric gland mucous cell type mucin. alpha-N-Acetylglucosaminidases (alpha GNases) belonging to glycoside hydrolase family 89 are widely distributed from bacteria to higher eukaryotes. Human lysosomal alpha GNase is well known to degrade heparin and heparan sulfate. Here, we reveal the substrate specificity of alpha GNase (AgnC) from Clostridium perfringens strain 13, a bacterial homolog of human alpha GNase, by chemically synthesizing a series of disaccharide substrates containing alpha-linked GlcNAc. AgnC was found to release GlcNAc from GlcNAc alpha 1,4Gal beta 1pMP and GlcNAc alpha 1pNP substrates (where pMP and pNP represent p-methoxyphenyl and p-nitrophenyl, respectively). AgnC also released GlcNAc from porcine gastric mucin and cell surface mucin. Because AgnC showed no activity against any of the GlcNAc alpha 1,2Gal beta 1pMP, GlcNAc alpha 1,3Gal beta 1pMP, GlcNAc alpha 1,6Gal beta 1pMP, and GlcNAc alpha 1,4GlcA beta 1pMP substrates, this enzyme may represent a specific glycosidase required for degrading alpha-GlcNAc-capped O-glycans of the class III mucin secreted from the stomach and duodenum. Deletion of the C-terminal region containing several carbohydrate-binding module 32 (CBM32) domains significantly reduced the activity for porcine gastric mucin; however, activity against GlcNAc alpha 1,4Gal beta 1pMP was markedly enhanced. Dot blot and ELISA analyses revealed that the deletion construct containing the C-terminal CBM-C2 to CBM-C6 domains binds strongly to porcine gastric mucin. Consequently, tandem CBM32 domains located near the C terminus of AgnC should function by increasing the affinity for branched or clustered alpha-GlcNAc-containing glycans. The agnC gene-disrupted strain showed significantly reduced growth on the class III mucin-containing medium compared with the wild type strain, suggesting that AgnC might have an important role in dominant growth in intestines.	[Fujita, Masaya; Tsuchida, Akiko; Kobayashi, Natsumi; Goto, Kohtaro; Osumi, Kenji; Hirose, Yuriko; Yamanoi, Takashi; Mizuno, Mamoru] Noguchi Inst, Itabashi Ku, Tokyo 1730003, Japan; [Nakayama, Jun] Shinshu Univ, Sch Med, Dept Pathol, Matsumoto, Nagano 3908621, Japan; [Hirata, Akiko; Ashida, Hisashi] Kyoto Univ, Grad Sch Biostudies, Kyoto 6068502, Japan	Shinshu University; Kyoto University	Fujita, M (corresponding author), Noguchi Inst, Itabashi Ku, 1-8-1 Kaga, Tokyo 1730003, Japan.	fujita@noguchi.or.jp; ashida@lif.kyoto-u.ac.jp	Ashida, Hisashi/HCI-0293-2022	Ashida, Hisashi/0000-0001-5844-4075	Kieikai Research Foundation; Grants-in-Aid for Scientific Research [21390104] Funding Source: KAKEN	Kieikai Research Foundation(Kieikai Research Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a grant from the Kieikai Research Foundation (to H. A.).	Abbott DW, 2008, MOL BIOL EVOL, V25, P155, DOI 10.1093/molbev/msm243; Anderson K, 2000, ANAL BIOCHEM, V287, P337, DOI 10.1006/abio.2000.4829; Anderson KM, 2005, J BIOL CHEM, V280, P7720, DOI 10.1074/jbc.M414099200; Ashida H, 2002, BIOCHEMISTRY-US, V41, P2388, DOI 10.1021/bi011940e; Ashida H, 2001, J BIOL CHEM, V276, P28226, DOI 10.1074/jbc.M103589200; Ashida H, 2008, GLYCOBIOLOGY, V18, P727, DOI 10.1093/glycob/cwn053; Ashida H, 2009, GLYCOBIOLOGY, V19, P1010, DOI 10.1093/glycob/cwp082; Boraston AB, 2007, BIOCHEMISTRY-US, V46, P11352, DOI 10.1021/bi701317g; Chen Y, 2005, APPL ENVIRON MICROB, V71, P7542, DOI 10.1128/AEM.71.11.7542-7547.2005; Ficko-Blean E, 2008, P NATL ACAD SCI USA, V105, P6560, DOI 10.1073/pnas.0711491105; Ficko-Blean E, 2006, J BIOL CHEM, V281, P37748, DOI 10.1074/jbc.M606126200; Ficko-Blean E, 2009, J MOL BIOL, V390, P208, DOI 10.1016/j.jmb.2009.04.066; Ficko-Blean E, 2009, J BIOL CHEM, V284, P9876, DOI 10.1074/jbc.M808954200; Fujita K, 2005, J BIOL CHEM, V280, P37415, DOI 10.1074/jbc.M506874200; Fujita M., 2007, GLYCOCONJ J, V24, P326; Gregg KJ, 2008, J BIOL CHEM, V283, P12604, DOI 10.1074/jbc.M709865200; Homer KA, 1996, MICROBIOL-UK, V142, P1221, DOI 10.1099/13500872-142-5-1221; HOMER KA, 1993, INFECT IMMUN, V61, P295, DOI 10.1128/IAI.61.1.295-302.1993; HOPWOOD JJ, 1982, CLIN CHIM ACTA, V120, P77, DOI 10.1016/0009-8981(82)90079-1; HSIEH TCY, 1981, J BIOL CHEM, V256, P7747; Ishihara K, 1996, BIOCHEM J, V318, P409, DOI 10.1042/bj3180409; JANN B, 1994, CARBOHYD RES, V264, P305, DOI 10.1016/S0008-6215(05)80014-X; Kawakubo M, 2004, SCIENCE, V305, P1003, DOI 10.1126/science.1099250; Kobayashi M, 2009, CURR DRUG METAB, V10, P29, DOI 10.2174/138920009787048428; Lee H, 2008, GLYCOBIOLOGY, V18, P549, DOI 10.1093/glycob/cwn037; Lee H, 2006, BIOCHEM BIOPH RES CO, V349, P1235, DOI 10.1016/j.bbrc.2006.08.145; LLOYD KO, 1969, J IMMUNOL, V102, P1354; Mikami Y, 2004, MODERN PATHOL, V17, P962, DOI 10.1038/modpathol.3800148; Miwa M, 2010, GLYCOBIOLOGY, V20, P1402, DOI 10.1093/glycob/cwq101; Nakayama J, 1999, P NATL ACAD SCI USA, V96, P8991, DOI 10.1073/pnas.96.16.8991; Ogawa H, 2000, J BIOL CHEM, V275, P19368, DOI 10.1074/jbc.M001888200; Ota H, 2001, AM J CLIN PATHOL, V115, P69; PAROLIS H, 1990, CARBOHYD RES, V200, P449, DOI 10.1016/0008-6215(90)84210-L; ROSEMAN S, 1951, J BIOL CHEM, V191, P607; SCHMIDT RR, 1984, LIEBIGS ANN CHEM, P1343, DOI 10.1002/jlac.198419840710; Shimizu T, 2002, P NATL ACAD SCI USA, V99, P996, DOI 10.1073/pnas.022493799; Utsugi K, 1999, GYNECOL ONCOL, V75, P345, DOI 10.1006/gyno.1999.5622; VANHALBEEK H, 1983, BIOCHIM BIOPHYS ACTA, V747, P107, DOI 10.1016/0167-4838(83)90128-0; VONFIGURA K, 1977, EUR J BIOCHEM, V80, P535; Weber B, 1996, HUM MOL GENET, V5, P771, DOI 10.1093/hmg/5.6.771; WEISSMANN B, 1967, BIOCHEMISTRY-US, V6, P207, DOI 10.1021/bi00853a033	41	25	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6479	6489		10.1074/jbc.M110.206722	http://dx.doi.org/10.1074/jbc.M110.206722			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21177247	hybrid, Green Published			2022-12-27	WOS:000287476400058
J	Guo, C; Zhang, XY; Pfeifer, GP				Guo, Cai; Zhang, Xiaoying; Pfeifer, Gerd P.			The Tumor Suppressor RASSF1A Prevents Dephosphorylation of the Mammalian STE20-like Kinases MST1 and MST2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIGENETIC INACTIVATION; CELL-PROLIFERATION; PROTEIN-KINASE; HIPPO PATHWAY; ORGAN SIZE; APOPTOSIS; PHOSPHORYLATION; ACTIVATION; INDUCTION; INTERACTS	The RASSF1A tumor suppressor protein interacts with the pro-apoptotic mammalian STE20-like kinases MST1 and MST2 and induces their autophosphorylation and activation, but the mechanism of how RASSF1A activates MST1/2 is unclear. Okadaic acid treatment and PP2A knockdown promoted MST1/2 phosphorylation. Data from dephosphorylation assays and reduced activation of MST1/2 seen after RASSF1A depletion suggest that dephosphorylation of MST1/2 on Thr-183 and Thr-180 by PP2A is prevented by RASSF1A, shifting the balance of MST1/2 to the activated autophosphorylated form. In addition to preventing dephosphorylation, RASSF1A also stabilized the MST2 protein. Through binding to MST1/2, RASSF1A supports maintenance of MST1/2 phosphorylation, promoting an active state of the MST kinases and favoring induction of apoptosis. This is one of the first examples of a tumor suppressor acting as an inhibitor of a specific dephosphorylation pathway.	[Guo, Cai; Zhang, Xiaoying; Pfeifer, Gerd P.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Pfeifer, GP (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Biol, Duarte, CA 91010 USA.	gpfeifer@coh.org			University of California [17RT-0116]	University of California(University of California System)	This work was supported by University of California Tobacco-Related Disease Research Program Grant 17RT-0116.	Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088; Avruch J, 2006, METHOD ENZYMOL, V407, P290, DOI 10.1016/S0076-6879(05)07025-4; Burbee DG, 2001, JNCI-J NATL CANCER I, V93, P691, DOI 10.1093/jnci/93.9.691; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Chiba S, 2009, CURR BIOL, V19, P675, DOI 10.1016/j.cub.2009.02.054; Cooper WN, 2009, ONCOGENE, V28, P2988, DOI 10.1038/onc.2009.152; CREASY CL, 1995, J BIOL CHEM, V270, P21695, DOI 10.1074/jbc.270.37.21695; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Dammann R, 2005, HISTOL HISTOPATHOL, V20, P645, DOI 10.14670/HH-20.645; Deng Y, 2003, J BIOL CHEM, V278, P11760, DOI 10.1074/jbc.M211085200; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hergovich A, 2009, CURR BIOL, V19, P1692, DOI 10.1016/j.cub.2009.09.020; Ikeda M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000300; Katagiri K, 2009, EMBO J, V28, P1319, DOI 10.1038/emboj.2009.82; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Kilili GK, 2010, J BIOL CHEM, V285, P15076, DOI 10.1074/jbc.M109.078915; Lee KK, 2001, J BIOL CHEM, V276, P19276, DOI 10.1074/jbc.M005109200; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lian JP, 2001, J IMMUNOL, V166, P6349, DOI 10.4049/jimmunol.166.10.6349; Liu L, 2008, ONCOGENE, V27, P6175, DOI 10.1038/onc.2008.220; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Matallanas D, 2008, CELL CYCLE, V7, P879, DOI 10.4161/cc.7.7.5630; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Oh HJ, 2006, CANCER RES, V66, P2562, DOI 10.1158/0008-5472.CAN-05-2951; Pfeifer GP, 2010, CURR BIOL, V20, pR344, DOI 10.1016/j.cub.2010.02.019; Polesello C, 2006, CURR BIOL, V16, P2459, DOI 10.1016/j.cub.2006.10.060; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Praskova M, 2008, CURR BIOL, V18, P311, DOI 10.1016/j.cub.2008.02.006; Rabizadeh S, 2004, J BIOL CHEM, V279, P29247, DOI 10.1074/jbc.M401699200; Radu M, 2009, CURR BIOL, V19, pR421, DOI 10.1016/j.cub.2009.04.022; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Scheel H, 2003, CURR BIOL, V13, pR899, DOI 10.1016/j.cub.2003.11.007; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; Taylor LK, 1996, P NATL ACAD SCI USA, V93, P10099, DOI 10.1073/pnas.93.19.10099; Tommasi S, 2005, CANCER RES, V65, P92; Ura S, 2007, MOL CELL BIOL, V27, P5514, DOI 10.1128/MCB.00199-07; van der Weyden L, 2005, MOL CELL BIOL, V25, P8356, DOI 10.1128/MCB.25.18.8356-8367.2005; Vichalkovski A, 2008, CURR BIOL, V18, P1889, DOI 10.1016/j.cub.2008.10.060; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	44	80	87	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6253	6261		10.1074/jbc.M110.178210	http://dx.doi.org/10.1074/jbc.M110.178210			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21199877	hybrid, Green Published			2022-12-27	WOS:000287476400035
J	Helbig, S; Patzer, SI; Schiene-Fischer, C; Zeth, K; Braun, V				Helbig, Stephanie; Patzer, Silke I.; Schiene-Fischer, Cordelia; Zeth, Kornelius; Braun, Volkmar			Activation of Colicin M by the FkpA Prolyl Cis-Trans Isomerase/Chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIOPHAGE-T7 RNA-POLYMERASE; HIGH-LEVEL EXPRESSION; ESCHERICHIA-COLI; OUTER-MEMBRANE; PERIPLASMIC PROTEIN; SIGNAL-TRANSDUCTION; CHAPERONE FUNCTION; ISOMERASE; SURA; SKP	Colicin M (Cma) is specifically imported into the periplasm of Escherichia coli and kills the cells. Killing depends on the periplasmic peptidyl prolyl cis-trans isomerase/chaperone FkpA. To identify the Cma prolyl bonds targeted by FkpA, we replaced the 15 proline residues individually with alanine. Seven mutant proteins were fully active; Cma(P129A), Cma(P176A), and Cma(P260A) displayed 1%, and Cma(P107A) displayed 10% of the wild-type activity. Cma(P107A), Cma(P129A), and Cma(P260A), but not Cma(P176A), killed cells after entering the periplasm via osmotic shock, indicating that the former mutants were translocation-deficient; Cma(P129A) did not bind to the FhuA outer membrane receptor. The crystal structures of Cma and Cma(P176A) were identical, excluding inactivation of the activity domain located far from Pro-176. In a new peptidyl prolyl cis-trans isomerase assay, FkpA isomerized the Cma prolyl bond in peptide Phe-Pro-176 at a high rate, but Lys-Pro-107 and Leu-Pro-260 isomerized at only < 10% of that rate. The four mutant proteins secreted into the periplasm via a fused signal sequence were toxic but much less than wild-type Cma. Wild-type and mutant Cma proteins secreted or translocated across the outer membrane by energy-coupled import or unspecific osmotic shock were only active in the presence of FkpA. We propose that Cma unfolds during transfer across the outer or cytoplasmic membrane and refolds to the active form in the periplasm assisted by FkpA. Weak refolding of Cma(P176A) would explain its low activity in all assays. Of the four proline residues identified as being important for Cma activity, Phe-Pro-176 is most likely targeted by FkpA.	Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; [Schiene-Fischer, Cordelia] Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Germany	Max Planck Society; Max Planck Society		volkmar.braun@tuebingen.mpg.de			Max Planck Society; German Science Foundation [BR 30/25-1]; Fonds der Chemischen Industrie	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Science Foundation(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by the Max Planck Society, the German Science Foundation (BR 30/25-1), and the Fonds der Chemischen Industrie.	Arie JP, 2001, MOL MICROBIOL, V39, P199, DOI 10.1046/j.1365-2958.2001.02250.x; Barreteau H, 2010, J BIOL CHEM, V285, P12378, DOI 10.1074/jbc.M109.093583; BENSON SA, 1984, P NATL ACAD SCI-BIOL, V81, P3830, DOI 10.1073/pnas.81.12.3830; Betton JM, 2007, PERIPLASM, P141; Bothmann H, 2000, J BIOL CHEM, V275, P17100, DOI 10.1074/jbc.M910233199; Braun M, 2003, J BACTERIOL, V185, P5508, DOI 10.1128/JB.185.18.5508-5518.2003; BRAUN V, 1980, J BACTERIOL, V142, P162, DOI 10.1128/JB.142.1.162-168.1980; BRAUN V, 1995, FEMS MICROBIOL REV, V16, P295, DOI 10.1111/j.1574-6976.1995.tb00177.x; Braun V, 2002, BIOCHIMIE, V84, P365, DOI 10.1016/S0300-9084(02)01427-X; Chen R, 1996, MOL MICROBIOL, V19, P1287, DOI 10.1111/j.1365-2958.1996.tb02473.x; Danese PN, 1997, GENE DEV, V11, P1183, DOI 10.1101/gad.11.9.1183; DREHER R, 1985, ARCH MICROBIOL, V140, P343, DOI 10.1007/BF00446975; El Ghachi M, 2006, J BIOL CHEM, V281, P22761, DOI 10.1074/jbc.M602834200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer G, 2004, REV PHYSIOL BIOCH P, V148, P105, DOI 10.1007/s10254-003-0011-3; Gross P, 1996, MOL GEN GENET, V251, P388, DOI 10.1007/BF02172531; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HARKNESS RE, 1990, MOL GEN GENET, V222, P37, DOI 10.1007/BF00283020; HARKNESS RE, 1989, J BIOL CHEM, V264, P6177; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P3813, DOI 10.1021/bi00468a001; Hullmann J, 2008, MOL MICROBIOL, V69, P926, DOI 10.1111/j.1365-2958.2008.06327.x; Justice SS, 2005, J BACTERIOL, V187, P7680, DOI 10.1128/JB.187.22.7680-7686.2005; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KADNER RJ, 1995, J BACTERIOL, V177, P4829, DOI 10.1128/jb.177.17.4829-4835.1995; Kleinschmidt JH, 2007, PERIPLASM, P30; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; MENDE J, 1990, MOL MICROBIOL, V4, P1523, DOI 10.1111/j.1365-2958.1990.tb02063.x; Mogensen JE, 2005, MOL MICROBIOL, V57, P326, DOI 10.1111/j.1365-2958.2005.04674.x; NOSSAL NG, 1966, J BIOL CHEM, V241, P3055; OLSCHLAGER T, 1991, MOL MICROBIOL, V5, P1105, DOI 10.1111/j.1365-2958.1991.tb01883.x; OLSCHLAGER T, 1991, ARCH MICROBIOL, V156, P449, DOI 10.1007/BF00245391; PILSL H, 1993, MOL GEN GENET, V240, P103, DOI 10.1007/BF00276889; Postle K, 2007, BIOMETALS, V20, P453, DOI 10.1007/s10534-006-9071-6; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Qu J, 2007, J MOL BIOL, V374, P91, DOI 10.1016/j.jmb.2007.09.020; Ramm K, 2001, J MOL BIOL, V310, P485, DOI 10.1006/jmbi.2001.4747; Rizzitello AE, 2001, J BACTERIOL, V183, P6794, DOI 10.1128/JB.183.23.6794-6800.2001; Rouviere PE, 1996, GENE DEV, V10, P3170, DOI 10.1101/gad.10.24.3170; Saul FA, 2004, J MOL BIOL, V335, P595, DOI 10.1016/j.jmb.2003.10.056; Schafer U, 1999, J BIOL CHEM, V274, P24567, DOI 10.1074/jbc.274.35.24567; SCHALLER K, 1982, J BACTERIOL, V152, P994; SCHALLER K, 1981, J BACTERIOL, V146, P54, DOI 10.1128/JB.146.1.54-63.1981; Schiene-Fischer C, 2002, NAT STRUCT BIOL, V9, P419, DOI 10.1038/nsb804; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Stymest KH, 2008, FEBS J, V275, P3470, DOI 10.1111/j.1742-4658.2008.06493.x; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; THUMM G, 1988, PLASMID, V20, P75, DOI 10.1016/0147-619X(88)90009-1; TILBY M, 1978, J BACTERIOL, V136, P1189, DOI 10.1128/JB.136.3.1189-1191.1978; Vertommen D, 2009, PROTEOMICS, V9, P2432, DOI 10.1002/pmic.200800794; WEISSHOFF H, 1995, FEBS LETT, V372, P203, DOI 10.1016/0014-5793(95)00982-F; Zeth K, 2008, J BIOL CHEM, V283, P25324, DOI 10.1074/jbc.M802591200	54	24	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6280	6290		10.1074/jbc.M110.165274	http://dx.doi.org/10.1074/jbc.M110.165274			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21149455	hybrid, Green Published			2022-12-27	WOS:000287476400038
J	Holley, RJ; Pickford, CE; Rushton, G; Lacaud, G; Gallagher, JT; Kouskoff, V; Merry, CLR				Holley, Rebecca J.; Pickford, Claire E.; Rushton, Graham; Lacaud, Georges; Gallagher, John T.; Kouskoff, Valerie; Merry, Catherine L. R.			Influencing Hematopoietic Differentiation of Mouse Embryonic Stem Cells using Soluble Heparin and Heparan Sulfate Saccharides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMITIVE STREAK; MITOGENIC ACTIVITY; ENDOTHELIAL-CELLS; PROGENITOR CELLS; SELF-RENEWAL; IN-VITRO; EXPRESSION; MICE; WNT; ACTIVATION	Heparan sulfate proteoglycans (HSPG) encompass some of the most abundant macromolecules on the surface of almost every cell type. Heparan sulfate (HS) chains provide a key interaction surface for the binding of numerous proteins such as growth factors and morphogens, helping to define the ability of a cell to respond selectively to environmental cues. The specificity of HS-protein interactions are governed predominantly by the order and positioning of sulfate groups, with distinct cell types expressing unique sets of HS epitopes. Embryos deficient in HS-synthesis (Ext1(-/-)) exhibit pre-gastrulation lethality and lack recognizable organized mesoderm and extraembryonic tissues. Here we demonstrate that embryonic stem cells (ESCs) derived from Ext1(-/-) embryos are unable to differentiate into hematopoietic lineages, instead retaining ESC marker expression throughout embryoid body (EB) culture. However hematopoietic differentiation can be restored by the addition of soluble heparin. Consistent with specific size and composition requirements for HS: growth factor signaling, chains measuring at least 12 saccharides were required for partial rescue of hematopoiesis with longer chains (18 saccharides or more) required for complete rescue. Critically N- and 6-O-sulfate groups were essential for rescue. Heparin addition restored the activity of multiple signaling pathways including bone morphogenic protein (BMP) with activation of phospho-SMADs re-established by the addition of heparin. Heparin addition to wild-type cultures also altered the outcome of differentiation, promoting hematopoiesis at low concentrations, yet inhibiting blood formation at high concentrations. Thus altering the levels of HS and HS sulfation within differentiating ESC cultures provides an attractive and accessible mechanism for influencing cell fate.	[Merry, Catherine L. R.] Univ Manchester, Sch Mat, Ctr Mat Sci, Stem Cell Glycobiol Grp, Manchester M13 9PL, Lancs, England; [Rushton, Graham; Lacaud, Georges; Gallagher, John T.; Kouskoff, Valerie] Univ Manchester, Paterson Inst Canc Res, Manchester M20 4BX, Lancs, England	University of Manchester; Paterson Institute for Cancer Research; University of Manchester	Merry, CLR (corresponding author), Univ Manchester, Sch Mat, Ctr Mat Sci, Stem Cell Glycobiol Grp, Manchester M13 9PL, Lancs, England.	Catherine.merry@manchester.ac.uk	Merry, Catherine/B-5713-2013; lacaud, Georges/ABH-5215-2020; Pickford, Claire/C-9815-2013	Lacaud, Georges/0000-0002-5630-2417; merry, catherine/0000-0002-3490-2809	Cancer Research UK; Human Frontier Science Program; Medical Research Council; MRC [G0701165] Funding Source: UKRI; Cancer Research UK [12486, 12487] Funding Source: researchfish; Medical Research Council [G0701165] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Human Frontier Science Program(Human Frontier Science Program); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported, in whole or in part, by Cancer Research UK (to V. K., J. T. G., G. R., and G. L.), The Human Frontier Science Program (to R. J. H. and C. L. R. M.), and The Medical Research Council (to C. E. P. and C. L. R. M.). John Gallagher is CEO of Iduron plc, the supplier of the oligosaccharides used in this study.	Akita K, 2008, STEM CELLS, V26, P798, DOI 10.1634/stemcells.2007-0448; Baldwin RJ, 2008, STEM CELLS, V26, P3108, DOI 10.1634/stemcells.2008-0311; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; CONLON FL, 1994, DEVELOPMENT, V120, P1919; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Forsberg E, 2001, J CLIN INVEST, V108, P175, DOI 10.1172/JCI13561; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Grunewald FS, 2010, BBA-PROTEINS PROTEOM, V1804, P567, DOI 10.1016/j.bbapap.2009.09.002; Holmborn K, 2004, J BIOL CHEM, V279, P42355, DOI 10.1074/jbc.C400373200; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Johnson CE, 2007, STEM CELLS, V25, P1913, DOI 10.1634/stemcells.2006-0445; JONES CM, 1991, DEVELOPMENT, V111, P531; Kawamura H, 2008, BLOOD, V112, P3638, DOI 10.1182/blood-2007-12-125856; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Kouskoff V, 2005, P NATL ACAD SCI USA, V102, P13170, DOI 10.1073/pnas.0501672102; Kraushaar DC, 2010, J BIOL CHEM, V285, P5907, DOI 10.1074/jbc.M109.066837; Lanner F, 2010, STEM CELLS, V28, P191, DOI 10.1002/stem.265; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Mitjavila-Garcia MT, 2002, DEVELOPMENT, V129, P2003; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; OGAWA M, 1991, J EXP MED, V174, P63, DOI 10.1084/jem.174.1.63; Palis J, 1999, DEVELOPMENT, V126, P5073; Park C, 2004, DEVELOPMENT, V131, P2749, DOI 10.1242/dev.01130; Pearson S, 2008, DEVELOPMENT, V135, P1525, DOI 10.1242/dev.011767; Pye DA, 2000, GLYCOBIOLOGY, V10, P1183, DOI 10.1093/glycob/10.11.1183; Pye DA, 1998, J BIOL CHEM, V273, P22936, DOI 10.1074/jbc.273.36.22936; Robinson CJ, 2006, J BIOL CHEM, V281, P1731, DOI 10.1074/jbc.M510760200; Robson P, 2001, DEV BIOL, V234, P317, DOI 10.1006/dbio.2001.0274; Sasaki N, 2008, J BIOL CHEM, V283, P3594, DOI 10.1074/jbc.M705621200; Stickens D, 2005, DEVELOPMENT, V132, P5055, DOI 10.1242/dev.02088; Sugaya N, 2008, J BIOL CHEM, V283, P10366, DOI 10.1074/jbc.M705948200; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; VECCHI A, 1994, EUR J CELL BIOL, V63, P247; Vittet D, 1996, BLOOD, V88, P3424, DOI 10.1182/blood.V88.9.3424.bloodjournal8893424; Viviano BL, 2004, J BIOL CHEM, V279, P5604, DOI 10.1074/jbc.M310691200; Ward CM, 2003, J CELL SCI, V116, P4533, DOI 10.1242/jcs.00767; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	41	37	38	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6241	6252		10.1074/jbc.M110.178483	http://dx.doi.org/10.1074/jbc.M110.178483			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21148566	Green Published, hybrid			2022-12-27	WOS:000287476400034
J	Takawira, D; Budinger, GRS; Hopkinson, SB; Jones, JCR				Takawira, Desire; Budinger, G. R. Scott; Hopkinson, Susan B.; Jones, Jonathan C. R.			A Dystroglycan/Plectin Scaffold Mediates Mechanical Pathway Bifurcation in Lung Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; ACETYL-COA CARBOXYLASE; DYSTROPHIN-GLYCOPROTEIN COMPLEX; EPIDERMOLYSIS-BULLOSA; SIGNAL-TRANSDUCTION; MUSCULAR-DYSTROPHY; BETA-DYSTROGLYCAN; TIDAL VOLUME; PLECTIN; BINDING	In alveolar epithelial cells (AECs), the membrane-anchored proteoglycan dystroglycan (DG) is a mechanoreceptor that transmits mechanical stretch forces to activate independently the ERK1/2 and the adenosine 5'-monophosphate-activated protein kinase (AMPK) signaling cascades in a process called pathway bifurcation. We tested the hypothesis that the cytoskeleton cross-linker plectin, known to bind both DG and AMPK in muscle cells, acts as a scaffold to regulate DG-mediated mechanical stimulation and pathway bifurcation. We demonstrate that plectin and DG form a complex in AECs and that this complex interacts with ERK1/2 and AMPK. Plectin knockdown reduces DG interaction with AMPK but not with ERK1/2. Despite this, mechanoactivation of both signaling pathways is significantly attenuated in AECs deficient in plectin. Thus, DG has the dual role of mechanical receptor and scaffold for ERK1/2, whereas plectin acts as a scaffold for AMPK signaling but is also required for DG-mediated ERK1/2 activation. We conclude that the DG-plectin complex plays a central role in transmitting mechanical stress from the extracellular matrix to the cytoplasm.	[Jones, Jonathan C. R.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Budinger, G. R. Scott; Jones, Jonathan C. R.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Jones, JCR (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA.	j-jones3@northwestern.edu	Jones, Jonathan C R/T-9467-2017	Jones, Jonathan C R/0000-0002-1496-4922	National Institutes of Health [RO1 HL092963]; American Heart Association (Midwest Affiliate) [0815527G]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (Midwest Affiliate)(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HL092963 (to J. C. R. J. and G. R. S. B.).; Supported by Predoctoral Fellowship Award 0815527G from the American Heart Association (Midwest Affiliate).	Arreola-Mendoza L, 2009, TOXICOL LETT, V191, P279, DOI 10.1016/j.toxlet.2009.09.011; Barresi R, 2006, J CELL SCI, V119, P199, DOI 10.1242/jcs.02814; Bodart JFL, 2010, J CELL BIOCHEM, V109, P850, DOI 10.1002/jcb.22477; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Bozzi M, 2009, MATRIX BIOL, V28, P179, DOI 10.1016/j.matbio.2009.03.003; Budinger GRS, 2008, AM J RESP CELL MOL, V39, P666, DOI 10.1165/rcmb.2007-0432OC; Cohen TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010385; CORBRIDGE TC, 1990, AM REV RESPIR DIS, V142, P311, DOI 10.1164/ajrccm/142.2.311; Correa-Meyer E, 2002, AM J PHYSIOL-LUNG C, V282, pL883, DOI 10.1152/ajplung.00203.2001; DAVIES SP, 1990, EUR J BIOCHEM, V187, P183, DOI 10.1111/j.1432-1033.1990.tb15293.x; DeBiase PJ, 2006, J HISTOCHEM CYTOCHEM, V54, P665, DOI 10.1369/jhc.5A6889.2006; DREYFUSS D, 1988, AM REV RESPIR DIS, V137, P1159, DOI 10.1164/ajrccm/137.5.1159; DRISCOLL KE, 1995, IN VITRO CELL DEV-AN, V31, P516; Durbeej M, 1999, J BIOL CHEM, V274, P26609, DOI 10.1074/jbc.274.37.26609; Edwards YS, 2001, COMP BIOCHEM PHYS A, V129, P245, DOI 10.1016/S1095-6433(01)00321-X; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Feng YY, 1998, CURR BIOL, V8, P267, DOI 10.1016/S0960-9822(98)70108-3; GEE SH, 1993, J BIOL CHEM, V268, P14972; Gregor M, 2006, J CELL SCI, V119, P1864, DOI 10.1242/jcs.02891; Harlow E, 1988, ANTIBODIES LABORATOR, P471; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Hijikata T, 2003, HISTOCHEM CELL BIOL, V119, P109, DOI 10.1007/s00418-003-0496-5; Holt KH, 2000, FEBS LETT, V468, P79, DOI 10.1016/S0014-5793(00)01195-9; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Ilsley JL, 2001, CELL SIGNAL, V13, P625, DOI 10.1016/S0898-6568(01)00188-7; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; Jones JCR, 2005, J CELL SCI, V118, P2557, DOI 10.1242/jcs.02395; Karagounis LG, 2009, INT J BIOCHEM CELL B, V41, P2360, DOI 10.1016/j.biocel.2009.07.004; KIM KH, 1989, FASEB J, V3, P2250, DOI 10.1096/fasebj.3.11.2570725; KLATTE DH, 1989, J CELL BIOL, V109, P3377, DOI 10.1083/jcb.109.6.3377; Koster J, 2004, MOL BIOL CELL, V15, P1211, DOI 10.1091/mbc.E03-09-0697; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Liu MY, 1999, AM J PHYSIOL-LUNG C, V277, pL667, DOI 10.1152/ajplung.1999.277.4.L667; Lunter PC, 2002, BIOCHEM BIOPH RES CO, V296, P904, DOI 10.1016/S0006-291X(02)02007-7; Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; McLean WHI, 1996, GENE DEV, V10, P1724, DOI 10.1101/gad.10.14.1724; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; Moore CJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-3; MUNDAY MR, 1988, EUR J BIOCHEM, V175, P331, DOI 10.1111/j.1432-1033.1988.tb14201.x; Na S, 2009, AM J PHYSIOL-CELL PH, V296, pC868, DOI 10.1152/ajpcell.00604.2008; Osmanagic-Myers S, 2004, J BIOL CHEM, V279, P18701, DOI 10.1074/jbc.M312382200; Osmanagic-Myers S, 2006, J CELL BIOL, V174, P557, DOI 10.1083/jcb.200605172; Pryciak PM, 1998, GENE DEV, V12, P2684, DOI 10.1101/gad.12.17.2684; Reichelt J, 2007, EUR J CELL BIOL, V86, P807, DOI 10.1016/j.ejcb.2007.06.004; Rezniczek GA, 2007, J CELL BIOL, V176, P965, DOI 10.1083/jcb.200604179; Schaeffer HJ, 1998, SCIENCE, V281, P1668, DOI 10.1126/science.281.5383.1668; Shimizu H, 1999, J BIOL CHEM, V274, P11995, DOI 10.1074/jbc.274.17.11995; SMALHEISER NR, 1987, P NATL ACAD SCI USA, V84, P6457, DOI 10.1073/pnas.84.18.6457; SMALHEISER NR, 1995, J BIOL CHEM, V270, P15425, DOI 10.1074/jbc.270.25.15425; Smith FJD, 1996, NAT GENET, V13, P450, DOI 10.1038/ng0896-450; Spence HJ, 2004, EMBO REP, V5, P484, DOI 10.1038/sj.embor.7400140; Tsunozaki M, 2009, CURR OPIN NEUROBIOL, V19, P362, DOI 10.1016/j.conb.2009.07.008; van der Flier A, 2001, CELL TISSUE RES, V305, P285, DOI 10.1007/s004410100417; Vlahakis NE, 2005, AM J RESP CRIT CARE, V171, P1328, DOI 10.1164/rccm.200408-1036SO; Weir ML, 2006, J CELL SCI, V119, P4047, DOI 10.1242/jcs.03103; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Wiche G, 1998, J CELL SCI, V111, P2477; Winder WW, 1997, J APPL PHYSIOL, V82, P219, DOI 10.1152/jappl.1997.82.1.219; Wirtz HR, 2000, RESP PHYSIOL, V119, P1, DOI 10.1016/S0034-5687(99)00092-4; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	65	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6301	6310		10.1074/jbc.M110.178988	http://dx.doi.org/10.1074/jbc.M110.178988			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21149456	hybrid, Green Published			2022-12-27	WOS:000287476400040
J	Tanaka, M; Mazuyama, E; Arakaki, A; Matsunaga, T				Tanaka, Masayoshi; Mazuyama, Eri; Arakaki, Atsushi; Matsunaga, Tadashi			MMS6 Protein Regulates Crystal Morphology during Nano-sized Magnetite Biomineralization in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP STRAIN AMB-1; COMPLETE GENOME SEQUENCE; MAGNETOTACTIC BACTERIA; MAGNETOSPIRILLUM-MAGNETICUM; PROTEOMIC ANALYSIS; MAGNETOSOMES; REVEALS; GROWTH; CRYSTALLIZATION; NANOCRYSTALS	Biomineralization, the process by which minerals are deposited by organisms, has attracted considerable attention because this mechanism has shown great potential to inspire bottom-up material syntheses. To understand the mechanism for morphological regulation that occurs during biomineralization, many regulatory proteins have been isolated from various biominerals. However, the molecular mechanisms that regulate the morphology of biominerals remain unclear because there is a lack of in vivo evidence. Magnetotactic bacteria synthesize intracellular magnetosomes that comprise membrane-enveloped single crystalline magnetite (Fe3O4). These nano-sized magnetite crystals (< 100 nm) are bacterial species dependent in shape and size. Mms6 is a protein that is tightly associated with magnetite crystals. Based on in vitro experiments, this protein was first implicated in morphological regulation during nano-sized magnetite biomineralization. In this study, we analyzed the mms6 gene deletion mutant (Delta mms6) of Magnetospirillum magneticum (M. magneticum) AMB-1. Surprisingly, the Delta mms6 strain was found to synthesize the smaller magnetite crystals with uncommon crystal faces, while the wild-type and complementation strains synthesized highly ordered cubo-octahedral crystals. Furthermore, deletion of mms6 gene led to drastic changes in the profiles of the proteins tightly bound to magnetite crystals. It was found that Mms6 plays a role in the in vivo regulation of the crystal structure to impart the cubo-octahedral morphology to the crystals during biomineralization in magnetotactic bacteria. Magnetotactic bacteria synthesize magnetite crystals under ambient conditions via a highly controlled morphological regulation system that uses biological molecules.	[Tanaka, Masayoshi; Mazuyama, Eri; Arakaki, Atsushi; Matsunaga, Tadashi] Tokyo Univ Agr & Technol, Dept Biotechnol, Tokyo 1848588, Japan	Tokyo University of Agriculture & Technology	Matsunaga, T (corresponding author), Tokyo Univ Agr & Technol, Dept Biotechnol, 2-24-16 Naka Cho, Tokyo 1848588, Japan.	tmatsuna@cc.tuat.ac.jp	Arakaki, Atsushi/B-9984-2013; Tanaka, Masayoshi/G-1072-2013; Matsunaga, Tadashi/A-6293-2015; Tanaka, Masayoshi/O-5259-2018	Arakaki, Atsushi/0000-0001-6692-9398; Tanaka, Masayoshi/0000-0002-4701-5352; Matsunaga, Tadashi/0000-0002-6216-3687; Tanaka, Masayoshi/0000-0002-4701-5352	Japan Society for the Promotion of Science (JSPS) [20246119]; Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [2206]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by a Grant-in-Aid for Scientific Research (A) (No. 20246119) from the Japan Society for the Promotion of Science (JSPS), and the Grant-in-Aid for Scientific Research on Innovative Areas of "Fusion Materials: Creative Development of Materials and Exploration of Their Function through Molecular Control" (No. 2206) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT).	Alphandery E, 2009, ACS NANO, V3, P1539, DOI 10.1021/nn900289n; Amemiya Y, 2007, BIOMATERIALS, V28, P5381, DOI 10.1016/j.biomaterials.2007.07.051; Arakaki A, 2003, J BIOL CHEM, V278, P8745, DOI 10.1074/jbc.M211729200; Arakaki A, 2010, J COLLOID INTERF SCI, V343, P65, DOI 10.1016/j.jcis.2009.11.043; Avasthi DK, 2010, J NANOSCI NANOTECHNO, V10, P3767, DOI 10.1166/jnn.2010.1979; Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; Colfen H, 2005, ANGEW CHEM INT EDIT, V44, P5576, DOI 10.1002/anie.200500496; De Yoreo JJ, 2007, CRYSTENGCOMM, V9, P1144, DOI 10.1039/b713006f; Devouard B, 1998, AM MINERAL, V83, P1387, DOI 10.2138/am-1998-11-1228; Faivre D, 2007, ANGEW CHEM INT EDIT, V46, P8495, DOI 10.1002/anie.200700927; Fukuda Y, 2006, FEBS LETT, V580, P801, DOI 10.1016/j.febslet.2006.01.003; Hu XL, 2010, LANGMUIR, V26, P3031, DOI 10.1021/la902142b; Jogler C, 2009, ENVIRON MICROBIOL, V11, P1267, DOI 10.1111/j.1462-2920.2009.01854.x; Komeili A, 2006, SCIENCE, V311, P242, DOI 10.1126/science.1123231; Kwak SY, 2009, J BIOL CHEM, V284, P18972, DOI 10.1074/jbc.M109.020370; Lakshminarayanan R, 2002, P NATL ACAD SCI USA, V99, P5155, DOI 10.1073/pnas.072658899; Maeda Y, 2008, APPL ENVIRON MICROB, V74, P5139, DOI 10.1128/AEM.00618-08; Matsunaga T, 2005, DNA RES, V12, P157, DOI 10.1093/dnares/dsi002; Matsunaga T, 2009, PROTEOMICS, V9, P3341, DOI 10.1002/pmic.200800881; Murat D, 2010, P NATL ACAD SCI USA, V107, P5593, DOI 10.1073/pnas.0914439107; NAKAMURA C, 1995, J BIOL CHEM, V270, P28392; Nakazawa H, 2009, GENOME RES, V19, P1801, DOI 10.1101/gr.088906.108; Oaki K, 2005, ANGEW CHEM INT EDIT, V44, P6571, DOI 10.1002/anie.200500338; Oaki Y, 2006, ADV FUNCT MATER, V16, P1633, DOI 10.1002/adfm.200600262; Okamura Y, 2003, APPL ENVIRON MICROB, V69, P4274, DOI 10.1128/AEM.69.7.4274-4277.2003; Okamura Y, 2001, J BIOL CHEM, V276, P48183, DOI 10.1074/jbc.M106408200; Posfai M, 1998, AM MINERAL, V83, P1469, DOI 10.2138/am-1998-11-1235; Radha AV, 2010, P NATL ACAD SCI USA, V107, P16438, DOI 10.1073/pnas.1009959107; Richter M, 2007, J BACTERIOL, V189, P4899, DOI 10.1128/JB.00119-07; SAKAGUCHI T, 1993, NATURE, V365, P47, DOI 10.1038/365047a0; Scheffel A, 2006, NATURE, V440, P110, DOI 10.1038/nature04382; Scheffel A, 2008, J BACTERIOL, V190, P377, DOI 10.1128/JB.01371-07; Schubbe S, 2003, J BACTERIOL, V185, P5779, DOI 10.1128/JB.185.19.5779-5790.2003; Schubbe S, 2009, APPL ENVIRON MICROB, V75, P4835, DOI 10.1128/AEM.02874-08; Taller A, 2007, BIOPHYS J, V93, P1768, DOI 10.1529/biophysj.106.101881; Tanaka M, 2006, PROTEOMICS, V6, P5234, DOI 10.1002/pmic.200500887; Tanaka M, 2010, APPL ENVIRON MICROB, V76, P5526, DOI 10.1128/AEM.00589-10; Tanaka M, 2010, MOL MICROBIOL, V76, P480, DOI 10.1111/j.1365-2958.2010.07117.x; Taoka A, 2007, J BACTERIOL, V189, P8737, DOI 10.1128/JB.00899-07; Teng HH, 1998, SCIENCE, V282, P724, DOI 10.1126/science.282.5389.724; Tian N, 2007, SCIENCE, V316, P732, DOI 10.1126/science.1140484; Wang TX, 2005, J AM CHEM SOC, V127, P3246, DOI 10.1021/ja045331g; Xiao JW, 2010, LANGMUIR, V26, P4977, DOI 10.1021/la903641k; Yang CD, 2001, ENZYME MICROB TECH, V29, P13, DOI 10.1016/S0141-0229(01)00343-X; Yoshino T, 2004, APPL ENVIRON MICROB, V70, P2880, DOI 10.1128/AEM.70.5.2880-2885.2004; Zhang J. S., 2003, SELF ASSEMBLED NANOS	46	127	136	2	64	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6386	6392		10.1074/jbc.M110.183434	http://dx.doi.org/10.1074/jbc.M110.183434			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21169637	Green Published, hybrid			2022-12-27	WOS:000287476400049
J	Young, JA; Sermwittayawong, D; Kim, HJ; Nandu, S; An, N; Erdjument-Bromage, H; Tempst, P; Coscoy, L; Winoto, A				Young, Jennifer A.; Sermwittayawong, Decha; Kim, Hee-Jung; Nandu, Suruchi; An, Namsil; Erdjument-Bromage, Hediye; Tempst, Paul; Coscoy, Laurent; Winoto, Astar			Fas-associated Death Domain (FADD) and the E3 Ubiquitin-Protein Ligase TRIM21 Interact to Negatively Regulate Virus-induced Interferon Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-RECEPTOR; DOUBLE-STRANDED-RNA; AUTOANTIGEN RO52; INNATE IMMUNITY; CUTTING EDGE; CYTOKINE EXPRESSION; ANTIVIRAL RESPONSE; MASS-SPECTROMETRY; FAMILY PROTEINS; BETA PRODUCTION	The production of cytokines such as type I interferon (IFN) is an essential component of innate immunity. Insufficient amounts of cytokines lead to host sensitivity to infection, whereas abundant cytokine production can lead to inflammation. A tight regulation of cytokine production is, thus, essential for homeostasis of the immune system. IFN-alpha production during RNA virus infection is mediated by the master transcription factor IRF7, which is activated upon ubiquitination by TRAF6 and phosphorylation by IKK epsilon and TBK1 kinases. We found that Fas-associated death domain (FADD), first described as an apoptotic protein, is involved in regulating IFN-alpha production through a novel interaction with TRIM21. TRIM21 is a member of a large family of proteins that can impart ubiquitin modification onto its cellular targets. The interaction between FADD and TRIM21 enhances TRIM21 ubiquitin ligase activity, and together they cooperatively repress IFN-alpha activation in Sendai virus-infected cells. FADD and TRIM21 can directly ubiquitinate IRF7, affect its phosphorylation status, and interfere with the ubiquitin ligase activity of TRAF6. Conversely, a reduction of FADD and TRIM21 levels leads to higher IFN-alpha induction, IRF7 phosphorylation, and lower titers of RNA virus of infected cells. We conclude that FADD and TRIM21 together negatively regulate the late IFN-alpha pathway in response to viral infection.	[Young, Jennifer A.; Sermwittayawong, Decha; Kim, Hee-Jung; Nandu, Suruchi; An, Namsil; Coscoy, Laurent; Winoto, Astar] Univ Calif Berkeley, Canc Res Lab, Berkeley, CA 94720 USA; [Young, Jennifer A.; Sermwittayawong, Decha; Kim, Hee-Jung; Nandu, Suruchi; An, Namsil; Coscoy, Laurent; Winoto, Astar] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 94720 USA; [Erdjument-Bromage, Hediye; Tempst, Paul] Mem Sloan Kettering Canc Ctr, Mol Biol Programs, New York, NY 10065 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Memorial Sloan Kettering Cancer Center	Winoto, A (corresponding author), Univ Calif Berkeley, Canc Res Lab, 465 LSA, Berkeley, CA 94720 USA.	winoto@berkeley.edu	Sermwittayawong, Decha/AAX-1695-2020	Sermwittayawong, Decha/0000-0001-8941-3642; Tempst, Paul/0000-0002-6680-3987; Erdjument-Bromage, Hediye/0000-0003-0224-3594	National Institutes of Health [PO1AI065831]; NCI Cancer Center Support Grant [P30 CA08748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI065831] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health grants PO1AI065831 (to L. C. and A. W.) and NCI Cancer Center Support Grant P30 CA08748.	Balachandran S, 2004, NATURE, V432, P401, DOI 10.1038/nature03124; Balachandran S, 2007, J IMMUNOL, V178, P2429, DOI 10.4049/jimmunol.178.4.2429; Beisner DR, 2005, J IMMUNOL, V175, P3469, DOI 10.4049/jimmunol.175.6.3469; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894; Chaudhary PM, 2000, ONCOGENE, V19, P4451, DOI 10.1038/sj.onc.1203812; Chelbi-Alix MK, 1998, J VIROL, V72, P1043, DOI 10.1128/JVI.72.2.1043-1051.1998; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Curto M, 2004, CANCER CELL, V5, P113, DOI 10.1016/S1535-6108(04)00031-5; Eberstadt M, 1998, NATURE, V392, P941, DOI 10.1038/31972; Erdjument-Bromage H, 1998, J CHROMATOGR A, V826, P167, DOI 10.1016/S0021-9673(98)00705-5; Espinosa A, 2006, J IMMUNOL, V176, P6277, DOI 10.4049/jimmunol.176.10.6277; Espinosa A, 2009, J EXP MED, V206, P1661, DOI 10.1084/jem.20090585; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Higgs R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011776; Hiscott J, 2006, TRENDS MOL MED, V12, P53, DOI 10.1016/j.molmed.2005.12.003; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hsu HL, 1996, CELL, V84, P299, DOI 10.1016/S0092-8674(00)80984-8; Imtiyaz HZ, 2006, J IMMUNOL, V176, P6852, DOI 10.4049/jimmunol.176.11.6852; Jeong EJ, 1999, J BIOL CHEM, V274, P16337, DOI 10.1074/jbc.274.23.16337; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Komatsu T, 2004, VIROLOGY, V325, P137, DOI 10.1016/j.virol.2004.04.025; Kong HJ, 2007, J IMMUNOL, V179, P26, DOI 10.4049/jimmunol.179.1.26; Konno H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005674; Leulier F, 2002, CURR BIOL, V12, P996, DOI 10.1016/S0960-9822(02)00873-4; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Naitza S, 2002, IMMUNITY, V17, P575, DOI 10.1016/S1074-7613(02)00454-5; Ning SB, 2008, MOL CELL BIOL, V28, P6536, DOI 10.1128/MCB.00785-08; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Poole E, 2002, VIROLOGY, V303, P33, DOI 10.1006/viro.2002.1737; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Sabile A, 2006, MOL CELL BIOL, V26, P5994, DOI 10.1128/MCB.01630-05; Sandu C, 2006, CELL DEATH DIFFER, V13, P2052, DOI 10.1038/sj.cdd.4401966; Scott FL, 2009, NATURE, V457, P1019, DOI 10.1038/nature07606; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; STETSON DB, 2006, J EXP MED, V203, pIL2; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Vanden Berghe T, 2004, J BIOL CHEM, V279, P7925, DOI 10.1074/jbc.M307807200; Wada K, 2006, BIOCHEM BIOPH RES CO, V339, P415, DOI 10.1016/j.bbrc.2005.11.029; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wilson NS, 2009, NAT IMMUNOL, V10, P348, DOI 10.1038/ni.1714; Winkler GS, 2002, METHODS, V26, P260, DOI 10.1016/S1046-2023(02)00030-0; Yang K, 2009, J IMMUNOL, V182, P3782, DOI 10.4049/jimmunol.0803126; Yoshimi R, 2009, J IMMUNOL, V182, P7527, DOI 10.4049/jimmunol.0804121; Zhang M, 2008, CELL RES, V18, P1096, DOI 10.1038/cr.2008.277	58	48	50	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6521	6531		10.1074/jbc.M110.172288	http://dx.doi.org/10.1074/jbc.M110.172288			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21183682	Green Published, hybrid			2022-12-27	WOS:000287476400062
J	Sanchez-Martin, D; Cuesta, AM; Fogal, V; Ruoslahti, E; Alvarez-Vallina, L				Sanchez-Martin, David; Cuesta, Angel M.; Fogal, Valentina; Ruoslahti, Erkki; Alvarez-Vallina, Luis			The Multicompartmental p32/gClqR as a New Target for Antibody-based Tumor Targeting Strategies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; ENDOTHELIAL-CELLS; IN-VIVO; BINDING-PROTEIN; HOMING PEPTIDE; GLOBULAR HEADS; SURFACE; C1Q; LOCALIZATION; EXPRESSION	Tumor-associated cell surface antigens and tumor-associated vascular markers have been used as a target for cancer intervention strategies. However, both types of targets have limitations due to accessibility, low and/or heterogeneous expression, and presence of tumor-associated serum antigen. It has been previously reported that a mitochondrial/cell surface protein, p32/gC1qR, is the receptor for a tumor-homing peptide, LyP-1, which specifically recognizes an epitope in tumor cells, tumor lymphatics, and tumor-associated macrophages/myeloid cells. Using antibody phage technology, we have generated an anti-p32 human monoclonal antibody (2.15). The 2.15 antibody, expressed in single-chain fragment variable and in trimerbody format, was then characterized in vivo using mice grafted subcutaneously with MDA-MB-231 human breast cancers cells, revealing a highly selective tumor uptake. The intratumoral distribution of the antibody was consistent with the expression pattern of p32 in the surface of some clusters of cells. These results demonstrate the potential of p32 for antibody-based tumor targeting strategies and the utility of the 2.15 antibody as targeting moiety for the selective delivery of imaging and therapeutic agents to tumors.	[Alvarez-Vallina, Luis] Hosp Univ Puerta Hierro, Unidad Inmunol Mol, Madrid 28222, Spain; [Fogal, Valentina; Ruoslahti, Erkki] Sanford Burnham Med Res Inst, Canc Res Ctr, La Jolla, CA 92037 USA; [Ruoslahti, Erkki] Univ Calif Santa Barbara, Vasc Mapping Ctr, Sanford Burnham Med Res Inst, Santa Barbara, CA 93106 USA	Hospital Puerta de Hierro-Majadahonda; Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California Santa Barbara	Alvarez-Vallina, L (corresponding author), Hosp Univ Puerta Hierro, Unidad Inmunol Mol, C Manuel Falla 1, Madrid 28222, Spain.	lalvarezv.hpth@salud.madrid.org	Cuesta, Angel/F-1668-2011; AM, Cuesta/AAA-9356-2020; Sánchez-Martín, David/C-9927-2013; Álvarez-Vallina, Luis/A-2032-2010; Alvarez-Vallina, Luis/ABD-2431-2020; Alvarez-Vallina, Luis/A-2033-2010	Cuesta, Angel/0000-0002-6596-9600; AM, Cuesta/0000-0002-6596-9600; Sánchez-Martín, David/0000-0002-2712-4762; Alvarez-Vallina, Luis/0000-0003-3053-6757; 	Ministerio de Ciencia e Innovacion [BIO2008-03233]; Comunidad Autonoma de Madrid [BIO-0236-2006]; European Union [SUDOE-FEDER (IMMUNONET-SOE1/P1/E014]; U.S. Department of Defense; Comunidad Autonoma de Madrid/Fondo Social Europeo Training [FPI-000531]; Susan Komen Foundation	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); European Union(European Commission); U.S. Department of Defense(United States Department of Defense); Comunidad Autonoma de Madrid/Fondo Social Europeo Training(Comunidad de Madrid); Susan Komen Foundation(Susan G. Komen Breast Cancer Foundation)	This work was supported by grants from the Ministerio de Ciencia e Innovacion (BIO2008-03233), the Comunidad Autonoma de Madrid (S-BIO-0236-2006), the European Union (SUDOE-FEDER (IMMUNONET-SOE1/P1/E014; to L.A.-V.), and a grant from the U.S. Department of Defense Breast Cancer Program (to E. R.).; Supported by Comunidad Autonoma de Madrid/Fondo Social Europeo Training Grant FPI-000531.; Supported a fellowship from the Susan Komen Foundation.	Begent RHJ, 1996, NAT MED, V2, P979, DOI 10.1038/nm0996-979; Birchler M, 1999, J IMMUNOL METHODS, V231, P239, DOI 10.1016/S0022-1759(99)00160-X; Birchler MT, 2007, OTOLARYNG HEAD NECK, V136, P543, DOI 10.1016/j.otohns.2006.07.027; Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458; Buchsbaum GM, 2004, INT UROGYNECOL J, V15, P432, DOI 10.1007/s00192-004-1181-5; CARTER P, 1985, NUCLEIC ACIDS RES, V13, P4431, DOI 10.1093/nar/13.12.4431; Cuesta AM, 2010, TRENDS BIOTECHNOL, V28, P355, DOI 10.1016/j.tibtech.2010.03.007; Cuesta AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005381; Dedio J, 1996, FEBS LETT, V399, P255, DOI 10.1016/S0014-5793(96)01339-7; Eggleton P, 2000, CLIN EXP IMMUNOL, V120, P406, DOI 10.1046/j.1365-2249.2000.01218.x; EGGLETON P, 1995, J CLIN INVEST, V95, P1569, DOI 10.1172/JCI117830; Fogal V, 2008, CANCER RES, V68, P7210, DOI 10.1158/0008-5472.CAN-07-6752; GHEBREHIWET B, 1994, J EXP MED, V179, P1809, DOI 10.1084/jem.179.6.1809; Gibson T., 1984, THESIS U CAMBRIDGE C; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; GUPTA S, 1991, EUR J CELL BIOL, V56, P58; Harries M, 2002, ENDOCR-RELAT CANCER, V9, DOI 10.1677/erc.0.0090075; HAWKINS RE, 1992, J MOL BIOL, V226, P889, DOI 10.1016/0022-2836(92)90639-2; JACOBSSON H, 1994, EUR J NUCL MED, V21, P582; Karmali PP, 2009, NANOMED-NANOTECHNOL, V5, P73, DOI 10.1016/j.nano.2008.07.007; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; KRAINER AR, 1991, CELL, V66, P383, DOI 10.1016/0092-8674(91)90627-B; Kristensen P, 1998, FOLD DES, V3, P321, DOI 10.1016/S1359-0278(98)00044-3; Kuna P, 1996, CLIN IMMUNOL IMMUNOP, V81, P48, DOI 10.1006/clin.1996.0156; Laakkonen P, 2004, P NATL ACAD SCI USA, V101, P9381, DOI 10.1073/pnas.0403317101; Laakkonen P, 2002, NAT MED, V8, P751, DOI 10.1038/nm720; Lynch NJ, 1997, FEBS LETT, V418, P111, DOI 10.1016/S0014-5793(97)01348-3; Mahdi F, 2002, BLOOD, V99, P3585, DOI 10.1182/blood.V99.10.3585; Mahdi F, 2001, BLOOD, V97, P2342, DOI 10.1182/blood.V97.8.2342; McDevitt MR, 2000, CANCER RES, V60, P6095; Neri D, 1997, NAT BIOTECHNOL, V15, P1271, DOI 10.1038/nbt1197-1271; Nguyen BD, 2009, CURR PROBL DIAGN RAD, V38, P68, DOI 10.1067/j.cpradiol.2007.10.003; NISSIM A, 1994, EMBO J, V13, P692, DOI 10.1002/j.1460-2075.1994.tb06308.x; OIKI S, 1988, J IMMUNOL, V141, P3177; Peerschke EIB, 1996, J IMMUNOL, V157, P4154; PEERSCHKE EIB, 1994, J IMMUNOL, V152, P5896; Retter I, 2005, NUCLEIC ACIDS RES, V33, pD671, DOI 10.1093/nar/gki088; Ruoslahti E, 2010, J CELL BIOL, V188, P759, DOI 10.1083/jcb.200910104; Sanz L, 2002, GENE THER, V9, P1049, DOI 10.1038/sj.gt.3301725; Sanz L, 2001, CANCER IMMUNOL IMMUN, V50, P557, DOI 10.1007/s00262-001-0235-5; Silacci M, 2006, PROTEIN ENG DES SEL, V19, P471, DOI 10.1093/protein/gzl033; Steffen AC, 2006, EUR J NUCL MED MOL I, V33, P631, DOI 10.1007/s00259-005-0012-3; Steinberger P, 2002, J LEUKOCYTE BIOL, V71, P133; Teesalu T, 2009, P NATL ACAD SCI USA, V106, P16157, DOI 10.1073/pnas.0908201106; vandenBerg RH, 1997, J IMMUNOL, V158, P3909; Vegh Z, 2003, INT IMMUNOPHARMACOL, V3, P345, DOI 10.1016/S1567-5769(02)00234-5; VOGEL CA, 1993, BRIT J CANCER, V68, P684, DOI 10.1038/bjc.1993.410; YU L, 1995, J VIROL, V69, P3017, DOI 10.1128/JVI.69.5.3017-3023.1995	48	34	35	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5197	5203		10.1074/jbc.M110.161927	http://dx.doi.org/10.1074/jbc.M110.161927			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21156793	hybrid, Green Published			2022-12-27	WOS:000287230600028
J	Bulusu, V; Jayaraman, V; Balaram, H				Bulusu, Vinay; Jayaraman, Vijay; Balaram, Hemalatha			Metabolic Fate of Fumarate, a Side Product of the Purine Salvage Pathway in the Intraerythrocytic Stages of Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBON-DIOXIDE FIXATION; DIHYDROOROTATE DEHYDROGENASE; ASPARTATE-AMINOTRANSFERASE; ENERGY-METABOLISM; NUCLEOTIDE CYCLE; MALATE-QUINONE; MALARIA; LOCALIZATION; MITOCHONDRIA; SPECIFICITY	In aerobic respiration, the tricarboxylic acid cycle is pivotal to the complete oxidation of carbohydrates, proteins, and lipids to carbon dioxide and water. Plasmodium falciparum, the causative agent of human malaria, lacks a conventional tricarboxylic acid cycle and depends exclusively on glycolysis for ATP production. However, all of the constituent enzymes of the tricarboxylic acid cycle are annotated in the genome of P. falciparum, which implies that the pathway might have important, yet unidentified biosynthetic functions. Here we show that fumarate, a side product of the purine salvage pathway and a metabolic intermediate of the tricarboxylic acid cycle, is not a metabolic waste but is converted to aspartate through malate and oxaloacetate. P. falciparum-infected erythrocytes and free parasites incorporated [2,3-C-14] fumarate into the nucleic acid and protein fractions. C-13 NMR of parasites incubated with [2,3-C-13] fumarate showed the formation of malate, pyruvate, lactate, and aspartate but not citrate or succinate. Further, treatment of free parasites with atovaquone inhibited the conversion of fumarate to aspartate, thereby indicating this pathway as an electron transport chain-dependent process. This study, therefore, provides a biosynthetic function for fumarate hydratase, malate quinone oxidoreductase, and aspartate aminotransferase of P. falciparum.	[Bulusu, Vinay; Jayaraman, Vijay; Balaram, Hemalatha] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Balaram, H (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India.	hb@jncasr.ac.in		Bulusu, Vinay/0000-0002-6006-8766	Department of Science and Technology, India; University Grants Commission-Council for Scientific and Industrial Research (UGC-CSIR); CSIR	Department of Science and Technology, India(Department of Science & Technology (India)); University Grants Commission-Council for Scientific and Industrial Research (UGC-CSIR); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Department of Science and Technology, India.; Supported by a University Grants Commission-Council for Scientific and Industrial Research (UGC-CSIR) senior research fellowship.; Supported by a CSIR junior research fellowship.	Aragon J J, 1981, Curr Top Cell Regul, V18, P131; ARAGON JJ, 1980, EUR J BIOCHEM, V110, P371, DOI 10.1111/j.1432-1033.1980.tb04877.x; Berger LC, 2001, J BACTERIOL, V183, P4421, DOI 10.1128/JB.183.15.4421-4434.2001; BLUM JJ, 1984, J PROTOZOOL, V31, P167, DOI 10.1111/j.1550-7408.1984.tb04310.x; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; BRYANT C, 1964, AM J TROP MED HYG, V13, P515, DOI 10.4269/ajtmh.1964.13.515; Bulusu V, 2009, BBA-PROTEINS PROTEOM, V1794, P642, DOI 10.1016/j.bbapap.2008.11.021; Carlton JM, 2002, NATURE, V419, P512, DOI 10.1038/nature01099; Cassera MB, 2008, J BIOL CHEM, V283, P32889, DOI 10.1074/jbc.M804497200; CHEN JJ, 1976, ARCH BIOCHEM BIOPHYS, V176, P82, DOI 10.1016/0003-9861(76)90143-0; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Coustou V, 2006, J BIOL CHEM, V281, P26832, DOI 10.1074/jbc.M601377200; Downie MJ, 2008, EUKARYOT CELL, V7, P1231, DOI 10.1128/EC.00159-08; Foth BJ, 2005, MOL MICROBIOL, V55, P39, DOI 10.1111/j.1365-2958.2004.04407.x; FRY M, 1991, PARASITOLOGY, V102, P17, DOI 10.1017/S0031182000060297; FRYDMAN B, 1990, EUR J BIOCHEM, V192, P363, DOI 10.1111/j.1432-1033.1990.tb19235.x; Hodges M, 2005, MOL BIOCHEM PARASIT, V143, P29, DOI 10.1016/j.molbiopara.2005.05.004; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kather B, 2000, J BACTERIOL, V182, P3204, DOI 10.1128/JB.182.11.3204-3209.2000; Kirk K, 1996, MOL BIOCHEM PARASIT, V82, P195, DOI 10.1016/0166-6851(96)02734-X; KRUNGKRAI J, 1995, BBA-GEN SUBJECTS, V1243, P351, DOI 10.1016/0304-4165(94)00158-T; Laloi M, 1999, CELL MOL LIFE SCI, V56, P918, DOI 10.1007/s000180050484; Lian LY, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-38; Mather MW, 2005, J BIOL CHEM, V280, P27458, DOI 10.1074/jbc.M502319200; Olszewski KL, 2010, NATURE, V466, P774, DOI 10.1038/nature09301; Olszewski KL, 2009, CELL HOST MICROBE, V5, P191, DOI 10.1016/j.chom.2009.01.004; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Pradhan A, 2009, MOL CELL BIOCHEM, V325, P141, DOI 10.1007/s11010-009-0028-2; Raman J, 2004, MOL BIOCHEM PARASIT, V138, P1, DOI 10.1016/j.molbiopara.2004.06.013; RIVADENEIRA EM, 1983, J PROTOZOOL, V30, P367, DOI 10.1111/j.1550-7408.1983.tb02932.x; SHERMAN IW, 1979, MICROBIOL REV, V43, P453, DOI 10.1128/MMBR.43.4.453-495.1979; SHERMAN IW, 1966, NATURE, V212, P1387, DOI 10.1038/2121387a0; SHERMAN IW, 1968, COMP BIOCHEM PHYSIOL, V24, P639, DOI 10.1016/0010-406X(68)91018-9; Storm J, 2010, MALAR J S2, V9, pP49; Teng RW, 2009, NMR BIOMED, V22, P292, DOI 10.1002/nbm.1323; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Uyemura SA, 2004, J BIOL CHEM, V279, P385, DOI 10.1074/jbc.M307264200; Vaidya AB, 2009, ANNU REV MICROBIOL, V63, P249, DOI 10.1146/annurev.micro.091208.073424; van Dooren GG, 2006, FEMS MICROBIOL REV, V30, P596, DOI 10.1111/j.1574-6976.2006.00027.x; WINTER HC, 1989, PLANT PHYSIOL, V89, P1122, DOI 10.1104/pp.89.4.1122; Wrenger C, 2003, EUR J BIOCHEM, V270, P1775, DOI 10.1046/j.1432-1033.2003.03536.x; Wrenger C, 2011, J MOL BIOL, V405, P956, DOI 10.1016/j.jmb.2010.11.018	43	47	47	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9236	9245		10.1074/jbc.M110.173328	http://dx.doi.org/10.1074/jbc.M110.173328			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21209090	hybrid, Green Published			2022-12-27	WOS:000288247700054
J	Fulton, S; Thibault, D; Mendez, JA; Lahaie, N; Tirotta, E; Borrelli, E; Bouvier, M; Tempel, BL; Trudeau, LE				Fulton, Stephanie; Thibault, Dominic; Mendez, Jose A.; Lahaie, Nicolas; Tirotta, Emanuele; Borrelli, Emiliana; Bouvier, Michel; Tempel, Bruce L.; Trudeau, Louis-Eric			Contribution of Kv1.2 Voltage-gated Potassium Channel to D2 Autoreceptor Regulation of Axonal Dopamine Overflow	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROMULTIMERIC K+ CHANNELS; SUBSTANTIA-NIGRA; DEPENDENT REGULATION; RECEPTORS COUPLE; XENOPUS OOCYTES; ALPHA-SUBUNITS; MICE LACKING; G-PROTEINS; IN-VIVO; NEURONS	Impairments in axonal dopamine release are associated with neurological disorders such as schizophrenia and attention deficit hyperactivity disorder and pathophysiological conditions promoting drug abuse and obesity. The D2 dopamine autoreceptor (D2-AR) exerts tight regulatory control of axonal dopamine (DA) release through a mechanism suggested to involve K+ channels. To evaluate the contribution of Kv1 voltage-gated potassium channels of the Shaker gene family to the regulation of axonal DA release by the D2-AR, the present study employed expression analyses, real time measurements of striatal DA overflow, K+ current measurements and immunoprecipitation assays. Kv1.1, -1.2, -1.3, and -1.6 mRNA and protein were detected in midbrain DA neurons purified by fluorescence-activated cell sorting and in primary DA neuron cultures. In addition, Kv1.1, -1.2, and -1.6 were localized to DA axonal processes in the dorsal striatum. By means of fast scan cyclic voltammetry in striatal slice preparations, we found that the inhibition of stimulation-evoked DA overflow by a D2 agonist was attenuated by Kv1.1, -1.2, and -1.6 toxin blockers. A particular role for the Kv1.2 subunit in the process whereby axonal D2-AR inhibits DA overflow was established with the use of a selective Kv1.2 blocker and Kv1.2 knock-out mice. Moreover, we demonstrate the ability of D2-AR activation to increase Kv1.2 currents in co-transfected cells and its reliance on G beta gamma subunit signaling along with the physical coupling of D2-AR and Kv1.2-containing channels in striatal tissue. These findings underline the contribution of Kv1.2 in the regulation of nigrostriatal DA release by the D2-AR and thereby offer a novel mechanism by which DA release is regulated.	[Fulton, Stephanie; Thibault, Dominic; Mendez, Jose A.; Trudeau, Louis-Eric] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Fulton, Stephanie; Thibault, Dominic; Mendez, Jose A.; Trudeau, Louis-Eric] Univ Montreal, Grp Rech Syst Nerveux Cent, Montreal, PQ H3C 3J7, Canada; [Lahaie, Nicolas; Bouvier, Michel] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Lahaie, Nicolas; Bouvier, Michel] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Tirotta, Emanuele; Borrelli, Emiliana] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92617 USA; [Tempel, Bruce L.] Univ Washington, Dept Otolaryngol, Seattle, WA 98915 USA; [Tempel, Bruce L.] Univ Washington, Dept Pharmacol, Seattle, WA 98915 USA	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; University of California System; University of California Irvine; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Trudeau, LE (corresponding author), Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada.	louis-eric.trudeau@umontreal.ca	Trudeau, Louis-Eric/AAE-4782-2020; Bouvier, Michel/H-2758-2014; Mendez, J Alfredo/E-2031-2015; Borrelli, Emiliana/M-8994-2018	Trudeau, Louis-Eric/0000-0003-4684-1377; Bouvier, Michel/0000-0003-1128-0100; Mendez, J Alfredo/0000-0002-2859-7086; 	National Institutes of Health [RO1-DC002739, DA024689]; Canadian Institutes of Health Research [MOP-49591, MOP-10501]; Fonds de la Recherche en Sante du Quebec; Faculty of Graduate studies of Universite de Montreal; National Science and Engineering Research Council; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024689] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Faculty of Graduate studies of Universite de Montreal; National Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-DC002739 (to B.L.T.) and DA024689 (to E.B.), Canadian Institutes of Health Research Grant MOP-49591 and a Fonds de la Recherche en Sante du Quebec infrastructure grant to the Groupe de Recherche sur le Systeme Nerveux Central (to L.-E.T.), Canadian Institutes of Health Research Grant MOP-10501 (to M.B.), a studentship from the Canadian Institutes of Health Research and grant from the Faculty of Graduate studies of Universite de Montreal (to N.L.), and a National Science and Engineering Research Council postdoctoral fellowship (to S.F.).	BAIK JH, 1995, NATURE, V377, P424, DOI 10.1038/377424a0; Bath BD, 2000, ANAL CHEM, V72, P5994, DOI 10.1021/ac000849y; Birnbaum SG, 2004, PHYSIOL REV, V84, P803, DOI 10.1152/physrev.00039.2003; Bouvier D, 2008, J NEUROCHEM, V106, P682, DOI 10.1111/j.1471-4159.2008.05416.x; Brew HM, 2007, J NEUROPHYSIOL, V98, P1501, DOI 10.1152/jn.00640.2006; Carelli RM, 2004, CURR OPIN NEUROBIOL, V14, P763, DOI 10.1016/j.conb.2004.10.001; CASS WA, 1991, J NEUROCHEM, V57, P147, DOI 10.1111/j.1471-4159.1991.tb02109.x; Castle NA, 2003, MOL PHARMACOL, V63, P409, DOI 10.1124/mol.63.2.409; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; Congar P, 2002, J NEUROPHYSIOL, V87, P1046, DOI 10.1152/jn.00459.2001; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; CRESPO P, 1995, J BIOL CHEM, V270, P25259, DOI 10.1074/jbc.270.42.25259; DALTOSO R, 1989, EMBO J, V8, P4025, DOI 10.1002/j.1460-2075.1989.tb08585.x; Davila V, 2003, J NEUROSCI, V23, P5693; DEAL KK, 1994, J NEUROSCI, V14, P1666, DOI 10.1523/JNEUROSCI.14-03-01666.1994; Dodson PD, 2003, J PHYSIOL-LONDON, V550, P27, DOI 10.1113/jphysiol.2003.046250; FASANO C, 2008, CURR PROTOC NEUROSCI, V44; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Geiger BM, 2008, FASEB J, V22, P2740, DOI 10.1096/fj.08-110759; GIROS B, 1989, NATURE, V342, P923, DOI 10.1038/342923a0; GONON FG, 1985, NEUROSCIENCE, V14, P765, DOI 10.1016/0306-4522(85)90141-1; Grace AA, 2007, TRENDS NEUROSCI, V30, P220, DOI 10.1016/j.tins.2007.03.003; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Harvey AL, 2001, TOXICON, V39, P15, DOI 10.1016/S0041-0101(00)00162-8; Hochstetler SE, 2000, ANAL CHEM, V72, P489, DOI 10.1021/ac991119x; Hopkins WF, 1998, J PHARMACOL EXP THER, V285, P1051; Inanobe A, 1999, J NEUROSCI, V19, P1006; JOHN CE, 2006, ELECTROCHEMICAL METH, P49; Jomphe C, 2005, J NEUROSCI METH, V146, P1, DOI 10.1016/j.jneumeth.2005.01.014; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; LACEY MG, 1987, J PHYSIOL-LONDON, V392, P397, DOI 10.1113/jphysiol.1987.sp016787; Liss B, 2001, EMBO J, V20, P5715, DOI 10.1093/emboj/20.20.5715; Mendez JA, 2008, J NEUROSCI, V28, P6309, DOI 10.1523/JNEUROSCI.1331-08.2008; Misonou H, 2004, CRIT REV BIOCHEM MOL, V39, P125, DOI 10.1080/10409230490475417; MONTMAYEUR JP, 1993, MOL ENDOCRINOL, V7, P161, DOI 10.1210/me.7.2.161; Mouhat S, 2005, BIOCHEM J, V385, P95, DOI 10.1042/BJ20041379; Pillai G, 1998, NEUROPHARMACOLOGY, V37, P983, DOI 10.1016/S0028-3908(98)00092-6; Ramu Y, 2006, NATURE, V442, P696, DOI 10.1038/nature04880; Rasband W., 2006, IMAGEJ; Rhodes KJ, 2006, J NEUROSCI, V26, P8017, DOI 10.1523/JNEUROSCI.2728-06.2006; Rhodes KJ, 1997, J NEUROSCI, V17, P8246; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCOTT VES, 1994, BIOCHEMISTRY-US, V33, P1617, DOI 10.1021/bi00173a001; SHAPIRO MS, 1994, J NEUROSCI, V14, P7109; SHENG M, 1994, J NEUROSCI, V14, P2408; SHENG M, 1993, NATURE, V365, P72, DOI 10.1038/365072a0; SHENG M, 1992, NEURON, V9, P271, DOI 10.1016/0896-6273(92)90166-B; Southan AP, 1998, BRIT J PHARMACOL, V125, P1375, DOI 10.1038/sj.bjp.0702218; Tirotta E, 2008, CELL CYCLE, V7, P2241, DOI 10.4161/cc.7.14.6307; Tsai W, 1999, EMBO J, V18, P109, DOI 10.1093/emboj/18.1.109; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Volkow ND, 1997, NATURE, V386, P830, DOI 10.1038/386830a0; Wang FC, 1999, EUR J BIOCHEM, V263, P222, DOI 10.1046/j.1432-1327.1999.00494.x; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WANG H, 1994, J NEUROSCI, V14, P4588; Werner P, 1996, MOL PHARMACOL, V49, P656; Williams MR, 2007, P NATL ACAD SCI USA, V104, P17412, DOI 10.1073/pnas.0703865104; Wu ZZ, 2009, J BIOL CHEM, V284, P36453, DOI 10.1074/jbc.M109.075523	59	35	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9360	9372		10.1074/jbc.M110.153262	http://dx.doi.org/10.1074/jbc.M110.153262			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21233214	hybrid, Green Published			2022-12-27	WOS:000288247700065
J	Haithcock, J; Billington, N; Choi, K; Fordham, J; Sellers, JR; Stafford, WF; White, H; Forgacs, E				Haithcock, Jessica; Billington, Neil; Choi, Kevin; Fordham, Jennifer; Sellers, James R.; Stafford, Walter F.; White, Howard; Forgacs, Eva			The Kinetic Mechanism of Mouse Myosin VIIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BASED MOTOR; USHER-SYNDROME; SEDIMENTATION-VELOCITY; TRYPTOPHAN RESIDUE; DROSOPHILA; DEAFNESS; DOMAIN; MUTATIONS; PROTEIN; COEFFICIENTS	Myosin VIIa is crucial in hearing and visual processes. We examined the kinetic and association properties of the baculovirus expressed, truncated mouse myosin VIIa construct containing the head, all 5IQ motifs and the putative coiled coil domain (myosin VIIa-5IQ). The construct appears to be monomeric as determined by analytical ultracentrifugation experiments, and only single headed molecules were detected by negative stain electron microscopy. The relatively high basal steady-state rate of 0.18 s(-1) is activated by actin only by similar to 3.5-fold resulting in a V-max of 0.7 s(-1) and a K-ATPase of 11.5 mu M. There is no single rate-limiting step of the ATP hydrolysis cycle. The ATP hydrolysis step (M.T reversible arrow M.D.P) is slow (12 s(-1)) and the equilibrium constant (K-H) of 1 suggests significant reversal of hydrolysis. In the presence of actin ADP dissociates with a rate constant of 1.2 s(-1). Phosphate dissociation is relatively fast (> 12 s(-1)), but the maximal rate could not be experimentally obtained at actin concentrations <= 50 mu M because of the weak binding of the myosin VIIa-ADP-P-i complex to actin. At higher actin concentrations the rate of attached hydrolysis (0.4 s(-1)) becomes significant and partially rate-limiting. Our findings suggest that the myosin VIIa is a "slow", monomeric molecular motor with a duty ratio of 0.6.	[White, Howard; Forgacs, Eva] Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA; [Fordham, Jennifer] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Billington, Neil; Sellers, James R.] NHLBI, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Stafford, Walter F.] Boston Biomed Res Inst, Integrat Prot Biol Program, Watertown, MA 02472 USA	Eastern Virginia Medical School; University of London; King's College London; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston Biomedical Research Institute	Forgacs, E (corresponding author), Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23507 USA.	forgace@evms.edu	Stafford, Walter/ABC-6553-2020	Billington, Neil/0000-0003-2306-0228	National Institutes of Health [DC009335, NIH/EB00209]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006049] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant DC009335 (to E. F.) and NIH/EB00209 (to H. W.).	Burgess S, 2002, J CELL BIOL, V159, P983, DOI 10.1083/jcb.200208172; El-Amraoui A, 2005, J CELL SCI, V118, P4593, DOI 10.1242/jcs.02636; El-Amraoui A, 2002, EMBO REP, V3, P463, DOI 10.1093/embo-reports/kvf090; Ernest S, 2000, HUM MOL GENET, V9, P2189, DOI 10.1093/hmg/9.14.2189; Forgacs E, 2006, BIOCHEMISTRY-US, V45, P13035, DOI 10.1021/bi060712n; Forgacs E, 2009, J BIOL CHEM, V284, P2138, DOI 10.1074/jbc.M805530200; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gillespie PG, 2002, NAT NEUROSCI, V5, P3, DOI 10.1038/nn0102-3; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Hasson T, 1999, CURR BIOL, V9, pR838, DOI 10.1016/S0960-9822(00)80040-8; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Inoue A, 2003, J BIOL CHEM, V278, P5478, DOI 10.1074/jbc.M210489200; Kiehart DP, 2004, GENETICS, V168, P1337, DOI 10.1534/genetics.104.026369; Knight PJ, 2005, J BIOL CHEM, V280, P34702, DOI 10.1074/jbc.M504887200; Kremer H, 2006, HUM MOL GENET, V15, pR262, DOI 10.1093/hmg/ddl205; Kros CJ, 2002, NAT NEUROSCI, V5, P41, DOI 10.1038/nn784; Kuroda TS, 2005, J BIOL CHEM, V280, P28015, DOI 10.1074/jbc.M501465200; Liu XR, 1999, J NEUROSCI, V19, P6267; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Malnasi-Csizmadia A, 2001, BIOCHEMISTRY-US, V40, P12727, DOI 10.1021/bi010963q; Malnasi-Csizmadia A, 2001, J BIOL CHEM, V276, P19483, DOI 10.1074/jbc.M010886200; Malnasi-Csizmadia A, 2000, BIOCHEMISTRY-US, V39, P16135, DOI 10.1021/bi001125j; Maniak M, 2001, CURR BIOL, V11, pR315, DOI 10.1016/S0960-9822(01)00173-7; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Mooseker MS, 2008, MYOS SUP MOL MOT, P1; Odronitz F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-103; Park S, 2000, BIOCHEMISTRY-US, V39, P11732, DOI 10.1021/bi000945t; Phichith D, 2009, P NATL ACAD SCI USA, V106, P17320, DOI 10.1073/pnas.0909748106; Riazuddin S, 2008, HUM MUTAT, V29, P502, DOI 10.1002/humu.20677; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stafford WF, 2000, METHOD ENZYMOL, V323, P302; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028; Titus MA, 1999, CURR BIOL, V9, P1297, DOI 10.1016/S0960-9822(00)80051-2; Todi SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002115; Todi SV, 2005, CURR BIOL, V15, P862, DOI 10.1016/j.cub.2005.03.050; Udovichenko IP, 2002, J CELL SCI, V115, P445; Umeki N, 2009, P NATL ACAD SCI USA, V106, P8483, DOI 10.1073/pnas.0812930106; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Watanabe S, 2006, J BIOL CHEM, V281, P7151, DOI 10.1074/jbc.M511592200; Watanabe S, 2008, BIOCHEMISTRY-US, V47, P9505, DOI 10.1021/bi8007142; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; Wolfrum U, 1998, CELL MOTIL CYTOSKEL, V40, P261, DOI 10.1002/(SICI)1097-0169(1998)40:3<261::AID-CM5>3.3.CO;2-#; Yamashita RA, 2000, J MUSCLE RES CELL M, V21, P491, DOI 10.1023/A:1026589626422; Yang Y, 2006, P NATL ACAD SCI USA, V103, P5746, DOI 10.1073/pnas.0509935103; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	49	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8819	8828		10.1074/jbc.M110.163592	http://dx.doi.org/10.1074/jbc.M110.163592			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21212272	Green Published, hybrid			2022-12-27	WOS:000288247700012
J	Kanno, Y; Ishisaki, A; Kawashita, E; Chosa, N; Nakajima, K; Nishihara, T; Toyoshima, K; Okada, K; Ueshima, S; Matsushita, K; Matsuo, O; Matsuno, H				Kanno, Yosuke; Ishisaki, Akira; Kawashita, Eri; Chosa, Naoyuki; Nakajima, Keiichi; Nishihara, Tatsuji; Toyoshima, Kuniaki; Okada, Kiyotaka; Ueshima, Shigeru; Matsushita, Kenji; Matsuo, Osamu; Matsuno, Hiroyuki			Plasminogen/Plasmin Modulates Bone Metabolism by Regulating the Osteoblast and Osteoclast Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B LIGAND; ACTIVATOR INHIBITOR-1; RECEPTOR ACTIVATOR; TGF-BETA; EXPRESSION; GROWTH; MICE; PLASMIN; ALPHA-2-ANTIPLASMIN; OSTEOPROTEGERIN	The contribution of plasminogen (Plg)/plasmin, which have claimed to be the main fibrinolytic regulators in the bone metabolism, remains unclear. This study evaluated how the absence of Plg affects the function of osteoblast (OB) and osteoclast (OC). There was a larger population of pre-OCs in bone marrow-derived cells from the Plg(-/-) mice than the population of that from the WT mice. In addition, the absence of Plg suppressed the expression of osteoprotegerin in OBs. Moreover, an exogenous plasmin clearly induced the osteoprotegerin expression in Plg(-/-) OBs. The osteoclastogenesis of RAW264.7 mouse monocyte/macrophage lineage cells in co-culture with OBs from the Plg(-/-) mice was significantly accelerated in comparison with that in co-culture with OBs from the WT mice. Intriguingly, the accelerated OC differentiation of RAW264.7 cells co-cultured with Plg(-/-) OBs was clearly suppressed by the treatment of an exogenous plasmin. Consequently, Plg(-/-) mice display decreased bone mineral density. These findings could eventually lead to the development of new clinical therapies for bone disease caused by a disorder of the fibrinolytic system.	[Kanno, Yosuke; Kawashita, Eri; Matsuno, Hiroyuki] Doshisha Womens Coll Liberal Arts, Dept Clin Pathol Biochem, Fac Pharmaceut Sci, Kyoto 6100395, Japan; [Ishisaki, Akira; Chosa, Naoyuki] Iwate Med Univ, Sch Dent, Dept Biochem, Morioka, Iwate 0208505, Japan; [Nakajima, Keiichi] Natl Agr Res Ctr Hokkaido Reg, Dept Anim Prod & Grassland, Sapporo, Hokkaido 0628555, Japan; [Nishihara, Tatsuji] Kyushu Dent Coll, Div Infect & Mol Biol, Dept Hlth Promot, Kokurakita Ku, Kitakyushu, Fukuoka 8038580, Japan; [Toyoshima, Kuniaki] Kyushu Dent Coll, Div Oral Histol & Neurobiol, Dept Biosci, Kokurakita Ku, Kitakyushu, Fukuoka 8038580, Japan; [Okada, Kiyotaka; Ueshima, Shigeru; Matsuo, Osamu] Kinki Univ, Sch Med, Dept Physiol 2, Osaka 5898511, Japan; [Ueshima, Shigeru] Kinki Univ, Sch Agr, Dept Food Sci & Nutr, Nara 6318505, Japan; [Matsushita, Kenji] Natl Ctr Geriatr & Gerontol, Lab Oral Dis Res, Natl Inst Longev Sci, Aichi 4748522, Japan	Iwate Medical University; National Agriculture & Food Research Organization - Japan; Kyushu Dental University; Kyushu Dental University; Kindai University (Kinki University); Kindai University (Kinki University); National Center for Geriatrics & Gerontology	Kanno, Y (corresponding author), Doshisha Womens Coll Liberal Arts, Dept Clin Pathol Biochem, Fac Pharmaceut Sci, 97-1 Kodo Kyo Tanabe, Kyoto 6100395, Japan.	ykanno@dwc.doshisha.ac.jp	Chosa, Naoyuki/G-5538-2014; MATSUO, OSAMU/AAM-9703-2020	Chosa, Naoyuki/0000-0002-5399-2061; Matsuo, Osamu/0000-0002-9806-2204; Ishisaki, Akira/0000-0001-6704-4436	Ministry of Education, Culture, Sports, Science and Technology [21790097]; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [23590291] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-aid for Young Scientists B: 21790097 (to Y.K.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan Society for the Promotion of Science, and Grant-in-aid for Strategic Medical Science Research Center from the Ministry of Education, Culture, Sports, Science and Technology of Japan, 2010-2014.	BRAATEN JV, 1993, BLOOD, V81, P1290; Carmeliet Peter, 1996, Seminars in Thrombosis and Hemostasis, V22, P525, DOI 10.1055/s-2007-999055; Daci E, 1999, J BONE MINER RES, V14, P946, DOI 10.1359/jbmr.1999.14.6.946; Daci E, 2000, J BONE MINER RES, V15, P1510, DOI 10.1359/jbmr.2000.15.8.1510; Everts V, 2008, BONE, V43, P915, DOI 10.1016/j.bone.2008.07.004; Furlan F, 2007, J BONE MINER RES, V22, P1387, DOI 10.1359/JBMR.070516; Hofbauer LC, 2001, J MOL MED, V79, P243, DOI 10.1007/s001090100226; Kanazawa S, 2006, P NATL ACAD SCI USA, V103, P14465, DOI 10.1073/pnas.0606450103; Kanno Y, 2007, J THROMB HAEMOST, V5, P2266, DOI 10.1111/j.1538-7836.2007.02745.x; Kanno Y, 2006, J THROMB HAEMOST, V4, P1602, DOI 10.1111/j.1538-7836.2006.01978.x; Kanno Y, 2008, J INVEST DERMATOL, V128, P2792, DOI 10.1038/jid.2008.157; Kanno Y, 2008, CARDIOVASC RES, V77, P221, DOI 10.1093/cvr/cvm049; Kanno Y, 2010, AM J PATHOL, V176, P238, DOI 10.2353/ajpath.2010.090150; Kanno Y, 2008, THROMB RES, V123, P336, DOI 10.1016/j.thromres.2008.05.004; Li J, 2000, P NATL ACAD SCI USA, V97, P1566, DOI 10.1073/pnas.97.4.1566; Li Q, 2007, ARTERIOSCL THROM VAS, V27, P1383, DOI 10.1161/ATVBAHA.107.142901; LIJNEN HR, 1994, EUR J BIOCHEM, V224, P143, DOI 10.1111/j.1432-1033.1994.tb20005.x; LYONS RM, 1990, J CELL BIOL, V110, P1361, DOI 10.1083/jcb.110.4.1361; Majumdar M, 2004, J BIOL CHEM, V279, P37528, DOI 10.1074/jbc.M401372200; Matsuno H, 2003, BLOOD, V102, P3621, DOI 10.1182/blood-2003-03-0700; Nakashima T, 2000, BIOCHEM BIOPH RES CO, V275, P768, DOI 10.1006/bbrc.2000.3379; Nishiwaki T, 2006, J BONE MINER RES, V21, P596, DOI 10.1359/JBMR.051216; PLOPLIS VA, 1995, CIRCULATION, V92, P2585, DOI 10.1161/01.CIR.92.9.2585; Suda T, 1997, METHOD ENZYMOL, V282, P223; Thirunavukkarasu K, 2001, J BIOL CHEM, V276, P36241, DOI 10.1074/jbc.M104319200; Wada T, 2006, TRENDS MOL MED, V12, P17, DOI 10.1016/j.molmed.2005.11.007	26	37	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8952	8960		10.1074/jbc.M110.152181	http://dx.doi.org/10.1074/jbc.M110.152181			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21239499	Green Published, hybrid			2022-12-27	WOS:000288247700027
J	Pulinilkunnil, T; He, HM; Kong, D; Asakura, K; Peroni, OD; Lee, A; Kahn, BB				Pulinilkunnil, Thomas; He, Huamei; Kong, Dong; Asakura, Kenji; Peroni, Odile D.; Lee, Anna; Kahn, Barbara B.			Adrenergic Regulation of AMP-activated Protein Kinase in Brown Adipose Tissue in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDIDYMAL FAT-CELLS; PERIPHERAL-TISSUES; SKELETAL-MUSCLE; ACID OXIDATION; FOOD-INTAKE; RAT; HEART; EXPRESSION; INSULIN; PHOSPHORYLATION	AMP-activated protein kinase (AMPK), an evolutionarily conserved serine-threonine kinase that senses cellular energy status, is activated by stress and neurohumoral stimuli. We investigated the mechanisms by which adrenergic signaling alters AMPK activation in vivo. Brown adipose tissue (BAT) is highly enriched in sympathetic innervation, which is critical for regulation of energy homeostasis. We performed unilateral denervation of BAT in wild type (WT) mice to abolish neural input. Six days post-denervation, UCP-1 protein levels and AMPK alpha 2 protein and activity were reduced by 45%. In beta(1,2,3)-adrenergic receptor knock-out mice, unilateral denervation led to a 25-45% decrease in AMPK activity, protein expression, and Thr(172) phosphorylation. In contrast, acute alpha -or beta-adrenergic blockade in WT mice resulted in increased AMPK alpha Thr(172) phosphorylation and AMPK alpha 1 and alpha 2 activity in BAT. But short term blockade of alpha-adrenergic signaling in beta(1,2,3)-adrenergic receptor knock-out mice resulted in decreased AMPK activity in BAT, which strongly correlated with enhanced phosphorylation of AMPK on Ser(485/491), a site associated with inhibition of AMPK activity. Both PKA and AKT inhibitors attenuated AMPK Ser(485/491) phosphorylation resulting from alpha-adrenergic blockade and prevented decreases in AMPK activity. In vitro mechanistic studies in BAT explants showed that the effects of alpha-adrenergic blockade appeared to be secondary to inhibition of oxygen consumption. In conclusion, adrenergic pathways regulate AMPK activity in vivo acutely via alterations in Thr(172) phosphorylation and chronically through changes in the alpha catalytic subunit protein levels. Furthermore, AMPK alpha Ser(485/491) phosphorylation may be a novel mechanism to inhibit AMPK activity in vivo and alter its biological effects.	[Pulinilkunnil, Thomas; Kong, Dong; Asakura, Kenji; Peroni, Odile D.; Lee, Anna; Kahn, Barbara B.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [He, Huamei] Brigham & Womens Hosp, Dept Med, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Kahn, BB (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, 330 Brookline Ave, Boston, MA 02215 USA.	bkahn@bidmc.harvard.edu	Pulinilkunnil, Thomas/H-4387-2019; Pulinilkunnil, Thomas C/L-5511-2016	Pulinilkunnil, Thomas/0000-0003-1228-893X; Pulinilkunnil, Thomas C/0000-0003-1228-893X	National Institutes of Health [P01 DK56116]; Heart and Stroke Foundation of Canada and Canadian Diabetes Association;  [P30 DK57521]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, P01DK056116] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Canada and Canadian Diabetes Association; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 DK56116 and the Physiology Core of P30 DK57521 (both to B. B. K.).; Supported by fellowships from the Heart and Stroke Foundation of Canada and Canadian Diabetes Association.	Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; BAK MI, 1994, J CLIN INVEST, V93, P40, DOI 10.1172/JCI116974; Berggreen C, 2009, AM J PHYSIOL-ENDOC M, V296, pE635, DOI 10.1152/ajpendo.90596.2008; BORST SE, 1994, GEN PHARMACOL-VASC S, V25, P1703, DOI 10.1016/0306-3623(94)90375-1; Clark H, 2004, EUR J BIOCHEM, V271, P2215, DOI 10.1111/j.1432-1033.2004.04151.x; Clerk A, 1999, AM J CARDIOL, V83, p64H; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Funahashi K, 2009, PROSTAG OTH LIPID M, V88, P31, DOI 10.1016/j.prostaglandins.2008.09.002; Goodwin GW, 1999, AM J PHYSIOL-ENDOC M, V277, pE772, DOI 10.1152/ajpendo.1999.277.4.E772; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Horman S, 2006, J BIOL CHEM, V281, P5335, DOI 10.1074/jbc.M506850200; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Hutchinson DS, 2006, DIABETES, V55, P682, DOI 10.2337/diabetes.55.03.06.db05-0901; Hutchinson DS, 2005, DIABETOLOGIA, V48, P2386, DOI 10.1007/s00125-005-1936-7; Jaswal JS, 2006, AM J PHYSIOL-HEART C, V291, pH1883, DOI 10.1152/ajpheart.01147.2005; Kishi K, 2000, BIOCHEM BIOPH RES CO, V276, P16, DOI 10.1006/bbrc.2000.3417; Koh HJ, 2007, BIOCHEM J, V403, P473, DOI 10.1042/BJ20061479; Langfort J, 2003, SCAND J MED SCI SPOR, V13, P169, DOI 10.1034/j.1600-0838.2003.20120.x; LEFKOWITZ RJ, 1993, ADV SEC MESS PHOSPH, V28, P1; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MA SWY, 1984, CAN J PHYSIOL PHARM, V62, P949, DOI 10.1139/y84-159; Mankouri J, 2010, P NATL ACAD SCI USA, V107, P11549, DOI 10.1073/pnas.0912426107; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Morissette MR, 2006, CIRC RES, V99, P15, DOI 10.1161/01.RES.0000231290.45676.d4; Moule SK, 1998, FEBS LETT, V439, P287, DOI 10.1016/S0014-5793(98)01392-1; Moule SK, 1997, J BIOL CHEM, V272, P7713, DOI 10.1074/jbc.272.12.7713; Mulligan JD, 2007, J PHYSIOL-LONDON, V580, P677, DOI 10.1113/jphysiol.2007.128652; Qi JZ, 2008, EMBO J, V27, P1537, DOI 10.1038/emboj.2008.92; Scarpace PJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE259, DOI 10.1152/ajpendo.1998.275.2.E259; Silva JE, 2006, PHYSIOL REV, V86, P435, DOI 10.1152/physrev.00009.2005; Steinberg GR, 2003, AM J PHYSIOL-ENDOC M, V284, pE648, DOI 10.1152/ajpendo.00318.2002; Steinberg GR, 2010, J BIOL CHEM, V285, P37198, DOI 10.1074/jbc.M110.102434; Strom K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001793; Takekoshi K, 2006, METABOLISM, V55, P1122, DOI 10.1016/j.metabol.2006.04.007; Turner N, 2008, DIABETES, V57, P1414, DOI 10.2337/db07-1552; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; Xu Ming, 2007, Shengli Xuebao, V59, P175; Xue BZ, 2006, J PHYSIOL-LONDON, V574, P73, DOI 10.1113/jphysiol.2006.113217; Xue B, 2009, MOL CELL BIOL, V29, P4563, DOI 10.1128/MCB.01914-08	42	66	66	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8798	8809		10.1074/jbc.M111.218719	http://dx.doi.org/10.1074/jbc.M111.218719			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21209093	Green Published, hybrid			2022-12-27	WOS:000288247700010
J	Sarangapani, KK; Marshall, BT; McEver, RP; Zhu, C				Sarangapani, Krishna K.; Marshall, Bryan T.; McEver, Rodger P.; Zhu, Cheng			Molecular Stiffness of Selectins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-SELECTIN; GLYCOPROTEIN LIGAND-1; SINGLE-MOLECULE; MECHANICAL STABILITY; DNA MECHANICS; CELL-ADHESION; ELASTICITY; ENDOGLYCAN; DOMAINS; SHEAR	During inflammation, selectin-ligand interactions provide forces for circulating leukocytes to adhere to vascular surfaces, which stretch the interacting molecules, suggesting that mechanical properties may be pertinent to their biological function. From mechanical measurements with atomic force microscopy, we analyzed the molecular characteristics of selectins complexed with ligands and antibodies. Respective stiffness of L-, E-, and P-selectins (4.2, 1.4, and 0.85 piconewton/nm) correlated inversely with the number (2, 6, and 9) of consensus repeats in the selectin structures that acted as springs in series to dominate their compliance. After reconstitution into a lipid bilayer, purified membrane P-selectin remained a dimer, capable of forming dimeric bonds with P-selectin glycoprotein ligand (PSGL)-1, endoglycan-Ig, and a dimeric form of a glycosulfopeptide modeled after the N terminus of PSGL-1. By comparison, purified membrane L- and E-selectin formed only monomeric bonds under identical conditions. Ligands and antibodies were much less stretchable than selectins. The length of endoglycan-Ig was found to be 51 +/- 12 nm. These results provide a comprehensive characterization of the molecular stiffness of selectins and illustrate how mechanical measurements can be utilized for molecular analysis, e.g. evaluating the multimericity of selectins and determining the molecular length of endoglycan.	Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Marshall, Bryan T.; Zhu, Cheng] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [McEver, Rodger P.] Univ Oklahoma, Hlth Sci Ctr, Cardiovasc Biol Res Program, Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [McEver, Rodger P.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Zhu, C (corresponding author), 315 Ferst Dr,IBB Bldg,Rm 3312, Atlanta, GA 30332 USA.	cheng.zhu@bme.gatech.edu	Zhu, Cheng/A-5724-2011		National Institutes of Health [AI77343]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077343, R56AI077343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI77343.	Barkalow FJ, 2000, BLOOD, V96, P3070; Bryant Z, 2003, NATURE, V424, P338, DOI 10.1038/nature01810; Bustamante C, 2003, NATURE, V421, P423, DOI 10.1038/nature01405; Bustamante C, 2000, CURR OPIN STRUC BIOL, V10, P279, DOI 10.1016/S0959-440X(00)00085-3; Carrion-Vazquez M, 2003, NAT STRUCT BIOL, V10, P738, DOI 10.1038/nsb965; Chen SQ, 1999, J CELL BIOL, V144, P185, DOI 10.1083/jcb.144.1.185; Fieger CB, 2003, J BIOL CHEM, V278, P27390, DOI 10.1074/jbc.M304204200; HARRIS LJ, 1992, NATURE, V360, P369, DOI 10.1038/360369a0; Lawrence MB, 1997, J CELL BIOL, V136, P717, DOI 10.1083/jcb.136.3.717; Li FG, 1996, J BIOL CHEM, V271, P6342, DOI 10.1074/jbc.271.11.6342; Marshall BT, 2006, BIOPHYS J, V90, P681, DOI 10.1529/biophysj.105.061010; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; MCCONNELL HM, 1986, BIOCHIM BIOPHYS ACTA, V864, P95, DOI 10.1016/0304-4157(86)90016-X; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; Mehta P, 1997, BLOOD, V90, P2381, DOI 10.1182/blood.V90.6.2381.2381_2381_2389; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; PATEL KD, 1995, J CLIN INVEST, V96, P1887, DOI 10.1172/JCI118234; Ramachandran V, 2001, P NATL ACAD SCI USA, V98, P10166, DOI 10.1073/pnas.171248098; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1998, BIOPHYS J, V75, P3008, DOI 10.1016/S0006-3495(98)77741-0; Sarangapani KK, 2004, J BIOL CHEM, V279, P2291, DOI 10.1074/jbc.M310396200; Sassetti C, 2000, J BIOL CHEM, V275, P9001, DOI 10.1074/jbc.275.12.9001; USHIYAMA S, 1993, J BIOL CHEM, V268, P15229; Yago T, 2002, J CELL BIOL, V158, P787, DOI 10.1083/jcb.200204041; Zhu C, 2002, ANN BIOMED ENG, V30, P305, DOI 10.1114/1.1467923	27	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9567	9576		10.1074/jbc.M110.196485	http://dx.doi.org/10.1074/jbc.M110.196485			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21216951	Green Published, hybrid			2022-12-27	WOS:000288247700082
J	Shipston, MJ				Shipston, Michael J.			Ion Channel Regulation by Protein Palmitoylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							2-STEP REACTION-MECHANISM; CELL-SURFACE EXPRESSION; S-ACYLATION; AMPA RECEPTOR; POSTTRANSLATIONAL MODIFICATIONS; DIFFERENTIAL PALMITOYLATION; BETA-2-ADRENERGIC RECEPTOR; MEDIATED PALMITOYLATION; TERMINAL PALMITOYLATION; DEPENDENT REGULATION	Protein S-palmitoylation, the reversible thioester linkage of a 16-carbon palmitate lipid to an intracellular cysteine residue, is rapidly emerging as a fundamental, dynamic, and wide-spread post-translational mechanism to control the properties and function of ligand- and voltage-gated ion channels. Palmitoylation controls multiple stages in the ion channel life cycle, from maturation to trafficking and regulation. An emerging concept is that palmitoylation is an important determinant of channel regulation by other signaling pathways. The elucidation of enzymes controlling palmitoylation and developments in proteomics tools now promise to revolutionize our understanding of this fundamental post-translational mechanism in regulating ion channel physiology.	Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland	University of Edinburgh	Shipston, MJ (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland.	mike.shipston@ed.ac.uk	Shipston, Mike/C-7309-2013	Shipston, Mike/0000-0001-7544-582X	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Alexander JK, 2010, J MOL NEUROSCI, V40, P12, DOI 10.1007/s12031-009-9246-z; Belanger C, 2001, FEBS LETT, V499, P59, DOI 10.1016/S0014-5793(01)02513-3; Britto PJ, 2002, J BIOL CHEM, V277, P29018, DOI 10.1074/jbc.M204263200; Charron G, 2009, CURR OPIN CHEM BIOL, V13, P382, DOI 10.1016/j.cbpa.2009.07.010; Charych EI, 2010, J NEUROSCI, V30, P9027, DOI 10.1523/JNEUROSCI.1635-10.2010; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Crane JM, 2009, BIOPHYS J, V97, P3010, DOI 10.1016/j.bpj.2009.09.017; Dekker FJ, 2010, NAT CHEM BIOL, V6, P449, DOI 10.1038/nchembio.362; Devedjiev Y, 2000, STRUCTURE, V8, P1137, DOI 10.1016/S0969-2126(00)00529-3; Draper JM, 2009, MOL MEMBR BIOL, V26, P5, DOI 10.1080/09687680802683839; Drisdel RC, 2004, J NEUROSCI, V24, P10502, DOI 10.1523/JNEUROSCI.3315-04.2004; Drisdel RC, 2004, BIOTECHNIQUES, V36, P276, DOI 10.2144/04362RR02; Drisdel RC, 2006, METHODS, V40, P127, DOI 10.1016/j.ymeth.2006.04.015; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Gonnord P, 2009, FASEB J, V23, P795, DOI 10.1096/fj.08-114637; Greaves J, 2009, MOL MEMBR BIOL, V26, P67, DOI 10.1080/09687680802620351; Gubitosi-Klug RA, 2005, P NATL ACAD SCI USA, V102, P5964, DOI 10.1073/pnas.0501999102; Hanley LJ, 2010, NEUROSCI LETT, V485, P167, DOI 10.1016/j.neulet.2010.09.003; Hannoush AN, 2010, NAT CHEM BIOL, V6, P498, DOI [10.1038/NCHEMBIO.388, 10.1038/nchembio.388]; Hannoush RN, 2009, ACS CHEM BIOL, V4, P581, DOI 10.1021/cb900085z; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Heneghan JF, 2009, J GEN PHYSIOL, V134, P369, DOI 10.1085/jgp.200910203; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hou HT, 2009, TRAFFIC, V10, P1061, DOI 10.1111/j.1600-0854.2009.00925.x; Iwanaga T, 2009, PROG LIPID RES, V48, P117, DOI 10.1016/j.plipres.2009.02.001; Jeffries O, 2010, J BIOL CHEM, V285, P33307, DOI 10.1074/jbc.M110.153940; Jennings BC, 2009, J LIPID RES, V50, P233, DOI 10.1194/jlr.M800270-JLR200; Jindal HK, 2008, AM J PHYSIOL-HEART C, V294, pH2012, DOI 10.1152/ajpheart.01374.2007; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kim SJ, 2008, J CLIN INVEST, V118, P3075, DOI 10.1172/JCI33482; Kummel D, 2006, P NATL ACAD SCI USA, V103, P12701, DOI 10.1073/pnas.0603513103; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Locke D, 2006, FASEB J, V20, P1221, DOI 10.1096/fj.05-5309fje; Mansouri MR, 2005, EUR J HUM GENET, V13, P970, DOI 10.1038/sj.ejhg.5201445; Martin BR, 2009, NAT METHODS, V6, P135, DOI [10.1038/NMETH.1293, 10.1038/nmeth.1293]; Matsuda K, 2006, J BIOL CHEM, V281, P25577, DOI 10.1074/jbc.M602044200; Mitchell DA, 2010, J BIOL CHEM, V285, P38104, DOI 10.1074/jbc.M110.169102; Mitra-Ganguli T, 2009, J GEN PHYSIOL, V134, P385, DOI 10.1085/jgp.200910204; MOFFETT S, 1993, EMBO J, V12, P349, DOI 10.1002/j.1460-2075.1993.tb05663.x; MOUILLAC B, 1992, J BIOL CHEM, V267, P21733; Mueller GM, 2010, J BIOL CHEM, V285, P30453, DOI 10.1074/jbc.M110.151845; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Mukai J, 2008, NAT NEUROSCI, V11, P1302, DOI 10.1038/nn.2204; Noritake J, 2009, J CELL BIOL, V186, P147, DOI 10.1083/jcb.200903101; Oyama T, 2000, GENE CHROMOSOME CANC, V29, P9, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1001>3.0.CO;2-#; Pickering DS, 1995, P NATL ACAD SCI USA, V92, P12090, DOI 10.1073/pnas.92.26.12090; Qin N, 1998, P NATL ACAD SCI USA, V95, P4690, DOI 10.1073/pnas.95.8.4690; Rathenberg J, 2004, MOL CELL NEUROSCI, V26, P251, DOI 10.1016/j.mcn.2004.01.012; Raymond FL, 2007, AM J HUM GENET, V80, P982, DOI 10.1086/513609; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Resh MD, 2006, METHODS, V40, P191, DOI 10.1016/j.ymeth.2006.04.013; RESH MD, 2006, SCI STKE, pRE14, DOI DOI 10.1126/STKE.3592006RE14; SCHMIDT JW, 1987, J BIOL CHEM, V262, P13713; SCHMIDT MF, 1979, NAT REV NEUROSCI, V17, P55; Stephens GJ, 2000, J PHYSIOL-LONDON, V525, P377, DOI 10.1111/j.1469-7793.2000.t01-1-00377.x; SUGRUE RJ, 1990, VIROLOGY, V179, P51, DOI 10.1016/0042-6822(90)90272-S; Suzuki H, 2008, BBA-BIOMEMBRANES, V1778, P1181, DOI 10.1016/j.bbamem.2007.12.007; Takimoto K, 2002, J BIOL CHEM, V277, P26904, DOI 10.1074/jbc.M203651200; Tian LJ, 2010, J BIOL CHEM, V285, P23954, DOI 10.1074/jbc.M110.137802; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Tomatis VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015045; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; VEIT M, 1991, J VIROL, V65, P2491, DOI 10.1128/JVI.65.5.2491-2500.1991; Veit Michael, 2008, V446, P163, DOI 10.1007/978-1-60327-084-7_12; Verkruyse LA, 1996, J BIOL CHEM, V271, P15831, DOI 10.1074/jbc.271.26.15831; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wang XB, 2009, PROTEIN ENG DES SEL, V22, P707, DOI 10.1093/protein/gzp055; Wilson JP, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.001198; Yamazaki M, 2001, NEUROSCI LETT, V304, P81, DOI 10.1016/S0304-3940(01)01766-9; Yang G, 2009, EUR J NEUROSCI, V30, P35, DOI 10.1111/j.1460-9568.2009.06788.x; Yang W, 2010, MOL CELL PROTEOMICS, V9, P54, DOI 10.1074/mcp.M800448-MCP200; Yap MC, 2010, J LIPID RES, V51, P1566, DOI 10.1194/jlr.D002790; Yeh DC, 1999, J BIOL CHEM, V274, P33148, DOI 10.1074/jbc.274.46.33148; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Zhang L, 2007, AM J PHYSIOL-CELL PH, V293, pC152, DOI 10.1152/ajpcell.00480.2006; Zhang ZJ, 2006, HUM MOL GENET, V15, P337, DOI 10.1093/hmg/ddi451	83	102	103	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8709	8716		10.1074/jbc.R110.210005	http://dx.doi.org/10.1074/jbc.R110.210005			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21216969	hybrid, Green Published			2022-12-27	WOS:000288247700001
J	Wang, YQ; Guan, SH; Acharya, P; Koop, DR; Liu, Y; Liao, MX; Burlingame, AL; Correia, MA				Wang, YongQiang; Guan, Shenheng; Acharya, Poulomi; Koop, Dennis R.; Liu, Yi; Liao, Mingxiang; Burlingame, Alma L.; Correia, Maria Almira			Ubiquitin-dependent Proteasomal Degradation of Human Liver Cytochrome P450 2E1 IDENTIFICATION OF SITES TARGETED FOR PHOSPHORYLATION AND UBIQUITINATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-ALPHA; RETICULUM-ASSOCIATED DEGRADATION; MOTILITY FACTOR-RECEPTOR; PROTEIN-KINASE-C; SACCHAROMYCES-CEREVISIAE; RAT HEPATOCYTES; HETEROLOGOUS EXPRESSION; MEDIATED DEGRADATION; CYP2E1 DEGRADATION; MASS-SPECTROMETRY	Human liver CYP2E1 is a monotopic, endoplasmic reticulum-anchored cytochrome P450 responsible for the biotransformation of clinically relevant drugs, low molecular weight xenobiotics, carcinogens, and endogenous ketones. CYP2E1 substrate complexation converts it into a stable slow-turnover species degraded largely via autophagic lysosomal degradation. Substrate decomplexation/withdrawal results in a fast turnover CYP2E1 species, putatively generated through its futile oxidative cycling, that incurs endoplasmic reticulum-associated ubiquitin-dependent proteasomal degradation (UPD). CYP2E1 thus exhibits biphasic turnover in the mammalian liver. We now show upon heterologous expression of human CYP2E1 in Saccharomyces cerevisiae that its autophagic lysosomal degradation and UPD pathways are evolutionarily conserved, even though its potential for futile catalytic cycling is low due to its sluggish catalytic activity in yeast. This suggested that other factors (i.e. post-translational modifications or "degrons") contribute to its UPD. Indeed, in cultured human hepatocytes, CYP2E1 is detectably ubiquitinated, and this is enhanced on its mechanism-based inactivation. Studies in Ubc7p and Ubc5p genetically deficient yeast strains versus corresponding isogenic wild types identified these ubiquitin-conjugating E2 enzymes as relevant to CYP2E1 UPD. Consistent with this, in vitro functional reconstitution analyses revealed that mammalian UBC7/gp78 and UbcH5a/CHIP E2-E3 ubiquitin ligases were capable of ubiquitinating CYP2E1, a process enhanced by protein kinase (PK) A and/or PKC inclusion. Inhibition of PKA or PKC blocked intracellular CYP2E1 ubiquitination and turnover. Here, through mass spectrometric analyses, we identify some CYP2E1 phosphorylation/ubiquitination sites in spatially associated clusters. We propose that these CYP2E1 phosphorylation clusters may serve to engage each E2-E3 ubiquitination complex in vitro and intracellularly.	[Correia, Maria Almira] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Guan, Shenheng; Burlingame, Alma L.; Correia, Maria Almira] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Correia, Maria Almira] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Correia, Maria Almira] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94158 USA; [Koop, Dennis R.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97239 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Oregon Health & Science University	Correia, MA (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, Mission Bay Campus,Genentech Hall,N572F,Box 2280,, San Francisco, CA 94158 USA.	almira.correia@ucsf.edu			National Institutes of Health [GM44037, DK26506, NCRRRR 01614]; NIDDK, National Institutes of Health [P30DK26743]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK026506, R01DK026506, P30DK026743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM44037 (to M.A.C.), DK26506 (to M.A.C.), and NCRRRR 01614 (to A.L.B.).; We sincerely thank Dr. Todd Porter (University of Kentucky, Lexington) for the human CYP2E1 cDNA and Drs. Randy Hampton (University of California, San Diego) and Mark Hochstrasser (Yale University) for the yeast strains; Dr. A. M. Weissman (NCI, National Institutes of Health) for the UBC7 and gp78C expression plasmids; Dr. Cam Patterson (University of North Carolina) for the CHIP expression plasmid; Dr. Lucy Waskell (University of Michigan) for the b<INF>5</INF> expression plasmid; and Dr. Charles Kasper (University of Wisconsin) for the OR expression plasmid. We also thank Dr. Ed LeCluyse and Rachel Whisnant (CellzDirect, Invitrogen) for the human hepatocytes, and Chris Her (University of California, San Francisco, Liver Center Cell and Tissue Biology Core Facility; Dr. J. J. Maher, Director) for rat hepatocyte isolation. We also acknowledge the University of California, San Francisco, Liver Center Core on Cell and Tissue Biology, supported by National Institutes of Health Grant P30DK26743 from NIDDK.	Acharya P, 2011, J BIOL CHEM, V286, P3815, DOI 10.1074/jbc.M110.186981; Acharya P, 2010, MOL PHARMACOL, V77, P575, DOI 10.1124/mol.109.061259; Acharya P, 2009, MOL PHARMACOL, V76, P503, DOI 10.1124/mol.109.056002; Aguiar M, 2005, DRUG METAB REV, V37, P379, DOI 10.1081/DMR-200046136; Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Balgley BM, 2007, MOL CELL PROTEOMICS, V6, P1599, DOI 10.1074/mcp.M600469-MCP200; Banerjee A, 2000, DRUG METAB DISPOS, V28, P118; Bardag-Gorce F, 2002, FREE RADICAL BIO MED, V32, P17, DOI 10.1016/S0891-5849(01)00768-7; Bardag-Gorce F, 2006, EXP MOL PATHOL, V81, P191, DOI 10.1016/j.yexmp.2006.07.007; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Butler MP, 2007, J BIOL CHEM, V282, P29729, DOI 10.1074/jbc.M704558200; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Chalkley RJ, 2008, MOL CELL PROTEOMICS, V7, P2386, DOI 10.1074/mcp.M800021-MCP200; Chen JY, 1997, DRUG METAB DISPOS, V25, P1165; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; Correia MA, 2007, EXPERT OPIN DRUG MET, V3, P33, DOI 10.1517/17425255.3.1.33; Correia M.A., 2005, CYTOCHROME P450 STRU, V3rd ed., P247, DOI DOI 10.1007/0-387-27447-2_7; Correia M. A., 2005, CYTOCHROME P450 STRU, P619; Correia MA, 2005, ANNU REV PHARMACOL, V45, P439, DOI 10.1146/annurev.pharmtox.45.120403.100127; Correia MA, 2003, DRUG METAB REV, V35, P107, DOI 10.1081/DMR-120023683; CORREIA MA, 1987, ARCH BIOCHEM BIOPHYS, V258, P436, DOI 10.1016/0003-9861(87)90365-1; CORREIA MA, 1992, ARCH BIOCHEM BIOPHYS, V297, P228, DOI 10.1016/0003-9861(92)90666-K; CORREIA MA, 1991, METHOD ENZYMOL, V206, P315; Cripps D, 2006, J BIOL CHEM, V281, P10825, DOI 10.1074/jbc.M512786200; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; ELIASSON E, 1990, P NATL ACAD SCI USA, V87, P3225, DOI 10.1073/pnas.87.8.3225; ELIASSON E, 1992, J BIOL CHEM, V267, P15765; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Faouzi S, 2007, BIOCHEMISTRY-US, V46, P7793, DOI 10.1021/bi700340n; Feldman RMR, 1997, CELL, V91, P221, DOI 10.1016/S0092-8674(00)80404-3; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; FREEMAN JE, 1994, BIOCHEMISTRY-US, V33, P13963, DOI 10.1021/bi00251a002; Goasduff T, 1999, ARCH BIOCHEM BIOPHYS, V370, P258, DOI 10.1006/abbi.1999.1399; Goasduff T, 2000, ARCH BIOCHEM BIOPHYS, V379, P321, DOI 10.1006/abbi.2000.1870; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; He K, 1998, BIOCHEMISTRY-US, V37, P17448, DOI 10.1021/bi9808464; Hewitt NJ, 2007, DRUG METAB REV, V39, P159, DOI 10.1080/03602530601093489; Huan JY, 2004, TOXICOL APPL PHARM, V199, P332, DOI 10.1016/j.taap.2003.12.019; Huan JY, 1999, DRUG METAB DISPOS, V27, P549; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Ishikura S, 2010, J BIOL CHEM, V285, P23916, DOI 10.1074/jbc.M110.127936; Kalgutkar AS, 2007, CURR DRUG METAB, V8, P407; Kaplan KB, 1997, CELL, V91, P491, DOI 10.1016/S0092-8674(00)80435-3; Kikkert M, 2004, J BIOL CHEM, V279, P3525, DOI 10.1074/jbc.M307453200; Kim SM, 2010, J BIOL CHEM, V285, P35866, DOI 10.1074/jbc.M110.167189; Klotz K, 2009, EXP CELL RES, V315, P1832, DOI 10.1016/j.yexcr.2008.11.017; KOOP DR, 1984, MOL PHARMACOL, V25, P494; Korsmeyer KK, 1999, ARCH BIOCHEM BIOPHYS, V365, P31, DOI 10.1006/abbi.1999.1138; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Lee CM, 2008, J BIOL CHEM, V283, P889, DOI 10.1074/jbc.M708821200; Li F, 2009, J BIOL CHEM, V284, P20090, DOI 10.1074/jbc.M109.017046; Liao M, 2006, MOL PHARMACOL, V69, P1897, DOI 10.1124/mol.105.021816; Liao MX, 2005, MOL PHARMACOL, V67, P1460, DOI 10.1124/mol.104.009654; Lown KS, 1997, J CLIN INVEST, V99, P2545, DOI 10.1172/JCI119439; MASAKI R, 1987, J CELL BIOL, V104, P1207, DOI 10.1083/jcb.104.5.1207; Masimirembwa CM, 1999, DRUG METAB DISPOS, V27, P1117; MENEZ JF, 1993, ALCOHOL ALCOHOLISM, V28, P445; Miranda M, 2005, J BIOL CHEM, V280, P35617, DOI 10.1074/jbc.M506618200; MIYAMOTO S, 1994, P NATL ACAD SCI USA, V91, P12740, DOI 10.1073/pnas.91.26.12740; Morishima Y, 2005, BIOCHEMISTRY-US, V44, P16333, DOI 10.1021/bi0515570; Murray BP, 2002, MOL PHARMACOL, V61, P1146, DOI 10.1124/mol.61.5.1146; Oesch-Bartlomowicz B, 2005, BIOCHEM BIOPH RES CO, V338, P446, DOI 10.1016/j.bbrc.2005.08.092; Olsen BB, 2008, MOL CELL BIOCHEM, V316, P115, DOI 10.1007/s11010-008-9817-2; Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208; Pabarcus MK, 2009, ARCH BIOCHEM BIOPHYS, V483, P66, DOI 10.1016/j.abb.2008.12.001; Paine MF, 2006, AM J CLIN NUTR, V83, P1097, DOI 10.1093/ajcn/83.5.1097; Pearce RE, 2008, DRUG METAB DISPOS, V36, P1637, DOI 10.1124/dmd.107.019562; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200; PYERIN W, 1989, EMBO J, V8, P3003, DOI 10.1002/j.1460-2075.1989.tb08450.x; Redlich G, 2008, J PROTEOME RES, V7, P4678, DOI 10.1021/pr800231w; Reed Steven I., 2006, V42, P147, DOI 10.1007/b136681; Rees I, 2006, BBA-PROTEINS PROTEOM, V1764, P1073, DOI 10.1016/j.bbapap.2006.03.013; ROBERTS BJ, 1995, J BIOL CHEM, V270, P29632; Roberts BJ, 1997, J BIOL CHEM, V272, P9771; RONIS MJJ, 1991, EUR J BIOCHEM, V198, P383, DOI 10.1111/j.1432-1033.1991.tb16026.x; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; SOHN DH, 1991, BIOCHEM BIOPH RES CO, V179, P449, DOI 10.1016/0006-291X(91)91391-O; SONG BJ, 1989, J BIOL CHEM, V264, P3568; Steen H, 2005, P NATL ACAD SCI USA, V102, P3948, DOI 10.1073/pnas.0409536102; Steen JAJ, 2008, P NATL ACAD SCI USA, V105, P6069, DOI 10.1073/pnas.0709807104; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; TIERNEY DJ, 1992, ARCH BIOCHEM BIOPHYS, V293, P9, DOI 10.1016/0003-9861(92)90358-4; UMENO M, 1988, BIOCHEMISTRY-US, V27, P9006, DOI 10.1021/bi00425a019; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; Wang HF, 1999, ARCH BIOCHEM BIOPHYS, V365, P45, DOI 10.1006/abbi.1999.1139; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XY, 2001, BIOCHEMISTRY-US, V40, P11318, DOI 10.1021/bi010690z; Wang YQ, 2009, J BIOL CHEM, V284, P5671, DOI 10.1074/jbc.M806104200; WATKINS PB, 1986, J BIOL CHEM, V261, P6264; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Willems AR, 1996, CELL, V86, P453, DOI 10.1016/S0092-8674(00)80118-X; Xu L, 2009, DRUG METAB DISPOS, V37, P2330, DOI 10.1124/dmd.108.025494; Yang JS, 2008, CURR DRUG METAB, V9, P384, DOI 10.2174/138920008784746382; Yang MX, 1997, ARCH BIOCHEM BIOPHYS, V341, P25, DOI 10.1006/abbi.1997.9907; Zhukov A, 1999, BIOCHEM J, V340, P453, DOI 10.1042/0264-6021:3400453; ZHUKOV A, 1993, BIOCHEM BIOPH RES CO, V197, P221, DOI 10.1006/bbrc.1993.2464	103	39	39	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9443	9456		10.1074/jbc.M110.176685	http://dx.doi.org/10.1074/jbc.M110.176685			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21209460	hybrid, Green Published			2022-12-27	WOS:000288247700072
J	Ahmad, H; Gubbels, R; Ehlers, E; Meyer, F; Waterbury, T; Lin, RT; Zhang, LW				Ahmad, Humera; Gubbels, Rachel; Ehlers, Erica; Meyer, Florencia; Waterbury, Thomas; Lin, Rongtuan; Zhang, Luwen			Kaposi Sarcoma-associated Herpesvirus Degrades Cellular Toll-Interleukin-1 Receptor Domain-containing Adaptor-inducing beta-Interferon (TRIF)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPSTEIN-BARR-VIRUS; DOUBLE-STRANDED-RNA; MICROVASCULAR ENDOTHELIAL-CELLS; UBIQUITIN-PROTEASOME PATHWAY; RTA PROMOTES DEGRADATION; LYTIC SWITCH PROTEIN; RBP-J-KAPPA; REGULATORY FACTOR; GENE-EXPRESSION; I INTERFERON	Kaposi sarcoma-associated herpesvirus (KSHV) is a human gamma-herpesvirus associated with several human malignancies. The replication and transcription activator (RTA) is necessary and sufficient for the switch from KSHV latency to lytic replication. Toll-interleukin-1 receptor (TIR) domain-containing adaptor-inducing beta-interferon (TRIF, also called TIR-domain-containing adaptor molecule-1 (TICAM-1)) is a signaling adaptor molecule that is critically involved in the Toll-like receptor 3 (TLR-3) and TLR-4 signaling pathways for type I interferon (IFN) production, a key component of innate immunity against microbial infection. In this report, we find a new mechanism by which RTA blocks innate immunity by targeting cellular TRIF. RTA specifically degrades TRIF by shortening the half-life of TRIF protein. This RTA-mediated degradation is at least partially mediated through the ubiquitin-proteasome pathway because proteasome inhibitors as well as knockdown of cellular ubiquitin expression alleviate the degradation. RTA may not directly interact with TRIF and may activate TRIF degradation indirectly through an unknown mediator(s). RTA targets multiple regions of TRIF and may use its ubiquitin ligase domain for the degradation. In addition, physiological levels of TRIF protein are down-regulated during KSHV lytic replication when RTA is expressed. Finally, RTA down-regulates double-stranded RNA-initiated activation of TLR-3 pathway, in the absence of degradation of IFN regulatory factor 7 (IRF-7). Taken together, these data suggest that KSHV employs a novel mechanism to block the innate immunity by degrading TRIF protein. This work may contribute to our understandings on how KSHV evades host immunity for its survival in vivo.	[Zhang, Luwen] Univ Nebraska, Nebraska Ctr Virol, Lincoln, NE 68583 USA; [Ahmad, Humera; Gubbels, Rachel; Ehlers, Erica; Meyer, Florencia; Waterbury, Thomas; Zhang, Luwen] Univ Nebraska, Sch Biol Sci, Lincoln, NE 68583 USA; [Lin, Rongtuan] McGill Univ, Dept Med, Lady Davis Inst Med Res, Montreal, PQ H3A 2T5, Canada	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Lady Davis Institute; McGill University	Zhang, LW (corresponding author), Univ Nebraska, Nebraska Ctr Virol, 238 Morrison Ctr,4240 Fair St, Lincoln, NE 68583 USA.	lzhang2@unlnotes.unl.edu	Meyer, Florencia/V-3406-2019; Lin, Rongtuan/A-1442-2008	Lin, Rongtuan/0000-0002-2238-3503	National Center for Research Resources (NCRR) [CA138213, CA108951, RR15635]; NATIONAL CANCER INSTITUTE [R01CA138213, R01CA108951] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015635] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA138213 and CA108951 and COBRA Grant RR15635 from the National Center for Research Resources (NCRR) (to L. Z.).	Bisson SA, 2009, J VIROL, V83, P5056, DOI 10.1128/JVI.02516-08; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Carroll KD, 2006, J VIROL, V80, P9697, DOI 10.1128/JVI.00746-06; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chang Y, 1996, INFECT AGENT DIS, V5, P215; Ciechanover A, 1998, EMBO J, V17, P7151, DOI 10.1093/emboj/17.24.7151; Cirone M, 2007, IMMUNOL LETT, V113, P40, DOI 10.1016/j.imlet.2007.07.013; Cloutier N, 2010, J BIOL CHEM, V285, P7208, DOI 10.1074/jbc.M109.018838; Dourmishev LA, 2003, MICROBIOL MOL BIOL R, V67, P175, DOI 10.1128/MMBR.67.2.175-212.2003; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Gould F, 2009, J VIROL, V83, P6727, DOI 10.1128/JVI.00351-09; Gradoville L, 2000, J VIROL, V74, P6207, DOI 10.1128/JVI.74.13.6207-6212.2000; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Gregory SM, 2009, P NATL ACAD SCI USA, V106, P11725, DOI 10.1073/pnas.0905316106; HARADA H, 1993, SCIENCE, V259, P971, DOI 10.1126/science.8438157; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Jiang YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001569; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Krug LT, 2004, J VIROL, V78, P8359, DOI 10.1128/jvi.78.15.8359-8371.2004; Lagos D, 2008, CELL HOST MICROBE, V4, P470, DOI 10.1016/j.chom.2008.09.012; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Liang YY, 2003, P NATL ACAD SCI USA, V100, P8490, DOI 10.1073/pnas.1432843100; Liang YY, 2002, GENE DEV, V16, P1977, DOI 10.1101/gad.996502; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Lukac DM, 1999, J VIROL, V73, P9348, DOI 10.1128/JVI.73.11.9348-9361.1999; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Monini P, 1999, J VIROL, V73, P4029, DOI 10.1128/JVI.73.5.4029-4041.1999; Moore P., 2001, VIROLOGY, P2803; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Papugani A, 2008, VIRUS RES, V131, P1, DOI 10.1016/j.virusres.2007.07.019; Perry ST, 2006, J VIROL, V80, P11105, DOI 10.1128/JVI.00846-06; Poole LJ, 2002, J VIROL, V76, P3395, DOI 10.1128/JVI.76.7.3395-3420.2002; Pozharskaya VP, 2004, J GEN VIROL, V85, P2779, DOI 10.1099/vir.0.80214-0; Rappocciolo G, 2006, J IMMUNOL, V176, P1741, DOI 10.4049/jimmunol.176.3.1741; Rappocciolo G, 2008, J VIROL, V82, P4793, DOI 10.1128/JVI.01587-07; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Sakakibara S, 2001, J VIROL, V75, P6894, DOI 10.1128/JVI.75.15.6894-6900.2001; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Sanchez DJ, 2008, J VIROL, V82, P2208, DOI 10.1128/JVI.01718-07; Sarid R, 1998, J VIROL, V72, P1005, DOI 10.1128/JVI.72.2.1005-1012.1998; Sarkar SN, 2003, J BIOL CHEM, V278, P4393, DOI 10.1074/jbc.C200655200; Sarkar SN, 2004, NAT STRUCT MOL BIOL, V11, P1060, DOI 10.1038/nsmb847; Saveliev AK, 2002, VIROLOGY, V299, P301, DOI 10.1006/viro.2002.1561; Schoenemeyer A, 2005, J BIOL CHEM, V280, P17005, DOI 10.1074/jbc.M412584200; Sen GC, 2005, CYTOKINE GROWTH F R, V16, P1, DOI 10.1016/j.cytogfr.2005.01.006; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Sun R, 1999, J VIROL, V73, P2232, DOI 10.1128/JVI.73.3.2232-2242.1999; TAKEDA K, 2007, CURR PROTOC IMMUNOL, pCH14, DOI DOI 10.1002/0471142735.IM1412S77; Viswanathan K, 2010, CURR OPIN MICROBIOL, V13, P517, DOI 10.1016/j.mib.2010.05.012; West JT, 2003, ONCOGENE, V22, P5150, DOI 10.1038/sj.onc.1206555; Wu W, 2006, BLOOD, V108, P141, DOI 10.1182/blood-2005-04-1697; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yang ZL, 2008, J VIROL, V82, P3590, DOI 10.1128/JVI.02229-07; Yu YX, 2005, IMMUNITY, V22, P59, DOI 10.1016/j.immuni.2004.11.011; Zhang J, 2005, J VIROL, V79, P5640, DOI 10.1128/JVI.79.9.5640-5652.2005; Zhang LW, 2004, J VIROL, V78, P12987, DOI 10.1128/JVI.78.23.12987-12995.2004; Zhang LW, 1997, MOL CELL BIOL, V17, P5748, DOI 10.1128/MCB.17.10.5748; Zhang LW, 2000, MOL BIOTECHNOL, V14, P73, DOI 10.1385/MB:14:1:73; Zhang LW, 2001, J VIROL, V75, P12393, DOI 10.1128/JVI.75.24.12393-12401.2001; Zhang LW, 1999, MOL CELL BIOL, V19, P3216; Zhang LW, 2000, J VIROL, V74, P1061, DOI 10.1128/JVI.74.3.1061-1068.2000; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465; Zhu FX, 1999, J VIROL, V73, P5556, DOI 10.1128/JVI.73.7.5556-5567.1999; Zhu FX, 2002, P NATL ACAD SCI USA, V99, P5573, DOI 10.1073/pnas.082420599	71	49	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7865	7872		10.1074/jbc.M110.191452	http://dx.doi.org/10.1074/jbc.M110.191452			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21212282	Green Published, hybrid			2022-12-27	WOS:000288013300017
J	Dennis, MD; Baum, JI; Kimball, SR; Jefferson, LS				Dennis, Michael D.; Baum, Jamie I.; Kimball, Scot R.; Jefferson, Leonard S.			Mechanisms Involved in the Coordinate Regulation of mTORC1 by Insulin and Amino Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATES PROTEIN-SYNTHESIS; MESSENGER-RNA TRANSLATION; GTP-BINDING PROTEINS; MAMMALIAN TARGET; SKELETAL-MUSCLE; CELL-GROWTH; RAG GTPASES; LIVER; KINASE; DEFICIENCY	In this study, we explored the coordinate regulation of mTORC1 by insulin and amino acids. Rat livers were perfused with medium containing various concentrations of insulin and/or amino acids. At fasting (1x) or 2x (2 x AA) concentrations of amino acids, insulin maximally stimulated Akt phosphorylation but had no effect on global rates of protein synthesis. In the absence of insulin, 4 x AA produced a moderate stimulation of protein synthesis and activation of mTORC1. The combination of 4 x AA and insulin produced a maximal stimulation of protein synthesis and activation of mTORC1. These effects were accompanied by decreases in raptor and PRAS40 and an increase in RagC associated with mTOR (mammalian target of rapamycin). The studies were extended to a cell culture model in which mTORC1 activity was repressed by deprivation of leucine and serum, and resupplementation with the amino acid and insulin acted in an additive manner to restore mTORC1 activation. In deprived cells, mTORC1 was activated by expressing either constitutively active (ca) Rheb or a caRagB.caRagC complex, and coexpression of the constructs had an additive effect. Notably, resupplementation with leucine in cells expressing caRheb or with insulin in cells expressing the caRagB.caRagC complex was as effective as resupplementation with both leucine and insulin in non-transfected cells. Moreover, changes in mTORC1 activity correlated directly with altered association of mTOR with RagB/RagC, Rheb, raptor, and PRAS40. Overall, the results suggest that amino acids signal through the Rag complex and insulin through Rheb to achieve coordinate activation of mTORC1.	[Dennis, Michael D.; Baum, Jamie I.; Kimball, Scot R.; Jefferson, Leonard S.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Kimball, SR (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, H166,500 Univ Dr, Hershey, PA 17033 USA.	skimball@psu.edu		Dennis, Michael/0000-0002-0645-6864	National Institutes of Health [DK13499, DK15658]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK015658, R01DK013499, R37DK013499] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK13499 and DK15658 (to L. S. J.).	Acosta-Jaquez HA, 2009, MOL CELL BIOL, V29, P4308, DOI 10.1128/MCB.01665-08; Anthony TG, 2001, AM J PHYSIOL-ENDOC M, V281, pE430, DOI 10.1152/ajpendo.2001.281.3.E430; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881; FLAIM KE, 1982, J BIOL CHEM, V257, P2939; GARLICK PJ, 1980, BIOCHEM J, V192, P719, DOI 10.1042/bj1920719; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Kimball SR, 2000, AM J PHYSIOL-ENDOC M, V279, pE1080, DOI 10.1152/ajpendo.2000.279.5.E1080; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Kimball SR, 1997, AM J PHYSIOL-CELL PH, V272, pC754, DOI 10.1152/ajpcell.1997.272.2.C754; MADER S, 1995, MOL CELL BIOL, V15, P4990; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102; O'Connor PMJ, 2004, AM J PHYSIOL-ENDOC M, V286, pE994, DOI 10.1152/ajpendo.00391.2003; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; SCHURMANN A, 1995, J BIOL CHEM, V270, P28982, DOI 10.1074/jbc.270.48.28982; Sekiguchi T, 2001, J BIOL CHEM, V276, P7246, DOI 10.1074/jbc.M004389200; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Yan LJ, 2010, MOL CELL, V37, P633, DOI 10.1016/j.molcel.2010.01.031; Yoshizawa F, 1998, AM J PHYSIOL-ENDOC M, V275, pE814, DOI 10.1152/ajpendo.1998.275.5.E814	29	76	83	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8287	8296		10.1074/jbc.M110.209171	http://dx.doi.org/10.1074/jbc.M110.209171			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21239491	Green Published, hybrid			2022-12-27	WOS:000288013300058
J	Czabotar, PE; Lee, EF; Thompson, GV; Wardak, AZ; Fairlie, WD; Colman, PM				Czabotar, Peter E.; Lee, Erinna F.; Thompson, Geoff V.; Wardak, Ahmad Z.; Fairlie, W. Douglas; Colman, Peter M.			Mutation to Bax beyond the BH3 Domain Disrupts Interactions with Pro-survival Proteins and Promotes Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BCL-2 FAMILY-MEMBERS; CRYSTALLOGRAPHIC STRUCTURE DETERMINATION; PROGRAMMED CELL-DEATH; BH3-ONLY PROTEINS; MEMBRANE PERMEABILIZATION; X-RAY; CONFORMATIONAL-CHANGE; ANTIAPOPTOTIC BCL-2; ACTIVATION; BCL-X(L)	Pro-survival members of the Bcl-2 family of proteins restrain the pro-apoptotic activity of Bax, either directly through interactions with Bax or indirectly by sequestration of activator BH3-only proteins, or both. Mutations in Bax that promote apoptosis can provide insight into how Bax is regulated. Here, we describe crystal structures of the pro-survival proteins Mcl-1 and Bcl-x(L) in complex with a 34-mer peptide from Bax that encompasses its BH3 domain. These structures reveal canonical interactions between four signature hydrophobic amino acids from the BaxBH3 domain and the BH3-binding groove of the pro-survival proteins. In both structures, Met-74 from the Bax peptide engages with the BH3-binding groove in a fifth hydrophobic interaction. Various Bax Met-74 mutants disrupt interactions between Bax and all pro-survival proteins, but these Bax mutants retain pro-apoptotic activity. Bax/Bak-deficient mouse embryonic fibroblast cells reconstituted with several Bax Met-74 mutants are more sensitive to the BH3 mimetic compound ABT-737 as compared with cells expressing wild-type Bax. Furthermore, the cells expressing Bax Met-74 mutants are less viable in colony assays even in the absence of an external apoptotic stimulus. These results support a model in which direct restraint of Bax by pro-survival Bcl-2 proteins is a barrier to apoptosis.	[Czabotar, Peter E.; Lee, Erinna F.; Thompson, Geoff V.; Wardak, Ahmad Z.; Fairlie, W. Douglas; Colman, Peter M.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Fairlie, W. Douglas; Colman, Peter M.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Walter & Eliza Hall Institute; University of Melbourne	Czabotar, PE (corresponding author), WEHI, 1G Royale Parade, Parkville, Vic 3052, Australia.	czabotar@wehi.edu.au; pcolman@wehi.edu.au	Lee, Erinna/N-1523-2015; Fairlie, Walter/M-8401-2015	Lee, Erinna/0000-0003-1255-9808; Fairlie, Walter/0000-0002-2498-1160; Czabotar, Peter/0000-0002-2594-496X	Australian Research Council; National Health and Medical Research Council (NHMRC) Australia [575561, 461221]; Leukemia and Lymphoma Society [SCOR 7015-02]; Cancer Council of Victoria [461239]; Leukaemia Foundation of Australia; Australian Cancer Research Foundation	Australian Research Council(Australian Research Council); National Health and Medical Research Council (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Leukaemia Foundation of Australia; Australian Cancer Research Foundation	This work was supported by a fellowship from the Australian Research Council (to P. E. C.), National Health and Medical Research Council (NHMRC) Australia Project Grant 575561 (to P. E. C.), Program Grant 461221 fellowships (to W. D. F. and P. M. C.), Leukemia and Lymphoma Society (SCOR 7015-02), Cancer Council of Victoria Grant-in-Aid 461239 (to W. D. F.), a Leukaemia Foundation of Australia Phillip Desbrow Postdoctoral Fellowship (to E. F. L.), and an Australian Cancer Research Foundation grant (to P. M. C.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Cartron PF, 2004, MOL CELL, V16, P807, DOI 10.1016/j.molcel.2004.10.028; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Czabotar PE, 2010, CURR PHARM DESIGN, V16, P3132; Day CL, 2008, J MOL BIOL, V380, P958, DOI 10.1016/j.jmb.2008.05.071; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Hawkins CJ, 1999, P NATL ACAD SCI USA, V96, P2885, DOI 10.1073/pnas.96.6.2885; Hinds MG, 2007, CELL DEATH DIFFER, V14, P128, DOI 10.1038/sj.cdd.4401934; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Jabbour AM, 2006, J CELL SCI, V119, P2572, DOI 10.1242/jcs.02985; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; Ku B, 2011, CELL RES, V21, P627, DOI 10.1038/cr.2010.149; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Leber B, 2010, ONCOGENE, V29, P5221, DOI 10.1038/onc.2010.283; Lee EF, 2007, CELL DEATH DIFFER, V14, P1711, DOI 10.1038/sj.cdd.4402178; Lee EF, 2009, J BIOL CHEM, V284, P31315, DOI 10.1074/jbc.M109.048009; Lee EF, 2009, ANGEW CHEM INT EDIT, V48, P4318, DOI 10.1002/anie.200805761; Letai A, 2004, CANCER CELL, V6, P241, DOI 10.1016/j.ccr.2004.07.011; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Meyerkord CL, 2008, ONCOGENE, V27, P7248, DOI 10.1038/onc.2008.336; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; Nie C, 2008, J BIOL CHEM, V283, P15359, DOI 10.1074/jbc.M800847200; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pagliari LJ, 2005, P NATL ACAD SCI USA, V102, P17975, DOI 10.1073/pnas.0506712102; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Vogler M, 2009, CELL DEATH DIFFER, V16, P1030, DOI 10.1038/cdd.2009.48; Wang K, 1998, MOL CELL BIOL, V18, P6083, DOI 10.1128/MCB.18.10.6083; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhou H, 2007, ONCOGENE, V26, P7092, DOI 10.1038/sj.onc.1210517; Zwart P.H., 2005, CCP4 NEWSLETTER PROT, V43, P27	58	85	88	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7123	7131		10.1074/jbc.M110.161281	http://dx.doi.org/10.1074/jbc.M110.161281			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21199865	Green Published, hybrid			2022-12-27	WOS:000287737300029
J	Lamanna, WC; Lawrence, R; Sarrazin, S; Esko, JD				Lamanna, William C.; Lawrence, Roger; Sarrazin, Stephane; Esko, Jeffrey D.			Secondary Storage of Dermatan Sulfate in Sanfilippo Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II-THROMBIN COMPLEX; INTRACELLULAR CALCIUM STORES; MASS-SPECTROMETRY; HUMAN-FIBROBLASTS; ENZYME ASSAY; MPS DISEASE; MUCOPOLYSACCHARIDOSIS; DISORDERS; AUTOPHAGY; GLYCOSAMINOGLYCANS	Mucopolysaccharidoses are a group of genetically inherited disorders that result from the defective activity of lysosomal enzymes involved in glycosaminoglycan catabolism, causing their intralysosomal accumulation. Sanfilippo disease describes a subset of mucopolysaccharidoses resulting from defects in heparan sulfate catabolism. Sanfilippo disorders cause severe neuropathology in affected children. The reason for such extensive central nervous system dysfunction is unresolved, but it may be associated with the secondary accumulation of metabolites such as gangliosides. In this article, we describe the accumulation of dermatan sulfate as a novel secondary metabolite in Sanfilippo. Based on chondroitinase ABC digestion, chondroitin/dermatan sulfate levels in fibroblasts from Sanfilippo patients were elevated 2-5-fold above wild-type dermal fibroblasts. Lysosomal turnover of chondroitin/dermatan sulfate in these cell lines was significantly impaired but could be normalized by reducing heparan sulfate storage using enzyme replacement therapy. Examination of chondroitin/dermatan sulfate catabolic enzymes showed that heparan sulfate and heparin can inhibit iduronate 2-sulfatase. Analysis of the chondroitin/dermatan sulfate fraction by chondroitinase ACII digestion showed dermatan sulfate storage, consistent with inhibition of iduronate 2-sulfatase. The discovery of a novel storage metabolite in Sanfilippo patients may have important implications for diagnosis and understanding disease pathology.	[Lamanna, William C.; Lawrence, Roger; Sarrazin, Stephane; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, Glycobiol Res & Training Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Esko, JD (corresponding author), 9500 Gilman Dr 0687,Rm 1055, La Jolla, CA 92093 USA.	jesko@ucsd.edu			NIDDK [F32DK85905]; NIGMS [GM077471]; National MPS Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK085905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077471] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National MPS Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant F32DK85905 from the NIDDK (to W. C. L.), Grant GM077471 from the NIGMS, and by a grant from the National MPS Society (to J. D. E.).	AKATSU C, 2010, GLYCOBIOLOG IN PRESS; Bai XM, 1997, J BIOL CHEM, V272, P23172, DOI 10.1074/jbc.272.37.23172; BAUMKOTTER J, 1983, BIOCHIM BIOPHYS ACTA, V761, P163, DOI 10.1016/0304-4165(83)90225-8; Esko J.D., 2009, ESSENTIALS GLYCOBIOL; ESKO JD, 2001, CURR PROTOC MOL BIOL, V3; FRATANTONI JC, 1968, P NATL ACAD SCI USA, V60, P699, DOI 10.1073/pnas.60.2.699; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; HARDY MR, 1989, METHOD ENZYMOL, V179, P76; HOPWOOD JJ, 1979, CLIN CHIM ACTA, V92, P257, DOI 10.1016/0009-8981(79)90121-9; Kaneiwa T, 2010, GLYCOBIOLOGY, V20, P300, DOI 10.1093/glycob/cwp174; KINT JA, 1973, SCIENCE, V181, P352, DOI 10.1126/science.181.4097.352; Klein A, 1997, GLYCOBIOLOGY, V7, P421, DOI 10.1093/glycob/7.3.421; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Langford-Smith K, 2010, MOL GENET METAB, V99, P269, DOI 10.1016/j.ymgme.2009.10.175; Lawrence R, 2008, J BIOL CHEM, V283, P33674, DOI 10.1074/jbc.M804288200; LEABACK DH, 1961, BIOCHEM J, V78, pP22; LIE SO, 1972, P NATL ACAD SCI USA, V69, P2361, DOI 10.1073/pnas.69.9.2361; Liour SS, 2001, MOL GENET METAB, V72, P239, DOI 10.1006/mgme.2000.3139; Malstrom A, 1975, Biochem J, V151, P477; McGlynn R, 2004, J COMP NEUROL, V480, P415, DOI 10.1002/cne.20355; Mitsunaga C, 2006, J BIOL CHEM, V281, P18942, DOI 10.1074/jbc.M510870200; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Nguyen HN, 2002, BRAIN RES, V924, P159, DOI 10.1016/S0006-8993(01)03229-2; Nielsen TC, 2008, GLYCOBIOLOGY, V18, P1119, DOI 10.1093/glycob/cwn097; Pelled D, 2003, J BIOL CHEM, V278, P29496, DOI 10.1074/jbc.M302964200; PETERS C, 1991, BIOCHEM J, V276, P499, DOI 10.1042/bj2760499; Randall DR, 2008, MOL GENET METAB, V94, P456, DOI 10.1016/j.ymgme.2008.05.001; Randall DR, 2006, MOL GENET METAB, V88, P235, DOI 10.1016/j.ymgme.2006.01.005; ROME LH, 1979, CELL, V17, P143, DOI 10.1016/0092-8674(79)90302-7; Settembre C, 2008, AUTOPHAGY, V4, P113, DOI 10.4161/auto.5227; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; SIEGEL DA, 1994, J NEUROCHEM, V62, P1852; Taylor KR, 2006, FASEB J, V20, P9, DOI 10.1096/fj.05-4682rev; Thomas G.H., METABOLIC MOL BASES, V3, P3507; Tomatsu S, 2010, MOL GENET METAB, V99, P124, DOI 10.1016/j.ymgme.2009.10.001; Trowbridge JM, 2002, GLYCOBIOLOGY, V12, p117R, DOI 10.1093/glycob/cwf066; VANDIGGELEN OP, 1990, CLIN CHIM ACTA, V187, P131, DOI 10.1016/0009-8981(90)90339-T; Voznyi YV, 2001, J INHERIT METAB DIS, V24, P675, DOI 10.1023/A:1012763026526; Vreys V, 2007, J CELL MOL MED, V11, P427, DOI 10.1111/j.1582-4934.2007.00039.x; Walkley SU, 2009, BBA-MOL CELL RES, V1793, P726, DOI 10.1016/j.bbamcr.2008.11.014; Walkley SU, 2004, SEMIN CELL DEV BIOL, V15, P433, DOI 10.1016/j.semcdb.2004.03.002; WASTESON A, 1971, J CHROMATOGR, V59, P87, DOI 10.1016/S0021-9673(01)80009-1; Wei HF, 1998, J NEUROCHEM, V70, P2305	44	40	40	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6955	6962		10.1074/jbc.M110.192062	http://dx.doi.org/10.1074/jbc.M110.192062			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193389	hybrid, Green Published			2022-12-27	WOS:000287737300011
J	Valverde, RHF; Britto-Borges, T; Lowe, J; Einicker-Lamas, M; Mintz, E; Cuillel, M; Vieyra, A				Valverde, Rafael H. F.; Britto-Borges, Thiago; Lowe, Jennifer; Einicker-Lamas, Marcelo; Mintz, Elisabeth; Cuillel, Martine; Vieyra, Adalberto			Two Serine Residues Control Sequential Steps during Catalysis of the Yeast Copper ATPase through Different Mechanisms That Involve Kinase-mediated Phosphorylations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WILSONS-DISEASE PROTEIN; P-TYPE ATPASE; METAL-BINDING DOMAINS; TRANSPORTING ATPASE; FUNCTIONAL-CHARACTERIZATION; PROXIMAL TUBULE; ATP7B; GENE; CELLS; CA2+-ATPASE	Ccc2, the yeast copper-transporting ATPase, pumps copper from the cytosol to the Golgi lumen. During its catalytic cycle, Ccc2 undergoes auto-phosphorylation on Asp(627) and uses the energy gained to transport copper across the cell membrane. We previously demonstrated that cAMP-dependent protein kinase (PKA) controls the energy interconversion E-Cu similar to P -> E-P + Cu when Ser(258) is phosphorylated. We now demonstrate that Ser(258) is essential in vivo for copper homeostasis in extremely low copper and iron concentrations. The S258A mutation abrogates all PKA-mediated phosphorylations of Ccc2, whereas the S971A mutation leads to a 100% increase in its global regulatory phosphorylation. With S258A, the first-order rate constant of catalytic phosphorylation by ATP decreases from 0.057 to 0.030 s(-1), with an 8-fold decrease in the burst of initial phosphorylation. With the S971A mutant, the rate constant decreases to 0.007 s(-1). PKAi(5-24) decreases the amount of the aspartylphosphate intermediate (EP) in Ccc2 wt by 50% within 1 min, but not in S258A, S971A, or S258A/S971A. The increase of the initial burst and the extremely slow phosphorylation when the "phosphomimetic" mutant S258D was assayed (k = 0.0036 s(-1)), indicate that electrostatic and conformational (non-electrostatic) mechanisms are involved in the regulatory role of Ser(258). Accumulation of an ADP-insensitive form in S971A demonstrates that Ser(971) is required to accelerate the hydrolysis of the E-P form during turnover. We propose that Ser(258) and Ser(971) are under long-range intramolecular, reciprocal and concerted control, in a sequential process that is crucial for catalysis and copper transport in the yeast copper ATPase.	[Mintz, Elisabeth; Cuillel, Martine] CEA, DSV, IRTSV, Lab Chim & Biol Met, F-38054 Grenoble, France; [Valverde, Rafael H. F.; Britto-Borges, Thiago; Lowe, Jennifer; Einicker-Lamas, Marcelo; Vieyra, Adalberto] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21949900 Rio De Janeiro, Brazil; [Valverde, Rafael H. F.; Britto-Borges, Thiago; Lowe, Jennifer; Einicker-Lamas, Marcelo; Vieyra, Adalberto] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, BR-21949900 Rio De Janeiro, Brazil; [Mintz, Elisabeth; Cuillel, Martine] Univ Grenoble 1, F-38000 Grenoble, France; [Mintz, Elisabeth; Cuillel, Martine] CNRS, UMR 5249, F-38054 Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Cuillel, M (corresponding author), CEA, DSV, IRTSV, Lab Chim & Biol Met, 17 Rue Martyrs, F-38054 Grenoble, France.	martine.cuillel@cea.fr; avieyra@biof.ufrj.br	Valverde, Rafael H.F./K-6567-2012; Lowe, Jennifer/F-1148-2013; Fisiologia, Ciencias Biologicas/C-2407-2012; Britto-Borges, Thiago/J-4953-2016	Valverde, Rafael H.F./0000-0002-1244-814X; Lowe, Jennifer/0000-0001-7378-4561; Britto-Borges, Thiago/0000-0002-6218-4429	EGIDE (France); CAPES/COFECUB (Brazil/France); CAPES (Brazil); Rio de Janeiro State Funding Agency (FAPERJ, Brazil); Brazilian Research Council (CNPq, Brazil); Programme de Toxicologie Nucleaire Environnementale (France); CAPES/PNPD	EGIDE (France); CAPES/COFECUB (Brazil/France)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Rio de Janeiro State Funding Agency (FAPERJ, Brazil)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Brazilian Research Council (CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Programme de Toxicologie Nucleaire Environnementale (France); CAPES/PNPD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by EGIDE (France), CAPES/COFECUB (Brazil/France) and the CAPES National Program of Post-doctoral Training (Brazil), the Rio de Janeiro State Funding Agency (FAPERJ, Brazil), the Brazilian Research Council (CNPq, Brazil), and the Programme de Toxicologie Nucleaire Environnementale (France).; Recipient of a fellowship from the CAPES/PNPD Program.	Arokium H, 2007, J BIOL CHEM, V282, P35104, DOI 10.1074/jbc.M704891200; Bartee MY, 2009, BIOCHEMISTRY-US, V48, P5573, DOI 10.1021/bi900325k; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; BULL PC, 1993, NAT GENET, V5, P327, DOI 10.1038/ng1293-327; Cabral LMP, 2007, J BIOL CHEM, V282, P24599, DOI 10.1074/jbc.M701669200; Caruso-Neves C, 2000, BBA-BIOMEMBRANES, V1468, P107, DOI 10.1016/S0005-2736(00)00248-0; Cobbold C, 2002, HUM MOL GENET, V11, P2855, DOI 10.1093/hmg/11.23.2855; Forbes JR, 1998, AM J HUM GENET, V63, P1663, DOI 10.1086/302163; FU DD, 1995, YEAST, V11, P283, DOI 10.1002/yea.320110310; Gromadzka G, 2005, CLIN GENET, V68, P524, DOI 10.1111/j.1399-0004.2005.00528.x; Kaplan JH, 2009, J BIOL CHEM, V284, P25461, DOI 10.1074/jbc.R109.031286; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI M, 1993, SCIENCE, V261, P1439, DOI 10.1126/science.8396273; Lowe J, 2004, J BIOL CHEM, V279, P25986, DOI 10.1074/jbc.M308736200; Lutsenko S, 2002, J BIOENERG BIOMEMBR, V34, P351, DOI 10.1023/A:1021297919034; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Maia J.C.C., 1983, GENES ANTIGENES PARA, P146; Miras R, 2001, PROTEIN EXPRES PURIF, V22, P299, DOI 10.1006/prep.2001.1436; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Morin I, 2009, FEBS J, V276, P4483, DOI 10.1111/j.1742-4658.2009.07155.x; Neuberger G, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-1; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P349, DOI 10.1007/s10863-007-9123-9; Pilankatta R, 2009, J BIOL CHEM, V284, P21307, DOI 10.1074/jbc.M109.023341; Rensing C, 2000, P NATL ACAD SCI USA, V97, P652, DOI 10.1073/pnas.97.2.652; Rodriguez M, 2004, J BIOL CHEM, V279, P8802, DOI 10.1074/jbc.M311886200; Rosen BP, 2002, COMP BIOCHEM PHYS A, V133, P689, DOI 10.1016/S1095-6433(02)00201-5; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Sweadner KJ, 2001, AM J PHYSIOL-CELL PH, V280, pC1017, DOI 10.1152/ajpcell.2001.280.4.C1017; Terada K, 1998, J BIOL CHEM, V273, P1815, DOI 10.1074/jbc.273.3.1815; Tsivkovskii R, 2002, J BIOL CHEM, V277, P976, DOI 10.1074/jbc.M109368200; Valverde RHF, 2008, FEBS LETT, V582, P891, DOI 10.1016/j.febslet.2008.02.022; Vanderwerf SM, 2002, BIOCHEM SOC T, V30, P739, DOI 10.1042/bst0300739; Vanderwerf SM, 2001, J BIOL CHEM, V276, P36289, DOI 10.1074/jbc.M102055200; Veldhuis NA, 2009, INT J BIOCHEM CELL B, V41, P2403, DOI 10.1016/j.biocel.2009.06.008; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632	35	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6879	6889		10.1074/jbc.M110.207704	http://dx.doi.org/10.1074/jbc.M110.207704			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21163943	Green Published, hybrid			2022-12-27	WOS:000287737300003
J	Katsuyama, Y; Miyazono, K; Tanokura, M; Ohnishi, Y; Horinouchi, S				Katsuyama, Yohei; Miyazono, Ken-ichi; Tanokura, Masaru; Ohnishi, Yasuo; Horinouchi, Sueharu			Structural and Biochemical Elucidation of Mechanism for Decarboxylative Condensation of beta-Keto Acid by Curcumin Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							III POLYKETIDE SYNTHASE; CHALCONE SYNTHASE; BIOSYNTHESIS; SPECIFICITY; COENZYME; PQSD	The typical reaction catalyzed by type III polyketide synthases (PKSs) is a decarboxylative condensation between acyl-CoA (starter substrate) and malonyl-CoA (extender substrate). In contrast, curcumin synthase 1 (CURS1), which catalyzes curcumin synthesis by condensing feruloyl-CoA with a diketide-CoA, uses a beta-keto acid (which is derived from diketide-CoA) as an extender substrate. Here, we determined the crystal structure of CURS1 at 2.32 angstrom resolution. The overall structure of CURS1 was very similar to the reported structures of type III PKSs and exhibited the alpha beta alpha beta alpha fold. However, CURS1 had a unique hydrophobic cavity in the CoA-binding tunnel. Replacement of Gly-211 with Phe greatly reduced the enzyme activity. The crystal structure of the G211F mutant (at 2.5 angstrom resolution) revealed that the side chain of Phe-211 occupied the hydrophobic cavity. Biochemical studies demonstrated that CURS1 catalyzes the decarboxylative condensation of a beta-keto acid using a mechanism identical to that for normal decarboxylative condensation of malonyl-CoA by typical type III PKSs. Furthermore, the extender substrate specificity of CURS1 suggested that hydrophobic interaction between CURS1 and a beta-keto acid may be important for CURS1 to use an extender substrate lacking the CoA moiety. From these results and a modeling study on substrate binding, we concluded that the hydrophobic cavity is responsible for the hydrophobic interaction between CURS1 and a beta-keto acid, and this hydrophobic interaction enables the beta-keto acid moiety to access the catalytic center of CURS1 efficiently.	[Katsuyama, Yohei; Ohnishi, Yasuo; Horinouchi, Sueharu] Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Miyazono, Ken-ichi; Tanokura, Masaru] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo; University of Tokyo	Ohnishi, Y (corresponding author), Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan.	ayasuo@mail.ecc.u-tokyo.ac.jp	Miyazono, Kenichi/P-9654-2019	Miyazono, Kenichi/0000-0002-9354-2604; Tanokura, Masaru/0000-0001-5072-2480; Katsuyama, Yohei/0000-0003-4905-5320; Ohnishi, Yasuo/0000-0001-7633-9236	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Targeted Proteins Research Program of the Ministry of Education, Culture, Sports, Science, and Technology of Japan.; Supported by the Japan Society for the Promotion of Science.	Abe I, 2010, NAT PROD REP, V27, P809, DOI 10.1039/b909988n; Austin MB, 2004, CHEM BIOL, V11, P1179, DOI 10.1016/j.chembiol.2004.05.024; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Bera AK, 2009, BIOCHEMISTRY-US, V48, P8644, DOI 10.1021/bi9009055; Brand S, 2006, PLANTA, V224, P413, DOI 10.1007/s00425-006-0228-x; Coleman JP, 2008, J BACTERIOL, V190, P1247, DOI 10.1128/JB.01140-07; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferrer JL, 2008, PLANT PHYSIOL BIOCH, V46, P356, DOI 10.1016/j.plaphy.2007.12.009; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Hertweck C, 2009, ANGEW CHEM INT EDIT, V48, P4688, DOI 10.1002/anie.200806121; Jez JM, 2000, CHEM BIOL, V7, P919, DOI 10.1016/S1074-5521(00)00041-7; Jez JM, 2000, J BIOL CHEM, V275, P39640, DOI 10.1074/jbc.M008569200; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Kamo T, 2000, BIOSCI BIOTECH BIOCH, V64, P2089, DOI 10.1271/bbb.64.2089; Katsuyama Y, 2007, J BIOL CHEM, V282, P37702, DOI 10.1074/jbc.M707569200; Katsuyama Y, 2009, FEBS LETT, V583, P2799, DOI 10.1016/j.febslet.2009.07.029; Katsuyama Y, 2009, J BIOL CHEM, V284, P11160, DOI 10.1074/jbc.M900070200; Morita H, 2007, CHEM BIOL, V14, P359, DOI 10.1016/j.chembiol.2007.02.003; Morita H, 2010, P NATL ACAD SCI USA, V107, P669, DOI 10.1073/pnas.0909982107; Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ramirez-Ahumada MD, 2006, PHYTOCHEMISTRY, V67, P2017, DOI 10.1016/j.phytochem.2006.06.028; Sukovich DJ, 2010, APPL ENVIRON MICROB, V76, P3842, DOI 10.1128/AEM.00433-10; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Zhang YM, 2008, J BIOL CHEM, V283, P28788, DOI 10.1074/jbc.M804555200	25	18	22	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6659	6668		10.1074/jbc.M110.196279	http://dx.doi.org/10.1074/jbc.M110.196279			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21148316	hybrid, Green Published			2022-12-27	WOS:000287476400074
J	Xue, ML; Chow, SO; Dervish, S; Chan, YKA; Julovi, SM; Jackson, CJ				Xue, Meilang; Chow, Shu-Oi; Dervish, Suat; Chan, Yee-Ka Agnes; Julovi, Sohel M.; Jackson, Christopher J.			Activated Protein C Enhances Human Keratinocyte Barrier Integrity via Sequential Activation of Epidermal Growth Factor Receptor and Tie2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL CONTACTS; SIGNALING PATHWAYS; TIGHT JUNCTIONS; ANGIOPOIETIN-1; SKIN; EXPRESSION; SURVIVAL; TRANSACTIVATION; DIFFERENTIATION; PSORIASIS	Keratinocytes play a critical role in maintaining epidermal barrier function. Activated protein C (APC), a natural anticoagulant with anti-inflammatory and endothelial barrier protective properties, significantly increased the barrier impedance of keratinocyte monolayers, measured by electric cell substrate impedance sensing and FITC-dextran flux. In response to APC, Tie2, a tyrosine kinase receptor, was rapidly activated within 30 min, and relocated to cell-cell contacts. APC also increased junction proteins zona occludens, claudin-1 and VE-cadherin. Inhibition of Tie2 by its peptide inhibitor or small interfering RNA abolished the barrier protective effect of APC. Interestingly, APC did not activate Tie2 through its major ligand, angiopoietin-1, but instead acted by binding to endothelial protein C receptor, cleaving protease-activated receptor-1 and transactivating EGF receptor. Furthermore, when activation of Akt, but not ERK, was inhibited, the barrier protective effect of APC on keratinocytes was abolished. Thus, APC activates Tie2, via a mechanism requiring, in sequential order, the receptors, endothelial protein C receptor, protease-activated receptor-1, and EGF receptor, which selectively enhances the PI3K/Akt signaling to enhance junctional complexes and reduce keratinocyte permeability.	[Xue, Meilang; Chow, Shu-Oi; Dervish, Suat; Chan, Yee-Ka Agnes; Julovi, Sohel M.; Jackson, Christopher J.] Univ Sydney, Royal N Shore Hosp, Sutton Arthrit Res Labs, Inst Bone & Joint Res,Kolling Inst Med Res, St Leonards, NSW 2065, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research	Xue, ML (corresponding author), Univ Sydney, Royal N Shore Hosp, Sutton Res Labs, Level 10,Kolling Bldg, St Leonards, NSW 2065, Australia.	meilang.xue@sydney.edu.au	Julovi, Sohel/AAQ-4539-2020	Julovi, Sohel/0000-0003-0834-2366; Jackson, Christopher/0000-0002-9234-9116; Xue, Meilang/0000-0002-8563-7216	National Health and Medical Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a career development award and a project grant from the National Health and Medical Research Council.	Babaei S, 2003, AM J PATHOL, V162, P1927, DOI 10.1016/S0002-9440(10)64326-X; Brandner JM, 2009, EUR J PHARM BIOPHARM, V72, P289, DOI 10.1016/j.ejpb.2008.08.007; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Carpenter G, 1999, J CELL BIOL, V146, P697, DOI 10.1083/jcb.146.4.697; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DeBusk LM, 2004, EXP CELL RES, V298, P167, DOI 10.1016/j.yexcr.2004.04.013; Eckert RL, 2002, J INVEST DERM SYMP P, V7, P36, DOI 10.1046/j.1523-1747.2002.19634.x; Feistritzer C, 2006, J IMMUNOL, V176, P1019, DOI 10.4049/jimmunol.176.2.1019; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Findley CM, 2007, ARTERIOSCL THROM VAS, V27, P2619, DOI 10.1161/ATVBAHA.107.150482; Finigan JH, 2005, J BIOL CHEM, V280, P17286, DOI 10.1074/jbc.M412427200; Fischer OM, 2003, BIOCHEM SOC T, V31, P1203; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Fukuhara S, 2009, EXP MOL MED, V41, P133, DOI 10.3858/emm.2009.41.3.016; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Harfouche R, 2003, FASEB J, V17, P1523, DOI 10.1096/fj.02-0698fje; Honari Shari, 2004, Crit Care Nurs Clin North Am, V16, P1, DOI 10.1016/j.ccell.2003.09.008; Jackson CJ, 2008, INT J BIOCHEM CELL B, V40, P2692, DOI 10.1016/j.biocel.2007.12.013; Jost M, 2000, EUR J DERMATOL, V10, P505; Jost M, 2001, J BIOL CHEM, V276, P6320, DOI 10.1074/jbc.M008210200; Kim I, 2000, CIRC RES, V86, P952, DOI 10.1161/01.RES.86.9.952; Koster MI, 2009, ANN NY ACAD SCI, V1170, P7, DOI 10.1111/j.1749-6632.2009.04363.x; Kuroda K, 2001, J INVEST DERMATOL, V116, P713, DOI 10.1046/j.1523-1747.2001.01316.x; Makinde T, 2008, J CELL MOL MED, V12, P810, DOI 10.1111/j.1582-4934.2008.00254.x; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Markham T, 2006, J AM ACAD DERMATOL, V54, P1003, DOI 10.1016/j.jaad.2006.01.038; Materazzi S, 2007, J PATHOL, V212, P440, DOI 10.1002/path.2197; McCarthy KM, 2000, J CELL SCI, V113, P3387; Minhas N, 2010, FASEB J, V24, P873, DOI 10.1096/fj.09-134445; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Peters KG, 2004, RECENT PROG HORM RES, V59, P51, DOI 10.1210/rp.59.1.51; Piepkorn M, 2003, ARCH DERMATOL RES, V295, P93, DOI 10.1007/s00403-003-0391-x; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Proksch E, 2008, EXP DERMATOL, V17, P1063, DOI 10.1111/j.1600-0625.2008.00786.x; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sabri A, 2002, CIRC RES, V91, P532, DOI 10.1161/01.RES.0000035242.96310.45; Thrash BR, 2006, J BIOL CHEM, V281, P12155, DOI 10.1074/jbc.M512116200; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Voskas D, 2005, AM J PATHOL, V166, P843, DOI 10.1016/S0002-9440(10)62305-X; Wolfram JA, 2009, AM J PATHOL, V174, P1443, DOI 10.2353/ajpath.2009.080858; Xue ML, 2007, J BIOL CHEM, V282, P13610, DOI 10.1074/jbc.M610740200; Xue ML, 2010, CELL MOL LIFE SCI, V67, P1537, DOI 10.1007/s00018-010-0269-y; Xue ML, 2005, J INVEST DERMATOL, V125, P1279, DOI 10.1111/j.0022-202X.2005.23952.x; Xue ML, 2004, EXP CELL RES, V299, P119, DOI 10.1016/j.yexcr.2004.05.015	47	38	38	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6742	6750		10.1074/jbc.M110.181388	http://dx.doi.org/10.1074/jbc.M110.181388			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21173154	Green Published, hybrid			2022-12-27	WOS:000287476400081
J	Hagihara, M; Endo, M; Hata, K; Higuchi, C; Takaoka, K; Yoshikawa, H; Yamashita, T				Hagihara, Meiko; Endo, Mitsuharu; Hata, Katsuhiko; Higuchi, Chikahisa; Takaoka, Kunio; Yoshikawa, Hideki; Yamashita, Toshihide			Neogenin, a Receptor for Bone Morphogenetic Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPULSIVE GUIDANCE MOLECULE; NEURONAL DIFFERENTIATION; SPINAL-CORD; EXPRESSION; FOREBRAIN; SURVIVAL; RGMA; DCC	Bone morphogenetic proteins (BMPs) regulate many mammalian physiologic and pathophysiologic processes. These proteins bind with the kinase receptors BMPR-I and BMPR-II, thereby activating Smad transcription factor. In this study, we demonstrate that neogenin, a receptor for netrins and proteins of the repulsive guidance molecule family, is a receptor for BMPs and modulates Smad signal transduction. Neogenin was found to bind directly with BMP-2, BMP-4, BMP-6, and BMP-7. Knockdown of neogenin in C2C12 cells resulted in the enhancement of the BMP-2-induced processes of osteoblastic differentiation and phosphorylation of Smad1, Smad5, and Smad8. Conversely, overexpression of neogenin in C2C12 cells suppressed these processes. Our results also indicated that BMP-induced activation of RhoA was mediated by neogenin. Inhibition of RhoA promoted BMP-2-induced processes of osteoblastic differentiation and phosphorylation of Smad1/5/8. However, treatment with Y-27632, an inhibitor of Rho-associated protein kinase, did not modulate BMP-induced phosphorylation of Smad1/5/8. Taken together, our findings suggest that neogenin negatively regulates the functions of BMP and that this effect of neogenin is mediated by the activation of RhoA.	[Hagihara, Meiko; Endo, Mitsuharu; Hata, Katsuhiko; Yamashita, Toshihide] Osaka Univ, Dept Mol Neurosci, Grad Sch Med, Suita, Osaka 5650871, Japan; [Higuchi, Chikahisa; Yoshikawa, Hideki] Osaka Univ, Dept Orthoped Surg, Grad Sch Med, Suita, Osaka 5650871, Japan; [Takaoka, Kunio] Osaka City Univ, Dept Orthopaed Surg, Grad Sch Med, Abeno Ku, Osaka 5458585, Japan; [Yamashita, Toshihide] CREST, JST, Chiyoda Ku, Tokyo 1020075, Japan	Osaka University; Osaka University; Osaka Metropolitan University; Japan Science & Technology Agency (JST)	Yamashita, T (corresponding author), Osaka Univ, Dept Mol Neurosci, Grad Sch Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yamashita@molneu.med.osaka-u.ac.jp	Hata, Katsuhiko/AAA-5015-2021	Yamashita, Toshihide/0000-0003-4559-7018	JSPS	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-in-Aid for Young Scientists (S) from JSPS.	Corradini E, 2009, CYTOKINE GROWTH F R, V20, P389, DOI 10.1016/j.cytogfr.2009.10.008; Fitzgerald DP, 2006, NEUROSCIENCE, V142, P703, DOI 10.1016/j.neuroscience.2006.06.041; Fujita Y, 2008, CELL DEATH DIFFER, V15, P1593, DOI 10.1038/cdd.2008.92; Gad JM, 1997, DEV BIOL, V192, P258, DOI 10.1006/dbio.1997.8756; Hata K, 2006, J CELL BIOL, V173, P47, DOI 10.1083/jcb.200508143; Hata K, 2009, J CELL BIOL, V184, P737, DOI 10.1083/jcb.200807029; Kirsch T, 2000, FEBS LETT, V468, P215, DOI 10.1016/S0014-5793(00)01214-X; Manitt C, 2004, J NEUROSCI RES, V77, P690, DOI 10.1002/jnr.20199; Matsunaga E, 2004, NAT CELL BIOL, V6, P749, DOI 10.1038/ncb1157; Matsunaga E, 2006, J NEUROSCI, V26, P6082, DOI 10.1523/JNEUROSCI.4556-05.2006; Meyerhardt JA, 1997, ONCOGENE, V14, P1129, DOI 10.1038/sj.onc.1200935; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Rajagopalan S, 2004, NAT CELL BIOL, V6, P756, DOI 10.1038/ncb1156; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Ruppert R, 1996, EUR J BIOCHEM, V237, P295, DOI 10.1111/j.1432-1033.1996.0295n.x; VIELMETTER J, 1994, J CELL BIOL, V127, P2009, DOI 10.1083/jcb.127.6.2009; Wilson NH, 2006, DEV BIOL, V296, P485, DOI 10.1016/j.ydbio.2006.06.018; YAMAGUCHI A, 1991, J CELL BIOL, V113, P681, DOI 10.1083/jcb.113.3.681; Yoshikawa H, 2009, CLIN ORTHOP RELAT R, V467, P3087, DOI 10.1007/s11999-009-0976-6; Zhou Z, 2010, DEV CELL, V19, P90, DOI 10.1016/j.devcel.2010.06.016	21	67	71	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5157	5165		10.1074/jbc.M110.180919	http://dx.doi.org/10.1074/jbc.M110.180919			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21149453	Green Published, hybrid			2022-12-27	WOS:000287230600024
J	Xiong, SQ; Salazar, G; Patrushev, N; Alexander, RW				Xiong, Shiqin; Salazar, Gloria; Patrushev, Nikolay; Alexander, R. Wayne			FoxO1 Mediates an Autofeedback Loop Regulating SIRT1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR SMOOTH-MUSCLE; SMALL-MOLECULE ACTIVATORS; TRANSCRIPTION FACTORS; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; LIFE-SPAN; DEPENDENT REGULATION; MAMMALIAN SIRTUINS; INSULIN-RESISTANCE; CELL-SURVIVAL	Forkhead transcription factor FoxO1 and the NAD(+) dependent histone deacetylase SIRT1 are evolutionarily conserved regulators of the development of aging, oxidative stress resistance, insulin resistance, and metabolism in species ranging from invertebrates to mammals. SIRT1 deacetylates FoxO1 and enables activation of FoxO1 transcription in multiple systems. The functional consequences of the interactions between FoxO1 and SIRT1 remain incompletely understood. Here, we demonstrate that the 1.5-kb rat sirt1 promoter region contains a cluster of five putative FoxO1 core binding repeat motifs (5xIRS-1) and a forkhead-like consensus binding site (FKHD-L). Luciferase promoter assays demonstrate that FoxO1 directly activates SIRT1 promoter activity and that both the IRS-1 and FKHD-L enable FoxO1-dependent SIRT1 transcription. Electrophoretic mobility shift and chromatin immunoprecipitation assays show that FoxO1 binds to the IRS-1 and FKHD-L sites of the SIRT1 promoter. Consistently, FoxO1 overexpression increases SIRT1 expression, and FoxO1 depletion by siRNA reduces SIRT1 expression at both the messenger RNA and protein levels in vascular smooth muscle cells and HEK293 cells. Thus, endogenous FoxO1 is a positive transcriptional regulator of SIRT1. Conversely, SIRT1 promotes FoxO1-driven SIRT1 autotranscription through interacting with and deacetylating FoxO1. Moreover, resveratrol, a plant polyphenol activator of SIRT1, increases FoxO1-dependent SIRT1 transcription activity and thus induces its expression. These findings suggest that positive feedback mechanisms regulate FoxO1-dependent SIRT1 transcription and indicate a previously unappreciated function for FoxO1. This signaling network may coordinate multiple pathways acting upon immune, inflammatory, regenerative, and metabolic processes.	[Alexander, R. Wayne] Emory Univ, Sch Med, Emory Univ Hosp, Div Cardiol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA 30322 USA	Emory University; Emory University	Alexander, RW (corresponding author), Emory Univ, Sch Med, Emory Univ Hosp, Div Cardiol, Suite H-153,1364 Clifton Rd NE, Atlanta, GA 30322 USA.	ralexan@emory.edu			National Institutes of Health [UO1 HL80711, HL60728]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060728, U01HL080711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants UO1 HL80711 and HL60728.	Abdelmohsen K, 2007, MOL CELL, V25, P543, DOI 10.1016/j.molcel.2007.01.011; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; BERK BC, 1989, HYPERTENSION, V13, P305, DOI 10.1161/01.HYP.13.4.305; Biggs WH, 2001, MAMM GENOME, V12, P416, DOI 10.1007/s003350020002; Boily G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001759; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chen W, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2061222; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Feige JN, 2008, CELL METAB, V8, P347, DOI 10.1016/j.cmet.2008.08.017; Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; GRIENDLING KK, 1989, J CARDIOVASC PHARM, V14, pS27, DOI 10.1097/00005344-198906146-00008; GRIENDLING KK, 1988, CLIN EXP PHARMACOL P, V15, P105, DOI 10.1111/j.1440-1681.1988.tb01051.x; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; GUNTHER S, 1982, J CELL BIOL, V92, P289, DOI 10.1083/jcb.92.2.289; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Li Y, 2008, CELL METAB, V8, P38, DOI 10.1016/j.cmet.2008.05.004; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Nakae J, 2006, J CLIN INVEST, V116, P2473, DOI 10.1172/JCI25518; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Ni YG, 2006, CIRCULATION, V114, P1159, DOI 10.1161/CIRCULATIONAHA.106.637124; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ronnebaum SM, 2010, ANNU REV PHYSIOL, V72, P81, DOI 10.1146/annurev-physiol-021909-135931; Schilling MM, 2006, NATURE, V443, pE10, DOI 10.1038/nature05288; Sedding DG, 2008, BIOL CHEM, V389, P279, DOI 10.1515/BC.2008.033; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Um J. H., DIABETES, V59, P554; Vander Kooi BT, 2003, J BIOL CHEM, V278, P11782, DOI 10.1074/jbc.M212570200; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Xiong SQ, 2010, J BIOL CHEM, V285, P2474, DOI 10.1074/jbc.M109.065235; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zhang QH, 2007, P NATL ACAD SCI USA, V104, P829, DOI 10.1073/pnas.0610590104	54	153	157	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5289	5299		10.1074/jbc.M110.163667	http://dx.doi.org/10.1074/jbc.M110.163667			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21149440	Green Published, hybrid			2022-12-27	WOS:000287230600037
J	Higgins, CE; Gross, SS				Higgins, Christina E.; Gross, Steven S.			The N-terminal Peptide of Mammalian GTP Cyclohydrolase I Is an Autoinhibitory Control Element and Contributes to Binding the Allosteric Regulatory Protein GFRP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; GUANOSINE TRIPHOSPHATE; REACTION-MECHANISM; ESCHERICHIA-COLI; FUSION PROTEINS; NITRIC-OXIDE; TETRAHYDROBIOPTERIN; BIOSYNTHESIS; INHIBITION; ENZYME	GTP cyclohydrolase I (GTPCH) is the rate-limiting enzyme for biosynthesis of tetrahydrobiopterin (BH4), an obligate cofactor for NO synthases and aromatic amino acid hydroxylases. BH4 can limit its own synthesis by triggering decameric GTPCH to assemble in an inhibitory complex with two GTPCH feedback regulatory protein (GFRP) pentamers. Subsequent phenylalanine binding to the GTPCH center dot GFRP inhibitory complex converts it to a stimulatory complex. An N-terminal inhibitory peptide in GTPCH may also contribute to autoregulation of GTPCH activity, but mechanisms are undefined. To characterize potential regulatory actions of the N-terminal peptide in rat GTPCH, we expressed, purified, and characterized a truncation mutant, devoid of 45 N-terminal amino acids (Delta 45-GTPCH) and contrasted its catalytic and GFRP binding properties to wild type GTPCH (wt-GTPCH). Contrary to prior reports, we show that GFRP binds wt-GTPCH in the absence of any small molecule effector, resulting in allosteric stimulation of GTPCH activity: a 20% increase in V-max, 50% decrease in K-m(GTP), and increase in Hill coefficient to 1.6, from 1.0. These features of GFRP-stimulated wt-GTPCH activity were phenocopied by Delta 45-GTPCH in the absence of bound GFRP. Addition of GFRP to Delta 45-GTPCH failed to elicit complex formation or a substantial further increase in GTPCH catalytic activity. Expression of Delta 45-GTPCH in HEK-293 cells elicited 3-fold greater BH4 accumulation than an equivalent of wt-GTPCH. Together, results indicate that the N-terminal peptide exerts autoinhibitory control over rat GTPCH and is required for GFRP binding on its own. Displacement of the autoinhibitory peptide provides a molecular mechanism for physiological up-regulation of GTPCH activity.	[Higgins, Christina E.; Gross, Steven S.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; [Higgins, Christina E.; Gross, Steven S.] Cornell Univ, Weill Med Coll, Program Neurosci, New York, NY 10021 USA	Cornell University; Cornell University	Gross, SS (corresponding author), 1300 York Ave, New York, NY 10021 USA.	ssgross@med.cornell.edu			National Institutes of Health [R37 HL087062, PO1 HL046403, T32 HL007423]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007423, R37HL087062, P01HL046403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R37 HL087062, PO1 HL046403 (to S. S. G.), and T32 HL007423 (to C. E. H.).	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Auerbach G, 2000, P NATL ACAD SCI USA, V97, P13567, DOI 10.1073/pnas.240463497; Bowling KM, 2008, J BIOL CHEM, V283, P31449, DOI 10.1074/jbc.M802552200; BURG AW, 1968, J BIOL CHEM, V243, P2349; Du JH, 2009, ARTERIOSCL THROM VAS, V29, P2161, DOI 10.1161/ATVBAHA.109.194464; Foxton RH, 2007, NEUROCHEM RES, V32, P751, DOI 10.1007/s11064-006-9201-0; Funderburk CD, 2006, J BIOL CHEM, V281, P33302, DOI 10.1074/jbc.M602196200; HARADA T, 1993, SCIENCE, V260, P1507, DOI 10.1126/science.8502995; HATAKEYAMA K, 1991, J BIOL CHEM, V266, P765; Higgins C.E., 2010, NITRIC OXIDE-BIOL CH, V2nd Edition, P169, DOI [10.1016/B978-0-12-373866-0.00006-X, DOI 10.1016/B978-0-12-373866-0.00006-X]; HOWELLS DW, 1987, CLIN CHIM ACTA, V167, P23, DOI 10.1016/0009-8981(87)90081-7; ICHINOSE H, 1994, NAT GENET, V8, P236, DOI 10.1038/ng1194-236; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Kolinsky MA, 2004, J BIOL CHEM, V279, P40677, DOI 10.1074/jbc.M405370200; Lapize C, 1998, BIOCHEM BIOPH RES CO, V251, P802, DOI 10.1006/bbrc.1998.9552; Li L, 2010, CIRC RES, V106, P328, DOI 10.1161/CIRCRESAHA.109.210658; Luttik MAH, 2008, METAB ENG, V10, P141, DOI 10.1016/j.ymben.2008.02.002; Maita N, 2004, J BIOL CHEM, V279, P51534, DOI 10.1074/jbc.M409440200; Maita N, 2002, P NATL ACAD SCI USA, V99, P1212, DOI 10.1073/pnas.022646999; NAGAI K, 1985, P NATL ACAD SCI USA, V82, P7252, DOI 10.1073/pnas.82.21.7252; Nardese V, 1996, BIOCHEM BIOPH RES CO, V218, P273, DOI 10.1006/bbrc.1996.0048; NIEDERWIESER A, 1984, EUR J PEDIATR, V141, P208, DOI 10.1007/BF00572762; PARKS TD, 1991, VIROLOGY, V182, P17, DOI 10.1016/0042-6822(91)90643-P; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; QUINLAN RA, 1989, J CELL SCI, V93, P71; Rebelo J, 2003, J MOL BIOL, V326, P503, DOI 10.1016/S0022-2836(02)01303-7; Schramek N, 2002, J MOL BIOL, V316, P829, DOI 10.1006/jmbi.2001.5339; Schramek N, 2001, J BIOL CHEM, V276, P44157, DOI 10.1074/jbc.M107306200; SHIOTA T, 1967, J BIOL CHEM, V242, P1961; Suzuki T, 1999, J NEUROCHEM, V73, P2510, DOI 10.1046/j.1471-4159.1999.0732510.x; Swick L, 2006, J NEUROCHEM, V97, P1447, DOI 10.1111/j.1471-4159.2006.03836.x; Tegeder I, 2006, NAT MED, V12, P1269, DOI 10.1038/nm1490; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; WEARNE SJ, 1990, FEBS LETT, V263, P23, DOI 10.1016/0014-5793(90)80696-G; Wilson-Grady JT, 2008, J PROTEOME RES, V7, P1088, DOI 10.1021/pr7006335; Wu GY, 2009, BIOFACTORS, V35, P21, DOI 10.1002/biof.3; Xie LJ, 1998, J BIOL CHEM, V273, P21091, DOI 10.1074/jbc.273.33.21091; Yoneyama T, 1998, J BIOL CHEM, V273, P20102, DOI 10.1074/jbc.273.32.20102	38	9	9	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.196204	http://dx.doi.org/10.1074/jbc.M110.196204			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21163945	hybrid, Green Published			2022-12-27	WOS:000289077500005
J	Kamata, Y; Yamamoto, M; Kawakami, F; Tsuboi, R; Takeda, A; Ishihara, K; Hibino, T				Kamata, Yayoi; Yamamoto, Mami; Kawakami, Fumitaka; Tsuboi, Ryoji; Takeda, Atsushi; Ishihara, Kazuhiko; Hibino, Toshihiko			Bleomycin Hydrolase Is Regulated Biphasically in a Differentiation- and Cytokine-dependent Manner RELEVANCE TO ATOPIC DERMATITIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKIN-BARRIER FUNCTION; TRANSCRIPTIONAL REGULATION; ICHTHYOSIS VULGARIS; STRATUM-CORNEUM; GENE-EXPRESSION; FILAGGRIN; FAMILY; MZF1; SP1; LOCALIZATION	Loss-of-function mutation in the profilaggrin gene is a major risk factor for atopic dermatitis (AD). Previously, we showed that a neutral cysteine protease, bleomycin hydrolase (BH), has a role in generating natural moisturizing factors, and calpain I is an upstream protease in the filaggrin degradation pathway. Here, we investigated the transcriptional regulatory mechanisms of BH and the relevance of BH to AD. First, we cloned the 5'-flanking region of BH. Deletion analyses identified a critical region for BH promoter activity within -216 bp upstream. Electrophoretic mobility shift assay revealed that MZF-1, Sp-1, and interferon regulatory factor-1/2 could bind to this region in vitro. Moreover, site-directed mutagenesis of the MZF-1 and Sp-1 motifs markedly reduced BH promoter activity. These data indicate that BH expression is up-regulated via MZF-1 and Sp-1. Interestingly, a Th1 cytokine, IFN-gamma, significantly reduced the expression of BH. Analyses with site-directed mutagenesis and small interference RNA supported the suppressing effect of IFN-gamma on BH expression. On the other hand, a Th2 cytokine, IL-4, did not show any direct effect on BH expression. However, it down-regulated MZF-1 and Sp-1 in cultured keratinocytes, indicating that IL-4 could work as a suppressor in BH regulation. Lastly, we examined expression of BH in skins of patients with AD. BH activity and expression were markedly decreased in AD lesional skin, suggesting a defect of the filaggrin degradation pathway in AD. Our results suggest that BH transcription would be modulated during both differentiation and inflammation.	[Kamata, Yayoi; Yamamoto, Mami; Hibino, Toshihiko] Shiseido Res Ctr, Kanagawa 2388643, Japan; Kitasato Univ, Grad Sch Med Sci, Dept Biochem Regulat, Kanagawa 2520373, Japan; [Yamamoto, Mami; Tsuboi, Ryoji] Tokyo Med Univ, Dept Dermatol, Shinjuku Ku, Tokyo 1608402, Japan; [Takeda, Atsushi] Sagami Womens Univ, Fac Nutr Sci, Biochem Lab, Kanagawa 2520383, Japan	Shiseido Company, Limited; Kitasato University; Tokyo Medical University	Hibino, T (corresponding author), Shiseido Res Ctr, Kanagawa 2388643, Japan.	toshihiko.hibino@to.shiseido.co.jp	Perry, George/A-8611-2009	Perry, George/0000-0002-6547-0172				Allam JP, 2006, CLIN EXP DERMATOL, V31, P89, DOI 10.1111/j.1365-2230.2005.01980.x; Chavanas S, 2006, J DERMATOL SCI, V44, P63, DOI 10.1016/j.jdermsci.2006.07.004; Cork MJ, 2009, J INVEST DERMATOL, V129, P1892, DOI 10.1038/jid.2009.133; Dong S, 2008, J INVEST DERMATOL, V128, P549, DOI 10.1038/sj.jid.5701048; Dong S, 2006, BIOCHEM J, V397, P449, DOI 10.1042/BJ20051939; Dong SJ, 2005, J INVEST DERMATOL, V124, P1026, DOI 10.1111/j.0022-202X.2005.23690.x; Fallon PG, 2009, NAT GENET, V41, P602, DOI 10.1038/ng.358; Ferrando AA, 1997, J BIOL CHEM, V272, P33298, DOI 10.1074/jbc.272.52.33298; Ferrando AA, 1996, CANCER RES, V56, P1746; Gaboli M, 2001, GENE DEV, V15, P1625, DOI 10.1101/gad.902301; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kajiya A, 2006, PROTEIN PEPTIDE LETT, V13, P119, DOI 10.2174/092986606775101562; Kamata Y, 2007, J BIOCHEM, V141, P69, DOI 10.1093/jb/mvm005; Kamata Y, 2009, J BIOL CHEM, V284, P12829, DOI 10.1074/jbc.M807908200; Kim E, 2009, J IMMUNOL, V183, P7379, DOI 10.4049/jimmunol.0901489; Le Mee S, 2005, EXP CELL RES, V302, P129, DOI 10.1016/j.yexcr.2004.08.028; Lefterov IM, 2000, FASEB J, V14, P1837, DOI 10.1096/fj.99-0938com; Marenholz I, 1996, GENOMICS, V37, P295, DOI 10.1006/geno.1996.0563; McGrath JA, 2008, TRENDS MOL MED, V14, P20, DOI 10.1016/j.molmed.2007.10.006; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; Nakamura Y, 2007, EXP DERMATOL, V16, P143, DOI 10.1111/j.1600-0625.2006.00528.x; Nomura T, 2008, J INVEST DERMATOL, V128, P1436, DOI 10.1038/sj.jid.5701205; Odanagi M, 2004, EXP DERMATOL, V13, P773, DOI 10.1111/j.0906-6705.2004.00219.x; Ozato K, 2007, J BIOL CHEM, V282, P20065, DOI 10.1074/jbc.R700003200; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Presland RB, 2000, J INVEST DERMATOL, V115, P1072, DOI 10.1046/j.1523-1747.2000.00178.x; Rawlings A.V., 2004, DERMATOL THER S1, V17, P43, DOI [10.1111/j.1396-0296.2004.04s1005.x, DOI 10.1111/J.1396-0296.2004.04S1005.X]; RAWLINGS AV, 1994, J INVEST DERMATOL, V103, P731, DOI 10.1111/1523-1747.ep12398620; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Schwartz DR, 1999, P NATL ACAD SCI USA, V96, P4680, DOI 10.1073/pnas.96.8.4680; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Takahashi M, 2004, ARCH DERMATOL RES, V295, P448, DOI 10.1007/s00403-003-0448-x; Takeda A, 1996, J BIOCHEM-TOKYO, V119, P29; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tokura Y, 2010, J DERMATOL SCI, V58, P1, DOI 10.1016/j.jdermsci.2010.02.008; UMEZAWA H, 1974, Journal of Antibiotics (Tokyo), V27, P419; Verdier-Sevrain Sylvie, 2007, J Cosmet Dermatol, V6, P75, DOI 10.1111/j.1473-2165.2007.00300.x; Wang Y, 2007, CANCER RES, V67, P2535, DOI 10.1158/0008-5472.CAN-06-3530; Zimny J, 2006, J BIOL CHEM, V281, P22485, DOI 10.1074/jbc.M603656200	42	35	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8204	8212		10.1074/jbc.M110.169292	http://dx.doi.org/10.1074/jbc.M110.169292			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21190945	Green Published, hybrid			2022-12-27	WOS:000288013300051
J	Pieulle, L; Stocker, P; Vinay, M; Nouailler, M; Vita, N; Brasseur, G; Garcin, E; Sebban-Kreuzer, C; Dolla, A				Pieulle, Laetitia; Stocker, Pierre; Vinay, Manon; Nouailler, Matthieu; Vita, Nicolas; Brasseur, Gael; Garcin, Edwige; Sebban-Kreuzer, Corinne; Dolla, Alain			Study of the Thiol/Disulfide Redox Systems of the Anaerobe Desulfovibrio vulgaris Points Out Pyruvate:Ferredoxin Oxidoreductase as a New Target for Thioredoxin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRUVATE-FERREDOXIN OXIDOREDUCTASE; OXIDATIVE STRESS-RESPONSE; BACTEROIDES-FRAGILIS; ESCHERICHIA-COLI; SUPEROXIDE REDUCTASE; HYDROGEN-PEROXIDE; STRICT ANAEROBE; OXYGEN; HILDENBOROUGH; IDENTIFICATION	Sulfate reducers have developed a multifaceted adaptative strategy to survive against oxidative stresses. Along with this oxidative stress response, we recently characterized an elegant reversible disulfide bond-dependent protective mechanism in the pyruvate: ferredoxin oxidoreductase (PFOR) of various Desulfovibrio species. Here, we searched for thiol redox systems involved in this mechanism. Using thiol fluorescent labeling, we show that glutathione is not the major thiol/disulfide balance-controlling compound in four different Desulfovibrio species and that no other plentiful low molecular weight thiol can be detected. Enzymatic analyses of two thioredoxins (Trxs) and three thioredoxin reductases allow us to propose the existence of two independent Trx systems in Desulfovibrio vulgaris Hildenborough (DvH). The TR1/Trx1 system corresponds to the typical bacterial Trx system. We measured a TR1 apparent K-m value for Trx1 of 8.9 mu M. Moreover, our results showed that activity of TR1 was NADPH-dependent. The second system named TR3/Trx3 corresponds to an unconventional Trx system as TR3 used preferentially NADH (K-m for NADPH, 743 mu M; K-m for NADH, 5.6 mu M), and Trx3 was unable to reduce insulin. The K-m value of TR3 for Trx3 was 1.12 mu M. In vitro experiments demonstrated that the TR1/Trx1 system was the only one able to reactivate the oxygen-protected form of Desulfovibrio africanus PFOR. Moreover, ex vivo pulldown assays using the mutant Trx1(C33S) as bait allowed us to capture PFOR from the DvH extract. Altogether, these data demonstrate that PFOR is a new target for Trx1, which is probably involved in the protective switch mechanism of the enzyme.	[Pieulle, Laetitia; Vinay, Manon; Nouailler, Matthieu; Vita, Nicolas; Brasseur, Gael; Garcin, Edwige; Sebban-Kreuzer, Corinne; Dolla, Alain] CNRS UPR3243 IFR88, Lab Interact & Modulateurs Reponses, F-13402 Marseille 20, France; [Stocker, Pierre] FST Univ Paul Cezanne, Case 342, UMR6263, Equipe Biosci iSm2, F-13397 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Pieulle, L (corresponding author), CNRS UPR3243 IFR88, Lab Interact & Modulateurs Reponses, 31 Chemin Joseph Aiguier, F-13402 Marseille 20, France.	pieulle@ibsm.cnrs-mrs.fr		garcin, edwige b./0000-0002-0533-6940				Alkhalfioui F, 2007, J EXP BOT, V58, P969, DOI 10.1093/jxb/erl248; Baughn AD, 2004, NATURE, V427, P441, DOI 10.1038/nature02285; Briukhanov A L, 2007, Prikl Biokhim Mikrobiol, V43, P635; Chabriere E, 1999, NAT STRUCT BIOL, V6, P182; Collet JF, 2003, J BIOL CHEM, V278, P45325, DOI 10.1074/jbc.M307818200; Cypionka H, 2000, ANNU REV MICROBIOL, V54, P827, DOI 10.1146/annurev.micro.54.1.827; Dolla A, 2006, J BIOTECHNOL, V126, P87, DOI 10.1016/j.jbiotec.2006.03.041; Emerson JP, 2002, BIOCHEMISTRY-US, V41, P4348, DOI 10.1021/bi0119159; FAHEY RC, 1987, METHOD ENZYMOL, V143, P85; FAHEY RC, 1978, J BACTERIOL, V133, P1126, DOI 10.1128/JB.133.3.1126-1129.1978; Fareleira P, 2003, MICROBIOL-SGM, V149, P1513, DOI 10.1099/mic.0.26155-0; Foloppe N, 2004, STRUCTURE, V12, P289, DOI 10.1016/j.str.2004.01.009; Fournier M, 2003, J BACTERIOL, V185, P71, DOI 10.1128/JB.185.1.71-79.2003; FURSTE JP, 1986, GENE, V48, P119, DOI 10.1016/0378-1119(86)90358-6; Garczarek F, 2007, J STRUCT BIOL, V159, P9, DOI 10.1016/j.jsb.2007.01.020; Heidelberg JF, 2004, NAT BIOTECHNOL, V22, P554, DOI 10.1038/nbt959; Hisabori T, 2005, J EXP BOT, V56, P1463, DOI 10.1093/jxb/eri170; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOLMGREN A, 1979, J BIOL CHEM, V254, P9113; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Hummel CS, 2005, FEMS MICROBIOL LETT, V252, P229, DOI 10.1016/j.femsle.2005.09.004; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Imlay JA, 2008, MOL MICROBIOL, V68, P801, DOI 10.1111/j.1365-2958.2008.06213.x; Jacquot JP, 2009, TRENDS PLANT SCI, V14, P336, DOI 10.1016/j.tplants.2009.03.005; Jeon SJ, 2002, EUR J BIOCHEM, V269, P5423, DOI 10.1046/j.1432-1033.2002.03231.x; JOHNSON TC, 1984, J BACTERIOL, V158, P1061, DOI 10.1128/JB.158.3.1061-1069.1984; Kawasaki S, 2005, APPL ENVIRON MICROB, V71, P8442, DOI 10.1128/AEM.71.12.8442-8450.2005; Kumar JK, 2004, P NATL ACAD SCI USA, V101, P3759, DOI 10.1073/pnas.0308701101; Lemaire SD, 2004, P NATL ACAD SCI USA, V101, P7475, DOI 10.1073/pnas.0402221101; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; Li XK, 2009, J BACTERIOL, V191, P4924, DOI 10.1128/JB.00197-09; Meyer Y, 2009, ANNU REV GENET, V43, P335, DOI 10.1146/annurev-genet-102108-134201; Montrichard F, 2009, J PROTEOMICS, V72, P452, DOI 10.1016/j.jprot.2008.12.002; Motohashi Ken, 2009, V479, P117, DOI 10.1007/978-1-59745-289-2_8; Mukhopadhyay A, 2007, J BACTERIOL, V189, P5996, DOI 10.1128/JB.00368-07; Navarro F, 1996, PLANT PHYSIOL, V111, P1067, DOI 10.1104/pp.111.4.1067; Newton GL, 2009, NAT CHEM BIOL, V5, P625, DOI 10.1038/nchembio.189; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; Niviere V, 2004, BIOCHEMISTRY-US, V43, P808, DOI 10.1021/bi035698i; Obiero J, 2010, J BACTERIOL, V192, P494, DOI 10.1128/JB.01046-09; ONDARZA RN, 1983, J MOL EVOL, V19, P371, DOI 10.1007/BF02101641; Pasternak C, 1997, MICROBIOL-UK, V143, P83, DOI 10.1099/00221287-143-1-83; Pereira PM, 2008, ARCH MICROBIOL, V189, P451, DOI 10.1007/s00203-007-0335-5; Pereira PM, 2008, ANTON LEEUW INT J G, V93, P347, DOI 10.1007/s10482-007-9212-0; PIEULLE L, 1995, BBA-PROTEIN STRUCT M, V1250, P49, DOI 10.1016/0167-4838(95)00029-T; Postgate J. R., 1984, SULFATE REDUCING BAC, P12; Potamitou A, 2002, J BIOL CHEM, V277, P18561, DOI 10.1074/jbc.M201225200; Reott MA, 2009, J BACTERIOL, V191, P3384, DOI 10.1128/JB.01665-08; Ritz D, 2000, J BIOL CHEM, V275, P2505, DOI 10.1074/jbc.275.4.2505; Rocha ER, 2007, J BACTERIOL, V189, P8015, DOI 10.1128/JB.00714-07; Ruocco MR, 2004, BIOCHIMIE, V86, P883, DOI 10.1016/j.biochi.2004.10.008; Sambrook J., 1989, MOL CLONING, pA1; Sarin R, 2006, GENE, V376, P107, DOI 10.1016/j.gene.2006.02.012; SENEZ JC, 1954, B SOC CHIM BIOL, V36, P541; Setterdahl AT, 2003, BIOCHEMISTRY-US, V42, P14877, DOI 10.1021/bi0302088; Smalley D, 2002, J BACTERIOL, V184, P895, DOI 10.1128/jb.184.4.895-903.2002; Strand KR, 2010, ARCH MICROBIOL, V192, P447, DOI 10.1007/s00203-010-0570-z; Sund CJ, 2008, MOL MICROBIOL, V67, P129, DOI 10.1111/j.1365-2958.2007.06031.x; Tang Y, 2007, J BACTERIOL, V189, P940, DOI 10.1128/JB.00948-06; Vita N, 2008, BIOCHEMISTRY-US, V47, P957, DOI 10.1021/bi7014713; Yang XQ, 2010, J BACTERIOL, V192, P1370, DOI 10.1128/JB.01035-09; Zeller T, 2006, NATURWISSENSCHAFTEN, V93, P259, DOI 10.1007/s00114-006-0106-1; Zhang WW, 2006, ANTON LEEUW INT J G, V90, P41, DOI 10.1007/s10482-006-9059-9; Zhou AF, 2010, ENVIRON MICROBIOL, V12, P2645, DOI 10.1111/j.1462-2920.2010.02234.x	66	19	20	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7812	7821		10.1074/jbc.M110.197988	http://dx.doi.org/10.1074/jbc.M110.197988			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21199874	Green Published, hybrid			2022-12-27	WOS:000288013300012
J	Yu, F; Sun, L; Courjaret, R; Machaca, K				Yu, Fang; Sun, Lu; Courjaret, Raphael; Machaca, Khaled			Role of the STIM1 C-terminal Domain in STIM1 Clustering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CALCIUM-ENTRY; CA2+ STORE DEPLETION; FAST CA2+-DEPENDENT INACTIVATION; STROMAL INTERACTION MOLECULE-1; XENOPUS OOCYTE MATURATION; MAMMALIAN-CELL LINES; PLASMA-MEMBRANE; CRAC CHANNELS; ORAI CHANNELS; I-CRAC	Store-operated Ca2+ entry (SOCE) represents a ubiquitous Ca2+ influx pathway activated by the filling state of intracellular Ca2+ stores. SOCE is mediated by coupling of STIM1, the endoplasmic reticulum Ca2+ sensor, to the Orai1 channel. SOCE inactivates during meiosis, partly because of the inability of STIM1 to cluster in response to store depletion. STIM1 has several functional domains, including the Orai1 interaction domain (STIM1 Orai Activating Region (SOAR) or CRAC Activation Domain (CAD)) and STIM1 homomerization domain. When Ca2+ stores are full, these domains are inactive to prevent constitutive Ca2+ entry. Here we show, using the Xenopus oocyte as an expression system, that the C-terminal 200 residues of STIM1 are important to maintain STIM1 in an inactive state when Ca2+ stores are full, through predicted intramolecular shielding of the active STIM1 domains (SOAR/CAD and STIM1 homomerization domain). Interestingly, our data argue that the C-terminal 200 residues accomplish this through a steric hindrance mechanism because they can be substituted by GFP or mCherry while maintaining all aspects of STIM1 function. We further show that STIM1 clustering inhibition during meiosis is independent of the C-terminal 200 residues.	[Yu, Fang; Sun, Lu; Courjaret, Raphael; Machaca, Khaled] Qatar Fdn, Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, Doha 24144, Qatar	Qatar Foundation (QF); Weill Cornell Medical College Qatar	Machaca, K (corresponding author), Qatar Fdn, Weill Cornell Med Coll Qatar, Dept Physiol & Biophys, POB 24144, Doha 24144, Qatar.	khm2002@qatar-med.cornell.edu	Machaca, Khaled/AAF-3579-2019	Machaca, Khaled/0000-0001-6215-2411	Qatar National Research Fund [NPRP08-395-3-088, NPRP08-138-3-050]; Weill Cornell Medical College; Qatar Foundation	Qatar National Research Fund(Qatar National Research Fund (QNRF)); Weill Cornell Medical College; Qatar Foundation(Qatar Foundation (QF)Qatar National Research Fund (QNRF))	This work was supported by Qatar National Research Fund Grants NPRP08-395-3-088 and NPRP08-138-3-050 and the Biomedical Research Program funds at Weill Cornell Medical College, a program funded by the Qatar Foundation.	Derler I, 2009, J BIOL CHEM, V284, P24933, DOI 10.1074/jbc.C109.024083; Fahmer M, 2009, IMMUNOL REV, V231, P99, DOI 10.1111/j.1600-065X.2009.00815.x; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Lee KP, 2009, P NATL ACAD SCI USA, V106, P14687, DOI 10.1073/pnas.0904664106; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Machaca K, 2002, J CELL BIOL, V156, P75, DOI 10.1083/jcb.200110059; Machaca K, 1999, J GEN PHYSIOL, V113, P249, DOI 10.1085/jgp.113.2.249; Machaca K, 2000, J BIOL CHEM, V275, P38710, DOI 10.1074/jbc.M007887200; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Petersen KR, 1999, PFLUG ARCH EUR J PHY, V437, P381, DOI 10.1007/s004240050792; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Smyth JT, 2009, NAT CELL BIOL, V11, P1465, DOI 10.1038/ncb1995; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Tani D, 2007, CELL CALCIUM, V41, P249, DOI 10.1016/j.ceca.2006.07.004; Terasaki M, 2001, MOL BIOL CELL, V12, P1103, DOI 10.1091/mbc.12.4.1103; Uebele VN, 1996, J BIOL CHEM, V271, P2406, DOI 10.1074/jbc.271.5.2406; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; VOLPI M, 1988, J CELL BIOL, V107, P2533, DOI 10.1083/jcb.107.6.2533; Walsh CM, 2010, BIOCHEM J, V425, P159, DOI 10.1042/BJ20090884; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yu F, 2010, J CELL BIOL, V191, P523, DOI 10.1083/jcb.201006022; Yu F, 2009, P NATL ACAD SCI USA, V106, P17401, DOI 10.1073/pnas.0904651106; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842	35	22	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8375	8384		10.1074/jbc.M110.188789	http://dx.doi.org/10.1074/jbc.M110.188789			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21220431	Green Published, hybrid			2022-12-27	WOS:000288013300066
J	Ando, K; Uemura, K; Kuzuya, A; Maesako, M; Asada-Utsugi, M; Kubota, M; Aoyagi, N; Yoshioka, K; Okawa, K; Inoue, H; Kawamata, J; Shimohama, S; Arai, T; Takahashi, R; Kinoshita, A				Ando, Koichi; Uemura, Kengo; Kuzuya, Akira; Maesako, Masato; Asada-Utsugi, Megumi; Kubota, Masakazu; Aoyagi, Nobuhisa; Yoshioka, Katsuji; Okawa, Katsuya; Inoue, Haruhisa; Kawamata, Jun; Shimohama, Shun; Arai, Tetsuaki; Takahashi, Ryosuke; Kinoshita, Ayae			N-cadherin Regulates p38 MAPK Signaling via Association with JNK-associated Leucine Zipper Protein IMPLICATIONS FOR NEURODEGENERATION IN ALZHEIMER DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA; SCAFFOLDING PROTEIN; MISSENSE MUTATIONS; NEURITE OUTGROWTH; SYNAPSE LOSS; KINASE; ACTIVATION; PATHWAY; ADHESION; PRESENILIN-1	Synaptic loss, which strongly correlates with the decline of cognitive function, is one of the pathological hallmarks of Alzheimer disease. N-cadherin is a cell adhesion molecule essential for synaptic contact and is involved in the intracellular signaling pathway at the synapse. Here we report that the functional disruption of N-cadherin-mediated cell contact activated p38 MAPK in murine primary neurons, followed by neuronal death. We further observed that treatment with A beta(42) decreased cellular N-cadherin expression through NMDA receptors accompanied by increased phosphorylation of both p38 MAPK and Tau in murine primary neurons. Moreover, expression levels of phosphorylated p38 MAPK were negatively correlated with that of N-cadherin in human brains. Proteomic analysis of human brains identified a novel interaction between N-cadherin and JNK-associated leucine zipper protein (JLP), a scaffolding protein involved in the p38 MAPK signaling pathway. We demonstrated that N-cadherin expression had an inhibitory effect on JLP-mediated p38 MAPK signal activation by decreasing the interaction between JLP and p38 MAPK in COS7 cells. Also, this study demonstrated a novel physical and functional association between N-cadherin and p38 MAPK and suggested neuroprotective roles of cadherin-based synaptic contact. The dissociation of N-cadherin-mediated synaptic contact by A beta may underlie the pathological basis of neurodegeneration such as neuronal death, synaptic loss, and Tau phosphorylation in Alzheimer disease brain.	[Kinoshita, Ayae] Kyoto Univ, Grad Sch Med, Sch Human Hlth Sci, Sakyo Ku, Kyoto 6068507, Japan; [Aoyagi, Nobuhisa; Kawamata, Jun; Takahashi, Ryosuke] Kyoto Univ, Grad Sch Med, Dept Neurol, Kyoto 6068507, Japan; [Uemura, Kengo] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Charlestown, MA 02129 USA; [Yoshioka, Katsuji] Kanazawa Univ, Canc Res Inst, Div Mol Cell Signaling, Kanazawa, Ishikawa 9201192, Japan; [Okawa, Katsuya] Kyowa Hakko Kirin Co, Tokyo 1008185, Japan; [Inoue, Haruhisa] Kyoto Univ, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan; [Shimohama, Shun] Sapporo Med Univ, Dept Neurol, Sapporo, Hokkaido 0608556, Japan; [Arai, Tetsuaki] Tokyo Inst Psychiat, Tokyo 1568585, Japan	Kyoto University; Kyoto University; Harvard University; Massachusetts General Hospital; Kanazawa University; Kyowa Kirin Ltd; Kyoto University; Sapporo Medical University; Tokyo Institute of Psychiatry	Kinoshita, A (corresponding author), Kyoto Univ, Grad Sch Med, Sch Human Hlth Sci, Sakyo Ku, 53 Shogoinkawahara Cho, Kyoto 6068507, Japan.	akinoshita@hs.med.kyoto-u.ac.jp		Inoue, Haruhisa/0000-0003-4736-9537				Baki L, 2004, EMBO J, V23, P2586, DOI 10.1038/sj.emboj.7600251; Benson DL, 1998, J NEUROSCI, V18, P6892; Blank JL, 1996, J BIOL CHEM, V271, P5361, DOI 10.1074/jbc.271.10.5361; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; Gylys KH, 2004, AM J PATHOL, V165, P1809, DOI 10.1016/S0002-9440(10)63436-0; Hansen SM, 2008, CELL MOL LIFE SCI, V65, P3809, DOI 10.1007/s00018-008-8290-0; Hensley K, 1999, J NEUROCHEM, V72, P2053, DOI 10.1046/j.1471-4159.1999.0722053.x; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Ito M, 1999, MOL CELL BIOL, V19, P7539; Jang YN, 2009, J NEUROSCI, V29, P5974, DOI 10.1523/JNEUROSCI.6178-08.2009; Johnson GVW, 2003, EXP NEUROL, V183, P263, DOI 10.1016/S0014-4886(03)00268-1; Kang JS, 2003, P NATL ACAD SCI USA, V100, P3989, DOI 10.1073/pnas.0736565100; Kelkar N, 2005, MOL CELL BIOL, V25, P2733, DOI 10.1128/MCB.25.7.2733-2743.2005; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Lee CM, 2002, P NATL ACAD SCI USA, V99, P14189, DOI 10.1073/pnas.232310199; LU M, P NATL ACAD SCI US, V107, P4212; MASLIAH E, 1989, NEUROSCI LETT, V103, P234, DOI 10.1016/0304-3940(89)90582-X; Murase S, 2002, NEURON, V35, P91, DOI 10.1016/S0896-6273(02)00764-X; Reynolds CH, 1997, J NEUROCHEM, V69, P191; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Savage MJ, 2002, J NEUROSCI, V22, P3376; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Takaesu G, 2006, J CELL BIOL, V175, P383, DOI 10.1083/jcb.200608031; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Thinakaran G, 1999, J CLIN INVEST, V104, P1321, DOI 10.1172/JCI8728; Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1; Tran NL, 2002, J BIOL CHEM, V277, P32905, DOI 10.1074/jbc.M200300200; Uemura K, 2007, J BIOL CHEM, V282, P15823, DOI 10.1074/jbc.M610708200; Uemura K, 2009, J NEUROCHEM, V108, P350, DOI 10.1111/j.1471-4159.2008.05760.x; Williams E, 2000, J BIOL CHEM, V275, P4007, DOI 10.1074/jbc.275.6.4007; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P11223, DOI 10.1021/bi991080q; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xu H, 2010, J BIOL CHEM, V285, P3548, DOI 10.1074/jbc.M109.064113; Yasuda S, 2007, NEURON, V56, P456, DOI 10.1016/j.neuron.2007.08.020; Zhu XW, 2005, NEUROCHEM RES, V30, P791, DOI 10.1007/s11064-005-6872-x; Zhu XW, 2001, J NEUROCHEM, V79, P311, DOI 10.1046/j.1471-4159.2001.00597.x	40	52	58	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7619	7628		10.1074/jbc.M110.158477	http://dx.doi.org/10.1074/jbc.M110.158477			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177868	hybrid, Green Published			2022-12-27	WOS:000287737300075
J	Anupam, R; Datta, A; Kesic, M; Green-Church, K; Shkriabai, N; Kvaratskhelia, M; Lairmore, MD				Anupam, Rajaneesh; Datta, Antara; Kesic, Matthew; Green-Church, Kari; Shkriabai, Nikolozi; Kvaratskhelia, Mamuka; Lairmore, Michael D.			Human T-lymphotropic Virus Type 1 p30 Interacts with REG gamma and Modulates ATM (Ataxia Telangiectasia Mutated) to Promote Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEASOME ACTIVATOR PA28-GAMMA; INFECTIVITY IN-VIVO; READING FRAME II; DNA-DAMAGE; HISTONE ACETYLTRANSFERASE; HTLV-1 TAX; LEUKEMIA; PROTEIN; REPLICATION; P30(II)	Human T-lymphotropic virus type 1 (HTLV-1) is a causative agent of adult T cell leukemia/lymphoma and a variety of inflammatory disorders. HTLV-1 encodes a nuclear localizing protein, p30, that selectively alters viral and cellular gene expression, activates G(2)-M cell cycle checkpoints, and is essential for viral spread. Here, we used immunoprecipitation and affinity pulldown of ectopically expressed p30 coupled with mass spectrometry to identify cellular binding partners of p30. Our data indicate that p30 specifically binds to cellular ATM (ataxia telangiectasia mutated) and REG gamma (a nuclear 20 S proteasome activator). Under conditions of genotoxic stress, p30 expression was associated with reduced levels of ATM and increased cell survival. Knockdown or overexpression of REG gamma paralleled p30 expression, suggesting an unexpected enhancement of p30 expression in the presence of REG gamma. Finally, size exclusion chromatography revealed the presence of p30 in a high molecular mass complex along with ATM and REG gamma. On the basis of our findings, we propose that HTLV-1 p30 interacts with ATM and REG gamma to increase viral spread by facilitating cell survival.	[Lairmore, Michael D.] Ohio State Univ, Dept Vet Biosci, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Green-Church, Kari] Ohio State Univ, Mass Spectrometry & Prote Facil, Columbus, OH 43210 USA; [Shkriabai, Nikolozi; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, Columbus, OH 43210 USA; [Lairmore, Michael D.] Ohio State Univ, Ctr Comprehens Canc, Arthur G James Canc Hosp, Columbus, OH 43210 USA; [Lairmore, Michael D.] Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Lairmore, MD (corresponding author), Ohio State Univ, Dept Vet Biosci, Ctr Retrovirus Res, 1900 Coffey Rd, Columbus, OH 43210 USA.	lairmore.1@osu.edu	Green, Kari B/H-3541-2011		National Institutes of Health, NCI [P01 CA100730]; NATIONAL CANCER INSTITUTE [P01CA100730] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023647] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Program Project Grant P01 CA100730 from NCI (to M. D. L.).	Arnold J, 2006, BLOOD, V107, P3976, DOI 10.1182/blood-2005-11-4551; Awasthi S, 2005, MOL CELL BIOL, V25, P6178, DOI 10.1128/MCB.25.14.6178-6198.2005; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bartoe JT, 2000, J VIROL, V74, P1094, DOI 10.1128/JVI.74.3.1094-1100.2000; Barton LF, 2004, J IMMUNOL, V172, P3948, DOI 10.4049/jimmunol.172.6.3948; Chen YMA, 1997, INT J CANCER, V71, P196, DOI 10.1002/(SICI)1097-0215(19970410)71:2&lt;196::AID-IJC12&gt;3.0.CO;2-G; Chlichlia K, 2010, CHEM-BIOL INTERACT, V188, P359, DOI 10.1016/j.cbi.2010.06.005; Collins ND, 1998, BLOOD, V91, P4701, DOI 10.1182/blood.V91.12.4701.412k23_4701_4707; Datta A, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-49; Derheimer FA, 2010, FEBS LETT, V584, P3675, DOI 10.1016/j.febslet.2010.05.031; DUBIEL W, 1992, J BIOL CHEM, V267, P22369; Ghorbel S, 2006, J BIOL CHEM, V281, P37150, DOI 10.1074/jbc.M603981200; Giam CZ, 2007, FRONT BIOSCI, V12, P1496, DOI 10.2741/2163; Goncalves DU, 2010, CLIN MICROBIOL REV, V23, P577, DOI 10.1128/CMR.00063-09; Goodarzi AA, 2004, DNA REPAIR, V3, P753, DOI 10.1016/j.dnarep.2004.03.041; Hiraragi H, 2006, J VIROL, V80, P3469, DOI 10.1128/JVI.80.7.3469-3476.2006; KORALNIK IJ, 1993, J VIROL, V67, P2360, DOI 10.1128/JVI.67.4.2360-2366.1993; Lairmore M. D., 2007, FIELDS VIROLOGY, P2071; Li J, 2001, EMBO J, V20, P3359, DOI 10.1093/emboj/20.13.3359; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Li XT, 2006, CELL, V124, P381, DOI 10.1016/j.cell.2005.11.037; MA CP, 1992, J BIOL CHEM, V267, P10515; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Michael B, 2006, VIROLOGY, V354, P225, DOI 10.1016/j.virol.2006.07.002; Michael Bindhu, 2004, Retrovirology, V1, P39, DOI 10.1186/1742-4690-1-39; Moriishi K, 2003, J VIROL, V77, P10237, DOI 10.1128/JVI.77.19.10237-10249.2003; Moriishi K, 2007, P NATL ACAD SCI USA, V104, P1661, DOI 10.1073/pnas.0607312104; Murata S, 1999, J BIOL CHEM, V274, P38211, DOI 10.1074/jbc.274.53.38211; Nicot C, 2004, NAT MED, V10, P197, DOI 10.1038/nm984; Pique C, 2000, J EXP MED, V191, P567, DOI 10.1084/jem.191.3.567; Pise-Masison CA, 2005, ARCH IMMUNOL THER EX, V53, P283; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Realini C, 1997, J BIOL CHEM, V272, P25483, DOI 10.1074/jbc.272.41.25483; Rechsteiner M, 2005, TRENDS CELL BIOL, V15, P27, DOI 10.1016/j.tcb.2004.11.003; Satou Y, 2010, J CLIN EXP HEMATOP, V50, P1, DOI 10.3960/jslrt.50.1; Silverman LR, 2004, J VIROL, V78, P3837, DOI 10.1128/JVI.78.8.3837-3845.2004; Sinha-Datta U, 2007, J BIOL CHEM, V282, P14608, DOI 10.1074/jbc.M611219200; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Taylor JM, 2009, J VIROL, V83, P11467, DOI 10.1128/JVI.00952-09; Tichy Ales, 2010, Acta Medica (Hradec Kralove), V53, P13; Valeri VW, 2010, BLOOD, V116, P3809, DOI 10.1182/blood-2010-05-284141; Weinberg WC, 2002, CRIT REV ORAL BIOL M, V13, P453, DOI 10.1177/154411130201300603; Yoshida M, 2005, ONCOGENE, V24, P5931, DOI 10.1038/sj.onc.1208981; YOSHIDA M, 1982, P NATL ACAD SCI-BIOL, V79, P2031, DOI 10.1073/pnas.79.6.2031; Younis I, 2004, J VIROL, V78, P11077, DOI 10.1128/JVI.78.20.11077-11083.2004; Zhang WQ, 2001, J VIROL, V75, P9885, DOI 10.1128/JVI.75.20.9885-9895.2001; Zhang WQ, 2000, J VIROL, V74, P11270, DOI 10.1128/JVI.74.23.11270-11277.2000; Zhang Z, 2008, EMBO J, V27, P852, DOI 10.1038/emboj.2008.25; Zhou PB, 2006, CELL, V124, P256, DOI 10.1016/j.cell.2006.01.003	50	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7661	7668		10.1074/jbc.M110.176354	http://dx.doi.org/10.1074/jbc.M110.176354			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21216954	hybrid, Green Published			2022-12-27	WOS:000287737300079
J	Devi, YS; Seibold, AM; Shehu, A; Maizels, E; Halperin, J; Le, J; Binart, N; Bao, L; Gibori, G				Devi, Y. Sangeeta; Seibold, Anita M.; Shehu, Aurora; Maizels, Evelyn; Halperin, Julia; Le, Jamie; Binart, Nadine; Bao, Lei; Gibori, Geula			Inhibition of MAPK by Prolactin Signaling through the Short Form of Its Receptor in the Ovary and Decidua INVOLVEMENT OF A NOVEL PHOSPHATASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; GRANULOSA-CELLS; UP-REGULATION; PRL RECEPTOR; EXPRESSION; KINASE; GENE; RAT; LONG; CLONING	Prolactin (PRL) is essential for normal reproduction and signals through two types of receptors, the short (PRL-RS) and long (PRL-RL) form. We have previously shown that transgenic mice expressing only PRL-RS (PRLR-/-RS) display abnormal follicular development and premature ovarian failure. Here, we report that MAPK, essential for normal follicular development, is critically inhibited by PRL in reproductive tissues of PRLR-/-RS mice. Consequently, the phosphorylation of MAPK downstream targets are also markedly inhibited by PRL without affecting immediate upstream kinases, suggesting involvement of MAPK specific phosphatase(s) in this inhibition. Similar results are obtained in a PRL-responsive ovary-derived cell line (GG-CL) that expresses only PRL-RS. However, we found the expression/activation of several known MAPK phosphatases not to be affected by PRL, suggesting a role of unidentified phosphatase(s). We detected a 27-kDa protein that binds to the intracellular domain of PRL-RS and identified it as dual specific phosphatase DUPD1. PRL does not induce expression of DUDP1 but represses its phosphorylation on Thr-155. We also show a physical association of this phosphatase with ERK1/2 and p38 MAPK. Using an in vitro phosphatase assay and overexpression studies, we established that DUPD1 is a MAPK phosphatase. Dual specific phosphatase inhibitors as well as siRNA to DUPD1, completely prevent PRL-mediated MAPK inhibition in ovarian cells. Our results strongly suggest that deactivation of MAPK by PRL/PRL-RS contributes to the severe ovarian defect in PRLR-/-RS mice and demonstrate the novel association of PRL-RS with DUPD1 and a role for this phosphatase in MAPK deactivation.	[Bao, Lei; Gibori, Geula] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA; [Binart, Nadine] Univ Paris 11, INSERM, U693, Paris, France	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Gibori, G (corresponding author), Univ Illinois, Coll Med, Dept Physiol & Biophys, M-C 901, Chicago, IL 60612 USA.	ggibori@uic.edu	Binart, Nadine/F-2949-2013	Binart, Nadine/0000-0002-5606-3866; Halperin, Julia/0000-0003-1794-9776; Maizels, Evelyn/0000-0001-9072-1095	National Institutes of Health [HD11119, HD 12356, T32 HL007692]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD012356, R01HD011119, R37HD011119] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007692] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HD11119 and HD 12356 (to G. G.) and T32 HL007692 (to J. L. and A. M. S.).	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Bachelot A, 2007, REPRODUCTION, V133, P361, DOI 10.1530/REP-06-0299; Bao L, 2007, ENDOCRINOLOGY, V148, P2326, DOI 10.1210/en.2006-1643; Bao L, 2006, MOL ENDOCRINOL, V20, P3240, DOI 10.1210/me.2006-0296; Ben-Jonathan N, 2008, ENDOCR REV, V29, P1, DOI 10.1210/er.2007-0017; Berlanga JJ, 1997, MOL ENDOCRINOL, V11, P1449, DOI 10.1210/me.11.10.1449; Bignon C, 1997, J MOL ENDOCRINOL, V19, P109, DOI 10.1677/jme.0.0190109; Binart N, 2003, MOL ENDOCRINOL, V17, P1066, DOI 10.1210/me.2002-0181; BOUTIN JM, 1988, CELL, V53, P69, DOI 10.1016/0092-8674(88)90488-6; Chang WP, 1998, MOL CELL BIOL, V18, P896, DOI 10.1128/MCB.18.2.896; Chi HB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.141pe44; CLARKE DL, 1993, ENDOCRINOLOGY, V133, P224, DOI 10.1210/en.133.1.224; DAS R, 1995, MOL ENDOCRINOL, V9, P1750, DOI 10.1210/me.9.12.1750; DAVIS JA, 1989, MOL ENDOCRINOL, V3, P674, DOI 10.1210/mend-3-4-674; Devi YS, 2009, ENDOCRINOLOGY, V150, P3327, DOI 10.1210/en.2008-1719; Duan WR, 1996, J BIOL CHEM, V271, P15602, DOI 10.1074/jbc.271.26.15602; Fan HY, 2008, DEVELOPMENT, V135, P2127, DOI 10.1242/dev.020560; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Frasor J, 1999, J CLIN ENDOCR METAB, V84, P3344, DOI 10.1210/jc.84.9.3344; Friedberg I, 2007, FEBS LETT, V581, P2527, DOI 10.1016/j.febslet.2007.04.059; Gebauer G, 1999, J CELL BIOCHEM, V75, P547, DOI 10.1002/(SICI)1097-4644(19991215)75:4<547::AID-JCB1>3.3.CO;2-X; GU Y, 1992, ENDOCRINOLOGY, V131, P1321, DOI 10.1210/en.131.3.1321; Gu Y, 1996, ENDOCRINOLOGY, V137, P4878, DOI 10.1210/en.137.11.4878; Guo J, 2007, ANTICANCER RES, V27, P3067; Halperin J, 2008, MOL ENDOCRINOL, V22, P513, DOI 10.1210/me.2007-0399; Hu ZZ, 2001, J BIOL CHEM, V276, P41086, DOI 10.1074/jbc.M102109200; Huang KT, 2008, J MAMMARY GLAND BIOL, V13, P69, DOI 10.1007/s10911-008-9072-x; Hunzicker-Dunn M, 2006, CELL SIGNAL, V18, P1351, DOI 10.1016/j.cellsig.2006.02.011; Jabbour HN, 1998, J CLIN ENDOCR METAB, V83, P2545, DOI 10.1210/jc.83.7.2545; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; LESUEUR L, 1991, P NATL ACAD SCI USA, V88, P824, DOI 10.1073/pnas.88.3.824; Llovera M, 2000, EXP GERONTOL, V35, P41, DOI 10.1016/S0531-5565(99)00078-9; Nemoto K, 2004, PROSTATE, V58, P95, DOI 10.1002/pros.10292; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; ONEAL KD, 1994, J BIOL CHEM, V269, P26076; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Risk M, 2001, ENDOCRIN UPDAT, V12, P265; Russell DL, 1999, MOL ENDOCRINOL, V13, P2049, DOI 10.1210/me.13.12.2049; Shepherd EG, 2004, J BIOL CHEM, V279, P54023, DOI 10.1074/jbc.M408444200; Shoji T, 2007, J REPROD IMMUNOL, V75, P82, DOI 10.1016/j.jri.2007.05.002; Stocco C, 2007, ENDOCR REV, V28, P117, DOI 10.1210/er.2006-0022; Sugino N, 1998, ENDOCRINOLOGY, V139, P1936, DOI 10.1210/en.139.4.1936; Tamura M, 2004, J REPROD DEVELOP, V50, P47, DOI 10.1262/jrd.50.47; Telleria CM, 1997, ENDOCRINOLOGY, V138, P4812, DOI 10.1210/en.138.11.4812; Thienel T, 2002, MOL HUM REPROD, V8, P465, DOI 10.1093/molehr/8.5.465; Wang PY, 2003, EMBO J, V22, P2658, DOI 10.1093/emboj/cdg255; Wu W, 2005, CANCER RES, V65, P7509, DOI 10.1158/0008-5472.CAN-04-3350; Yan JX, 2000, ELECTROPHORESIS, V21, P3666, DOI 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6; Yoshino O, 2003, J CLIN ENDOCR METAB, V88, P2236, DOI 10.1210/jc.2002-021788; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	51	31	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7609	7618		10.1074/jbc.M110.166603	http://dx.doi.org/10.1074/jbc.M110.166603			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21199871	Green Published, hybrid			2022-12-27	WOS:000287737300074
J	Huambachano, O; Herrera, F; Rancourt, A; Satoh, MS				Huambachano, Orlando; Herrera, Fatima; Rancourt, Ann; Satoh, Masahiko S.			Double-stranded DNA Binding Domain of Poly(ADP-ribose) Polymerase-1 and Molecular Insight into the Regulation of Its Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER DOMAIN; CHROMATIN-STRUCTURE; ADP-RIBOSYLATION; LIGASE-III; POSTTRANSLATIONAL MODIFICATION; ENZYME ACTIVATION; LYSINE RESIDUES; IN-VITRO; PARP-1; TRANSCRIPTION	Poly(ADP-ribose) polymerase-1 (PARP-1) modifies various proteins, including itself, with ADP-ribose polymers (automodification). Polymer synthesis is triggered by binding of its zinc finger 1 (Zn1) and 2 (Zn2) to DNA breaks and is followed by inactivation through automodification. The multiple functional domains of PARP-1 appear to regulate activation and automodification-mediated inactivation of PARP-1. However, the roles of these domains in activation-inactivation processes are not well understood. Our results suggest that Zn1, Zn2, and a domain identified in this study, the double-stranded DNA binding (DsDB) domain, are involved in DNA break-dependent activation of PARP-1. We found that binding of the DsDB domain to double-stranded DNA and DNA break recognition by Zn1 and Zn2, whose actual binding targets are likely to be single-stranded DNA, lead to the activation of PARP-1. In turn, the displacement of single-and double-stranded DNA from Zn2 and the DsDB domain caused by ADP-ribose polymer synthesis results in the dissociation of PARP-1 from DNA breaks and thus its inactivation. We also found that the WGR domain is one of the domains involved in the RNA-dependent activation of PARP-1. Furthermore, because zinc finger 3 (Zn3) has the ability to bind to single-stranded RNA, it may have an indirect role in RNA-dependent activation. PARP-1 functional domains, which are involved in oligonucleic acid binding, therefore coordinately regulate PARP-1 activity depending on the status of the neighboring oligonucleic acids. Based on these results, we proposed a model for the regulation of PARP-1 activity.	[Huambachano, Orlando; Herrera, Fatima; Rancourt, Ann; Satoh, Masahiko S.] Univ Laval, Lab DNA Damage Responses & Bioimaging, Fac Med, Med Ctr CHUQ, Quebec City, PQ G1V 4G2, Canada	Laval University	Satoh, MS (corresponding author), 2705 Blvd Laurier, Quebec City, PQ G1V 4G2, Canada.	Masahiko.sato@crchul.ulaval.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research.	ADAMIETZ P, 1984, J BIOL CHEM, V259, P6841; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; ALTHAUS FR, 1987, ADP RIBOSYLATION PRO; Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Bauer PI, 2001, FEBS LETT, V506, P239, DOI 10.1016/S0014-5793(01)02919-2; BENJAMIN RC, 1980, J BIOL CHEM, V255, P502; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; D'Silva I, 1999, BBA-PROTEIN STRUCT M, V1430, P119, DOI 10.1016/S0167-4838(98)00278-7; DEMURCIA G, 1991, BIOESSAYS, V13, P455, DOI 10.1002/bies.950130905; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; FAKAN S, 1988, EXP CELL RES, V179, P517, DOI 10.1016/0014-4827(88)90289-3; Frizzell KM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2451; Frizzell KM, 2009, J BIOL CHEM, V284, P33926, DOI 10.1074/jbc.M109.023879; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; GRADWOHL G, 1990, P NATL ACAD SCI USA, V87, P2990, DOI 10.1073/pnas.87.8.2990; Hassa PO, 2005, J BIOL CHEM, V280, P40450, DOI 10.1074/jbc.M507553200; Heale JT, 2006, MOL CELL, V21, P837, DOI 10.1016/j.molcel.2006.01.036; IKEJIMA M, 1990, J BIOL CHEM, V265, P21907; Jorgensen TJ, 2009, J MOL RECOGNIT, V22, P446, DOI 10.1002/jmr.962; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; KAMESHITA I, 1984, J BIOL CHEM, V259, P4770; Kanno SI, 2007, EMBO J, V26, P2094, DOI 10.1038/sj.emboj.7601663; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Komori T, 2009, GENES CELLS, V14, P343, DOI 10.1111/j.1365-2443.2008.01273.x; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Krishnakumar R, 2010, MOL CELL, V39, P736, DOI 10.1016/j.molcel.2010.08.014; Kulczyk AW, 2004, J MOL BIOL, V341, P723, DOI 10.1016/j.jmb.2004.06.035; Langelier MF, 2008, J BIOL CHEM, V283, P4105, DOI 10.1074/jbc.M708558200; Langelier MF, 2010, J BIOL CHEM, V285, P18877, DOI 10.1074/jbc.M110.105668; LINDAHL T, 1995, TRENDS BIOCHEM SCI, V20, P405, DOI 10.1016/S0968-0004(00)89089-1; Lonskaya I, 2005, J BIOL CHEM, V280, P17076, DOI 10.1074/jbc.M413483200; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Meder VS, 2005, J CELL SCI, V118, P211, DOI 10.1242/jcs.01606; MENDOZAALVAREZ H, 1993, J BIOL CHEM, V268, P22575; Messner S, 2010, NUCLEIC ACIDS RES, V38, P6350, DOI 10.1093/nar/gkq463; OGATA N, 1980, J BIOL CHEM, V255, P7616; Parent M, 2005, J BIOL CHEM, V280, P448, DOI 10.1074/jbc.M408435200; Pion E, 2005, BIOCHEMISTRY-US, V44, P14670, DOI 10.1021/bi050755o; Pion E, 2003, BIOCHEMISTRY-US, V42, P12409, DOI 10.1021/bi0344432; POIRIER GG, 1982, P NATL ACAD SCI-BIOL, V79, P3423, DOI 10.1073/pnas.79.11.3423; Rancourt A, 2009, DNA REPAIR, V8, P286, DOI 10.1016/j.dnarep.2008.11.018; SATOH MS, 1994, BIOCHEMISTRY-US, V33, P7099, DOI 10.1021/bi00189a012; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Soldatenkov VA, 2004, CURR DRUG TARGETS, V5, P357, DOI 10.2174/1389450043345498; TANUMA SI, 1985, ARCH BIOCHEM BIOPHYS, V237, P38, DOI 10.1016/0003-9861(85)90251-6; Tao ZH, 2008, BIOCHEMISTRY-US, V47, P5804, DOI 10.1021/bi800018a; Tao ZH, 2009, J AM CHEM SOC, V131, P14258, DOI 10.1021/ja906135d; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; UEDA K, 1975, P NATL ACAD SCI USA, V72, P205, DOI 10.1073/pnas.72.1.205; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Woodhouse BC, 2008, DNA REPAIR, V7, P1077, DOI 10.1016/j.dnarep.2008.03.009; Yung TMC, 2004, J BIOL CHEM, V279, P39686, DOI 10.1074/jbc.M402729200; ZAHRADKA P, 1982, EUR J BIOCHEM, V127, P579; Zlatanova J, 2009, STRUCTURE, V17, P160, DOI 10.1016/j.str.2008.12.016	60	41	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7149	7160		10.1074/jbc.M110.175190	http://dx.doi.org/10.1074/jbc.M110.175190			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21183686	Green Published, hybrid			2022-12-27	WOS:000287737300032
J	Singh, SK; Wilczynska, KM; Grzybowski, A; Yester, J; Osrah, B; Bryan, L; Wright, S; Griswold-Prenner, I; Kordula, T				Singh, Sandeep K.; Wilczynska, Katarzyna M.; Grzybowski, Adrian; Yester, Jessie; Osrah, Bahiya; Bryan, Lauren; Wright, Sarah; Griswold-Prenner, Irene; Kordula, Tomasz			The Unique Transcriptional Activation Domain of Nuclear Factor-I-X3 Is Critical to Specifically Induce Marker Gene Expression in Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRILLARY ACIDIC PROTEIN; NEURAL STEM-CELLS; FACTOR-I; DNA-REPLICATION; PRECURSOR CELLS; JC VIRUS; COMPLEX; BRAIN; BINDING; NFI	Transcription factors of the nuclear factor 1 (NFI) family regulate normal brain development in vertebrates. However, multiple splice variants of four NFI isoforms exist, and their biological functions have yet to be elucidated. Here, we cloned and analyzed human NFI-X3, a novel splice variant of the nfix gene, which contains a unique transcriptional activation (TA) domain completely conserved in primates. In contrast to previously cloned NFI-X1, overexpression of NFI-X3 potently activates NFI reporters, including glial fibrillary acidic protein (GFAP) reporter, in astrocytes and glioma cells. The GAL4 fusion protein containing the TA domain of NFI-X3 strongly activates the GAL4 reporter, whereas the TA domain of NFI-X1 is ineffective. The expression of NFI-X3 is dramatically up-regulated during the differentiation of neural progenitors to astrocytes and precedes the expression of astrocyte markers, such as GFAP and SPARCL1 (Secreted Protein, Acidic and Rich in Cysteines-like 1). Overexpression of NFI-X3 dramatically up-regulates GFAP and SPARCL1 expression in glioma cells, whereas the knockdown of NFI-X3 diminishes the expression of both GFAP and SPARCL1 in astrocytes. Although activation of astrocyte-specific genes involves DNA demethylation and subsequent increase of histone acetylation, NFI-X3 activates GFAP expression, in part, by inducing alterations in the nucleosome architecture that lead to the increased recruitment of RNA polymerase II.	[Singh, Sandeep K.; Wilczynska, Katarzyna M.; Grzybowski, Adrian; Yester, Jessie; Osrah, Bahiya; Bryan, Lauren; Kordula, Tomasz] Virginia Commonwealth Univ, Dept Biochem, Massey Canc Ctr, Richmond, VA 23298 USA; [Singh, Sandeep K.; Wilczynska, Katarzyna M.; Grzybowski, Adrian; Yester, Jessie; Osrah, Bahiya; Bryan, Lauren; Kordula, Tomasz] Virginia Commonwealth Univ, Dept Mol Biol, Massey Canc Ctr, Richmond, VA 23298 USA; [Grzybowski, Adrian] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, PL-30387 Krakow, Poland; [Wright, Sarah; Griswold-Prenner, Irene] Elan Pharmaceut, San Francisco, CA 94080 USA	Virginia Commonwealth University; Virginia Commonwealth University; Jagiellonian University	Kordula, T (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	tkordula@vcu.edu	Grzybowski, Adrian/X-1558-2019	Grzybowski, Adrian/0000-0002-7340-9603	National Institutes of Health [R01NS044118, R21NS063283, F31NS060433]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS060433, R01NS044118, R21NS063283] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS044118 and R21NS063283 (to T. K.).; Supported by National Institutes of Health Grant F31NS060433.	Al-Kandari W, 2007, J MOL BIOL, V369, P1175, DOI 10.1016/j.jmb.2007.04.033; ALLORE RJ, 1990, J BIOL CHEM, V265, P15537; ALTMANN H, 1994, P NATL ACAD SCI USA, V91, P3901, DOI 10.1073/pnas.91.9.3901; AMEMIYA K, 1992, J BIOL CHEM, V267, P14204; Arteaga MF, 2008, P NATL ACAD SCI USA, V105, P4459, DOI 10.1073/pnas.0800958105; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Barry G, 2008, J NEUROSCI, V28, P12328, DOI 10.1523/JNEUROSCI.4000-08.2008; BESNARD F, 1991, J BIOL CHEM, V266, P18877; Bisgrove DA, 2000, J BIOL CHEM, V275, P30668, DOI 10.1074/jbc.M003828200; Cairns BR, 2009, NATURE, V461, P193, DOI 10.1038/nature08450; Campbell CE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-52; Cebolla B, 2006, J NEUROCHEM, V97, P1057, DOI 10.1111/j.1471-4159.2006.03804.x; Chaudhry AZ, 1997, DEV DYNAM, V208, P313; Chu HY, 2007, MOL CELL BIOL, V27, P3743, DOI 10.1128/MCB.01561-06; das Neves L, 1999, P NATL ACAD SCI USA, V96, P11946, DOI 10.1073/pnas.96.21.11946; DELEGEANE AM, 1987, MOL CELL BIOL, V7, P3994, DOI 10.1128/MCB.7.11.3994; Deneen B, 2006, NEURON, V52, P953, DOI 10.1016/j.neuron.2006.11.019; Driller K, 2007, MOL CELL BIOL, V27, P3855, DOI 10.1128/MCB.02293-06; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fukuda S, 2007, MOL CELL BIOL, V27, P4931, DOI 10.1128/MCB.02435-06; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Ge WH, 2002, J NEUROSCI RES, V69, P848, DOI 10.1002/jnr.10364; Gevry N, 2009, METHODS MOL BIOL, V543, P281, DOI 10.1007/978-1-60327-015-1_19; Gomes WA, 2003, DEV BIOL, V255, P164, DOI 10.1016/S0012-1606(02)00037-4; Gopalan SM, 2006, J BIOL CHEM, V281, P13126, DOI 10.1074/jbc.M601194200; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; Grunder A, 2003, GENE, V304, P171, DOI 10.1016/S0378-1119(02)01204-0; Hermanson O, 2002, NATURE, V419, P934, DOI 10.1038/nature01156; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; Kordula T, 1998, J BIOL CHEM, V273, P4112, DOI 10.1074/jbc.273.7.4112; Krohn K, 1999, J NEUROCHEM, V72, P1353, DOI 10.1046/j.1471-4159.1999.721353.x; KRUSE U, 1994, J MOL BIOL, V238, P860, DOI 10.1006/jmbi.1994.1343; Mason S, 2009, MOL NEUROBIOL, V39, P10, DOI 10.1007/s12035-008-8048-6; Michelhaugh SK, 2005, J NEUROCHEM, V95, P1342, DOI 10.1111/j.1471-4159.2005.03458.x; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Mudhasani R, 2002, MOL CELL BIOL, V22, P5019, DOI 10.1128/MCB.22.14.5019-5026.2002; Muller K, 2000, J BIOL CHEM, V275, P1645, DOI 10.1074/jbc.275.3.1645; NAGATA K, 1982, P NATL ACAD SCI-BIOL, V79, P6438, DOI 10.1073/pnas.79.21.6438; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014; NEBL G, 1995, CELL MOL BIOL RES, V41, P85; O'Donnell A, 2008, MOL CELL, V29, P780, DOI 10.1016/j.molcel.2008.01.019; Ouellet S, 2006, NUCLEIC ACIDS RES, V34, P6472, DOI 10.1093/nar/gkl861; Pekarik Vladimir, 2008, Journal of Biology (London), V7, DOI 10.1186/jbiol94; Plachez C, 2008, J COMP NEUROL, V508, P385, DOI 10.1002/cne.21645; Ravichandran V, 2006, J VIROL, V80, P10506, DOI 10.1128/JVI.01355-06; ROULET E, 1995, MOL CELL BIOL, V15, P5552; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; Schwartz ML, 1998, MOL BRAIN RES, V57, P21, DOI 10.1016/S0169-328X(98)00049-7; Shu TZ, 2003, J NEUROSCI, V23, P203; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Steele-Perkins G, 2003, MOL CELL BIOL, V23, P1075, DOI 10.1128/MCB.23.3.1075-1084.2003; TAMURA T, 1988, NUCLEIC ACIDS RES, V16, P11441, DOI 10.1093/nar/16.24.11441; Vihma H, 2008, GENOMICS, V92, P279, DOI 10.1016/j.ygeno.2008.06.011; Wilczynska KM, 2009, STEM CELLS, V27, P1173, DOI 10.1002/stem.35; Zhao LH, 2005, ACTA BIOCH BIOPH SIN, V37, P440, DOI 10.1111/j.1745-7270.2005.00061.x	56	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7315	7326		10.1074/jbc.M110.152421	http://dx.doi.org/10.1074/jbc.M110.152421			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21189253	Green Published, hybrid			2022-12-27	WOS:000287737300048
J	Lejard, V; Blais, F; Guerquin, MJ; Bonnet, A; Bonnin, MA; Havis, E; Malbouyres, M; Bidaud, CB; Maro, G; Gilardi-Hebenstreit, P; Rossert, J; Ruggiero, F; Duprez, D				Lejard, Veronique; Blais, Frederic; Guerquin, Marie-Justine; Bonnet, Aline; Bonnin, Marie-Ange; Havis, Emmanuelle; Malbouyres, Maryline; Bidaud, Christelle Bonod; Maro, Geraldine; Gilardi-Hebenstreit, Pascale; Rossert, Jerome; Ruggiero, Florence; Duprez, Delphine			EGR1 and EGR2 Involvement in Vertebrate Tendon Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED T-CELLS; PRO-ALPHA-1(I) COLLAGEN PROMOTER; SKELETAL-MUSCLE DIFFERENTIATION; GENE-EXPRESSION; MYOTUBE GUIDANCE; TRANSGENIC MICE; NUCLEAR FACTOR; GROWTH-FACTOR; SCLERAXIS; TRANSCRIPTION	The molecules involved in vertebrate tendon formation during development remain largely unknown. To date, only two DNA-binding proteins have been identified as being involved in vertebrate tendon formation, the basic helix-loop-helix transcription factor Scleraxis and, recently, the Mohawk homeobox gene. We investigated the involvement of the early growth response transcription factors Egr1 and Egr2 in vertebrate tendon formation. We established that Egr1 and Egr2 expression in tendon cells was correlated with the increase of collagen expression during tendon cell differentiation in embryonic limbs. Vertebrate tendon differentiation relies on a muscle-derived FGF (fibroblast growth factor) signal. FGF4 was able to activate the expression of Egr genes and that of the tendon-associated collagens in chick limbs. Egr gene misexpression experiments using the chick model allowed us to establish that either Egr gene has the ability to induce de novo expression of the reference tendon marker scleraxis, the main tendon collagen Col1a1, and other tendon-associated collagens Col3a1, Col5a1, Col12a1, and Col14a1. Mouse mutants for Egr1 or Egr2 displayed reduced amounts of Col1a1 transcripts and a decrease in the number of collagen fibrils in embryonic tendons. Moreover, EGR1 and EGR2 trans-activated the mouse Col1a1 proximal promoter and were recruited to the tendon regulatory regions of this promoter. These results identify EGRs as novel DNA-binding proteins involved in vertebrate tendon differentiation by regulating type I collagen production.	[Havis, Emmanuelle; Duprez, Delphine] Univ Paris 06, UMR7622, CNRS, F-75005 Paris, France; [Lejard, Veronique; Malbouyres, Maryline; Bidaud, Christelle Bonod; Ruggiero, Florence] Univ Lyon 1, CNRS, Inst Biol & Chim Prot, UMR 5086, F-69367 Lyon, France; [Maro, Geraldine; Gilardi-Hebenstreit, Pascale] Ecole Normale Super, INSERM, U784, F-75005 Paris, France; [Rossert, Jerome] Paris Descartes Univ, INSERM, U652, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Duprez, D (corresponding author), Univ Paris 06, UMR7622, CNRS, Campus Jussieu,9 Quai St Bernard,Bat C,6E,Case 24, F-75005 Paris, France.	delphine.duprez@upmc.fr	Havis, Emmanuelle/K-1874-2017; bonod-bidaud, christelle/AAN-9236-2021; Duprez, Delphine/K-1856-2017	Havis, Emmanuelle/0000-0001-5634-3174; Duprez, Delphine/0000-0003-0248-7417; RUGGIERO, Florence/0000-0003-2915-5359; GUERQUIN, Marie-Justine/0000-0002-1752-7250; Bonnin, Marie-Ange/0000-0002-6521-3387; BONOD, Christelle/0000-0002-7180-2727	Association Francaise contre les Myopathies (AFM); Association pour la Recherche sur le Cancer (ARC); Agence Nationale de la Recherche (ANR); sixth PCRDT through the MYORES network of excellence; Rhone-Alpes region; Fondation pour la Recherche Medicale (FRM); MYORES network of excellence; French Ministry of Research	Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); sixth PCRDT through the MYORES network of excellence; Rhone-Alpes region(Region Auvergne-Rhone-Alpes); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); MYORES network of excellence; French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by the Association Francaise contre les Myopathies (AFM), Association pour la Recherche sur le Cancer (ARC), Agence Nationale de la Recherche (ANR), the sixth PCRDT through the MYORES network of excellence, the Rhone-Alpes region, and the Fondation pour la Recherche Medicale (FRM).; Supported by the Fondation pour la Recherche Medicale (FRM), Agence Nationale de la Recherche (ANR), and the MYORES network of excellence.; Supported by the French Ministry of Research and by the Association Francaise contre les Myopathies (AFM).	Alfonso-Jaume MA, 2004, BIOCHEM J, V380, P735, DOI 10.1042/BJ20031281; Banos Charles C., 2008, Birth Defects Research, V84, P228, DOI 10.1002/bdrc.20130; Becker S, 1997, DEVELOPMENT, V124, P2615; Birk DE, 1997, EUR J CELL BIOL, V72, P352; Boardman PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4; Bonnet A, 2010, MECH DEVELOP, V127, P120, DOI 10.1016/j.mod.2009.10.001; Bonnin MA, 2005, MECH DEVELOP, V122, P573, DOI 10.1016/j.mod.2004.11.005; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; Brent AE, 2004, DEVELOPMENT, V131, P3885, DOI 10.1242/dev.01275; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; Carter JH, 2007, J IMMUNOL, V178, P3038, DOI 10.4049/jimmunol.178.5.3038; Chen SJ, 2006, J BIOL CHEM, V281, P21183, DOI 10.1074/jbc.M603270200; Coulpier F, 2010, J NEUROSCI, V30, P5958, DOI 10.1523/JNEUROSCI.0017-10.2010; Decker EL, 2003, NUCLEIC ACIDS RES, V31, P911, DOI 10.1093/nar/gkg186; Delfini MC, 2004, DEVELOPMENT, V131, P713, DOI 10.1242/dev.00967; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; Edom-Vovard F, 2004, DEV DYNAM, V229, P449, DOI 10.1002/dvdy.10481; Edom-Vovard F, 2002, DEV BIOL, V247, P351, DOI 10.1006/dbio.2002.0707; Eldredge LC, 2008, DEVELOPMENT, V135, P2949, DOI 10.1242/dev.023960; Eloy-Trinquet S, 2009, DEV DYNAM, V238, P1195, DOI 10.1002/dvdy.21946; Frommer G, 1996, EMBO J, V15, P1642, DOI 10.1002/j.1460-2075.1996.tb00509.x; Giudicelli F, 2001, GENE DEV, V15, P567, DOI 10.1101/gad.189801; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Havis E, 2006, BIOTECHNIQUES, V40, P34, DOI 10.2144/000112098; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Ito Y, 2010, P NATL ACAD SCI USA, V107, P10538, DOI 10.1073/pnas.1000525107; Kardon G, 1998, DEVELOPMENT, V125, P4019; KIENY M, 1979, J EMBRYOL EXP MORPH, V49, P153; Lejard V, 2007, J BIOL CHEM, V282, P17665, DOI 10.1074/jbc.M610113200; Liu WJ, 2010, MOL CELL BIOL, V30, P4797, DOI 10.1128/MCB.00207-10; Lorda-Diez CI, 2009, J BIOL CHEM, V284, P29988, DOI 10.1074/jbc.M109.014811; MCMAHON AP, 1990, DEVELOPMENT, V108, P281; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; ROS MA, 1995, ANAT EMBRYOL, V192, P483; ROSSERT J, 1995, J CELL BIOL, V129, P1421, DOI 10.1083/jcb.129.5.1421; Roulet M, 2007, CELL TISSUE RES, V327, P323, DOI 10.1007/s00441-006-0294-1; Schabbauer G, 2007, THROMB HAEMOSTASIS, V97, P988, DOI 10.1160/TH07-01-0037; SCHNEIDERMAUNOURY S, 1993, CELL, V75, P1199, DOI 10.1016/0092-8674(93)90329-O; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Schweitzer R, 2010, DEVELOPMENT, V137, P2807, DOI 10.1242/dev.047498; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Terraz C, 2002, J BIOL CHEM, V277, P19019, DOI 10.1074/jbc.M200125200; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; Tozer Samuel, 2005, Birth Defects Research, V75, P226, DOI 10.1002/bdrc.20049; Volk T, 1999, TRENDS GENET, V15, P448, DOI 10.1016/S0168-9525(99)01862-4; Volohonsky G, 2007, DEVELOPMENT, V134, P347, DOI 10.1242/dev.02735; Vorbruggen G, 1997, P NATL ACAD SCI USA, V94, P8606, DOI 10.1073/pnas.94.16.8606; Zhang G., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P5	50	134	137	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5855	5867		10.1074/jbc.M110.153106	http://dx.doi.org/10.1074/jbc.M110.153106			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21173153	Green Published, hybrid			2022-12-27	WOS:000287230600094
J	Levic, S; Yamoah, EN				Levic, Snezana; Yamoah, Ebenezer N.			Plasticity in Membrane Cholesterol Contributes toward Electrical Maturation of Hearing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNER HAIR-CELLS; NEURAL STEM-CELLS; POTASSIUM CURRENTS; SURFACE EXPRESSION; LIPID RAFTS; CHANNELS; LOCALIZATION; MECHANISM; MICE; CAVEOLIN-1	Advances in refining the "fluid mosaic" model of the plasma membrane have revealed that it is wrought with an ordered lipid composition that undergoes remarkable plasticity during cell development. Despite the evidence that specific signaling proteins and ion channels gravitate toward these lipid microdomains, identification of their functional impact remains a formidable challenge. We report that in contrast to matured auditory hair cells, depletion of membrane cholesterol in developing hair cells produced marked potentiation of voltage-gated K+ currents (I-Kv). The enhanced magnitude of I-Kv in developing hair cells was in keeping with the reduced cholesterol-rich microdomains in matured hair cells. Remarkably, potentiation of the cholesterol-sensitive current was sufficient to abolish spontaneous activity, a functional blueprint of developing and regenerating hair cells. Collectively, these findings provide evidence that developmental plasticity of lipid microdomains and the ensuing changes in K+ currents are important determinants of one of the hallmarks in the maturation of hearing.	[Levic, Snezana; Yamoah, Ebenezer N.] Univ Calif Davis, Sch Med, Program Commun Sci, Dept Anesthesiol & Pain Med, Davis, CA 95618 USA	University of California System; University of California Davis	Yamoah, EN (corresponding author), Univ Calif Davis, Sch Med, Program Commun Sci, Dept Anesthesiol & Pain Med, 1515 Newton Ct, Davis, CA 95618 USA.	enyamoah@ucdavis.edu		Levic, Snezana/0000-0002-6171-896X	National Institutes of Health, NIDCD [DC003826]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC010917, R01DC003826] Funding Source: NIH RePORTER	National Institutes of Health, NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant DC003826 from NIDCD (to E.N.Y.).	Abi-Char J, 2007, J PHYSIOL-LONDON, V582, P1205, DOI 10.1113/jphysiol.2007.134809; Alioua A, 2008, J BIOL CHEM, V283, P4808, DOI 10.1074/jbc.M709802200; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Christian AE, 1997, J LIPID RES, V38, P2264; Cogolludo A, 2006, CIRC RES, V98, P931, DOI 10.1161/01.RES.0000216858.04599.e1; Ehret G, 1976, J Am Audiol Soc, V1, P179; Evans MB, 2006, OTOL NEUROTOL, V27, P609, DOI 10.1097/01.mao.0000226286.19295.34; FUCHS PA, 1990, P ROY SOC B-BIOL SCI, V241, P122, DOI 10.1098/rspb.1990.0075; FUCHS PA, 1990, J PHYSIOL-LONDON, V429, P529, DOI 10.1113/jphysiol.1990.sp018271; Gillespie PG, 2004, ANNU REV PHYSIOL, V66, P521, DOI 10.1146/annurev.physiol.66.032102.112842; Hafidi A, 2005, NEUROSCIENCE, V130, P475, DOI 10.1016/j.neuroscience.2004.09.038; Huertas-Vazquez A, 2010, HUM GENET, V127, P83, DOI 10.1007/s00439-009-0749-z; JONES OT, 1988, BIOCHEMISTRY-US, V27, P2364, DOI 10.1021/bi00407a018; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Langer P, 2003, J COMP NEUROL, V455, P198, DOI 10.1002/cne.10471; Lee IH, 2009, J BIOL CHEM, V284, P12663, DOI 10.1074/jbc.M809737200; LeMasurier M, 2007, NAT NEUROSCI, V10, P11, DOI 10.1038/nn0107-11; Levic S, 2007, P NATL ACAD SCI USA, V104, P19108, DOI 10.1073/pnas.0705927104; Levitan I, 2000, J GEN PHYSIOL, V115, P405, DOI 10.1085/jgp.115.4.405; Lindblom G, 2009, BBA-BIOMEMBRANES, V1788, P234, DOI 10.1016/j.bbamem.2008.08.016; Lundbaek JA, 1996, BIOCHEMISTRY-US, V35, P3825, DOI 10.1021/bi952250b; Marcotti W, 2003, J PHYSIOL-LONDON, V548, P383, DOI 10.1113/jphysiol.2002.034801; Martinez-Marmol R, 2008, J CELL PHYSIOL, V217, P667, DOI 10.1002/jcp.21538; Misonou H, 2004, CRIT REV BIOCHEM MOL, V39, P125, DOI 10.1080/10409230490475417; Niemela PS, 2007, PLOS COMPUT BIOL, V3, P304, DOI 10.1371/journal.pcbi.0030034; Oertel D, 2000, P NATL ACAD SCI USA, V97, P11773, DOI 10.1073/pnas.97.22.11773; Oliver D, 2004, SCIENCE, V304, P265, DOI 10.1126/science.1094113; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; Pyott SJ, 2004, J NEUROSCI, V24, P9469, DOI 10.1523/JNEUROSCI.3162-04.2004; Pyott SJ, 2007, J BIOL CHEM, V282, P3312, DOI 10.1074/jbc.M608726200; Radhakrishnan A, 2004, MOL CELL, V15, P259, DOI 10.1016/j.molcel.2004.06.019; Rajagopalan L, 2007, J BIOL CHEM, V282, P36659, DOI 10.1074/jbc.M705078200; Rajagopalan L, 2010, JARO-J ASSOC RES OTO, V11, P39, DOI 10.1007/s10162-009-0196-5; Razani B, 2002, MOL CELL BIOL, V22, P2329, DOI 10.1128/MCB.22.7.2329-2344.2002; Razani B, 2002, J BIOL CHEM, V277, P8635, DOI 10.1074/jbc.M110970200; Reid PC, 2004, J LIPID RES, V45, P582, DOI 10.1194/jlr.D300032-JLR200; Ren T, 2007, CURR OPIN NEUROBIOL, V17, P498, DOI 10.1016/j.conb.2007.07.013; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; SAITO K, 1990, J ELECTRON MICR TECH, V15, P173, DOI 10.1002/jemt.1060150209; SAUNDERS JC, 1973, BRAIN RES, V63, P59, DOI 10.1016/0006-8993(73)90076-0; Sfondouris J, 2008, J BIOL CHEM, V283, P22473, DOI 10.1074/jbc.M803722200; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Sturm AK, 2007, OTOLARYNG HEAD NECK, V136, P434, DOI 10.1016/j.otohns.2006.10.030; Toselli M, 2005, BIOPHYS J, V89, P2443, DOI 10.1529/biophysj.105.065623; Tyska MJ, 2005, MOL BIOL CELL, V16, P2443, DOI 10.1091/mbc.E04-12-1116; Wong W, 2004, J BIOL CHEM, V279, P444, DOI 10.1074/jbc.M304675200; Yanagisawa M, 2007, GLYCOBIOLOGY, V17, p57R, DOI 10.1093/glycob/cwm018; Yu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007923; Yu RK, 2007, J NEUROCHEM, V103, P39, DOI 10.1111/j.1471-4159.2007.04710.x	49	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5768	5773		10.1074/jbc.M110.186486	http://dx.doi.org/10.1074/jbc.M110.186486			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21163952	Green Published, hybrid			2022-12-27	WOS:000287230600085
J	Lu, YH; Guan, ZQ; Zhao, JS; Raetz, CRH				Lu, Yi-Hsueh; Guan, Ziqiang; Zhao, Jinshi; Raetz, Christian R. H.			Three Phosphatidylglycerol-phosphate Phosphatases in the Inner Membrane of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNDECAPRENYL PYROPHOSPHATE PHOSPHATASE; CDP-DIGLYCERIDE SYNTHETASE; EXPRESSION CLONING; BOUND PHOSPHATASES; CHROMOSOMAL GENES; OUTER-MEMBRANE; MULTIPLE GENES; PCR PRODUCTS; PGPB GENE; MUTANT	The phospholipids of Escherichia coli consist mainly of phosphatidylethanolamine, phosphatidylglycerol (PG), and cardiolipin. PG makes up similar to 25% of the cellular phospholipid and is essential for growth in wild-type cells. PG is synthesized on the inner surface of the inner membrane from cytidine diphosphate-diacylglycerol and glycerol 3-phosphate, generating the precursor phosphatidylglycerol-phosphate (PGP). This compound is present at low levels (similar to 0.1% of the total lipid). Dephosphorylation of PGP to PG is catalyzed by several PGP-phosphatases. The pgpA and pgpB genes, which encode structurally distinct PGP-phosphatases, were identified previously. Double deletion mutants lacking pgpA and pgpB are viable and still make PG, suggesting the presence of additional phosphatase( s). We have identified a third PGP-phosphatase gene (previously annotated as yfhB but renamed pgpC) using an expression cloning strategy. A mutant with deletions in all three phosphatase genes is not viable unless covered by a plasmid expressing either pgpA, pgpB, or pgpC. When the triple mutant is covered with the temperature-sensitive plasmid pMAK705 expressing any one of the three pgp genes, the cells grow at 30 but not 42 degrees C. As growth slows at 42 degrees C, PGP accumulates to high levels, and the PG content declines. PgpC orthologs are present in many other bacteria.	[Lu, Yi-Hsueh; Guan, Ziqiang; Zhao, Jinshi; Raetz, Christian R. H.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Raetz, CRH (corresponding author), Duke Univ, Med Ctr, Dept Biochem, POB 3711, Durham, NC 27710 USA.	raetz@biochem.duke.edu	Guan, Ziqiang/AAE-5110-2019		National Institutes of Health [GM-51796, GM-069338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051796, U54GM069338, R37GM051796] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-51796 (to C. R. H. R.) and the Large Scale Collaborative Grant GM-069338 (to Z. G. and the Lipid MAPS mass spectrometry facility at Duke University).	Allen KN, 2004, TRENDS BIOCHEM SCI, V29, P495, DOI 10.1016/j.tibs.2004.07.008; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CHANG YY, 1967, J LIPID RES, V8, P456; Chung HS, 2010, BIOCHEMISTRY-US, V49, P4126, DOI 10.1021/bi100343e; Cronan JE, 2003, ANNU REV MICROBIOL, V57, P203, DOI 10.1146/annurev.micro.57.030502.090851; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DECHAVIGNY A, 1991, J BIOL CHEM, V266, P5323; Dillon DA, 1996, J BIOL CHEM, V271, P30548, DOI 10.1074/jbc.271.48.30548; Doerrler WT, 2005, J BIOL CHEM, V280, P27679, DOI 10.1074/jbc.M504796200; Doublet B, 2008, J MICROBIOL METH, V75, P359, DOI 10.1016/j.mimet.2008.06.010; Dowhan W, 2009, J LIPID RES, V50, pS305, DOI 10.1194/jlr.R800041-JLR200; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; El Ghachi M, 2005, J BIOL CHEM, V280, P18689, DOI 10.1074/jbc.M412277200; FUNK CR, 1992, J BACTERIOL, V174, P205, DOI 10.1128/jb.174.1.205-213.1992; GANONG BR, 1980, J BIOL CHEM, V255, P1623; Garrett TA, 1998, J BIOL CHEM, V273, P12457, DOI 10.1074/jbc.273.20.12457; GOPALAKRISHNAN AS, 1986, J BIOL CHEM, V261, P1329; HAMILTON CM, 1989, J BACTERIOL, V171, P4617, DOI 10.1128/jb.171.9.4617-4622.1989; HIRSCHBERG CB, 1972, P NATL ACAD SCI USA, V69, P648, DOI 10.1073/pnas.69.3.648; ICHO T, 1985, J BIOL CHEM, V260, P2078; ICHO T, 1983, J BACTERIOL, V153, P722, DOI 10.1128/JB.153.2.722-730.1983; ICHO T, 1988, J BACTERIOL, V170, P5117, DOI 10.1128/jb.170.11.5117-5124.1988; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; KANFER J, 1964, J BIOL CHEM, V239, P1720; Karbarz MJ, 2003, J BIOL CHEM, V278, P39269, DOI 10.1074/jbc.M305830200; KENNEDY EUGENE P., 1962, HARVEY LECTURES, V57, P143; Kikuchi S, 2000, J BACTERIOL, V182, P371, DOI 10.1128/JB.182.2.371-376.2000; Kumaran D, 2006, PROTEINS, V64, P851, DOI 10.1002/prot.21039; Matsumoto K, 2001, MOL MICROBIOL, V39, P1427, DOI 10.1046/j.1365-2958.2001.02320.x; Metzger LE, 2010, BIOCHEMISTRY-US, V49, P6715, DOI 10.1021/bi1008744; Mileykovskaya E, 2009, J BIOL CHEM, V284, P2990, DOI 10.1074/jbc.M805189200; Miller J.H., 1972, EXPT MOL GENETICS; NEUWALD AF, 1985, NUCLEIC ACIDS RES, V13, P7025, DOI 10.1093/nar/13.19.7025; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; RAETZ CRH, 1986, ANNU REV GENET, V20, P253, DOI 10.1146/annurev.ge.20.120186.001345; RAETZ CRH, 1972, J BIOL CHEM, V247, P2008; RAETZ CRH, 1985, J BIOL CHEM, V260, P6080; RAETZ CRH, 1973, J BIOL CHEM, V248, P1098; Shiba Y, 2004, J BACTERIOL, V186, P6526, DOI 10.1128/jb.186.19.6526-6535.2004; SHIBUYA I, 1992, PROG LIPID RES, V31, P245, DOI 10.1016/0163-7827(92)90010-G; Sigal YJ, 2005, BIOCHEM J, V387, P281, DOI 10.1042/BJ20041771; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Song S, 1993, Chin J Biotechnol, V9, P197; Touze T, 2008, J BIOL CHEM, V283, P16573, DOI 10.1074/jbc.M800394200; USUI M, 1994, J BACTERIOL, V176, P3389, DOI 10.1128/jb.176.11.3389-3392.1994; Wang XY, 2006, J BIOL CHEM, V281, P9321, DOI 10.1074/jbc.M600435200; Wang XY, 2004, J BIOL CHEM, V279, P49470, DOI 10.1074/jbc.M409078200; Zhang YM, 2008, J LIPID RES, V49, P1867, DOI 10.1194/jlr.R800005-JLR200	54	64	69	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5506	5518		10.1074/jbc.M110.199265	http://dx.doi.org/10.1074/jbc.M110.199265			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148555	hybrid, Green Published			2022-12-27	WOS:000287230600060
J	Nalaskowski, MM; Fliegert, R; Ernst, O; Brehm, MA; Fanick, W; Windhorst, S; Lin, HY; Giehler, S; Hein, JM; Lin, YN; Mayr, GW				Nalaskowski, Marcus M.; Fliegert, Ralf; Ernst, Olga; Brehm, Maria A.; Fanick, Werner; Windhorst, Sabine; Lin, Hongying; Giehler, Susanne; Hein, Jamin; Lin, Yuan-Na; Mayr, Georg W.			Human Inositol 1,4,5-Trisphosphate 3-Kinase Isoform B (IP3KB) Is a Nucleocytoplasmic Shuttling Protein Specifically Enriched at Cortical Actin Filaments and at Invaginations of the Nuclear Envelope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCELLULAR-LOCALIZATION; CA2+ OSCILLATIONS; MOLECULAR-CLONING; GENE-EXPRESSION; EXPORT SIGNALS; MESSENGER-RNA; HELA-CELLS; 1,3,4,5-TETRAKISPHOSPHATE; ITPKB; IDENTIFICATION	Recent studies have shown that inositol 1,4,5-trisphosphate 3-kinase isoform B (IP3KB) possesses important roles in the development of immune cells. IP3KB can be targeted to multiple cellular compartments, among them nuclear localization and binding in close proximity to the plasma membrane. The B isoform is the only IP3K that is almost ubiquitously expressed in mammalian cells. Detailed mechanisms of its targeting regulation will be important in understanding the role of Ins(1,4,5)P-3 phosphorylation on subcellular calcium signaling and compartment-specific initiation of pathways leading to regulatory active higher phosphorylated inositol phosphates. Here, we identified an exportin 1-dependent nuclear export signal ((134)LQRELQNVQV) and characterized the amino acids responsible for nuclear localization of IP3KB ((RKLR)-R-129). These two targeting domains regulate the amount of nuclear IP3KB in cells. We also demonstrated that the localization of IP3KB at the plasma membrane is due to its binding to cortical actin structures. Intriguingly, all three of these targeting activities reside in one small polypeptide segment (amino acids 104-165), which acts as a multitargeting domain (MTD). Finally, a hitherto unknown subnuclear localization of IP3KB could be demonstrated in rapidly growing H1299 cells. IP3KB is specifically enriched at nuclear invaginations extending perpendicular between the apical and basal surface of the nucleus of these flat cells. Such nuclear invaginations are known to be involved in Ins(1,4,5)P-3-mediated Ca2+ signaling of the nucleus. Our findings indicate that IP3KB not only regulates cytoplasmic Ca2+ signals by phosphorylation of subplasmalemmal and cytoplasmic Ins(1,4,5)P-3 but may also be involved in modulating nuclear Ca2+ signals generated from these nuclear envelope invaginations.	[Nalaskowski, Marcus M.; Fliegert, Ralf; Ernst, Olga; Brehm, Maria A.; Fanick, Werner; Windhorst, Sabine; Lin, Hongying; Giehler, Susanne; Hein, Jamin; Lin, Yuan-Na; Mayr, Georg W.] Univ Med Ctr Hamburg Eppendorf, Inst Biochem Mol Biol I Cellular Signal Transduct, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Nalaskowski, MM (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Biochem Mol Biol I Cellular Signal Transduct, Martinistr 52, D-20246 Hamburg, Germany.	nalaskowski@uke.uni-hamburg.de		Brehm, Maria Alexandra/0000-0003-0416-8233; Hein, Jamin/0000-0002-2887-5082	Deutsche Forschungsgemeinschaft [MA 989/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant MA 989/3-1 (to G. W. M.).	Barrat FJ, 1997, GENOMICS, V43, P111, DOI 10.1006/geno.1997.4785; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; Bogerd HP, 1996, MOL CELL BIOL, V16, P4207; Brehm MA, 2004, BIOCHEM J, V382, P353, DOI 10.1042/BJ20031751; CHOI KY, 1990, SCIENCE, V248, P64, DOI 10.1126/science.2157285; Clubb BH, 1998, TISSUE CELL, V30, P684, DOI 10.1016/S0040-8166(98)80087-6; Dewaste V, 2003, BIOCHEM J, V374, P41, DOI 10.1042/BJ20021963; Dewaste V, 2002, BIOCHEM BIOPH RES CO, V291, P400, DOI 10.1006/bbrc.2002.6456; Dewaste V, 2000, BIOCHEM J, V352, P343, DOI 10.1042/0264-6021:3520343; Dupont G, 1997, CELL CALCIUM, V22, P321, DOI 10.1016/S0143-4160(97)90017-8; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; Emilsson L, 2006, NEUROBIOL DIS, V21, P618, DOI 10.1016/j.nbd.2005.09.004; ERNEUX C, 1992, GENOMICS, V14, P546, DOI 10.1016/S0888-7543(05)80265-4; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Fricker M, 1997, J CELL BIOL, V136, P531, DOI 10.1083/jcb.136.3.531; Gyorffy B, 2007, J INVEST DERMATOL, V127, P394, DOI 10.1038/sj.jid.5700543; Hebert MD, 2000, MOL BIOL CELL, V11, P4159, DOI 10.1091/mbc.11.12.4159; Henao-Mejia J, 2009, EXP CELL RES, V315, P3381, DOI 10.1016/j.yexcr.2009.07.011; Hermosura MC, 2000, NATURE, V408, P735, DOI 10.1038/35047115; Hernandez-Munoz I, 2005, MOL CELL BIOL, V25, P11047, DOI 10.1128/MCB.25.24.11047-11058.2005; Huang YH, 2008, EXPERT OPIN THER TAR, V12, P391, DOI 10.1517/14728222.12.4.391 ; Irvine RF, 2001, NAT REV MOL CELL BIO, V2, P327, DOI 10.1038/35073015; Jia YH, 2008, P NATL ACAD SCI USA, V105, P4739, DOI 10.1073/pnas.0800218105; Jia YH, 2007, IMMUNITY, V27, P453, DOI 10.1016/j.immuni.2007.07.016; Johnson N, 2003, DIFFERENTIATION, V71, P414, DOI 10.1046/j.1432-0436.2003.7107003.x; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; la Cour T, 2003, NUCLEIC ACIDS RES, V31, P393, DOI 10.1093/nar/gkg101; Lui PPY, 2003, BIOCHEM BIOPH RES CO, V308, P826, DOI 10.1016/S0006-291X(03)01469-4; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Malviya AN, 2006, CAN J PHYSIOL PHARM, V84, P403, DOI 10.1139/Y05-130; Marechal Y, 2007, P NATL ACAD SCI USA, V104, P13978, DOI 10.1073/pnas.0704312104; Millard TH, 2000, BIOCHEM J, V352, P709, DOI 10.1042/0264-6021:3520709; Miller AT, 2007, NAT IMMUNOL, V8, P514, DOI 10.1038/ni1458; Nalaskowski MM, 2006, BIOL CHEM, V387, P583, DOI 10.1515/BC.2006.075; Nalaskowski MM, 2003, J BIOL CHEM, V278, P19765, DOI 10.1074/jbc.M211059200; Nalaskowski MM, 2002, BIOCHEM J, V366, P549, DOI 10.1042/BJ20020327; Pattni K, 2003, BIOCHEM J, V375, P643, DOI 10.1042/BJ20030505; Politi A, 2006, BIOPHYS J, V90, P3120, DOI 10.1529/biophysj.105.072249; Pouillon V, 2003, NAT IMMUNOL, V4, P1136, DOI 10.1038/ni980; Salichs E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000397; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Tajouri L, 2005, BRAIN RES PROTOC, V15, P79, DOI 10.1016/j.brainresprot.2005.04.003; TAKAZAWA K, 1991, BIOCHEM J, V278, P883, DOI 10.1042/bj2780883; Tripathi K, 2008, J BIOSCIENCES, V33, P345, DOI 10.1007/s12038-008-0054-3; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Windhorst S, 2010, J BIOL CHEM, V285, P5541, DOI 10.1074/jbc.M109.047050; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Yu JCH, 2005, BIOCHEM J, V392, P435, DOI 10.1042/BJ20050829; Zeidman R, 2002, MOL BIOL CELL, V13, P12, DOI 10.1091/mbc.01-04-0210	50	27	29	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4500	4510		10.1074/jbc.M110.173062	http://dx.doi.org/10.1074/jbc.M110.173062			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21148483	Green Published, hybrid			2022-12-27	WOS:000286975700050
J	Novgorodov, SA; Chudakova, DA; Wheeler, BW; Bielawski, J; Kindy, MS; Obeid, LM; Gudz, TI				Novgorodov, Sergei A.; Chudakova, Daria A.; Wheeler, Brian W.; Bielawski, Jacek; Kindy, Mark S.; Obeid, Lina M.; Gudz, Tatyana I.			Developmentally Regulated Ceramide Synthase 6 Increases Mitochondrial Ca2+ Loading Capacity and Promotes Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; NERVE GROWTH-FACTOR; BRAIN MITOCHONDRIA; CELL-DEATH; CYSTINE/GLUTAMATE ANTIPORTER; (DIHYDRO)CERAMIDE SYNTHASE; SUBSTRATE-SPECIFICITY; N-ACYLTRANSFERASE; CALPAIN INHIBITOR; CNS MITOCHONDRIA	Ceramides, which are membrane sphingolipids and key mediators of cell-stress responses, are generated by a family of (dihydro) ceramide synthases (Lass1-6/CerS1-6). Here, we report that brain development features significant increases in sphingomyelin, sphingosine, and most ceramide species. In contrast, C-16:0-ceramide was gradually reduced and CerS6 was down-regulated in mitochondria, thereby implicating CerS6 as a primary ceramide synthase generating C-16:0-ceramide. Investigations into the role of CerS6 in mitochondria revealed that ceramide synthase down-regulation is associated with dramatically decreased mitochondrial Ca2+-loading capacity, which could be rescued by addition of ceramide. Selective CerS6 complexing with the inner membrane component of the mitochondrial permeability transition pore was detected by immunoprecipitation. This suggests that CerS6-generated ceramide could prevent mitochondrial permeability transition pore opening, leading to increased Ca2+ accumulation in the mitochondrial matrix. We examined the effect of high CerS6 expression on cell survival in primary oligodendrocyte (OL) precursor cells, which undergo apoptotic cell death during early postnatal brain development. Exposure of OLs to glutamate resulted in apoptosis that was prevented by inhibitors of de novo ceramide biosynthesis, myriocin and fumonisin B1. Knockdown of CerS6 with siRNA reduced glutamate-triggered OL apoptosis, whereas knockdown of CerS5 had no effect: the pro-apoptotic role of CerS6 was not stimulus-specific. Knockdown of CerS6 with siRNA improved cell survival in response to nerve growth factor-induced OL apoptosis. Also, blocking mitochondrial Ca2+ uptake or decreasing Ca2+-dependent protease calpain activity with specific inhibitors prevented OL apoptosis. Finally, knocking down CerS6 decreased calpain activation. Thus, our data suggest a novel role for CerS6 in the regulation of both mitochondrial Ca2+ homeostasis and calpain, which appears to be important in OL apoptosis during brain development.	[Obeid, Lina M.; Gudz, Tatyana I.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA; [Chudakova, Daria A.; Wheeler, Brian W.; Kindy, Mark S.; Gudz, Tatyana I.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [Novgorodov, Sergei A.; Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Novgorodov, Sergei A.; Bielawski, Jacek; Obeid, Lina M.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Gudz, TI (corresponding author), 114 Doughty St, Charleston, SC 29425 USA.	gudz@musc.edu	Chudakova, Daria/ABB-3032-2020	obeid, lina/0000-0002-0734-0847	National Institutes of Health for NCCR COBRE in Lipidomics and Pathobiology [P20 RR 17677, AG16583]; Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016583] Funding Source: NIH RePORTER	National Institutes of Health for NCCR COBRE in Lipidomics and Pathobiology; Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant P20 RR 17677 for NCCR COBRE in Lipidomics and Pathobiology (to T. I. G.), Grant AG16583 (to L. M. O.), and Veterans Affairs Rehabilitation Research and Development Merit Awards (to T. I. G. and M. S. K.).	Ardail D, 2001, FEBS LETT, V488, P160, DOI 10.1016/S0014-5793(00)02332-2; Arrington DD, 2006, AM J PHYSIOL-CELL PH, V291, pC1159, DOI 10.1152/ajpcell.00207.2006; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Barres BA, 1999, J CELL BIOL, V147, P1123, DOI 10.1083/jcb.147.6.1123; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Bionda C, 2004, BIOCHEM J, V382, P527, DOI 10.1042/BJ20031819; Blochl A, 2007, J NEUROCHEM, V102, P289, DOI 10.1111/j.1471-4159.2007.04496.x; Brann AB, 1999, J NEUROSCI, V19, P8199; Brustovetsky N, 2000, J NEUROSCI, V20, P103, DOI 10.1523/JNEUROSCI.20-01-00103.2000; Brustovetsky N, 2000, J NEUROSCI, V20, P8229, DOI 10.1523/JNEUROSCI.20-22-08229.2000; CasacciaBonnefil P, 1996, NATURE, V383, P716, DOI 10.1038/383716a0; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; Chudakova DA, 2008, J BIOL CHEM, V283, P28806, DOI 10.1074/jbc.M803301200; Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595; Csordas G, 2009, BBA-BIOENERGETICS, V1787, P1352, DOI 10.1016/j.bbabio.2009.06.004; Das A, 2005, J NEUROSCI RES, V81, P551, DOI 10.1002/jnr.20581; de la Rosa EJ, 2000, TRENDS NEUROSCI, V23, P454, DOI 10.1016/S0166-2236(00)01628-3; Degroote S, 2004, SEMIN CELL DEV BIOL, V15, P375, DOI 10.1016/j.semcdb.2004.03.007; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; El Bawab S, 2001, J BIOL CHEM, V276, P16758, DOI 10.1074/jbc.M009331200; Elce JS, 1997, J BIOL CHEM, V272, P11268; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; FUTERMAN AH, 1990, J BIOL CHEM, V265, P8650; Futerman AH, 2006, BBA-BIOMEMBRANES, V1758, P1885, DOI 10.1016/j.bbamem.2006.08.004; Goldberg MP, 2003, STROKE, V34, P330, DOI 10.1161/01.STR.0000054048.22626.B9; Grassme H, 2003, ONCOGENE, V22, P5457, DOI 10.1038/sj.onc.1206540; Gu CH, 1999, J NEUROSCI, V19, P3043; Gudz TI, 2006, J NEUROSCI, V26, P2458, DOI 10.1523/JNEUROSCI.4054-05.2006; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Harrington AW, 2002, J NEUROSCI, V22, P156, DOI 10.1523/JNEUROSCI.22-01-00156.2002; Hoppe UC, 2010, FEBS LETT, V584, P1975, DOI 10.1016/j.febslet.2010.04.017; Iemata M, 2007, J CELL PHYSIOL, V213, P721, DOI 10.1002/jcp.21145; Ishihara I, 2000, NEUROSCI LETT, V279, P97, DOI 10.1016/S0304-3940(99)00960-X; Joshi A, 2009, EXP NEUROL, V218, P221, DOI 10.1016/j.expneurol.2009.04.013; Kar P, 2008, ARCH BIOCHEM BIOPHYS, V470, P176, DOI 10.1016/j.abb.2007.11.018; Kar P, 2010, ARCH BIOCHEM BIOPHYS, V495, P1, DOI 10.1016/j.abb.2009.12.020; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kitatani K, 2006, J BIOL CHEM, V281, P36793, DOI 10.1074/jbc.M608137200; Kolesnick RN, 2000, J CELL PHYSIOL, V184, P285; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; Kristian T, 2007, J NEUROCHEM, V102, P1346, DOI 10.1111/j.1471-4159.2007.04626.x; Kushnareva YE, 2005, J BIOL CHEM, V280, P28894, DOI 10.1074/jbc.M503090200; Lahiri S, 2005, J BIOL CHEM, V280, P33735, DOI 10.1074/jbc.M506485200; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; LAMPI KJ, 1992, TOXICOL APPL PHARM, V117, P53, DOI 10.1016/0041-008X(92)90216-F; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; MANDON EC, 1992, J BIOL CHEM, V267, P11144; Matute C, 2006, GLIA, V53, P212, DOI 10.1002/glia.20275; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; MORELL P, 1970, J BIOL CHEM, V245, P342; NICHOLLS DG, 1985, PROG BRAIN RES, V63, P97; Noureddine L, 2008, PROSTAG OTH LIPID M, V86, P49, DOI 10.1016/j.prostaglandins.2008.02.003; NOVGORODOV SA, 1992, J BIOL CHEM, V267, P16274; Novgorodov SA, 1996, J BIOENERG BIOMEMBR, V28, P139, DOI 10.1007/BF02110644; Novgorodov SA, 2008, J BIOL CHEM, V283, P24707, DOI 10.1074/jbc.M801810200; Noygorodov SA, 2009, J CARDIOVASC PHARM, V53, P198, DOI 10.1097/FJC.0b013e31819b52d5; Ozaki T, 2009, BBA-MOL CELL RES, V1793, P1848, DOI 10.1016/j.bbamcr.2009.10.002; Potter DA, 1998, J CELL BIOL, V141, P647, DOI 10.1083/jcb.141.3.647; Shimeno H, 1998, LIPIDS, V33, P601, DOI 10.1007/s11745-998-0246-2; SHIMENO H, 1995, BIOL PHARM BULL, V18, P1335; Sot J, 2005, BIOPHYS J, V88, p72A; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Tserng KY, 2003, ANAL BIOCHEM, V323, P84, DOI 10.1016/j.ab.2003.08.026; TSUJINAKA T, 1988, BIOCHEM BIOPH RES CO, V153, P1201, DOI 10.1016/S0006-291X(88)81355-X; ULLMAN MD, 1972, ARCH BIOCHEM BIOPHYS, V152, P767, DOI 10.1016/0003-9861(72)90272-X; van Blitterswijk WJ, 2003, BIOCHEM J, V369, P199, DOI 10.1042/BJ20021528; van Meer G, 2005, EMBO J, V24, P3159, DOI 10.1038/sj.emboj.7600798; Wang KKW, 1996, P NATL ACAD SCI USA, V93, P6687, DOI 10.1073/pnas.93.13.6687; Wang LY, 2006, J BIOL CHEM, V281, P24553, DOI 10.1074/jbc.M600939200; Wang XY, 2009, J NEUROSCI, V29, P2588, DOI 10.1523/JNEUROSCI.5832-08.2009; Wooten-Blanks LG, 2007, FASEB J, V21, P3386, DOI 10.1096/fj.07-8621com; Wu BX, 2010, J BIOL CHEM, V285, P17993, DOI 10.1074/jbc.M110.102988; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200	79	62	65	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4644	4658		10.1074/jbc.M110.164392	http://dx.doi.org/10.1074/jbc.M110.164392			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21148554	hybrid, Green Published			2022-12-27	WOS:000286975700064
J	Butcher, AJ; Prihandoko, R; Kong, KC; McWilliams, P; Edwards, JM; Bottrill, A; Mistry, S; Tobin, AB				Butcher, Adrian J.; Prihandoko, Rudi; Kong, Kok Choi; McWilliams, Phillip; Edwards, Jennifer M.; Bottrill, Andrew; Mistry, Sharad; Tobin, Andrew B.			Differential G-protein-coupled Receptor Phosphorylation Provides Evidence for a Signaling Bar Code	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUSCARINIC ACETYLCHOLINE-RECEPTOR; M-3-MUSCARINIC RECEPTOR; BIASED LIGANDS; KINASES; ARRESTINS; ROLES; GRKS	G-protein-coupled receptors are hyper-phosphorylated in a process that controls receptor coupling to downstream signaling pathways. The pattern of receptor phosphorylation has been proposed to generate a "bar code" that can be varied in a tissue-specific manner to direct physiologically relevant receptor signaling. If such a mechanism existed, receptors would be expected to be phosphorylated in a cell/tissue-specific manner. Using tryptic phosphopeptide maps, mass spectrometry, and phospho-specific antibodies, it was determined here that the prototypical G(q/11)-coupled M-3-muscarinic receptor was indeed differentially phosphorylated in various cell and tissue types supporting a role for differential receptor phosphorylation in directing tissue-specific signaling. Furthermore, the phosphorylation profile of the M-3-muscarinic receptor was also dependent on the stimulus. Full and partial agonists to the M3-muscarinic receptor were observed to direct phosphorylation preferentially to specific sites. This hitherto unappreciated property of ligands raises the possibility that one mechanism underlying ligand bias/functional selectivity, a process where ligands direct receptors to preferred signaling pathways, may be centered on the capacity of ligands to promote receptor phosphorylation at specific sites.	[Butcher, Adrian J.; Prihandoko, Rudi; Kong, Kok Choi; McWilliams, Phillip; Tobin, Andrew B.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Bottrill, Andrew; Mistry, Sharad] Univ Leicester, Prot & Nucle Acid Chem Lab, Leicester LE1 9HN, Leics, England; [Edwards, Jennifer M.] Univ Leicester, MRC Toxicol Unit, Leicester LE1 9HN, Leics, England	University of Leicester; University of Leicester; University of Leicester	Tobin, AB (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	tba@le.ac.uk	Bottrill, Andrew/C-6367-2013; Bottrill, Andrew/ABD-1459-2021	Bottrill, Andrew/0000-0002-5182-3643; Bottrill, Andrew/0000-0002-5182-3643	Wellcome Trust [047600]; Heptares Inc.	Wellcome Trust(Wellcome TrustEuropean Commission); Heptares Inc.	This work was supported by Wellcome Trust Grant 047600 and Heptares Inc.	Budd DC, 2001, J BIOL CHEM, V276, P4581, DOI 10.1074/jbc.M008827200; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P407, DOI 10.1016/j.tips.2007.06.009; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Lee HM, 1998, J NEUROCHEM, V70, P1189; Luo JS, 2008, MOL PHARMACOL, V74, P338, DOI 10.1124/mol.107.044750; Poulin B, 2010, P NATL ACAD SCI USA, V107, P9440, DOI 10.1073/pnas.0914801107; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Szekeres PG, 1998, MOL PHARMACOL, V53, P759, DOI 10.1124/mol.53.4.759; Tobin AB, 2008, BRIT J PHARMACOL, V153, pS167, DOI 10.1038/sj.bjp.0707662; Tobin AB, 1997, J BIOL CHEM, V272, P20844, DOI 10.1074/jbc.272.33.20844; TOBIN AB, 1993, J BIOL CHEM, V268, P9817; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Torrecilla I, 2007, J CELL BIOL, V177, P127, DOI 10.1083/jcb.200610018; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Tsuga H, 1998, J PHARMACOL EXP THER, V284, P1218; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Willets JM, 2001, MOL PHARMACOL, V60, P321, DOI 10.1124/mol.60.2.321; Yamada M, 2001, NATURE, V410, P207, DOI 10.1038/35065604; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106	25	142	143	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11506	11518		10.1074/jbc.M110.154526	http://dx.doi.org/10.1074/jbc.M110.154526			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21177246	Green Published, hybrid			2022-12-27	WOS:000288797100061
J	Smith, MA; Wright, G; Wu, JA; Tailor, P; Ozato, K; Chen, XH; Wei, S; Piskurich, JF; Ting, JPY; Wright, KL				Smith, Matthew A.; Wright, Gabriela; Wu, Jian; Tailor, Prafullakumar; Ozato, Keiko; Chen, Xianghong; Wei, Sheng; Piskurich, Janet F.; Ting, Jenny P. -Y.; Wright, Kenneth L.			Positive Regulatory Domain I (PRDM1) and IRF8/PU.1 Counter-regulate MHC Class II Transactivator (CIITA) Expression during Dendritic Cell Maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL REPRESSOR BLIMP-1; IFN-GAMMA; B-LYMPHOCYTES; MICE LACKING; DEVELOPMENTAL REGULATION; RECEPTOR EXPRESSION; BINDING-PROTEIN; DOWN-REGULATION; PROMOTER-III; GENES	Dendritic cells (DCs) are key mediators of immune function through robust and tightly regulated presentation of antigen in the context of the MHC Class II. MHC Class II expression is controlled by the transactivator CIITA. CIITA expression in conventional DCs is uniquely dependent on an uncharacterized myeloid cell-specific promoter, CIITApI. We now identify in vivo the promoter structure and factors regulating CIITApI. In immature DCs transcription requires binding of PU.1, IRF8, NF kappa B, and Sp1 to the promoter. PU.1 binds independently at one site and in a required heterodimer with IRF8 at a composite element. DCs from IRF8-null mice have an unoccupied CIITApI promoter that can be rescued by reconstitution with IRF8 in vitro. Furthermore, mutation of either PU.1 site or the IFR8 site inhibits transcriptional activation. In vivo footprinting and chromatin immunoprecipitation reveals that DC maturation induces complete disassociation of the bound activators paralleled by recruitment of PRDM1/Blimp-1 to the promoter. PRDM1 is a transcriptional repressor with essential roles in B cells, T cells, NK cells, and DCs. We show that PRDM1 co-repressors, G9a and HDAC2, are recruited to CIITApI, leading to a loss of histone acetylation and acquisition of histone H3K9 dimethylation and heterochromatin protein 1 gamma (HP1 gamma). PRDM1 binding also blocks IRF8-mediated activation dependent on the PU.1/IRF composite element. Together these findings reveal the mechanisms regulating CIITA and, thus, antigen presentation in DCs, demonstrating that PRDM1 and IRF8/PU.1 counter-regulate expression. The activity of PRDM1 in silencing all three cell type-specific CIITA promoters places it as a central regulator of antigen presentation.	[Smith, Matthew A.; Wright, Gabriela; Wu, Jian; Chen, Xianghong; Wei, Sheng; Wright, Kenneth L.] Univ S Florida, Dept Mol Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Smith, Matthew A.; Wright, Gabriela; Wu, Jian; Chen, Xianghong; Wei, Sheng; Wright, Kenneth L.] Univ S Florida, Dept Oncol Sci, Tampa, FL 33612 USA; [Tailor, Prafullakumar; Ozato, Keiko] NICHD, Lab Mol Growth Regulat, NIH, Bethesda, MD 20892 USA; [Piskurich, Janet F.] Texas Tech Univ Hlth Sci Ctr, Dept Med Educ, Paul L Foster Sch Med, El Paso, TX 79905 USA; [Ting, Jenny P. -Y.] Univ N Carolina, Dept Immunol, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Texas Tech University System; Texas Tech University Health Science Center; University of North Carolina; University of North Carolina Chapel Hill	Wright, KL (corresponding author), Univ S Florida, Dept Mol Med, H Lee Moffitt Canc Ctr & Res Inst, 12902 Magnolia Dr,MRC 4 E, Tampa, FL 33612 USA.	ken.wright@moffitt.org			National Institutes of Health [CA114504, CA080990, AI029564]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001310] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA076292, R01CA080990, R01CA114504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029564, R56AI029564, R37AI029564] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants CA114504 and CA080990 (to K. L. W.) and AI029564.	Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; Chan YH, 2009, J IMMUNOL, V183, P7039, DOI 10.4049/jimmunol.0901543; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; Chen H, 2007, MOL IMMUNOL, V44, P1461, DOI 10.1016/j.molimm.2006.04.026; CHIN KC, 1994, IMMUNITY, V1, P687, DOI 10.1016/1074-7613(94)90039-6; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; De Gassart A, 2008, P NATL ACAD SCI USA, V105, P3491, DOI 10.1073/pnas.0708874105; Desai S, 2010, MOL CANCER RES, V8, P907, DOI 10.1158/1541-7786.MCR-10-0131; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doody GM, 2010, NUCLEIC ACIDS RES, V38, P5336, DOI 10.1093/nar/gkq268; Drozina G, 2005, CURR TOP MICROBIOL, V290, P147; Ghosh N, 1999, J BIOL CHEM, V274, P32342, DOI 10.1074/jbc.274.45.32342; Ghosh N, 2001, J BIOL CHEM, V276, P15264, DOI 10.1074/jbc.M100862200; Gong DP, 2007, J IMMUNOL, V178, P242, DOI 10.4049/jimmunol.178.1.242; Guerriero A, 2000, BLOOD, V95, P879, DOI 10.1182/blood.V95.3.879.003k13_879_885; Gyory I, 2004, NAT IMMUNOL, V5, P299, DOI 10.1038/ni1046; Heath WR, 2009, NAT IMMUNOL, V10, P1237, DOI 10.1038/ni.1822; Ito T, 2009, INT IMMUNOL, V21, P803, DOI 10.1093/intimm/dxp048; Itoh-Lindstrom Y, 1999, J IMMUNOL, V163, P2425; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kuo TC, 2004, J IMMUNOL, V173, P5556, DOI 10.4049/jimmunol.173.9.5556; Landmann S, 2001, J EXP MED, V194, P379, DOI 10.1084/jem.194.4.379; LeibundGut-Landmann S, 2004, NAT IMMUNOL, V5, P899, DOI 10.1038/ni1109; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; LopezRodriguez C, 1995, EUR J IMMUNOL, V25, P3496, DOI 10.1002/eji.1830251243; Marecki S, 2000, CELL BIOCHEM BIOPHYS, V33, P127, DOI 10.1385/CBB:33:2:127; Martins GA, 2006, NAT IMMUNOL, V7, P457, DOI 10.1038/ni1320; Martins G, 2008, ANNU REV IMMUNOL, V26, P133, DOI 10.1146/annurev.immunol.26.021607.090241; Morris AC, 2002, MOL CELL BIOL, V22, P4781, DOI 10.1128/MCB.22.13.4781-4791.2002; Muhlethaler-Mottet A, 1998, IMMUNITY, V8, P157, DOI 10.1016/S1074-7613(00)80468-9; MuhlethalerMOttet A, 1997, EMBO J, V16, P2851, DOI 10.1093/emboj/16.10.2851; Ouaaz F, 2002, IMMUNITY, V16, P257, DOI 10.1016/S1074-7613(02)00272-8; Pantano S, 2006, EXP CELL RES, V312, P1312, DOI 10.1016/j.yexcr.2005.12.020; Park SJ, 2004, J IMMUNOL, V173, P3844, DOI 10.4049/jimmunol.173.6.3844; Pecora ND, 2009, CELL IMMUNOL, V254, P94, DOI 10.1016/j.cellimm.2008.07.002; Pennini ME, 2007, J IMMUNOL, V179, P6910, DOI 10.4049/jimmunol.179.10.6910; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Piskurich JF, 2006, MOL IMMUNOL, V43, P519, DOI 10.1016/j.molimm.2005.05.005; Piskurich JF, 1999, MOL CELL BIOL, V19, P431; Piskurich JF, 2000, NAT IMMUNOL, V1, P526, DOI 10.1038/82788; Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Sadaka C, 2009, BLOOD, V113, P2127, DOI 10.1182/blood-2008-10-178152; Sallusto F, 2000, IMMUNOL REV, V177, P134, DOI 10.1034/j.1600-065X.2000.17717.x; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15050, DOI 10.1073/pnas.96.26.15050; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; Smith MA, 2010, J IMMUNOL, V185, P6058, DOI 10.4049/jimmunol.1001682; STEIMLE V, 1993, CELL, V75, P135, DOI 10.1016/0092-8674(93)90685-J; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Su ST, 2009, MOL CELL BIOL, V29, P1421, DOI 10.1128/MCB.01158-08; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Tooze RM, 2006, J IMMUNOL, V177, P4584, DOI 10.4049/jimmunol.177.7.4584; Tsujimura H, 2003, BLOOD, V101, P961, DOI 10.1182/blood-2002-05-1327; van der Stoep N, 2004, BLOOD, V104, P2849, DOI 10.1182/blood-2004-03-0790; van der Stoep N, 2002, J IMMUNOL, V169, P5061, DOI 10.4049/jimmunol.169.9.5061; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; Waldburger JM, 2001, J EXP MED, V194, P393, DOI 10.1084/jem.194.4.393; WEISZ A, 1992, J BIOL CHEM, V267, P25589; Williams GS, 1998, INT IMMUNOL, V10, P1957, DOI 10.1093/intimm/10.12.1957; Wright KL, 2006, TRENDS IMMUNOL, V27, P405, DOI 10.1016/j.it.2006.07.007; Yao YX, 2006, J IMMUNOL, V177, P70, DOI 10.4049/jimmunol.177.1.70; Yoon H, 2010, J IMMUNOL, V184, P5018, DOI 10.4049/jimmunol.1000079; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Yu J, 2000, MOL CELL BIOL, V20, P2592, DOI 10.1128/MCB.20.7.2592-2603.2000	68	31	32	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7893	7904		10.1074/jbc.M110.165431	http://dx.doi.org/10.1074/jbc.M110.165431			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21216962	Green Submitted, hybrid, Green Published			2022-12-27	WOS:000288013300020
J	Xiao, L; Chen, YH; Ji, M; Dong, JX				Xiao, Ling; Chen, Yuanhong; Ji, Ming; Dong, Jixin			KIBRA Regulates Hippo Signaling Activity via Interactions with Large Tumor Suppressor Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGAN SIZE CONTROL; CELL CONTACT INHIBITION; WW DOMAIN; YAP ONCOPROTEIN; GROWTH-CONTROL; PATHWAY; PROTEIN; PROLIFERATION; DROSOPHILA; APOPTOSIS	The Hippo pathway controls tissue growth and tumorigenesis by inhibiting cell proliferation and promoting apoptosis. Recent genetic studies in Drosophila identified Kibra as a novel regulator of Hippo signaling. Human KIBRA has been associated with memory performance and cell migration. However, it is unclear whether or how KIBRA is connected to the Hippo pathway in mammalian cells. Here, we show that KIBRA associates with and activates Lats (large tumor suppressor) 1 and 2 kinases by stimulating their phosphorylation on the hydrophobic motif. KIBRA overexpression stimulates the phosphorylation of Yes-associated protein (YAP), the Hippo pathway effector. Conversely, depletion of KIBRA by RNA interference reduces YAP phosphorylation. Furthermore, KIBRA stabilizes Lats2 by inhibiting its ubiquitination. We also found that KIBRA mRNA is induced by YAP overexpression in both murine and human cells, suggesting the evolutionary conservation of KIBRA as a transcriptional target of the Hippo signaling pathway. Thus, our study revealed a new connection between KIBRA and mammalian Hippo signaling.	[Xiao, Ling; Chen, Yuanhong; Ji, Ming; Dong, Jixin] Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Dong, JX (corresponding author), Univ Nebraska, Med Ctr, Eppley Inst Res Canc & Allied Dis, 985950 Nebraska Med Ctr, Omaha, NE 68198 USA.	dongj@unmc.edu			National Center for Research Resources [5P20-RR018759-07]; Nebraska Department of Health and Human Services; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018759] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Nebraska Department of Health and Human Services; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by National Institutes of Health Grant 5P20-RR018759-07 from the National Center for Research Resources and a grant from the Nebraska Department of Health and Human Services (to J. D.).	Bates TC, 2009, NEUROSCI LETT, V458, P140, DOI 10.1016/j.neulet.2009.04.050; Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Buther K, 2004, BIOCHEM BIOPH RES CO, V317, P703, DOI 10.1016/j.bbrc.2004.03.107; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Corneveaux JJ, 2010, NEUROBIOL AGING, V31, P901, DOI 10.1016/j.neurobiolaging.2008.07.014; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Duning K, 2008, J AM SOC NEPHROL, V19, P1891, DOI 10.1681/ASN.2007080916; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Einbond A, 1996, FEBS LETT, V384, P1, DOI 10.1016/0014-5793(96)00263-3; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Grzeschik NA, 2010, CURR BIOL, V20, P573, DOI 10.1016/j.cub.2010.01.055; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kremerskothen J, 2003, BIOCHEM BIOPH RES CO, V300, P862, DOI 10.1016/S0006-291X(02)02945-5; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lee KM, 2005, LAB INVEST, V85, P1003, DOI 10.1038/labinvest.3700298; Ling C, 2010, P NATL ACAD SCI USA, V107, P10532, DOI 10.1073/pnas.1004279107; Lu L, 2010, P NATL ACAD SCI USA, V107, P1437, DOI 10.1073/pnas.0911427107; Margolis B, 2005, J CELL SCI, V118, P5157, DOI 10.1242/jcs.02597; Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Reddy BVVG, 2008, DEVELOPMENT, V135, P2827, DOI 10.1242/dev.020974; Robinson BS, 2010, CURR BIOL, V20, P582, DOI 10.1016/j.cub.2010.03.019; Rosse C, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000235; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Schaper K, 2008, NEUROBIOL AGING, V29, P1123, DOI 10.1016/j.neurobiolaging.2007.02.001; Schneider A, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.004.2010; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Song H, 2010, P NATL ACAD SCI USA, V107, P1431, DOI 10.1073/pnas.0911409107; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Takahashi Y, 2005, CLIN CANCER RES, V11, P1380, DOI 10.1158/1078-0432.CCR-04-1773; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zeng Q, 2008, CANCER CELL, V13, P188, DOI 10.1016/j.ccr.2008.02.011; Zhang NL, 2010, DEV CELL, V19, P27, DOI 10.1016/j.devcel.2010.06.015; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zhou DW, 2009, CANCER CELL, V16, P425, DOI 10.1016/j.ccr.2009.09.026	43	136	144	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7788	7796		10.1074/jbc.M110.173468	http://dx.doi.org/10.1074/jbc.M110.173468			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21233212	hybrid, Green Published			2022-12-27	WOS:000288013300010
J	Palkowitsch, L; Marienfeld, U; Brunner, C; Eitelhuber, A; Krappmann, D; Marienfeld, RB				Palkowitsch, Lysann; Marienfeld, Uta; Brunner, Cornelia; Eitelhuber, Andrea; Krappmann, Daniel; Marienfeld, Ralf B.			The Ca2+-dependent Phosphatase Calcineurin Controls the Formation of the Carma1-Bcl10-Malt1 Complex during T Cell Receptor-induced NF-kappa B Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PKC-THETA; PHOSPHORYLATION; CARMA1; LYMPHOCYTES; BCL10; UBIQUITINATION; DEGRADATION; INTERFERES; CALMODULIN	T cell receptor (TCR) ligation induces increased diacylglycerol and Ca2+ levels in T cells, and both secondary messengers are crucial for TCR-induced nuclear factor of activated T cells (NF-AT) and NF-kappa B signaling pathways. One prominent calcium-dependent enzyme involved in the regulation of NF-AT and NF-kappa B signaling pathways is the protein phosphatase calcineurin. However, in contrast to NF-AT, which is directly dephosphorylated by calcineurin, the molecular basis of the calcium-calcineurin dependence of the TCR-induced NF-kappa B activity remains largely unknown. Here, we demonstrate that calcineurin regulates TCR-induced NF-kappa B activity by controlling the formation of a protein complex composed of Carma1, Bcl10, and Malt1 (CBM complex). For instance, increased calcium levels induced by ionomycin or thapsigargin augmented the phorbol 12-myristate 13-acetate-induced formation of the CBM complex and activation of NF-kappa B, whereas removal of calcium by the calcium chelator EGTA-acetoxymethyl ester (AM) attenuated both processes. Furthermore, inhibition of the calcium-dependent phosphatase calcineurin with the immunosuppressive agent cyclosporin A (CsA) or FK506 as well as siRNA-mediated knockdown of calcineurin A strongly affected the PMA + ionomycin- or anti-CD3 + CD28-induced CBM complex assembly. Mechanistically, the positive effect of calcineurin on the CBM complex formation seems to be linked to a dephosphorylation of Bcl10. For instance, Bcl10 was found to be hyperphosphorylated in Jurkat T cells upon treatment with CsA or EGTA-AM, and calcineurin dephosphorylated Bcl10 in vivo and in vitro. Furthermore, we show here that calcineurin A interacts with the CBM complex. In summary, the evidence provided here argues for a previously unanticipated role of calcineurin in CBM complex formation as a molecular basis of the inhibitory function of CsA or FK506 on TCR-induced NF-kappa B activity.	[Marienfeld, Ralf B.] Univ Ulm, Inst Pathol, D-89081 Ulm, Germany; [Palkowitsch, Lysann; Marienfeld, Uta; Brunner, Cornelia; Marienfeld, Ralf B.] Univ Ulm, Inst Physiol Chem, D-89081 Ulm, Germany; [Eitelhuber, Andrea; Krappmann, Daniel] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Toxicol, D-85764 Neuherberg, Germany	Ulm University; Ulm University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Marienfeld, RB (corresponding author), Univ Ulm, Inst Pathol, Albert Einstein Allee 11, D-89081 Ulm, Germany.	ralf.marienfeld@uni-ulm.de	Brunner, Cornelia/L-1291-2013; Brunner, Cornelia/H-8893-2018; Krappmann, Daniel/ABF-4038-2021; Krappmann, Daniel/AAT-4354-2021	Brunner, Cornelia/0000-0002-6456-5508; Krappmann, Daniel/0000-0001-7640-3234; Krappmann, Daniel/0000-0001-7640-3234	Ministry of Science and Culture of the State of Baden-Wurttemberg; Deutsche Forschungsgemeinschaft [MA 2367/3-2]	Ministry of Science and Culture of the State of Baden-Wurttemberg; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a Junior professor program grant of the Ministry of Science and Culture of the State of Baden-Wurttemberg (to M. W. K.) and by Deutsche Forschungsgemeinschaft Grant MA 2367/3-2 (to R. M.).	Bidere N, 2006, CURR BIOL, V16, P1666, DOI 10.1016/j.cub.2006.06.062; Brenner D, 2009, P NATL ACAD SCI USA, V106, P14508, DOI 10.1073/pnas.0900457106; Edin S, 2010, MOL IMMUNOL, V47, P2057, DOI 10.1016/j.molimm.2010.04.005; HINZ M, 2007, SCI STKE, pPE19; Hughes K, 2001, J BIOL CHEM, V276, P36008, DOI 10.1074/jbc.M106125200; INESI G, 1992, ARCH BIOCHEM BIOPHYS, V298, P313, DOI 10.1016/0003-9861(92)90416-T; Ishiguro K, 2007, MOL IMMUNOL, V44, P2095, DOI 10.1016/j.molimm.2006.09.012; Ishiguro K, 2006, MOL CELL BIOL, V26, P5497, DOI 10.1128/MCB.02469-05; Marienfeld R, 2003, J BIOL CHEM, V278, P19852, DOI 10.1074/jbc.M301945200; Marienfeld R, 1997, EUR J IMMUNOL, V27, P1601, DOI 10.1002/eji.1830270703; Moreno-Garcia ME, 2010, MOL CELL BIOL, V30, P922, DOI 10.1128/MCB.01129-09; Moreno-Garcia ME, 2009, J IMMUNOL, V183, P7362, DOI 10.4049/jimmunol.0902438; Oeckinghaus A, 2007, EMBO J, V26, P4634, DOI 10.1038/sj.emboj.7601897; Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004; Palkowitsch L, 2008, J BIOL CHEM, V283, P76, DOI 10.1074/jbc.M708856200; Scharschmidt E, 2004, MOL CELL BIOL, V24, P3860, DOI 10.1128/MCB.24.9.3860-3873.2004; Schulze-Luehrmann J, 2006, IMMUNITY, V25, P701, DOI 10.1016/j.immuni.2006.10.010; SERFLING E, 1995, BBA-GENE STRUCT EXPR, V1263, P181, DOI 10.1016/0167-4781(95)00112-T; Shibasaki F, 2002, J BIOCHEM, V131, P1, DOI 10.1093/oxfordjournals.jbchem.a003063; Shinohara H, 2007, J EXP MED, V204, P3285, DOI 10.1084/jem.20070379; Sommer K, 2005, IMMUNITY, V23, P561, DOI 10.1016/j.immuni.2005.09.014; Thome M, 2007, TRENDS IMMUNOL, V28, P281, DOI 10.1016/j.it.2007.04.004; Trushin SA, 2003, MOL CELL BIOL, V23, P7068, DOI 10.1128/MCB.23.19.7068-7081.2003; Trushin SA, 1999, J BIOL CHEM, V274, P22923, DOI 10.1074/jbc.274.33.22923; Wegener E, 2006, MOL CELL, V23, P13, DOI 10.1016/j.molcel.2006.05.027; Welteke V, 2009, EMBO REP, V10, P642, DOI 10.1038/embor.2009.64; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101; Zeng H, 2007, MOL CELL BIOL, V27, P5235, DOI 10.1128/MCB.01645-06	28	81	82	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7522	7534		10.1074/jbc.M110.155895	http://dx.doi.org/10.1074/jbc.M110.155895			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21199863	Green Published, hybrid			2022-12-27	WOS:000287737300066
J	Zevian, S; Winterwood, NE; Stipp, CS				Zevian, Shannin; Winterwood, Nicole E.; Stipp, Christopher S.			Structure-Function Analysis of Tetraspanin CD151 Reveals Distinct Requirements for Tumor Cell Behaviors Mediated by alpha 3 beta 1 versus alpha 6 beta 4 Integrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LAMININ-BINDING INTEGRINS; SUPERFAMILY MEMBER CD151; MICE LACKING; IN-VIVO; HEPATOCELLULAR-CARCINOMA; MONOCLONAL-ANTIBODIES; CLINICAL-SIGNIFICANCE; EPITHELIAL-CELLS; EXPRESSION; PALMITOYLATION	The basement membrane protein laminin-332 (laminin-5) mediates both stable cell adhesion and rapid cell migration and thus has the potential to either restrain or promote tumor cell metastasis. The major cellular receptors for laminin-332 are integrin alpha 3 beta 1, which mediates rapid tumor cell migration, and integrin alpha 6 beta 4, which often mediates stable cell attachment. Tetraspanin protein CD151 interacts directly with both alpha 3 beta 1 and alpha 6 beta 4 integrins and with other tetraspanins, thereby promoting alpha 3 beta 1 and alpha 6 beta 4 association with tetraspanin-enriched microdomains on the cell surface. To explore the possibility of selectively modulating tumor cell responses to laminin-332, we re-expressed a series of CD151 mutants in epidermoid carcinoma cells with near total, RNAi-mediated silencing of endogenous CD151. The interactions of CD151 with its integrin partners or its interactions with other tetraspanins were selectively disrupted by specific mutations in the CD151 large extracellular loop (EC2 domain) or in intracellular CD151 palmitoylation sites, respectively. CD151-integrin association and CD151-tetraspanin association were both important for alpha 3 beta 1 integrin-dependent initial adhesion and rapid migration on laminin-332. Remarkably, however, only CD151-integrin association was required for stable, alpha 6 beta 4 integrin-dependent cell attachment on laminin-332. In addition, we found that a QRD amino acid motif in the CD151 EC2 domain, which had been thought to be crucial for CD151-integrin interaction, is not essential for CD151-integrin association or for the ability of CD151 to promote several different integrin functions. These new data suggest potential strategies for selectively modulating migratory cell responses to laminin-332, while leaving stable cell attachment on laminin-332 intact.	[Zevian, Shannin; Winterwood, Nicole E.; Stipp, Christopher S.] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Stipp, Christopher S.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Stipp, CS (corresponding author), 210 E Iowa Ave,BBE 236, Iowa City, IA 52242 USA.	christopher-stipp@uiowa.edu			National Institutes of Health [CA136664]; American Cancer Society [RSG-07-043-01-CSM]; NATIONAL CANCER INSTITUTE [R01CA136664] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA136664. This work was also supported by American Cancer Society Research Scholar Award RSG-07-043-01-CSM.	Ang J, 2004, CANCER EPIDEM BIOMAR, V13, P1717; Baleato RM, 2008, AM J PATHOL, V173, P927, DOI 10.2353/ajpath.2008.071149; Berditchevski F, 2002, J BIOL CHEM, V277, P36991, DOI 10.1074/jbc.M205265200; Chometon G, 2006, EXP CELL RES, V312, P983, DOI 10.1016/j.yexcr.2005.12.034; Cowin AJ, 2006, J INVEST DERMATOL, V126, P680, DOI 10.1038/sj.jid.5700142; Crew VK, 2004, BLOOD, V104, P2217, DOI 10.1182/blood-2004-04-1512; DIPERSIO CM, 1995, J CELL SCI, V108, P2321; FUKUDOME K, 1992, J VIROL, V66, P1394, DOI 10.1128/JVI.66.3.1394-1401.1992; Geary SM, 2008, EXP CELL RES, V314, P2165, DOI 10.1016/j.yexcr.2008.04.011; Hasegawa M, 2007, LAB INVEST, V87, P882, DOI 10.1038/labinvest.3700657; Hashida H, 2003, BRIT J CANCER, V89, P158, DOI 10.1038/sj.bjc.6601015; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Johnson JL, 2009, J CELL SCI, V122, P2263, DOI 10.1242/jcs.045997; Kazarov AR, 2002, J CELL BIOL, V158, P1299, DOI 10.1083/jcb.200204056; Ke AW, 2009, HEPATOLOGY, V49, P491, DOI 10.1002/hep.22639; Lammerding J, 2003, P NATL ACAD SCI USA, V100, P7616, DOI 10.1073/pnas.1337546100; Lau LM, 2004, BLOOD, V104, P2368, DOI 10.1182/blood-2003-12-4430; LEE RT, 1995, CIRC RES, V76, P209, DOI 10.1161/01.RES.76.2.209; MARINKOVICH MP, 1992, J BIOL CHEM, V267, P17900; Nishiuchi R, 2005, P NATL ACAD SCI USA, V102, P1939, DOI 10.1073/pnas.0409493102; Novitskaya V, 2010, CANCER RES, V70, P4698, DOI 10.1158/0008-5472.CAN-09-4330; Orlowski E, 2009, J THROMB HAEMOST, V7, P2074, DOI 10.1111/j.1538-7836.2009.03612.x; Ports MO, 2009, CANCER RES, V69, P5007, DOI 10.1158/0008-5472.CAN-09-0354; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Rasband W., 2006, IMAGEJ; Raymond K, 2005, J CELL SCI, V118, P1045, DOI 10.1242/jcs.01689; Sachs N, 2006, J CELL BIOL, V175, P33, DOI 10.1083/jcb.200603073; Sadej R, 2010, CANCER RES, V70, P6059, DOI 10.1158/0008-5472.CAN-09-3497; Sadej R, 2009, MOL CANCER RES, V7, P787, DOI 10.1158/1541-7786.MCR-08-0574; Serru V, 1999, BIOCHEM J, V340, P103, DOI 10.1042/0264-6021:3400103; Sharma C, 2008, MOL BIOL CELL, V19, P3415, DOI 10.1091/mbc.E07-11-1164; Shi GM, 2010, HEPATOLOGY, V52, P183, DOI 10.1002/hep.23661; Sincock PM, 1999, J CELL SCI, V112, P833; Sterk LMT, 2000, J CELL BIOL, V149, P969, DOI 10.1083/jcb.149.4.969; Stipp CS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399409001355; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Takeda Y, 2007, BLOOD, V109, P1524, DOI 10.1182/blood-2006-08-041970; Tokuhara T, 2001, CLIN CANCER RES, V7, P4109; WEITZMAN JB, 1993, J BIOL CHEM, V268, P8651; Winterwood NE, 2006, MOL BIOL CELL, V17, P2707, DOI 10.1091/mbc.E05-11-1042; Wright MD, 2004, MOL CELL BIOL, V24, P5978, DOI 10.1128/MCB.24.13.5978-5988.2004; Yamada M, 2008, BIOCHEM J, V415, P417, DOI 10.1042/BJ20071625; Yamada M, 2008, FEBS J, V275, P3335, DOI 10.1111/j.1742-4658.2008.06481.x; Yang XWH, 2008, CANCER RES, V68, P3204, DOI 10.1158/0008-5472.CAN-07-2949; Yang XWH, 2010, CANCER RES, V70, P2256, DOI 10.1158/0008-5472.CAN-09-4032; Yang XW, 2004, J CELL BIOL, V167, P1231, DOI 10.1083/jcb.200404100; Yang XW, 2002, MOL BIOL CELL, V13, P767, DOI 10.1091/mbc.01-05-0275; Yauch RL, 1998, MOL BIOL CELL, V9, P2751, DOI 10.1091/mbc.9.10.2751; Zijlstra A, 2008, CANCER CELL, V13, P221, DOI 10.1016/j.ccr.2008.01.031; Zuo HJ, 2010, ACTA PHARMACOL SIN, V31, P805, DOI 10.1038/aps.2010.65	50	40	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7496	7506		10.1074/jbc.M110.173583	http://dx.doi.org/10.1074/jbc.M110.173583			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193415	hybrid, Green Published			2022-12-27	WOS:000287737300064
J	Chen, CR; McLachlan, SM; Rapoport, B				Chen, Chun-Rong; McLachlan, Sandra M.; Rapoport, Basil			Evidence That the Thyroid-stimulating Hormone (TSH) Receptor Transmembrane Domain Influences Kinetics of TSH Binding to the Receptor Ectodomain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN THYROTROPIN RECEPTOR; EXTRACELLULAR DOMAIN; NEGATIVE COOPERATIVITY; LUTROPIN RECEPTOR; LIPID RAFTS; SIGNAL-TRANSDUCTION; INVERSE AGONIST; HINGE REGION; PROTEIN; ACTIVATION	Thyroid-stimulating hormone (TSH)-induced reduction in ligand binding affinity (negative cooperativity) requires TSH receptor (TSHR) homodimerization, the latter involving primarily the transmembrane domain (TMD) but with the extracellular domain (ECD) also contributing to this association. To test the role of the TMD in negative cooperativity, we studied the TSHR ECD tethered to the cell surface by a glycosylphosphatidylinositol (GPI) anchor that multimerizes despite the absence of the TMD. Using the infinite ligand dilution approach, we confirmed that TSH increased the rate of dissociation (k(off)) of prebound I-125-TSH from CHO cells expressing the TSH holoreceptor. Such negative cooperativity did not occur with TSHR ECD-GPI-expressing cells. However, even in the absence of added TSH, I-125-TSH dissociated much more rapidly from the TSHR ECD-GPI than from the TSH holoreceptor. This phenomenon, suggesting a lower TSH affinity for the former, was surprising because both the TSHR ECD and TSH holoreceptor contain the entire TSH-binding site, and the TSH binding affinities for both receptor forms should, theoretically, be identical. In ligand competition studies, we observed that the TSH binding affinity for the TSHR ECD-GPI was significantly lower than that for the TSH holoreceptor. Further evidence for a difference in ligand binding kinetics for the TSH holoreceptor and TSHR ECD-GPI was obtained upon comparison of the TSH K-d values for these two receptor forms at 4 degrees C versus room temperature. Our data provide the first evidence that the wild-type TSHR TMD influences ligand binding affinity for the ECD, possibly by altering the conformation of the closely associated hinge region that contributes to the TSH-binding site.	Cedars Sinai Res Inst, Thyroid Autoimmune Dis Unit, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Rapoport, B (corresponding author), Cedars Sinai Med Ctr, 8700 Beverly Blvd,Suite B-131, Los Angeles, CA 90048 USA.	rapoportb@cshs.org			National Institutes of Health [DK19289]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK19289 (to B. R.).	Chazenbalk GD, 1996, ENDOCRINOLOGY, V137, P4586, DOI 10.1210/en.137.11.4586; Chazenbalk GD, 1999, ENDOCRINOLOGY, V140, P4516, DOI 10.1210/en.140.10.4516; Chen CR, 2007, ENDOCRINOLOGY, V148, P2375, DOI 10.1210/en.2006-1754; Costagliola S, 1998, FEBS LETT, V436, P427, DOI 10.1016/S0014-5793(98)01177-6; Costagliola S, 2002, EMBO J, V21, P504, DOI 10.1093/emboj/21.4.504; Da Costa CR, 1998, J BIOL CHEM, V273, P11874, DOI 10.1074/jbc.273.19.11874; DEMEYTS P, 1973, BIOCHEM BIOPH RES CO, V55, P154, DOI 10.1016/S0006-291X(73)80072-5; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Grace CRR, 2010, J BIOL CHEM, V285, P38580, DOI 10.1074/jbc.M110.121897; Graves PN, 1996, ENDOCRINOLOGY, V137, P3915, DOI 10.1210/en.137.9.3915; Guan RB, 2010, CELL SIGNAL, V22, P247, DOI 10.1016/j.cellsig.2009.09.023; Guan RB, 2009, J BIOL CHEM, V284, P7483, DOI 10.1074/jbc.M809150200; JI I, 1991, J BIOL CHEM, V266, P13076; JI IH, 1991, J BIOL CHEM, V266, P14953; Kleinau G, 2004, J BIOL CHEM, V279, P51590, DOI 10.1074/jbc.M404748200; Kleinau G, 2009, ENDOCR REV, V30, P133, DOI 10.1210/er.2008-0044; KOSUGI S, 1991, J BIOL CHEM, V266, P19413; Latif R, 2007, ENDOCRINOLOGY, V148, P3164, DOI 10.1210/en.2006-1580; Latif R, 2003, ENDOCRINOLOGY, V144, P4725, DOI 10.1210/en.2003-0932; Latif R, 2001, J BIOL CHEM, V276, P45217, DOI 10.1074/jbc.M103727200; Latif R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009449; Latrofa F, 2004, THYROID, V14, P801, DOI 10.1089/1050725042451310; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Mizutori Y, 2008, MOL ENDOCRINOL, V22, P1171, DOI 10.1210/me.2007-0407; Mueller S, 2008, J BIOL CHEM, V283, P18048, DOI 10.1074/jbc.M800449200; NAGAYAMA Y, 1991, P NATL ACAD SCI USA, V88, P902, DOI 10.1073/pnas.88.3.902; NAGAYAMA Y, 1989, BIOCHEM BIOPH RES CO, V165, P1184, DOI 10.1016/0006-291X(89)92727-7; NAGAYAMA Y, 1992, ENDOCRINOLOGY, V131, P548, DOI 10.1210/en.131.2.548; NUNEZ MR, 2004, THYROID, V14, P991; Osuga Y, 1997, MOL ENDOCRINOL, V11, P1659, DOI 10.1210/me.11.11.1659; Parthier C, 2009, TRENDS BIOCHEM SCI, V34, P303, DOI 10.1016/j.tibs.2009.02.004; POWELLJONES CHJ, 1980, J BIOL CHEM, V255, P4001; POWELLJONES CHJ, 1979, P NATL ACAD SCI USA, V76, P705, DOI 10.1073/pnas.76.2.705; QUINTANA J, 1993, MOL ENDOCRINOL, V7, P767, DOI 10.1210/me.7.6.767; Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106; SALTIEL AR, 1982, MOL CELL ENDOCRINOL, V28, P299, DOI 10.1016/0303-7207(82)90128-9; Sanders J, 2007, THYROID, V17, P395, DOI 10.1089/thy.2007.0034; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Siu FY, 2010, STRUCTURE, V18, P1067, DOI 10.1016/j.str.2010.08.004; Smits G, 2003, EMBO J, V22, P2692, DOI 10.1093/emboj/cdg260; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Vassart G, 2004, TRENDS BIOCHEM SCI, V29, P119, DOI 10.1016/j.tibs.2004.01.006; Vlaeminck-Guillem V, 2002, MOL ENDOCRINOL, V16, P736, DOI 10.1210/me.16.4.736	43	14	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6219	6224		10.1074/jbc.M110.211003	http://dx.doi.org/10.1074/jbc.M110.211003			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21190937	hybrid, Green Published			2022-12-27	WOS:000287476400031
J	Lee, YH; Schiemann, WP				Lee, Yong-Hun; Schiemann, William P.			Fibromodulin Suppresses Nuclear Factor-kappa B Activity by Inducing the Delayed Degradation of IKBA via a JNK-dependent Pathway Coupled to Fibroblast Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; CALPAIN-MEDIATED DEGRADATION; NEGATIVE BREAST-CANCER; TGF-BETA; PROSTATE-CANCER; PROTEIN-KINASE; LYSYL OXIDASE; EXTRACELLULAR-MATRIX; EXPRESSION PATTERNS; SMALL PROTEOGLYCANS	Fibulin-5 (FBLN5) belongs to the Fibulin family of secreted extracellular matrix proteins, and our laboratory first established FBLN5 as a novel target for TGF-beta in fibroblasts and endothelial cells. To better understand the pathophysiology of FBLN5, we carried out microarray analysis to identify fibroblast genes whose expressions were regulated by FBLN5 and TGF-beta. In doing so, we identified fibromodulin (Fmod) as a novel target gene of FBLN5, and we validated the differential expression of Fmod and 12 other FBLN5-regulated genes by semi-quantitative real time PCR. Fmod belongs to the small leucine-rich family of proteoglycans, which are important constituents of mammalian extracellular matrices. Interestingly, parental 3T3-L1 fibroblasts displayed high levels of nuclear factor-kappa B (NF-kappa B) activity, although those engineered to express Fmod constitutively exhibited significantly reduced NF-kappa B activity, suggesting that Fmod functions to inhibit NF-kappa B signaling. By monitoring alterations in the activation of NF-kappa B and the degradation of its inhibitor, I kappa B alpha, we demonstrate for the first time that Fmod contributes to the constitutive degradation of I kappa B alpha protein in 3T3-L1 fibroblasts. Mechanistically, we observed Fmod to delay the degradation of I kappa B alpha by promoting the following: (i) activation of c-Jun N-terminal kinase; (ii) inhibition of calpain and casein kinase 2 activity; and (iii) induction of fibroblast apoptosis. Taken together, our study identified a novel function for Fmod in directing extracellular signaling, particularly the regulation of NF-kappa B activity and cell survival.	[Lee, Yong-Hun; Schiemann, William P.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University	Schiemann, WP (corresponding author), Case Western Reserve Univ, Case Comprehens Canc Ctr, Wolstein Res Bldg,Rm 2131,2103 Cornell Rd, Cleveland, OH 44121 USA.	William.Schiemann@case.edu			National Institutes of Health [CA129359]; Department of Defense [BC084651]; Komen Foundation [BCTR0706967]; NATIONAL CANCER INSTITUTE [R01CA129359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Komen Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA129359. This work was also supported by Department of Defense Grant BC084651 and Komen Foundation Grant BCTR0706967 (to W. P. S.).	Albig AR, 2006, CANCER RES, V66, P2621, DOI 10.1158/0008-5472.CAN-04-4096; Albig AR, 2004, DNA CELL BIOL, V23, P367, DOI 10.1089/104454904323145254; Ameye L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0848com; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Benjamin M, 2004, INT REV CYTOL, V233, P1, DOI 10.1016/S0074-7696(04)33001-9; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Birdsey GM, 2008, BLOOD, V111, P3498, DOI 10.1182/blood-2007-08-105346; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Cavin LG, 2003, HEPATOLOGY, V38, P1540, DOI 10.1016/j.hep.2003.09.019; Chen F, 2001, AM J PATHOL, V159, P387, DOI 10.1016/S0002-9440(10)61708-7; DeRisi J, 1996, NAT GENET, V14, P457; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Droguett R, 2006, MATRIX BIOL, V25, P332, DOI 10.1016/j.matbio.2006.04.004; Ferreiro DU, 2010, BIOCHEMISTRY-US, V49, P1560, DOI 10.1021/bi901948j; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; HARDINGHAM TE, 1992, FASEB J, V6, P861, DOI 10.1096/fasebj.6.3.1740236; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hirai M, 2007, EMBO J, V26, P3283, DOI 10.1038/sj.emboj.7601768; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Jeay S, 2003, MOL CELL BIOL, V23, P2251, DOI 10.1128/MCB.23.7.2251-2263.2003; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kobayashi T, 2003, ACTA DERM-VENEREOL, V83, P105, DOI 10.1080/00015550310007436; LaTulippe E, 2002, CANCER RES, V62, P4499; Lee CH, 2007, BIOFACTORS, V29, P19, DOI 10.1002/biof.5520290103; Lee MJ, 2004, J AM COLL SURGEONS, V199, P403, DOI 10.1016/j.jamcollsurg.2004.04.021; Lee YH, 2008, CARCINOGENESIS, V29, P2243, DOI 10.1093/carcin/bgn199; Lin RT, 1996, MOL CELL BIOL, V16, P1401; Liu J, 2007, ONCOGENE, V26, P3267, DOI 10.1038/sj.onc.1210417; Liu XQ, 2004, NAT GENET, V36, P178, DOI 10.1038/ng1297; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Magee JA, 2001, CANCER RES, V61, P5692; Marton MJ, 1998, NAT MED, V4, P1293, DOI 10.1038/3282; Miyamoto S, 1998, MOL CELL BIOL, V18, P19, DOI 10.1128/MCB.18.1.19; Neil JR, 2008, CARCINOGENESIS, V29, P2227, DOI 10.1093/carcin/bgn202; Neil JR, 2008, CANCER RES, V68, P1462, DOI 10.1158/0008-5472.CAN-07-3094; O'Connor S, 2004, MOL CELL BIOL, V24, P4895, DOI 10.1128/MCB.24.11.4895-4908.2004; OLDBERG A, 1989, EMBO J, V8, P2601, DOI 10.1002/j.1460-2075.1989.tb08399.x; Oldberg A, 2007, P NATL ACAD SCI USA, V104, P13966, DOI 10.1073/pnas.0702014104; Pahl HL, 1999, PHYSIOL REV, V79, P683, DOI 10.1152/physrev.1999.79.3.683; Payne SL, 2006, J CELL BIOCHEM, V98, P827, DOI 10.1002/jcb.20792; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Petri J B, 1999, Mol Cell Biol Res Commun, V1, P59, DOI 10.1006/mcbr.1999.0113; Pianetti S, 2001, ONCOGENE, V20, P1287, DOI 10.1038/sj.onc.1204257; Ponnappan Subramaniam, 2005, Immun Ageing, V2, P15, DOI 10.1186/1742-4933-2-15; Provenzano PP, 2005, MATRIX BIOL, V23, P543, DOI 10.1016/j.matbio.2004.09.008; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Roughley PJ, 2006, EUR CELLS MATER, V12, P92, DOI 10.22203/eCM.v012a11; Schaefer L, 2000, KIDNEY INT, V58, P1557, DOI 10.1046/j.1523-1755.2000.00317.x; Schiemann WP, 2002, J BIOL CHEM, V277, P27367, DOI 10.1074/jbc.M200148200; SCHIEMANN WP, 1995, P NATL ACAD SCI USA, V92, P5361, DOI 10.1073/pnas.92.12.5361; Schmidt M, 2008, CANCER RES, V68, P5405, DOI 10.1158/0008-5472.CAN-07-5206; Shen J, 2001, J IMMUNOL, V167, P4919, DOI 10.4049/jimmunol.167.9.4919; Sjoberg A, 2005, J BIOL CHEM, V280, P32301, DOI 10.1074/jbc.M504828200; Tian M, 2009, FUTURE ONCOL, V5, P259, DOI 10.2217/14796694.5.2.259; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wendt MK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2360; WESTERGRENTHORSSON G, 1991, MATRIX, V11, P177, DOI 10.1016/S0934-8832(11)80156-3; WESTERGRENTHORSSON G, 1993, J CLIN INVEST, V92, P632, DOI 10.1172/JCI116631	65	21	23	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6414	6422		10.1074/jbc.M110.168682	http://dx.doi.org/10.1074/jbc.M110.168682			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21156791	hybrid, Green Published			2022-12-27	WOS:000287476400052
J	Li, CM; Pan, WS; Braunewell, KH; Ames, JB				Li, Congmin; Pan, Wensheng; Braunewell, Karl H.; Ames, James B.			Structural Analysis of Mg2+ and Ca2+ Binding, Myristoylation, and Dimerization of the Neuronal Calcium Sensor and Visinin-like Protein 1 (VILIP-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; PHOTORECEPTOR GUANYLYL CYCLASE; C6 GLIOMA-CELLS; HIPPOCAMPAL-NEURONS; CA2+-SENSOR PROTEINS; ALZHEIMERS-DISEASE; BOVINE NEUROCALCIN; CRYSTAL-STRUCTURE; CATION-BINDING; IN-VITRO	Visinin-like protein 1 (VILIP-1) belongs to the neuronal calcium sensor family of Ca2+-myristoyl switch proteins that regulate signal transduction in the brain and retina. Here we analyze Ca2+ and Mg2+ binding, characterize metal-induced conformational changes, and determine structural effects of myristoylation and dimerization. Mg2+ binds functionally to VILIP-1 at EF3 (Delta H = +1.8 kcal/mol and K-D = 20 mu M). Un-myristoylated VILIP-1 binds two Ca2+ sequentially at EF2 and EF3 (K-EF3 = 0.1 mu M and K-EF2 = 1-4 mu M), whereas myristoylated VILIP-1 binds two Ca2+ with lower affinity (K-D = 1.2 mu M) and positive cooperativity (Hill slope = 1.5). NMR assignments and structural analysis indicate that Ca2+-free VILIP-1 contains a sequestered myristoyl group like that of recoverin. NMR resonances of the attached myristate exhibit Ca2+-dependent chemical shifts and NOE patterns consistent with Ca2+-induced extrusion of the myristate. VILIP-1 forms a dimer in solution independent of Ca2+ and myristoylation. The dimerization site is composed of residues in EF4 and the loop region between EF3 and EF4, confirmed by mutagenesis. We present the structure of the VILIP-1 dimer and a Ca2+-myristoyl switch to provide structural insights into Ca2+-induced trafficking of nicotinic acetylcholine receptors.	[Li, Congmin; Ames, James B.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA; [Pan, Wensheng; Braunewell, Karl H.] So Res Inst, Dept Biochem & Mol Biol, Mol & Cellular Neurosci Lab, Birmingham, AL 35205 USA	University of California System; University of California Davis	Ames, JB (corresponding author), Univ Calif Davis, Dept Chem, 1 Shields Ave, Davis, CA 95616 USA.	ames@chem.ucdavis.edu			National Institutes of Health [EY012347, NS059969]; NATIONAL EYE INSTITUTE [R01EY012347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants EY012347 and NS059969 (to J. B. A.).	Alekseev AM, 1998, FEBS LETT, V440, P116, DOI 10.1016/S0014-5793(98)01426-4; Ames JB, 2006, J BIOL CHEM, V281, P37237, DOI 10.1074/jbc.M606913200; Ames JB, 2000, BIOCHEMISTRY-US, V39, P12149, DOI 10.1021/bi0012890; AMES JB, 1995, J BIOL CHEM, V270, P4526, DOI 10.1074/jbc.270.9.4526; Ames JB, 1995, J BIOL CHEM, V270, P30909, DOI 10.1074/jbc.270.52.30909; Ames JB, 2002, BIOCHEMISTRY-US, V41, P5776, DOI 10.1021/bi012153k; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Bernstein HG, 2003, NEUROSCI LETT, V339, P95, DOI 10.1016/S0304-3940(02)01482-9; Bernstein HG, 2002, NEUROREPORT, V13, P393, DOI 10.1097/00001756-200203250-00006; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bourne Y, 2001, J BIOL CHEM, V276, P11949, DOI 10.1074/jbc.M009373200; Brackmann M, 2005, J CELL SCI, V118, P2495, DOI 10.1242/jcs.02376; Brackmann M, 2004, BIOCHEM BIOPH RES CO, V322, P1073, DOI 10.1016/j.bbrc.2004.08.028; Braunewell KH, 2009, CELL TISSUE RES, V335, P301, DOI 10.1007/s00441-008-0716-3; Braunewell KH, 1997, J NEUROCHEM, V68, P2129; Braunewell KH, 2003, NEUROPHARMACOLOGY, V44, P707, DOI 10.1016/S0028-3908(03)00051-0; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; Braunewell KH, 2001, DEMENT GERIATR COGN, V12, P110, DOI 10.1159/000051244; Braunewell KH, 2001, J NEUROCHEM, V78, P1277, DOI 10.1046/j.1471-4159.2001.00506.x; Braunewell KH, 1997, NEUROSCI LETT, V234, P139, DOI 10.1016/S0304-3940(97)00696-4; Braunewell KH, 2005, TRENDS PHARMACOL SCI, V26, P345, DOI 10.1016/j.tips.2005.04.008; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Chen KC, 2009, J PEPT SCI, V15, P89, DOI 10.1002/psc.1097; Clore GM, 1997, NAT STRUCT BIOL, V4, P849; COX JA, 1994, J BIOL CHEM, V269, P32807; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; FLAHERTY KM, 1993, CELL, V75, P709, DOI 10.1016/0092-8674(93)90491-8; Gierke P, 2008, NEUROBIOL DIS, V32, P162, DOI 10.1016/j.nbd.2008.07.008; GOMEZ J, 1995, PROTEINS, V22, P404, DOI 10.1002/prot.340220410; Hogg RC, 2003, REV PHYSIOL BIOCH P, V147, P1, DOI 10.1007/s10254-003-0005-1; Huang H, 2010, PROTEIN SCI, V19, P475, DOI 10.1002/pro.325; Hubbard SJ, 1998, PROTEIN ENG, V11, P349, DOI 10.1093/protein/11.5.349; LADANT D, 1995, J BIOL CHEM, V270, P3179; Li CM, 2009, J BIOL CHEM, V284, P2472, DOI 10.1074/jbc.M806513200; Lim S, 2009, BIOCHEMISTRY-US, V48, P850, DOI 10.1021/bi801897p; Lin L, 2002, BIOCHEM BIOPH RES CO, V296, P827, DOI 10.1016/S0006-291X(02)00943-9; Lin L, 2002, J BIOL CHEM, V277, P41872, DOI 10.1074/jbc.M206857200; Olshevskaya EV, 1999, J BIOL CHEM, V274, P25583, DOI 10.1074/jbc.274.36.25583; Osawa M, 2005, J BIOL CHEM, V280, P18008, DOI 10.1074/jbc.M500338200; Paterlini M, 2000, NEUROSCIENCE, V99, P205, DOI 10.1016/S0306-4522(00)00201-3; Schnurra I, 2001, NEUROBIOL DIS, V8, P900, DOI 10.1006/nbdi.2001.0432; Spilker C, 2002, J NEUROSCI, V22, P7331; Strahl T, 2007, J BIOL CHEM, V282, P30949, DOI 10.1074/jbc.M705499200; TANAKA T, 1995, NATURE, V376, P444, DOI 10.1038/376444a0; Vijay-Kumar S, 1999, NAT STRUCT BIOL, V6, P80; Wingard JN, 2005, J BIOL CHEM, V280, P37461, DOI 10.1074/jbc.M508541200; Yamniuk AP, 2005, PROTEIN SCI, V14, P1429, DOI 10.1110/ps.041312805; Yamniuk AP, 2004, BIOCHEMISTRY-US, V43, P2558, DOI 10.1021/bi035432b; Zhao C, 2008, NEUROSCIENCE, V153, P1202, DOI 10.1016/j.neuroscience.2007.10.067; Zhao CJ, 2009, MOL CELL NEUROSCI, V40, P280, DOI 10.1016/j.mcn.2008.11.001; Zhao CJ, 2009, CELL MOL NEUROBIOL, V29, P273, DOI 10.1007/s10571-008-9320-z; Zhou W, 2004, NEURON, V41, P573, DOI 10.1016/S0896-6273(04)00045-5; ZOZULYA S, 1992, P NATL ACAD SCI USA, V89, P11569, DOI 10.1073/pnas.89.23.11569	57	30	31	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6354	6366		10.1074/jbc.M110.173724	http://dx.doi.org/10.1074/jbc.M110.173724			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21169352	Green Published, hybrid			2022-12-27	WOS:000287476400046
J	Lee, JH; Lu, H				Lee, Jun-Ho; Lu, Hua			14-3-3 gamma Inhibition of MDMX-mediated p21 Turnover Independent of p53	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REG-GAMMA-PROTEASOME; DNA-DAMAGE; RIBOSOMAL STRESS; ACTIVATES P53; BREAST-CANCER; DEGRADATION; UBIQUITIN; PROTEIN; P21(WAF1/CIP1); EXPRESSION	The stability of p21, a cyclin-dependent kinase inhibitor, is highly regulated by various protein molecules through the cell cycle and in response to extracellular signals. One of the p21 regulators is MDMX, which can directly bind to p21 and mediate its proteasomal degradation in an ubiquitination-independent fashion. The fact that 14-3-3 gamma binds to the MDMX domain adjacent to p21 binding suggests that this 14-3-3 gamma may affect MDMX-mediated p21 proteasomal turnover. Indeed, we found that overexpression of 14-3-3 gamma increased the level of both endogenous and exogenous p21 in p53-null cells by extending its half-life, leading to p21-dependent G1 arrest. Also, 14-3-3 gamma excluded p21 from binding to MDMX in a dose-dependent manner as determined by co-immunroprecipitation in vitro using purified proteins and in cells. In response to DNA damage, the level of the 14-3-3 gamma-MDMX complex increased whereas that of the MDMX-p21 complex declined as detected by co-immunoprecipitation assays, leading to the induction of p21 in p53-null cells. Knockdown of 14-3-3 gamma inversely alleviated the induction of p21 levels by DNA damage. Hence, our study as presented here unravels a new role for 14-3-3 gamma in protecting p21 from MDMX-mediated proteasomal turnover, which may partially account for DNA damage-induced elevation of p21 levels independent of p53.	Indiana Univ, Dept Biochem & Mol Biol, Sch Med, Indianapolis, IN 46202 USA; Indiana Univ, Simon Canc Ctr, Sch Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Lu, H (corresponding author), IN Univ, Dept Biochem & Mol Biol, Sch Med, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	hualu@iupui.edu			National Institutes of Health [CA095441, CA 079721, CA129828]; NATIONAL CANCER INSTITUTE [R01CA095441, R01CA079721, R01CA129828] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health NCI Grants CA095441, CA 079721, and CA129828 (to H. L.).	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Chen LH, 2005, EMBO J, V24, P3411, DOI 10.1038/sj.emboj.7600812; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; Chen-Kiang S, 2003, IMMUNOL REV, V194, P39, DOI 10.1034/j.1600-065X.2003.00065.x; Coleman ML, 2003, EMBO J, V22, P2036, DOI 10.1093/emboj/cdg189; Dai MS, 2004, J BIOL CHEM, V279, P44475, DOI 10.1074/jbc.M403722200; Dai MS, 2004, MOL CELL BIOL, V24, P7654, DOI 10.1128/MCB.24.17.7654-7668.2004; Dai MS, 2006, J BIOL CHEM, V281, P24304, DOI 10.1074/jbc.M602596200; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fang MZ, 2010, CANCER PREV RES, V3, P640, DOI 10.1158/1940-6207.CAPR-09-0170; Gilkes DM, 2007, CELL CYCLE, V6, P151, DOI 10.4161/cc.6.2.3719; Gilkes DM, 2006, EMBO J, V25, P5614, DOI 10.1038/sj.emboj.7601424; Grechez-Cassiau A, 2008, J BIOL CHEM, V283, P4535, DOI 10.1074/jbc.M705576200; Griniatsos J, 2006, WORLD J GASTROENTERO, V12, P2109, DOI 10.3748/wjg.v12.i13.2109; HARPER JW, 1993, CELL, V75, P805; Jin Y, 2008, MOL CELL BIOL, V28, P1218, DOI 10.1128/MCB.01198-07; Jin YT, 2006, EMBO J, V25, P1207, DOI 10.1038/sj.emboj.7601010; Jin YT, 2003, EMBO J, V22, P6365, DOI 10.1093/emboj/cdg600; Kasahara K, 2010, EMBO J, V29, P2802, DOI 10.1038/emboj.2010.157; Kim DH, 2010, MOL CELL BIOL, V30, P4120, DOI 10.1128/MCB.01135-09; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; LeBron C, 2006, EMBO J, V25, P1196, DOI 10.1038/sj.emboj.7601032; Lee EW, 2009, EMBO J, V28, P2100, DOI 10.1038/emboj.2009.164; Lee H, 2006, J BIOL CHEM, V281, P26876, DOI 10.1074/jbc.M605366200; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; Lu J, 2009, CANCER CELL, V16, P195, DOI 10.1016/j.ccr.2009.08.010; MACLEOD KF, 1995, GENE DEV, V9, P935, DOI 10.1101/gad.9.8.935; Mancini F, 2009, CURR GENOMICS, V10, P42, DOI 10.2174/138920209787581280; Marine JC, 2004, CELL CYCLE, V3, P900; MICHIELI P, 1994, CANCER RES, V54, P3391; Okamoto K, 2005, MOL CELL BIOL, V25, P9608, DOI 10.1128/MCB.25.21.9608-9620.2005; Pereg Y, 2006, MOL CELL BIOL, V26, P6819, DOI 10.1128/MCB.00562-06; Rossig L, 2002, J BIOL CHEM, V277, P9684, DOI 10.1074/jbc.M106157200; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Touitou R, 2001, EMBO J, V20, P2367, DOI 10.1093/emboj/20.10.2367; VIDAL A, 2000, ONCOGENE, V247, P2756; Wang B, 2010, MOL CELL BIOL, V30, P1508, DOI 10.1128/MCB.01335-09; Wang YYV, 2009, CANCER CELL, V16, P33, DOI 10.1016/j.ccr.2009.05.008; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Xu HX, 2010, J BIOL CHEM, V285, P18407, DOI 10.1074/jbc.M109.059568; Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717; Zhang Z, 2004, J BIOL CHEM, V279, P16000, DOI 10.1074/jbc.M312264200	45	14	16	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5136	5142		10.1074/jbc.M110.190470	http://dx.doi.org/10.1074/jbc.M110.190470			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148311	hybrid, Green Published			2022-12-27	WOS:000287230600021
J	Liu, CY; Lv, XB; Li, TT; Xu, YP; Zhou, X; Zhao, SM; Xiong, Y; Lei, QY; Guan, KL				Liu, Chen-Ying; Lv, Xianbo; Li, Tingting; Xu, Yanping; Zhou, Xin; Zhao, Shimin; Xiong, Yue; Lei, Qun-Ying; Guan, Kun-Liang			PP1 Cooperates with ASPP2 to Dephosphorylate and Activate TAZ	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; CELL-PROLIFERATION; SERINE/THREONINE PHOSPHATASES; NEGATIVE REGULATOR; PROTEIN; INTERACTS; TRANSCRIPTION; COACTIVATOR; INHIBITOR; TUMORIGENESIS	The Hippo pathway regulates organ size by controlling both cell proliferation and apoptosis. TAZ functions as a transcriptional co-activator downstream of the Hippo pathway and has been implicated in human cancer development. A key step in the Hippo-TAZ pathway is phosphorylation of TAZ by LATS kinase, which leads to TAZ inhibition by both cytoplasmic retention and degradation. However, the mechanism of TAZ dephosphorylation and the responsible phosphatase are unknown. Here, we identified PP1 as a bona fide TAZ phosphatase. PP1A dephosphorylates TAZ at Ser-89 and Ser-311, promotes TAZ nuclear translocation, and stabilizes TAZ by disrupting the binding to the SCF E3 ubiquitin ligase. Furthermore, ASPP2 facilitates the interaction between TAZ and PP1 to promote TAZ dephosphorylation. As a result, PP1 and ASPP2 increase TAZ-dependent gene expression. This study demonstrates that PP1A and ASPP2 play a critical role in promoting TAZ function by antagonizing the LATS kinase through TAZ dephosphorylation.	[Liu, Chen-Ying; Lei, Qun-Ying; Guan, Kun-Liang] Fudan Univ, Key Lab Mol Med, Minist Educ, Dept Biochem & Mol Biol,Sch Med, Shanghai 200032, Peoples R China; [Liu, Chen-Ying; Lv, Xianbo; Li, Tingting; Xu, Yanping; Zhou, Xin; Zhao, Shimin; Xiong, Yue; Lei, Qun-Ying; Guan, Kun-Liang] Fudan Univ, Sch Life Sci, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Liu, Chen-Ying; Lv, Xianbo; Li, Tingting; Xu, Yanping; Zhou, Xin; Zhao, Shimin; Xiong, Yue; Lei, Qun-Ying; Guan, Kun-Liang] Fudan Univ, Mol & Cell Biol Lab, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Xiong, Yue] Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Fudan University; Fudan University; Fudan University; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; University of California System; University of California San Diego	Lei, QY (corresponding author), Fudan Univ, Key Lab Mol Med, Minist Educ, Dept Biochem & Mol Biol,Sch Med, Shanghai 200032, Peoples R China.	qlei@fudan.edu.cn; kuguan@ucsd.edu	Zhou, Xin/AAD-6937-2019; Guan, Kun-Liang/ADK-7088-2022; Lei, Qun-Ying/J-1390-2017	Lei, Qun-Ying/0000-0002-8547-8518; Liu, Chen-Ying/0000-0002-8930-6182	National Natural Science Foundation of China, NSFC [2009CB918401, 2011CB910600, 30600112, 30871255, 31071192]; 985 Program; Chinese Ministry of Education [NCET-09-0315]; National Institutes of Health [GM067113, CA132809]; Shanghai Key Project [09JC1402300]; Shanghai Leading Academic Discipline Project [B110]; NATIONAL CANCER INSTITUTE [R01CA132809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067113] Funding Source: NIH RePORTER	National Natural Science Foundation of China, NSFC(National Natural Science Foundation of China (NSFC)); 985 Program; Chinese Ministry of Education(Ministry of Education, China); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shanghai Key Project; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by 973 Program Grants 2009CB918401 and 2011CB910600, National Natural Science Foundation of China Grants NSFC grants 30600112, 30871255, and 31071192. This work was also supported by the 985 Program and New Century Talent from the Chinese Ministry of Education Grant NCET-09-0315, in whole or in part by National Institutes of Health Grants (to Y. X. and K.-L. G.: GM067113 and CA132809), by Shanghai Key Project Grant 09JC1402300, and by the Shanghai Leading Academic Discipline Project (Project Number B110).	Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chen YZ, 2003, J NEUROCHEM, V85, P801, DOI 10.1046/j.1471-4159.2003.01727.x; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COHEN P, 2003, METHOD ENZYMOL, V366, P1; COHEN P, 2003, METHOD ENZYMOL, V366, pR15; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Espanel X, 2001, J BIOL CHEM, V276, P14514, DOI 10.1074/jbc.M008568200; Fernandez A, 2009, GENE DEV, V23, P2729, DOI 10.1101/gad.1824509; Gallego M, 2005, CURR OPIN CELL BIOL, V17, P197, DOI 10.1016/j.ceb.2005.01.002; Hakuno F, 2007, J BIOL CHEM, V282, P37747, DOI 10.1074/jbc.M702472200; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Helps NR, 1995, FEBS LETT, V377, P295, DOI 10.1016/0014-5793(95)01347-4; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Nakaga H, 2000, CANCER RES, V60, P101; Naumovski L, 1996, MOL CELL BIOL, V16, P3884; Park KS, 2004, J BIOL CHEM, V279, P17384, DOI 10.1074/jbc.M312569200; Ribeiro PS, 2010, MOL CELL, V39, P521, DOI 10.1016/j.molcel.2010.08.002; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; SHENOLIKAR S, 1991, ADV SEC MESS PHOSPH, V23, P1; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Slee EA, 2003, TOXICOL LETT, V139, P81, DOI 10.1016/S0378-4274(02)00421-6; SUGANUMA M, 1990, CANCER RES, V50, P3521; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Vives V, 2006, GENE DEV, V20, P1262, DOI 10.1101/gad.374006; Yang JP, 1999, J BIOL CHEM, V274, P15662, DOI 10.1074/jbc.274.22.15662; Zhang H, 2009, J BIOL CHEM, V284, P13355, DOI 10.1074/jbc.M900843200; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210	40	101	105	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5558	5566		10.1074/jbc.M110.194019	http://dx.doi.org/10.1074/jbc.M110.194019			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21189257	Green Published, hybrid			2022-12-27	WOS:000287230600065
J	Thaler, R; Agsten, M; Spitzer, S; Paschalis, EP; Karlic, H; Klaushofer, K; Varga, F				Thaler, Roman; Agsten, Marlies; Spitzer, Silvia; Paschalis, Eleftherios P.; Karlic, Heidrun; Klaushofer, Klaus; Varga, Franz			Homocysteine Suppresses the Expression of the Collagen Cross-linker Lysyl Oxidase Involving IL-6, Fli1, and Epigenetic DNA Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA HOMOCYSTEINE; HIP FRACTURE; GENE; INTERLEUKIN-6; RISK; METHYLTRANSFERASES; TRANSCRIPTION; CYTOKINES; ARTHRITIS; DISEASE	Elevated homocysteine (Hcys) serum levels represent a risk factor for several chronic pathologies, including cardiovascular disease, atherosclerosis, and chronic renal failure, and affect bone development, quality, and homeostasis. Hcys influences the formation of a stable bone matrix directly through the inhibition of the collagen cross-linking enzyme lysyl oxidase (Lox) and, as we have shown recently, by repressing its mRNA expression. The aim of this study was to investigate the mechanisms involved in this process. Through evaluation of gene arrays, quantitative RT-PCR, immunoblots, and ELISA, we identified a Hcys-dependent stimulation of interleukin 6 (IL-6) and genes involved in IL-6/Janus kinase 2 (JAK2)-dependent signal transduction pathways in pre-osteoblastic MC3T3-E1 cells. Moreover, up-regulation of genes essential for epigenetic DNA methylation (DNA (cytosine-5)-methyltransferases and helicase lymphoid-specific (Hells) was observed. Further investigations demonstrated that Hcys increased via IL-6/JAK2 the expression of Fli1 (Friend leukemia virus integration 1), a transcription factor, which we found essential for IL-6-dependent Dnmt1 stimulation. CpG methylation analysis of CpG-rich Lox proximal promoter revealed an increased CpG methylation status after treatment of the cells with Hcys indicating an epigenetic origin for Hcys-dependent Lox repression. Inhibition of the IL-6/JAK2 pathway or of CpG methylation reversed the repressive effect of Hcys on Lox expression. In conclusion, we demonstrate that Hcys stimulates IL-6 synthesis in osteoblasts, which is known to affect bone metabolism via osteoclasts. Furthermore, IL-6 stimulation results via JAK2, Fli1, and Dnmt1 in down-regulation of Lox expression by epigenetic CpG methylation revealing a new mechanism negatively affecting bone matrix formation.	[Thaler, Roman; Agsten, Marlies; Spitzer, Silvia; Paschalis, Eleftherios P.; Klaushofer, Klaus; Varga, Franz] Hanusch Hosp, Ludwig Boltzmann Inst Osteol, Dept Med 1, Wiener Gebietskrankenkasse & AUVA Trauma Ctr Meid, A-1140 Vienna, Austria; [Karlic, Heidrun] Hanusch Hosp, Ludwig Boltzmann Inst Leukemia Res & Hematol, A-1140 Vienna, Austria	Ludwig Boltzmann Institute; WGKK - Hanusch Hospital; Ludwig Boltzmann Institute; WGKK - Hanusch Hospital	Varga, F (corresponding author), Hanusch Hosp, Ludwig Boltzmann Inst Osteol, Dept Med 1, Wiener Gebietskrankenkasse & AUVA Trauma Ctr Meid, Heinrich Collin Str 30, A-1140 Vienna, Austria.	franz.varga@osteologie.at	/AAC-1939-2021		Fonds zur Foerderung der Wissenschaftlichen Forschung from the Austrian Science Fund [P20646-B11]; Social Health Insurance Vienna; Austrian Social Insurance for Occupational Risk	Fonds zur Foerderung der Wissenschaftlichen Forschung from the Austrian Science Fund(Austrian Science Fund (FWF)); Social Health Insurance Vienna; Austrian Social Insurance for Occupational Risk	This work was supported by the Fonds zur Foerderung der Wissenschaftlichen Forschung from the Austrian Science Fund Project P20646-B11, the Social Health Insurance Vienna, and the Austrian Social Insurance for Occupational Risk.	[Anonymous], 2009, J CLIN ENDOCR METAB, V94, P1207, DOI 10.1210/jc.2008-1777; Audelin MC, 2001, ATHEROSCLEROSIS, V159, P497, DOI 10.1016/S0021-9150(01)00531-7; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Blanchard F, 2009, CYTOKINE GROWTH F R, V20, P19, DOI 10.1016/j.cytogfr.2008.11.004; Blouin S, 2009, BONE, V44, P959, DOI 10.1016/j.bone.2008.12.023; Claes L, 2009, CALCIFIED TISSUE INT, V85, P17, DOI 10.1007/s00223-009-9262-6; Dean W, 2003, SEMIN CELL DEV BIOL, V14, P93, DOI 10.1016/S1084-9521(02)00141-6; Duplomb L, 2008, ENDOCRINOLOGY, V149, P3688, DOI 10.1210/en.2007-1719; Esteller M, 2002, J PATHOL, V196, P1, DOI 10.1002/path.1024; Foran E, 2010, MOL CANCER RES, V8, P471, DOI 10.1158/1541-7786.MCR-09-0496; Franchimont N, 2005, BONE, V37, P601, DOI 10.1016/j.bone.2005.06.002; Gazin C, 2007, NATURE, V449, P1073, DOI 10.1038/nature06251; Gerdhem P, 2007, J BONE MINER RES, V22, P127, DOI 10.1359/JBMR.061003; Ghoshal K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010338; Gjesdal CG, 2007, J BONE MINER RES, V22, P747, DOI 10.1359/JBMR.070210; Hodge DR, 2002, BIOCHEM BIOPH RES CO, V292, P287, DOI 10.1006/bbrc.2002.6652; Hodge DR, 2001, J BIOL CHEM, V276, P39508, DOI 10.1074/jbc.C100343200; Iannucci CV, 2007, CURR PHARM DESIGN, V13, P2148; JILKA RL, 1992, SCIENCE, V257, P88, DOI 10.1126/science.1621100; Kaneda A, 2004, CANCER RES, V64, P6410, DOI 10.1158/0008-5472.CAN-04-1543; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Karmakar S, 2010, RHEUM DIS CLIN N AM, V36, P385, DOI 10.1016/j.rdc.2010.03.003; Kishikawa S, 2002, EUR J BIOCHEM, V269, P2961, DOI 10.1046/j.1432-1033.2002.02972.x; Liu GM, 1997, J BIOL CHEM, V272, P32370, DOI 10.1074/jbc.272.51.32370; McLean RR, 2004, NEW ENGL J MED, V350, P2042, DOI 10.1056/NEJMoa032739; Myant K, 2008, MOL CELL BIOL, V28, P215, DOI 10.1128/MCB.01073-07; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; POLI V, 1994, EMBO J, V13, P1189, DOI 10.1002/j.1460-2075.1994.tb06368.x; Raisz LG, 2004, NEW ENGL J MED, V350, P2089, DOI 10.1056/NEJMe048030; Raposo B, 2004, ATHEROSCLEROSIS, V177, P1, DOI 10.1016/j.atherosclerosis.2004.06.015; Schiller C, 1997, ENDOCRINOLOGY, V138, P4567, DOI 10.1210/en.138.11.4567; So KJ, 2006, CANCER SCI, V97, P1155, DOI 10.1111/j.1349-7006.2006.00302.x; Sun LQ, 2004, GENE DEV, V18, P1035, DOI 10.1101/gad.1176104; Tamura G, 2009, PATHOL INT, V59, P895, DOI 10.1111/j.1440-1827.2009.02458.x; Thaler R, 2010, APOPTOSIS, V15, P728, DOI 10.1007/s10495-010-0462-3; Thaler R, 2010, BONE, V46, P703, DOI 10.1016/j.bone.2009.10.038; Turecek C, 2008, CALCIFIED TISSUE INT, V82, pS121; van Meurs JBJ, 2004, NEW ENGL J MED, V350, P2033, DOI 10.1056/NEJMoa032546; Wong PKK, 2003, ARTHRITIS RHEUM-US, V48, P1177, DOI 10.1002/art.10943; Yi P, 2000, J BIOL CHEM, V275, P29318, DOI 10.1074/jbc.M002725200; Zhang Q, 2006, BLOOD, V108, P1058, DOI 10.1182/blood-2005-08-007377; Zhu K, 2009, OSTEOPOROSIS INT, V20, P1183, DOI 10.1007/s00198-008-0804-y	43	80	84	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5578	5588		10.1074/jbc.M110.166181	http://dx.doi.org/10.1074/jbc.M110.166181			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148317	Green Published, hybrid			2022-12-27	WOS:000287230600067
J	Ross, FA; Rafferty, JN; Dallas, ML; Ogunbayo, O; Ikematsu, N; McClafferty, H; Tian, LJ; Widmer, H; Rowe, ICM; Wyatt, CN; Shipston, MJ; Peers, C; Hardie, DG; Evans, AM				Ross, Fiona A.; Rafferty, J. Nicole; Dallas, Mark L.; Ogunbayo, Oluseye; Ikematsu, Naoko; McClafferty, Heather; Tian, Lijun; Widmer, Helene; Rowe, Iain C. M.; Wyatt, Christopher N.; Shipston, Michael J.; Peers, Chris; Hardie, D. Grahame; Evans, A. Mark			Selective Expression in Carotid Body Type I Cells of a Single Splice Variant of the Large Conductance Calcium- and Voltage-activated Potassium Channel Confers Regulation by AMP-activated Protein Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED K+ CURRENTS; PHOSPHORYLATION; HYPOXIA; INHIBITION; SENSITIVITY; MECHANISM; SUBSTRATE; ENERGY; ALPHA; CA	Inhibition of large conductance calcium-activated potassium (BKCa) channels mediates, in part, oxygen sensing by carotid body type I cells. However, BKCa channels remain active in cells that do not serve to monitor oxygen supply. Using a novel, bacterially derived AMP-activated protein kinase (AMPK), we show that AMPK phosphorylates and inhibits BKCa channels in a splice variant-specific manner. Inclusion of the stress-regulated exon within BKCa channel alpha subunits increased the stoichiometry of phosphorylation by AMPK when compared with channels lacking this exon. Surprisingly, however, the increased phosphorylation conferred by the stress-regulated exon abolished BKCa channel inhibition by AMPK. Point mutation of a single serine (Ser-657) within this exon reduced channel phosphorylation and restored channel inhibition by AMPK. Significantly, RT-PCR showed that rat carotid body type I cells express only the variant of BKCa that lacks the stress-regulated exon, and intracellular dialysis of bacterially expressed AMPK markedly attenuated BKCa currents in these cells. Conditional regulation of BKCa channel splice variants by AMPK may therefore determine the response of carotid body type I cells to hypoxia.	[Rafferty, J. Nicole; Ogunbayo, Oluseye; McClafferty, Heather; Tian, Lijun; Rowe, Iain C. M.; Shipston, Michael J.; Evans, A. Mark] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Ross, Fiona A.; Ikematsu, Naoko; Hardie, D. Grahame] Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland; [Dallas, Mark L.; Peers, Chris] Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England; [Widmer, Helene] Glasgow Caledonian Univ, Glasgow G4 0BA, Lanark, Scotland; [Wyatt, Christopher N.] Wright State Univ, Boonshoft Sch Med, Dept Neurosci Cell Biol & Physiol, Dayton, OH 45435 USA	University of Edinburgh; University of Dundee; University of Leeds; Glasgow Caledonian University; University System of Ohio; Wright State University Dayton	Evans, AM (corresponding author), Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Hugh Robson Bldg, Edinburgh EH8 9XD, Midlothian, Scotland.	mark.evans@ed.ac.uk	Hardie, David/Z-1979-2019; Shipston, Mike/C-7309-2013; Dallas, Mark L/A-6654-2013	Shipston, Mike/0000-0001-7544-582X; Dallas, Mark/0000-0002-5190-0522; Peers, Chris/0000-0002-8354-346X; Rowe, Iain C M/0000-0002-0148-5332; Hardie, Grahame/0000-0002-8373-7379	Wellcome Trust [81195, 080982, 082407]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Programme Grants 81195 (to A. M. E., C. P., and D. G. H.), 080982 (to D. G. H.), and 082407 (to M. J. S.).	Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; DALE S, 1995, FEBS LETT, V361, P191, DOI 10.1016/0014-5793(95)00172-6; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Evans AM, 2005, J BIOL CHEM, V280, P41504, DOI 10.1074/jbc.M510040200; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; GONZALEZ C, 1994, PHYSIOL REV, V74, P829, DOI 10.1152/physrev.1994.74.4.829; GRATECOS D, 1974, BIOCHEM BIOPH RES CO, V58, P960, DOI 10.1016/S0006-291X(74)80237-8; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Lai GJ, 2002, P NATL ACAD SCI USA, V99, P7722, DOI 10.1073/pnas.112619799; Lai GJ, 2006, ENDOCRINOLOGY, V147, P3961, DOI 10.1210/en.2005-1551; Lopez-Barneo J, 2008, EUR RESPIR J, V32, P1386, DOI 10.1183/09031936.00056408; McCartney CE, 2005, P NATL ACAD SCI USA, V102, P17870, DOI 10.1073/pnas.0505270102; Meredith AL, 2004, J BIOL CHEM, V279, P36746, DOI 10.1074/jbc.M405621200; PEERS C, 1991, J PHYSIOL-LONDON, V437, P589, DOI 10.1113/jphysiol.1991.sp018613; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Sausbier M, 2005, CIRCULATION, V112, P60, DOI 10.1161/01.CIR.0000156448.74296.FE; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Shipston MJ, 2001, TRENDS CELL BIOL, V11, P353, DOI 10.1016/S0962-8924(01)02068-2; Tian L, 2004, P NATL ACAD SCI USA, V101, P11897, DOI 10.1073/pnas.0402590101; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; Toro L, 1998, NEWS PHYSIOL SCI, V13, P112; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	36	38	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.189779	http://dx.doi.org/10.1074/jbc.M110.189779			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21209098	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000289077500006
J	Reijns, MAM; Bubeck, D; Gibson, LCD; Graham, SC; Baillie, GS; Jones, EY; Jackson, AP				Reijns, Martin A. M.; Bubeck, Doryen; Gibson, Lucien C. D.; Graham, Stephen C.; Baillie, George S.; Jones, E. Yvonne; Jackson, Andrew P.			The Structure of the Human RNase H2 Complex Defines Key Interaction Interfaces Relevant to Enzyme Function and Human Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AICARDI-GOUTIERES-SYNDROME; PEPTIDE ARRAYS; DNA; MUTATIONS; ELECTROSTATICS; REFINEMENT; ALIGNMENT; SUBUNITS	Ribonuclease H2 (RNase H2) is the major nuclear enzyme involved in the degradation of RNA/DNA hybrids and removal of ribonucleotides misincorporated in genomic DNA. Mutations in each of the three RNase H2 subunits have been implicated in a human auto-inflammatory disorder, Aicardi-Goutieres Syndrome (AGS). To understand how mutations impact on RNase H2 function we determined the crystal structure of the human heterotrimer. In doing so, we correct several key regions of the previously reported murine RNase H2 atomic model and provide biochemical validation for our structural model. Our results provide new insights into how the subunits are arranged to form an enzymatically active complex. In particular, we establish that the RNASEH2A C terminus is a eukaryotic adaptation for binding the two accessory subunits, with residues within it required for enzymatic activity. This C-terminal extension interacts with the RNASEH2C C terminus and both are necessary to form a stable, enzymatically active heterotrimer. Disease mutations cluster at this interface between all three subunits, destabilizing the complex and/or impairing enzyme activity. Altogether, we locate 25 out of 29 residues mutated in AGS patients, establishing a firm basis for future investigations into disease pathogenesis and function of the RNase H2 enzyme.	[Bubeck, Doryen; Graham, Stephen C.; Jones, E. Yvonne] Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Reijns, Martin A. M.; Jackson, Andrew P.] Western Gen Hosp, MRC, Human Genet Unit, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Gibson, Lucien C. D.; Baillie, George S.] Univ Glasgow, Inst Neurosci & Psychol, Sch Life Sci, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; [Graham, Stephen C.] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Graham, Stephen C.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 0XY, England	University of Oxford; Wellcome Centre for Human Genetics; University of Edinburgh; University of Glasgow; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Bubeck, D (corresponding author), Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England.	doryen@strubi.ox.ac.uk; yvonne@strubi.ox.ac.uk	Jones, Yvonne/J-2293-2016; Jackson, Andrew P/D-3442-2009; Reijns, Martin/L-4355-2013; Jones, Yvonne/N-8111-2019	Jones, Yvonne/0000-0002-3834-1893; Jackson, Andrew P/0000-0002-8739-2646; Reijns, Martin/0000-0002-5048-2752; Jones, Yvonne/0000-0002-3834-1893; Graham, Stephen/0000-0003-4547-4034	Medical Research Council; Cancer Research UK; Wellcome Trust [075491/Z04]; EMBO; CRI; SJC; MRC [MC_EX_G0601852, G0900084] Funding Source: UKRI; Medical Research Council [G0900084, MC_EX_G0601852] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome Trust); EMBO(European Molecular Biology Organization (EMBO)); CRI; SJC; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was funded in part by a Medical Research Council Senior Clinical Fellowship grant (to A. P. J.) and Cancer Research UK grant (to E. Y. J.). The work was also supported by the Wellcome Trust Core Award (Grant 075491/Z04).; Supported by EMBO, CRI, and SJC. To whom correspondence may be addressed. E-mail: doryen@strubi.ox.ac.uk.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Bond CS, 2009, ACTA CRYSTALLOGR D, V65, P510, DOI 10.1107/S0907444909007835; Chapados BR, 2001, J MOL BIOL, V307, P541, DOI 10.1006/jmbi.2001.4494; Chon HG, 2009, NUCLEIC ACIDS RES, V37, P96, DOI 10.1093/nar/gkn913; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dikmans A, 2006, QSAR COMB SCI, V25, P1069, DOI 10.1002/qsar.200640130; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; EDER PS, 1991, J BIOL CHEM, V266, P6472; Forstemann K, 2005, EMBO REP, V6, P361, DOI 10.1038/sj.embor.7400374; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Jeong HS, 2004, NUCLEIC ACIDS RES, V32, P407, DOI 10.1093/nar/gkh209; Kleywegt GJ, 2004, ACTA CRYSTALLOGR D, V60, P2240, DOI 10.1107/S0907444904013253; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Li X, 2009, FEBS LETT, V583, P3310, DOI 10.1016/j.febslet.2009.09.035; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; MACHIDA Y, 1977, P NATL ACAD SCI USA, V74, P2776, DOI 10.1073/pnas.74.7.2776; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Meng D, 2009, J BIOL CHEM, V284, P11425, DOI 10.1074/jbc.M806395200; Nettleship Joanne E., 2008, V426, P299, DOI 10.1007/978-1-60327-058-8_19; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrino FW, 2009, J MOL MED-JMM, V87, P25, DOI 10.1007/s00109-008-0422-3; Ramantani G, 2010, ARTHRITIS RHEUM-US, V62, P1469, DOI 10.1002/art.27367; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rohman MS, 2008, FEBS J, V275, P4836, DOI 10.1111/j.1742-4658.2008.06622.x; Shaban NM, 2010, J BIOL CHEM, V285, P3617, DOI 10.1074/jbc.M109.059048; Smart O., 2008, ANN M ACA KNOXV TN, P137; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Tronrud DE, 1996, J APPL CRYSTALLOGR, V29, P100, DOI 10.1107/S002188989501421X; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Winkler DFH, 2009, METHODS MOL BIOL, V570, P157, DOI 10.1007/978-1-60327-394-7_5; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017	36	72	74	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10530	10539		10.1074/jbc.M110.177394	http://dx.doi.org/10.1074/jbc.M110.177394			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21177854	hybrid, Green Published			2022-12-27	WOS:000288547000069
J	Rousselet, E; Benjannet, S; Marcinkiewicz, E; Asselin, MC; Lazure, C; Seidah, NG				Rousselet, Estelle; Benjannet, Suzanne; Marcinkiewicz, Edwidge; Asselin, Marie-Claude; Lazure, Claude; Seidah, Nabil G.			Proprotein Convertase PC7 Enhances the Activation of the EGF Receptor Pathway through Processing of the EGF Precursor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; IN-VITRO; SERINE-PROTEASE; POSTTRANSLATIONAL MODIFICATIONS; TYROSINE PHOSPHORYLATION; PROHORMONE CONVERTASES; SUBSTRATE-SPECIFICITY; POTENT INHIBITORS; MESSENGER-RNA; CELL-SURFACE	Although the processing profile of the membrane-bound epidermal growth factor precursor (pro-EGF) is tissue-specific, it has not been investigated at the cellular level nor have the cognate proteinases been defined. Among the proprotein convertases (PCs), only the membrane-bound PC7, the most ancient and conserved basic amino acid-specific PC family member, induces the processing of pro-EGF into an similar to 115-kDa transmembrane form (EGF-115) at an unusual VHPR290 down arrow A motif. Because site-directed mutagenesis revealed that Arg(290) is not critical, the generation of EGF-115 by PC7 is likely indirect. This was confirmed by testing a wide range of protease inhibitors, which revealed that the production of EGF-115 is most probably achieved via the activation by PC7 of a latent serine and/or cysteine protease(s). EGF-115 is more abundant at the cell surface than pro-EGF and is associated with a stronger EGF receptor (EGFR) activation, as evidenced by higher levels of phosphorylated ERK1/2. This suggests that the generation of EGF-115 represents a regulatory mechanism of juxtacrine EGFR activation. Thus, PC7 is distinct from the other PCs in its ability to enhance the activation of the cell surface EGFR.	[Rousselet, Estelle; Benjannet, Suzanne; Marcinkiewicz, Edwidge; Asselin, Marie-Claude; Seidah, Nabil G.] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Lazure, Claude] Clin Res Inst Montreal, Lab Neuropeptide Struct & Metab, Montreal, PQ H2W 1R7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Seidah, NG (corresponding author), Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342	Canadian Institutes of Health Research [MOP-44363]; Strauss Foundation; Canada Chair [216684]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Strauss Foundation; Canada Chair	This research was supported by Canadian Institutes of Health Research Grant MOP-44363, a Strauss Foundation grant, and a Canada Chair Grant 216684.	Basak S, 2004, BIOCHEM J, V380, P505, DOI 10.1042/BJ20031405; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; BENJANNET S, 1992, J BIOL CHEM, V267, P11417; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; BREYER JA, 1990, J BIOL CHEM, V265, P16564; Canaff L, 1999, ENDOCRINOLOGY, V140, P3633, DOI 10.1210/en.140.8.3633; Creemers JWM, 2008, FRONT BIOSCI-LANDMRK, V13, P4960, DOI 10.2741/3055; Decroly E, 1997, FEBS LETT, V405, P68, DOI 10.1016/S0014-5793(97)00156-7; Decroly E, 1996, J BIOL CHEM, V271, P30442, DOI 10.1074/jbc.271.48.30442; Djie MZ, 1996, BIOCHEMISTRY-US, V35, P11461, DOI 10.1021/bi952717i; Dutta PR, 2007, CANCER LETT, V254, P165, DOI 10.1016/j.canlet.2007.02.006; Essalmani R, 2008, P NATL ACAD SCI USA, V105, P5750, DOI 10.1073/pnas.0709428105; FREY P, 1979, P NATL ACAD SCI USA, V76, P6294, DOI 10.1073/pnas.76.12.6294; Fugere M, 2007, MOL PHARMACOL, V71, P323, DOI 10.1124/mol.106.027946; Geraghty P, 2008, THORAX, V63, P621, DOI 10.1136/thx.2007.088559; Glading A, 2000, J BIOL CHEM, V275, P2390, DOI 10.1074/jbc.275.4.2390; Grandis JR, 2004, PHARMACOL THERAPEUT, V102, P37, DOI 10.1016/j.pharmthera.2004.01.002; Hooper JD, 2003, BIOCHEM J, V373, P689, DOI 10.1042/BJ20030390; Iwashita K, 2003, J AM SOC NEPHROL, V14, P11, DOI 10.1097/01.ASN.0000043900.39397.48; Janciauskiene S, 2008, AM J RESP CELL MOL, V39, P631, DOI 10.1165/rcmb.2008-0015RC; JORGENSEN PE, 1991, BIOCHIM BIOPHYS ACTA, V1074, P284, DOI 10.1016/0304-4165(91)90165-D; JORGENSEN PE, 1994, GROWTH FACTORS, V11, P113, DOI 10.3109/08977199409001053; Journe F, 1997, BBA-MOL CELL RES, V1357, P18, DOI 10.1016/S0167-4889(97)00012-8; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; KING CR, 1988, EMBO J, V7, P1647, DOI 10.1002/j.1460-2075.1988.tb02991.x; KING ICL, 1986, BIOCHEM BIOPH RES CO, V140, P837, DOI 10.1016/0006-291X(86)90710-2; Kwan RWP, 1999, INT J ONCOL, V15, P281; Le Gall SM, 2004, REGUL PEPTIDES, V122, P119, DOI 10.1016/j.regpep.2004.06.008; LIPPINCOTTSCHWARTZ J, 1991, CELL, V67, P601, DOI 10.1016/0092-8674(91)90534-6; Longpre JM, 2009, INT J BIOCHEM CELL B, V41, P1116, DOI 10.1016/j.biocel.2008.10.008; Lopez-Perez E, 1999, J NEUROCHEM, V73, P2056; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mahrus S, 2004, J BIOL CHEM, V279, P54275, DOI 10.1074/jbc.M411482200; Mansell A, 2001, FEBS LETT, V508, P313, DOI 10.1016/S0014-5793(01)03077-0; Marechal H, 1999, AM J PHYSIOL-CELL PH, V276, pC734, DOI 10.1152/ajpcell.1999.276.3.C734; Meerabux J, 1996, CANCER RES, V56, P448; MENTLEIN R, 1994, J NEUROCHEM, V62, P27; Mishima Y, 2007, CANCER SCI, V98, P364, DOI 10.1111/j.1349-7006.2007.00393.x; MROCZKOWSKI B, 1989, MOL CELL BIOL, V9, P2771, DOI 10.1128/MCB.9.7.2771; Munzer JS, 1997, J BIOL CHEM, V272, P19672, DOI 10.1074/jbc.272.32.19672; Nelsen SM, 2009, J BIOL CHEM, V284, P27157, DOI 10.1074/jbc.M109.028506; Okada T, 2003, J BIOL CHEM, V278, P31024, DOI 10.1074/jbc.M300923200; Ozden S, 2008, J BIOL CHEM, V283, P21899, DOI 10.1074/jbc.M802444200; PARRIES G, 1995, J BIOL CHEM, V270, P27954, DOI 10.1074/jbc.270.46.27954; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Pullikotil P, 2004, J BIOL CHEM, V279, P17338, DOI 10.1074/jbc.M313764200; RAAB G, 1994, BIOCHEM BIOPH RES CO, V204, P592, DOI 10.1006/bbrc.1994.2500; RALL LB, 1985, NATURE, V313, P228, DOI 10.1038/313228a0; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Rousselet E, 2011, J BIOL CHEM, V286, P2728, DOI 10.1074/jbc.M110.192344; Scamuffa N, 2008, GUT, V57, P1573, DOI 10.1136/gut.2007.141812; Scheel AA, 1996, BIOCHEMISTRY-US, V35, P10203, DOI 10.1021/bi960807x; Schneider MR, 2009, J CELL PHYSIOL, V218, P460, DOI 10.1002/jcp.21635; SCOTT J, 1985, J CELL SCI, P19; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Seidah NG, 1996, P NATL ACAD SCI USA, V93, P3388, DOI 10.1073/pnas.93.8.3388; Siegfried G, 2003, J CLIN INVEST, V111, P1723, DOI 10.1172/JCI200317220; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; STERN DF, 1988, EMBO J, V7, P995, DOI 10.1002/j.1460-2075.1988.tb02906.x; Stirnberg M, 2010, BIOCHEM J, V430, P87, DOI 10.1042/BJ20091565; Svenningsen P, 2009, AM J PHYSIOL-REG I, V297, pR1733, DOI 10.1152/ajpregu.00321.2009; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tofighi R, 2006, BRAIN RES, V1098, P1, DOI 10.1016/j.brainres.2006.04.095; Toure BB, 2000, J BIOL CHEM, V275, P2349, DOI 10.1074/jbc.275.4.2349; Valcarce C, 1999, EUR J BIOCHEM, V260, P200, DOI 10.1046/j.1432-1327.1999.00156.x; van de Loo JWHP, 2000, BIOCHEM J, V352, P827, DOI 10.1042/0264-6021:3520827; vandeLoo JWHP, 1997, J BIOL CHEM, V272, P27116, DOI 10.1074/jbc.272.43.27116; Wouters S, 1999, FEBS LETT, V456, P97, DOI 10.1016/S0014-5793(99)00938-2; Zelvyte I, 2004, CANCER CELL INT, V4, DOI 10.1186/1475-2867-4-7; Zhong M, 1999, J BIOL CHEM, V274, P33913, DOI 10.1074/jbc.274.48.33913	73	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9185	9195		10.1074/jbc.M110.189936	http://dx.doi.org/10.1074/jbc.M110.189936			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21209099	Green Published, hybrid			2022-12-27	WOS:000288247700049
J	Sun, XL; Wu, YL; Chen, B; Zhang, ZH; Zhou, WH; Tong, YG; Yuan, JY; Xia, K; Gronemeyer, H; Flavell, RA; Song, WH				Sun, Xiulian; Wu, Yili; Chen, Bin; Zhang, Zhuohua; Zhou, Weihui; Tong, Yigang; Yuan, Junying; Xia, Kun; Gronemeyer, Hinrich; Flavell, Richard A.; Song, Weihong			Regulator of Calcineurin 1 (RCAN1) Facilitates Neuronal Apoptosis through Caspase-3 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME CRITICAL REGION; ALZHEIMERS-DISEASE; DOWN-SYNDROME; CELL-DEATH; PRECURSOR PROTEIN; DSCR1 ADAPT78; TRANSCRIPTIONAL REGULATION; INHIBITS CALCINEURIN; STRIATED-MUSCLES; OXIDATIVE STRESS	Individuals with Down syndrome (DS) will inevitably develop Alzheimer disease (AD) neuropathology sometime after middle age, which may be attributable to genes triplicated in individuals with DS. The characteristics of AD neuropathology include neuritic plaques, neurofibrillary tangles, and neuronal loss in various brain regions. The mechanism underlying neurodegeneration in AD and DS remains elusive. Regulator of calcineurin 1 (RCAN1) has been implicated in the pathogenesis of DS. Our data show that RCAN1 expression is elevated in the cortex of DS and AD patients. RCAN1 expression can be activated by the stress hormone dexamethasone. A functional glucocorticoid response element was identified in the RCAN1 isoform 1 (RCAN1-1) promoter region, which is able to mediate the up-regulation of RCAN1 expression. Here we show that overexpression of RCAN1-1 in primary neurons activates caspase-9 and caspase-3 and subsequently induces neuronal apoptosis. Furthermore, we found that the neurotoxicity of RCAN1-1 is inhibited by knock-out of caspase-3 in caspase-3(-/-) neurons. Our study provides a novel mechanism by which RCAN1 functions as a mediator of stress- and A beta-induced neuronal death, and overexpression of RCAN1 due to an extra copy of the RCAN1 gene on chromosome 21 contributes to AD pathogenesis in DS.	[Sun, Xiulian; Wu, Yili; Chen, Bin; Zhou, Weihui; Tong, Yigang; Song, Weihong] Univ British Columbia, Townsend Family Labs, Dept Psychiat, Brain Res Ctr,Grad Program Neurosci, Vancouver, BC V6T 1Z3, Canada; [Sun, Xiulian] Shandong Univ, Qilu Hosp, Jinan 250012, Shandong, Peoples R China; [Zhang, Zhuohua] Burnham Inst, Ctr Neurosci & Aging, La Jolla, CA 92037 USA; [Yuan, Junying] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Xia, Kun] Cent S Univ, Natl Lab Med Genet China, Changsha 410078, Hunan, Peoples R China; [Gronemeyer, Hinrich] CU Strasbourg, Dept Cell Biol & Signal Transduct, Inst Genet & Biol Mol & Cellulaire, CNRS INSERM ULP, F-67404 Illkirch Graffenstaden, France; [Flavell, Richard A.] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	University of British Columbia; Shandong University; Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Harvard Medical School; Central South University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Yale University	Song, WH (corresponding author), 2255 Wesbrook Mall, Vancouver, BC V6T 1Z3, Canada.	weihong@exchange.ubc.ca	Gronemeyer, Hinrich/G-6240-2011; Gronemeyer, Hinrich/H-7002-2016; Song, Weihong/O-7623-2017; Gronemeyer, Hinrich/AAH-5575-2019; XIA, KUN/AAO-3525-2020	Gronemeyer, Hinrich/0000-0001-9454-2449; Gronemeyer, Hinrich/0000-0001-9454-2449; Song, Weihong/0000-0001-9928-889X; Gronemeyer, Hinrich/0000-0001-9454-2449; wu, yili/0000-0002-2369-6974; Tong, Yigang/0000-0002-8503-8045	Canadian Institutes of Health Research; Jack Brown and Family Alzheimer's Research Foundation; Michael Smith Foundation for Health Research; National Natural Science Foundation of China [30528015]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Jack Brown and Family Alzheimer's Research Foundation; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Canadian Institutes of Health Research, the Jack Brown and Family Alzheimer's Research Foundation, the Michael Smith Foundation for Health Research, and the National Natural Science Foundation of China (Distinguished Young Scholars (Oversea) Fund Grant 30528015) (to W. S.).	Abbasi S, 2006, J BIOL CHEM, V281, P7717, DOI 10.1074/jbc.M510775200; Abbasi S, 2005, J BIOL CHEM, V280, P36737, DOI 10.1074/jbc.M506493200; Alzheimer A, 1906, NEUROLOGISCHES CENTR, V23, P1129; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Asai A, 1999, J BIOL CHEM, V274, P34450, DOI 10.1074/jbc.274.48.34450; Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; Cano E, 2005, J BIOL CHEM, V280, P29435, DOI 10.1074/jbc.M506205200; Chang KT, 2005, NAT NEUROSCI, V8, P1577, DOI 10.1038/nn1564; Chang KT, 2003, P NATL ACAD SCI USA, V100, P15794, DOI 10.1073/pnas.2536696100; Christensen MA, 2004, MOL CELL BIOL, V24, P865, DOI 10.1128/MCB.24.2.865-874.2004; Cook CN, 2005, J ALZHEIMERS DIS, V8, P63; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; de Quervain DJF, 2003, EUR J NEUROSCI, V17, P1296, DOI 10.1046/j.1460-9568.2003.02542.x; Down J. T., 1866, LONDON HOSP REPORTS, V3, P259; Eckert A, 2003, ANN NY ACAD SCI, V1010, P604, DOI 10.1196/annals.1299.113; Ermak G, 2002, FASEB J, V16, DOI 10.1096/fj.01-0846com; Ermak G, 2001, J BIOL CHEM, V276, P38787, DOI 10.1074/jbc.M102829200; Friedlander RM, 2003, NEW ENGL J MED, V348, P1365, DOI 10.1056/NEJMra022366; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Genesca L, 2003, BIOCHEM J, V374, P567, DOI 10.1042/BJ20030267; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; Gorlach J, 2000, EMBO J, V19, P3618, DOI 10.1093/emboj/19.14.3618; Guo Q, 1998, NAT MED, V4, P957, DOI 10.1038/nm0898-957; Hampton T, 2005, JAMA-J AM MED ASSOC, V293, P284, DOI 10.1001/jama.293.3.284; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Harris CD, 2007, FEBS J, V274, P1715, DOI 10.1111/j.1742-4658.2007.05717.x; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Hoeffer CA, 2007, J NEUROSCI, V27, P13161, DOI 10.1523/JNEUROSCI.3974-07.2007; JACOBS PA, 1959, LANCET, V1, P710; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kang SJ, 2002, CELL DEATH DIFFER, V9, P1115, DOI 10.1038/sj.cdd.4401087; Kang SJ, 2003, J NEUROSCI, V23, P5455; Kawata M, 1998, J STEROID BIOCHEM, V65, P273, DOI 10.1016/S0960-0760(98)00026-0; Kitamura Y, 1997, BIOCHEM BIOPH RES CO, V232, P418, DOI 10.1006/bbrc.1997.6301; Kitamura Y, 1998, BRAIN RES, V780, P260, DOI 10.1016/S0006-8993(97)01202-X; Kluetzman KS, 2005, BIOCHEM BIOPH RES CO, V337, P595, DOI 10.1016/j.bbrc.2005.09.069; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Lee J, 2008, J BIOL CHEM, V283, P3392, DOI 10.1074/jbc.M706707200; LEJEUNE J., 1959, BULL ACAD NATL MED [PARIS], V143, P256; Li YP, 1996, BRAIN RES, V738, P196, DOI 10.1016/S0006-8993(96)00733-0; Lin HY, 2003, FREE RADICAL BIO MED, V35, P528, DOI 10.1016/S0891-5849(03)00358-7; Liu H, 2009, FASEB J, V23, P3383, DOI 10.1096/fj.09-134296; Liu QH, 2009, NAT CELL BIOL, V11, P154, DOI 10.1038/ncb1823; Ma H, 2004, J NEUROCHEM, V88, P1485, DOI 10.1046/j.1471-4159.2003.02294.x; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; Newcomer JW, 1999, ARCH GEN PSYCHIAT, V56, P527, DOI 10.1001/archpsyc.56.6.527; Newcomer JW, 1998, PSYCHONEUROENDOCRINO, V23, P65, DOI 10.1016/S0306-4530(97)00081-4; NISHIMURA T, 1995, BRAIN RES, V695, P137, DOI 10.1016/0006-8993(95)00699-Q; Oh M, 2005, MOL CELL BIOL, V25, P6629, DOI 10.1128/MCB.25.15.6629-6638.2005; Pomara Nunzio, 2003, Psychopharmacol Bull, V37, P120; Porta S, 2007, HUM MOL GENET, V16, P1039, DOI 10.1093/hmg/ddm049; Reagan LP, 1997, J CHEM NEUROANAT, V13, P149, DOI 10.1016/S0891-0618(97)00031-8; Reeves RH, 2001, TRENDS GENET, V17, P83, DOI 10.1016/S0168-9525(00)02172-7; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Rothermel BA, 2001, P NATL ACAD SCI USA, V98, P3328, DOI 10.1073/pnas.041614798; Rothermel BA, 2003, TRENDS CARDIOVAS MED, V13, P15, DOI 10.1016/S1050-1738(02)00188-3; SHARKEY J, 1994, NATURE, V371, P336, DOI 10.1038/371336a0; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Shi YG, 2004, CELL, V117, P855, DOI 10.1016/j.cell.2004.06.007; SHIBASAKI F, 1995, J CELL BIOL, V131, P735, DOI 10.1083/jcb.131.3.735; Sousa N, 1999, NEUROSCIENCE, V89, P1079, DOI 10.1016/S0306-4522(98)00311-X; Stadelmann C, 1999, AM J PATHOL, V155, P1459, DOI 10.1016/S0002-9440(10)65460-0; Su JH, 1997, J NEUROPATH EXP NEUR, V56, P86, DOI 10.1097/00005072-199701000-00009; Sun XL, 2006, FASEB J, V20, P1369, DOI 10.1096/FJ.05-5632COM; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Sun XL, 2006, FASEB J, V20, P1361, DOI 10.1096/fj.05-5628com; Sun XL, 2005, FASEB J, V19, P739, DOI 10.1096/fj.04-3426com; Tesco G, 2003, J BIOL CHEM, V278, P46074, DOI 10.1074/jbc.M307809200; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; van Rooij E, 2004, CIRC RES, V94, pE18, DOI 10.1161/01.RES.0000118597.54416.00; Vega RB, 2002, J BIOL CHEM, V277, P30401, DOI 10.1074/jbc.M200123200; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang SY, 1996, J BIOL CHEM, V271, P20580, DOI 10.1074/jbc.271.34.20580; Wang SY, 1998, CELL, V92, P501, DOI 10.1016/S0092-8674(00)80943-5; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Yuan J, 2003, NEURON, V40, P401, DOI 10.1016/S0896-6273(03)00601-9	84	89	97	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9049	9062		10.1074/jbc.M110.177519	http://dx.doi.org/10.1074/jbc.M110.177519			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21216952	Green Published, hybrid			2022-12-27	WOS:000288247700036
J	Zhou, XH; Keller, R; Volkmer, R; Krauss, N; Scheerer, P; Hunke, S				Zhou, Xiaohui; Keller, Rebecca; Volkmer, Rudolf; Krauss, Norbert; Scheerer, Patrick; Hunke, Sabine			Structural Basis for Two-component System Inhibition and Pilus Sensing by the Auxiliary CpxP Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENVELOPE STRESS-RESPONSE; COMPLETE GENOME SEQUENCE; SIGNAL-TRANSDUCTION; CHAPERONE FUNCTION; MODEL; CRYSTALLOGRAPHY; BIOGENESIS; EXPRESSION; SUBSTRATE; PATHWAY	Bacteria are equipped with two-component systems to cope with environmental changes, and auxiliary proteins provide response to additional stimuli. The Cpx two-component system is the global modulator of cell envelope stress in Gram-negative bacteria that integrates very different signals and consists of the kinase CpxA, the regulator CpxR, and the dual function auxiliary protein CpxP. CpxP both inhibits activation of CpxA and is indispensable for the quality control system of P pili that are crucial for uropathogenic Escherichia coli during kidney colonization. How these two essential biological functions of CpxP are linked is not known. Here, we report the crystal structure of CpxP at 1.45 angstrom resolution with two monomers being interdigitated like "left hands" forming a cap-shaped dimer. Our combined structural and functional studies suggest that CpxP inhibits the kinase CpxA through direct interaction between its concave polar surface and the negatively charged sensor domain on CpxA. Moreover, an extended hydrophobic cleft on the convex surface suggests a potent substrate recognition site for misfolded pilus subunits. Altogether, the structural details of CpxP provide a first insight how a periplasmic two-component system inhibitor blocks its cognate kinase and is released from it.	[Krauss, Norbert] Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England; [Zhou, Xiaohui; Keller, Rebecca; Hunke, Sabine] Humboldt Univ, Inst Biol, D-10115 Berlin, Germany; [Volkmer, Rudolf] Charite, Inst Med Immunol, D-10115 Berlin, Germany; [Scheerer, Patrick] Charite, Inst Med Phys & Biophys CC2, D-10117 Berlin, Germany	University of London; Queen Mary University London; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Krauss, N (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London E1 4NS, England.	n.krauss@qmul.ac.uk; patrick.scheerer@charite.de; sabine.hunke@hu-berlin.de	Hunke, Sabine/B-7169-2011	Volkmer, Rudolf/0000-0003-4710-1143; Scheerer, Patrick/0000-0001-5028-2075; Krauss, Norbert/0000-0002-7128-4632	Deutsche Forschungsgemeinschaft [Hu1011/1-3]; Yousef Jameel Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Yousef Jameel Foundation(American University Cairo)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Hu1011/1-3) and the Yousef Jameel Foundation.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Behrens S, 2001, EMBO J, V20, P285, DOI 10.1093/emboj/20.1.285; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchner J, 1998, METHOD ENZYMOL, V290, P323, DOI 10.1016/S0076-6879(98)90029-5; Buelow DR, 2010, MOL MICROBIOL, V75, P547, DOI 10.1111/j.1365-2958.2009.06982.x; Buelow DR, 2005, J BACTERIOL, V187, P6622, DOI 10.1128/JB.187.19.6622-6630.2005; Bury-Mone S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000651; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818; Cheung J, 2010, CURR OPIN MICROBIOL, V13, P116, DOI 10.1016/j.mib.2010.01.016; Danese PN, 1998, J BACTERIOL, V180, P831, DOI 10.1128/JB.180.4.831-839.1998; DiGiuseppe PA, 2003, J BACTERIOL, V185, P2432, DOI 10.1128/JB.185.8.2432-2440.2003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fleischer R, 2007, J BIOL CHEM, V282, P8583, DOI 10.1074/jbc.M605785200; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gerken H, 2010, MOL MICROBIOL, V75, P1033, DOI 10.1111/j.1365-2958.2009.07042.x; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; He FL, 2009, J BACTERIOL, V191, P5802, DOI 10.1128/JB.00451-09; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hung DL, 2001, EMBO J, V20, P1508, DOI 10.1093/emboj/20.7.1508; Hunke S, 2003, MOL MICROBIOL, V50, P1579, DOI 10.1046/j.1365-2958.2003.03785.x; Isaac DD, 2005, P NATL ACAD SCI USA, V102, P17775, DOI 10.1073/pnas.0508936102; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Jones CH, 1997, EMBO J, V16, P6394, DOI 10.1093/emboj/16.21.6394; Keller RF, 2009, RES MICROBIOL, V160, P396, DOI 10.1016/j.resmic.2009.07.002; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Kumar S, 1999, J MOL BIOL, V293, P1241, DOI 10.1006/jmbi.1999.3218; Kwon E, 2010, PROTEIN SCI, V19, P2252, DOI 10.1002/pro.489; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MacRitchie DM, 2008, ADV EXP MED BIOL, V631, P80, DOI 10.1007/978-0-387-78885-2_6; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Miller JH, 1992, SHORT COURSE BACTERI, V2; Neiditch MB, 2006, CELL, V126, P1095, DOI 10.1016/j.cell.2006.07.032; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Rodriguez R, 1998, BIOINFORMATICS, V14, P523, DOI 10.1093/bioinformatics/14.6.523; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; SABLONNIERE B, 1987, J CHROMATOGR, V403, P183, DOI 10.1016/S0021-9673(00)96352-0; Sauer FG, 2002, CELL, V111, P543, DOI 10.1016/S0092-8674(02)01050-4; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Stephenson K, 2002, CURR OPIN PHARMACOL, V2, P507, DOI 10.1016/S1471-4892(02)00194-7; SWIDERSKY UE, 1992, EUR J BIOCHEM, V207, P803, DOI 10.1111/j.1432-1033.1992.tb17111.x; Szurmant H, 2007, CURR OPIN STRUC BIOL, V17, P706, DOI 10.1016/j.sbi.2007.08.019; van Stelten J, 2009, SCIENCE, V325, P753, DOI 10.1126/science.1172221; VOLKMERENGERT R, 1994, LETT PEPT SCI, V1, P243; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Wenschuh H, 2000, BIOPOLYMERS, V55, P188, DOI 10.1002/1097-0282(2000)55:3<188::AID-BIP20>3.0.CO;2-T	61	53	58	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9805	9814		10.1074/jbc.M110.194092	http://dx.doi.org/10.1074/jbc.M110.194092			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21239493	Green Published, hybrid			2022-12-27	WOS:000288247700103
J	Diez-Sampedro, A; Barcelona, S				Diez-Sampedro, Ana; Barcelona, Stephanie			Sugar Binding Residue Affects Apparent Na+ Affinity and Transport Stoichiometry in Mouse Sodium/Glucose Cotransporter Type 3B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-GALACTOSE MALABSORPTION; NA+/GLUCOSE COTRANSPORTER; CRYSTAL-STRUCTURE; SODIUM; MECHANISM; SUBSTRATE; RELEASE; CHARGE; FAMILY; SGLT3	SGLT1 is a sodium/glucose cotransporter that moves two Na+ ions with each glucose molecule per cycle. SGLT3 proteins belong to the same family and are described as glucose sensors rather than glucose transporters. Thus, human SGLT3 (hSGLT3) does not transport sugar, but extracellular glucose depolarizes the cell in which it is expressed. Mouse SGLT3b (mSGLT3b), although it transports sugar, has low apparent sugar affinity and partially uncoupled stoichiometry compared with SGLT1, suggesting that mSGLT3b is also a sugar sensor. The crystal structure of the Vibrio parahaemolyticus SGLT showed that residue Gln(428) interacts directly with the sugar. The corresponding amino acid in mammalian proteins, 457, is conserved in all SGLT1 proteins as glutamine. In SGLT3 proteins, glutamate is the most common residue at this position, although it is a glycine in mSGLT3b and a serine in rat SGLT3b. To test the contribution of this residue to the function of SGLT3 proteins, we constructed SGLT3b mutants that recapitulate residue 457 in SGLT1 and hSGLT3, glutamine and glutamate, respectively. The presence of glutamine at residue 457 increased the apparent Na+ and sugar affinities, whereas glutamate decreased the apparent Na+ affinity. Moreover, glutamate transported more cations per sugar molecule than the wild type protein. We propose a model where cations are released intracellularly without the release of sugar from an intermediate state. This model explains the uncoupled charge: sugar transport phenotype observed in wild type and G457E-mSGLT3b compared with SGLT1 and the sugar-activated cation transport without sugar transport that occurs in hSGLT3.	[Diez-Sampedro, Ana; Barcelona, Stephanie] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA	University of Miami	Diez-Sampedro, A (corresponding author), Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Rm 4054,Rosenstiel Bldg,1600 NW 10th Ave, Miami, FL 33136 USA.	adiezsampedro@med.miami.edu			Florida Biomedical Research Program	Florida Biomedical Research Program	This work was supported by the Florida Biomedical Research Program (to A.D.-S.).	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Aljure O, 2010, AM J PHYSIOL-CELL PH, V299, pC58, DOI 10.1152/ajpcell.00030.2010; Bianchi L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010241; Diez-Sampedro A, 2003, P NATL ACAD SCI USA, V100, P11753, DOI 10.1073/pnas.1733027100; Diez-Sampedro A, 2001, J BIOL CHEM, V276, P49188, DOI 10.1074/jbc.M108286200; Diez-Sampedro A, 2001, AM J PHYSIOL-RENAL, V280, pF278, DOI 10.1152/ajprenal.2001.280.2.F278; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Forrest LR, 2009, PHYSIOLOGY, V24, P377, DOI 10.1152/physiol.00030.2009; Lam JT, 1999, BBA-MOL BASIS DIS, V1453, P297, DOI 10.1016/S0925-4439(98)00109-4; Li J, 2009, BIOPHYS J, V97, pL29, DOI 10.1016/j.bpj.2009.09.005; Liu TM, 2009, BIOPHYS J, V96, P748, DOI 10.1016/j.bpj.2008.09.045; Loo DDF, 1998, P NATL ACAD SCI USA, V95, P7789, DOI 10.1073/pnas.95.13.7789; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; Loo DDF, 2006, J GEN PHYSIOL, V128, P701, DOI 10.1085/jgp.200609643; Mackenzie B, 1998, J MEMBRANE BIOL, V162, P101, DOI 10.1007/s002329900347; PANAYOTOVAHEIERMANN M, 1994, J BIOL CHEM, V269, P21016; PARENT L, 1992, J MEMBRANE BIOL, V125, P63; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Voss AA, 2007, MOL PHARMACOL, V71, P628, DOI 10.1124/mol.106.030288; Watanabe A, 2010, NATURE, V468, P988, DOI 10.1038/nature09580; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6; Wright EM, 2002, CELL BIOCHEM BIOPHYS, V36, P115, DOI 10.1385/CBB:36:2-3:115; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978	23	6	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7975	7982		10.1074/jbc.M110.187880	http://dx.doi.org/10.1074/jbc.M110.187880			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21187287	Green Published, hybrid			2022-12-27	WOS:000288013300028
J	Lu, R; Yang, A; Jin, Y				Lu, Rui; Yang, Acong; Jin, Ying			Dual Functions of T-Box 3 (Tbx3) in the Control of Self-renewal and Extraembryonic Endoderm Differentiation in Mouse Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ULNAR-MAMMARY SYNDROME; PROTEIN-INTERACTION NETWORK; ES CELLS; TRANSCRIPTIONAL NETWORK; SIGNALING PATHWAYS; GENE-EXPRESSION; PLURIPOTENCY; LINEAGE; SOX2; ACTIVATION	Embryonic stem cells (ESCs) possess the capacity to proliferate indefinitely in an undifferentiated state and to differentiate into various cell types in an organism. However, the critical question of how self-renewal and differentiation are precisely regulated in ESCs is not entirely understood at present. Here, we report the essential role of Tbx3, a pluripotency-related transcription factor of the T-box gene family, for both the maintenance of self-renewal of mouse ESCs and for their differentiation into extraembryonic endoderm (ExEn). We show that Tbx3 is highly expressed in ExEn cells in addition to undifferentiated ESCs. Knockdown of Tbx3 expression using tetracycline-regulated Tbx3 siRNA resulted in the attenuation of ESC self-renewal ability and aberrant differentiation processes, including reduced ExEn differentiation but enhanced ectoderm and trophectoderm differentiation. Conversely, inducible forced expression of Tbx3 triggered ExEn lineage commitment. Mechanistically, Tbx3 directly activated the expression of Gata6, an essential regulator of ExEn. Interestingly, Tbx3 modulated H3K27me3 modification and the association of the PRC2 complex with the promoter region of Gata6. Taken together, the results of this study revealed a previously unappreciated role of a pluripotency factor in ExEn differentiation. Additionally, our data reveal that Tbx3 may function through direct binding and epigenetic modification of histones on the Gata6 promoter to maintain the ExEn differentiation potential of ESCs.	[Lu, Rui; Yang, Acong; Jin, Ying] CAS Shanghai Jiao Tong Univ Sch Med, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai 200025, Peoples R China; [Yang, Acong; Jin, Ying] Shanghai Jiao Tong Univ Sch Med, Inst Med Sci, Shanghai Stem Cell Inst, Shanghai 200025, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Jin, Y (corresponding author), 225 S Chongqing Rd, Shanghai 200025, Peoples R China.	yjin@sibs.ac.cn	Yang, Acong/B-2929-2012	Yang, Acong/0000-0002-1279-566X; , jin ying/0000-0003-0070-2048; Lu, Rui/0000-0003-1593-2612	National Natural Science Foundation [30730051, 30700116, 30911130361, 91019929]; National High Technology Research and Development Program of China [2009CB941103, 2007CB947904, 2007CB948004, 2010CB945200]; Shanghai Science and Technology Developmental Foundations [08dj1400502]; Shanghai Leading Academic Discipline Project [S30201]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Shanghai Science and Technology Developmental Foundations; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by National Natural Science Foundation Grants 30730051, 30700116, 30911130361, and 91019929, National High Technology Research and Development Program of China Grants 2009CB941103, 2007CB947904, 2007CB948004, and 2010CB945200, and Shanghai Science and Technology Developmental Foundations Grant 08dj1400502. The work was also supported by the Shanghai Leading Academic Discipline Project (S30201).	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bamshad M, 1999, AM J HUM GENET, V64, P1550, DOI 10.1086/302417; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chapman DL, 1996, DEV DYNAM, V206, P379, DOI 10.1002/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Coll M, 2002, STRUCTURE, V10, P343, DOI 10.1016/S0969-2126(02)00722-0; Davenport TG, 2003, DEVELOPMENT, V130, P2263, DOI 10.1242/dev.00431; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Hoogaars WMH, 2008, PIGM CELL MELANOMA R, V21, P379, DOI 10.1111/j.1755-148X.2008.00461.x; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Krawetz R, 2008, CELL SIGNAL, V20, P163, DOI 10.1016/j.cellsig.2007.10.011; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller SA, 2008, GENE DEV, V22, P2980, DOI 10.1101/gad.1689708; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Rossant J, 2007, REPROD FERT DEVELOP, V19, P111, DOI 10.1071/RD06125; Shimozaki K, 2003, DEVELOPMENT, V130, P2505, DOI 10.1242/dev.00476; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang BB, 2006, BIOCHEM BIOPH RES CO, V347, P1129, DOI 10.1016/j.bbrc.2006.07.020; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Zeineddine D, 2006, DEV CELL, V11, P535, DOI 10.1016/j.devcel.2006.07.013	38	59	66	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8425	8436		10.1074/jbc.M110.202150	http://dx.doi.org/10.1074/jbc.M110.202150			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21189255	Green Published, hybrid			2022-12-27	WOS:000288013300071
J	Mohammad, MM; Howard, KR; Movileanu, L				Mohammad, Mohammad M.; Howard, Khalil R.; Movileanu, Liviu			Redesign of a Plugged beta-Barrel Membrane Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI OUTER-MEMBRANE; FHUA TRANSPORT PROTEIN; SECONDARY STRUCTURE ANALYSES; PLANAR LIPID-BILAYERS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; CIRCULAR-DICHROISM; FUNCTIONAL-CHARACTERIZATION; COBALAMIN TRANSPORTER; DYNAMICS SIMULATIONS	The redesign of biological nanopores is focused on bacterial outer membrane proteins and pore-forming toxins, because their robust beta-barrel structure makes them the best choice for developing stochastic biosensing elements. Using membrane protein engineering and single-channel electrical recordings, we explored the ferric hydroxamate uptake component A (FhuA), a monomeric 22-stranded beta-barrel protein from the outer membrane of Escherichia coli. FhuA has a luminal cross-section of 3.1 x 4.4 nm and is filled by a globular N-terminal cork domain. Various redesigned FhuA proteins were investigated, including single, double, and multiple deletions of the large extracellular loops and the cork domain. We identified four large extracellular loops that partially occlude the lumen when the cork domain is removed. The newly engineered protein, FhuA Delta C/Delta 4L, was the result of a removal of almost one-third of the total number of amino acids of the wild-type FhuA (WT-FhuA) protein. This extensive protein engineering encompassed the entire cork domain and four extracellular loops. Remarkably, FhuA Delta C/Delta 4L forms a functional open pore in planar lipid bilayers, with a measured unitary conductance of similar to 4.8 nanosiemens, which is much greater than the values recorded previously with other engineered FhuA protein channels. There are numerous advantages and prospects of using such an engineered outer membrane protein not only in fundamental studies of membrane protein folding and design, and the mechanisms of ion conductance and gating, but also in more applicative areas of stochastic single-molecule sensing of proteins and nucleic acids.	[Movileanu, Liviu] Syracuse Univ, Dept Phys, Syracuse, NY 13244 USA; [Howard, Khalil R.; Movileanu, Liviu] Syracuse Univ, Struct Biol Biochem & Biophys Program, Syracuse, NY 13244 USA; [Movileanu, Liviu] Syracuse Univ, Syracuse Biomat Inst, Syracuse, NY 13244 USA	Syracuse University; Syracuse University; Syracuse University	Movileanu, L (corresponding author), Syracuse Univ, Dept Phys, 201 Phys Bldg, Syracuse, NY 13244 USA.	lmovilea@physics.syr.edu			National Institutes of Health [R01 GM088403]; National Science Foundation [DMR-0706517, DMR-1006332]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM088403 (to L. M.). This work was also supported by Grants DMR-0706517 and DMR-1006332 from the National Science Foundation (to L. M.).	Arora A, 2000, J BIOL CHEM, V275, P1594, DOI 10.1074/jbc.275.3.1594; Bayley H, 2001, NATURE, V413, P226, DOI 10.1038/35093038; BAYLEY H, 2004, NANOBIOTECHNOLOGY, P93; Berkane E, 2005, J Nanobiotechnology, V3, P3, DOI 10.1186/1477-3155-3-3; Bikwemu R, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454117; Biswas S, 2008, STRUCTURE, V16, P1027, DOI 10.1016/j.str.2008.04.009; Biswas S, 2007, NAT STRUCT MOL BIOL, V14, P1108, DOI 10.1038/nsmb1304; Bohm J, 2001, CURR BIOL, V11, P1168, DOI 10.1016/S0960-9822(01)00349-9; Bonhivers M, 1996, EMBO J, V15, P1850, DOI 10.1002/j.1460-2075.1996.tb00535.x; Bonhivers M, 2001, BIOCHEMISTRY-US, V40, P2606, DOI 10.1021/bi001725i; Boulanger P, 1996, BIOCHEMISTRY-US, V35, P14216, DOI 10.1021/bi9608673; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Braun M, 2002, EUR J BIOCHEM, V269, P4948, DOI 10.1046/j.1432-1033.2002.03195.x; BRAUN V, 1994, FEBS LETT, V346, P59, DOI 10.1016/0014-5793(94)00431-5; Braun V, 2009, J BACTERIOL, V191, P3431, DOI 10.1128/JB.00106-09; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Cao Z, 2002, BIOCHIMIE, V84, P399, DOI 10.1016/S0300-9084(02)01455-4; Chen M, 2008, P NATL ACAD SCI USA, V105, P6272, DOI 10.1073/pnas.0711561105; Cherezov V, 2006, J MOL BIOL, V364, P716, DOI 10.1016/j.jmb.2006.09.022; Chimento DP, 2003, NAT STRUCT BIOL, V10, P394, DOI 10.1038/nsb914; Chimerel C, 2008, EUR BIOPHYS J BIOPHY, V38, P121, DOI 10.1007/s00249-008-0366-0; Chow MKM, 2006, NUCLEIC ACIDS RES, V34, pD207, DOI 10.1093/nar/gkj080; COWAN SW, 1995, STRUCTURE, V3, P1041, DOI 10.1016/S0969-2126(01)00240-4; Destoumieux-Garzon D, 2005, BIOCHEM J, V389, P869, DOI 10.1042/BJ20042107; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Endriss F, 2004, J BACTERIOL, V186, P4818, DOI 10.1128/JB.186.14.4818-4823.2004; Endriss F, 2003, J BACTERIOL, V185, P4683, DOI 10.1128/JB.185.16.4683-4692.2003; Faraldo-Gomez JD, 2003, BIOPHYS J, V85, P1406, DOI 10.1016/S0006-3495(03)74573-1; Ferguson AD, 2002, SCIENCE, V295, P1715, DOI 10.1126/science.1067313; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; Ferguson AD, 2001, STRUCTURE, V9, P707, DOI 10.1016/S0969-2126(01)00631-1; Goodrich CP, 2007, J PHYS CHEM B, V111, P3332, DOI 10.1021/jp071364h; HOFFMANN H, 1986, J BACTERIOL, V166, P404, DOI 10.1128/jb.166.2.404-411.1986; Howorka S, 2000, J AM CHEM SOC, V122, P2411, DOI 10.1021/ja993221h; Howorka S, 2009, CHEM SOC REV, V38, P2360, DOI 10.1039/b813796j; Huang YH, 2009, P NATL ACAD SCI USA, V106, P7403, DOI 10.1073/pnas.0902789106; Jung Y, 2006, J AM CHEM SOC, V128, P15332, DOI 10.1021/ja065827t; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; KILLMANN H, 1993, EMBO J, V12, P3007, DOI 10.1002/j.1460-2075.1993.tb05969.x; Killmann H, 1996, J BACTERIOL, V178, P6913, DOI 10.1128/jb.178.23.6913-6920.1996; Lambert O, 2000, P NATL ACAD SCI USA, V97, P7248, DOI 10.1073/pnas.130187297; Letellier L, 1999, RES MICROBIOL, V150, P499, DOI 10.1016/S0923-2508(99)00107-2; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; Maglia G, 2008, P NATL ACAD SCI USA, V105, P19720, DOI 10.1073/pnas.0808296105; Mapingire OS, 2009, J BIOL CHEM, V284, P36324, DOI 10.1074/jbc.M109.055798; Mdzinarashvili T, 2006, EUR BIOPHYS J BIOPHY, V35, P231, DOI 10.1007/s00249-005-0029-3; Mohammad MM, 2008, EUR BIOPHYS J BIOPHY, V37, P913, DOI 10.1007/s00249-008-0309-9; Mohammad MM, 2008, J AM CHEM SOC, V130, P4081, DOI 10.1021/ja710787a; Mohammad MM, 2010, J PHYS CHEM B, V114, P8750, DOI 10.1021/jp101311s; Movileanu L, 2000, INT J PHARMACEUT, V205, P135, DOI 10.1016/S0378-5173(00)00503-2; Movileanu L, 2000, NAT BIOTECHNOL, V18, P1091, DOI 10.1038/80295; Movileanu L, 2005, BIOPHYS J, V89, P1030, DOI 10.1529/biophysj.104.057406; Movileanu L, 2003, BIOPHYS J, V85, P897, DOI 10.1016/S0006-3495(03)74529-9; Movileanu L, 2001, P NATL ACAD SCI USA, V98, P10137, DOI 10.1073/pnas.181089798; Movileanu L, 2001, J GEN PHYSIOL, V117, P239, DOI 10.1085/jgp.117.3.239; Movileanu L, 2008, SOFT MATTER, V4, P925, DOI 10.1039/b719850g; Movileanu L, 2009, TRENDS BIOTECHNOL, V27, P333, DOI 10.1016/j.tibtech.2009.02.008; Nallani Madhavan, 2006, Biotechnology Journal, V1, P828, DOI 10.1002/biot.200600042; Nallani M, 2006, J BIOTECHNOL, V123, P50, DOI 10.1016/j.jbiotec.2005.10.025; Nestorovich EM, 2002, P NATL ACAD SCI USA, V99, P9789, DOI 10.1073/pnas.152206799; Niedzwiecki DJ, 2010, J AM CHEM SOC, V132, P10816, DOI 10.1021/ja1026858; Onaca O, 2008, ANGEW CHEM INT EDIT, V47, P7029, DOI 10.1002/anie.200801076; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Ramakrishnan M, 2005, BIOCHEMISTRY-US, V44, P3515, DOI 10.1021/bi047603y; Ramakrishnan M, 2004, BIOCHEMISTRY-US, V43, P11630, DOI 10.1021/bi048858e; SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; Subbarao GV, 2006, J MOL BIOL, V360, P750, DOI 10.1016/j.jmb.2006.05.045; Talaga DS, 2009, J AM CHEM SOC, V131, P9287, DOI 10.1021/ja901088b; Udho E, 2009, P NATL ACAD SCI USA, V106, P21990, DOI 10.1073/pnas.0910023106; van den Berg B, 2005, CURR OPIN STRUC BIOL, V15, P401, DOI 10.1016/j.sbi.2005.06.003; Wendell D, 2009, NAT NANOTECHNOL, V4, P765, DOI [10.1038/NNANO.2009.259, 10.1038/nnano.2009.259]; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wolfe AJ, 2007, J AM CHEM SOC, V129, P14034, DOI 10.1021/ja0749340	76	55	56	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8000	8013		10.1074/jbc.M110.197723	http://dx.doi.org/10.1074/jbc.M110.197723			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21189254	Green Published, hybrid			2022-12-27	WOS:000288013300031
J	Zander, U; Faust, A; Klink, BU; de Sanctis, D; Panjikar, S; Quentmeier, A; Bardischewsky, F; Friedrich, CG; Scheidig, AJ				Zander, Ulrich; Faust, Annette; Klink, Bjoern U.; de Sanctis, Daniele; Panjikar, Santosh; Quentmeier, Armin; Bardischewsky, Frank; Friedrich, Cornelius G.; Scheidig, Axel J.			Structural Basis for the Oxidation of Protein-bound Sulfur by the Sulfur Cycle Molybdohemo-Enzyme Sulfane Dehydrogenase SoxCD	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMOLECULAR ELECTRON-TRANSFER; SULFITE-OXIDIZING ENZYMES; PARACOCCUS-PANTOTROPHUS; CRYSTAL-STRUCTURE; CYTOCHROME C(6); MOLYBDENUM COFACTOR; CROSS-VALIDATION; MOLECULAR-BASIS; GENE-CLUSTER; PULSED EPR	The sulfur cycle enzyme sulfane dehydrogenase SoxCD is an essential component of the sulfur oxidation (Sox) enzyme system of Paracoccus pantotrophus. SoxCD catalyzes a six-electron oxidation reaction within the Sox cycle. SoxCD is an alpha(2)beta(2) heterotetrameric complex of the molybdenum cofactor-containing SoxC protein and the diheme c-type cytochrome SoxD with the heme domains D-1 and D-2. SoxCD(1) misses the heme-2 domain D-2 and is catalytically as active as SoxCD. The crystal structure of SoxCD(1) was solved at 1.33 angstrom. The substrate of SoxCD is the outer (sulfane) sulfur of Cys-110-persulfide located at the C-terminal peptide swinging arm of SoxY of the SoxYZ carrier complex. The SoxCD(1) substrate funnel toward the molybdopterin is narrow and partially shielded by side-chain residues of SoxD(1). For access of the sulfane-sulfur of SoxY-Cys-110 persulfide we propose that (i) the blockage by SoxD-Arg-98 is opened via interaction with the C terminus of SoxY and (ii) the C-terminal peptide VTIGGCGG of SoxY provides interactions with the entrance path such that the cysteine-bound persulfide is optimally positioned near the molybdenum atom. The subsequent oxidation reactions of the sulfane-sulfur are initiated by the nucleophilic attack of the persulfide anion on the molybdenum atom that is, in turn, reduced. The close proximity of heme-1 to the molybdopterin allows easy acceptance of the electrons. Because SoxYZ, SoxXA, and SoxB are already structurally characterized, with SoxCD(1) the structures of all key enzymes of the Sox cycle are known with atomic resolution.	[Quentmeier, Armin; Bardischewsky, Frank; Friedrich, Cornelius G.] Tech Univ Dortmund, Fak Bio & Chem Ingn, D-44221 Dortmund, Germany; [Zander, Ulrich; Faust, Annette; Scheidig, Axel J.] Univ Kiel, Inst Zool, Dept Biol Struct, D-24118 Kiel, Germany; [Zander, Ulrich; Klink, Bjoern U.; Scheidig, Axel J.] Univ Saarland, Dept Biophys Struct Biol, D-66421 Homburg, Germany; [de Sanctis, Daniele] European Synchrotron Radiat Facil, Struct Biol Grp, F-38043 Grenoble 9, France; [Panjikar, Santosh] DESY, EMBL Hamburg Outstn, D-22603 Hamburg, Germany	Dortmund University of Technology; University of Kiel; Saarland University; European Synchrotron Radiation Facility (ESRF); European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Friedrich, CG (corresponding author), Tech Univ Dortmund, Fak Bio & Chem Ingn, Emil Figge Str 66, D-44221 Dortmund, Germany.	cornelius.friedrich@udo.edu; axel.scheidig@strubio.uni-kiel.de	Scheidig, Axel/C-9141-2011; Panjikar, Santosh/D-2709-2012	Panjikar, Santosh/0000-0001-7429-3879	Deutsche Forschungsgemeinschaft [Fr318/10-1, Sche545/9-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants Fr318/10-1 and Sche545/9-1.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akazaki H, 2008, ACTA CRYSTALLOGR F, V64, P674, DOI 10.1107/S1744309108017752; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bailey S, 2009, J BIOL CHEM, V284, P2053, DOI 10.1074/jbc.M807718200; Bamford VA, 2002, BIOCHEMISTRY-US, V41, P2921, DOI 10.1021/bi015765d; Bamford VA, 2002, EMBO J, V21, P5599, DOI 10.1093/emboj/cdf566; Banci L, 1996, J BIOL INORG CHEM, V1, P330, DOI 10.1007/s007750050061; Bardischewsky F, 2005, BIOCHEMISTRY-US, V44, P7024, DOI 10.1021/bi047334b; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertero MG, 2003, NAT STRUCT BIOL, V10, P681, DOI 10.1038/nsb969; Bowman SEJ, 2008, NAT PROD REP, V25, P1118, DOI 10.1039/b717196j; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; Dahl C, 2005, J BACTERIOL, V187, P1392, DOI 10.1128/JB.187.4.1392-1404.2005; Dambe T, 2005, J STRUCT BIOL, V152, P229, DOI 10.1016/j.jsb.2005.09.002; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Emesh S, 2009, BIOCHEMISTRY-US, V48, P2156, DOI 10.1021/bi801553q; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischer K, 2005, PLANT CELL, V17, P1167, DOI 10.1105/tpc.104.029694; Friedrich CG, 2005, CURR OPIN MICROBIOL, V8, P253, DOI 10.1016/j.mib.2005.04.005; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; Friedrich CG, 2000, J BACTERIOL, V182, P4677, DOI 10.1128/JB.182.17.4677-4687.2000; Frigaard NU, 2009, ADV MICROB PHYSIOL, V54, P103, DOI 10.1016/S0065-2911(08)00002-7; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grimm F, 2010, MICROBIOL-SGM, V156, P764, DOI 10.1099/mic.0.034645-0; Hao Q, 2004, J APPL CRYSTALLOGR, V37, P498, DOI 10.1107/S0021889804008696; Hille R, 2005, ARCH BIOCHEM BIOPHYS, V433, P107, DOI 10.1016/j.abb.2004.08.012; HILLE R, 1994, BBA-BIOENERGETICS, V1184, P143, DOI 10.1016/0005-2728(94)90220-8; HOBBS JD, 1995, J PROTEIN CHEM, V14, P19, DOI 10.1007/BF01902840; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Jones S, 2000, PROTEIN ENG, V13, P77, DOI 10.1093/protein/13.2.77; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kappler U, 2005, J BIOL CHEM, V280, P24999, DOI 10.1074/jbc.M503237200; KELLY DP, 1982, PHILOS T R SOC B, V298, P499, DOI 10.1098/rstb.1982.0094; Kelly DP, 1997, ANTON LEEUW INT J G, V71, P95, DOI 10.1023/A:1000135707181; Kisker C, 1997, CELL, V91, P973, DOI 10.1016/S0092-8674(00)80488-2; LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nurizzo D, 2006, J SYNCHROTRON RADIAT, V13, P227, DOI 10.1107/S0909049506004341; Oliveira TF, 2008, J BIOL CHEM, V283, P34141, DOI 10.1074/jbc.M805643200; Ozawa K, 2003, BIOPHYS J, V85, P3367, DOI 10.1016/S0006-3495(03)74756-0; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Quentmeier A, 2000, ARCH MICROBIOL, V173, P117, DOI 10.1007/s002039900118; Rainey FA, 1999, INT J SYST BACTERIOL, V49, P645, DOI 10.1099/00207713-49-2-645; Raitsimring AM, 2005, INORG CHEM, V44, P7283, DOI 10.1021/ic0509534; Rapson TD, 2010, J BIOL INORG CHEM, V15, P505, DOI 10.1007/s00775-009-0619-0; Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161; Rocchia W, 2001, J PHYS CHEM B, V105, P6507, DOI 10.1021/jp010454y; Rother D, 2001, J BACTERIOL, V183, P4499, DOI 10.1128/JB.183.15.4499-4508.2001; Sauve V, 2007, J BIOL CHEM, V282, P23194, DOI 10.1074/jbc.M701602200; Sauve V, 2009, J BIOL CHEM, V284, P21707, DOI 10.1074/jbc.M109.002709; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schrader N, 2003, STRUCTURE, V11, P1251, DOI 10.1016/j.str.2003.09.001; Schwarz G, 2005, CELL MOL LIFE SCI, V62, P2792, DOI 10.1007/s00018-005-5269-y; Sezer D, 2009, PHYS CHEM CHEM PHYS, V11, P6626, DOI 10.1039/b905709a; Sheldrick G.M, 2001, International Tables for Macromolecular Crystallography, P333; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Tickle IJ, 2000, ACTA CRYSTALLOGR D, V56, P442, DOI 10.1107/S0907444999016868; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; WOOTTON JC, 1991, BIOCHIM BIOPHYS ACTA, V1057, P157, DOI 10.1016/S0005-2728(05)80100-8; Worrall JAR, 2007, J AM CHEM SOC, V129, P9468, DOI 10.1021/ja072346g	71	28	30	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8349	8360		10.1074/jbc.M110.193631	http://dx.doi.org/10.1074/jbc.M110.193631			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21147779	Green Published, hybrid			2022-12-27	WOS:000288013300063
J	Karpuj, MV; Gelibter-Niv, S; Tiran, A; Rambold, A; Tatzelt, J; Nunziante, M; Schatzl, HM				Karpuj, Marcela Viviana; Gelibter-Niv, Sagit; Tiran, Anat; Rambold, Angelika; Tatzelt, Joerg; Nunziante, Max; Schatzl, Hermann M.			Conditional Modulation of Membrane Protein Expression in Cultured Cells Mediated by Prion Protein Recognition of Short Phosphorothioate Oligodeoxynucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COPPER-BINDING; NUCLEIC-ACID; SCRAPIE; ENDOCYTOSIS; MICE; GLYCOSYLATION; PRPC; NEURODEGENERATION; OLIGONUCLEOTIDES; CONTRIBUTES	We demonstrate that the levels of native as well as transfected prion protein (PrP) are lowered in various cell lines exposed to phosphorothioate oligodeoxynucleotides (PS-DNA) and can be rapidly reverted to their normal amounts by removal of PS-DNA. This transient modulation was independent of the glycosylation state of PrP, and in addition, all three PrP glycoforms were susceptible to PS-DNA treatment. Deletion of the N-terminal domain (amino acids 23-99), but not of the other domains of PrP, abrogated its PS-DNA-mediated down-regulation. PrP versions localized in the mitochondria, cytoplasm, or nucleus were not modulated by PS-DNA, indicating that PrP surface exposure is required for executing this effect. Proteins that in their native forms were not responsive to PS-DNA, such as thymocyte antigen 1 (Thy1), Doppel protein (Dpl), green fluorescent protein (GFP), and cyan fluorescent protein (CFP), became susceptible to PS-DNA-mediated down-regulation following introduction of the N terminus of PrP into their sequence. These observations demonstrate the essential role of the N-terminal domain for promoting oligonucleotide-mediated reduction of the PrP level and suggest that transient treatment of cultured cells with PS-DNA may provide a general method for targeted modulation of the levels of desired surface proteins in a conditional and reversible manner.	[Karpuj, Marcela Viviana; Gelibter-Niv, Sagit; Tiran, Anat] Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr Food & Environm Qual, Fac Agr, IL-76100 Rehovot, Israel; [Rambold, Angelika; Tatzelt, Joerg] Univ Munich, Dept Neurobiochem, Adolf Butenandt Inst, D-80336 Munich, Germany; [Nunziante, Max; Schatzl, Hermann M.] Tech Univ Munich, Inst Virol, D-81675 Munich, Germany; [Schatzl, Hermann M.] Univ Wyoming, Dept Vet Sci, Laramie, WY 82071 USA; [Schatzl, Hermann M.] Univ Wyoming, Dept Mol Biol, Laramie, WY 82071 USA	Hebrew University of Jerusalem; University of Munich; Technical University of Munich; University of Wyoming; University of Wyoming	Karpuj, MV (corresponding author), Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr Food & Environm Qual, Fac Agr, IL-76100 Rehovot, Israel.	mvkarpuj@gmail.com	Schatzl, Hermann/G-4958-2011	Schatzl, Hermann/0000-0003-4972-8740; Tatzelt, Jorg/0000-0001-5017-5528	Human Frontier Science Program; Deutsche Forschungsgemeinschaft [SFB 596]; Max Planck Society; BMBF (BioDisc) [DIP5.1]; European Union NoE Neuroprion	Human Frontier Science Program(Human Frontier Science Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); BMBF (BioDisc)(Federal Ministry of Education & Research (BMBF)); European Union NoE Neuroprion	This work was supported by the Career Development Award Grant, Human Frontier Science Program (to M. V. K.), grants from the Deutsche Forschungsgemeinschaft (SFB 596), the Max Planck Society, and the BMBF (BioDisc, DIP5.1) (to J. T.), and grants from the Deutsche Forschungsgemeinschaft (SFB 596) and European Union NoE Neuroprion (to H. M. S.).	Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Calzolai L, 2005, P NATL ACAD SCI USA, V102, P651, DOI 10.1073/pnas.0408939102; CAPELLARI S, 2000, ALZHEIMERS DIS, V2, P27; Chakrabarti O, 2009, CELL, V137, P1136, DOI 10.1016/j.cell.2009.03.042; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; Gabus C, 2001, J BIOL CHEM, V276, P19301, DOI 10.1074/jbc.M009754200; Gilch S, 2004, TRAFFIC, V5, P300, DOI 10.1111/j.1600-0854.2004.0175.x; Gilch S, 2007, FEBS J, V274, P5834, DOI 10.1111/j.1742-4658.2007.06105.x; Haigh CL, 2005, MOL CELL NEUROSCI, V30, P186, DOI 10.1016/j.mcn.2005.07.001; Heske J, 2004, J BIOL CHEM, V279, P5435, DOI 10.1074/jbc.M309570200; Hollrigel GS, 1998, P ROY SOC B-BIOL SCI, V265, P63, DOI 10.1098/rspb.1998.0265; HORI H, 1981, PLANT PHYSIOL, V67, P882, DOI 10.1104/pp.67.5.882; Karpuj MV, 2007, MOL MED, V13, P190, DOI 10.2119/2006-00073.Karpuj; KELLER GA, 1992, EMBO J, V11, P863, DOI 10.1002/j.1460-2075.1992.tb05124.x; Kiachopoulos S, 2004, TRAFFIC, V5, P426, DOI 10.1111/j.1398-9219.2004.00185.x; Kocisko DA, 2006, ANTIMICROB AGENTS CH, V50, P1034, DOI 10.1128/AAC.50.3.1034-1044.2006; Korth C, 2000, J GEN VIROL, V81, P2555, DOI 10.1099/0022-1317-81-10-2555; Lehmann S, 1997, J BIOL CHEM, V272, P21479, DOI 10.1074/jbc.272.34.21479; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Muramoto T, 1996, P NATL ACAD SCI USA, V93, P15457, DOI 10.1073/pnas.93.26.15457; Nandi PK, 2002, J MOL BIOL, V322, P153, DOI 10.1016/S0022-2836(02)00750-7; Neuendorf E, 2004, J BIOL CHEM, V279, P53306, DOI 10.1074/jbc.M410796200; Nunziante M, 2003, J BIOL CHEM, V278, P3726, DOI 10.1074/jbc.M206313200; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner Stanley B., 2004, VVolume 41, P961; Rachidi W, 2003, J BIOL CHEM, V278, P9064, DOI 10.1074/jbc.M211830200; Radford HE, 2010, CURR ISSUES MOL BIOL, V12, P119; Rambold AS, 2006, MOL BIOL CELL, V17, P3356, DOI 10.1091/mbc.E06-01-0083; Rane NS, 2008, DEV CELL, V15, P359, DOI 10.1016/j.devcel.2008.06.015; Roucou X, 2005, J MOL MED, V83, P3, DOI 10.1007/s00109-004-0605-5; SCHATZL HM, 1995, J MOL BIOL, V245, P362, DOI 10.1006/jmbi.1994.0030; SCOTT MR, 1992, PROTEIN SCI, V1, P986, DOI 10.1002/pro.5560010804; Sethi S, 2002, LANCET, V360, P229, DOI 10.1016/S0140-6736(02)09513-2; SHYNG SL, 1995, J BIOL CHEM, V270, P30221; Silva JL, 2008, TRENDS BIOCHEM SCI, V33, P132, DOI 10.1016/j.tibs.2007.11.003; Spielhaupter C, 2001, J BIOL CHEM, V276, P44604, DOI 10.1074/jbc.M103289200; Spinner DS, 2008, J VIROL, V82, P10701, DOI 10.1128/JVI.00522-08; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Lima LMTR, 2006, BIOCHEMISTRY-US, V45, P9180, DOI 10.1021/bi060532d; Whyte SM, 2003, BIOCHEM J, V373, P485, DOI 10.1042/BJ20021911; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Zou WQ, 2004, P NATL ACAD SCI USA, V101, P1380, DOI 10.1073/pnas.0307825100	46	5	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6911	6917		10.1074/jbc.M110.194662	http://dx.doi.org/10.1074/jbc.M110.194662			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21156803	Green Published, hybrid			2022-12-27	WOS:000287737300006
J	Herskowitz, JH; Seyfried, NT; Gearing, M; Kahn, RA; Peng, JM; Levey, AI; Lah, JJ				Herskowitz, Jeremy H.; Seyfried, Nicholas T.; Gearing, Marla; Kahn, Richard A.; Peng, Junmin; Levey, Allan I.; Lah, James J.			Rho Kinase II Phosphorylation of the Lipoprotein Receptor LR11/SORLA Alters Amyloid-beta Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SORTILIN-RELATED RECEPTOR; APOLIPOPROTEIN-E RECEPTOR; PHOSPHOPROTEOMIC ANALYSIS; SERINE/THREONINE KINASE; CYTOPLASMIC DOMAIN; PROTEIN; BINDING; SORLA; LR11; ACTIVATION	LR11, also known as SorLA, is a mosaic low-density lipoprotein receptor that exerts multiple influences on Alzheimer disease susceptibility. LR11 interacts with the amyloid-beta precursor protein (APP) and regulates APP traffic and processing to amyloid-beta peptide (A beta). The functional domains of LR11 suggest that it can act as a cell surface receptor and as an intracellular sorting receptor for trans-Golgi network to endosome traffic. We show that LR11 over-expressed in HEK293 cells is radiolabeled following incubation of cells with [P-32(i)] orthophosphate. Liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) was used to discover putative LR11 interacting kinases. Rho-associated coiled-coil containing protein kinase (ROCK) 2 was identified as a binding partner and a candidate kinase acting on LR11. LR11 and ROCK2 co-immunoprecipitate from post-mortem human brain tissue and drug inhibition of ROCK activity reduces LR11 phosphorylation in vivo. Targeted knockdown of ROCK2 with siRNA decreased LR11 ectodomain shedding while simultaneously increasing intracellular LR11 protein level. Site-directed mutagenesis of serine 2206 in the LR11 cytoplasmic tail reduced LR11 shedding, decreased LR11 phosphorylation in vitro, and abrogated LR11 mediated A beta reduction. These findings provide direct evidence that LR11 is phosphorylated in vivo and indicate that ROCK2 phosphorylation of LR11 may enhance LR11 mediated processing of APP and amyloid production.	[Lah, James J.] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Dept Neurol, Atlanta, GA 30322 USA; [Seyfried, Nicholas T.; Peng, Junmin] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Gearing, Marla] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Kahn, Richard A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Peng, Junmin] Emory Univ, Sch Med, Prote Serv Ctr, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University; Emory University	Lah, JJ (corresponding author), 615 Michael St,Suite 500, Atlanta, GA 30322 USA.	jlah@emory.edu	Kahn, Richard/ABD-2666-2020; Levey, Allan/F-2104-2011; Peng, Junmin/N-2614-2018	Kahn, Richard/0000-0002-0259-0601; Levey, Allan/0000-0002-3153-502X; Peng, Junmin/0000-0003-0472-7648	ADR, American Health Assistance Foundation; National Institutes of Health NINDS [T32 NS007480-07]; NIA [P01AG1449, R01GM067226]; Alzheimer Disease Research Center [AG025688, F32AG032848-02]; American Cancer Society [RSG-09-181-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077, T32NS007480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688, F32AG032848] Funding Source: NIH RePORTER	ADR, American Health Assistance Foundation; National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer Disease Research Center; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Lah/Levey, Peng, and Mao Laboratories for constructive discussion regarding this manuscript, Marla Gearing, and the National Institutes of Health through the Emory NINDS Neuroscience Core Facilities (NS055077). Acknowledgment is made to the donors of ADR, a program of the American Health Assistance Foundation, for support of this research.; This work was supported, in whole or in part, by National Institutes of Health NINDS Training and Translational Research in Neurology Grant T32 NS007480-07, and Grants NIA P01AG1449 and R01GM067226. This work was also supported by Alzheimer Disease Research Center Grant AG025688, Training Grant (F32AG032848-02, to N. T. S.), and a Research Scholar Grant RSG-09-181-01 from the American Cancer Society.	Amano M, 2003, J NEUROCHEM, V87, P780, DOI 10.1046/j.1471-4159.2003.02054.x; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Bohm C, 2006, J BIOL CHEM, V281, P14547, DOI 10.1074/jbc.M601660200; Cramer JF, 2010, TRAFFIC, V11, P259, DOI 10.1111/j.1600-0854.2009.01017.x; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Dodson SE, 2008, J NEUROSCI, V28, P12877, DOI 10.1523/JNEUROSCI.4582-08.2008; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fukata Y, 1999, J CELL BIOL, V145, P347, DOI 10.1083/jcb.145.2.347; Goto H, 1998, J BIOL CHEM, V273, P11728, DOI 10.1074/jbc.273.19.11728; Hampe W, 2000, J CELL SCI, V113, P4475; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; Hashimoto R, 1999, BIOCHEM BIOPH RES CO, V263, P575, DOI 10.1006/bbrc.1999.1409; Hayashida K, 2010, ANAT REC, V293, P925, DOI 10.1002/ar.20757; Herskowitz JH, 2010, J PROTEOME RES, V9, P6368, DOI 10.1021/pr100666c; HUNG AY, 1994, EMBO J, V13, P534, DOI 10.1002/j.1460-2075.1994.tb06291.x; Ikenoya M, 2002, J NEUROCHEM, V81, P9, DOI 10.1046/j.1471-4159.2002.00801.x; Jacobsen L, 2002, FEBS LETT, V511, P155, DOI 10.1016/S0014-5793(01)03299-9; Jacobsen L, 1996, J BIOL CHEM, V271, P31379, DOI 10.1074/jbc.271.49.31379; Jacobsen L, 2001, J BIOL CHEM, V276, P22788, DOI 10.1074/jbc.M100857200; Kaneko T, 2000, BIOCHEM BIOPH RES CO, V273, P110, DOI 10.1006/bbrc.2000.2901; Kang JH, 2007, BIOCHIMIE, V89, P39, DOI 10.1016/j.biochi.2006.08.003; Kawano Y, 1999, J CELL BIOL, V147, P1023, DOI 10.1083/jcb.147.5.1023; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kosako H, 1997, J BIOL CHEM, V272, P10333; Kubo Takekazu, 2008, Ther Clin Risk Manag, V4, P605; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Motoi Y, 1999, BRAIN RES, V833, P209, DOI 10.1016/S0006-8993(99)01542-5; Nagumo H, 2001, BIOCHEM BIOPH RES CO, V280, P605, DOI 10.1006/bbrc.2000.4179; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Nielsen MS, 2007, MOL CELL BIOL, V27, P6842, DOI 10.1128/MCB.00815-07; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nyborg AC, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-3; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Pedrini S, 2005, PLOS MED, V2, P69, DOI 10.1371/journal.pmed.0020018; Puertollano R, 2001, SCIENCE, V292, P1712, DOI 10.1126/science.1060750; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943; Rohe M, 2008, J BIOL CHEM, V283, P14826, DOI 10.1074/jbc.M710574200; Sager KL, 2007, ANN NEUROL, V62, P640, DOI 10.1002/ana.21190; Sasaki Y, 2003, J PHARMACOL SCI, V93, P35, DOI 10.1254/jphs.93.35; Sasaki Y, 2002, PHARMACOL THERAPEUT, V93, P225, DOI 10.1016/S0163-7258(02)00191-2; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Schilling O, 2010, NAT METHODS, V7, P508, DOI [10.1038/NMETH.1467, 10.1038/nmeth.1467]; Schmandke A, 2007, NEUROSCIENTIST, V13, P454, DOI 10.1177/1073858407303611; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Taira K, 2001, ARTERIOSCL THROM VAS, V21, P1501, DOI 10.1161/hq0901.094500; Xia QW, 2008, J PROTEOME RES, V7, P2845, DOI 10.1021/pr8000496; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; Xu P, 2009, J PROTEOME RES, V8, P3944, DOI 10.1021/pr900251d; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Zhou FF, 2004, BIOCHEM BIOPH RES CO, V325, P1443, DOI 10.1016/j.bbrc.2004.11.001; Zhou Y, 2003, SCIENCE, V302, P1215, DOI 10.1126/science.1090154; Zhu YX, 2001, SCIENCE, V292, P1716, DOI 10.1126/science.1060896	59	45	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6117	6127		10.1074/jbc.M110.167239	http://dx.doi.org/10.1074/jbc.M110.167239			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21147781	hybrid, Green Published			2022-12-27	WOS:000287476400021
J	Joshi, S; Sharma, B; Kaur, S; Majchrzak, B; Ueda, T; Fukunaga, R; Verma, AK; Fish, EN; Platanias, LC				Joshi, Sonali; Sharma, Bhumika; Kaur, Surinder; Majchrzak, Beata; Ueda, Takeshi; Fukunaga, Rikiro; Verma, Amit K.; Fish, Eleanor N.; Platanias, Leonidas C.			Essential Role for Mnk Kinases in Type II Interferon (IFN gamma) Signaling and Its Suppressive Effects on Normal Hematopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; INITIATION-FACTOR 4E; CAP-INDEPENDENT TRANSLATION; TUMOR-NECROSIS-FACTOR; REGULATORY FACTOR-I; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSCRIPTIONAL ACTIVATION; EIF4E PHOSPHORYLATION; PROGENITOR CELLS; CELLULAR-RESPONSES	IFN gamma exhibits potent antitumor effects and plays important roles in the innate immunity against cancer. However, the mechanisms accounting for the antiproliferative effects of IFN gamma still remain to be elucidated. We examined the role of Mnk1 (MAPK-interacting protein kinase 1) in IFN gamma signaling. Our data demonstrate that IFN gamma treatment of sensitive cells results in engagement of Mnk1, activation of its kinase domain, and downstream phosphorylation of the cap-binding protein eIF4E on Ser-209. Such engagement of Mnk1 plays an important role in IFN gamma-induced IRF-1 (IFN regulatory factor 1) gene mRNA translation/protein expression and is essential for generation of antiproliferative responses. In studies aimed to determine the role of Mnk1 in the induction of the suppressive effects of IFNs on primitive hematopoietic progenitors, we found that siRNA-mediated Mnk1/2 knockdown results in partial reversal of the suppressive effects of IFN gamma on human CD34+-derived myeloid (CFU-GM) and erythroid (BFU-E) progenitors. These findings establish a key role for the Mnk/eIF4E pathway in the regulatory effects of IFN gamma on normal hematopoiesis and identify Mnk kinases as important elements in the control of IFN gamma-inducible ISG mRNA translation.	[Platanias, Leonidas C.] Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Platanias, Leonidas C.] Northwestern Univ, Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60611 USA; [Majchrzak, Beata; Fish, Eleanor N.] Univ Toronto, Toronto Res Inst, Div Cell & Mol Biol, Univ Hlth Network, Toronto, ON M5G2M1, Canada; [Majchrzak, Beata; Fish, Eleanor N.] Univ Toronto, Dept Immunol, Toronto, ON M5G2M1, Canada; [Ueda, Takeshi] Hiroshima Univ, Dept Dis Model, Res Inst Radiat Biol & Med, Hiroshima 7378553, Japan; [Fukunaga, Rikiro] Kyoto Univ, Grad Sch Med, Dept Med Chem, Kyoto 6068501, Japan; [Verma, Amit K.] Albert Einstein Coll Med, Dept Med, Div Hematol Oncol, Bronx, NY 10461 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Hiroshima University; Kyoto University; Yeshiva University; Albert Einstein College of Medicine	Platanias, LC (corresponding author), Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, 303 E Super St,Lurie 3-107, Chicago, IL 60611 USA.	l-platanias@northwestern.edu	Fukunaga, Rikiro/CAG-2891-2022	Ueda, Takeshi/0000-0001-9823-6764	National Institutes of Health [CA77816, CA121192, AG029138, HL08294]; Department of Veterans Affairs; Malkin Scholars Award; NATIONAL CANCER INSTITUTE [R01CA121192, P30CA060553, R01CA077816] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029138] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); Malkin Scholars Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77816, CA121192, AG029138, and HL08294. This work was also supported by a Merit Review grant from the Department of Veterans Affairs and a Malkin Scholars Award.	Ahmad S, 1997, J BIOL CHEM, V272, P29991, DOI 10.1074/jbc.272.48.29991; Andersson K, 2006, CYTOKINE, V33, P52, DOI 10.1016/j.cyto.2005.11.017; Bianchini A, 2008, CARCINOGENESIS, V29, P2279, DOI 10.1093/carcin/bgn221; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Bouker KB, 2005, CARCINOGENESIS, V26, P1527, DOI 10.1093/carcin/bgi113; Bowie ML, 2008, ADV EXP MED BIOL, V617, P367, DOI 10.1007/978-0-387-69080-3_35; BROXMEYER HE, 1986, J IMMUNOL, V136, P4487; Buard A, 1998, CANCER RES, V58, P840; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Buxade M, 2008, FRONT BIOSCI-LANDMRK, V13, P5359, DOI 10.2741/3086; Buxade M, 2008, J BIOL CHEM, V283, P57, DOI 10.1074/jbc.M705286200; Choudhury GG, 2004, J BIOL CHEM, V279, P27399, DOI 10.1074/jbc.M403530200; DaSilva J, 2006, MOL CELL BIOL, V26, P1898, DOI 10.1128/MCB.26.5.1898-1907.2006; Deb DK, 2003, J IMMUNOL, V171, P267, DOI 10.4049/jimmunol.171.1.267; Dolniak B, 2008, J BIOL CHEM, V283, P12034, DOI 10.1074/jbc.M708816200; FLYNN A, 1995, J BIOL CHEM, V270, P21684, DOI 10.1074/jbc.270.37.21684; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Goetz C, 2010, MOL THER, V18, P1937, DOI 10.1038/mt.2010.145; Hefner Y, 2000, J BIOL CHEM, V275, P37542, DOI 10.1074/jbc.M003395200; Horiuchi M, 2006, J BIOL CHEM, V281, P20095, DOI 10.1074/jbc.M603179200; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; Hu JB, 2001, J BIOL CHEM, V276, P287, DOI 10.1074/jbc.M004885200; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Ishida M, 2003, CIRC RES, V93, P1218, DOI 10.1161/01.RES.0000105570.34585.F2; Joshi S, 2009, P NATL ACAD SCI USA, V106, P12097, DOI 10.1073/pnas.0900562106; Katsoulidis E, 2005, CANCER RES, V65, P9029, DOI 10.1158/0008-5472.CAN-04-4555; Kaur S, 2008, J IMMUNOL, V181, P7316, DOI 10.4049/jimmunol.181.10.7316; Kaur S, 2008, P NATL ACAD SCI USA, V105, P4808, DOI 10.1073/pnas.0710907105; Kaur S, 2007, J BIOL CHEM, V282, P1757, DOI 10.1074/jbc.M607365200; Kroger A, 2003, ONCOGENE, V22, P1045, DOI 10.1038/sj.onc.1206260; Mayer IA, 2001, J BIOL CHEM, V276, P28570, DOI 10.1074/jbc.M011685200; McLaren JE, 2009, CYTOKINE GROWTH F R, V20, P125, DOI 10.1016/j.cytogfr.2008.11.003; Meng QJ, 2005, J IMMUNOL, V174, P6203, DOI 10.4049/jimmunol.174.10.6203; Miller CHT, 2009, ANN NY ACAD SCI, V1182, P69, DOI 10.1111/j.1749-6632.2009.05069.x; Nguyen H, 2001, J BIOL CHEM, V276, P33361, DOI 10.1074/jbc.M105070200; Origanti S, 2007, CANCER RES, V67, P4834, DOI 10.1158/0008-5472.CAN-06-4627; Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x; Platanias LC, 2003, BLOOD, V101, P4667, DOI 10.1182/blood-2002-12-3647; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Platanias LC, 2003, PHARMACOL THERAPEUT, V98, P129, DOI 10.1016/S0163-7258(03)00016-0; Pyronnet S, 2001, GENE DEV, V15, P2083, DOI 10.1101/gad.889201; Rowlett RM, 2008, AM J PHYSIOL-GASTR L, V294, pG452, DOI 10.1152/ajpgi.00077.2007; Roy SK, 2002, P NATL ACAD SCI USA, V99, P7945, DOI 10.1073/pnas.122075799; Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021; Salmenpera P, 2003, AM J PHYSIOL-CELL PH, V284, pC1133, DOI 10.1152/ajpcell.00293.2002; SATO T, 1995, BLOOD, V86, P3373, DOI 10.1182/blood.V86.9.3373.bloodjournal8693373; Scheper GC, 2001, MOL CELL BIOL, V21, P743, DOI 10.1128/MCB.21.3.743-754.2001; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Srivastava KK, 2004, J BIOL CHEM, V279, P29911, DOI 10.1074/jbc.M401997200; Uddin S, 2000, J BIOL CHEM, V275, P27634; UDDIN S, 1995, J BIOL CHEM, V270, P15938, DOI 10.1074/jbc.270.27.15938; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Ueda T, 2010, P NATL ACAD SCI USA, V107, P13984, DOI 10.1073/pnas.1008136107; Valledor AF, 2008, J IMMUNOL, V180, P4523, DOI 10.4049/jimmunol.180.7.4523; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200; Verma A, 2002, J IMMUNOL, V168, P5984, DOI 10.4049/jimmunol.168.12.5984; Wang XM, 1998, J BIOL CHEM, V273, P9373, DOI 10.1074/jbc.273.16.9373; Wang Y, 2010, GLIA, V58, P195, DOI 10.1002/glia.20912; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Weyand CM, 2011, CURR OPIN RHEUMATOL, V23, P43, DOI 10.1097/BOR.0b013e32833ee946; Wheater MJ, 2010, CANCER BIOL THER, V10, P728, DOI 10.4161/cbt.10.7.12965; Xiao WH, 1997, P NATL ACAD SCI USA, V94, P103, DOI 10.1073/pnas.94.1.103; Young NS, 2006, BLOOD, V108, P2509, DOI 10.1182/blood-2006-03-010777	68	27	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6017	6026		10.1074/jbc.M110.197921	http://dx.doi.org/10.1074/jbc.M110.197921			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21149447	Green Published, hybrid			2022-12-27	WOS:000287476400009
J	Thomas, CJ; Casquilho-Gray, HE; York, J; DeCamp, DL; Dai, DC; Petrilli, EB; Boger, DL; Slayden, RA; Amberg, SM; Sprang, SR; Nunberg, JH				Thomas, Celestine J.; Casquilho-Gray, Hedi E.; York, Joanne; DeCamp, Dianne L.; Dai, Dongcheng; Petrilli, Erin B.; Boger, Dale L.; Slayden, Richard A.; Amberg, Sean M.; Sprang, Stephen R.; Nunberg, Jack H.			A Specific Interaction of Small Molecule Entry Inhibitors with the Envelope Glycoprotein Complex of the Junin Hemorrhagic Fever Arenavirus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STABLE SIGNAL PEPTIDE; CHORIOMENINGITIS VIRUS GLYCOPROTEIN; RECOMBINANT VACCINIA VIRUS; PH-INDUCED ACTIVATION; IMPORTED LASSA FEVER; MEMBRANE-FUSION; INFLUENZA HEMAGGLUTININ; REVERSE-TRANSCRIPTASE; AMINO-ACID; GP-C	Arenaviruses are responsible for acute hemorrhagic fevers worldwide and are recognized to pose significant threats to public health and biodefense. Small molecule compounds have recently been discovered that inhibit arenavirus entry and protect against lethal infection in animal models. These chemically distinct inhibitors act on the tripartite envelope glycoprotein (GPC) through its unusual stable signal peptide subunit to stabilize the complex against pH-induced activation of membrane fusion in the endosome. Here, we report the production and characterization of the intact transmembrane GPC complex of Junin arenavirus and its interaction with these inhibitors. The solubilized GPC is antigenically indistinguishable from the native protein and forms a homogeneous trimer in solution. When reconstituted into a lipid bilayer, the purified complex interacts specifically with its cell-surface receptor transferrin receptor-1. We show that small molecule entry inhibitors specific to New World or Old World arenaviruses bind to the membrane-associated GPC complex in accordance with their respective species selectivities and with dissociation constants comparable with concentrations that inhibit GPC-mediated membrane fusion. Furthermore, competitive binding studies reveal that these chemically distinct inhibitors share a common binding pocket on GPC. In conjunction with previous genetic studies, these findings identify the pH-sensing interface of GPC as a highly vulnerable target for antiviral intervention. This work expands our mechanistic understanding of arenavirus entry and provides a foundation to guide the development of small molecule compounds for the treatment of arenavirus hemorrhagic fevers.	[Thomas, Celestine J.; DeCamp, Dianne L.; Sprang, Stephen R.] Univ Montana, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA; [Thomas, Celestine J.; Sprang, Stephen R.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Casquilho-Gray, Hedi E.; York, Joanne; Nunberg, Jack H.] Univ Montana, Montana Biotechnol Ctr, Missoula, MT 59812 USA; [DeCamp, Dianne L.] Univ Montana, Dept Biomed & Pharmaceut Sci, Missoula, MT 59812 USA; [Dai, Dongcheng; Amberg, Sean M.] SIGA Technol Inc, Corvallis, OR 97333 USA; [Petrilli, Erin B.; Slayden, Richard A.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Boger, Dale L.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	University of Montana System; University of Montana; University of Montana System; University of Montana; University of Montana System; University of Montana; University of Montana System; University of Montana; Colorado State University; Scripps Research Institute	Thomas, CJ (corresponding author), Univ Montana, Ctr Biomol Struct & Dynam, Missoula, MT 59812 USA.	celestine.thomas@umontana.edu; jack.nunberg@umontana.edu	Slayden, Richard/O-8626-2016; Slayden, Richard/AAV-2582-2021	Slayden, Richard/0000-0001-6857-7277; Slayden, Richard/0000-0001-6857-7277	National Institutes of Health [R01 AI074818, U54 AI065357, P01 CA078045]; Rocky Mountain Regional Center of Excellence for Biodefense and Emerging Infectious Diseases; NATIONAL CANCER INSTITUTE [P01CA078045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074818, U54AI065357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rocky Mountain Regional Center of Excellence for Biodefense and Emerging Infectious Diseases; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AI074818 and U54 AI065357 (to J. H. N.) and P01 CA078045 (to D. L. B.). D. Dai and S. Amberg are employees of SIGA Technologies, which has interests in the compounds reported.; Recipient of a Rocky Mountain Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research Travel award.	Abraham J, 2010, NAT STRUCT MOL BIOL, V17, P438, DOI 10.1038/nsmb.1772; Agnihothram SS, 2007, J VIROL, V81, P4331, DOI 10.1128/JVI.02779-06; Agnihothram SS, 2006, J VIROL, V80, P5189, DOI 10.1128/JVI.00208-06; Amorosa V, 2010, EMERG INFECT DIS, V16, P1598, DOI 10.3201/eid1610.100774; Beyer WR, 2003, J VIROL, V77, P2866, DOI 10.1128/JVI.77.5.2866-2872.2003; Beyer WR, 2001, J VIROL, V75, P1061, DOI 10.1128/JVI.75.2.1061-1064.2001; Bolken TC, 2006, ANTIVIR RES, V69, P86, DOI 10.1016/j.antiviral.2005.10.008; Briknarova K, 2011, J BIOL CHEM, V286, P1528, DOI 10.1074/jbc.M110.166025; Buchmeier MJ., 2007, FIELDS VIROLOGY, P1791; Capul AA, 2007, J VIROL, V81, P9451, DOI 10.1128/JVI.00499-07; Chen J, 1998, CELL, V95, P409, DOI 10.1016/S0092-8674(00)81771-7; De Clercq E, 2004, CHEM BIODIVERS, V1, P44, DOI 10.1002/cbdv.200490012; Delgado S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000047; Department of Health and Human Services, 2007, FED REG, V72, P20117; EARL PL, 1990, P NATL ACAD SCI USA, V87, P648, DOI 10.1073/pnas.87.2.648; Eichler R, 2003, EMBO REP, V4, P1084, DOI 10.1038/sj.embor.7400002; Eschli B, 2006, J VIROL, V80, P5897, DOI 10.1128/JVI.00008-06; ESNOUF R, 1995, NAT STRUCT BIOL, V2, P303, DOI 10.1038/nsb0495-303; Froeschke M, 2003, J BIOL CHEM, V278, P41914, DOI 10.1074/jbc.M302343200; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; Haas WH, 2003, CLIN INFECT DIS, V36, P1254, DOI 10.1086/374853; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; Hoffman LR, 1997, J VIROL, V71, P8808, DOI 10.1128/JVI.71.11.8808-8820.1997; Jorgensen WL, 2006, BIOORG MED CHEM LETT, V16, P663, DOI 10.1016/j.bmcl.2005.10.038; Larson RA, 2008, J VIROL, V82, P10768, DOI 10.1128/JVI.00941-08; Lee AM, 2008, J BIOL CHEM, V283, P18734, DOI 10.1074/jbc.M802089200; Lenz O, 2001, P NATL ACAD SCI USA, V98, P12701, DOI 10.1073/pnas.221447598; MARTIN YC, 1998, DESIGNING BIOACTIVE, P121; MATSUURA Y, 1987, J GEN VIROL, V68, P1233, DOI 10.1099/0022-1317-68-5-1233; MCCORMICK JB, 1987, J INFECT DIS, V155, P437, DOI 10.1093/infdis/155.3.437; NIAID, 2011, NIAID CAT A B C PRIO; NUSSBAUM O, 1994, J VIROL, V68, P5411, DOI 10.1128/JVI.68.9.5411-5422.1994; Palacios G, 2010, J GEN VIROL, V91, P1315, DOI 10.1099/vir.0.017798-0; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Peters CJ, 2002, CURR TOP MICROBIOL, V262, P65; Radoshitzky SR, 2008, P NATL ACAD SCI USA, V105, P2664, DOI 10.1073/pnas.0709254105; Reed ML, 2009, J VIROL, V83, P3568, DOI 10.1128/JVI.02238-08; Rojek JM, 2008, J VIROL, V82, P6045, DOI 10.1128/JVI.02392-07; Russell RJ, 2008, P NATL ACAD SCI USA, V105, P17736, DOI 10.1073/pnas.0807142105; SANCHEZ A, 1989, J GEN VIROL, V70, P1125, DOI 10.1099/0022-1317-70-5-1125; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stenlund P, 2003, ANAL BIOCHEM, V316, P243, DOI 10.1016/S0003-2697(03)00046-0; Thoennes S, 2008, VIROLOGY, V370, P403, DOI 10.1016/j.virol.2007.08.035; Thomas CJ, 1998, J AM CHEM SOC, V120, P12428, DOI 10.1021/ja981777j; Vanderlinden E, 2010, J VIROL, V84, P4277, DOI 10.1128/JVI.02325-09; White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]; York J, 2005, VIROLOGY, V343, P267, DOI 10.1016/j.virol.2005.08.030; York J, 2004, J VIROL, V78, P10783, DOI 10.1128/JVI.78.19.10783-10792.2004; York J, 2008, J VIROL, V82, P10932, DOI 10.1128/JVI.01140-08; York J, 2006, J VIROL, V80, P7775, DOI 10.1128/JVI.00642-06; York J, 2010, J VIROL, V84, P6119, DOI 10.1128/JVI.02700-09; York J, 2009, J VIROL, V83, P4121, DOI 10.1128/JVI.02410-08	52	36	36	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6192	6200		10.1074/jbc.M110.196428	http://dx.doi.org/10.1074/jbc.M110.196428			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21159779	Green Published, hybrid			2022-12-27	WOS:000287476400028
J	Geiger, R; Gautschi, M; Thor, F; Hayer, A; Helenius, A				Geiger, Roger; Gautschi, Matthias; Thor, Friederike; Hayer, Arnold; Helenius, Ari			Folding, Quality Control, and Secretion of Pancreatic Ribonuclease in Live Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; DISULFIDE BONDS; G-PROTEIN; ER; PATHWAY; GLYCOSYLATION; GLYCOPROTEINS; STABILITY; CALNEXIN; DISEASES	Although bovine pancreatic RNase is one of the best characterized proteins in respect to structure and in vitro refolding, little is known about its synthesis and maturation in the endoplasmic reticulum (ER) of live cells. We expressed the RNase in live cells and analyzed its folding, quality control, and secretion using pulse-chase analysis and other cell biological techniques. In contrast to the slow in vitro refolding, the protein folded almost instantly after translation and translocation into the ER lumen (t(1/2) < 3 min). Despite high stability of the native protein, only about half of the RNase reached a secretion competent, monomeric form and was rapidly transported from the rough ER via the Golgi complex (t(1/2) = 16 min) to the extracellular space (t(1/2) = 35 min). The rest remained in the ER mainly in the form of dimers and was slowly degraded. The dimers were most likely formed by C-terminal domain swapping since mutation of Asn(113), a residue that stabilizes such dimers, to Ser increased the efficiency of secretion from 59 to 75%. Consistent with stringent ER quality control in vivo, the secreted RNase in the bovine pancreas was mainly monomeric, whereas the enzyme present in the cells also contained 20% dimers. These results suggest that the efficiency of secretion is not only determined by the stability of the native protein but by multiple factors including the stability of secretion-incompetent side products of folding. The presence of N-glycans had little effect on the folding and secretion process.	[Geiger, Roger; Gautschi, Matthias; Thor, Friederike; Hayer, Arnold; Helenius, Ari] ETH, Inst Biochem, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Helenius, A (corresponding author), Schafmattstr 18, CH-8093 Zurich, Switzerland.	ari.helenius@bc.biol.ethz.ch	Hayer, Arnold/W-8863-2019	Hayer, Arnold/0000-0001-7808-8880; Geiger, Roger/0000-0002-8016-1669	Swiss National Research Foundation; ETH Zurich	Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); ETH Zurich(ETH Zurich)	This work was supported by the Swiss National Research Foundation and ETH Zurich.	ALLEN S, 1995, J BIOL CHEM, V270, P4797, DOI 10.1074/jbc.270.9.4797; ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309; Arnold U, 1997, BIOCHEMISTRY-US, V36, P2166, DOI 10.1021/bi962723u; Bolt G, 2005, GLYCOBIOLOGY, V15, P541, DOI 10.1093/glycob/cwi032; BRAAKMAN I, 1992, NATURE, V356, P260, DOI 10.1038/356260a0; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; CRESTFIELD AM, 1962, ARCH BIOCHEM BIOPHYS, P217; Deprez P, 2005, MOL CELL, V19, P183, DOI 10.1016/j.molcel.2005.05.029; DESILVA A, 1993, J CELL BIOL, V120, P647, DOI 10.1083/jcb.120.3.647; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; FRIES E, 1984, EMBO J, V3, P147, DOI 10.1002/j.1460-2075.1984.tb01775.x; HAMMOND C, 1994, SCIENCE, V266, P456, DOI 10.1126/science.7939687; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; HIRS CHW, 1953, J BIOL CHEM, V200, P493; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Kleizen B, 2005, MOL CELL, V20, P277, DOI 10.1016/j.molcel.2005.09.007; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kowalski JM, 1998, BIOCHEMISTRY-US, V37, P1264, DOI 10.1021/bi9722397; LAITY JH, 1993, P NATL ACAD SCI USA, V90, P615, DOI 10.1073/pnas.90.2.615; Libonati M, 1996, BIOCHEM J, V318, P287, DOI 10.1042/bj3180287; Liu YS, 2001, NAT STRUCT BIOL, V8, P211, DOI 10.1038/84941; LODISH HF, 1993, J BIOL CHEM, V268, P20598; Maeda T, 2002, J BIOCHEM, V132, P737, DOI 10.1093/oxfordjournals.jbchem.a003281; Mancini R, 2003, J BIOL CHEM, V278, P46895, DOI 10.1074/jbc.M302979200; Park C, 2000, PROTEIN SCI, V9, P2026, DOI 10.1110/ps.9.10.2026; Pearce FG, 2009, BIOCHEM BIOPH RES CO, V382, P114, DOI 10.1016/j.bbrc.2009.02.142; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h; Ritter C, 2005, EMBO J, V24, P1730, DOI 10.1038/sj.emboj.7600645; Russo N, 2000, BIOCHEMISTRY-US, V39, P3585, DOI 10.1021/bi992367q; SCHULTZ DA, 1992, PROTEIN SCI, V1, P917, DOI 10.1002/pro.5560010710; Sohda M, 2005, BIOCHEM BIOPH RES CO, V338, P1268, DOI 10.1016/j.bbrc.2005.10.084; Thor F, 2009, TRAFFIC, V10, P1819, DOI 10.1111/j.1600-0854.2009.00989.x; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P191, DOI 10.1080/10409230591008161; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang N, 2006, PIGM CELL RES, V19, P3, DOI 10.1111/j.1600-0749.2005.00288.x; Wedemeyer WJ, 2000, BIOCHEMISTRY-US, V39, P4207, DOI 10.1021/bi992922o; Wiseman RL, 2007, CELL, V131, P809, DOI 10.1016/j.cell.2007.10.025; Xu GQ, 2005, BIOCHEMISTRY-US, V44, P9817, DOI 10.1021/bi0506932; Zapun A, 1998, J BIOL CHEM, V273, P6009, DOI 10.1074/jbc.273.11.6009	42	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5813	5822		10.1074/jbc.M110.171694	http://dx.doi.org/10.1074/jbc.M110.171694			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21156800	hybrid, Green Published			2022-12-27	WOS:000287230600090
J	Mandal, CC; Ghosh-Choudhury, N; Yoneda, T; Choudhury, GG; Ghosh-Choudhury, N				Mandal, Chandi Charan; Ghosh-Choudhury, Nayana; Yoneda, Toshi; Choudhury, Goutam Ghosh; Ghosh-Choudhury, Nandini			Simvastatin Prevents Skeletal Metastasis of Breast Cancer by an Antagonistic Interplay between p53 and CD44	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; CELL-LINES; STEM-CELLS; LUNG METASTASIS; ANTICANCER AGENTS; BINDING PROTEIN; BONE METASTASES; MUTANT P53; EXPRESSION; GROWTH	Substantial data from clinical trials and epidemiological studies show promising results for use of statins in many cancers, including mammary carcinoma. Breast tumor primarily metastasizes to bone to form osteolytic lesions, causing severe pain and pathological fracture. Here, we report that simvastatin acts as an inhibitor of osteolysis in a mouse model of breast cancer skeletal metastasis of human mammary cancer cell MDA-MB-231, which expresses the mutant p53R280K. Simvastatin and lovastatin attenuated migration and invasion of MDA-MB- 231 and BT-20 breast tumor cells in culture. Acquisition of phenotype to express the cancer stem cell marker, CD44, leads to invasive potential of the tumor cells. Interestingly, statins significantly decreased the expression of CD44 protein via a transcriptional mechanism. shRNA-mediated down-regulation of CD44 markedly reduced the migration and invasion of breast cancer cells in culture. We identified that in the MDA-MB-231 cells, simvastatin elevated the levels of mutated p53R280K, which was remarkably active as a transcription factor. shRNA-derived inhibition of mutant p53R280K augmented the expression of CD44, leading to increased migration and invasion. Finally, we demonstrate an inverse correlation between expression of p53 and CD44 in the tumors of mice that received simvastatin. Our results reveal a unique function of statins, which foster enhanced expression of mutant p53R280K to prevent breast cancer cell metastasis to bone.	[Yoneda, Toshi; Choudhury, Goutam Ghosh; Ghosh-Choudhury, Nandini] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Mandal, Chandi Charan; Ghosh-Choudhury, Nayana; Ghosh-Choudhury, Nandini] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Choudhury, Goutam Ghosh] S Texas Vet Hlth Care Syst, Ctr Geriatr Res Educ & Clin, San Antonio, TX 78229 USA; [Choudhury, Goutam Ghosh] S Texas Vet Hlth Care Syst, Vet Affairs Res, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Choudhury, GG (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA.	choudhuryg@uthscsa.edu; choudhury@uthscsa.edu		Mandal, Chandi/0000-0002-2292-6635	National Institutes of Health [RO1 AR52425, ROI DK50190]; Veterans Affairs; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050190] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AR52425 (to N.G.-C.) and ROI DK50190 (to G.G.C.) This work was also supported by Veterans Affairs merit review grants (to N.G.-C. and G.G.C.).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bange J, 2002, CANCER RES, V62, P840; Barbour AP, 2003, CANCER RES, V63, P887; Beck P, 2003, J CLIN EPIDEMIOL, V56, P280, DOI 10.1016/S0895-4356(02)00614-5; Brazda V, 2006, BIOCHEM BIOPH RES CO, V351, P499, DOI 10.1016/j.bbrc.2006.10.065; Cauley JA, 2003, J WOMENS HEALTH, V12, P749, DOI 10.1089/154099903322447710; Chan KKW, 2003, CLIN CANCER RES, V9, P10; Charafe-Jauffret E, 2006, ONCOGENE, V25, P2273, DOI 10.1038/sj.onc.1209254; Chu MC, 2004, CANCER BIOL THER, V3, P568, DOI 10.4161/cbt.3.6.848; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Concin N, 2003, BREAST CANCER RES TR, V79, P37, DOI 10.1023/A:1023351717408; Damm S, 2010, J INVEST DERMATOL, V130, P1893, DOI 10.1038/jid.2010.45; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; Dey N, 2010, J CELL PHYSIOL, V225, P27, DOI 10.1002/jcp.22186; Dontu G, 2005, STEM CELL REV, V1, P207, DOI 10.1385/SCR:1:3:207; Edwards DR, 1998, NATURE, V394, P527, DOI 10.1038/28961; Evan GI, 2008, CANCER CELL, V14, P108, DOI 10.1016/j.ccr.2008.07.012; Fitzgerald KA, 1999, J IMMUNOL, V162, P4920; Ghosh-Choudhury N, 2007, J BIOL CHEM, V282, P4983, DOI 10.1074/jbc.M606706200; Ghosh-Choudhury N, 2006, J BIOL CHEM, V281, P20160, DOI 10.1074/jbc.M511071200; Ghosh-Choudhury N, 2010, CELL SIGNAL, V22, P749, DOI 10.1016/j.cellsig.2009.12.010; Ghosh-Choudhury T, 2009, BREAST CANCER RES TR, V118, P213, DOI 10.1007/s10549-008-0227-7; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gordon LA, 2003, INT J CANCER, V106, P8, DOI 10.1002/ijc.11172; Graaf MR, 2004, J CLIN ONCOL, V22, P2388, DOI 10.1200/JCO.2004.02.027; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; HARVEY M, 1995, NAT GENET, V9, P305, DOI 10.1038/ng0395-305; Hayes DF, 2007, NEW ENGL J MED, V357, P1496, DOI 10.1056/NEJMoa071167; Hiraga T, 2001, CANCER RES, V61, P4418; HSIAO M, 1994, AM J PATHOL, V145, P702; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; Li F, 2007, CELL RES, V17, P3, DOI 10.1038/sj.cr.7310118; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; Mandal CC, 2009, ENDOCRINOLOGY, V150, P4989, DOI 10.1210/en.2009-0026; Mandal CC, 2010, CALCIFIED TISSUE INT, V87, P533, DOI 10.1007/s00223-010-9419-3; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Monti P, 2002, ONCOGENE, V21, P1641, DOI 10.1038/sj.onc.1205250; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nakamura H, 2008, J BONE MINER METAB, V26, P642, DOI 10.1007/s00774-008-0857-1; Naor D, 2008, SEMIN CANCER BIOL, V18, P260, DOI 10.1016/j.semcancer.2008.03.015; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; OConnor PM, 1997, CANCER RES, V57, P4285; Orian-Rousseau V, 2010, EUR J CANCER, V46, P1271, DOI 10.1016/j.ejca.2010.02.024; Ouhtit A, 2007, AM J PATHOL, V171, P2033, DOI 10.2353/ajpath.2007.070535; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Rao S, 1999, P NATL ACAD SCI USA, V96, P7797, DOI 10.1073/pnas.96.14.7797; Recio JA, 2003, CANCER RES, V63, P1576; Ries L., 2005, SEER CANC STAT REV 1; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Smid M, 2006, J CLIN ONCOL, V24, P2261, DOI 10.1200/JCO.2005.03.8802; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Toy EP, 2005, CLIN EXP METASTAS, V22, P1, DOI 10.1007/s10585-005-0718-4; Ukomadu C, 2003, J BIOL CHEM, V278, P43586, DOI 10.1074/jbc.M307194200; Wang SP, 2009, NAT CELL BIOL, V11, P694, DOI 10.1038/ncb1875; Weber GF, 2008, CANCER LETT, V270, P181, DOI 10.1016/j.canlet.2008.04.030; Weber GF, 2002, CANCER RES, V62, P2281; Weinberg RA, 2008, NAT CELL BIOL, V10, P1021, DOI 10.1038/ncb0908-1021; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Wu JH, 2004, CANCER RES, V64, P6461, DOI 10.1158/0008-5472.CAN-04-0866; Yin JJ, 1999, J CLIN INVEST, V103, P197, DOI 10.1172/JCI3523; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Zilfou JT, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001883	71	88	91	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11314	11327		10.1074/jbc.M110.193714	http://dx.doi.org/10.1074/jbc.M110.193714			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21199873	hybrid, Green Published			2022-12-27	WOS:000288797100044
J	Rul, F; Ben-Yahia, L; Chegdani, F; Wrzosek, L; Thomas, S; Noordine, ML; Gitton, C; Cherbuy, C; Langella, P; Thomas, M				Rul, Francoise; Ben-Yahia, Leila; Chegdani, Fatima; Wrzosek, Laura; Thomas, Stephane; Noordine, Marie-Louise; Gitton, Christophe; Cherbuy, Claire; Langella, Philippe; Thomas, Muriel			Impact of the Metabolic Activity of Streptococcus thermophilus on the Colon Epithelium of Gnotobiotic Rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE DIGESTIVE-TRACT; CELL-CYCLE; LACTOBACILLUS-PLANTARUM; SMALL-INTESTINE; GASTROINTESTINAL-TRACT; LACTOSE-INTOLERANCE; LACTOCOCCUS-LACTIS; HEALTHY-VOLUNTEERS; ESCHERICHIA-COLI; HUMAN GUT	The thermophilic lactic acid bacterium Streptococcus thermophilus is widely and traditionally used in the dairy industry. Despite the vast level of consumption of S. thermophilus through yogurt or probiotic functional food, very few data are available about its physiology in the gastrointestinal tract (GIT). The objective of the present work was to explore both the metabolic activity and host response of S. thermophilus in vivo. Our study profiles the protein expression of S. thermophilus after its adaptation to the GIT of gnotobiotic rats and describes the impact of S. thermophilus colonization on the colonic epithelium. S. thermophilus colonized progressively the GIT of germ-free rats to reach a stable population in 30 days (10(8) cfu/g of feces). This progressive colonization suggested that S. thermophilus undergoes an adaptation process within GIT. Indeed, we showed that the main response of S. thermophilus in the rat's GIT was the massive induction of the glycolysis pathway, leading to formation of lactate in the cecum. At the level of the colonic epithelium, the abundance of monocarboxylic acid transporter mRNAs (SLC16A1 and SLC5A8) and a protein involved in the cell cycle arrest (p27(kip1)) increased in the presence of S. thermophilus compared with germ-free rats. Based on different mono-associated rats harboring two different strains of S. thermophilus (LMD-9 or LMG18311) or weak lactate-producing commensal bacteria (Bacteroides thetaiotaomicron and Ruminococcus gnavus), we propose that lactate could be a signal produced by S. thermophilus and modulating the colon epithelium.	[Rul, Francoise; Ben-Yahia, Leila; Chegdani, Fatima; Wrzosek, Laura; Thomas, Stephane; Noordine, Marie-Louise; Gitton, Christophe; Cherbuy, Claire; Langella, Philippe; Thomas, Muriel] INRA, MICALIS UMR 1319, F-78352 Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Rul, F (corresponding author), INRA, MICALIS UMR 1319, Domaine Vilvert, F-78352 Jouy En Josas, France.	francoise.rul@jouy.inra.fr; muriel.thomas@jouy.inra.fr	thomas, muriel/HDO-3887-2022; Chegdani, Fatima/AAW-9322-2021; Langella, Philippe/N-8368-2017	Chegdani, Fatima/0000-0002-2473-0302; Langella, Philippe/0000-0001-5960-4341; Rul, Francoise/0000-0002-7093-3098	Syndifrais-CNIEL (Paris, France)	Syndifrais-CNIEL (Paris, France)	This work was supported by Syndifrais-CNIEL (Paris, France).	ALAM M, 1994, SCAND J GASTROENTERO, V29, P445, DOI 10.3109/00365529409096836; Alpert C, 2009, ENVIRON MICROBIOL, V11, P751, DOI 10.1111/j.1462-2920.2008.01798.x; Beganovic J, 2010, J PROTEOME RES, V9, P677, DOI 10.1021/pr9000866; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; Bolotin A, 2004, NAT BIOTECHNOL, V22, P1554, DOI 10.1038/nbt1034; Bron PA, 2004, J BACTERIOL, V186, P5721, DOI 10.1128/JB.186.17.5721-5729.2004; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; CHERBUY C, 1995, GASTROENTEROLOGY, V109, P1890, DOI 10.1016/0016-5085(95)90756-4; Cherbuy C, 2010, AM J PHYSIOL-GASTR L, V299, pG348, DOI 10.1152/ajpgi.00384.2009; Chiaramonte F, 2009, APPL ENVIRON MICROB, V75, P4498, DOI 10.1128/AEM.02868-08; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cresci GA, 2010, J GASTROINTEST SURG, V14, P449, DOI 10.1007/s11605-009-1045-x; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Derzelle S, 2005, APPL ENVIRON MICROB, V71, P8597, DOI 10.1128/AEM.71.12.8597-8605.2005; Drouault S, 2002, APPL ENVIRON MICROB, V68, P938, DOI 10.1128/AEM.68.2.938-941.2002; Druesne N, 2004, CARCINOGENESIS, V25, P1227, DOI 10.1093/carcin/bgh123; Elli M, 2006, APPL ENVIRON MICROB, V72, P5113, DOI 10.1128/AEM.02950-05; Firmesse O, 2008, INT J FOOD MICROBIOL, V125, P176, DOI 10.1016/j.ijfoodmicro.2008.03.044; Frank H, 2008, J BIOL CHEM, V283, P24729, DOI 10.1074/jbc.M802681200; Ganapathy V, 2008, AAPS J, V10, P193, DOI 10.1208/s12248-008-9022-y; Gardan R, 2009, J BACTERIOL, V191, P4647, DOI 10.1128/JB.00257-09; Giraud A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040002; Guarner F, 2005, BRIT J NUTR, V93, pS61, DOI 10.1079/BJN20041345; He T, 2008, EUR J CLIN INVEST, V38, P541, DOI 10.1111/j.1365-2362.2008.01966.x; Herve-Jimenez L, 2008, PROTEOMICS, V8, P4273, DOI 10.1002/pmic.200700489; Higashikawa F, 2010, NUTRITION, V26, P367, DOI 10.1016/j.nut.2009.05.008; Hols P, 2005, FEMS MICROBIOL REV, V29, P435, DOI 10.1016/j.femsre.2005.04.008; HOVE H, 1995, DIGEST DIS SCI, V40, P320, DOI 10.1007/BF02065417; HOVE H, 1995, DIGEST DIS SCI, V40, P1372, DOI 10.1007/BF02065554; HOVE H, 1993, GUT, V34, P625, DOI 10.1136/gut.34.5.625; Hsiao YP, 2009, J DERMATOL SCI, V54, P175, DOI 10.1016/j.jdermsci.2009.02.012; Joly F, 2010, BIOCHIMIE, V92, P753, DOI 10.1016/j.biochi.2010.02.015; Lomer MCE, 2008, ALIMENT PHARM THER, V27, P93, DOI 10.1111/j.1365-2036.2007.03557.x; Marco ML, 2009, ENVIRON MICROBIOL, V11, P2747, DOI 10.1111/j.1462-2920.2009.02001.x; Marquet P, 2009, FEMS MICROBIOL LETT, V299, P128, DOI 10.1111/j.1574-6968.2009.01750.x; Mater DDG, 2005, FEMS MICROBIOL LETT, V250, P185, DOI 10.1016/j.femsle.2005.07.006; Mater DDG, 2006, BRIT J NUTR, V96, P177, DOI 10.1079/BJN20061724; MOREAU MC, 1986, REPROD NUTR DEV, V26, P745, DOI 10.1051/rnd:19860429; Nougayrede JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002; Pagnini C, 2010, P NATL ACAD SCI USA, V107, P454, DOI 10.1073/pnas.0910307107; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Perez PF, 2007, PEDIATRICS, V119, pE724, DOI 10.1542/peds.2006-1649; Preidis GA, 2009, GASTROENTEROLOGY, V136, P2015, DOI 10.1053/j.gastro.2009.01.072; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rabot S, 2010, J NUTR, V140, p677S, DOI 10.3945/jn.109.113738; Ramiah K, 2007, INT J FOOD MICROBIOL, V116, P405, DOI 10.1016/j.ijfoodmicro.2007.02.011; Roy K, 2008, PROTEOMICS, V8, P1661, DOI 10.1002/pmic.200700698; Samba-Louaka A, 2008, CELL MICROBIOL, V10, P2496, DOI 10.1111/j.1462-5822.2008.01224.x; Shima T, 2008, FEMS IMMUNOL MED MIC, V52, P69, DOI 10.1111/j.1574-695X.2007.00344.x; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Thwaites DT, 2007, EXP PHYSIOL, V92, P603, DOI 10.1113/expphysiol.2005.029959; Veiga P, 2010, P NATL ACAD SCI USA, V107, P18132, DOI 10.1073/pnas.1011737107; Willing BP, 2007, J ANIM SCI, V85, P3256, DOI 10.2527/jas.2007-0320; Yuan J, 2008, J PROTEOME RES, V7, P375, DOI 10.1021/pr0704940; Zheng Y, 2008, CANCER BIOL THER, V7, P873, DOI 10.4161/cbt.7.6.5868	55	37	39	3	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10288	10296		10.1074/jbc.M110.168666	http://dx.doi.org/10.1074/jbc.M110.168666			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21239485	Green Published, hybrid			2022-12-27	WOS:000288547000046
J	Dassau, L; Conti, LR; Radeke, CM; Ptacek, LJ; Vandenberg, CA				Dassau, Lior; Conti, Lisa R.; Radeke, Carolyn M.; Ptacek, Louis J.; Vandenberg, Carol A.			Kir2.6 Regulates the Surface Expression of Kir2.x Inward Rectifier Potassium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE FIBERS; SELECTIVE GOLGI EXPORT; RECTIFYING K+ CHANNEL; ANDERSENS-SYNDROME; PERIODIC PARALYSIS; FUNCTIONAL EXPRESSION; TUBULAR SYSTEM; DISULFIDE BOND; CURRENT I-K1; ER EXPORT	Precise trafficking, localization, and activity of inward rectifier potassium Kir2 channels are important for shaping the electrical response of skeletal muscle. However, how coordinated trafficking occurs to target sites remains unclear. Kir2 channels are tetrameric assemblies of Kir2. x subunits. By immunocytochemistry we show that endogenous Kir2.1 and Kir2.2 are localized at the plasma membrane and T-tubules in rodent skeletal muscle. Recently, a new subunit, Kir2.6, present in human skeletal muscle, was identified as a gene in which mutations confer susceptibility to thyrotoxic hypokalemic periodic paralysis. Here we characterize the trafficking and interaction of wild type Kir2.6 with other Kir2. x in COS-1 cells and skeletal muscle in vivo. Immunocytochemical and electrophysiological data demonstrate that Kir2.6 is largely retained in the endoplasmic reticulum, despite high sequence identity with Kir2.2 and conserved endoplasmic reticulum and Golgi trafficking motifs shared with Kir2.1 and Kir2.2. We identify amino acids responsible for the trafficking differences of Kir2.6. Significantly, we show that Kir2.6 subunits can coassemble with Kir2.1 and Kir2.2 in vitro and in vivo. Notably, this interaction limits the surface expression of both Kir2.1 and Kir2.2. We provide evidence that Kir2.6 functions as a dominant negative, in which incorporation of Kir2.6 as a subunit in a Kir2 channel heterotetramer reduces the abundance of Kir2 channels on the plasma membrane.	[Dassau, Lior; Conti, Lisa R.; Radeke, Carolyn M.; Vandenberg, Carol A.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Dassau, Lior; Conti, Lisa R.; Radeke, Carolyn M.; Vandenberg, Carol A.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Ptacek, Louis J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California San Francisco	Vandenberg, CA (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA.	vandenbe@lifesci.ucsb.edu			American Heart Association Western Affiliate [0655234Y]; Muscular Dystrophy Association [4137]; Cottage Hospital	American Heart Association Western Affiliate(American Heart Association); Muscular Dystrophy Association(Muscular Dystrophy Association); Cottage Hospital	This work was supported by grants from American Heart Association Western Affiliate Grant 0655234Y, the Muscular Dystrophy Association Grant 4137, and the Cottage Hospital Research Program (to C. A. V.).	ALMERS W, 1972, J PHYSIOL-LONDON, V225, P57, DOI 10.1113/jphysiol.1972.sp009929; Anumonwo JMB, 2010, J MOL CELL CARDIOL, V48, P45, DOI 10.1016/j.yjmcc.2009.08.013; ASHCROFT FM, 1985, J PHYSIOL-LONDON, V359, P269, DOI 10.1113/jphysiol.1985.sp015585; Bendahhou S, 2005, J PHYSIOL-LONDON, V565, P731, DOI 10.1113/jphysiol.2004.081620; Bendahhou S, 2003, J BIOL CHEM, V278, P51779, DOI 10.1074/jbc.M310278200; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Bloquel C, 2004, J GENE MED, V6, pS11, DOI 10.1002/jgm.508; Cho HC, 2000, BIOCHEMISTRY-US, V39, P4649, DOI 10.1021/bi992469g; Christe G, 1999, J MOL CELL CARDIOL, V31, P2207, DOI 10.1006/jmcc.1999.1034; Clark RB, 2001, J PHYSIOL-LONDON, V537, P979; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Fang Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1134, DOI 10.1152/ajpcell.00077.2005; FLUCHER BE, 1990, NEURON, V5, P339, DOI 10.1016/0896-6273(90)90170-K; Fontaine B, 2008, ADV GENET, V63, P3, DOI 10.1016/S0065-2660(08)01001-8; Grady RM, 2003, J CELL BIOL, V160, P741, DOI 10.1083/jcb.200209045; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hofherr A, 2005, J CELL SCI, V118, P1935, DOI 10.1242/jcs.02322; Inanobe A, 2002, AM J PHYSIOL-CELL PH, V282, pC1396, DOI 10.1152/ajpcell.00615.2001; Kaisto T, 2003, EXP CELL RES, V289, P47, DOI 10.1016/S0014-4827(03)00231-3; Kristensen M, 2006, AM J PHYSIOL-REG I, V290, pR766, DOI 10.1152/ajpregu.00534.2004; Kung AWC, 2006, J CLIN ENDOCR METAB, V91, P2490, DOI 10.1210/jc.2006-0356; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; Leonoudakis D, 2001, J CELL SCI, V114, P987; Leyland ML, 2004, J BIOL CHEM, V279, P43427, DOI 10.1074/jbc.M407575200; Leyland ML, 1999, PFLUG ARCH EUR J PHY, V438, P778, DOI 10.1007/s004240051106; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; McMahon JM, 2001, GENE THER, V8, P1264, DOI 10.1038/sj.gt.3301522; Melnyk P, 2002, AM J PHYSIOL-HEART C, V283, pH1123, DOI 10.1152/ajpheart.00934.2001; Namba N, 1996, FEBS LETT, V386, P211, DOI 10.1016/0014-5793(96)00445-0; Nehring RB, 2000, J NEUROSCI, V20, P156, DOI 10.1523/JNEUROSCI.20-01-00156.2000; Olsen O, 2002, AM J PHYSIOL-CELL PH, V282, pC183, DOI 10.1152/ajpcell.00249.2001; Ottschytsch N, 2005, J PHYSIOL-LONDON, V568, P737, DOI 10.1113/jphysiol.2005.090142; Panama BK, 2010, PFLUG ARCH EUR J PHY, V460, P839, DOI 10.1007/s00424-010-0864-7; Percival JM, 2007, TRAFFIC, V8, P184, DOI 10.1111/j.1600-0854.2006.00523.x; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Preisig-Muller R, 2002, P NATL ACAD SCI USA, V99, P7774, DOI 10.1073/pnas.102609499; Priori SG, 2005, CIRC RES, V96, P800, DOI 10.1161/01.RES.0000162101.76263.8c; Rahkila P, 1997, EXP CELL RES, V234, P452, DOI 10.1006/excr.1997.3633; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; Ryan DP, 2010, CELL, V140, P88, DOI 10.1016/j.cell.2009.12.024; Sacconi S, 2009, AM J PHYSIOL-CELL PH, V297, pC876, DOI 10.1152/ajpcell.00519.2008; Salinas M, 1997, J BIOL CHEM, V272, P8774, DOI 10.1074/jbc.272.13.8774; SCHNEIDER MF, 1976, J GEN PHYSIOL, V67, P125, DOI 10.1085/jgp.67.2.125; Schram G, 2003, CARDIOVASC RES, V59, P328, DOI 10.1016/S0008-6363(03)00366-3; STANDEN NB, 1979, J PHYSIOL-LONDON, V294, P497, DOI 10.1113/jphysiol.1979.sp012943; Stockklausner C, 2003, J BIOL CHEM, V278, P17000, DOI 10.1074/jbc.M212243200; Stockklausner C, 2001, FEBS LETT, V493, P129, DOI 10.1016/S0014-5793(01)02286-4; Struyk AF, 2008, MUSCLE NERVE, V37, P326, DOI 10.1002/mus.20928; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Vaidyanathan R, 2010, J BIOL CHEM, V285, P28000, DOI 10.1074/jbc.M110.110858; Wallinga W, 1999, EUR BIOPHYS J BIOPHY, V28, P317, DOI 10.1007/s002490050214; WIBLE BA, 1995, CIRC RES, V76, P343, DOI 10.1161/01.RES.76.3.343; Wong SHA, 2005, NEUROMUSCULAR DISORD, V15, P630, DOI 10.1016/j.nmd.2005.04.008; Zaritsky JJ, 2001, J PHYSIOL-LONDON, V533, P697, DOI 10.1111/j.1469-7793.2001.t01-1-00697.x; Zaritsky JJ, 2000, CIRC RES, V87, P160, DOI 10.1161/01.RES.87.2.160; Zobel C, 2003, J PHYSIOL-LONDON, V550, P365, DOI 10.1113/jphysiol.2002.036400	57	30	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9526	9541		10.1074/jbc.M110.170597	http://dx.doi.org/10.1074/jbc.M110.170597			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21209095	Green Published, hybrid			2022-12-27	WOS:000288247700079
J	Kozlov, SV; Graham, ME; Jakob, B; Tobias, F; Kijas, AW; Tanuji, M; Chen, PL; Robinson, PJ; Taucher-Scholz, G; Suzuki, K; So, SR; Chen, DV; Lavin, MF				Kozlov, Sergei V.; Graham, Mark E.; Jakob, Burkhard; Tobias, Frank; Kijas, Amanda W.; Tanuji, Marcel; Chen, Philip; Robinson, Phillip J.; Taucher-Scholz, Gisela; Suzuki, Keiji; So, Sairai; Chen, David; Lavin, Martin F.			Autophosphorylation and ATM Activation ADDITIONAL SITES ADD TO THE COMPLEXITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; DNA-DAMAGE RESPONSE; ATAXIA-TELANGIECTASIA; MRN COMPLEX; NUCLEAR FOCI; N-TERMINUS; PROTEIN; PHOSPHORYLATION; NBS1; RECRUITMENT	The recognition and signaling of DNA double strand breaks involves the participation of multiple proteins, including the protein kinase ATM (mutated in ataxia-telangiectasia). ATM kinase is activated in the vicinity of the break and is recruited to the break site by the Mre11-Rad50-Nbs1 complex, where it is fully activated. In human cells, the activation process involves autophosphorylation on three sites (Ser(367), Ser(1893), and Ser(1981)) and acetylation on Lys(3016). We now describe the identification of a new ATM phosphorylation site, Thr(P)(1885) and an additional autophosphorylation site, Ser(P)(2996), that is highly DNA damage-inducible. We also confirm that human and murine ATM share five identical phosphorylation sites. We targeted the ATM phosphorylation sites, Ser(367) and Ser(2996), for further study by generating phosphospecific antibodies against these sites and demonstrated that phosphorylation of both was rapidly induced by radiation. These phosphorylations were abolished by a specific inhibitor of ATM and were dependent on ATM and the Mre11-Rad50-Nbs1 complex. As found for Ser(P)(1981), ATM phosphorylated at Ser(367) and Ser(2996) localized to sites of DNA damage induced by radiation, but ATM recruitment was not dependent on phosphorylation at these sites. Phosphorylation at Ser(367) and Ser(2996) was functionally important because mutant forms of ATM were defective in correcting the S phase checkpoint defect and restoring radioresistance in ataxia-telangiectasia cells. These data provide further support for the importance of autophosphorylation in the activation and function of ATM in vivo.	[Kozlov, Sergei V.; Kijas, Amanda W.; Tanuji, Marcel; Chen, Philip; Lavin, Martin F.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Graham, Mark E.; Robinson, Phillip J.] Univ Sydney, Childrens Med Res Inst, Westmead, NSW 2145, Australia; [Jakob, Burkhard; Tobias, Frank; Taucher-Scholz, Gisela] GSI Helmholtzzentrum Schwerionenforsch GmbH, D-64291 Darmstadt, Germany; [Suzuki, Keiji] Nagasaki Univ, Grad Sch Biomed Sci, Dept Mol Med, Nagasaki 8528523, Japan; [So, Sairai; Chen, David] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Lavin, Martin F.] Univ Queensland, Clin Res Ctr, Brisbane, Qld 4029, Australia	QIMR Berghofer Medical Research Institute; Children's Medical Research Institute - Australia; University of Sydney; Helmholtz Association; GSI Helmholtz-Center for Heavy Ion Research; Nagasaki University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Queensland	Kozlov, SV (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4029, Australia.	sergei.kozlov@qimr.edu.au; martin.lavin@qimr.edu.au	Chen, Phang-Lang/J-5031-2013; Classen, Scott/AAY-8176-2020; Kozlov, Sergei/T-9779-2019; Jakob, Burkhard/D-2047-2013; Kozlov, Sergei/M-2067-2014; Graham, Mark E/A-6480-2014; Robinson, Phillip J/G-4008-2011; Lavin, Martin F/F-5961-2014	Jakob, Burkhard/0000-0003-2404-377X; Kozlov, Sergei/0000-0001-6183-7339; Graham, Mark E/0000-0002-7290-1217; Robinson, Phillip J/0000-0002-7878-0313; Lavin, Martin F/0000-0002-5940-4769; Kijas, Amanda/0000-0001-8538-7766	National Institutes of Health [CA050519, CA92584]; National Health and Medical Research Council; GSI Helmholtzzentrum fur Schwerionenforschung GmbH; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA050519, R37CA050519] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); GSI Helmholtzzentrum fur Schwerionenforschung GmbH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA050519 and CA92584 (to D. C.). This work was also supported by grants from the National Health and Medical Research Council (to M. F. L.) and GSI Helmholtzzentrum fur Schwerionenforschung GmbH (to G.T.-S. and B.J.).	ATEN JA, 1992, HISTOCHEM J, V24, P251, DOI 10.1007/BF01046839; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Beamish H, 2002, J BIOL CHEM, V277, P30515, DOI 10.1074/jbc.M203801200; Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101; Bensimon A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001034; Berkovich E, 2007, NAT CELL BIOL, V9, P683, DOI 10.1038/ncb1599; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Cerosaletti K, 2004, J BIOL CHEM, V279, P38813, DOI 10.1074/jbc.M404294200; Chan LS, 2010, J PROTEOME RES, V9, P4028, DOI 10.1021/pr100223n; Chapman JR, 2008, EMBO REP, V9, P795, DOI 10.1038/embor.2008.103; Chen XP, 2007, EXP CELL RES, V313, P1667, DOI 10.1016/j.yexcr.2007.02.015; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Daniel JA, 2008, J CELL BIOL, V183, P777, DOI 10.1083/jcb.200805154; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Dupre A, 2006, NAT STRUCT MOL BIOL, V13, P451, DOI 10.1038/nsmb1090; Falck J, 2005, NATURE, V434, P605, DOI 10.1038/nature03442; Fernandes N, 2005, J BIOL CHEM, V280, P15158, DOI 10.1074/jbc.M412065200; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Heffernan TP, 2002, MOL CELL BIOL, V22, P8552, DOI 10.1128/MCB.22.24.8552-8561.2002; Helmink BA, 2009, J EXP MED, V206, P669, DOI 10.1084/jem.20081326; HOULDSWORTH J, 1983, BIOCHEM INT, V6, P349; Hsu JL, 2003, ANAL CHEM, V75, P6843, DOI 10.1021/ac0348625; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Jakob B, 2000, RADIAT RES, V154, P398, DOI 10.1667/0033-7587(2000)154[0398:ILCPRR]2.0.CO;2; Jakob B, 2003, RADIAT RES, V159, P676, DOI 10.1667/0033-7587(2003)159[0676:BIOHCT]2.0.CO;2; Jakob B, 2005, RADIAT RES, V163, P681, DOI 10.1667/RR3374; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kitagawa R, 2005, COLD SH Q B, V70, P99, DOI 10.1101/sqb.2005.70.002; Kitagawa R, 2004, GENE DEV, V18, P1423, DOI 10.1101/gad.1200304; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Kozlov S, 2003, J BIOL CHEM, V278, P9309, DOI 10.1074/jbc.M300003200; Kozlov SV, 2006, EMBO J, V25, P3504, DOI 10.1038/sj.emboj.7601231; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lavin MF, 1997, ANNU REV IMMUNOL, V15, P177, DOI 10.1146/annurev.immunol.15.1.177; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Lemeer S, 2008, MOL CELL PROTEOMICS, V7, P2176, DOI 10.1074/mcp.M800081-MCP200; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; Lukas C, 2005, CHROMOSOMA, V114, P146, DOI 10.1007/s00412-005-0011-y; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; Melander F, 2008, J CELL BIOL, V181, P213, DOI 10.1083/jcb.200708210; Mordes DA, 2008, CELL CYCLE, V7, P2809, DOI 10.4161/cc.7.18.6689; PARRA I, 1993, NAT GENET, V5, P17, DOI 10.1038/ng0993-17; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pellegrini M, 2006, NATURE, V443, P222, DOI 10.1038/nature05112; RASIO D, 1995, CANCER RES, V55, P6053; Rass E, 2009, NAT STRUCT MOL BIOL, V16, P819, DOI 10.1038/nsmb.1641; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; So SR, 2009, J CELL BIOL, V187, P977, DOI 10.1083/jcb.200906064; Soutoglou E, 2008, SCIENCE, V320, P1507, DOI [10.1126/science.1159051, 10.1126/science.ll59051]; Stewart GS, 2009, CELL CYCLE, V8, P1532, DOI 10.4161/cc.8.10.8351; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stracker TH, 2004, DNA REPAIR, V3, P845, DOI 10.1016/j.dnarep.2004.03.014; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Sun YL, 2009, NAT CELL BIOL, V11, P1376, DOI 10.1038/ncb1982; TAUCHERSCHOLZ G, 2007, ION IRRADIATION TOOL, V1, P453; Tian B, 2009, NAT CELL BIOL, V11, P211, DOI 10.1038/ncb1829; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Waltes R, 2009, AM J HUM GENET, V84, P605, DOI 10.1016/j.ajhg.2009.04.010; Wood LD, 2001, ONCOGENE, V20, P278, DOI 10.1038/sj.onc.1204072; Xie AY, 2009, NAT STRUCT MOL BIOL, V16, P814, DOI 10.1038/nsmb.1640; You ZS, 2007, NAT CELL BIOL, V9, P311, DOI 10.1038/ncb1651; Young DB, 2005, J BIOL CHEM, V280, P27587, DOI 10.1074/jbc.M411689200; Zhang N, 1997, P NATL ACAD SCI USA, V94, P8021, DOI 10.1073/pnas.94.15.8021	74	136	138	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9107	9119		10.1074/jbc.M110.204065	http://dx.doi.org/10.1074/jbc.M110.204065			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21149446	Green Published, hybrid			2022-12-27	WOS:000288247700041
J	Midzak, A; Akula, N; Lecanu, L; Papadopoulos, V				Midzak, Andrew; Akula, Nagaraju; Lecanu, Laurent; Papadopoulos, Vassilios			Novel Androstenetriol Interacts with the Mitochondrial Translocator Protein and Controls Steroidogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE REGULATORY PROTEIN; LEYDIG TUMOR-CELLS; PERIPHERAL BENZODIAZEPINE-RECEPTOR; CHOLESTEROL-RICH DOMAINS; IN-VITRO; STEROID-BIOSYNTHESIS; ADRENAL-CORTEX; BINDING-SITES; DRUG DESIGN; SIDE-CHAIN	Steroid hormones are metabolically derived from multiple enzymatic transformations of cholesterol. The controlling step in steroid hormone biogenesis is the delivery of cholesterol from intracellular stores to the cytochrome P450 enzyme CYP11A1 in the mitochondrial matrix. The 18-kDa translocator protein (TSPO) plays an integral part in this mitochondrial cholesterol transport. Consistent with its role in intracellular cholesterol movement, TSPO possesses a cholesterol recognition/interaction amino acid consensus (CRAC) motif that has been demonstrated to bind cholesterol. To further investigate the TSPO CRAC motif, we performed molecular modeling studies and identified a novel ligand, 3,17,19-androsten-5-triol (19-Atriol) that inhibits cholesterol binding at the CRAC motif. 19-Atriol could bind a synthetic CRAC peptide and rapidly inhibited hormonally induced steroidogenesis in MA-10 mouse Leydig tumor cells and constitutive steroidogenesis in R2C rat Leydig tumor cells at low micromolar concentrations. Inhibition at these concentrations was not due to toxicity or inhibition of the CYP11A1 enzyme and was reversed upon removal of the compound. In addition, 19-Atriol was an even more potent inhibitor of PK 11195-stimulated steroidogenesis, with activity in the high nanomolar range. This was accomplished without affecting PK 11195 binding or basal steroidogenesis. Finally, 19-Atriol inhibited mitochondrial import and processing of the steroidogenic acute regulatory protein without any effect on TSPO protein levels. In conclusion, we have identified a novel androstenetriol that can interact with the CRAC domain of TSPO, can control hormonal and constitutive steroidogenesis, and may prove to be a useful tool in the therapeutic control of diseases of excessive steroid formation.	[Midzak, Andrew; Akula, Nagaraju; Lecanu, Laurent; Papadopoulos, Vassilios] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ H3G 1A4, Canada; [Midzak, Andrew; Lecanu, Laurent; Papadopoulos, Vassilios] McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada; [Papadopoulos, Vassilios] McGill Univ, Dept Biochem, Montreal, PQ H3G 1A4, Canada; [Papadopoulos, Vassilios] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University; McGill University; McGill University	Papadopoulos, V (corresponding author), McGill Univ, Montreal Gen Hosp, Ctr Hlth, Res Inst, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	vassilios.papadopoulos@mcgill.ca	Papadopoulos, Vassilios/AAI-2613-2019	Papadopoulos, Vassilios/0000-0002-1183-8568; lecanu, laurent/0000-0001-6935-1384	National Institutes of Health [ES007747, HD037031]; Canadian Institutes of Health Research [MOP102647, TGF36110]; Canada Research Chair in Biochemical Pharmacology; Le Fonds de la Recherche en Sante du Quebec; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD037031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES007747] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Biochemical Pharmacology; Le Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES007747 and HD037031. This work was also supported by Canadian Institutes of Health Research Grant MOP102647 and a Canada Research Chair in Biochemical Pharmacology (to V.P.). The Research Institute of the McGill University Health Centre was supported by a Center grant from Le Fonds de la Recherche en Sante du Quebec. Drs. Akula, Lecanu, and Papadopoulos are named inventors in a patent pertaining to the work described here. The patent has been licensed to Samaritan Pharmaceuticals. Drs. Lecanu and Papadopoulos served in the past (until 2006) as consultants of Samaritan Pharmaceuticals.; Supported in part by Canadian Institutes of Health Research Postdoctoral Fellowship TGF36110.	Allen JA, 2006, ENDOCRINOLOGY, V147, P3924, DOI 10.1210/en.2005-1204; Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arakane F, 1997, J BIOL CHEM, V272, P32656, DOI 10.1074/jbc.272.51.32656; Artemenko IP, 2001, J BIOL CHEM, V276, P46583, DOI 10.1074/jbc.M107815200; Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Bornstein SR, 1999, ANN INTERN MED, V130, P759, DOI 10.7326/0003-4819-130-9-199905040-00017; Bose HS, 2002, NATURE, V417, P87, DOI 10.1038/417087a; Bose M, 2008, J BIOL CHEM, V283, P8837, DOI 10.1074/jbc.M709221200; Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAESTRUP C, 1977, P NATL ACAD SCI USA, V74, P3805, DOI 10.1073/pnas.74.9.3805; Christenson LK, 2000, BBA-MOL CELL BIOL L, V1529, P175, DOI 10.1016/S1388-1981(00)00147-5; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; Clark BJ, 2001, MOL CELL ENDOCRINOL, V173, P183, DOI 10.1016/S0303-7207(00)00410-X; Clark RD, 2002, J MOL GRAPH MODEL, V20, P281, DOI 10.1016/S1093-3263(01)00125-5; Culty M, 1999, J STEROID BIOCHEM, V69, P123, DOI 10.1016/S0960-0760(99)00056-4; Epand RF, 2006, BIOCHEMISTRY-US, V45, P6105, DOI 10.1021/bi060245+; Epand RF, 2005, BIOCHEMISTRY-US, V44, P5525, DOI 10.1021/bi0500224; Epand RM, 2005, J MOL BIOL, V345, P339, DOI 10.1016/j.jmb.2004.10.064; Follesa P, 2006, PSYCHOPHARMACOLOGY, V186, P267, DOI 10.1007/s00213-005-0126-0; FREEMAN DA, 1986, ENDOCR REV, V7, P204, DOI 10.1210/edrv-7-2-204; GARNIER M, 1994, MOL PHARMACOL, V45, P201; Gavish M, 1999, PHARMACOL REV, V51, P629; Gazouli M, 2002, J PHARMACOL EXP THER, V303, P627, DOI 10.1124/jpet.102.039388; Gomez-Sanchez EP, 2010, EXP PHYSIOL, V95, P120, DOI 10.1113/expphysiol.2009.048900; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; Granot Z, 2003, MOL ENDOCRINOL, V17, P2461, DOI 10.1210/me.2003-0074; Hardwick M, 1999, CANCER RES, V59, P831; Hauet T, 2005, MOL ENDOCRINOL, V19, P540, DOI 10.1210/me.2004-0307; Jamin N, 2005, MOL ENDOCRINOL, V19, P588, DOI 10.1210/me.2004-0308; Jefcoate C, 2002, J CLIN INVEST, V110, P881, DOI 10.1172/JCI200216771; JosephLiauzun E, 1997, J BIOL CHEM, V272, P28102, DOI 10.1074/jbc.272.44.28102; KING SR, 1995, ENDOCRINOLOGY, V136, P5165, DOI 10.1210/en.136.11.5165; Korkhov VM, 2010, STRUCTURE, V18, P677, DOI 10.1016/j.str.2010.03.001; Kramer B, 1999, PROTEINS, V37, P228, DOI 10.1002/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8; KRUEGER KE, 1990, J BIOL CHEM, V265, P15015; KUNTZ ID, 1992, SCIENCE, V257, P1078, DOI 10.1126/science.257.5073.1078; Lacapere JJ, 2003, STEROIDS, V68, P569, DOI 10.1016/S0039-128X(03)00101-6; Lacapere JJ, 2001, BIOCHEM BIOPH RES CO, V284, P536, DOI 10.1006/bbrc.2001.4975; LEFUR G, 1983, LIFE SCI, V32, P1839, DOI 10.1016/0024-3205(83)90062-0; Li H, 2001, MOL ENDOCRINOL, V15, P2211, DOI 10.1210/me.15.12.2211; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Li H, 2001, P NATL ACAD SCI USA, V98, P1267, DOI 10.1073/pnas.031461598; LIN D, 1995, SCIENCE, V267, P1828, DOI 10.1126/science.7892608; MARTIN YC, 1992, J MED CHEM, V35, P2145, DOI 10.1021/jm00090a001; Miller WL, 2007, BBA-MOL CELL BIOL L, V1771, P663, DOI 10.1016/j.bbalip.2007.02.012; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; PAPADOPOULOS V, 1993, ENDOCR REV, V14, P222, DOI 10.1210/er.14.2.222; Papadopoulos V, 1997, J BIOL CHEM, V272, P32129, DOI 10.1074/jbc.272.51.32129; PAPADOPOULOS V, 1990, J BIOL CHEM, V265, P3772; Papadopoulos V, 2007, MOL CELL ENDOCRINOL, V265, P59, DOI 10.1016/j.mce.2006.12.004; Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Petrescu AD, 2001, J BIOL CHEM, V276, P36970, DOI 10.1074/jbc.M101939200; PIKULEVA IA, 1995, ARCH BIOCHEM BIOPHYS, V322, P189, DOI 10.1006/abbi.1995.1451; PON LA, 1986, J BIOL CHEM, V261, P6594; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Rone MB, 2009, BBA-MOL CELL BIOL L, V1791, P646, DOI 10.1016/j.bbalip.2009.03.001; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Shalet S, 2008, CURR OPIN ENDOCRINOL, V15, P234, DOI 10.1097/MED.0b013e3282fc7025; SHIN SI, 1968, ENDOCRINOLOGY, V82, P614, DOI 10.1210/endo-82-3-614; Spat A, 2004, PHYSIOL REV, V84, P489, DOI 10.1152/physrev.00030.2003; STOCCO DM, 1988, BIOCHEM J, V249, P95, DOI 10.1042/bj2490095; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Vassylyev DG, 1998, J BIOL CHEM, V273, P17604, DOI 10.1074/jbc.273.28.17604; Veenman L, 2008, J BIOENERG BIOMEMBR, V40, P199, DOI 10.1007/s10863-008-9142-1; Vishwanathan SA, 2008, BIOCHEMISTRY-US, V47, P124, DOI 10.1021/bi7018892; Wendler G, 2003, BIOCHEM BIOPH RES CO, V311, P847, DOI 10.1016/j.bbrc.2003.10.070; Xie HDQ, 2010, J BIOL CHEM, V285, P11537, DOI 10.1074/jbc.M109.038711	70	47	48	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9875	9887		10.1074/jbc.M110.203216	http://dx.doi.org/10.1074/jbc.M110.203216			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21209087	Green Published, hybrid			2022-12-27	WOS:000288247700111
J	Santos-Aberturas, J; Vicente, CM; Guerra, SM; Payero, TD; Martin, JF; Aparicio, JF				Santos-Aberturas, Javier; Vicente, Claudia M.; Guerra, Susana M.; Payero, Tamara D.; Martin, Juan F.; Aparicio, Jesus F.			Molecular Control of Polyene Macrolide Biosynthesis DIRECT BINDING OF THE REGULATOR PimM TO EIGHT PROMOTERS OF PIMARICIN GENES AND IDENTIFICATION OF BINDING BOXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUORUM-SENSING REGULATOR; STREPTOMYCES-NATALENSIS; ANTIBIOTIC BIOSYNTHESIS; PIMARICIN BIOSYNTHESIS; GENE-CLUSTER; CHOLESTEROL OXIDASES; POSITIVE REGULATOR; TARGET PROMOTERS; SEQUENCE LOGOS; BINDING	Control of polyene macrolide production in Streptomyces natalensis is mediated by the transcriptional activator PimM. This regulator, which combines an N-terminal PAS domain with a C-terminal helix-turn-helix motif, is highly conserved among polyene biosynthetic gene clusters. PimM, truncated forms of the protein without the PAS domain (PimM(Delta PAS)), and forms containing just the DNA-binding domain (DBD) (PimM(DBD)) were overexpressed in Escherichia coli as GST-fused proteins. GST-PimM binds directly to eight promoters of the pimaricin cluster, as demonstrated by electrophoretic mobility shift assays. Assays with truncated forms of the protein revealed that the PAS domain does not mediate specificity or the distinct recognition of target genes, which rely on the DBD domain, but significantly reduces binding affinity up to 500-fold. Transcription start points were identified by 5'-rapid amplification of cDNA ends, and the binding regions of PimMDBD were investigated by DNase I protection studies. In all cases, binding took place covering the -35 hexamer box of each promoter, suggesting an interaction of PimM and RNA polymerase to cause transcription activation. Information content analysis of the 16 sequences protected in target promoters was used to deduce the structure of the PimM-binding site. This site displays dyad symmetry, spans 14 nucleotides, and adjusts to the consensus TVGGGAWWTCCCBA. Experimental validation of this binding site was performed by using synthetic DNA duplexes. Binding of PimM to the promoter region of one of the polyketide synthase genes from the Streptomyces nodosus amphotericin cluster containing the consensus binding site was also observed, thus proving the applicability of the findings reported here to other antifungal polyketides.	[Aparicio, Jesus F.] Inst Biotechnol INBIOTEC, Leon 24006, Spain; Univ Leon, Fac Biol, Area Microbiol, E-24071 Leon, Spain	Universidad de Leon	Aparicio, JF (corresponding author), Inst Biotechnol INBIOTEC, Avda Real 1, Leon 24006, Spain.	jesus.aparicio@unileon.es	Susana, Susana/L-9204-2015; Aparicio, Jesús F./K-8686-2014; Santos-Aberturas, Javier/AAE-8162-2021	Susana, Susana/0000-0003-2243-2376; Aparicio, Jesús F./0000-0003-4242-4701; Vicente, Claudia M./0000-0001-8205-6486	Spanish Ministerio de Ciencia e Innovacion [BIO2007-67585, BIO2010-19911]; Junta de Castilla y Leon Grupo de Excelencia [GR117]; Ministerio de Ciencia e Innovacion F.P.U. [AP2005-3644, AP2007-02055]; University of Leon; Junta de Castilla y Leon [E-24-2009-0053914]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Castilla y Leon Grupo de Excelencia(Junta de Castilla y Leon); Ministerio de Ciencia e Innovacion F.P.U.(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); University of Leon; Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported by Spanish Ministerio de Ciencia e Innovacion Grants BIO2007-67585 and BIO2010-19911 (to J. F. A.), Junta de Castilla y Leon Grupo de Excelencia GR117, Ministerio de Ciencia e Innovacion F.P.U. Fellowships AP2005-3644 (to J.S.-A.) and AP2007-02055 (to T. D. P.), a fellowship from the University of Leon (to S. M. G.), and Junta de Castilla y Leon Contract E-24-2009-0053914 (to C. M. V.).	Anton N, 2004, J BACTERIOL, V186, P2567, DOI 10.1128/JB.186.9.2567-2575.2004; Anton N, 2007, MICROBIOL-SGM, V153, P3174, DOI 10.1099/mic.0.2007/009126-0; Aparicio JF, 2008, MOL BIOSYST, V4, P804, DOI 10.1039/b717500k; Aparicio JF, 2004, CURR MED CHEM, V11, P1645; Aparicio JF, 2003, APPL MICROBIOL BIOT, V61, P179, DOI 10.1007/s00253-002-1183-5; Aparicio JF, 1999, J BIOL CHEM, V274, P10133, DOI 10.1074/jbc.274.15.10133; Bi CP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-76; Bibb M, 1996, MICROBIOL-SGM, V142, P1335, DOI 10.1099/13500872-142-6-1335; BOURN WR, 1995, NUCLEIC ACIDS RES, V23, P3696, DOI 10.1093/nar/23.18.3696; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; Caffrey P, 2008, CURR TOP MED CHEM, V8, P639, DOI 10.2174/156802608784221479; Carmody M, 2004, GENE, V343, P107, DOI 10.1016/j.gene.2004.08.006; Chen S, 2003, CHEM BIOL, V10, P1065, DOI 10.1016/j.chembiol.2003.10.007; Ellison DW, 2000, J BACTERIOL, V182, P6592, DOI 10.1128/JB.182.23.6592-6597.2000; Hefti MH, 2004, EUR J BIOCHEM, V271, P1198, DOI 10.1111/j.1432-1033.2004.04023.x; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Kells PM, 2010, CHEM BIOL, V17, P841, DOI 10.1016/j.chembiol.2010.05.026; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Martin JF, 2009, METHOD ENZYMOL, V459, P215, DOI 10.1016/S0076-6879(09)04610-2; Mendes MV, 2007, CHEM BIOL, V14, P279, DOI 10.1016/j.chembiol.2007.01.010; Mendes MV, 2007, METAB ENG, V9, P217, DOI 10.1016/j.ymben.2006.10.003; Mendes MV, 2005, BIOCHEM J, V386, P57, DOI 10.1042/BJ20040490; Mendes MV, 2001, CHEM BIOL, V8, P635, DOI 10.1016/S1074-5521(01)00033-3; Omura S, 2001, P NATL ACAD SCI USA, V98, P12215, DOI 10.1073/pnas.211433198; Pompeani AJ, 2008, MOL MICROBIOL, V70, P76, DOI 10.1111/j.1365-2958.2008.06389.x; Ponting CP, 1997, CURR BIOL, V7, pR674, DOI 10.1016/S0960-9822(06)00352-6; RodriguezGarcia A, 1997, MOL MICROBIOL, V25, P219, DOI 10.1046/j.1365-2958.1997.4511815.x; Sambrook J, 2001, MOL CLONING LAB MANU; Schneider TD, 1997, J THEOR BIOL, V189, P427, DOI 10.1006/jtbi.1997.0540; Schneider TD, 1996, METHOD ENZYMOL, V274, P445; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Sekurova ON, 2004, J BACTERIOL, V186, P1345, DOI 10.1128/JB.186.5.1345-1354.2004; Sola-Landa A, 2005, MOL MICROBIOL, V56, P1373, DOI 10.1111/j.1365-2958.2005.04631.x; STEVENS AM, 1994, P NATL ACAD SCI USA, V91, P12619, DOI 10.1073/pnas.91.26.12619; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; Vannini A, 2002, EMBO J, V21, P4393, DOI 10.1093/emboj/cdf459; Vicente CM, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-33; Weingart CL, 2005, MOL MICROBIOL, V57, P452, DOI 10.1111/j.1365-2958.2005.04656.x; Welscher YMT, 2008, J BIOL CHEM, V283, P6393, DOI 10.1074/jbc.M707821200; Zelzer E, 1997, GENE DEV, V11, P2079, DOI 10.1101/gad.11.16.2079	42	40	46	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9150	9161		10.1074/jbc.M110.182428	http://dx.doi.org/10.1074/jbc.M110.182428			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21187288	Green Published, hybrid			2022-12-27	WOS:000288247700046
J	He, ZH; Cai, J; Lim, JW; Kroll, K; Ma, LA				He, Zhenhua; Cai, Jing; Lim, Jong-Won; Kroll, Kristen; Ma, Liang			A Novel KRAB Domain-containing Zinc Finger Transcription Factor ZNF431 Directly Represses Patched1 Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE COMPLEXES; SONIC HEDGEHOG; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; PROTEINS; GENE; IDENTIFICATION; EXPRESSION; DIFFERENTIATION; MORPHOGENESIS	Kruppel- like zinc finger transcription factors compose the largest transcription factor family in the mammalian genome. However, the functions for the majority of these transcription factors as well as their in vivo downstream targets are not clear. We have functionally characterized a novel KRAB domain zinc finger transcription factor ZNF431 using both in vitro and in vivo assays. ZNF431 is a nuclear transcriptional repressor whose repressive activity depends on its association with HDAC1 and -2. Using the limb mesenchymal cell line MPLB, we identified Patched1 as a direct transcriptional target of ZNF431. Promoter analyses revealed three ZNF431 binding sites that bind to ZNF431 both in vitro and in vivo as revealed by gel-shift and chromatin immunoprecipitation, respectively. Mutations of these three sites abolished ZNF431 repression in transient transfection assays. Moreover, overexpressing ZNF431 in MPLB cells or in Xenopus and mouse embryos strongly repressed Patched1 expression. On the other hand, shRNA knockdown of ZNF431 in MPLB cells elevated Patched1 expression. Finally, hedgehog signaling readout was reduced in ZNF431 overexpression but elevated in ZNF431 knockdown MPLB cells. Our results indicate that ZNF431 directly represses Patched1 expression and likely functions to repress the hedgehog response in cells.	[He, Zhenhua; Cai, Jing; Ma, Liang] Washington Univ, Sch Med, Div Dermatol, Dept Med, St Louis, MO 63110 USA; [Lim, Jong-Won; Kroll, Kristen; Ma, Liang] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Ma, LA (corresponding author), Campus Box 8123,660 S Euclid Ave, St Louis, MO 63110 USA.	lima@dom.wustl.edu	Lim, Jong-Won/AAB-3761-2021	Kroll, Kristen/0000-0002-5450-6694	National Institutes of Health [ES014482, ES016597]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016597, R01ES014482] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066815] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES014482 and ES016597.	Agren M, 2004, GENE, V330, P101, DOI 10.1016/j.gene.2004.01.010; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Ahringer J, 2000, TRENDS GENET, V16, P351, DOI 10.1016/S0168-9525(00)02066-7; BELLEFROID EJ, 1991, P NATL ACAD SCI USA, V88, P3608, DOI 10.1073/pnas.88.9.3608; BELLEFROID EJ, 1989, DNA-J MOLEC CELL BIO, V8, P377, DOI 10.1089/dna.1.1989.8.377; Ding G, 2009, NUCLEIC ACIDS RES, V37, pD267, DOI 10.1093/nar/gkn782; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; FRIED M, 1981, NUCLEIC ACIDS RES, V9, P6505, DOI 10.1093/nar/9.23.6505; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Gebelein B, 2001, MOL CELL BIOL, V21, P928, DOI 10.1128/MCB.21.3.928-939.2001; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Groner AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000869; Hardcastle Z, 1998, DEVELOPMENT, V125, P2803; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Helms JA, 1997, DEV BIOL, V187, P25, DOI 10.1006/dbio.1997.8589; Hennemann H, 2003, J BIOL CHEM, V278, P28799, DOI 10.1074/jbc.M207196200; Hering TM, 2004, EXP CELL RES, V299, P137, DOI 10.1016/j.yexcr.2004.05.030; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Jheon AH, 2001, J BIOL CHEM, V276, P18282, DOI 10.1074/jbc.M010885200; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Kovacs JJ, 2009, DEV CELL, V17, P443, DOI 10.1016/j.devcel.2009.09.011; Lin CX, 2009, DEVELOPMENT, V136, P3959, DOI 10.1242/dev.039768; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Matsuda E, 2001, J BIOL CHEM, V276, P14222, DOI 10.1074/jbc.M010663200; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Nagao K, 2005, GENOMICS, V85, P462, DOI 10.1016/j.ygeno.2004.11.014; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Seo S, 2005, GENE DEV, V19, P1723, DOI 10.1101/gad.1319105; Sinha S, 2006, NAT CHEM BIOL, V2, P29, DOI 10.1038/nchembio753; SOLOMON MJ, 1988, CELL, V53, P937, DOI 10.1016/S0092-8674(88)90469-2; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; TREVINO C, 1993, PROG CLIN BIOL RES, V383, P295; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; VISSING H, 1995, FEBS LETT, V369, P153, DOI 10.1016/0014-5793(95)00728-R; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200	40	12	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7279	7289		10.1074/jbc.M110.178780	http://dx.doi.org/10.1074/jbc.M110.178780			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177534	Green Published, hybrid			2022-12-27	WOS:000287737300044
J	Posey, AD; Pytel, P; Gardikiotes, K; Demonbreun, AR; Rainey, M; George, M; Band, H; McNally, EM				Posey, Avery D., Jr.; Pytel, Peter; Gardikiotes, Konstantina; Demonbreun, Alexis R.; Rainey, Mark; George, Manju; Band, Hamid; McNally, Elizabeth M.			Endocytic Recycling Proteins EHD1 and EHD2 Interact with Fer-1-like-5 (Fer1L5) and Mediate Myoblast Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIRDLE MUSCULAR-DYSTROPHY; PHOSPHOLIPID-BINDING; SYNAPTOTAGMIN-I; PLASMA-MEMBRANE; DOMAIN; MYOFERLIN; GENE; DYSFERLIN; COMPLEX; MUSCLE	The mammalian ferlins are calcium-sensing, C2 domain-containing proteins involved in vesicle trafficking. Myoferlin and dysferlin regulate myoblast fusion and muscle membrane resealing, respectively. Correspondingly, myoferlin is most highly expressed in singly nucleated myoblasts, whereas dysferlin expression is increased in mature, multinucleated myotubes. Myoferlin also mediates endocytic recycling and participates in trafficking the insulin-like growth factor receptor. We have now characterized a novel member of the ferlin family, Fer1L5, because of its high homology to dysferlin and myoferlin. We found that Fer1L5 protein is expressed in small myotubes that contain only two to four nuclei. We also found that Fer1L5 protein binds directly to the endocytic recycling proteins EHD1 and EHD2 and that the second C2 domain in Fer1L5 mediates this interaction. Reduction of EHD1 and/or EHD2 inhibits myoblast fusion, and EHD2 is required for normal translocation of Fer1L5 to the plasma membrane. The characterization of Fer1L5 and its interaction with EHD1 and EHD2 underscores the complex requirement of ferlin proteins and mediators of endocytic recycling for membrane trafficking events during myotube formation.	[Posey, Avery D., Jr.; McNally, Elizabeth M.] Univ Chicago, Comm Genet Genom & Syst Biol, Chicago, IL 60637 USA; [Pytel, Peter] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Gardikiotes, Konstantina; Demonbreun, Alexis R.; McNally, Elizabeth M.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [McNally, Elizabeth M.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Rainey, Mark; George, Manju; Band, Hamid] Univ Nebraska Med Ctr, Eppley Inst Canc & Allied Dis, Omaha, NE 68198 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Nebraska System; University of Nebraska Medical Center	McNally, EM (corresponding author), Univ Chicago, Comm Genet Genom & Syst Biol, 5841 S Maryland,MC6088, Chicago, IL 60637 USA.	emcnally@uchicago.edu	McNally, Elizabeth/W-4909-2019; Posey, Avery D./P-4890-2019; Band, Hamid/AAF-4701-2020	Posey, Avery D./0000-0001-8711-629X; Demonbreun, Alexis/0000-0001-6823-125X; McNally, Elizabeth/0000-0002-1221-719X	National Institutes of Health [NS047726, CA105489, CA99163, CA87986, CA116552, T32 HL7381]; Muscular Dystrophy Association; Jain Foundation; NATIONAL CANCER INSTITUTE [R01CA116552, R01CA099163, R01CA105489, R01CA087986] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007381] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047726] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Jain Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS047726 (to E. M. M.), CA105489 (to H. B.), CA99163 (to H. B.), CA87986 (to H. B.), CA116552 (to H. B.), and T32 HL7381. This work was also supported by the Muscular Dystrophy Association and the Jain Foundation.	Achanzar WE, 1997, J CELL SCI, V110, P1073; Bai JH, 2002, P NATL ACAD SCI USA, V99, P1665, DOI 10.1073/pnas.032541099; Bai JH, 2000, J BIOL CHEM, V275, P25427, DOI 10.1074/jbc.M906729199; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Beuchle D, 2007, MECH DEVELOP, V124, P390, DOI 10.1016/j.mod.2007.01.006; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; Davis DB, 2000, HUM MOL GENET, V9, P217, DOI 10.1093/hmg/9.2.217; Davis DB, 2002, J BIOL CHEM, V277, P22883, DOI 10.1074/jbc.M201858200; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; de Beer T, 2000, NAT STRUCT BIOL, V7, P1018, DOI 10.1038/80924; de Beer T, 1998, SCIENCE, V281, P1357, DOI 10.1126/science.281.5381.1357; Demonbreun AR, 2010, FASEB J, V24, P1284, DOI 10.1096/fj.09-136309; Doberstein SK, 1997, J CELL BIOL, V136, P1249, DOI 10.1083/jcb.136.6.1249; Doherty KR, 2008, J BIOL CHEM, V283, P20252, DOI 10.1074/jbc.M802306200; Doherty KR, 2005, DEVELOPMENT, V132, P5565, DOI 10.1242/dev.02155; Enmon JL, 2000, BIOCHEMISTRY-US, V39, P4309, DOI 10.1021/bi9927383; Fischer J, 2005, BIOCHEM BIOPH RES CO, V328, P415, DOI 10.1016/j.bbrc.2004.12.182; George M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-3; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Guilherme A, 2004, J BIOL CHEM, V279, P40062, DOI 10.1074/jbc.M401918200; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Hung RJ, 2010, NATURE, V463, P823, DOI 10.1038/nature08724; KALDERON N, 1979, J CELL BIOL, V81, P411, DOI 10.1083/jcb.81.2.411; Kieken F, 2009, PROTEIN SCI, V18, P2471, DOI 10.1002/pro.258; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Mintz L, 1999, GENOMICS, V59, P66, DOI 10.1006/geno.1999.5800; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Park SW, 2004, J AM COLL CARDIOL, V43, p50A, DOI 10.1016/S0735-1097(04)90213-6; Patel P, 2008, J MOL BIOL, V379, P981, DOI 10.1016/j.jmb.2008.04.046; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Peuvot J, 1999, J THEOR BIOL, V198, P173, DOI 10.1006/jtbi.1999.0908; Pohl U, 2000, GENOMICS, V63, P255, DOI 10.1006/geno.1999.6087; Rotem-Yehudar R, 2001, J BIOL CHEM, V276, P33054, DOI 10.1074/jbc.M009913200; Salcini AE, 1997, GENE DEV, V11, P2239, DOI 10.1101/gad.11.17.2239; Shao YF, 2002, J CELL BIOL, V157, P679, DOI 10.1083/jcb.200201063; Sharma M, 2009, MOL BIOL CELL, V20, P5181, DOI 10.1091/mbc.E09-06-0535; Therrien C, 2006, J NEUROL SCI, V250, P71, DOI 10.1016/j.jns.2006.07.004; Washington NL, 2006, J CELL SCI, V119, P2552, DOI 10.1242/jcs.02980; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693	47	39	45	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7379	7388		10.1074/jbc.M110.157222	http://dx.doi.org/10.1074/jbc.M110.157222			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177873	Green Published, hybrid			2022-12-27	WOS:000287737300054
J	Sommer, ME; Hofmann, KP; Heck, M				Sommer, Martha E.; Hofmann, Klaus Peter; Heck, Martin			Arrestin-Rhodopsin Binding Stoichiometry in Isolated Rod Outer Segment Membranes Depends on the Percentage of Activated Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; ANGSTROM CRYSTAL-STRUCTURE; METARHODOPSIN-II; MONOMERIC RHODOPSIN; VISUAL ARRESTIN; FUNCTIONAL UNIT; DISK MEMBRANES; BOVINE; LIGHT; PHOSPHORYLATION	In the rod cell of the retina, arrestin is responsible for blocking signaling of the G-protein-coupled receptor rhodopsin. The general visual signal transduction model implies that arrestin must be able to interact with a single light-activated, phosphorylated rhodopsin molecule (Rho*P), as would be generated at physiologically relevant low light levels. However, the elongated bi-lobed structure of arrestin suggests that it might be able to accommodate two rhodopsin molecules. In this study, we directly addressed the question of binding stoichiometry by quantifying arrestin binding to Rho*P in isolated rod outer segment membranes. We manipulated the "photoactivation density," i.e. the percentage of active receptors in the membrane, with the use of a light flash or by partially regenerating membranes containing phosphorylated opsin with 11-cis-retinal. Curiously, we found that the apparent arrestin-Rho*P binding stoichiometry was linearly dependent on the photoactivation density, with one-to-one binding at low photoactivation density and one-to-two binding at high photoactivation density. We also observed that, irrespective of the photoactivation density, a single arrestin molecule was able to stabilize the active metarhodopsin II conformation of only a single Rho*P. We hypothesize that, although arrestin requires at least a single Rho*P to bind the membrane, a single arrestin can actually interact with a pair of receptors. The ability of arrestin to interact with heterogeneous receptor pairs composed of two different photo-intermediate states would be well suited to the rod cell, which functions at low light intensity but is routinely exposed to several orders of magnitude more light.	[Sommer, Martha E.; Hofmann, Klaus Peter; Heck, Martin] Charite, Inst Med Phys & Biophys CC2, D-10117 Berlin, Germany; [Hofmann, Klaus Peter] Humboldt Univ, Zentrum Biophys & Bioinformat, D-10115 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin	Heck, M (corresponding author), Charite, Inst Med Phys & Biophys CC2, Charitepl 1, D-10117 Berlin, Germany.	martin.heck@charite.de		Sommer, Martha E./0000-0003-0493-8584	National Science Foundation [0700410]; Deutsche Forschungsgemeinschaft [SFB 740, HE 2704/1-1, SO 1037/1-1]	National Science Foundation(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by International Research Fellowship 0700410 from the National Science Foundation and Grants SFB 740, HE 2704/1-1, and SO 1037/1-1 from the Deutsche Forschungsgemeinschaft.	Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; CONE RA, 1972, NATURE-NEW BIOL, V236, P39, DOI 10.1038/newbio236039a0; Edrington TC, 2008, BIOPHYS J, V95, P2859, DOI 10.1529/biophysj.108.128868; EMEIS D, 1982, FEBS LETT, V143, P29, DOI 10.1016/0014-5793(82)80266-4; Garwin GG, 2000, METHOD ENZYMOL, V316, P313; Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Gurevich VV, 2000, METHOD ENZYMOL, V315, P422; Gurevich VV, 2004, TRENDS PHARMACOL SCI, V25, P105, DOI 10.1016/j.tips.2003.12.008; Han M, 2001, STRUCTURE, V9, P869, DOI 10.1016/S0969-2126(01)00644-X; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Hanson SM, 2007, P NATL ACAD SCI USA, V104, P3125, DOI 10.1073/pnas.0610886104; Heck M, 2000, METHOD ENZYMOL, V315, P329; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; HOFMANN KP, 1992, J BIOL CHEM, V267, P15701; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Janz JM, 2003, J BIOL CHEM, V278, P16982, DOI 10.1074/jbc.M210567200; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; KUHN H, 1982, METHOD ENZYMOL, V81, P489; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lewis JW, 1997, VISION RES, V37, P1, DOI 10.1016/S0042-6989(96)00138-1; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; LIEBMAN PA, 1974, SCIENCE, V185, P457, DOI 10.1126/science.185.4149.457; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Milligan G, 2007, BBA-BIOMEMBRANES, V1768, P825, DOI 10.1016/j.bbamem.2006.09.021; Modzelewska A, 2006, CELL BIOCHEM BIOPHYS, V46, P1, DOI 10.1385/CBB:46:1:1; Molday RS, 1998, INVEST OPHTH VIS SCI, V39, P2493; Naarendorp F, 2010, J NEUROSCI, V30, P12495, DOI 10.1523/JNEUROSCI.2186-10.2010; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Park PSH, 2004, BIOCHEMISTRY-US, V43, P15643, DOI 10.1021/bi047907k; PARKES JH, 1984, BIOCHEMISTRY-US, V23, P5054, DOI 10.1021/bi00316a035; Pulvermuller A, 1997, BIOCHEMISTRY-US, V36, P9253, DOI 10.1021/bi970772g; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Satoh AK, 2010, NEURON, V67, P997, DOI 10.1016/j.neuron.2010.08.024; Schertler GFX, 2005, CURR OPIN STRUC BIOL, V15, P408, DOI 10.1016/j.sbi.2005.07.010; SCHLEICHER A, 1989, BIOCHEMISTRY-US, V28, P1770, DOI 10.1021/bi00430a052; Skegro D, 2007, PHOTOCHEM PHOTOBIOL, V83, P385, DOI 10.1562/2006-08-25-RA-1014; Sommer ME, 2007, J BIOL CHEM, V282, P25560, DOI 10.1074/jbc.M702155200; Sommer ME, 2006, J BIOL CHEM, V281, P9407, DOI 10.1074/jbc.M510037200; Sommer ME, 2005, J BIOL CHEM, V280, P6861, DOI 10.1074/jbc.M411341200; Sutton RB, 2005, J MOL BIOL, V354, P1069, DOI 10.1016/j.jmb.2005.10.023; Tsukamoto H, 2010, J MOL BIOL, V399, P501, DOI 10.1016/j.jmb.2010.04.029; Vishnivetskiy SA, 2007, J BIOL CHEM, V282, P32075, DOI 10.1074/jbc.M706057200; Wachtler T, 2004, VISION RES, V44, P2843, DOI 10.1016/j.visres.2004.06.016; WILDEN U, 1982, BIOCHEMISTRY-US, V21, P3014, DOI 10.1021/bi00541a032	55	34	35	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7359	7369		10.1074/jbc.M110.204941	http://dx.doi.org/10.1074/jbc.M110.204941			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21169358	Green Published, hybrid			2022-12-27	WOS:000287737300052
J	Zhang, J; Yan, H; Wu, YP; Li, C; Zhang, GY				Zhang, Jia; Yan, Hui; Wu, Yong-Ping; Li, Chong; Zhang, Guang-Yi			Activation of GluR6-containing Kainate Receptors Induces Ubiquitin- dependent Bcl-2 Degradation via Denitrosylation in the Rat Hippocampus after Kainate Treatment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN S-NITROSYLATION; NF-KAPPA-B; NITRIC-OXIDE; CEREBRAL-ISCHEMIA; SIGNALING PATHWAY; INDUCED APOPTOSIS; BAX; INHIBITION; PROTEASOME; DOMAIN	We previously showed that Bcl-2 (B-cell lymphoma 2) is down-regulated in a kainate (KA)-induced rat epileptic seizure model. The underlying mechanism had remained largely unknown, but we here report for the first time that denitrosylation and ubiquitination are involved. Our results show that the S-nitrosylation levels of Bcl-2 are down-regulated after KA injection and that the GluR6 (glutamate receptor 6) antagonist NS102 can inhibit the denitrosylation of Bcl-2. Moreover, the ubiquitin-dependent degradation of Bcl-2 was found to be promoted after KA treatment, which could be suppressed by the proteasome inhibitor MG132 and the NO donors, sodium nitroprusside and S-nitrosoglutathione. In addition, experiments based on siRNA transfections were performed in the human SH-SY5Y neuroblastoma cell line to verify that the stability of Bcl-2 is causal to neuronal survival. At the same time, it was found that the exogenous NO donor GSNO could protect neurons when Bcl-2 is targeted. Subsequently, these mechanisms were morphologically validated by immunohistochemistry, cresyl violet staining, and in situ TUNEL staining to analyze the expression of Bcl-2 as well as the survival of CA1 and CA3/DG pyramidal neurons. NS102, GSNO, sodium nitroprusside, and MG132 contribute to the survival of CA1 and CA3/DG pyramidal neurons by attenuating Bcl-2 denitrosylation. Taken together, our data reveal that Bcl-2 ubiquitin-dependent degradation is induced by Bcl-2 denitrosylation during neuronal apoptosis after KA treatment.	[Zhang, Jia; Yan, Hui; Li, Chong; Zhang, Guang-Yi] Xuzhou Med Coll, Res Ctr Biochem & Mol Biol, Jiangsu Key Lab Brain Dis Bioinformat, Xuzhou 221002, Jiangsu, Peoples R China; [Wu, Yong-Ping] Xuzhou Med Coll, Jiangsu Prov Key Lab Anesthesiol, Xuzhou 221002, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University	Zhang, GY (corresponding author), Xuzhou Med Coll, Res Ctr Biochem & Mol Biol, Jiangsu Key Lab Brain Dis Bioinformat, Xuzhou 221002, Jiangsu, Peoples R China.	gyzhang@xzmc.edu.cn		Yan, Hui/0000-0002-6990-2526	National Natural Science Foundation of China [30870543]; Education Departmental Nature Science Funds of Jiangsu Province of China [09KJB310015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Departmental Nature Science Funds of Jiangsu Province of China	This work was supported by Project Grant 30870543 from the National Natural Science Foundation of China and Education Departmental Nature Science Funds of Jiangsu Province of China (09KJB310015).	Azad N, 2006, J BIOL CHEM, V281, P34124, DOI 10.1074/jbc.M602551200; Baliga BC, 2002, HEMATOL ONCOL, V20, P63, DOI 10.1002/hon.685; Benhar M, 2008, SCIENCE, V320, P1050, DOI 10.1126/science.1158265; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Bentires-Alj M, 2001, ONCOGENE, V20, P2805, DOI 10.1038/sj.onc.1204343; Bloss EB, 2010, VITAM HORM, V82, P167, DOI 10.1016/S0083-6729(10)82009-6; Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000; CARDOZO C, 1993, ENZYME PROTEIN, V47, P296, DOI 10.1159/000468687; Chanvorachote P, 2006, CANCER RES, V66, P6353, DOI 10.1158/0008-5472.CAN-05-4533; Chvanov M, 2006, EMBO J, V25, P3024, DOI 10.1038/sj.emboj.7601207; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; Genovese T, 2007, SHOCK, V27, P258, DOI 10.1097/01.shk.0000239775.41022.54; Glasgow JN, 2001, NEUROCHEM RES, V26, P647, DOI 10.1023/A:1010987220034; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hirotani M, 1999, J BIOL CHEM, V274, P20415, DOI 10.1074/jbc.274.29.20415; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Kelekar A, 1997, MOL CELL BIOL, V17, P7040, DOI 10.1128/MCB.17.12.7040; Li BY, 2000, P NATL ACAD SCI USA, V97, P3850, DOI 10.1073/pnas.070047997; Li C, 2010, EPILEPSIA, V51, P391, DOI 10.1111/j.1528-1167.2009.02270.x; Li DC, 2004, CANCER SCI, V95, P644, DOI 10.1111/j.1349-7006.2004.tb03323.x; Li T, 2008, FEBS LETT, V582, P1894, DOI 10.1016/j.febslet.2008.05.009; Liu XM, 2006, J BIOL CHEM, V281, P17432, DOI 10.1074/jbc.M513490200; Lutz RJ, 2000, BIOCHEM SOC T, V28, P51, DOI 10.1042/bst0280051; Mannick JB, 1999, SCIENCE, V284, P651, DOI 10.1126/science.284.5414.651; Mitchell KO, 2000, CANCER RES, V60, P6318; Pei DS, 2008, J NEUROCHEM, V106, P1952, DOI 10.1111/j.1471-4159.2008.05531.x; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tannenbaum SR, 2005, NAT CHEM BIOL, V1, P126, DOI 10.1038/nchembio0805-126; Tian H, 2005, BRAIN RES, V1061, P57, DOI 10.1016/j.brainres.2005.09.001; Wei L, 2004, BRAIN RES, V1022, P54, DOI 10.1016/j.brainres.2004.06.080; Yang YL, 2003, FASEB J, V17, P790, DOI 10.1096/fj.02-0654rev; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200	37	17	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7669	7680		10.1074/jbc.M110.156299	http://dx.doi.org/10.1074/jbc.M110.156299			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21148565	Green Published, hybrid			2022-12-27	WOS:000287737300080
J	Doczi, J; Turiak, L; Vajda, S; Mandi, M; Torocsik, B; Gerencser, AA; Kiss, G; Konrad, C; Adam-Vizi, V; Chinopoulos, C				Doczi, Judit; Turiak, Lilla; Vajda, Szilvia; Mandi, Miklos; Toeroecsik, Beata; Gerencser, Akos A.; Kiss, Gergely; Konrad, Csaba; Adam-Vizi, Vera; Chinopoulos, Christos			Complex Contribution of Cyclophilin D to Ca2+-induced Permeability Transition in Brain Mitochondria, with Relation to the Bioenergetic State	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL CELL-DEATH; IN-SITU; LIVER-MITOCHONDRIA; MATRIX PH; PORE; MODULATION; INHIBITION; CALCIUM; MECHANISMS; APOPTOSIS	Cyclophilin D (cypD)-deficient mice exhibit resistance to focal cerebral ischemia and to necrotic but not apoptotic stimuli. To address this disparity, we investigated isolated brain and in situ neuronal and astrocytic mitochondria from cypD-deficient and wild-type mice. Isolated mitochondria were challenged by high Ca2+, and the effects of substrates and respiratory chain inhibitors were evaluated on permeability transition pore opening by light scatter. In situ neuronal and astrocytic mitochondria were visualized by mito-DsRed2 targeting and challenged by calcimycin, and the effects of glucose, NaCN, and an uncoupler were evaluated by measuring mitochondrial volume. In isolated mitochondria, Ca2+ caused a large cypD-dependent change in light scatter in the absence of substrates that was insensitive to Ruthenium red or Ru360. Uniporter inhibitors only partially affected the entry of free Ca2+ in the matrix. Inhibition of complex III/IV negated the effect of substrates, but inhibition of complex I was protective. Mitochondria within neurons and astrocytes exhibited cypD-independent swelling that was dramatically hastened when NaCN and 2-deoxyglucose were present in a glucose-free medium during calcimycin treatment. In the presence of an uncoupler, cypD-deficient astrocytic mitochondria performed better than wild-type mitochondria, whereas the opposite was observed in neurons. Neuronal mitochondria were examined further during glutamate-induced delayed Ca2+ deregulation. CypD-knock-out mitochondria exhibited an absence or a delay in the onset of mitochondrial swelling after glutamate application. Apparently, some conditions involving deenergization render cypD an important modulator of PTP in the brain. These findings could explain why absence of cypD protects against necrotic (deenergized mitochondria), but not apoptotic (energized mitochondria) stimuli.	[Doczi, Judit; Turiak, Lilla; Vajda, Szilvia; Mandi, Miklos; Toeroecsik, Beata; Kiss, Gergely; Konrad, Csaba; Adam-Vizi, Vera; Chinopoulos, Christos] Semmelweis Univ, Dept Biochem Med, H-1094 Budapest, Hungary; [Gerencser, Akos A.] Buck Inst Age Res, Novato, CA 94945 USA	Semmelweis University; Buck Institute for Research on Aging	Chinopoulos, C (corresponding author), Semmelweis Univ, Dept Biochem Med, H-1094 Budapest, Hungary.	chinopoulos.christos@eok.sote.hu	Mándi, Miklós/AGF-9798-2022	Mandi, Miklos/0000-0002-0971-7695; Chinopoulos, Christos/0000-0003-0183-4149; Torocsik, Beata/0000-0002-9838-3710; Adam-Vizi, Vera/0000-0002-8350-8701	Orszagos Tudomanyos Kutatasi Alapprogram (OTKA) [NNF78905]; Magyar Tudomanyos Akademia (MTA); Nemzeti Kutatasi es Technologiai Hivatal (NKTH); Egeszsegugyi Tudomanyos Tanacs (ETT) [55160]; Semmelweis University [63320]; OTKA-NKTH [NF68294]	Orszagos Tudomanyos Kutatasi Alapprogram (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Magyar Tudomanyos Akademia (MTA); Nemzeti Kutatasi es Technologiai Hivatal (NKTH)(National Office for Research and Technology); Egeszsegugyi Tudomanyos Tanacs (ETT); Semmelweis University; OTKA-NKTH(National Office for Research and TechnologyOrszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by grants from the Orszagos Tudomanyos Kutatasi Alapprogram (OTKA), Magyar Tudomanyos Akademia (MTA), Nemzeti Kutatasi es Technologiai Hivatal (NKTH), and Egeszsegugyi Tudomanyos Tanacs (ETT) (to V. A.-V.) and Semmelweis University Research Grant 63320, OTKA-NKTH Grant NF68294, OTKA Grant NNF78905, and ETT Grant 55160 (to C. C.).	AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; BERNARDI P, 1992, J BIOL CHEM, V267, P8834; Brustovetsky N, 2000, J NEUROSCI, V20, P8229, DOI 10.1523/JNEUROSCI.20-22-08229.2000; Chauvin C, 2001, J BIOL CHEM, V276, P41394, DOI 10.1074/jbc.M106417200; Chinopoulos C, 2006, FEBS J, V273, P433, DOI 10.1111/j.1742-4658.2005.05103.x; Chinopoulos C, 2004, J NEUROCHEM, V91, P471, DOI 10.1111/j.1471-4159.2004.02732.x; Chinopoulos C, 2003, J BIOL CHEM, V278, P27382, DOI 10.1074/jbc.M303808200; Chinopoulos C, 2010, FEBS J, V277, P3637, DOI 10.1111/j.1742-4658.2010.07755.x; Chinopoulos C, 2010, FASEB J, V24, P2405, DOI 10.1096/fj.09-149898; Chinopoulos C, 2010, BBA-MOL BASIS DIS, V1802, P221, DOI 10.1016/j.bbadis.2009.08.008; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; Fiskum G, 2003, ANN NY ACAD SCI, V991, P111; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Gerencser AA, 2008, BIOPHYS J, V95, P2583, DOI 10.1529/biophysj.107.118620; Giorgio V, 2010, BBA-BIOENERGETICS, V1797, P1113, DOI 10.1016/j.bbabio.2009.12.006; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hansson MJ, 2004, J NEUROCHEM, V89, P715, DOI 10.1111/j.1471-4159.2004.02400.x; HUNTER DR, 1979, ARCH BIOCHEM BIOPHYS, V195, P453, DOI 10.1016/0003-9861(79)90371-0; Kristian T, 2002, J NEUROCHEM, V83, P1297, DOI 10.1046/j.1471-4159.2002.01238.x; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Leverve XM, 2001, IUBMB LIFE, V52, P221; Li YM, 2004, BIOCHEM J, V383, P101, DOI 10.1042/BJ20040669; Matlib MA, 1998, J BIOL CHEM, V273, P10223, DOI 10.1074/jbc.273.17.10223; MOORE GA, 1983, FEBS LETT, V153, P289, DOI 10.1016/0014-5793(83)80626-7; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; NICOLLI A, 1993, BIOCHEMISTRY-US, V32, P4461, DOI 10.1021/bi00067a039; Panov A, 2007, AM J PHYSIOL-CELL PH, V292, pC708, DOI 10.1152/ajpcell.00202.2006; PETRONILLI V, 1993, J BIOL CHEM, V268, P1011; PETRONILLI V, 1993, J BIOL CHEM, V268, P21939; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; RIGOBELLO MP, 1995, ARCH BIOCHEM BIOPHYS, V319, P225, DOI 10.1006/abbi.1995.1286; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Sattler R, 2001, MOL NEUROBIOL, V24, P107, DOI 10.1385/MN:24:1-3:107; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Scorrano L, 1997, J BIOL CHEM, V272, P12295, DOI 10.1074/jbc.272.19.12295; SELWYN MJ, 1970, FEBS LETT, V10, P1, DOI 10.1016/0014-5793(70)80402-1; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; Vajda S, 2009, FEBS J, V276, P2713, DOI 10.1111/j.1742-4658.2009.06995.x; Volbracht C, 1999, MOL MED, V5, P477; Yamamoto T, 2008, J BIOENERG BIOMEMBR, V40, P619, DOI 10.1007/s10863-008-9190-6; Zorov DB, 2009, CARDIOVASC RES, V83, P213, DOI 10.1093/cvr/cvp151	45	27	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6345	6353		10.1074/jbc.M110.196600	http://dx.doi.org/10.1074/jbc.M110.196600			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21173147	hybrid, Green Published			2022-12-27	WOS:000287476400045
J	Guo, JF; Gertsberg, Z; Ozgen, N; Sabri, A; Steinberg, SF				Guo, Jianfen; Gertsberg, Zoya; Ozgen, Nazira; Sabri, Abdelkarim; Steinberg, Susan F.			Protein Kinase D Isoforms Are Activated in an Agonist-specific Manner in Cardiomyocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC TROPONIN-I; ELEMENT-BINDING PROTEIN; G(Q)-COUPLED RECEPTORS; SER(748) PHOSPHORYLATION; CATALYTIC ACTIVATION; LOOP SER(744); LOCALIZATION; HYPERTROPHY; MECHANISMS; EXPRESSION	Protein kinase D (PKD) exists as a family of structurally related enzymes that are activated through similar phosphorylation-dependent mechanisms involving protein kinase C (PKC). While individual PKD isoforms could in theory mediate distinct biological functions, previous studies identify a high level of functional redundancy for PKD1 and PKD2 in various cellular contexts. This study shows that PKD1 and PKD2 are activated in a stimulus-specific manner in neonatal cardiomyocytes. The alpha(1)-adrenergic receptor agonist norepinephrine selectively activates PKD1, thrombin and PDGF selectively activate PKD2, and endothelin-1 and PMA activate both PKD1 and PKD2. PKC activity is implicated in the alpha(1)-adrenergic receptor pathway that activates PKD1 and the thrombin- and PDGF-dependent pathways that activate PKD2. Endothelin-1 activates PKD via both rapid PKC-dependent and more sustained PKC-independent mechanisms. The functional consequences of PKD activation were assessed by tracking phosphorylation of CREB and cardiac troponin I (cTnI), two physiologically relevant PKD substrates in cardiomyocytes. We show that overexpression of an activated PKD1-S744E/S748E transgene increases CREB-Ser(133) and cTnI-Ser(23)/Ser(24) phosphorylation, but agonist-dependent pathways that activate native PKD1 or PKD2 selectively increase CREB-Ser(133) phosphorylation; there is no associated increase in cTnI-Ser(23)/Ser(24) phosphorylation. Gene silencing studies provide unanticipated evidence that PKD1 down-regulation leads to a compensatory increase in PKD2 activity and that down-regulation of PKD1 (alone or in combination with PKD2) leads to an increase in CREB-Ser(133) phosphorylation. Collectively, these studies identify distinct roles for native PKD1 and PKD2 enzymes in stress-dependent pathways that influence cardiac remodeling and the progression of heart failure.	[Steinberg, Susan F.] Columbia Univ, Dept Pharmacol, Coll Phys & Surg, New York, NY 10032 USA; [Guo, Jianfen; Sabri, Abdelkarim] Temple Univ, Cardiovasc Res Ctr, Philadelphia, PA 19140 USA	Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Steinberg, SF (corresponding author), Columbia Univ, Dept Pharmacol, Coll Phys & Surg, 630 W 168 St, New York, NY 10032 USA.	sfs1@columbia.edu			USPHS-NHLBI, National Institutes of Health [HL77860, HL-67101, HL-28958]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028958, R01HL077860, R01HL067101, R01HL112388] Funding Source: NIH RePORTER	USPHS-NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by USPHS-NHLBI, National Institutes of Health Grants HL77860, HL-67101, and HL-28958.	Bossard C, 2007, J CELL BIOL, V179, P1123, DOI 10.1083/jcb.200703166; Carnegie GK, 2004, MOL CELL, V15, P889, DOI 10.1016/j.molcel.2004.09.015; Carnegie GK, 2008, MOL CELL, V32, P169, DOI 10.1016/j.molcel.2008.08.030; Cuello F, 2007, CIRC RES, V100, P864, DOI 10.1161/01.RES.0000260809.15393.fa; Harrison BC, 2006, MOL CELL BIOL, V26, P3875, DOI 10.1128/MCB.26.10.3875-3888.2006; Haworth RS, 2000, J MOL CELL CARDIOL, V32, P1013, DOI 10.1006/jmcc.2000.1143; Haworth RS, 2004, CIRC RES, V95, P1091, DOI 10.1161/01.RES.0000149299.34793.3c; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; Johannessen M, 2007, J BIOL CHEM, V282, P14777, DOI 10.1074/jbc.M610669200; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Lee YJ, 2005, J BIOL CHEM, V280, P18108, DOI 10.1074/jbc.M501131200; Maizels ET, 1998, BIOCHEM J, V332, P703, DOI 10.1042/bj3320703; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; Maturana AD, 2008, CARDIOVASC RES, V78, P458, DOI 10.1093/cvr/cvn052; Metzger JM, 2004, CIRC RES, V94, P146, DOI 10.1161/01.RES.0000110083.17024.60; Oster H, 2006, GENE EXPR PATTERNS, V6, P400, DOI 10.1016/j.modgep.2005.09.006; Ozgen N, 2008, J BIOL CHEM, V283, P17009, DOI 10.1074/jbc.M709851200; Rey O, 2003, J BIOL CHEM, V278, P23773, DOI 10.1074/jbc.M300226200; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rybin VO, 2009, J BIOL CHEM, V284, P2332, DOI 10.1074/jbc.M806381200; Rybin VO, 2004, J BIOL CHEM, V279, P19350, DOI 10.1074/jbc.M311096200; Sinnett-Smith J, 2009, J BIOL CHEM, V284, P13434, DOI 10.1074/jbc.M806554200; Steiner TS, 2010, CELL IMMUNOL, V264, P135, DOI 10.1016/j.cellimm.2010.05.012; Sumandea MP, 2008, J BIOL CHEM, V283, P22680, DOI 10.1074/jbc.M802396200; Vega RB, 2004, MOL CELL BIOL, V24, P8374, DOI 10.1128/MCB.24.19.8374-8385.2004; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	26	32	34	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6500	6509		10.1074/jbc.M110.208058	http://dx.doi.org/10.1074/jbc.M110.208058			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21156805	hybrid, Green Published			2022-12-27	WOS:000287476400060
J	Liu, JY; Stevens, PD; Gao, TY				Liu, Jianyu; Stevens, Payton D.; Gao, Tianyan			mTOR-Dependent Regulation of PHLPP Expression Controls the Rapamycin Sensitivity in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AKT ISOFORMS; AKT/PKB; COMPLEX; GROWTH; RICTOR; RAPTOR; PHOSPHORYLATION; PROLIFERATION; TUMORIGENESIS; INHIBITION	PHLPP belongs to a novel family of protein phosphatases that serve as negative regulators of Akt. There are two isoforms, PHLPP1 and PHLPP2, identified in this family. Our previous studies indicated a tumor suppressor role of both PHLPP isoforms in colon cancer. Here we report that the expression of PHLPP is controlled by mTOR-dependent protein translation in colon and breast cancer cells. Treating cells with rapamycin or knockdown of mTOR using RNAi results in a marked decrease of PHLPP protein expression. In contrast, stable knockdown of TSC2, a negative regulator of mTOR activity, increases PHLPP expression. The rapamycin-mediated down-regulation of PHLPP is blocked by expression of a rapamycin-insensitive mutant of p70S6K. In addition, depletion of 4E-BP1 expression by RNAi results in an increase of PHLPP expression and resistance to rapamycin-induced down-regulation. Moreover, inhibition of mTOR activity by amino acid or glucose starvation reduces PHLPP expression in cells. Functionally, we show that rapamycin-mediated inhibition of PHLPP expression contributes to rapamycin resistance in colon cancer cells. Thus, our studies identify a compensatory feedback regulation in which the activation of Akt is inhibited by up-regulation of PHLPP through mTOR, and this mTOR-dependent expression of PHLPP subsequently determines the rapamycin sensitivity of cancer cells.	[Gao, Tianyan] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Gao, TY (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.	tianyan.gao@uky.edu			National Institutes of Health [R01 CA133429-01A1]; American Cancer Society [RSG0822001TBE]; NATIONAL CANCER INSTITUTE [R01CA133429] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA133429-01A1 (to T. G.). This work was also supported by American Cancer Society Grant RSG0822001TBE (to T. G.).	Alessi DR, 1998, CURR OPIN GENET DEV, V8, P55, DOI 10.1016/S0959-437X(98)80062-2; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Efeyan A, 2010, CURR OPIN CELL BIOL, V22, P169, DOI 10.1016/j.ceb.2009.10.007; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gleason CE, 2007, J BIOL CHEM, V282, P10341, DOI 10.1074/jbc.M610631200; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Gulhati P, 2009, CLIN CANCER RES, V15, P7207, DOI 10.1158/1078-0432.CCR-09-1249; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hirano I, 2009, J BIOL CHEM, V284, P22155, DOI 10.1074/jbc.M808182200; Huang S, 2003, CURR OPIN PHARMACOL, V3, P371, DOI 10.1016/S1471-4892(03)00071-7; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2009, HUM MOL GENET, V18, pR94, DOI 10.1093/hmg/ddp032; Knight ZA, 2010, NAT REV CANCER, V10, P130, DOI 10.1038/nrc2787; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Li X, 2009, MOL CELL BIOL, V29, P6192, DOI 10.1128/MCB.00681-09; Liu J, 2009, ONCOGENE, V28, P994, DOI 10.1038/onc.2008.450; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mariappan MM, 2007, DIABETES, V56, P476, DOI 10.2337/db05-1334; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2009, BIOCHEM SOC T, V37, P289, DOI 10.1042/BST0370289; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206; Zeng ZH, 2007, BLOOD, V109, P3509, DOI 10.1182/blood-2006-06-030833	41	52	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6510	6520		10.1074/jbc.M110.183087	http://dx.doi.org/10.1074/jbc.M110.183087			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21177869	Green Published, hybrid			2022-12-27	WOS:000287476400061
J	Friis, S; Godiksen, S; Bornholdt, J; Selzer-Plon, J; Rasmussen, HB; Bugge, TH; Lin, CY; Vogel, LK				Friis, Stine; Godiksen, Sine; Bornholdt, Jette; Selzer-Plon, Joanna; Rasmussen, Hanne Borger; Bugge, Thomas H.; Lin, Chen-Yong; Vogel, Lotte K.			Transport via the Transcytotic Pathway Makes Prostasin Available as a Substrate for Matriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR ACTIVATOR INHIBITOR-1; EPIDERMAL BARRIER FUNCTION; PROTEOLYTIC CASCADE; PROTEASE; CHANNEL; PURIFICATION; EXPRESSION; PROTEINS; COMPLEX	The matriptase-prostasin proteolytic cascade is essential for epidermal tight junction formation and terminal epidermal differentiation. This proteolytic pathway may also be operative in a variety of other epithelia, as both matriptase and prostasin are involved in tight junction formation in epithelial monolayers. However, in polarized epithelial cells matriptase is mainly located on the basolateral plasma membrane whereas prostasin is mainly located on the apical plasma membrane. To determine how matriptase and prostasin interact, we mapped the subcellular itinerary of matriptase and prostasin in polarized colonic epithelial cells. We show that zymogen matriptase is activated on the basolateral plasma membrane where it is able to cleave relevant substrates. After activation, matriptase forms a complex with the cognate matriptase inhibitor, hepatocyte growth factor activator inhibitor (HAI)-1 and is efficiently endocytosed. The majority of prostasin is located on the apical plasma membrane albeit a minor fraction of prostasin is present on the basolateral plasma membrane. Basolateral prostasin is endocytosed and transcytosed to the apical plasma membrane where a long retention time causes an accumulation of prostasin. Furthermore, we show that prostasin on the basolateral membrane is activated before it is transcytosed. This study shows that matriptase and prostasin co-localize for a brief period of time at the basolateral plasma membrane after which prostasin is transported to the apical membrane as an active protease. This study suggests a possible explanation for how matriptase or other basolateral serine proteases activate prostasin on its way to its apical destination.	[Vogel, Lotte K.] Univ Copenhagen, Dept Cellular & Mol Med, DK-2200 Copenhagen, Denmark; [Godiksen, Sine] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Rasmussen, Hanne Borger] Univ Copenhagen, Dept Biomed Sci, DK-2200 Copenhagen, Denmark; [Bugge, Thomas H.] NIDCR, Proteases & Tissue Remodeling Unit, NIH, Bethesda, MD 20892 USA; [Lin, Chen-Yong] Univ Maryland, Dept Biochem & Mol Biol, Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University of Copenhagen; University of Copenhagen; University of Copenhagen; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University System of Maryland; University of Maryland Baltimore	Vogel, LK (corresponding author), Blegdamsvej 3,Bldg 6-4, DK-2200 Copenhagen N, Denmark.	vogel@sund.ku.dk	Rasmussen, Hanne B/N-9652-2016	Rasmussen, Hanne B/0000-0002-2218-5646; Vogel, Lotte K./0000-0001-9920-0982; johnson, Michael/0000-0001-6260-7586	NIDCR; National Institutes of Health [R01-CA-123223]; Harboe Foundation; Augustinus Foundation; Brothers Hartmanns Foundation; A.P. Mollers Foundation for the Advancement of Medical Science; University of Copenhagen; Lundbeck Foundation; NATIONAL CANCER INSTITUTE [R01CA123223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000699] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harboe Foundation; Augustinus Foundation; Brothers Hartmanns Foundation; A.P. Mollers Foundation for the Advancement of Medical Science; University of Copenhagen; Lundbeck Foundation(Lundbeckfonden); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by the NIDCR Intramural Research Program and by National Institutes of Health Grant R01-CA-123223. This work was also supported by The Harboe Foundation, The Augustinus Foundation, The Brothers Hartmanns Foundation, The A.P. Mollers Foundation for the Advancement of Medical Science, The Cluster of Cell Biology at the University of Copenhagen, and the Lundbeck Foundation.	Alef T, 2009, J INVEST DERMATOL, V129, P862, DOI 10.1038/jid.2008.311; Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; BACHER A, 1992, EXP CELL RES, V200, P97, DOI 10.1016/S0014-4827(05)80076-X; Beliveau F, 2009, FEBS J, V276, P2213, DOI 10.1111/j.1742-4658.2009.06950.x; Buzza MS, 2010, P NATL ACAD SCI USA, V107, P4200, DOI 10.1073/pnas.0903923107; Chen M., 2008, BIOCHIM BIOPHYS ACTA, V1785, P896; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Farkas K., 2010, INFLAMM BOW IN PRESS; Godiksen S, 2008, BIOCHEM J, V413, P251, DOI 10.1042/BJ20071496; LEBIVIC A, 1990, J CELL BIOL, V111, P1351, DOI 10.1083/jcb.111.4.1351; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Lin CY, 2008, FRONT BIOSCI-LANDMRK, V13, P621, DOI 10.2741/2707; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1997, J BIOL CHEM, V272, P9147; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; List K, 2007, J CELL PHYSIOL, V213, P237, DOI 10.1002/jcp.21115; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; Mauro T, 2002, J INVEST DERMATOL, V118, P589, DOI 10.1046/j.1523-1747.2002.01721.x; Myerburg MM, 2010, AM J RESP CELL MOL, V43, P712, DOI 10.1165/rcmb.2009-0348OC; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; Ovaere P, 2009, TRENDS BIOCHEM SCI, V34, P453, DOI 10.1016/j.tibs.2009.08.001; Satomi S, 2001, BIOCHEM BIOPH RES CO, V287, P995, DOI 10.1006/bbrc.2001.5686; Selzer-Plon J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-201; Steensgaard M, 2010, ACTA PHYSIOL, V200, P347, DOI 10.1111/j.1748-1716.2010.02170.x; Sullivan S, 2009, INFLAMM BOWEL DIS, V15, P261, DOI 10.1002/ibd.20743; Szabo R, 2009, AM J PATHOL, V174, P2015, DOI 10.2353/ajpath.2009.090053; Tseng IC, 2008, AM J PHYSIOL-CELL PH, V295, pC423, DOI 10.1152/ajpcell.00164.2008; Tsuzuki S, 2005, BIOCHEM J, V388, P679, DOI 10.1042/BJ20041639; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Verghese GM, 2006, AM J PHYSIOL-CELL PH, V291, pC1258, DOI 10.1152/ajpcell.00637.2005; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009; YU JX, 1995, J BIOL CHEM, V270, P13483, DOI 10.1074/jbc.270.22.13483; Zeissig S, 2008, GASTROENTEROLOGY, V134, P1436, DOI 10.1053/j.gastro.2008.02.030	34	37	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5793	5802		10.1074/jbc.M110.186874	http://dx.doi.org/10.1074/jbc.M110.186874			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148558	Green Published, hybrid			2022-12-27	WOS:000287230600088
J	Mast, N; Annalora, AJ; Lodowski, DT; Palczewski, K; Stout, CD; Pikuleva, IA				Mast, Natalia; Annalora, Andrew J.; Lodowski, David T.; Palczewski, Krzysztof; Stout, C. David; Pikuleva, Irina A.			Structural Basis for Three-step Sequential Catalysis by the Cholesterol Side Chain Cleavage Enzyme CYP11A1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE ADRENOCORTICAL PREPARATIONS; F-G LOOP; SUBSTRATE-SPECIFICITY; ADRENODOXIN-BINDING; CYTOCHROME-P450 46A1; P450SCC CYP11A1; PREGNENOLONE; SITE; INHIBITION; CONVERSION	Mitochondrial cytochrome P450 11A1 (CYP11A1 or P450 11A1) is the only known enzyme that cleaves the side chain of cholesterol, yielding pregnenolone, the precursor of all steroid hormones. Pregnenolone is formed via three sequential monooxygenation reactions that involve the progressive production of 22R-hydroxycholesterol (22HC) and 20 alpha,22R-dihydroxycholesterol, followed by the cleavage of the C20-C22 bond. Herein, we present the 2.5-angstrom crystal structure of CYP11A1 in complex with the first reaction intermediate, 22HC. The active site cavity in CYP11A1 represents a long curved tube that extends from the protein surface to the heme group, the site of catalysis. 22HC occupies two-thirds of the cavity with the 22R-hydroxyl group nearest the heme, 2.56 angstrom from the iron. The space at the entrance to the active site is not taken up by 22HC but filled with ordered water molecules. The network formed by these water molecules allows the "soft" recognition of the 22HC 3 beta-hydroxyl. Such a mode of 22HC binding suggests shuttling of the sterol intermediates between the active site entrance and the heme group during the three-step reaction. Translational freedom of 22HC and torsional motion of its aliphatic tail are supported by solution studies. The CYP11A1-22HC co-complex also provides insight into the structural basis of the strict substrate specificity and high catalytic efficiency of the enzyme and highlights conserved structural motifs involved in redox partner interactions by mitochondrial P450s.	[Annalora, Andrew J.; Stout, C. David] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Mast, Natalia; Pikuleva, Irina A.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Lodowski, David T.; Palczewski, Krzysztof] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	Scripps Research Institute; Case Western Reserve University; Case Western Reserve University	Stout, CD (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dave@scripps.edu; iap8@case.edu		Annalora, Andrew J./0000-0001-6415-8921; Pikuleva, Irina/0000-0001-9742-6232	United States Public Health Service [GM62882, AG024336, EY019718, EY0090339]; Department of Energy, Office of Biological and Environmental Research; National Center for Research Resources, National Institutes of Health; NIGMS; NATIONAL EYE INSTITUTE [K99EY019718, R00EY019718] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K02AG024336] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by United States Public Health Service Grants GM62882 and AG024336 (to I. A. P.), EY019718 (to D. T. L.), and EY0090339 (to K. P.). Portions of this work were carried out at the Stanford Synchrotron Radiation Lightsource, a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The Stanford Synchrotron Radiation Lightsource Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, by the Biomedical Technology Program of the National Center for Research Resources, National Institutes of Health, and by NIGMS.	Annalora AJ, 2010, J MOL BIOL, V396, P441, DOI 10.1016/j.jmb.2009.11.057; ARINGER L, 1979, J STEROID BIOCHEM, V11, P1271, DOI 10.1016/0022-4731(79)90196-1; BURSTEIN S, 1976, STEROIDS, V27, P361, DOI 10.1016/0039-128X(76)90057-X; BURSTEIN S, 1975, J BIOL CHEM, V250, P9028; DEGENHART HJ, 1984, J STEROID BIOCHEM, V21, P447, DOI 10.1016/0022-4731(84)90310-8; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Headlam MJ, 2003, BBA-BIOMEMBRANES, V1617, P96, DOI 10.1016/j.bbamem.2003.09.007; HEYL BL, 1986, J BIOL CHEM, V261, P2743; KOBAYASHI S, 1969, J BIOCHEM, V66, P51, DOI 10.1093/oxfordjournals.jbchem.a129119; LAMBETH JD, 1983, J BIOL CHEM, V258, P5596; LAMBETH JD, 1986, ENDOCR RES, V12, P371, DOI 10.3109/07435808609035446; LAMBETH JD, 1982, J BIOL CHEM, V257, P1876; LAMBETH JD, 1985, J BIOL CHEM, V260, P8810; LAMBETH JD, 1980, J BIOL CHEM, V255, P138; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Mast N, 2003, BIOCHEMISTRY-US, V42, P14284, DOI 10.1021/bi035512f; Mast N, 2008, P NATL ACAD SCI USA, V105, P9546, DOI 10.1073/pnas.0803717105; MORISAKI M, 1980, J STEROID BIOCHEM, V13, P545; MORISAKI M, 1982, J STEROID BIOCHEM, V16, P101; Nelson DR, 1998, COMP BIOCHEM PHYS C, V121, P15, DOI 10.1016/S0742-8413(98)10027-0; Omdahl JL, 2002, ANNU REV NUTR, V22, P139, DOI 10.1146/annurev.nutr.22.120501.150216; OMURA T, 1964, J BIOL CHEM, V239, P2370; ORMEJOHNSON NR, 1979, J BIOL CHEM, V254, P2103; Pikuleva IA, 2006, DRUG METAB DISPOS, V34, P513, DOI 10.1124/dmd.105.008789; Pikuleva IA, 2004, MOL CELL ENDOCRINOL, V215, P161, DOI 10.1016/j.mce.2003.11.005; PIKULEVA IA, 1995, ARCH BIOCHEM BIOPHYS, V322, P189, DOI 10.1006/abbi.1995.1451; Pikuleva IA, 1999, J BIOL CHEM, V274, P2045, DOI 10.1074/jbc.274.4.2045; Pikuleva IA, 2006, PHARMACOL THERAPEUT, V112, P761, DOI 10.1016/j.pharmthera.2006.05.014; Pikuleva I, 2008, LIPIDS, V43, P1127, DOI 10.1007/s11745-008-3234-x; Russell DW, 2009, ANNU REV BIOCHEM, V78, P1017, DOI 10.1146/annurev.biochem.78.072407.103859; Shaik S, 2005, CHEM REV, V105, P2279, DOI 10.1021/cr030722j; SHEETS JJ, 1983, J BIOL CHEM, V258, P1720; SIMPSON ER, 1967, EUR J BIOCHEM, V2, P275, DOI 10.1111/j.1432-1033.1967.tb00136.x; TROUT EC, 1971, P SOC EXP BIOL MED, V136, P469; TSUBAKI M, 1988, BIOCHEMISTRY-US, V27, P4856, DOI 10.1021/bi00413a041; TSUBAKI M, 1989, BIOCHEMISTRY-US, V28, P6899, DOI 10.1021/bi00443a019; TUCKEY RC, 1983, J BIOL CHEM, V258, P4232; TULS J, 1989, J BIOL CHEM, V264, P16421; Urushino N, 2006, BIOCHEMISTRY-US, V45, P4405, DOI 10.1021/bi060072o; WADA A, 1992, J BIOL CHEM, V267, P22877	40	98	99	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5607	5613		10.1074/jbc.M110.188433	http://dx.doi.org/10.1074/jbc.M110.188433			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21159775	Green Published, hybrid			2022-12-27	WOS:000287230600070
J	Weatherspoon-Griffin, N; Zhao, GA; Kong, W; Kong, Y; Morigen; Andrews-Polymenis, H; McClelland, M; Shi, YX				Weatherspoon-Griffin, Natasha; Zhao, Guang; Kong, Wei; Kong, Ying; Morigen; Andrews-Polymenis, Helene; McClelland, Michael; Shi, Yixin			The CpxR/CpxA Two-component System Up-regulates Two Tat-dependent Peptidoglycan Amidases to Confer Bacterial Resistance to Antimicrobial Peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; PROTEIN; EXPORT; IDENTIFICATION; RECOGNITION; TRANSPORT; PROTAMINE; MAGAININS; SEQUENCE; MELITTIN	We demonstrate that the twin arginine translocation (Tat) system contributes to bacterial resistance to cationic antimicrobial peptides (CAMPs). Our results show that a deletion at the tatC gene, which encodes a subunit of the Tat complex, caused Salmonella and Escherichia coli to become susceptible to protamine. We screened chromosomal loci that encode known and predicted Tat-dependent proteins and found that two N-acetylmuramoyl-L-alanine amidases, encoded by amiA and amiC, elevated bacterial resistance to protamine and alpha-helical peptides magainin 2 and melittin but not to beta-sheet defensin HNP-1 and lipopeptide polymyxin B. Genetic analysis suggests that transcription of both amiA and amiC loci in Salmonella is up-regulated by the CpxR/CpxA two-component system when nlpE is overexpressed. A footprinting analysis reveals that CpxR protein can interact with amiA and amiC promoters at the CpxR box, which is localized between the predicted -10 and -35 regions but present on different strands in these two genes. In addition, our results show that activation of the CpxR/CpxA system can facilitate protamine resistance because nlpE overexpression elevates this resistance in the wild-type strain but not the cpxR deletion mutant. Thus, we uncover a new transcriptional regulation pathway in which the Cpx envelope stress response system modulates the integrity of the cell envelope in part by controlling peptidoglycan amidase activity, which confers bacterial resistance to protamine and alpha-helical CAMPs. Our studies have important implications for understanding transcriptional regulation of peptidoglycan metabolism and also provide new insights into the role of the bacterial envelope in CAMP resistance.	[Weatherspoon-Griffin, Natasha; Zhao, Guang; Shi, Yixin] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Kong, Wei; Shi, Yixin] Arizona State Univ, Ctr Infect Dis & Vaccinol, Biodesign Inst, Tempe, AZ 85287 USA; [Kong, Ying] Dalian Med Univ, Dept Biochem & Mol Biol, Dalian 116044, Liaoning, Peoples R China; [Morigen] Inner Mongolia Univ, Coll Life Sci, Hohhot 010021, Peoples R China; [Andrews-Polymenis, Helene] Texas A&M Univ Syst Hlth Sci Ctr, Coll Med, College Stn, TX 77843 USA; [McClelland, Michael] Vaccine Res Inst San Diego, San Diego, CA 92121 USA; [McClelland, Michael] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA 92697 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Dalian Medical University; Inner Mongolia University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of California System; University of California Irvine	Shi, YX (corresponding author), Arizona State Univ, Sch Life Sci, POB 874501, Tempe, AZ 85287 USA.	yixin.shi@asu.edu	zhao, guang/E-4702-2013; McClelland, Michael/A-8583-2011; SHI, YIXIN/M-5751-2019	zhao, guang/0000-0003-0002-5972; McClelland, Michael/0000-0003-1788-9347; Morigen, Morigen/0000-0001-5782-376X	National Institutes of Health [U01A152237-05, R01AI07397-01, R01AI039557-11, R01AI075093-01, R21AI083964-01, 1R01AI083646-01, 1R56AI077645, R01 AI075093]; Center for Infectious Diseases and Vaccinology in the Biodesign Institute; Arizona State University; National Natural Science Foundation of China [30770483, 30970646]; United States Department of Agriculture [AFRI CSREES 2009-03579]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075093, R21AI083964, R01AI039557, R01AI083646, R56AI077645] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Infectious Diseases and Vaccinology in the Biodesign Institute; Arizona State University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants U01A152237-05, R01AI07397-01, R01AI039557-11, and R01AI075093-01) (to M. M.) and R21AI083964-01, 1R01AI083646-01, 1R56AI077645, and R01 AI075093 (to H. A.-P.). This study was also supported by research funds from the Center for Infectious Diseases and Vaccinology in the Biodesign Institute (to G. Z.) and Arizona State University (to Y. S.) and National Natural Science Foundation of China Grants 30770483 and 30970646 (to Y. K.) and United States Department of Agriculture Grant AFRI CSREES 2009-03579 (to H. A.-P.).	Ando T, 1973, Mol Biol Biochem Biophys, V12, P1; Aspedon A, 1996, MICROBIOL-SGM, V142, P3389, DOI 10.1099/13500872-142-12-3389; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Bauer R, 2005, INT J FOOD MICROBIOL, V101, P201, DOI 10.1016/j.ijfoodmicro.2004.11.007; Bechinger B, 1997, J MEMBRANE BIOL, V156, P197, DOI 10.1007/s002329900201; Berks BC, 2000, MOL MICROBIOL, V35, P260, DOI 10.1046/j.1365-2958.2000.01719.x; Bernhardt TG, 2003, MOL MICROBIOL, V48, P1171, DOI 10.1046/j.1365-2958.2003.03511.x; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis R., 1980, ADV BACTERIAL GENETI; De Wulf P, 2002, J BIOL CHEM, V277, P26652, DOI 10.1074/jbc.M203487200; Dilks K, 2003, J BACTERIOL, V185, P1478, DOI 10.1128/JB.185.4.1478-1483.2003; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Eswarappa SM, 2008, MICROBIOL-SGM, V154, P666, DOI 10.1099/mic.0.2007/011114-0; FIELDS PI, 1989, SCIENCE, V243, P1059, DOI 10.1126/science.2646710; Guina T, 2000, J BACTERIOL, V182, P4077, DOI 10.1128/JB.182.14.4077-4086.2000; Gunn JS, 2008, TRENDS MICROBIOL, V16, P284, DOI 10.1016/j.tim.2008.03.007; Gunn JS, 1996, J BACTERIOL, V178, P6857, DOI 10.1128/jb.178.23.6857-6864.1996; GUPTA SD, 1995, J BACTERIOL, V177, P4207, DOI 10.1128/jb.177.15.4207-4215.1995; HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Heidrich C, 2001, MOL MICROBIOL, V41, P167, DOI 10.1046/j.1365-2958.2001.02499.x; Ize B, 2003, MOL MICROBIOL, V48, P1183, DOI 10.1046/j.1365-2958.2003.03504.x; Kong W, 2008, J BIOL CHEM, V283, P16612, DOI 10.1074/jbc.M800547200; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; Lee MT, 2004, BIOCHEMISTRY-US, V43, P3590, DOI 10.1021/bi036153r; Lejona S, 2003, J BACTERIOL, V185, P6287, DOI 10.1128/JB.185.21.6287-6294.2003; McClelland M, 2001, NATURE, V413, P852, DOI 10.1038/35101614; McPhee JB, 2003, MOL MICROBIOL, V50, P205, DOI 10.1046/j.1365-2958.2003.03673.x; Otto K, 2002, P NATL ACAD SCI USA, V99, P2287, DOI 10.1073/pnas.042521699; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Palmer T, 2007, PERIPLASM, P16; PARRALOPEZ C, 1994, EMBO J, V13, P3964, DOI 10.1002/j.1460-2075.1994.tb06712.x; PARRALOPEZ C, 1993, EMBO J, V12, P4053, DOI 10.1002/j.1460-2075.1993.tb06089.x; Pogliano J, 1997, GENE DEV, V11, P1169, DOI 10.1101/gad.11.9.1169; Raivio TL, 1999, CURR OPIN MICROBIOL, V2, P159, DOI 10.1016/S1369-5274(99)80028-9; Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477; Shi YX, 2004, MOL MICROBIOL, V53, P229, DOI 10.1111/j.1365-2958.2004.04107.x; SNYDER WB, 1995, J BACTERIOL, V177, P4216, DOI 10.1128/jb.177.15.4216-4223.1995; SONCINI FC, 1995, J BACTERIOL, V177, P4364, DOI 10.1128/jb.177.15.4364-4371.1995; Stanley NR, 2001, J BACTERIOL, V183, P139, DOI 10.1128/JB.183.1.139-144.2001; Stumpe S, 1998, J BACTERIOL, V180, P4002, DOI 10.1128/JB.180.15.4002-4006.1998; TOMIOKA S, 1983, J BACTERIOL, V156, P463, DOI 10.1128/JB.156.1.463-465.1983; VAARA M, 1983, ANTIMICROB AGENTS CH, V24, P107, DOI 10.1128/AAC.24.1.107; Yamamoto K, 2006, BIOSCI BIOTECH BIOCH, V70, P1688, DOI 10.1271/bbb.60024; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yang L, 1998, BIOPHYS J, V75, P641, DOI 10.1016/S0006-3495(98)77554-X; Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	53	75	79	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5529	5539		10.1074/jbc.M110.200352	http://dx.doi.org/10.1074/jbc.M110.200352			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21149452	Green Published, hybrid			2022-12-27	WOS:000287230600062
J	Yamamoto, T; Lu, C; Ryan, RO				Yamamoto, Taichi; Lu, Christine; Ryan, Robert O.			A Two-step Binding Model of PCSK9 Interaction with the Low Density Lipoprotein Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL DOMAIN; LDL-RECEPTOR; FAMILIAL HYPERCHOLESTEROLEMIA; LIGAND INTERACTIONS; APOLIPOPROTEIN-E; CHOLESTEROL; PH; ANTIBODY; DEGRADATION; DECREASES	PCSK9 (proprotein convertase subtilisin-like/ kexin type 9) is an emerging target for pharmaceutical intervention. This multidomain protein interacts with the LDL receptor (LDLR), promoting receptor degradation. Insofar as PCSK9 inhibition induces a decrease in plasma cholesterol levels, understanding the nature of the binding interaction between PCSK9 and the LDLR is of critical importance. In this study, the ability of PCSK9 to compete with apoE3 N-terminal domain-containing reconstituted HDL for receptor binding was examined. Whereas full-length PCSK9 was an effective competitor, the N-terminal domain (composed of the prodomain and catalytic domain) was not. Surprisingly, the C-terminal domain (CT domain) of PCSK9 was able to compete. Using a direct binding interaction assay, we show that the PCSK9 CT domain bound to the LDLR in a calcium-dependent manner and that co-incubation with the prodomain and catalytic domain had no effect on this binding. To further characterize this interaction, two LDLR fragments, the classical ligand-binding domain (LBD) and the EGF precursor homology domain, were expressed in stably transfected HEK 293 cells and isolated. Binding assays showed that the PCSK9 CT domain bound to the LBD at pH 5.4. Thus, CT domain interaction with the LBD of the LDLR at endosomal pH constitutes a second step in the PCSK9-mediated LDLR binding that leads to receptor degradation.	[Yamamoto, Taichi; Lu, Christine; Ryan, Robert O.] Childrens Hosp Oakland Res Inst, Ctr Prevent Obes Cardiovasc Dis & Diabet, Oakland, CA 94609 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Ryan, RO (corresponding author), Childrens Hosp Oakland Res Inst, Ctr Prevent Obes Cardiovasc Dis & Diabet, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	rryan@chori.org			National Institutes of Health [HL 64159]; California Tobacco-Related Disease Research Program [17KT-0026]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL064159, R01HL064159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Tobacco-Related Disease Research Program(University of California System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL 64159. This work was also supported by California Tobacco-Related Disease Research Program New Investigator Award 17KT-0026 (to T. Y.).	Bajari TM, 2005, METHODS, V36, P109, DOI 10.1016/j.ymeth.2004.11.007; Beglova N, 2004, MOL CELL, V16, P281, DOI 10.1016/j.molcel.2004.09.038; Bottomley MJ, 2009, J BIOL CHEM, V284, P1313, DOI 10.1074/jbc.M808363200; Chan JCY, 2009, P NATL ACAD SCI USA, V106, P9820, DOI 10.1073/pnas.0903849106; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Davignon J, 2010, CURR ATHEROSCLER REP, V12, P308, DOI 10.1007/s11883-010-0123-6; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; Fisher CA, 1997, BIOCHEM CELL BIOL, V75, P45, DOI 10.1139/bcb-75-1-45; Fisher TS, 2007, J BIOL CHEM, V282, P20502, DOI 10.1074/jbc.M701634200; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lagace TA, 2006, J CLIN INVEST, V116, P2995, DOI 10.1172/JCI29383; McNutt MC, 2009, J BIOL CHEM, V284, P10561, DOI 10.1074/jbc.M808802200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Ni YG, 2011, J LIPID RES, V52, P78, DOI 10.1194/jlr.M011445; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Raussens V, 1998, J BIOL CHEM, V273, P25825, DOI 10.1074/jbc.273.40.25825; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Weers PMM, 2001, EUR J BIOCHEM, V268, P3728, DOI 10.1046/j.1432-1327.2001.02282.x; Yamamoto T, 2008, BIOCHEMISTRY-US, V47, P11647, DOI 10.1021/bi801117t; Yamamoto T, 2006, J LIPID RES, V47, P1091, DOI 10.1194/jlr.D600001-JLR200; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	27	81	88	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5464	5470		10.1074/jbc.M110.199042	http://dx.doi.org/10.1074/jbc.M110.199042			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21149300	Green Published, hybrid			2022-12-27	WOS:000287230600055
J	Xiao, JY; Liu, C; Hou, JJ; Cui, C; Wu, DD; Fan, HY; Sun, XH; Meng, J; Yang, FQ; Wang, EH; Yu, BZ				Xiao, Jianying; Liu, Chao; Hou, Junjie; Cui, Cheng; Wu, Didi; Fan, Huiyu; Sun, Xiaohan; Meng, Jun; Yang, Fuquan; Wang, Enhua; Yu, Bingzhi			Ser(149) Is Another Potential PKA Phosphorylation Target of Cdc25B in G(2)/M Transition of Fertilized Mouse Eggs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; IN-VITRO; MEIOTIC RESUMPTION; XENOPUS OOCYTES; CAMP; PHOSPHATASE; ACTIVATION; MEIOSIS; MITOSIS; ARREST	It is well documented that protein kinase A (PKA) acts as a negative regulator of M phase promoting factor (MPF) by phosphorylating cell division cycle 25 homolog B (Cdc25B) in mammals. However, the molecular mechanism remains unclear. In this study, we identified PKA phosphorylation sites in vitro by LC-MS/MS analysis, including Ser(149), Ser(229), and Ser(321) of Cdc25B, and explored the role of Ser(149) in G(2)/M transition of fertilized mouse eggs. The results showed that the overexpressed Cdc25B-S149A mutant initiated efficient MPF activation by direct dephosphorylation of Cdc2-Tyr(15), resulting in triggering mitosis prior to Cdc25B-WT. Conversely, overexpression of the phosphomimic Cdc25B-S149D mutant showed no significant difference in comparison with the control groups. Furthermore, we found that Cdc25B-Ser(149) was phosphorylated at G(1) and S phases, whereas dephosphorylated at G(2) and M phases, and the phosphorylation of Cdc25B-Ser(149) was modulated by PKA in vivo. In addition, we examined endogenous and exogenous Cdc25B, which were expressed mostly in the cytoplasm at the G(1) and S phases and translocated to the nucleus at the G(2) phase. Collectively, our findings provide evidence that Ser(149) may be another potential PKA phosphorylation target of Cdc25B in G(2)/M transition of fertilized mouse eggs and Cdc25B as a direct downstream substrate of PKA in mammals, which plays important roles in the regulation of early development of mouse embryos.	[Xiao, Jianying; Liu, Chao; Cui, Cheng; Wu, Didi; Meng, Jun; Yu, Bingzhi] China Med Univ, Dept Biochem & Mol Biol, Minist Educ China, Shenyang 110001, Liaoning Prov, Peoples R China; [Wang, Enhua; Yu, Bingzhi] China Med Univ, Inst Pathol & Pathopysiol, Minist Educ China, Shenyang 110001, Liaoning Prov, Peoples R China; [Yu, Bingzhi] China Med Univ, Key Lab Med Cell Biol, Minist Educ China, Shenyang 110001, Liaoning Prov, Peoples R China; [Xiao, Jianying; Liu, Chao; Fan, Huiyu; Sun, Xiaohan] Liaoning Medial Univ, Dept Biochem & Mol Biol, Jinzhou 121001, Liaoning Prov, Peoples R China; [Hou, Junjie; Yang, Fuquan] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China	China Medical University; Ministry of Education, China; China Medical University; Ministry of Education, China; China Medical University; Ministry of Education, China; Jinzhou Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Yu, BZ (corresponding author), China Med Univ, Dept Biochem & Mol Biol, Minist Educ China, 92 Bei Er Rd, Shenyang 110001, Liaoning Prov, Peoples R China.	ybzbiochem@yeah.net			National Nature Science Foundation of China [30900514]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Nature Science Foundation of China Grant 30900514.	Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Bouche JP, 2008, J PROTEOME RES, V7, P1264, DOI 10.1021/pr700623p; Boutros R, 2006, CURR OPIN CELL BIOL, V18, P185, DOI 10.1016/j.ceb.2006.02.003; Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Bugler B, 2006, MOL CANCER THER, V5, P1446, DOI 10.1158/1535-7163.MCT-06-0099; Chen J, 2006, DEV BIOL, V291, P227, DOI 10.1016/j.ydbio.2005.11.039; Cui C, 2008, BIOL REPROD, V79, P991, DOI 10.1095/biolreprod.108.068205; Donzelli M, 2003, EMBO REP, V4, P671, DOI 10.1038/sj.embor.embor887; Duckworth BC, 2002, P NATL ACAD SCI USA, V99, P16794, DOI 10.1073/pnas.222661299; Duncan FE, 2006, DEV DYNAM, V235, P2961, DOI 10.1002/dvdy.20930; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Eyers PA, 2005, J BIOL CHEM, V280, P24339, DOI 10.1074/jbc.M412442200; Forrest A, 2001, ONCOGENE, V20, P4393, DOI 10.1038/sj.onc.1204574; Gallicano GI, 1997, MOL REPROD DEV, V46, P587, DOI 10.1002/(SICI)1098-2795(199704)46:4&lt;587::AID-MRD16&gt;3.0.CO;2-T; Giles N, 2003, J BIOL CHEM, V278, P28580, DOI 10.1074/jbc.M304027200; GRIECO D, 1994, P NATL ACAD SCI USA, V91, P9896, DOI 10.1073/pnas.91.21.9896; Grieco D, 1996, SCIENCE, V271, P1718, DOI 10.1126/science.271.5256.1718; Han SJ, 2006, CELL CYCLE, V5, P227, DOI 10.4161/cc.5.3.2395; HOGAN B, 1986, MANIPULATING MOUSE E, P249; Jiang XN, 2008, J PROTEOME RES, V7, P1640, DOI 10.1021/pr700675j; Karlsson C, 1999, J CELL BIOL, V146, P573, DOI 10.1083/jcb.146.3.573; Kovo M, 2006, REPRODUCTION, V132, P33, DOI 10.1530/rep.1.00824; Lammer C, 1998, J CELL SCI, V111, P2445; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Lincoln AJ, 2002, NAT GENET, V30, P446, DOI 10.1038/ng856; Lobjois V, 2009, BBA-MOL CELL RES, V1793, P462, DOI 10.1016/j.bbamcr.2008.12.015; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nilsson I, 2000, Prog Cell Cycle Res, V4, P107; Pirino G, 2009, CELL CYCLE, V8, P665, DOI 10.4161/cc.8.4.7846; Rudolph J, 2007, BIOCHEMISTRY-US, V46, P3595, DOI 10.1021/bi700026j; Schultz R, 2009, CELL CYCLE, V8, P516; SCHULTZ RM, 1983, DEV BIOL, V97, P264, DOI 10.1016/0012-1606(83)90085-4; Solc P, 2008, DEV BIOL, V317, P260, DOI 10.1016/j.ydbio.2008.02.028; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Woo ES, 1999, ONCOGENE, V18, P2770, DOI 10.1038/sj.onc.1202614; Yamada K, 2006, PATHOBIOLOGY, V73, P1, DOI 10.1159/000093086; Yu BZ, 2005, DEV DYNAM, V232, P98, DOI 10.1002/dvdy.20205; Zhang Y, 2008, DEV DYNAM, V237, P3777, DOI 10.1002/dvdy.21799; Zhang Z, 2007, MOL REPROD DEV, V74, P1247, DOI 10.1002/mrd.20703	41	13	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10356	10366		10.1074/jbc.M110.150524	http://dx.doi.org/10.1074/jbc.M110.150524			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21212267	hybrid, Green Published			2022-12-27	WOS:000288547000052
J	Balsera, M; Buey, RM; Li, XD				Balsera, Monica; Buey, Ruben M.; Li, Xiao-Dan			Quaternary Structure of the Oxaloacetate Decarboxylase Membrane Complex and Mechanistic Relationships to Pyruvate Carboxylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENERGY COUPLING MECHANISM; SMALL-ANGLE SCATTERING; X-RAY SOLUTION; NA+ PUMP; BETA-SUBUNIT; KLEBSIELLA-PNEUMONIAE; BIOLOGICAL MACROMOLECULES; ESCHERICHIA-COLI; VIBRIO-CHOLERAE; COENZYME-A	The oxaloacetate decarboxylase primary Na+ pump (OAD) is an essential membrane protein complex that functions in the citrate fermentation pathway of some pathogenic bacteria under anaerobic conditions. OAD contains three different subunits: Oad-alpha, a biotinylated extrinsic protein that catalyzes the alpha-ketodecarboxylation of oxaloacetate; Oad-gamma, a structural bitopic membrane protein whose cytosolic tail (named as Oad-gamma') binds tightly to Oad-alpha; and Oad-beta, a multispan transmembrane alpha-helical protein that constitutes the Na+ channel. How OAD is organized structurally at the membrane and what the molecular determinants are that lead to an efficient energy coupling mechanism remain elusive. In the present work, we elucidate the stoichiometry of the native complex as well as the low resolution structure of the peripheral components of OAD (Oad-alpha and Oad-gamma') by small angle x-ray scattering. Our results point to a quaternary assembly similar to the pyruvate carboxylase complex organization. Herein, we propose a model in which the association in pairs of Oad-alpha dimers, mediated by Oad-gamma, results in the acquisition of a functional oligomeric state at the bacterial membrane. New structural insights for the conformational rearrangements associated with the carboxylbiotin transfer reaction within OAD are provided.	[Balsera, Monica; Buey, Ruben M.; Li, Xiao-Dan] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Balsera, Monica] CSIC, Dept Estres Abiot, Inst Recursos Nat & Agrobiol Salamanca, Salamanca 37008, Spain; [Buey, Ruben M.] Univ Salamanca, CSIC, Inst Biol Mol & Celular Canc, E-37008 Salamanca, Spain	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Salamanca (IRNASA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Li, XD (corresponding author), Paul Scherrer Inst, CH-5232 Villigen, Switzerland.	xiao.li@psi.ch	Balsera, Monica/K-2877-2014; Martinez-Buey, Ruben/K-4296-2014	Balsera, Monica/0000-0002-5586-6050; Martinez-Buey, Ruben/0000-0003-1263-0221; li, xiaodan/0000-0001-8647-7317	Swiss National Science Foundation [1122.0036 NF]; Consejo Superior de Investigaciones Cientificas [200940I204]; Federation of European Biochemical Societies; Juan de la Cierva	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Consejo Superior de Investigaciones Cientificas; Federation of European Biochemical Societies; Juan de la Cierva(Instituto de Salud Carlos III)	This work was supported by Swiss National Science Foundation Grant 1122.0036 NF (to X.-D.L.).; Supported by Consejo Superior de Investigaciones Cientificas Grant 200940I204.; Supported by a Federation of European Biochemical Societies fellowship and a contract from the Juan de la Cierva program.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; ATTWOOD PV, 1986, BIOCHEMISTRY-US, V25, P8191, DOI 10.1021/bi00373a011; Dahinden P, 2005, FEBS J, V272, P846, DOI 10.1111/j.1742-4658.2004.04524.x; Dahinden P, 2005, ARCH MICROBIOL, V183, P121, DOI 10.1007/s00203-004-0754-5; DIBERARDINO M, 1995, EUR J BIOCHEM, V231, P790; DiBerardino M, 1996, EMBO J, V15, P1842, DOI 10.1002/j.1460-2075.1996.tb00534.x; DIMROTH P, 1982, EUR J BIOCHEM, V121, P435, DOI 10.1111/j.1432-1033.1982.tb05806.x; DIMROTH P, 1980, FEBS LETT, V122, P234, DOI 10.1016/0014-5793(80)80446-7; Dimroth P, 2001, BBA-BIOENERGETICS, V1505, P1, DOI 10.1016/S0005-2728(00)00272-3; DIMROTH P, 1984, BIOCHEMISTRY-US, V23, P5360, DOI 10.1021/bi00317a039; DIMROTH P, 1993, BIOCHEMISTRY-US, V32, P1734, DOI 10.1021/bi00058a006; DIMROTH P, 1983, EUR J BIOCHEM, V137, P107, DOI 10.1111/j.1432-1033.1983.tb07802.x; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Jitrapakdee S, 2003, CURR PROTEIN PEPT SC, V4, P217, DOI 10.2174/1389203033487199; Jitrapakdee S, 2008, BIOCHEM J, V413, P369, DOI 10.1042/BJ20080709; Jockel P, 2000, BIOCHEMISTRY-US, V39, P2307, DOI 10.1021/bi992261v; Jockel P, 2000, BIOCHEMISTRY-US, V39, P4320, DOI 10.1021/bi992817e; Jockel P, 1999, BIOCHEMISTRY-US, V38, P13461, DOI 10.1021/bi990303+; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Lasso G, 2010, STRUCTURE, V18, P1300, DOI 10.1016/j.str.2010.07.008; Mulkidjanian AY, 2008, BBA-BIOENERGETICS, V1777, P985, DOI 10.1016/j.bbabio.2008.04.028; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Schmid M, 2002, EUR J BIOCHEM, V269, P2997, DOI 10.1046/j.1432-1033.2002.02983.x; Schmid M, 2002, BIOCHEMISTRY-US, V41, P1285, DOI 10.1021/bi015764l; St Maurice M, 2007, SCIENCE, V317, P1076, DOI 10.1126/science.1144504; Studer R, 2007, J MOL BIOL, V367, P547, DOI 10.1016/j.jmb.2006.12.035; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wild MR, 2003, BIOCHEMISTRY-US, V42, P11615, DOI 10.1021/bi034753k; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Xiang S, 2008, NAT STRUCT MOL BIOL, V15, P295, DOI 10.1038/nsmb.1393; Yu LPC, 2009, STRUCTURE, V17, P823, DOI 10.1016/j.str.2009.04.008	33	14	14	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9457	9467		10.1074/jbc.M110.197442	http://dx.doi.org/10.1074/jbc.M110.197442			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21209096	hybrid, Green Published			2022-12-27	WOS:000288247700073
J	Bettaieb, A; Liu, SM; Xi, YN; Nagata, N; Matsuo, K; Matsuo, I; Chahed, S; Bakke, J; Keilhack, H; Tiganis, T; Haj, FG				Bettaieb, Ahmed; Liu, Siming; Xi, Yannan; Nagata, Naoto; Matsuo, Kosuke; Matsuo, Izumi; Chahed, Samah; Bakke, Jesse; Keilhack, Heike; Tiganis, Tony; Haj, Fawaz G.			Differential Regulation of Endoplasmic Reticulum Stress by Protein Tyrosine Phosphatase 1B and T Cell Protein Tyrosine Phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; TRANSLATIONAL CONTROL; ER STRESS; GLUCOSE-HOMEOSTASIS; INSULIN SENSITIVITY; DIABETES-MELLITUS; INDUCED APOPTOSIS; MICE; KINASE; ACTIVATION	Protein-tyrosine phosphatase 1B (PTP1B) and T cell protein-tyrosine phosphatase (TCPTP) are closely related intracellular phosphatases implicated in the control of glucose homeostasis. PTP1B and TCPTP can function coordinately to regulate protein tyrosine kinase signaling, and PTP1B has been implicated previously in the regulation of endoplasmic reticulum (ER) stress. In this study, we assessed the roles of PTP1B and TCPTP in regulating ER stress in the endocrine pancreas. PTP1B and TCPTP expression was determined in pancreases from chow and high fat fed mice and the impact of PTP1B and TCPTP over-or underexpression on palmitate- or tunicamycin-induced ER stress signaling assessed in MIN6 insulinoma beta cells. PTP1B expression was increased, and TCPTP expression decreased in pancreases of mice fed a high fat diet, as well as in MIN6 cells treated with palmitate. PTP1B overexpression or TCPTP knockdown in MIN6 cells mitigated palmitate- or tunicamycin-induced PERK/eIF2 alpha ER stress signaling, whereas PTP1B deficiency enhanced ER stress. Moreover, PTP1B deficiency increased ER stress-induced cell death, whereas TCPTP deficiency protected MIN6 cells from ER stress-induced death. ER stress coincided with the inhibition of Src family kinases (SFKs), which was exacerbated by PTP1B overexpression and largely prevented by TCPTP knockdown. Pharmacological inhibition of SFKs ameliorated the protective effect of TCPTP deficiency on ER stress-induced cell death. These results demonstrate that PTP1B and TCPTP play nonredundant roles in modulating ER stress in pancreatic beta cells and suggest that changes in PTP1B and TCPTP expression may serve as an adaptive response for the mitigation of chronic ER stress.	[Bettaieb, Ahmed; Liu, Siming; Xi, Yannan; Nagata, Naoto; Matsuo, Kosuke; Matsuo, Izumi; Chahed, Samah; Bakke, Jesse; Haj, Fawaz G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Keilhack, Heike] Merck Res Labs, Boston, MA 02115 USA; [Tiganis, Tony] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	University of California System; University of California Davis; Merck & Company; Monash University	Haj, FG (corresponding author), Univ Calif Davis, Dept Nutr, 3135 Meyer Hall,1 Shields Ave, Davis, CA 95616 USA.	fghaj@ucdavis.edu	Tiganis, Tony/AAV-3495-2020; NAGATA, Naoto/D-9261-2012	Tiganis, Tony/0000-0002-8065-9942; NAGATA, Naoto/0000-0002-2389-2334; Bakke, Jesse/0000-0003-0305-5165	National Institutes of Health [R56 DK084317]; Juvenile Diabetes Research Foundation [1-2009-337]; American Diabetes Association [7-06-JF-28]; National Health and Medical Research Council of Australia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK084317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R56 (R56 DK084317 to F.G.H.). This work was also supported by Research Grant 1-2009-337 from the Juvenile Diabetes Research Foundation, Junior Faculty Award 7-06-JF-28 from the American Diabetes Association, and the National Health and Medical Research Council of Australia (to T.T.).	Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Bachar E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004954; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Bjorge JD, 2000, J BIOL CHEM, V275, P41439, DOI 10.1074/jbc.M004852200; Blake RA, 2000, MOL CELL BIOL, V20, P9018, DOI 10.1128/MCB.20.23.9018-9027.2000; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cheng A, 2001, J BIOL CHEM, V276, P25848, DOI 10.1074/jbc.M009734200; Cregan SP, 1999, J NEUROSCI, V19, P7860; Dahmer MK, 2005, J NEUROSCI RES, V80, P576, DOI 10.1002/jnr.20471; Dalgarno D, 2006, CHEM BIOL DRUG DES, V67, P46, DOI 10.1111/j.1747-0285.2005.00316.x; Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Fukushima A, 2010, DIABETES, V59, P1906, DOI 10.2337/db09-1365; Galic S, 2005, MOL CELL BIOL, V25, P819, DOI 10.1128/MCB.25.2.819-829.2005; Galic S, 2003, MOL CELL BIOL, V23, P2096, DOI 10.1128/MCB.23.6.2096-2108.2003; Gu F, 2004, J BIOL CHEM, V279, P49689, DOI 10.1074/jbc.C400261200; Haj FG, 2005, J BIOL CHEM, V280, P15038, DOI 10.1074/jbc.M413240200; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Heinonen KM, 2009, P NATL ACAD SCI USA, V106, P9368, DOI 10.1073/pnas.0812109106; Hellemans KH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007266; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Jeffrey KD, 2008, P NATL ACAD SCI USA, V105, P8452, DOI 10.1073/pnas.0711232105; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Kushner JA, 2004, DIABETES, V53, P61, DOI 10.2337/diabetes.53.1.61; Lai E, 2008, AM J PHYSIOL-ENDOC M, V294, pE540, DOI 10.1152/ajpendo.00478.2007; Li JZ, 2006, J BIOL CHEM, V281, P7260, DOI 10.1074/jbc.M509868200; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Lovis P, 2008, DIABETES, V57, P2728, DOI 10.2337/db07-1252; Ma YL, 2001, RAPID COMMUN MASS SP, V15, P1693, DOI 10.1002/rcm.426; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Matveyenko AV, 2009, DIABETES, V58, P906, DOI 10.2337/db08-1464; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Moore F, 2009, DIABETES, V58, P1283, DOI 10.2337/db08-1510; MOSINGER B, 1992, P NATL ACAD SCI USA, V89, P499, DOI 10.1073/pnas.89.2.499; Nair S, 2007, TOXICOL LETT, V168, P21, DOI 10.1016/j.toxlet.2006.10.012; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Su Q, 2008, J BIOL CHEM, V283, P469, DOI 10.1074/jbc.M704612200; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Tiganis T, 1997, J BIOL CHEM, V272, P21548, DOI 10.1074/jbc.272.34.21548; Tiganis T, 1998, MOL CELL BIOL, V18, P1622, DOI 10.1128/MCB.18.3.1622; Ulianich L, 2008, J CELL SCI, V121, P477, DOI 10.1242/jcs.017202; van Vliet C, 2005, NAT IMMUNOL, V6, P253, DOI 10.1038/ni1169; YouTen KE, 1997, J EXP MED, V186, P683, DOI 10.1084/jem.186.5.683	53	50	52	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9225	9235		10.1074/jbc.M110.186148	http://dx.doi.org/10.1074/jbc.M110.186148			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21216966	Green Published, hybrid			2022-12-27	WOS:000288247700053
J	Das, S; Samant, RS; Shevde, LA				Das, Shamik; Samant, Rajeev S.; Shevde, Lalita A.			Hedgehog Signaling Induced by Breast Cancer Cells Promotes Osteoclastogenesis and Osteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SONIC-HEDGEHOG; BONE SIALOPROTEIN; CATHEPSIN-K; SHORT-RANGE; OSTEOPONTIN; METASTASIS; EXPRESSION; DIFFERENTIATION; OSTEOBLASTS; PATHWAY	Bone integrity is maintained by a dynamic equilibrium between the activities of bone-forming osteoblasts and bone-resorbing osteoclasts. Osteolytic lesions are a painful consequence of metastasis of breast cancer cells to bone in an overwhelming majority of breast cancer patients. Factors secreted by breast cancer cells propel a cascade of events that trigger osteoclastogenesis and elevated bone resorption. In the present study, we show that the Hedgehog (Hh) ligands secreted by breast cancer cells promote osteoclast differentiation and potentiate the activity of mature osteoclasts. Paracrine Hh signaling induced by breast cancer cells mediates a detrimental chain of events by the up-regulation of osteopontin (OPN), which in turn enhances osteoclastic activity by up-regulating cathepsin K and MMP9. Hh signaling is essential for osteoclasts because blocking the Hh pathway using the pharmacological Hh inhibitor, cyclopamine, results in an overall decrease in osteoclastogenesis and resorptive activity. Our studies suggest that inhibiting Hh signaling interferes with the ability of pre-osteoclasts to respond to the stimulatory effects of the breast cancer cells, indicating that Hh signaling is vital to osteoclast activity.	[Das, Shamik; Samant, Rajeev S.; Shevde, Lalita A.] Univ S Alabama, Mitchell Canc Inst, Dept Oncol Sci, Mobile, AL 36604 USA	University of South Alabama	Shevde, LA (corresponding author), 1660 Springhill Ave, Mobile, AL 36604 USA.	lsamant@usouthal.edu		Samant, Rajeev/0000-0001-5681-4976	Department of Defense [07-01-0400]; National Institutes of Health [1R01CA140472-01A1]; Mitchell Cancer Institute, University of South Alabama; NATIONAL CANCER INSTITUTE [R01CA140472] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mitchell Cancer Institute, University of South Alabama; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by Department of Defense IDEA Award 07-01-0400 (to L. A. S.). This work was also supported by National Institutes of Health Grant 1R01CA140472-01A1 (to R. S. S.) and support from the Mitchell Cancer Institute, University of South Alabama.	ABELOFF MD, 1995, CLIN ONCOLOGY; Bailey JM, 2009, ONCOGENE, V28, P3513, DOI 10.1038/onc.2009.220; Bendre M, 2003, CLIN ORTHOP RELAT R, pS39, DOI 10.1097/01.blo.0000093844.72468.f4; Blair HC, 2005, BIOCHEM BIOPH RES CO, V328, P728, DOI 10.1016/j.bbrc.2004.11.077; Bramwell VHC, 2006, CLIN CANCER RES, V12, P3337, DOI 10.1158/1078-0432.CCR-05-2354; Carlinfante G, 2003, CLIN EXP METASTAS, V20, P437, DOI 10.1023/A:1025419708343; CASEY G, 2006, CLIN EXP METASTAS, V23, P123; Chellaiah MA, 2003, MOL BIOL CELL, V14, P173, DOI 10.1091/mbc.E02-06-0354; Chellaiah MA, 2003, CALCIFIED TISSUE INT, V72, P197, DOI 10.1007/s00223-002-1025-6; Cook AC, 2006, J BIOL CHEM, V281, P24381, DOI 10.1074/jbc.M602694200; Czupalla C, 2005, PROTEOMICS, V5, P3868, DOI 10.1002/pmic.200402059; Das S, 2009, J BIOL CHEM, V284, P22888, DOI 10.1074/jbc.M109.021949; Delaisse JM, 2003, MICROSC RES TECHNIQ, V61, P504, DOI 10.1002/jemt.10374; Dillon R, 2003, P NATL ACAD SCI USA, V100, P10152, DOI 10.1073/pnas.1830500100; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Ek-Rylander B, 2010, EXP CELL RES, V316, P443, DOI 10.1016/j.yexcr.2009.10.019; FLORES ME, 1992, EXP CELL RES, V201, P526, DOI 10.1016/0014-4827(92)90305-R; Garnero P, 1998, J BIOL CHEM, V273, P32347, DOI 10.1074/jbc.273.48.32347; Goetz JA, 2006, J BIOL CHEM, V281, P4087, DOI 10.1074/jbc.M511427200; Guise TA, 2002, BONE, V30, P670, DOI 10.1016/S8756-3282(02)00685-3; Guise TA, 2006, CLIN CANCER RES, V12, p6213S, DOI 10.1158/1078-0432.CCR-06-1007; HARADA M, 1992, ADV EXP MED BIOL, V324, P83; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kasper M, 2009, CARCINOGENESIS, V30, P903, DOI 10.1093/carcin/bgp048; Kingsley LA, 2007, MOL CANCER THER, V6, P2609, DOI 10.1158/1535-7163.MCT-07-0234; Kubo M, 2004, CANCER RES, V64, P6071, DOI 10.1158/0008-5472.CAN-04-0416; Mak KK, 2008, DEV CELL, V14, P674, DOI 10.1016/j.devcel.2008.02.003; Matsubara T, 2010, J BONE MINER RES, V25, P1068, DOI 10.1359/jbmr.091039; Maun HR, 2010, J BIOL CHEM, V285, P26570, DOI 10.1074/jbc.M110.112284; McKee MD, 1996, MICROSC RES TECHNIQ, V33, P141, DOI 10.1002/(SICI)1097-0029(19960201)33:2<141::AID-JEMT5>3.0.CO;2-W; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nemoto H, 2001, J BONE MINER RES, V16, P652, DOI 10.1359/jbmr.2001.16.4.652; Rittling SR, 1998, J BONE MINER RES, V13, P1101, DOI 10.1359/jbmr.1998.13.7.1101; Shijubo N, 2000, CRIT REV ONCOGENESIS, V11, P135; Shimoyama A, 2007, MOL BIOL CELL, V18, P2411, DOI 10.1091/mbc.E06-08-0743; Shkumatava A, 2004, DEVELOPMENT, V131, P3849, DOI 10.1242/dev.01247; Siclari VA, 2006, CANCER METAST REV, V25, P621, DOI 10.1007/s10555-006-9023-1; Standal T, 2004, EXP ONCOL, V26, P179; Stecca B, 2005, TRENDS MOL MED, V11, P199, DOI 10.1016/j.molmed.2005.03.004; Sterling JA, 2006, CANCER RES, V66, P7548, DOI 10.1158/0008-5472.CAN-06-0452; Sugatani T, 2003, J BIOL CHEM, V278, P5001, DOI 10.1074/jbc.M209299200; Terai K, 1999, J BONE MINER RES, V14, P839, DOI 10.1359/jbmr.1999.14.6.839; Thomas RJ, 1999, ENDOCRINOLOGY, V140, P4451, DOI 10.1210/en.140.10.4451; Wysolmerski JJ, 2002, J BONE MINER RES, V17, P1164, DOI 10.1359/jbmr.2002.17.7.1164; Yin JJ, 2003, P NATL ACAD SCI USA, V100, P10954, DOI 10.1073/pnas.1830978100; YONEDA T, 1994, BREAST CANCER RES TR, V32, P73, DOI 10.1007/BF00666208; Zhao M, 2006, MOL CELL BIOL, V26, P6197, DOI 10.1128/MCB.02214-05	47	43	44	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9612	9622		10.1074/jbc.M110.174920	http://dx.doi.org/10.1074/jbc.M110.174920			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21169638	Green Published, hybrid			2022-12-27	WOS:000288247700086
J	Kakiashvili, E; Dan, QH; Vandermeer, M; Zhang, YQ; Waheed, F; Pham, M; Szaszi, K				Kakiashvili, Eli; Dan, Qinghong; Vandermeer, Matthew; Zhang, Yuqian; Waheed, Faiza; Pham, Monica; Szaszi, Katalin			The Epidermal Growth Factor Receptor Mediates Tumor Necrosis Factor-alpha-induced Activation of the ERK/GEF-H1/RhoA Pathway in Tubular Epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; NUCLEOTIDE-EXCHANGE FACTORS; SRC FAMILY KINASES; TNF-ALPHA; EGF RECEPTOR; C-SRC; PARACELLULAR PERMEABILITY; AMPHIREGULIN RELEASE; ENDOTHELIAL-CELLS; CONVERTING-ENZYME	Tumor necrosis factor (TNF)-alpha induces cytoskeleton and intercellular junction remodeling in tubular epithelial cells; the underlying mechanisms, however, are incompletely explored. We have previously shown that ERK-mediated stimulation of the RhoA GDP/GTP exchange factor GEF-H1/Lfc is critical for TNF-alpha-induced RhoA stimulation. Here we investigated the upstream mechanisms of ERK/GEF-H1 activation. Surprisingly, TNF-alpha-induced ERK and RhoA stimulation in tubular cells were prevented by epidermal growth factor receptor (EGFR) inhibition or silencing. TNF-alpha also enhanced phosphorylation of the EGFR. EGF treatment mimicked the effects of TNF-alpha, as it elicited potent, ERK-dependent GEF-H1 and RhoA activation. Moreover, EGF-induced RhoA activation was prevented by GEF-H1 silencing, indicating that GEF-H1 is a key downstream effector of the EGFR. The TNF-alpha-elicited EGFR, ERK, and RhoA stimulation were mediated by the TNF-alpha convertase enzyme (TACE) that can release EGFR ligands. Further, EGFR transactivation also required the tyrosine kinase Src, as Src inhibition prevented TNF-alpha-induced activation of the EGFR/ERK/GEF-H1/RhoA pathway. Importantly, a bromodeoxyuridine (BrdU) incorporation assay and electric cell substrate impedance-sensing (ECIS) measurements revealed that TNF-alpha stimulated cell growth in an EGFR-dependent manner. In contrast, TNF-alpha-induced NF kappa B activation was not prevented by EGFR or Src inhibition, suggesting that TNF-alpha exerts both EGFR-dependent and -independent effects. In summary, in the present study we show that the TNF-alpha-induced activation of the ERK/GEF-H1/RhoA pathway in tubular cells is mediated through Src- and TACE-dependent EGFR activation. Such a mechanism could couple inflammatory and proliferative stimuli and, thus, may play a key role in the regulation of wound healing and fibrogenesis.	[Szaszi, Katalin] Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; Univ Toronto, Dept Surg, Toronto, ON M5B 1W8, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Szaszi, K (corresponding author), Univ Toronto, St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, 30 Bond St,LKSKI Rm 622, Toronto, ON M5B 1W8, Canada.	szaszik@smh.ca	Vandermeer, Matthew/AAY-8637-2020; Szaszi, Katalin/J-7522-2012	Vandermeer, Matthew/0000-0002-8797-6713; Szaszi, Katalin/0000-0002-2490-8422	Kidney Foundation of Canada; Canadian Institutes of Health Research [MOP-97774]; Natural Sciences and Engineering Research Council of Canada [480619]; Canadian Nephrology Society	Kidney Foundation of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Nephrology Society	This work was supported in part by grants from the Kidney Foundation of Canada, Canadian Institutes of Health Research Grant MOP-97774, and Natural Sciences and Engineering Research Council of Canada Grant 480619.; Supported by a Natural Sciences and Engineering Research Council of Canada Undergraduate Student Research Award.; Recipient of a KRESCENT New Investigator Award (a joint award of the Kidney Foundation of Canada, Canadian Nephrology Society, and Canadian Institute of Health Research). To whom correspondence should be addressed: St. Michael's Hospital, 30 Bond St., LKSKI Rm. 622, Toronto, ON M5B 1W8, Canada. Tel.: 416-847-1752; Fax: 416-864-5167; E-mail: szaszik@smh.ca.	Aijaz S, 2005, DEV CELL, V8, P777, DOI 10.1016/j.devcel.2005.03.003; Al-Lamki RS, 2005, FASEB J, V19, P1637, DOI 10.1096/fj.05-3841com; Argast GM, 2004, J BIOL CHEM, V279, P34530, DOI 10.1074/jbc.M405703200; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; BELKA C, 1995, EMBO J, V14, P1156, DOI 10.1002/j.1460-2075.1995.tb07099.x; Belsches A P, 1997, Front Biosci, V2, pd501; Benais-Pont G, 2003, J CELL BIOL, V160, P729, DOI 10.1083/jcb.200211047; Bens M, 2008, PFLUG ARCH EUR J PHY, V457, P1, DOI 10.1007/s00424-008-0507-4; Bhola NE, 2008, FRONT BIOSCI-LANDMRK, V13, P1857, DOI 10.2741/2805; Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Birkenfeld J, 2007, DEV CELL, V12, P699, DOI 10.1016/j.devcel.2007.03.014; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Bruewer M, 2006, ANN NY ACAD SCI, V1072, P242, DOI 10.1196/annals.1326.017; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; Chokki M, 2006, LIFE SCI, V78, P3051, DOI 10.1016/j.lfs.2005.12.023; Clark IA, 2007, CYTOKINE GROWTH F R, V18, P335, DOI 10.1016/j.cytogfr.2007.04.002; Di Ciano-Oliveira C, 2003, AM J PHYSIOL-CELL PH, V285, pC555, DOI 10.1152/ajpcell.00086.2003; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Doedens JR, 2003, BIOCHEM BIOPH RES CO, V308, P331, DOI 10.1016/S0006-291X(03)01381-0; Fujishiro SH, 2008, BIOCHEM BIOPH RES CO, V368, P162, DOI 10.1016/j.bbrc.2008.01.066; GAEEFAMATA R, 2006, METHOD ENZYMOL, V406, P425; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; GSTRAUNTHALER G, 1985, AM J PHYSIOL, V248, pF536, DOI 10.1152/ajprenal.1985.248.4.F536; Hanna AN, 2001, MOL BIOL CELL, V12, P3618, DOI 10.1091/mbc.12.11.3618; Heijink IH, 2010, EUR RESPIR J, V35, P894, DOI 10.1183/09031936.00065809; Higashiyama S, 2008, CANCER SCI, V99, P214, DOI 10.1111/j.1349-7006.2007.00676.x; Hirota K, 2001, J BIOL CHEM, V276, P25953, DOI 10.1074/jbc.M011021200; Huang WC, 2003, J BIOL CHEM, V278, P9944, DOI 10.1074/jbc.M208521200; HULL RN, 1976, IN VITRO CELL DEV B, V12, P670, DOI 10.1007/BF02797469; IZUMI H, 1994, EXP CELL RES, V214, P654, DOI 10.1006/excr.1994.1303; Kakiashvili E, 2009, J BIOL CHEM, V284, P11454, DOI 10.1074/jbc.M805933200; Kim JY, 2010, BIOCHEM PHARMACOL, V79, P431, DOI 10.1016/j.bcp.2009.09.016; Kodama A, 2000, MOL BIOL CELL, V11, P2565, DOI 10.1091/mbc.11.8.2565; Lee CW, 2007, AM J PHYSIOL-LUNG C, V292, pL799, DOI 10.1152/ajplung.00311.2006; Lee NK, 2002, J BIOCHEM MOL BIOL, V35, P61; Lo CM, 1995, BIOPHYS J, V69, P2800, DOI 10.1016/S0006-3495(95)80153-0; LOHI J, 1992, J CELL BIOCHEM, V50, P337, DOI 10.1002/jcb.240500402; Luschen S, 2005, EXP CELL RES, V310, P33, DOI 10.1016/j.yexcr.2005.07.022; MacEwan DJ, 2002, BRIT J PHARMACOL, V135, P855, DOI 10.1038/sj.bjp.0704549; MARETZKY T, 2010, ONCOGENE IN PRESS; Masszi A, 2010, J CELL BIOL, V188, P383, DOI 10.1083/jcb.200906155; Mathew SJ, 2009, J CELL SCI, V122, P1939, DOI 10.1242/jcs.044487; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Moon SY, 2003, TRENDS CELL BIOL, V13, P13, DOI 10.1016/S0962-8924(02)00004-1; Mullin JM, 2005, DRUG DISCOV TODAY, V10, P395, DOI 10.1016/S1359-6446(05)03379-9; Mullin JM, 1997, J CELL PHYSIOL, V171, P226, DOI 10.1002/(SICI)1097-4652(199705)171:2<226::AID-JCP14>3.0.CO;2-B; Navarro JF, 2006, CYTOKINE GROWTH F R, V17, P441, DOI 10.1016/j.cytogfr.2006.09.011; Nie M, 2009, EMBO REP, V10, P1125, DOI 10.1038/embor.2009.182; Papakonstanti EA, 2004, MOL BIOL CELL, V15, P1273, DOI 10.1091/mbc.E03-07-0491; Pascher A, 2005, BIODRUGS, V19, P211, DOI 10.2165/00063030-200519040-00002; Patrick David M, 2006, BMC Physiol, V6, P2, DOI 10.1186/1472-6793-6-2; Peng FF, 2010, CELL SIGNAL, V22, P34, DOI 10.1016/j.cellsig.2009.09.003; Pincheira R, 2008, J IMMUNOL, V181, P1288, DOI 10.4049/jimmunol.181.2.1288; Puls A, 1999, J CELL SCI, V112, P2983; Radeff-Huang J, 2007, J BIOL CHEM, V282, P863, DOI 10.1074/jbc.M601698200; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Reinehr R, 2005, J BIOL CHEM, V280, P27179, DOI 10.1074/jbc.M414361200; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Samson T, 2010, MOL BIOL CELL, V21, P1629, DOI 10.1091/mbc.E09-09-0809; Shah BH, 2006, TRENDS PHARMACOL SCI, V27, P235, DOI 10.1016/j.tips.2006.03.010; Smith JP, 2009, AM J PHYSIOL-RENAL, V296, pF957, DOI 10.1152/ajprenal.90490.2008; Smith PC, 2009, J PERIODONTAL RES, V44, P73, DOI 10.1111/j.1600-0765.2007.01081.x; Soler AP, 1996, AM J PHYSIOL-RENAL, V270, pF869, DOI 10.1152/ajprenal.1996.270.5.F869; Taub M, 1979, Methods Enzymol, V58, P552; Tsapara A, 2010, MOL BIOL CELL, V21, P860, DOI 10.1091/mbc.E09-07-0567; Ueno Y, 2005, BRIT J CANCER, V92, P1690, DOI 10.1038/sj.bjc.6602548; van Vliet C, 2005, NAT IMMUNOL, V6, P253, DOI 10.1038/ni1169; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Vielhauer V, 2007, SEMIN NEPHROL, V27, P286, DOI 10.1016/j.semnephrol.2007.02.004; Waheed F, 2010, AM J PHYSIOL-CELL PH, V298, pC1376, DOI 10.1152/ajpcell.00408.2009; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wallach D, 1999, ANNU REV IMMUNOL, V17, P331, DOI 10.1146/annurev.immunol.17.1.331; Wegener J, 1998, EUR BIOPHYS J BIOPHY, V28, P26, DOI 10.1007/s002490050180; Wegener J, 2000, EXP CELL RES, V259, P158, DOI 10.1006/excr.2000.4919; Wojciak-Stothard B, 1998, J CELL PHYSIOL, V176, P150, DOI 10.1002/(SICI)1097-4652(199807)176:1<150::AID-JCP17>3.0.CO;2-B; Yamaoka T, 2008, P NATL ACAD SCI USA, V105, P11772, DOI 10.1073/pnas.0801463105; Zhang Q, 2006, P NATL ACAD SCI USA, V103, P6901, DOI 10.1073/pnas.0509719103; Ziv E, 2008, J CELL BIOCHEM, V104, P606, DOI 10.1002/jcb.21650	79	54	55	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9268	9279		10.1074/jbc.M110.179903	http://dx.doi.org/10.1074/jbc.M110.179903			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21212278	Green Published, hybrid			2022-12-27	WOS:000288247700057
J	Meux, E; Prosper, P; Ngadin, A; Didierjean, C; Morel, M; Dumarcay, S; Lamant, T; Jacquot, JP; Favier, F; Gelhaye, E				Meux, Edgar; Prosper, Pascalita; Ngadin, Andrew; Didierjean, Claude; Morel, Melanie; Dumarcay, Stephane; Lamant, Tiphaine; Jacquot, Jean-Pierre; Favier, Frederique; Gelhaye, Eric			Glutathione Transferases of Phanerochaete chrysosporium S-GLUTATHIONYL-p-HYDROQUINONE REDUCTASE BELONGS TO A NEW STRUCTURAL CLASS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OMEGA-CLASS; CRYSTAL-STRUCTURE; ANTIOXIDANT SYSTEMS; DEHALOGENASE SYSTEM; THIOREDOXIN-H; CONJUGATE; MECHANISM; LIGNIN; MODEL; CHLORINATION	The white rot fungus Phanerochaete chrysosporium, a saprophytic basidiomycete, possesses a large number of cytosolic glutathione transferases, eight of them showing similarity to the Omega class. PcGSTO1 (subclass I, the bacterial homologs of which were recently proposed, based on their enzymatic function, to constitute a new class of glutathione transferase named S-glutathionyl-(chloro)hydroquinone reductases) and PcGSTO3 (subclass II related to mammalian homologs) have been investigated in this study. Biochemical investigations demonstrate that both enzymes are able to catalyze deglutathionylation reactions thanks to the presence of a catalytic cysteinyl residue. This reaction leads to the formation of a disulfide bridge between the conserved cysteine and the removed glutathione from their substrate. The substrate specificity of each isoform differs. In particular PcGSTO1, in contrast to PcGSTO3, was found to catalyze deglutathionylation of S-glutathionyl-p-hydroquinone substrates. The three-dimensional structure of PcGSTO1 presented here confirms the hypothesis that it belongs not only to a new biological class but also to a new structural class that we propose to name GST xi. Indeed, it shows specific features, the most striking ones being a new dimerization mode and a catalytic site that is buried due to the presence of long loops and that contains the catalytic cysteine.	[Prosper, Pascalita; Didierjean, Claude; Favier, Frederique] Nancy Univ, Fac Sci & Tech, Inst Jean Barriol, CRM2,Equipe Biocristallog,CNRS UHP,UMR 7036, F-54506 Vandoeuvre Les Nancy, France; [Meux, Edgar; Ngadin, Andrew; Morel, Melanie; Lamant, Tiphaine; Jacquot, Jean-Pierre; Gelhaye, Eric] Nancy Univ, Fac Sci & Tech, UMR INRA UHP Interactions Arbres Microorganismes, Ecosyst Forestiers Agroressources Bioprocedes & A, F-54506 Vandoeuvre Les Nancy, France; [Dumarcay, Stephane] Nancy Univ, Fac Sci & Tech, Lab Etud & Rech Mat Bois, EA UHP 4370, F-54506 Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); CHU de Nancy; Universite de Lorraine; INRAE; Universite de Lorraine; Universite de Lorraine	Favier, F (corresponding author), Nancy Univ, Fac Sci & Tech, Inst Jean Barriol, CRM2,Equipe Biocristallog,CNRS UHP,UMR 7036, F-54506 Vandoeuvre Les Nancy, France.	Frederique.Favier@crm2.uhp-nancy.fr; Eric.Gelhaye@lcb.uhp-nancy.fr	DIDIERJEAN, Claude/L-1493-2013; gelhaye, eric/K-7390-2013; Jacquot, Jean-Pierre/A-1571-2012; Ngadin, Andrew Anak/ABG-3668-2020; Favier, Frederique/B-3090-2013	DIDIERJEAN, Claude/0000-0002-3176-8974; gelhaye, eric/0000-0002-0699-9113; Jacquot, Jean-Pierre/0000-0003-4975-8587; Ngadin, Andrew Anak/0000-0002-1070-6934; Favier, Frederique/0000-0003-3249-997X; Morel-Rouhier, Melanie/0000-0001-5149-0474	Agence Nationale de la Recherche [ANR-06-BLAN-0386, ANR-09-BLAN-0012]; Ministere de l'Enseignement Superieur de la Recherche et de la Technologie; Institut National de la Recherche Agronomique; CNRS	Agence Nationale de la Recherche(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur de la Recherche et de la Technologie; Institut National de la Recherche Agronomique; CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by Agence Nationale de la Recherche Research Grants ANR-06-BLAN-0386 and ANR-09-BLAN-0012, Ministere de l'Enseignement Superieur de la Recherche et de la Technologie, Institut National de la Recherche Agronomique, and CNRS.	[Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Board PG, 2008, ANAL BIOCHEM, V374, P25, DOI 10.1016/j.ab.2007.09.029; Board PG, 2007, CHEM RES TOXICOL, V20, P149, DOI 10.1021/tx600305y; BRUNMARK A, 1988, CHEM-BIOL INTERACT, V68, P273, DOI 10.1016/0009-2797(88)90021-X; Burmeister C, 2008, FASEB J, V22, P343, DOI 10.1096/fj.06-7426com; Couturier J, 2009, J BIOL CHEM, V284, P9299, DOI 10.1074/jbc.M807998200; Cowtan K., 1994, CRYSTALLOGRAPHY, V31, P34; Doddapaneni H, 2005, MOL GENET GENOMICS, V274, P454, DOI 10.1007/s00438-005-0051-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcera A, 2006, BIOCHEM J, V398, P187, DOI 10.1042/BJ20060034; Gelhaye E, 2004, P NATL ACAD SCI USA, V101, P14545, DOI 10.1073/pnas.0405282101; Gelhaye E, 2002, PHYSIOL PLANTARUM, V114, P165, DOI 10.1034/j.1399-3054.2002.1140202.x; Herrero E, 2006, PHOTOSYNTH RES, V89, P127, DOI 10.1007/s11120-006-9079-3; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang Y, 2008, J BACTERIOL, V190, P7595, DOI 10.1128/JB.00489-08; JI X, 1993, BIOCHEMISTRY-US, V32, P12949, DOI 10.1021/bi00211a001; JI XH, 1995, BIOCHEMISTRY-US, V34, P5317, DOI 10.1021/bi00016a003; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kasai N, 2010, APPL MICROBIOL BIOT, V86, P773, DOI 10.1007/s00253-009-2413-x; Kasai N, 2009, BIOCHEM BIOPH RES CO, V387, P103, DOI 10.1016/j.bbrc.2009.06.134; Koh CS, 2008, J BIOL CHEM, V283, P23062, DOI 10.1074/jbc.M802093200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Mannervik B, 2005, METHOD ENZYMOL, V401, P1, DOI 10.1016/S0076-6879(05)01001-3; Martinez D, 2004, NAT BIOTECHNOL, V22, P695, DOI 10.1038/nbt967; Matsuzaki F, 2004, BIOCHEM BIOPH RES CO, V324, P387, DOI 10.1016/j.bbrc.2004.09.062; Mauzeroll J, 2004, P NATL ACAD SCI USA, V101, P7862, DOI 10.1073/pnas.0402556101; Morel M, 2008, NEW PHYTOL, V180, P391, DOI 10.1111/j.1469-8137.2008.02498.x; Morel M, 2009, ADV BOT RES, V52, P153, DOI 10.1016/S0065-2296(10)52006-8; Morel M, 2009, CELL MOL LIFE SCI, V66, P3711, DOI 10.1007/s00018-009-0104-5; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NICKERSON WJ, 1963, BIOCHEMISTRY-US, V2, P537, DOI 10.1021/bi00903a025; Oakley AJ, 1999, J MOL BIOL, V291, P913, DOI 10.1006/jmbi.1999.3029; Oakley AJ, 2001, PROTEIN SCI, V10, P2176, DOI 10.1110/ps.21201; Ortiz-Bermudez P, 2003, APPL ENVIRON MICROB, V69, P5015, DOI 10.1128/AEM.69.8.5015-5018.2003; Ortiz-Bermudez P, 2007, P NATL ACAD SCI USA, V104, P3895, DOI 10.1073/pnas.0610074104; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Patskovsky Y, 2006, BIOCHEMISTRY-US, V45, P3852, DOI 10.1021/bi051823+; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; RAMAKRISHNAN V, 1993, NATURE, V362, P219, DOI 10.1038/362219a0; RAO DNR, 1988, J BIOL CHEM, V263, P17981; Reddy GVB, 2001, ARCH BIOCHEM BIOPHYS, V391, P271; Reddy GVB, 1999, BIOCHEM BIOPH RES CO, V257, P901, DOI 10.1006/bbrc.1999.0561; Roth M, 2002, ACTA CRYSTALLOGR D, V58, P805, DOI 10.1107/S0907444902003943; SCHENK PM, 1995, BIOTECHNIQUES, V19, P196; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schroder P, 2007, ENVIRON SCI POLLUT R, V14, P114, DOI 10.1065/espr2006.10.352; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Song Y, 2009, P NATL ACAD SCI USA, V106, P9725, DOI 10.1073/pnas.0810352106; Thom R, 2002, BIOCHEMISTRY-US, V41, P7008, DOI 10.1021/bi015964x; Vararattanavech A, 2007, BIOCHEM J, V406, P247, DOI 10.1042/BJ20070422; VINCE R, 1971, J MED CHEM, V14, P402, DOI 10.1021/jm00287a006; Whitbread AK, 2005, METHOD ENZYMOL, V401, P78, DOI 10.1016/S0076-6879(05)01005-0; Xun LY, 2010, BIOCHEM J, V428, P419, DOI 10.1042/BJ20091863; Zakharyan RA, 2001, CHEM RES TOXICOL, V14, P1051, DOI 10.1021/tx010052h	56	34	34	0	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9162	9173		10.1074/jbc.M110.194548	http://dx.doi.org/10.1074/jbc.M110.194548			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21177852	Green Published, hybrid			2022-12-27	WOS:000288247700047
J	Mikula, M; Bomsztyk, K				Mikula, Michal; Bomsztyk, Karol			Direct Recruitment of ERK Cascade Components to Inducible Genes Is Regulated by Heterogeneous Nuclear Ribonucleoprotein (hnRNP) K	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA TRANSLATION; RECEPTOR TYROSINE KINASES; ACTIVATED PROTEIN-KINASE; MAP-KINASE; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; CYTOPLASMIC ACCUMULATION; INSULIN-RECEPTOR; TARGET GENES; IN-VIVO	Components of the ERK cascade are recruited to genes, but it remains unknown how they are regulated at these sites. The RNA-binding protein heterogeneous nuclear ribonucleoprotein (hnRNP) K interacts with kinases and is found along genes including the mitogen-inducible early response gene EGR-1. Here, we used chromatin immunoprecipitations to study co-recruitment of hnRNP K and ERK cascade activity along the EGR-1 gene. These measurements revealed that the spatiotemporal binding patterns of ERK cascade transducers (GRB2, SOS, B-Raf, MEK, and ERK) at the EGR-1 locus resemble both hnRNP K and RNA polymerase II (Pol II). Inhibition of EGR-1 transcription with either serum-responsive factor knockdown or 5,6-di-chloro-1-beta-D-ribofuranosylbenzimidazole altered recruitment of all of the above ERK cascade components along this locus that mirrored the changes in Pol II and hnRNP K profiles. siRNA knockdown of hnRNP K decreased the levels of active MEK and ERK at the EGR-1, changes associated with decreased levels of elongating pre-mRNA and less efficient splicing. The hnRNP K dependence and pattern of ERK cascade activation at the c-MYC locus were different from at EGR-1. Ribonucleoprotein immunoprecipitations revealed that hnRNP K was associated with the EGR-1 but not c-MYC mRNAs. These data suggest a model where Pol II transcription-driven recruitment of hnRNP K along the EGR-1 locus compartmentalizes activation of the ERK cascade at these genes, events that regulate synthesis of mature mRNA.	[Mikula, Michal; Bomsztyk, Karol] Univ Washington, Dept Med, Seattle, WA 98109 USA; [Mikula, Michal] Maria Sklodowska Curie Mem Canc Ctr, Dept Oncol Genet, PL-02781 Warsaw, Poland; [Mikula, Michal] Inst Oncol, PL-02781 Warsaw, Poland	University of Washington; University of Washington Seattle; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology	Bomsztyk, K (corresponding author), Univ Washington, Dept Med, Seattle, WA 98109 USA.	karolb@u.washington.edu	Mikula, Michal/G-8276-2011	Mikula, Michal/0000-0003-3447-7328	National Institutes of Health [R37-DK45978, RO-1 GM45134]; Polish Ministry of Education and Science [16/MOB/2007/0]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK045978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045134] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Polish Ministry of Education and Science(Ministry of Science and Higher Education, Poland); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37-DK45978 and RO-1 GM45134 (to K. B.).; Supported by Polish Ministry of Education and Science Program "Support for the International Mobility of Researchers" Grant 16/MOB/2007/0.	Adolph D, 2007, MOL CELL BIOL, V27, P1758, DOI 10.1128/MCB.02014-06; Afonina I, 2007, BIOTECHNIQUES, V43, P770, DOI 10.2144/000112631; Aleksic T, 2010, CANCER RES, V70, P6412, DOI 10.1158/0008-5472.CAN-10-0052; BEZANCON A, 2002, J BIOL CHEM, V277, P16614; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Bomsztyk K, 2004, BIOESSAYS, V26, P629, DOI 10.1002/bies.20048; Bungard D, 2010, SCIENCE, V329, P1201, DOI 10.1126/science.1191241; Carpenter G, 2003, CURR OPIN CELL BIOL, V15, P143, DOI 10.1016/S0955-0674(03)00015-2; Chang JW, 2009, INT IMMUNOL, V21, P1351, DOI 10.1093/intimm/dxp106; Chen LC, 2009, ONCOGENE, V28, P1904, DOI 10.1038/onc.2009.55; Chow CW, 2006, CELL, V127, P887, DOI 10.1016/j.cell.2006.11.015; Denisenko ON, 1996, J BIOL CHEM, V271, P27701, DOI 10.1074/jbc.271.44.27701; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Edmunds JW, 2006, SCIENCE, V313, P449, DOI 10.1126/science.1131158; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; Flanagin S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn001; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; George R, 2009, CELL MOL LIFE SCI, V66, P711, DOI 10.1007/s00018-009-8667-8; Glover-Cutter K, 2008, NAT STRUCT MOL BIOL, V15, P71, DOI 10.1038/nsmb1352; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Hasan RN, 2008, CIRC RES, V102, P42, DOI 10.1161/CIRCRESAHA.107.155143; Hsu SC, 2007, J BIOL CHEM, V282, P10432, DOI 10.1074/jbc.M610014200; Ishibe S, 2004, MOL CELL, V16, P257, DOI 10.1016/j.molcel.2004.10.006; Janknecht R, 1997, EMBO J, V16, P1620, DOI 10.1093/emboj/16.7.1620; Kim SJ, 1997, BIOCHEM J, V323, P621, DOI 10.1042/bj3230621; Klimek-Tomczak K, 2004, J MOL BIOL, V342, P1131, DOI 10.1016/j.jmb.2004.07.099; Kocher HM, 2005, NEPHROL DIAL TRANSPL, V20, P886, DOI 10.1093/ndt/gfh744; Kubosaki A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r41; KYRIAKIS JM, 1992, NATURE, V358, P417, DOI 10.1038/358417a0; Kyriakis JM, 2007, BBA-MOL CELL RES, V1773, P1238, DOI 10.1016/j.bbamcr.2006.11.003; Laury-Kleintop LD, 2005, J CELL BIOCHEM, V95, P1042, DOI 10.1002/jcb.20486; Lawrence MC, 2008, P NATL ACAD SCI USA, V105, P13315, DOI 10.1073/pnas.0806465105; Lewis TS, 2000, MOL CELL, V6, P1343, DOI 10.1016/S1097-2765(00)00132-5; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; MATUNIS MJ, 1994, NUCLEIC ACIDS RES, V22, P1059, DOI 10.1093/nar/22.6.1059; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Michelotti EF, 1996, MOL CELL BIOL, V16, P2350, DOI 10.1128/mcb.16.5.2350; Mikula M, 2006, PROTEOMICS, V6, P2395, DOI 10.1002/pmic.200500632; Mikula M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-4; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Naito M, 2009, J AM SOC NEPHROL, V20, P1787, DOI 10.1681/ASN.2009010118; Nelson JD, 2011, DIABETES, V60, P127, DOI 10.2337/db09-1806; NIGG EA, 1985, EMBO J, V4, P2801, DOI 10.1002/j.1460-2075.1985.tb04006.x; Notari M, 2006, BLOOD, V107, P2507, DOI 10.1182/blood-2005-09-3732; OLAH Z, 1991, EXP BRAIN RES, V84, P403; Ostrowski J, 2003, NUCLEIC ACIDS RES, V31, P3954, DOI 10.1093/nar/gkg452; Ostrowski J, 2000, J BIOL CHEM, V275, P3619, DOI 10.1074/jbc.275.5.3619; Ostrowski J, 2001, P NATL ACAD SCI USA, V98, P9044, DOI 10.1073/pnas.161284098; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Perales R, 2009, MOL CELL, V36, P178, DOI 10.1016/j.molcel.2009.09.018; PODLECKI DA, 1987, J BIOL CHEM, V262, P3362; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Reiterer G, 2010, CELL CYCLE, V9, P3297, DOI 10.4161/cc.9.16.12631; Revil T, 2009, J BIOL CHEM, V284, P21458, DOI 10.1074/jbc.M109.019711; Romero F, 1998, J BIOL CHEM, V273, P7776, DOI 10.1074/jbc.273.13.7776; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Schullery DS, 1999, J BIOL CHEM, V274, P15101, DOI 10.1074/jbc.274.21.15101; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; SETH A, 1992, J BIOL CHEM, V267, P24796; SHILATIFARD A, 2003, ANN REV BIOCH; Shnyreva M, 2000, J BIOL CHEM, V275, P15498, DOI 10.1074/jbc.275.20.15498; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Skalweit A, 2003, CIRC RES, V92, P419, DOI 10.1161/01.RES.0000059300.67152.4E; SUKHATME VP, 1990, J AM SOC NEPHROL, V1, P859; SWANSON MS, 1988, MOL CELL BIOL, V8, P2237, DOI 10.1128/MCB.8.5.2237; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; VANSEUNINGEN I, 1995, J BIOL CHEM, V270, P26976, DOI 10.1074/jbc.270.45.26976; Vicent GP, 2006, MOL CELL, V24, P367, DOI 10.1016/j.molcel.2006.10.011; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Weg-Remers S, 2001, EMBO J, V20, P4194, DOI 10.1093/emboj/20.15.4194; Wei CC, 2006, J BIOL CHEM, V281, P25344, DOI 10.1074/jbc.M601945200; WENG ZG, 1994, MOL CELL BIOL, V14, P4509, DOI 10.1128/MCB.14.7.4509; Wolf D, 2008, CELL HOST MICROBE, V4, P398, DOI 10.1016/j.chom.2008.08.013; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wu SQ, 2002, BLOOD, V100, P4454, DOI 10.1182/blood-2002-02-0415; YANKULOV K, 1995, J BIOL CHEM, V270, P23922, DOI 10.1074/jbc.270.41.23922; Yano M, 2005, J BIOL CHEM, V280, P12690, DOI 10.1074/jbc.M411119200; Yao Z, 2009, BIOFACTORS, V35, P407, DOI 10.1002/biof.52; Zehorai E, 2010, MOL CELL ENDOCRINOL, V314, P213, DOI 10.1016/j.mce.2009.04.008; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429	83	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9763	9775		10.1074/jbc.M110.213330	http://dx.doi.org/10.1074/jbc.M110.213330			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21233203	Green Published, hybrid			2022-12-27	WOS:000288247700099
J	Ogunbayo, OA; Zhu, YM; Rossi, D; Sorrentino, V; Ma, JJ; Zhu, MX; Evans, AM				Ogunbayo, Oluseye A.; Zhu, Yingmin; Rossi, Daniela; Sorrentino, Vincenzo; Ma, Jianjie; Zhu, Michael X.; Evans, A. Mark			Cyclic Adenosine Diphosphate Ribose Activates Ryanodine Receptors, whereas NAADP Activates Two-pore Domain Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIC PULMONARY VASOCONSTRICTION; ADENINE-DINUCLEOTIDE PHOSPHATE; ADP-RIBOSE; CA2+ RELEASE; SKELETAL-MUSCLE; INOSITOL TRISPHOSPHATE; SARCOPLASMIC-RETICULUM; RAT VENTRICLE; SMOOTH-MUSCLE; CADP-RIBOSE	The mechanism by which cyclic adenosine diphosphate ribose (cADPR) and nicotinic acid adenine dinucleotide phosphate (NAADP) mobilize intracellular Ca2+ stores remains controversial. It is open to question whether cADPR regulates ryanodine receptors (RyRs) directly, as originally proposed, or indirectly by promoting Ca2+ uptake into the sarco/endoplasmic reticulum by sarco/endoplasmic reticulum Ca2+-ATPases. Conversely, although we have proposed that NAADP mobilizes endolysosomal Ca2+ stores by activating two-pore domain channels (TPCs), others suggest that NAADP directly activates RyRs. We therefore assessed Ca2+ signals evoked by intracellular dialysis from a patch pipette of cADPR and NAADP into HEK293 cells that stably overexpress either TPC1, TPC2, RyR1, or RyR3. No change in intracellular Ca2+ concentration was triggered by cADPR in either wild-type HEK293 cells (which are devoid of RyRs) or in cells that stably overexpress TPC1 and TPC2, respectively. By contrast, a marked Ca2+ transient was triggered by cADPR in HEK293 cells that stably expressed RyR1 and RyR3. The Ca2+ transient was abolished following depletion of endoplasmic reticulum stores by thapsigargin and block of RyRs by dantrolene but not following depletion of acidic Ca2+ stores by bafilomycin. By contrast, NAADP failed to evoke a Ca2+ transient in HEK293 cells that expressed RyR1 or RyR3, but it induced robust Ca2+ transients in cells that stably overexpressed TPC1 or TPC2 and in a manner that was blocked following depletion of acidic stores by bafilomycin. We conclude that cADPR triggers Ca2+ release by activating RyRs but not TPCs, whereas NAADP activates TPCs but not RyRs.	[Ogunbayo, Oluseye A.; Evans, A. Mark] Univ Edinburgh, Ctr Integrat Physiol, Coll Med & Vet Med, Edinburgh EH8 9XD, Midlothian, Scotland; [Zhu, Yingmin; Zhu, Michael X.] Univ Texas Houston, Hlth Sci Ctr, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Rossi, Daniela; Sorrentino, Vincenzo] Univ Siena, Dept Pharmacol, I-53100 Siena, Italy; [Rossi, Daniela; Sorrentino, Vincenzo] Univ Siena, Dept Neurosci, I-53100 Siena, Italy; [Ma, Jianjie] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA	University of Edinburgh; University of Texas System; University of Texas Health Science Center Houston; University of Siena; University of Siena; Rutgers State University New Brunswick; Rutgers State University Medical Center	Evans, AM (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Coll Med & Vet Med, Hugh Robson Bldg, Edinburgh EH8 9XD, Midlothian, Scotland.	mark.evans@ed.ac.uk	Rossi, Daniela/G-7764-2012; Sorrentino, Vincenzo/A-4793-2014	Rossi, Daniela/0000-0003-0463-7327; Sorrentino, Vincenzo/0000-0002-8573-8631	National Institutes of Health; British Heart Foundation [PG/05/128]; Telethon [GGP08153]; British Heart Foundation [PG/10/95/28657] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081658] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); Telethon(Fondazione Telethon); British Heart Foundation(British Heart Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants (to M. X. Z. and J. M.). This work was also supported by British Heart Foundation Project Grant PG/05/128 (to A. M. E.). Telethon Grant GGP08153 (to V. S.).	Aoyama M, 2004, J CELL SCI, V117, P2813, DOI 10.1242/jcs.01136; BASTIANUTTO C, 1995, J CELL BIOL, V130, P847, DOI 10.1083/jcb.130.4.847; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Boittin FX, 2003, J BIOL CHEM, V278, P9602, DOI 10.1074/jbc.M204891200; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Cancela JM, 2000, EMBO J, V19, P2549, DOI 10.1093/emboj/19.11.2549; Copello JA, 2001, CELL CALCIUM, V30, P269, DOI 10.1054/ceca.2001.0235; Cui Y, 1999, BIOCHEM J, V342, P269, DOI 10.1042/0264-6021:3420269; Dammermann W, 2009, P NATL ACAD SCI USA, V106, P10678, DOI 10.1073/pnas.0809997106; Dipp M, 2001, CIRC RES, V89, P77, DOI 10.1161/hh1301.093616; FURUCHI T, 1993, J BIOL CHEM, V268, P27345; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; Guse AH, 2009, CURR BIOL, V19, pR521, DOI 10.1016/j.cub.2009.05.045; GYORKE S, 2008, NATURE, V459, P596; Hohenegger M, 2002, BIOCHEM J, V367, P423, DOI 10.1042/BJ20020584; Jin HF, 2010, J ALZHEIMERS DIS, V20, P261, DOI 10.3233/JAD-2010-1360; Lang KS, 2003, CELL PHYSIOL BIOCHEM, V13, P257, DOI 10.1159/000074540; Lee HC, 2004, CURR MOL MED, V4, P227, DOI 10.2174/1566524043360753; Macgregor A, 2007, J BIOL CHEM, V282, P15302, DOI 10.1074/jbc.M611167200; Macgregor AT, 2007, CELL CALCIUM, V41, P537, DOI 10.1016/j.ceca.2006.10.005; MORRISSETTE J, 1993, FEBS LETT, V330, P270, DOI 10.1016/0014-5793(93)80886-Y; Noguchi N, 1997, J BIOL CHEM, V272, P3133, DOI 10.1074/jbc.272.6.3133; Rossi D, 2002, J CELL SCI, V115, P2497; Tang WX, 2002, AM J PHYSIOL-HEART C, V282, pH1304, DOI 10.1152/ajpheart.00843.2001; Wang YX, 2004, AM J PHYSIOL-CELL PH, V286, pC538, DOI 10.1152/ajpcell.00106.2003; Wilson HL, 2001, J BIOL CHEM, V276, P11180, DOI 10.1074/jbc.M004849200; Yamasaki-Mann M, 2010, J BIOL CHEM, V285, P25053, DOI 10.1074/jbc.M109.095257; Yamasaki-Mann M, 2009, CELL CALCIUM, V45, P293, DOI 10.1016/j.ceca.2008.11.008; Zhao FY, 2001, J BIOL CHEM, V276, P13810, DOI 10.1074/jbc.M006104200; Zhu MX, 2010, AM J PHYSIOL-CELL PH, V298, pC430, DOI 10.1152/ajpcell.00475.2009; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	32	66	66	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9136	9140		10.1074/jbc.M110.202002	http://dx.doi.org/10.1074/jbc.M110.202002			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21216967	Green Published, hybrid			2022-12-27	WOS:000288247700044
J	Panosian, TD; Nannemann, DP; Watkins, GR; Phelan, VV; McDonald, WH; Wadzinski, BE; Bachmann, BO; Iverson, TM				Panosian, Timothy D.; Nannemann, David P.; Watkins, Guy R.; Phelan, Vanessa V.; McDonald, W. Hayes; Wadzinski, Brian E.; Bachmann, Brian O.; Iverson, Tina M.			Bacillus cereus Phosphopentomutase Is an Alkaline Phosphatase Family Member That Exhibits an Altered Entry Point into the Catalytic Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOGLYCERATE MUTASE; MUSCLE PHOSPHOGLUCOMUTASE; BETA-PHOSPHOGLUCOMUTASE; CRYSTAL-STRUCTURES; XANTHINE-OXIDASE; WHEAT-GERM; MECHANISM; IDENTIFICATION; PHOSPHOHEXOMUTASE; CRYSTALLOGRAPHY	Bacterial phosphopentomutases (PPMs) are alkaline phosphatase superfamily members that interconvert alpha-D-ribose 5-phosphate (ribose 5-phosphate) and alpha-D-ribose 1-phosphate (ribose 1-phosphate). We investigated the reaction mechanism of Bacillus cereus PPM using a combination of structural and biochemical studies. Four high resolution crystal structures of B. cereus PPM revealed the active site architecture, identified binding sites for the substrate ribose 5-phosphate and the activator alpha-D-glucose 1,6-bisphosphate (glucose 1,6-bisphosphate), and demonstrated that glucose 1,6-bisphosphate increased phosphorylation of the active site residue Thr-85. The phosphorylation of Thr-85 was confirmed by Western and mass spectroscopic analyses. Biochemical assays identified Mn2+-dependent enzyme turnover and demonstrated that glucose 1,6-bisphosphate treatment increases enzyme activity. These results suggest that protein phosphorylation activates the enzyme, which supports an intermolecular transferase mechanism. We confirmed intermolecular phosphoryl transfer using an isotope relay assay in which PPM reactions containing mixtures of ribose 5-[O-18(3)] phosphate and [U-C-13(5)] ribose 5-phosphate were analyzed by mass spectrometry. This intermolecular phosphoryl transfer is seemingly counter to what is anticipated from phosphomutases employing a general alkaline phosphatase reaction mechanism, which are reported to catalyze intramolecular phosphoryl transfer. However, the two mechanisms may be reconciled if substrate encounters the enzyme at a different point in the catalytic cycle.	[Bachmann, Brian O.] Vanderbilt Univ, Dept Chem, Stevenson Ctr 7300, Nashville, TN 37235 USA; [Panosian, Timothy D.; Watkins, Guy R.; Wadzinski, Brian E.; Iverson, Tina M.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [McDonald, W. Hayes; Bachmann, Brian O.; Iverson, Tina M.] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Bachmann, BO (corresponding author), Vanderbilt Univ, Dept Chem, Stevenson Ctr 7300, Box 1583, Nashville, TN 37235 USA.	brian.bachmann@vanderbilt.edu; tina.iverson@vanderbilt.edu	McDonald, W. Hayes/B-4109-2016	McDonald, W. Hayes/0000-0002-3510-426X; Bachmann, Brian/0000-0001-5815-1176; Nannemann, David/0000-0002-4946-3263; Phelan, Vanessa/0000-0001-7156-9294	National Institutes of Health [GM079419, GM077189, GM051366, DK070787, T32 NS07491, T32 GM008320, T90 DA022873, T32 GM07628]; Vanderbilt Institute of Chemical Biology; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, NCRR; NIGMS;  [P30EY008126]; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077189, R01GM079419, T32GM008320, R01GM051366, R56GM051366, T32GM007628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T90DA022873] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Institute of Chemical Biology; United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants GM079419 (to T. M. I.), GM077189 (to B. O. B.), GM051366 (to B. E. W.), DK070787 (to B. E. W.), T32 NS07491 (to T. D. P.), T32 GM008320 (to T. D. P.), T90 DA022873 (to D. P. N.), and T32 GM07628 (to G. R. W.). This work was also supported by a pilot award funded by the Vanderbilt Institute of Chemical Biology (to B. O. B.).; Use of the LS-CAT beamline at the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract DE-AC02-06CH11357. Portions of this research were carried out at the Stanford Synchrotron Radiation Lightsource (SSRL), a national user facility operated by Stanford University on behalf of the United States Department of Energy, Office of Basic Energy Sciences. The SSRL Structural Molecular Biology Program is supported by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, NCRR, Biomedical Technology Program, and NIGMS. A portion of this work used facilities that were supported by Vanderbilt Core Grant in Vision Research P30EY008126. We thank Dr. H. Alex Brown and Dr. John Exton for critical reading of the manuscript.	Allen KN, 2004, TRENDS BIOCHEM SCI, V29, P495, DOI 10.1016/j.tibs.2004.07.008; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ball EG, 1939, J BIOL CHEM, V128, P51; BREATHNACH R, 1977, BIOCHEMISTRY-US, V16, P3054, DOI 10.1021/bi00633a002; BRITTON HG, 1968, BIOCHEM J, V110, P161, DOI 10.1042/bj1100161; BRITTON HG, 1971, BIOCHEMISTRY-US, V10, P4522, DOI 10.1021/bi00800a028; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; COLEMAN JE, 1992, ANNU REV BIOPH BIOM, V21, P441, DOI 10.1146/annurev.biophys.21.1.441; DAI JB, 1992, J BIOL CHEM, V267, P6322; Dai JY, 2006, BIOCHEMISTRY-US, V45, P7818, DOI 10.1021/bi060136v; DEGROOT H, 1985, BIOCHEM J, V230, P255, DOI 10.1042/bj2300255; DeLano W.L, PYMOL MOL GRAPHICS S; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Galperin MY, 1998, PROTEIN SCI, V7, P1829, DOI 10.1002/pro.5560070819; Galperin MY, 2001, PROTEINS, V45, P318, DOI 10.1002/prot.1152; GATEHOUSE JA, 1977, BIOCHEMISTRY-US, V16, P3045, DOI 10.1021/bi00633a001; HAMMER-JESPERSEN K, 1970, European Journal of Biochemistry, V17, P397, DOI 10.1111/j.1432-1033.1970.tb01179.x; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Horzempa J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-172; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KEMP BE, 1980, FEBS LETT, V110, P308, DOI 10.1016/0014-5793(80)80099-8; KIM EE, 1991, J MOL BIOL, V218, P449, DOI 10.1016/0022-2836(91)90724-K; KNOWLES JR, 1980, ANNU REV BIOCHEM, V49, P877, DOI 10.1146/annurev.bi.49.070180.004305; Lahiri SD, 2002, BIOCHEMISTRY-US, V41, P8351, DOI 10.1021/bi0202373; Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Maliekal P, 2007, J BIOL CHEM, V282, P31844, DOI 10.1074/jbc.M706818200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nannemann DP, 2010, PROTEIN ENG DES SEL, V23, P607, DOI 10.1093/protein/gzq033; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Panosian TD, 2010, ACTA CRYSTALLOGR F, V66, P811, DOI 10.1107/S1744309110017549; QIAN N, 1994, J BACTERIOL, V176, P5304, DOI 10.1128/JB.176.17.5304-5311.1994; Rasband W., 2009, IMAGE J; RAY WJ, 1976, BIOCHEMISTRY-US, V15, P4018, DOI 10.1021/bi00663a016; RAY WJ, 1964, J BIOL CHEM, V239, P1228; Regni C, 2006, J BIOL CHEM, V281, P15564, DOI 10.1074/jbc.M600590200; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Scism RA, 2010, CHEMBIOCHEM, V11, P67, DOI 10.1002/cbic.200900620; Segal I. H., 1976, BIOCH CALCULATIONS S, P291; Silvaggi NR, 2006, J BIOL CHEM, V281, P14918, DOI 10.1074/jbc.M601505200; Tozzi MG, 2006, FEBS J, V273, P1089, DOI 10.1111/j.1742-4658.2006.05155.x; Wang J, 2006, PROTEIN SCI, V15, P2395, DOI 10.1110/ps.062351506; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736	49	24	25	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8043	8054		10.1074/jbc.M110.201350	http://dx.doi.org/10.1074/jbc.M110.201350			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21193409	hybrid, Green Published			2022-12-27	WOS:000288013300035
J	Huckaba, TM; Gennerich, A; Wilhelm, JE; Chishti, AH; Vale, RD				Huckaba, Thomas M.; Gennerich, Arne; Wilhelm, James E.; Chishti, Athar H.; Vale, Ronald D.			Kinesin-73 Is a Processive Motor That Localizes to Rab5-containing Organelles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE PLUS END; LARGE TUMOR-SUPPRESSOR; CAP-GLY DOMAINS; MONOMERIC MOTOR; MEMBRANE-TRANSPORT; AXONAL-TRANSPORT; NERVOUS-SYSTEM; IN-VIVO; PROTEIN; MOTILITY	Drosophila Kinesin-73 (Khc-73), which plays a role in mitotic spindle polarity in neuroblasts, is a metazoan-specific member of the Kinesin-3 family of motors, which includes mammalian KIF1A and Caenorhabditis elegans Unc-104. The mechanism of Kinesin-3 motors has been controversial because some studies have reported that they transport cargo as monomers whereas other studies have suggested a dimer mechanism. Here, we have performed single-molecule motility and cell biological studies of Khc-73. We find that constructs containing the motor and the conserved short stretches of putative coiled-coil-forming regions are predominantly monomeric in vitro, but that dimerization allows for fast, processive movement and high force production (7 piconewtons). In Drosophila cell lines, we present evidence that Khc-73 can dimerize in vivo. We also show that Khc-73 is recruited specifically to Rab5-containing endosomes through its "tail" domain. Our results suggest that the N-terminal half of Khc-73 can undergo a monomer-dimer transition to produce a fast processive motor and that its C-terminal half possesses a specific Rab5-vesicle binding domain.	[Huckaba, Thomas M.; Vale, Ronald D.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Gennerich, Arne] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Gennerich, Arne] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10461 USA; [Wilhelm, James E.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Chishti, Athar H.] Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA; [Vale, Ronald D.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of California System; University of California San Diego; Tufts University; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu	Gennerich, Arne/W-5488-2019		National Institutes of Health [38499, CA094414]; NATIONAL CANCER INSTITUTE [R01CA094414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 38499 (to R. D. V.) and CA094414 (to A. H. C.).	Al-Bassam J, 2003, J CELL BIOL, V163, P743, DOI 10.1083/jcb.200308020; Asaba N, 2003, J BIOL CHEM, V278, P8395, DOI 10.1074/jbc.M210362200; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Deneka M, 2003, CRIT REV BIOCHEM MOL, V38, P121, DOI 10.1080/713609214; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Griffis ER, 2007, J CELL BIOL, V177, P1005, DOI 10.1083/jcb.200702062; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hammond JW, 2009, PLOS BIOL, V7, P650, DOI 10.1371/journal.pbio.1000072; Hanada T, 2000, J BIOL CHEM, V275, P28774, DOI 10.1074/jbc.M000715200; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P877, DOI 10.1038/nrm2807; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Horiguchi K, 2006, J CELL BIOL, V174, P425, DOI 10.1083/jcb.200604031; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Hwang W, 2008, STRUCTURE, V16, P62, DOI 10.1016/j.str.2007.11.008; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; Kural C, 2007, P NATL ACAD SCI USA, V104, P5378, DOI 10.1073/pnas.0700145104; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Li HP, 1997, P NATL ACAD SCI USA, V94, P1086, DOI 10.1073/pnas.94.4.1086; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Nitta R, 2004, SCIENCE, V305, P678, DOI 10.1126/science.1096621; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; Perez F, 1999, CELL, V96, P517, DOI 10.1016/S0092-8674(00)80656-X; PFISTER KK, 1989, J CELL BIOL, V108, P1453, DOI 10.1083/jcb.108.4.1453; RECKPETERSON SL, 2010, COLD SPRING HARBOR P; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rogers SL, 2003, J CELL BIOL, V162, P1079, DOI 10.1083/jcb.200303023; SCHNAPP BJ, 1992, J CELL BIOL, V119, P389, DOI 10.1083/jcb.119.2.389; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Steinmetz MO, 2008, TRENDS BIOCHEM SCI, V33, P535, DOI 10.1016/j.tibs.2008.08.006; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; UITEI K, 1994, NEUROSCI LETT, V174, P85, DOI 10.1016/0304-3940(94)90125-2; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Weisbrich A, 2007, NAT STRUCT MOL BIOL, V14, P959, DOI 10.1038/nsmb1291; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Zhang J, 2007, GENETICS, V176, P1307, DOI 10.1534/genetics.106.066761	45	37	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7457	7467		10.1074/jbc.M110.167023	http://dx.doi.org/10.1074/jbc.M110.167023			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21169635	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000287737300060
J	Tamura, K; Ohbayashi, N; Ishibashi, K; Fukuda, M				Tamura, Kanako; Ohbayashi, Norihiko; Ishibashi, Koutaro; Fukuda, Mitsunori			Structure-Function Analysis of VPS9-Ankyrin-repeat Protein (Varp) in the Trafficking of Tyrosinase-related Protein 1 in Melanocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAB BINDING-SPECIFICITY; MELANOSOME TRANSPORT; MYOSIN-VA; CRITICAL DETERMINANT; EXCHANGE FACTOR; DOMAIN; SLAC2-A/MELANOPHILIN; GTPASES; ORGANELLE; EFFECTOR	Because Varp (VPS9-ankyrin-repeat protein)/Ankrd27 specifically binds two small GTPases, Rab32 and Rab38, which redundantly regulate the trafficking of melanogenic enzymes in mammalian epidermal melanocytes, it has recently been implicated in the regulation of trafficking of a melanogenic enzyme tyrosinase-related protein 1 (Tyrp1) to melanosomes. However, the functional interaction between Rab32/38 and Varp and the involvement of the VPS9 domain (i.e. Rab21-GEF domain) in Tyrp1 trafficking have never been elucidated. In this study, we succeeded in identifying critical residues of Rab32/38 and Varp that are critical for the formation of the Rab32/38.Varp complex by performing Ala-based site-directed mutagenesis, and we discovered that a conserved Val residue in the switch II region of Rab32(Val-92) and Rab38(Val-78) is required for Varp binding activity and that its point mutant, Rab38(V78A), does not support Tyrp1 trafficking in Rab32/38-deficient melanocytes. We also identified two critical residues for Rab32/38 binding in the Varp ANKR1 domain and demonstrated that their point mutants, Varp(Q509A) and Varp(Y550A), do not support peripheral melanosomal distribution of Tyrp1 in Varp-deficient cells. Interestingly, the VPS9 domain point mutants, Varp(D310A) and Varp(Y350A), did support Tyrp1 trafficking in Varp-deficient cells, and knockdown of Rab21 had no effect on Tyrp1 distribution. We also found evidence for the functional interaction between a vesicle SNARE VAMP7/TI-VAMP and Varp in Tyrp1 trafficking. These results collectively indicated that both the Rab32/38 binding activity and VAMP7 binding activity of Varp are essential for trafficking of Tyrp1 in melanocytes but that activation of Rab21 by the VPS9 domain is not necessary for Tyrp1 trafficking.	[Tamura, Kanako; Ohbayashi, Norihiko; Ishibashi, Koutaro; Fukuda, Mitsunori] Tohoku Univ, Grad Sch Life Sci, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci,Aoba Ku, Sendai, Miyagi 9808578, Japan	Tohoku University	Fukuda, M (corresponding author), Tohoku Univ, Grad Sch Life Sci, Lab Membrane Trafficking Mech, Dept Dev Biol & Neurosci,Aoba Ku, Sendai, Miyagi 9808578, Japan.	nori@m.tohoku.ac.jp	Fukuda, MItsunori/I-1511-2015	Fukuda, MItsunori/0000-0002-8620-5853	Ministry of Education, Culture, Sports, and Technology of Japan; Kato Memorial Bioscience Foundation; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [20113006] Funding Source: KAKEN	Ministry of Education, Culture, Sports, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kato Memorial Bioscience Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, and Technology of Japan (to N. O. and M. F.), by a grant from the Global COE Program (Basic and Translational Research Center for Global Brain Science) from the Ministry of Education, Culture, Sports, and Technology of Japan (to N. O. and M. F.), and by a grant from the Kato Memorial Bioscience Foundation (to M. F.).; Supported by the Japan Society for the Promotion of Science.	Ando H, 2004, J BIOL CHEM, V279, P15427, DOI 10.1074/jbc.M313701200; Ando H, 2009, INT J MOL SCI, V10, P4428, DOI 10.3390/ijms10104428; Bahadoran P, 2001, J CELL BIOL, V152, P843, DOI 10.1083/jcb.152.4.843; BENNETT DC, 1987, INT J CANCER, V39, P414, DOI 10.1002/ijc.2910390324; Burgo A, 2009, EMBO REP, V10, P1117, DOI 10.1038/embor.2009.186; Chaineau M, 2009, FEBS LETT, V583, P3817, DOI 10.1016/j.febslet.2009.10.026; Chi A, 2006, J PROTEOME RES, V5, P3135, DOI 10.1021/pr060363j; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 2003, J BIOL CHEM, V278, P15373, DOI 10.1074/jbc.M212341200; Fukuda M, 2005, METHOD ENZYMOL, V403, P445, DOI 10.1016/S0076-6879(05)03039-9; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; Fukuda M, 1999, J BIOL CHEM, V274, P31428, DOI 10.1074/jbc.274.44.31428; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Fukuda M, 2002, J BIOL CHEM, V277, P40118, DOI 10.1074/jbc.M205765200; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Fukuda M, 2008, MOL CELL PROTEOMICS, V7, P1031, DOI 10.1074/mcp.M700569-MCP200; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Honing S, 1998, EMBO J, V17, P1304, DOI 10.1093/emboj/17.5.1304; Hume AN, 2001, J CELL BIOL, V152, P795, DOI 10.1083/jcb.152.4.795; Itoh T, 2008, MOL BIOL CELL, V19, P2916, DOI 10.1091/mbc.E07-12-1231; Itoh T, 2006, GENES CELLS, V11, P1023, DOI 10.1111/j.1365-2443.2006.00997.x; Itzen A, 2008, STRUCTURE, V16, P1437, DOI 10.1016/j.str.2008.09.002; James P, 1996, GENETICS, V144, P1425; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Kageyama A, 2004, J BIOL CHEM, V279, P27774, DOI 10.1074/jbc.M401786200; Kanno E, 2010, TRAFFIC, V11, P491, DOI 10.1111/j.1600-0854.2010.01038.x; Kukimoto-Niino M, 2008, STRUCTURE, V16, P1478, DOI 10.1016/j.str.2008.07.014; Kuroda TS, 2004, NAT CELL BIOL, V6, P1195, DOI 10.1038/ncb1197; Kuroda TS, 2003, MOL CELL BIOL, V23, P5245, DOI 10.1128/MCB.23.15.5245-5255.2003; Loftus SK, 2002, P NATL ACAD SCI USA, V99, P4471, DOI 10.1073/pnas.072087599; Marks MS, 2001, NAT REV MOL CELL BIO, V2, P738, DOI 10.1038/35096009; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Park M, 2007, CURR BIOL, V17, P2030, DOI 10.1016/j.cub.2007.10.051; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Strom M, 2002, J BIOL CHEM, V277, P25423, DOI 10.1074/jbc.M202574200; Tamura K, 2009, MOL BIOL CELL, V20, P2900, DOI 10.1091/mbc.E08-12-1161; Tomita Y, 2004, AM J MED GENET C, V131C, P75, DOI 10.1002/ajmg.c.30036; Van Gele M, 2009, PIGM CELL MELANOMA R, V22, P268, DOI 10.1111/j.1755-148X.2009.00558.x; Wang F, 2008, BIOCHEM BIOPH RES CO, V372, P162, DOI 10.1016/j.bbrc.2008.05.017; Wasmeier C, 2006, J CELL BIOL, V175, P271, DOI 10.1083/jcb.200606050; Watabe H, 2004, J BIOL CHEM, V279, P7971, DOI 10.1074/jbc.M309714200; Wu XF, 2001, J CELL SCI, V114, P1091; Wu XFS, 2002, NAT CELL BIOL, V4, P271, DOI 10.1038/ncb760; Zhang XJ, 2006, J CELL SCI, V119, P1053, DOI 10.1242/jcs.02810	49	49	52	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7507	7521		10.1074/jbc.M110.191205	http://dx.doi.org/10.1074/jbc.M110.191205			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21187289	hybrid, Green Published			2022-12-27	WOS:000287737300065
J	Ge, CR; Georgiev, A; Ohman, A; Wieslander, A; Kelly, AA				Ge, Changrong; Georgiev, Alexander; Ohman, Anders; Wieslander, Ake; Kelly, Amelie A.			Tryptophan Residues Promote Membrane Association for a Plant Lipid Glycosyltransferase Involved in Phosphate Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICAL TRANSMEMBRANE PROTEINS; ACHOLEPLASMA-LAIDLAWII; ESCHERICHIA-COLI; 1,2-DIACYLGLYCEROL 3-GLUCOSYLTRANSFERASE; DIGALACTOSYLDIACYLGLYCEROL SYNTHASE; PHOTOSYNTHETIC MEMBRANES; CRYSTAL-STRUCTURE; SWISS-MODEL; BINDING; BILAYER	Chloroplast membranes contain a substantial excess of the nonbilayer-prone monogalactosyldiacylglycerol (GalDAG) over the biosynthetically consecutive, bilayer-forming digalactosyldiacylglycerol (GalGalDAG), yielding a high membrane curvature stress. During phosphate shortage, plants replace phospholipids with GalGalDAG to rescue phosphate while maintaining membrane homeostasis. Here we investigate how the activity of the corresponding glycosyltransferase (GT) in Arabidopsis thaliana (atDGD2) depends on local bilayer properties by analyzing structural and activity features of recombinant protein. Fold recognition and sequence analyses revealed a two-domain GT-B monotopic structure, present in other plant and bacterial glycolipid GTs, such as the major chloroplast GalGalDAG GT atDGD1. Modeling led to the identification of catalytically important residues in the active site of atDGD2 by site-directed mutagenesis. The DGD synthases share unique bilayer interface segments containing conserved tryptophan residues that are crucial for activity and for membrane association. More detailed localization studies and liposome binding analyses indicate differentiated anchor and substrate-binding functions for these separated enzyme interface regions. Anionic phospholipids, but not curvature-increasing nonbilayer lipids, strongly stimulate enzyme activity. From our studies, we propose a model for bilayer "control" of enzyme activity, where two tryptophan segments act as interface anchor points to keep the substrate region close to the membrane surface. Binding of the acceptor substrate is achieved by interaction of positive charges in a surface cluster of lysines, arginines, and histidines with the surrounding anionic phospholipids. The diminishing phospholipid fraction during phosphate shortage stress will then set the new GalGalDAG/phospholipid balance by decreasing stimulation of atDGD2.	[Ge, Changrong; Georgiev, Alexander; Wieslander, Ake; Kelly, Amelie A.] Stockholm Univ, Ctr Biomembrane Res, SE-10691 Stockholm, Sweden; [Ohman, Anders] Umea Univ, Umea Ctr Mol Pathogenesis, SE-90187 Umea, Sweden	Stockholm University; Umea University	Kelly, AA (corresponding author), HRI Univ Warwick, Warwick CV35 9EF, England.	a.a.b.kelly@warwick.ac.uk	Georgiev, Alexander/D-3258-2011	Georgiev, Alexander/0000-0001-5669-5962	Wenner-Gren Foundation; Royal Swedish Academy of Sciences; European Commission; Swedish Research Council	Wenner-Gren Foundation; Royal Swedish Academy of Sciences; European Commission(European CommissionEuropean Commission Joint Research Centre); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by the Wenner-Gren Foundation, the Royal Swedish Academy of Sciences, European Commission FP6 Marie-Curie Action BIOCONTROL, and the Swedish Research Council.	Alley SH, 2008, BIOPHYS J, V94, P2938, DOI 10.1529/biophysj.107.118380; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Awai K, 2006, P NATL ACAD SCI USA, V103, P10817, DOI 10.1073/pnas.0602754103; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balali-Mood K, 2009, BIOCHEMISTRY-US, V48, P2135, DOI 10.1021/bi8017398; Barkan L, 2006, PLANT PHYSIOL, V141, P1012, DOI 10.1104/pp.106.080481; Barreras M, 2008, J BIOL CHEM, V283, P25027, DOI 10.1074/jbc.M801227200; Beers SA, 2003, BIOCHEMISTRY-US, V42, P7326, DOI 10.1021/bi0343222; Bhardwaj N, 2006, J MOL BIOL, V359, P486, DOI 10.1016/j.jmb.2006.03.039; BLOCK MA, 1983, J BIOL CHEM, V258, P3281; Booth PJ, 2009, CURR OPIN STRUC BIOL, V19, P8, DOI 10.1016/j.sbi.2008.12.005; Botte C, 2005, J BIOL CHEM, V280, P34691, DOI 10.1074/jbc.M505622200; BrUnger A. T., 1992, X PLOR VERSION 3 1 S; Buser CA, 1998, METH MOL B, V84, P267; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen JP, 2006, PLANT CELL ENVIRON, V29, P1437, DOI 10.1111/j.1365-3040.2006.01527.x; Cladera J, 1997, EUR J BIOCHEM, V243, P798, DOI 10.1111/j.1432-1033.1997.00798.x; Cruz-Ramirez A, 2006, P NATL ACAD SCI USA, V103, P6765, DOI 10.1073/pnas.0600863103; DEMEL RA, 1995, MOL MEMBR BIOL, V12, P255, DOI 10.3109/09687689509072425; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Doyen JR, 2008, PROSTAG OTH LIPID M, V85, P134, DOI 10.1016/j.prostaglandins.2007.12.001; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Dubots E, 2010, J BIOL CHEM, V285, P6003, DOI 10.1074/jbc.M109.071928; Edman M, 2003, J BIOL CHEM, V278, P8420, DOI 10.1074/jbc.M211492200; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; Fernandez-Vidall M, 2007, J MOL BIOL, V370, P459, DOI 10.1016/j.jmb.2007.05.016; Gaude N, 2004, J BIOL CHEM, V279, P34624, DOI 10.1074/jbc.M404098200; Gaude N, 2007, PLANT J, V49, P729, DOI 10.1111/j.1365-313X.2006.02992.x; Gelb MH, 1999, CURR OPIN STRUC BIOL, V9, P428, DOI 10.1016/S0959-440X(99)80059-1; Georgiev A., 2008, THESIS STOCKHOLM U; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Goss R, 2007, BBA-BIOMEMBRANES, V1768, P67, DOI 10.1016/j.bbamem.2006.06.006; Granseth E, 2005, J MOL BIOL, V352, P489, DOI 10.1016/j.jmb.2005.07.053; Guerin ME, 2007, J BIOL CHEM, V282, P20705, DOI 10.1074/jbc.M702087200; Guerin ME, 2005, ACTA CRYSTALLOGR F, V61, P518, DOI 10.1107/S1744309105012364; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Ha S, 2000, PROTEIN SCI, V9, P1045, DOI 10.1110/ps.9.6.1045; He J, 2009, PROTEINS, V76, P852, DOI 10.1002/prot.22392; Holzl G, 2005, GLYCOBIOLOGY, V15, P874, DOI 10.1093/glycob/cwi066; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Hu YN, 2003, P NATL ACAD SCI USA, V100, P845, DOI 10.1073/pnas.0235749100; JENSEN JW, 1988, BIOCHEMISTRY-US, V27, P6315, DOI 10.1021/bi00417a017; Johansson ACV, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3129863; Jones JA, 2005, BIOCHEMISTRY-US, V44, P13235, DOI 10.1021/bi0505159; Jorasch P, 1998, MOL MICROBIOL, V29, P419, DOI 10.1046/j.1365-2958.1998.00930.x; Karlsson OP, 1997, J BIOL CHEM, V272, P929, DOI 10.1074/jbc.272.2.929; Kelly A. A., 2003, THESIS U POTSDAM GER; Kelly AA, 2003, PLANT CELL, V15, P2694, DOI 10.1105/tpc.016675; Kelly AA, 2002, J BIOL CHEM, V277, P1166, DOI 10.1074/jbc.M110066200; Kelly AA, 2004, CURR OPIN PLANT BIOL, V7, P262, DOI 10.1016/j.pbi.2004.03.009; KELLY AA, 2007, CURRENT ADV BIOCH CE, P25; Klement MLR, 2007, MOL MICROBIOL, V65, P1444, DOI 10.1111/j.1365-2958.2007.05865.x; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li L, 2003, BIOCHEMISTRY-US, V42, P9677, DOI 10.1021/bi034360l; Li MY, 2006, PLANT PHYSIOL, V142, P750, DOI 10.1104/pp.106.085647; Lind J, 2007, BIOCHEMISTRY-US, V46, P5664, DOI 10.1021/bi700042x; Linde K, 2004, FEBS LETT, V575, P77, DOI 10.1016/j.febslet.2004.08.038; Liu W, 2006, BIOCHEMISTRY-US, V45, P11713, DOI 10.1021/bi0608414; Malik A, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-1; Marsico A, 2010, NUCLEIC ACIDS RES, V38, pD181, DOI 10.1093/nar/gkp1042; Matsumoto K, 1998, J BACTERIOL, V180, P100, DOI 10.1128/JB.180.1.100-106.1998; Mattjus P, 2009, BBA-BIOMEMBRANES, V1788, P267, DOI 10.1016/j.bbamem.2008.10.003; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; MINNIKIN DE, 1972, FEBS LETT, V27, P16, DOI 10.1016/0014-5793(72)80398-3; MirAfzali Z, 2006, J BIOL CHEM, V281, P28354, DOI 10.1074/jbc.M605206200; Mizusawa N, 2009, FEBS LETT, V583, P718, DOI 10.1016/j.febslet.2009.01.021; Mock T, 2002, PHYTOCHEMISTRY, V61, P41, DOI 10.1016/S0031-9422(02)00216-9; Moellering ER, 2010, SCIENCE, V330, P226, DOI 10.1126/science.1191803; Nakamura Y, 2009, P NATL ACAD SCI USA, V106, P20978, DOI 10.1073/pnas.0907173106; NAVARRO J, 1984, BIOCHEMISTRY-US, V23, P130, DOI 10.1021/bi00296a021; Palsdottir H, 2004, BBA-BIOMEMBRANES, V1666, P2, DOI 10.1016/j.bbamem.2004.06.012; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Sakurai I, 2007, PLANT PHYSIOL, V145, P1361, DOI 10.1104/pp.107.106781; Sanderson JM, 2004, PHYS CHEM CHEM PHYS, V6, P1012, DOI 10.1039/b312184d; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Snider C, 2009, PROTEIN SCI, V18, P2624, DOI 10.1002/pro.256; Spencer AG, 1999, J BIOL CHEM, V274, P32936, DOI 10.1074/jbc.274.46.32936; SUSS KH, 1986, PLANT PHYSIOL, V81, P192, DOI 10.1104/pp.81.1.192; Torres-Franklin ML, 2007, PHYSIOL PLANTARUM, V131, P201, DOI 10.1111/j.1399-3054.2007.00943.x; van den Brink-van der Laan E, 2001, BIOCHEMISTRY-US, V40, P9677, DOI 10.1021/bi002903a; VANWALRAVEN HS, 1984, EUR J BIOCHEM, V144, P563; Viklund H, 2006, J MOL BIOL, V361, P591, DOI 10.1016/j.jmb.2006.06.037; Vikstrom S, 1999, BIOCHEMISTRY-US, V38, P5511, DOI 10.1021/bi982532m; WEBB MS, 1991, BIOCHIM BIOPHYS ACTA, V1060, P133, DOI 10.1016/S0005-2728(09)91002-7; Wikstrom M, 2009, J BIOL CHEM, V284, P954, DOI 10.1074/jbc.M804482200; WILLIAMS WP, 1987, J BIOENERG BIOMEMBR, V19, P605, DOI 10.1007/BF00762299; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	91	25	27	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6669	6684		10.1074/jbc.M110.138495	http://dx.doi.org/10.1074/jbc.M110.138495			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21156807	Green Published, hybrid			2022-12-27	WOS:000287476400075
J	Mason, FM; Heimsath, EG; Higgs, HN; Soderling, SH				Mason, Frank M.; Heimsath, Ernest G.; Higgs, Henry N.; Soderling, Scott H.			Bi-modal Regulation of a Formin by srGAP2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDRICH-SYNDROME PROTEIN; FC-GAMMA-R; RHO-GTPASES; MEDIATED PHAGOCYTOSIS; NEURONAL MIGRATION; ARP2/3 COMPLEX; FRL-ALPHA; ACTIN; DOMAIN; RAC	The maintenance of rapid and efficient actin dynamics in vivo requires coordination of filament assembly and disassembly. This regulation requires temporal and spatial integration of signaling pathways by protein complexes. However, it remains unclear how these complexes form and then regulate the actin cytoskeleton. Here, we identify a srGAP2 and formin-like 1 (FMNL1, also known as FRL1 or FRL alpha) complex whose assembly is regulated by Rac signaling. Our data suggest srGAP2 regulates FMNL1 in two ways; 1) Rac-mediated activation of FMNL1 leads to the recruitment of srGAP2, which contains a Rac-specific GAP domain; 2) the SH3 domain of srGAP2 binds the formin homology 1 domain of FMNL1 to inhibit FMNL1-mediated actin severing. Thus, srGAP2 can efficiently terminate the upstream activating Rac signal while also opposing an important functional output of FMNL1, namely actin severing. We also show that FMNL1 and srGAP2 localize to the actin-rich phagocytic cup of macrophage-derived cells, suggesting the complex may regulate this Rac- and actin-driven process in vivo. We propose that after Rac-dependent activation of FMNL1, srGAP2 mediates a potent mechanism to limit the duration of Rac action and inhibit formin activity during rapid actin dynamics.	[Mason, Frank M.; Soderling, Scott H.] Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27710 USA; [Heimsath, Ernest G.; Higgs, Henry N.] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Duke University; Dartmouth College	Soderling, SH (corresponding author), Duke Univ, Sch Med, Dept Cell Biol, Durham, NC 27516 USA.	s.soderling@cellbio.duke.edu		Mason, Frank/0000-0003-1338-494X; Heimsath Jr, Ernest G/0000-0002-1839-6686; Higgs, Henry/0000-0002-2917-9644	National Institutes of Health [NS059957]; March of Dimes [5-FY07-671, GM069818]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059957, R56NS059957] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS059957 (to S. H. S.). This work was also supported by March of Dimes Grant 5-FY07-671 (to S. H. S.) and GM069818 (to H. N. H.).	Cai L, 2008, CELL, V134, P828, DOI 10.1016/j.cell.2008.06.054; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Chesarone M, 2009, DEV CELL, V16, P292, DOI 10.1016/j.devcel.2008.12.001; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Diakonova M, 2002, MOL BIOL CELL, V13, P402, DOI 10.1091/mbc.01-05-0273; Eisenmann KM, 2007, CURR BIOL, V17, P579, DOI 10.1016/j.cub.2007.03.024; ERPEL T, 1995, EMBO J, V14, P963, DOI 10.1002/j.1460-2075.1995.tb07077.x; Esue O, 2008, J MOL BIOL, V384, P324, DOI 10.1016/j.jmb.2008.09.043; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200; Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565; Higgs HN, 2005, TRENDS BIOCHEM SCI, V30, P342, DOI 10.1016/j.tibs.2005.04.014; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kovar DR, 2006, CURR OPIN CELL BIOL, V18, P11, DOI 10.1016/J.CEB.2005.12.011; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; Lorenzi R, 2000, BLOOD, V95, P2943, DOI 10.1182/blood.V95.9.2943.009k17_2943_2946; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; Otomo T, 2005, MOL CELL, V18, P273, DOI 10.1016/j.molcel.2005.04.002; Ouyang MX, 2008, P NATL ACAD SCI USA, V105, P14353, DOI 10.1073/pnas.0807537105; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Rose R, 2005, NATURE, V435, P513, DOI 10.1038/nature03604; Seth A, 2006, J CELL BIOL, V174, P701, DOI 10.1083/jcb.200605006; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Soderling SH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.255pe5; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Takahashi M, 2008, GENES CELLS, V13, P549, DOI 10.1111/j.1365-2443.2008.01187.x; Wang QQ, 2008, J IMMUNOL, V180, P2419, DOI 10.4049/jimmunol.180.4.2419; Weaver AM, 2003, CURR OPIN CELL BIOL, V15, P23, DOI 10.1016/S0955-0674(02)00015-7; Westphal RS, 2000, EMBO J, V19, P4589, DOI 10.1093/emboj/19.17.4589; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Yayoshi-Yamamoto S, 2000, MOL CELL BIOL, V20, P6872, DOI 10.1128/MCB.20.18.6872-6881.2000	40	33	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6577	6586		10.1074/jbc.M110.190397	http://dx.doi.org/10.1074/jbc.M110.190397			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21148482	Green Published, hybrid			2022-12-27	WOS:000287476400067
J	Coloff, JL; Mason, EF; Altman, BJ; Gerriets, VA; Liu, TY; Nichols, AN; Zhao, YX; Wofford, JA; Jacobs, SR; Ilkayeva, O; Garrison, SP; Zambetti, GP; Rathmell, JC				Coloff, Jonathan L.; Mason, Emily F.; Altman, Brian J.; Gerriets, Valerie A.; Liu, Tingyu; Nichols, Amanda N.; Zhao, Yuxing; Wofford, Jessica A.; Jacobs, Sarah R.; Ilkayeva, Olga; Garrison, Sean P.; Zambetti, Gerard P.; Rathmell, Jeffrey C.			Akt Requires Glucose Metabolism to Suppress Puma Expression and Prevent Apoptosis of Leukemic T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; CANCER-CELLS; MITOCHONDRIAL HEXOKINASE; AEROBIC GLYCOLYSIS; SIGNALING PATHWAY; GROWTH; ACTIVATION; SURVIVAL; PHOSPHORYLATION; PROTEIN	The PI3K/Akt pathway is activated in stimulated cells and in many cancers to promote glucose metabolism and prevent cell death. Although inhibition of Akt-mediated cell survival may provide a means to eliminate cancer cells, this survival pathway remains incompletely understood. In particular, unlike anti-apoptotic Bcl-2 family proteins that prevent apoptosis independent of glucose, Akt requires glucose metabolism to inhibit cell death. This glucose dependence may occur in part through metabolic regulation of pro-apoptotic Bcl-2 family proteins. Here, we show that activated Akt relies on glycolysis to inhibit induction of Puma, which was uniquely sensitive to metabolic status among pro-apoptotic Bcl-2 family members and was rapidly up-regulated in glucose-deficient conditions. Importantly, preventing Puma expression was critical for Akt-mediated cell survival, as Puma deficiency protected cells from glucose deprivation and Akt could not readily block Puma-mediated apoptosis. In contrast, the pro-apoptotic Bcl-2 family protein Bim was induced normally even when constitutively active Akt was expressed, yet Akt could provide protection from Bim cytotoxicity. Up-regulation of Puma appeared mediated by decreased availability of mitochondrial metabolites rather than glycolysis itself, as alternative mitochondrial fuels could suppress Puma induction and apoptosis upon glucose deprivation. Metabolic regulation of Puma was mediated through combined p53-dependent transcriptional induction and control of Puma protein stability, with Puma degraded in nutrient-replete conditions and long lived in nutrient deficiency. Together, these data identify a key role for Bcl-2 family proteins in Akt-mediated cell survival that may be critical in normal immunity and in cancer through Akt-dependent stimulation of glycolysis to suppress Puma expression.	[Zhao, Yuxing; Wofford, Jessica A.; Jacobs, Sarah R.; Rathmell, Jeffrey C.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Rathmell, Jeffrey C.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Ilkayeva, Olga; Rathmell, Jeffrey C.] Duke Univ, Med Ctr, Sarah W Stedman Ctr Nutr & Metab, Durham, NC 27710 USA; [Garrison, Sean P.; Zambetti, Gerard P.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA	Duke University; Duke University; Duke University; St Jude Children's Research Hospital	Rathmell, JC (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	jeff.rathmell@duke.edu	Gerriets, Valerie/AAD-6611-2019; Altman, Brian J./X-2783-2019; Zambetti, Gerard/N-8093-2018	Altman, Brian J./0000-0002-3954-4916; Zambetti, Gerard/0000-0002-0929-5007; Gerriets, Valerie/0000-0002-1553-2590	National Institutes of Health [R01CA123350, R01AI063345, R01GM083159, F30HL094044]; American Asthma Foundation; Leukemia and Lymphoma Society; Gabrielle's Angel Foundation for Cancer Research; Alex's Lemonade Stand; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [R01CA123350] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL094044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Gabrielle's Angel Foundation for Cancer Research; Alex's Lemonade Stand; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA123350 and R01AI063345 (to J. C. R.), R01GM083159 (to G. P. Z.), and F30HL094044 (to E. F. M.). This work was also supported by American Asthma Foundation (to J. C. R.), Leukemia and Lymphoma Society scholar award (to J. C. R.), Gabrielle's Angel Foundation for Cancer Research (to J. C. R.), Alex's Lemonade Stand (to J. C. R.), and the American Lebanese Syrian Associated Charities (to G. P. Z.).	Altman BJ, 2009, MOL BIOL CELL, V20, P1180, DOI 10.1091/mbc.E08-08-0829; Alves NL, 2006, IMMUNITY, V24, P703, DOI 10.1016/j.immuni.2006.03.018; An J, 2004, NAT MED, V10, P268, DOI 10.1038/nm995; Barata JT, 2004, J EXP MED, V200, P659, DOI 10.1084/jem.20040789; Biswas SC, 2002, J BIOL CHEM, V277, P49511, DOI 10.1074/jbc.M208086200; BOISE LH, 1995, IMMUNITY, V3, P87, DOI 10.1016/1074-7613(95)90161-2; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Cham CM, 2008, EUR J IMMUNOL, V38, P2438, DOI 10.1002/eji.200838289; Cham CM, 2005, J IMMUNOL, V174, P4670, DOI 10.4049/jimmunol.174.8.4670; Chi MMY, 2000, J BIOL CHEM, V275, P40252, DOI 10.1074/jbc.M005508200; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Danial NN, 2003, NATURE, V424, P952, DOI 10.1038/nature01825; de Frias M, 2009, HAEMATOL-HEMATOL J, V94, P1698, DOI 10.3324/haematol.2008.004028; DeBerardinis RJ, 2006, J BIOL CHEM, V281, P37372, DOI 10.1074/jbc.M608372200; Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Erlacher M, 2006, J EXP MED, V203, P2939, DOI 10.1084/jem.20061552; Ferrara CT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000034; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Frauwirth KA, 2002, FASEB J, V16, pA711; Fricker M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.38; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Ishihara T, 2007, BIOCHEM BIOPH RES CO, V356, P711, DOI 10.1016/j.bbrc.2007.03.034; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Khatri S, 2010, J BIOL CHEM, V285, P15960, DOI 10.1074/jbc.M110.121871; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Majewski N, 2004, MOL CELL BIOL, V24, P730, DOI 10.1128/MCB.24.2.730-740.2004; Mason EF, 2010, CANCER RES, V70, P8066, DOI 10.1158/0008-5472.CAN-10-0608; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; Miyamoto S, 2008, CELL DEATH DIFFER, V15, P521, DOI 10.1038/sj.cdd.4402285; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Nutt LK, 2005, CELL, V123, P89, DOI 10.1016/j.cell.2005.07.032; Palomero T, 2008, CELL CYCLE, V7, P965, DOI 10.4161/cc.7.8.5753; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Plas DR, 2002, TRENDS ENDOCRIN MET, V13, P74; Plas DR, 2002, NAT IMMUNOL, V3, P515, DOI 10.1038/ni0602-515; Pradelli LA, 2010, ONCOGENE, V29, P1641, DOI 10.1038/onc.2009.448; Qi XJ, 2006, J BIOL CHEM, V281, P813, DOI 10.1074/jbc.M505546200; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Sauter B, 2000, J EXP MED, V191, P423, DOI 10.1084/jem.191.3.423; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; You H, 2006, J EXP MED, V203, P1657, DOI 10.1084/jem.20060353; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07; Zhao YX, 2008, J BIOL CHEM, V283, P36344, DOI 10.1074/jbc.M803580200	57	72	77	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5921	5933		10.1074/jbc.M110.179101	http://dx.doi.org/10.1074/jbc.M110.179101			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21159778	Green Published, hybrid			2022-12-27	WOS:000287230600101
J	Frank, DJ; Denisov, IG; Sligar, SG				Frank, Daniel J.; Denisov, Ilia G.; Sligar, Stephen G.			Analysis of Heterotropic Cooperativity in Cytochrome P450 3A4 Using alpha-Naphthoflavone and Testosterone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; DRUG-INTERACTIONS; ACTIVE-SITE; IN-VITRO; KINETICS; CYP3A4; MODEL; P450; MODULATION; ACTIVATION	Cytochrome P450 3A4 (CYP3A4) displays non-Michaelis-Menten kinetics for many of the substrates it metabolizes, including testosterone (TST) and alpha-naphthoflavone (ANF). Heterotropic effects between these two substrates can further complicate the metabolic profile of the enzyme. In this work, monomeric CYP3A4 solubilized in Nanodiscs has been studied for its ability to interact with varying molar ratios of ANF and TST. Comparison of the observed heme spin state, NADPH consumption, and product formation rates with a non-cooperative model calculated from a linear combination of the global analysis of each substrate reveals a detailed landscape of the heterotropic interactions and indicates negligible binding cooperativity between ANF and TST. The observed effect of ANF on the kinetics of TST metabolism is due to the additive action of the second substrate with no specific allosteric effects.	[Frank, Daniel J.; Denisov, Ilia G.; Sligar, Stephen G.] Univ Illinois, Dept Biochem, Sch Mol & Cellular Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Sligar, SG (corresponding author), Univ Illinois, Dept Biochem, Sch Mol & Cellular Biol, 116 Morrill Hall,505 S Goodwin Ave, Urbana, IL 61801 USA.	s-sligar@uiuc.edu	Frank, Daniel/G-5821-2010; Denisov, Ilia G/J-6590-2013	Frank, Daniel/0000-0003-0063-7557; Denisov, Ilia G/0000-0002-7878-2626; Frank, Daniel/0000-0002-9774-5580	National Institutes of Health [GM31756, GM33775]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031756, R37GM031756, R01GM033775] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31756 and GM33775 (to S. G. S.).	Atkins WM, 2006, EXPERT OPIN DRUG MET, V2, P573, DOI 10.1517/17425255.2.4.573; Atkins WM, 2005, ANNU REV PHARMACOL, V45, P291, DOI 10.1146/annurev.pharmtox.45.120403.100004; Baas BJ, 2004, ARCH BIOCHEM BIOPHYS, V430, P218, DOI 10.1016/j.abb.2004.07.003; Borek-Dohalska L, 2010, COLLECT CZECH CHEM C, V75, P201, DOI 10.1135/cccc2009525; Davydov DR, 2008, EXPERT OPIN DRUG MET, V4, P1523, DOI 10.1517/17425250802500028 ; Denisov IG, 2007, J BIOL CHEM, V282, P7066, DOI 10.1074/jbc.M609589200; Denisov IG, 2011, BBA-PROTEINS PROTEOM, V1814, P223, DOI 10.1016/j.bbapap.2010.05.017; Denisov IG, 2009, PHARMACOL THERAPEUT, V124, P151, DOI 10.1016/j.pharmthera.2009.05.011; Di Cera E., 1995, THERMODYNAMIC THEORY; Domanski TL, 2000, J PHARMACOL EXP THER, V293, P585; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Frank DJ, 2009, ARCH BIOCHEM BIOPHYS, V488, P146, DOI 10.1016/j.abb.2009.06.013; Grinkova YV, 2010, BIOCHEM BIOPH RES CO, V398, P194, DOI 10.1016/j.bbrc.2010.06.058; Guengerich F. P., 2005, CYTOCHROME P450 STRU, P337; Harlow GR, 1998, P NATL ACAD SCI USA, V95, P6636, DOI 10.1073/pnas.95.12.6636; Hosea NA, 2000, BIOCHEMISTRY-US, V39, P5929, DOI 10.1021/bi992765t; Isin EM, 2006, J BIOL CHEM, V281, P9127, DOI 10.1074/jbc.M511375200; Kenworthy KE, 2001, DRUG METAB DISPOS, V29, P1644; Klotz I. M., 1997, LIGAND RECEPTOR ENER; Nath A, 2007, J BIOL CHEM, V282, P28309, DOI 10.1074/jbc.M703568200; SCHWAB GE, 1988, MOL PHARMACOL, V33, P493; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; SHOU M, 1994, BIOCHEMISTRY-US, V33, P6450, DOI 10.1021/bi00187a009; Shou M, 2001, J BIOL CHEM, V276, P2256, DOI 10.1074/jbc.M008799200; Sligar SG, 2007, DRUG METAB REV, V39, P567, DOI 10.1080/03602530701498521; STRAUME M, 1992, METHOD ENZYMOL, V210, P117; Tellinghuisen J, 2009, METHOD ENZYMOL, V467, P499, DOI 10.1016/S0076-6879(09)67019-1; Tsalkova TN, 2007, BIOCHEMISTRY-US, V46, P106, DOI 10.1021/bi061944p; Ueng YF, 1997, BIOCHEMISTRY-US, V36, P370, DOI 10.1021/bi962359z; Wienkers LC, 2005, NAT REV DRUG DISCOV, V4, P825, DOI 10.1038/nrd1851; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736	31	27	27	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5540	5545		10.1074/jbc.M110.182055	http://dx.doi.org/10.1074/jbc.M110.182055			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21177853	Green Published, hybrid			2022-12-27	WOS:000287230600063
J	Jeon, Y; Ko, E; Lee, KY; Ko, MJ; Park, SY; Kang, J; Jeon, CH; Lee, H; Hwang, DS				Jeon, Yoon; Ko, Eun; Lee, Kyung Yong; Ko, Min Ji; Park, Seo Young; Kang, Jeeheon; Jeon, Chang Hwan; Lee, Ho; Hwang, Deog Su			TopBP1 Deficiency Causes an Early Embryonic Lethality and Induces Cellular Senescence in Primary Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTAINING PROTEIN TOPBP1; S-PHASE CHECKPOINT; DNA-REPLICATION; BUDDING YEAST; GENOME INTEGRITY; DAMAGE RESPONSE; ATR; PHOSPHORYLATION; DOMAIN; ACTIVATION	TopBP1 plays important roles in chromosome replication, DNA damage response, and other cellular regulatory functions in vertebrates. Although the roles of TopBP1 have been studied mostly in cancer cell lines, its physiological function remains unclear in mice and untransformed cells. We generated conditional knock-out mice in which exons 5 and 6 of the TopBP1 gene are flanked by loxP sequences. Although TopBP1-deficient embryos developed to the blastocyst stage, no homozygous mutant embryos were recovered at E8.5 or beyond, and completely resorbed embryos were frequent at E7.5, indicating that mutant embryos tend to die at the peri-implantation stage. This finding indicated that TopBP1 is essential for cell proliferation during early embryogenesis. Ablation of TopBP1 in TopBP1(flox/flox) mouse embryonic fibroblasts and 3T3 cells using Cre recombinase-expressing retrovirus arrests cell cycle progression at the G(1), S, and G(2)/M phases. The TopBP1-ablated mouse cells exhibit phosphorylation of H2AX and Chk2, indicating that the cells contain DNA breaks. The TopBP1-ablated mouse cells enter cellular senescence. Although RNA interference-mediated knockdown of TopBP1 induced cellular senescence in human primary cells, it induced apoptosis in cancer cells. Therefore, TopBP1 deficiency in untransformed mouse and human primary cells induces cellular senescence rather than apoptosis. These results indicate that TopBP1 is essential for cell proliferation and maintenance of chromosomal integrity.	[Ko, Eun; Lee, Kyung Yong; Ko, Min Ji; Kang, Jeeheon; Hwang, Deog Su] Seoul Natl Univ, Dept Biol Sci, Seoul 151742, South Korea; [Lee, Ho] Natl Canc Ctr, Canc Expt Resources Branch, Goyang Si 410769, Gyeonggi Do, South Korea	Seoul National University (SNU); National Cancer Center - Korea (NCC)	Hwang, DS (corresponding author), Seoul Natl Univ, Dept Biol Sci, Seoul 151742, South Korea.	dshwang@snu.ac.kr			Brain Korea 21 Project; Ministry of Education, Science, and Technology [2010-0002209, 0020879, 0029782]; National Cancer Center of Korea [NCC-0810082]; government of Korea [2009-0053226]; National Research Foundation of Korea [2009-0078699]	Brain Korea 21 Project(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Cancer Center of Korea; government of Korea(Korean Government); National Research Foundation of Korea(National Research Foundation of Korea)	Supported by the second stage of the Brain Korea 21 Project.; Supported by the Pioneer Research Center Program (2010-0002209, 0020879, 0029782) through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology and by the National Cancer Center of Korea (NCC-0810082). To whom correspondence may be addressed. E-mail: ho25lee@ncc.re.kr.; Supported by grants from the National Research Foundation Grant funded by the government of Korea (2009-0053226) and the Nuclear R&D Program of the National Research Foundation of Korea (2009-0078699). To whom correspondence may be addressed. E-mail: dshwang@snu.ac.kr.	Balestrini A, 2010, NAT CELL BIOL, V12, P484, DOI 10.1038/ncb2050; Chen QM, 2000, J CELL SCI, V113, P4087; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Dunn KL, 2005, ONCOGENE, V24, P3492, DOI 10.1038/sj.onc.1208521; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; Hammet A, 2007, EMBO REP, V8, P851, DOI 10.1038/sj.embor.7401036; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; Hwang ES, 2009, CELL MOL LIFE SCI, V66, P2503, DOI 10.1007/s00018-009-0034-2; Jeon Y, 2007, J BIOL CHEM, V282, P14882, DOI 10.1074/jbc.M609116200; Kim JE, 2005, MOL CELL BIOL, V25, P10907, DOI 10.1128/MCB.25.24.10907-10915.2005; Kumagai A, 2010, CELL, V140, P349, DOI 10.1016/j.cell.2009.12.049; Lee H, 2006, MOL CELL BIOL, V26, P5373, DOI 10.1128/MCB.00043-06; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Liu K, 2004, GENE DEV, V18, P673, DOI 10.1101/gad.1180204; Liu K, 2003, MOL CELL BIOL, V23, P3287, DOI 10.1128/MCB.23.9.3287-3304.2003; Liu K, 2006, EMBO J, V25, P4795, DOI 10.1038/sj.emboj.7601355; Liu K, 2009, MOL CELL BIOL, V29, P2673, DOI 10.1128/MCB.01140-08; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Liu S, 2006, MOL CELL BIOL, V26, P6056, DOI 10.1128/MCB.00492-06; Makiniemi M, 2001, J BIOL CHEM, V276, P30399, DOI 10.1074/jbc.M102245200; Morishima K, 2007, BIOCHEM BIOPH RES CO, V362, P872, DOI 10.1016/j.bbrc.2007.08.086; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; Nowak RA, 1999, BIOL REPROD, V60, P85, DOI 10.1095/biolreprod60.1.85; Olson E, 2007, J BIOL CHEM, V282, P22939, DOI 10.1074/jbc.M702162200; Perera D, 2004, MOL BIOL CELL, V15, P1568, DOI 10.1091/mbc.E03-06-0444; Sansam CL, 2010, GENE DEV, V24, P183, DOI 10.1101/gad.1860310; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Taylor RM, 2000, MOL CELL BIOL, V20, P735, DOI 10.1128/MCB.20.2.735-740.2000; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Wakeman TP, 2006, MUTAT RES-GEN TOX EN, V610, P14, DOI 10.1016/j.mrgentox.2006.06.007; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Williams JS, 2010, EMBO J, V29, P1136, DOI 10.1038/emboj.2009.413; Xu C, 2008, J MOL BIOL, V381, P361, DOI 10.1016/j.jmb.2008.05.087; Yamane K, 1999, ONCOGENE, V18, P5194, DOI 10.1038/sj.onc.1202922; Yamane K, 2002, MOL CELL BIOL, V22, P555, DOI 10.1128/MCB.22.2.555-566.2002; Yan S, 2006, J CELL BIOL, V173, P181, DOI 10.1083/jcb.200601076; Yoo HY, 2009, MOL BIOL CELL, V20, P2351, DOI 10.1091/mbc.E08-12-1190; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zheng P, 2005, BIOL REPROD, V72, P1359, DOI 10.1095/biolreprod.104.039073	44	47	47	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5414	5422		10.1074/jbc.M110.189704	http://dx.doi.org/10.1074/jbc.M110.189704			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21149450	Green Published, hybrid			2022-12-27	WOS:000287230600050
J	Bjorklund, CC; Ma, WC; Wang, ZQ; Davis, RE; Kuhn, DJ; Kornblau, SM; Wang, M; Shah, JJ; Orlowski, RZ				Bjorklund, Chad C.; Ma, Wencai; Wang, Zhi-Qiang; Davis, R. Eric; Kuhn, Deborah J.; Kornblau, Steven M.; Wang, Michael; Shah, Jatin J.; Orlowski, Robert Z.			Evidence of a Role for Activation of Wnt/beta-Catenin Signaling in the Resistance of Plasma Cells to Lenalidomide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REFRACTORY MULTIPLE-MYELOMA; MEDIATED DRUG-RESISTANCE; SYNTHASE KINASE 3; PLUS DEXAMETHASONE; COMBINATION THERAPY; THALIDOMIDE; PATHWAY; MECHANISM; ADHESION; WNT	Lenalidomide plays an important role in our chemotherapeutic armamentarium against multiple myeloma, in part by exerting direct anti-proliferative and pro-apoptotic effects. Unfortunately, long-term exposure leads to the development of drug resistance through unknown mechanisms, and we therefore sought to identify pathways that could be responsible for this phenotype. Chronic drug exposure produced myeloma cell lines that were tolerant of the direct effects of lenalidomide, with a degree of resistance of up to 2,500-fold. Gene expression profiling and pathway analysis identified dysregulation of the Wnt/beta-catenin pathway as a consistent change across four independent cell isolates, and a pair of primary plasma cell samples. Acute drug treatment also increased beta-catenin transcription by 3-fold or more, and both acute and chronic exposure resulted in enhanced accumulation of beta-catenin protein by up to 20-fold or more. This produced Wnt/beta-catenin pathway activation, as judged by increased activity of a lymphoid enhancer factor/T-cell factor promoter reporter, and enhanced accumulation of the downstream targets cyclin D1 and c-Myc. Components of the beta-catenin destruction complex were also impacted by lenalidomide, which suppressed casein kinase 1 alpha expression while augmenting glycogen synthase kinase 3 alpha/beta phosphorylation. Stimulation of Wnt/beta-catenin signaling with recombinant Wnt-3a, or by overexpression of beta-catenin, reduced the anti-proliferative activity of lenalidomide. Conversely, suppression of beta-catenin with small hairpin RNAs restored plasma cell sensitivity to lenalidomide. Together, these findings support the hypothesis that lenalidomide mediates activation of Wnt/beta-catenin signaling in plasma cells as a mechanism of inducible chemoresistance through effects at the transcriptional and post-translational levels.	[Bjorklund, Chad C.; Ma, Wencai; Wang, Zhi-Qiang; Davis, R. Eric; Kuhn, Deborah J.; Wang, Michael; Shah, Jatin J.; Orlowski, Robert Z.] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA; [Kornblau, Steven M.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Kornblau, Steven M.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Orlowski, Robert Z.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Orlowski, RZ (corresponding author), 1515 Holcombe Blvd,Unit 429, Houston, TX 77030 USA.	rorlowsk@mdanderson.org	Ma, Wencai/K-3684-2013; Bjorklund, Chad/G-3645-2013	Orlowski, Robert/0000-0002-5723-4129	Multiple Myeloma Research Foundation; National Institutes of Health, NCI [CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Multiple Myeloma Research Foundation; National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Leukemia and Lymphoma Society Scholar in Clinical Research, supported by a Multiple Myeloma Research Foundation Senior Research Award.; All flow cytometry experiments were performed at The University of Texas M. D. Anderson Cancer Center Flow Cytometry and Cellular Imaging Center, supported by National Institutes of Health Grant CA16672 from the NCI.	Aguilera Oscar, 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P13; Bandapalli OR, 2009, J PATHOL, V218, P370, DOI 10.1002/path.2539; Chanan-Khan AA, 2008, J CLIN ONCOL, V26, P1544, DOI 10.1200/JCO.2007.14.5367; Cimbora-Zovko T, 2007, EUR J PHARMACOL, V558, P27, DOI 10.1016/j.ejphar.2006.11.077; Colla S, 2007, BLOOD, V109, P4470, DOI 10.1182/blood-2006-11-056747; Dalton WS, 2003, CANCER TREAT REV, V29, P1, DOI 10.1016/S0305-7372(03)00078-1; De Toni F, 2006, ONCOGENE, V25, P3113, DOI 10.1038/sj.onc.1209346; Dimopoulos M, 2007, NEW ENGL J MED, V357, P2123, DOI 10.1056/NEJMoa070594; Escoubet-Lozach L, 2009, CANCER RES, V69, P7347, DOI 10.1158/0008-5472.CAN-08-4898; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Flahaut M, 2009, ONCOGENE, V28, P2245, DOI 10.1038/onc.2009.80; Fulciniti M, 2009, BLOOD, V114, P371, DOI 10.1182/blood-2008-11-191577; Gandhi AK, 2006, LEUKEMIA RES, V30, P849, DOI 10.1016/j.leukres.2006.01.010; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; Gunn WG, 2006, STEM CELLS, V24, P986, DOI 10.1634/stemcells.2005-0220; Hazlehurst LA, 2001, CANCER METAST REV, V20, P43, DOI 10.1023/A:1013156407224; Hideshima T, 2000, BLOOD, V96, P2943, DOI 10.1182/blood.V96.9.2943; Kikuchi A, 2003, CANCER SCI, V94, P225, DOI 10.1111/j.1349-7006.2003.tb01424.x; Knobloch J, 2008, CELL CYCLE, V7, P1121, DOI 10.4161/cc.7.9.5793; Knobloch J, 2007, FASEB J, V21, P1410, DOI 10.1096/fj.06-7603com; Knobloch J, 2008, MOL PHARMACEUT, V5, P1138, DOI 10.1021/mp8001232; Kobune M, 2007, MOL CANCER THER, V6, P1774, DOI 10.1158/1535-7163.MCT-06-0684; Kumar G, 2009, CANCER CHEMOTH PHARM, V63, P1171, DOI 10.1007/s00280-008-0867-7; Li QJ, 2004, GENOMICS, V83, P231, DOI 10.1016/j.ygeno.2003.08.004; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mateos M.V., 2009, BLOOD, V114; MCCARTHY PL, 2009, BLOOD, V114; Noda T, 2009, BRIT J CANCER, V100, P1647, DOI 10.1038/sj.bjc.6605064; Palumbo A, 2009, BLOOD, P114; Podar K, 2009, LEUKEMIA, V23, P10, DOI 10.1038/leu.2008.259; Quach H, 2010, LEUKEMIA, V24, P22, DOI 10.1038/leu.2009.236; Rajkumar SV, 2010, LANCET ONCOL, V11, P29, DOI 10.1016/S1470-2045(09)70284-0; Rajkumar SV, 2005, BLOOD, V106, P4050, DOI 10.1182/blood-2005-07-2817; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Richardson P, 2009, BLOOD, V114, P772, DOI 10.1182/blood-2008-12-196238; Richardson PG, 2005, ONCOLOGY-NY, V19, P1781; Richardson PG, 2002, BLOOD, V100, P3063, DOI 10.1182/blood-2002-03-0996; Shah JJ, 2009, LEUKEMIA, V23, P1964, DOI 10.1038/leu.2009.173; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Suppiah R, 2006, CLIN LYMPHOMA MYELOM, V6, P301, DOI 10.3816/CLM.2006.n.004; Vallet S, 2008, LEUKEMIA LYMPHOMA, V49, P1238, DOI 10.1080/10428190802005191; Verhelle D, 2007, CANCER RES, V67, P746, DOI 10.1158/0008-5472.CAN-06-2317; Weber DM, 2007, NEW ENGL J MED, V357, P2133, DOI 10.1056/NEJMoa070596; Yata K, 2003, INT J ONCOL, V22, P165	45	94	99	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11009	11020		10.1074/jbc.M110.180208	http://dx.doi.org/10.1074/jbc.M110.180208			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21189262	hybrid, Green Published			2022-12-27	WOS:000288797100013
J	Patrick, M; Korotkov, KV; Hol, WGJ; Sandkvist, M				Patrick, Marcella; Korotkov, Konstantin V.; Hol, Wim G. J.; Sandkvist, Maria			Oligomerization of EpsE Coordinates Residues from Multiple Subunits to Facilitate ATPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II SECRETION SYSTEM; PILUS RETRACTION MOTOR; VIBRIO-CHOLERAE; PROTEIN-SECRETION; CRYSTAL-STRUCTURE; PSEUDOMONAS-AERUGINOSA; CYTOPLASMIC DOMAIN; OUTER-MEMBRANE; IV SECRETION; IDENTIFICATION	EpsE is an ATPase that powers transport of cholera toxin and hydrolytic enzymes through the Type II secretion (T2S) apparatus in the Gram-negative bacterium, Vibrio cholerae. On the basis of structures of homologous Type II/IV secretion ATPases and our biochemical data, we believe that EpsE is active as an oligomer, likely a hexamer, and the binding, hydrolysis, and release of nucleotide cause EpsE to undergo dynamic structural changes, thus converting chemical energy to mechanical work, ultimately resulting in extracellular secretion. The conformational changes that occur as a consequence of nucleotide binding would realign conserved arginines (Arg(210), Arg(225), Arg(320), Arg(324), Arg(336), and Arg(369)) from adjoining domains and subunits to complete the active site around the bound nucleotide. Our data suggest that these arginines are essential for ATP hydrolysis, although their roles in shaping the active site of EpsE are varied. Specifically, we have shown that replacements of these arginine residues abrogate the T2S process due to a reduction of ATPase activity yet do not have any measurable effect on nucleotide binding or oligomerization of EpsE. We have further demonstrated that point mutations in the EpsE intersubunit interface also reduce ATPase activity without disrupting oligomerization, strengthening the idea that residues from multiple subunits must precisely interact in order for EpsE to be sufficiently active to support T2S. Our findings suggest that the action of EpsE is similar to that of other Type II/IV secretion ATPase family members, and thus these results may be widely applicable to the family as a whole.	[Patrick, Marcella; Sandkvist, Maria] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48105 USA; [Korotkov, Konstantin V.; Hol, Wim G. J.] Univ Washington, Dept Biochem, Biomol Struct Ctr, Seattle, WA 98195 USA	University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle	Sandkvist, M (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48105 USA.	mariasan@umich.edu		Korotkov, Konstantin/0000-0002-2182-6843	National Institutes of Health [RO1AI049294]; NIAID [RO1AI34501]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034501, R01AI049294, R56AI034501] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1AI049294 (to M. S.) and RO1AI34501 (to W. G. J. H.) from the NIAID.	Abendroth J, 2005, J MOL BIOL, V348, P845, DOI 10.1016/j.jmb.2005.02.061; Abendroth J, 2004, J MOL BIOL, V344, P619, DOI 10.1016/j.jmb.2004.09.062; Camberg JL, 2005, J BACTERIOL, V187, P249, DOI 10.1128/JB.187.1.249-256.2005; Camberg JL, 2007, EMBO J, V26, P19, DOI 10.1038/sj.emboj.7601481; Chiang P, 2008, MICROBIOL-SGM, V154, P114, DOI 10.1099/mic.0.2007/011320-0; Cianciotto NP, 2005, TRENDS MICROBIOL, V13, P581, DOI 10.1016/j.tim.2005.09.005; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003; Gray MD, 2011, MOL MICROBIOL, V79, P786, DOI 10.1111/j.1365-2958.2010.07487.x; Hare S, 2007, EMBO J, V26, P4926, DOI 10.1038/sj.emboj.7601904; Hare S, 2006, J MOL BIOL, V360, P56, DOI 10.1016/j.jmb.2006.04.060; HOBBS M, 1993, MOL MICROBIOL, V10, P233, DOI 10.1111/j.1365-2958.1993.tb01949.x; Johnson TL, 2007, J BACTERIOL, V189, P9082, DOI 10.1128/JB.01256-07; Johnson TL, 2006, FEMS MICROBIOL LETT, V255, P175, DOI 10.1111/j.1574-6968.2006.00102.x; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Lybarger SR, 2009, J BACTERIOL, V191, P3149, DOI 10.1128/JB.01701-08; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Misic AM, 2010, J MOL BIOL, V400, P1011, DOI 10.1016/j.jmb.2010.05.066; Peabody CR, 2003, MICROBIOL-SGM, V149, P3051, DOI 10.1099/mic.0.26364-0; Planet PJ, 2001, P NATL ACAD SCI USA, V98, P2503, DOI 10.1073/pnas.051436598; POSSOT O, 1994, MOL MICROBIOL, V12, P287, DOI 10.1111/j.1365-2958.1994.tb01017.x; Py B, 2001, EMBO REP, V2, P244, DOI 10.1093/embo-reports/kve042; Robert V, 2005, FEMS MICROBIOL LETT, V252, P43, DOI 10.1016/j.femsle.2005.08.029; Robien MA, 2003, J MOL BIOL, V333, P657, DOI 10.1016/j.jmb.2003.07.015; SANDKVIST M, 1993, GENE, V123, P81, DOI 10.1016/0378-1119(93)90543-C; Sandkvist M, 1997, J BACTERIOL, V179, P6994, DOI 10.1128/jb.179.22.6994-7003.1997; SANDKVIST M, 1995, EMBO J, V14, P1664, DOI 10.1002/j.1460-2075.1995.tb07155.x; Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x; Satyshur KA, 2007, STRUCTURE, V15, P363, DOI 10.1016/j.str.2007.01.018; Savvides SN, 2003, EMBO J, V22, P1969, DOI 10.1093/emboj/cdg223; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Shiue SJ, 2007, MOL MICROBIOL, V65, P401, DOI 10.1111/j.1365-2958.2007.05795.x; STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0; Thomsen ND, 2008, MOL MICROBIOL, V69, P1071, DOI 10.1111/j.1365-2958.2008.06364.x; Yamagata A, 2007, EMBO J, V26, P878, DOI 10.1038/sj.emboj.7601544; Yeo HJ, 2000, MOL CELL, V6, P1461, DOI 10.1016/S1097-2765(00)00142-8	36	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10378	10386		10.1074/jbc.M110.167031	http://dx.doi.org/10.1074/jbc.M110.167031			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21209100	Green Published, hybrid			2022-12-27	WOS:000288547000054
J	Wang, KH; Li, P; Dong, YY; Cai, X; Hou, DX; Guo, JG; Yin, YA; Zhang, YJ; Li, J; Liang, HW; Yu, BW; Chen, JN; Zen, K; Zhang, JF; Zhang, CY; Chen, X				Wang, Kehui; Li, Peng; Dong, Yanye; Cai, Xing; Hou, Dongxia; Guo, Jigang; Yin, Yuan; Zhang, Yujing; Li, Jing; Liang, Hongwei; Yu, Bowen; Chen, Jiangning; Zen, Ke; Zhang, Junfeng; Zhang, Chen-Yu; Chen, Xi			A Microarray-based Approach Identifies ADP Ribosylation Factor-like Protein 2 as a Target of microRNA-16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEINS; MESSENGER-RNA; COFACTOR-D; FAMILY; ARL2; EXPRESSION; BIOGENESIS; DYNAMICS; CLEAVAGE; GENES	microRNAs (miRNAs) are generally thought to negatively regulate the expression of their target genes by mRNA degradation or by translation repression. Here we show an efficient way to identify miRNA target genes by screening alterations in global mRNA levels following changes in miRNA levels. In this study, we used mRNA microarrays to measure global mRNA expression in three cell lines with increased or decreased levels of miR-16 and performed bioinformatics analysis based on multiple target prediction algorithms. For further investigation among the predicted miR-16 target genes, we selected genes that show an expression pattern opposite to that of miR-16. One of the candidate target genes that may interact with miR-16, ADP-ribosylation factor-like protein 2 (ARL2), was further investigated. First, ARL2 was deduced to be an ideal miR-16 target by computational predictions. Second, ARL2 mRNA and protein levels were significantly abolished by treatment with miR-16 precursors, whereas a miR-16 inhibitor increased ARL2 mRNA and protein levels. Third, a luciferase reporter assay confirmed that miR-16 directly recognizes the 3'-untranslated region (3'-UTR) of ARL2. Finally, we showed that miR-16 could regulate proliferation and induce a significant G0/G1 cell cycle arrest, which was due at least in part, to the down-regulation of ARL2. In summary, the present study suggests that integrating global mRNA profiling and bioinformatics tools may provide the basis for further investigation of the potential targets of a given miRNA. These results also illustrate a novel function of miR-16 targeting ARL2 in modulating proliferation and cell cycle progression.	[Wang, Kehui; Li, Peng; Dong, Yanye; Cai, Xing; Hou, Dongxia; Guo, Jigang; Yin, Yuan; Zhang, Yujing; Li, Jing; Liang, Hongwei; Yu, Bowen; Chen, Jiangning; Zen, Ke; Zhang, Junfeng; Zhang, Chen-Yu; Chen, Xi] Nanjing Univ, Jiangsu Diabet Ctr, State Key Lab Pharmaceut Biotechnol, Sch Life Sci, Nanjing 210093, Jiangsu, Peoples R China	Nanjing University	Zen, K (corresponding author), Nanjing Univ, Jiangsu Diabet Ctr, State Key Lab Pharmaceut Biotechnol, Sch Life Sci, Nanjing 210093, Jiangsu, Peoples R China.	kzen@nju.edu.cn; jfzhang@nju.edu.cn; cyzhang@nju.edu.cn; xichensunny@gmail.com	殷, 媛/GSE-4523-2022; Yin, Yuan/AAG-1707-2020		National Natural Science Foundation of China [90813035, 81070653, 30890044, 30771036, 30772484, 30725008, 30890032, 31071232, 90608010]; National Basic Research Program of China (973 Program) [2006CB503908, 2006CB503909, 2007CB815701, 2007CB815703, 2007CB815705, 2007CB815804]; Chinese 863 program [2006AA02Z177, 2006AA10A121]; "111" Project; Chinese Academy of Science [GJHZ0701-6, KSCX2-YWN-023]; Natural Science Foundation of Jiangsu Province [BK2006714]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Chinese 863 program(National High Technology Research and Development Program of China); "111" Project(Ministry of Education, China - 111 Project); Chinese Academy of Science(Chinese Academy of Sciences); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by Grants from the National Natural Science Foundation of China (Nos. 90813035, 81070653, 30890044, 30771036, 30772484, 30725008, 30890032, 31071232, 90608010), National Basic Research Program of China (973 Program) (Nos. 2006CB503908, 2006CB503909, 2007CB815701, 2007CB815703, 2007CB815705, 2007CB815804), the Chinese 863 program (2006AA02Z177, 2006AA10A121), the "111" Project, the Chinese Academy of Science (GJHZ0701-6, KSCX2-YWN-023), and the Natural Science Foundation of Jiangsu Province (No. BK2006714).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Antoshechkin I, 2002, DEV CELL, V2, P579, DOI 10.1016/S1534-5807(02)00146-6; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen RW, 2008, BLOOD, V112, P822, DOI 10.1182/blood-2008-03-142182; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Hoyt MA, 1997, GENETICS, V146, P849; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kahn RA, 2005, BIOCHEM SOC T, V33, P1269, DOI 10.1042/BST0331269; KAHN RA, 1991, J BIOL CHEM, V266, P2606; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; McElver J, 2000, PLANT CELL, V12, P1379, DOI 10.1105/tpc.12.8.1379; Radcliffe PA, 2000, FEBS LETT, V468, P84, DOI 10.1016/S0014-5793(00)01202-3; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sharer JD, 2002, MOL BIOL CELL, V13, P71, DOI 10.1091/mbc.01-05-0245; Shern JF, 2003, J BIOL CHEM, V278, P40829, DOI 10.1074/jbc.M308678200; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yu ZR, 2005, BIOL REPROD, V73, P427, DOI 10.1095/biolreprod.105.040998; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929	30	25	25	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9468	9476		10.1074/jbc.M110.178335	http://dx.doi.org/10.1074/jbc.M110.178335			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21199864	Green Published, hybrid			2022-12-27	WOS:000288247700074
J	He, P; Laidlaw, T; Maekawa, A; Kanaoka, Y; Xu, KY; Lam, BK				He, Ping; Laidlaw, Tanya; Maekawa, Akiko; Kanaoka, Yoshihide; Xu, Kongyi; Lam, Bing K.			Oxidative Stress Suppresses Cysteinyl Leukotriene Generation by Mouse Bone Marrow-derived Mast Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; MOLECULAR-CLONING; 5-LIPOXYGENASE; GLUTATHIONE; PROTEIN; EXPRESSION; ACID; PURIFICATION; INFLAMMATION; MEDIATORS	Cysteinyl leukotrienes and oxidative stress have both been implicated in bronchial asthma; however, there is no previous study that focused on the ability of oxidative stress to alter cysteinyl leukotriene generation. In this study, treatment of bone marrow-derived mast cells with prostaglandin D-2 reduced their ability to generate leukotriene (LT) C-4 upon calcium ionophore stimulation but had little effect on LTB4 generation. This effect could be reproduced by a selective agonist of the DP2 receptor, 15R-methyl prostaglandin D-2 (15R-D-2). 15R-D-2 dose-dependently inhibited LTC4 generation with an IC50 of 2 mu M, and the effect was not altered by a DP2/thromboxane antagonist or by a peroxisome proliferator-activated receptor-gamma antagonist. 15R-D-2 exerted its suppressive effect via a reduction in intracellular GSH, a mechanism that involved the conjugation of its non-enzymatic breakdown product to GSH. At 10 mu M, 15R-D-2 reduced LTC4 generation to 10%, intracellular GSH to 50%, and LTC4 synthase (LTC4S) activity to 33.5% of untreated cells without altering immunoreactive LTC4S protein expression or 5-lipoxygenase activity. The effects of 15R-D-2 on LTC4S activity could be partially reversed by reducing reagent. The sulfhydryl-reactive oxidative agent diamide suppressed LTC4S activity and induced a reversible formation of covalent dimer LTC4S. LTC4S bearing a C56S mutation was resistant to the effect of diamide. Covalent dimer LTC4S was observed in nasal polyp biopsies, indicating that dimerization and inactivation of LTC4S can occur at the site of inflammation. These results suggest a cellular redox regulation of LTC4S function through a post-translational mechanism.	[Lam, Bing K.] Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Lam, BK (corresponding author), Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Smith Bldg,Rm 628,1 Jimmy Fund Way, Boston, MA 02115 USA.	blam@rics.bwh.harvard.edu			National Institutes of Health [HL36110, HL082695, HL090630]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090630, P01HL036110, R01HL082695] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL36110, HL082695, and HL090630.	Adamjee J, 2006, J PATHOL, V209, P392, DOI 10.1002/path.1979; Ago H, 2007, NATURE, V448, P609, DOI 10.1038/nature05936; ATSMON J, 1990, CANCER RES, V50, P1879; Banu SK, 2008, ENDOCRINOLOGY, V149, P219, DOI 10.1210/en.2007-1087; BROCK TG, 1994, J BIOL CHEM, V269, P22059; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; DAHLEN SE, 1980, NATURE, V288, P484, DOI 10.1038/288484a0; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Diamant Z, 1997, AM J RESP CRIT CARE, V155, P1247, DOI 10.1164/ajrccm.155.4.9105062; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; FORDHUTCHINSON AW, 1994, ANNU REV BIOCHEM, V63, P383, DOI 10.1146/annurev.bi.63.070194.002123; Fratelli M, 2005, P NATL ACAD SCI USA, V102, P13998, DOI 10.1073/pnas.0504398102; FUNK CD, 1987, P NATL ACAD SCI USA, V84, P6677, DOI 10.1073/pnas.84.19.6677; Hadzic T, 2005, J IMMUNOL, V175, P7965, DOI 10.4049/jimmunol.175.12.7965; HATZELMANN A, 1987, EUR J BIOCHEM, V169, P175, DOI 10.1111/j.1432-1033.1987.tb13595.x; Henderson WR, 2002, AM J RESP CRIT CARE, V165, P108, DOI 10.1164/ajrccm.165.1.2105051; Henderson WR, 1996, J EXP MED, V184, P1483, DOI 10.1084/jem.184.4.1483; Hevko JM, 2002, J BIOL CHEM, V277, P7037, DOI 10.1074/jbc.M108942200; Jakobsson PJ, 1999, PROTEIN SCI, V8, P689, DOI 10.1110/ps.8.3.689; Kanaoka Y, 2001, J BIOL CHEM, V276, P22608, DOI 10.1074/jbc.M103562200; Kim EH, 2006, BIOCHEM PHARMACOL, V72, P1516, DOI 10.1016/j.bcp.2006.07.030; Kim SF, 2005, SCIENCE, V310, P1966, DOI 10.1126/science.1119407; LAITINEN LA, 1993, LANCET, V341, P989, DOI 10.1016/0140-6736(93)91073-U; LAM BK, 1994, P NATL ACAD SCI USA, V91, P7663, DOI 10.1073/pnas.91.16.7663; Luo M, 2004, J BIOL CHEM, V279, P41512, DOI 10.1074/jbc.M312568200; MAROM ZVI, 1982, AM REV RESPIR DIS, V126, P449; Mesquita-Santos FP, 2006, J IMMUNOL, V176, P1326, DOI 10.4049/jimmunol.176.3.1326; Molina DM, 2007, NATURE, V448, P613, DOI 10.1038/nature06009; NICHOLSON DW, 1993, P NATL ACAD SCI USA, V90, P2015, DOI 10.1073/pnas.90.5.2015; Okuno T, 2008, J EXP MED, V205, P759, DOI 10.1084/jem.20072329; PENROSE JF, 1992, P NATL ACAD SCI USA, V89, P11603, DOI 10.1073/pnas.89.23.11603; ROUZER CA, 1986, P NATL ACAD SCI USA, V83, P857, DOI 10.1073/pnas.83.4.857; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Swindle EJ, 2002, J IMMUNOL, V169, P5866, DOI 10.4049/jimmunol.169.10.5866; WEISS JW, 1982, SCIENCE, V216, P196, DOI 10.1126/science.7063880; Werz O, 2000, P NATL ACAD SCI USA, V97, P5261, DOI 10.1073/pnas.050588997; Werz O, 2002, FASEB J, V16, P1441, DOI 10.1096/fj.01-0909fje; Xu L, 2008, J BIOL CHEM, V283, P3077, DOI 10.1074/jbc.M705709200	38	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8277	8286		10.1074/jbc.M110.205567	http://dx.doi.org/10.1074/jbc.M110.205567			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21233206	Green Published, hybrid			2022-12-27	WOS:000288013300057
J	Kubota, T; Matsuoka, M; Xu, SX; Otsuki, N; Takeda, M; Kato, A; Ozato, K				Kubota, Toru; Matsuoka, Mayumi; Xu, Songxiao; Otsuki, Noriyuki; Takeda, Makoto; Kato, Atsushi; Ozato, Keiko			PIASy Inhibits Virus-induced and Interferon-stimulated Transcription through Distinct Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; STAT1-MEDIATED GENE ACTIVATION; TOLL-LIKE RECEPTORS; NEGATIVE REGULATION; SIGNALING PATHWAYS; INNATE IMMUNITY; RIG-I; NUCLEAR-BODIES; RNA HELICASE; SUMO	The protein inhibitor of activated STAT (PIAS) family proteins regulates innate immune responses by controlling transcription induced by Toll-like receptor, RIG-I-like receptor signaling, and JAK/STAT pathways. Here, we show that PIASy negatively regulates type I interferon (IFN) transcription. Virus infection led to enhanced type I IFN induction in PIASy null cells, and conversely PIASy overexpression reduced IFN transcription. A mutation in the LXXLL motif of the SAP domain abolished inhibition of IFN-stimulated gene expression but did not affect virus or Toll-like receptor/RIG-I-like receptor-stimulated IFN transcription, indicating that PIASy employs distinct mechanisms to inhibit virus-induced and IFN-stimulated transcription. SUMO E3 activity was not required for PIASy inhibition of IFN transcription; however, PIASy relied on the SUMO modification mechanism to inhibit IFN transcription, because the activity of the SUMO-interacting motif was required for inhibition, and knockdown of SUMO E2 enzyme UBC9 decreased inhibitory activity of PIASy. Our results demonstrate that PIASy negatively regulates both IFN transcription and IFN-stimulated gene expression through multiple mechanisms utilizing the function of different domains.	[Kubota, Toru; Otsuki, Noriyuki; Takeda, Makoto; Kato, Atsushi] Natl Inst Infect Dis, Dept Virol 3, Tokyo 2080011, Japan; [Matsuoka, Mayumi] Natl Inst Infect Dis, Dept Bacterial Pathogenesis & Infect Control, Tokyo 2080011, Japan; [Xu, Songxiao; Ozato, Keiko] NICHD, Lab Mol Growth Regulat, Genom Differentiat Program, NIH, Bethesda, MD 20892 USA	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Kubota, T (corresponding author), Natl Inst Infect Dis, Dept Virol 3, Tokyo 2080011, Japan.	kubota@nih.go.jp	Takeda, Makoto/J-2550-2018; Xu, Songxiao/L-5737-2019	Takeda, Makoto/0000-0002-8194-7727; 	NICHD; NIH; Ministry of Education, Culture, Sports, Science, and Technology of Japan [22590424]	NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported, in whole or in part, by National Institutes of Health grant from the Intramural Research Program of NICHD and Trans NIH Bio-defense Program. This work was also supported by Grant-in-aid 22590424 for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Akaike T, 2000, FASEB J, V14, P1447, DOI 10.1096/fj.14.10.1447; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Bin L, 2008, TRENDS PHARMACOL SCI, V29, P505, DOI 10.1016/j.tips.2008.07.008; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Durbin JE, 2000, J IMMUNOL, V164, P4220, DOI 10.4049/jimmunol.164.8.4220; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Glass CK, 2000, GENE DEV, V14, P121; Gross M, 2004, ONCOGENE, V23, P3059, DOI 10.1038/sj.onc.1207443; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hengel H, 2005, TRENDS IMMUNOL, V26, P396, DOI 10.1016/j.it.2005.05.004; Hiscott J, 2006, TRENDS MOL MED, V12, P53, DOI 10.1016/j.molmed.2005.12.003; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Jackson PK, 2001, GENE DEV, V15, P3053, DOI 10.1101/gad.955501; Jian Ouyang, 2009, V497, P141, DOI 10.1007/978-1-59745-566-4_9; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kerscher O, 2007, EMBO REP, V8, P550, DOI 10.1038/sj.embor.7400980; Kipp M, 2000, MOL CELL BIOL, V20, P7480, DOI 10.1128/MCB.20.20.7480-7489.2000; Komuro A, 2008, CYTOKINE, V43, P350, DOI 10.1016/j.cyto.2008.07.011; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Kubota T, 2008, J BIOL CHEM, V283, P25660, DOI 10.1074/jbc.M804479200; Levy DE, 2001, CYTOKINE GROWTH F R, V12, P143, DOI 10.1016/S1359-6101(00)00027-7; Liao JY, 2000, P NATL ACAD SCI USA, V97, P5267, DOI 10.1073/pnas.97.10.5267; Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Liu B, 2005, MOL CELL BIOL, V25, P1113, DOI 10.1128/MCB.25.3.1113-1123.2005; Liu B, 2001, P NATL ACAD SCI USA, V98, P3203, DOI 10.1073/pnas.051489598; Liu B, 2007, CELL, V129, P903, DOI 10.1016/j.cell.2007.03.056; Long JY, 2003, P NATL ACAD SCI USA, V100, P9791, DOI 10.1073/pnas.1733973100; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; Moore CB, 2008, IMMUNITY, V28, P735, DOI 10.1016/j.immuni.2008.05.005; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Palvimo JJ, 2007, BIOCHEM SOC T, V35, P1405, DOI 10.1042/BST0351405; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Sakai Y, 1999, FEBS LETT, V456, P221, DOI 10.1016/S0014-5793(99)00960-6; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Sharrocks AD, 2006, GENE DEV, V20, P754, DOI 10.1101/gad.1421006; Shuai K, 2006, CELL RES, V16, P196, DOI 10.1038/sj.cr.7310027; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Tahk S, 2007, P NATL ACAD SCI USA, V104, P11643, DOI 10.1073/pnas.0701877104; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Wang J, 2009, MICROBES INFECT, V11, P321, DOI 10.1016/j.micinf.2008.12.011; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zhang J, 2004, FEBS LETT, V570, P97, DOI 10.1016/j.febslet.2004.05.081; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	54	30	30	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8165	8175		10.1074/jbc.M110.195255	http://dx.doi.org/10.1074/jbc.M110.195255			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21199872	Green Published, hybrid			2022-12-27	WOS:000288013300047
J	Vigetti, D; Clerici, M; Deleonibus, S; Karousou, E; Viola, M; Moretto, P; Heldin, P; Hascall, VC; De Luca, G; Passi, A				Vigetti, Davide; Clerici, Moira; Deleonibus, Sara; Karousou, Evgenia; Viola, Manuela; Moretto, Paola; Heldin, Paraskevi; Hascall, Vincent C.; De Luca, Giancarlo; Passi, Alberto			Hyaluronan Synthesis Is Inhibited by Adenosine Monophosphate-activated Protein Kinase through the Regulation of HAS2 Activity in Human Aortic Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS; INTRACELLULAR HYALURONAN; GLUCOSE DEHYDROGENASE; CHONDROITIN-SULFATE; MOLECULAR-CLONING; SYNTHASE 2; CYCLIN D3; ATHEROSCLEROSIS; PROLIFERATION; EXPRESSION	Hyaluronan (HA) is an extracellular matrix glycosaminoglycan (GAG) involved in cell motility, proliferation, tissue remodeling, development, differentiation, inflammation, tumor progression, and invasion and controls vessel thickening in cardiovascular diseases. Therefore, the control of HA synthesis could permit the fine-tuning of cell behavior, but the mechanisms that regulate HA synthesis are largely unknown. Recent studies suggest that the availability of the nucleotide-sugar precursors has a critical role. Because the formation of UDP-sugars is a highly energetically demanding process, we have analyzed whether the energy status of the cell could control GAG production. AMP-activated protein kinase (AMPK) is the main ATP/AMP sensor of mammalian cells, and we mimicked an energy stress by treating human aortic smooth muscle cells (AoSMCs) with the AMPK activators 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside and metformin. Under these conditions, HA synthesis, but not that of the other GAGs, was greatly reduced. We confirmed the inhibitory effect of AMPK using a specific inhibitor and knock-out cell lines. We found that AMPK phosphorylated Thr-110 of human HAS2, which inhibits its enzymatic activity. In contrast, the other two HAS isoenzymes (HAS1 and HAS3) were not modified by the kinase. The reduction of HA decreased the ability of AoSMCs to proliferate, migrate, and recruit immune cells, thereby reducing the pro-atherosclerotic AoSMC phenotype. Interestingly, such effects were not recovered by treatment with exogenous HA, suggesting that AMPK can block the pro-atherosclerotic signals driven by HA by interaction with its receptors.	[Vigetti, Davide; Clerici, Moira; Deleonibus, Sara; Karousou, Evgenia; Viola, Manuela; Moretto, Paola; De Luca, Giancarlo; Passi, Alberto] Univ Insubria, Dipartimento Sci Biomed Sperimentali & Clin, I-21100 Varese, Italy; [Heldin, Paraskevi] Uppsala Univ, Biomed Ctr, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden; [Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44195 USA	University of Insubria; Ludwig Institute for Cancer Research; Uppsala University; Cleveland Clinic Foundation	Passi, A (corresponding author), Univ Insubria, Dipartimento Sci Biomed Sperimentali & Clin, Via JH Dunant 5, I-21100 Varese, Italy.	alberto.passi@uninsubria.it	passi, alberto g/A-1752-2018; Viola, Manuela/B-7120-2011; Vigetti, Davide/C-9861-2010	passi, alberto g/0000-0003-3328-3089; Viola, Manuela/0000-0002-0634-6390; Vigetti, Davide/0000-0002-6339-8453	Fondazione Comunitaria del Varesotto-ONLUS; Fondo di Ateneo per la Ricerca; Centro Insubre di Biotecnologie per la Salute Umana	Fondazione Comunitaria del Varesotto-ONLUS; Fondo di Ateneo per la Ricerca; Centro Insubre di Biotecnologie per la Salute Umana	This work was supported by the Fondazione Comunitaria del Varesotto-ONLUS, PRIN 2007 (to G. D. L.), Fondo di Ateneo per la Ricerca, and a Centro Insubre di Biotecnologie per la Salute Umana young researcher award (to D. V.).	Athea Y, 2007, DIABETES, V56, P786, DOI 10.2337/db06-0187; BALDUINI C, 1973, BIOCHEM J, V133, P243, DOI 10.1042/bj1330243; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Caride AJ, 1996, BIOCHEM J, V316, P353, DOI 10.1042/bj3160353; Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; de Dios ST, 2007, J DIABETES COMPLICAT, V21, P108, DOI 10.1016/j.jdiacomp.2006.03.003; de la Motte C, 2009, AM J PATHOL, V174, P2254, DOI 10.2353/ajpath.2009.080831; DeGrendele HC, 1997, SCIENCE, V278, P672, DOI 10.1126/science.278.5338.672; Foretz M, 2011, FASEB J, V25, P337, DOI 10.1096/fj.10-169383; Goentzel BJ, 2006, BIOCHEM J, V396, P347, DOI 10.1042/BJ20051782; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; Hedegaard J, 2004, PROTEOMICS, V4, P2448, DOI 10.1002/pmic.200300761; Igata M, 2005, CIRC RES, V97, P837, DOI 10.1161/01.RES.0000185823.73556.06; Jiang D, 2007, ANNU REV CELL DEV BI, V23, P435, DOI 10.1146/annurev.cellbio.23.090506.123337; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Karousou EG, 2005, BIOMED CHROMATOGR, V19, P761, DOI 10.1002/bmc.511; Karousou E, 2010, J BIOL CHEM, V285, P23647, DOI 10.1074/jbc.M110.127050; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Kothapalli D, 2007, J CELL BIOL, V176, P535, DOI 10.1083/jcb.200611058; Laderoute KR, 2006, MOL CELL BIOL, V26, P5336, DOI 10.1128/MCB.00166-06; Motoshima H, 2006, J PHYSIOL-LONDON, V574, P63, DOI 10.1113/jphysiol.2006.108324; Nagata D, 2004, CIRCULATION, V110, P444, DOI 10.1161/01.CIR.0000136025.96811.76; Nardini M, 2004, GENE EXPR PATTERNS, V4, P303, DOI 10.1016/j.modgep.2003.10.006; Ori M, 2006, DEVELOPMENT, V133, P631, DOI 10.1242/dev.02225; Ren J, 2009, J BIOL CHEM, V284, P16621, DOI 10.1074/jbc.M806430200; Riessen R, 1996, CIRCULATION, V93, P1141, DOI 10.1161/01.CIR.93.6.1141; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; TIMAR J, 1995, INT J CANCER, V62, P755, DOI 10.1002/ijc.2910620618; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Vigetti D, 2003, MATRIX BIOL, V22, P511, DOI 10.1016/S0945-053X(03)00082-9; Vigetti D, 2008, J BIOL CHEM, V283, P4448, DOI 10.1074/jbc.M709051200; Vigetti D, 2006, FASEB J, V20, P1118, DOI 10.1096/fj.05-4504com; Vigetti D, 2010, J BIOL CHEM, V285, P24639, DOI 10.1074/jbc.M110.134536; Vigetti D, 2009, J BIOL CHEM, V284, P30684, DOI 10.1074/jbc.M109.040386; Vigetti D, 2009, GLYCOBIOLOGY, V19, P537, DOI 10.1093/glycob/cwp022; Vigetti D, 2008, THESCIENTIFICWORLDJO, V8, P1116, DOI 10.1100/tsw.2008.145; Viola M, 2008, ELECTROPHORESIS, V29, P3168, DOI 10.1002/elps.200700855; Wang AM, 2009, AUTOPHAGY, V5, P864, DOI 10.4161/auto.9041; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; Weigel PH, 2007, J BIOL CHEM, V282, P36777, DOI 10.1074/jbc.R700036200; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505	46	82	86	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7917	7924		10.1074/jbc.M110.193656	http://dx.doi.org/10.1074/jbc.M110.193656			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21228273	Green Published, hybrid			2022-12-27	WOS:000288013300022
J	Heil, A; Nazmi, AR; Koltzscher, M; Poeter, M; Austermann, J; Assard, N; Baudier, J; Kaibuchi, K; Gerke, V				Heil, Annika; Nazmi, Ali Reza; Koltzscher, Max; Poeter, Michaela; Austermann, Judith; Assard, Nicole; Baudier, Jacques; Kaibuchi, Kozo; Gerke, Volker			S100P Is a Novel Interaction Partner and Regulator of IQGAP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRATES CA2+/CALMODULIN; BINDING PROTEIN; B-RAF; CDC42; CALMODULIN; ACTIVATION; MIGRATION; CYTOSKELETON; ADHESION; SCAFFOLD	Ca2+-binding proteins of the S100 family participate in intracellular Ca2+ signaling by binding to and regulating specific cellular targets in their Ca2+-loaded conformation. Because the information on specific cellular targets of different S100 proteins is still limited, we developed an affinity approach that selects for protein targets only binding to the physiologically active dimer of an S100 protein. Using this approach, we here identify IQGAP1 as a novel and dimer-specific target of S100P, a member of the S100 family enriched in the cortical cytoskeleton. The interaction between S100P and IQGAP1 is strictly Ca2+-dependent and characterized by a dissociation constant of 0.2 mu M. Binding occurs primarily through the IQ domain of IQGAP1 and the first EF hand loop of S100P, thus representing a novel structural principle of S100-target protein interactions. Upon cell stimulation, S100P and IQGAP1 co-localize at or in close proximity to the plasma membrane, and complex formation can be linked to altered signal transduction properties of IQGAP1. Specifically, the EGF-induced tyrosine phosphorylation of IQGAP1 that is thought to function in assembling signaling intermediates at IQGAP1 scaffolds in the subplasmalemmal region is markedly reduced in cells overexpressing S100P but not in cells expressing an S100P mutant deficient in IQGAP1 binding. Furthermore, B-Raf binding to IQGAP1 and MEK1/2 activation occurring downstream of IQGAP1 in EGF-triggered signaling cascades are compromised at elevated S100P levels. Thus, S100P is a novel Ca2+-dependent regulator of IQGAP1 that can down-regulate the function of IQGAP1 as a signaling intermediate by direct interaction.	[Heil, Annika; Nazmi, Ali Reza; Koltzscher, Max; Poeter, Michaela; Austermann, Judith; Gerke, Volker] Univ Munster, Inst Med Biochem, Ctr Mol Biol Inflammat, D-48149 Munster, Germany; [Assard, Nicole; Baudier, Jacques] INSERM, U873, Lab Transduct Signal, F-38054 Grenoble, France; [Kaibuchi, Kozo] Nagoya Univ, Dept Cell Pharmacol, Grad Sch Med, Aichi 4668550, Japan	University of Munster; Institut National de la Sante et de la Recherche Medicale (Inserm); Nagoya University	Gerke, V (corresponding author), Univ Munster, Inst Med Biochem, Ctr Mol Biol Inflammat, Von Esmarch Str 56, D-48149 Munster, Germany.	gerke@uni-muenster.de	Baudier, Jacques/O-2183-2016; jacques, baudier/T-3300-2019	Nazmi, Ali Reza/0000-0003-1262-5078; jacques, baudier/0000-0001-8427-4444	Interdisciplinary Centre for Clinical Research of the Muenster University Medical School [Ge2/016/10]	Interdisciplinary Centre for Clinical Research of the Muenster University Medical School	This work was supported by Grant Ge2/016/10 from the Interdisciplinary Centre for Clinical Research of the Muenster University Medical School (to V. G.).	Austermann J, 2008, J BIOL CHEM, V283, P29331, DOI 10.1074/jbc.M806145200; BECKER T, 1992, EUR J BIOCHEM, V207, P541, DOI 10.1111/j.1432-1033.1992.tb17080.x; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Brandt DT, 2007, EMBO REP, V8, P1019, DOI 10.1038/sj.embor.7401089; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; DONATO T, 1999, BIOCHIM BIOPHYS ACTA, V1450, P191; Grohmanova K, 2004, J BIOL CHEM, V279, P48495, DOI 10.1074/jbc.M408113200; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; Johnson M, 2009, CELL SIGNAL, V21, P1471, DOI 10.1016/j.cellsig.2009.02.023; Koltzscher M, 2000, BIOCHEMISTRY-US, V39, P9533, DOI 10.1021/bi000257+; Koltzscher M, 2003, MOL BIOL CELL, V14, P2372, DOI 10.1091/mbc.E02-09-0553; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Li ZG, 2003, J BIOL CHEM, V278, P4347, DOI 10.1074/jbc.M208579200; Mbele GO, 2002, J BIOL CHEM, V277, P49998, DOI 10.1074/jbc.M205363200; Meyer RD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003848; Noritake J, 2005, J CELL SCI, V118, P2085, DOI 10.1242/jcs.02379; Ren JG, 2008, J BIOL CHEM, V283, P22972, DOI 10.1074/jbc.M804626200; Ren JG, 2007, P NATL ACAD SCI USA, V104, P10465, DOI 10.1073/pnas.0611308104; Roy M, 2005, MOL CELL BIOL, V25, P7940, DOI 10.1128/MCB.25.18.7940-7952.2005; Roy M, 2004, J BIOL CHEM, V279, P17329, DOI 10.1074/jbc.M308405200; Sacks DB, 2006, BIOCHEM SOC T, V34, P833, DOI 10.1042/BST0340833; Santamaria-Kisiel L, 2006, BIOCHEM J, V396, P201, DOI 10.1042/BJ20060195; Usatyuk PV, 2009, J BIOL CHEM, V284, P15339, DOI 10.1074/jbc.M109.005439; Weissbach L, 1998, BIOCHEM BIOPH RES CO, V251, P269, DOI 10.1006/bbrc.1998.9371; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; Yamaoka-Tojo M, 2006, ARTERIOSCL THROM VAS, V26, P1991, DOI 10.1161/01.ATV.0000231524.14873.e7; Zimmer DB, 2003, MICROSC RES TECHNIQ, V60, P552, DOI 10.1002/jemt.10297; Zobiack N, 2001, FEBS LETT, V500, P137, DOI 10.1016/S0014-5793(01)02604-7	33	34	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7227	7238		10.1074/jbc.M110.135095	http://dx.doi.org/10.1074/jbc.M110.135095			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177863	Green Published, hybrid			2022-12-27	WOS:000287737300039
J	Yang, M; Ge, W; Chowdhury, R; Claridge, TDW; Kramer, HB; Schmierer, B; McDonough, MA; Gong, LZ; Kessler, BM; Ratcliffe, PJ; Coleman, ML; Schofield, CJ				Yang, Ming; Ge, Wei; Chowdhury, Rasheduzzaman; Claridge, Timothy D. W.; Kramer, Holger B.; Schmierer, Bernhard; McDonough, Michael A.; Gong, Lingzhi; Kessler, Benedikt M.; Ratcliffe, Peter J.; Coleman, Mathew L.; Schofield, Christopher J.			Asparagine and Aspartate Hydroxylation of the Cytoskeletal Ankyrin Family Is Catalyzed by Factor-inhibiting Hypoxia-inducible Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERYTHROCYTE ANION-EXCHANGER; DOMAIN-CONTAINING PROTEINS; KAPPA-B-ALPHA; REPEAT DOMAIN; HIF FIH; TRANSCRIPTIONAL ACTIVITY; TRYPTOPHAN RESIDUES; CYTOPLASMIC DOMAIN; BETA-HYDROXYLATION; CRYSTAL-STRUCTURE	Factor-inhibiting hypoxia-inducible factor (FIH) catalyzes the beta-hydroxylation of an asparagine residue in the C-terminal transcriptional activation domain of the hypoxia inducible factor (HIF), a modification that negatively regulates HIF transcriptional activity. FIH also catalyzes the hydroxylation of highly conserved Asn residues within the ubiquitous ankyrin repeat domain (ARD)-containing proteins. Hydroxylation has been shown to stabilize localized regions of the ARD fold in the case of a three-repeat consensus ankyrin protein, but this phenomenon has not been demonstrated for the extensive naturally occurring ARDs. Here we report that the cytoskeletal ankyrin family are substrates for FIH-catalyzed hydroxylations. We show that the ARD of ankyrinR is multiply hydroxylated by FIH both in vitro and in endogenous proteins purified from human and mouse erythrocytes. Hydroxylation of the D34 region of ankyrinR ARD (ankyrin repeats 13-24) increases its conformational stability and leads to a reduction in its interaction with the cytoplasmic domain of band 3 (CDB3), demonstrating the potential for FIH-catalyzed hydroxylation to modulate protein-protein interactions. Unexpectedly we found that aspartate residues in ankyrinR and ankyrinB are hydroxylated and that FIH-catalyzed aspartate hydroxylation also occurs in other naturally occurring AR sequences. The crystal structure of an FIH variant in complex with an Asp-substrate peptide together with NMR analyses of the hydroxylation product identifies the 3S regio- and stereoselectivity of the FIH-catalyzed Asp hydroxylation, revealing a previously unprecedented posttranslational modification.	[Yang, Ming; Ge, Wei; Chowdhury, Rasheduzzaman; Claridge, Timothy D. W.; McDonough, Michael A.; Gong, Lingzhi; Schofield, Christopher J.] Univ Oxford, Chem Res Lab, Oxford OX1 3TA, England; [Yang, Ming; Ge, Wei; Chowdhury, Rasheduzzaman; Claridge, Timothy D. W.; McDonough, Michael A.; Gong, Lingzhi; Schofield, Christopher J.] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford OX1 3TA, England; [Schmierer, Bernhard] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Schmierer, Bernhard] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England; [Kramer, Holger B.; Kessler, Benedikt M.; Ratcliffe, Peter J.; Coleman, Mathew L.] Univ Oxford, Oxford OX3 7BN, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford; University of Oxford	Schofield, CJ (corresponding author), Univ Oxford, Chem Res Lab, 12 Mansfield Rd, Oxford OX1 3TA, England.	christopher.schofield@chem.ox.ac.uk	McDonough, Michael/N-8913-2019; McDonough, Michael A/G-2744-2013; Coleman, Mathew L/C-1676-2014; Schmierer, Bernhard/P-4208-2019; Kessler, Benedikt/AAY-8614-2021; Kramer, Holger/AAL-4433-2020; Schmierer, Bernhard/C-1416-2009; Claridge, Tim/A-8324-2018; Chowdhury, Rashed/I-7697-2014	McDonough, Michael/0000-0003-4664-6942; McDonough, Michael A/0000-0003-4664-6942; Coleman, Mathew L/0000-0001-6020-9023; Schmierer, Bernhard/0000-0002-9082-7022; Kessler, Benedikt/0000-0002-8160-2446; Kramer, Holger/0000-0002-6400-0945; Schmierer, Bernhard/0000-0002-9082-7022; Claridge, Tim/0000-0001-5583-6460; Chowdhury, Rashed/0000-0002-8058-6149; Schofield, Christopher/0000-0002-0290-6565; Ratcliffe, Peter/0000-0002-2853-806X	Biotechnology and Biological Sciences Research Council; European Union; OAK Foundation; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/G014124/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union(European Commission); OAK Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Biotechnology and Biological Sciences Research Council, the European Union, the OAK Foundation, and the Wellcome Trust.	Anderson LB, 2002, P NATL ACAD SCI USA, V99, P14676, DOI 10.1073/pnas.232591599; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; BENNETT V, 1980, J BIOL CHEM, V255, P2540; Bienvenut WV, 2002, PROTEOMICS, V2, P868, DOI 10.1002/1615-9861(200207)2:7<868::AID-PROT868>3.0.CO;2-D; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; BORK P, 1993, PROTEINS, V17, P363, DOI 10.1002/prot.340170405; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chang SH, 2003, J BIOL CHEM, V278, P6879, DOI 10.1074/jbc.M211137200; Cockman ME, 2006, P NATL ACAD SCI USA, V103, P14767, DOI 10.1073/pnas.0606877103; Cockman ME, 2009, ANN NY ACAD SCI, V1177, P9, DOI 10.1111/j.1749-6632.2009.05042.x; Cockman ME, 2009, MOL CELL PROTEOMICS, V8, P535, DOI 10.1074/mcp.M800340-MCP200; Coleman ML, 2007, J BIOL CHEM, V282, P24027, DOI 10.1074/jbc.M704102200; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; DAVIS L, 1989, J BIOL CHEM, V264, P9665; Ding Y, 2004, PROTEIN EXPRES PURIF, V34, P167, DOI 10.1016/j.pep.2003.10.019; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferguson JE, 2007, MOL CELL BIOL, V27, P6407, DOI 10.1128/MCB.00511-07; Finley EL, 1998, PROTEIN SCI, V7, P2391, DOI 10.1002/pro.5560071116; Flashman E, 2010, BIOCHEM J, V427, P135, DOI 10.1042/BJ20091609; Hardy AP, 2009, J MOL BIOL, V392, P994, DOI 10.1016/j.jmb.2009.07.070; Hewitson KS, 2008, J BIOL CHEM, V283, P25971, DOI 10.1074/jbc.M804999200; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Kelly L, 2009, MOL BIOSYST, V5, P52, DOI 10.1039/b815271c; Kim M, 2010, BIOPHYS J, V98, P3086, DOI 10.1016/j.bpj.2010.02.054; KURODA M, 1975, J BIOCHEM-TOKYO, V78, P641, DOI 10.1093/oxfordjournals.jbchem.a130951; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee G, 2006, NATURE, V440, P246, DOI 10.1038/nature04437; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; McNeill LA, 2002, BIOCHEM J, V367, P571, DOI 10.1042/BJ20021162; MICHAELY P, 1995, J BIOL CHEM, V270, P22050, DOI 10.1074/jbc.270.37.22050; Michaely P, 1992, Trends Cell Biol, V2, P127, DOI 10.1016/0962-8924(92)90084-Z; Michaely P, 2002, EMBO J, V21, P6387, DOI 10.1093/emboj/cdf651; Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604; Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4; Myllyharju J, 2001, ANN MED, V33, P7, DOI 10.3109/07853890109002055; Neidig ML, 2007, J AM CHEM SOC, V129, P14224, DOI 10.1021/ja074557r; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; PREVIERO A, 1967, J MOL BIOL, V24, P261, DOI 10.1016/0022-2836(67)90331-2; PRZYSIECKI CT, 1987, P NATL ACAD SCI USA, V84, P7856, DOI 10.1073/pnas.84.22.7856; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; STENFLO J, 1991, BLOOD, V78, P1637; STENFLO J, 1989, P NATL ACAD SCI USA, V86, P444, DOI 10.1073/pnas.86.2.444; Su Y, 2006, MOL CELL BIOCHEM, V289, P159, DOI 10.1007/s11010-006-9159-x; Sue SC, 2008, J MOL BIOL, V380, P917, DOI 10.1016/j.jmb.2008.05.048; Taylor SW, 2003, J BIOL CHEM, V278, P19587, DOI 10.1074/jbc.C300135200; Truhlar SME, 2008, J MOL BIOL, V380, P67, DOI 10.1016/j.jmb.2008.02.053; Webb JD, 2009, BIOCHEM J, V420, P327, DOI 10.1042/BJ20081905; Werbeck ND, 2007, P NATL ACAD SCI USA, V104, P7863, DOI 10.1073/pnas.0610315104	53	54	58	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7648	7660		10.1074/jbc.M110.193540	http://dx.doi.org/10.1074/jbc.M110.193540			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177872	hybrid, Green Published			2022-12-27	WOS:000287737300078
J	Araki, T; Kusakabe, M; Nishida, E				Araki, Tetsuro; Kusakabe, Morioh; Nishida, Eisuke			A Transmembrane Protein EIG121L Is Required for Epidermal Differentiation during Early Embryonic Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPULSIVE GUIDANCE MOLECULE; TGF-BETA; XENOPUS; CHORDIN; GENE; INHIBITION; INDUCTION; SIGNALS; BINDS; EXPRESSION	Epidermal differentiation in the ventral ectoderm of Xenopus embryos is regulated by the bone morphogenetic protein (BMP) pathway. However, it remains unclear how the BMP pathway is activated and induces the epidermal fate in the ventral ectoderm. Here, we identify a novel player in the BMP pathway that is required for epidermal differentiation during Xenopus early embryonic development. We show that Xenopus EIG121L (xEIG121L) protein, an evolutionarily conserved transmembrane protein, is expressed in the ventral ectoderm at the gastrula and neurula stages. Almost complete knockdown of xEIG121L protein with antisense morpholino oligonucleotides in early Xenopus embryos results in severe developmental defects, including the inhibition of epidermal differentiation and the induction of neural genes. Remarkably, our analysis shows that BMP/Smad1 signaling is severely suppressed in the xEIG121L knockdown ectoderm. Moreover, immunoprecipitation and immunostaining experiments suggest that xEIG121L protein physically interacts, and co-localizes, with BMP receptors. Thus, our results identify a novel regulator of the BMP pathway that has a positive role in BMP signaling and plays an essential role in epidermal differentiation during early embryonic development.	[Kusakabe, Morioh] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan; [Kusakabe, Morioh; Nishida, Eisuke] Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1020075, Japan	Kyoto University; Japan Science & Technology Agency (JST)	Kusakabe, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan.	morioh@lif.kyoto-u.ac.jp; nishida@lif.kyoto-u.ac.jp		Araki, Tetsuro/0000-0001-8933-2156	Kao Foundation for Arts and Sciences; Ministry of Education, Culture, Sports, Science and Technology of Japan; Grants-in-Aid for Scientific Research [22770211, 21227004] Funding Source: KAKEN	Kao Foundation for Arts and Sciences; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Kao Foundation for Arts and Sciences (to M. K.) and the Ministry of Education, Culture, Sports, Science and Technology of Japan (to E. N. and M. K.).	Ambrosio AL, 2008, DEV CELL, V15, P248, DOI 10.1016/j.devcel.2008.06.013; Araki T, 2007, GENE EXPR PATTERNS, V7, P666, DOI 10.1016/j.modgep.2007.03.004; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Babitt JL, 2005, J BIOL CHEM, V280, P29820, DOI 10.1074/jbc.M503511200; De Robertis EM, 2009, MECH DEVELOP, V126, P925, DOI 10.1016/j.mod.2009.08.004; Deng L, 2005, CLIN CANCER RES, V11, P8258, DOI 10.1158/1078-0432.CCR-05-1189; Deng L, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.9; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Fainsod A, 1997, MECH DEVELOP, V63, P39, DOI 10.1016/S0925-4773(97)00673-4; Feledy JA, 1999, DEV BIOL, V212, P455, DOI 10.1006/dbio.1999.9374; Gessert S, 2008, BIOL CELL, V100, P659, DOI 10.1042/BC20080023; GRAFF JM, 1994, CELL, V79, P169, DOI 10.1016/0092-8674(94)90409-X; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Inomata H, 2008, CELL, V134, P854, DOI 10.1016/j.cell.2008.07.008; Lee HX, 2009, GENE DEV, V23, P2551, DOI 10.1101/gad.1839309; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Mizuseki K, 1998, DEVELOPMENT, V125, P579; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nishimoto S, 2007, J BIOL CHEM, V282, P24255, DOI 10.1074/jbc.M704277200; Oelgeschlager M, 2000, NATURE, V405, P757, DOI 10.1038/35015500; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Onichtchouk D, 1996, DEVELOPMENT, V122, P3045; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Suzuki A, 1997, DEVELOPMENT, V124, P3037; SUZUKI A, 1994, P NATL ACAD SCI USA, V91, P10255, DOI 10.1073/pnas.91.22.10255; Tao JN, 2005, DEVELOPMENT, V132, P1021, DOI 10.1242/dev.01641; Wharton K, 2009, DEVELOPMENT, V136, P3691, DOI 10.1242/dev.040584; Wilson NH, 2006, DEV BIOL, V296, P485, DOI 10.1016/j.ydbio.2006.06.018; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	40	5	5	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6760	6768		10.1074/jbc.M110.177907	http://dx.doi.org/10.1074/jbc.M110.177907			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21177533	Green Published, hybrid			2022-12-27	WOS:000287476400083
J	Deleris, P; Trost, M; Topisirovic, I; Tanguay, PL; Borden, KLB; Thibault, P; Meloche, S				Deleris, Paul; Trost, Matthias; Topisirovic, Ivan; Tanguay, Pierre-Luc; Borden, Katherine L. B.; Thibault, Pierre; Meloche, Sylvain			Activation Loop Phosphorylation of ERK3/ERK4 by Group I p21-activated Kinases (PAKs) Defines a Novel PAK-ERK3/4-MAPK-activated Protein Kinase 5 Signaling Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-ACTIN REARRANGEMENT; NUCLEAR EXPORT; ERK3; MK5; EXPRESSION; PROTEIN-KINASE-5; LOCALIZATION; TRANSDUCTION; SPECIFICITY; INVOLVEMENT	Classical mitogen-activated protein (MAP) kinases are activated by dual phosphorylation of the Thr-Xxx-Tyr motif in their activation loop, which is catalyzed by members of the MAP kinase kinase family. The atypical MAP kinases extracellular signal-regulated kinase 3 (ERK3) and ERK4 contain a single phospho-acceptor site in this segment and are not substrates of MAP kinase kinases. Previous studies have shown that ERK3 and ERK4 are phosphorylated on activation loop residue Ser-189/Ser-186, resulting in their catalytic activation. However, the identity of the protein kinase mediating this regulatory event has remained elusive. We have used an unbiased biochemical purification approach to isolate the kinase activity responsible for ERK3 Ser-189 phosphorylation. Here, we report the identification of group I p21-activated kinases (PAKs) as ERK3/ERK4 activation loop kinases. We show that group I PAKs phosphorylate ERK3 and ERK4 on Ser-189 and Ser-186, respectively, both in vitro and in vivo, and that expression of activated Rac1 augments this response. Reciprocally, silencing of PAK1/2/3 expression by RNA interference (RNAi) completely abolishes Rac1-induced Ser-189 phosphorylation of ERK3. Importantly, we demonstrate that PAK-mediated phosphorylation of ERK3/ERK4 results in their enzymatic activation and in downstream activation of MAP kinase-activated protein kinase 5 (MK5) in vivo. Our results reveal that group I PAKs act as upstream activators of ERK3 and ERK4 and unravel a novel PAK-ERK3/ERK4-MK5 signaling pathway.	[Deleris, Paul; Trost, Matthias; Topisirovic, Ivan; Tanguay, Pierre-Luc; Borden, Katherine L. B.; Thibault, Pierre; Meloche, Sylvain] Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ H3C 3J7, Canada; [Tanguay, Pierre-Luc; Meloche, Sylvain] Univ Montreal, Dept Mol Biol, Montreal, PQ H3C 3J7, Canada; [Borden, Katherine L. B.] Univ Montreal, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada; [Thibault, Pierre] Univ Montreal, Dept Chem, Montreal, PQ H3C 3J7, Canada; [Meloche, Sylvain] Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Meloche, S (corresponding author), Univ Montreal, Inst Rech Immunol & Cancerol, Montreal, PQ H3C 3J7, Canada.	sylvain.meloche@umontreal.ca	Trost, Matthias/A-9999-2009; Topisirovic, Ivan/A-9426-2008	Trost, Matthias/0000-0002-5732-700X; Topisirovic, Ivan/0000-0002-5510-9762	National Institutes of Health [98781]; Fonds de la Recherche en Sante du Quebec; Fondation pour la Recherche Medicale; Leukemia and Lymphoma Society; Canadian Institutes for Health Research; NATIONAL CANCER INSTITUTE [R01CA080728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 98781 (to K. L. B. B.). This work was also supported by the Fonds de la Recherche en Sante du Quebec and the Fondation pour la Recherche Medicale (to P. D.), the Leukemia and Lymphoma Society (to I. T.), and the Canadian Institutes for Health Research (to S. M. and P.-L. T.).	Aberg E, 2006, J BIOL CHEM, V281, P35499, DOI 10.1074/jbc.M606225200; Arias-Romero LE, 2008, BIOL CELL, V100, P97, DOI 10.1042/BC20070109; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bokoch GM, 1998, CELL DEATH DIFFER, V5, P637, DOI 10.1038/sj.cdd.4400405; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Cheng M, 1996, J BIOL CHEM, V271, P12057, DOI 10.1074/jbc.271.20.12057; Coulombe P, 2003, MOL CELL BIOL, V23, P4542, DOI 10.1128/MCB.23.13.4542-4558.2003; Coulombe P, 2002, ANAL BIOCHEM, V310, P219, DOI 10.1016/S0003-2697(02)00319-6; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; Deleris P, 2008, J CELL PHYSIOL, V217, P778, DOI 10.1002/jcp.21560; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; ENGLISH JM, 1995, J BIOL CHEM, V270, P28897, DOI 10.1074/jbc.270.48.28897; Gerits N, 2007, J BIOL CHEM, V282, P37232, DOI 10.1074/jbc.M704873200; GONZALEZ FA, 1992, FEBS LETT, V304, P170, DOI 10.1016/0014-5793(92)80612-K; Hofmann C, 2004, J CELL SCI, V117, P4343, DOI 10.1242/jcs.01392; Julien C, 2003, J BIOL CHEM, V278, P42615, DOI 10.1074/jbc.M302724200; Kant S, 2006, J BIOL CHEM, V281, P35511, DOI 10.1074/jbc.M606693200; Kostenko S, 2009, CELL SIGNAL, V21, P712, DOI 10.1016/j.cellsig.2009.01.009; Manza LL, 2005, PROTEOMICS, V5, P1742, DOI 10.1002/pmic.200401063; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Perander M, 2008, BIOCHEM J, V411, P613, DOI 10.1042/BJ20071369; Rennefahrt UEE, 2007, J BIOL CHEM, V282, P15667, DOI 10.1074/jbc.M700253200; Robinson MJ, 1996, J BIOL CHEM, V271, P29734, DOI 10.1074/jbc.271.47.29734; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Schumacher S, 2004, EMBO J, V23, P4770, DOI 10.1038/sj.emboj.7600467; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Servant MJ, 2000, J CELL BIOL, V148, P543, DOI 10.1083/jcb.148.3.543; Seternes OM, 2004, EMBO J, V23, P4780, DOI 10.1038/sj.emboj.7600489; Szczepanowska J, 2009, ACTA BIOCHIM POL, V56, P225; Tak H, 2007, CELL SIGNAL, V19, P2379, DOI 10.1016/j.cellsig.2007.07.016; Tanguay PL, 2010, BIOCHEM J, V428, P103, DOI 10.1042/BJ20091604	31	44	48	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6470	6478		10.1074/jbc.M110.181529	http://dx.doi.org/10.1074/jbc.M110.181529			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21177870	Green Published, hybrid			2022-12-27	WOS:000287476400057
J	Grass, J; Pabst, M; Kolarich, D; Poltl, G; Leonard, R; Brecker, L; Altmann, F				Grass, Josephine; Pabst, Martin; Kolarich, Daniel; Poeltl, Gerald; Leonard, Renaud; Brecker, Lothar; Altmann, Friedrich			Discovery and Structural Characterization of Fucosylated Oligomannosidic N-Glycans in Mushrooms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; ASTRAEUS-HYGROMETRICUS; GRAPHITIC CARBON; LINKED GLYCANS; GLYCOPROTEINS; NMR; OLIGOSACCHARIDES; FUCOSE; GLYCOSYLATION	L-Fucose is a common constituent of Asn-linked glycans in vertebrates, invertebrates, and plants, but in fungal glycoproteins, fucose has not been found so far. However, by mass spectrometry we detected N-glycans and O-glycans containing one to six deoxyhexose residues in fruit bodies of several basidiomycetes. The N-glycans of chanterelles (Cantharellus cibarius) contained a deoxyhexose chromatographically identical to fucose and sensitive to alpha-L-fucosidase. Analysis of individual glycan species by tandem MS, glycosidase digestion, and finally H-1 NMR revealed the presence of L-fucose in alpha 1,6-linkage to an alpha 1,6-mannose of oligomannosidic N-glycans. The substitution by alpha 1,6-mannose of alpha 1,2-mannosyl residues of the canonical precursor structure was yet another hitherto unknown modification. No indication for the occurrence of yet other modifications, e. g. bisecting N-acetylglucosamine, was seen. Besides fucosylated N-glycans, short O-linked mannan chains substituted with fucose were present on chanterelle proteins. Although undiscovered so far, L-fucose appears to represent a prominent feature of protein-linked glycans in the fungal kingdom.	[Altmann, Friedrich] Univ Nat Resources & Life Sci, Dept Chem, A-1190 Vienna, Austria; [Brecker, Lothar] Univ Vienna, Inst Organ Chem, A-1090 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Vienna	Altmann, F (corresponding author), BOKU, Muthgasse 18, A-1190 Vienna, Austria.	friedrich.altmann@boku.ac.at	Kolarich, Daniel/B-6893-2012; Kolarich, Daniel/AAJ-3550-2020; Pabst, Martin/GOH-1766-2022	Kolarich, Daniel/0000-0002-8452-1350; Kolarich, Daniel/0000-0002-8452-1350; Pabst, Martin/0000-0001-9897-0723; Altmann, Friedrich/0000-0002-0112-7877; Leonard, Renaud/0000-0001-5023-1032				Altmann F, 2001, BIOCHIMIE, V83, P703, DOI 10.1016/S0300-9084(01)01297-4; ANUMULA KR, 1994, ANAL BIOCHEM, V220, P275, DOI 10.1006/abio.1994.1338; Berends E, 2009, APPL ENVIRON MICROB, V75, P4648, DOI 10.1128/AEM.00352-09; Bilan MI, 2008, CARBOHYD RES, V343, P2605, DOI 10.1016/j.carres.2008.06.001; BRUCH RC, 1982, J BIOL CHEM, V257, P3409; Brull LP, 1998, RAPID COMMUN MASS SP, V12, P1520; Buser R, 2010, J BIOL CHEM, V285, P10715, DOI 10.1074/jbc.M109.076075; Chai WG, 1997, GLYCOBIOLOGY, V7, P861, DOI 10.1093/glycob/7.6.861; Chakraborty I, 2007, CARBOHYD RES, V342, P982, DOI 10.1016/j.carres.2007.02.004; Deshpande N, 2008, GLYCOBIOLOGY, V18, P626, DOI 10.1093/glycob/cwn044; Gemmill TR, 1999, BBA-GEN SUBJECTS, V1426, P227, DOI 10.1016/S0304-4165(98)00126-3; Gminder A., 2008, HDB PILZSAMMLER ARTE; Goto M, 2007, BIOSCI BIOTECH BIOCH, V71, P1415, DOI 10.1271/bbb.70080; Hanniffy OM, 1999, CARBOHYD RES, V319, P124, DOI 10.1016/S0008-6215(99)00129-9; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; KONDO A, 1990, AGR BIOL CHEM TOKYO, V54, P2169, DOI 10.1080/00021369.1990.10870232; Ma B, 2006, GLYCOBIOLOGY, V16, p158R, DOI 10.1093/glycob/cwl040; Maiti D, 2008, CARBOHYD RES, V343, P817, DOI 10.1016/j.carres.2007.12.003; Mondal S, 2008, CARBOHYD RES, V343, P1062, DOI 10.1016/j.carres.2008.02.017; Pabst M, 2008, ANAL CHEM, V80, P7534, DOI 10.1021/ac801024r; Pabst M, 2010, ANAL CHEM, V82, P9782, DOI 10.1021/ac101975k; Pabst M, 2010, CARBOHYD RES, V345, P1389, DOI 10.1016/j.carres.2010.02.017; Packer NH, 1998, GLYCOCONJUGATE J, V15, P737, DOI 10.1023/A:1006983125913; Petrescu AJ, 1997, EMBO J, V16, P4302, DOI 10.1093/emboj/16.14.4302; Ren Y, 2010, BIOCHEM BIOPH RES CO, V391, P1663, DOI 10.1016/j.bbrc.2009.12.116; Rendic D, 2007, ELECTROPHORESIS, V28, P4484, DOI 10.1002/elps.200700098; Roitinger A, 1998, GLYCOCONJUGATE J, V15, P89, DOI 10.1023/A:1006951802623; Sandstrom C, 2004, BIOCHEMISTRY-US, V43, P13926, DOI 10.1021/bi048676k; Sato H, 2008, CARBOHYD RES, V343, P1333, DOI 10.1016/j.carres.2008.03.008; Staudacher E, 1999, BBA-GEN SUBJECTS, V1473, P216, DOI 10.1016/S0304-4165(99)00181-6; Taylor AM, 2006, PROTEOMICS, V6, P2936, DOI 10.1002/pmic.200500331; VANHALBEEK H, 1980, FEBS LETT, V121, P65; Wilson IBH, 2001, GLYCOBIOLOGY, V11, P261, DOI 10.1093/glycob/11.4.261; Wuhrer M, 2006, RAPID COMMUN MASS SP, V20, P1747, DOI 10.1002/rcm.2509; Wuhrer M, 2009, ANAL CHEM, V81, P4422, DOI 10.1021/ac900278q; Ye LB, 2009, FOOD CHEM, V112, P962, DOI 10.1016/j.foodchem.2008.07.017; Zhang LY, 2003, J CHROMATOGR B, V793, P159, DOI 10.1016/S1570-0232(03)00373-8	37	23	23	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					5977	5984		10.1074/jbc.M110.191304	http://dx.doi.org/10.1074/jbc.M110.191304			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21169363	Green Published, hybrid			2022-12-27	WOS:000287476400005
J	Inoue, J; Nagae, T; Mishima, M; Ito, Y; Shibata, T; Mikawa, T				Inoue, Jin; Nagae, Takayuki; Mishima, Masaki; Ito, Yutaka; Shibata, Takehiko; Mikawa, Tsutomu			A Mechanism for Single-stranded DNA-binding Protein (SSB) Displacement from Single-stranded DNA upon SSB-RecO Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI SSB; DEINOCOCCUS-RADIODURANS; GENETIC-RECOMBINATION; BREAK REPAIR; CRYSTAL-STRUCTURE; DUPLEX DNA; THERMUS-THERMOPHILUS; EXONUCLEASE-I; REPLICATION; POLYMERASE	Displacement of single-stranded DNA (ssDNA)-binding protein (SSB) from ssDNA is necessary for filament formation of RecA on ssDNA to initiate homologous recombination. The interaction between RecO and SSB is considered to be important for SSB displacement; however, the interaction has not been characterized at the atomic level. In this study, to clarify the mechanism underlying SSB displacement from ssDNA upon RecO binding, we examined the interaction between Thermus thermophilus RecO and cognate SSB by NMR analysis. We found that SSB interacts with the C-terminal positively charged region of RecO. Based on this result, we constructed some RecO mutants. The R127A mutant had considerably decreased binding affinity for SSB and could not anneal SSB-coated ssDNAs. Further, the mutant in the RecOR complex prevented the recovery of ssDNA-dependent ATPase activity of RecA from inhibition by SSB. These results indicated that the region surrounding Arg-127 is the binding site of SSB. We also performed NMR analysis using the C-terminal peptide of SSB and found that the acidic region of SSB is involved in the interaction with RecO, as seen in other protein-SSB interactions. Taken together with the findings of previous studies, we propose a model for SSB displacement from ssDNA where the acidic C-terminal region of SSB weakens the ssDNA binding affinity of SSB when the dynamics of the C-terminal region are suppressed by interactions with other proteins, including RecO.	[Mikawa, Tsutomu] Yokohama City Univ, Grad Sch Nanobiosci, RIKEN Adv Sci Inst, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Inoue, Jin; Shibata, Takehiko; Mikawa, Tsutomu] RIKEN Adv Sci Inst, Wako, Saitama 3510198, Japan; [Nagae, Takayuki; Mishima, Masaki; Ito, Yutaka] Tokyo Metropolitan Univ, Dept Chem, Tokyo 1920397, Japan; [Mikawa, Tsutomu] RIKEN SPring 8 Ctr, Sayo, Hyogo 6795148, Japan	RIKEN; Yokohama City University; RIKEN; Tokyo Metropolitan University; RIKEN	Mikawa, T (corresponding author), Yokohama City Univ, Grad Sch Nanobiosci, RIKEN Adv Sci Inst, Tsurumi Ku, 1-7-29 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	mikawa@riken.jp	Mikawa, Tsutomu/E-6510-2013; Ito, Yutaka/P-2604-2015	Mikawa, Tsutomu/0000-0003-2325-5084; Ito, Yutaka/0000-0002-1030-4660	Grant-in-Aid for Scientific Research on Innovative Areas [21200058]	Grant-in-Aid for Scientific Research on Innovative Areas(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (21200058).	Arad G, 2008, J BIOL CHEM, V283, P8274, DOI 10.1074/jbc.M710290200; Bernstein DA, 2004, P NATL ACAD SCI USA, V101, P8575, DOI 10.1073/pnas.0401331101; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Bork JM, 2001, EMBO J, V20, P7313, DOI 10.1093/emboj/20.24.7313; Buss JA, 2008, NUCLEIC ACIDS RES, V36, P7029, DOI 10.1093/nar/gkn795; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Dabrowski S, 2002, MICROBIOL-SGM, V148, P3307, DOI 10.1099/00221287-148-10-3307; Eggington JM, 2006, BIOCHEMISTRY-US, V45, P14490, DOI 10.1021/bi061178m; Genschel J, 2000, BIOL CHEM, V381, P183, DOI 10.1515/BC.2000.025; Handa N, 2009, GENE DEV, V23, P1234, DOI 10.1101/gad.1780709; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; HOWARDFLANDERS P, 1984, NATURE, V309, P215, DOI 10.1038/309215a0; Inoue J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl350; Inoue J, 2008, NUCLEIC ACIDS RES, V36, P94, DOI 10.1093/nar/gkm1004; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; Kantake N, 2002, P NATL ACAD SCI USA, V99, P15327, DOI 10.1073/pnas.252633399; Kato R, 1999, EUR J BIOCHEM, V259, P592, DOI 10.1046/j.1432-1327.1999.00044.x; KOWALCZYKOWSKI SC, 1987, P NATL ACAD SCI USA, V84, P3127, DOI 10.1073/pnas.84.10.3127; Kowalczykowski SC, 2000, TRENDS BIOCHEM SCI, V25, P156, DOI 10.1016/S0968-0004(00)01569-3; Kozlov AG, 2010, J BIOL CHEM, V285, P17246, DOI 10.1074/jbc.M110.118273; KRAULIS PJ, 1989, J MAGN RESON, V84, P627, DOI 10.1016/0022-2364(89)90130-3; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; Leiros I, 2005, EMBO J, V24, P906, DOI 10.1038/sj.emboj.7600582; LLOYD RG, 1985, J BACTERIOL, V164, P836, DOI 10.1128/JB.164.2.836-844.1985; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; Lu D, 2008, P NATL ACAD SCI USA, V105, P9169, DOI 10.1073/pnas.0800741105; LUISIDELUCA C, 1995, J BACTERIOL, V177, P566, DOI 10.1128/jb.177.3.566-572.1995; Makharashvili N, 2004, STRUCTURE, V12, P1881, DOI 10.1016/j.str.2004.08.006; Mazloum N, 2009, MOL CELL, V33, P160, DOI 10.1016/j.molcel.2008.12.023; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; Nimonkar AV, 2009, P NATL ACAD SCI USA, V106, P3077, DOI 10.1073/pnas.0813247106; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; PUGH BF, 1988, J MOL BIOL, V203, P479, DOI 10.1016/0022-2836(88)90014-9; PUGH BF, 1987, J BIOL CHEM, V262, P1326; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Rajesh S, 1999, BIOCHEMISTRY-US, V38, P9242, DOI 10.1021/bi9903953; Rocha EPC, 2005, PLOS GENET, V1, P247, DOI 10.1371/journal.pgen.0010015; Roy R, 2009, NATURE, V461, P1092, DOI 10.1038/nature08442; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Savvides SN, 2004, PROTEIN SCI, V13, P1942, DOI 10.1110/ps.04661904; Sharma R, 2009, J MOL BIOL, V385, P1375, DOI 10.1016/j.jmb.2008.11.041; Shereda RD, 2007, J BIOL CHEM, V282, P19247, DOI 10.1074/jbc.M608011200; Shereda RD, 2009, J MOL BIOL, V386, P612, DOI 10.1016/j.jmb.2008.12.065; Song BW, 2000, J BIOL CHEM, V275, P15895, DOI 10.1074/jbc.M910244199; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Sugiyama T, 2006, EMBO J, V25, P5539, DOI 10.1038/sj.emboj.7601412; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; Timmins J, 2007, EMBO J, V26, P3260, DOI 10.1038/sj.emboj.7601760; TSENG YC, 1994, MUTAT RES, V315, P1; UMEZU K, 1993, P NATL ACAD SCI USA, V90, P3875, DOI 10.1073/pnas.90.9.3875; UMEZU K, 1994, J BIOL CHEM, V269, P30005; Witte G, 2005, NUCLEIC ACIDS RES, V33, P1662, DOI 10.1093/nar/gki310; Witte G, 2003, NUCLEIC ACIDS RES, V31, P4434, DOI 10.1093/nar/gkg498; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X	58	25	25	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6720	6732		10.1074/jbc.M110.164210	http://dx.doi.org/10.1074/jbc.M110.164210			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21169364	Green Published, hybrid			2022-12-27	WOS:000287476400079
J	Kasai, K; Takano, J; Miwa, K; Toyoda, A; Fujiwara, T				Kasai, Koji; Takano, Junpei; Miwa, Kyoko; Toyoda, Atsushi; Fujiwara, Toru			High Boron-induced Ubiquitination Regulates Vacuolar Sorting of the BOR1 Borate Transporter in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; PREVACUOLAR COMPARTMENTS; RHAMNOGALACTURONAN-II; PLANT DEVELOPMENT; CROSS-LINKING; ENDOCYTOSIS; TOXICITY; CELLS; EXPRESSION; TOLERANCE	Boron homeostasis is important for plants, as boron is essential but is toxic in excess. Under high boron conditions, the Arabidopsis thaliana borate transporter BOR1 is trafficked from the plasma membrane (PM) to the vacuole via the endocytic pathway for degradation to avoid excess boron transport. Here, we show that boron-induced ubiquitination is required for vacuolar sorting of BOR1. We found that a substitution of lysine 590 with alanine (K590A) in BOR1 blocked degradation. BOR1 was mono-or diubiquitinated within several minutes after applying a high concentration of boron, whereas the K590A mutant was not. The K590A mutation abolished vacuolar transport of BOR1 but did not apparently affect polar localization to the inner PM domains. Furthermore, brefeldin A and wortmannin treatment suggested that Lys-590 is required for BOR1 translocation from an early endosomal compartment to multivesicular bodies. Our results show that boron-induced ubiquitination of BOR1 is not required for endocytosis from the PM but is crucial for the sorting of internalized BOR1 to multivesicular bodies for subsequent degradation in vacuoles.	[Fujiwara, Toru] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; [Kasai, Koji; Miwa, Kyoko; Toyoda, Atsushi; Fujiwara, Toru] Univ Tokyo, Biotechnol Res Ctr, Tokyo 1138657, Japan; [Takano, Junpei] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan; [Fujiwara, Toru] Japan Sci & Technol Agcy, Saitama 3320012, Japan	University of Tokyo; University of Tokyo; Hokkaido University; Japan Science & Technology Agency (JST)	Fujiwara, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	atorufu@mail.ecc.u-tokyo.ac.jp	MIWA, Kyoko/D-4220-2009; Takano, Junpei/A-5255-2012	Takano, Junpei/0000-0002-7474-3101; Miwa, Kyoko/0000-0001-7328-3628	Japan Society for the Promotion of Science [19-7094]; Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [21228002] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grant-in-aid 19-7094 for JSPS Fellows from the Japan Society for the Promotion of Science (to K. K.), a grant-in-aid for scientific research (to T. F.), and a grant-in-aid for scientific research priority areas (to T. F.) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Abas L, 2006, NAT CELL BIOL, V8, P249, DOI 10.1038/ncb1369; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Arai M, 2004, NUCLEIC ACIDS RES, V32, pW390, DOI 10.1093/nar/gkh380; Bolte S, 2004, J MICROSC-OXFORD, V214, P159, DOI 10.1111/j.0022-2720.2004.01348.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Duan L, 2003, J BIOL CHEM, V278, P28950, DOI 10.1074/jbc.M304474200; Frommer WB, 2002, NATURE, V420, P282, DOI 10.1038/420282a; FUJIWARA T, 1992, PLANT PHYSIOL, V99, P263, DOI 10.1104/pp.99.1.263; Geldner N, 2007, GENE DEV, V21, P1598, DOI 10.1101/gad.1561307; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; ITO K, 1981, CELL, V24, P707, DOI 10.1016/0092-8674(81)90097-0; Iwai H, 2006, P NATL ACAD SCI USA, V103, P16592, DOI 10.1073/pnas.0605141103; Jaillais Y, 2008, PLANT J, V53, P237, DOI 10.1111/j.1365-313X.2007.03338.x; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Kato Y, 2009, PLANT CELL PHYSIOL, V50, P58, DOI 10.1093/pcp/pcn168; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kerkeb L, 2008, PLANT PHYSIOL, V146, P1964, DOI 10.1104/pp.107.113282; Kleine-Vehn J, 2008, P NATL ACAD SCI USA, V105, P17812, DOI 10.1073/pnas.0808073105; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Lee HK, 2009, PLANT CELL, V21, P622, DOI 10.1105/tpc.108.061994; Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525; Miwa K, 2007, SCIENCE, V318, P1417, DOI 10.1126/science.1146634; Miwa K, 2006, PLANT J, V46, P1084, DOI 10.1111/j.1365-313X.2006.02763.x; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nable RO, 1997, PLANT SOIL, V193, P181, DOI 10.1023/A:1004272227886; Nozawa A, 2006, FEMS MICROBIOL LETT, V262, P216, DOI 10.1111/j.1574-6968.2006.00395.x; Nozawa A, 2006, BIOSCI BIOTECH BIOCH, V70, P1724, DOI 10.1271/bbb.60065; O'Neill MA, 2001, SCIENCE, V294, P846, DOI 10.1126/science.1062319; Ochiai K, 2008, THEOR APPL GENET, V117, P125, DOI 10.1007/s00122-008-0758-7; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Reid RJ, 2004, PLANT CELL ENVIRON, V27, P1405, DOI 10.1111/j.1365-3040.2004.01243.x; Robinson DG, 2008, PLANT PHYSIOL, V147, P1482, DOI 10.1104/pp.108.120105; Rotin D, 2000, J MEMBRANE BIOL, V176, P1; Ruiz JM, 2003, PLANT SCI, V165, P811, DOI 10.1016/S0168-9452(03)00276-0; Saksena S, 2007, TRENDS BIOCHEM SCI, V32, P561, DOI 10.1016/j.tibs.2007.09.010; Shorrocks VM, 1997, PLANT SOIL, V193, P121, DOI 10.1023/A:1004216126069; Spitzer C, 2009, PLANT CELL, V21, P749, DOI 10.1105/tpc.108.064865; Takano J, 2002, NATURE, V420, P337, DOI 10.1038/nature01139; Takano J, 2005, P NATL ACAD SCI USA, V102, P12276, DOI 10.1073/pnas.0502060102; Takano J, 2008, TRENDS PLANT SCI, V13, P451, DOI 10.1016/j.tplants.2008.05.007; Takano J, 2006, PLANT CELL, V18, P1498, DOI 10.1105/tpc.106.041640; Takano Junpei, 2010, Proc Natl Acad Sci U S A, V107, P5220, DOI 10.1073/pnas.0910744107; Tamura K, 2003, PLANT J, V35, P545, DOI 10.1046/j.1365-313X.2003.01822.x; Tse YC, 2004, PLANT CELL, V16, P672, DOI 10.1105/tpc.019703; Viotti C, 2010, PLANT CELL, V22, P1344, DOI 10.1105/tpc.109.072637; Wang JQ, 2009, J EXP BOT, V60, P3075, DOI 10.1093/jxb/erp136	47	144	147	0	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6175	6183		10.1074/jbc.M110.184929	http://dx.doi.org/10.1074/jbc.M110.184929			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21148314	Green Published, hybrid			2022-12-27	WOS:000287476400026
J	Riano-Umbarila, L; Contreras-Ferrat, G; Olamendi-Portugal, T; Morelos-Juarez, C; Corzo, G; Possani, LD; Becerril, B				Riano-Umbarila, Lidia; Contreras-Ferrat, Gabriel; Olamendi-Portugal, Timoteo; Morelos-Juarez, Citlalli; Corzo, Gerardo; Possani, Lourival D.; Becerril, Baltazar			Exploiting Cross-reactivity to Neutralize Two Different Scorpion Venoms with One Single Chain Antibody Fragment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANDROCTONUS-AUSTRALIS-HECTOR; CENTRUROIDES-NOXIUS HOFFMANN; LIMPIDUS-LIMPIDUS KARSCH; DIRECTED EVOLUTION; MONOCLONAL-ANTIBODIES; FUNCTIONAL-EVALUATION; PHAGE DISPLAY; FV ANTIBODIES; NA+-CHANNELS; TOXIN CN2	We report the optimization of a family of human single chain antibody fragments (scFv) for neutralizing two scorpion venoms. The parental scFv 3F recognizes the main toxins of Centruroides noxius Hoffmann (Cn2) and Centruroides suffusus suffusus (Css2), albeit with low affinity. This scFv was subjected to independent processes of directed evolution to improve its recognition toward Cn2 (Riano-Umbarila, L., Juarez-Gonzalez, V. R., Olamendi-Portugal, T., Ortiz-Leon, M., Possani, L. D., and Becerril, B. (2005) FEBS J. 272, 2591-2601) and Css2 (this work). Each evolved variant showed strong cross-reactivity against several toxins, and was capable of neutralizing Cn2 and Css2. Furthermore, each variant neutralized the whole venoms of the above species. As far as we know, this is the first report of antibodies with such characteristics. Maturation processes revealed key residue changes to attain expression, stability, and affinity improvements as compared with the parental scFv. Combination of these changes resulted in the scFv LR, which is capable of rescuing mice from severe envenomation by 3 LD50 of freshly prepared whole venom of C. noxius (7.5 mu g/20 g of mouse) and C. suffusus (26.25 mu g/20 g of mouse), with surviving rates between 90 and 100%. Our research is leading to the formulation of an antivenom consisting of a discrete number of human scFvs endowed with strong cross-reactivity and low immunogenicity.	[Riano-Umbarila, Lidia; Contreras-Ferrat, Gabriel; Olamendi-Portugal, Timoteo; Morelos-Juarez, Citlalli; Corzo, Gerardo; Possani, Lourival D.; Becerril, Baltazar] Univ Nacl Autonoma Mexico, Dept Med Mol & Bioproc, Inst Biotecnol, Cuernavaca 62250, Morelos, Mexico	Universidad Nacional Autonoma de Mexico	Becerril, B (corresponding author), Av Univ 2001, Cuernavaca 62210, Morelos, Mexico.	baltazar@ibt.unam.mx	Possani, Lourival D/J-2397-2013; Corzo, Gerardo/B-3778-2014	Corzo, Gerardo/0000-0002-9513-1622; Riano-Umbarila, Lidia/0000-0002-2531-9232	Instituto Bioclon [P-156]	Instituto Bioclon	This work was supported by Grant P-156 from the Instituto Bioclon.	Adams GP, 1998, CANCER RES, V58, P485; ALAGON AC, 1988, COMP BIOCHEM PHYS B, V89, P153, DOI 10.1016/0305-0491(88)90277-5; Aubrey N, 2004, TOXICON, V43, P233, DOI 10.1016/j.toxicon.2003.11.024; Aubrey N, 2003, CELL MOL LIFE SCI, V60, P617, DOI 10.1007/s000180300053; Batra SK, 2002, CURR OPIN BIOTECH, V13, P603, DOI 10.1016/S0958-1669(02)00352-X; Ben Abderrazek R, 2009, BIOCHEM J, V424, P263, DOI 10.1042/BJ20090697; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; BRADEN BC, 1995, FASEB J, V9, P9, DOI 10.1096/fasebj.9.1.7821765; Cadwell R C, 1992, PCR Methods Appl, V2, P28, DOI 10.1101/gr.2.1.28; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Chippaux JP, 2008, ACTA TROP, V107, P71, DOI 10.1016/j.actatropica.2008.05.021; Daugherty PS, 2000, P NATL ACAD SCI USA, V97, P2029, DOI 10.1073/pnas.030527597; de la Vega RCR, 2005, TOXICON, V46, P831, DOI 10.1016/j.toxicon.2005.09.006; DEHESADAVILA M, 1994, TOXICON, V32, P1015, DOI 10.1016/0041-0101(94)90383-2; Devaux C, 1997, FEBS LETT, V412, P456, DOI 10.1016/S0014-5793(97)00826-0; Devaux C, 2001, EUR J BIOCHEM, V268, P694, DOI 10.1046/j.1432-1327.2001.01923.x; DIXON WJ, 1948, J AM STAT ASSOC, V43, P109, DOI 10.2307/2280071; Dubreuil O, 2005, J BIOL CHEM, V280, P24880, DOI 10.1074/jbc.M500048200; Espino-Solis GP, 2009, J PROTEOMICS, V72, P183, DOI 10.1016/j.jprot.2009.01.020; Ewert S, 2003, J MOL BIOL, V325, P531, DOI 10.1016/S0022-2836(02)01237-8; FOOTE J, 1995, P NATL ACAD SCI USA, V92, P1254, DOI 10.1073/pnas.92.5.1254; FOOTE J, 1992, J MOL BIOL, V224, P487, DOI 10.1016/0022-2836(92)91010-M; Garcia-Rodriguez C, 2007, NAT BIOTECHNOL, V25, P107, DOI 10.1038/nbt1269; Graff CP, 2004, PROTEIN ENG DES SEL, V17, P293, DOI 10.1093/protein/gzh038; Harvey BR, 2006, J IMMUNOL METHODS, V308, P43, DOI 10.1016/j.jim.2005.09.017; Hernandez-Salgado K, 2009, IMMUNOL LETT, V125, P93, DOI 10.1016/j.imlet.2009.06.001; Hmila I, 2008, MOL IMMUNOL, V45, P3847, DOI 10.1016/j.molimm.2008.04.011; Hmila I, 2010, FASEB J, V24, P3479, DOI 10.1096/fj.09-148213; Isbister GK, 2003, J TOXICOL-CLIN TOXIC, V41, P291, DOI 10.1081/CLT-120021114; Juarez-Gonzalez VR, 2005, J MOL BIOL, V346, P1287, DOI 10.1016/j.jmb.2004.12.060; Korpimaki T, 2003, PROTEIN ENG, V16, P37, DOI 10.1093/proeng/gzg010; Leung D. W., 1989, TECHNIQUE, V1, P11; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; Miyazaki C, 1999, PROTEIN ENG, V12, P407, DOI 10.1093/protein/12.5.407; Mousli M, 1999, FEBS LETT, V442, P183, DOI 10.1016/S0014-5793(98)01647-0; Oppezzo P, 2004, EUR J IMMUNOL, V34, P1423, DOI 10.1002/eji.200424936; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; RAMIREZ AN, 1994, TOXICON, V32, P479, DOI 10.1016/0041-0101(94)90300-X; Riano-Umbarila L, 2005, FEBS J, V272, P2591, DOI 10.1111/j.1742-4658.2005.04687.x; Schiavon E, 2006, J BIOL CHEM, V281, P20326, DOI 10.1074/jbc.M600565200; Schier R, 1996, GENE, V169, P147, DOI 10.1016/0378-1119(95)00821-7; Schier Robert, 1996, Human Antibodies and Hybridomas, V7, P97; Selisko B, 2004, TOXICON, V43, P43, DOI 10.1016/j.toxicon.2003.10.015; Selisko B, 1999, PROTEINS, V37, P130, DOI 10.1002/(SICI)1097-0134(19991001)37:1&lt;130::AID-PROT13&gt;3.0.CO;2-S; Seo MJ, 2009, PROTEIN SCI, V18, P259, DOI 10.1002/pro.31; Short MK, 2001, PROTEIN ENG, V14, P287, DOI 10.1093/protein/14.4.287; Weaver-Feldhaus JM, 2005, PROTEIN ENG DES SEL, V18, P527, DOI 10.1093/protein/gzi060; ZAMUDIO F, 1992, EUR J BIOCHEM, V204, P281, DOI 10.1111/j.1432-1033.1992.tb16635.x	49	35	37	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6143	6151		10.1074/jbc.M110.189175	http://dx.doi.org/10.1074/jbc.M110.189175			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21156801	Green Published, hybrid			2022-12-27	WOS:000287476400023
J	Sun, J; Conn, CS; Han, Y; Yeung, V; Qian, SB				Sun, Jun; Conn, Crystal S.; Han, Yan; Yeung, Vincent; Qian, Shu-Bing			PI3K-mTORC1 Attenuates Stress Response by Inhibiting Cap-independent Hsp70 Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; LIFE-SPAN; MOLECULAR CHAPERONES; PREFERENTIAL TRANSLATION; BINDING PARTNER; CELL STRESS; MTOR; TOR; INITIATION; KINASE	Protein synthesis is a key regulated cellular process that links nutrient availability and organismal growth. It has long been known that some cellular proteins continue to be synthesized under conditions where global translation is severely compromised. One prominent example is the selective translation of heat shock proteins (Hsps) under stress conditions. Although the transcriptional regulation of Hsp genes has been well established, neither the specific translation-promoting features nor the regulatory mechanism of the translation machinery have been clearly defined. Here we show that the stress-induced preferential translation of Hsp70 mRNA is negatively regulated by PI3K-mTORC1 signaling. Despite the transcriptional up-regulation, the translation of Hsp70 mRNA is deficient in cells lacking tuberous sclerosis complex 2. Conversely, Hsp70 synthesis is enhanced under the reduced PI3K-mTORC1 signaling. We found that the 5' UTR of Hsp70 mRNA contributes to cap-independent translation without exhibiting typical features of internal ribosome entry site. Our findings imply a plausible mechanism for how persistent PI3K-mTORC1 signaling favors the development of age-related pathologies by attenuating stress resistance.	[Conn, Crystal S.; Qian, Shu-Bing] Cornell Univ, Grad Field Genet & Dev, Ithaca, NY 14853 USA; Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University	Qian, SB (corresponding author), Cornell Univ, Grad Field Genet & Dev, 301 Biotech, Ithaca, NY 14853 USA.	sq38@cornell.edu	Conn, Crystal S/ABF-8464-2020	Conn, Crystal S/0000-0003-3209-0445	National Institutes of Health; Ellison Medical Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation)	This work was supported, in whole or in part, by a National Institutes of Health grant and the Ellison Medical Foundation (to S.- B. Q.).	Andreev DE, 2009, NUCLEIC ACIDS RES, V37, P6135, DOI 10.1093/nar/gkp665; Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; CHOU MM, 1995, CURR OPIN CELL BIOL, V7, P806, DOI 10.1016/0955-0674(95)80064-6; Clemens MJ, 2001, J CELL MOL MED, V5, P221, DOI 10.1111/j.1582-4934.2001.tb00157.x; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Feldman DE, 2000, CURR OPIN STRUC BIOL, V10, P26, DOI 10.1016/S0959-440X(99)00044-5; Fuda NJ, 2009, NATURE, V461, P186, DOI 10.1038/nature08449; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hipkiss AR, 2006, EXP GERONTOL, V41, P464, DOI 10.1016/j.exger.2006.03.004; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; KLEMENZ R, 1985, EMBO J, V4, P2053, DOI 10.1002/j.1460-2075.1985.tb03891.x; Li SN, 2002, MOL CELL BIOL, V22, P2853, DOI 10.1128/MCB.22.8.2853-2861.2002; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mayer MP, 2002, ADV PROTEIN CHEM, V59, P1; McClellan AJ, 2005, NAT CELL BIOL, V7, P736, DOI 10.1038/ncb0805-736; MCGARRY TJ, 1985, CELL, V42, P903, DOI 10.1016/0092-8674(85)90286-7; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; MOSELEY PL, 1993, AM J PHYSIOL, V264, pL533, DOI 10.1152/ajplung.1993.264.6.L533; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Neef DW, 2009, MOL MICROBIOL, V73, P1032, DOI 10.1111/j.1365-2958.2009.06827.x; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; PANNIERS R, 1994, BIOCHIMIE, V76, P737, DOI 10.1016/0300-9084(94)90078-7; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; PELLETIER J, 1988, NATURE, V334, P320, DOI 10.1038/334320a0; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; PETERSEN RB, 1989, CELL REGUL, V1, P135, DOI 10.1091/mbc.1.1.135; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Qian SB, 2006, NATURE, V440, P551, DOI 10.1038/nature04600; Qin XL, 2004, J BIOL CHEM, V279, P13721, DOI 10.1074/jbc.M312854200; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Rubtsova MP, 2003, J BIOL CHEM, V278, P22350, DOI 10.1074/jbc.M303213200; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Sarnow P, 2005, BIOCHEM SOC T, V33, P1479, DOI 10.1042/BST0331479; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cellbio.11.1.441; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103	63	37	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6791	6800		10.1074/jbc.M110.172882	http://dx.doi.org/10.1074/jbc.M110.172882			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21177857	hybrid, Green Published			2022-12-27	WOS:000287476400086
J	Bolusani, S; Young, BA; Cole, NA; Tibbetts, AS; Momb, J; Bryant, JD; Solmonson, A; Appling, DR				Bolusani, Swetha; Young, Blake A.; Cole, Nicola A.; Tibbetts, Anne S.; Momb, Jessica; Bryant, Joshua D.; Solmonson, Ashley; Appling, Dean R.			Mammalian MTHFD2L Encodes a Mitochondrial Methylenetetrahydrofolate Dehydrogenase Isozyme Expressed in Adult Tissues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONE-CARBON METABOLISM; SERINE HYDROXYMETHYLTRANSFERASE ISOZYMES; C-13 NMR ANALYSIS; SACCHAROMYCES-CEREVISIAE; METHENYLTETRAHYDROFOLATE CYCLOHYDROLASE; C-1-TETRAHYDROFOLATE SYNTHASE; 5,10-METHYLENETETRAHYDROFOLATE DEHYDROGENASE; SUBMITOCHONDRIAL LOCALIZATION; C1-TETRAHYDROFOLATE SYNTHASE; HOMOCYSTEINE REMETHYLATION	Previous studies in our laboratory showed that isolated, intact adult rat liver mitochondria are able to oxidize the 3-carbon of serine and the N-methyl carbon of sarcosine to formate without the addition of any other cofactors or substrates. Conversion of these 1-carbon units to formate requires several folate-interconverting enzymes in mitochondria. The enzyme(s) responsible for conversion of 5,10-methylene-tetrahydrofolate (CH2-THF) to 10-formyl-THF in adult mammalian mitochondria are currently unknown. A new mitochondrial CH2-THF dehydrogenase isozyme, encoded by the MTHFD2L gene, has now been identified. The recombinant protein exhibits robust NADP(+)-dependent CH2-THF dehydrogenase activity when expressed in yeast. The enzyme is localized to mitochondria when expressed in CHO cells and behaves as a peripheral membrane protein, tightly associated with the matrix side of the mitochondrial inner membrane. The MTHFD2L gene is subject to alternative splicing and is expressed in adult tissues in humans and rodents. This CH2-THF dehydrogenase isozyme thus fills the remaining gap in the pathway from CH2-THF to formate in adult mammalian mitochondria.	[Appling, Dean R.] Univ Texas Austin, Dept Chem & Biochem, Austin, TX 78712 USA; Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Appling, DR (corresponding author), Univ Texas Austin, Dept Chem & Biochem, 1 Univ Stn A5300, Austin, TX 78712 USA.	dappling@mail.utexas.edu		Solmonson, Ashley/0000-0001-8863-4558	National Institutes of Health [DK61425, GM086856]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK61425 and GM086856 (to D. R. A.).	Alonso G, 1997, CELL TISSUE RES, V288, P59, DOI 10.1007/s004410050792; Anguera MC, 2006, J BIOL CHEM, V281, P18335, DOI 10.1074/jbc.M510623200; APPLING DR, 1991, FASEB J, V5, P2645, DOI 10.1096/fasebj.5.12.1916088; BARLOWE C K, 1988, Biofactors, V1, P171; BARLOWE CK, 1990, MOL CELL BIOL, V10, P5679, DOI 10.1128/MCB.10.11.5679; BELANGER C, 1989, J BIOL CHEM, V264, P4837; Bergeron F, 1998, EUR J BIOCHEM, V257, P556, DOI 10.1046/j.1432-1327.1998.2570556.x; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; Christensen KE, 2005, J BIOL CHEM, V280, P7597, DOI 10.1074/jbc.M409380200; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; Darley-Usmar V.M., 1987, MITOCHONDRIA PRACTIC, P4; Davis SR, 2004, AM J PHYSIOL-ENDOC M, V286, pE272, DOI 10.1152/ajpendo.00351.2003; Di Pietro E, 2004, BBA-GEN SUBJECTS, V1674, P78, DOI 10.1016/j.bbagen.2004.06.014; Di Pietro E, 2002, MOL CELL BIOL, V22, P4158, DOI 10.1128/MCB.22.12.4158-4166.2002; Fu TF, 2001, ARCH BIOCHEM BIOPHYS, V393, P42, DOI 10.1006/abbi.2001.2471; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; GARCIAMARTINEZ LF, 1993, BIOCHEMISTRY-US, V32, P4671, DOI 10.1021/bi00068a027; Garesse R, 2001, GENE, V263, P1, DOI 10.1016/S0378-1119(00)00582-5; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Greenawalt J W, 1974, Methods Enzymol, V31, P310; Gregory JF, 2000, AM J CLIN NUTR, V72, P1535; Herbig K, 2002, J BIOL CHEM, V277, P38381, DOI 10.1074/jbc.M205000200; Howard KM, 2003, GENE, V319, P85, DOI 10.1016/S0378-1119(03)00796-0; HUM DW, 1988, J BIOL CHEM, V263, P15946; KAO FT, 1975, GENETICS, V79, P343; KAO FT, 1969, P NATL ACAD SCI USA, V64, P1284, DOI 10.1073/pnas.64.4.1284; Kastanos EK, 1997, BIOCHEMISTRY-US, V36, P14956, DOI 10.1021/bi971610n; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Lamers Y, 2009, J NUTR, V139, P666, DOI 10.3945/jn.108.103580; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; MacFarlane AJ, 2008, J BIOL CHEM, V283, P25846, DOI 10.1074/jbc.M802671200; MacFarlane AJ, 2009, J BIOL CHEM, V284, P1533, DOI 10.1074/jbc.M808281200; MEJIA NR, 1988, BIOCHEM BIOPH RES CO, V155, P1, DOI 10.1016/S0006-291X(88)81040-4; MEJIA NR, 1986, J BIOL CHEM, V261, P9509; MEJIA NR, 1985, J BIOL CHEM, V260, P4616; MOTOKAWA Y, 1971, ARCH BIOCHEM BIOPHYS, V146, P461, DOI 10.1016/0003-9861(71)90149-4; Nair JR, 2005, BBA-MOL CELL RES, V1746, P38, DOI 10.1016/j.bbamcr.2005.08.004; *NAT RES COUNC, 1996, GUID CAR US LAB AN; Pasternack LB, 1996, ARCH BIOCHEM BIOPHYS, V326, P158, DOI 10.1006/abbi.1996.0060; PASTERNACK LB, 1994, BIOCHEMISTRY-US, V33, P74, DOI 10.1021/bi00167a010; Patel H, 2003, J BIOL CHEM, V278, P19436, DOI 10.1074/jbc.M301718200; PAUKERT JL, 1977, BIOCHEM BIOPH RES CO, V77, P147, DOI 10.1016/S0006-291X(77)80176-9; Pedersen P L, 1978, Methods Cell Biol, V20, P411, DOI 10.1016/S0091-679X(08)62030-0; Pike ST, 2010, J BIOL CHEM, V285, P4612, DOI 10.1074/jbc.M109.079855; Prasannan P, 2003, J BIOL CHEM, V278, P43178, DOI 10.1074/jbc.M304319200; Prasannan P, 2009, ARCH BIOCHEM BIOPHYS, V481, P86, DOI 10.1016/j.abb.2008.10.028; Quinlivan EP, 2005, J NUTR, V135, P389, DOI 10.1093/jn/135.3.389; SCHIRCH L, 1978, ARCH BIOCHEM BIOPHYS, V189, P283, DOI 10.1016/0003-9861(78)90214-X; SMITH GK, 1980, BIOCHEMISTRY-US, V19, P4313, DOI 10.1021/bi00559a026; Suliman HS, 2005, ARCH BIOCHEM BIOPHYS, V441, P56, DOI 10.1016/j.abb.2005.06.016; THIGPEN AE, 1990, J BIOL CHEM, V265, P7907; Vijayvergiya C, 2005, J NEUROSCI, V25, P2463, DOI 10.1523/JNEUROSCI.4385-04.2005; Walkup AS, 2005, ARCH BIOCHEM BIOPHYS, V442, P196, DOI 10.1016/j.abb.2005.08.007; WEST MG, 1993, J BIOL CHEM, V268, P153; West MG, 1996, BIOCHEMISTRY-US, V35, P3122, DOI 10.1021/bi952713d; Woeller CF, 2007, J BIOL CHEM, V282, P17623, DOI 10.1074/jbc.M702526200	58	44	50	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5166	5174		10.1074/jbc.M110.196840	http://dx.doi.org/10.1074/jbc.M110.196840			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21163947	Green Published, hybrid			2022-12-27	WOS:000287230600025
J	Kang, YH; Zhang, Y; Liang, T; Leung, YM; Ng, B; Xie, HL; Chang, N; Chan, J; Shyng, SL; Tsushima, RG; Gaisano, HY				Kang, Youhou; Zhang, Yi; Liang, Tao; Leung, Yuk-Man; Ng, Betty; Xie, Huanli; Chang, Nathan; Chan, Joseph; Shyng, Show-Ling; Tsushima, Robert G.; Gaisano, Herbert Y.			ATP Modulates Interaction of Syntaxin-1A with Sulfonylurea Receptor 1 to Regulate Pancreatic beta-Cell K-ATP Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; CONGENITAL HYPERINSULINISM; EXOCYTOTIC PROTEINS; POTASSIUM CHANNELS; INSULIN-SECRETION; SENSITIVITY; ACTIVATION; SUR1; EXCITABILITY; TRAFFICKING	ATP-sensitive potassium (K-ATP) channels are regulated by a variety of cytosolic factors (adenine nucleotides, Mg2+, phospholipids, and pH). We previously reported that K-ATP channels are also regulated by endogenous membrane-bound SNARE protein syntaxin-1A (Syn-1A), which binds both nucleotide-binding folds of sulfonylurea receptor (SUR) 1 and 2A, causing inhibition of K-ATP channel activity in pancreatic islet beta-cells and cardiac myocytes, respectively. In this study, we show that ATP dose-dependently inhibits Syn-1A binding to SUR1 at physiological concentrations, with the addition of Mg2+ causing a decrease in the ATP-induced inhibitory effect. This ATP disruption of Syn-1A binding to SUR1 was confirmed by FRET analysis in living HEK293 cells. Electrophysiological studies in pancreatic beta-cells demonstrated that reduced ATP concentrations increased K-ATP channel sensitivity to Syn-1A inhibition. Depletion of endogenous Syn-1A in insulinoma cells by botulinum neurotoxin C1 proteolysis followed by rescue with exogenous Syn-1A showed that Syn-1A modulates K-ATP channel sensitivity to ATP. Thus, our data indicate that although both ATP and Syn-1A independently inhibit beta-cell K-ATP channel gating, they could also influence the sensitivity of K-ATP channels to each other. These findings provide new insight into an alternate mechanism by which ATP regulates pancreatic beta-cell K-ATP channel activity, not only by its direct actions on Kir6.2 pore subunit, but also via ATP modulation of Syn-1A binding to SUR1.	[Gaisano, Herbert Y.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Gaisano, Herbert Y.] Univ Hlth Network, Toronto, ON M5S 1A8, Canada; [Shyng, Show-Ling] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97239 USA; [Tsushima, Robert G.] York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Oregon Health & Science University; York University - Canada	Gaisano, HY (corresponding author), Univ Toronto, Dept Med, 1 Kings Coll Circle,Rm 7368, Toronto, ON M5S 1A8, Canada.	herbert.gaisano@utoronto.ca			Canadian Institutes for Health Research [MOP 69083]; Heart and Stroke Foundation of Ontario [T-6064]; National Institutes of Health [R01DK066485]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066485] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the Canadian Institutes for Health Research (MOP 69083), the Heart and Stroke Foundation of Ontario (T-6064) ( to H.Y.G.), and the National Institutes of Health (R01DK066485 to S.-L.S.).	ASHCROFT FM, 1989, J PHYSIOL-LONDON, V416, P349, DOI 10.1113/jphysiol.1989.sp017765; Atlas D, 2001, J NEUROCHEM, V77, P972, DOI 10.1046/j.1471-4159.2001.00347.x; Babenko AP, 1999, J BIOL CHEM, V274, P11587, DOI 10.1074/jbc.274.17.11587; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Cui NG, 2004, J BIOL CHEM, V279, P53259, DOI 10.1074/jbc.M410171200; Flechtner I, 2008, BEST PRACT RES CL EN, V22, P17, DOI 10.1016/j.beem.2007.08.003; Gribble FM, 1997, EMBO J, V16, P1145, DOI 10.1093/emboj/16.6.1145; Gribble FM, 1998, P NATL ACAD SCI USA, V95, P7185, DOI 10.1073/pnas.95.12.7185; Grubbs RD, 2002, BIOMETALS, V15, P251, DOI 10.1023/A:1016026831789; HOPKINS WF, 1992, J MEMBRANE BIOL, V129, P287; Hou JCQ, 2009, VITAM HORM, V80, P473, DOI 10.1016/S0083-6729(08)00616-X; INAGAKI N, 1995, J BIOL CHEM, V270, P5691, DOI 10.1074/jbc.270.11.5691; James C, 2009, J MED GENET, V46, P289, DOI 10.1136/jmg.2008.064337; Kang YH, 2004, J BIOL CHEM, V279, P47125, DOI 10.1074/jbc.M404954200; Kang YH, 2006, J BIOL CHEM, V281, P19019, DOI 10.1074/jbc.M513160200; Leung YM, 2007, ENDOCR REV, V28, P653, DOI 10.1210/er.2007-0010; Lin CW, 2005, DIABETES, V54, P2852, DOI 10.2337/diabetes.54.10.2852; Lin YW, 2008, J BIOL CHEM, V283, P9146, DOI 10.1074/jbc.M708798200; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; McHugh D, 1996, J PHYSIOL-LONDON, V492, P359, DOI 10.1113/jphysiol.1996.sp021314; Mikhailov MV, 2005, EMBO J, V24, P4166, DOI 10.1038/sj.emboj.7600877; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Ostenson CG, 2006, DIABETES, V55, P435, DOI 10.2337/diabetes.55.02.06.db04-1575; Pasyk EA, 2004, J BIOL CHEM, V279, P4234, DOI 10.1074/jbc.M309667200; Proks P, 2009, PROG BIOPHYS MOL BIO, V99, P7, DOI 10.1016/j.pbiomolbio.2008.10.002; Sharma N, 1999, J BIOL CHEM, V274, P20628, DOI 10.1074/jbc.274.29.20628; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Suzuki M, 2002, J CLIN INVEST, V109, P509, DOI 10.1172/JC1200214270; Tarasov AI, 2006, DIABETES, V55, P2446, DOI 10.2337/db06-0360; Tramier M, 2006, MICROSC RES TECHNIQ, V69, P933, DOI 10.1002/jemt.20370; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Webster NJ, 2008, ENDOCRINOLOGY, V149, P3679, DOI 10.1210/en.2007-1138; Wu J, 2002, J MEMBRANE BIOL, V190, P105, DOI 10.1007/s00232-002-1029-1; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	35	12	12	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5876	5883		10.1074/jbc.M109.089607	http://dx.doi.org/10.1074/jbc.M109.089607			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21173146	Green Published, hybrid			2022-12-27	WOS:000287230600096
J	Langelier, MF; Planck, JL; Roy, S; Pascal, JM				Langelier, Marie-France; Planck, Jamie L.; Roy, Swati; Pascal, John M.			Crystal Structures of Poly(ADP-ribose) Polymerase-1 (PARP-1) Zinc Fingers Bound to DNA STRUCTURAL AND FUNCTIONAL INSIGHTS INTO DNA-DEPENDENT PARP-1 ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGASE-III; CHROMATIN-STRUCTURE; BINDING; ENZYME; DOMAIN; IDENTIFICATION; PROTEINS; BREAKS; RECRUITMENT; MODULATION	Poly(ADP-ribose) polymerase-1 (PARP-1) has two homologous zinc finger domains, Zn1 and Zn2, that bind to a variety of DNA structures to stimulate poly(ADP-ribose) synthesis activity and to mediate PARP-1 interaction with chromatin. The structural basis for interaction with DNA is unknown, which limits our understanding of PARP-1 regulation and involvement in DNA repair and transcription. Here, we have determined crystal structures for the individual Zn1 and Zn2 domains in complex with a DNA double strand break, providing the first views of PARP-1 zinc fingers bound to DNA. The Zn1-DNA and Zn2-DNA structures establish a novel, bipartite mode of sequence-independent DNA interaction that engages a continuous region of the phosphodiester backbone and the hydrophobic faces of exposed nucleotide bases. Biochemical and cell biological analysis indicate that the Zn1 and Zn2 domains perform distinct functions. The Zn2 domain exhibits high binding affinity to DNA compared with the Zn1 domain. However, the Zn1 domain is essential for DNA-dependent PARP-1 activity in vitro and in vivo, whereas the Zn2 domain is not strictly required. Structural differences between the Zn1-DNA and Zn2-DNA complexes, combined with mutational and structural analysis, indicate that a specialized region of the Zn1 domain is re-configured through the hydrophobic interaction with exposed nucleotide bases to initiate PARP-1 activation.	[Langelier, Marie-France; Planck, Jamie L.; Roy, Swati; Pascal, John M.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University	Pascal, JM (corresponding author), 233 S 10th St,BLSB 804, Philadelphia, PA 19107 USA.	John.Pascal@KimmelCancerCenter.org			American Cancer Society [RSG0918301DMC, IRG0806001]; Emerald Foundation, Inc.,; Ladies of Port Richmond; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087282] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Emerald Foundation, Inc.,; Ladies of Port Richmond; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Cancer Society Grants RSG0918301DMC and IRG0806001, The Emerald Foundation, Inc., and The Ladies of Port Richmond.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BENJAMIN RC, 1980, J BIOL CHEM, V255, P493; Bewley CA, 1998, ANNU REV BIOPH BIOM, V27, P105, DOI 10.1146/annurev.biophys.27.1.105; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; D'Silva I, 1999, BBA-PROTEIN STRUCT M, V1430, P119, DOI 10.1016/S0167-4838(98)00278-7; David KK, 2009, FRONT BIOSCI-LANDMRK, V14, P1116, DOI 10.2741/3297; El-Khamisy SF, 2003, NUCLEIC ACIDS RES, V31, P5526, DOI 10.1093/nar/gkg761; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gagne JP, 2009, J PROTEOME RES, V8, P1014, DOI 10.1021/pr800810n; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; GRADWOHL G, 1990, P NATL ACAD SCI USA, V87, P2990, DOI 10.1073/pnas.87.8.2990; Haince JF, 2008, J BIOL CHEM, V283, P1197, DOI 10.1074/jbc.M706734200; Hassa PO, 2008, FRONT BIOSCI-LANDMRK, V13, P3046, DOI 10.2741/2909; IKEJIMA M, 1990, J BIOL CHEM, V265, P21907; Kim MY, 2004, CELL, V119, P803, DOI 10.1016/j.cell.2004.11.002; Kotova E, 2010, P NATL ACAD SCI USA, V107, P6406, DOI 10.1073/pnas.0914152107; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kraus WL, 2009, NAT STRUCT MOL BIOL, V16, P904, DOI 10.1038/nsmb0909-904; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Kulczyk AW, 2004, J MOL BIOL, V341, P723, DOI 10.1016/j.jmb.2004.06.035; Langelier MF, 2008, J BIOL CHEM, V283, P4105, DOI 10.1074/jbc.M708558200; Langelier MF, 2010, J BIOL CHEM, V285, P18877, DOI 10.1074/jbc.M110.105668; Lilyestrom W, 2010, J MOL BIOL, V395, P983, DOI 10.1016/j.jmb.2009.11.062; Lonskaya I, 2005, J BIOL CHEM, V280, P17076, DOI 10.1074/jbc.M413483200; Mackey ZB, 1999, J BIOL CHEM, V274, P21679, DOI 10.1074/jbc.274.31.21679; Masson M, 1998, MOL CELL BIOL, V18, P3563, DOI 10.1128/MCB.18.6.3563; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petrucco S, 2003, NUCLEIC ACIDS RES, V31, P6689, DOI 10.1093/nar/gkg890; Petrucco S, 2002, J BIOL CHEM, V277, P23675, DOI 10.1074/jbc.M201411200; Pion E, 2005, BIOCHEMISTRY-US, V44, P14670, DOI 10.1021/bi050755o; Pion E, 2003, BIOCHEMISTRY-US, V42, P12409, DOI 10.1021/bi0344432; POIRIER GG, 1982, P NATL ACAD SCI-BIOL, V79, P3423, DOI 10.1073/pnas.79.11.3423; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Tao ZH, 2008, BIOCHEMISTRY-US, V47, P5804, DOI 10.1021/bi800018a; Taylor RM, 2000, NUCLEIC ACIDS RES, V28, P3558, DOI 10.1093/nar/28.18.3558; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509	45	148	151	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10690	10701		10.1074/jbc.M110.202507	http://dx.doi.org/10.1074/jbc.M110.202507			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21233213	hybrid, Green Published			2022-12-27	WOS:000288547000083
J	Safdar, A; Little, JP; Stokl, AJ; Hettinga, BP; Akhtar, M; Tarnopolsky, MA				Safdar, Adeel; Little, Jonathan P.; Stokl, Andrew J.; Hettinga, Bart P.; Akhtar, Mahmood; Tarnopolsky, Mark A.			Exercise Increases Mitochondrial PGC-1 alpha Content and Promotes Nuclear-Mitochondrial Cross-talk to Coordinate Mitochondrial Biogenesis (Publication with Expression of Concern. See vol. 293, pg. 4953, 2018) (Withdrawn Publication. See vol. 295, pg. 17888, 2020)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; MESSENGER-RNA EXPRESSION; HUMAN SKELETAL-MUSCLE; ENDURANCE EXERCISE; GENE-EXPRESSION; OXIDATIVE-PHOSPHORYLATION; 1-ALPHA PGC-1-ALPHA; PROTEINS; LOCALIZATION; ACTIVATION	Endurance exercise is known to induce metabolic adaptations in skeletal muscle via activation of the transcriptional co-activator peroxisome proliferator-activated receptor gamma co-activator 1 alpha (PGC-1 alpha). PGC-1 alpha regulates mitochondrial biogenesis via regulating transcription of nuclear-encoded mitochondrial genes. Recently, PGC-1 alpha has been shown to reside in mitochondria; however, the physiological consequences of mitochondrial PGC-1 alpha remain unknown. We sought to delineate if an acute bout of endurance exercise can mediate an increase in mitochondrial PGC-1 alpha content where it may co-activate mitochondrial transcription factor A to promote mtDNA transcription. C57Bl/6J mice (n = 12/group; female = male) were randomly assigned to sedentary (SED), forced-endurance (END) exercise (15 m/min for 90 min), or forced endurance + 3 h of recovery (END + 3h) group. The END group was sacrificed immediately after exercise, whereas the SED and END + 3h groups were euthanized 3 h after acute exercise. Acute exercise coordinately increased the mRNA expression of nuclear and mitochondrial DNA-encoded mitochondrial transcripts. Nuclear and mitochondrial abundance of PGC-1 alpha in END and END + 3h groups was significantly higher versus SED mice. In mitochondria, PGC-1 alpha is in a complex with mitochondrial transcription factor A at mtDNA D-loop, and this interaction was positively modulated by exercise, similar to the increased binding of PGC-1 alpha at the NRF-1 promoter. We conclude that in response to acute altered energy demands, PGC-1 alpha re-localizes into nuclear and mitochondrial compartments where it functions as a transcriptional co-activator for both nuclear and mitochondrial DNA transcription factors. These results suggest that PGC-1 alpha may dynamically facilitate nuclear-mitochondrial DNA cross-talk to promote net mitochondrial biogenesis.	[Tarnopolsky, Mark A.] McMaster Univ, Med Ctr, Dept Pediat, Hamilton, ON L8N 3Z5, Canada; [Safdar, Adeel; Little, Jonathan P.] McMaster Univ, Dept Kinesiol, Hamilton, ON L8N 3Z5, Canada; [Safdar, Adeel; Tarnopolsky, Mark A.] McMaster Univ, Dept Med, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University; McMaster University	Tarnopolsky, MA (corresponding author), McMaster Univ, Med Ctr, Dept Pediat, HSC-2H26,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	tarnopol@mcmaster.ca	Little, Jonathan P./T-4076-2019	Little, Jonathan P./0000-0002-9796-2008; Safdar, Adeel/0000-0002-7453-7770; Safdar, Adeel/0000-0003-2469-0467	Canadian Institutes of Health Research [MOP97805]; Warren Lammert and family; Canadian Institutes of Health Research Institute of Aging; Canada PRESTIGE Fellowship; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Warren Lammert and family; Canadian Institutes of Health Research Institute of Aging(Canadian Institutes of Health Research (CIHR)); Canada PRESTIGE Fellowship; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was primarily supported by the Canadian Institutes of Health Research Grant MOP97805 (to M. A. T.) and a kind donation from Warren Lammert and family.; Funded by the Canadian Institutes of Health Research Institute of Aging Doctoral Research Scholarship and the Canada PRESTIGE Fellowship.; Funded by Natural Sciences and Engineering Research Council of Canada Graduate Scholarship.	Adhihetty PJ, 2009, AM J PHYSIOL-CELL PH, V297, pC217, DOI 10.1152/ajpcell.00070.2009; Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Anderson RM, 2008, AGING CELL, V7, P101, DOI 10.1111/j.1474-9726.2007.00357.x; Arciuch VGA, 2009, ADV DRUG DELIVER REV, V61, P1234, DOI 10.1016/j.addr.2009.04.025; Aquilano K, 2010, J BIOL CHEM, V285, P21590, DOI 10.1074/jbc.M109.070169; Arany Z, 2008, CURR OPIN GENET DEV, V18, P426, DOI 10.1016/j.gde.2008.07.018; Beal MF, 2009, PARKINSONISM RELAT D, V15, pS189, DOI 10.1016/S1353-8020(09)70812-0; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chaturvedi RK, 2009, HUM MOL GENET, V18, P3048, DOI 10.1093/hmg/ddp243; Choi YS, 2004, BIOCHEM BIOPH RES CO, V314, P118, DOI 10.1016/j.bbrc.2003.12.065; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Cowell RM, 2007, J COMP NEUROL, V502, P1, DOI 10.1002/cne.21211; Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206; Handschin C, 2009, TRENDS PHARMACOL SCI, V30, P322, DOI 10.1016/j.tips.2009.03.006; HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421; HOVIUS R, 1990, BIOCHIM BIOPHYS ACTA, V1021, P217, DOI 10.1016/0005-2736(90)90036-N; Huang JY, 2010, BBA-PROTEINS PROTEOM, V1804, P1645, DOI 10.1016/j.bbapap.2009.12.021; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Joseph AM, 2006, ESSAYS BIOCHEM, V42, P13, DOI 10.1042/bse0420013; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Kucej M, 2008, J CELL SCI, V121, P1861, DOI 10.1242/jcs.028605; Kuroda Y, 2006, HUM MOL GENET, V15, P883, DOI 10.1093/hmg/ddl006; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Little JP, 2010, AM J PHYSIOL-REG I, V298, pR912, DOI 10.1152/ajpregu.00409.2009; Little JP, 2010, J PHYSIOL-LONDON, V588, P1011, DOI 10.1113/jphysiol.2009.181743; Ljubicic V, 2010, BBA-GEN SUBJECTS, V1800, P223, DOI 10.1016/j.bbagen.2009.07.031; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Milon L, 2000, J BIOL CHEM, V275, P14264, DOI 10.1074/jbc.275.19.14264; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Pan YP, 2010, TRENDS GENET, V26, P75, DOI 10.1016/j.tig.2009.12.003; Pellon-Malson M, 2007, BBA-MOL CELL BIOL L, V1771, P830, DOI 10.1016/j.bbalip.2007.04.001; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Powers SK, 2010, EXP PHYSIOL, V95, P1, DOI 10.1113/expphysiol.2009.050526; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rim JS, 2004, J BIOL CHEM, V279, P25916, DOI 10.1074/jbc.M402102200; Safdar A, 2010, FREE RADICAL BIO MED, V49, P1487, DOI 10.1016/j.freeradbiomed.2010.08.010; Safdar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010778; Safdar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005610; Saleem A, 2009, PHYSIOL GENOMICS, V37, P58, DOI 10.1152/physiolgenomics.90346.2008; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Shannon MF, 2001, J LEUKOCYTE BIOL, V69, P21; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Sutherland LN, 2009, J PHYSIOL-LONDON, V587, P1607, DOI 10.1113/jphysiol.2008.165464; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Warburton DER, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-39; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Wenz T, 2009, J APPL PHYSIOL, V106, P1712, DOI 10.1152/japplphysiol.91571.2008; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	69	228	237	0	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10605	10617		10.1074/jbc.M110.211466	http://dx.doi.org/10.1074/jbc.M110.211466			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21245132	hybrid, Green Published			2022-12-27	WOS:000288547000075
J	Comstock, CES; Augello, MA; Schiewer, MJ; Karch, J; Burd, CJ; Ertel, A; Knudsen, ES; Jessen, WJ; Aronow, BJ; Knudsen, KE				Comstock, Clay E. S.; Augello, Michael A.; Schiewer, Matthew J.; Karch, Jason; Burd, Craig J.; Ertel, Adam; Knudsen, Erik S.; Jessen, Walter J.; Aronow, Bruce J.; Knudsen, Karen E.			Cyclin D1 Is a Selective Modifier of Androgen-dependent Signaling and Androgen Receptor Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; GENE-EXPRESSION; CELL-PROLIFERATION; ESTROGEN-RECEPTOR; TRANSCRIPTIONAL ACTIVITY; RESPONSIVE GENES; KINASE-ACTIVITY; CO-REPRESSOR; ACTIVATION; NUCLEAR	D-type cyclins regulate cellular outcomes in part through cyclin-dependent, kinase-independent mechanisms that modify transcription factor action, and recent in vivo studies showed that cyclin D1 associates with a large number of transcriptional regulators in cells of the retina and breast. Given the frequency of cyclin D1 alterations in cancer, it is imperative to delineate the molecular mechanisms by which cyclin D1 controls key transcription factor networks in human disease. Prostate cancer was used as a paradigm because this tumor type is reliant at all stages of the disease on androgen receptor (AR) signaling, and cyclin D1 has been shown to negatively modulate AR-dependent expression of prostate-specific antigen (KLK3/PSA). Strategies were employed to control cyclin D1 expression under conditions of hormone depletion, and the effect of cyclin D1 on subsequent androgen-dependent gene expression was determined using unbiased gene expression profiling. Modulating cyclin D1 conferred widespread effects on androgen signaling and revealed cyclin D1 to be a selective effector of hormone action. A subset of androgen-induced target genes, known to be directly regulated by AR, was strongly suppressed by cyclin D1. Analyses of AR occupancy at target gene regulatory loci of clinical relevance demonstrated that cyclin D1 limits AR residence after hormone stimulation. Together, these findings reveal a new function for cyclin D1 in controlling hormone-dependent transcriptional outcomes and demonstrate a pervasive role for cyclin D1 in regulating transcription factor dynamics.	[Comstock, Clay E. S.; Augello, Michael A.; Schiewer, Matthew J.; Ertel, Adam; Knudsen, Erik S.; Knudsen, Karen E.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Comstock, Clay E. S.; Augello, Michael A.; Schiewer, Matthew J.; Ertel, Adam; Knudsen, Erik S.; Knudsen, Karen E.] Thomas Jefferson Univ, Dept Canc Biol, Philadelphia, PA 19107 USA; [Knudsen, Karen E.] Thomas Jefferson Univ, Dept Urol, Philadelphia, PA 19107 USA; [Knudsen, Karen E.] Thomas Jefferson Univ, Dept Radiat Oncol, Philadelphia, PA 19107 USA; [Karch, Jason] Univ Cincinnati, Dept Cell & Canc Biol, Cincinnati, OH 45221 USA; [Burd, Craig J.] NIEHS, NIH, Res Triangle Pk, NC 27709 USA; [Jessen, Walter J.] Covance Biomarker Ctr Excellence, Greenfield, IN 46140 USA; [Aronow, Bruce J.] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH 45229 USA	Jefferson University; Jefferson University; Jefferson University; Jefferson University; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Covance; Cincinnati Children's Hospital Medical Center	Knudsen, KE (corresponding author), 233 S 10th St,BLSB 1008A, Philadelphia, PA 19107 USA.	Karen.Knudsen@kimmelcancercenter.org	Comstock, Clay/B-6122-2008; Aronow, Bruce J/F-8438-2012	Comstock, Clay/0000-0001-5867-1489; Jessen, Walter/0000-0003-3840-4337; Burd, Craig/0000-0002-6899-6751; Schiewer, Matthew/0000-0002-2325-4228; Knudsen, Karen/0000-0002-1301-890X	National Institutes of Health [CA099996]; Department of Defense [PC094507, PC094195, PC094596]; NATIONAL CANCER INSTITUTE [R01CA099996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA099996 (to K. E. K.). This work was also supported by Department of Defense New Investigator Award PC094507 (to C. E. S. C.) and Department of Defense Predoctoral Fellowships PC094195 (to M. J. S.) and PC094596 (to M. A. A.).	Alt JR, 2002, J BIOL CHEM, V277, P8517, DOI 10.1074/jbc.M108867200; BATES S, 1994, ONCOGENE, V9, P71; BERNARDS R, 1999, BIOCHIM BIOPHYS ACTA, V1424, P17; Bienvenu F, 2010, NATURE, V463, P374, DOI 10.1038/nature08684; Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207; Burd CJ, 2006, P NATL ACAD SCI USA, V103, P2190, DOI 10.1073/pnas.0506281103; Burd CJ, 2005, MOL ENDOCRINOL, V19, P607, DOI 10.1210/me.2004-0266; Burd CJ, 2006, ENDOCR-RELAT CANCER, V13, P979, DOI 10.1677/erc.1.01115; BUSSEY KJ, 2003, GENOME BIOL, V4, pNIL81; Cai C, 2007, PROSTATE CANCER P D, V10, P39, DOI 10.1038/sj.pcan.4500912; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Ciemerych MA, 2008, INT J DEV BIOL, V52, P299, DOI 10.1387/ijdb.072336mc; Clark EL, 2008, CANCER RES, V68, P7938, DOI 10.1158/0008-5472.CAN-08-0932; Comstock CES, 2007, BRIT J CANCER, V96, P970, DOI 10.1038/sj.bjc.6603615; Comstock CES, 2008, CONTEMP ENDOCRINOL S, P83, DOI 10.1007/978-1-59745-309-7_5; Comstock CES, 2009, CLIN CANCER RES, V15, P5338, DOI 10.1158/1078-0432.CCR-08-2865; Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; DELAUNOIT Y, 1991, CANCER RES, V51, P5165; DePrimo SE, 2002, GENOME BIOL, V3; Ewen ME, 2004, TRENDS MOL MED, V10, P158, DOI 10.1016/j.molmed.2004.02.005; Fritah A, 2005, MOL CELL BIOL, V25, P2419, DOI 10.1128/MCB.25.6.2419-2430.2005; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Fu MF, 2005, J BIOL CHEM, V280, P16934, DOI 10.1074/jbc.M500403200; Gan L, 2009, CELL DEATH DIFFER, V16, P1408, DOI 10.1038/cdd.2009.86; Henrique R, 2006, J MOL MED, V84, P911, DOI 10.1007/s00109-006-0099-4; Ho LL, 2008, PROSTATE, V68, P1421, DOI 10.1002/pros.20809; Holzbeierlein J, 2004, AM J PATHOL, V164, P217, DOI 10.1016/S0002-9440(10)63112-4; Inoue K, 1998, MOL CELL BIOL, V18, P1590, DOI 10.1128/MCB.18.3.1590; Jia L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003645; Kang ZG, 2004, MOL ENDOCRINOL, V18, P2633, DOI 10.1210/me.2004-0245; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Knudsen KE, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-15; Knudsen KE, 2009, CLIN CANCER RES, V15, P4792, DOI 10.1158/1078-0432.CCR-08-2660; Knudsen KE, 1999, CANCER RES, V59, P2297; Knudsen KE, 1998, J BIOL CHEM, V273, P20213, DOI 10.1074/jbc.273.32.20213; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Kruh GD, 2007, CANCER METAST REV, V26, P5, DOI 10.1007/s10555-007-9039-1; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; Lacombe L, 2001, INT J CANCER, V95, P135, DOI 10.1002/1097-0215(20010520)95:3<135::AID-IJC1023>3.0.CO;2-3; Lam EWF, 2000, J BIOL CHEM, V275, P3479, DOI 10.1074/jbc.275.5.3479; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Li H, 2008, P NATL ACAD SCI USA, V105, P20179, DOI 10.1073/pnas.0807121105; Li JW, 2002, GENE DEV, V16, P687, DOI 10.1101/gad.962502; Lin BY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006589; Lin BY, 1999, CANCER RES, V59, P4180; Lin HM, 2002, J BIOL CHEM, V277, P28733, DOI 10.1074/jbc.M203380200; Link KA, 2008, CANCER RES, V68, P4551, DOI 10.1158/0008-5472.CAN-07-6392; Makkonen H, 2011, MOL CELL ENDOCRINOL, V331, P57, DOI 10.1016/j.mce.2010.08.008; Makkonen H, 2009, NUCLEIC ACIDS RES, V37, P4135, DOI 10.1093/nar/gkp352; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; Mendiratta P, 2009, J CLIN ONCOL, V27, P2022, DOI 10.1200/JCO.2008.17.2882; MEYERSON M, 1994, MOL CELL BIOL, V14, P2077, DOI 10.1128/MCB.14.3.2077; Muller I, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-297; Mullany LK, 2008, CELL CYCLE, V7, P2215, DOI 10.4161/cc.7.14.6274; Nelson PS, 2002, P NATL ACAD SCI USA, V99, P11890, DOI 10.1073/pnas.182376299; Neuman E, 1997, MOL CELL BIOL, V17, P5338, DOI 10.1128/MCB.17.9.5338; Ngan S, 2009, ONCOGENE, V28, P2051, DOI 10.1038/onc.2009.68; Obiezu CV, 2005, CANCER LETT, V224, P1, DOI 10.1016/j.canlet.2004.09.024; Olshavsky NA, 2008, ONCOGENE, V27, P3111, DOI 10.1038/sj.onc.1210981; Omar EA, 2001, PROSTATE, V49, P191, DOI 10.1002/pros.1134; PENDAS AM, 1994, CYTOGENET CELL GENET, V66, P263, DOI 10.1159/000133708; Peng Y, 2008, P NATL ACAD SCI USA, V105, P5236, DOI 10.1073/pnas.0712262105; Petre CE, 2002, J BIOL CHEM, V277, P2207, DOI 10.1074/jbc.M106399200; Petre-Draviam CE, 2005, ONCOGENE, V24, P431, DOI 10.1038/sj.onc.1208200; Petre-Draviam CE, 2003, CANCER RES, V63, P4903; Reutens AT, 2001, MOL ENDOCRINOL, V15, P797, DOI 10.1210/me.15.5.797; Rigaud J, 2004, PROSTATE, V58, P269, DOI 10.1002/pros.10329; Sarkar FH, 1999, PROSTATE, V40, P256; Schiewer MJ, 2009, ONCOGENE, V28, P1016, DOI 10.1038/onc.2008.446; Shi XB, 2008, PROSTATE, V68, P1816, DOI 10.1002/pros.20849; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Vellaichamy A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010936; Waltering KK, 2009, CANCER RES, V69, P8141, DOI 10.1158/0008-5472.CAN-09-0919; Wang CG, 2003, MOL CELL BIOL, V23, P6159, DOI 10.1128/MCB.23.17.6159-6173.2003; Wang G, 2006, ONCOGENE, V25, P7311, DOI 10.1038/sj.onc.1209715; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang QB, 2009, CELL, V138, P245, DOI 10.1016/j.cell.2009.04.056; Wetherill YB, 2002, MOL CANCER THER, V1, P515; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; WONG CI, 1993, J BIOL CHEM, V268, P19004; Xu LL, 2000, GENOMICS, V66, P257, DOI 10.1006/geno.2000.6214; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; Yu QY, 2005, ONCOGENE, V24, P7114, DOI 10.1038/sj.onc.1208853; Zhao HJ, 2005, PROSTATE, V63, P187, DOI 10.1002/pros.20158; Zwijsen RML, 1997, CELL, V88, P405, DOI 10.1016/S0092-8674(00)81879-6	92	28	28	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8117	8127		10.1074/jbc.M110.170720	http://dx.doi.org/10.1074/jbc.M110.170720			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21212260	Green Published, hybrid			2022-12-27	WOS:000288013300042
J	Ghanta, KS; Pakala, SB; Reddy, SDN; Li, DQ; Nair, SS; Kumar, R				Ghanta, Krishna Sumanth; Pakala, Suresh B.; Reddy, Sirigiri Divijendra Natha; Li, Da-Qiang; Nair, Sujit S.; Kumar, Rakesh			MTA1 Coregulation of Transglutaminase 2 Expression and Function during Inflammatory Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSACTIVATOR PROTEIN HBX; TISSUE TRANSGLUTAMINASE; BREAST-CANCER; METASTASIS; CELLS; ADENOCARCINOMA; COACTIVATOR; ACTIVATION; CIRCUITRY	Although both metastatic tumor antigen 1 (MTA1), a master chromatin modifier, and transglutaminase 2 (TG2), a multifunctional enzyme, are known to be activated during inflammation, it remains unknown whether these molecules regulate inflammatory response in a coordinated manner. Here we investigated the role of MTA1 in the regulation of TG2 expression in bacterial lipopolysaccharide (LPS)-stimulated mammalian cells. While studying the impact of MTA1 status on global gene expression, we unexpectedly discovered that MTA1 depletion impairs the basal as well as the LPS-induced expression of TG2 in multiple experimental systems. We found that TG2 is a chromatin target of MTA1 and of NF-kappa B signaling in LPS-stimulated cells. In addition, LPS-mediated stimulation of TG2 expression is accompanied by the enhanced recruitment of MTA1, p65RelA, and RNA polymerase II to the NF-kappa B consensus sites in the TG2 promoter. Interestingly, both the recruitment of p65 and TG2 expression are effectively blocked by a pharmacological inhibitor of the NF-kappa B pathway. These findings reveal an obligatory coregulatory role of MTA1 in the regulation of TG2 expression and of the MTA1-TG2 pathway, at least in part, in LPS modulation of the NF-kappa B signaling in stimulated macrophages.	[Kumar, Rakesh] George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA; George Washington Univ, Med Ctr, Inst Coregulator Biol, Washington, DC 20037 USA	George Washington University; George Washington University	Kumar, R (corresponding author), George Washington Univ, Med Ctr, Dept Biochem & Mol Biol, Washington, DC 20037 USA.	bcmrxk@gwumc.edu	Kumar, Rakesh/ABD-1065-2020; sirigiri, divijendra reddy/E-1031-2017; sirigiri, divijendranathareddy/A-9857-2010; Ghanta, Krishna S./M-1307-2019	Kumar, Rakesh/0000-0001-7664-0803; sirigiri, divijendra reddy/0000-0003-4657-2285; Ghanta, Krishna S./0000-0001-7502-3141; Pakala, Suresh Babu/0000-0002-5679-4837	National Institute of Health [CA98823, CA98823-S1]; NATIONAL CANCER INSTITUTE [R01CA098823] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institute of Health Grants CA98823 and CA98823-S1 (to R. K.).	Bui-Nguyen TM, 2010, ONCOGENE, V29, P1179, DOI 10.1038/onc.2009.404; Bui-Nguyen TM, 2010, J BIOL CHEM, V285, P6980, DOI 10.1074/jbc.M109.065987; El Gazzar M, 2009, MOL CELL BIOL, V29, P1959, DOI 10.1128/MCB.01862-08; Facchiano F, 2006, FRONT BIOSCI, V11, P1758, DOI 10.2741/1921; Falasca L, 2008, J IMMUNOL, V180, P2616, DOI 10.4049/jimmunol.180.4.2616; Heppner GH, 2000, BREAST CANCER RES, V2, P331; Iismaa SE, 2009, PHYSIOL REV, V89, P991, DOI 10.1152/physrev.00044.2008; Kausar T, 2011, CANCER INVEST, V29, P42, DOI 10.3109/07357907.2010.512597; Kim SY, 2006, FRONT BIOSCI-LANDMRK, V11, P3026, DOI 10.2741/2030; Kishida Y, 2007, CLIN CANCER RES, V13, P59, DOI 10.1158/1078-0432.CCR-06-1559; KOJIMA S, 1993, J CELL BIOL, V121, P439, DOI 10.1083/jcb.121.2.439; Kumar R, 2003, SEMIN ONCOL, V30, P30, DOI 10.1053/j.seminoncol.2003.08.005; Kumar R, 2010, CANCER RES, V70, P6649, DOI 10.1158/0008-5472.CAN-10-0909; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Li DQ, 2010, J BIOL CHEM, V285, P10044, DOI 10.1074/jbc.M109.079095; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Manavathi Bramanandam, 2007, Nucl Recept Signal, V5, pe010, DOI 10.1621/nrs.05010; Manavathi B, 2007, J BIOL CHEM, V282, P1529, DOI 10.1074/jbc.R600029200; Mangala LS, 2005, PROG EXP TUMOR RES, V38, P125; Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; Mehta K, 2010, BIOCHEM PHARMACOL, V80, P1921, DOI 10.1016/j.bcp.2010.06.029; Murthy SNP, 1999, P NATL ACAD SCI USA, V96, P11815, DOI 10.1073/pnas.96.21.11815; Nardacci R, 2003, AM J PATHOL, V162, P1293, DOI 10.1016/S0002-9440(10)63925-9; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Pakala SB, 2010, J BIOL CHEM, V285, P32787, DOI 10.1074/jbc.M110.151340; Pakala SB, 2010, J BIOL CHEM, V285, P23590, DOI 10.1074/jbc.M110.139469; Perkins ND, 1997, SCIENCE, V275, P523, DOI 10.1126/science.275.5299.523; Satpathy N, 2007, CANCER RES, V67, P7194, DOI 10.1158/0008-5472.CAN-07-0307; Szondy Z, 2003, P NATL ACAD SCI USA, V100, P7812, DOI 10.1073/pnas.0832466100; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TOH Y, 1994, J BIOL CHEM, V269, P22958; UPCHURCH HF, 1991, J CELL PHYSIOL, V149, P375, DOI 10.1002/jcp.1041490304; Verma A, 2006, CANCER RES, V66, P10525, DOI 10.1158/0008-5472.CAN-06-2387; Yu CD, 2007, MOL CELL, V25, P765, DOI 10.1016/j.molcel.2007.01.025	37	31	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7132	7138		10.1074/jbc.M110.199273	http://dx.doi.org/10.1074/jbc.M110.199273			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21156794	hybrid, Green Published			2022-12-27	WOS:000287737300030
J	Lee, Y; Chen, RM; Lee, HM; Lee, C				Lee, Yongjin; Chen, Rongmin; Lee, Hyeong-min; Lee, Choogon			Stoichiometric Relationship among Clock Proteins Determines Robustness of Circadian Rhythms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; INDIVIDUAL FIBROBLASTS; REVEALS PERSISTENT; MOLECULAR ANALYSIS; NEGATIVE FEEDBACK; CKI-EPSILON; TRANSCRIPTION; NEUROSPORA; PHOSPHORYLATION; MECHANISMS	The mammalian circadian oscillator is primarily driven by an essential negative feedback loop comprising a positive component, the CLOCK-BMAL1 complex, and a negative component, the PER-CRY complex. Numerous studies suggest that feedback inhibition of CLOCK-BMAL1 is mediated by time-dependent physical interaction with its direct target gene products PER and CRY, suggesting that the ratio between the negative and positive complexes must be important for the molecular oscillator and rhythm generation. We explored this idea by altering expression of clock components in fibroblasts derived from Per2(Luc) and Per mutant mice, a cell system extensively used to study in vivo clock mechanisms. Our data demonstrate that the stoichiometric relationship between clock components is critical for the robustness of circadian rhythms and provide insights into the mechanistic organization of the negative feedback loop. Our findings may explain why certain mutant mice or cells are arrhythmic, whereas others are rhythmic, and suggest that robustness of circadian rhythms can be increased even in wild-type cells by modulating the stoichiometry.	[Lee, Yongjin; Chen, Rongmin; Lee, Hyeong-min; Lee, Choogon] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32312 USA	State University System of Florida; Florida State University	Lee, C (corresponding author), Florida State Univ, Dept Biomed Sci, Coll Med, 1115 W Call St, Tallahassee, FL 32306 USA.	choogon.lee@med.fsu.edu	Lee, HM/D-2777-2011; Lee, HM/ABC-2680-2020	Lee, HM/0000-0002-9381-3611; Lee, HM/0000-0002-9381-3611	National Institutes of Health [NS-053616]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053616] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS-053616 (to C. L.).	Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BAYLIES MK, 1987, NATURE, V326, P390, DOI 10.1038/326390a0; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Cuninkova L, 2008, ANN NY ACAD SCI, V1129, P358, DOI 10.1196/annals.1417.005; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; DeBruyne JP, 2006, NEURON, V50, P465, DOI 10.1016/j.neuron.2006.03.041; Denault DL, 2001, EMBO J, V20, P109, DOI 10.1093/emboj/20.1.109; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dibner C, 2009, EMBO J, V28, P123, DOI 10.1038/emboj.2008.262; Duffield GE, 2009, CURR BIOL, V19, P297, DOI 10.1016/j.cub.2008.12.052; Etchegaray JP, 2009, MOL CELL BIOL, V29, P3853, DOI 10.1128/MCB.00338-09; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hao HP, 1999, J NEUROSCI, V19, P987; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He QY, 2005, J BIOL CHEM, V280, P17526, DOI 10.1074/jbc.M414010200; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hida A, 2000, GENOMICS, V65, P224, DOI 10.1006/geno.2000.6166; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Kadener S, 2008, PLOS BIOL, V6, P965, DOI 10.1371/journal.pbio.0060119; Kim EY, 2006, P NATL ACAD SCI USA, V103, P6178, DOI 10.1073/pnas.0511215103; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lee C, 2004, MOL CELL BIOL, V24, P584, DOI 10.1128/MCB.24.2.584-594.2004; Lee H, 2009, P NATL ACAD SCI USA, V106, P21359, DOI 10.1073/pnas.0906651106; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Liu Y, 2006, EUKARYOT CELL, V5, P1184, DOI 10.1128/EC.00133-06; Loros JJ, 2001, ANNU REV PHYSIOL, V63, P757, DOI 10.1146/annurev.physiol.63.1.757; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; Menet JS, 2010, GENE DEV, V24, P358, DOI 10.1101/gad.1883910; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reddy AB, 2010, TRENDS CELL BIOL, V20, P36, DOI 10.1016/j.tcb.2009.10.005; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; RUTILA JE, 1992, J NEUROGENET, V8, P101, DOI 10.3109/01677069209084155; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Schafmeier T, 2005, CELL, V122, P235, DOI 10.1016/j.cell.2005.05.032; Schibler U, 2005, EMBO REP, V6, pS9, DOI 10.1038/sj.embor.7400424; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yu WJ, 2006, GENE DEV, V20, P723, DOI 10.1101/gad.1404406	59	59	59	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7033	7042		10.1074/jbc.M110.207217	http://dx.doi.org/10.1074/jbc.M110.207217			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21199878	Green Published, hybrid			2022-12-27	WOS:000287737300020
J	Shimomura, T; Irie, K; Nagura, H; Imai, T; Fujiyoshi, Y				Shimomura, Takushi; Irie, Katsumasa; Nagura, Hitoshi; Imai, Tomoya; Fujiyoshi, Yoshinori			Arrangement and Mobility of the Voltage Sensor Domain in Prokaryotic Voltage-gated Sodium Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SHAKER K+ CHANNEL; PORE DOMAIN; GATING-CHARGE; S4 SEGMENT; POTASSIUM CHANNEL; LIPID-MEMBRANE; ION CHANNELS; NA+ CHANNEL; RESIDUES; MOVEMENT	Prokaryotic voltage-gated sodium channels (Na(V)s) form homotetramers with each subunit contributing six transmembrane alpha-helices (S1-S6). Helices S5 and S6 form the ion-conducting pore, and helices S1-S4 function as the voltage sensor with helix S4 thought to be the essential element for voltage-dependent activation. Although the crystal structures have provided insight into voltage-gated K channels (K(V)s), revealing a characteristic domain arrangement in which the voltage sensor domain of one subunit is close to the pore domain of an adjacent subunit in the tetramer, the structural and functional information on Na(V)s remains limited. Here, we show that the domain arrangement in NaChBac, a firstly cloned prokaryotic Na-V, is similar to that in K(V)s. Cysteine substitutions of three residues in helix S4, Q107C, T110C, and R113C, effectively induced intersubunit disulfide bond formation with a cysteine introduced in helix S5, M164C, of the adjacent subunit. In addition, substituting two acidic residues with lysine, E43K and D60K, shifted the activation of the channel to more positive membrane potentials and consistently shifted the preferentially formed disulfide bond from T110C/M164C to Q107C/M164C. Because Gln-107 is located closer to the extracellular side of helix S4 than Thr-110, this finding suggests that the functional shift in the voltage dependence of activation is related to a restriction of the position of helix S4 in the lipid bilayer. The domain arrangement and vertical mobility of helix S4 in NaChBac indicate that the structure and the mechanism of voltage-dependent activation in prokaryotic Na(V)s are similar to those in canonical K(V)s.	[Shimomura, Takushi; Irie, Katsumasa; Nagura, Hitoshi; Fujiyoshi, Yoshinori] Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; [Irie, Katsumasa; Fujiyoshi, Yoshinori] Japan Biol Informat Consortium, Sakyo Ku, Kyoto 6068502, Japan; [Imai, Tomoya] Kyoto Univ, Res Inst Sustainable Humanosphere, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Fujiyoshi, Y (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.	yoshi@em.biophys.kyoto-u.ac.jp	Fujiyoshi, Yoshinori/E-5989-2012; 今井, 友也/M-1834-2019; Irie, Katsumasa/D-7332-2013	Fujiyoshi, Yoshinori/0000-0002-8070-1493; 今井, 友也/0000-0001-7026-0287; Irie, Katsumasa/0000-0002-8178-1552	Japan New Energy and Industrial Technology Development Organization; Kyoto University	Japan New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Kyoto University	This work was supported by Grants-in-Aid for Scientific Research, the Japan New Energy and Industrial Technology Development Organization, and the Kyoto University Global COE Program, Formation of a Strategic Base for Biodiversity and Evolutionary Research: From Genome to Ecosystem.	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1974, J GEN PHYSIOL, V63, P533, DOI 10.1085/jgp.63.5.533; Blanchet J, 2007, BIOPHYS J, V92, P3513, DOI 10.1529/biophysj.106.090464; Broomand A, 2003, J GEN PHYSIOL, V122, P741, DOI 10.1085/jgp.200308927; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Chahine M, 2004, J MEMBRANE BIOL, V201, P9, DOI 10.1007/s00232-004-0701-z; Chakrapani S, 2010, P NATL ACAD SCI USA, V107, P5435, DOI 10.1073/pnas.0914109107; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; DeCaen PG, 2009, P NATL ACAD SCI USA, V106, P22498, DOI 10.1073/pnas.0912307106; Elinder F, 2001, J GEN PHYSIOL, V118, P1, DOI 10.1085/jgp.118.1.1; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Irie K, 2010, J BIOL CHEM, V285, P3685, DOI 10.1074/jbc.M109.057455; Ito M, 2004, P NATL ACAD SCI USA, V101, P10566, DOI 10.1073/pnas.0402692101; Koishi R, 2004, J BIOL CHEM, V279, P9532, DOI 10.1074/jbc.M313100200; Kuzmenkin A, 2004, J GEN PHYSIOL, V124, P349, DOI 10.1085/jgp.200409139; Lai HC, 2005, NEURON, V47, P395, DOI 10.1016/j.neuron.2005.06.019; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Larsson HP, 2000, NEURON, V27, P573, DOI 10.1016/S0896-6273(00)00067-2; Lee SY, 2005, P NATL ACAD SCI USA, V102, P15441, DOI 10.1073/pnas.0507651102; Li-Smerin YY, 2000, NEURON, V25, P411, DOI 10.1016/S0896-6273(00)80904-6; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Nagura H, 2010, BIOCHEM BIOPH RES CO, V399, P341, DOI 10.1016/j.bbrc.2010.07.070; Neale EJ, 2003, J BIOL CHEM, V278, P29079, DOI 10.1074/jbc.M301991200/6493; Paldi T, 2010, BIOPHYS J, V99, P456, DOI 10.1016/j.bpj.2010.04.053; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Pavlov E, 2005, BIOPHYS J, V89, P232, DOI 10.1529/biophysj.104.056994; Posson DJ, 2005, NATURE, V436, P848, DOI 10.1038/nature03819; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Richardson J, 2006, P NATL ACAD SCI USA, V103, P15865, DOI 10.1073/pnas.0607532103; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Schulteis CT, 1996, BIOCHEMISTRY-US, V35, P12133, DOI 10.1021/bi961083s; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Tiwari-Woodruff SK, 2000, J GEN PHYSIOL, V115, P123, DOI 10.1085/jgp.115.2.123; Wahlberg E, 2006, J AM CHEM SOC, V128, P7651, DOI 10.1021/ja060933g; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; YU FH, 2004, SCI STKE; Zhao Y, 2004, P NATL ACAD SCI USA, V101, P17873, DOI 10.1073/pnas.0408270101	39	13	13	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7409	7417		10.1074/jbc.M110.186510	http://dx.doi.org/10.1074/jbc.M110.186510			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177850	hybrid, Green Published			2022-12-27	WOS:000287737300056
J	Wang, LJ; Wang, J; Li, N; Ge, LA; Li, BL; Song, BL				Wang, Li-Juan; Wang, Jing; Li, Na; Ge, Liang; Li, Bo-Liang; Song, Bao-Liang			Molecular Characterization of the NPC1L1 Variants Identified from Cholesterol Low Absorbers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; RECOMBINANT ADENOVIRUSES; GENETIC-VARIATION; ABSORPTION; EZETIMIBE; PROTEIN; METABOLISM; TRANSPORT; MEMBRANE; COMPLEX	Niemann-Pick C1-like 1 (NPC1L1) is an essential protein for dietary cholesterol absorption. Nonsynonymous (NS) variants of NPC1L1 in humans have been suggested to associate with cholesterol absorption variations. However, information concerning the characteristics and mechanism of these variants in cholesterol uptake is limited. In this study, we analyzed the cholesterol uptake ability of the 19 reported NS variants of NPC1L1 identified from cholesterol low absorbers. Among these variants, L110F, R306C, A395V, G402S, T413M, R693C, R1214H, and R1268H could partially mediate cellular cholesterol uptake and were categorized as partially dysfunctional variants. The other 11 variants including T61M, N132S, D398G, R417W, G434R, T499M, S620C, I647N, G672R, S881L, and R1108W could barely facilitate cholesterol uptake, and were classified into the severely dysfunctional group. The partially dysfunctional variants showed mild defects in one or multiple aspects of cholesterol-regulated recycling, subcellular localization, glycosylation, and protein stability. The severely dysfunctional ones displayed remarkable defects in all these aspects and were rapidly degraded through the ER-associated degradation (ERAD) pathway. In vivo analyses using adenovirus-mediated expression in mouse liver confirmed that the S881L variant failed to localize to liver canalicular membrane, and the mice showed defects in biliary cholesterol re-absorption, while the G402S variant appeared to be similar to wildtype NPC1L1 in mouse liver. This study suggests that the dysfunction of the 19 variants on cholesterol absorption is due to the impairment of recycling, subcellular localization, glycosylation, or stability of NPC1L1.	[Wang, Li-Juan; Wang, Jing; Li, Na; Ge, Liang; Li, Bo-Liang; Song, Bao-Liang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Song, BL (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	blsong@sibs.ac.cn		Song, Bao-Liang/0000-0002-6397-5935; Ge, Liang/0000-0002-7371-2039	Ministry of Science and Technology of China [2009CB919000, 2011CB910900]; National Natural Science Foundation of China [30925012, 90713025]; Shanghai Science and Technology Committee [10QH1402900]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This work was supported by grants from the Ministry of Science and Technology of China (2009CB919000 and 2011CB910900), National Natural Science Foundation of China (30925012 and 90713025), and Shanghai Science and Technology Committee (10QH1402900).	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Bosner MS, 1999, J LIPID RES, V40, P302; Brown AJ, 2002, MOL CELL, V10, P237, DOI 10.1016/S1097-2765(02)00591-9; Cao J, 2007, CELL METAB, V6, P115, DOI 10.1016/j.cmet.2007.07.002; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Chakravarthy MV, 2009, CELL, V138, P476, DOI 10.1016/j.cell.2009.05.036; Chen CW, 2009, J HUM GENET, V54, P242, DOI 10.1038/jhg.2009.18; Chu BB, 2009, J BIOL CHEM, V284, P22481, DOI 10.1074/jbc.M109.034355; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Davies JP, 2005, J BIOL CHEM, V280, P12710, DOI 10.1074/jbc.M409110200; Davis HR, 2007, J ATHEROSCLER THROMB, V14, P99, DOI 10.5551/jat.14.99; Davis HR, 2009, BBA-MOL CELL BIOL L, V1791, P679, DOI 10.1016/j.bbalip.2009.01.002; Fahmi S, 2008, HUM MOL GENET, V17, P2101, DOI 10.1093/hmg/ddn108; Garcia-Calvo M, 2005, P NATL ACAD SCI USA, V102, P8132, DOI 10.1073/pnas.0500269102; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; GRUNDY SM, 1983, ANNU REV NUTR, V3, P71, DOI 10.1146/annurev.nu.03.070183.000443; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hegele Robert A, 2005, Lipids Health Dis, V4, P16, DOI 10.1186/1476-511X-4-16; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Maeda T, 2010, J ATHEROSCLER THROMB, V17, P356, DOI 10.5551/jat.2451; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Martin B, 2010, NUTR METAB CARDIOVAS, V20, P236, DOI 10.1016/j.numecd.2009.03.023; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Paulusma CC, 1999, BIOCHEM J, V338, P393, DOI 10.1042/0264-6021:3380393; Pisciotta L, 2007, ATHEROSCLEROSIS, V194, pE116, DOI 10.1016/j.atherosclerosis.2006.10.036; PLUMMER T H JR, 1991, Glycobiology, V1, P257, DOI 10.1093/glycob/1.3.257; Polisecki E, 2010, J LIPID RES, V51, P1201, DOI 10.1194/jlr.P001172; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Severs N J, 1997, Subcell Biochem, V28, P477; Simon JS, 2005, GENOMICS, V86, P648, DOI 10.1016/j.ygeno.2005.08.007; Temel RE, 2007, J CLIN INVEST, V117, P1968, DOI 10.1172/JCI30060; Ullrich O, 1996, J CELL BIOL, V135, P913, DOI 10.1083/jcb.135.4.913; VARKI A, 2009, CURRENT PROTOCOLS PR, P57; Wang J, 2005, CLIN GENET, V67, P175, DOI 10.1111/j.1399-0004.2004.00388.x; Wang J, 2009, J LIPID RES, V50, P1653, DOI 10.1194/jlr.M800669-JLR200; Weinglass AB, 2008, P NATL ACAD SCI USA, V105, P11140, DOI 10.1073/pnas.0800936105; Yamanashi Y, 2009, PHARMACOGENET GENOM, V19, P884, DOI 10.1097/FPC.0b013e3283327925; Zhao H, 2008, LIPIDS, V43, P1155, DOI 10.1007/s11745-008-3241-y	42	50	57	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7397	7408		10.1074/jbc.M110.178368	http://dx.doi.org/10.1074/jbc.M110.178368			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21189420	Green Published, hybrid			2022-12-27	WOS:000287737300055
J	Behnke-Parks, WM; Vendome, J; Honig, B; Maliga, Z; Moores, C; Rosenfeld, SS				Behnke-Parks, William M.; Vendome, Jeremie; Honig, Barry; Maliga, Zoltan; Moores, Carolyn; Rosenfeld, Steven S.			Loop L5 Acts as a Conformational Latch in the Mitotic Kinesin Eg5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALLOSTERIC INHIBITOR; DIMERIC KINESIN; ATP HYDROLYSIS; NECK-LINKER; HUMAN KSP; SWITCH-I; MOTOR; MECHANISM; MONASTROL; PROTEIN	All members of the kinesin superfamily of molecular motors contain an unusual structural motif consisting of an alpha-helix that is interrupted by a flexible loop, referred to as L5. We have examined the function of L5 in the mitotic kinesin Eg5 by combining site-directed mutagenesis of L5 with transient state kinetics, molecular dynamics simulations, and docking using cryo electron microscopy density. We find that mutation of a proline residue located at a turn within this loop profoundly slows nucleotide-induced structural changes both at the catalytic site as well as at the microtubule binding domain and the neck linker. Molecular dynamics simulations reveal that this mutation affects the dynamics not only of L5 itself but also of the switch I structural elements that sense ATP binding to the catalytic site. Our results lead us to propose that L5 regulates the rate of conformational change in key elements of the nucleotide binding site through its interactions with alpha 3 and in so doing controls the speed of movement and force generation in kinesin motors.	[Rosenfeld, Steven S.] Columbia Univ, Dept Neurol, Coll Phys & Surg, New York, NY 10032 USA; Columbia Univ, Dept Biol, New York, NY 10032 USA; [Vendome, Jeremie; Honig, Barry] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Maliga, Zoltan] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Moores, Carolyn] Univ London, Birkbeck Coll, Sch Crystallog, London WC1E 7HX, England	Columbia University; Columbia University; Columbia University; Max Planck Society; University of London; Birkbeck University London	Rosenfeld, SS (corresponding author), Columbia Univ, Dept Neurol, Coll Phys & Surg, 710 W 168th St, New York, NY 10032 USA.	sr2327@columbia.edu	Moores, Carolyn/A-4942-2010		National Institutes of Health [AR048565]; Biotechnology and Biological Sciences Research Council; BBSRC [BB/H005137/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/H005137/1] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR048565 (NIAMS; to S.S.R.). This work was also supported by the Biotechnology and Biological Sciences Research Council.	Adams SR, 2002, J AM CHEM SOC, V124, P6063, DOI 10.1021/ja017687n; Bodey AJ, 2009, J MOL BIOL, V388, P218, DOI 10.1016/j.jmb.2009.03.008; Brier S, 2006, J MOL BIOL, V360, P360, DOI 10.1016/j.jmb.2006.04.062; Cochran JC, 2009, CELL, V136, P110, DOI 10.1016/j.cell.2008.11.048; Cochran JC, 2005, BIOCHEMISTRY-US, V44, P16633, DOI 10.1021/bi051724w; Creighton TE, 1983, PROTEINS STRUCTURES; DeBonis S, 2003, BIOCHEMISTRY-US, V42, P338, DOI 10.1021/bi026716j; HACKNEY DD, 1995, NATURE, V377, P448, DOI 10.1038/377448a0; HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4; Kikkawa M, 2001, NATURE, V411, P439, DOI 10.1038/35078000; Kim ED, 2010, J BIOL CHEM, V285, P18650, DOI 10.1074/jbc.M109.092072; Klumpp LM, 2003, J BIOL CHEM, V278, P39059, DOI 10.1074/jbc.M304250200; Kull FJ, 2002, J CELL SCI, V115, P15; Lad L, 2008, BIOCHEMISTRY-US, V47, P3576, DOI 10.1021/bi702061g; Larson AG, 2010, BIOPHYS J, V98, P2619, DOI 10.1016/j.bpj.2010.03.014; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Luo LS, 2004, BIOCHEMISTRY-US, V43, P15258, DOI 10.1021/bi048282t; Maliga Z, 2002, CHEM BIOL, V9, P989, DOI 10.1016/S1074-5521(02)00212-0; Maliga Z, 2006, J BIOL CHEM, V281, P7977, DOI 10.1074/jbc.M511955200; Maliga Zoltan, 2006, BMC Chemical Biology, V6, P2, DOI 10.1186/1472-6769-6-2; Marx A, 2005, ADV PROTEIN CHEM, V71, P299, DOI 10.1016/S0065-3233(04)71008-6; Moyer ML, 1998, BIOCHEMISTRY-US, V37, P800, DOI 10.1021/bi9711184; Nitta R, 2004, SCIENCE, V305, P678, DOI 10.1126/science.1096621; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rosenfeld SS, 2001, J BIOL CHEM, V276, P40167, DOI 10.1074/jbc.M103899200; Rosenfeld SS, 2005, J BIOL CHEM, V280, P35684, DOI 10.1074/jbc.M506561200; Turner J, 2001, J BIOL CHEM, V276, P25496, DOI 10.1074/jbc.M100395200; Wood KW, 2010, P NATL ACAD SCI USA, V107, P5839, DOI 10.1073/pnas.0915068107	30	42	42	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5242	5253		10.1074/jbc.M110.192930	http://dx.doi.org/10.1074/jbc.M110.192930			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148480	Green Published, hybrid			2022-12-27	WOS:000287230600033
J	Zhang, K; Harada, Y; Wei, XR; Shukla, D; Rajendran, A; Tawansy, K; Bedell, M; Lim, S; Shaw, PX; He, X; Yang, ZL				Zhang, Kang; Harada, Yuko; Wei, Xinran; Shukla, Dhananjay; Rajendran, Anand; Tawansy, Khaled; Bedell, Matthew; Lim, Sharon; Shaw, Peter X.; He, Xi; Yang, Zhenglin			An Essential Role of the Cysteine-rich Domain of FZD4 in Norrin/Wnt Signaling and Familial Exudative Vitreoretinopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NORRIE-DISEASE GENE; WILD-TYPE; FRIZZLED-4; MUTATIONS; LRP5; PROTEIN; RETINA; NDP	The Wnt pathway plays important yet diverse roles in health and disease. Mutations in the Wnt receptor FZD4 gene have been confirmed to cause familial exudative vitreoretinopathy (FEVR). FEVR is characterized by incomplete vascularization of the peripheral retina, which can lead to vitreous bleeding, tractional retinal detachment, and blindness. We screened for mutations in the FZD4 gene in five families with FEVR and identified five mutations (C45Y, Y58C, W226X, C204R, and W496X), including three novel mutations (C45Y, Y58C, and W226X). In the retina, Norrin serves as a ligand and binds to FZD4 to activate the Wnt signaling pathway in normal angiogenesis and vascularization. The cysteine-rich domain (CRD) of FZD4 has been shown to play a critical role in Norrin-FZD4 binding. We investigated the effect of mutations in the FZD4 CRD in Norrin binding and signaling in vitro and in vivo. Wild-type and mutant FZD4 proteins were assayed for Norrin binding and Norrin-dependent activation of the canonical Wnt pathway by cell-surface and overlay binding assays and luciferase reporter assays. In HEK293 transfection studies, C45Y, Y58C, and C204R mutants did not bind to Norrin and failed to transduce FZD4-mediated Wnt/beta-catenin signaling. In vivo studies using Xenopus embryos showed that these FZD4 mutations disrupt Norrin/beta-catenin signaling as evidenced by decreased Siamois and Xnr3 expression. This study identified a new class of FZD4 gene mutations in human disease and demonstrates a critical role of the CRD in Norrin binding and activation of the beta-catenin pathway.	[Zhang, Kang; Wei, Xinran; Bedell, Matthew; Lim, Sharon; Shaw, Peter X.] Sichuan Univ, W China Hosp, Mol Med Res Ctr, Chengdu 610041, Sichuan, Peoples R China; [Zhang, Kang; Wei, Xinran; Bedell, Matthew; Lim, Sharon; Shaw, Peter X.] Sichuan Univ, W China Hosp, Dept Ophthalmol, Chengdu 610041, Sichuan, Peoples R China; [Zhang, Kang; Wei, Xinran; Bedell, Matthew; Lim, Sharon; Shaw, Peter X.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA; [Zhang, Kang; Wei, Xinran; Bedell, Matthew; Lim, Sharon; Shaw, Peter X.] Univ Calif San Diego, Shiley Eye Ctr, La Jolla, CA 92093 USA; [Harada, Yuko; He, Xi] Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Childrens Hosp Boston, Boston, MA 02115 USA; [Shukla, Dhananjay; Rajendran, Anand] Aravind Eye Hosp, Madurai 625020, Tamil Nadu, India; [Shukla, Dhananjay; Rajendran, Anand] Postgrad Inst Ophthalmol, Madurai 625020, Tamil Nadu, India; [Tawansy, Khaled] Childrens Retina Inst Calif, Los Angeles, CA 90041 USA; [Yang, Zhenglin] Sichuan Acad Med Sci, Ctr Human Mol Biol & Genet, Chengdu 610041, Sichuan, Peoples R China; [Yang, Zhenglin] Sichuan Prov Peoples Hosp, Chengdu 610041, Sichuan, Peoples R China	Sichuan University; Sichuan University; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; Boston Children's Hospital; Harvard Medical School; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Zhang, K (corresponding author), Sichuan Univ, W China Hosp, Mol Med Res Ctr, Chengdu 610041, Sichuan, Peoples R China.	kangzhang@gmail.com; zliny@yahoo.com	Zhang, Kang/Y-2740-2019	Zhang, Kang/0000-0002-4549-1697	National Institutes of Health [GM57603, RO1EY021374, RO1EY018860, RO1EY019270, RO1EY014428]; Leukemia and Lymphoma Society; Chinese National 985 Project; West China Hospital; Veterans Administration; Research to Prevent Blindness; BWF; National Natural Science Foundation of China; NATIONAL EYE INSTITUTE [R01EY014428, R01EY021374, R01EY019270, R01EY018660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057603, R55GM057603] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Chinese National 985 Project; West China Hospital; Veterans Administration(US Department of Veterans Affairs); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); BWF; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM57603 (to X. H.) and RO1EY021374, RO1EY018860, RO1EY019270, and RO1EY014428 (to K. Z.). This work was also supported by a Leukemia and Lymphoma Society scholarship (to X. H.); by a grant from the Chinese National 985 Project to Sichuan University and West China Hospital, a Veterans Administration merit award, a grant from Research to Prevent Blindness, and the BWF Clinical Scientist Award in Translational Research (to K. Z.); and by grants from the National Natural Science Foundation of China (to Z. Y.).	CANNY CLB, 1976, ARCH OPHTHALMOL-CHIC, V94, P1114; CHEN ZY, 1993, NAT GENET, V5, P180, DOI 10.1038/ng1093-180; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Karan G, 2004, MOL VIS, V10, P248; Kato Y, 1999, J NEUROSCI, V19, P9364; Kaykas A, 2004, NAT CELL BIOL, V6, P52, DOI 10.1038/ncb1081; Liu H, 2006, INVEST OPHTH VIS SCI, V47, P5088, DOI 10.1167/iovs.06-0403; Nikopoulos K, 2010, HUM MUTAT, V31, P656, DOI 10.1002/humu.21250; Nikopoulos K, 2010, AM J HUM GENET, V86, P240, DOI 10.1016/j.ajhg.2009.12.016; Osakada F, 2007, J NEUROSCI, V27, P4210, DOI 10.1523/JNEUROSCI.4193-06.2007; Pendergast SD, 1998, OPHTHALMOLOGY, V105, P1015, DOI 10.1016/S0161-6420(98)96002-X; Pendergast SD, 1998, ARCH OPHTHALMOL-CHIC, V116, P381; Poulter JA, 2010, AM J HUM GENET, V86, P248, DOI 10.1016/j.ajhg.2010.01.012; Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957; Smallwood PM, 2007, J BIOL CHEM, V282, P4057, DOI 10.1074/jbc.M609618200; Toomes C, 2004, AM J HUM GENET, V74, P721, DOI 10.1086/383202; VANNOUHUYS CE, 1991, AM J OPHTHALMOL, V111, P34, DOI 10.1016/S0002-9394(14)76893-X; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Ye X, 2009, CELL, V139, P285, DOI 10.1016/j.cell.2009.07.047	21	24	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10210	10215		10.1074/jbc.M110.194399	http://dx.doi.org/10.1074/jbc.M110.194399			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21177847	hybrid, Green Published			2022-12-27	WOS:000288547000037
J	Gentilella, A; Khalili, K				Gentilella, Antonio; Khalili, Kamel			BAG3 Expression in Glioblastoma Cells Promotes Accumulation of Ubiquitinated Clients in an Hsp70-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK FACTOR-1; PROTEASOME INHIBITION; FAMILY PROTEINS; CANCER-CELLS; ACTIVATION; APOPTOSIS; GENE; HEAT-SHOCK-PROTEIN-70; MACROAUTOPHAGY; DEGRADATION	Disposal of damaged proteins and protein aggregates is a prerequisite for the maintenance of cellular homeostasis and impairment of this disposal can lead to a broad range of pathological conditions, most notably in brain-associated disorders including Parkinson and Alzheimer diseases, and cancer. In this respect, the Protein Quality Control (PQC) pathway plays a central role in the clearance of damaged proteins. The Hsc/Hsp70-co-chaperone BAG3 has been described as a new and critical component of the PQC in several cellular contexts. For example, the expression of BAG3 in the rodent brain correlates with the engagement of protein degradation machineries in response to proteotoxic stress. Nevertheless, little is known about the molecular events assisted by BAG3. Here we show that ectopic expression of BAG3 in glioblastoma cells leads to the activation of an HSF1-driven stress response, as attested by transcriptional activation of BAG3 and Hsp70. BAG3 overexpression determines an accumulation of ubiquitinated proteins and this event requires the N-terminal region, WW domain of BAG3 and the association of BAG3 with Hsp70. The ubiquitination mainly occurs on BAG3-client proteins and the inhibition of proteasomal activity results in a further accumulation of ubiquitinated clients. At the cellular level, overexpression of BAG3 in glioblastoma cell lines, but not in non-glial cells, results in a remarkable decrease in colony formation capacity and this effect is reverted when the binding of BAG3 to Hsp70 is impaired. These observations provide the first evidence for an involvement of BAG3 in the ubiquitination and turnover of its partners.	[Khalili, Kamel] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19140 USA; Temple Univ, Sch Med, Ctr Neurovirol, Philadelphia, PA 19140 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Khalili, K (corresponding author), Temple Univ, Sch Med, Dept Neurosci, 3500 N Broad St, Philadelphia, PA 19140 USA.	kamel.khalili@temple.edu	Gentilella, Antonio/AAA-9864-2020		National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by grants awarded by the National Institutes of Health (to K. K.).	Arndt V, 2010, CURR BIOL, V20, P143, DOI 10.1016/j.cub.2009.11.022; Bloom J, 2005, METHOD ENZYMOL, V399, P249, DOI 10.1016/S0076-6879(05)99017-4; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; Doong H, 2003, J BIOL CHEM, V278, P28490, DOI 10.1074/jbc.M209682200; Doong H, 2000, ONCOGENE, V19, P4385, DOI 10.1038/sj.onc.1203797; Du ZX, 2009, J CELL PHYSIOL, V218, P631, DOI 10.1002/jcp.21634; Franceschelli S, 2008, J CELL PHYSIOL, V215, P575, DOI 10.1002/jcp.21397; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Gentilella A, 2008, ONCOGENE, V27, P5011, DOI 10.1038/onc.2008.142; Gentilella A, 2009, J CELL BIOCHEM, V108, P1117, DOI 10.1002/jcb.22343; Homma S, 2006, AM J PATHOL, V169, P761, DOI 10.2353/ajpath.2006.060250; Jacobs AT, 2009, J BIOL CHEM, V284, P9176, DOI 10.1074/jbc.M808656200; Jung SE, 2010, BRAIN RES, V1349, P1, DOI 10.1016/j.brainres.2010.06.043; Kalia SK, 2004, NEURON, V44, P931, DOI 10.1016/j.neuron.2004.11.026; Kawazoe Y, 1998, EUR J BIOCHEM, V255, P356, DOI 10.1046/j.1432-1327.1998.2550356.x; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Liu P, 2009, FEBS LETT, V583, P401, DOI 10.1016/j.febslet.2008.12.032; Mathew A, 2001, MOL CELL BIOL, V21, P7163, DOI 10.1128/MCB.21.21.7163-7171.2001; McClellan AJ, 2001, NAT CELL BIOL, V3, pE51, DOI 10.1038/35055162; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Pagliuca MG, 2003, FEBS LETT, V541, P11, DOI 10.1016/S0014-5793(03)00274-6; Rosati A, 2007, INT J BIOCHEM CELL B, V39, P1337, DOI 10.1016/j.biocel.2007.03.007; Schneider L, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-14; Shamovsky I, 2006, NATURE, V440, P556, DOI 10.1038/nature04518; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Takayama S, 2001, NAT CELL BIOL, V3, pE237, DOI 10.1038/ncb1001-e237; Voellmy R, 2004, PROG NUCLEIC ACID RE, V78, P143, DOI 10.1016/S0079-6603(04)78004-6; Wang HQ, 2008, BIOCHEM BIOPH RES CO, V365, P381, DOI 10.1016/j.bbrc.2007.11.001; Yin D, 2005, ONCOGENE, V24, P344, DOI 10.1038/sj.onc.1208225; Zapata JM, 1998, J BIOL CHEM, V273, P6916, DOI 10.1074/jbc.273.12.6916	31	30	31	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9205	9215		10.1074/jbc.M110.175836	http://dx.doi.org/10.1074/jbc.M110.175836			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21233200	Green Published, hybrid			2022-12-27	WOS:000288247700051
J	Huo, LH; Li, DW; Sun, XO; Shi, XJ; Karna, P; Yang, W; Liu, M; Qiao, WT; Aneja, R; Zhou, J				Huo, Lihong; Li, Dengwen; Sun, Xiaoou; Shi, Xingjuan; Karna, Prasanthi; Yang, Wei; Liu, Min; Qiao, Wentao; Aneja, Ritu; Zhou, Jun			Regulation of Tat Acetylation and Transactivation Activity by the Microtubule-associated Deacetylase HDAC6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 TAT; CYCLIN T1; PROTEIN; LOOP; APOPTOSIS; INTERACTS; SEQUENCE; REQUIRES; BINDING; PCAF	Reversible acetylation of Tat is critical for its transactivation activity toward HIV-1 transcription. However, the enzymes involved in the acetylation/deacetylation cycles have not been fully characterized. In this study, by yeast two-hybrid assay, we have discovered the histone deacetylase HDAC6 to be a binding partner of Tat. Our data show that HDAC6 interacts with Tat in the cytoplasm in a microtubule-dependent manner. In addition, HDAC6 deacetylates Tat at Lys-28 and thereby suppresses Tat-mediated transactivation of the HIV-1 promoter. Inactivation of HDAC6 promotes the interaction of Tat with cyclin T1 and leads to an increase in Tat transactivation activity. These findings establish HDAC6 as a Tat deacetylase and support a model in which Lys-28 deacetylation decreases Tat transactivation activity through affecting the ability of Tat to form a ribonucleoprotein complex with cyclin T1 and the transactivation-responsive RNA.	[Huo, Lihong; Li, Dengwen; Sun, Xiaoou; Shi, Xingjuan; Yang, Wei; Qiao, Wentao; Zhou, Jun] Nankai Univ, Dept Genet & Cell Biol, Coll Life Sci, Key Lab Mol Microbiol & Biotechnol,Minist Educ, Tianjin 300071, Peoples R China; [Karna, Prasanthi; Aneja, Ritu] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA; [Liu, Min] Tianjin Med Univ, Dept Biochem, Key Lab Cellular & Mol Immunol Tianjin, Basic Med Coll, Tianjin 300070, Peoples R China	Nankai University; University System of Georgia; Georgia State University; Tianjin Medical University	Zhou, J (corresponding author), Nankai Univ, Dept Genet & Cell Biol, Coll Life Sci, Key Lab Mol Microbiol & Biotechnol,Minist Educ, 94 Weijin Rd, Tianjin 300071, Peoples R China.	junzhou@nankai.edu.cn	Huo, Lihong/ABI-4909-2020; Zhou, Jun/D-4654-2017	Zhou, Jun/0000-0001-7858-8260; Huo, Lihong/0000-0001-7901-6758	National Science and Technology Major Project [2008ZX10001-002]; Tianjin Natural Science Foundation [09JCYBJC08900]; National Basic Research Program of China [2007CB914802]; National Natural Science Foundation of China [30825022, 90913021, 30800565]; Fok Ying Tung Education Foundation [111036]	National Science and Technology Major Project; Tianjin Natural Science Foundation(Natural Science Foundation of Tianjin); National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fok Ying Tung Education Foundation(Fok Ying Tung Education Foundation)	This work was supported by National Science and Technology Major Project Grant 2008ZX10001-002, Tianjin Natural Science Foundation Grant 09JCYBJC08900, National Basic Research Program of China Grant 2007CB914802, National Natural Science Foundation of China Grants 30825022, 90913021, and 30800565, and Fok Ying Tung Education Foundation Grant 111036.	BERKHOUT B, 1989, J VIROL, V63, P5501, DOI 10.1128/JVI.63.12.5501-5504.1989; Bieniasz PD, 1998, EMBO J, V17, P7056, DOI 10.1093/emboj/17.23.7056; Chen D, 2002, EMBO J, V21, P6801, DOI 10.1093/emboj/cdf683; Col E, 2001, J BIOL CHEM, V276, P28179, DOI 10.1074/jbc.M101385200; D'Orso I, 2009, P NATL ACAD SCI USA, V106, P3101, DOI 10.1073/pnas.0900012106; De Marco A, 2010, AMINO ACIDS, V38, P1583, DOI 10.1007/s00726-009-0378-9; Dorr A, 2002, EMBO J, V21, P2715, DOI 10.1093/emboj/21.11.2715; Egele C, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-62; FENG S, 1988, NATURE, V334, P165, DOI 10.1038/334165a0; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Garber ME, 1998, GENE DEV, V12, P3512, DOI 10.1101/gad.12.22.3512; Gautier VW, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-47; Gautier VW, 2005, P NATL ACAD SCI USA, V102, P16362, DOI 10.1073/pnas.0503519102; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Huo LH, 2011, J PATHOL, V223, P28, DOI 10.1002/path.2768; Kaehlcke K, 2003, MOL CELL, V12, P167, DOI 10.1016/S1097-2765(03)00245-4; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Mujtaba S, 2002, MOL CELL, V9, P575, DOI 10.1016/S1097-2765(02)00483-5; Ott M, 1999, CURR BIOL, V9, P1489, DOI 10.1016/S0960-9822(00)80120-7; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Parmigiani RB, 2008, P NATL ACAD SCI USA, V105, P9633, DOI 10.1073/pnas.0803749105; Valenzuela-Fernandez A, 2005, MOL BIOL CELL, V16, P5445, DOI 10.1091/mbc.e05-04-0354; Vardabasso C, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-8; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhu YR, 1997, GENE DEV, V11, P2622, DOI 10.1101/gad.11.20.2622	28	52	55	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9280	9286		10.1074/jbc.M110.208884	http://dx.doi.org/10.1074/jbc.M110.208884			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21220424	hybrid, Green Published			2022-12-27	WOS:000288247700058
J	Justilien, V; Jameison, L; Der, CJ; Rossman, KL; Fields, AP				Justilien, Verline; Jameison, Lee; Der, Channing J.; Rossman, Kent L.; Fields, Alan P.			Oncogenic Activity of Ect2 Is Regulated through Protein Kinase C iota-mediated Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE FACTOR; G2/M PHASE; CYTOKINESIS; ACTIVATION; TRANSFORMATION; DOMAINS; GTPASES; CANCER; LINKS; LUNG	The Rho GTPase guanine nucleotide exchange factor Ect2 is genetically and biochemically linked to the PKC iota oncogene in non-small cell lung cancer (NSCLC). Ect2 is overexpressed and mislocalized to the cytoplasm of NSCLC cells where it binds the oncogenic PKC iota-Par6 complex, leading to activation of the Rac1 small GTPase. Here, we identify a previously uncharacterized phosphorylation site on Ect2, threonine 328, that serves to regulate the oncogenic activity of Ect2 in NSCLC cells. PKC iota directly phosphorylates Ect2 at Thr-328 in vitro, and RNAi-mediated knockdown of either PKC iota or Par6 leads to a decrease in phospho-Thr-328 Ect2, indicating that PKC iota regulates Thr-328 Ect2 phosphorylation in NSCLC cells. Both wild-type Ect2 and a phosphomimetic T328D Ect2 mutant bind the PKC iota-Par6 complex, activate Rac1, and restore transformed growth and invasion when expressed in NSCLC cells made deficient in endogenous Ect2 by RNAi-mediated knockdown. In contrast, a phosphorylation-deficient T328A Ect2 mutant fails to bind the PKC iota-Par6 complex, activate Rac1, or restore transformation. Our data support a model in which PKC iota-mediated phosphorylation regulates Ect2 binding to the oncogenic PKC iota-Par6 complex thereby activating Rac1 activity and driving transformed growth and invasion.	[Justilien, Verline; Jameison, Lee; Fields, Alan P.] Mayo Clin, Coll Med, Dept Canc Biol, Jacksonville, FL 32224 USA; [Der, Channing J.; Rossman, Kent L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA	Mayo Clinic; University of North Carolina; University of North Carolina Chapel Hill	Fields, AP (corresponding author), Mayo Clin, Coll Med, Dept Canc Biol, Griffin Canc Res Bldg,Rm 211,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	fields.alan@mayo.edu		Der, Channing/0000-0002-7751-2747	National Institutes of Health [R01 CA081436-13, R21 CA151250-01]; V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA081436, R21CA151250] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA081436-13 and R21 CA151250-01. This work was also supported by the V Foundation for Cancer Research (to A. P. F.).	Chianale F, 2010, P NATL ACAD SCI USA, V107, P4182, DOI 10.1073/pnas.0908326107; Frederick LA, 2008, ONCOGENE, V27, P4841, DOI 10.1038/onc.2008.119; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Hara T, 2006, ONCOGENE, V25, P566, DOI 10.1038/sj.onc.1209078; Hirata D, 2009, CLIN CANCER RES, V15, P256, DOI 10.1158/1078-0432.CCR-08-1672; Jamieson L, 1999, J BIOL CHEM, V274, P3927, DOI 10.1074/jbc.274.7.3927; Justilien V, 2009, ONCOGENE, V28, P3597, DOI 10.1038/onc.2009.217; Kanada M, 2008, MOL BIOL CELL, V19, P8, DOI 10.1091/mbc.E07-04-0370; Kim JE, 2005, J BIOL CHEM, V280, P5733, DOI 10.1074/jbc.M409298200; MIKI T, 1993, NATURE, V362, P462, DOI 10.1038/362462a0; Niiya F, 2006, ONCOGENE, V25, P827, DOI 10.1038/sj.onc.1209124; Niiya F, 2005, J BIOL CHEM, V280, P36502, DOI 10.1074/jbc.M508007200; Noda Y, 2001, GENES CELLS, V6, P107, DOI 10.1046/j.1365-2443.2001.00404.x; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Saito S, 2004, J BIOL CHEM, V279, P7169, DOI 10.1074/jbc.M306725200; Saito S, 2003, J CELL BIOCHEM, V90, P819, DOI 10.1002/jcb.10688; Salhia B, 2008, AM J PATHOL, V173, P1828, DOI 10.2353/ajpath.2008.080043; Sano M, 2006, ONCOL REP, V16, P1093; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Westwick JK, 1998, J BIOL CHEM, V273, P16739, DOI 10.1074/jbc.273.27.16739; Zhang J, 2004, J BIOL CHEM, V279, P22118, DOI 10.1074/jbc.M400774200	21	59	63	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8149	8157		10.1074/jbc.M110.196113	http://dx.doi.org/10.1074/jbc.M110.196113			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21189248	Green Published, hybrid			2022-12-27	WOS:000288013300045
J	Kandasamy, P; Zarini, S; Chan, ED; Leslie, CC; Murphy, RC; Voelker, DR				Kandasamy, Pitchaimani; Zarini, Simona; Chan, Edward D.; Leslie, Christina C.; Murphy, Robert C.; Voelker, Dennis R.			Pulmonary Surfactant Phosphatidylglycerol Inhibits Mycoplasma pneumoniae-stimulated Eicosanoid Production from Human and Mouse Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); INNATE IMMUNE-RESPONSES; NUCLEAR-ENVELOPE; ASTHMA; ACTIVATION; CELLS; TRANSLOCATION; INFLAMMATION; PROTEIN; KINASE	Mycoplasma pneumoniae is a human pathogen causing respiratory infections that are also associated with serious exacerbations of chronic lung diseases. Membranes and lipoproteins from M. pneumoniae induced a 4-fold increase in arachidonic acid (AA) release from RAW264.7 and a 2-fold increase in AA release from primary human alveolar macrophages. The bacterial lipoprotein mimic and TLR2/1 agonist Pam3Cys and the TLR2/6 agonist MALP-2 produced effects similar to those elicited by M. pneumoniae in macrophages by inducing the phosphorylation of p38(MAPK) and p44/42(ERK1/2) MAP kinases and cyclooxygenase-2 (COX-2) expression. M. pneumoniae induced the generation of prostaglandins PGD(2) and PGE(2) from RAW264.7 cells and thromboxane B-2 (TXB2) from human alveolar macrophages. Anti-TLR2 antibody completely abolished M. pneumoniae-induced AA release and TNF alpha secretion from RAW264.7 cells and human alveolar macrophages. Disruption of the phosphorylation of p44/42(ERK1/2) or inactivation of cytosolic phospholipase A(2)alpha (cPLA(2)alpha) completely inhibited M. pneumoniae-induced AA release from macrophages. The minor pulmonary surfactant phospholipid, palmitoyl-oleoyl-phosphatidylglycerol (POPG), antagonized the proinflammatory actions of M. pneumoniae, Pam3Cys, and MALP-2 by reducing the production of AA metabolites from macrophages. The effect of POPG was specific, insofar as saturated PG, and saturated and unsaturated phosphatidylcholines did not have significant effect on M. pneumoniae-induced AA release. Collectively, these data demonstrate that M. pneumoniae stimulates the production of eicosanoids from macrophages through TLR2, and POPG suppresses this pathogen-induced response.	[Kandasamy, Pitchaimani; Chan, Edward D.; Voelker, Dennis R.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Leslie, Christina C.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Zarini, Simona; Leslie, Christina C.; Murphy, Robert C.] Univ Colorado Denver Sch Med, Dept Pharmacol, Aurora, CO 80011 USA	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus	Voelker, DR (corresponding author), Natl Jewish Hlth, Dept Med, 1400 Jackson St,K601, Denver, CO 80206 USA.	voelkerd@njhealth.org	Murphy, Robert/AAO-5349-2020	Murphy, Robert/0000-0002-9430-6515; Zarini, Simona/0000-0002-7460-3299	National Institutes of Health [HL094629, HL073907, HL34303, M01 RR00051]; Clinical and Translational Science Award (CTSA) [1UL1 RR025780]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025780, M01RR000051] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034303, R01HL094629, P01HL073907] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Science Award (CTSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL094629, HL073907 (to D. R. V.), HL34303 (to C. C. L. and R. C. M.), and infrastructure Grants M01 RR00051, and Clinical and Translational Science Award (CTSA) 1UL1 RR025780.	Aizawa H, 1996, CHEST, V109, P338, DOI 10.1378/chest.109.2.338; Allen IC, 2006, AM J PHYSIOL-LUNG C, V290, pL526, DOI 10.1152/ajplung.00340.2005; BESKIND DL, 1994, ANN EMERG MED, V23, P1375, DOI 10.1016/S0196-0644(94)70365-5; Chan ED, 1999, CHEST, V115, P1188, DOI 10.1378/chest.115.4.1188; Chmura K, 2008, AM J PHYSIOL-LUNG C, V295, pL220, DOI 10.1152/ajplung.90204.2008; Christie PE, 1996, THORAX, V51, P1171, DOI 10.1136/thx.51.12.1171; Chu HW, 2005, J IMMUNOL, V174, P5713, DOI 10.4049/jimmunol.174.9.5713; CLARK JD, 1995, J LIPID MEDIAT CELL, V12, P83, DOI 10.1016/0929-7855(95)00012-F; Diaz N. A., 1996, ANAL CHIM ACTA, V327, P161; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Evans JH, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-30; Fonseca-Aten M, 2005, AM J RESP CELL MOL, V32, P201, DOI 10.1165/rcmb.2004-0197OC; GIL JC, 1993, ANN ALLERGY, V70, P23; GLOVER S, 1995, J BIOL CHEM, V270, P15359, DOI 10.1074/jbc.270.25.15359; Hardy RD, 2001, INFECT IMMUN, V69, P3869, DOI 10.1128/IAI.69.6.3869-3876.2001; Harizi H, 2005, TISSUE ANTIGENS, V65, P507, DOI 10.1111/j.1399-0039.2005.00394.x; Hashimoto M, 2003, J BIOL CHEM, V278, P44205, DOI 10.1074/jbc.M306735200; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Hirabayashi T, 1999, J BIOL CHEM, V274, P5163, DOI 10.1074/jbc.274.8.5163; Hoshino M, 1999, J ALLERGY CLIN IMMUN, V103, P1054, DOI 10.1016/S0091-6749(99)70179-X; Johnston SL, 2005, AM J RESP CRIT CARE, V172, P1078, DOI 10.1164/rccm.200412-1743PP; Kim SH, 2005, CLIN EXP ALLERGY, V35, P585, DOI 10.1111/j.1365-2222.2005.02220.x; Kraft M, 1998, AM J RESP CRIT CARE, V158, P998, DOI 10.1164/ajrccm.158.3.9711092; Kuronuma K, 2009, J BIOL CHEM, V284, P25488, DOI 10.1074/jbc.M109.040832; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Lieberman D, 2003, AM J RESP CRIT CARE, V167, P406, DOI 10.1164/rccm.200209-996OC; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Martin RJ, 2006, CLIN CHEST MED, V27, P87, DOI 10.1016/j.ccm.2005.10.004; Moore ML, 2006, J ALLERGY CLIN IMMUN, V117, P1036, DOI 10.1016/j.jaci.2005.12.1314; Mueller M, 2005, J IMMUNOL, V174, P1091, DOI 10.4049/jimmunol.174.2.1091; Nag K, 1998, BIOPHYS J, V74, P2983, DOI 10.1016/S0006-3495(98)78005-1; NEMENOFF RA, 1993, J BIOL CHEM, V268, P1960; Nisar N, 2007, POSTGRAD MED J, V83, P100, DOI 10.1136/pgmj.2006.049023; Numata M, 2010, P NATL ACAD SCI USA, V107, P320, DOI 10.1073/pnas.0909361107; OBYRNE PM, 1989, EUR RESPIR J, V2, P782; Oosaki R, 1997, INT ARCH ALLERGY IMM, V114, P373, DOI 10.1159/000237697; PATTLE RE, 1955, NATURE, V175, P1125, DOI 10.1038/1751125b0; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Profita M, 2003, J ALLERGY CLIN IMMUN, V112, P709, DOI 10.1016/S0091-6749(03)01889-X; Qi HY, 2005, J BIOL CHEM, V280, P38969, DOI 10.1074/jbc.M509352200; Rawadi G, 1998, J IMMUNOL, V160, P1330; Rocca B, 2002, INT IMMUNOPHARMACOL, V2, P603, DOI 10.1016/S1567-5769(01)00204-1; Schievella AR, 1995, J BIOL CHEM, V270, P30749, DOI 10.1074/jbc.270.51.30749; Seno K, 2000, J MED CHEM, V43, P1041, DOI 10.1021/jm9905155; Shimizu T, 2005, J IMMUNOL, V175, P4641, DOI 10.4049/jimmunol.175.7.4641; Shimizu T, 2008, INFECT IMMUN, V76, P270, DOI 10.1128/IAI.00955-07; Shin HD, 2003, J ALLERGY CLIN IMMUN, V112, P454, DOI 10.1067/mai.2003.1641; Singh AM, 2006, THORAX, V61, P809, DOI 10.1136/thx.2005.045179; Stamm B, 2008, EMERG INFECT DIS, V14, P641, DOI 10.3201/eid1404.061366; Tanaka F, 1997, Respirology, V2, P119, DOI 10.1111/j.1440-1843.1997.tb00064.x; TAYLOR IK, 1991, AM REV RESPIR DIS, V143, P119, DOI 10.1164/ajrccm/143.1.119; Tonks A, 2001, CLIN EXP IMMUNOL, V124, P86, DOI 10.1046/j.1365-2249.2001.01479.x; Tsiodras S, 2005, J INFECTION, V51, P343, DOI 10.1016/j.jinf.2005.07.005; Wieslander Ake, 1992, P93; Yang J, 2002, INFECT IMMUN, V70, P3649, DOI 10.1128/IAI.70.7.3649-3655.2002	55	54	60	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7841	7853		10.1074/jbc.M110.170241	http://dx.doi.org/10.1074/jbc.M110.170241			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21205826	hybrid, Green Published			2022-12-27	WOS:000288013300015
J	Maillard, PV; Zoete, V; Michielin, O; Trono, D				Maillard, Pierre V.; Zoete, Vincent; Michielin, Olivier; Trono, Didier			Homology-based Identification of Capsid Determinants That Protect HIV1 from Human TRIM5 alpha Restriction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; MURINE LEUKEMIA-VIRUS; AMINO-TERMINAL DOMAIN; MULTIPLE SEQUENCE ALIGNMENT; TRIM FAMILY PROTEINS; HUMAN CYCLOPHILIN-A; OLD-WORLD MONKEY; RETROVIRUS RESTRICTION; B30.2/SPRY DOMAIN; CRYSTAL-STRUCTURE	The tropism of retroviruses relies on their ability to exploit cellular factors for their replication as well as to avoid host-encoded inhibitory activities such as TRIM5 alpha. N-tropic murine leukemia virus is sensitive to human TRIM5 alpha (huTRIM5 alpha) restriction, whereas human immunodeficiency virus type 1 (HIV1) escapes this antiviral factor. We previously revealed that mutation of four critical amino acid residues within the capsid can render murine leukemia virus resistant to huTRIM5 alpha. Here, we exploit the high degree of conservation in the tertiary structure of retroviral capsids to map the corresponding positions on the HIV1 capsid. We then demonstrated that, when changes were introduced at some of these positions, HIV1 becomes sensitive to huTRIM5 alpha restriction, a phenomenon reinforced by additionally mutating the nearby cyclophilin A binding loop of the viral protein. These results indicate that retroviruses have evolved similar mechanisms to escape TRIM5 alpha restriction via the interference of structurally homologous determinants in the viral capsid.	[Maillard, Pierre V.; Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci & Frontiers Genet, Natl Ctr Competence Res, CH-1015 Lausanne, Switzerland; [Zoete, Vincent; Michielin, Olivier] Swiss Inst Bioinformat, Mol Modeling Grp, CH-1015 Lausanne, Switzerland; [Michielin, Olivier] Ludwig Inst Canc Res Ltd, CH-1066 Epalinges, Switzerland; [Michielin, Olivier] Lausanne Univ Hosp CHUV, Pluridisciplinary Ctr Clin Oncol CePO, CH-1011 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics; Ludwig Institute for Cancer Research; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Trono, D (corresponding author), EPFL SV GHI LVG, SV 3805,Batiment SV,Stn 19, CH-1015 Lausanne, Switzerland.	didier.trono@epfl.ch	Maillard, Pierre V/V-4305-2019; Michielin, Olivier/ABE-7924-2020	Maillard, Pierre V/0000-0003-4611-388X; 	Swiss National Science Foundation; Infectigen Association; Strauss Foundation; National Institutes of Health [P41 RR-01081]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001081] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Infectigen Association; Strauss Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Swiss National Science Foundation, the Infectigen Association, and the Strauss Foundation.; We thank Greg Towers for the pCXCR-sqTRIM5 alpha plasmid, Priscilla Turelli for advice, Helen Rowe for reading the manuscript, and Sujana Nylakonda and Charlene Raclot for technical assistance. The modeling part of this work was performed within the Protein Modeling Facility of the University of Lausanne. Molecular graphics images were produced using the UCSF Chimera package from the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by National Institutes of Health Grant P41 RR-01081).	AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berthet-Colominas C, 1999, EMBO J, V18, P1124, DOI 10.1093/emboj/18.5.1124; Berthoux L, 2005, P NATL ACAD SCI USA, V102, P14849, DOI 10.1073/pnas.0505659102; Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Bosco DA, 2004, BIOCHEMISTRY-US, V43, P6110, DOI 10.1021/bi049841z; Bosco DA, 2002, P NATL ACAD SCI USA, V99, P5247, DOI 10.1073/pnas.082100499; Braaten D, 1996, J VIROL, V70, P3551, DOI 10.1128/JVI.70.6.3551-3560.1996; Braaten D, 1996, J VIROL, V70, P5170, DOI 10.1128/JVI.70.8.5170-5176.1996; Braaten D, 1996, J VIROL, V70, P4220, DOI 10.1128/JVI.70.7.4220-4227.1996; Brennan G, 2008, P NATL ACAD SCI USA, V105, P3569, DOI 10.1073/pnas.0709511105; Bukovsky AA, 1997, P NATL ACAD SCI USA, V94, P10943, DOI 10.1073/pnas.94.20.10943; Byeon IJL, 2009, CELL, V139, P780, DOI 10.1016/j.cell.2009.10.010; Campos-Olivas R, 2000, J MOL BIOL, V296, P633, DOI 10.1006/jmbi.1999.3475; Cornilescu CC, 2001, J MOL BIOL, V306, P783, DOI 10.1006/jmbi.2000.4395; Diaz-Griffero F, 2008, VIROLOGY, V378, P233, DOI 10.1016/j.virol.2008.05.008; Diaz-Griffero F, 2006, VIROLOGY, V351, P404, DOI 10.1016/j.virol.2006.03.023; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Goldschmidt V, 2008, J VIROL, V82, P2089, DOI 10.1128/JVI.01828-07; Grutter C, 2006, FEBS LETT, V580, P99, DOI 10.1016/j.febslet.2005.11.076; Hatziioannou T, 2005, J VIROL, V79, P176, DOI 10.1128/JVI.79.1.176-183.2005; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; Hatziioannou T, 2004, J VIROL, V78, P6005, DOI 10.1128/JVI.78.11.6005-6012.2004; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Howard BR, 2003, NAT STRUCT BIOL, V10, P475, DOI 10.1038/nsb927; Huthoff H, 2008, TRENDS MICROBIOL, V16, P612, DOI 10.1016/j.tim.2008.08.013; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Jern P, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-50; Jin ZM, 1999, J MOL BIOL, V286, P83, DOI 10.1006/jmbi.1998.2443; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaiser SM, 2007, SCIENCE, V316, P1756, DOI 10.1126/science.1140579; Kar AK, 2008, J VIROL, V82, P11669, DOI 10.1128/JVI.01559-08; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Keckesova Z, 2006, J VIROL, V80, P4683, DOI 10.1128/JVI.80.10.4683-4690.2006; Khorasanizadeh S, 1999, J MOL BIOL, V291, P491, DOI 10.1006/jmbi.1999.2986; Kingston RL, 2000, STRUCTURE, V8, P617, DOI 10.1016/S0969-2126(00)00148-9; Langelier CR, 2008, J VIROL, V82, P11682, DOI 10.1128/JVI.01562-08; Lassaux A, 2005, J VIROL, V79, P6560, DOI 10.1128/JVI.79.10.6560-6564.2005; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Li Y, 2006, J VIROL, V80, P6738, DOI 10.1128/JVI.00270-06; Li Y, 2009, J VIROL, V83, P10951, DOI 10.1128/JVI.00682-09; Lin TY, 2008, VIROLOGY, V379, P335, DOI 10.1016/j.virol.2008.06.037; Lin TY, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-70; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Maillard PV, 2007, PLOS PATHOG, V3, P2052, DOI 10.1371/journal.ppat.0030200; Maillard PV, 2010, J VIROL, V84, P5790, DOI 10.1128/JVI.02413-09; Momany C, 1996, NAT STRUCT BIOL, V3, P763, DOI 10.1038/nsb0996-763; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Mortuza GB, 2008, J MOL BIOL, V376, P1493, DOI 10.1016/j.jmb.2007.12.043; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Newman RM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000003; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Nisole S, 2004, P NATL ACAD SCI USA, V101, P13324, DOI 10.1073/pnas.0404640101; Ohkura S, 2006, J VIROL, V80, P8554, DOI 10.1128/JVI.00688-06; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Pantophlet R, 2009, J VIROL, V83, P1649, DOI 10.1128/JVI.02046-08; Perez-Caballero D, 2005, J VIROL, V79, P8969, DOI 10.1128/JVI.79.14.8969-8978.2005; Perron MJ, 2006, J VIROL, V80, P5631, DOI 10.1128/JVI.00219-06; Perron MJ, 2004, P NATL ACAD SCI USA, V101, P11827, DOI 10.1073/pnas.0403364101; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Price AJ, 2009, NAT STRUCT MOL BIOL, V16, P1036, DOI 10.1038/nsmb.1667; Raska M, 2010, J BIOL CHEM, V285, P20860, DOI 10.1074/jbc.M109.085472; Rhodes DA, 2005, IMMUNOLOGY, V116, P411, DOI 10.1111/j.1365-2567.2005.02248.x; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Sokolskaja E, 2006, J VIROL, V80, P2855, DOI 10.1128/JVI.80.6.2855-2862.2006; Sokolskaja E, 2006, CURR OPIN MICROBIOL, V9, P404, DOI 10.1016/j.mib.2006.06.011; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Song H, 2007, J VIROL, V81, P7280, DOI 10.1128/JVI.00406-07; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2005, J VIROL, V79, P3139, DOI 10.1128/JVI.79.5.3139-3145.2005; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Stremlau M, 2006, VIROLOGY, V351, P112, DOI 10.1016/j.virol.2006.03.015; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; Towers G, 2000, P NATL ACAD SCI USA, V97, P12295, DOI 10.1073/pnas.200286297; Towers GJ, 2003, NAT MED, V9, P1138, DOI 10.1038/nm910; Towers GJ, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-40; Virgen CA, 2008, P NATL ACAD SCI USA, V105, P3563, DOI 10.1073/pnas.0709258105; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Wilson SJ, 2008, J VIROL, V82, P7243, DOI 10.1128/JVI.00307-08; Wilson SJ, 2008, P NATL ACAD SCI USA, V105, P3557, DOI 10.1073/pnas.0709003105; Wolf D, 2008, ANNU REV GENET, V42, P143, DOI 10.1146/annurev.genet.42.110807.091704; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161; Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042; Yap MW, 2004, P NATL ACAD SCI USA, V101, P10786, DOI 10.1073/pnas.0402876101; Ylinen LMJ, 2005, J VIROL, V79, P11580, DOI 10.1128/JVI.79.18.11580-11587.2005; Zhang FW, 2006, VIROLOGY, V353, P396, DOI 10.1016/j.virol.2006.05.035	96	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8128	8140		10.1074/jbc.M110.187609	http://dx.doi.org/10.1074/jbc.M110.187609			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21169362	Green Published, hybrid			2022-12-27	WOS:000288013300043
J	Stranzl, GR; Santelli, E; Bankston, LA; La Clair, C; Bobkov, A; Schwarzenbacher, R; Godzik, A; Perego, M; Grynberg, M; Liddington, RC				Stranzl, Gudrun R.; Santelli, Eugenio; Bankston, Laurie A.; La Clair, Chandra; Bobkov, Andrey; Schwarzenbacher, Robert; Godzik, Adam; Perego, Marta; Grynberg, Marcin; Liddington, Robert C.			Structural Insights into Inhibition of Bacillus anthracis Sporulation by a Novel Class of Non-heme Globin Sensor Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIN GENE-EXPRESSION; CRYSTAL-STRUCTURE; SIGNAL-TRANSDUCTION; VIRULENCE PLASMIDS; CAPSULE SYNTHESIS; BINDING DOMAIN; REGULATOR; TRANSCRIPTION; SEQUENCE; CHLORIDE	Pathogenesis by Bacillus anthracis requires coordination between two distinct activities: plasmid-encoded virulence factor expression (which protects vegetative cells from immune surveillance during outgrowth and replication) and chromosomally encoded sporulation (required only during the final stages of infection). Sporulation is regulated by at least five sensor histidine kinases that are activated in response to various environmental cues. One of these kinases, BA2291, harbors a sensor domain that has similar to 35% sequence identity with two plasmid proteins, pXO1-118 and pXO2-61. Because overexpression of pXO2-61 (or pXO1-118) inhibits sporulation of B. anthracis in a BA2291-dependent manner, and pXO2-61 expression is strongly up-regulated by the major virulence gene regulator, AtxA, it was suggested that their function is to titrate out an environmental signal that would otherwise promote untimely sporulation. To explore this hypothesis, we determined crystal structures of both plasmid-encoded proteins. We found that they adopt a dimeric globin fold but, most unusually, do not bind heme. Instead, they house a hydrophobic tunnel and hydrophilic chamber that are occupied by fatty acid, which engages a conserved arginine and chloride ion via its carboxyl head group. In vivo, these domains may therefore recognize changes in fatty acid synthesis, chloride ion concentration, and/or pH. Structure-based comparisons with BA2291 suggest that it binds ligand and dimerizes in an analogous fashion, consistent with the titration hypothesis. Analysis of newly sequenced bacterial genomes points to the existence of a much broader family of non-heme, globin-based sensor domains, with related but distinct functionalities, that may have evolved from an ancestral heme-linked globin.	[Stranzl, Gudrun R.; Santelli, Eugenio; Bankston, Laurie A.; Bobkov, Andrey; Schwarzenbacher, Robert; Godzik, Adam; Grynberg, Marcin; Liddington, Robert C.] Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [La Clair, Chandra; Perego, Marta] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Grynberg, Marcin] Inst Biochem & Biophys PAS, PL-02106 Warsaw, Poland	Sanford Burnham Prebys Medical Discovery Institute; Scripps Research Institute; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Liddington, RC (corresponding author), Sanford Burnham Med Res Inst, Infect & Inflammatory Dis Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	rlidding@sanfordburnham.org	Godzik, Adam/A-7279-2009; Godzik, Adam/AAW-1467-2020	Godzik, Adam/0000-0002-2425-852X; Godzik, Adam/0000-0002-2425-852X; Grynberg, Marcin/0000-0003-1887-7209	National Institutes of Health [AI055789, AI055860]; Department of Defense [W81XWH-10-1-0093]; United States Department of Energy, Division of Materials Sciences and Division of Chemical Sciences [DE-AC02-98CH10886]; Austrian Science Fund; Polish State Committee for Scientific Research [2 PO4B 026 28]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI055789, R01AI055860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); United States Department of Energy, Division of Materials Sciences and Division of Chemical Sciences(United States Department of Energy (DOE)); Austrian Science Fund(Austrian Science Fund (FWF)); Polish State Committee for Scientific Research(Polish State Committee for Scientific Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI055789 and AI055860. This work was also supported by Department of Defense Grant W81XWH-10-1-0093. The Brookhaven National Synchrotron Light Source is supported by the United States Department of Energy, Division of Materials Sciences and Division of Chemical Sciences Contract DE-AC02-98CH10886.; Received an Erwin Schrodinger fellowship from the Austrian Science Fund.; Supported in part by Grant 2 PO4B 026 28 from the Polish State Committee for Scientific Research.	Aguilar PS, 2001, EMBO J, V20, P1681, DOI 10.1093/emboj/20.7.1681; Biegert A, 2009, P NATL ACAD SCI USA, V106, P3770, DOI 10.1073/pnas.0810767106; Bongiorni C, 2006, J BACTERIOL, V188, P487, DOI 10.1128/JB.188.2.487-498.2006; Bongiorni C, 2007, J BACTERIOL, V189, P2637, DOI 10.1128/JB.01798-06; Bourgogne A, 2003, INFECT IMMUN, V71, P2736, DOI 10.1128/IAI.71.5.2736-2743.2003; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunsing RL, 2005, J BACTERIOL, V187, P6972, DOI 10.1128/JB.187.20.6972-6981.2005; Candela T, 2005, J BACTERIOL, V187, P7765, DOI 10.1128/JB.187.22.7765-7772.2005; Contreras-Martel C, 2007, BIOPHYS CHEM, V125, P388, DOI 10.1016/j.bpc.2006.09.014; DAI ZH, 1995, MOL MICROBIOL, V16, P1171, DOI 10.1111/j.1365-2958.1995.tb02340.x; de Sanctis D, 2004, J MOL BIOL, V336, P917, DOI 10.1016/j.jmb.2003.12.063; Dhe-Paganon S, 2002, J BIOL CHEM, V277, P37973, DOI 10.1074/jbc.C200420200; Drysdale M, 2005, EMBO J, V24, P221, DOI 10.1038/sj.emboj.7600495; Drysdale M, 2004, J BACTERIOL, V186, P307, DOI 10.1128/JB.186.2.307-315.2004; Ezzell JW, 1999, J APPL MICROBIOL, V87, P250, DOI 10.1046/j.1365-2672.1999.00881.x; Giardina B, 2004, ACTA PHYSIOL SCAND, V182, P229, DOI 10.1111/j.1365-201X.2004.01360.x; Gut H, 2006, EMBO J, V25, P2643, DOI 10.1038/sj.emboj.7601107; Hadjifrangiskou M, 2007, J BACTERIOL, V189, P1874, DOI 10.1128/JB.01333-06; HARRISON CJ, 1994, SCIENCE, V263, P224, DOI 10.1126/science.8284672; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu HJ, 2006, CELL MICROBIOL, V8, P1634, DOI 10.1111/j.1462-5822.2006.00738.x; Kang TJ, 2005, INFECT IMMUN, V73, P7495, DOI 10.1128/IAI.73.11.7495-7501.2005; Kleywegt G. J., 2001, INT TABLES CRYSTALLO, VF, P353, DOI DOI 10.1107/97809553602060000111; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lodish H., 2000, MOL CELL BIOL, P640; Mignot T, 2003, MOL MICROBIOL, V47, P917, DOI 10.1046/j.1365-2958.2003.03345.x; Murray JW, 2005, P NATL ACAD SCI USA, V102, P17320, DOI 10.1073/pnas.0506599102; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nogi Y, 2005, INT J SYST EVOL MICR, V55, P2309, DOI 10.1099/ijs.0.63649-0; Okinaka RT, 1999, J BACTERIOL, V181, P6509, DOI 10.1128/JB.181.20.6509-6515.1999; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perego M, 2008, TRENDS MICROBIOL, V16, P215, DOI 10.1016/j.tim.2008.01.010; Perez-Pantoja D, 2008, FEMS MICROBIOL REV, V32, P736, DOI 10.1111/j.1574-6976.2008.00122.x; Saile E, 2002, J BACTERIOL, V184, P370, DOI 10.1128/JB.184.2.370-380.2002; Sakurai H, 2010, PHOTOSYNTH RES, V104, P163, DOI 10.1007/s11120-010-9531-2; Scaramozzino F, 2009, J BACTERIOL, V191, P687, DOI 10.1128/JB.01184-08; Song YF, 2009, J MOL BIOL, V387, P840, DOI 10.1016/j.jmb.2009.01.038; Stephenson K, 2002, MOL MICROBIOL, V46, P297, DOI 10.1046/j.1365-2958.2002.03186.x; Szurmant H, 2010, CURR OPIN MICROBIOL, V13, P190, DOI 10.1016/j.mib.2010.01.007; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; UCHIDA I, 1993, J BACTERIOL, V175, P5329, DOI 10.1128/JB.175.17.5329-5338.1993; White AK, 2006, J BACTERIOL, V188, P6354, DOI 10.1128/JB.00656-06; Zhang W, 2003, STRUCTURE, V11, P1097, DOI 10.1016/S0969-2126(03)00169-2	44	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8448	8458		10.1074/jbc.M110.207126	http://dx.doi.org/10.1074/jbc.M110.207126			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21216948	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000288013300073
J	Yang, ZY; Chi, XL; Funabashi, M; Baba, S; Nonaka, K; Pahari, P; Unrine, J; Jacobsen, JM; Elliott, GI; Rohr, J; Van Lanen, SG				Yang, Zhaoyong; Chi, Xiuling; Funabashi, Masanori; Baba, Satoshi; Nonaka, Koichi; Pahari, Pallab; Unrine, Jason; Jacobsen, Jesse M.; Elliott, Gregory I.; Rohr, Juergen; Van Lanen, Steven G.			Characterization of LipL as a Non-heme, Fe(II)-dependent alpha-Ketoglutarate:UMP Dioxygenase That Generates Uridine-5 '-aldehyde during A-90289 Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL TRANSLOCASE-I; GENE-CLUSTER; STREPTOMYCES SP; ESCHERICHIA-COLI; PEPTIDOGLYCAN SYNTHESIS; NUCLEOSIDE ANTIBIOTICS; CLAVAMINATE SYNTHASE; CRYSTAL-STRUCTURE; 2 ISOZYMES; IDENTIFICATION	Fe(II)- and alpha-ketoglutarate (alpha-KG)-dependent dioxygenases are a large and diverse superfamily of mononuclear, non-heme enzymes that perform a variety of oxidative transformations typically coupling oxidative decarboxylation of alpha-KG with hydroxylation of a prime substrate. The biosynthetic gene clusters for several nucleoside antibiotics that contain a modified uridine component, including the lipopeptidyl nucleoside A-90289 from Streptomyces sp. SANK 60405, have recently been reported, revealing a shared open reading frame with sequence similarity to proteins annotated as alpha-KG:taurine dioxygenases (TauD), a well characterized member of this dioxygenase superfamily. We now provide in vitro data to support the functional assignment of LipL, the putative TauD enzyme from the A-90289 gene cluster, as a non-heme, Fe(II)- dependent alpha-KG: UMP dioxygenase that produces uridine-5`-aldehyde to initiate the biosynthesis of the modified uridine component of A-90289. The activity of LipL is shown to be dependent on Fe(II), alpha-KG, and O-2, stimulated by ascorbic acid, and inhibited by several divalent metals. In the absence of the prime substrate UMP, LipL is able to catalyze oxidative decarboxylation of alpha-KG, although at a significantly reduced rate. The steady-state kinetic parameters using optimized conditions were determined to be K-m(alpha-KG) = 7.5 mu M, K-m(UMP) = 14 mu M, and k(cat) approximate to 80 min(-1). The discovery of this new activity not only sets the stage to explore the mechanism of LipL and related dioxygenases further but also has critical implications for delineating the biosynthetic pathway of several related nucleoside antibiotics.	[Yang, Zhaoyong; Chi, Xiuling; Pahari, Pallab; Jacobsen, Jesse M.; Elliott, Gregory I.; Rohr, Juergen; Van Lanen, Steven G.] Univ Kentucky, Coll Pharm, Dept Pharmaceut Sci, Lexington, KY 40536 USA; [Funabashi, Masanori; Baba, Satoshi; Nonaka, Koichi] Daiichi Sankyo Co Ltd, Biopharmaceut Res Grp 1, Biopharmaceut Technol Res Labs, Pharmaceut Technol Div, Iwaki, Fukushima 9718183, Japan; [Unrine, Jason] Univ Kentucky, Coll Agr, Dept Plant & Soil Sci, Lexington, KY 40536 USA	University of Kentucky; Daiichi Sankyo Company Limited; University of Kentucky	Van Lanen, SG (corresponding author), 789 S Limestone, Lexington, KY 40539 USA.	svanlanen@uky.edu	Pahari, Pallab/AAF-5664-2019; Funabashi, Masanori/GQZ-8735-2022; Rohr, Jurgen/G-5375-2014	Rohr, Jurgen/0000-0001-6447-5951; Pahari, Pallab/0000-0003-3662-2015; Unrine, Jason/0000-0003-3012-5261	Kentucky Science and Technology Corporation; National Science Foundation	Kentucky Science and Technology Corporation; National Science Foundation(National Science Foundation (NSF))	This work was supported in part by the Kentucky Science and Technology Corporation (S. G. V. L.) and a National Science Foundation predoctoral fellowship (J. J.).	Bollinger JM, 2005, EUR J INORG CHEM, P4245, DOI 10.1002/ejic.200500476; BUSBY RW, 1995, J BIOL CHEM, V270, P4262, DOI 10.1074/jbc.270.9.4262; CHEN RH, 1989, J ANTIBIOT, V42, P512, DOI 10.7164/antibiotics.42.512; Cleland WW, 2006, CHEM REV, V106, P3252, DOI 10.1021/cr050287o; Eichhorn E, 1997, J BIOL CHEM, V272, P23031, DOI 10.1074/jbc.272.37.23031; Elkins JM, 2002, BIOCHEMISTRY-US, V41, P5185, DOI 10.1021/bi016014e; FISHER DK, 1994, PHARMACEUT RES, V11, P759, DOI 10.1023/A:1018996817529; Funabashi M, 2010, NAT CHEM BIOL, V6, P581, DOI [10.1038/NCHEMBIO.393, 10.1038/nchembio.393]; Funabashi M, 2010, CHEMBIOCHEM, V11, P184, DOI 10.1002/cbic.200900665; Funabashi M, 2009, J ANTIBIOT, V62, P325, DOI 10.1038/ja.2009.38; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; Hausinger RP, 2004, CRIT REV BIOCHEM MOL, V39, P21, DOI 10.1080/10409230490440541; Holt A, 1997, ANAL BIOCHEM, V244, P384, DOI 10.1006/abio.1996.9911; Igarashi M, 2005, J ANTIBIOT, V58, P327, DOI 10.1038/ja.2005.41; ISONO F, 1991, ANTIMICROB AGENTS CH, V35, P234, DOI 10.1128/AAC.35.2.234; ISONO K, 1978, J AM CHEM SOC, V100, P3937, DOI 10.1021/ja00480a052; IWASA T, 1977, J ANTIBIOT, V30, P1; JONES GH, 1979, J ORG CHEM, V44, P1309, DOI 10.1021/jo01322a025; Ju JH, 2004, CHEMBIOCHEM, V5, P1281, DOI 10.1002/cbic.200400136; Kaysser L, 2010, CHEMBIOCHEM, V11, P191, DOI 10.1002/cbic.200900637; Kaysser L, 2009, J BIOL CHEM, V284, P14987, DOI 10.1074/jbc.M901258200; KNAPP S, 1994, J ORG CHEM, V59, P946, DOI 10.1021/jo00084a005; LINDBLAD B, 1970, J AM CHEM SOC, V92, P7446, DOI 10.1021/ja00728a032; Luo LS, 2006, ANAL BIOCHEM, V353, P69, DOI 10.1016/j.ab.2006.03.033; MARSH EN, 1992, BIOCHEMISTRY-US, V31, P12648, DOI 10.1021/bi00165a015; McCusker KP, 2009, P NATL ACAD SCI USA, V106, P19791, DOI 10.1073/pnas.0910660106; Muller I, 2004, BIOCHEMISTRY-US, V43, P3075, DOI 10.1021/bi035752v; Murakami R, 2008, J ANTIBIOT, V61, P537, DOI 10.1038/ja.2008.71; Murakami R, 2007, J ANTIBIOT, V60, P690, DOI 10.1038/ja.2007.88; Muramatsu Y, 2004, J ANTIBIOT, V57, P639, DOI 10.7164/antibiotics.57.639; Muramatsu Y, 2003, J ANTIBIOT, V56, P253, DOI 10.7164/antibiotics.56.253; Ohnuki T, 2003, J ANTIBIOT, V56, P268, DOI 10.7164/antibiotics.56.268; PFITZNER KE, 1963, J AM CHEM SOC, V85, P3027, DOI 10.1021/ja00902a035; Rackham EJ, 2010, CHEMBIOCHEM, V11, P1700, DOI 10.1002/cbic.201000200; Schirch V, 2005, CURR OPIN CHEM BIOL, V9, P482, DOI 10.1016/j.cbpa.2005.08.017; TAKAHASHI S, 1985, J ANTIBIOT, V38, P830, DOI 10.7164/antibiotics.38.830; TAMURA G, 1976, AGR BIOL CHEM TOKYO, V40, P447, DOI 10.1080/00021369.1976.10862071; Tsvetanova BC, 2002, J BIOL CHEM, V277, P35289, DOI 10.1074/jbc.M201345200; Unrine JM, 2006, ENVIRON TOXICOL CHEM, V25, P1864, DOI 10.1897/05-598R.1; Winn M, 2010, NAT PROD REP, V27, P279, DOI 10.1039/b816215h; WYATT PJ, 1993, ANAL CHIM ACTA, V272, P1, DOI 10.1016/0003-2670(93)80373-S; Yan F, 2006, BIOCHEMISTRY-US, V45, P11473, DOI 10.1021/bi060839c; Yin XH, 2004, CHEMBIOCHEM, V5, P1274, DOI 10.1002/cbic.200400082; Zhang WJ, 2010, P NATL ACAD SCI USA, V107, P16828, DOI 10.1073/pnas.1011557107; Zhang ZH, 2000, NAT STRUCT BIOL, V7, P127	45	40	41	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7885	7892		10.1074/jbc.M110.203562	http://dx.doi.org/10.1074/jbc.M110.203562			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21216959	hybrid, Green Published			2022-12-27	WOS:000288013300019
J	Guilherme, L; Alba, MP; Ferreira, FM; Oshiro, SE; Higa, F; Patarroyo, ME; Kalil, J				Guilherme, Luiza; Alba, Martha P.; Ferreira, Frederico Moraes; Oshiro, Sandra Emiko; Higa, Fabio; Patarroyo, Manuel E.; Kalil, Jorge			Anti-Group A Streptococcal Vaccine Epitope STRUCTURE, STABILITY, AND ITS ABILITY TO INTERACT WITH HLA CLASS II MOLECULES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHEUMATIC HEART-DISEASE; M-PROTEIN; SECONDARY-STRUCTURE; COIL TRANSITION; CELL EPITOPES; INTRANASAL; HELIX; IMMUNOGENICITY; ANTIBODIES; INFECTION	Streptococcus pyogenes infections remain a health problem in several countries due to poststreptococcal sequelae. We developed a vaccine epitope (StreptInCor) composed of 55 amino acids residues of the C-terminal portion of the M protein that encompasses both T and B cell protective epitopes. The nuclear magnetic resonance (NMR) structure of the StreptInCor peptide showed that the structure was composed of two microdomains linked by an 18-residue alpha-helix. A chemical stability study of the StreptInCor folding/unfolding process using far-UV circular dichroism showed that the structure was chemically stable with respect to pH and the concentration of urea. The T cell epitope is located in the first microdomain and encompasses 11 out of the 18 alpha-helix residues, whereas the B cell epitope is in the second microdomain and showed no alpha-helical structure. The prediction of StreptInCor epitope binding to different HLA class II molecules was evaluated based on an analysis of the 55 residues and the theoretical possibilities for the processed peptides to fit into the P1, P4, P6, and P9 pockets in the groove of several HLA class II molecules. We observed 7 potential sites along the amino acid sequence of StreptInCor that were capable of recognizing HLA class II molecules (DRB1*, DRB3*, DRB4*, and DRB5*). StreptInCoroverlapping peptides induced cellular and humoral immune responses of individuals bearing different HLA class II molecules and could be considered as a universal vaccine epitope.	[Guilherme, Luiza; Oshiro, Sandra Emiko; Higa, Fabio; Kalil, Jorge] Univ Sao Paulo, Heart Inst InCor, BR-5403903 Sao Paulo, Brazil; [Guilherme, Luiza; Oshiro, Sandra Emiko; Higa, Fabio; Kalil, Jorge] Univ Sao Paulo, Inst Invest Immunol, Natl Inst Sci & Technol, BR-5403903 Sao Paulo, Brazil; [Kalil, Jorge] Univ Sao Paulo, Dept Clin Med, Sch Med, BR-01246000 Sao Paulo, Brazil; [Ferreira, Frederico Moraes] Univ Sao Paulo, Lab Cellular Genet & Mol Nephrol, Dept Clin Med, Sch Med, BR-01246000 Sao Paulo, Brazil; [Alba, Martha P.; Patarroyo, Manuel E.] Fdn Inst Immunol Colombia FIDIC, Bogota 020304, Zona Can, Colombia; [Alba, Martha P.] Univ Rosario, Bogota 020304, Zona Can, Colombia; [Patarroyo, Manuel E.] Univ Nacl Colombia, Bogota 020304, Zona Can, Colombia	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidad del Rosario; Universidad Nacional de Colombia	Guilherme, L (corresponding author), Inst Coracao HC FMUSP, Lab Imunol, Av Dr Eneas de Carvalho Aguiar,44-9 Andar, BR-05403903 Sao Paulo, Brazil.	luizagui@usp.br	Ferreira, Frederico/A-4622-2013; Guglielmi, Luiza G/E-7676-2013; Murillo, Manuel Elkin M.E Patarroyo/S-1422-2017; KALIL, JORGE/C-8029-2012	Ferreira, Frederico/0000-0002-7403-9165; Murillo, Manuel Elkin M.E Patarroyo/0000-0002-1119-6040; KALIL, JORGE/0000-0001-8415-4274; Alba, Martha patricia/0000-0003-0641-5162	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)," Brazil; "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)," Colombia	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)," Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)," Colombia(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by "Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)" and "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)," Brazil and Colombia.	Batzloff MR, 2005, J INFECT DIS, V192, P1450, DOI 10.1086/466528; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BESSEN D, 1988, INFECT IMMUN, V56, P2666, DOI 10.1128/IAI.56.10.2666-2672.1988; Brandau DT, 2003, J PHARM SCI-US, V92, P218, DOI 10.1002/jps.10296; Brandt ER, 2000, NAT MED, V6, P455, DOI 10.1038/74719; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cunningham MW, 1997, INFECT IMMUN, V65, P3913, DOI 10.1128/IAI.65.9.3913-3923.1997; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DAJANI AS, 1994, CIRCULATION, V89, P916, DOI 10.1161/01.CIR.89.2.916; Dale JB, 2005, CLIN DIAGN LAB IMMUN, V12, P833, DOI 10.1128/CDLI.12.7.833-836.2005; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; FISCHETTI VA, 1988, REV INFECT DIS, V10, pS356; Gasteiger E., 2005, PROTEIN IDENTIFICATI, DOI 10.1385/1592598900; Guilherme L, 2006, CLIN DEV IMMUNOL, V13, P125, DOI 10.1080/17402520600877026; GUILHERME L, 1991, CIRCULATION, V83, P1995, DOI 10.1161/01.CIR.83.6.1995; Guilherme L, 2009, METHODS, V49, P316, DOI 10.1016/j.ymeth.2009.03.024; Guilherme L, 2001, INFECT IMMUN, V69, P5345, DOI 10.1128/IAI.69.9.5345-5351.2001; GUILHERME L, 1995, CIRCULATION, V92, P415, DOI 10.1161/01.CIR.92.3.415; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hu MC, 2002, INFECT IMMUN, V70, P2171, DOI 10.1128/IAI.70.4.2171-2177.2002; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kaufmann SHE, 2007, NAT REV MICROBIOL, V5, P491, DOI 10.1038/nrmicro1688; Kotloff KL, 2005, INFECT IMMUN, V73, P2360, DOI 10.1128/IAI.73.4.2360-2366.2005; MANJULA BN, 1985, P NATL ACAD SCI USA, V82, P1064, DOI 10.1073/pnas.82.4.1064; McNeil SA, 2005, CLIN INFECT DIS, V41, P1114, DOI 10.1086/444458; MEDAGLINI D, 1995, P NATL ACAD SCI USA, V92, P6868, DOI 10.1073/pnas.92.15.6868; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Olive C, 2005, VACCINE, V23, P2298, DOI 10.1016/j.vaccine.2005.01.041; OOI T, 1991, P NATL ACAD SCI USA, V88, P2859, DOI 10.1073/pnas.88.7.2859; Pace C N, 1986, Methods Enzymol, V131, P266; Pandey M, 2009, IMMUNOL CELL BIOL, V87, P391, DOI 10.1038/icb.2009.29; PRUKSAKORN S, 1994, INT IMMUNOL, V6, P1235, DOI 10.1093/intimm/6.8.1235; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; ROBINSON JH, 1991, INFECT IMMUN, V59, P4324, DOI 10.1128/IAI.59.12.4324-4331.1991; Roccatano D, 2002, P NATL ACAD SCI USA, V99, P12179, DOI 10.1073/pnas.182199699; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SCHOLTZ JM, 1991, P NATL ACAD SCI USA, V88, P2854, DOI 10.1073/pnas.88.7.2854; SEGREST JP, 1992, J LIPID RES, V33, P141; Shaila MS, 2007, VACCINE, V25, P3567, DOI 10.1016/j.vaccine.2007.01.079; Smeesters PR, 2008, VACCINE, V26, P5835, DOI 10.1016/j.vaccine.2008.08.037; Steer AC, 2009, CURR OPIN INFECT DIS, V22, P544, DOI 10.1097/QCO.0b013e328332bbfe; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Vohra H, 2005, RES MICROBIOL, V156, P575, DOI 10.1016/j.resmic.2004.12.009; WHO, 2008, PHARMAFORUM 0121; WUTHRICK K, 1986, NMR PROTEINS NUCL AC	46	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6989	6998		10.1074/jbc.M110.132118	http://dx.doi.org/10.1074/jbc.M110.132118			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21169359	hybrid, Green Published			2022-12-27	WOS:000287737300015
J	Minard, LV; Williams, JS; Walker, AC; Schultz, MC				Minard, Laura V.; Williams, Jessica S.; Walker, Amelia C.; Schultz, Michael C.			Transcriptional Regulation by Asf1 NEW MECHANISTIC INSIGHTS FROM STUDIES OF THE DNA DAMAGE RESPONSE TO REPLICATION STRESS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE CHAPERONE ASF1; SISTER-CHROMATID COHESION; H3 LYSINE-56 ACETYLATION; DEPOSITION PROTEIN ASF1; SACCHAROMYCES-CEREVISIAE; S-PHASE; CHECKPOINT PATHWAYS; REPLISOME INTEGRITY; STRUCTURAL BASIS; GENE DISRUPTION	Asf1 is a conserved histone H3/H4 chaperone. We find that Asf1 in budding yeast promotes an essential cellular response to replication stress caused by the ribonucleotide reductase inhibitor hydroxyurea. That is, Asf1 stimulates derepression of DNA damage response (DDR) genes during the S phase. Derepression of DDR genes strongly correlates with Asf1 binding to their promoters. Having identified the C terminus and histone-binding domains of Asf1 as molecular determinants of its constitutive and inducible association with chromatin, we tested whether Asf1 binding to DDR genes is mechanistically important for their derepression. Our results provide little support for this hypothesis. Rather, the contribution of Asf1 to DDR gene derepression depends on its ability to stimulate H3K56 acetylation by lysine acetyltransferase Rtt109. The precise regulation of H3K56 acetylation in the promoters of DDR genes is unexpected: DDR gene promoters are occupied by H3K56-acetylated nucleosomes under repressing conditions, and the steady state level of H3K56 promoter acetylation does not change upon derepression. We propose that replication-coupled deposition of Lys(56)-acetylated H3 poises the DDR genes in newly synthesized daughter duplexes for derepression during the S phase. In this model, the presence of a histone mark that destabilizes nucleosomes is compatible with suppression of transcription because in the uninduced state, DDR gene promoters are constitutively occupied by a potent repressor-corepressor complex.	[Minard, Laura V.; Williams, Jessica S.; Walker, Amelia C.; Schultz, Michael C.] Univ Alberta, Dept Biochem, Sch Mol & Syst Med, Fac Med & Dent, Edmonton, AB T6G 2H7, Canada	University of Alberta	Schultz, MC (corresponding author), Univ Alberta, Dept Biochem, Sch Mol & Syst Med, Fac Med & Dent, Edmonton, AB T6G 2H7, Canada.	michael.schultz@ualberta.ca			Canadian Institutes for Health Research; Alberta Heritage Foundation for Medical Research; Government of Alberta; Natural Science and Engineering Research Council of Canada	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Government of Alberta; Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants (to M. C. S.) from the Canadian Institutes for Health Research and the Alberta Heritage Foundation for Medical Research.; Supported by a Queen Elizabeth II Scholarship from the Government of Alberta, a Master's Award from the Canadian Institutes for Health Research, and a scholarship from the Natural Science and Engineering Research Council of Canada.	Adkins MW, 2007, MOL CELL BIOL, V27, P6372, DOI 10.1128/MCB.00981-07; Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Adkins MW, 2004, MOL CELL, V14, P657, DOI 10.1016/j.molcel.2004.05.016; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; APARICIO O, 2004, CURRENT PROTOCOLS CE; Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; Basrai MA, 1999, MOL CELL BIOL, V19, P7041; Biddick R, 2009, YEAST, V26, P205, DOI 10.1002/yea.1660; Brachmann CB, 1998, YEAST, V14, P115; Celic I, 2008, GENETICS, V179, P1769, DOI 10.1534/genetics.108.088914; Daganzo SM, 2003, CURR BIOL, V13, P2148, DOI 10.1016/S0960-9822(03)00869-8; Das C, 2009, NATURE, V459, P113, DOI 10.1038/nature07861; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; Dubacq C, 2006, MOL GENET GENOMICS, V275, P114, DOI 10.1007/s00438-005-0077-5; English CM, 2006, CELL, V127, P495, DOI 10.1016/j.cell.2006.08.047; Franco AA, 2005, GENE DEV, V19, P1365, DOI 10.1101/gad.1305005; Friis RMN, 2009, NUCLEIC ACIDS RES, V37, P3969, DOI 10.1093/nar/gkp270; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Green EM, 2005, CURR BIOL, V15, P2044, DOI 10.1016/j.cub.2005.10.053; Groth A, 2005, MOL CELL, V17, P301, DOI 10.1016/j.molcel.2004.12.018; Han JH, 2007, J BIOL CHEM, V282, P28587, DOI 10.1074/jbc.M702496200; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Hu FH, 2001, GENE DEV, V15, P1061, DOI 10.1101/gad.873201; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Jasencakova Z, 2010, MOL CELL, V37, P736, DOI 10.1016/j.molcel.2010.01.033; Kaplan T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000270; Korber P, 2006, J BIOL CHEM, V281, P5539, DOI 10.1074/jbc.M513340200; Li B, 2001, J BIOL CHEM, V276, P33788, DOI 10.1074/jbc.M104220200; Li Q, 2008, CELL, V134, P244, DOI 10.1016/j.cell.2008.06.018; Lin LJ, 2010, MOL CELL BIOL, V30, P1116, DOI 10.1128/MCB.01229-09; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Mousson F, 2005, P NATL ACAD SCI USA, V102, P5975, DOI 10.1073/pnas.0500149102; Mousson F, 2007, CHROMOSOMA, V116, P79, DOI 10.1007/s00412-006-0087-z; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Nourani A, 2004, EMBO J, V23, P2597, DOI 10.1038/sj.emboj.7600230; Parnas O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005497; Pondugula S, 2009, MOL CELL BIOL, V29, P4891, DOI 10.1128/MCB.00222-09; Ramaswamy V, 2003, MOL CELL BIOL, V23, P9136, DOI 10.1128/MCB.23.24.9136-9149.2003; Ramey CJ, 2004, MOL CELL BIOL, V24, P10313, DOI 10.1128/MCB.24.23.10313-10327.2004; Recht J, 2006, P NATL ACAD SCI USA, V103, P6988, DOI 10.1073/pnas.0601676103; Rufiange A, 2007, MOL CELL, V27, P393, DOI 10.1016/j.molcel.2007.07.011; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Sharma VM, 2007, MOL CELL BIOL, V27, P3199, DOI 10.1128/MCB.02311-06; Sharma VM, 2003, GENE DEV, V17, P502, DOI 10.1101/gad.1039503; Sharp JA, 2005, GENETICS, V171, P885, DOI 10.1534/genetics.105.044719; Tamburini BA, 2006, GENETICS, V173, P599, DOI 10.1534/genetics.105.054783; Thaminy S, 2007, J BIOL CHEM, V282, P37805, DOI 10.1074/jbc.M706384200; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; TRECO DA, 1993, CURRENT PROTOCOLS MO, V2; Tsubota T, 2007, MOL CELL, V25, P703, DOI 10.1016/j.molcel.2007.02.006; Wade SL, 2009, EMBO J, V28, P2919, DOI 10.1038/emboj.2009.229; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zhang Z, 2004, J BIOL CHEM, V279, P39240, DOI 10.1074/jbc.M407159200; Zhang Z, 2004, EMBO J, V23, P2246, DOI 10.1038/sj.emboj.7600227	59	24	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7082	7092		10.1074/jbc.M110.193813	http://dx.doi.org/10.1074/jbc.M110.193813			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21190944	Green Published, hybrid			2022-12-27	WOS:000287737300025
J	Zutz, A; Hoffmann, J; Hellmich, UA; Glaubitz, C; Ludwig, B; Brutschy, B; Tampe, R				Zutz, Ariane; Hoffmann, Jan; Hellmich, Ute A.; Glaubitz, Clemens; Ludwig, Bernd; Brutschy, Bernd; Tampe, Robert			Asymmetric ATP Hydrolysis Cycle of the Heterodimeric Multidrug ABC Transport Complex TmrAB from Thermus thermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAINS; LASER MASS-SPECTROMETRY; P-GLYCOPROTEIN; LACTOCOCCUS-LACTIS; RESISTANCE PROTEIN-1; HOECHST-33342 TRANSPORT; STAPHYLOCOCCUS-AUREUS; SUBSTRATE-SPECIFICITY; MEMBRANE-PROTEINS; LMRA	ATP-binding cassette (ABC) systems translocate a wide range of solutes across cellular membranes. The thermophilic Gram-negative eubacterium Thermus thermophilus, a model organism for structural genomics and systems biology, discloses similar to 46 ABC proteins, which are largely uncharacterized. Here, we functionally analyzed the first two and only ABC half-transporters of the hyperthermophilic bacterium, TmrA and TmrB. The ABC system mediates uptake of the drug Hoechst 33342 in inside-out oriented vesicles that is inhibited by verapamil. TmrA and TmrB form a stable heterodimeric complex hydrolyzing ATP with a K-m of 0.9 mM and k(cat) of 9 s(-1) at 68 degrees C. Two nucleotides can be trapped in the heterodimeric ABC complex either by vanadate or by mutation inhibiting ATP hydrolysis. Nucleotide trapping requires permissive temperatures, at which a conformational ATP switch is possible. We further demonstrate that the canonic glutamate 523 of TmrA is essential for rapid conversion of the ATP/ATP-bound complex into its ADP/ATP state, whereas the corresponding aspartate in TmrB (Asp-500) has only a regulatory role. Notably, exchange of this single noncanonic residue into a catalytic glutamate cannot rescue the function of the E523Q/D500E complex, implicating a built-in asymmetry of the complex. However, slow ATP hydrolysis in the newly generated canonic site (D500E) strictly depends on the formation of a posthydrolysis state in the consensus site, indicating an allosteric coupling of both active sites.	[Zutz, Ariane; Ludwig, Bernd; Tampe, Robert] Goethe Univ Frankfurt, Inst Biochem, Bioctr, D-60438 Frankfurt, Germany; [Hoffmann, Jan; Brutschy, Bernd] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, D-60438 Frankfurt, Germany; [Hellmich, Ute A.; Glaubitz, Clemens] Goethe Univ Frankfurt, Inst Biophys Chem, D-60438 Frankfurt, Germany; [Glaubitz, Clemens; Ludwig, Bernd; Tampe, Robert] Goethe Univ Frankfurt, Ctr Membrane Prote, D-60438 Frankfurt, Germany; [Glaubitz, Clemens; Ludwig, Bernd; Brutschy, Bernd; Tampe, Robert] Cluster Excellence Frankfurt, Macromol Complexes, D-60438 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt; Goethe University Frankfurt	Tampe, R (corresponding author), Goethe Univ Frankfurt, Inst Biochem, Bioctr, D-60438 Frankfurt, Germany.	tampe@em.uni-frankfurt.de	Tampé, Robert/H-2953-2015; Glaubitz, Clemens/D-5714-2011	Tampé, Robert/0000-0002-0403-2160; Glaubitz, Clemens/0000-0002-3554-6586; Hellmich, Ute/0000-0001-7162-285X	German Research Foundation [SFB807, TA157/7-1, AB149/1-1]; European Community	German Research Foundation(German Research Foundation (DFG)); European Community(European Commission)	This work was supported by German Research Foundation Grants (SFB807-Transport and Communication across Biological Membranes, TA157/7-1, and AB149/1-1) and funds from the European Community Seventh Framework Program as part of the European Drug Initiative on Channels and Transporters.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Beaudet L, 1998, BIOCHEMISTRY-US, V37, P9073, DOI 10.1021/bi972656j; Chen M, 2004, J BIOL CHEM, V279, P46073, DOI 10.1074/jbc.M404042200; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Ecker GF, 2004, MOL PHARMACOL, V66, P1169, DOI 10.1124/mol.104.001420; ENDICOTT JA, 1989, ANNU REV BIOCHEM, V58, P137, DOI 10.1146/annurev.bi.58.070189.001033; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Gorbulev S, 2001, P NATL ACAD SCI USA, V98, P3732, DOI 10.1073/pnas.061467898; Gottesman M M, 1994, Cancer Treat Res, V73, P107; Henne A, 2004, NAT BIOTECHNOL, V22, P547, DOI 10.1038/nbt956; Herget M, 2009, J BIOL CHEM, V284, P33740, DOI 10.1074/jbc.M109.047779; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hofacker M, 2007, J BIOL CHEM, V282, P3951, DOI 10.1074/jbc.M609899200; Hoffman J, 2010, PHYS CHEM CHEM PHYS, V12, P3480, DOI 10.1039/b924630d; Hou YX, 2002, J BIOL CHEM, V277, P5110, DOI 10.1074/jbc.M107133200; Huang Y, 2006, CANCER LETT, V239, P168, DOI 10.1016/j.canlet.2005.07.032; Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200; Jenkinson HF, 1996, J DENT RES, V75, P736, DOI 10.1177/00220345960750020201; Johnson BJH, 2010, BIOCHEMISTRY-US, V49, P3403, DOI 10.1021/bi902064g; Johnson ZI, 2004, GENOME RES, V14, P2268, DOI 10.1101/gr.2433104; Leonard GD, 2003, ONCOLOGIST, V8, P411, DOI 10.1634/theoncologist.8-5-411; Leslie EM, 2001, TOXICOLOGY, V167, P3, DOI 10.1016/S0300-483X(01)00454-1; Linton KJ, 2007, PFLUG ARCH EUR J PHY, V453, P555, DOI 10.1007/s00424-006-0126-x; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; LOO TW, 1994, BIOCHEMISTRY-US, V33, P14049, DOI 10.1021/bi00251a013; Lubelski J, 2006, BIOCHEMISTRY-US, V45, P648, DOI 10.1021/bi051276s; Lubelski J, 2004, J BIOL CHEM, V279, P34449, DOI 10.1074/jbc.M404072200; Lubelski J, 2007, MICROBIOL MOL BIOL R, V71, P463, DOI 10.1128/MMBR.00001-07; Lubelski J, 2006, MOL MICROBIOL, V61, P771, DOI 10.1111/j.1365-2958.2006.05267.x; Margolles A, 1999, BIOCHEMISTRY-US, V38, P16298, DOI 10.1021/bi990855s; Matsuo T, 2008, J BACTERIOL, V190, P648, DOI 10.1128/JB.01513-07; Morgner N, 2006, AUST J CHEM, V59, P109, DOI 10.1071/CH05285; Morgner N, 2007, J AM SOC MASS SPECTR, V18, P1429, DOI 10.1016/j.jasms.2007.04.013; Orelle C, 2003, J BIOL CHEM, V278, P47002, DOI 10.1074/jbc.M308268200; Payen LF, 2003, J BIOL CHEM, V278, P38537, DOI 10.1074/jbc.M305786200; Poelarends GJ, 2002, J BIOL CHEM, V277, P42891, DOI 10.1074/jbc.M206508200; Procko E, 2006, MOL CELL, V24, P51, DOI 10.1016/j.molcel.2006.07.034; Qin L, 2008, BIOCHEMISTRY-US, V47, P13952, DOI 10.1021/bi801532g; Robey RW, 2001, CLIN CANCER RES, V7, P145; Sauna ZE, 2006, J BIOL CHEM, V281, P26501, DOI 10.1074/jbc.M601917200; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; Steinfels E, 2004, BIOCHEMISTRY-US, V43, P7491, DOI 10.1021/bi0362018; Tombline G, 2005, BIOCHEMISTRY-US, V44, P12879, DOI 10.1021/bi0509797; Torres C, 2009, BBA-BIOMEMBRANES, V1788, P615, DOI 10.1016/j.bbamem.2008.12.012; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; van Saparoea HBV, 2005, BIOCHEMISTRY-US, V44, P16931, DOI 10.1021/bi051497y; van Veen HW, 1998, NATURE, V391, P291, DOI 10.1038/34669; Velamakanni S, 2008, BIOCHEMISTRY-US, V47, P9300, DOI 10.1021/bi8006737; Venter H, 2008, BIOCHEM PHARMACOL, V75, P866, DOI 10.1016/j.bcp.2007.10.022; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zhang DW, 2006, J BIOL CHEM, V281, P4507, DOI 10.1074/jbc.M512277200	55	50	50	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7104	7115		10.1074/jbc.M110.201178	http://dx.doi.org/10.1074/jbc.M110.201178			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21190941	Green Published, hybrid			2022-12-27	WOS:000287737300027
J	Lee, JW; Chen, H; Pullikotil, P; Quon, MJ				Lee, Ji-Won; Chen, Hui; Pullikotil, Philomena; Quon, Michael J.			Protein Kinase A-alpha Directly Phosphorylates FoxO1 in Vascular Endothelial Cells to Regulate Expression of Vascular Cellular Adhesion Molecule-1 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; FORKHEAD TRANSCRIPTION FACTORS; STIMULATES PHOSPHORYLATION; CAMP; PKA; ANGIOGENESIS; INVOLVEMENT; METABOLISM; ACTIVATION; MECHANISMS	FoxO1, a forkhead box O class transcription factor, is abundant in insulin-responsive tissues. Akt, downstream from phosphatidylinositol 3-kinase in insulin signaling, phosphorylates FoxO1 at Thr(24), Ser(256), and Ser(319), negatively regulating its function. We previously reported that dehydroepiandrosterone-stimulated phosphorylation of FoxO1 in endothelial cells requires cAMP-dependent protein kinase alpha (PKA-alpha). Therefore, we hypothesized that FoxO1 is a novel direct substrate for PKA-alpha. Using an immune complex kinase assay with [gamma-P-32] ATP, purified PKA-alpha directly phosphorylated wildtype FoxO1 but not FoxO1-AAA (mutant with alanine substitutions at known Akt phosphorylation sites). Phosphorylation of wild-type FoxO1 (but not FoxO1-AAA) was detectable using phospho-specific antibodies. Similar results were obtained using purified GST-FoxO1 protein as the substrate. Thus, FoxO1 is a direct substrate for PKA-alpha in vitro. In bovine aortic endothelial cells, interaction between endogenous PKA-alpha and endogenous FoxO1 was detected by co-immunoprecipitation. In human aortic endothelial cells (HAEC), pretreatment with H89 (PKA inhibitor) or siRNA knockdown of PKA-alpha decreased forskolin-or prostaglandin E-2-stimulated phosphorylation of FoxO1. In HAEC transfected with a FoxO-promoter luciferase reporter, co-expression of the catalytic domain of PKA-alpha, catalytically inactive mutant PKA-alpha, or siRNA against PKA-alpha caused corresponding increases or decreases in trans-activation of the FoxO promoter. Expression of vascular cellular adhesion molecule-1 mRNA, up-regulated by FoxO1 in endothelial cells, was enhanced by siRNA knockdown of PKA-alpha or treatment of HAEC with the PKA inhibitor H89. Adhesion of monocytes to endothelial cells was enhanced by H89 treatment or overexpression of FoxO1-AAA, similar to effects of TNF-alpha treatment. We conclude that FoxO1 is a novel physiological substrate for PKA-alpha in vascular endothelial cells.	[Lee, Ji-Won; Chen, Hui; Pullikotil, Philomena; Quon, Michael J.] NIH, Diabet Unit, Natl Ctr Complementary & Alternat Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Center for Complementary & Alternative Medicine	Quon, MJ (corresponding author), Univ Maryland, Div Endocrinol Diabet & Nutr, 660 W Redwood St,HH 495, Baltimore, MD 21201 USA.	quonm@medicine.umaryland.edu		QUON, MICHAEL/0000-0002-5289-3707; Quon, Michael/0000-0002-9601-9915	National Center for Complementary and Alternative Medicine, National Institutes of Health	National Center for Complementary and Alternative Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported in part by funds from the Intramural Research Program, National Center for Complementary and Alternative Medicine, National Institutes of Health (to M. J. Q.).	Abid MR, 2006, J BIOL CHEM, V281, P35544, DOI 10.1074/jbc.M608620200; Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Anderson P, 2010, MOL CELL BIOL, V30, P2537, DOI 10.1128/MCB.01282-09; BEVILACQUA MP, 1993, ANNU REV IMMUNOL, V11, P767, DOI 10.1146/annurev.iy.11.040193.004003; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; Burgering BMT, 2003, J LEUKOCYTE BIOL, V73, P689, DOI 10.1189/jlb.1202629; CARLOS TM, 1990, BLOOD, V76, P965; Chen H, 2008, J BIOL CHEM, V283, P29228, DOI 10.1074/jbc.M802906200; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Cosentino C, 2007, ONCOGENE, V26, P2095, DOI 10.1038/sj.onc.1210027; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Goldberg RB, 2009, J CLIN ENDOCR METAB, V94, P3171, DOI 10.1210/jc.2008-2534; Huang SY, 2007, J PROTEOME RES, V6, P2674, DOI 10.1021/pr070134c; IADEMARCO MF, 1995, J CLIN INVEST, V95, P264, DOI 10.1172/JCI117650; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Kops GJPL, 1999, J MOL MED-JMM, V77, P656, DOI 10.1007/s001099900050; Madsen L, 2010, ANN NY ACAD SCI, V1190, P1, DOI 10.1111/j.1749-6632.2009.05262.x; Michell BJ, 2001, J BIOL CHEM, V276, P17625, DOI 10.1074/jbc.C100122200; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Niisato N, 1999, AM J PHYSIOL-LUNG C, V277, pL727, DOI 10.1152/ajplung.1999.277.4.L727; Ollivier V, 1996, J BIOL CHEM, V271, P20828, DOI 10.1074/jbc.271.34.20828; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Qu S, 2006, ENDOCRINOLOGY, V147, P5641, DOI 10.1210/en.2006-0541; Richards JS, 2002, MOL ENDOCRINOL, V16, P580, DOI 10.1210/me.16.3.580; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190	32	39	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6423	6432		10.1074/jbc.M110.180661	http://dx.doi.org/10.1074/jbc.M110.180661			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21177856	Green Published, hybrid			2022-12-27	WOS:000287476400053
J	Luse, DS; Spangler, LC; Ujvari, A				Luse, Donal S.; Spangler, Lisa C.; Ujvari, Andrea			Efficient and Rapid Nucleosome Traversal by RNA Polymerase II Depends on a Combination of Transcript Elongation Factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT HISTONES; CHROMATIN TEMPLATES; DNA INTERACTIONS; PAF1 COMPLEX; PROMOTER; DSIF; CLEAVAGE; RECONSTITUTION; ACTIVATION; BARRIER	The nucleosome is generally found to be a strong barrier to transcript elongation by RNA polymerase II (pol II) in vitro. The elongation factors TFIIF and TFIIS have been shown to cooperate in maintaining pol II in the catalytically competent state on pure DNA templates. We now show that although TFIIF or TFIIS alone is modestly stimulatory for nucleosome traversal, both factors together increase transcription through nucleosomes in a synergistic manner. We also studied the effect of TFIIF and TFIIS on transcription of nucleosomes containing a Sin mutant histone. The Sin point mutations reduce critical histone-DNA contacts near the center of the nucleosome. Significantly, we found that nucleosomes with a Sin mutant histone are traversed to the same extent and at nearly the same rate as equivalent pure DNA templates if both TFIIS and TFIIF are present. Thus, the nucleosome is not necessarily an insurmountable barrier to transcript elongation by pol II. If unfolding of template DNA from the nucleosome surface is facilitated and the tendency of pol II to retreat from barriers is countered, transcription of nucleosomal templates can be rapid and efficient.	[Luse, Donal S.; Spangler, Lisa C.; Ujvari, Andrea] Cleveland Clin, Dept Mol Genet, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Luse, DS (corresponding author), Cleveland Clin, Dept Mol Genet, Lerner Res Inst, NE20,9500 Euclid Ave, Cleveland, OH 44195 USA.	lused@ccf.org			National Science Foundation [0743298]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant 0743298 (to D. S. L.).	Aso T, 1996, EMBO J, V15, P5557, DOI 10.1002/j.1460-2075.1996.tb00940.x; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Brower-Toland B, 2005, J MOL BIOL, V346, P135, DOI 10.1016/j.jmb.2004.11.056; Chen YX, 2009, GENE DEV, V23, P2765, DOI 10.1101/gad.1834709; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Cojocaru M, 2008, BIOCHEM J, V409, P139, DOI 10.1042/BJ20070751; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Gerber M, 2005, J BIOL CHEM, V280, P4017, DOI 10.1074/jbc.C400487200; Gilmour DS, 2009, CHROMOSOMA, V118, P1, DOI 10.1007/s00412-008-0182-4; Guermah M, 2006, CELL, V125, P275, DOI 10.1016/j.cell.2006.01.055; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Hsieh FK, 2010, EMBO REP, V11, P705, DOI 10.1038/embor.2010.113; IZBAN MG, 1993, J BIOL CHEM, V268, P12874; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; Jiang CZ, 2009, NAT REV GENET, V10, P161, DOI 10.1038/nrg2522; KADESCH TR, 1982, J BIOL CHEM, V257, P5286; Kim J, 2010, CELL, V140, P491, DOI 10.1016/j.cell.2009.12.050; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Kireeva ML, 2002, MOL CELL, V9, P541, DOI 10.1016/S1097-2765(02)00472-0; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; KRUGER W, 1995, GENE DEV, V9, P2770, DOI 10.1101/gad.9.22.2770; Kulaeva OI, 2009, NAT STRUCT MOL BIOL, V16, P1272, DOI 10.1038/nsmb.1689; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Maldonado E, 1996, METHOD ENZYMOL, V274, P72; Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027; Muthurajan UM, 2004, EMBO J, V23, P260, DOI 10.1038/sj.emboj.7600046; Nechaev S, 2008, CELL CYCLE, V7, P1539, DOI 10.4161/cc.7.11.6006; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Pal M, 2005, MOL CELL, V19, P101, DOI 10.1016/j.molcel.2005.05.024; Price DH, 2008, MOL CELL, V30, P7, DOI 10.1016/j.molcel.2008.03.001; REINES D, 1992, J BIOL CHEM, V267, P15516; Samkurashvili I, 1996, J BIOL CHEM, V271, P23495, DOI 10.1074/jbc.271.38.23495; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Ujvari A, 2006, NAT STRUCT MOL BIOL, V13, P49, DOI 10.1038/nsmb1026; Ujvari A, 2008, J BIOL CHEM, V283, P32236, DOI 10.1074/jbc.M806636200; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; WANG BQ, 1994, PROTEIN EXPRES PURIF, V5, P476, DOI 10.1006/prep.1994.1067; WANG BQ, 1993, PROTEIN EXPRES PURIF, V4, P207, DOI 10.1006/prep.1993.1027; Wang YM, 2010, CURR BIOL, V20, P548, DOI 10.1016/j.cub.2010.01.052; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Zhang CF, 2003, J BIOL CHEM, V278, P50101, DOI 10.1074/jbc.M307590200; Zhu WY, 2007, NUCLEIC ACIDS RES, V35, P4064, DOI 10.1093/nar/gkm430	51	26	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6040	6048		10.1074/jbc.M110.174722	http://dx.doi.org/10.1074/jbc.M110.174722			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21177855	Green Published, hybrid			2022-12-27	WOS:000287476400012
J	Wellhauser, L; Luna-Chavez, C; D'Antonio, C; Tainer, J; Bear, CE				Wellhauser, Leigh; Luna-Chavez, Cesar; D'Antonio, Christina; Tainer, John; Bear, Christine E.			ATP Induces Conformational Changes in the Carboxyl-terminal Region of ClC-5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAIN; X-RAY-SCATTERING; CHLORIDE CHANNEL; DENTS-DISEASE; CYTOPLASMIC DOMAIN; ADENINE-NUCLEOTIDES; CYSTIC-FIBROSIS; MOLECULAR-BASIS; P-GLYCOPROTEIN; TRANSPORTER	ATP binding enhances the activity of ClC-5, the transporter mutated in Dent disease, a disease affecting the renal proximal tubule. Previously, the ATP binding site was revealed in x-ray crystal structures of the cytoplasmic region of this membrane protein. Disruption of this site by mutagenesis (Y617A-ClC-5) reduced the functional expression and ATP-dependent regulation of the full-length transporter in Xenopus oocytes. However, insight into the conformational changes underlying ATP-dependent regulation is lacking. Here, we show that ATP binding induces a change in protein conformation. Specifically, small angle x-ray scattering experiments indicate that ATP binding promotes a clamp-like closure of the isolated ClC-5 carboxyl-terminal region. Limited proteolysis studies show that ATP binding induces conformational compaction of the carboxyl-terminal region in the intact membrane protein as well. In the context of fibroblasts and proximal tubule epithelial cells, disruption of the ATP binding site in full-length ClC-5 (Y617A-ClC-5) led to a defect in processing and trafficking out of the endoplasmic reticulum. These latter findings account for the decrease in functional expression previously reported for this ATP-binding mutant and prompt future study of a model whereby conformational compaction caused by ATP binding promotes biosynthetic maturation.	Hosp Sick Children, Res Inst, Programme Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Wellhauser, Leigh; Bear, Christine E.] Univ Toronto, Fac Med, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Luna-Chavez, Cesar; Tainer, John] Univ Calif Berkeley, Lawrence Berkeley Natl Lib, Berkeley, CA 94720 USA; [Tainer, John] Scripps Res Inst, La Jolla, CA 92037 USA; Skaggs Inst Chem Biol, Dept Mol Biol, La Jolla, CA 92037 USA; [D'Antonio, Christina; Bear, Christine E.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Scripps Research Institute; Scripps Research Institute; University of Toronto	Bear, CE (corresponding author), 555 Univ Ave, Toronto, ON M5S 1X8, Canada.	bear@sickkids.on.ca	Tainer, John/GWQ-4878-2022	Tainer, John/0000-0003-1659-2429	Kidney Foundation of Canada; Natural Sciences and Engineering Research Council of Canada; U.S. Department of Energy [DE-AC02-05CH11231]	Kidney Foundation of Canada; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported by a grant from the Kidney Foundation of Canada (to C.E.B.) and a postgraduate studentship from the Natural Sciences and Engineering Research Council of Canada (to L.W.). Support for advancement of SAXS technologies at the Lawrence Berkeley National Laboratory SIBYLS beamline came from the Integrated Diffraction Analysis Technologies program under Contract DE-AC02-05CH11231 with the U.S. Department of Energy.	Bell SP, 2006, BIOCHEMISTRY-US, V45, P6773, DOI 10.1021/bi0523815; Bernocco S, 2003, J BIOL CHEM, V278, P7199, DOI 10.1074/jbc.M210857200; Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Dhani SU, 2003, J BIOL CHEM, V278, P16262, DOI 10.1074/jbc.M209828200; Drumm K, 2001, EUR J MED RES, V6, P422; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Elvington SM, 2009, EMBO J, V28, P3090, DOI 10.1038/emboj.2009.259; Fan L, 2008, CELL, V133, P789, DOI 10.1016/j.cell.2008.04.030; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; GARBOCZI DN, 1990, J BIOL CHEM, V265, P14632; Grand T, 2009, KIDNEY INT, V76, P999, DOI 10.1038/ki.2009.305; Gunther W, 1998, P NATL ACAD SCI USA, V95, P8075, DOI 10.1073/pnas.95.14.8075; He LP, 2006, BIOPHYS J, V90, P3570, DOI 10.1529/biophysj.105.078295; Hilge M, 2003, NAT STRUCT BIOL, V10, P468, DOI 10.1038/nsb924; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Jentsch TJ, 2005, J AM SOC NEPHROL, V16, P1549, DOI 10.1681/ASN.2005020207; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Landolt-Marticorena C, 1999, J BIOL CHEM, V274, P26057, DOI 10.1074/jbc.274.37.26057; Lloyd SE, 1997, HUM MOL GENET, V6, P1233, DOI 10.1093/hmg/6.8.1233; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Lucas M, 2008, ACTA CRYSTALLOGR F, V64, P936, DOI 10.1107/S1744309108027930; LUCKOW VA, 1988, VIROLOGY, V167, P56, DOI 10.1016/0042-6822(88)90054-2; Markovic S, 2007, STRUCTURE, V15, P715, DOI 10.1016/j.str.2007.04.013; Meyer S, 2006, STRUCTURE, V14, P299, DOI 10.1016/j.str.2005.10.008; Meyer S, 2007, NAT STRUCT MOL BIOL, V14, P60, DOI 10.1038/nsmb1188; Mohammad-Panah R, 2003, J BIOL CHEM, V278, P29267, DOI 10.1074/jbc.M304357200; Mohammad-Panah R, 2009, J CELL SCI, V122, P1229, DOI 10.1242/jcs.037317; Moncoq K, 2004, BIOPHYS J, V87, P4056, DOI 10.1529/biophysj.104.048645; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Piwon N, 2000, NATURE, V408, P369, DOI 10.1038/35042597; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Riek U, 2008, J BIOL CHEM, V283, P18331, DOI 10.1074/jbc.M708379200; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Schulz P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012585; Segel DJ, 1999, BIOCHEMISTRY-US, V38, P15352, DOI 10.1021/bi991337k; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Sharom FJ, 1998, BIOCHEM CELL BIOL, V76, P695, DOI 10.1139/bcb-76-5-695; Shin DS, 2009, J MOL BIOL, V385, P1534, DOI 10.1016/j.jmb.2008.11.031; Stratford FLL, 2007, BIOCHEM J, V401, P581, DOI 10.1042/BJ20060968; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Wellhauser L, 2006, BIOCHEM J, V398, P289, DOI 10.1042/BJ20060142; Wellhauser L, 2009, MOL PHARMACOL, V75, P1430, DOI 10.1124/mol.109.055608; WRONG OM, 1994, Q J MED, V87, P473; Yamagata A, 2007, EMBO J, V26, P878, DOI 10.1038/sj.emboj.7601544; Zifarelli G, 2009, EMBO REP, V10, P1111, DOI 10.1038/embor.2009.159	47	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6733	6741		10.1074/jbc.M110.175877	http://dx.doi.org/10.1074/jbc.M110.175877			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21173145	hybrid, Green Published			2022-12-27	WOS:000287476400080
J	Matsuo, A; Bellier, JP; Nishimura, M; Yasuhara, O; Saito, N; Kimura, H				Matsuo, Akinori; Bellier, Jean-Pierre; Nishimura, Masaki; Yasuhara, Osamu; Saito, Naoaki; Kimura, Hiroshi			Nuclear Choline Acetyltransferase Activates Transcription of a High-affinity Choline Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VESICULAR ACETYLCHOLINE TRANSPORTER; NERVE GROWTH-FACTOR; GENE-EXPRESSION; PERIPHERAL-TYPE; SIGNALING PATHWAYS; SYNAPTIC VESICLES; MOLECULAR-CLONING; ALZHEIMER-DISEASE; PLASMA-MEMBRANE; SPLICE VARIANT	Choline acetyltransferase (ChAT) synthesizes the neurotransmitter, acetylcholine, at cholinergic nerve terminals. ChAT contains nuclear localization signals and is also localized in the nuclei of neural and non-neuronal cells. Nuclear ChAT might have an as yet unidentified function, such as transcriptional regulation. In this study, we investigated the alteration of candidate gene transcription by ChAT. We chose high affinity choline transporter (CHT1) and vesicular acetylcholine transporter (VACHT) as candidate genes, which function together with ChAT in acetylcholine production. Using SH-SY5Y human neuroblastoma cells stably expressing wild-type human ChAT, we found that overexpressed ChAT enhanced transcription of the CHT1 gene but not the VACHT gene. In contrast, nuclear localization signal disrupted, and catalytically inactive mutant ChATs could not induce, CHT1 expression. Additionally, ChAT did not alter CHT1 expression in non-neuronal HEK293 cells. Our results suggest that ChAT activates the transcription of selected target genes in neuronal cells. Both enzymatic activity and nuclear translocation of ChAT are required for its transcriptional enhancement.	Shiga Univ Med Sci, Mol Neurosci Res Ctr, Shiga 5202192, Japan; [Saito, Naoaki] Kobe Univ, Biosignal Res Ctr, Mol Pharmacol Lab, Kobe, Hyogo 6578501, Japan	Shiga University of Medical Science; Kobe University		akimatsu@belle.shiga-med.ac.jp	Bellier, Jean-Pierre/M-4845-2019	Bellier, Jean-Pierre/0000-0002-8758-8075	Shiga University of Medical Science	Shiga University of Medical Science(Shiga University of Medical Science)	This work was supported, in part, by a presidential Grant-in-aid from the Shiga University of Medical Science.	ADEM A, 1987, DEV BRAIN RES, V33, P235, DOI 10.1016/0165-3806(87)90156-8; Apparsundaram S, 2000, BIOCHEM BIOPH RES CO, V276, P862, DOI 10.1006/bbrc.2000.3561; Apparsundaram S, 2001, BIOCHEM SOC T, V29, P711, DOI 10.1042/0300-5127:0290711; Augusti-Tocco G, 2006, J MOL NEUROSCI, V30, P45, DOI 10.1385/JMN:30:1:45; Bellier JP, 2007, J NEUROCHEM, V101, P1607, DOI 10.1111/j.1471-4159.2007.04458.x; BERRARD S, 1995, J NEUROCHEM, V65, P939; Berse B, 1999, BIOCHEM J, V342, P301, DOI 10.1042/0264-6021:3420301; Berse B, 2005, DEV BRAIN RES, V157, P132, DOI 10.1016/j.devbrainres.2005.03.013; BERSE B, 1995, J BIOL CHEM, V270, P22101, DOI 10.1074/jbc.270.38.22101; Brandon EP, 2004, J NEUROSCI, V24, P5459, DOI 10.1523/JNEUROSCI.1106-04.2004; Brock M, 2007, BRAIN RES, V1145, P1, DOI 10.1016/j.brainres.2007.01.119; Cai YY, 2004, EMBO J, V23, P2047, DOI 10.1038/sj.emboj.7600221; CARBINI LA, 1993, J NEUROCHEM, V61, P247, DOI 10.1111/j.1471-4159.1993.tb03561.x; CHIREUX MA, 1995, J NEUROSCI RES, V40, P427, DOI 10.1002/jnr.490400402; De Jaco A, 2000, J NEUROCHEM, V75, P1123; ERICKSON JD, 1994, J BIOL CHEM, V269, P21929; Ferguson SM, 2004, MOL INTERV, V4, P22, DOI 10.1124/mi.4.1.22; FONNUM F, 1975, J NEUROCHEM, V24, P407, DOI 10.1111/j.1471-4159.1975.tb11895.x; Fujii T, 2003, LIFE SCI, V72, P2131, DOI 10.1016/S0024-3205(03)00073-0; Gill SK, 2007, NEUROBIOL AGING, V28, P1028, DOI 10.1016/j.neurobiolaging.2006.05.011; Gill SK, 2003, J BIOL CHEM, V278, P20217, DOI 10.1074/jbc.M213153200; Gobeil F, 2006, CAN J PHYSIOL PHARM, V84, P287, DOI 10.1139/Y05-127; Haberberger RV, 2002, J INVEST DERMATOL, V119, P943, DOI 10.1046/j.1523-1747.2002.00182.x; Hanna-Mitchell AT, 2007, LIFE SCI, V80, P2298, DOI 10.1016/j.lfs.2007.02.010; JACOB MH, 1986, J CELL BIOL, V103, P205, DOI 10.1083/jcb.103.1.205; Kimura S, 2007, NEUROCHEM INT, V50, P251, DOI 10.1016/j.neuint.2006.08.011; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; KUHAR MJ, 1978, J NEUROCHEM, V30, P15, DOI 10.1111/j.1471-4159.1978.tb07029.x; LAMBERT DG, 1989, EUR J PHARMACOL, V165, P71, DOI 10.1016/0014-2999(89)90771-1; Lecomte MJ, 2005, MOL CELL NEUROSCI, V28, P303, DOI 10.1016/j.mcn.2004.09.014; LIND GJ, 1993, INVEST OPHTH VIS SCI, V34, P2943; LIND GJ, 1995, INVEST OPHTH VIS SCI, V36, P1492; Lips KS, 2003, J HISTOCHEM CYTOCHEM, V51, P1645, DOI 10.1177/002215540305101208; Lips KS, 2002, CELL TISSUE RES, V307, P275, DOI 10.1007/s00441-002-0520-4; Lopez-Coviella I, 2000, SCIENCE, V289, P313, DOI 10.1126/science.289.5477.313; Madziar B, 2005, J NEUROCHEM, V92, P767, DOI 10.1111/j.1471-4159.2004.02908.x; Madziar B, 2008, J NEUROCHEM, V107, P1284, DOI 10.1111/j.1471-4159.2008.05681.x; Matsuo A, 2005, NEUROCHEM INT, V46, P423, DOI 10.1016/j.neuint.2004.11.006; Misawa H, 1997, MOL BRAIN RES, V44, P323, DOI 10.1016/S0169-328X(96)00231-8; Nishimura M, 1999, NAT MED, V5, P164, DOI 10.1038/5526; Oda Y, 1999, PATHOL INT, V49, P921, DOI 10.1046/j.1440-1827.1999.00977.x; ODA Y, 1992, MOL BRAIN RES, V16, P287, DOI 10.1016/0169-328X(92)90237-6; Ohno K, 2001, P NATL ACAD SCI USA, V98, P2017, DOI 10.1073/pnas.98.4.2017; OKUDA H, 1993, BRAIN RES, V625, P145, DOI 10.1016/0006-8993(93)90147-F; Okuda T, 2000, FEBS LETT, V484, P92, DOI 10.1016/S0014-5793(00)02134-7; Okuda T, 2000, NAT NEUROSCI, V3, P120, DOI 10.1038/72059; Okuda T, 2002, J BIOL CHEM, V277, P45315, DOI 10.1074/jbc.M207742200; Pfeil U, 2003, LIFE SCI, V72, P2087, DOI 10.1016/S0024-3205(03)00088-2; Resendes MC, 1999, J BIOL CHEM, V274, P19417, DOI 10.1074/jbc.274.27.19417; Ribeiro FM, 2007, EUR J NEUROSCI, V26, P3437, DOI 10.1111/j.1460-9568.2007.05967.x; Ribeiro FM, 2006, J NEUROCHEM, V97, P1, DOI 10.1111/j.1471-4159.2006.03695.x; Ribeiro FM, 2005, J NEUROCHEM, V94, P86, DOI 10.1111/j.1471-4159.2005.03171.x; Ribeiro FM, 2003, J NEUROCHEM, V87, P136, DOI 10.1046/j.1471-4159.2003.01974.x; SIMON JR, 1976, J NEUROCHEM, V26, P909, DOI 10.1111/j.1471-4159.1976.tb06472.x; Tooyama I, 2000, J CHEM NEUROANAT, V17, P217, DOI 10.1016/S0891-0618(99)00043-5; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wessler I, 2003, LIFE SCI, V72, P2055, DOI 10.1016/S0024-3205(03)00083-3; Xie J, 2004, J BIOL CHEM, V279, P28266, DOI 10.1074/jbc.M401495200	58	14	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5836	5845		10.1074/jbc.M110.147611	http://dx.doi.org/10.1074/jbc.M110.147611			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21163949	hybrid, Green Published			2022-12-27	WOS:000287230600092
J	Prasad, S; Yadav, VR; Kannappan, R; Aggarwal, BB				Prasad, Sahdeo; Yadav, Vivek R.; Kannappan, Ramaswamy; Aggarwal, Bharat B.			RETRACTED: Ursolic Acid, a Pentacyclin Triterpene, Potentiates TRAIL-induced Apoptosis through p53-independent Up-regulation of Death Receptors EVIDENCE FOR THE ROLE OF REACTIVE OXYGEN SPECIES AND JNK (Retracted article. See vol. 291, pg. 16924, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							DOWN-REGULATION; TRAIL/APO2L-INDUCED APOPTOSIS; IONIZING-RADIATION; ANTITUMOR-ACTIVITY; OLEANOLIC ACID; HEPATOMA-CELLS; DECOY RECEPTOR; GLIOMA-CELLS; CANCER CELLS; IN-VITRO	Discovery of the molecular targets of traditional medicine and its chemical footprints can validate the use of such medicine. In the present report, we investigated the effect of ursolic acid (UA), a pentacyclic triterpenoid found in rosemary and holy basil, on apoptosis induced by TRAIL. We found that UA potentiated TRAIL-induced apoptosis in cancer cells. In addition, UA also sensitized TRAIL-resistant cancer cells to the cytokine. When we investigated the mechanism, we found that UA down-regulated cell survival proteins and induced the cell surface expression of both TRAIL receptors, death receptors 4 and 5 (DR4 and -5). Induction of receptors by UA occurred independently of cell type. Gene silencing of either receptor by small interfering RNA reduced the apoptosis induced by UA and the effect of TRAIL. In addition, UA also decreased the expression of decoy receptor 2 (DcR2) but not DcR1. Induction of DRs was independent of p53 because UA induced DR4 and DR5 in HCT116 p53(-/-) cells. Induction of DRs, however, was dependent on JNK because UA induced JNK, and its pharmacologic inhibition abolished the induction of the receptors. The down-regulation of survival proteins and up-regulation of the DRs required reactive oxygen species (ROS) because UA induced ROS, and its quenching abolished the effect of the terpene. Also, potentiation of TRAIL-induced apoptosis by UA was significantly reduced by both ROS quenchers and JNK inhibitor. In addition, UA was also found to induce the expression of DRs, down-regulate cell survival proteins, and activate JNK in orthotopically implanted human colorectal cancer in a nude mouse model. Overall, our results showed that UA potentiates TRAIL-induced apoptosis through activation of ROS and JNK-mediated up-regulation of DRs and down-regulation of DcR2 and cell survival proteins.	[Prasad, Sahdeo; Yadav, Vivek R.; Kannappan, Ramaswamy; Aggarwal, Bharat B.] Univ Texas Houston, MD Anderson Canc Ctr, Cytokine Res Lab, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Aggarwal, BB (corresponding author), 1515 Holcombe Blvd,Unit 143, Houston, TX 77030 USA.	aggarwal@mdanderson.org	Aggarwal, Bharat B/G-3388-2013		National Institutes of Health [CA-16672, CA-124787-01A2]; Clayton Foundation for Research; Center for Targeted Therapy of M. D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE [P30CA016672, P01CA124787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clayton Foundation for Research; Center for Targeted Therapy of M. D. Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA-16672 and CA-124787-01A2. This work was also supported by a grant from the Clayton Foundation for Research (to B. B. A.) and a grant from the Center for Targeted Therapy of M. D. Anderson Cancer Center.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Baek JH, 1997, INT J CANCER, V73, P725, DOI 10.1002/(SICI)1097-0215(19971127)73:5<725::AID-IJC19>3.3.CO;2-T; Belyanskaya LL, 2008, LUNG CANCER, V60, P355, DOI 10.1016/j.lungcan.2007.11.005; Butler Mark S., 2008, V65; Cha HJ, 1998, ONCOGENE, V16, P771, DOI 10.1038/sj.onc.1201587; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; Choi BM, 2000, PHARMACOL TOXICOL, V86, P53, DOI 10.1034/j.1600-0773.2000.d01-10.x; Choi YH, 2000, INT J ONCOL, V17, P565; Corazza N, 2006, J CLIN INVEST, V116, P2493, DOI 10.1172/JCI27726; Essaady D, 1996, CANCER LETT, V106, P193, DOI 10.1016/0304-3835(96)04312-1; Fulda S, 2002, ONCOGENE, V21, P2283, DOI 10.1038/sj.onc.1205258; Gayathri R, 2009, ASIAN PAC J CANCER P, V10, P933; Gliniak B, 1999, CANCER RES, V59, P6153; Grotzer MA, 2000, ONCOGENE, V19, P4604, DOI 10.1038/sj.onc.1203816; Harmand PO, 2005, INT J CANCER, V114, P1, DOI 10.1002/ijc.20588; Hetschko H, 2008, FEBS J, V275, P1925, DOI 10.1111/j.1742-4658.2008.06351.x; Hinz S, 2000, ONCOGENE, V19, P5477, DOI 10.1038/sj.onc.1203936; Hsu YL, 2004, LIFE SCI, V75, P2303, DOI 10.1016/j.lfs.2004.04.027; Huang J, 2008, J PHARMACOL SCI, V107, P370, DOI 10.1254/jphs.08044FP; HUANG MT, 1994, CANCER RES, V54, P701; Hyer ML, 2005, CANCER RES, V65, P4799, DOI 10.1158/0008-5472.CAN-04-3319; Insinga A, 2005, NAT MED, V11, P71, DOI 10.1038/nm1160; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jacobson MD, 1996, TRENDS BIOCHEM SCI, V21, P83, DOI 10.1016/0968-0004(96)20008-8; Jung EM, 2005, CARCINOGENESIS, V26, P1905, DOI 10.1093/carcin/bgi167; Kassi E, 2009, CANCER INVEST, V27, P723, DOI 10.1080/07357900802672712; Kim DK, 2000, INT J CANCER, V87, P629, DOI 10.1002/1097-0215(20000901)87:5<629::AID-IJC2>3.0.CO;2-P; Kim H, 2006, CANCER RES, V66, P1740, DOI 10.1158/0008-5472.CAN-05-1568; Kim JY, 2008, J CELL BIOCHEM, V105, P1386, DOI 10.1002/jcb.21958; Kowalczyk MC, 2009, CARCINOGENESIS, V30, P1008, DOI 10.1093/carcin/bgp069; Kunnumakkara AB, 2008, CLIN CANCER RES, V14, P2128, DOI 10.1158/1078-0432.CCR-07-4722; Li J, 2002, WORLD J GASTROENTERO, V8, P493, DOI 10.3748/wjg.v8.i3.493; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Martelli AM, 2003, LEUKEMIA, V17, P1794, DOI 10.1038/sj.leu.2403044; Meng RD, 2000, MOL THER, V1, P130, DOI 10.1006/mthe.2000.0025; Merino D, 2006, MOL CELL BIOL, V26, P7046, DOI 10.1128/MCB.00520-06; Nagane M, 2007, J NEUROSURG, V106, P407, DOI 10.3171/jns.2007.106.3.407; Ng CP, 2002, PROSTATE, V53, P286, DOI 10.1002/pros.10155; Ozoren N, 2000, INT J ONCOL, V16, P917; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pathak AK, 2007, MOL CANCER RES, V5, P943, DOI 10.1158/1541-7786.MCR-06-0348; Prasad S, 2010, MOL CANCER THER, V9, P856, DOI 10.1158/1535-7163.MCT-09-1113; Ravi R, 2002, CANCER RES, V62, P1583; Schimmer AD, 2004, CANCER CELL, V5, P25, DOI 10.1016/S1535-6108(03)00332-5; Shenoy K, 2009, CANCER RES, V69, P1941, DOI 10.1158/0008-5472.CAN-08-1996; Shiiki K, 2000, CELL DEATH DIFFER, V7, P939, DOI 10.1038/sj.cdd.4400727; Shishodia S, 2003, CANCER RES, V63, P4375; Singletary K, 1996, CANCER LETT, V104, P43, DOI 10.1016/0304-3835(96)04227-9; Srivastava Rakesh K., 2000, Molecular Cell Biology Research Communications, V4, P67, DOI 10.1006/mcbr.2001.0265; Subbaramaiah K, 2000, CANCER RES, V60, P2399; Suh N, 1998, CANCER RES, V58, P717; Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang QD, 2002, J BIOL CHEM, V277, P36602, DOI 10.1074/jbc.M206306200; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wu WG, 2000, ANTICANCER RES, V20, P4525; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yamai H, 2009, INT J CANCER, V125, P952, DOI 10.1002/ijc.24433; Yodkeeree S, 2009, CANCER RES, V69, P6581, DOI 10.1158/0008-5472.CAN-09-1161; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; Zhang YX, 2010, MOL CARCINOGEN, V49, P374, DOI 10.1002/mc.20610; Zou W, 2004, CANCER RES, V64, P7570, DOI 10.1158/0008-5472.CAN-04-1238	63	101	104	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5546	5557		10.1074/jbc.M110.183699	http://dx.doi.org/10.1074/jbc.M110.183699			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21156789	Green Published, hybrid			2022-12-27	WOS:000287230600064
J	Hamel, B; Monaghan-Benson, E; Rojas, RJ; Temple, BRS; Marston, DJ; Burridge, K; Sondek, J				Hamel, Brant; Monaghan-Benson, Elizabeth; Rojas, Rafael J.; Temple, Brenda R. S.; Marston, Daniel J.; Burridge, Keith; Sondek, John			SmgGDS Is a Guanine Nucleotide Exchange Factor That Specifically Activates RhoA and RhoC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTP-BINDING PROTEINS; BOVINE BRAIN CYTOSOL; C-TERMINAL REGION; NEURITE OUTGROWTH; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SMALL GTPASES; RAS; MECHANISM; RAC1	SmgGDS is an atypical guanine nucleotide exchange factor (GEF) that promotes both cell proliferation and migration and is up-regulated in several types of cancer. SmgGDS has been previously shown to activate a wide variety of small GTPases, including the Ras family members Rap1a, Rap1b, and K-Ras, as well as the Rho family members Cdc42, Rac1, Rac2, RhoA, and RhoB. In contrast, here we show that SmgGDS exclusively activates RhoA and RhoC among a large panel of purified GTPases. Consistent with the well known properties of GEFs, this activation is catalytic, and SmgGDS preferentially binds to nucleotide-depleted RhoA relative to either GDP- or GTP gamma S-bound forms. However, mutational analyses indicate that SmgGDS utilizes a distinct exchange mechanism compared with canonical GEFs and in contrast to known GEFs requires RhoA to retain a polybasic region for activation. A homology model of SmgGDS highlights an electronegative surface patch and a highly conserved binding groove. Mutation of either area ablates the ability of SmgGDS to activate RhoA. Finally, the in vitro specificity of SmgGDS for RhoA and RhoC is retained in cells. Together, these results indicate that SmgGDS is a bona fide GEF that specifically activates RhoA and RhoC through a unique mechanism not used by other Rho family exchange factors.	[Rojas, Rafael J.; Marston, Daniel J.; Sondek, John] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Hamel, Brant; Temple, Brenda R. S.; Sondek, John] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Monaghan-Benson, Elizabeth; Burridge, Keith] Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Burridge, Keith; Sondek, John] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sondek, J (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, 4009 Genet Med Bldg,Campus Box 7365, Chapel Hill, NC 27599 USA.	sondek@med.unc.edu		Sondek, John/0000-0002-1127-8310	National Institutes of Health [R01-GM062299, R01-GM029860]; American Cancer Society [PF-09-119-01-CSM]; NATIONAL CANCER INSTITUTE [P30CA016086] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029860, R01GM062299] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM062299 (to J. S.) and R01-GM029860 (to K. B.). This work was also supported by American Cancer Society Grant PF-09-119-01-CSM (to E. M.-B.).	Arthur WT, 2002, J BIOL CHEM, V277, P42964, DOI 10.1074/jbc.M207401200; Berg TJ, 2010, J BIOL CHEM, V285, P35255, DOI 10.1074/jbc.M110.129916; Buchwald G, 2002, EMBO J, V21, P3286, DOI 10.1093/emboj/cdf329; CHUANG TH, 1994, BIOCHEM J, V303, P761, DOI 10.1042/bj3030761; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Erickson JW, 2004, BIOCHEMISTRY-US, V43, P837, DOI 10.1021/bi036026v; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; HIRAOKA K, 1992, BIOCHEM BIOPH RES CO, V182, P921, DOI 10.1016/0006-291X(92)91820-G; HIROYOSHI M, 1991, J BIOL CHEM, V266, P2962; HORI Y, 1991, ONCOGENE, V6, P515; Hutchinson JP, 2000, BIOCHEMISTRY-US, V39, P11348, DOI 10.1021/bi0007573; ISOMURA M, 1990, BIOCHEM BIOPH RES CO, V169, P652, DOI 10.1016/0006-291X(90)90380-6; KAIBUCHI K, 1991, MOL CELL BIOL, V11, P2873, DOI 10.1128/MCB.11.5.2873; Klink BU, 2010, J BIOL CHEM, V285, P17197, DOI 10.1074/jbc.M110.107953; Lanning CC, 2003, J BIOL CHEM, V278, P12495, DOI 10.1074/jbc.M211286200; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Mazhab-Jafari MT, 2010, J BIOL CHEM, V285, P5132, DOI 10.1074/jbc.C109.064766; MIZUNO T, 1991, P NATL ACAD SCI USA, V88, P6442, DOI 10.1073/pnas.88.15.6442; Narumiya S, 2006, CURR OPIN CELL BIOL, V18, P199, DOI 10.1016/j.ceb.2006.02.002; Nikolic M, 2002, INT J BIOCHEM CELL B, V34, P731, DOI 10.1016/S1357-2725(01)00167-4; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Rojas RJ, 2003, COMB CHEM HIGH T SCR, V6, P409; Rossman KL, 2002, EMBO J, V21, P1315, DOI 10.1093/emboj/21.6.1315; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Shin EY, 2006, J BIOL CHEM, V281, P35954, DOI 10.1074/jbc.M602399200; Snyder JT, 2002, NAT STRUCT BIOL, V9, P468, DOI 10.1038/nsb796; Soundararajan M, 2008, PROTEINS, V72, P498, DOI 10.1002/prot.22017; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Tew GW, 2008, J BIOL CHEM, V283, P963, DOI 10.1074/jbc.M707526200; Vikis HG, 2002, ONCOGENE, V21, P2425, DOI 10.1038/sj.onc.1205306; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Wu H, 2008, TRENDS CELL BIOL, V18, P397, DOI 10.1016/j.tcb.2008.06.007; Xing Y, 2008, STRUCTURE, V16, P478, DOI 10.1016/j.str.2007.12.021; YAKU H, 1994, BIOCHEM BIOPH RES CO, V198, P811, DOI 10.1006/bbrc.1994.1116; YAMAMOTO T, 1990, J BIOL CHEM, V265, P16626; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468; Zhi H, 2009, J PATHOL, V217, P389, DOI 10.1002/path.2456	40	43	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.191122	http://dx.doi.org/10.1074/jbc.M110.191122			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21242305	Green Published, hybrid			2022-12-27	WOS:000289077500029
J	Kario, E; Amar, N; Elazar, Z; Navon, A				Kario, Edith; Amar, Nira; Elazar, Zvulun; Navon, Ami			A New Autophagy-related Checkpoint in the Degradation of an ERAD-M Target	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; MANNOSIDASE-LIKE PROTEIN; HMG-COA REDUCTASE; CRYSTALLOID ENDOPLASMIC-RETICULUM; E3 UBIQUITIN LIGASE; SACCHAROMYCES-CEREVISIAE; MISFOLDED GLYCOPROTEINS; QUALITY-CONTROL; MOLECULAR CHAPERONES; MEMBRANE-PROTEIN	The endoplasmic reticulum (ER) harbors elaborate quality control mechanisms to ensure proper folding and post-translational modifications of polypeptides targeted to this organelle. Once an aberrant protein is detected, it is dislocated from the ER and routed to the proteasome for destruction. Autophagy has been recently implicated in the elevation of the ER stress response; however, the involvement of this pathway in selective removal of ER-associated degradation (ERAD) substrates has not been demonstrated. In the present study, we show that an ER membrane lesion, associated with the accumulation of the yeast ERAD-M substrate 6Myc-Hmg2p elicits the recruitment of Atg8 and elements of the cytosol to vacuole targeting (CVT) to the membrane, leading to attenuation in the degradation process. Deletion of peptide: N-glycanase (PNG1) stabilizes this association, a process accompanied by slowdown of 6MycHmg2p degradation. Truncation of the unstructured C-terminal 23 amino acids of 6Myc-Hmg2p rendered its degradation PNG1-independent and allowed its partial delivery to the vacuole in an autophagy-dependent manner. These findings demonstrate a new conduit for the selective vacuolar/lysosomal removal of ERAD misfolded proteins by an autophagy-related machinery acting concomitantly with the proteasome.	[Kario, Edith; Navon, Ami] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Amar, Nira; Elazar, Zvulun] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Elazar, Z (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	zvulun.elazar@weizmann.ac.il; ami.navon@weizmann.ac.il			Israel Science Foundation; Israeli Cancer Research Foundation; Weizmann Institute Minerva Center; Minerva Foundation (Germany); German-Israeli Foundation for Scientific Research and Development	Israel Science Foundation(Israel Science Foundation); Israeli Cancer Research Foundation; Weizmann Institute Minerva Center; Minerva Foundation (Germany); German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development)	Supported in part by the Israel Science Foundation, the Israeli Cancer Research Foundation, and the Weizmann Institute Minerva Center. Incumbent of the Harold Korda Chair of Biology.; Incumbent of the Recanati career development chair of cancer research. Research in the laboratory of A. N. is supported by the Israel Science Foundation, the Minerva Foundation (Germany), the German-Israeli Foundation for Scientific Research and Development, and a special gift from Rolando Uziel.	ANDERSON RGW, 1983, J CELL SCI, V63, P1; Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458; Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Brodsky JL, 1999, J BIOL CHEM, V274, P3453, DOI 10.1074/jbc.274.6.3453; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Casagrande R, 2000, MOL CELL, V5, P729, DOI 10.1016/S1097-2765(00)80251-8; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Farre JC, 2008, DEV CELL, V14, P365, DOI 10.1016/j.devcel.2007.12.011; Gardner RG, 2001, MOL CELL BIOL, V21, P4276, DOI 10.1128/MCB.21.13.4276-4291.2001; Hampton RY, 1996, P NATL ACAD SCI USA, V93, P828, DOI 10.1073/pnas.93.2.828; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosomi A, 2010, J BIOL CHEM, V285, P24324, DOI 10.1074/jbc.M109.095919; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Istvan ES, 2000, EMBO J, V19, P819, DOI 10.1093/emboj/19.5.819; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jakob CA, 2001, EMBO REP, V2, P423; JINGAMI H, 1987, J CELL BIOL, V104, P1693, DOI 10.1083/jcb.104.6.1693; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Katiyar S, 2005, MOL BIOL CELL, V16, P4584, DOI 10.1091/mbc.E05-04-0345; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435; Koning AJ, 1996, MOL BIOL CELL, V7, P769, DOI 10.1091/mbc.7.5.769; Kostova Z, 2005, J CELL SCI, V118, P1485, DOI 10.1242/jcs.01740; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Loayza D, 1998, MOL BIOL CELL, V9, P2767, DOI 10.1091/mbc.9.10.2767; Lynch-Day MA, 2010, FEBS LETT, V584, P1359, DOI 10.1016/j.febslet.2010.02.013; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Mazon MJ, 2007, MOL MICROBIOL, V63, P1069, DOI 10.1111/j.1365-2958.2006.05580.x; Meijer Alfred J., 2006, Molecular Aspects of Medicine, V27, P411, DOI 10.1016/j.mam.2006.08.002; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Olivari S, 2005, J BIOL CHEM, V280, P2424, DOI 10.1074/jbc.C400534200; ORCI L, 1984, CELL, V36, P835, DOI 10.1016/0092-8674(84)90033-3; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Perlmutter DH, 2006, AUTOPHAGY, V2, P258, DOI 10.4161/auto.2882; Qin ZH, 2003, HUM MOL GENET, V12, P3231, DOI 10.1093/hmg/ddg346; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Scott SV, 2001, MOL CELL, V7, P1131, DOI 10.1016/S1097-2765(01)00263-5; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Shintani T, 2004, J BIOL CHEM, V279, P29889, DOI 10.1074/jbc.M404399200; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Sidrauski C, 1996, CELL, V87, P405, DOI 10.1016/S0092-8674(00)81361-6; Spear ED, 2003, MOL BIOL CELL, V14, P2756, DOI 10.1091/mbc.E02-11-0717; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Stolz A, 2010, TRAFFIC, V11, P1363, DOI 10.1111/j.1600-0854.2010.01093.x; Straub M, 1997, J BACTERIOL, V179, P3875, DOI 10.1128/jb.179.12.3875-3883.1997; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V279, pG961, DOI 10.1152/ajpgi.2000.279.5.G961; Teckman JH, 2004, AM J PHYSIOL-GASTR L, V286, pG851, DOI 10.1152/ajpgi.00175.2003; Teckman JH, 2002, AM J PHYSIOL-GASTR L, V283, pG1156, DOI 10.1152/ajpgi.00041.2002; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; Wilhovsky S, 2000, MOL BIOL CELL, V11, P1697, DOI 10.1091/mbc.11.5.1697; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Yoshida Y, 2002, NATURE, V418, P438, DOI 10.1038/nature00890; Yoshida Y, 2003, J BIOL CHEM, V278, P43877, DOI 10.1074/jbc.M304157200; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Zhao G, 2007, P NATL ACAD SCI USA, V104, P8785, DOI 10.1073/pnas.0702966104	80	11	13	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11479	11491		10.1074/jbc.M110.177618	http://dx.doi.org/10.1074/jbc.M110.177618			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21228276	Green Published, hybrid			2022-12-27	WOS:000288797100059
J	Klaus-Heisen, D; Nurisso, A; Pietraszewska-Bogiel, A; Mbengue, M; Camut, S; Timmers, T; Pichereaux, C; Rossignol, M; Gadella, TWJ; Imberty, A; Lefebvre, B; Cullimore, JV				Klaus-Heisen, Doerte; Nurisso, Alessandra; Pietraszewska-Bogiel, Anna; Mbengue, Malick; Camut, Sylvie; Timmers, Ton; Pichereaux, Carole; Rossignol, Michel; Gadella, Theodorus W. J.; Imberty, Anne; Lefebvre, Benoit; Cullimore, Julie V.			Structure-Function Similarities between a Plant Receptor-like Kinase and the Human Interleukin-1 Receptor-associated Kinase-4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDICAGO-TRUNCATULA; TYROSINE PHOSPHORYLATION; PROTEIN-KINASES; IRAK-4 KINASE; ACTIVATION; DOMAIN; GENE; AUTOPHOSPHORYLATION; COMPLEX; FAMILY	Phylogenetic analysis has previously shown that plant receptor-like kinases (RLKs) are monophyletic with respect to the kinase domain and share an evolutionary origin with the animal interleukin-1 receptor-associated kinase/Pellesoluble kinases. The lysin motif domain-containing receptorlike kinase-3 (LYK3) of the legume Medicago truncatula shows 33% amino acid sequence identity with human IRAK-4 over the kinase domain. Using the structure of this animal kinase as a template, homology modeling revealed that the plant RLK contains structural features particular to this group of kinases, including the tyrosine gatekeeper and the N-terminal extension alpha-helix B. Functional analysis revealed the importance of these conserved features for kinase activity and suggests that kinase activity is essential for the biological role of LYK3 in the establishment of the root nodule nitrogen-fixing symbiosis with rhizobia bacteria. The kinase domain of LYK3 has dual serine/threonine and tyrosine specificity, and mass spectrometry analysis identified seven serine, eight threonine, and one tyrosine residue as autophosphorylation sites in vitro. Three activation loop serine/threonine residues are required for biological activity, and molecular dynamics simulations suggest that Thr-475 is the prototypical phosphorylated residue that interacts with the conserved arginine in the catalytic loop, whereas Ser-471 and Thr-472 may be secondary sites. A threonine in the juxtamembrane region and two threonines in the C-terminal lobe of the kinase domain are important for biological but not kinase activity. We present evidence that the structure-function similarities that we have identified between LYK3 and IRAK-4 may be more widely applicable to plant RLKs in general.	[Klaus-Heisen, Doerte; Mbengue, Malick; Camut, Sylvie; Timmers, Ton; Lefebvre, Benoit; Cullimore, Julie V.] INRA, CNRS, Lab Plant Microbe Interact, F-31326 Castanet Tolosan, France; [Nurisso, Alessandra; Imberty, Anne] Univ Grenoble 1, CNRS, CERMAV, F-38041 Grenoble 9, France; [Nurisso, Alessandra; Imberty, Anne] Inst Chim Mol Grenoble, F-38041 Grenoble 9, France; [Pietraszewska-Bogiel, Anna; Gadella, Theodorus W. J.] Swammerdam Inst Life Sci, NL-1098 SM Amsterdam, Netherlands; [Pichereaux, Carole; Rossignol, Michel] Univ Toulouse, Inst Pharmacol & Biol Struct, Inst Federatif Rech, IFR40, F-31077 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); INRAE; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Amsterdam; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Cullimore, JV (corresponding author), INRA, CNRS, Lab Plant Microbe Interact, BP 52627, F-31326 Castanet Tolosan, France.	julie.cullimore@toulouse.inra.fr	Mbengue, Malick/G-4837-2012; lefebvre, benoit/G-2028-2012; Imberty, Anne/P-6451-2018	Mbengue, Malick/0000-0002-7723-7757; Lefebvre, Benoit/0000-0002-3810-605X; Pichereaux, Carole/0000-0002-7559-5358; Cullimore, Julie/0000-0001-8804-4849; Imberty, Anne/0000-0001-6825-9527; Gadella, Theodorus/0000-0002-7639-219X	European Community [MRTN-CT-2006-035546]; Fondation pour la Recherche Medicale; Toulouse Midi-Pyrenees Genopole; Midi-Pyrenees Regional Council [CR07003760]; French National Research Agency	European Community(European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Toulouse Midi-Pyrenees Genopole; Midi-Pyrenees Regional Council(Region Occitanie); French National Research Agency(French National Research Agency (ANR))	This work was supported in part by the European Community Marie Curie Research Training Network Programme Contract MRTN-CT-2006-035546 "NODPERCEPTION," French National Research Agency Contracts "NodBindsLysM" and "Sympasignal," Fondation pour la Recherche Medicale Contract "Grands Equipements," the Toulouse Midi-Pyrenees Genopole, and the Midi-Pyrenees Regional Council Grant CR07003760.	Arrighi JF, 2006, PLANT PHYSIOL, V142, P265, DOI 10.1104/pp.106.084657; Boisson-Dernier A, 2001, MOL PLANT MICROBE IN, V14, P695, DOI 10.1094/MPMI.2001.14.6.695; Borderies G, 2003, ELECTROPHORESIS, V24, P3421, DOI 10.1002/elps.200305608; Catoira R, 2001, DEVELOPMENT, V128, P1507; Chen XW, 2010, J BIOL CHEM, V285, P10454, DOI 10.1074/jbc.M109.093427; Cheng H, 2007, BIOCHEM BIOPH RES CO, V352, P609, DOI 10.1016/j.bbrc.2006.11.068; Dong J, 2009, PLANT CELL, V21, P1846, DOI 10.1105/tpc.109.066878; Geldner N, 2008, PLANT PHYSIOL, V147, P1565, DOI 10.1104/pp.108.120287; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Karlova R, 2009, PROTEOMICS, V9, P368, DOI 10.1002/pmic.200701059; Kollewe C, 2004, J BIOL CHEM, V279, P5227, DOI 10.1074/jbc.M309251200; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Kuglstatter A, 2007, J IMMUNOL, V178, P2641, DOI 10.4049/jimmunol.178.5.2641; Levy J, 2004, SCIENCE, V303, P1361, DOI 10.1126/science.1093038; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; Liu GZ, 2002, J BIOL CHEM, V277, P20264, DOI 10.1074/jbc.M110999200; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Madsen EB, 2011, PLANT J, V65, P404, DOI 10.1111/j.1365-313X.2010.04431.x; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Miyahara A, 2008, J BIOL CHEM, V283, P25381, DOI 10.1074/jbc.M800400200; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Nuhse TS, 2004, PLANT CELL, V16, P2394, DOI 10.1105/tpc.104.023150; Oh MH, 2009, P NATL ACAD SCI USA, V106, P658, DOI 10.1073/pnas.0810249106; Oldroyd GED, 2008, ANNU REV PLANT BIOL, V59, P519, DOI 10.1146/annurev.arplant.59.032607.092839; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Shiu SH, 2001, P NATL ACAD SCI USA, V98, P10763, DOI 10.1073/pnas.181141598; Smit P, 2007, PLANT PHYSIOL, V145, P183, DOI 10.1104/pp.107.100495; van Bentem SD, 2009, TRENDS PLANT SCI, V14, P71, DOI 10.1016/j.tplants.2008.11.003; Van Ooijen G, 2008, J EXP BOT, V59, P1383, DOI 10.1093/jxb/ern045; Wang XF, 2005, PLANT CELL, V17, P1685, DOI 10.1105/tpc.105.031393; Wang XF, 2008, DEV CELL, V15, P220, DOI 10.1016/j.devcel.2008.06.011; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Wang ZL, 2006, STRUCTURE, V14, P1835, DOI 10.1016/j.str.2006.11.001; Xing W, 2007, NATURE, V449, P243, DOI 10.1038/nature06109; Yoshida S, 2005, J BIOL CHEM, V280, P9203, DOI 10.1074/jbc.M411665200	37	44	44	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11202	11210		10.1074/jbc.M110.186171	http://dx.doi.org/10.1074/jbc.M110.186171			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21205819	Green Published, hybrid			2022-12-27	WOS:000288797100031
J	Yano, T; Kassovska-Bratinova, S; Teh, JS; Winkler, J; Sullivan, K; Isaacs, A; Schechter, NM; Rubin, H				Yano, Takahiro; Kassovska-Bratinova, Sacha; Teh, J. Shin; Winkler, Jeffrey; Sullivan, Kevin; Isaacs, Andre; Schechter, Norman M.; Rubin, Harvey			Reduction of Clofazimine by Mycobacterial Type 2 NADH: Quinone Oxidoreductase A PATHWAY FOR THE GENERATION OF BACTERICIDAL LEVELS OF REACTIVE OXYGEN SPECIES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TETRAMETHYLPIPERIDINE-SUBSTITUTED PHENAZINES; MENAQUINONE OXIDOREDUCTASE; ANTIMICROBIAL ACTIVITIES; IN-VITRO; MITOCHONDRIA; TUBERCULOSIS; ANALOGS; METABOLISM; MECHANISMS; PARACOCCUS	The mechanism of action of clofazimine (CFZ), an antimycobacterial drug with a long history, is not well understood. The present study describes a redox cycling pathway that involves the enzymatic reduction of CFZ by NDH-2, the primary respiratory chain NADH: quinone oxidoreductase of mycobacteria and nonenzymatic oxidation of reduced CFZ by O-2 yielding CFZ and reactive oxygen species (ROS). This pathway was demonstrated using isolated membranes and purified recombinant NDH-2. The reduction and oxidation of CFZ was measured spectrally, and the production of ROS was measured using a coupled assay system with Amplex Red. Supporting the ROS-based killing mechanism, bacteria grown in the presence of antioxidants are more resistant to CFZ. CFZ-mediated increase in NADH oxidation and ROS production were not observed in membranes from three different Gram-negative bacteria but was observed in Staphylococcus aureus and Saccharomyces cerevisiae, which is consistent with the known antimicrobial specificity of CFZ. A more soluble analog of CFZ, KS6, was synthesized and was shown to have the same activities as CFZ. These studies describe a pathway for a continuous and high rate of reactive oxygen species production in Mycobacterium smegmatis treated with CFZ and a CFZ analog as well as evidence that cell death produced by these agents are related to the production of these radical species.	[Yano, Takahiro; Kassovska-Bratinova, Sacha; Teh, J. Shin; Rubin, Harvey] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Schechter, Norman M.] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA; [Schechter, Norman M.; Rubin, Harvey] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Winkler, Jeffrey; Sullivan, Kevin; Isaacs, Andre] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Rubin, H (corresponding author), 522 Johnson Pavil,3610 Hamilton Walk, Philadelphia, PA 19104 USA.	rubinh@upenn.edu		Isaacs, Andre/0000-0002-7222-1668; Sullivan, Kevin/0000-0001-7455-2308	National Institutes of Health [R01-AI068942-02]; Global Alliance for New Tuberculosis Drug Development; Institute for the Translational Medicine and Therapeutics from the University of Pennsylvania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068942] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Global Alliance for New Tuberculosis Drug Development; Institute for the Translational Medicine and Therapeutics from the University of Pennsylvania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AI068942-02. This work was also supported by grants from the Global Alliance for New Tuberculosis Drug Development and the Institute for the Translational Medicine and Therapeutics from the University of Pennsylvania.; We thank Khisi Mdluli, Zhenkun Ma, and Takushi Kaneko of the Global Alliance for New Tuberculosis Drug Development for intellectual and financial support of this work, whose interest in reinvestigating clofazimine as a tuberculosis drug played a large role in the initiation of this work. We also thank Val Bratinov, Jennifer Yano, and Yashashree Angadi for excellent technical support throughout this study.	Baker SC, 1998, MICROBIOL MOL BIOL R, V62, P1046, DOI 10.1128/MMBR.62.4.1046-1078.1998; BARRY VC, 1957, NATURE, V179, P1013, DOI 10.1038/1791013a0; Bopape MC, 2004, J ANTIMICROB CHEMOTH, V53, P971, DOI 10.1093/jac/dkh215; Cholo MC, 2006, J ANTIMICROB CHEMOTH, V57, P79, DOI 10.1093/jac/dki409; DEVRIES S, 1988, EUR J BIOCHEM, V176, P377; Durandt C, 2001, INT J ONCOL, V19, P579; Epand RF, 2007, BBA-BIOMEMBRANES, V1768, P2500, DOI 10.1016/j.bbamem.2007.05.023; Epand RM, 2008, J AM CHEM SOC, V130, P14346, DOI 10.1021/ja8062327; FAHELELBOM KMS, 1993, PHARMACEUT RES, V10, P631, DOI 10.1023/A:1018978809545; FRANZBLAU SG, 1989, ANTIMICROB AGENTS CH, V33, P2004, DOI 10.1128/AAC.33.11.2004; Hoff DR, 2008, ANTIMICROB AGENTS CH, V52, P4137, DOI 10.1128/AAC.00196-08; Inbaraj JJ, 2004, CHEM RES TOXICOL, V17, P55, DOI 10.1021/tx034132s; JOHN P, 1975, NATURE, V254, P495, DOI 10.1038/254495a0; Johnson  D., 1967, METHOD ENZYMOL, V10, P94, DOI DOI 10.1016/0076-6879(67)10018-9; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; KOVACIC P, 1989, BIOELECTROCH BIOENER, V21, P269, DOI 10.1016/0302-4598(89)85006-8; KRAJEWSKA MM, 1993, INT J IMMUNOPHARMACO, V15, P99, DOI 10.1016/0192-0561(93)90086-E; Lai XZ, 2008, ACCOUNTS CHEM RES, V41, P1233, DOI 10.1021/ar700270t; Lenaerts AJ, 2008, TRENDS MICROBIOL, V16, P48, DOI 10.1016/j.tim.2007.12.002; MEISINGER C, 2006, METHOD MOL BIOL, V313, P33039; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; Mochizuki M, 1999, J BIOL CHEM, V274, P33403, DOI 10.1074/jbc.274.47.33403; MORRISON NE, 1976, INT J LEPROSY, V44, P475; NIWA Y, 1984, J CLIN MICROBIOL, V20, P837, DOI 10.1128/JCM.20.5.837-842.1984; OConnor R, 1995, DRUG METAB REV, V27, P591, DOI 10.3109/03602539508994208; Oliva B, 2004, J ANTIMICROB CHEMOTH, V53, P435, DOI 10.1093/jac/dkh114; PON L, 1989, J CELL BIOL, V109, P2603, DOI 10.1083/jcb.109.6.2603; Raha S, 2000, TRENDS BIOCHEM SCI, V25, P502, DOI 10.1016/S0968-0004(00)01674-1; Reddy VM, 1999, J ANTIMICROB CHEMOTH, V43, P615, DOI 10.1093/jac/43.5.615; Reddy VM, 1996, ANTIMICROB AGENTS CH, V40, P633, DOI 10.1128/AAC.40.3.633; Ren YZR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004009; RHODES PM, 1973, BIOCHEM PHARMACOL, V22, P1047, DOI 10.1016/0006-2952(73)90169-X; ROSNER JL, 1994, ANTIMICROB AGENTS CH, V38, P1829, DOI 10.1128/AAC.38.8.1829; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Sanchez MR, 2000, CLIN DERMATOL, V18, P131, DOI 10.1016/S0738-081X(99)00103-0; Sano K, 2004, ANTIMICROB AGENTS CH, V48, P2132, DOI 10.1128/AAC.48.6.2132-2139.2004; Teh J. S., 2007, Infectious Disorders - Drug Targets, V7, P169; Timmins GS, 2006, MOL MICROBIOL, V62, P1220, DOI 10.1111/j.1365-2958.2006.05467.x; van Rensburg CEJ, 2000, CHEMOTHERAPY, V46, P43, DOI 10.1159/000007255; VANRENSBURG CEJ, 1982, ANTIMICROB AGENTS CH, V21, P693, DOI 10.1128/AAC.21.5.693; VANRENSBURG CEJ, 1992, ANTIMICROB AGENTS CH, V36, P2729, DOI 10.1128/AAC.36.12.2729; VANRENSBURG CEJ, 1993, CANCER RES, V53, P318; Castro FAV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003999; Weinstein EA, 2005, P NATL ACAD SCI USA, V102, P4548, DOI 10.1073/pnas.0500469102; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1; Yang LH, 2007, J AM CHEM SOC, V129, P12141, DOI 10.1021/ja072310o; Yano T, 2006, J BIOL CHEM, V281, P11456, DOI 10.1074/jbc.M508844200; Yano T, 2001, J BIOENERG BIOMEMBR, V33, P213, DOI 10.1023/A:1010782903144; ZEIS BM, 1986, INT J IMMUNOPHARMACO, V8, P731, DOI 10.1016/0192-0561(86)90009-3; ZEIS BM, 1987, ANTIMICROB AGENTS CH, V31, P789, DOI 10.1128/AAC.31.5.789	51	208	219	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10276	10287		10.1074/jbc.M110.200501	http://dx.doi.org/10.1074/jbc.M110.200501			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21193400	hybrid, Green Published			2022-12-27	WOS:000288547000045
J	Bate, C; Williams, A				Bate, Clive; Williams, Alun			Monoacylated Cellular Prion Protein Modifies Cell Membranes, Inhibits Cell Signaling, and Reduces Prion Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GPI-ANCHORED PROTEINS; LIPID RAFTS; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHOR; SCRAPIE ISOFORM; CHOLESTEROL; DISEASE; PRP; ACCUMULATION; TRAFFICKING; RESISTANT	Prion diseases occur following the conversion of the cellular prion protein (PrPC) into a disease related, protease-resistant isoform (PrPSc). In these studies, a cell painting technique was used to introduce PrPC to prion-infected neuronal cell lines (ScGT1, ScN2a, or SMB cells). The addition of PrPC resulted in increased PrPSc formation that was preceded by an increase in the cholesterol content of cell membranes and increased activation of cytoplasmic phospholipase A(2) (cPLA(2)). In contrast, although PrPC lacking one of the two acyl chains from its glycosylphosphatidylinositol (GPI) anchor (PrPC-G-lyso-PI) bound readily to cells, it did not alter the amount of cholesterol in cell membranes, was not found within detergent-resistant membranes (lipid rafts), and did not activate cPLA(2). It remained within cells for longer than PrPC with a conventional GPI anchor and was not converted to PrPSc. Moreover, the addition of high amounts of PrPC-G-lyso-PI displaced cPLA(2) from PrPSc-containing lipid rafts, reduced the activation of cPLA(2), and reduced PrPSc formation in all three cell lines. In addition, ScGT1 cells treated with PrPC-G-lyso-PI did not transmit infection following intracerebral injection to mice. We propose that that the chemical composition of the GPI anchor attached to PrPC modified the local membrane microenvironments that control cell signaling, the fate of PrPC, and hence PrPSc formation. In addition, our observations raise the possibility that pharmacological modification of GPI anchors might constitute a novel therapeutic approach to prion diseases.	[Bate, Clive; Williams, Alun] Royal Vet Coll, Dept Pathol & Infect Dis, N Mymms AL9 7TA, Herts, England	University of London; University of London Royal Veterinary College	Bate, C (corresponding author), Royal Vet Coll, Dept Pathol & Infect Dis, Hawkshead Lane, N Mymms AL9 7TA, Herts, England.	cbate@rvc.ac.uk			European Commission	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by a grant from the European Commission FP6 "Neuroprion" Network of Excellence.	Bate C, 2004, J BIOL CHEM, V279, P14983, DOI 10.1074/jbc.M313061200; Bate C, 2010, J BIOL CHEM, V285, P22017, DOI 10.1074/jbc.M110.108548; Bate C, 2010, BIOCHEM J, V428, P95, DOI 10.1042/BJ20091469; Bate C, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-8; Beranger F, 2002, J BIOL CHEM, V277, P38972, DOI 10.1074/jbc.M205110200; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; de Figueiredo P, 1998, P NATL ACAD SCI USA, V95, P8642, DOI 10.1073/pnas.95.15.8642; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; GOCZE PM, 1992, ENDOCRINOLOGY, V131, P2972, DOI 10.1210/en.131.6.2972; Graham JF, 2010, J BIOL CHEM, V285, P9868, DOI 10.1074/jbc.M109.093484; Jeffrey M, 2000, NEUROPATH APPL NEURO, V26, P41, DOI 10.1046/j.1365-2990.2000.00216.x; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; Magalhaes AC, 2002, J BIOL CHEM, V277, P33311, DOI 10.1074/jbc.M203661200; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; McNally KL, 2009, J VIROL, V83, P4469, DOI 10.1128/JVI.02412-08; Medof ME, 1996, FASEB J, V10, P574, DOI 10.1096/fasebj.10.5.8621057; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Parkyn CJ, 2008, J CELL SCI, V121, P773, DOI 10.1242/jcs.021816; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; TARABOULOS A, 1995, J CELL BIOL, V129, P121, DOI 10.1083/jcb.129.1.121; Taylor DR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000666; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Warner RG, 2002, J BIOL CHEM, V277, P18421, DOI 10.1074/jbc.M110406200	34	15	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8752	8758		10.1074/jbc.M110.186833	http://dx.doi.org/10.1074/jbc.M110.186833			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21212283	Green Published, hybrid			2022-12-27	WOS:000288247700006
J	Jiang, R; Shi, ZG; Johnson, JJ; Liu, YY; Stack, MS				Jiang, Rong; Shi, Zonggao; Johnson, Jeffrey J.; Liu, Yueying; Stack, M. Sharon			Kallikrein-5 Promotes Cleavage of Desmoglein-1 and Loss of Cell-Cell Cohesion in Oral Squamous Cell Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN TISSUE KALLIKREINS; PROTEOLYTIC CASCADE; SERINE PROTEASES; DESMOSOMAL CADHERINS; IN-VITRO; EXPRESSION; MODEL; SKIN; DIFFERENTIATION; DEGRADATION	Oral squamous cell carcinoma (OSCC) ranks among the top 8 causes of cancer death worldwide, with only a 60% 5-year survival rate, highlighting the need for discovery of novel biomarkers and therapeutic targets. We have previously reported that expression of a panel of serine proteinase kallikreins (KLK 5, 7, 8, and 10) is correlated with formation of more aggressive OSCC tumors in a murine orthotopic OSCC model and is elevated in human OSCC. Current studies focus on understanding the potential role of KLK5 in OSCC progression. In initial studies, KLK levels in malignant OSCC cells (SCC25) were compared with cells from normal oral mucosa (OKF/6) and pre-malignant oral keratinocytes (pp126) using qPCR. A marked elevation of all KLKs was observed in aggressive SCC25 cells relative to OKF/6 cells. In normal skin, KLKs are involved in desquamation during epidermal differentiation via proteolytic cleavage of the desmosomal cadherin component desmoglein 1 (Dsg1). As loss of cell-cell cohesion is prevalent in tumor metastasis, Dsg1 integrity was evaluated. Results show that SCC25 cells exhibit cleavage of Dsg1, which is blocked by proteinase inhibitor treatment as well as by siRNA silencing of KLK5 expression. Furthermore, cell-cell aggregation assays demonstrate that silencing of KLK5 enforces cell-cell adhesion; conversely, overexpression of KLK5 in normal oral mucosal cells (OKF/6) enhances cell dispersal. These data suggest that KLK5 may promote metastatic dissemination of OSCC by promoting loss of junctional integrity through cleavage of desmoglein 1.	[Jiang, Rong; Shi, Zonggao; Johnson, Jeffrey J.; Liu, Yueying; Stack, M. Sharon] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO 65212 USA	University of Missouri System; University of Missouri Columbia	Stack, MS (corresponding author), Univ Missouri, Sch Med, Dept Pathol & Anat Sci, 1 Hosp Dr,M214C Med Sci Bldg, Columbia, MO 65212 USA.	stackm@missouri.edu	Jiang, Rong/K-4143-2013	Shi, Zonggao/0000-0001-7503-2953	NCI, National Institutes of Health [CA085870]; NATIONAL CANCER INSTITUTE [R01CA085870] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by Research Grant CA085870 (to M. S. S.) from the NCI, National Institutes of Health.	ARNEMANN J, 1993, J CELL SCI, V104, P741; BEYNON R, 2001, PROTEOLYTIC ENZYMES, P320; Borgono CA, 2004, MOL CANCER RES, V2, P257; Borgono CA, 2007, J BIOL CHEM, V282, P3640, DOI 10.1074/jbc.M607567200; Brattsand M, 2005, J INVEST DERMATOL, V124, P198, DOI 10.1111/j.0022-202X.2004.23547.x; Buxton R S, 1992, Semin Cell Biol, V3, P157; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Caubet C, 2004, J INVEST DERMATOL, V122, P1235, DOI 10.1111/j.0022-202X.2004.22512.x; Cheng X, 2004, J DERMATOL, V31, P171, DOI 10.1111/j.1346-8138.2004.tb00654.x; Denning MF, 1998, EXP CELL RES, V239, P50, DOI 10.1006/excr.1997.3890; Descargues P, 2005, NAT GENET, V37, P56, DOI 10.1038/ng1493; Descargues P, 2006, J INVEST DERMATOL, V126, P1622, DOI 10.1038/sj.jid.5700284; Egelrud T, 2005, BRIT J DERMATOL, V153, P1200, DOI 10.1111/j.1365-2133.2005.06834.x; EGELRUD T, 1993, J INVEST DERMATOL, V101, P200, DOI 10.1111/1523-1747.ep12363804; Ekholm IE, 2000, J INVEST DERMATOL, V114, P56, DOI 10.1046/j.1523-1747.2000.00820.x; Garrod D, 1996, CURR OPIN CELL BIOL, V8, P670, DOI 10.1016/S0955-0674(96)80108-6; Garrod DR, 1993, CURR OPIN CELL BIOL, V5, P30, DOI 10.1016/S0955-0674(05)80005-5; Getsios S, 2004, DIFFERENTIATION, V72, P419, DOI 10.1111/j.1432-0436.2004.07208008.x; Ghosh S, 2010, MOL CANCER RES, V8, P145, DOI 10.1158/1541-7786.MCR-09-0045; Green KJ, 2000, NAT REV MOL CELL BIO, V1, P208, DOI 10.1038/35043032; HARADA T, 1992, INT J ORAL MAX SURG, V21, P346, DOI 10.1016/S0901-5027(05)80759-3; HORNER MJ, 2009, SEER CANC STAT REV; Huen AC, 2002, J CELL BIOL, V159, P1005, DOI 10.1083/jcb.200206098; IMAI K, 1995, HEAD NECK-J SCI SPEC, V17, P204, DOI 10.1002/hed.2880170307; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; KOCH PJ, 1994, CURR OPIN CELL BIOL, V6, P682, DOI 10.1016/0955-0674(94)90094-9; Kowalczyk AP, 1996, J INVEST DERMATOL, V107, P293, DOI 10.1111/1523-1747.ep12363000; Lawrence MG, 2010, ENDOCR REV, V31, P407, DOI 10.1210/er.2009-0034; LUNDSTROM A, 1990, ARCH DERMATOL RES, V282, P234, DOI 10.1007/BF00371642; LUNDSTROM A, 1988, J INVEST DERMATOL, V91, P340, DOI 10.1111/1523-1747.ep12475679; LUNDSTROM A, 1990, J INVEST DERMATOL, V94, P216, DOI 10.1111/1523-1747.ep12874531; Lundwall A, 2006, BIOL CHEM, V387, P637, DOI 10.1515/BC.2006.082; Michael IP, 2006, J BIOL CHEM, V281, P12743, DOI 10.1074/jbc.M600326200; North AJ, 1999, J CELL SCI, V112, P4325; Oda D, 1996, EXP CELL RES, V226, P164, DOI 10.1006/excr.1996.0215; Paliouras M, 2007, CANCER LETT, V249, P61, DOI 10.1016/j.canlet.2006.12.018; Pampalakis G, 2007, BBA-REV CANCER, V1776, P22, DOI 10.1016/j.bbcan.2007.06.001; Pettus JR, 2009, HISTOL HISTOPATHOL, V24, P197, DOI 10.14670/HH-24.197; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Rusthoven K, 2008, CANCER-AM CANCER SOC, V112, P345, DOI 10.1002/cncr.23183; Sales KU, 2010, NAT GENET, V42, P676, DOI 10.1038/ng.629; Sano D, 2007, CANCER METAST REV, V26, P645, DOI 10.1007/s10555-007-9082-y; Shi ZG, 2007, BIOCHEM J, V407, P153, DOI 10.1042/BJ20071037; Shi Z, 2010, HISTOL HISTOPATHOL, V25, P917, DOI 10.14670/HH-25.917; Ye H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-69; ZHAO H, 2010, HEAD NECK IN PRESS	46	47	51	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9127	9135		10.1074/jbc.M110.191361	http://dx.doi.org/10.1074/jbc.M110.191361			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21163944	Green Published, hybrid			2022-12-27	WOS:000288247700043
J	Oh, MK; Park, HJ; Kim, NH; Park, SJ; Park, IY; Kim, IS				Oh, Mi-Kyung; Park, Hyo-Jung; Kim, Nam-Hoon; Park, Seon-Joo; Park, In-Yang; Kim, In-Sook			Hypoxia-inducible Factor-1 alpha Enhances Haptoglobin Gene Expression by Improving Binding of STAT3 to the Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRE-LIKE SITE; RESPONSE ELEMENT; DNA-BINDING; REGULATORY FACTOR; VEGF EXPRESSION; CELL-MIGRATION; JUNB PROMOTER; TUMOR-GROWTH; PROTEIN; IDENTIFICATION	Haptoglobin (Hp) is known to play a role in angiogenesis as well as in anti-inflammation. STAT3 is a major transcription factor for expression of human Hp. We investigated whether hypoxia-inducible factor-1 alpha (HIF-1 alpha), a key mediator of angiogenesis, participates in Hp gene expression. HIF-1 alpha overexpression by gene transfection or hypoxia augmented Hp transcription in HepG2 human hepatoma cells. Conversely, knockdown of HIF-1 alpha by specific siRNA transfection diminished Hp expression, although the level of STAT3 phosphorylation remained unchanged. A luciferase reporter assay using mutant Hp promoters demonstrated that two adjacent DNA elements, a STAT3-binding element (SBE) and a cAMP-response element (CRE)-like site in human Hp promoter - 120/ - 97, were required for HIF-1 alpha-stimulated transactivation of the Hp gene. HIF-1 alpha, STAT3, and p300/CBP were simultaneously bound to the SBE/CRE as a complex form. When HIF-1 alpha was knocked down, STAT3 binding to the SBE in the Hp promoter was attenuated. Our findings suggest that HIF-1 alpha assists STAT3 in strong binding to the proximal SBE in the Hp promoter. The CRE-like site located near the SBE may contribute to the formation of a stable complex of STAT3, HIF-1 alpha, and p300/CBP, which leads to maximum transcription of the Hp gene.	[Oh, Mi-Kyung; Park, Hyo-Jung; Kim, Nam-Hoon; Park, Seon-Joo; Kim, In-Sook] Catholic Univ Korea, Dept Med Lifesci, Coll Med, Seoul 137701, South Korea; [Park, In-Yang] Catholic Univ Korea, Coll Med, Dept Obstet & Gynecol, Seoul 137701, South Korea	Catholic University of Korea; Catholic University of Korea	Kim, IS (corresponding author), Catholic Univ Korea, Dept Med Lifesci, Coll Med, Seoul 137701, South Korea.	ikim@catholic.ac.kr		Park, Hyo-Jung/0000-0002-1601-7638	Korea Research Foundation from the Korean Government [KRF-2007-313-E00095]; Ministry of Health and Welfare, Republic of Korea [A050209]	Korea Research Foundation from the Korean Government; Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by Korea Research Foundation Grant KRF-2007-313-E00095 from the Korean Government and by Korea Health 21 R&D Project Grant A050209 from the Ministry of Health and Welfare, Republic of Korea.	Ahmed N, 2004, BRIT J CANCER, V91, P129, DOI 10.1038/sj.bjc.6601882; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; BAUMANN H, 1994, BLOOD, V15, P764; Choi SO, 2007, BIOCHEM BIOPH RES CO, V356, P312, DOI 10.1016/j.bbrc.2007.02.137; CID MC, 1993, J CLIN INVEST, V91, P977, DOI 10.1172/JCI116319; Dasqupta A, 2009, EUR J CANCER, V45, P677, DOI 10.1016/j.ejca.2008.11.027; de Kleijn DPV, 2002, FASEB J, V16, P1123, DOI 10.1096/fj.02-0019fje; Duan HO, 2003, J BIOL CHEM, V278, P41270, DOI 10.1074/jbc.M304210200; Ebert BL, 1998, MOL CELL BIOL, V18, P4089, DOI 10.1128/MCB.18.7.4089; Gariboldi MB, 2010, BIOCHEM PHARMACOL, V80, P455, DOI 10.1016/j.bcp.2010.05.011; Gray MJ, 2005, ONCOGENE, V24, P3110, DOI 10.1038/sj.onc.1208513; Grigorov I, 2000, MOL BIOL REP, V27, P81, DOI 10.1023/A:1007177605135; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; HARROCH S, 1994, EMBO J, V13, P1942, DOI 10.1002/j.1460-2075.1994.tb06463.x; Ichiba M, 1998, J BIOL CHEM, V273, P6132, DOI 10.1074/jbc.273.11.6132; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; Kim HK, 1997, J BIOL CHEM, V272, P14571, DOI 10.1074/jbc.272.23.14571; Kim NH, 2007, IMMUNOLOGY, V122, P607, DOI 10.1111/j.1365-2567.2007.02679.x; Kim NH, 2010, J PHARMACOL SCI, V113, P246, DOI 10.1254/jphs.09330FP; Kojima H, 1996, ONCOGENE, V12, P547; Kumar DM, 2010, J PROTEOME RES, V9, P5557, DOI 10.1021/pr1001737; Lee MY, 2002, J CEREBR BLOOD F MET, V22, P1176, DOI 10.1097/01.wcb.0000037989.07114.d1; Lim SK, 1998, BLOOD, V92, P1870, DOI 10.1182/blood.V92.6.1870.418k38_1870_1877; Lim YK, 2000, KIDNEY INT, V58, P1033, DOI 10.1046/j.1523-1755.2000.00261.x; Lohr NL, 2005, AM J PHYSIOL-HEART C, V288, pH1389, DOI 10.1152/ajpheart.00938.2004; Look DC, 1995, J BIOL CHEM, V270, P30264, DOI 10.1074/jbc.270.51.30264; MARINKOVIC S, 1990, MOL CELL BIOL, V10, P1573, DOI 10.1128/MCB.10.4.1573; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Milacic V, 2006, CANCER RES, V66, P10478, DOI 10.1158/0008-5472.CAN-06-3017; NAKAJIMA K, 1993, MOL CELL BIOL, V13, P3027, DOI 10.1128/MCB.13.5.3027; Noman MZ, 2009, J IMMUNOL, V182, P3510, DOI 10.4049/jimmunol.0800854; OLIVIERO S, 1989, EMBO J, V8, P1145, DOI 10.1002/j.1460-2075.1989.tb03485.x; Park SJ, 2008, BRIT J PHARMACOL, V154, P1196, DOI 10.1038/bjp.2008.197; Park SJ, 2009, FEBS LETT, V583, P3235, DOI 10.1016/j.febslet.2009.09.014; Paulson M, 1999, J BIOL CHEM, V274, P25343, DOI 10.1074/jbc.274.36.25343; Ruas JL, 2010, J BIOL CHEM, V285, P2601, DOI 10.1074/jbc.M109.021824; SCHAEFER TS, 1995, P NATL ACAD SCI USA, V92, P9097, DOI 10.1073/pnas.92.20.9097; Wang YP, 2001, REDOX REP, V6, P379, DOI 10.1179/135100001101536580; WENGER RH, 1995, J BIOL CHEM, V270, P27865, DOI 10.1074/jbc.270.46.27865; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W	43	40	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8857	8865		10.1074/jbc.M110.150557	http://dx.doi.org/10.1074/jbc.M110.150557			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21224490	hybrid, Green Published			2022-12-27	WOS:000288247700016
J	Yu, YL; Chou, RH; Chen, LT; Shyu, WC; Hsieh, SC; Wu, CS; Zeng, HJ; Yeh, SP; Yang, DM; Hung, SC; Hung, MC				Yu, Yung-Luen; Chou, Ruey-Hwang; Chen, Ling-Tzu; Shyu, Woei-Cherng; Hsieh, Su-Ching; Wu, Chen-Shiou; Zeng, Hong-Jie; Yeh, Su-Peng; Yang, De-Ming; Hung, Shih-Chieh; Hung, Mien-Chie			EZH2 Regulates Neuronal Differentiation of Mesenchymal Stem Cells through PIP5K1C-dependent Calcium Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BONE-MARROW; I PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASES; LIPID KINASE FAMILY; GROUP PROTEIN EZH2; INTRACEREBRAL TRANSPLANTATION; 4-PHOSPHATE 5-KINASE; POLYCOMB COMPLEXES; MOUSE DEVELOPMENT; PHOSPHATE KINASE; SKELETAL-MUSCLE	Enhancer of zeste homolog 2 (EZH2) regulates stem cells renewal, maintenance, and differentiation into different cell lineages including neuron. Changes in intracellular Ca2+ concentration play a critical role in the differentiation of neurons. However, whether EZH2 modulates intracellular Ca2+ signaling in regulating neuronal differentiation from human mesenchymal stem cells (hMSCs) still remains unclear. When hMSCs were treated with a Ca2+ chelator or a PLC inhibitor to block IP3-mediated Ca2+ signaling, neuronal differentiation was disrupted. EZH2 bound to the promoter region of PIP5K1C to suppress its transcription in proliferating hMSCs. Interestingly, knockdown of EZH2 enhanced the expression of PIP5K1C, which in turn increased the amount of PI(4,5)P-2, a precursor of IP3, and resulted in increasing the intracellular Ca2+ level, suggesting that EZH2 negatively regulates intracellular Ca2+ through suppression of PIP5K1C. Knockdown of EZH2 also enhanced hMSCs differentiation into functional neuron both in vitro and in vivo. In contrast, knockdown of PIP5K1C significantly reduced PI(4,5)P-2 contents and intracellular Ca2+ release in EZH2-silenced cells and resulted in the disruption of neuronal differentiation from hMSCs. Here, we provide the first evidence to demonstrate that after induction to neuronal differentiation, decreased EZH2 activates the expression of PIP5K1C to evoke intracellular Ca2+ signaling, which leads hMSCs to differentiate into functional neuron lineage. Activation of intracellular Ca2+ signaling by repressing or knocking down EZH2 might be a potential strategy to promote neuronal differentiation from hMSCs for application to neurological dysfunction diseases.	[Yu, Yung-Luen; Chou, Ruey-Hwang; Hsieh, Su-Ching; Hung, Mien-Chie] China Med Univ Hosp, Ctr Mol Med, Taichung 404, Taiwan; [Shyu, Woei-Cherng] China Med Univ Hosp, Ctr Neuropsychiat, Taichung 404, Taiwan; [Yeh, Su-Peng] China Med Univ Hosp, Div Hematol & Oncol, Dept Med, Taichung 404, Taiwan; [Yu, Yung-Luen; Zeng, Hong-Jie; Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung 404, Taiwan; [Shyu, Woei-Cherng] China Med Univ, Grad Inst Immunol, Taichung 404, Taiwan; [Yu, Yung-Luen; Wu, Chen-Shiou] China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung 404, Taiwan; [Yu, Yung-Luen; Chou, Ruey-Hwang; Chen, Ling-Tzu] Asia Univ, Dept Biotechnol, Taichung 413, Taiwan; [Yang, De-Ming] Natl Yang Ming Univ, Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei 112, Taiwan; [Yang, De-Ming] Natl Yang Ming Univ, Inst Biophoton, Taipei 112, Taiwan; [Hung, Shih-Chieh] Natl Yang Ming Univ, Stem Cell Lab, Dept Med Res & Educ Orthopaed & Traumatol, Taipei Vet Gen Hosp, Taipei 112, Taiwan; [Hung, Shih-Chieh] Natl Yang Ming Univ, Inst Clin Med, Inst Pharmacol, Taipei 112, Taiwan; [Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; University of Texas System; UTMD Anderson Cancer Center	Yu, YL (corresponding author), China Med Univ Hosp, Ctr Mol Med, Taichung 404, Taiwan.	ylyu@mail.cmu.edu.tw; mhung@mdanderson.org	Chou, Ruey-Hwang/K-8541-2013; Yang, De-Ming/AAW-9886-2020; Hung, Mien-Chie/ABD-5911-2021	Chou, Ruey-Hwang/0000-0002-2297-2180; Yang, De-Ming/0000-0002-6923-4855; Hung, Mien-Chie/0000-0003-4317-4740; Wu, Chen-Shiou/0000-0003-0791-1483	National Institutes of Health [R01 CA109311, P01 CA099031]; The University of Texas M.D. Anderson-China Medical University; Hospital Sister Institution; Cancer Center Research of Excellence [DOH-99-TDC-111-05, NSC-2632-B-039-001-MY3, NSC-2320-B-039-032-MY3, NSC-3111-B-039]; NATIONAL CANCER INSTITUTE [P01CA099031, R01CA109311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The University of Texas M.D. Anderson-China Medical University; Hospital Sister Institution; Cancer Center Research of Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported, in whole or in part, by National Institutes of Health Grants R01 CA109311 and P01 CA099031. This work was also supported by The University of Texas M.D. Anderson-China Medical University and Hospital Sister Institution Fund, Cancer Center Research of Excellence DOH-99-TDC-111-05 (to M. C. H.); NSC-2632-B-039-001-MY3 (to M. C. H.); NSC-2320-B-039-032-MY3 (to Y. L. Y.); and NSC-3111-B-039 (to M. C. H., and Y. L. Y.).	Aoki R, 2010, J HEPATOL, V52, P854, DOI 10.1016/j.jhep.2010.01.027; Bae JS, 2007, STEM CELLS, V25, P1307, DOI 10.1634/stemcells.2006-0561; Banerjee S, 2005, BIOESSAYS, V27, P1035, DOI 10.1002/bies.20298; Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Cho SR, 2009, CELL TRANSPLANT, V18, P1359, DOI 10.3727/096368909X475329; Chu MS, 2006, CELL SIGNAL, V18, P519, DOI 10.1016/j.cellsig.2005.05.018; de la Cruz CC, 2005, CHROMOSOMA, V114, P183, DOI 10.1007/s00412-005-0008-6; Dezawa M, 2004, J CLIN INVEST, V113, P1701, DOI 10.1172/JCI200420935; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; Giudici ML, 2004, BIOCHEM J, V379, P489, DOI 10.1042/BJ20031394; Gray A, 2003, ANAL BIOCHEM, V313, P234, DOI 10.1016/S0003-2697(02)00607-3; Gu WD, 2010, NEUROPATHOLOGY, V30, P205, DOI 10.1111/j.1440-1789.2009.01063.x; Heck JN, 2007, CRIT REV BIOCHEM MOL, V42, P15, DOI 10.1080/10409230601162752; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; HOLLIDAY J, 1990, DEV BIOL, V141, P13, DOI 10.1016/0012-1606(90)90098-4; Hung SC, 2004, STEM CELLS, V22, P1321, DOI 10.1634/stemcells.2003-0176; Hung SC, 2004, INT J CANCER, V110, P313, DOI 10.1002/ijc.20126; Hung SC, 2002, STEM CELLS, V20, P522, DOI 10.1634/stemcells.20-6-522; Hung SC, 2002, STEM CELLS, V20, P249, DOI 10.1634/stemcells.20-3-249; Ishihara H, 1996, J BIOL CHEM, V271, P23611, DOI 10.1074/jbc.271.39.23611; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Jackson M B, 1999, Adv Neurol, V79, P511; Jin HK, 2002, J CLIN INVEST, V109, P1183, DOI 10.1072/JCI200214862; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kanaho Y, 2007, BIOL PHARM BULL, V30, P1605, DOI 10.1248/bpb.30.1605; Lee JK, 2010, STEM CELLS, V28, P329, DOI 10.1002/stem.277; Lee SY, 2005, J CELL BIOL, V168, P789, DOI 10.1083/jcb.200409028; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Ling K, 2006, TRENDS CELL BIOL, V16, P276, DOI 10.1016/j.tcb.2006.03.007; Loijens JC, 1996, J BIOL CHEM, V271, P32937, DOI 10.1074/jbc.271.51.32937; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Resende RR, 2010, STEM CELLS DEV, V19, P379, DOI 10.1089/scd.2008.0289; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Sher F, 2008, STEM CELLS, V26, P2875, DOI 10.1634/stemcells.2008-0121; Shyu WC, 2008, J CLIN INVEST, V118, P2482, DOI 10.1172/JCI34363; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Spitzer NC, 2000, BIOESSAYS, V22, P811; Tondreau T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-166; Tsai CC, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-64; Tsien Richard W., 1995, Trends in Neurosciences, V18, P52, DOI 10.1016/0166-2236(95)93867-W; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; van Horck FPG, 2002, CURR BIOL, V12, P241, DOI 10.1016/S0960-9822(01)00660-1; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang YF, 2007, P NATL ACAD SCI USA, V104, P11748, DOI 10.1073/pnas.0700019104; Wang YJ, 2004, J CELL BIOL, V167, P1005, DOI 10.1083/jcb.200408008; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Yamazaki M, 2002, J BIOL CHEM, V277, P17226, DOI 10.1074/jbc.M109795200; Zhao LR, 2002, EXP NEUROL, V174, P11, DOI 10.1006/exnr.2001.7853	55	46	46	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9657	9667		10.1074/jbc.M110.185124	http://dx.doi.org/10.1074/jbc.M110.185124			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21216957	Green Published, hybrid			2022-12-27	WOS:000288247700090
J	Grasso, D; Ropolo, A; Lo Re, A; Boggio, V; Molejon, MI; Iovanna, JL; Gonzalez, CD; Urrutia, R; Vaccaro, MI				Grasso, Daniel; Ropolo, Alejandro; Lo Re, Andrea; Boggio, Veronica; Molejon, Maria I.; Iovanna, Juan L.; Gonzalez, Claudio D.; Urrutia, Raul; Vaccaro, Maria I.			Zymophagy, a Novel Selective Autophagy Pathway Mediated by VMP1-USP9x-p62, Prevents Pancreatic Cell Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACINAR-CELLS; TRYPSINOGEN ACTIVATION; ENZYME ACTIVATION; VACUOLE FORMATION; PROTEIN; MYELOPEROXIDASE; DEGRADATION; PREMATURE; SCAFFOLD; MICE	Autophagy has recently elicited significant attention as a mechanism that either protects or promotes cell death, although different autophagy pathways, and the cellular context in which they occur, remain to be elucidated. We report a thorough cellular and biochemical characterization of a novel selective autophagy that works as a protective cell response. This new selective autophagy is activated in pancreatic acinar cells during pancreatitis-induced vesicular transport alteration to sequester and degrade potentially deleterious activated zymogen granules. We have coined the term "zymophagy" to refer to this process. The autophagy-related protein VMP1, the ubiquitin-protease USP9x, and the ubiquitin-binding protein p62 mediate zymophagy. Moreover, VMP1 interacts with USP9x, indicating that there is a close cooperation between the autophagy pathway and the ubiquitin recognition machinery required for selective autophagosome formation. Zymophagy is activated by experimental pancreatitis in genetically engineered mice and cultured pancreatic acinar cells and by acute pancreatitis in humans. Furthermore, zymophagy has pathophysiological relevance by controlling pancreatitis-induced intracellular zymogen activation and helping to prevent cell death. Together, these data reveal a novel selective form of autophagy mediated by the VMP1-USP9x-p62 pathway, as a cellular protective response.	[Grasso, Daniel; Ropolo, Alejandro; Lo Re, Andrea; Boggio, Veronica; Molejon, Maria I.; Gonzalez, Claudio D.; Vaccaro, Maria I.] Univ Buenos Aires, Sch Pharm & Biochem, Dept Pathophysiol, Buenos Aires, DF, Argentina; [Iovanna, Juan L.] INSERM, U624, F-13288 Marseille, France; [Urrutia, Raul] Mayo Clin, Chromatin Dynam & Epigenet Lab, Rochester, MN 55905 USA	University of Buenos Aires; Institut National de la Sante et de la Recherche Medicale (Inserm); Mayo Clinic	Vaccaro, MI (corresponding author), Univ Buenos Aires, Sch Pharm & Biochem, Dept Pathophysiol, 956 Junin,C1113AAD, Buenos Aires, DF, Argentina.	mvaccaro@ffyb.uba.ar	Vaccaro, Maria I./L-8348-2017; Iovanna, Juan/M-9805-2017	Iovanna, Juan/0000-0003-1822-2237; Vaccaro, Maria/0000-0002-2456-747X; GRASSO, DANIEL/0000-0002-8932-716X; Gonzalez, Claudio/0000-0002-3772-8850	Agencia Nacional de Promocion Cientifica y Tecnologica [ANPCyT-PICT01627]; Consejo Nacional de Investigaciones Cientificas y Tecnicas [CONICET-PIP2527]; University of Buenos Aires [UBA-UBACyTM072]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052913] Funding Source: NIH RePORTER	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); University of Buenos Aires(University of Buenos Aires); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by the Agencia Nacional de Promocion Cientifica y Tecnologica Grant ANPCyT-PICT01627, Consejo Nacional de Investigaciones Cientificas y Tecnicas Grant CONICET-PIP2527, and the University of Buenos Aires Grant UBA-UBACyTM072.	Bergink S, 2006, GENE DEV, V20, P1343, DOI 10.1101/gad.373706; Calvo-Garrido J, 2010, AUTOPHAGY, V6, P100, DOI 10.4161/auto.6.1.10697; CHANSON M, 1989, J CELL PHYSIOL, V139, P147, DOI 10.1002/jcp.1041390121; Cox B, 2006, NAT PROTOC, V1, P1872, DOI 10.1038/nprot.2006.273; Criddle DN, 2007, CELL DEATH DIFFER, V14, P1285, DOI 10.1038/sj.cdd.4402150; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Dawra R, 2008, PANCREAS, V37, P62, DOI 10.1097/MPA.0b013e3181607761; De Lisle RC, 2005, AM J PHYSIOL-CELL PH, V289, pC1169, DOI 10.1152/ajpcell.00099.2005; DiMagno MJ, 2004, AM J PHYSIOL-GASTR L, V287, pG80, DOI 10.1152/ajpgi.00525.2003; Fernandez-Zapico ME, 2003, EMBO J, V22, P4748, DOI 10.1093/emboj/cdg470; Fortunato F, 2009, AUTOPHAGY, V5, P850, DOI 10.4161/auto.8839; Gaisano HY, 2009, GASTROENTEROLOGY, V136, P2040, DOI 10.1053/j.gastro.2009.04.023; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Halangk W, 2002, AM J PHYSIOL-GASTR L, V282, pG367, DOI 10.1152/ajpgi.00315.2001; Hashimoto D, 2008, J CELL BIOL, V181, P1065, DOI 10.1083/jcb.200712156; Hofbauer B, 1998, AM J PHYSIOL-GASTR L, V275, pG352, DOI 10.1152/ajpgi.1998.275.2.G352; HOWELL KE, 1989, METHOD CELL BIOL, V31, P265; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Kraft C, 2009, BBA-MOL CELL RES, V1793, P1404, DOI 10.1016/j.bbamcr.2009.02.006; Kruger B, 2000, AM J PATHOL, V157, P43, DOI 10.1016/S0002-9440(10)64515-4; Mareninova OA, 2009, J CLIN INVEST, V119, P3340, DOI 10.1172/JCI38674; Millard SM, 2006, J CELL BIOL, V173, P463, DOI 10.1083/jcb.200602082; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; NIEDERAU C, 1985, GASTROENTEROLOGY, V88, P1192, DOI 10.1016/S0016-5085(85)80079-2; Nishida Y, 2009, NATURE, V461, P654, DOI 10.1038/nature08455; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Raraty M, 2000, P NATL ACAD SCI USA, V97, P13126, DOI 10.1073/pnas.97.24.13126; Ropolo A, 2007, J BIOL CHEM, V282, P37124, DOI 10.1074/jbc.M706956200; Saluja AK, 1999, AM J PHYSIOL-GASTR L, V276, pG835, DOI 10.1152/ajpgi.1999.276.4.G835; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Sherwood MW, 2007, P NATL ACAD SCI USA, V104, P5674, DOI 10.1073/pnas.0700951104; SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2; Suzuki K, 2007, FEBS LETT, V581, P2156, DOI 10.1016/j.febslet.2007.01.096; Thrower E, 2008, CURR OPIN GASTROEN, V24, P580, DOI 10.1097/MOG.0b013e32830b10e6; Tian Y, 2010, CELL, V141, P1042, DOI 10.1016/j.cell.2010.04.034; Vaccaro MI, 2008, PANCREATOLOGY, V8, P425, DOI 10.1159/000151480; Williams JA, 2008, CURR OPIN GASTROEN, V24, P573, DOI 10.1097/MOG.0b013e32830b110c	41	142	147	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8308	8324		10.1074/jbc.M110.197301	http://dx.doi.org/10.1074/jbc.M110.197301			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21173155	Green Published, hybrid			2022-12-27	WOS:000288013300060
J	Huang, CC; Tesmer, JJG				Huang, Chih-chin; Tesmer, John J. G.			Recognition in the Face of Diversity: Interactions of Heterotrimeric G proteins and G Protein-coupled Receptor (GPCR) Kinases with Activated GPCRs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ANGSTROM CRYSTAL-STRUCTURE; N-TERMINAL REGION; G-BETA-GAMMA; RHODOPSIN KINASE; ALPHA-SUBUNIT; TRANSDUCIN ACTIVATION; MONOMERIC RHODOPSIN; STRUCTURAL BASIS; BINDING-SITES; ARRESTIN	G protein-coupled receptors (GPCRs) represent the largest class of integral membrane protein receptors in the human genome. Despite the great diversity of ligands that activate these GPCRs, they interact with a relatively small number of intracellular proteins to induce profound physiological change. Both heterotrimeric G proteins and GPCR kinases are well known for their ability to specifically recognize GPCRs in their active state. Recent structural studies now suggest that heterotrimeric G proteins and GPCR kinases identify activated receptors via a common molecular mechanism despite having completely different folds.	[Huang, Chih-chin; Tesmer, John J. G.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Tesmer, John J. G.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Tesmer, JJG (corresponding author), Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.	johntesmer@umich.edu		Tesmer, John/0000-0003-1125-3727	National Institutes of Health [HL086865, HL071818]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071818, R01HL086865] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL086865 and HL071818 (to J. J. G. T.). This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Abdulaev NG, 2006, BIOCHEMISTRY-US, V45, P12986, DOI 10.1021/bi061088h; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Boguth CA, 2010, EMBO J, V29, P3249, DOI 10.1038/emboj.2010.206; Cai K, 1999, BIOCHEMISTRY-US, V38, P12893, DOI 10.1021/bi9912443; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cherfils J, 2003, TRENDS BIOCHEM SCI, V28, P13, DOI 10.1016/S0968-0004(02)00006-3; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Gruber CW, 2010, CURR PHARM DESIGN, V16, P3071; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Herrmann R, 2006, J BIOL CHEM, V281, P30234, DOI 10.1074/jbc.M600797200; Hirsch JA, 1999, CELL, V97, P257, DOI 10.1016/S0092-8674(00)80735-7; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; Huang CC, 2009, J BIOL CHEM, V284, P17206, DOI 10.1074/jbc.M809544200; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Janz JM, 2004, J BIOL CHEM, V279, P29767, DOI 10.1074/jbc.M402567200; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; Kenakin T, 2010, PHARMACOL REV, V62, P265, DOI 10.1124/pr.108.000992; Kisselev OG, 1998, P NATL ACAD SCI USA, V95, P4270, DOI 10.1073/pnas.95.8.4270; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Leitz AJ, 2006, BIOTECHNIQUES, V40, P601, DOI 10.2144/000112169; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Lodowski DT, 2006, J BIOL CHEM, V281, P16785, DOI 10.1074/jbc.M601327200; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Milligan G, 2008, BRIT J PHARMACOL, V153, pS216, DOI 10.1038/sj.bjp.0707490; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Mustafi D, 2009, MOL PHARMACOL, V75, P1, DOI 10.1124/mol.108.051938; Natochin M, 2003, J BIOL CHEM, V278, P37574, DOI 10.1074/jbc.M305136200; Natochin M, 2000, J BIOL CHEM, V275, P2669, DOI 10.1074/jbc.275.4.2669; Natochin M, 2001, J NEUROCHEM, V77, P202, DOI 10.1046/j.1471-4159.2001.00221.x; Noble B, 2003, J BIOL CHEM, V278, P47466, DOI 10.1074/jbc.M308257200; Oldham WM, 2006, Q REV BIOPHYS, V39, P117, DOI 10.1017/S0033583506004306; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; PALCZEWSKI K, 1993, J BIOL CHEM, V268, P6004; Palczewski K, 1997, EUR J BIOCHEM, V248, P261, DOI 10.1111/j.1432-1033.1997.00261.x; Pao CS, 2009, BIOCHEMISTRY-US, V48, P7325, DOI 10.1021/bi900408g; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pitcher JA, 1996, J BIOL CHEM, V271, P24907, DOI 10.1074/jbc.271.40.24907; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Posner BA, 1998, J BIOL CHEM, V273, P21752, DOI 10.1074/jbc.273.34.21752; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Raman D, 2003, J NEUROCHEM, V84, P1040, DOI 10.1046/j.1471-4159.2003.01598.x; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Reiner S, 2010, J BIOL CHEM, V285, P36188, DOI 10.1074/jbc.M110.175604; Rondard P, 2001, P NATL ACAD SCI USA, V98, P6150, DOI 10.1073/pnas.101136198; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Scheerer P, 2009, P NATL ACAD SCI USA, V106, P10660, DOI 10.1073/pnas.0900072106; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; SHI W, 1995, J BIOL CHEM, V270, P2112, DOI 10.1074/jbc.270.5.2112; Singh P, 2008, J BIOL CHEM, V283, P14053, DOI 10.1074/jbc.M708974200; Sterne-Marr R, 2009, BIOCHEMISTRY-US, V48, P4285, DOI 10.1021/bi900151g; Tall GG, 2003, J BIOL CHEM, V278, P8356, DOI 10.1074/jbc.M211862200; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; Tsukamoto H, 2010, J MOL BIOL, V399, P501, DOI 10.1016/j.jmb.2010.04.029; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396	70	46	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7715	7721		10.1074/jbc.R109.051847	http://dx.doi.org/10.1074/jbc.R109.051847			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21199869	hybrid, Green Published			2022-12-27	WOS:000288013300001
J	Willis, KL; Langland, JO; Shisler, JL				Willis, Kristen L.; Langland, Jeffrey O.; Shisler, Joanna L.			Viral Double-stranded RNAs from Vaccinia Virus Early or Intermediate Gene Transcripts Possess PKR Activating Function, Resulting in NF-kappa B Activation, When the K1 Protein Is Absent or Mutated	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN HELA-CELLS; HOST-RANGE; KINASE PKR; INFECTED-CELLS; DNA VIRUSES; LIFE-CYCLE; INHIBITION; INTERFERON; TRANSLATION; TERMINATION	PKR is a potent antiviral molecule that can terminate infection by inhibiting protein synthesis and stimulating NF-kappa B activation and apoptosis. Originally, it was thought that only intermediate and late gene transcription produced double-stranded (ds) RNA to activate PKR during vaccinia virus (VACV) infection. The VACV E3 or K3 proteins squelch this effect by binding to either dsRNA or PKR. However, in the absence of the K1 protein, VACV infection activates PKR at very early times post-infection and despite the presence of E3 and K3. These data suggest that VACV infection induces PKR activation by a currently unknown mechanism. To determine this mechanism, cells were infected with K1L-containing or -deficient VACVs. By using conditions that limited the progression of the poxvirus replication cycle, we observed that early gene transcripts activated PKR in RK13 cells, identifying a new PKR-activating mechanism of poxvirus infection. Using a similar approach for HeLa cells, intermediate gene transcription was sufficient to activate PKR. RNA isolated from infected RK13 or HeLa cells maintained PKR-activating properties only when dsRNA was present. Moreover, viral dsRNA was directly detected in infected cells either by RT-PCR or immunofluorescent microscopy. Interestingly, dsRNA levels were higher in infected cells in which the K1 protein was nonfunctional. Only K1 proteins with PKR inhibitory function prevented downstream NF-kappa B activation. These results reveal a new PKR activation pathway during VACV infection, in which the K1 protein reduces dsRNA levels early in VACV infection to directly inhibit PKR and several of its downstream antiviral effects, thereby enhancing virus survival.	[Willis, Kristen L.; Shisler, Joanna L.] Univ Illinois, Coll Med, Dept Microbiol, Urbana, IL 61801 USA; [Langland, Jeffrey O.] SW Coll Naturopath Med, Dept Naturopath Res, Tempe, AZ 85282 USA; [Langland, Jeffrey O.] Arizona State Univ, Biodesign Inst, Tempe, AZ 85287 USA	University of Illinois System; University of Illinois Urbana-Champaign; Arizona State University; Arizona State University-Tempe	Shisler, JL (corresponding author), B103 Chem & Life Sci Bldg,601 S Goodwin Ave, Urbana, IL 61801 USA.	jshisler@illinois.edu		Shisler, Joanna/0000-0003-4833-1557	NIAID [AI055530, T32 GM007283]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007283] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI055530 from NIAID (to J. L. S.).; Supported by National Institutes of Health Training Grant T32 GM007283.	Backes S, 2010, J GEN VIROL, V91, P470, DOI 10.1099/vir.0.015347-0; BAYLISS CD, 1993, VIROLOGY, V194, P254, DOI 10.1006/viro.1993.1256; BEATTIE E, 1991, VIROLOGY, V183, P419, DOI 10.1016/0042-6822(91)90158-8; BEAUD G, 1980, VIROLOGY, V100, P10, DOI 10.1016/0042-6822(80)90547-4; Bond M, 2001, CARDIOVASC RES, V50, P556, DOI 10.1016/S0008-6363(01)00220-6; BOONE RF, 1979, J VIROL, V30, P365, DOI 10.1128/JVI.30.1.365-374.1979; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; Chang SJ, 2009, J VIROL, V83, P4140, DOI 10.1128/JVI.01835-08; Condit RC, 2002, BBA-GENE STRUCT EXPR, V1577, P325, DOI 10.1016/S0167-4781(02)00461-X; EARL PL, 1990, J VIROL, V64, P2448, DOI 10.1128/JVI.64.5.2448-2451.1990; ESTEBAN M, 1973, J GEN VIROL, V20, P111, DOI 10.1099/0022-1317-20-1-111; FRIEDMAN RM, 1972, FEBS LETT, V24, P273, DOI 10.1016/0014-5793(72)80371-5; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Gedey R, 2006, J VIROL, V80, P8676, DOI 10.1128/JVI.00935-06; Gil J, 2004, MOL CELL BIOL, V24, P4502, DOI 10.1128/MCB.24.10.4502-4512.2004; Gil J, 2001, J GEN VIROL, V82, P3027, DOI 10.1099/0022-1317-82-12-3027; Hsiao JC, 2004, VIROLOGY, V329, P199, DOI 10.1016/j.virol.2004.07.032; Jacobs BL, 2009, ANTIVIR RES, V84, P1, DOI 10.1016/j.antiviral.2009.06.006; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; KERR IM, 1974, J VIROL, V13, P9, DOI 10.1128/JVI.13.1.9-21.1974; Langland JO, 2006, VIRUS RES, V119, P100, DOI 10.1016/j.virusres.2005.10.014; Langland JO, 2002, VIROLOGY, V299, P133, DOI 10.1006/viro.2002.1479; Li YC, 2010, J VIROL, V84, P3331, DOI 10.1128/JVI.02332-09; Ludwig H, 2006, J GEN VIROL, V87, P1145, DOI 10.1099/vir.0.81623-0; Ludwig H, 2005, J VIROL, V79, P2584, DOI 10.1128/JVI.79.4.2584-2596.2005; Lynch HE, 2009, VIROLOGY, V391, P177, DOI 10.1016/j.virol.2009.06.012; Martin S, 2009, VIROLOGY, V390, P298, DOI 10.1016/j.virol.2009.05.014; Meng XZ, 2006, VIROLOGY, V353, P220, DOI 10.1016/j.virol.2006.05.032; Moss B, 2007, FIELDS VIROLOGY; Myskiw C, 2009, J VIROL, V83, P6757, DOI 10.1128/JVI.02570-08; PERKUS ME, 1990, VIROLOGY, V179, P276, DOI 10.1016/0042-6822(90)90296-4; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; RamseyEwing AL, 1996, VIROLOGY, V222, P75, DOI 10.1006/viro.1996.0399; Raven JF, 2008, CELL CYCLE, V7, P1146, DOI 10.4161/cc.7.9.5811; Robertson HD, 1996, BIOCHIMIE, V78, P909, DOI 10.1016/S0300-9084(97)86712-0; SHUMAN S, 1988, J BIOL CHEM, V263, P6220; Weaver JR, 2007, VIRUS RES, V130, P269, DOI 10.1016/j.virusres.2007.05.012; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Willis KL, 2009, VIROLOGY, V394, P73, DOI 10.1016/j.virol.2009.08.020; Yang ZL, 2010, P NATL ACAD SCI USA, V107, P11513, DOI 10.1073/pnas.1006594107; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417; Zhang P, 2008, J VIROL, V82, P840, DOI 10.1128/JVI.01891-07	42	36	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7765	7778		10.1074/jbc.M110.194704	http://dx.doi.org/10.1074/jbc.M110.194704			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21183678	Green Published, hybrid			2022-12-27	WOS:000288013300008
J	Kawai, Y; Garduno, L; Theodore, M; Yang, JQ; Arinze, IJ				Kawai, Yumiko; Garduno, LaKisha; Theodore, Melanie; Yang, Jianqi; Arinze, Ifeanyi J.			Acetylation-Deacetylation of the Transcription Factor Nrf2 (Nuclear Factor Erythroid 2-related Factor 2) Regulates Its Transcriptional Activity and Nucleocytoplasmic Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIOXIDANT RESPONSE ELEMENT; ADENOVIRAL ONCOPROTEIN E1A; SUBSTRATE ADAPTER PROTEIN; PROMOTES CELL-SURVIVAL; CREB-BINDING-PROTEIN; GENE-EXPRESSION; KAPPA-B; ACETYLTRANSFERASE ACTIVITY; NEUROBLASTOMA-CELLS; OXIDATIVE STRESS	Activation of Nrf2 by covalent modifications that release it from its inhibitor protein Keap1 has been extensively documented. In contrast, covalent modifications that may regulate its action after its release from Keap1 have received little attention. Here we show that CREB-binding protein induced acetylation of Nrf2, increased binding of Nrf2 to its cognate response element in a target gene promoter, and increased Nrf2-dependent transcription from target gene promoters. Heterologous sirtuin 1 (SIRT1) decreased acetylation of Nrf2 as well as Nrf2-dependent gene transcription, and its effects were overridden by dominant negative SIRT1 (SIRT1-H355A). The SIRT1-selective inhibitors EX-527 and nicotinamide stimulated Nrf2-dependent gene transcription, whereas resveratrol, a putative activator of SIRT1, was inhibitory, mimicking the effect of SIRT1. Mutating lysine to alanine or to arginine at Lys(588) and Lys(591) of Nrf2 resulted in decreased Nrf2-dependent gene transcription and abrogated the transcription-activating effect of CREB-binding protein. Furthermore, SIRT1 had no effect on transcription induced by these mutants, indicating that these sites are acetylation sites. Microscope imaging of GFP-Nrf2 in HepG2 cells as well as immunoblotting for Nrf2 showed that acetylation conditions resulted in increased nuclear localization of Nrf2, whereas deacetylation conditions enhanced its cytoplasmic rather than its nuclear localization. We posit that Nrf2 in the nucleus undergoes acetylation, resulting in binding, with basic-region leucine zipper protein(s), to the antioxidant response element and consequently in gene transcription, whereas deacetylation disengages it from the antioxidant response element, thereby resulting in transcriptional termination and subsequently in its nuclear export.	[Kawai, Yumiko; Garduno, LaKisha; Theodore, Melanie; Arinze, Ifeanyi J.] Meharry Med Coll, Dept Physiol, Nashville, TN 37208 USA; [Yang, Jianqi] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA	Meharry Medical College; University of Iowa	Arinze, IJ (corresponding author), Meharry Med Coll, Dept Physiol, Rm 2105,Basic Sci Bldg, Nashville, TN 37208 USA.	iarinze@mmc.edu			National Institutes of Health [SO6-GM08037, SC1CA143985, U54NS041071, U54CA9140, U54RR026140, G12RR03032, 5T32HL007737]; Meharry Medical College Morphology Core Laboratory; Alpha Omega Alpha Carolyn L. Kuckein; Center of Excellence [HRSA D34HP00003]; NATIONAL CANCER INSTITUTE [SC1CA143985, T32CA009140] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003032, U54RR026140] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS041071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Meharry Medical College Morphology Core Laboratory; Alpha Omega Alpha Carolyn L. Kuckein; Center of Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants SO6-GM08037 and SC1CA143985. This work was also supported by the Meharry Medical College Morphology Core Laboratory, which is supported in part by National Institutes of Health Grants U54NS041071, U54CA9140, U54RR026140, and G12RR03032. This work was presented in poster form at the Experimental Biology Meeting, April 18-22, 2009, New Orleans, LA (Garduno, L., Theodore, M., Kawai, Y., and Arinze, I.J. (2009) FASEB J.23, A495.13).; Supported in part by an Alpha Omega Alpha Carolyn L. Kuckein Student Research Fellowship and by Center of Excellence Grant HRSA D34HP00003 to the School of Medicine, Meharry Medical College.; Supported by National Institutes of Health Training Grant 5T32HL007737.	Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; Apopa PL, 2008, J BIOCHEM MOL TOXIC, V22, P63, DOI 10.1002/jbt.20212; Arinze IJ, 2005, J BIOL CHEM, V280, P9786, DOI 10.1074/jbc.M414006200; Arinze IJ, 2003, J BIOL CHEM, V278, P17785, DOI 10.1074/jbc.M209430200; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Blackwell JS, 2007, J BIOL CHEM, V282, P20142, DOI 10.1074/jbc.M701989200; Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brown SL, 2008, CANCER RES, V68, P364, DOI 10.1158/0008-5472.CAN-07-2170; Cesena TI, 2007, J BIOL CHEM, V282, P956, DOI 10.1074/jbc.M511451200; Chakravarti D, 1999, CELL, V96, P393, DOI 10.1016/S0092-8674(00)80552-8; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Chen LF, 2003, J MOL MED, V81, P549, DOI 10.1007/s00109-003-0469-0; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Davis MG, 2000, BIOCHEM J, V346, P455, DOI 10.1042/0264-6021:3460455; Ellis L, 2009, MOL CANCER THER, V8, P1409, DOI 10.1158/1535-7163.MCT-08-0860; Flint J, 1997, ANNU REV GENET, V31, P177, DOI 10.1146/annurev.genet.31.1.177; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Forsberg EC, 1999, J BIOL CHEM, V274, P26850, DOI 10.1074/jbc.274.38.26850; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Goodman RH, 2000, GENE DEV, V14, P1553; Hamamori Y, 1999, CELL, V96, P405, DOI 10.1016/S0092-8674(00)80553-X; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hong F, 2005, J BIOL CHEM, V280, P31768, DOI 10.1074/jbc.M503346200; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Isobe T, 2009, J BIOL CHEM, V284, P27766, DOI 10.1074/jbc.M109.006809; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jain AK, 2005, J BIOL CHEM, V280, P29158, DOI 10.1074/jbc.M502083200; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Katoh Y, 2001, GENES CELLS, V6, P857, DOI 10.1046/j.1365-2443.2001.00469.x; Kawai Y, 2006, CANCER RES, V66, P6563, DOI 10.1158/0008-5472.CAN-06-0814; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Li A, 2006, BIOCHEM BIOPH RES CO, V350, P818, DOI 10.1016/j.bbrc.2006.08.199; Li K, 2008, J BIOL CHEM, V283, P7590, DOI 10.1074/jbc.M709707200; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Li W, 2008, BBA-MOL CELL RES, V1783, P1847, DOI 10.1016/j.bbamcr.2008.05.024; Li WG, 2006, J BIOL CHEM, V281, P27251, DOI 10.1074/jbc.M602746200; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Li WG, 2005, J BIOL CHEM, V280, P28430, DOI 10.1074/jbc.M410601200; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mai A, 2005, J MED CHEM, V48, P7789, DOI 10.1021/jm050100l; Manohar M, 2009, J BIOL CHEM, V284, P23312, DOI 10.1074/jbc.M109.003202; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; Moehlenkamp JD, 1999, ARCH BIOCHEM BIOPHYS, V363, P98, DOI 10.1006/abbi.1998.1046; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nguyen T, 2005, J BIOL CHEM, V280, P32485, DOI 10.1074/jbc.M503074200; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nioi P, 2005, MOL CELL BIOL, V25, P10895, DOI 10.1128/MCB.25.24.10895-10906.2005; Orino K, 1999, FEBS LETT, V461, P334, DOI 10.1016/S0014-5793(99)01443-X; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Papaiahgari S, 2004, J BIOL CHEM, V279, P42302, DOI 10.1074/jbc.M408275200; Perissi V, 1999, P NATL ACAD SCI USA, V96, P3652, DOI 10.1073/pnas.96.7.3652; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Rajamohan SB, 2009, MOL CELL BIOL, V29, P4116, DOI 10.1128/MCB.00121-09; Salazar M, 2006, J BIOL CHEM, V281, P14841, DOI 10.1074/jbc.M513737200; Simonsson M, 2006, J BIOL CHEM, V281, P39870, DOI 10.1074/jbc.M607868200; Solomon JM, 2006, MOL CELL BIOL, V26, P28, DOI 10.1128/MCB.26.1.28-38.2006; Soutoglou E, 2000, MOL CELL, V5, P745, DOI 10.1016/S1097-2765(00)80253-1; Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07; Sun Z, 2009, MOL CELL BIOL, V29, P2658, DOI 10.1128/MCB.01639-08; Theodore M, 2008, J BIOL CHEM, V283, P8984, DOI 10.1074/jbc.M709040200; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Watai Y, 2007, GENES CELLS, V12, P1163, DOI 10.1111/j.1365-2443.2007.01118.x; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Yang JQ, 2001, J BIOL CHEM, V276, P25742, DOI 10.1074/jbc.M102821200; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	79	227	239	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7629	7640		10.1074/jbc.M110.208173	http://dx.doi.org/10.1074/jbc.M110.208173			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21196497	Green Published, hybrid			2022-12-27	WOS:000287737300076
J	Higashi, Y; Kutchan, TM; Smith, TJ				Higashi, Yasuhiro; Kutchan, Toni M.; Smith, Thomas J.			Atomic Structure of Salutaridine Reductase from the Opium Poppy (Papaver somniferum)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE GLUTAMATE-DEHYDROGENASE; CARBONYL REDUCTASE; COMPLEXES; PURIFICATION	The opium poppy (Papaver somniferum L.) is one of the oldest known medicinal plants. In the biosynthetic pathway for morphine and codeine, salutaridine is reduced to salutaridinol by salutaridine reductase (SalR; EC 1.1.1.248) using NADPH as coenzyme. Here, we report the atomic structure of SalR to a resolution of similar to 1.9 angstrom in the presence of NADPH. The core structure is highly homologous to other members of the short chain dehydrogenase/reductase family. The major difference is that the nicotinamide moiety and the substrate-binding pocket are covered by a loop (residues 265-279), on top of which lies a large "flap"-like domain (residues 105-140). This configuration appears to be a combination of the two common structural themes found in other members of the short chain dehydrogenase/reductase family. Previous modeling studies suggested that substrate inhibition is due to mutually exclusive productive and nonproductive modes of substrate binding in the active site. This model was tested via site-directed mutagenesis, and a number of these mutations abrogated substrate inhibition. However, the atomic structure of SalR shows that these mutated residues are instead distributed over a wide area of the enzyme, and many are not in the active site. To explain how residues distal to the active site might affect catalysis, a model is presented whereby SalR may undergo significant conformational changes during catalytic turnover.	[Higashi, Yasuhiro; Kutchan, Toni M.; Smith, Thomas J.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA	Donald Danforth Plant Science Center	Smith, TJ (corresponding author), Donald Danforth Plant Sci Ctr, 975 N Warson Rd, St Louis, MO 63132 USA.	tsmith@danforthcenter.org	Higashi, Yasuhiro/C-9726-2017; Smith, Thomas J/K-9086-2013; Kutchan, Toni/L-4625-2013	Higashi, Yasuhiro/0000-0003-0784-7960; Smith, Thomas J/0000-0003-3528-6793; 	Donald Danforth Plant Science Center; Mallinckrodt Foundation, St. Louis; Uehara Memorial Foundation	Donald Danforth Plant Science Center; Mallinckrodt Foundation, St. Louis; Uehara Memorial Foundation(Uehara Memorial Foundation)	This work was supported by start-up funds from the Donald Danforth Plant Science Center (to T. J. S.), by the Mallinckrodt Foundation, St. Louis (to T. M. K.), and by a Uehara Memorial Foundation postdoctoral fellowship (to Y. H.).	Afonine PV, 2005, CCP4 NEWSL, V42; BAILEY J, 1982, J BIOL CHEM, V257, P5579; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerjee S, 2003, BIOCHEMISTRY-US, V42, P3446, DOI 10.1021/bi0206917; BARTON DHR, 1965, J CHEM SOC, P2423, DOI 10.1039/jr9650002423; Bateman R, 2007, ORG BIOMOL CHEM, V5, P3363, DOI 10.1039/b707602a; Bateman RL, 2008, J BIOL CHEM, V283, P35756, DOI 10.1074/jbc.M807125200; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gangloff A, 2001, BIOCHEM J, V356, P269, DOI 10.1042/0264-6021:3560269; Geissler R, 2007, PLANT PHYSIOL, V143, P1493, DOI 10.1104/pp.106.095166; GERARDY R, 1993, PHYTOCHEMISTRY, V34, P125, DOI 10.1016/S0031-9422(00)90793-3; GHOSH D, 1991, P NATL ACAD SCI USA, V88, P10064, DOI 10.1073/pnas.88.22.10064; Higashi Y, 2010, ACTA CRYSTALLOGR F, V66, P163, DOI 10.1107/S174430910904932X; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kempe K, 2009, PHYTOCHEMISTRY, V70, P579, DOI 10.1016/j.phytochem.2009.03.002; Koropatkin NM, 2006, P NATL ACAD SCI USA, V103, P9820, DOI 10.1073/pnas.0602517103; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LOTTER H, 1992, TETRAHEDRON LETT, V33, P2443, DOI 10.1016/S0040-4039(00)92210-X; MacKenzie AK, 2007, BIOCHEMISTRY-US, V46, P1523, DOI 10.1021/bi061978x; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pilka ES, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007113; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Smith TJ, 2008, TRENDS BIOCHEM SCI, V33, P557, DOI 10.1016/j.tibs.2008.07.007; Smith TJ, 2001, J MOL BIOL, V307, P707, DOI 10.1006/jmbi.2001.4499; Tanaka M, 2005, PLOS BIOL, V3, P764, DOI 10.1371/journal.pbio.0030128; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; WERMUTH B, 1981, J BIOL CHEM, V256, P1206; Ziegler J, 2006, PLANT J, V48, P177, DOI 10.1111/j.1365-313X.2006.02860.x; Ziegler J, 2009, J BIOL CHEM, V284, P26758, DOI 10.1074/jbc.M109.030957	35	12	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6532	6541		10.1074/jbc.M110.168633	http://dx.doi.org/10.1074/jbc.M110.168633			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21169353	Green Published, hybrid			2022-12-27	WOS:000287476400063
J	Jiang, H; Wang, HM; Tan, ZH; Hu, SW; Wang, H; Shi, BZ; Yang, L; Li, PY; Gu, JR; Wang, HY; Li, ZH				Jiang, Hua; Wang, Huamao; Tan, Zhonghua; Hu, Suwen; Wang, Hai; Shi, Bizhi; Yang, Lin; Li, Peiyong; Gu, Jianren; Wang, Hongyang; Li, Zonghai			Growth Suppression of Human Hepatocellular Carcinoma Xenografts by a Monoclonal Antibody CH12 Directed to Epidermal Growth Factor Receptor Variant III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFERS ENHANCED TUMORIGENICITY; FACTOR-ALPHA; BCL-XL; CANCER; EXPRESSION; EGFR; THERAPY; LIVER; OVEREXPRESSION; AMPLIFICATION	Human hepatocellular carcinoma (HCC) is considered difficult to cure because it is resistant to radio-and chemotherapy and has a high recurrence rate after curative liver resection. Epidermal growth factor receptor variant III (EGFRvIII) has been reported to express in HCC tissues and cell lines. This article describes the efficacy of an anti-EGFRvIII monoclonal antibody (mAb CH12) in the treatment of HCC xenografts with EGFRvIII expression and the underlying mechanism of EGFRvIII as an oncogene in HCC. The results demonstrated that CH12 bound preferentially to EGFRvIII with a dissociation constant (K-d) of 1.346 nm/liter. In addition, CH12 induces strong antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity in Huh7-EGFRvIII (with exogenous expression of EGFRvIII) and SMMC-7721 (with endogenous expression of EGFRvIII) cells. Notably, CH12 significantly inhibited the growth of Huh7-EGFRvIII and SMMC-7721 xenografts in vivo with a growth inhibition ratio much higher than C225, a U.S. Food and Drug Administration-approved anti-EGFR antibody. Treatment of the two HCC xenografts with CH12 significantly suppressed tumor proliferation and angiogenesis. Mechanistically, in vivo treatment with CH12 reduced the phosphorylation of constitutively active EGFRvIII, Akt, and ERK. Down-regulation of the apoptotic protectors Bcl-x(L), Bcl-2, and the cell cycle regulator cyclin D1, as well as up-regulation of the cell-cycle inhibitor p27, were also observed after in vivo CH12 treatment. Collectively, these results indicate that the monoclonal antibody CH12 is a promising therapeutic agent for HCC with EGFRvIII expression.	[Jiang, Hua; Wang, Huamao; Hu, Suwen; Wang, Hai; Shi, Bizhi; Yang, Lin; Gu, Jianren; Wang, Hongyang; Li, Zonghai] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200032, Peoples R China; [Wang, Huamao] Zhejiang Acad Med Sci, Inst Bioengn, Hangzhou 310013, Zhejiang, Peoples R China; [Tan, Zhonghua; Li, Peiyong] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai 200030, Peoples R China; [Wang, Hongyang] Second Mil Med Univ, Eastern Hepatobiliary Surg Inst, Int Cooperat Lab Signal Transduct, Shanghai 200438, Peoples R China	Shanghai Jiao Tong University; Zhejiang Academy of Medical Sciences; Shanghai Jiao Tong University; Naval Medical University	Wang, HY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, 25 Ln 2200,Xie Tu Rd, Shanghai 200032, Peoples R China.	Zonghaili@shsmu.edu.cn			"Eleventh Five-year Plan" for Science & Technology Research of China [2008ZX10002-024, 2009ZX09103-701]; National Basic Research Program [2010CB529902]; National High Technology Research and Development Program of China [2007AA021203]; State Key Laboratory of Oncogenes and Related Genes [91-09-05]; National Natural Science Foundation [30901820]; Foundation of Institutions of Higher Education of China [20090073120109]	"Eleventh Five-year Plan" for Science & Technology Research of China; National Basic Research Program(National Basic Research Program of China); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); State Key Laboratory of Oncogenes and Related Genes; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Foundation of Institutions of Higher Education of China	This work was supported by a supporting program of the "Eleventh Five-year Plan" for Science & Technology Research of China (Grant 2008ZX10002-024 and 2009ZX09103-701), the National Basic Research Program (Grant 2010CB529902), the National High Technology Research and Development Program of China (Grant 2007AA021203), the research fund of the State Key Laboratory of Oncogenes and Related Genes (Grant 91-09-05), the National Natural Science Foundation (Grant 30901820), and the doctoral program of the Foundation of Institutions of Higher Education of China (Grant 20090073120109).	Carr BI, 2004, GASTROENTEROLOGY, V127, pS218, DOI 10.1053/j.gastro.2004.09.036; Daveau M, 2003, MOL CARCINOGEN, V36, P130, DOI 10.1002/mc.10103; DeCicco LA, 1997, CANCER LETT, V111, P149, DOI 10.1016/S0304-3835(96)04524-7; Faloppi L, 2011, CANCER TREAT REV, V37, P169, DOI 10.1016/j.ctrv.2010.08.001; Fiorentino M, 2000, CLIN CANCER RES, V6, P3966; Gainet M, 2003, Cancer Radiother, V7, P195, DOI 10.1016/S1278-3218(03)00019-2; Harari PM, 2004, ENDOCR-RELAT CANCER, V11, P689, DOI 10.1677/erc.1.00600; Hopfner M., 2004, J HEPATOL, V41, P1008; Huang SM, 2004, CANCER RES, V64, P5355, DOI 10.1158/0008-5472.CAN-04-0562; Huether A, 2005, BIOCHEM PHARMACOL, V70, P1568, DOI 10.1016/j.bcp.2005.09.007; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Ito Y, 1999, HEPATOLOGY, V30, P90, DOI 10.1002/hep.510300114; Johns TG, 2004, J BIOL CHEM, V279, P30375, DOI 10.1074/jbc.M401218200; Kira S, 1997, LIVER, V17, P177; Kuan CT, 2001, ENDOCR-RELAT CANCER, V8, P83, DOI 10.1677/erc.0.0080083; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Luwor RB, 2001, CANCER RES, V61, P5355; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; MOSCATELLO DK, 1995, CANCER RES, V55, P5536; Moser GJ, 1997, TOXICOL PATHOL, V25, P275, DOI 10.1177/019262339702500305; Nagane M, 1996, CANCER RES, V56, P5079; NISHIDA N, 1994, CANCER RES, V54, P3107; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Nygren P, 2005, ACTA ONCOL, V44, P203, DOI 10.1080/02841860510029798; Okamoto I, 2003, CANCER SCI, V94, P50, DOI 10.1111/j.1349-7006.2003.tb01351.x; Ou Chao, 2005, Ai Zheng, V24, P166; Panousis C, 2005, BRIT J CANCER, V92, P1069, DOI 10.1038/sj.bjc.6602470; Poon RTP, 2002, J CLIN ONCOL, V20, P1775, DOI 10.1200/JCO.2002.07.089; Scott AM, 2007, P NATL ACAD SCI USA, V104, P4071, DOI 10.1073/pnas.0611693104; Sok JC, 2006, CLIN CANCER RES, V12, P5064, DOI 10.1158/1078-0432.CCR-06-0913; Takehara T, 2001, HEPATOLOGY, V34, P55, DOI 10.1053/jhep.2001.25387; Wang HM, 2009, CANCER LETT, V279, P30, DOI 10.1016/j.canlet.2009.01.019; Watanabe J, 2004, SURGERY, V135, P604, DOI 10.1016/j.surg.2003.11.015; Worns MA, 2009, J CLIN GASTROENTEROL, V43, P489, DOI 10.1097/MCG.0b013e31818ddfc6; Yang L, 2010, CANCER IMMUNOL IMMUN, V59, P1481, DOI 10.1007/s00262-010-0872-7; Yu XT, 2007, J CANCER RES CLIN, V133, P145, DOI 10.1007/s00432-006-0139-z; ZHANG YJ, 1993, BIOCHEM BIOPH RES CO, V196, P1010, DOI 10.1006/bbrc.1993.2350; Zhao Yin-Nong, 2004, Ai Zheng, V23, P762; Zhou M, 2010, LIVER INT, V30, P925, DOI 10.1111/j.1478-3231.2010.02233.x; Zhu AX, 2006, ONCOLOGIST, V11, P790, DOI 10.1634/theoncologist.11-7-790	40	39	53	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5913	5920		10.1074/jbc.M110.192252	http://dx.doi.org/10.1074/jbc.M110.192252			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21163950	hybrid, Green Published			2022-12-27	WOS:000287230600100
J	Muhlen, S; Ruchaud-Sparagano, MH; Kenny, B				Muehlen, Sabrina; Ruchaud-Sparagano, Marie-Helene; Kenny, Brendan			Proteasome-independent Degradation of Canonical NF kappa B Complex Components by the NleC Protein of Pathogenic Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INNATE IMMUNE-RESPONSES; ACTIVATION; PATHWAY; PHOSPHORYLATION; MANIPULATION; PROTEOLYSIS; SUBUNIT; SYSTEM; FAMILY; VIRUS	The NF kappa B transcription factor is a key component of immune and inflammatory signaling as its activation induces the expression of antimicrobial reagents, chemokines, cytokines, and anti-apoptotic factors. Many pathogens encode effector proteins that target factors regulating NF kappa B activity and can provide novel insights on regulatory mechanisms. Given the link of NF kappa B dysfunction with inflammatory diseases and some cancers, these effectors have therapeutic potential. Here, screening enteropathogenic Escherichia coli proteins for those implicated in suppressing NF kappa B function revealed that eGFP-NleC, unlike eGFP, strongly inhibited basal and TNF alpha-induced NF kappa B reporter activity to prevent secretion of the chemokine, IL-8. Work involving NleC variants, chemical inhibitors, and immunoprecipitation studies support NleC being a zinc metalloprotease that degrades NF kappa B-I kappa B alpha complexes. The findings are consistent with features between residues 33-65 recruiting NF kappa B for proteasomal-independent degradation by a mechanism inhibited by metalloprotease inhibitors or disruption of a consensus zinc metalloprotease motif spanning NleC residues 183-187. This raises the prospect that mammalian cells, or other pathogens, employ a similar mechanism to modulate NF kappa B activity. Moreover, NleC represents a novel tool for validating NF kappa B as a therapeutic target and, indeed, as a possible therapeutic reagent.	[Muehlen, Sabrina; Ruchaud-Sparagano, Marie-Helene; Kenny, Brendan] Newcastle Univ, Inst Cell & Mol Biosci, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Kenny, B (corresponding author), Newcastle Univ, Inst Cell & Mol Biosci, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	brendan.kenny@ncl.ac.uk		Muehlen, Sabrina/0000-0001-7474-705X; , Brendan/0000-0001-7455-360X	Wellcome Trust [083313]; Deutsche Forschungsgemeinschaft [MU3050/2-1]	Wellcome Trust(Wellcome TrustEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Wellcome Trust Grant 083313 (to B. K.).; Supported by Deutsche Forschungsgemeinschaft Research Fellowship MU3050/2-1.	Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; CHIAO PJ, 1994, P NATL ACAD SCI USA, V91, P28, DOI 10.1073/pnas.91.1.28; Dean P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000961; Dean P, 2009, CURR OPIN MICROBIOL, V12, P101, DOI 10.1016/j.mib.2008.11.006; FINCO TS, 1995, IMMUNITY, V3, P263, DOI 10.1016/1074-7613(95)90112-4; FRANZOSO G, 1994, J EXP MED, V180, P1445, DOI 10.1084/jem.180.4.1445; Gao XF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000708; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hiscott J, 2006, ONCOGENE, V25, P6844, DOI 10.1038/sj.onc.1209941; HOOPER NM, 1994, FEBS LETT, V354, P1, DOI 10.1016/0014-5793(94)01079-X; Iguchi A, 2009, J BACTERIOL, V191, P347, DOI 10.1128/JB.01238-08; JONGENEEL CV, 1989, FEBS LETT, V242, P211, DOI 10.1016/0014-5793(89)80471-5; Kelly M, 2006, INFECT IMMUN, V74, P2328, DOI 10.1128/IAI.74.4.2328-2337.2006; Kim DW, 2005, P NATL ACAD SCI USA, V102, P14046, DOI 10.1073/pnas.0504466102; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; KUNSCH C, 1994, J IMMUNOL, V153, P153; Lad SP, 2007, P NATL ACAD SCI USA, V104, P2933, DOI 10.1073/pnas.0608393104; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Marches O, 2005, INFECT IMMUN, V73, P8411, DOI 10.1128/IAI.73.12.8411-8417.2005; Mittal R, 2006, P NATL ACAD SCI USA, V103, P18574, DOI 10.1073/pnas.0608995103; Nadler C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000743; Newton HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000898; O'Dea E, 2009, WIRES SYST BIOL MED, V1, P107, DOI 10.1002/wsbm.30; Orange JS, 2008, CELL MOL LIFE SCI, V65, P3564, DOI 10.1007/s00018-008-8222-z; Radons J, 2002, J BIOL CHEM, V277, P16456, DOI 10.1074/jbc.M201000200; Ravi R, 1998, CANCER RES, V58, P882; Roe AJ, 2007, MICROBIOL-SGM, V153, P1350, DOI 10.1099/mic.0.2006/003707-0; ROTHE M, 1995, SCIENCE, V269, P1424, DOI 10.1126/science.7544915; Ruchaud-Sparagano MH, 2007, CELL MICROBIOL, V9, P1909, DOI 10.1111/j.1462-5822.2007.00923.x; Ruckdeschel K, 2001, J IMMUNOL, V166, P1823, DOI 10.4049/jimmunol.166.3.1823; Saccani S, 2004, J EXP MED, V200, P107, DOI 10.1084/jem.20040196; Sansonetti PJ, 2007, IMMUNITY, V26, P149, DOI 10.1016/j.immuni.2007.02.004; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Schroder M, 2007, BIOCHEM SOC T, V35, P1512, DOI 10.1042/BST0351512; Sethi G, 2008, EXP BIOL MED, V233, P21, DOI 10.3181/0707-MR-196; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641	37	69	70	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5100	5107		10.1074/jbc.M110.172254	http://dx.doi.org/10.1074/jbc.M110.172254			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148319	Green Published, hybrid			2022-12-27	WOS:000287230600017
J	Spears, E; Neufeld, KL				Spears, Erick; Neufeld, Kristi L.			Novel Double-negative Feedback Loop between Adenomatous Polyposis Coli and Musashi1 in Colon Epithelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN MUSASHI-1; INTESTINAL STEM-CELLS; APC TUMOR-SUPPRESSOR; NUCLEAR EXPORT; MESSENGER-RNA; IN-VIVO; MARKER; CANCER; WNT; IDENTIFICATION	Loss of tumor suppressor adenomatous polyposis coli (APC) is thought to initiate the majority of all colorectal cancers. The predominant theory of colorectal carcinogenesis implicates stem cells as the initiating cells. However, relatively little is known about the function of APC in governing the homeostasis of normal intestinal stem cells. Here, we identify a novel double-negative feedback loop between APC and a translation inhibitor protein, Musashi1 (MSI1), in cultured human colonocytes. We show APC as a key factor in MSI1 regulation through Wnt signaling and identify APC mRNA as a novel target of translational inhibition by MSI1. We propose that APC/MSI1 interactions maintain homeostatic balance in the intestinal epithelium.	[Spears, Erick; Neufeld, Kristi L.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	Neufeld, KL (corresponding author), 1200 Sunnyside Ave,Haworth Hall 7049, Lawrence, KS 66045 USA.	klneuf@ku.edu		Neufeld, Kristi/0000-0003-3653-9385	Kansas Masonic Cancer Research Institute; Kansas Institutional Development Award Network of Biomedical Research Excellence [NIH P20 RR016475]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER	Kansas Masonic Cancer Research Institute; Kansas Institutional Development Award Network of Biomedical Research Excellence; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by funds from the Kansas Masonic Cancer Research Institute and the Kansas Institutional Development Award Network of Biomedical Research Excellence, NIH P20 RR016475.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Battelli C, 2006, MOL CELL NEUROSCI, V31, P85, DOI 10.1016/j.mcn.2005.09.003; Chan TA, 2002, P NATL ACAD SCI USA, V99, P8265, DOI 10.1073/pnas.082240999; Clarke AR, 2006, ONCOGENE, V25, P7512, DOI 10.1038/sj.onc.1210065; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Fukui T, 2006, DIGEST DIS SCI, V51, P1260, DOI 10.1007/s10620-006-8046-3; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Imai T, 2001, MOL CELL BIOL, V21, P3888, DOI 10.1128/MCB.21.12.3888-3900.2001; Kawahara H, 2008, J CELL BIOL, V181, P639, DOI 10.1083/jcb.200708004; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; May R, 2008, STEM CELLS, V26, P630, DOI 10.1634/stemcells.2007-0621; Miyanoiri Y, 2003, J BIOL CHEM, V278, P41309, DOI 10.1074/jbc.M306210200; Neufeld KL, 2000, P NATL ACAD SCI USA, V97, P12085, DOI 10.1073/pnas.220401797; Neufeld KL, 2000, EMBO REP, V1, P519; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Rezza A, 2010, J CELL SCI, V123, P3256, DOI 10.1242/jcs.065284; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sierra J, 2006, GENE DEV, V20, P586, DOI 10.1101/gad.1385806; Sureban SM, 2008, GASTROENTEROLOGY, V134, pA86; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218	27	39	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					4946	4950		10.1074/jbc.C110.205922	http://dx.doi.org/10.1074/jbc.C110.205922			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21199875	hybrid, Green Published			2022-12-27	WOS:000287230600002
J	Shakibaei, M; Buhrmann, C; Mobasheri, A				Shakibaei, Mehdi; Buhrmann, Constanze; Mobasheri, Ali			Resveratrol-mediated SIRT-1 Interactions with p300 Modulate Receptor Activator of NF-kappa B Ligand (RANKL) Activation of NF-kappa B Signaling and Inhibit Osteoclastogenesis in Bone-derived Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTES IN-VITRO; OSTEOPROTEGERIN LIGAND; DIFFERENTIATION FACTOR; LIFE-SPAN; ACETYLATION; MICE; TRANSCRIPTION; OSTEOPOROSIS; MECHANISMS; TRANCE/RANKL	Resveratrol is a polyphenolic phytoestrogen that has been shown to exhibit potent anti-oxidant, anti-inflammatory, and anti-catabolic properties. Increased osteoclastic and decreased osteoblastic activities result in bone resorption and loss of bone mass. These changes have been implicated in pathological processes in rheumatoid arthritis and osteoporosis. Receptor activator of NF-kappa B ligand (RANKL), a member of the TNF superfamily, is a major mediator of bone loss. In this study, we investigated the effects of resveratrol on RANKL during bone morphogenesis in high density bone cultures in vitro. Untreated bone-derived cell cultures produced well organized bone-like structures with a bone-specific matrix. Treatment with RANKL induced formation of tartrate-resistant acid phosphatase-positive multinucleated cells that exhibited morphological features of osteoclasts. RANKL induced NF-kappa B activation, whereas pretreatment with resveratrol completely inhibited this activation and suppressed the activation of I kappa B alpha kinase and I kappa B alpha phosphorylation and degradation. RANKL up-regulated p300 (a histone acetyltransferase) expression, which, in turn, promoted acetylation of NF-kappa B. Resveratrol inhibited RANKL-induced acetylation and nuclear translocation of NF-kappa B in a time-and concentration-dependent manner. In addition, activation of Sirt-1 (a histone deacetylase) by resveratrol induced Sirt-1-p300 association in bone-derived and preosteoblastic cells, leading to deacetylation of RANKL-induced NF-kappa B, inhibition of NF-kappa B transcriptional activation, and osteoclastogenesis. Co-treatment with resveratrol activated the bone transcription factors Cbfa-1 and Sirt-1 and induced the formation of Sirt-1-Cbfa-1 complexes. Overall, these results demonstrate that resveratrol-activated Sirt-1 plays pivotal roles in regulating the balance between the osteoclastic versus osteoblastic activity result in bone formation in vitro thereby highlighting its therapeutic potential for treating osteoporosis and rheumatoid arthritis-related bone loss.	[Shakibaei, Mehdi; Buhrmann, Constanze] Univ Munich, Musculoskeletal Res Grp, Inst Anat, D-80336 Munich, Germany; [Mobasheri, Ali] Univ Nottingham, Musculoskeletal Res Grp, Div Vet Med, Sch Vet Med & Sci, Loughborough LE12 5RD, England	University of Munich; University of Nottingham	Shakibaei, M (corresponding author), Univ Munich, Musculoskeletal Res Grp, Inst Anat, Pettenkoferstr 11, D-80336 Munich, Germany.	mehdi.shakibaei@med.uni-muenchen.de	Prof. Dr. Shakibaei, Mehdi/AAA-7004-2020; Mobasheri, Ali/D-5770-2011	Prof. Dr. Shakibaei, Mehdi/0000-0002-6304-7506; Mobasheri, Ali/0000-0001-6261-1286; Buhrmann, Constanze/0000-0002-0786-0463	Wellcome Trust (United Kingdom)	Wellcome Trust (United Kingdom)(Wellcome Trust)	Supported by the Wellcome Trust (United Kingdom).	Aggarwal BB, 2004, ANN NY ACAD SCI, V1030, P434, DOI 10.1196/annals.1329.054; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Boyce BF, 1999, BONE, V25, P137, DOI 10.1016/S8756-3282(99)00105-2; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Cao J, 2003, J BONE MINER RES, V18, P270, DOI 10.1359/jbmr.2003.18.2.270; Chen LF, 2001, SCIENCE, V293, P1653, DOI 10.1126/science.1062374; Clarke BL, 2010, RADIOL CLIN N AM, V48, P483, DOI 10.1016/j.rcl.2010.02.014; Csaki C, 2008, BIOCHEM PHARMACOL, V75, P677, DOI 10.1016/j.bcp.2007.09.014; Csaki C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2850; Dai S, 2004, J BIOL CHEM, V279, P37219, DOI 10.1074/jbc.C400258200; Dong ZG, 2003, MUTAT RES-FUND MOL M, V523, P145, DOI 10.1016/S0027-5107(02)00330-5; Drake FH, 1996, J BIOL CHEM, V271, P12511, DOI 10.1074/jbc.271.21.12511; Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C; Fatokun AA, 2006, BONE, V39, P542, DOI 10.1016/j.bone.2006.02.062; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Graham B, 2005, CELL CYCLE, V4, P1342, DOI 10.4161/cc.4.10.2047; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Gusman J, 2001, CARCINOGENESIS, V22, P1111, DOI 10.1093/carcin/22.8.1111; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Janknecht R, 1996, NATURE, V383, P22, DOI 10.1038/383022a0; JANOWSKAWIECZOREK A, 1991, BLOOD, V77, P1796; Jimi E, 1999, J IMMUNOL, V163, P434; Kanno T, 2007, J CELL BIOCHEM, V101, P1266, DOI 10.1002/jcb.21249; Katagiri T, 2002, ORAL DIS, V8, P147, DOI 10.1034/j.1601-0825.2002.01829.x; Kiernan RE, 1999, EMBO J, V18, P6106, DOI 10.1093/emboj/18.21.6106; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Leiro J, 2004, DIS AQUAT ORGAN, V59, P171, DOI 10.3354/dao059171; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Liu BL, 2004, PLANTA MED, V70, P305, DOI 10.1055/s-2004-818940; LOBO RA, 1995, AM J OBSTET GYNECOL, V173, P982, DOI 10.1016/0002-9378(95)90247-3; Manna SK, 2000, J IMMUNOL, V164, P6509, DOI 10.4049/jimmunol.164.12.6509; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; McKinsey TA, 2002, CURR OPIN CELL BIOL, V14, P763, DOI 10.1016/S0955-0674(02)00389-7; MINKIN C, 1982, CALCIFIED TISSUE INT, V34, P285, DOI 10.1007/BF02411252; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Pacifici R, 1998, ENDOCRINOLOGY, V139, P2659, DOI 10.1210/en.139.6.2659; Pettit AR, 2001, AM J PATHOL, V159, P1689, DOI 10.1016/S0002-9440(10)63016-7; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Raggatt LJ, 2010, J BIOL CHEM, V285, P25103, DOI 10.1074/jbc.R109.041087; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; ROBINSON RA, 1979, JOHNS HOPKINS MED J, V145, P10; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Shakibaei M, 1998, EXP CELL RES, V240, P95, DOI 10.1006/excr.1998.3933; Shakibaei M, 1999, BIOCHEM J, V342, P615, DOI 10.1042/0264-6021:3420615; SHAKIBAEI M, 1993, HISTOL HISTOPATHOL, V8, P463; Shakibaei M, 2008, BIOCHEM PHARMACOL, V76, P1426, DOI 10.1016/j.bcp.2008.05.029; Shakibaei M, 2007, ANN NY ACAD SCI, V1095, P554, DOI 10.1196/annals.1397.060; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Wei S, 2001, ENDOCRINOLOGY, V142, P1290, DOI 10.1210/en.142.3.1290; Xing LP, 2002, J BONE MINER RES, V17, P1200, DOI 10.1359/jbmr.2002.17.7.1200; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	62	157	173	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 1	2011	286	13					11492	11505		10.1074/jbc.M110.198713	http://dx.doi.org/10.1074/jbc.M110.198713			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	740LW	21239502	Green Published, hybrid			2022-12-27	WOS:000288797100060
J	Schmidt, J; Smith, NJ; Christiansen, E; Tikhonova, IG; Grundmann, M; Hudson, BD; Ward, RJ; Drewke, C; Milligan, G; Kostenis, E; Ulven, T				Schmidt, Johannes; Smith, Nicola J.; Christiansen, Elisabeth; Tikhonova, Irina G.; Grundmann, Manuel; Hudson, Brian D.; Ward, Richard J.; Drewke, Christel; Milligan, Graeme; Kostenis, Evi; Ulven, Trond			Selective Orthosteric Free Fatty Acid Receptor 2 (FFA2) Agonists IDENTIFICATION OF THE STRUCTURAL AND CHEMICAL REQUIREMENTS FOR SELECTIVE ACTIVATION OF FFA2 VERSUS FFA3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; DRUG DISCOVERY; NICOTINIC-ACID; FUNCTIONAL-CHARACTERIZATION; LIGAND EFFICIENCY; 7TM RECEPTORS; PUMA-G; BINDING; PHARMACOLOGY; EFFICACY	Free fatty acid receptor 2 (FFA2; GPR43) is a G protein-coupled seven-transmembrane receptor for short-chain fatty acids (SCFAs) that is implicated in inflammatory and metabolic disorders. The SCFA propionate has close to optimal ligand efficiency for FFA2 and can hence be considered as highly potent given its size. Propionate, however, does not discriminate between FFA2 and the closely related receptor FFA3 (GPR41). To identify FFA2-selective ligands and understand the molecular basis for FFA2 selectivity, a targeted library of small carboxylic acids was examined using holistic, label-free dynamic mass redistribution technology for primary screening and the receptor-proximal G protein [S-35] guanosine 5'-(3-O-thio) triphosphate activation, inositol phosphate, and cAMP accumulation assays for hit confirmation. Structure-activity relationship analysis allowed formulation of a general rule to predict selectivity for small carboxylic acids at the orthosteric binding site where ligands with substituted sp(3)-hybridized alpha-carbons preferentially activate FFA3, whereas ligands with sp(2)- or sp-hybridized alpha-carbons prefer FFA2. The orthosteric binding mode was verified by site-directed mutagenesis: replacement of orthosteric site arginine residues by alanine in FFA2 prevented ligand binding, and molecular modeling predicted the detailed mode of binding. Based on this, selective mutation of three residues to their non-conserved counterparts in FFA3 was sufficient to transfer FFA3 selectivity to FFA2. Thus, selective activation of FFA2 via the orthosteric site is achievable with rather small ligands, a finding with significant implications for the rational design of therapeutic compounds selectively targeting the SCFA receptors.	[Smith, Nicola J.; Hudson, Brian D.; Ward, Richard J.; Milligan, Graeme] Univ Glasgow, Inst Neurosci & Psychol, Coll Med Vet & Life Sci, Mol Pharmacol Grp, Glasgow G12 8QQ, Lanark, Scotland; [Schmidt, Johannes; Grundmann, Manuel; Drewke, Christel; Kostenis, Evi] Univ Bonn, Inst Pharmaceut Biol, Mol Cellular & Pharmacobiol Sect, D-53115 Bonn, Germany; [Christiansen, Elisabeth; Ulven, Trond] Univ So Denmark, Dept Chem & Phys, DK-5230 Odense M, Denmark; [Tikhonova, Irina G.] Queens Univ Belfast, Sch Pharm, Ctr Med Biol, Belfast BT9 7BL, Antrim, North Ireland	University of Glasgow; University of Bonn; University of Southern Denmark; Queens University Belfast	Milligan, G (corresponding author), Univ Glasgow, Inst Neurosci & Psychol, Coll Med Vet & Life Sci, Mol Pharmacol Grp, Wolfson Link Bldg 253, Glasgow G12 8QQ, Lanark, Scotland.	Graeme.Milligan@glasgow.ac.uk; kostenis@uni-bonn.de; ulven@ifk.sdu.dk	Hudson, B. D./H-4845-2013; Milligan, Graeme/F-9426-2011; Rexen Ulven, Elisabeth/S-2026-2017; Ulven, Trond/H-5500-2015	Hudson, B. D./0000-0001-7059-0091; Milligan, Graeme/0000-0002-6946-3519; Rexen Ulven, Elisabeth/0000-0003-1243-7587; Ulven, Trond/0000-0002-8135-1755; Smith, Nicola J/0000-0002-7247-9562	Danish Council for Independent Research Technology and Production [09-070364]; Danish Medical Research Council; Wellcome Trust [089600/Z/09/Z]	Danish Council for Independent Research Technology and Production(Det Frie Forskningsrad (DFF)); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported in part by Danish Council for Independent Research Technology and Production Grant 09-070364, the Danish Medical Research Council, and Wellcome Trust Grant 089600/Z/09/Z.	Abad-Zapatero C, 2005, DRUG DISCOV TODAY, V10, P464, DOI 10.1016/S1359-6446(05)03386-6; Ahmed K, 2009, TRENDS PHARMACOL SCI, V30, P557, DOI 10.1016/j.tips.2009.09.001; Ahmed K, 2009, J BIOL CHEM, V284, P21928, DOI 10.1074/jbc.M109.019455; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Coyne AG, 2010, CURR OPIN CHEM BIOL, V14, P299, DOI 10.1016/j.cbpa.2010.02.010; de Kloe GE, 2009, DRUG DISCOV TODAY, V14, P630, DOI 10.1016/j.drudis.2009.03.009; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Hopkins AL, 2004, DRUG DISCOV TODAY, V9, P430, DOI 10.1016/S1359-6446(04)03069-7; Kenakin T, 2008, COMB CHEM HIGH T SCR, V11, P337, DOI 10.2174/138620708784534824; Kenakin T, 2007, TRENDS PHARMACOL SCI, V28, P407, DOI 10.1016/j.tips.2007.06.009; Kenakin T, 2010, NAT BIOTECHNOL, V28, P928, DOI 10.1038/nbt0910-928; Kenakin TP, 2009, NAT REV DRUG DISCOV, V8, P617, DOI 10.1038/nrd2838; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lee T, 2008, MOL PHARMACOL, V74, P1599, DOI 10.1124/mol.108.049536; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Milligan G, 2009, BRIT J PHARMACOL, V158, P146, DOI 10.1111/j.1476-5381.2009.00421.x; Nilsson NE, 2003, BIOCHEM BIOPH RES CO, V303, P1047, DOI 10.1016/S0006-291X(03)00488-1; Offermanns S, 2006, TRENDS PHARMACOL SCI, V27, P384, DOI 10.1016/j.tips.2006.05.008; Rocheville M, 2009, CURR OPIN PHARMACOL, V9, P643, DOI 10.1016/j.coph.2009.06.015; Rosenkilde MM, 2010, TRENDS PHARMACOL SCI, V31, P567, DOI 10.1016/j.tips.2010.08.006; Rosenkilde MM, 2004, J BIOL CHEM, V279, P3033, DOI 10.1074/jbc.M309546200; *SCHROD LLC, 2009, GLID VERS 5; *SCHROD LLC, 2009, MAESTR 8 5 VERS 5 5; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Schwartz Thue W., 1994, Current Opinion in Biotechnology, V5, P434, DOI 10.1016/0958-1669(94)90054-X; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; Sleeth ML, 2010, NUTR RES REV, V23, P135, DOI 10.1017/S0954422410000089; Smith NJ, 2011, MOL CELL ENDOCRINOL, V331, P241, DOI 10.1016/j.mce.2010.07.009; Smith NJ, 2009, J BIOL CHEM, V284, P17527, DOI 10.1074/jbc.M109.012849; Stoddart LA, 2008, J BIOL CHEM, V283, P32913, DOI 10.1074/jbc.M805601200; Stoddart LA, 2008, PHARMACOL REV, V60, P405, DOI 10.1124/pr.108.00802; Sum CS, 2009, J BIOL CHEM, V284, P3529, DOI 10.1074/jbc.M806987200; Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031; Tunaru S, 2003, NAT MED, V9, P352, DOI 10.1038/nm824; Wang YC, 2010, BIOORG MED CHEM LETT, V20, P493, DOI 10.1016/j.bmcl.2009.11.112; Wellendorph P, 2009, MOL PHARMACOL, V76, P453, DOI 10.1124/mol.109.055244; Wise A, 2003, J BIOL CHEM, V278, P9869, DOI 10.1074/jbc.M210695200; Zaibi MS, 2010, FEBS LETT, V584, P2381, DOI 10.1016/j.febslet.2010.04.027	42	86	88	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10628	10640		10.1074/jbc.M110.210872	http://dx.doi.org/10.1074/jbc.M110.210872			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21220428	Green Published, hybrid			2022-12-27	WOS:000288547000077
J	Buntru, A; Kopp, K; Voges, M; Frank, R; Bachmann, V; Hauck, CR				Buntru, Alexander; Kopp, Kathrin; Voges, Maike; Frank, Ronald; Bachmann, Verena; Hauck, Christof R.			Phosphatidylinositol 3 '-Kinase Activity Is Critical for Initiating the Oxidative Burst and Bacterial Destruction during CEACAM3-mediated Phagocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-MEDIATED PHAGOCYTOSIS; CARCINOEMBRYONIC ANTIGENS CD66; GONOCOCCAL OPACITY PROTEINS; NEISSERIA-GONORRHOEAE; ADHESION MOLECULE; EPITHELIAL-CELLS; NADPH OXIDASE; OPA PROTEINS; PATHOGENIC NEISSERIAE; EXCHANGE FACTOR	Carcinoembryonic antigen-related cell adhesion molecule 3 (CEACAM3) is an immunoglobulin-related receptor expressed on human granulocytes. CEACAM3 functions as a single chain phagocytotic receptor recognizing Gram-negative bacteria such as Neisseria gonorrhoeae, which possess CEACAM-binding adhesins on their surface. The cytoplasmic domain of CEACAM3 contains an immunoreceptor tyrosine-based activation motif (ITAM)-like sequence that is phosphorylated upon receptor engagement. Here we show that the SH2 domains of the regulatory subunit of phosphatidylinositol 3'-kinase (PI3K) bind to tyrosine residue 230 of CEACAM3 in a phosphorylation-dependent manner. PI3K is rapidly recruited and directly associates with CEACAM3 upon bacterial binding as shown by FRET analysis. Although PI3K activity is not required for efficient uptake of the bacteria by CEACAM3-transfected cells or primary human granulocytes, it is critical for the stimulated production of reactive oxygen species by infected phagocytes and the intracellular degradation of CEACAM-binding bacteria. Together, our results highlight the ability of CEACAM3 to coordinate signaling events that not only mediate bacterial uptake, but also trigger the killing of internalized pathogens.	[Buntru, Alexander; Kopp, Kathrin; Voges, Maike; Bachmann, Verena; Hauck, Christof R.] Univ Konstanz, Lehrstuhl Zellbiol, D-78457 Constance, Germany; [Buntru, Alexander; Voges, Maike; Hauck, Christof R.] Univ Konstanz, Konstanz Res Sch Chem Biol, D-78457 Constance, Germany; [Frank, Ronald] Helmholtz Ctr Infect Res, Dept Biol Chem, D-38124 Braunschweig, Germany	University of Konstanz; University of Konstanz; Helmholtz Association; Helmholtz-Center for Infection Research	Hauck, CR (corresponding author), Postfach X908, D-78457 Constance, Germany.	christof.hauck@uni-konstanz.de			Landesstiftung BW [LS-Prot-66]; Ministry of Science, Research; Arts of Baden-Wurttemberg	Landesstiftung BW; Ministry of Science, Research; Arts of Baden-Wurttemberg	This work was supported by Landesstiftung BW (LS-Prot-66) and a grant from the Ministry of Science, Research and the Arts of Baden-Wurttemberg (to C. R. H.).	Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; ARCARO A, 1993, BIOCHEM J, V296, P297, DOI 10.1042/bj2960297; Bokoch GM, 2002, BLOOD, V100, P2692, DOI 10.1182/blood-2002-04-1149; Booth JW, 2003, J BIOL CHEM, V278, P14037, DOI 10.1074/jbc.M211879200; Bos MP, 1998, P NATL ACAD SCI USA, V95, P9584, DOI 10.1073/pnas.95.16.9584; Bos MP, 1997, INFECT IMMUN, V65, P2353, DOI 10.1128/IAI.65.6.2353-2361.1997; Buntru A, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-81; Chen T, 1997, J EXP MED, V185, P1557, DOI 10.1084/jem.185.9.1557; Chen T, 1996, P NATL ACAD SCI USA, V93, P14851, DOI 10.1073/pnas.93.25.14851; Cox D, 1999, J BIOL CHEM, V274, P1240, DOI 10.1074/jbc.274.3.1240; Cullen PJ, 2001, CURR BIOL, V11, pR882, DOI 10.1016/S0960-9822(01)00523-1; DEWALD B, 1988, J BIOL CHEM, V263, P16179; Ellson C, 2006, EMBO J, V25, P4468, DOI 10.1038/sj.emboj.7601346; Gray-Owen SD, 2006, NAT REV IMMUNOL, V6, P433, DOI 10.1038/nri1864; Gray-Owen SD, 1997, MOL MICROBIOL, V26, P971, DOI 10.1046/j.1365-2958.1997.6342006.x; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; Hauck CR, 2003, CURR OPIN MICROBIOL, V6, P43, DOI 10.1016/S1369-5274(03)00004-3; Hauck CR, 1998, EMBO J, V17, P443, DOI 10.1093/emboj/17.2.443; Hauck CR, 2001, J BIOL CHEM, V276, P17653, DOI 10.1074/jbc.M009329200; Hawkins PT, 2006, BIOCHEM SOC T, V34, P647, DOI 10.1042/BST0340647; Hawkins PT, 2007, BIOCHEM SOC SYMP, V74, P59, DOI 10.1042/BSS2007c06; INDIK ZK, 1995, BLOOD, V86, P4389, DOI 10.1182/blood.V86.12.4389.bloodjournal86124389; Kuespert K, 2007, J MICROBIOL METH, V68, P478, DOI 10.1016/j.mimet.2006.10.003; Kuespert K, 2006, CURR OPIN CELL BIOL, V18, P565, DOI 10.1016/j.ceb.2006.08.008; KUPSCH EM, 1993, EMBO J, V12, P641, DOI 10.1002/j.1460-2075.1993.tb05697.x; Marrazzo J, 2010, PRINCIPLES PRACTICE, P2753; McCaw SE, 2004, INFECT IMMUN, V72, P2742, DOI 10.1128/IAI.72.5.2742-2752.2004; McCaw SE, 2003, MOL MICROBIOL, V49, P623, DOI 10.1046/j.1365-2958.2003.03591.x; MEYER TF, 1990, ANNU REV MICROBIOL, V44, P451; Muenzner P, 2005, J CELL BIOL, V170, P825, DOI 10.1083/jcb.200412151; Muenzner P, 2008, CELL MICROBIOL, V10, P1074, DOI 10.1111/j.1462-5822.2007.01106.x; Muenzner P, 2010, SCIENCE, V329, P1197, DOI 10.1126/science.1190892; PICCIONE E, 1993, BIOCHEMISTRY-US, V32, P3197, DOI 10.1021/bi00064a001; Pils S, 2008, INT J MED MICROBIOL, V298, P553, DOI 10.1016/j.ijmm.2008.04.005; Pils S, 2006, J MICROBIOL METH, V65, P301, DOI 10.1016/j.mimet.2005.08.013; Popp A, 1999, CELL MICROBIOL, V1, P169, DOI 10.1046/j.1462-5822.1999.00017.x; Sarantis H, 2007, CELL MICROBIOL, V9, P2167, DOI 10.1111/j.1462-5822.2007.00947.x; Schmitter T, 2004, J EXP MED, V199, P35, DOI 10.1084/jem.20030204; Schmitter T, 2007, INFECT IMMUN, V75, P4116, DOI 10.1128/IAI.01835-06; STERN A, 1986, CELL, V47, P61, DOI 10.1016/0092-8674(86)90366-1; Suh CI, 2006, J EXP MED, V203, P1915, DOI 10.1084/jem.20052085; Swanson JA, 2004, J LEUKOCYTE BIOL, V76, P1093, DOI 10.1189/jlb.0804439; Vanhaesebroeck B, 2001, ANNU REV BIOCHEM, V70, P535, DOI 10.1146/annurev.biochem.70.1.535; Virji M, 1996, MOL MICROBIOL, V22, P929, DOI 10.1046/j.1365-2958.1996.01548.x; Virji M, 1996, MOL MICROBIOL, V22, P941, DOI 10.1046/j.1365-2958.1996.01551.x; Voges M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-117; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Zebhauser R, 2005, GENOMICS, V86, P566, DOI 10.1016/j.ygeno.2005.07.008; Zhao TM, 2007, J LEUKOCYTE BIOL, V81, P1127, DOI 10.1189/jlb.0406251; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	50	23	23	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9555	9566		10.1074/jbc.M110.216085	http://dx.doi.org/10.1074/jbc.M110.216085			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21216968	Green Published, hybrid			2022-12-27	WOS:000288247700081
J	Liu, IJ; Chiu, CY; Chen, YC; Wu, HC				Liu, I-Ju; Chiu, Chien-Yu; Chen, Yun-Ching; Wu, Han-Chung			Molecular Mimicry of Human Endothelial Cell Antigen by Autoantibodies to Nonstructural Protein 1 of Dengue Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASTROCYTE ELEVATED GENE-1; HEMORRHAGIC-FEVER; MONOCLONAL-ANTIBODIES; SYSTEMIC-SCLEROSIS; PEPTIDE LIBRARIES; DRUG-DELIVERY; IN-VITRO; INFECTION; APOPTOSIS; EPITOPE	The pathogenesis of dengue hemorrhagic fever and dengue shock syndrome (DHF/DSS), both serious complications of dengue virus (DV) infection, remains unclear. In this study, we found that anti-DV NS1 (nonstructural protein 1) polyclonal antibodies cross-reacted with human umbilical vein endothelial cells (HUVECs). We further identified a complex-specific mAb, DB16-1, which could recognize DV NS1 and cross-react with HUVECs and human blood vessels. The target protein of DB16-1 was further purified by immunoaffinity chromatography. LC-MS/MS analysis and co-immunoprecipitation revealed that the target protein of DB16-1 was human LYRIC (lysine-rich CEACAM1 co-isolated). Our newly generated anti-LYRIC mAbs bound to HUVECs in a pattern similar to that of DB16-1. The B-cell epitope of DB16-1 displayed a consensus motif, Lys-X-Trp-Gly (KXWG), which corresponded to amino acid residues 116-119 of DV NS1 and mimicked amino acid residues 334-337 in LYRIC. Moreover, the binding activity of DB16-1 in NS1 of DV-2 and in LYRIC disappeared after the KXWG epitope was deleted in each. In conclusion, DB16-1 targeted the same epitope in DV NS1 and LYRIC protein on human endothelial cells, suggesting that it might play a role in the pathogenesis of DHF/DSS. Future studies on the role of the anti-NS1 antibody in causing vascular permeability will undoubtedly be performed on sera collected from individuals before, during, and after the endothelial cell malfunction phase of a dengue illness.	[Liu, I-Ju; Wu, Han-Chung] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 114, Taiwan; [Liu, I-Ju; Chiu, Chien-Yu; Chen, Yun-Ching; Wu, Han-Chung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan	National Defense Medical Center; Academia Sinica - Taiwan	Wu, HC (corresponding author), 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	hcw0928@gate.sinica.edu.tw	Wu, Han-Chung/B-1209-2011	Wu, Han-Chung/0000-0002-5185-1169	Academia Sinica; National Science Council, Taiwan [NSC-98-3111-B-001-004, NSC-98-2323-B-001-001]	Academia Sinica(Academia Sinica - Taiwan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Academia Sinica (to H.-C. W.) and National Science Council, Taiwan, Grants NSC-98-3111-B-001-004 and NSC-98-2323-B-001-001 (to H.-C. W.).	Avirutnan P, 1998, J IMMUNOL, V161, P6338; BANKI K, 1992, P NATL ACAD SCI USA, V89, P1939, DOI 10.1073/pnas.89.5.1939; BielefeldtOhmann H, 1997, TRENDS MICROBIOL, V5, P409, DOI 10.1016/S0966-842X(97)01126-8; Bordron A, 1998, J CLIN INVEST, V101, P2029, DOI 10.1172/JCI2261; Bowditch RD, 1996, BLOOD, V88, P4579, DOI 10.1182/blood.V88.12.4579.bloodjournal88124579; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Carlos CC, 2005, AM J TROP MED HYG, V73, P435, DOI 10.4269/ajtmh.2005.73.435; Carvalho D, 1996, J CLIN INVEST, V97, P111, DOI 10.1172/JCI118377; Chen YC, 2007, CLIN VACCINE IMMUNOL, V14, P404, DOI 10.1128/CVI.00249-06; Di Rosa F, 1998, IMMUNOL REV, V164, P17; Diamond MS, 2000, J VIROL, V74, P7814, DOI 10.1128/JVI.74.17.7814-7823.2000; Emdad L, 2006, CANCER RES, V66, P1509, DOI 10.1158/0008-5472.CAN-05-3029; Falconar AKI, 1997, ARCH VIROL, V142, P897, DOI 10.1007/s007050050127; Fink J, 2006, REV MED VIROL, V16, P263, DOI 10.1002/rmv.507; FUJINAMI RS, 1983, P NATL ACAD SCI-BIOL, V80, P2346, DOI 10.1073/pnas.80.8.2346; Gagnon SJ, 1999, J VIROL, V73, P3623, DOI 10.1128/JVI.73.5.3623-3629.1999; Green S, 1999, J INFECT DIS, V179, P755, DOI 10.1086/314680; GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; HALSTEAD SB, 1984, J IMMUNOL, V132, P1529; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Kang DC, 2005, GENE, V353, P8, DOI [10.1016/j.gene.2005.04.006, 10.1016/j.gene.2005.04.005]; KAPLAN C, 1992, SEMIN HEMATOL, V29, P34; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; KURANE I, 1989, J CLIN INVEST, V83, P506, DOI 10.1172/JCI113911; LANE DP, 1980, NATURE, V288, P167, DOI 10.1038/288167a0; Lee TY, 2007, CANCER RES, V67, P10958, DOI 10.1158/0008-5472.CAN-07-2233; Lee TY, 2004, CANCER RES, V64, P8002, DOI 10.1158/0008-5472.CAN-04-1948; Lin CF, 2003, J MED VIROL, V69, P82, DOI 10.1002/jmv.10261; Lin CF, 2002, J IMMUNOL, V169, P657, DOI 10.4049/jimmunol.169.2.657; Liu IJ, 2004, J INFECT DIS, V190, P797, DOI 10.1086/422753; Lunardi C, 2006, PLOS MED, V3, P94, DOI 10.1371/journal.pmed.0030002; Lunardi C, 2000, NAT MED, V6, P1183, DOI 10.1038/80533; Namboodiri AM, 2004, AUTOIMMUNITY, V37, P241, DOI 10.1080/08916930410001710046; Nechansky A, 2009, J PHARMACEUT BIOMED, V49, P1014, DOI 10.1016/j.jpba.2009.01.029; QUERY CC, 1987, CELL, V51, P211, DOI 10.1016/0092-8674(87)90148-6; Rhodes GH, 1997, J AUTOIMMUN, V10, P447, DOI 10.1006/jaut.1997.9996; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; Rose AL, 2002, BLOOD, V100, P1765, DOI 10.1182/blood.V100.5.1765.h81702001765_1765_1773; Sibille P, 1997, EUR J IMMUNOL, V27, P1221, DOI 10.1002/eji.1830270525; Sutherland HGE, 2004, EXP CELL RES, V294, P94, DOI 10.1016/j.yexcr.2003.11.020; Wu HC, 2003, J GEN VIROL, V84, P2771, DOI 10.1099/vir.0.19228-0; Wu HC, 2001, J CLIN MICROBIOL, V39, P977, DOI 10.1128/JCM.39.3.977-982.2001	44	73	77	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9726	9736		10.1074/jbc.M110.170993	http://dx.doi.org/10.1074/jbc.M110.170993			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21233208	hybrid, Green Published			2022-12-27	WOS:000288247700096
J	Anaya, ZEA; Savistchenko, J; Massonneau, V; Lacroux, C; Andreoletti, O; Vilette, D				Anaya, Zaira E. Arellano; Savistchenko, Jimmy; Massonneau, Veronique; Lacroux, Caroline; Andreoletti, Olivier; Vilette, Didier			Recovery of Small Infectious PrPres Aggregates from Prion-infected Cultured Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCRAPIE PRION; MONOCLONAL-ANTIBODIES; TRANSGENIC MICE; SHEEP SCRAPIE; PROTEIN; DISEASE; NEURODEGENERATION; PROPAGATION; PARTICLES; AGENT	Prion diseases are characterized by deposits of abnormal conformers of the PrP protein. Although large aggregates of proteinase K-resistant PrP (PrPres) are infectious, the precise relationships between aggregation state and infectivity remain to be established. In this study, we have fractionated detergent lysates from prion-infected cultured cells by differential ultracentrifugation and ultrafiltration and have characterized a previously unnoticed PrP species. This abnormal form is resistant to proteinase K digestion but, in contrast to typical aggregated PrPres, remains in the soluble fraction at intermediate centrifugal forces and is not retained by filters of 300-kDa cutoff. Cell-based assay and inoculation to animals demonstrate that these entities are infectious. The finding that cell-derived small infectious PrPres aggregates can be recovered in the absence of strong in vitro denaturating treatments now gives a biological basis for investigating the role of small PrP aggregates in the pathogenicity and/or the multiplication cycle of prions.	[Anaya, Zaira E. Arellano; Savistchenko, Jimmy; Massonneau, Veronique; Lacroux, Caroline; Andreoletti, Olivier; Vilette, Didier] Univ Toulouse, Inst Natl Polytech, Ecole Natl Vet Toulouse, Inst Natl Rech Agron,UMR 1225, F-31076 Toulouse, France	INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse	Vilette, D (corresponding author), Univ Toulouse, Inst Natl Polytech, Ecole Natl Vet Toulouse, Inst Natl Rech Agron,UMR 1225, F-31076 Toulouse, France.	d.vilette@envt.fr			Agence Nationale de la Recherche (France) [ANR-08-MIEN-010]; Department for Environment, Food and Rural Affairs (United Kingdom)	Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); Department for Environment, Food and Rural Affairs (United Kingdom)(Department for Environment, Food & Rural Affairs (DEFRA))	This work was supported in part by Agence Nationale de la Recherche Grant ANR-08-MIEN-010 (France) and the Department for Environment, Food and Rural Affairs (United Kingdom).	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Barron RM, 2007, J BIOL CHEM, V282, P35878, DOI 10.1074/jbc.M704329200; Berardi VA, 2006, TRANSFUSION, V46, P652, DOI 10.1111/j.1537-2995.2006.00763.x; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Carimalo J, 2005, EUR J NEUROSCI, V21, P2311, DOI 10.1111/j.1460-9568.2005.04080.x; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Cronier S, 2004, P NATL ACAD SCI USA, V101, P12271, DOI 10.1073/pnas.0402725101; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; Deleault AM, 2008, J GEN VIROL, V89, P2642, DOI 10.1099/vir.0.2008/002303-0; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; GABIZON R, 1987, P NATL ACAD SCI USA, V84, P4017, DOI 10.1073/pnas.84.12.4017; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Harrison CF, 2007, J NEUROCHEM, V103, P1709, DOI 10.1111/j.1471-4159.2007.04936.x; HECKER R, 1992, GENE DEV, V6, P1213, DOI 10.1101/gad.6.7.1213; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Manousis T, 2000, J GEN VIROL, V81, P1615, DOI 10.1099/0022-1317-81-6-1615; Morel N, 2004, J BIOL CHEM, V279, P30143, DOI 10.1074/jbc.M403896200; Pastrana MA, 2006, BIOCHEMISTRY-US, V45, P15710, DOI 10.1021/bi0615442; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; PRUSINER SB, 1992, BIOCHEMISTRY-US, V31, P12277, DOI 10.1021/bi00164a001; Riesner D, 1996, J VIROL, V70, P1714, DOI 10.1128/JVI.70.3.1714-1722.1996; Romanova NV, 2009, PROTEIN PEPTIDE LETT, V16, P598, DOI 10.2174/092986609788490078; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Safar JG, 2005, P NATL ACAD SCI USA, V102, P3501, DOI 10.1073/pnas.0409651102; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Soto C, 2004, NAT MED, V10, pS63, DOI 10.1038/nm1069; Soto C, 2008, DEV CELL, V15, P339, DOI 10.1016/j.devcel.2008.09.001; Thackray AM, 2007, BIOCHEM J, V401, P475, DOI 10.1042/BJ20061264; Tixador P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000859; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vilette D, 2008, VET RES, V39, DOI 10.1051/vetres:2007049; Vilotte JL, 2001, J VIROL, V75, P5977, DOI 10.1128/JVI.75.13.5977-5984.2001; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025	38	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8141	8148		10.1074/jbc.M110.165233	http://dx.doi.org/10.1074/jbc.M110.165233			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21212268	Green Published, hybrid			2022-12-27	WOS:000288013300044
J	Parsons, CJ; Stefanovic, B; Seki, E; Aoyama, T; Latour, AM; Marzluff, WF; Rippe, RA; Brenner, DA				Parsons, Christopher J.; Stefanovic, Branko; Seki, Ekihiro; Aoyama, Tomonori; Latour, Anne M.; Marzluff, William F.; Rippe, Richard A.; Brenner, David A.			Mutation of the 5 '-Untranslated Region Stem-Loop Structure Inhibits alpha 1(I) Collagen Expression in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC STELLATE CELL; MESSENGER-RNA; OSTEOGENESIS IMPERFECTA; GENE COL1A1; 1ST INTRON; POSTTRANSCRIPTIONAL REGULATION; TRANSLATION INITIATION; SPONTANEOUS FRACTURES; EXTRACELLULAR-MATRIX; DELETED GENE	Type I collagen is a heterotrimeric extracellular matrix protein consisting of two alpha 1(I) chains and one alpha 2(I) chain. During liver fibrosis, activated hepatic stellate cells (HSCs) are the major source of the type I collagen that accumulates in the damaged tissue. Expression of alpha 1(I) and alpha 2(I) collagen mRNA is increased 60-fold compared with quiescent stellate cells and is due predominantly to post-transcriptional message regulation. Specifically, a stem-loop structure in the 5'-untranslated region of alpha 1(I) collagen mRNA may regulate mRNA expression in activated HSCs through its interaction with stem-loop binding proteins. The stem-loop may also be necessary for efficient production and folding of the type I collagen heterotrimer. To assess the role of the stem-loop in type I collagen expression in vivo, we generated a knock-in mouse harboring a mutation that abolished the stem-loop structure. Heterozygous and homozygous knock-in mice exhibited a normal phenotype. However, steady-state levels of alpha 1(I) collagen mRNA decreased significantly in homozygous mutant MEFs as well as HSCs; intracellular and secreted type I collagen protein levels also decreased. Homozygous mutant mice developed less liver fibrosis. These results confirm an important role of the 5' stem-loop in regulating type I collagen mRNA and protein expression and provide a mouse model for further study of collagen-associated diseases.	[Seki, Ekihiro; Aoyama, Tomonori; Brenner, David A.] Univ Calif San Diego, Dept Med, Sch Med, La Jolla, CA 92093 USA; [Parsons, Christopher J.; Marzluff, William F.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Latour, Anne M.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Rippe, Richard A.] Univ N Carolina, Div Gastroenterol & Hepatol, Dept Med, Chapel Hill, NC 27599 USA; [Stefanovic, Branko] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA	University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; State University System of Florida; Florida State University	Brenner, DA (corresponding author), Univ Calif San Diego, Dept Med, Sch Med, 9500 Gilman Dr MC 0702, La Jolla, CA 92093 USA.	dbrenner@ucsd.edu	Seki, Ekihiro/K-2481-2016	Seki, Ekihiro/0000-0002-9472-6085; Brenner, David/0000-0003-2573-525X	National Institutes of Health [AA010459, DK065972, GM041804]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085252, R01DK065972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA010459, R29AA010459, R01AA020172] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants AA010459 and DK065972 (to R. A. R.) and GM041804 (to D. A. B.).	Aumailley M, 1998, J MOL MED-JMM, V76, P253, DOI 10.1007/s001090050215; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; BENSONCHANDA V, 1989, GENE, V78, P255, DOI 10.1016/0378-1119(89)90228-X; BERNARD MP, 1983, BIOCHEMISTRY-US, V22, P1139, DOI 10.1021/bi00274a023; Berro R, 2006, J VIROL, V80, P3189, DOI 10.1128/JVI.80.7.3189-3204.2006; Breault DT, 1997, J BIOL CHEM, V272, P31241, DOI 10.1074/jbc.272.50.31241; Brenner DA, 2000, J HEPATOL, V32, P32, DOI 10.1016/S0168-8278(00)80413-4; Bricker AL, 1999, J BACTERIOL, V181, P3587, DOI 10.1128/JB.181.11.3587-3590.1999; Cai Le, 2009, Expert Rev Gastroenterol Hepatol, V3, P1, DOI 10.1586/17474124.3.1.1; Cai L, 2010, J MOL BIOL, V395, P309, DOI 10.1016/j.jmb.2009.11.020; DALESSIO M, 1988, GENE, V67, P105, DOI 10.1016/0378-1119(88)90013-3; Doyle SA, 1998, J CELL BIOCHEM, V71, P233; Dubois GM, 2002, GENE, V294, P55, DOI 10.1016/S0378-1119(02)00770-9; ELEFTHERIADES EG, 1995, J MOL CELL CARDIOL, V27, P1459, DOI 10.1016/S0022-2828(95)90095-0; EXPOSITO JY, 1995, EUR J BIOCHEM, V234, P59, DOI 10.1111/j.1432-1033.1995.059_c.x; Forlino A, 1999, J BIOL CHEM, V274, P37923, DOI 10.1074/jbc.274.53.37923; Forlino A, 2000, MOL GENET METAB, V71, P225, DOI 10.1006/mgme.2000.3039; Fournier B, 2001, J BACTERIOL, V183, P2367, DOI 10.1128/JB.183.7.2367-2371.2001; FRIEDMAN SL, 1985, P NATL ACAD SCI USA, V82, P8681, DOI 10.1073/pnas.82.24.8681; FU XY, 1987, MOL CELL BIOL, V7, P738, DOI 10.1128/MCB.7.2.738; HELMINEN HJ, 1993, J CLIN INVEST, V92, P582, DOI 10.1172/JCI116625; Hensold JO, 1997, NUCLEIC ACIDS RES, V25, P2869, DOI 10.1093/nar/25.14.2869; HOGAN B, 1994, MANIPULATING MOUSE E, P1; Hormuzdi SG, 1999, MATRIX BIOL, V18, P287, DOI 10.1016/S0945-053X(99)00017-7; Karn J, 1999, J MOL BIOL, V293, P235, DOI 10.1006/jmbi.1999.3060; Kloc M, 2002, CELL, V108, P533, DOI 10.1016/S0092-8674(02)00651-7; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; Kvist AP, 2001, AM J PATHOL, V159, P1581, DOI 10.1016/S0002-9440(10)62542-4; Lang A, 1999, ITAL J GASTROENTEROL, V31, P173; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Ledermann B, 2000, EXP PHYSIOL, V85, P603, DOI 10.1017/S0958067000021059; Lindquist JN, 2000, AM J PHYSIOL-GASTR L, V279, pG471, DOI 10.1152/ajpgi.2000.279.3.G471; Lindquist JN, 2004, J BIOL CHEM, V279, P23822, DOI 10.1074/jbc.M314060200; Lipshitz HD, 2000, CURR OPIN GENET DEV, V10, P476, DOI 10.1016/S0959-437X(00)00116-7; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; MILANI S, 1990, AM J PATHOL, V137, P59; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Niederreither K, 1995, MATRIX BIOL, V14, P705, DOI 10.1016/S0945-053X(05)80013-7; PEREIRA R, 1994, J CLIN INVEST, V93, P1765, DOI 10.1172/JCI117161; PEREIRA R, 1993, J CLIN INVEST, V91, P709, DOI 10.1172/JCI116252; Rahkonen O, 2004, CIRC RES, V94, P83, DOI 10.1161/01.RES.0000108263.74520.15; RIPPE RA, 1989, MOL CELL BIOL, V9, P2224, DOI 10.1128/MCB.9.5.2224; RIPPE RA, 1995, HEPATOLOGY, V22, P241, DOI 10.1016/0270-9139(95)90378-X; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Roughley P. J., 2003, European Cells & Materials, V5, P41; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Saunders C, 1999, MOL CELL, V3, P43, DOI 10.1016/S1097-2765(00)80173-2; Schnabl B, 2001, HEPATOLOGY, V34, P89, DOI 10.1053/jhep.2001.25349; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sengupta P, 2005, J BIOL CHEM, V280, P21004, DOI 10.1074/jbc.M413191200; Shigeki TA, 2006, CLIN CHIM ACTA, V364, P33, DOI 10.1016/j.cca.2005.06.014; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; STACEY A, 1988, NATURE, V332, P131, DOI 10.1038/332131a0; Stefanovic B, 1999, MOL CELL BIOL, V19, P4334; Stefanovic B, 1997, MOL CELL BIOL, V17, P5201, DOI 10.1128/MCB.17.9.5201; Stefanovic B, 2003, J BIOL CHEM, V278, P927, DOI 10.1074/jbc.M209175200; Stefanovic B, 2002, J BIOL CHEM, V277, P18229, DOI 10.1074/jbc.M108065200; Wang YC, 2000, J VIROL, V74, P10571, DOI 10.1128/JVI.74.22.10571-10580.2000; YAMADA Y, 1983, J BIOL CHEM, V258, P4914	60	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8609	8619		10.1074/jbc.M110.189118	http://dx.doi.org/10.1074/jbc.M110.189118			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21193410	Green Published, hybrid			2022-12-27	WOS:000288013300087
J	Qiao, Q; Li, Y; Chen, Z; Wang, MZ; Reinberg, D; Xu, RM				Qiao, Qi; Li, Yan; Chen, Zhi; Wang, Mingzhu; Reinberg, Danny; Xu, Rui-Ming			The Structure of NSD1 Reveals an Autoregulatory Mechanism Underlying Histone H3K36 Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING GENE; TRANSCRIPTIONAL ELONGATION; PRODUCT SPECIFICITY; SOTOS-SYNDROME; METHYLTRANSFERASE; PROTEIN; H3; SET2; NUP98; MMSET	The Sotos syndrome gene product, NSD1, is a SET domain histone methyltransferase that primarily dimethylates nucleosomal histone H3 lysine 36 (H3K36). To date, the intrinsic properties of NSD1 that determine its nucleosomal substrate selectivity and dimethyl H3K36 product specificity remain unknown. The 1.7 angstrom structure of the catalytic domain of NSD1 presented here shows that a regulatory loop adopts a conformation that prevents free access of H3K36 to the bound S-adenosyl-L-methionine. Molecular dynamics simulation and computational docking revealed that this normally inhibitory loop can adopt an active conformation, allowing H3K36 access to the active site, and that the nucleosome may stabilize the active conformation of the regulatory loop. Hence, our study reveals an autoregulatory mechanism of NSD1 and provides insight into the molecular mechanism of the nucleosomal substrate selectivity of this disease-related H3K36 methyltransferase.	[Qiao, Qi; Chen, Zhi; Wang, Mingzhu; Xu, Rui-Ming] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Reinberg, Danny] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Li, Yan; Reinberg, Danny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Howard Hughes Medical Institute; New York University; New York University	Xu, RM (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	rmxu@sun5.ibp.ac.cn	xu, rui/GRX-5734-2022	Reinberg, Danny/0000-0003-4288-2016	National Institutes of Health [4R37G037120-24]; Chinese Ministry of Science and Technology [2009CB825501, 2010CB944903]; National Science Foundation of China [90919029, 3098801]; Novo Nordisk-Chinese Academy of Sciences Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Novo Nordisk-Chinese Academy of Sciences Foundation	This work was supported, in whole or in part, by National Institutes of Health Grant 4R37G037120-24 (to D. R.). This work was also supported by the Chinese Ministry of Science and Technology (Grants 2009CB825501 and 2010CB944903 to R.-M. X.), the National Science Foundation of China (Grants 90919029 and 3098801 to R.-M. X.), and the Novo Nordisk-Chinese Academy of Sciences Foundation.	An S, 2011, J BIOL CHEM, V286, P8369, DOI 10.1074/jbc.M110.203380; Angrand PO, 2001, GENOMICS, V74, P79, DOI 10.1006/geno.2001.6524; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell O, 2007, EMBO J, V26, P4974, DOI 10.1038/sj.emboj.7601926; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cheng XD, 2007, MUTAT RES-FUND MOL M, V618, P102, DOI 10.1016/j.mrfmmm.2006.05.041; Chesi M, 1998, BLOOD, V92, P3025, DOI 10.1182/blood.V92.9.3025.421k53_3025_3034; Couture JF, 2008, P NATL ACAD SCI USA, V105, P20659, DOI 10.1073/pnas.0806712105; Couture JF, 2005, GENE DEV, V19, P1455, DOI 10.1101/gad.1318405; DeLano W.L, PYMOL MOL GRAPHICS S; Douglas J, 2003, AM J HUM GENET, V72, P132, DOI 10.1086/345647; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Huang NW, 1998, EMBO J, V17, P3398, DOI 10.1093/emboj/17.12.3398; Jaju RJ, 2001, BLOOD, V98, P1264, DOI 10.1182/blood.V98.4.1264; Kang HB, 2009, FEBS LETT, V583, P1880, DOI 10.1016/j.febslet.2009.05.038; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim JY, 2008, MOL CELL BIOL, V28, P2023, DOI 10.1128/MCB.02130-07; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Landry J, 2003, MOL CELL BIOL, V23, P5972, DOI 10.1128/MCB.23.17.5972-5978.2003; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Marango J, 2008, BLOOD, V111, P3145, DOI 10.1182/blood-2007-06-092122; Min JR, 2003, CELL, V112, P711, DOI 10.1016/S0092-8674(03)00114-4; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rayasam GV, 2003, EMBO J, V22, P3153, DOI 10.1093/emboj/cdg288; Rosati R, 2002, BLOOD, V99, P3857, DOI 10.1182/blood.V99.10.3857; Saugier-Veber P, 2007, HUM MUTAT, V28, P1098, DOI 10.1002/humu.20568; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; Tatton-Brown K, 2005, AM J HUM GENET, V77, P193, DOI 10.1086/432082; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Wu H, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008570, 10.1371/journal.pone.0013316]; Xiao B, 2003, NATURE, V421, P652, DOI 10.1038/nature01378; Xiao B, 2005, GENE DEV, V19, P1444, DOI 10.1101/gad.1315905; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Yuan W, 2009, J BIOL CHEM, V284, P15701, DOI 10.1074/jbc.M808431200; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	49	122	127	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8361	8368		10.1074/jbc.M110.204115	http://dx.doi.org/10.1074/jbc.M110.204115			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21196496	hybrid, Green Published			2022-12-27	WOS:000288013300064
J	Bianchi, R; Kastrisianaki, E; Giambanco, I; Donato, R				Bianchi, Roberta; Kastrisianaki, Eirini; Giambanco, Ileana; Donato, Rosario			S100B Protein Stimulates Microglia Migration via RAGE-dependent Up-regulation of Chemokine Expression and Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCATION END-PRODUCTS; NEURITE OUTGROWTH; NITRIC-OXIDE; ALZHEIMERS-DISEASE; CYTOPLASMIC DOMAIN; GROWTH-FACTOR; RHO-GTPASES; IN-VITRO; RECEPTOR; ACTIVATION	The Ca2+-binding protein of the EF-hand type, S100B, is abundantly expressed in and secreted by astrocytes, and release of S100B from damaged astrocytes occurs during the course of acute and chronic brain disorders. Thus, the concept has emerged that S100B might act an unconventional cytokine or a damage-associated molecular pattern protein playing a role in the pathophysiology of neurodegenerative disorders and inflammatory brain diseases. S100B proinflammatory effects require relatively high concentrations of the protein, whereas at physiological concentrations S100B exerts trophic effects on neurons. Most if not all of the extracellular (trophic and toxic) effects of S100B in the brain are mediated by the engagement of RAGE (receptor for advanced glycation end products). We show here that high S100B stimulates murine microglia migration in Boyden chambers via RAGE-dependent activation of Src kinase, Ras, PI3K, MEK/ERK1/2, RhoA/ROCK, Rac1/JNK/AP-1, Rac1/NF-kappa B, and, to a lesser extent, p38 MAPK. Recruitment of the adaptor protein, diaphanous-1, a member of the formin protein family, is also required for S100B/RAGE-induced migration of microglia. The S100B/RAGE-dependent activation of diaphanous-1/Rac1/JNK/AP-1, Ras/Rac1/NF-kappa B and Src/Ras/PI3K/RhoA/diaphanous-1 results in the up-regulation of expression of the chemokines, CCL3, CCL5, and CXCL12, whose release and activity are required for S100B to stimulate microglia migration. Lastly, RAGE engagement by S100B in microglia results in up-regulation of the chemokine receptors, CCR1 and CCR5. These results suggests that S100B might participate in the pathophysiology of brain inflammatory disorders via RAGE-dependent regulation of several inflammation-related events including activation and migration of microglia.	[Bianchi, Roberta; Kastrisianaki, Eirini; Giambanco, Ileana; Donato, Rosario] Univ Perugia, Dept Expt Med & Biochem Sci, Sect Anat, I-06122 Perugia, Italy	University of Perugia	Donato, R (corresponding author), Univ Perugia, Dept Expt Med & Biochem Sci, Sect Anat, Via Giochetto, I-06122 Perugia, Italy.	donato@unipg.it	Donato, Rosario/I-3943-2019	Giambanco, Ileana/0000-0003-0286-6302	Associazione Italiana per la Ricerca sul Cancro [6021]; Fondazione Cassa di Risparmio di Perugia [2007.0218.020, 2009.020.0021]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia)	This work was supported by Associazione Italiana per la Ricerca sul Cancro Project 6021 and Fondazione Cassa di Risparmio di Perugia Grants 2007.0218.020 and 2009.020.0021 (to R. D.).	Adami C, 2004, BBA-MOL CELL RES, V1742, P169, DOI 10.1016/j.bbamcr.2004.09.008; Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; Ahlemeyer B, 2000, BRAIN RES, V858, P121, DOI 10.1016/S0006-8993(99)02438-5; ALLORE R, 1988, SCIENCE, V239, P1311, DOI 10.1126/science.2964086; Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084; Batra RK, 1999, AM J RESP CELL MOL, V21, P238, DOI 10.1165/ajrcmb.21.2.3470; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bianchi R, 2007, J LEUKOCYTE BIOL, V81, P108, DOI 10.1189/jlb.0306198; Bianchi R, 2010, NEUROBIOL AGING, V31, P665, DOI 10.1016/j.neurobiolaging.2008.05.017; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; BLASI E, 1995, J NEUROIMMUNOL, V58, P111, DOI 10.1016/0165-5728(95)00016-U; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; BOCCHINI V, 1992, J NEUROSCI RES, V31, P616, DOI 10.1002/jnr.490310405; Brozzi F, 2009, J BIOL CHEM, V284, P8788, DOI 10.1074/jbc.M805897200; Businaro R, 2006, J NEUROSCI RES, V83, P897, DOI 10.1002/jnr.20785; Chen X, 2007, CURR MOL MED, V7, P735; Das S, 2008, J NEUROSCI RES, V86, P1199, DOI 10.1002/jnr.21585; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; de Jong EK, 2008, J NEUROCHEM, V105, P1726, DOI 10.1111/j.1471-4159.2008.05267.x; Degryse B, 2001, J CELL BIOL, V152, P1197, DOI 10.1083/jcb.152.6.1197; DONATO R, 1988, J BIOL CHEM, V263, P106; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Esposito G, 2008, HUM MOL GENET, V17, P440, DOI 10.1093/hmg/ddm322; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Glezer I, 2007, NEUROSCIENCE, V147, P867, DOI 10.1016/j.neuroscience.2007.02.055; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hu JG, 1996, J BIOL CHEM, V271, P2543, DOI 10.1074/jbc.271.5.2543; Hu JR, 1997, J NEUROCHEM, V69, P2294; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Huttunen HJ, 1999, J BIOL CHEM, V274, P19919, DOI 10.1074/jbc.274.28.19919; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kim SH, 2004, NEUROBIOL AGING, V25, P431, DOI 10.1016/S0197-4580(03)00126-X; Kim SU, 2005, J NEUROSCI RES, V81, P302, DOI 10.1002/jnr.20562; Kogel D, 2004, NEUROSCIENCE, V127, P913, DOI 10.1016/j.neuroscience.2004.06.013; Kopec KK, 1998, J NEUROCHEM, V71, P2123; Koppal T, 2001, NEUROCHEM INT, V39, P401, DOI 10.1016/S0197-0186(01)00047-X; LEVI G, 1993, P NATL ACAD SCI USA, V90, P1541, DOI 10.1073/pnas.90.4.1541; Lue LF, 2001, EXP NEUROL, V171, P29, DOI 10.1006/exnr.2001.7732; Matsui T, 2002, J CEREBR BLOOD F MET, V22, P711, DOI 10.1097/00004647-200206000-00010; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; Mrak RE, 2004, J NEUROPATH EXP NEUR, V63, P679, DOI 10.1093/jnen/63.7.679; MRAK RE, 1995, HUM PATHOL, V26, P816, DOI 10.1016/0046-8177(95)90001-2; Okamoto T, 2002, FASEB J, V16, P1928, DOI 10.1096/fj.02-0030fje; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Palumbo R, 2007, J CELL BIOL, V179, P33, DOI 10.1083/jcb.200704015; Petrova TV, 2000, BRAIN RES, V853, P74, DOI 10.1016/S0006-8993(99)02251-9; Pichiule P, 2007, J BIOL CHEM, V282, P36330, DOI 10.1074/jbc.M706407200; Polk WW, 2007, AM J PHYSIOL-CELL PH, V293, pC1160, DOI 10.1152/ajpcell.00578.2006; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rauvala H, 2007, CURR MOL MED, V7, P725, DOI 10.2174/156652407783220750; Rauvala H, 2010, BBA-GENE REGUL MECH, V1799, P164, DOI 10.1016/j.bbagrm.2009.11.012; Reali C, 2005, J NEUROSCI RES, V81, P677, DOI 10.1002/jnr.20584; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Riuzzi F, 2007, AM J PATHOL, V171, P947, DOI 10.2353/ajpath.2007.070049; Rouhiainen A, 2004, BLOOD, V104, P1174, DOI 10.1182/blood-2003-10-3536; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI200114002; SCHMIDT AM, 1993, J CLIN INVEST, V91, P2155, DOI 10.1172/JCI116442; Seth A, 2006, J CELL BIOL, V174, P701, DOI 10.1083/jcb.200605006; Sheng JG, 2000, J NEUROCHEM, V74, P295, DOI 10.1046/j.1471-4159.2000.0740295.x; Sorci G, 2004, MOL CELL BIOL, V24, P4880, DOI 10.1128/MCB.24.11.4880-4894.2004; Sorci G, 2000, NEUROSCIENCE, V99, P773, DOI 10.1016/S0306-4522(00)00238-4; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Srikrishna G, 2009, NEOPLASIA, V11, P615, DOI 10.1593/neo.09284; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Town T, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-24; Van Eldik LJ, 2003, RESTOR NEUROL NEUROS, V21, P97; Wainwright MS, 2004, ANN NEUROL, V56, P61, DOI 10.1002/ana.20142; Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wasserman S, 1998, TRENDS CELL BIOL, V8, P111, DOI 10.1016/S0962-8924(97)01217-8; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Xie JJ, 2008, J BIOL CHEM, V283, P27255, DOI 10.1074/jbc.M801622200; Xiong ZG, 2000, EXP CELL RES, V257, P281, DOI 10.1006/excr.2000.4902; Xu DZ, 2003, J BIOL CHEM, V278, P39349, DOI 10.1074/jbc.M302771200; Yang D, 2007, J LEUKOCYTE BIOL, V81, P59, DOI 10.1189/jlb.0306180; Zozulya AL, 2007, J IMMUNOL, V178, P520, DOI 10.4049/jimmunol.178.1.520	83	170	180	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7214	7226		10.1074/jbc.M110.169342	http://dx.doi.org/10.1074/jbc.M110.169342			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21209080	Green Published, hybrid			2022-12-27	WOS:000287737300038
J	Iram, SH; Cole, SPC				Iram, Surtaj H.; Cole, Susan P. C.			Expression and Function of Human MRP1 (ABCC1) Is Dependent on Amino Acids in Cytoplasmic Loop 5 and Its Interface with Nucleotide Binding Domain 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE PROTEIN; TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE-ASSOCIATED MUTATIONS; P-GLYCOPROTEIN; CYSTIC-FIBROSIS; SUBSTRATE-SPECIFICITY; TRANSPORT ACTIVITY; MONOCLONAL-ANTIBODIES; INTRACELLULAR LOOP; MEMBRANE TOPOLOGY	Multidrug resistance protein 1 (MRP1) is an ATP-binding cassette transporter that effluxes drugs and organic anions across the plasma membrane. The 17 transmembrane helices of MRP1 are linked by extracellular and cytoplasmic loops (CLs), but their role in coupling the ATPase activity of MRP1 to the translocation of its substrates is poorly understood. Here we have examined the importance of CL5 by mutating eight conserved charged residues and the helix-disrupting Gly(511) in this region. Ala substitution of Lys(513), Lys(516), Glu(521), and Glu(535) markedly reduced MRP1 levels. Because three of these residues are predicted to lie at the interface of CL5 and the second nucleotide binding domain (NBD2), a critical role is indicated for this region in the plasma membrane expression of MRP1. Further support for this idea was obtained by mutating NBD2 amino acids His(1364) and Arg(1367) at the CL5 interface, which also resulted in reduced MRP1 levels. In contrast, mutation of Arg(501), Lys(503), Glu(507), Arg(532), and Gly(511) had no effect on MRP1 levels. Except for K503A, however, transport by these mutants was reduced by 50 to 75%, an effect largely attributable to reduced substrate binding and affinity. Studies with P-32-labeled azido-ATP also indicated that whereas ATP binding by the G511I mutant was unchanged, vanadate-induced trapping of azido-ADP was reduced, indicating changes in the catalytic activity of MRP1. Together, these data demonstrate the multiple roles for CL5 in the membrane expression and function of MRP1.	[Iram, Surtaj H.; Cole, Susan P. C.] Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Cole, SPC (corresponding author), Queens Univ, Canc Res Inst, Div Canc Biol & Genet, Kingston, ON K7L 3N6, Canada.	spc.cole@queensu.ca	Iram, Surtaj Hussain/T-5510-2019; Cole, Susan P.C./I-6389-2017	Cole, Susan P.C./0000-0001-6571-6884; Iram, Surtaj/0000-0002-0672-0936	Canadian Institutes of Health Research [MOP-10519]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Grant MOP-10519 from the Canadian Institutes of Health Research.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Bakos E, 1996, J BIOL CHEM, V271, P12322, DOI 10.1074/jbc.271.21.12322; Borst P, 2000, JNCI-J NATL CANCER I, V92, P1295, DOI 10.1093/jnci/92.16.1295; Brodsky JL, 2009, CURR OPIN CELL BIOL, V21, P516, DOI 10.1016/j.ceb.2009.04.006; Cohen BD, 2003, ENDOCRINOLOGY, V144, P4393, DOI 10.1210/en.2002-0063; COLE SPC, 1994, CANCER RES, V54, P5902; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Cole SPC, 2006, TRENDS PHARMACOL SCI, V27, P438, DOI 10.1016/j.tips.2006.06.008; Conseil G, 2005, BIOCHEM PHARMACOL, V69, P451, DOI 10.1016/j.bcp.2004.10.014; Conseil GRL, 2006, J BIOL CHEM, V281, P43, DOI 10.1074/jbc.M510143200; Conseil G, 2009, MOL PHARMACOL, V75, P397, DOI 10.1124/mol.108.052860; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, J BIOENERG BIOMEMBR, V33, P475, DOI 10.1023/A:1012823120935; Deeley RG, 2006, FEBS LETT, V580, P1103, DOI 10.1016/j.febslet.2005.12.036; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; DeGorter MK, 2008, BIOCHEM BIOPH RES CO, V365, P29, DOI 10.1016/j.bbrc.2007.10.141; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Gao M, 2000, J BIOL CHEM, V275, P13098, DOI 10.1074/jbc.275.17.13098; Haimeur A, 2004, MOL PHARMACOL, V65, P1375, DOI 10.1124/mol.65.6.1375; Hazai E, 2008, J STRUCT BIOL, V162, P63, DOI 10.1016/j.jsb.2007.12.001; Hipfner DR, 1997, J BIOL CHEM, V272, P23623, DOI 10.1074/jbc.272.38.23623; Hipfner DR, 1999, J BIOL CHEM, V274, P15420, DOI 10.1074/jbc.274.22.15420; HIPFNER DR, 1994, CANCER RES, V54, P5788; Hou YX, 2000, J BIOL CHEM, V275, P20280, DOI 10.1074/jbc.M001109200; Ito K, 2001, J BIOL CHEM, V276, P15616, DOI 10.1074/jbc.M011246200; Koike K, 2004, J BIOL CHEM, V279, P12325, DOI 10.1074/jbc.M311435200; Koike K, 2002, J BIOL CHEM, V277, P49495, DOI 10.1074/jbc.M206896200; Kwan T, 1998, BIOCHEMISTRY-US, V37, P3337, DOI 10.1021/bi972680x; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Letourneau IJ, 2005, PHARMACOGENET GENOM, V15, P647, DOI 10.1097/01.fpc.0000173484.51807.48; Li QL, 2009, EXP DERMATOL, V18, P1, DOI 10.1111/j.1600-0625.2008.00795.x; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; MERCIER B, 1995, AM J HUM GENET, V56, P272; Muller M, 2002, BIOCHEMISTRY-US, V41, P10123, DOI 10.1021/bi026075s; Oancea G, 2009, P NATL ACAD SCI USA, V106, P5551, DOI 10.1073/pnas.0811260106; Pagant S, 2008, J BIOL CHEM, V283, P26444, DOI 10.1074/jbc.M803912200; Ravna AW, 2008, EUR J MED CHEM, V43, P2557, DOI 10.1016/j.ejmech.2008.01.015; Ren XQ, 2006, J BIOCHEM, V140, P313, DOI 10.1093/jb/mvj155; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Roth J, 2008, HISTOCHEM CELL BIOL, V129, P163, DOI 10.1007/s00418-007-0366-7; Sauna ZE, 2002, BIOCHEMISTRY-US, V41, P13989, DOI 10.1021/bi026626e; Seeger MA, 2009, BBA-PROTEINS PROTEOM, V1794, P725, DOI 10.1016/j.bbapap.2008.12.004; Seibert FS, 1997, BIOCHEMISTRY-US, V36, P11966, DOI 10.1021/bi9712652; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Skach WR, 2009, NAT STRUCT MOL BIOL, V16, P606, DOI 10.1038/nsmb.1600; Wijnholds J, 1997, NAT MED, V3, P1275, DOI 10.1038/nm1197-1275; XIE JX, 1995, J BIOL CHEM, V270, P28084; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	49	25	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7202	7213		10.1074/jbc.M110.166959	http://dx.doi.org/10.1074/jbc.M110.166959			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177244	Green Published, hybrid			2022-12-27	WOS:000287737300037
J	Stawowczyk, M; Van Scoy, S; Kumar, KP; Reich, NC				Stawowczyk, Marcin; Van Scoy, Sarah; Kumar, K. Prasanna; Reich, Nancy C.			The Interferon Stimulated Gene 54 Promotes Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY FACTOR-3; ENDOPLASMIC-RETICULUM; ADENOVIRUS E4ORF6; INDUCIBLE PROTEIN; BCL-2 FAMILY; TARGET GENES; ALPHA; TRANSCRIPTION; ACTIVATION; P56	The ability of interferons (IFNs) to inhibit viral replication and cellular proliferation is well established, but the specific contribution of each IFN-stimulated gene (ISG) to these biological responses remains to be completely understood. In this report we demonstrate that ISG54, also known as IFN-induced protein with tetratricopeptide repeats 2 (IFIT2), is a mediator of apoptosis. Expression of ISG54, independent of IFN stimulation, elicits apoptotic cell death. Cell death and apoptosis were quantified by propidium iodide uptake and annexin-V staining, respectively. The activation of caspase-3, a key mediator of the execution phase of apoptosis, was clearly apparent in cells expressing ISG54. The anti-apoptotic B cell lymphoma-xl (Bcl-xl) protein inhibited the apoptotic effects of ISG54 as did the anti-apoptotic adenoviral E1B-19K protein. In addition, ISG54 was not able to promote cell death in the absence of pro-apoptotic Bcl family members, Bax and Bak. Analyses of binding partners of ISG54 revealed association with two homologous proteins, ISG56/IFIT1 and ISG60/IFIT3. In addition, ISG60 binding negatively regulates the apoptotic effects of ISG54. The results reveal a previously unidentified role of ISG54 in the induction of apoptosis via a mitochondrial pathway and shed new light on the mechanism by which IFN elicits anti-viral and anti-cancer effects.	[Stawowczyk, Marcin; Van Scoy, Sarah; Kumar, K. Prasanna; Reich, Nancy C.] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Reich, NC (corresponding author), SUNY Stony Brook, Dept Mol Genet & Microbiol, Life Sci Bldg, Stony Brook, NY 11794 USA.	nreich@notes.cc.sunysb.edu			National Institutes of Health [R21AI067885]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI067885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R21AI067885 (to N. C. R.).	Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Andersen J, 2008, GENES IMMUN, V9, P168, DOI 10.1038/sj.gene.6364449; Ausserlechner MJ, 2006, MOL CANCER THER, V5, P1927, DOI 10.1158/1535-7163.MCT-05-0500; Best SM, 2008, ANNU REV MICROBIOL, V62, P171, DOI 10.1146/annurev.micro.62.081307.163009; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chawla-Sarkar M, 2003, APOPTOSIS, V8, P237, DOI 10.1023/A:1023668705040; Clemens MJ, 2003, J INTERF CYTOK RES, V23, P277, DOI 10.1089/107999003766628124; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Degenhardt K, 2002, J BIOL CHEM, V277, P14127, DOI 10.1074/jbc.M109939200; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Dobner T, 1996, SCIENCE, V272, P1470, DOI 10.1126/science.272.5267.1470; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Fensterl V, 2008, J VIROL, V82, P11045, DOI 10.1128/JVI.01593-08; Fensterl V, 2009, BIOFACTORS, V35, P14, DOI 10.1002/biof.6; FU XY, 1990, P NATL ACAD SCI USA, V87, P8555, DOI 10.1073/pnas.87.21.8555; George CX, 2009, J INTERF CYTOK RES, V29, P477, DOI 10.1089/jir.2009.0065; Gomez D, 2003, J IMMUNOL, V170, P5373, DOI 10.4049/jimmunol.170.11.5373; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; GUTCH MJ, 1992, P NATL ACAD SCI USA, V89, P11411, DOI 10.1073/pnas.89.23.11411; Han JH, 1996, GENE DEV, V10, P461, DOI 10.1101/gad.10.4.461; Hui DJ, 2005, J BIOL CHEM, V280, P3433, DOI 10.1074/jbc.M406700200; Hui DJ, 2003, J BIOL CHEM, V278, P39477, DOI 10.1074/jbc.M305038200; Jagus R, 1999, INT J BIOCHEM CELL B, V31, P123, DOI 10.1016/S1357-2725(98)00136-8; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Karpenahalli MR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-2; Katsoulidis E, 2009, J BIOL CHEM, V284, P25051, DOI 10.1074/jbc.M109.030445; Kayagaki N, 1999, J EXP MED, V189, P1451, DOI 10.1084/jem.189.9.1451; KOFLER R, 2006, MOL CANCER THER, V5, P1927; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; KOTANIDES H, 1995, J BIOL CHEM, V270, P19481, DOI 10.1074/jbc.270.33.19481; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Kumar KP, 2000, MOL CELL BIOL, V20, P4159, DOI 10.1128/MCB.20.11.4159-4168.2000; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; LAFAGE M, 1992, GENOMICS, V13, P458, DOI 10.1016/0888-7543(92)90272-T; LEVY D, 1986, P NATL ACAD SCI USA, V83, P8929, DOI 10.1073/pnas.83.23.8929; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; LEVY DE, 1989, GENE DEV, V3, P1362, DOI 10.1101/gad.3.9.1362; Li W, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/15/155003; MartinezMoczygemba M, 1997, J BIOL CHEM, V272, P20070, DOI 10.1074/jbc.272.32.20070; Mawji IA, 2006, EXP BIOL MED, V231, P704; Miller CHT, 2009, ANN NY ACAD SCI, V1182, P69, DOI 10.1111/j.1749-6632.2009.05069.x; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Pokrovskaja K, 2005, J INTERF CYTOK RES, V25, P799, DOI 10.1089/jir.2005.25.799; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Samarajiwa SA, 2009, NUCLEIC ACIDS RES, V37, pD852, DOI 10.1093/nar/gkn732; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; SHAULIAN E, 1995, ONCOGENE, V10, P671; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Szegezdi E, 2009, AM J PHYSIOL-CELL PH, V296, pC941, DOI 10.1152/ajpcell.00612.2008; TAMURA T, 1995, NATURE, V376, P596, DOI 10.1038/376596a0; Terenzi F, 2005, VIROLOGY, V340, P116, DOI 10.1016/j.virol.2005.06.011; Terenzi F, 2006, J BIOL CHEM, V281, P34064, DOI 10.1074/jbc.M605771200; Terenzi F, 2008, EMBO J, V27, P3311, DOI 10.1038/emboj.2008.241; Thyrell L, 2002, ONCOGENE, V21, P1251, DOI 10.1038/sj.onc.1205179; Tschopp J, 1998, CURR OPIN GENET DEV, V8, P82, DOI 10.1016/S0959-437X(98)80066-X; VALES LD, 1989, GENE DEV, V3, P49, DOI 10.1101/gad.3.1.49; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang CF, 2003, J VIROL, V77, P3898, DOI 10.1128/JVI.77.7.3898-3912.2003; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Weaver BK, 1998, MOL CELL BIOL, V18, P1359, DOI 10.1128/MCB.18.3.1359; Weaver BK, 2001, FASEB J, V15, P501, DOI 10.1096/fj.00-0222com; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355; Zong WX, 2003, J CELL BIOL, V162, P59, DOI 10.1083/jcb.200302084	79	117	123	2	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7257	7266		10.1074/jbc.M110.207068	http://dx.doi.org/10.1074/jbc.M110.207068			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21190939	Green Published, hybrid			2022-12-27	WOS:000287737300042
J	Dani, N; Mayo, E; Stilla, A; Marchegiani, A; Di Paola, S; Corda, D; Di Girolamo, M				Dani, Nadia; Mayo, Emilia; Stilla, Annalisa; Marchegiani, Adriano; Di Paola, Simone; Corda, Daniela; Di Girolamo, Maria			Mono-ADP-ribosylation of the G Protein beta gamma Dimer Is Modulated by Hormones and Inhibited by Arf6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							39-KDA POLY(ADP-RIBOSE) GLYCOHYDROLASE; COUPLED RECEPTOR ENDOCYTOSIS; BINDING-PROTEINS; EXCHANGE FACTOR; CHOLERA-TOXIN; BOVINE BRAIN; ACTIVATION; MEMBRANE; ORGANIZATION; FAMILY	Mono-ADP-ribosylation is a reversible post-translational modification that can modulate the functions of target proteins. We have previously demonstrated that the beta subunit of heterotrimeric G proteins is endogenously mono-ADP-ribosylated, and once modified, the beta gamma dimer is inactive toward its effector enzymes. To better understand the physiological relevance of this post-translational modification, we have studied its hormonal regulation. Here, we report that G beta subunit mono-ADP-ribosylation is differentially modulated by G protein-coupled receptors. In intact cells, hormone stimulation of the thrombin receptor induces G beta subunit mono-ADP-ribosylation, which can affect G protein signaling. Conversely, hormone stimulation of the gonadotropin-releasing hormone receptor (GnRHR) inhibits G beta subunit mono-ADP-ribosylation. We also provide the first demonstration that activation of the GnRHR can activate the ADP-ribosylation factor Arf6, which in turn inhibits G beta subunit mono-ADP-ribosylation. Indeed, removal of Arf6 from purified plasma membranes results in loss of GnRHR-mediated inhibition of G beta subunit mono-ADP-ribosylation, which is fully restored by re-addition of purified, myristoylated Arf6. We show that Arf6 acts as a competitive inhibitor of the endogenous ADP-ribosyltransferase and is itself modified by this enzyme. These data provide further understanding of the mechanisms that regulate endogenous ADP-ribosylation of the G beta subunit, and they demonstrate a novel role for Arf6 in hormone regulation of G beta subunit mono-ADP-ribosylation.	[Dani, Nadia; Mayo, Emilia; Stilla, Annalisa; Marchegiani, Adriano; Di Paola, Simone; Corda, Daniela; Di Girolamo, Maria] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Prot Mediated Signalling Lab G, I-66030 Santa Maria Imbaro, Chieti, Italy	Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Di Girolamo, M (corresponding author), Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Prot Mediated Signalling Lab G, Via Nazl 8-A, I-66030 Santa Maria Imbaro, Chieti, Italy.	d.corda@ibp.cnr.it; mdigirolamo@negrisud.it	Corda, Daniela/K-6385-2016; Di Paola, Simone/GYU-0514-2022	Corda, Daniela/0000-0002-3614-751X; Di Paola, Simone/0000-0003-3753-5722	Ministero dell'Istruzione, Universita e Ricerca [RBIP06LSS2_005, DM26545]; Italian Association for Cancer Research	Ministero dell'Istruzione, Universita e Ricerca(Ministry of Education, Universities and Research (MIUR)); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	This work was supported in part by Ministero dell'Istruzione, Universita e Ricerca, Grants RBIP06LSS2_005 and DM26545.; Supported by Italian Association for Cancer Research fellowship. Present address: Institute for Cancer Research and Treatment and Dept. of Oncological Sciences, University of Torino, Candiolo 10060, Italy. To whom correspondence may be addressed. E-mail: nadia.dani@ircc.it.	Bourne H. R., 2006, E SCHERING FDN S P, V2, P1; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Caunt CJ, 2006, TRENDS ENDOCRIN MET, V17, P308, DOI 10.1016/j.tem.2006.08.001; Claing A, 2004, BIOCHEM CELL BIOL, V82, P610, DOI 10.1139/O04-113; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Dania N, 2009, P NATL ACAD SCI USA, V106, P4243, DOI 10.1073/pnas.0900066106; Deng Q, 2008, ANNU REV MICROBIOL, V62, P271, DOI 10.1146/annurev.micro.62.081307.162848; Dessauer CW, 1996, CLIN SCI, V91, P527, DOI 10.1042/cs0910527; Di Girolamo M, 2005, FEBS J, V272, P4565, DOI 10.1111/j.1742-4658.2005.04876.x; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; Franco M, 1999, EMBO J, V18, P1480, DOI 10.1093/emboj/18.6.1480; Gautam N, 1998, CELL SIGNAL, V10, P447, DOI 10.1016/S0898-6568(98)00006-0; Giguere P, 2006, CELL SIGNAL, V18, P1988, DOI 10.1016/j.cellsig.2006.03.003; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; HAWES BE, 1995, J BIOL CHEM, V270, P17148, DOI 10.1074/jbc.270.29.17148; Houndolo T, 2005, J BIOL CHEM, V280, P5598, DOI 10.1074/jbc.M411456200; Hunzicker-Dunn M, 2002, FEBS LETT, V521, P3, DOI 10.1016/S0014-5793(02)02822-3; KAHN RA, 1986, J BIOL CHEM, V261, P7906; Kleine H, 2008, MOL CELL, V32, P57, DOI 10.1016/j.molcel.2008.08.009; Koch-Nolte F, 2008, FRONT BIOSCI-LANDMRK, V13, P6716, DOI 10.2741/3184; LEE CM, 1991, J CLIN INVEST, V87, P1780, DOI 10.1172/JCI115197; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Lupi R, 2000, J BIOL CHEM, V275, P9418, DOI 10.1074/jbc.275.13.9418; Lupi R, 2002, BIOCHEM J, V367, P825, DOI 10.1042/BJ20020660; Maranda B, 2001, J BIOL CHEM, V276, P18540, DOI 10.1074/jbc.M011577200; Mariggio S, 2006, CELL SIGNAL, V18, P2200, DOI 10.1016/j.cellsig.2006.05.003; Mitchell R, 1998, NATURE, V392, P411, DOI 10.1038/32937; Niedergang F, 2003, J CELL BIOL, V161, P1143, DOI 10.1083/jcb.200210069; O'Neal CJ, 2005, SCIENCE, V309, P1093, DOI 10.1126/science.1113398; Offermanns S, 2003, PROG BIOPHYS MOL BIO, V83, P101, DOI 10.1016/S0079-6107(03)00052-X; Offermanns S, 1996, CANCER SURV, V27, P177; Oka S, 2006, J BIOL CHEM, V281, P705, DOI 10.1074/jbc.M510290200; Ono T, 2006, P NATL ACAD SCI USA, V103, P16687, DOI 10.1073/pnas.0607911103; Otto H, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-139; Randazzo Paul A, 2002, Methods Mol Biol, V189, P169; Riese MJ, 2002, J BIOL CHEM, V277, P12082, DOI 10.1074/jbc.M109039200; Robertson DN, 2003, MOL PHARMACOL, V64, P1239, DOI 10.1124/mol.64.5.1239; Salvador LM, 2001, J BIOL CHEM, V276, P33773, DOI 10.1074/jbc.M101498200; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Seman M, 2004, CURR MED CHEM, V11, P857, DOI 10.2174/0929867043455611; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; TSAI SC, 1988, J BIOL CHEM, V263, P1768; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005	48	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					5995	6005		10.1074/jbc.M110.112466	http://dx.doi.org/10.1074/jbc.M110.112466			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21148312	hybrid, Green Published			2022-12-27	WOS:000287476400007
J	Hernandez, JA; Phillips, AH; Erbil, WK; Zhao, DH; Demuez, M; Zeymer, C; Pelton, JG; Wemmer, DE; Rubio, LM				Hernandez, Jose A.; Phillips, Aaron H.; Erbil, W. Kaya; Zhao, Dehua; Demuez, Marie; Zeymer, Cathleen; Pelton, Jeffery G.; Wemmer, David E.; Rubio, Luis M.			A Sterile alpha-Motif Domain in NafY Targets Apo-NifDK for Iron-Molybdenum Cofactor Delivery via a Tethered Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITROGENASE MOFE PROTEIN; IN-VITRO SYNTHESIS; AZOTOBACTER-VINELANDII; KLEBSIELLA-PNEUMONIAE; APODINITROGENASE; PURIFICATION; CLUSTER; DINITROGENASE; BIOSYNTHESIS; SPECTROSCOPY	NafY participates in the final steps of nitrogenase maturation, having a dual role as iron-molybdenum cofactor (FeMo-co) carrier and as chaperone to the FeMo-co-deficient apo-NifDK (apo-dinitrogenase). NafY contains an N-terminal domain of unknown function (n-NafY) and a C-terminal domain (core-NafY) necessary for FeMo-co binding. We show here that n-NafY and core-NafY have very weak interactions in intact NafY. The NMR structure of n-NafY reveals that it belongs to the sterile alpha-motif (SAM) family of domains, which are frequently involved in protein-protein interactions. The presence of a SAM domain in NafY was unexpected and could not be inferred from its amino acid sequence. Although SAM domains are very commonly found in eukaryotic proteins, they have rarely been identified in prokaryotes. The n-NafY SAM domain binds apo-NifDK. As opposed to full-length NafY, n-NafY impaired FeMo-co insertion when present in molar excess relative to FeMo-co and apo-NifDK. The implications of these observations are discussed to offer a plausible mechanism of FeMo-co insertion. NafY domain structure, molecular tumbling, and interdomain motion, as well as NafY interaction with apo-NifDK are consistent with the function of NafY in FeMo-co delivery to apo-NifDK.	[Phillips, Aaron H.; Erbil, W. Kaya; Zeymer, Cathleen; Wemmer, David E.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Phillips, Aaron H.; Erbil, W. Kaya; Zeymer, Cathleen; Pelton, Jeffery G.; Wemmer, David E.] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [Phillips, Aaron H.; Erbil, W. Kaya; Zeymer, Cathleen; Pelton, Jeffery G.; Wemmer, David E.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Phys Biosci, Berkeley, CA 94720 USA; Midwestern Univ Arizona, Arizona Coll Osteopath Med, Dept Biochem, Glendale, AZ 85308 USA; [Zhao, Dehua] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Rubio, Luis M.] Inst Madrileno Estudios Avanzados IMDEA Energia, Madrid 28223, Spain	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Midwestern University; University of California System; University of California San Francisco; IMDEA Energy	Wemmer, DE (corresponding author), Univ Calif Berkeley, Dept Chem, MC-1460, Berkeley, CA 94720 USA.	dewemmer@lbl.gov; luis.rubio@imdea.org	Demuez, Marie/L-1266-2016; Demuez, Marie/L-1134-2014; Rubio, Luis M./B-5827-2009	Demuez, Marie/0000-0002-8702-1001; Rubio, Luis M./0000-0003-1596-2475; Zeymer, Cathleen/0000-0001-7138-381X	National Institutes of Health [GM-35332]; NIGMS [62163]; European Research Council [205442]; Ministerio de Ciencia e Innovacion de Espana [BIO2009-12661]; Midwestern University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035332, R37GM035332] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); European Research Council(European Research Council (ERC)European Commission); Ministerio de Ciencia e Innovacion de Espana(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Midwestern University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-35332 (to Paul Ludden) and Grant 62163 from NIGMS (to D. E. W.). This work was also supported by European Research Council Starting Grant 205442 and Ministerio de Ciencia e Innovacion de Espana Grant BIO2009-12661 (to L. M. R.) and by Midwestern University intramural funds (to J. A. H.).	Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Bernado P, 2004, J BIOMOL NMR, V29, P21, DOI 10.1023/B:JNMR.0000019499.60777.6e; Bonin I, 2004, P NATL ACAD SCI USA, V101, P13762, DOI 10.1073/pnas.0405883101; CHAN MK, 1993, SCIENCE, V260, P792, DOI 10.1126/science.8484118; Christiansen J, 1998, BIOCHEMISTRY-US, V37, P12611, DOI 10.1021/bi981165b; Curatti L, 2006, P NATL ACAD SCI USA, V103, P5297, DOI 10.1073/pnas.0601115103; Curatti L, 2007, P NATL ACAD SCI USA, V104, P17626, DOI 10.1073/pnas.0703050104; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dyer DH, 2003, J BIOL CHEM, V278, P39085, DOI 10.1074/jbc.M306214200; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Fischer MWF, 1999, BIOCHEMISTRY-US, V38, P9013, DOI 10.1021/bi9905213; George SJ, 2008, J AM CHEM SOC, V130, P5673, DOI 10.1021/ja0755358; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hernandez JA, 2007, MOL MICROBIOL, V63, P177, DOI 10.1111/j.1365-2958.2006.05514.x; HOMER MJ, 1993, J BACTERIOL, V175, P4907, DOI 10.1128/JB.175.15.4907-4910.1993; HOMER MJ, 1995, J BIOL CHEM, V270, P24745, DOI 10.1074/jbc.270.42.24745; Hu YL, 2008, BIOCHEMISTRY-US, V47, P3973, DOI 10.1021/bi7025003; Hu Y, 2007, P NATL ACAD SCI USA, V104, P10424, DOI 10.1073/pnas.0704297104; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kwan JJ, 2004, J MOL BIOL, V342, P681, DOI 10.1016/j.jmb.2004.06.064; Magnuson JK, 1997, TETRAHEDRON, V53, P11971, DOI 10.1016/S0040-4020(97)00710-2; PAUSTIAN TD, 1990, BIOCHEMISTRY-US, V29, P3515, DOI 10.1021/bi00466a014; PONTING CP, 1995, PROTEIN SCI, V4, P1928, DOI 10.1002/pro.5560040927; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Rubio LM, 2004, J BIOL CHEM, V279, P19739, DOI 10.1074/jbc.M400965200; Rubio LM, 2002, J BIOL CHEM, V277, P14299, DOI 10.1074/jbc.M107289200; Rubio LM, 2008, ANNU REV MICROBIOL, V62, P93, DOI 10.1146/annurev.micro.62.081307.162737; Schmid B, 2002, SCIENCE, V296, P352, DOI 10.1126/science.1070010; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; SHAH VK, 1973, BIOCHIM BIOPHYS ACTA, V305, P445, DOI 10.1016/0005-2728(73)90190-4; Tosi T, 2009, FEBS LETT, V583, P1581, DOI 10.1016/j.febslet.2009.04.033; WHITE TC, 1992, J BIOL CHEM, V267, P24007; Zhao DH, 2007, J BIOL CHEM, V282, P37016, DOI 10.1074/jbc.M708097200	34	11	11	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6321	6328		10.1074/jbc.M110.168732	http://dx.doi.org/10.1074/jbc.M110.168732			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21156797	hybrid, Green Published			2022-12-27	WOS:000287476400042
J	Hsieh, CY; Hsu, MJ; Hsiao, G; Wang, YH; Huang, CW; Chen, SAW; Jayakumar, T; Chiu, PT; Chiu, YH; Sheu, JR				Hsieh, Cheng Y.; Hsu, Ming J.; Hsiao, George; Wang, Yi H.; Huang, Chi W.; Chen, Shiuan W.; Jayakumar, Thanasekaran; Chiu, Pei T.; Chiu, Yi H.; Sheu, Joen R.			Andrographolide Enhances Nuclear Factor-kappa B Subunit p65 Ser(536) Dephosphorylation through Activation of Protein Phosphatase 2A in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOMYELINASE-CERAMIDE PATHWAY; NITRIC-OXIDE; NEOINTIMAL HYPERPLASIA; SIGNALING PATHWAYS; INFLAMMATION; INHIBITION; EXPRESSION; APOPTOSIS; DISEASE; DEATH	Recent studies have demonstrated that transcription factor nuclear factor (NF)-kappa B inhibition may contribute to the protective anti-inflammatory actions of andrographolide, an abundant component of plants of the genus Andrographis. However, the precise mechanism by which andrographolide inhibits NF-kappa B signaling remains unclear. We thus investigated the mechanism involved in andrographolide suppression of NF-kappa B signaling in rat vascular smooth muscle cells (VSMCs) exposed to proinflammatory stimuli, LPS, and IFN-gamma. Andrographolide was shown to suppress LPS/IFN-gamma-induced inducible nitric-oxide synthase and matrix metalloprotease 9 expression in rat VSMCs. Andrographolide also inhibited LPS/IFN-gamma-induced p65 nuclear translocation, DNA binding activity, p65 Ser(536) phosphorylation, and NF-kappa B reporter activity. However, IKK phosphorylation and downstream inhibitory kappa B alpha phosphorylation and degradation were not altered by the presence of andrographolide in LPS/IFN-gamma-stimulated VSMCs. These andrographolide inhibitory actions could be prevented by selective inhibition of neutral sphingomyelinase and protein phosphatase 2A (PP2A). Furthermore, andrographolide was demonstrated to increase ceramide formation and PP2A activity in VSMCs and to inhibit neointimal formation in rat carotid injury models. These results suggest that andrographolide caused neutral sphingomyelinase-mediated ceramide formation and PP2A activation to dephosphorylate p65 Ser(536), leading to NF-kappa B inactivation and subsequent inducible nitric-oxide synthase down-regulation in rat VSMCs stimulated by LPS and IFN-gamma.	[Hsieh, Cheng Y.; Hsu, Ming J.; Hsiao, George; Wang, Yi H.; Huang, Chi W.; Chen, Shiuan W.; Jayakumar, Thanasekaran; Sheu, Joen R.] Taipei Med Univ, Grad Inst Med Sci, Dept Pharmacol, Taipei 11031, Taiwan; [Hsu, Ming J.; Hsiao, George; Chiu, Pei T.; Sheu, Joen R.] Taipei Med Univ, Coll Med, Sch Med, Taipei 11031, Taiwan; [Chiu, Yi H.] Taipei Med Univ, Off Res & Dev, Instrument Ctr, Taipei 11031, Taiwan; [Wang, Yi H.] Natl Chengchi Univ, Inst Law & Interdiscipline, Taipei 11605, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; National Chengchi University	Sheu, JR (corresponding author), 250 Wu Hsing St, Taipei 11031, Taiwan.	sheujr@tmu.edu.tw		Hsu, Ming-Jen/0000-0001-9688-8494	National Science Council of Taiwan [NSC93-2321-B-038-001, 94-2321-B-038-001, 97-2320-B-038-016-MY3]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by National Science Council of Taiwan Grants NSC93-2321-B-038-001, 94-2321-B-038-001, and 97-2320-B-038-016-MY3.	Bao Z, 2009, AM J RESP CRIT CARE, V179, P657, DOI 10.1164/rccm.200809-1516OC; BEASLEY D, 1991, J CLIN INVEST, V87, P602, DOI 10.1172/JCI115036; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Birrell MA, 2005, AM J RESP CRIT CARE, V172, P962, DOI 10.1164/rccm.200412-1647OC; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Boos CJ, 2006, CLIN PHARMACOL THER, V79, P20, DOI 10.1016/j.clpt.2005.10.004; Cartwright N, 2007, AM J RESP CRIT CARE, V175, P595, DOI 10.1164/rccm.200608-1103OC; Chandrasekar B, 2006, J BIOL CHEM, V281, P15099, DOI 10.1074/jbc.M600200200; Chen BC, 2009, J BIOL CHEM, V284, P20562, DOI 10.1074/jbc.M109.028084; Chiou WF, 2000, BRIT J PHARMACOL, V129, P1553, DOI 10.1038/sj.bjp.0703191; Chung AWY, 2009, CARDIOVASC RES, V84, P494, DOI 10.1093/cvr/cvp242; Desmet C, 2004, J IMMUNOL, V173, P5766, DOI 10.4049/jimmunol.173.9.5766; Frantz S, 2007, NAT CLIN PRACT CARD, V4, P444, DOI 10.1038/ncpcardio0938; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Hattori Y, 2003, CARDIOVASC RES, V58, P186, DOI 10.1016/S0008-6363(02)00855-6; Hattori Y, 2004, CARDIOVASC RES, V63, P31, DOI 10.1016/j.cardiores.2004.03.014; Hsiao G, 2003, BIOCHEM PHARMACOL, V65, P1383, DOI 10.1016/S0006-2952(03)00070-4; Hsu MJ, 2007, J NEUROSCI, V27, P5719, DOI 10.1523/JNEUROSCI.1874-06.2007; Hsu MJ, 2002, J LEUKOCYTE BIOL, V72, P207; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Iruretagoyena MI, 2005, J PHARMACOL EXP THER, V312, P366, DOI 10.1124/jpet.104.072512; Jeremy JY, 1999, CARDIOVASC RES, V43, P580, DOI 10.1016/S0008-6363(99)00171-6; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kins S, 2003, AM J PATHOL, V163, P833, DOI 10.1016/S0002-9440(10)63444-X; Lanone S, 2002, J CLIN INVEST, V110, P463, DOI 10.1172/JCI200214136; Lee CS, 2009, ARTERIOSCL THROM VAS, V29, P472, DOI 10.1161/ATVBAHA.108.176230; Lee JT, 2004, J CELL BIOL, V164, P123, DOI 10.1083/jcb.200307017; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li ST, 2006, MOL CELL, V24, P497, DOI 10.1016/j.molcel.2006.10.015; McKellar GE, 2009, NAT REV CARDIOL, V6, P410, DOI 10.1038/nrcardio.2009.57; Negi AS, 2008, MED RES REV, V28, P746, DOI 10.1002/med.20115; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; PARRILLO JE, 1993, NEW ENGL J MED, V328, P1471, DOI 10.1056/nejm199305203282008; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Schiffmann S, 2009, J LIPID RES, V50, P32, DOI 10.1194/jlr.M800122-JLR200; Testi R, 1996, TRENDS BIOCHEM SCI, V21, P468, DOI 10.1016/S0968-0004(96)10056-6; Wang YJ, 2007, CELL RES, V17, P933, DOI 10.1038/cr.2007.89; Xia YF, 2004, J IMMUNOL, V173, P4207, DOI 10.4049/jimmunol.173.6.4207; Xu J, 1998, J BIOL CHEM, V273, P16521, DOI 10.1074/jbc.273.26.16521; Yang ZQ, 2009, ARTERIOSCL THROM VAS, V29, P1213, DOI 10.1161/ATVBAHA.109.189407; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Zhou J, 2008, MOL CANCER THER, V7, P2170, DOI 10.1158/1535-7163.MCT-08-0071	43	65	67	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					5942	5955		10.1074/jbc.M110.123968	http://dx.doi.org/10.1074/jbc.M110.123968			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21169355	Green Published, hybrid			2022-12-27	WOS:000287476400002
J	Alves, E; Bartlett, PJ; Garcia, CRS; Thomas, AP				Alves, Eduardo; Bartlett, Paula J.; Garcia, Celia R. S.; Thomas, Andrew P.			Melatonin and IP3-induced Ca2+ Release from Intracellular Stores in the Malaria Parasite Plasmodium falciparum within Infected Red Blood Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION; PHOSPHATIDYLINOSITOL SYNTHASE; INOSITOL 1,4,5-TRISPHOSPHATE; PHOSPHOINOSITIDE HYDROLYSIS; CALCIUM; CYCLE; MEMBRANE; KINASE; METABOLISM; RECEPTORS	IP3-dependent Ca2+ signaling controls a myriad of cellular processes in higher eukaryotes and similar signaling pathways are evolutionarily conserved in Plasmodium, the intracellular parasite that causes malaria. We have reported that isolated, permeabilized Plasmodium chabaudi, releases Ca2+ upon addition of exogenous IP3. In the present study, we investigated whether the IP3 signaling pathway operates in intact Plasmodium falciparum, the major disease-causing human malaria parasite. P. falciparum-infected red blood cells (RBCs) in the trophozoite stage were simultaneously loaded with the Ca2+ indicator Fluo-4/AM and caged-IP3. Photolytic release of IP3 elicited a transient Ca2+ increase in the cytosol of the intact parasite within the RBC. The intracellular Ca2+ pools of the parasite were selectively discharged, using thapsigargin to deplete endoplasmic reticulum (ER) Ca2+ and the antimalarial chloroquine to deplete Ca2+ from acidocalcisomes. These data show that the ER is the major IP3-sensitive Ca2+ store. Previous work has shown that the human host hormone melatonin regulates P. falciparum cell cycle via a Ca2+-dependent pathway. In the present study, we demonstrate that melatonin increases inositol-polyphosphate production in intact intraerythrocytic parasite. Moreover, the Ca2+ responses to melatonin and uncaging of IP3 were mutually exclusive in infected RBCs. Taken together these data provide evidence that melatonin activates PLC to generate IP3 and open ER-localized IP3-sensitive Ca2+ channels in P. falciparum. This receptor signaling pathway is likely to be involved in the regulation and synchronization of parasite cell cycle progression.	[Garcia, Celia R. S.] Univ Sao Paulo, Inst Biociencias, Dept Fisiol, BR-05508900 Sao Paulo, Brazil; [Alves, Eduardo; Bartlett, Paula J.; Thomas, Andrew P.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA; [Alves, Eduardo] Univ Sao Paulo, Inst Biociencias, Dept Parasitol, BR-05508900 Sao Paulo, Brazil	Universidade de Sao Paulo; Rutgers State University New Brunswick; Rutgers State University Medical Center; Universidade de Sao Paulo	Garcia, CRS (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Fisiol, BR-05508900 Sao Paulo, Brazil.	cgarcia@usp.br; thomasap@umdnj.edu	Garcia, Celia R. S./A-4093-2011; Inbeqmedi, Inct/I-1929-2013; 4, INCT/H-4499-2013; Thomas, Andrew/C-6755-2013	Garcia, Celia R. S./0000-0003-2825-1701; Thomas, Andrew/0000-0002-9026-7467	Thomas P. Infusino Endowment; National Institutes of Health [DK082954]; Fapesp [07/52924-0]; Malaria Pronex; INCT-INBqMed; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053315] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK082954] Funding Source: NIH RePORTER	Thomas P. Infusino Endowment; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Malaria Pronex; INCT-INBqMed; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the Thomas P. Infusino Endowment (to A.P.T.), National Institutes of Health Grant DK082954, Fapesp (07/52924-0), Malaria Pronex, and INCT-INBqMed.	Bagnaresi P, 2009, INT J GEN MED, V2, P47; Bannister L, 2003, TRENDS PARASITOL, V19, P209, DOI 10.1016/S1471-4922(03)00086-2; Beraldo FH, 2005, J CELL BIOL, V170, P551, DOI 10.1083/jcb.200505117; Beraldo FH, 2005, J PINEAL RES, V39, P224, DOI 10.1111/j.1600-079X.2005.00249.x; Beraldo FH, 2007, J PINEAL RES, V43, P360, DOI 10.1111/j.1600-079X.2007.00486.x; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; BERRIDGE MJ, 1982, BIOCHEM J, V206, P587, DOI 10.1042/bj2060587; Biagini GA, 2003, J BIOL CHEM, V278, P27910, DOI 10.1074/jbc.M304193200; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Breman Joel G., 2009, Science Progress, V92, P1, DOI 10.3184/003685009X440290; Brydon L, 1999, MOL ENDOCRINOL, V13, P2025, DOI 10.1210/me.13.12.2025; Budu A, 2007, J PINEAL RES, V42, P261, DOI 10.1111/j.1600-079X.2006.00414.x; Dakin K, 2007, CELL CALCIUM, V42, P291, DOI 10.1016/j.ceca.2006.12.003; DIVIRGILIO F, 1990, CELL CALCIUM, V11, P57, DOI 10.1016/0143-4160(90)90059-4; Docampo R, 2005, NAT REV MICROBIOL, V3, P251, DOI 10.1038/nrmicro1097; Doerig C, 2009, PARASITE, V16, P169, DOI 10.1051/parasite/2009163169; Doerig C, 2008, TRENDS PARASITOL, V24, P570, DOI 10.1016/j.pt.2008.08.007; DUBOCOVICH ML, 1988, J PHARMACOL EXP THER, V246, P902; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Dyer M, 2000, MOL BIOCHEM PARASIT, V110, P435, DOI 10.1016/S0166-6851(00)00312-1; Ekland EH, 2007, CURR OPIN MICROBIOL, V10, P363, DOI 10.1016/j.mib.2007.07.007; ELABBADI N, 1994, MOL BIOCHEM PARASIT, V63, P179, DOI 10.1016/0166-6851(94)90054-X; Fang JM, 2006, BIOCHEM J, V394, P417, DOI 10.1042/BJ20051393; Garcia CRS, 2008, INT REV CEL MOL BIO, V266, P85, DOI 10.1016/S1937-6448(07)66003-1; Garcia CRS, 2001, J BIOL RHYTHM, V16, P436, DOI 10.1177/074873001129002114; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gazarini ML, 2004, BIOCHEM BIOPH RES CO, V321, P138, DOI 10.1016/j.bbrc.2004.06.141; Gazarini ML, 2003, J CELL BIOL, V161, P103, DOI 10.1083/jcb.200212130; Haldar K, 2009, HEMATOL-AM SOC HEMAT, V2009, P87, DOI DOI 10.1182/ASHEDUCATI0N-2009.1.87; Hotta CT, 2003, BRAZ J MED BIOL RES, V36, P1583, DOI 10.1590/S0100-879X2003001100016; Hotta CT, 2000, NAT CELL BIOL, V2, P466, DOI 10.1038/35017112; IRVINE RF, 1985, BIOCHEM J, V229, P505, DOI 10.1042/bj2290505; Jockers R, 2008, BRIT J PHARMACOL, V154, P1182, DOI 10.1038/bjp.2008.184; Kappe SHI, 2010, SCIENCE, V328, P862, DOI 10.1126/science.1184785; Kooij TWA, 2006, NAT REV MICROBIOL, V4, P344, DOI 10.1038/nrmicro1392; Koyama FC, 2009, MOL BIOCHEM PARASIT, V165, P1, DOI 10.1016/j.molbiopara.2009.01.003; KRISHNA S, 1990, PARASITOL TODAY, V6, P196, DOI 10.1016/0169-4758(90)90356-9; Lai FPL, 2002, J NEUROCHEM, V80, P736, DOI 10.1046/j.0022-3042.2002.00767.x; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; Madeira L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001889; MARTIN SK, 1994, J PARASITOL, V80, P371, DOI 10.2307/3283406; Mullins UL, 1997, CELL SIGNAL, V9, P169, DOI 10.1016/S0898-6568(96)00137-4; Nagamune K, 2007, EUKARYOT CELL, V6, P2147, DOI 10.1128/EC.00262-07; Nagamune K, 2006, MOL BIOL EVOL, V23, P1613, DOI 10.1093/molbev/msl026; Olszewski KL, 2009, CELL HOST MICROBE, V5, P191, DOI 10.1016/j.chom.2009.01.004; Passos APD, 1998, BIOCHEM BIOPH RES CO, V245, P155, DOI 10.1006/bbrc.1998.8338; POUVELLE B, 1991, NATURE, V353, P73, DOI 10.1038/353073a0; Rohrbach P, 2005, J BIOL CHEM, V280, P27960, DOI 10.1074/jbc.M500777200; Singh S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000746; Skinner-Adams TS, 2010, TRENDS BIOCHEM SCI, V35, P53, DOI 10.1016/j.tibs.2009.08.004; Smith IF, 2009, CELL CALCIUM, V45, P65, DOI 10.1016/j.ceca.2008.06.001; Srinivasan V, 2010, J PINEAL RES, V48, P1, DOI 10.1111/j.1600-079X.2009.00728.x; Steffens F, 2003, MOL ENDOCRINOL, V17, P2103, DOI 10.1210/me.2003-0047; SUGDEN D, 1992, EUR J PHARMACOL, V213, P405, DOI 10.1016/0014-2999(92)90629-I; THOMAS AP, 1984, J BIOL CHEM, V259, P5574; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Tsim ST, 1997, J CELL SCI, V110, P1387; Vaid A, 2008, J BIOL CHEM, V283, P5589, DOI 10.1074/jbc.M708465200; Vaid A, 2006, J BIOL CHEM, V281, P27126, DOI 10.1074/jbc.M601914200; Varotti FP, 2003, CELL CALCIUM, V33, P137, DOI 10.1016/S0143-4160(02)00224-5; Wengelnik K, 2007, RES MICROBIOL, V158, P51, DOI 10.1016/j.resmic.2006.11.005	64	80	81	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5905	5912		10.1074/jbc.M110.188474	http://dx.doi.org/10.1074/jbc.M110.188474			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21149448	Green Published, hybrid			2022-12-27	WOS:000287230600099
J	Saijo, M; Takedachi, A; Tanaka, K				Saijo, Masafumi; Takedachi, Arato; Tanaka, Kiyoji			Nucleotide Excision Repair by Mutant Xeroderma Pigmentosum Group A (XPA) Proteins with Deficiency in Interaction with RPA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENTATION GROUP-A; HUMAN CELL-EXTRACTS; DNA-BINDING DOMAIN; DAMAGE-RECOGNITION; GROUP-C; TRANSCRIPTION FACTOR; MUTATIONAL ANALYSIS; COMPLEX; ERCC1; STRAND	The xeroderma pigmentosum group A protein (XPA) is a core component of nucleotide excision repair (NER). To coordinate early stage NER, XPA interacts with various proteins, including replication protein A (RPA), ERCC1, DDB2, and TFIIH, in addition to UV-damaged or chemical carcinogen-damaged DNA. In this study, we investigated the effects of mutations in the RPA binding regions of XPA on XPA function in NER. XPA binds through an N-terminal region to the middle subunit (RPA32) of the RPA heterotrimer and through a central region that overlaps with its damaged DNA binding region to the RPA70 subunit. In cell-free NER assays, an N-terminal deletion mutant of XPA showed loss of binding to RPA32 and reduced DNA repair activity, but it could still bind to UV-damaged DNA and RPA. In contrast, amino acid substitutions in the central region reduced incisions at the damaged site in the cell-free NER assay, and four of these mutants (K141A, T142A, K167A, and K179A) showed reduced binding to RPA70 but normal binding to damaged DNA. Furthermore, mutants that had one of the four aforementioned substitutions and an N-terminal deletion exhibited lower DNA incision activity and binding to RPA than XPA with only one of these substitutions or the deletion. Taken together, these results indicate that XPA interaction with both RPA32 and RPA70 is indispensable for NER reactions.	[Saijo, Masafumi; Takedachi, Arato; Tanaka, Kiyoji] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Osaka University	Saijo, M (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Yamadaoka 1-3, Suita, Osaka 5650871, Japan.	saijom@fbs.osaka-u.ac.jp; ktanaka@fbs.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and by the Solution-oriented Research for Science and Technology program of the Japan Science and Technology Agency.	Araujo SJ, 1999, MUTAT RES-DNA REPAIR, V435, P23, DOI 10.1016/S0921-8777(99)00042-7; ASAHINA H, 1994, MUTAT RES-DNA REPAIR, V315, P229, DOI 10.1016/0921-8777(94)90034-5; Bootsma D., 1998, GENETIC BASIS HUMAN, P245; Buchko GW, 1999, BIOCHEMISTRY-US, V38, P15116, DOI 10.1021/bi991755p; Buchko GW, 1998, NUCLEIC ACIDS RES, V26, P2779, DOI 10.1093/nar/26.11.2779; Camenisch U, 2007, DNA REPAIR, V6, P1819, DOI 10.1016/j.dnarep.2007.07.011; de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768; Evans E, 1997, EMBO J, V16, P6559, DOI 10.1093/emboj/16.21.6559; EVANS MK, 1993, J BIOL CHEM, V268, P4839; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Hanawalt PC, 1999, NATO ADV SCI I A-LIF, V302, P169; HE ZG, 1995, NATURE, V374, P566, DOI 10.1038/374566a0; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hermanson-Miller IL, 2002, BIOCHEMISTRY-US, V41, P2402, DOI 10.1021/bi0112863; Ikegami T, 1998, NAT STRUCT BIOL, V5, P701, DOI 10.1038/1400; Jaspers NGJ, 2007, AM J HUM GENET, V80, P457, DOI 10.1086/512486; JONES CJ, 1993, BIOCHEMISTRY-US, V32, P12096, DOI 10.1021/bi00096a021; KENNY M K, 1990, Journal of Biological Chemistry, V265, P7693; Kobayashi T, 1998, NUCLEIC ACIDS RES, V26, P4662, DOI 10.1093/nar/26.20.4662; Kuraoka I, 1996, MUTAT RES-DNA REPAIR, V362, P87, DOI 10.1016/0921-8777(95)00038-0; LI L, 1995, MOL CELL BIOL, V15, P1993; LI L, 1994, P NATL ACAD SCI USA, V91, P5012, DOI 10.1073/pnas.91.11.5012; LI L, 1995, MOL CELL BIOL, V15, P5396; MASUTANI C, 1993, J BIOL CHEM, V268, P9105; MATSUDA T, 1995, J BIOL CHEM, V270, P4152, DOI 10.1074/jbc.270.8.4152; MIYAMOTO I, 1992, J BIOL CHEM, V267, P12182; Moggs JG, 1996, J BIOL CHEM, V271, P7177, DOI 10.1074/jbc.271.12.7177; NAGAI A, 1995, BIOCHEM BIOPH RES CO, V211, P960, DOI 10.1006/bbrc.1995.1905; Nakatsu Y, 2000, J BIOL CHEM, V275, P34931, DOI 10.1074/jbc.M004936200; Nitta M, 2000, NUCLEIC ACIDS RES, V28, P4212, DOI 10.1093/nar/28.21.4212; Nocentini S, 1997, J BIOL CHEM, V272, P22991, DOI 10.1074/jbc.272.37.22991; PARK CH, 1995, J BIOL CHEM, V270, P4896, DOI 10.1074/jbc.270.9.4896; Patrick SM, 2002, J BIOL CHEM, V277, P16096, DOI 10.1074/jbc.M200816200; Rademakers S, 2003, MOL CELL BIOL, V23, P5755, DOI 10.1128/MCB.23.16.5755-5767.2003; Reardon JT, 2002, MOL CELL BIOL, V22, P5938, DOI 10.1128/MCB.22.16.5938-5945.2002; Riedl T, 2003, EMBO J, V22, P5293, DOI 10.1093/emboj/cdg489; Saijo M, 2004, BIOCHEM BIOPH RES CO, V321, P815, DOI 10.1016/j.bbrc.2004.07.030; Saijo M, 1996, NUCLEIC ACIDS RES, V24, P4719, DOI 10.1093/nar/24.23.4719; Stapleton AE, 1999, METH MOL B, V113, P157; VENEMA J, 1990, NUCLEIC ACIDS RES, V18, P443, DOI 10.1093/nar/18.3.443; VENEMA J, 1991, MOL CELL BIOL, V11, P4128, DOI 10.1128/MCB.11.8.4128; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7; Wakasugi M, 2009, NUCLEIC ACIDS RES, V37, P516, DOI 10.1093/nar/gkn964; Yang ZG, 2002, BIOCHEMISTRY-US, V41, P13012, DOI 10.1021/bi026064z; You JS, 2003, J BIOL CHEM, V278, P7476, DOI 10.1074/jbc.M210603200	45	27	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5476	5483		10.1074/jbc.M110.172916	http://dx.doi.org/10.1074/jbc.M110.172916			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148310	Green Published, hybrid			2022-12-27	WOS:000287230600057
J	Essalmani, R; Susan-Resiga, D; Chamberland, A; Abifadel, M; Creemers, JW; Boileau, C; Seidah, NG; Prat, A				Essalmani, Rachid; Susan-Resiga, Delia; Chamberland, Ann; Abifadel, Marianne; Creemers, John W.; Boileau, Catherine; Seidah, Nabil G.; Prat, Annik			In Vivo Evidence That Furin from Hepatocytes Inactivates PCSK9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONVERTASE SUBTILISIN/KEXIN TYPE-9; PROPROTEIN CONVERTASES; FAMILIAL HYPERCHOLESTEROLEMIA; RECEPTOR DEGRADATION; LIVER-REGENERATION; SECRETED PCSK9; MOUSE-LIVER; MUTATIONS; CHOLESTEROL; GENE	The proprotein convertase PCSK9 plays a key role in cholesterol homeostasis by binding the LDL receptor and targeting it toward degradation. PCSK9 is strongly expressed in the liver and is found in human and mouse plasma as mature (similar to 62 kDa) and inactivated (similar to 55 kDa) forms. Ex vivo data showed that human PCSK9 is inactivated by cleavage at Arg218 down arrow by the overexpressed convertases furin and PC5/6A. Analysis of the plasma of human heterozygotes for R218S and F216L mutations revealed a similar to 50% reduction in the levels of the similar to 55-kDa form. To identify the convertase(s) responsible for cleavage at Arg(218) in vivo, we inactivated the genes of furin and/or PC5/6 specifically in hepatocytes. The PCSK9-inactivated form was strongly reduced in mice lacking furin in hepatocytes (Fur-hKO) and only slightly reduced in PC5/6-hKO plasma. In agreement with a key role of furin in regulating PCSK9 activity in vivo, we observed an overall 26% drop in the LDL receptor protein levels of Fur-hKO livers, likely due to the compound effects of a 35% increase in PCSK9 mRNA levels and the loss of PCSK9 cleavage, suggesting a higher activity of PCSK9 in these mice. Overexpression of PCSK9 in primary hepatocytes obtained from these mice revealed that only full-length, membrane-bound, but not soluble, furin is the cognate convertase. We conclude that in hepatocytes furin regulates PCSK9 mRNA levels and is the key in vivo-inactivating protease of circulating PCSK9.	[Seidah, Nabil G.; Prat, Annik] Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Creemers, John W.] Katholieke Univ Leuven, Biochem Neuroendocrinol Lab, Ctr Human Genet, B-3000 Louvain, Belgium; [Abifadel, Marianne; Boileau, Catherine] Hop Bichat Claude Bernard, INSERM, UMR698, F-75877 Paris 18, France	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; KU Leuven; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Prat, A (corresponding author), Clin Res Inst Montreal, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	prata@ircm.qc.ca	boileau, catherine/M-4482-2017; Seidah, Nabil/I-3596-2013; Susan-Resiga@ircm.qc.ca, Delia/O-2548-2017; Abifadel, Marianne/ABH-5370-2020; Prat, Annik/S-6757-2018	boileau, catherine/0000-0002-0371-7539; Seidah, Nabil/0000-0001-6503-9342; Susan-Resiga@ircm.qc.ca, Delia/0000-0002-4856-090X; Prat, Annik/0000-0002-8007-5277; ABIFADEL, Marianne/0000-0001-7645-8323	Canadian Institutes of Health Research [MOP-102741, CTP-82946]; Strauss Foundation; Canada Chair [201652]; Fonds voor Wentenschappelijk Vlaanderen; Geconcerteerde Onderzoeks Actie [2008/16]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Strauss Foundation; Canada Chair; Fonds voor Wentenschappelijk Vlaanderen; Geconcerteerde Onderzoeks Actie	This work was supported by Canadian Institutes of Health Research Grants MOP-102741 and CTP-82946 (to N. G. S.), a Strauss Foundation grant (to N. G. S.), Canada Chair 201652 (to N. G. S.), Fonds voor Wentenschappelijk Vlaanderen (to J. W. C.), and Geconcerteerde Onderzoeks Actie 2008/16 Grant (to J. W. C.).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Allard Delphine, 2005, Hum Mutat, V26, P497, DOI 10.1002/humu.9383; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Cameron J, 2008, J INTERN MED, V263, P420, DOI 10.1111/j.1365-2796.2007.01915.x; Constam DB, 2000, GENE DEV, V14, P1146; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; Decroly E, 1996, J BIOL CHEM, V271, P30442, DOI 10.1074/jbc.271.48.30442; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Dubuc G, 2010, J LIPID RES, V51, P140, DOI 10.1194/jlr.M900273-JLR200; Essalmani R, 2008, P NATL ACAD SCI USA, V105, P5750, DOI 10.1073/pnas.0709428105; Hooper AJ, 2007, ATHEROSCLEROSIS, V193, P445, DOI 10.1016/j.atherosclerosis.2006.08.039; Kourimate S, 2008, J BIOL CHEM, V283, P9666, DOI 10.1074/jbc.M705831200; Li J, 2007, BIOCHEM J, V406, P203, DOI 10.1042/BJ20070664; Maxwell KN, 2005, P NATL ACAD SCI USA, V102, P2069, DOI 10.1073/pnas.0409736102; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; Mayne J, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-22; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Nour N, 2005, MOL BIOL CELL, V16, P5215, DOI 10.1091/mbc.E05-06-0504; Persson L, 2010, ARTERIOSCL THROM VAS, V30, P2666, DOI 10.1161/ATVBAHA.110.214130; Postic C, 2000, GENESIS, V26, P149, DOI 10.1002/(SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Seidah NG, 2007, J MOL MED, V85, P685, DOI 10.1007/s00109-007-0172-7; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Seidah NG, 1999, BRAIN RES, V848, pA14; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Villeneuve P, 2002, J NEUROCHEM, V82, P783, DOI 10.1046/j.1471-4159.2002.00988.x; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200; Zhao ZZ, 2006, AM J HUM GENET, V79, P514, DOI 10.1086/507488	35	118	125	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4257	4263		10.1074/jbc.M110.192104	http://dx.doi.org/10.1074/jbc.M110.192104			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21147780	Green Published, hybrid			2022-12-27	WOS:000286975700024
J	Ko, JK; Choi, KH; Peng, J; He, F; Zhang, Z; Weisleder, N; Lin, JL; Ma, JJ				Ko, Jae-Kyun; Choi, Kyoung-Han; Peng, Jun; He, Feng; Zhang, Zhi; Weisleder, Noah; Lin, Jialing; Ma, Jianjie			Amphipathic Tail-anchoring Peptide and Bcl-2 Homology Domain-3 (BH3) Peptides from Bcl-2 Family Proteins Induce Apoptosis through Different Mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; MEMBRANE PERMEABILIZATION; MITOCHONDRIAL-MEMBRANE; X-L; BCL-2-REGULATED APOPTOSIS; MIMETIC ABT-737; CYTOCHROME-C; BAX; CANCER; ACTIVATION	Bcl-2 homology domain-3 (BH3) peptides are potent cancer therapeutic reagents that target regulators of apoptotic cell death in cancer cells. However, their cytotoxic effects are affected by different expression levels of Bcl-2 family proteins. We recently found that the amphipathic tail-anchoring peptide (ATAP) from Bfl-1, a bifunctional Bcl-2 family member, produced strong pro-apoptotic activity by permeabilizing the mitochondrial outer membrane. Here, we test whether the activity of ATAP requires other cellular factors and whether ATAP has an advantage over the BH3 peptides in targeting cancer cells. Confocal microscopic imaging illustrates specific targeting of ATAP to mitochondria, whereas BH3 peptides show diffuse patterns of cytosolic distribution. Although the pro-apoptotic activities of BH3 peptides are largely inhibited by either overexpression of anti-apoptotic Bcl-2 or Bcl-xL or nullification of pro-apoptotic Bax and Bak in cells, the pro-apoptotic function of ATAP is not affected by these cellular factors. Reconstitution of synthetic ATAP into liposomal membranes results in release of fluorescent molecules of the size of cytochrome c from the liposomes, suggesting that the membrane permeabilizing activity of ATAP does not require additional protein factors. Because ATAP can target to the mitochondrial membrane and its pro-apoptotic activity does not depend on the content of Bcl-2 family proteins, it represents a promising candidate for anti-cancer drugs that can potentially overcome the intrinsic apoptosis-resistant nature of cancer cells.	[Peng, Jun; He, Feng; Zhang, Zhi; Lin, Jialing] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73126 USA; [Ko, Jae-Kyun; Choi, Kyoung-Han; Weisleder, Noah; Ma, Jianjie] Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Lin, JL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73126 USA.	jialing-lin@ouhsc.edu; maj2@umdnj.edu	He, Feng/J-6984-2019; Weisleder, Noah L/A-7098-2013	He, Feng/0000-0003-0276-3303; Weisleder, Noah L/0000-0002-2619-8022; Weisleder, Noah/0000-0003-2710-3088	National Institutes of Health [RO1-CA095739, RO1-AG028614, GM062964, K99/R00-AR054793]; NATIONAL CANCER INSTITUTE [R01CA095739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR054793, R00AR054793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028614] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-CA095739 and RO1-AG028614 (to J. M.), GM062964 (to J. L.), and K99/R00-AR054793 (to N. W.).	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Benz EJ, 2007, CLIN CANCER RES, V13, P7250, DOI 10.1158/1078-0432.CCR-07-2221; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Chen S, 2007, CANCER RES, V67, P782, DOI 10.1158/0008-5472.CAN-06-3964; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Cosulich SC, 1997, CURR BIOL, V7, P913, DOI 10.1016/S0960-9822(06)00410-6; Crisan D, 1996, CLIN LAB MED, V16, P23, DOI 10.1016/S0272-2712(18)30285-3; Degenhardt K, 2002, J BIOL CHEM, V277, P14127, DOI 10.1074/jbc.M109939200; Deng J, 2007, CANCER CELL, V12, P171, DOI 10.1016/j.ccr.2007.07.001; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Kitada S, 2003, J MED CHEM, V46, P4259, DOI 10.1021/jm030190z; Konopleva M, 2006, CANCER CELL, V10, P375, DOI 10.1016/j.ccr.2006.10.006; Krajewska M, 1996, CANCER RES, V56, P2422; KRAJEWSKI S, 1995, CANCER RES, V55, P4471; Kushnareva YE, 2001, ARCH BIOCHEM BIOPHYS, V386, P251, DOI 10.1006/abbi.2000.2201; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Labi V, 2008, CELL DEATH DIFFER, V15, P977, DOI 10.1038/cdd.2008.37; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Meng XW, 2006, CURR OPIN CELL BIOL, V18, P668, DOI 10.1016/j.ceb.2006.10.008; Muro C, 2003, BIOPHYS J, V84, P2981, DOI 10.1016/S0006-3495(03)70024-1; Oliver CL, 2005, MOL CANCER THER, V4, P23; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Peng J, 2006, J BIOL CHEM, V281, P35802, DOI 10.1074/jbc.M608303200; Polster BM, 2001, J BIOL CHEM, V276, P37887; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; Tan CB, 2006, J BIOL CHEM, V281, P14764, DOI 10.1074/jbc.M602374200; Uren RT, 2007, J CELL BIOL, V177, P277, DOI 10.1083/jcb.200606065; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Venturoli D, 2005, AM J PHYSIOL-RENAL, V288, pF605, DOI 10.1152/ajprenal.00171.2004; Vogler M, 2009, CELL DEATH DIFFER, V16, P1030, DOI 10.1038/cdd.2009.48; Vogler M, 2009, CELL DEATH DIFFER, V16, P360, DOI 10.1038/cdd.2008.137; Vogler M, 2009, BLOOD, V113, P4403, DOI 10.1182/blood-2008-08-173310; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Wang GP, 2006, J MED CHEM, V49, P6139, DOI 10.1021/jm060460o; Wang JL, 2000, P NATL ACAD SCI USA, V97, P7124, DOI 10.1073/pnas.97.13.7124; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Wood DE, 2000, EXP CELL RES, V256, P375, DOI 10.1006/excr.2000.4859; Xu L, 2005, MOL CANCER THER, V4, P197; Yang WS, 2005, J CELL BIOCHEM, V94, P1234, DOI 10.1002/jcb.20381; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Yin H, 2005, J AM CHEM SOC, V127, P10191, DOI 10.1021/ja050122x; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zeitlin BD, 2006, CANCER RES, V66, P8698, DOI 10.1158/0008-5472.CAN-05-3691; Zhang Z, 2004, J BIOL CHEM, V279, P43920, DOI 10.1074/jbc.M406412200	49	26	27	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9038	9048		10.1074/jbc.M110.198457	http://dx.doi.org/10.1074/jbc.M110.198457			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21189256	hybrid, Green Published			2022-12-27	WOS:000288247700035
J	Ravindran, S; Gao, Q; Ramachandran, A; Blond, S; Predescu, SA; George, A				Ravindran, Sriram; Gao, Qi; Ramachandran, Amsaveni; Blond, Sylvie; Predescu, Sanda A.; George, Anne			Stress Chaperone GRP-78 Functions in Mineralized Matrix Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-TRANSCRIPTION; SURFACE EXPRESSION; COXSACKIEVIRUS A9; IN-VITRO; DENTIN; PROTEIN-1; CELLS; DMP1; BIP; IDENTIFICATION	Mineralized matrix formation is a well orchestrated event requiring several players. Glucose-regulated protein-78 (GRP-78) is an endoplasmic reticulum chaperone protein that has been implicated in functional roles ranging from involvement in cancer biology to serving as a receptor for viruses. In the present study we explored the role of GRP-78 in mineralized matrix formation. Differential expression of GRP-78 mRNA and protein was observed upon in vitro differentiation of primary mouse calvarial cells. An interesting observation was that GRP-78 was identified in the secretome of these cells and in the bone matrix, suggesting an extracellular function during matrix formation. In vitro nucleation experiments under physiological concentrations of calcium and phosphate ions indicated that GRP-78 can induce the formation of calcium phosphate polymorphs by itself, when bound to immobilized type I collagen and on demineralized collagen wafers. We provide evidence that GRP-78 can bind to DMP1 and type I collagen independent of each other in a simulated extracellular environment. Furthermore, we demonstrate the cell surface localization of GRP-78 and provide evidence that it functions as a receptor for DMP1 endocytosis in pre-osteoblasts and primary calvarial cells. Overall, this study represents a paradigm shift in the biological function of GRP-78.	[Ravindran, Sriram; Gao, Qi; Ramachandran, Amsaveni; George, Anne] Univ Illinois, Dept Oral Biol, Chicago, IL 60612 USA; [Blond, Sylvie] Univ Illinois, Dept Pharmaceut Biotechnol, Chicago, IL 60612 USA; [Predescu, Sanda A.] Rush Univ, Med Ctr, Dept Pharmacol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rush University	George, A (corresponding author), Univ Illinois, Dept Oral Biol, Chicago, IL 60612 USA.	anneg@uic.edu		Predescu, Sanda/0000-0002-9386-6756; GEORGE, ANNE/0000-0002-9008-7642	National Institutes of Health [DE 11657]; Brodie Endowment Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE011657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R56DE011657] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brodie Endowment Fund; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE 11657. This work was also supported by the Brodie Endowment Fund.	Altmeyer A, 1996, INT J CANCER, V69, P340, DOI 10.1002/(SICI)1097-0215(19960822)69:4<340::AID-IJC18>3.0.CO;2-9; Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; Chen S, 2005, J BIOL CHEM, V280, P29717, DOI 10.1074/jbc.M502929200; CHESSLER SD, 1993, J BIOL CHEM, V268, P18226; Chiellini C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-26; Delpino A, 2002, BIOSCIENCE REP, V22, P407, DOI 10.1023/A:1020966008615; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Hayakawa K, 2009, J IMMUNOL, V182, P1182, DOI 10.4049/jimmunol.182.2.1182; He G, 2004, J BIOL CHEM, V279, P11649, DOI 10.1074/jbc.M309296200; Huang BZ, 2008, CALCIFIED TISSUE INT, V82, P401, DOI 10.1007/s00223-008-9140-7; Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x; Lievremont JP, 1997, J BIOL CHEM, V272, P30873, DOI 10.1074/jbc.272.49.30873; Lu YB, 2007, DEV BIOL, V303, P191, DOI 10.1016/j.ydbio.2006.11.001; Lu YB, 2009, CELLS TISSUES ORGANS, V189, P175, DOI 10.1159/000151727; Maciejewska I, 2009, CELLS TISSUES ORGANS, V189, P186, DOI 10.1159/000151372; Marin-Briggiler CI, 2010, FERTIL STERIL, V93, P1574, DOI 10.1016/j.fertnstert.2008.12.132; Misra UK, 2005, J BIOL CHEM, V280, P26278, DOI 10.1074/jbc.M414467200; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Narayanan K, 2003, J BIOL CHEM, V278, P17500, DOI 10.1074/jbc.M212700200; Narayanan K, 2006, J BIOL CHEM, V281, P19064, DOI 10.1074/jbc.M600714200; Ravindran S, 2004, THROMB HAEMOSTASIS, V92, P1277, DOI 10.1160/TH04-01-0008; Stan RV, 1997, MOL BIOL CELL, V8, P595, DOI 10.1091/mbc.8.4.595; Triantafilou K, 2003, VIROLOGY, V317, P128, DOI 10.1016/j.virol.2003.08.036; Triantafilou K, 2002, J VIROL, V76, P633, DOI 10.1128/JVI.76.2.633-643.2002; Wiest DL, 1997, P NATL ACAD SCI USA, V94, P1884, DOI 10.1073/pnas.94.5.1884; Xiao GQ, 1999, MOL BRAIN RES, V72, P121, DOI 10.1016/S0169-328X(99)00188-6; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200	27	17	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8729	8739		10.1074/jbc.M110.179341	http://dx.doi.org/10.1074/jbc.M110.179341			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21239500	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000288247700004
J	Yang, Y; Yamashita, T; Nakamaru-Ogiso, E; Hashimoto, T; Murai, M; Igarashi, J; Miyoshi, H; Mori, N; Matsuno-Yagi, A; Yagi, T; Kosaka, H				Yang, Yu; Yamashita, Tetsuo; Nakamaru-Ogiso, Eiko; Hashimoto, Takeshi; Murai, Masatoshi; Igarashi, Junsuke; Miyoshi, Hideto; Mori, Nozomu; Matsuno-Yagi, Akemi; Yagi, Takao; Kosaka, Hiroaki			Reaction Mechanism of Single Subunit NADH-Ubiquinone Oxidoreductase (Ndi1) from Saccharomyces cerevisiae EVIDENCE FOR A TERNARY COMPLEX MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; ELECTRON-TRANSFER; QUINONE OXIDOREDUCTASE; LATERAL DIFFUSION; CRYSTAL-STRUCTURE; BOUND UBIQUINONE; DT-DIAPHORASE; CIBACRON BLUE; INHIBITOR; BINDING	The flavoprotein rotenone-insensitive internal NADH-ubiquinone (UQ) oxidoreductase (Ndi1) is a member of the respiratory chain in Saccharomyces cerevisiae. We reported previously that bound UQ in Ndi1 plays a key role in preventing the generation of reactive oxygen species. Here, to elucidate this mechanism, we investigated biochemical properties of Ndi1 and its mutants in which highly conserved amino acid residues (presumably involved in NADH and/or UQ binding sites) were replaced. We found that wild-type Ndi1 formed a stable charge transfer (CT) complex (around 740 nm) with NADH, but not with NADPH, under anaerobic conditions. The intensity of the CT absorption band was significantly increased by the presence of bound UQ or externally added n-decylbenzoquinone. Interestingly, however, when Ndi1 was exposed to air, the CT band transiently reached the same maximum level regardless of the presence of UQ. This suggests that Ndi1 forms a ternary complex with NADH and UQ, but the role of UQ in withdrawing an electron can be substitutable with oxygen. Proteinase K digestion analysis showed that NADH (but not NADPH) binding induces conformational changes in Ndi1. The kinetic study of wild-type and mutant Ndi1 indicated that there is no overlap between NADH and UQ binding sites. Moreover, we found that the bound UQ can reversibly dissociate from Ndi1 and is thus replaceable with other quinones in the membrane. Taken together, unlike other NAD(P)H-UQ oxidoreductases, the Ndi1 reaction proceeds through a ternary complex (not a ping-pong) mechanism. The bound UQ keeps oxygen away from the reduced flavin.	[Yang, Yu; Yamashita, Tetsuo; Hashimoto, Takeshi; Igarashi, Junsuke; Kosaka, Hiroaki] Kagawa Univ, Dept Cardiovasc Physiol, Fac Med, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan; [Mori, Nozomu] Kagawa Univ, Dept Otolaryngol, Fac Med, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan; [Nakamaru-Ogiso, Eiko] Univ Penn, Dept Biochem & Biophys, Sch Med, Philadelphia, PA 19104 USA; [Murai, Masatoshi; Miyoshi, Hideto] Kyoto Univ, Div Appl Life Sci, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan; [Matsuno-Yagi, Akemi; Yagi, Takao] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Yang, Yu] China Med Univ, Fac Basic Med, Dept Physiol, Shenyang 110001, Peoples R China	Kagawa University; Kagawa University; University of Pennsylvania; Kyoto University; Scripps Research Institute; China Medical University	Yamashita, T (corresponding author), Kagawa Univ, Dept Cardiovasc Physiol, Fac Med, 1750-1 Ikenobe, Miki, Kagawa 7610793, Japan.	tyama@med.kagawa-u.ac.jp		Murai, Masatoshi/0000-0001-6601-2854	National Institutes of Health [R01GM033712]; Japan Society for the Promotion of Science [19870016]; Kagawa University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033712] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21590933] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kagawa University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM033712 (to T. Yagi). This work was also supported by Japan Society for the Promotion of Science Grant-in-aid for Young Scientists (Start-up) 19870016 (to T. Yamashita) and by the fund for Kagawa University Young Scientists 2007 (to T. Yamashita).	Asher G, 2006, BIOCHEMISTRY-US, V45, P6372, DOI 10.1021/bi0600087; Birrell JA, 2009, BIOCHEMISTRY-US, V48, P12005, DOI 10.1021/bi901706w; Chen SA, 1999, MOL PHARMACOL, V56, P272, DOI 10.1124/mol.56.2.272; Churbanova IY, 2008, J BIOL CHEM, V283, P5622, DOI 10.1074/jbc.M709147200; Eckenroth BE, 2007, BIOCHEMISTRY-US, V46, P4694, DOI 10.1021/bi602394p; Elias MD, 2004, J BIOL CHEM, V279, P3078, DOI 10.1074/jbc.M310163200; ERNSTER L, 1957, BIOCHIM BIOPHYS ACTA, V26, P408, DOI 10.1016/0006-3002(57)90023-9; Eschemann A, 2005, J BIOL CHEM, V280, P3138, DOI 10.1074/jbc.M411217200; GARTEN S, 1971, BIOCHEM PHARMACOL, V20, P1661, DOI 10.1016/0006-2952(71)90294-2; HOSODA S, 1974, J BIOL CHEM, V249, P6416; King MS, 2009, BIOCHEMISTRY-US, V48, P2053, DOI 10.1021/bi802282h; Kobayashi K, 2005, BIOCHEMISTRY-US, V44, P13567, DOI 10.1021/bi051347n; Kozlov AV, 1998, BIOORG CHEM, V26, P334, DOI 10.1006/bioo.1998.1109; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI RB, 1995, P NATL ACAD SCI USA, V92, P8846, DOI 10.1073/pnas.92.19.8846; Marella M, 2007, J BIOL CHEM, V282, P24146, DOI 10.1074/jbc.M701819200; MASSEY V, 1963, BIOCHEM Z, V338, P474; MATTEVI A, 1992, PROTEINS, V13, P336, DOI 10.1002/prot.340130406; Melo AMP, 2004, MICROBIOL MOL BIOL R, V68, P603, DOI 10.1128/MMBR.68.4.603-616.2004; Mogi T, 1999, FEBS LETT, V457, P61, DOI 10.1016/S0014-5793(99)01007-8; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Murai M, 2010, BIOCHEMISTRY-US, V49, P2973, DOI 10.1021/bi100005j; NONAKA Y, 1986, J BIOCHEM-TOKYO, V99, P803, DOI 10.1093/oxfordjournals.jbchem.a135540; PRESTERA T, 1992, BIOCHEMISTRY-US, V31, P824, DOI 10.1021/bi00118a027; PROCHASKA HJ, 1988, ARCH BIOCHEM BIOPHYS, V267, P529, DOI 10.1016/0003-9861(88)90060-4; Rieske J. S., 1967, METHOD ENZYMOL, V10, P239; SAKURAI T, 1966, BIOCHIM BIOPHYS ACTA, V112, P459, DOI 10.1016/0926-6585(66)90248-2; SCHIRMER RH, 1987, COENZYMES COFACTOR B, V2, P333; Schmid R, 2004, FEBS LETT, V578, P163, DOI 10.1016/j.febslet.2004.10.093; SCHNEIDER H, 1980, J BIOL CHEM, V255, P3748; SCHNEIDER H, 1982, J BIOL CHEM, V257, P789; Seo BB, 2006, FEBS LETT, V580, P6105, DOI 10.1016/j.febslet.2006.10.008; Velazquez I, 2001, ARCH BIOCHEM BIOPHYS, V389, P7, DOI 10.1006/abbi.2001.2293; WILLIAMS CH, 1995, FASEB J, V9, P1267, DOI 10.1096/fasebj.9.13.7557016; Williams Jr C. H., 1992, CHEM BIOCH FLAVOENZY, P121; YAGI T, 1986, ARCH BIOCHEM BIOPHYS, V250, P302, DOI 10.1016/0003-9861(86)90731-9; Yagi T, 2006, REJUV RES, V9, P191, DOI 10.1089/rej.2006.9.191; YAGI T, 2004, RESP ARCHAEA BACTERI, P15; Yamashita T, 2007, J BIOL CHEM, V282, P6012, DOI 10.1074/jbc.M610646200; Yano T, 2006, J BIOL CHEM, V281, P11456, DOI 10.1074/jbc.M508844200	40	19	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9287	9297		10.1074/jbc.M110.175547	http://dx.doi.org/10.1074/jbc.M110.175547			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21220430	hybrid, Green Published			2022-12-27	WOS:000288247700059
J	Sakamoto, K; Bu, GJ; Chen, S; Takei, Y; Hibi, K; Kodera, Y; McCormick, LM; Nakao, A; Noda, M; Muramatsu, T; Kadomatsu, K				Sakamoto, Kazuma; Bu, Guojun; Chen, Sen; Takei, Yoshifumi; Hibi, Kenji; Kodera, Yasuhiro; McCormick, Lynn M.; Nakao, Akimasa; Noda, Masaharu; Muramatsu, Takashi; Kadomatsu, Kenji			Premature Ligand-Receptor Interaction during Biosynthesis Limits the Production of Growth Factor Midkine and Its Receptor LDL Receptor-related Protein 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN-E; ALZHEIMER-DISEASE; DIFFERENTIAL FUNCTIONS; MOLECULAR CHAPERONE; AUTOCRINE SECRETION; ENDOTHELIAL-CELLS; CARCINOMA-CELLS; BETA-PEPTIDE; BINDING	Protein production within the secretory pathway is accomplished by complex but organized processes. Here, we demonstrate that the growth factor midkine interacts with LDL receptor-related protein 1 (LRP1) at high affinity (K-d value, 2.7 nM) not only at the cell surface but also within the secretory pathway during biosynthesis. The latter premature ligand-receptor interaction resulted in aggregate formation and consequently suppressed midkine secretion and LRP1 maturation. We utilized an endoplasmic reticulum (ER) retrieval signal and an LRP1 fragment, which strongly bound to midkine and the LRP1-specialized chaperone receptor-associated protein (RAP), to construct an ER trapper. The ER trapper efficiently trapped midkine and RAP and mimicked the premature ligand-receptor interaction, i.e. suppressed maturation of the ligand and receptor. The ER trapper also diminished the inhibitory function of LRP1 on platelet-derived growth factor-mediated cell migration. Complementary to these results, an increased expression of RAP was closely associated with midkine expression in human colorectal carcinomas (33 of 39 cases examined). Our results suggest that the premature ligand-receptor interaction plays a role in protein production within the secretory pathway.	[Sakamoto, Kazuma; Chen, Sen; Takei, Yoshifumi; Kadomatsu, Kenji] Nagoya Univ, Grad Sch Med, Dept Biochem, Showa Ku, Aichi 4668550, Japan; [Hibi, Kenji; Kodera, Yasuhiro; Nakao, Akimasa] Nagoya Univ, Grad Sch Med, Dept Surg, Showa Ku, Aichi 4668550, Japan; [Bu, Guojun; McCormick, Lynn M.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Bu, Guojun; McCormick, Lynn M.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Noda, Masaharu] Natl Inst Basic Biol, Div Mol Neurobiol, Okazaki, Aichi 4448787, Japan; [Muramatsu, Takashi] Aichi Gakuin Univ, Fac Psychol & Phys Sci, Dept Hlth Sci, Aichi 4800195, Japan	Nagoya University; Nagoya University; Washington University (WUSTL); Washington University (WUSTL); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Aichi Gakuin University	Kadomatsu, K (corresponding author), Nagoya Univ, Grad Sch Med, Dept Biochem, Showa Ku, 65 Tsurumai Cho, Aichi 4668550, Japan.	kkadoma@med.nagoya-u.ac.jp	TAKEI, Yoshifumi/I-7260-2014; Kodera, Yasuhiro/M-4912-2014; Noda, Masaharu/D-7146-2016; Sakamoto, Kazuma/B-7347-2016; Kadomatsu, Kenji/G-8083-2012	Noda, Masaharu/0000-0002-3796-524X; 	National Institutes of Health [R01 AG027924]; Ministry of Education, Culture, Sports, Science and Technology, Japan [20390092]; Ministry of Education, Culture, Sports, Science and Technology, Japan (Nagoya University); NATIONAL INSTITUTE ON AGING [R01AG027924] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology, Japan (Nagoya University)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AG027924 (to G. B.). This work was also supported by Grant-in-aid 20390092 from Ministry of Education, Culture, Sports, Science and Technology, Japan (to K. K.) and by the Global Center of Excellence program from Ministry of Education, Culture, Sports, Science and Technology, Japan (Nagoya University).	BEJCEK BE, 1989, SCIENCE, V245, P1496, DOI 10.1126/science.2551043; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; Chen S, 2007, J CELL SCI, V120, P4009, DOI 10.1242/jcs.013946; Deane R, 2004, NEURON, V43, P333, DOI 10.1016/j.neuron.2004.07.017; Deuel TF, 2002, ARCH BIOCHEM BIOPHYS, V397, P162, DOI 10.1006/abbi.2001.2705; DUNBAR CE, 1989, SCIENCE, V245, P1493, DOI 10.1126/science.2789432; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; HERZ J, 1992, CELL, V71, P411, DOI 10.1016/0092-8674(92)90511-A; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hobo A, 2009, J CLIN INVEST, V119, P1616, DOI 10.1172/JCI37249; Horiba M, 2000, J CLIN INVEST, V105, P489, DOI 10.1172/JCI7208; Ikematsu S, 2000, BRIT J CANCER, V83, P701, DOI 10.1054/bjoc.2000.1339; Ikematsu S, 2003, BRIT J CANCER, V88, P1522, DOI 10.1038/sj.bjc.6600938; KADOMATSU K, 1988, BIOCHEM BIOPH RES CO, V151, P1312, DOI 10.1016/S0006-291X(88)80505-9; Kadomatsu KJ, 2004, CANCER LETT, V204, P127, DOI 10.1016/S0304-3835(03)00450-6; KEATING MT, 1988, SCIENCE, V239, P914, DOI 10.1126/science.2829358; KOJIMA S, 1995, J BIOL CHEM, V270, P9590, DOI 10.1074/jbc.270.16.9590; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Li YH, 2001, J BIOL CHEM, V276, P18000, DOI 10.1074/jbc.M101589200; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Mashour GA, 2001, ONCOGENE, V20, P97, DOI 10.1038/sj.onc.1204026; Muramatsu H, 2000, BIOCHEM BIOPH RES CO, V270, P936, DOI 10.1006/bbrc.2000.2549; NAKAGAWARA A, 1995, CANCER RES, V55, P1792; Obermoeller LM, 1997, J BIOL CHEM, V272, P10761; Obermoeller LM, 1998, J BIOL CHEM, V273, P22374, DOI 10.1074/jbc.273.35.22374; Obermoeller-McCormick LM, 2001, J CELL SCI, V114, P899; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Rauvala H, 2000, MATRIX BIOL, V19, P377, DOI 10.1016/S0945-053X(00)00084-6; REBECK GW, 1993, NEURON, V11, P575; Shibata Y, 2002, MOL CELL BIOL, V22, P6788, DOI 10.1128/MCB.22.19.6788-6796.2002; SPORN MB, 1992, ANN INTERN MED, V117, P408, DOI 10.7326/0003-4819-117-5-408; SPORN MB, 1980, NEW ENGL J MED, V303, P878, DOI 10.1056/NEJM198010093031511; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P8098, DOI 10.1073/pnas.90.17.8098; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Takei Y, 2001, CANCER RES, V61, P8486; Takei Y, 2006, CANCER, V107, P864, DOI 10.1002/cncr.22068; Tamamizu-Kato S, 2008, BIOCHEMISTRY-US, V47, P5225, DOI 10.1021/bi702097s; TOMOMURA M, 1990, J BIOL CHEM, V265, P10765; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; TSUTSUI J, 1993, CANCER RES, V53, P1281; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; WILLNOW TE, 1994, J BIOL CHEM, V269, P15827; YASUHARA O, 1993, BIOCHEM BIOPH RES CO, V192, P246, DOI 10.1006/bbrc.1993.1406; Ye C, 1999, BRIT J CANCER, V79, P179, DOI 10.1038/sj.bjc.6690030	46	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8405	8413		10.1074/jbc.M110.176479	http://dx.doi.org/10.1074/jbc.M110.176479			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21212259	hybrid, Green Published			2022-12-27	WOS:000288013300069
J	Ayalon, G; Hostettler, JD; Hoffman, J; Kizhatil, K; Davis, JQ; Bennett, V				Ayalon, Gai; Hostettler, Janell D.; Hoffman, Jan; Kizhatil, Krishnakumar; Davis, Jonathan Q.; Bennett, Vann			Ankyrin-B Interactions with Spectrin and Dynactin-4 Are Required for Dystrophin-based Protection of Skeletal Muscle from Exercise Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-RELATED PROTEIN; NEONATAL CARDIOMYOCYTES; MUSCULAR-DYSTROPHIES; CYTOPLASMIC DOMAIN; EPITHELIAL-CELLS; F-ACTIN; MEMBRANE; COMPLEX; ARP1; ORGANIZATION	Costameres are cellular sites of mechanotransduction in heart and skeletal muscle where dystrophin and its membrane-spanning partner dystroglycan distribute intracellular contractile forces into the surrounding extracellular matrix. Resolution of a functional costamere interactome is still limited but likely to be critical for understanding forms of muscular dystrophy and cardiomyopathy. Dystrophin binds a set of membrane-associated proteins (the dystrophin-glycoprotein complex) as well as gamma-actin and microtubules and also is required to align sarcolemmal microtubules with costameres. Ankyrin-B binds to dystrophin, dynactin-4, and microtubules and is required for sarcolemmal association of these proteins as well as dystroglycan. We report here that ankyrin-B interactions with beta 2 spectrin and dynactin-4 are required for localization of dystrophin, dystroglycan, and microtubules at costameres as well as protection of muscle from exercise-induced injury. Knockdown of dynactin-4 in adult mouse skeletal muscle phenocopied depletion of ankyrin-B and resulted in loss of sarcolemmal dystrophin, dystroglycan, and microtubules. Moreover, mutations of ankyrin-B and of dynactin-4 that selectively impaired binary interactions between these proteins resulted in loss of their costamere-localizing activity and increased muscle fiber fragility as a result of loss of costamere-associated dystrophin and dystroglycan. In addition, costamere-association of dynactin-4 did not require dystrophin but did depend on beta 2 spectrin and ankyrin-B, whereas costamere association of ankyrin-B required beta 2 spectrin. Together, these results are consistent with a functional hierarchy beginning with beta 2 spectrin recruitment of ankyrin-B to costameres. Ankyrin-B then interacts with dynactin-4 and dystrophin, whereas dynactin-4 collaborates with dystrophin in coordinating costamere-aligned microtubules.	[Ayalon, Gai; Hostettler, Janell D.; Hoffman, Jan; Kizhatil, Krishnakumar; Davis, Jonathan Q.; Bennett, Vann] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Ayalon, Gai; Bennett, Vann] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Bennett, Vann] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Bennett, Vann] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University; Duke University	Bennett, V (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	benne012@mc.duke.edu	Kizhatil, Krish/AAR-5868-2021	Kizhatil, Krishnakumar/0000-0003-3755-6101	Muscular Dystrophy Association	Muscular Dystrophy Association(Muscular Dystrophy Association)	This work was supported in part by a grant from the Muscular Dystrophy Association.	Ayalon G, 2008, CELL, V135, P1189, DOI 10.1016/j.cell.2008.10.018; Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Cohn RD, 2000, MUSCLE NERVE, V23, P1456, DOI 10.1002/1097-4598(200010)23:10<1456::AID-MUS2>3.0.CO;2-T; CRAIG SW, 1983, CELL MOTIL CYTOSKEL, V3, P449, DOI 10.1002/cm.970030513; Dalkilic I, 2003, CURR OPIN GENET DEV, V13, P231, DOI 10.1016/S0959-437X(03)00048-0; DAVIS JQ, 1984, J BIOL CHEM, V259, P3550; DAVIS LH, 1991, J BIOL CHEM, V266, P11163; Eckley DM, 1999, J CELL BIOL, V147, P307, DOI 10.1083/jcb.147.2.307; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Garces JA, 1999, CURR BIOL, V9, P1497, DOI 10.1016/S0960-9822(00)80122-0; Holleran EA, 1996, J CELL BIOL, V135, P1815, DOI 10.1083/jcb.135.6.1815; Ipsaro JJ, 2010, BLOOD, V115, P4093, DOI 10.1182/blood-2009-11-255604; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Karki S, 2000, J BIOL CHEM, V275, P4834, DOI 10.1074/jbc.275.7.4834; Kizhatil K, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M703158200; Kizhatil K, 2007, J BIOL CHEM, V282, P2029, DOI 10.1074/jbc.M608921200; Lorenzo DN, 2010, J CELL BIOL, V189, P143, DOI 10.1083/jcb.200905158; McMahon JM, 2001, GENE THER, V8, P1264, DOI 10.1038/sj.gt.3301522; Mohler PJ, 2004, J BIOL CHEM, V279, P40185, DOI 10.1074/jbc.M406018200; Mohler PJ, 2002, J BIOL CHEM, V277, P10599, DOI 10.1074/jbc.M110958200; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; PARDO JV, 1983, P NATL ACAD SCI-BIOL, V80, P1008, DOI 10.1073/pnas.80.4.1008; Percival JM, 2007, TRAFFIC, V8, P1424, DOI 10.1111/j.1600-0854.2007.00622.x; Prins KW, 2009, J CELL BIOL, V186, P363, DOI 10.1083/jcb.200905048; Rybakova IN, 1996, J CELL BIOL, V135, P661, DOI 10.1083/jcb.135.3.661; SCHAFER DA, 1994, J CELL BIOL, V126, P403, DOI 10.1083/jcb.126.2.403; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Wang R, 2009, MOL CELL, V33, P692, DOI 10.1016/j.molcel.2009.02.016; Zhou DX, 1998, MOL BIOL CELL, V9, P47, DOI 10.1091/mbc.9.1.47	33	35	36	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7370	7378		10.1074/jbc.M110.187831	http://dx.doi.org/10.1074/jbc.M110.187831			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21186323	hybrid, Green Published			2022-12-27	WOS:000287737300053
J	Copsel, S; Garcia, C; Diez, F; Vermeulem, M; Baldi, A; Bianciotti, LG; Russel, FGM; Shayo, C; Davio, C				Copsel, Sabrina; Garcia, Corina; Diez, Federico; Vermeulem, Monica; Baldi, Alberto; Bianciotti, Liliana G.; Russel, Frans G. M.; Shayo, Carina; Davio, Carlos			Multidrug Resistance Protein 4 (MRP4/ABCC4) Regulates cAMP Cellular Levels and Controls Human Leukemia Cell Proliferation and Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-AMP; SIGNALING MOLECULES; MRP4 ABCC4; EFFLUX PUMP; NUCLEOTIDES; EXPRESSION; TRANSPORT; DRUGS; U937; RECEPTORS	Increased intracellular cAMP concentration plays a well established role in leukemic cell maturation. We previously reported that U937 cells stimulated by H2 receptor agonists, despite a robust increase in cAMP, fail to mature because of rapid H2 receptor desensitization and phosphodiesterase (PDE) activation. Here we show that intracellular cAMP levels not only in U937 cells but also in other acute myeloid leukemia cell lines are also regulated by multidrug resistance-associated proteins (MRPs), particularly MRP4. U937, HL-60, and KG-1a cells, exposed to amthamine (H2-receptor agonist), augmented intracellular cAMP concentration with a concomitant increase in the efflux. Extrusion of cAMP was ATP-dependent and probenecid-sensitive, supporting that the transport was MRP-mediated. Cells exposed to amthamine and the PDE4 inhibitor showed enhanced cAMP extrusion, but this response was inhibited by MRP blockade. Amthamine stimulation, combined with PDE4 and MRP inhibition, induced maximal cell arrest proliferation. Knockdown strategy by shRNA revealed that this process was mediated by MRP4. Furthermore, blockade by probenecid or MRP4 knockdown showed that increased intracellular cAMP levels induce maturation in U937 cells. These findings confirm the key role of intracellular cAMP levels in leukemic cell maturation and provide the first evidence that MRP4 may represent a new potential target for leukemia differentiation therapy.	[Copsel, Sabrina; Garcia, Corina; Diez, Federico; Davio, Carlos] Univ Buenos Aires, Lab Farmacol Receptores, Catedra Quim Med, Dept Farmacol,Fac Farm & Bioquim, RA-1113 Buenos Aires, DF, Argentina; [Copsel, Sabrina; Baldi, Alberto; Shayo, Carina] Inst Biol & Med Expt, Lab Patol & Farmacol Mol, RA-1428 Buenos Aires, DF, Argentina; [Copsel, Sabrina; Garcia, Corina; Vermeulem, Monica; Baldi, Alberto; Bianciotti, Liliana G.; Shayo, Carina; Davio, Carlos] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Vermeulem, Monica] Acad Nacl Med Buenos Aires, Dept Inmunol, Inst Invest Hematol, RA-1425 Buenos Aires, DF, Argentina; [Bianciotti, Liliana G.] Univ Buenos Aires, Fac Farm & Bioquim, Catedra Fisiopatol, Dept Ciencias Biol, RA-1113 Buenos Aires, DF, Argentina; [Russel, Frans G. M.] Radboud Univ Nijmegen, Dept Pharmacol & Toxicol, Nijmegen Ctr Mol Life Sci, Med Ctr, NL-6525 HP Nijmegen, Netherlands	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Institute of Biology & Experimental Medicine; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Buenos Aires National Academy of Medicine; IIHEMA - Instituto de Investigaciones Hematologicas; University of Buenos Aires; Radboud University Nijmegen	Davio, C (corresponding author), Junin 956 PP 1113, Buenos Aires, DF, Argentina.	cardavio@ffyb.uba.ar	Copsel, Sabrina/I-2245-2019; Baldi, Alfonso/ABG-2397-2021; Russel, Frans G.M./B-3184-2014	Copsel, Sabrina/0000-0001-5465-9052; Russel, Frans G.M./0000-0002-7959-2314; Bianciotti, Liliana Graciela/0000-0001-5410-4516	Universidad de Buenos Aires [UBACyT B0-50]; Consejo Nacional de Investigaciones Cientificas y Tecnologica [PIP 6110]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 38318, 01725]; National Institutes of Health, NCI [NO2-CO-41101]; Union for International Cancer Control International Cancer Technology; NATIONAL CANCER INSTITUTE [R01CA041101] Funding Source: NIH RePORTER	Universidad de Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnologica; Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Union for International Cancer Control International Cancer Technology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Universidad de Buenos Aires (Grant UBACyT B0-50); Consejo Nacional de Investigaciones Cientificas y Tecnologica (PIP 6110), and Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 38318 and 01725). This work was supported, in whole or in part, by National Institutes of Health Contract NO2-CO-41101 from the NCI (to S. C.), and this work was also supported by a Union for International Cancer Control International Cancer Technology Transfer Fellowship (to S. C.).	Adachi M, 2002, ADV DRUG DELIVER REV, V54, P1333, DOI 10.1016/S0169-409X(02)00166-7; Andric SA, 2006, ENDOCRINOLOGY, V147, P3435, DOI 10.1210/en.2006-0091; Bankir L, 2002, AM J PHYSIOL-RENAL, V282, pF376, DOI 10.1152/ajprenal.00202.2001; Burg M, 1996, J IMMUNOL, V157, P5574; Chen ZS, 2001, J BIOL CHEM, V276, P33747, DOI 10.1074/jbc.M104833200; Chou WC, 2005, BLOOD, V106, P304, DOI 10.1182/blood-2005-01-0241; Conti M, 2003, J BIOL CHEM, V278, P5493, DOI 10.1074/jbc.R200029200; DAVIO CA, 1995, BIOCHEM PHARMACOL, V50, P91, DOI 10.1016/0006-2952(95)00108-C; El-Sheikh AAK, 2007, J PHARMACOL EXP THER, V320, P229, DOI 10.1124/jpet.106.110379; Fernandez N, 2002, MOL PHARMACOL, V62, P1506, DOI 10.1124/mol.62.6.1506; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guo YP, 2009, CLIN CANCER RES, V15, P1762, DOI 10.1158/1078-0432.CCR-08-0442; Guo YP, 2003, J BIOL CHEM, V278, P29509, DOI 10.1074/jbc.M304059200; HENDRIE PC, 1994, INT J IMMUNOPHARMACO, V16, P547, DOI 10.1016/0192-0561(94)90106-6; HONMA Y, 1978, BIOCHEM BIOPH RES CO, V82, P1246, DOI 10.1016/0006-291X(78)90321-2; Jedlitschky G, 2000, J BIOL CHEM, V275, P30069, DOI 10.1074/jbc.M005463200; KARIN M, 1994, CURR OPIN CELL BIOL, V6, P415, DOI 10.1016/0955-0674(94)90035-3; Kobsar A, 2008, STEM CELLS DEV, V17, P81, DOI 10.1089/scd.2007.0060; Lee AW, 1999, BLOOD, V93, P537, DOI 10.1182/blood.V93.2.537.402k30_537_553; Legnazzi BL, 2000, BIOCHEM PHARMACOL, V60, P159, DOI 10.1016/S0006-2952(00)00295-1; Lerner A, 2006, BIOCHEM J, V393, P21, DOI 10.1042/BJ20051368; Lin ZP, 2008, MOL PHARMACOL, V73, P243, DOI 10.1124/mol.107.039594; Monczor F, 2006, BIOCHEM PHARMACOL, V71, P1219, DOI 10.1016/j.bcp.2005.12.037; Negrotto S, 2006, EXP HEMATOL, V34, P1420, DOI 10.1016/j.exphem.2006.05.017; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Oevermann L, 2009, INT J CANCER, V124, P2303, DOI 10.1002/ijc.24207; PINTO A, 1992, P NATL ACAD SCI USA, V89, P8884, DOI 10.1073/pnas.89.19.8884; Ritter CA, 2005, DRUG METAB REV, V37, P253, DOI 10.1081/DMR-200047984; Russel FGM, 2008, TRENDS PHARMACOL SCI, V29, P200, DOI 10.1016/j.tips.2008.01.006; Sager G, 2009, MINI-REV MED CHEM, V9, P1009, DOI 10.2174/138955709788681654; Sassi Y, 2008, J CLIN INVEST, V118, P2747, DOI 10.1172/JCI35067; Sassi Y, 2009, CELL CYCLE, V8, P962; SCAVENNEC J, 1981, CANCER RES, V41, P3222; Shayo C, 1997, MOL PHARMACOL, V51, P983, DOI 10.1124/mol.51.6.983; Shayo C, 2004, BIOCHEM BIOPH RES CO, V314, P798, DOI 10.1016/j.bbrc.2003.12.166; SNYDERMAN R, 1981, SCIENCE, V213, P830, DOI 10.1126/science.6266014; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Van Aubel RAMH, 2005, AM J PHYSIOL-RENAL, V288, pF327, DOI 10.1152/ajprenal.00133.2004; Wielinga PR, 2003, J BIOL CHEM, V278, P17664, DOI 10.1074/jbc.M212723200; Zhou SF, 2008, CURR MED CHEM, V15, P1981, DOI 10.2174/092986708785132870	40	120	129	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6979	6988		10.1074/jbc.M110.166868	http://dx.doi.org/10.1074/jbc.M110.166868			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21205825	Green Published, hybrid			2022-12-27	WOS:000287737300014
J	Hu, D; Wan, Y				Hu, Dong; Wan, Yong			Regulation of Kruppel-like Factor 4 by the Anaphase Promoting Complex Pathway Is Involved in TGF-beta Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; TUMOR-SUPPRESSOR; DNA-DAMAGE; GROWTH-INHIBITION; FACTOR EXPRESSION; UBIQUITIN LIGASE; GENE-EXPRESSION; DOWN-REGULATION; BREAST-CANCER; DEGRADATION	Kruppel-like factor 4 (KLF4), a zinc finger-containing transcriptional factor, regulates a variety of biological processes, including cell proliferation, differentiation, apoptosis, and stem cell reprogramming. Post-translational modifications of KLF4, including phosphorylation, acetylation, and sumoylation, regulate its transcriptional activity. Most recent studies also demonstrate that KLF4 is targeted for ubiquitin-dependent proteolysis during cell cycle progression. However, the underlying mechanism remains largely unknown. In this study, we demonstrated that KLF4 is profoundly degraded in response to TGF-beta signaling. We have identified the Cdh1-anaphase promoting complex as a putative E3 ligase that governs TGF-beta-induced KLF4 degradation. The TGF-beta-induced KLF4 degradation is mediated by the destruction box on the KLF4. Either depletion of Cdh1 by RNA interference or stabilization of KLF4 by disruption of its destruction box significantly attenuates TGF-beta-induced ubiquitylation and degradation. In addition, depletion of Cdh1 or stabilization of KLF4 antagonizes TGF-beta-induced activation of transcription. Determining the role of KLF4 proteolysis in response to TGF-beta signaling has opened a new perspective to understand the TGF-beta signaling pathway.	[Wan, Yong] Univ Pittsburgh, Hillman Canc Ctr, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Univ Pittsburgh Canc Inst, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wan, Y (corresponding author), Univ Pittsburgh, Hillman Canc Ctr, Sch Med, Dept Cell Biol & Physiol, Suite 2-6C,5117 Ctr Ave, Pittsburgh, PA 15213 USA.	yow4@pitt.edu	hu, dong/F-8812-2011		National Institutes of Health [CA115943]; NATIONAL CANCER INSTITUTE [R01CA154695, R01CA115943] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA115943.	ATTISANO L, 1994, BBA-MOL CELL RES, V1222, P71, DOI 10.1016/0167-4889(94)90026-4; Bengoechea-Alonso MT, 2010, ONCOGENE, V29, P5322, DOI 10.1038/onc.2010.278; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Blyth K, 2005, NAT REV CANCER, V5, P376, DOI 10.1038/nrc1607; Chen YG, 2009, CELL, V139, P658, DOI 10.1016/j.cell.2009.10.038; Chen ZY, 2000, FEBS LETT, V477, P67, DOI 10.1016/S0014-5793(00)01764-6; Chen ZY, 2005, CANCER RES, V65, P10394, DOI 10.1158/0008-5472.CAN-05-2059; Chen ZY, 2002, J BIOL CHEM, V277, P46831, DOI 10.1074/jbc.M204816200; Cullingford TE, 2008, BBA-MOL CELL RES, V1783, P1229, DOI 10.1016/j.bbamcr.2008.03.007; Dang DT, 2001, ONCOGENE, V20, P4884, DOI 10.1038/sj.onc.1204645; Datto M, 2005, CELL, V121, P2, DOI 10.1016/j.cell.2005.03.017; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Du JX, 2010, J BIOL CHEM, V285, P28298, DOI 10.1074/jbc.M110.101717; Evans PM, 2008, ACTA BIOCH BIOPH SIN, V40, P554, DOI 10.1111/j.1745-7270.2008.00439.x; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Feinberg MW, 2005, J BIOL CHEM, V280, P38247, DOI 10.1074/jbc.M509378200; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Foster KW, 2000, CANCER RES, V60, P6488; Ghaleb AM, 2007, ONCOGENE, V26, P2365, DOI 10.1038/sj.onc.1210022; Guan HF, 2010, BLOOD, V116, P1469, DOI 10.1182/blood-2009-12-256446; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Hu WX, 2009, CLIN CANCER RES, V15, P5688, DOI 10.1158/1078-0432.CCR-09-0310; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Kawai-Kowase K, 2009, ARTERIOSCL THROM VAS, V29, P99, DOI 10.1161/ATVBAHA.108.172700; King KE, 2003, J BIOL CHEM, V278, P11661, DOI 10.1074/jbc.M211337200; Koinuma D, 2003, EMBO J, V22, P6458, DOI 10.1093/emboj/cdg632; Le Scolan E, 2008, CANCER RES, V68, P3277, DOI 10.1158/0008-5472.CAN-07-6793; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Li HX, 2010, J BIOL CHEM, V285, P17846, DOI 10.1074/jbc.M109.076992; Li LY, 2004, MOL CELL BIOL, V24, P856, DOI 10.1128/MCB.24.2.856-864.2004; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Liu SA, 2008, MOL CANCER RES, V6, P306, DOI 10.1158/1541-7786.MCR-07-0159; Liu WJ, 2007, MOL CELL BIOL, V27, P2967, DOI 10.1128/MCB.01830-06; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Nagano Y, 2007, J BIOL CHEM, V282, P20492, DOI 10.1074/jbc.M701294200; Ohnishi S, 2003, BIOCHEM BIOPH RES CO, V308, P251, DOI 10.1016/S0006-291X(03)01356-1; Pandya AY, 2004, CLIN CANCER RES, V10, P2709, DOI 10.1158/1078-0432.CCR-03-0484; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shie JL, 2000, AM J PHYSIOL-GASTR L, V279, pG806, DOI 10.1152/ajpgi.2000.279.4.G806; Shie JL, 2000, NUCLEIC ACIDS RES, V28, P2969, DOI 10.1093/nar/28.15.2969; Shields JM, 1996, J BIOL CHEM, V271, P20009, DOI 10.1074/jbc.271.33.20009; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Stroschein SL, 2001, GENE DEV, V15, P2822; Sun Y, 1999, P NATL ACAD SCI USA, V96, P12442, DOI 10.1073/pnas.96.22.12442; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tetreault MP, 2010, GASTROENTEROLOGY, V139, P171, DOI 10.1053/j.gastro.2010.03.048; Wan Y, 2001, P NATL ACAD SCI USA, V98, P13066, DOI 10.1073/pnas.231487598; Wan Y, 2001, MOL CELL, V8, P1027, DOI 10.1016/S1097-2765(01)00382-3; Wang N, 2002, WORLD J GASTROENTERO, V8, P966, DOI 10.3748/wjg.v8.i6.966; Wei DY, 2008, CANCER RES, V68, P4631, DOI 10.1158/0008-5472.CAN-07-5953; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Wrighton KH, 2009, CELL RES, V19, P8, DOI 10.1038/cr.2008.327; Wtighton KH, 2008, CELL SIGNAL, V20, P1579, DOI 10.1016/j.cellsig.2008.02.003; Yoon HS, 2004, J BIOL CHEM, V279, P5035, DOI 10.1074/jbc.M307631200; Yoon HS, 2003, J BIOL CHEM, V278, P2101, DOI 10.1074/jbc.M211027200; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhou QB, 2009, CANCER RES, V69, P8284, DOI 10.1158/0008-5472.CAN-09-1345; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	67	41	42	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6890	6901		10.1074/jbc.M110.179952	http://dx.doi.org/10.1074/jbc.M110.179952			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177849	Green Published, hybrid			2022-12-27	WOS:000287737300004
J	Lin, ZH; Jiang, LG; Yuan, C; Jensen, JK; Zhang, X; Luo, ZP; Furie, BC; Furie, B; Andreasen, PA; Huang, MD				Lin, Zhonghui; Jiang, Longguang; Yuan, Cai; Jensen, Jan K.; Zhang, Xu; Luo, Zhipu; Furie, Barbara C.; Furie, Bruce; Andreasen, Peter A.; Huang, Mingdong			Structural Basis for Recognition of Urokinase-type Plasminogen Activator by Plasminogen Activator Inhibitor-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; CRYSTAL-STRUCTURE; REACTIVE-CENTER; TUMOR-MARKERS; SERPIN; COMPLEX; TARGET; POLYMERIZATION; FIBRINOLYSIS; VITRONECTIN	Plasminogen activator inhibitor-1 (PAI-1), together with its physiological target urokinase-type plasminogen activator (uPA), plays a pivotal role in fibrinolysis, cell migration, and tissue remodeling and is currently recognized as being among the most extensively validated biological prognostic factors in several cancer types. PAI-1 specifically and rapidly inhibits uPA and tissue-type PA (tPA). Despite extensive structural/functional studies on these two reactions, the underlying structural mechanism has remained unknown due to the technical difficulties of obtaining the relevant structures. Here, we report a strategy to generate a PAI-1.uPA(S195A) Michaelis complex and present its crystal structure at 2.3-angstrom resolution. In this structure, the PAI-1 reactive center loop serves as a bait to attract uPA onto the top of the PAI-1 molecule. The P4-P3' residues of the reactive center loop interact extensively with the uPA catalytic site, accounting for about two-thirds of the total contact area. Besides the active site, almost all uPA exosite loops, including the 37-, 60-, 97-, 147-, and 217-loops, are involved in the interaction with PAI-1. The uPA 37-loop makes an extensive interaction with PAI-1 beta-sheet B, and the 147-loop directly contacts PAI-1 beta-sheet C. Both loops are important for initial Michaelis complex formation. This study lays down a foundation for understanding the specificity of PAI-1 for uPA and tPA and provides a structural basis for further functional studies.	[Lin, Zhonghui; Jiang, Longguang; Yuan, Cai; Zhang, Xu; Luo, Zhipu; Huang, Mingdong] Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Peoples R China; [Lin, Zhonghui; Jiang, Longguang; Yuan, Cai; Jensen, Jan K.; Zhang, Xu; Luo, Zhipu; Andreasen, Peter A.; Huang, Mingdong] Danish Chinese Ctr Proteases & Canc, Fuzhou 350002, Peoples R China; [Jensen, Jan K.; Andreasen, Peter A.] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Yuan, Cai; Furie, Barbara C.; Furie, Bruce; Huang, Mingdong] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Hemostasis & Thrombosis, Boston, MA 02215 USA	Chinese Academy of Sciences; Fujian Institute of Research on the Structure of Matter, CAS; Aarhus University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Huang, MD (corresponding author), Chinese Acad Sci, Fujian Inst Res Struct Matter, State Key Lab Struct Chem, Fuzhou 350002, Peoples R China.	mhuang@fjirsm.ac.cn	zhang, xu/GYE-3558-2022; Huang, Mingdong/J-4278-2017; zhang, xu/GRX-9733-2022; zhang, xian/GYA-0290-2022; Luo, Zhipu/P-9168-2014; Zhang, xiaoyu/GXA-3206-2022	Huang, Mingdong/0000-0003-0085-9141; Jiang, Longguang/0000-0002-4734-3778	Fujian Institute of Research on the Structure of Matter [SZD08003]; Chinese Academy of Sciences [KSCX2-YW-R-082]; Natural Science Foundation of China [30811130467, 30625011, 30770429]; Ministry of Science of Technology [2007CB914304]	Fujian Institute of Research on the Structure of Matter(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science of Technology	This work was supported by Fujian Institute of Research on the Structure of Matter Grant SZD08003, Chinese Academy of Sciences Grant KSCX2-YW-R-082, Natural Science Foundation of China Grants 30811130467, 30625011, and 30770429, and Ministry of Science of Technology Grant 2007CB914304.	AERTGEERTS K, 1995, NAT STRUCT BIOL, V2, P891, DOI 10.1038/nsb1095-891; Andreasen PA, 1997, INT J CANCER, V72, P1, DOI 10.1002/(SICI)1097-0215(19970703)72:1<1::AID-IJC1>3.0.CO;2-Z; BERKENPAS MB, 1995, EMBO J, V14, P2969, DOI 10.1002/j.1460-2075.1995.tb07299.x; Blasi F, 2002, NAT REV MOL CELL BIO, V3, P932, DOI 10.1038/nrm977; DeLano W.L, PYMOL MOL GRAPHICS S; Devy L, 2002, FASEB J, V16, DOI 10.1096/fj.01-0552com; Dewilde M, 2009, J STRUCT BIOL, V165, P126, DOI 10.1016/j.jsb.2008.11.001; Duffy MJ, 2004, CLIN BIOCHEM, V37, P541, DOI 10.1016/j.clinbiochem.2004.05.013; Duffy MJ, 2002, CLIN CHEM, V48, P1194; DUGGAN C, 1995, INT J CANCER, V61, P597, DOI 10.1002/ijc.2910610502; Egelund R, 2001, J BIOL CHEM, V276, P13077, DOI 10.1074/jbc.M009024200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gutierrez LS, 2000, CANCER RES, V60, P5839; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Ibarra CA, 2004, J BIOL CHEM, V279, P3643, DOI 10.1074/jbc.M310601200; Jensen JK, 2008, PROTEIN SCI, V17, P1844, DOI 10.1110/ps.036707.108; Jensen JK, 2002, FEBS LETT, V521, P91, DOI 10.1016/S0014-5793(02)02830-2; Johnson DJD, 2006, EMBO J, V25, P2029, DOI 10.1038/sj.emboj.7601089; KEIJER J, 1991, BLOOD, V78, P1254; KVASSMAN JO, 1995, J BIOL CHEM, V270, P27942, DOI 10.1074/jbc.270.46.27942; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LEVIN EG, 1987, BLOOD, V70, P1090; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; MADISON EL, 1989, NATURE, V339, P721, DOI 10.1038/339721a0; Mondino A, 2004, TRENDS IMMUNOL, V25, P450, DOI 10.1016/j.it.2004.06.004; MOTTONEN J, 1992, NATURE, V355, P270, DOI 10.1038/355270a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nar H, 2000, J MOL BIOL, V297, P683, DOI 10.1006/jmbi.2000.3604; Nykjaer A, 1997, EMBO J, V16, P2610, DOI 10.1093/emboj/16.10.2610; Olson ST, 2001, BIOCHEMISTRY-US, V40, P11742, DOI 10.1021/bi0107290; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ploug M, 2003, CURR PHARM DESIGN, V9, P1499, DOI 10.2174/1381612033454630; Sharp AM, 1999, STRUCTURE, V7, P111, DOI 10.1016/S0969-2126(99)80018-5; SHERMAN PM, 1992, J BIOL CHEM, V267, P7588; SPRAGGON G, 1995, STRUCTURE, V3, P681, DOI 10.1016/S0969-2126(01)00203-9; Stout TJ, 2000, BIOCHEMISTRY-US, V39, P8460, DOI 10.1021/bi000290w; Ulisse S, 2009, CURR CANCER DRUG TAR, V9, P32, DOI 10.2174/156800909787314002; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Wendt MD, 2004, J MED CHEM, V47, P303, DOI 10.1021/jm0300072; Whisstock JC, 2010, J BIOL CHEM, V285, P24307, DOI 10.1074/jbc.R110.141408; Wind T, 2003, EUR J BIOCHEM, V270, P1680, DOI 10.1046/j.1432-1033.2003.03524.x; Xue YF, 1998, STRUCT FOLD DES, V6, P627, DOI 10.1016/S0969-2126(98)00064-1; Ye S, 2001, NAT STRUCT BIOL, V8, P979, DOI 10.1038/nsb1101-979; Zhao GX, 2007, J STRUCT BIOL, V160, P1, DOI 10.1016/j.jsb.2007.06.003; Zhou A, 2001, J BIOL CHEM, V276, P9115, DOI 10.1074/jbc.M010631200; Zhou AW, 2003, NAT STRUCT BIOL, V10, P541, DOI 10.1038/nsb943	46	51	55	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7027	7032		10.1074/jbc.M110.204537	http://dx.doi.org/10.1074/jbc.M110.204537			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21199867	Green Published, hybrid			2022-12-27	WOS:000287737300019
J	Yuan, F; Xie, Q; Wu, JB; Bai, YJ; Mao, BB; Dong, YL; Bi, WZ; Ji, GJ; Tao, WF; Wang, Y; Yuan, ZQ				Yuan, Fang; Xie, Qi; Wu, Junbing; Bai, Yujie; Mao, Beibei; Dong, Yongli; Bi, Wenzhi; Ji, Guangju; Tao, Wufan; Wang, Yan; Yuan, Zengqiang			MST1 Promotes Apoptosis through Regulating Sirt1-dependent p53 Deacetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STE20-LIKE PROTEIN-KINASE; HISTONE DEACETYLASE; CELL-PROLIFERATION; CALORIE RESTRICTION; STERILE-20 KINASE; PHOSPHORYLATION; ACTIVATION; CASPASE; SIRT1; SURVIVAL	Mammalian Sterile 20-like kinase 1 (MST1) protein kinase plays an important role in the apoptosis induced by a variety of stresses. The MST1 is a serine/threonine kinase that is activated upon apoptotic stimulation, which in turn activates its downstream targets, JNK/p38, histone H2B and FOXO. It has been reported that overexpression of MST1 initiates apoptosis by activating p53. However, the molecular mechanisms underlying MST1-p53 signaling during apoptosis are unclear. Here, we report that MST1 promotes genotoxic agent-induced apoptosis in a p53-dependent manner. We found that MST1 increases p53 acetylation and transactivation by inhibiting the deacetylation of Sirtuin 1 (Sirt1) and its interaction with p53 and that Sirt1 can be phosphorylated by MST1 leading to the inhibition of Sirt1 activity. Collectively, these findings define a novel regulatory mechanism involving the phosphorylation of Sirt1 by MST1 kinase which leads to p53 activation, with implications for our understanding of signaling mechanisms during DNA damage-induced apoptosis.	[Xie, Qi; Wu, Junbing; Bai, Yujie; Mao, Beibei; Yuan, Zengqiang] Chinese Acad Sci, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Xie, Qi; Wu, Junbing; Bai, Yujie; Mao, Beibei; Ji, Guangju; Yuan, Zengqiang] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Yuan, Fang] Third Mil Med Univ, Chongqing 400030, Peoples R China; [Bi, Wenzhi; Wang, Yan] Chinese People Liberty Army Gen Hosp, Dept Orthopaed, Beijing 100853, Peoples R China; [Dong, Yongli; Tao, Wufan] Fudan Univ, Sch Life Sci, Inst Dev Biol & Mol Med, Shanghai 200433, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Biophysics, CAS; Army Medical University; Chinese People's Liberation Army General Hospital; Fudan University	Wang, Y (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Orthopaed, Beijing 100853, Peoples R China.	yanwang301@yahoo.com; zqyuan@ibp.ac.cn	Dong, Yongli/K-1222-2016	Ji, Guangju/0000-0001-8626-3490; Xie, Qi/0000-0002-2370-2078; Yuan, Zengqiang/0000-0001-5739-2867	National Science Foundation of China [30870792, 81030025]; Ministry of Science and Technology of China [973-2009CB918704, 2006CB910903]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the National Science Foundation of China Grants 30870792 and 81030025 and the Ministry of Science and Technology of China Grants 973-2009CB918704 and 2006CB910903.	Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016; Alcendor RR, 2004, CIRC RES, V95, P971, DOI 10.1161/01.RES.0000147557.75257.ff; Bi WZ, 2010, J BIOL CHEM, V285, P6259, DOI 10.1074/jbc.M109.038570; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cheung WL, 2003, CELL, V113, P507, DOI 10.1016/S0092-8674(03)00355-6; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Creasy CL, 1996, J BIOL CHEM, V271, P21049, DOI 10.1074/jbc.271.35.21049; Glantschnig H, 2002, J BIOL CHEM, V277, P42987, DOI 10.1074/jbc.M208538200; GOLLIEB S, 1989, CELL, V56, P771; Graves JD, 2001, J BIOL CHEM, V276, P14909, DOI 10.1074/jbc.M010905200; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Huang CS, 1999, J BIOL CHEM, V274, P12229, DOI 10.1074/jbc.274.18.12229; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Lee KK, 1998, ONCOGENE, V16, P3029, DOI 10.1038/sj.onc.1201840; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lin YS, 2002, J BIOL CHEM, V277, P47991, DOI 10.1074/jbc.M202630200; Luo JY, 2000, NATURE, V408, P377, DOI 10.1038/35042612; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Matsushita N, 2005, GENES CELLS, V10, P321, DOI 10.1111/j.1365-2443.2005.00836.x; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Radhakrishnan SK, 2006, CELL CYCLE, V5, P519, DOI 10.4161/cc.5.5.2514; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Taylor LK, 1996, P NATL ACAD SCI USA, V93, P10099, DOI 10.1073/pnas.93.19.10099; Ura S, 2001, GENES CELLS, V6, P519, DOI 10.1046/j.1365-2443.2001.00439.x; Ura S, 2007, MOL CELL BIOL, V27, P5514, DOI 10.1128/MCB.00199-07; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; Yamaguchi H, 2009, J BIOL CHEM, V284, P11171, DOI 10.1074/jbc.M809268200; Yuan ZQ, 2010, J BIOL CHEM, V285, P3815, DOI 10.1074/jbc.M109.059675; Yuan ZQ, 2009, J BIOL CHEM, V284, P11285, DOI 10.1074/jbc.M900461200; Zhao Y, 2006, MOL CELL BIOL, V26, P2782, DOI 10.1128/MCB.26.7.2782-2790.2006; Zschoernig B, 2009, BIOCHEM BIOPH RES CO, V381, P372, DOI 10.1016/j.bbrc.2009.02.085	41	64	68	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					6940	6945		10.1074/jbc.M110.182543	http://dx.doi.org/10.1074/jbc.M110.182543			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21212262	hybrid, Green Published			2022-12-27	WOS:000287737300009
J	Garcia, MT; Blazquez, MA; Ferrandiz, MJ; Sanz, MJ; Silva-Martin, N; Hermoso, JA; de la Campa, AG				Teresa Garcia, Maria; Amparo Blazquez, Maria; Jose Ferrandiz, Maria; Jesus Sanz, Maria; Silva-Martin, Noella; Hermoso, Juan A.; de la Campa, Adela G.			New Alkaloid Antibiotics That Target the DNA Topoisomerase I of Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL FRAGMENT; PROTEIN; FLUOROQUINOLONES; CRYSTALLOGRAPHY; RESISTANCE; GENOME	Streptococcus pneumoniae has two type II DNA-topoisomerases (DNA-gyrase and DNA topoisomerase IV) and a single type I enzyme (DNA-topoisomerase I, TopA), as demonstrated here. Although fluoroquinolones target type II enzymes, antibiotics efficiently targeting TopA have not yet been reported. Eighteen alkaloids (seven aporphine and 11 phenanthrenes) were semisynthesized from boldine and used to test inhibition both of TopA activity and of cell growth. Two phenanthrenes (seconeolitsine and N-methyl-seconeolitsine) effectively inhibited both TopA activity and cell growth at equivalent concentrations (similar to 17 mu M). Evidence for in vivo TopA targeting by seconeolitsine was provided by the protection of growth inhibition in a S. pneumoniae culture in which the enzyme was overproduced. Additionally, hypernegative supercoiling was observed in an internal plasmid after drug treatment. Furthermore, a model of pneumococcal TopA was made based on the crystal structure of Escherichia coli TopA. Docking calculations indicated strong interactions of the alkaloids with the nucleotide-binding site in the closed protein conformation, which correlated with their inhibitory effect. Finally, although seconeolitsine and N-methyl-seconeolitsine inhibited TopA and bacterial growth, they did not affect human cell viability. Therefore, these new alkaloids can be envisaged as new therapeutic candidates for the treatment of S. pneumoniae infections resistant to other antibiotics.	[de la Campa, Adela G.] Inst Salud Carlos III, Unidad Genet Bacteriana, Ctr Nacl Microbiol, Madrid 28220, Spain; [de la Campa, Adela G.] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid 28220, Spain; [Amparo Blazquez, Maria; Jesus Sanz, Maria] Univ Valencia, Fac Farm, Dept Farmacol, Valencia 46100, Spain; [Silva-Martin, Noella; Hermoso, Juan A.] CSIC, Inst Quim Fis Rocasolano, Grp Cristalog Macromol & Biol Estructural, E-28006 Madrid, Spain	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	de la Campa, AG (corresponding author), Carretera & Pozuelo Km 2, Madrid 28220, Spain.	agcampa@isciii.es	Ferrandiz, Maria-Jose/K-2820-2014; de la Campa, Adela G/K-1654-2014; Hermoso, Juan/J-3433-2012	Ferrandiz, Maria-Jose/0000-0003-1428-9506; de la Campa, Adela G/0000-0002-3598-2548; Hermoso, Juan/0000-0002-1862-8950; Sanz, Maria Jesus/0000-0002-8885-294X; Blazquez, M. Amparo/0000-0001-7673-9328	Comunidad de Madrid [CM-BIO0260-2006, COMBACT]; Spanish Ministry of Science and Innovation [BIO2008-02154, BFU2008-01711, SAF2008-03477]; Spanish Ministry of Health, Carlos III Health Institute [RIER, RD08/0075/0016]	Comunidad de Madrid(Comunidad de Madrid); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Health, Carlos III Health Institute	The work was supported by Comunidad de Madrid Grant CM-BIO0260-2006, COMBACT (to J. H. and A. G. C.); Spanish Ministry of Science and Innovation Grants BIO2008-02154 (to A. G. C.), BFU2008-01711 (to J. A. H.), and SAF2008-03477 (to M. J. S.); and Spanish Ministry of Health, Carlos III Health Institute Grants RIER, RD08/0075/0016 (to M. J. S.).	Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caron P R, 1994, Adv Pharmacol, V29B, P271; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Cheng BK, 2007, J ANTIMICROB CHEMOTH, V59, P640, DOI 10.1093/jac/dkl556; de la Campa AG, 2009, EMERG INFECT DIS, V15, P905, DOI 10.3201/eid1506.080684; DEPEW RE, 1975, P NATL ACAD SCI USA, V72, P4275, DOI 10.1073/pnas.72.11.4275; Drlica K, 2008, ANTIMICROB AGENTS CH, V52, P385, DOI 10.1128/AAC.01617-06; Feinberg H, 1999, NAT STRUCT BIOL, V6, P918; Fernandez-Moreira E, 2000, MICROB DRUG RESIST, V6, P259, DOI 10.1089/mdr.2000.6.259; Ferrandiz MJ, 2010, NUCLEIC ACIDS RES, V38, P3570, DOI 10.1093/nar/gkq106; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Jacobs MR, 2003, J ANTIMICROB CHEMOTH, V52, P229, DOI 10.1093/jac/dkg321; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KELLER W, 1975, P NATL ACAD SCI USA, V72, P2550, DOI 10.1073/pnas.72.7.2550; LACKS SA, 1986, J MOL BIOL, V192, P753, DOI 10.1016/0022-2836(86)90026-4; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LIMA CD, 1994, NATURE, V367, P138, DOI 10.1038/367138a0; Macrae CF, 2008, J APPL CRYSTALLOGR, V41, P466, DOI 10.1107/S0021889807067908; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Martin MC, 2001, J BIOL CHEM, V276, P45041, DOI 10.1074/jbc.M105197200; Martin-Parras L, 1998, NUCLEIC ACIDS RES, V26, P3424, DOI 10.1093/nar/26.14.3424; Mateo T, 2007, BLOOD, V110, P1895, DOI 10.1182/blood-2007-01-070607; Milian L, 2004, CHEM PHARM BULL, V52, P696, DOI 10.1248/cpb.52.696; Munoz R, 1996, ANTIMICROB AGENTS CH, V40, P2252, DOI 10.1128/AAC.40.10.2252; National Committee for Clinical Laboratory Standards, 2004, M100S14 NAT COMM CLI; Nieto C, 2000, PLASMID, V43, P205, DOI 10.1006/plas.2000.1465; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SHARMA A, 1994, STRUCTURE, V2, P767, DOI 10.1016/S0969-2126(94)00077-8; Stupina VA, 2005, J BIOL CHEM, V280, P355, DOI 10.1074/jbc.M411924200; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; World Health Organization, 2007, WKLY EPIDEMIOL REC, V82, P93; YU LP, 1995, BIOCHEMISTRY-US, V34, P7622, DOI 10.1021/bi00023a008	33	38	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6402	6413		10.1074/jbc.M110.148148	http://dx.doi.org/10.1074/jbc.M110.148148			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21169356	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000287476400051
J	Encarnacao, M; Kollmann, K; Trusch, M; Braulke, T; Pohl, S				Encarnacao, Marisa; Kollmann, Katrin; Trusch, Maria; Braulke, Thomas; Pohl, Sandra			Post-translational Modifications of the gamma-Subunit Affect Intracellular Trafficking and Complex Assembly of GlcNAc-1-phosphotransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UDP-N-ACETYLGLUCOSAMINE; LYSOSOMAL-ENZYMES; ENDOPLASMIC-RETICULUM; WEB SERVER; III GAMMA; N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE	GlcNAc-1-phosphotransferase plays a key role in the generation of mannose 6-phosphate, a recognition marker essential for efficient transport of lysosomal hydrolases to lysosomes. The enzyme complex is composed of six subunits (alpha(2)beta(2)gamma(2)). The alpha-and beta-subunits are catalytically active, whereas the function of the gamma-subunit is still unclear. We have investigated structural properties, localization, and intracellular transport of the human and mouse gamma-subunits and the molecular requirements for the assembly of the phosphotransferase complex. The results showed that endogenous and overexpressed gamma-subunits were localized in the cis-Golgi apparatus. Secreted forms of gamma-subunits were detectable in media of cultured cells as well as in human serum. The gamma-subunit contains two in vivo used N-glycosylation sites at positions 88 and 115, equipped with high mannose-type oligosaccharides. S-35 pulse-chase experiments and size exclusion chromatography revealed that the majority of non-glycosylated gamma-subunit mutants were integrated in high molecular mass complexes, failed to exit the endoplasmic reticulum (ER), and were rapidly degraded. The substitution of cysteine 245 involved in dimerization of gamma-subunits impaired neither ER exit nor trafficking through the secretory pathway. Monomeric gamma-subunits failed, however, to associate with other GlcNAc-1-phosphotransferase subunits. The data provide evidence that assembly of the GlcNAc-1-phosphotransferase complex takes place in the ER and requires dimerization of the gamma-subunits.	[Encarnacao, Marisa; Kollmann, Katrin; Braulke, Thomas; Pohl, Sandra] Univ Med Ctr Hamburg Eppendorf, Dept Biochem, Childrens Hosp, D-20246 Hamburg, Germany; [Trusch, Maria] Univ Med Ctr Hamburg Eppendorf, Dept Clin Chem, D-20246 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Pohl, S (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Biochem, Childrens Hosp, Bldg N27,Martinistr 52, D-20246 Hamburg, Germany.	s.pohl@uke.uni-hamburg.de	Pohl, Sandra/AAF-1943-2020; Braulke, Thomas/AAV-9121-2020; Encarnação, Marisa/P-4261-2016; Encarnação, Marisa/AAY-4609-2020; Riedner, Maria/W-5546-2019	Braulke, Thomas/0000-0002-2336-8532; Encarnação, Marisa/0000-0002-3726-2851; Pohl, Sandra/0000-0001-7409-7042	Deutsche Forschungsgemeinschaft [GRK1459, FOR885, SFB877]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by Deutsche Forschungsgemeinschaft Grants GRK1459, FOR885, and SFB877.	Bao M, 1996, J BIOL CHEM, V271, P31437, DOI 10.1074/jbc.271.49.31437; BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; Braulke T, 2008, J INHERIT METAB DIS, V31, P253, DOI 10.1007/s10545-008-0862-5; Braulke T, 2009, BBA-MOL CELL RES, V1793, P605, DOI 10.1016/j.bbamcr.2008.10.016; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ferre F, 2005, NUCLEIC ACIDS RES, V33, pW230, DOI 10.1093/nar/gki412; HASILIK A, 1980, J BIOL CHEM, V255, P4937; Hogan B, 1986, MANIPULATING MOUSE E, P89; Kornfeld S., 2001, METABOLIC MOL BASES, P3421; Kudo M, 2006, J BIOL CHEM, V281, P11761, DOI 10.1074/jbc.M513717200; Lee WS, 2007, J BIOL CHEM, V282, P27198, DOI 10.1074/jbc.M704067200; Lippi M, 2008, BIOINFORMATICS, V24, P2094, DOI 10.1093/bioinformatics/btn371; Pohl S, 2010, J BIOL CHEM, V285, P23936, DOI 10.1074/jbc.M110.129684; Pohl S, 2010, AM J MED GENET A, V152A, P124, DOI 10.1002/ajmg.a.33170; Pohl S, 2009, BBA-MOL BASIS DIS, V1792, P221, DOI 10.1016/j.bbadis.2009.01.009; Qian Y, 2010, J BIOL CHEM, V285, P3360, DOI 10.1074/jbc.M109.068650; Raas-Rothschild A, 2000, J CLIN INVEST, V105, P673, DOI 10.1172/JCI5826; REITMAN ML, 1981, J BIOL CHEM, V256, P4275; Tiede S, 2005, NAT MED, V11, P1109, DOI 10.1038/nm1305; Tiede S, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9443; Tiede Stephan, 2004, Hum Mutat, V24, P535, DOI 10.1002/humu.9293; WAHEED A, 1981, J BIOL CHEM, V256, P4150; Wang N, 2005, MOL BIOL CELL, V16, P3740, DOI 10.1091/mbc.E05-05-0381	23	13	15	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5311	5318		10.1074/jbc.M110.202382	http://dx.doi.org/10.1074/jbc.M110.202382			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21173149	hybrid, Green Published			2022-12-27	WOS:000287230600039
J	Moreno, E; Hoffmann, H; Gonzalez-Sepulveda, M; Navarro, G; Casado, V; Cortes, A; Mallol, J; Vignes, M; McCormick, PJ; Canela, EI; Lluis, C; Moratalla, R; Ferre, S; Ortiz, J; Franco, R				Moreno, Estefana; Hoffmann, Hanne; Gonzalez-Sepulveda, Marta; Navarro, Gemma; Casado, Vicent; Cortes, Antoni; Mallol, Josefa; Vignes, Michel; McCormick, Peter J.; Canela, Enric I.; Lluis, Carme; Moratalla, Rosario; Ferre, Sergi; Ortiz, Jordi; Franco, Rafael			Dopamine D-1-histamine H-3 Receptor Heteromers Provide a Selective Link to MAPK Signaling in GABAergic Neurons of the Direct Striatal Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIUM SPINY NEURONS; HISTAMINE H-3; RAT-BRAIN; INHIBITION; AGONIST; D-1; H3; NEUROTRANSMITTER; PHARMACOLOGY; HALOPERIDOL	Previously, using artificial cell systems, we identified receptor heteromers between the dopamine D-1 or D-2 receptors and the histamine H-3 receptor. In addition, we demonstrated two biochemical characteristics of the dopamine D-1 receptor-histamine H-3 receptor heteromer. We have now extended this work to show the dopamine D-1 receptor-histamine H-3 receptor heteromer exists in the brain and serves to provide a novel link between the MAPK pathway and the GABAergic neurons in the direct striatal efferent pathway. Using the biochemical characteristics identified previously, we found that the ability of H-3 receptor activation to stimulate p44 and p42 extracellular signal-regulated MAPK (ERK 1/2) phosphorylation was only observed in striatal slices of mice expressing D-1 receptors but not in D-1 receptor-deficient mice. On the other hand, the ability of both D-1 and H-3 receptor antagonists to block MAPK activation induced by either D-1 or H-3 receptor agonists was also found in striatal slices. Taken together, these data indicate the occurrence of D-1-H-3 receptor complexes in the striatum and, more importantly, that H-3 receptor agonist-induced ERK 1/2 phosphorylation in striatal slices is mediated by D-1-H-3 receptor heteromers. Moreover, H-3 receptor-mediated phospho-ERK 1/2 labeling co-distributed with D-1 receptor-containing but not with D-2 receptor-containing striatal neurons. These results indicate that D-1-H-3 receptor heteromers work as processors integrating dopamine-and histamine-related signals involved in controlling the function of striatal neurons of the direct striatal pathway.	[Franco, Rafael] Univ Navarra, Ctr Invest Med Aplicada, Pamplona 31008, Spain; [Moreno, Estefana; Navarro, Gemma; Casado, Vicent; Cortes, Antoni; Mallol, Josefa; McCormick, Peter J.; Canela, Enric I.; Lluis, Carme; Franco, Rafael] Univ Barcelona, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Fac Biol, E-08028 Barcelona, Spain; [Moreno, Estefana; Navarro, Gemma; Casado, Vicent; Cortes, Antoni; Mallol, Josefa; McCormick, Peter J.; Canela, Enric I.; Lluis, Carme; Franco, Rafael] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; [Hoffmann, Hanne; Gonzalez-Sepulveda, Marta; Ortiz, Jordi] Univ Autonoma Barcelona, Fac Med, Inst Neurosci, Bellaterra 08193, Spain; [Hoffmann, Hanne; Gonzalez-Sepulveda, Marta; Ortiz, Jordi] Univ Autonoma Barcelona, Fac Med, Dept Biochem & Mol Biol, Bellaterra 08193, Spain; [Vignes, Michel] Univ Montpellier 2, Univ Montpellier 1&2, Max Mousseron Biomol Inst, CNRS,UMR 5247, F-34095 Montpellier, France; [Ferre, Sergi] Natl Inst Drug Abuse, Intramural Res Program, NIH, Dept Hlth & Human Serv, Baltimore, MD 21224 USA; [Moratalla, Rosario] CSIC, Inst Cajal, E-28002 Madrid, Spain	University of Navarra; CIBERNED; University of Barcelona; University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Franco, R (corresponding author), Univ Navarra, Ctr Invest Med Aplicada, Pio 12,5, I-31008 Pamplona, Italy.	rfranco@unav.es	Casadó, Vicent/K-1660-2014; Ortiz, Jordi/E-9018-2011; Guillén, Estefanía Moreno/ABE-4371-2020; Ferre, Sergi/K-6115-2014; Vignes, Michel/AAA-7693-2019; Canela, Enric I./M-8726-2013; Moratalla, Rosario V/H-9280-2015; Mallol, Josefa/I-4194-2015; Hoffmann, Hanne/W-6557-2019; Navarro, Gemma/AAO-7866-2021; McCormick, Peter/E-7387-2012; Franco, Rafael/C-3694-2015	Casadó, Vicent/0000-0002-1764-3825; Ortiz, Jordi/0000-0002-9748-2290; Ferre, Sergi/0000-0002-1747-1779; Vignes, Michel/0000-0003-0969-2966; Canela, Enric I./0000-0003-4992-7440; Moratalla, Rosario V/0000-0002-7623-8010; Mallol, Josefa/0000-0002-2479-4162; Navarro, Gemma/0000-0003-4654-0873; McCormick, Peter/0000-0002-2225-5181; Franco, Rafael/0000-0003-2549-4919; Gonzalez Sepulveda, Marta/0000-0002-5627-847X; Hoffmann, Hanne Mette/0000-0003-1555-1369; Moreno, Estefania/0000-0002-2491-5753	Spanish Ministerio de Ciencia y Tecnologia [SAF2008-00146, SAF2008-03229-E, SAF2009-07276, SAF2006-08240, SAF2009-12510]; Centre National de la Recherche Scintifique; French Ministry of Research and Higher Education; Red de Transtornos Adictivos [RD06/0001/0015]; Fundacio La Marato de TV3 [060110]; National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000493] Funding Source: NIH RePORTER	Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Centre National de la Recherche Scintifique; French Ministry of Research and Higher Education; Red de Transtornos Adictivos; Fundacio La Marato de TV3; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by Grants SAF2008-00146, SAF2008-03229-E, SAF2009-07276, SAF2006-08240, and SAF2009-12510 from the Spanish Ministerio de Ciencia y Tecnologia, the Centre National de la Recherche Scintifique, the French Ministry of Research and Higher Education, Red de Transtornos Adictivos RD06/0001/0015, Grant 060110 from Fundacio La Marato de TV3 and the Intramural Funds of the National Institute on Drug Abuse.	Albin Roger L., 1995, Trends in Neurosciences, V18, P63, DOI 10.1016/0166-2236(95)93872-U; Arias-Montano JA, 2001, BRIT J PHARMACOL, V133, P165, DOI 10.1038/sj.bjp.0704053; ARRANG JM, 1983, NATURE, V302, P832, DOI 10.1038/302832a0; Casado V, 2009, PHARMACOL THERAPEUT, V124, P248, DOI 10.1016/j.pharmthera.2009.07.005; Ellis J, 2006, J BIOL CHEM, V281, P38812, DOI 10.1074/jbc.M602494200; Ferrada C, 2008, NEUROPHARMACOLOGY, V55, P190, DOI 10.1016/j.neuropharm.2008.05.008; Ferrada C, 2009, BRIT J PHARMACOL, V157, P64, DOI 10.1111/j.1476-5381.2009.00152.x; Ferre S, 2007, TRENDS NEUROSCI, V30, P440, DOI 10.1016/j.tins.2007.07.001; Ferre S, 2009, NAT CHEM BIOL, V5, P131, DOI 10.1038/nchembio0309-131; Franco R, 2008, BRIT J PHARMACOL, V153, pS90, DOI 10.1038/sj.bjp.0707571; Franco R, 2009, BRIT J PHARMACOL, V158, P23, DOI 10.1111/j.1476-5381.2009.00181.x; Garcia-Ramirez M, 2004, BEHAV BRAIN RES, V154, P409, DOI 10.1016/j.bbr.2004.03.007; Gerfen C. R., 2004, RAT NERVOUS SYSTEM, P445; Hamill TG, 2009, SYNAPSE, V63, P1122, DOI 10.1002/syn.20689; Hasbi A, 2010, CURR OPIN PHARMACOL, V10, P93, DOI 10.1016/j.coph.2009.09.011; Hasbi A, 2009, P NATL ACAD SCI USA, V106, P21377, DOI 10.1073/pnas.0903676106; Hussain N, 2002, NEUROSCIENCE, V112, P427, DOI 10.1016/S0306-4522(02)00069-6; Leurs R, 2005, NAT REV DRUG DISCOV, V4, P107, DOI 10.1038/nrd1631; Milligan G, 2005, FEBS J, V272, P2914, DOI 10.1111/j.1742-4658.2005.04731.x; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Moreno-Delgado D, 2006, NEUROPHARMACOLOGY, V51, P517, DOI 10.1016/j.neuropharm.2006.04.010; Narushima M, 2006, EUR J NEUROSCI, V24, P2246, DOI 10.1111/j.1460-9568.2006.05119.x; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pillot C, 2002, NEUROSCIENCE, V114, P173, DOI 10.1016/S0306-4522(02)00135-5; Pillot C, 2002, J NEUROSCI, V22, P7272; Rashid AJ, 2007, P NATL ACAD SCI USA, V104, P654, DOI 10.1073/pnas.0604049104; RYU JH, 1994, NEUROREPORT, V5, P621, DOI 10.1097/00001756-199401000-00022; Sanchez-Lemus E, 2004, NEUROSCI LETT, V364, P179, DOI 10.1016/j.neulet.2004.04.045; Santini E, 2009, J NEUROCHEM, V108, P621, DOI 10.1111/j.1471-4159.2008.05831.x; Thomas GM, 2004, NAT REV NEUROSCI, V5, P173, DOI 10.1038/nrn1346; Torrent A, 2005, MOL PHARMACOL, V67, P195, DOI 10.1124/mol.104.005652; XU M, 1994, CELL, V79, P729, DOI 10.1016/0092-8674(94)90557-6	32	95	96	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5846	5854		10.1074/jbc.M110.161489	http://dx.doi.org/10.1074/jbc.M110.161489			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21173143	Green Published, hybrid			2022-12-27	WOS:000287230600093
J	Chen, X; Tomkinson, AE				Chen, Xi; Tomkinson, Alan E.			Yeast Nej1 Is a Key Participant in the Initial End Binding and Final Ligation Steps of Nonhomologous End Joining	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAK; DNA-LIGASE-IV; DEPENDENT PROTEIN-KINASE; HUMAN XLF; CATALYTIC SUBUNIT; CRYSTAL-STRUCTURE; COMPLEX; REPAIR; XRCC4; DNL4-LIF1	In Saccharomyces cerevisiae, the key components of the nonhomologous end joining (NHEJ) pathway that repairs DNA double-strand breaks (DSBs) are yeast Ku (yKu), Mre11-Rad50-Xrs2, Dnl4-Lif1, and Nej1. Here, we examined the role of Nej1 in NHEJ by a combination of molecular genetic and biochemical approaches. As expected, the recruitment of Nej1 to in vivo DSBs is dependent upon yKu. Surprisingly, Nej1 is required for the stable binding of yKu to in vivo DSBs, in addition to Dnl4-Lif1. Thus, Nej1 and Dnl4-Lif1 are independently recruited by yKu to in vivo DSBs, forming a stable ternary complex that channels DSBs into the NHEJ pathway. In accord with these results, purified Nej1 interacts with yKu and preferentially binds to DNA ends bound by yKu. Furthermore, the binding of a mixture of Nej1 and Dnl4-Lif1 to DNA ends bound by yKu is greater than the sum of the binding of the individual proteins, indicating that pairwise interactions among yKu, Nej1, and Dnl4-Lif1 contribute to complex assembly at DNA ends. Nej1 stimulates intermolecular ligation by Dnl4-Lif1, but, more interestingly, the addition of Nej1 results in more than one intermolecular ligation per Dnl4 molecule. Thus, Nej1 not only plays an important role in determining repair pathway choice by participating in the initial NHEJ complex formed at DSBs but also contributes to the reactivation of Dnl4-Lif1 after repair is complete, thereby increasing the capacity of the NHEJ repair pathway.	[Tomkinson, Alan E.] Univ Maryland, Sch Med, Dept Radiat Oncol, Radiat Oncol Res Lab, Baltimore, MD 21201 USA; Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Tomkinson, AE (corresponding author), Univ Maryland, Sch Med, Dept Radiat Oncol, Radiat Oncol Res Lab, 655 W Baltimore St,BRB 7-025, Baltimore, MD 21201 USA.	atomkinson@som.umaryland.edu			National Institutes of Health Grant [GM47251]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R29GM047251, R01GM047251] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM47251 (to A. E. T.).	Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Andres SN, 2007, MOL CELL, V28, P1093, DOI 10.1016/j.molcel.2007.10.024; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Carter SD, 2009, P NATL ACAD SCI USA, V106, P12037, DOI 10.1073/pnas.0903869106; Chan DW, 2002, GENE DEV, V16, P2333, DOI 10.1101/gad.1015202; Chen L, 2001, MOL CELL, V8, P1105, DOI 10.1016/S1097-2765(01)00388-4; Chen X, 2006, METHOD ENZYMOL, V409, P39, DOI 10.1016/S0076-6879(05)09003-8; Chen X, 2009, DNA REPAIR, V8, P961, DOI 10.1016/j.dnarep.2009.06.002; Clikeman JA, 2001, GENETICS, V157, P579; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; DeFazio LG, 2002, EMBO J, V21, P3192, DOI 10.1093/emboj/cdf299; Deshpande RA, 2007, DNA REPAIR, V6, P1507, DOI 10.1016/j.dnarep.2007.04.014; Dore AS, 2006, DNA REPAIR, V5, P362, DOI 10.1016/j.dnarep.2005.11.004; Dynan WS, 1998, NUCLEIC ACIDS RES, V26, P1551, DOI 10.1093/nar/26.7.1551; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Frank-Vaillant M, 2001, GENE DEV, V15, P3005, DOI 10.1101/gad.206801; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Grawunder U, 1997, NATURE, V388, P492, DOI 10.1038/41358; Gu JF, 2007, EMBO J, V26, P1010, DOI 10.1038/sj.emboj.7601559; Hefferin ML, 2005, DNA REPAIR, V4, P639, DOI 10.1016/j.dnarep.2004.12.005; Hentges P, 2006, J BIOL CHEM, V281, P37517, DOI 10.1074/jbc.M608727200; Herrmann G, 1998, EMBO J, V17, P4188, DOI 10.1093/emboj/17.14.4188; Huang Y, 2009, J EXP MED, V206, P893, DOI 10.1084/jem.20082396; Kegel A, 2001, CURR BIOL, V11, P1611, DOI 10.1016/S0960-9822(01)00488-2; Lee K, 2007, GENETICS, V176, P2003, DOI 10.1534/genetics.107.076539; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Li Y, 2008, EMBO J, V27, P290, DOI 10.1038/sj.emboj.7601942; Lu HH, 2007, J BIOL CHEM, V282, P11155, DOI 10.1074/jbc.M609904200; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; Miller CA, 1998, NUCLEIC ACIDS RES, V26, P3577, DOI 10.1093/nar/26.15.3577; Modesti M, 2003, J MOL BIOL, V334, P215, DOI 10.1016/j.jmb.2003.09.031; Ooi SL, 2001, SCIENCE, V294, P2552, DOI 10.1126/science.1065672; Palmbos PL, 2008, GENETICS, V180, P1809, DOI 10.1534/genetics.108.095539; Palmbos PL, 2005, MOL CELL BIOL, V25, P10782, DOI 10.1128/MCB.25.24.10782-10790.2005; Riballo E, 2001, J BIOL CHEM, V276, P31124, DOI 10.1074/jbc.M103866200; Riballo E, 2009, NUCLEIC ACIDS RES, V37, P482, DOI 10.1093/nar/gkn957; Robins P, 1996, J BIOL CHEM, V271, P24257, DOI 10.1074/jbc.271.39.24257; Schar P, 1997, GENE DEV, V11, P1912, DOI 10.1101/gad.11.15.1912; Teo SH, 1997, EMBO J, V16, P4788, DOI 10.1093/emboj/16.15.4788; Teo SH, 2000, CURR BIOL, V10, P165, DOI 10.1016/S0960-9822(00)00317-1; Tsai CJ, 2007, P NATL ACAD SCI USA, V104, P7851, DOI 10.1073/pnas.0702620104; Tseng HM, 2002, J BIOL CHEM, V277, P45630, DOI 10.1074/jbc.M206861200; Valencia M, 2001, NATURE, V414, P666, DOI 10.1038/414666a; Wang Y, 2007, BIOCHEMISTRY-US, V46, P4962, DOI 10.1021/bi0621516; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Wu DL, 2008, GENETICS, V178, P1237, DOI 10.1534/genetics.107.083535; Yano KI, 2008, EMBO REP, V9, P91, DOI 10.1038/sj.embor.7401137; Zhang Y, 2007, NAT STRUCT MOL BIOL, V14, P639, DOI 10.1038/nsmb1261	50	30	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4931	4940		10.1074/jbc.M110.195024	http://dx.doi.org/10.1074/jbc.M110.195024			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21149442	hybrid, Green Published			2022-12-27	WOS:000286975700089
J	Shapiro, DJ; Mao, CJ; Cherian, MT				Shapiro, David J.; Mao, Chengjian; Cherian, Milu T.			Small Molecule Inhibitors as Probes for Estrogen and Androgen Receptor Action	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							COACTIVATOR BINDING INHIBITORS; RECURRENT PROSTATE-CANCER; NATURAL-KILLER-CELLS; BREAST-CANCER; DNA-BINDING; RESPONSE ELEMENTS; STRUCTURAL BASIS; GENE-EXPRESSION; BIOLOGICAL EVALUATION; ALPHA CONCENTRATION	Because activated estrogen (ER) and androgen (AR) receptors stimulate cell proliferation in breast and prostate cancer, inhibiting their actions represents a major therapeutic goal. Most efforts to modulate ER and AR activity have focused on inhibiting the synthesis of estrogens or androgens or on the identification of small molecules that act by competing with agonist hormones for binding in the ligand-binding pocket of the receptor. An alternative approach is to implement screens for small molecule inhibitors that target other sites in the pathway of steroid receptor action. Many of these second-site inhibitors directly target ER or AR; others have still unknown sites of action. Small molecule inhibitors that target second sites represent new leads with clinical potential; they serve as novel modulators of receptor action; and they can reveal new and as yet unidentified interactions and pathways that modulate ER and AR action.	[Shapiro, David J.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; Univ Illinois, Dept Mol & Integrat Physiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Shapiro, DJ (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	djshapir@illinois.edu			National Institutes of Health [RO1 DK071909]; Endocrine Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Endocrine Society; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK071909. This work was also supported by a Bridge grant from the Endocrine Society. This is the fifth article in the Thematic Minireview Series on Nuclear Receptors in Biology and Diseases. This minireview will be reprinted in the 2011 Minireview Compendium, which will be available in January, 2012.	Askew EB, 2009, J BIOL CHEM, V284, P34793, DOI 10.1074/jbc.M109.065979; Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Bai SX, 2005, MOL CELL BIOL, V25, P1238, DOI 10.1128/MCB.25.4.1238-1257.2005; Carraz M, 2009, CHEM BIOL, V16, P702, DOI 10.1016/j.chembiol.2009.06.009; Chang CY, 2005, MOL ENDOCRINOL, V19, P2478, DOI 10.1210/me.2005-0072; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen Y, 2008, CURR OPIN PHARMACOL, V8, P440, DOI 10.1016/j.coph.2008.07.005; Cheng JW, 2007, ENDOCRINOLOGY, V148, P4634, DOI 10.1210/en.2007-0148; Debes JD, 2004, NEW ENGL J MED, V351, P1488, DOI 10.1056/NEJMp048178; Estebanez-Perpina E, 2005, J BIOL CHEM, V280, P8060, DOI 10.1074/jbc.M407046200; Estebanez-Perpina E, 2007, P NATL ACAD SCI USA, V104, P16074, DOI 10.1073/pnas.0708036104; Fowler AM, 2006, MOL ENDOCRINOL, V20, P291, DOI 10.1210/me.2005-0288; Fowler AM, 2004, FASEB J, V18, P81, DOI 10.1096/fj.03-0038com; Gearhart MD, 2005, BIOCHEMISTRY-US, V44, P4196, DOI 10.1021/bi047872o; Gregory CW, 2004, J BIOL CHEM, V279, P7119, DOI 10.1074/jbc.M307649200; Gunther JR, 2008, ACS CHEM BIOL, V3, P282, DOI 10.1021/cb800056r; Gunther JR, 2009, ACS CHEM BIOL, V4, P435, DOI 10.1021/cb900043e; Gunther JR, 2009, J BIOMOL SCREEN, V14, P181, DOI 10.1177/1087057108329349; He B, 2004, MOL CELL, V16, P425, DOI 10.1016/j.molcel.2004.09.036; Jiang X, 2007, ONCOGENE, V26, P4106, DOI 10.1038/sj.onc.1210197; Jiang XG, 2006, ENDOCRINOLOGY, V147, P1419, DOI 10.1210/en.2005-0996; Jones JO, 2008, ACS CHEM BIOL, V3, P412, DOI 10.1021/cb800054w; Jones JO, 2009, P NATL ACAD SCI USA, V106, P7233, DOI 10.1073/pnas.0807282106; Joseph JD, 2009, P NATL ACAD SCI USA, V106, P12178, DOI 10.1073/pnas.0900185106; Kretzer NM, 2010, J BIOL CHEM, V285, P41863, DOI 10.1074/jbc.M110.183723; Krieg AJ, 2004, J BIOL CHEM, V279, P5025, DOI 10.1074/jbc.M307076200; Krieg SA, 2001, MOL ENDOCRINOL, V15, P1971, DOI 10.1210/me.15.11.1971; LaFrate AL, 2008, BIOORGAN MED CHEM, V16, P10075, DOI 10.1016/j.bmc.2008.10.007; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; Mao C, 2008, J BIOL CHEM, V283, P12819, DOI 10.1074/jbc.M709936200; Mohler JL, 2004, CLIN CANCER RES, V10, P440, DOI 10.1158/1078-0432.CCR-1146-03; Nickols NG, 2007, P NATL ACAD SCI USA, V104, P10418, DOI 10.1073/pnas.0704217104; Pan YF, 2008, J BIOL CHEM, V283, P32977, DOI 10.1074/jbc.M802024200; Parent AA, 2008, J MED CHEM, V51, P6512, DOI 10.1021/jm800698b; Powell E, 2010, J BIOL CHEM, V285, P16125, DOI 10.1074/jbc.M110.104356; Pradhan M, 2010, J BIOL CHEM, V285, P31100, DOI 10.1074/jbc.M110.155309; Punchihewa C, 2007, MOL CANCER THER, V6, P213, DOI 10.1158/1535-7163.MCT-06-0392; REESE JC, 1991, NUCLEIC ACIDS RES, V19, P6595, DOI 10.1093/nar/19.23.6595; Rodriguez AL, 2004, J MED CHEM, V47, P600, DOI 10.1021/jm030404c; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; Shao DL, 2004, J STEROID BIOCHEM, V88, P351, DOI 10.1016/j.jsbmb.2004.01.007; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Taplin ME, 1999, CANCER RES, V59, P2511; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Wang LH, 2004, NAT MED, V10, P40, DOI 10.1038/nm969; Wang LH, 2006, CANCER CELL, V10, P487, DOI 10.1016/j.ccr.2006.09.015; Wang SY, 2004, BIOTECHNIQUES, V37, P807, DOI 10.2144/04375RR01; Wang Y, 2006, P NATL ACAD SCI USA, V103, P9908, DOI 10.1073/pnas.0510596103; Wei XL, 2006, MOL CELL, V21, P295, DOI 10.1016/j.molcel.2005.11.030; Wormke M, 2003, MOL CELL BIOL, V23, P1843, DOI 10.1128/MCB.23.6.1843-1855.2003; York B, 2010, J BIOL CHEM, V285, P38743, DOI 10.1074/jbc.R110.193367	51	26	28	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4043	4048		10.1074/jbc.R110.203026	http://dx.doi.org/10.1074/jbc.R110.203026			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21149443	Green Published, hybrid			2022-12-27	WOS:000286975700002
J	Pan, RL; Wang, P; Xiang, LX; Shao, JZ				Pan, Ruo-Lang; Wang, Ping; Xiang, Li-Xin; Shao, Jian-Zhong			Delta-like 1 Serves as a New Target and Contributor to Liver Fibrosis Down-regulated by Mesenchymal Stem Cell Transplantation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STROMAL CELLS; HEPATIC DIFFERENTIATION; MECHANISMS; INJURY; PROGRESSION; HEPATOCYTES; PREF-1	Chronic liver injury always progresses to fibrosis and eventually to cirrhosis, a massive health care burden worldwide. Deltalike 1 (Dlk1) is well known as an inhibitor of adipocyte differentiation. However, whether it is involved in liver fibrosis remains unclear. Here, we provide the first evidence that Dlk1 is a critical contributor to liver fibrosis through promoting activation of hepatic stellate cells (HSCs) during chronic liver injury. We found that upon liver injury, Dlk1 was dramatically induced and initially expressed in hepatocytes and then into the HSCs by a paracrine manner. It leads to the activation of HSCs, which is considered to be a pivotal event in liver fibrogenesis. Two forms (similar to 50 and similar to 25 kDa) of the Dlk1 protein were detected by Western blot analysis. In vitro administration of Dlk1 significantly promoted HSC activation, whereas in vivo knockdown of Dlk1 dramatically inhibited HSC activation and the subsequent fibrosis. The large soluble form (similar to 50 kDa) of Dlk1 was shown to contribute to HSC activation. We were encouraged to find the Dlk1-promoted HSC activation and liver fibrosis can be depressed by transplantation of bone marrow-mesenchymal stem cells (BM-MSCs). Furthermore, we demonstrated that FGF2 was up-regulated in BM-MSCs under injury stimulation, and it probably participated in the inhibition of Dlk1 by BM-MSCs. Our findings provide a novel role of Dlk1 in liver fibrosis leading to a better understanding of the molecular basis in fibrosis and cirrhosis and also give insights into the cellular and molecular mechanisms of MSC biology in liver repair.	[Pan, Ruo-Lang; Wang, Ping; Xiang, Li-Xin; Shao, Jian-Zhong] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Pan, Ruo-Lang; Wang, Ping; Xiang, Li-Xin; Shao, Jian-Zhong] Key Lab Cell & Gene Engn Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Xiang, LX (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	xianglx@zju.edu.cn; shaojz@zju.edu.cn			Science and Technology Foundation of the Ministry of Health of China [WKJ2007-2-037]	Science and Technology Foundation of the Ministry of Health of China	This work was supported by Science and Technology Foundation of the Ministry of Health of China Grant WKJ2007-2-037.	Almeida-Porada G, 2010, EXP HEMATOL, V38, P574, DOI 10.1016/j.exphem.2010.04.007; Andersen DC, 2009, STEM CELLS, V27, P898, DOI 10.1634/stemcells.2008-0826; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Chen Y, 2007, J CELL BIOCHEM, V102, P52, DOI 10.1002/jcb.21275; Chen Y, 2010, J CELL MOL MED, V14, P1494, DOI 10.1111/j.1582-4934.2009.00912.x; Chen Y, 2009, J CELL MOL MED, V13, P2582, DOI 10.1111/j.1582-4934.2008.00471.x; Chlebova K, 2009, CELL MOL LIFE SCI, V66, P225, DOI 10.1007/s00018-008-8440-4; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Friedman SL, 2008, TOXICOLOGY, V254, P120, DOI 10.1016/j.tox.2008.06.013; Friedman SL, 2003, J HEPATOL, V38, pS38, DOI 10.1016/S0168-8278(02)00429-4; Gabele E, 2003, FRONT BIOSCI-LANDMRK, V8, pD69, DOI 10.2741/887; Henderson NC, 2007, CLIN SCI, V112, P265, DOI 10.1042/CS20060242; Higashiyama R, 2007, HEPATOLOGY, V45, P213, DOI 10.1002/hep.21477; Huang CC, 2004, J PATHOL, V202, P172, DOI 10.1002/path.1505; Ishikawa T, 2007, CELL TISSUE RES, V327, P463, DOI 10.1007/s00441-006-0334-x; JinNo K, 1997, J GASTROENTEROL, V32, P119; Kinoshita T, 2002, BBA-MOL CELL RES, V1592, P303, DOI 10.1016/S0167-4889(02)00323-3; Lee KD, 2004, HEPATOLOGY, V40, P1275, DOI 10.1002/hep.20469; Luk JM, 2005, J IMMUNOL METHODS, V305, P39, DOI 10.1016/j.jim.2005.07.006; Mei BS, 2002, BIOCHEM J, V364, P137, DOI 10.1042/bj3640137; Meirelles LD, 2009, CYTOKINE GROWTH F R, V20, P419, DOI 10.1016/j.cytogfr.2009.10.002; Muddu AK, 2007, INT J BIOCHEM CELL B, V39, P695, DOI 10.1016/j.biocel.2006.10.006; Oyagi S, 2006, J HEPATOL, V44, P742, DOI 10.1016/j.jhep.2005.10.026; Pan RL, 2008, CYTOTHERAPY, V10, P668, DOI 10.1080/14653240802360704; Peng Xiaodong, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P166; Psaltis PJ, 2008, STEM CELLS, V26, P2201, DOI 10.1634/stemcells.2008-0428; Raghunandan R, 2008, STEM CELLS DEV, V17, P495, DOI 10.1089/scd.2007.0102; Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572; Song EW, 2003, NAT MED, V9, P347, DOI 10.1038/nm828; Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160; Uchinami H, 2006, HEPATOLOGY, V44, P420, DOI 10.1002/hep.21268; Wallace K, 2008, BIOCHEM J, V411, P1, DOI 10.1042/BJ20071570; Wang YH, 2009, CELL METAB, V9, P287, DOI 10.1016/j.cmet.2009.01.013; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yu CD, 2003, AM J PATHOL, V163, P1653, DOI 10.1016/S0002-9440(10)63522-5; Yu CD, 2002, AM J PATHOL, V161, P2003, DOI 10.1016/S0002-9440(10)64478-1; Zhao QJ, 2009, BIOL CELL, V101, P557, DOI 10.1042/BC20080105	38	45	49	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.194498	http://dx.doi.org/10.1074/jbc.M110.194498			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21239501	Green Published, hybrid			2022-12-27	WOS:000289077500048
J	Oroz, J; Valbuena, A; Vera, AM; Mendieta, J; Gomez-Puertas, P; Carrion-Vazquez, M				Oroz, Javier; Valbuena, Alejandro; Manuel Vera, Andres; Mendieta, Jesus; Gomez-Puertas, Paulino; Carrion-Vazquez, Mariano			Nanomechanics of the Cadherin Ectodomain "CANALIZATION" BYCa2 BINDING RESULTS IN A NEW MECHANICAL ELEMENT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-ADHESION; EXTRACELLULAR CALCIUM; MOLECULAR-DYNAMICS; HOMOPHILIC BINDING; FORCE; PROTEIN; STABILITY; ACTIN; ELASTICITY; STRENGTH	Cadherins form a large family of calcium-dependent cell-cell adhesion receptors involved in development, morphogenesis, synaptogenesis, differentiation, and carcinogenesis through signal mechanotransduction using an adaptor complex that connects them to the cytoskeleton. However, the molecular mechanisms underlying mechanotransduction through cadherins remain unknown, although their extracellular region (ectodomain) is thought to be critical in this process. By single molecule force spectroscopy, molecular dynamics simulations, and protein engineering, here we have directly examined the nanomechanics of the C-cadherin ectodomain and found it to be strongly dependent on the calcium concentration. In the presence of calcium, the ectodomain extends through a defined ("canalized") pathway that involves two mechanical resistance elements: a mechanical clamp from the cadherin domains and a novel mechanostable component from the interdomain calcium-binding regions ("calcium rivet") that is abolished by magnesium replacement and in a mutant intended to impede calcium coordination. By contrast, in the absence of calcium, the mechanical response of the ectodomain becomes largely "decanalized" and destabilized. The cadherin ectodomain may therefore behave as a calcium-switched "mechanical antenna" with very different mechanical responses depending on calcium concentration (which would affect its mechanical integrity and force transmission capability). The versatile mechanical design of the cadherin ectodomain and its dependence on extracellular calcium facilitate a variety of mechanical responses that, we hypothesize, could influence the various adhesive properties mediated by cadherins in tissue morphogenesis, synaptic plasticity, and disease. Our work represents the first step toward the mechanical characterization of the cadherin system, opening the door to understanding the mechanical bases of its mechanotransduction.	[Oroz, Javier; Valbuena, Alejandro; Manuel Vera, Andres; Carrion-Vazquez, Mariano] CSIC, Inst Cajal, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-28002 Madrid, Spain; [Oroz, Javier; Valbuena, Alejandro; Manuel Vera, Andres; Carrion-Vazquez, Mariano] Inst Madrileno Estudios Avanzados IMDEA Nanocienc, E-28002 Madrid, Spain; [Mendieta, Jesus; Gomez-Puertas, Paulino] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, CSIC, E-28049 Madrid, Spain; [Mendieta, Jesus] Biomol Informat SL, E-28049 Madrid, Spain	CIBERNED; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Carrion-Vazquez, M (corresponding author), CSIC, Inst Cajal, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Ave Doctor Arce 37, E-28002 Madrid, Spain.	mcarrion@cajal.csic.es	Mendieta, Jesús/P-4802-2016; Gomez-Puertas, Paulino/G-8821-2014; Valbuena, Alejandro/G-9682-2012; Oroz, Javier/J-3297-2015; Carrion-Vazquez, Mariano/Y-3741-2018	Mendieta, Jesús/0000-0002-5498-0871; Gomez-Puertas, Paulino/0000-0003-3131-729X; Valbuena, Alejandro/0000-0002-6801-640X; Oroz, Javier/0000-0003-2687-3013; Mendieta, Jesus/0000-0001-9286-2166; Vera, Andres Manuel/0000-0002-3932-8236; Carrion-Vazquez, Mariano/0000-0001-7319-406X	Ministerio de Ciencia e Innovacion, MICINN [BIO2007-67116, SAF2007-61926]; Consejeria de Educacion de la Comunidad de Madrid, CECM [S-0505/MAT/0283, S-BIO-0260/2006-COMBACT]; CSIC [200620F00]; European Union [FP7-223431]; Fundacion Areces; Fundacion Ramon Areces	Ministerio de Ciencia e Innovacion, MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consejeria de Educacion de la Comunidad de Madrid, CECM; CSIC; European Union(European Commission); Fundacion Areces; Fundacion Ramon Areces	This work was supported in part by grants from the Ministerio de Ciencia e Innovacion, MICINN (Grant BIO2007-67116), Consejeria de Educacion de la Comunidad de Madrid, CECM (Grant S-0505/MAT/0283), and CSIC (Grant 200620F00) (to M.C.-V.) and from the MICINN (Grant SAF2007-61926), the CECM (Grant S-BIO-0260/2006-COMBACT), and the European Union (Grant FP7-223431) (to P.G.-P.).; Recipient of a fellowship from the CECM.; Recipient of a fellowship from the Fundacion Areces.; We thank B. Gumbiner (University of Virginia, Charlottesville, VA) for kindly providing both the C-cadherin ectodomain and its cDNA clone. We thank also the members of the Carrion-Vazquez laboratory for discussion and critical reading of the manuscript. Financial support from the "Fundacion Ramon Areces" to the Centro de Biologia Molecular is also acknowledged.	Abe K, 2008, P NATL ACAD SCI USA, V105, P13, DOI 10.1073/pnas.0710504105; Ainavarapu RK, 2007, BIOPHYS J, V92, P225, DOI 10.1529/biophysj.106.091561; Ainavarapu RK, 2005, BIOPHYS J, V89, P3337, DOI 10.1529/biophysj.105.062034; Alattia JR, 1997, FEBS LETT, V417, P405, DOI 10.1016/S0014-5793(97)01333-1; Arias-Moreno X, 2010, PROTEINS, V78, P950, DOI 10.1002/prot.22619; Bajpai S, 2009, J BIOL CHEM, V284, P18252, DOI 10.1074/jbc.M109.000661; Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697; Baumgartner W, 2003, J NEUROSCI, V23, P11008; Bayas M V, 2004, Mech Chem Biosyst, V1, P101; BERS DM, 1994, METHOD CELL BIOL, V40, P3; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Bradbrook GM, 1998, J CHEM SOC FARADAY T, V94, P1603, DOI 10.1039/a800429c; Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955-0674(02)00373-3; Breitwieser GE, 2008, INT J BIOCHEM CELL B, V40, P1467, DOI 10.1016/j.biocel.2008.01.019; Brieher WM, 1996, J CELL BIOL, V135, P487, DOI 10.1083/jcb.135.2.487; BROWN EM, 1995, CELL, V83, P679, DOI 10.1016/0092-8674(95)90180-9; Bruses JL, 2006, MOL NEUROBIOL, V33, P237, DOI 10.1385/MN:33:3:237; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cailliez F, 2006, BIOPHYS J, V91, P3964, DOI 10.1529/biophysj.106.087213; Cao Y, 2008, P NATL ACAD SCI USA, V105, P11152, DOI 10.1073/pnas.0803446105; Carrion-Vazquez Mariano, 2006, V10, P163; CASE DA, 2002, AMBER7; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; CHOI YS, 1990, J CELL BIOL, V110, P1575, DOI 10.1083/jcb.110.5.1575; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Ciatto C, 2010, NAT STRUCT MOL BIOL, V17, P339, DOI 10.1038/nsmb.1781; Conacci-Sorrell M, 2002, J CLIN INVEST, V109, P987, DOI 10.1172/JCI200215429; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Elledge HM, 2010, P NATL ACAD SCI USA, V107, P10708, DOI 10.1073/pnas.1006284107; Evans E, 1999, BIOPHYS J, V76, P2439, DOI 10.1016/S0006-3495(99)77399-6; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Ganz A, 2006, BIOL CELL, V98, P721, DOI 10.1042/BC20060039; Giannone G, 2009, TRENDS CELL BIOL, V19, P475, DOI 10.1016/j.tcb.2009.07.001; GINSBERG D, 1991, DEVELOPMENT, V111, P315; HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312; Harrison OJ, 2010, NAT STRUCT MOL BIOL, V17, P348, DOI 10.1038/nsmb.1784; Haussinger D, 2002, J MOL BIOL, V324, P823, DOI 10.1016/S0022-2836(02)01137-3; He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957; Hewat EA, 2007, J MOL BIOL, V365, P744, DOI 10.1016/j.jmb.2006.10.052; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hynes RO, 1999, TRENDS CELL BIOL, V9, pM33, DOI 10.1016/S0962-8924(99)01667-0; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Kim SH, 2000, J BIOL CHEM, V275, P36999, DOI 10.1074/jbc.M003430200; Ko KS, 2001, J BIOL CHEM, V276, P35967, DOI 10.1074/jbc.M104106200; Koch AW, 1997, BIOCHEMISTRY-US, V36, P7697, DOI 10.1021/bi9705624; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Ladoux B, 2010, BIOPHYS J, V98, P534, DOI 10.1016/j.bpj.2009.10.044; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; le Duc Q, 2010, J CELL BIOL, V189, P1107, DOI 10.1083/jcb.201001149; Lee EH, 2009, STRUCTURE, V17, P1295, DOI 10.1016/j.str.2009.09.001; Li HB, 2001, P NATL ACAD SCI USA, V98, P10682, DOI 10.1073/pnas.191189098; Lu H, 1999, PROTEINS, V35, P453, DOI 10.1002/(SICI)1097-0134(19990601)35:4<453::AID-PROT9>3.3.CO;2-D; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Maurer P, 1997, MATRIX BIOL, V15, P569, DOI 10.1016/S0945-053X(97)90033-0; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Muller U, 2008, CURR OPIN CELL BIOL, V20, P557, DOI 10.1016/j.ceb.2008.06.004; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; OZAWA M, 1990, CELL, V63, P1033, DOI 10.1016/0092-8674(90)90506-A; Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x; Prasad A, 2006, PROTEINS, V62, P111, DOI 10.1002/prot.20657; Prasad A, 2005, BIOCHEMISTRY-US, V44, P13692, DOI 10.1021/bi0510274; RADER C, 1999, 1G SUPERFAMILY MOL N, P1; Rusakov DA, 1999, TRENDS NEUROSCI, V22, P382, DOI 10.1016/S0166-2236(99)01425-3; SALT AN, 1989, AM J OTOLARYNG, V10, P371, DOI 10.1016/0196-0709(89)90030-6; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Schwander M, 2009, P NATL ACAD SCI USA, V106, P5252, DOI 10.1073/pnas.0900691106; Schwartz MA, 2008, CURR OPIN CELL BIOL, V20, P551, DOI 10.1016/j.ceb.2008.05.005; SHAPIRO L, 1995, P NATL ACAD SCI USA, V92, P6793, DOI 10.1073/pnas.92.15.6793; Shin JB, 2009, P NATL ACAD SCI USA, V106, P4959, DOI 10.1073/pnas.0902008106; Sivasankar S, 2009, STRUCTURE, V17, P1075, DOI 10.1016/j.str.2009.06.012; Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001; Sotomayor M, 2008, BIOPHYS J, V94, P4621, DOI 10.1529/biophysj.107.125591; Sotomayor M, 2010, NEURON, V66, P85, DOI 10.1016/j.neuron.2010.03.028; Steward A, 2002, PROTEIN SCI, V11, P2179, DOI 10.1110/ps.0212702; Tai CY, 2008, CURR OPIN CELL BIOL, V20, P567, DOI 10.1016/j.ceb.2008.06.003; TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; Troyanovsky RB, 1999, J CELL SCI, V112, P4379; Tsui V, 2001, BIOPOLYMERS, V56, P275, DOI 10.1002/1097-0282(2000)56:4<275::AID-BIP10024>3.0.CO;2-E; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Valbuena A, 2009, P NATL ACAD SCI USA, V106, P13791, DOI 10.1073/pnas.0813093106; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Weiser J, 1999, J COMPUT CHEM, V20, P217, DOI 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A; Wiest MC, 2000, J NEUROPHYSIOL, V83, P1329, DOI 10.1152/jn.2000.83.3.1329; Yagi T, 2000, GENE DEV, V14, P1169; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Zhang YX, 2009, P NATL ACAD SCI USA, V106, P109, DOI 10.1073/pnas.0811350106; Zhu B, 2003, BIOPHYS J, V84, P4033, DOI 10.1016/S0006-3495(03)75129-7	93	31	33	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9405	9418		10.1074/jbc.M110.170399	http://dx.doi.org/10.1074/jbc.M110.170399			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21177864	Green Published, hybrid			2022-12-27	WOS:000288247700069
J	Ullrich, M; Bundschu, K; Benz, PM; Abesser, M; Freudinger, R; Fischer, T; Ullrich, J; Renne, T; Walter, U; Schuh, K				Ullrich, Melanie; Bundschu, Karin; Benz, Peter M.; Abesser, Marco; Freudinger, Ruth; Fischer, Tobias; Ullrich, Julia; Renne, Thomas; Walter, Ulrich; Schuh, Kai			Identification of SPRED2 (Sprouty-related Protein with EVH1 Domain 2) as a Negative Regulator of the Hypothalamic-Pituitary-Adrenal Axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICOTROPIN-RELEASING HORMONE; MAP KINASE ACTIVATION; TRANSGENIC MICE; CHRONIC STRESS; ALDOSTERONE SECRETION; BARTTERS-SYNDROME; BETA-ENDORPHIN; MOUSE MODEL; HPA AXIS; GENE	Sprouty-related proteins with EVH1 (enabled/vasodilator-stimulated phosphoprotein homology 1) domain (SPREDs) are inhibitors of MAPK signaling. To elucidate SPRED2 in vivo function, we characterized body homeostasis in SPRED2(-/-) mice. They showed a doubled daily water uptake, induced by elevated serum osmolality, originating from increased blood salt load. Accordingly, serum aldosterone was doubled, accompanied by augmented adrenal aldosterone synthase (AS) expression. Surprisingly, serum vasopressin (AVP) was unaltered, and, as evidenced by halved angiotensin II (Ang II) levels, the renin angiotensin system (RAS) was down-regulated. Adrenocorticotropic hormone (ACTH) was significantly elevated in SPRED2(-/-) mice, together with its secretagogue corticotropin-releasing hormone (CRH) and its downstream target corticosterone. ERK phosphorylation in brains was augmented, and hypothalamic CRH mRNA levels were elevated, both contributing to the increased CRH release. Our data were supported by CRH promoter reporter assays in hypothalamic mHypoE-44 cells, revealing a SPRED-dependent inhibition of Ets (ERK/E-twenty-six)-dependent transcription. Furthermore, SPRED suppressed CRH production in these cells. In conclusion, our study suggests that SPRED2 deficiency leads to an increased MAPK signaling, which results in an augmented CRH promoter activity. The subsequent CRH overproduction causes an up-regulation of downstream hypothalamic-pituitary-adrenal (HPA) hormone secretion. This constitutes a possible trigger for the observed compulsive grooming in SPRED2(-/-) mice and may, together with hyperplasia of aldosterone-producing cells, contribute to the hyperaldosteronism and homeostatic imbalances.	[Ullrich, Melanie; Benz, Peter M.; Abesser, Marco; Freudinger, Ruth; Fischer, Tobias; Ullrich, Julia; Schuh, Kai] Univ Wurzburg, Inst Physiol 1, D-97070 Wurzburg, Germany; [Bundschu, Karin] Univ Ulm, Inst Biochem & Mol Biol, D-89081 Ulm, Germany; [Renne, Thomas] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Mol Med & Surg, SE-17176 Stockholm, Sweden; [Walter, Ulrich] Univ Wurzburg, Inst Clin Biochem & Pathobiochem, D-97080 Wurzburg, Germany	University of Wurzburg; Ulm University; Karolinska Institutet; Karolinska University Hospital; University of Wurzburg	Ullrich, M (corresponding author), Univ Wurzburg, Inst Physiol 1, Roentgenring 9, D-97070 Wurzburg, Germany.	m.ullrich@uni-wuerzburg.de; kai.schuh@uni-wuerzburg.de	Walter, ulrich/W-2478-2017	Walter, ulrich/0000-0001-6784-2307; Renne, Thomas/0000-0003-4594-5975	Deutsche Forschungsgemeinschaft [SCHU1600/2-1]; Stiftung fuer Pathobiochemie und Molekulare Diagnostik of the Deutsche Vereinte Gesellschaft fuer Klinische Chemie und Laboratoriumsmedizin e.V.	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Stiftung fuer Pathobiochemie und Molekulare Diagnostik of the Deutsche Vereinte Gesellschaft fuer Klinische Chemie und Laboratoriumsmedizin e.V.	This work was supported by Deutsche Forschungsgemeinschaft Grant SCHU1600/2-1 (to K.S.) and a grant from the Stiftung fuer Pathobiochemie und Molekulare Diagnostik of the Deutsche Vereinte Gesellschaft fuer Klinische Chemie und Laboratoriumsmedizin e.V. (to K.S. and U.W.).	Bao AM, 2008, BRAIN RES REV, V57, P531, DOI 10.1016/j.brainresrev.2007.04.005; Blume A, 2009, ENDOCRINOLOGY, V150, P1841, DOI 10.1210/en.2008-1023; Brems H, 2007, NAT GENET, V39, P1120, DOI 10.1038/ng2113; Bundschu K, 2005, J BIOL CHEM, V280, P28572, DOI 10.1074/jbc.M503640200; Bundschu K, 2006, GENE EXPR PATTERNS, V6, P247, DOI 10.1016/j.modgep.2005.08.003; CURNOW KM, 1991, MOL ENDOCRINOL, V5, P1513, DOI 10.1210/mend-5-10-1513; Denayer E, 2008, J NEUROSCI, V28, P14443, DOI 10.1523/JNEUROSCI.4698-08.2008; Dirks A, 2002, EUR J NEUROSCI, V16, P1751, DOI 10.1046/j.1460-9568.2002.02245.x; DUNN FL, 1973, J CLIN INVEST, V52, P3212, DOI 10.1172/JCI107521; Engelhardt CM, 2004, HISTOCHEM CELL BIOL, V122, P527, DOI 10.1007/s00418-004-0725-6; Ferreira JG, 2007, J ENDOCRINOL, V192, P647, DOI 10.1677/JOE.1.06961; Gerrits M, 2006, NEUROSCIENCE, V142, P1293, DOI 10.1016/j.neuroscience.2006.07.014; GIROUD CJP, 1956, P SOC EXP BIOL MED, V92, P154; Groenink L, 2002, BIOL PSYCHIAT, V51, P875, DOI 10.1016/S0006-3223(02)01334-3; HANUKOGLU I, 1990, J BIOL CHEM, V265, P20602, DOI 10.1016/S0021-9258(17)30545-8; Hartner A, 2003, NEPHROL DIAL TRANSPL, V18, P1999, DOI 10.1093/ndt/gfg299; Heitzmann D, 2008, EMBO J, V27, P179, DOI 10.1038/sj.emboj.7601934; Hoeflich A, 2009, J MOL ENDOCRINOL, V42, P191, DOI 10.1677/JME-08-0160; Hoffmeyer A, 1998, J BIOL CHEM, V273, P10112, DOI 10.1074/jbc.273.17.10112; Horton WA, 2007, LANCET, V370, P162, DOI 10.1016/S0140-6736(07)61090-3; Inoue H, 2005, J EXP MED, V201, P73, DOI 10.1084/jem.20040616; JAMES VH, 1992, ADRENAL GLAND, P71; JOHN ME, 1986, P NATL ACAD SCI USA, V83, P4715, DOI 10.1073/pnas.83.13.4715; Kato R, 2003, BIOCHEM BIOPH RES CO, V302, P767, DOI 10.1016/S0006-291X(03)00259-6; Khan AM, 2004, ENDOCRINOLOGY, V145, P351, DOI 10.1210/en.2003-0539; King JAJ, 2006, J HEPATOL, V44, P758, DOI 10.1016/j.jhep.2005.10.031; King JAJ, 2005, BIOCHEM J, V388, P445, DOI 10.1042/BJ20041284; Lorenz JN, 2002, J BIOL CHEM, V277, P37871, DOI 10.1074/jbc.M205627200; Messiaen L, 2009, JAMA-J AM MED ASSOC, V302, P2111, DOI 10.1001/jama.2009.1663; Nielsen S, 1996, KIDNEY INT, V49, P1718, DOI 10.1038/ki.1996.254; Nobuhisa I, 2004, J EXP MED, V199, P737, DOI 10.1084/jem.20030830; Nonami A, 2004, J BIOL CHEM, V279, P52543, DOI 10.1074/jbc.M405189200; Papadimitriou A, 2009, NEUROIMMUNOMODULAT, V16, P265, DOI 10.1159/000216184; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Pasmant E, 2009, J MED GENET, V46, P425, DOI 10.1136/jmg.2008.065243; Phoenix TN, 2010, GENE DEV, V24, P45, DOI 10.1101/gad.1839510; QUINN SJ, 1988, ANNU REV PHYSIOL, V50, P409, DOI 10.1146/annurev.ph.50.030188.002205; RIVIER C, 1982, ENDOCRINOLOGY, V110, P272, DOI 10.1210/endo-110-1-272; Rojek A, 2006, P NATL ACAD SCI USA, V103, P6037, DOI 10.1073/pnas.0511324103; Rossi GP, 2008, TRENDS ENDOCRIN MET, V19, P88, DOI 10.1016/j.tem.2008.01.006; Seasholtz A, 2000, J CLIN INVEST, V105, P1187, DOI 10.1172/JCI10002; Sebaai N, 2002, EUR J ENDOCRINOL, V147, P835, DOI 10.1530/eje.0.1470835; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Singru PS, 2008, ENDOCRINOLOGY, V149, P2283, DOI 10.1210/en.2007-1478; SMITH AI, 1988, ENDOCR REV, V9, P159, DOI 10.1210/edrv-9-1-159; Sontia B, 2008, HYPERTENSION, V51, P915, DOI 10.1161/HYPERTENSIONAHA.107.100339; Spat A, 2004, PHYSIOL REV, V84, P489, DOI 10.1152/physrev.00030.2003; Spurlock G, 2009, J MED GENET, V46, P431, DOI 10.1136/jmg.2008.065474; STENZELPOORE MP, 1992, ENDOCRINOLOGY, V130, P3378, DOI 10.1210/en.130.6.3378; STENZELPOORE MP, 1994, J NEUROSCI, V14, P2579; Takahashi N, 2000, P NATL ACAD SCI USA, V97, P5434, DOI 10.1073/pnas.090091297; Taniguchi K, 2007, MOL CELL BIOL, V27, P4541, DOI 10.1128/MCB.01600-06; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; Ullrich Melanie, 2009, Methods Mol Biol, V561, P145, DOI 10.1007/978-1-60327-019-9_10; Ulrich-Lai YM, 2006, AM J PHYSIOL-ENDOC M, V291, pE965, DOI 10.1152/ajpendo.00070.2006; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; van Gaalen MM, 2002, EUR J NEUROSCI, V15, P2007, DOI 10.1046/j.1460-9568.2002.02040.x; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; WATERMAN MR, 1989, RECENT PROG HORM RES, V45, P533; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Wotus C, 1998, ENDOCRINOLOGY, V139, P4397, DOI 10.1210/en.139.10.4397; Yang BX, 2006, AM J PHYSIOL-RENAL, V291, pF465, DOI 10.1152/ajprenal.00494.2005; Yun J, 2000, J CLIN INVEST, V106, P1361, DOI 10.1172/JCI9154	64	11	12	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9477	9488		10.1074/jbc.M110.171306	http://dx.doi.org/10.1074/jbc.M110.171306			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21199868	Green Published, hybrid			2022-12-27	WOS:000288247700075
J	Genin, EC; Geillon, F; Gondcaille, C; Athias, A; Gambert, P; Trompier, D; Savary, S				Genin, Emmanuelle C.; Geillon, Flore; Gondcaille, Catherine; Athias, Anne; Gambert, Philippe; Trompier, Doriane; Savary, Stephane			Substrate Specificity Overlap and Interaction between Adrenoleukodystrophy Protein (ALDP/ABCD1) and Adrenoleukodystrophy-related Protein (ALDRP/ABCD2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-LINKED ADRENOLEUKODYSTROPHY; PEROXISOMAL ABCD2 TRANSPORTER; POLYUNSATURATED FATTY-ACIDS; ENDOPLASMIC-RETICULUM; DOCOSAHEXAENOIC ACID; MEMBRANE-PROTEIN; BETA-OXIDATION; GENE-THERAPY; EXPRESSION; ALDP	X-linked adrenoleukodystrophy (X-ALD) is a neurodegenerative disorder caused by mutations in the ABCD1 gene, which encodes a peroxisomal member of the ATP-binding cassette (ABC) transporter subfamily D called ALDP. ALDP is supposed to function as a homodimer allowing the entry of CoA-esters of very-long chain fatty acids (VLCFA) into the peroxisome, the unique site of their beta-oxidation. ALDP deficiency can be corrected by overexpression of ALDRP, its closest homolog. However, the exact nature of the substrates transported by ALDRP and its relationships with ALDP still remain unclear. To gain insight into the function of ALDRP, we used cell models allowing the induction in a dose-dependent manner of a wild type or a mutated non-functional ALDRP-EGFP fusion protein. We explored the consequences of the changes of ALDRP expression levels on the fatty acid content (saturated, monounsaturated, and polyunsaturated fatty acids) in phospholipids as well as on the levels of beta-oxidation of 3 suspected substrates:C26:0, C24:0, and C22:6n-3 (DHA). We found an inverse correlation between the fatty acid content of saturated (C26:0, C24:0) and monounsaturated (C26:1, C24:1) VLCFA and the expression level of ALDRP. Interestingly, we obtained a transdominant-negative effect of the inactive ALDRP-EGFP on ALDP function. This effect is due to a physical interaction between ALDRP and ALDP that we evidenced by proximity ligation assays and coimmunoprecipitation. Finally, the beta-oxidation assays demonstrate a role of ALDRP in the metabolism of saturated VLCFA (redundant with that of ALDP) but also a specific involvement of ALDRP in the metabolism of DHA.	[Savary, Stephane] Univ Bourgogne, LBMN, UMR866, INSERM,GDRCNRS 2583, F-21000 Dijon, France; [Genin, Emmanuelle C.; Geillon, Flore; Gondcaille, Catherine; Trompier, Doriane; Savary, Stephane] INSERM, UMR866, Ctr Rech Lipides, F-21000 Dijon, France; [Athias, Anne; Gambert, Philippe] Hop Bocage, Plateforme Lipid IFR100, F-21000 Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CHU Dijon Bourgogne	Savary, S (corresponding author), Univ Bourgogne, LBMN, UMR866, INSERM,GDRCNRS 2583, 6 Bd Gabriel, F-21000 Dijon, France.	stsavary@u-bourgogne.fr	Savary, Stephane/C-8137-2011; TROMPIER, Doriane/D-5862-2017	Savary, Stephane/0000-0002-9237-1727; Genin, Emmanuelle C./0000-0003-3039-7101; Trompier, Doriane/0000-0002-0746-1753	European Association Against Leukodystrophies (ELA Foundation, Nancy, France); regional council of Burgundy	European Association Against Leukodystrophies (ELA Foundation, Nancy, France); regional council of Burgundy(Region Bourgogne-Franche-Comte)	This work was supported by grants from the European Association Against Leukodystrophies (ELA Foundation, Nancy, France) and grants from the regional council of Burgundy.	Araseki M, 2005, BIOSCI BIOTECH BIOCH, V69, P483, DOI 10.1271/bbb.69.483; Berger J, 1999, EUR J BIOCHEM, V265, P719, DOI 10.1046/j.1432-1327.1999.00772.x; Berger J, 2006, BBA-MOL CELL RES, V1763, P1721, DOI 10.1016/j.bbamcr.2006.07.010; Bons JAP, 2008, CLIN CHIM ACTA, V387, P59, DOI 10.1016/j.cca.2007.09.002; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; EWART GD, 1994, J BIOL CHEM, V269, P10370; Ferdinandusse S, 2003, J LIPID RES, V44, P1992, DOI 10.1194/jlr.M300223-JLR200; Ferdinandusse S, 2001, J LIPID RES, V42, P1987; Ferrer I, 2005, HUM MOL GENET, V14, P3565, DOI 10.1093/hmg/ddi384; Flavigny E, 1999, FEBS LETT, V448, P261, DOI 10.1016/S0014-5793(99)00379-8; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fouquet F, 1997, NEUROBIOL DIS, V3, P271, DOI 10.1006/nbdi.1997.0127; Fourcade S, 2009, AM J PHYSIOL-ENDOC M, V296, pE211, DOI 10.1152/ajpendo.90736.2008; Gajadhar A, 2010, BIOTECHNIQUES, V48, P145, DOI 10.2144/000113354; Genin EC, 2009, J STEROID BIOCHEM, V116, P37, DOI 10.1016/j.jsbmb.2009.04.006; Gueugnon F, 2006, BIOCHEM BIOPH RES CO, V341, P150, DOI 10.1016/j.bbrc.2005.12.152; Guimaraes CP, 2004, BBA-MOL BASIS DIS, V1689, P235, DOI 10.1016/j.bbadis.2004.04.001; HASHIMOTO T, 1986, J BIOCHEM-TOKYO, V100, P301, DOI 10.1093/oxfordjournals.jbchem.a121716; Hillebrand M, 2007, J BIOL CHEM, V282, P26997, DOI 10.1074/jbc.M702122200; Holzinger A, 1997, BIOCHEM BIOPH RES CO, V239, P261, DOI 10.1006/bbrc.1997.7391; KAMIJO K, 1990, J BIOL CHEM, V265, P4534; Kashiwayama Y, 2009, EXP CELL RES, V315, P190, DOI 10.1016/j.yexcr.2008.10.031; Leclercq S, 2008, BIOCHIMIE, V90, P1602, DOI 10.1016/j.biochi.2008.05.022; Liu LX, 1999, J BIOL CHEM, V274, P32738, DOI 10.1074/jbc.274.46.32738; LombardPlatet G, 1996, P NATL ACAD SCI USA, V93, P1265, DOI 10.1073/pnas.93.3.1265; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Netik A, 1999, HUM MOL GENET, V8, P907, DOI 10.1093/hmg/8.5.907; Pujol A, 2004, HUM MOL GENET, V13, P2997, DOI 10.1093/hmg/ddh323; Shani N, 1997, HUM MOL GENET, V6, P1925, DOI 10.1093/hmg/6.11.1925; Troffer-Charlier N, 1998, EUR J CELL BIOL, V75, P254, DOI 10.1016/S0171-9335(98)80121-0; Unterrainer G, 2000, HUM MOL GENET, V9, P2609, DOI 10.1093/hmg/9.18.2609; Van Roermund C. W., 2010, BIOCH BIOPHYS ACTA M, V1811, P148; van Roermund CWT, 2008, FASEB J, V22, P4201, DOI 10.1096/fj.08-110866; Visser WF, 2007, BIOCHEM J, V401, P365, DOI 10.1042/BJ20061352; Wanders RJA, 1995, J INHERIT METAB DIS, V18, P113, DOI 10.1007/BF00711434	35	38	39	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8075	8084		10.1074/jbc.M110.211912	http://dx.doi.org/10.1074/jbc.M110.211912			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21209459	Green Published, hybrid			2022-12-27	WOS:000288013300038
J	Landeta, O; Landajuela, A; Gil, D; Taneva, S; Di Primo, C; Sot, B; Valle, M; Frolov, VA; Basanez, G				Landeta, Olatz; Landajuela, Ane; Gil, David; Taneva, Stefka; Di Primo, Carmelo; Sot, Begona; Valle, Mikel; Frolov, Vadim A.; Basanez, Gorka			Reconstitution of Proapoptotic BAK Function in Liposomes Reveals a Dual Role for Mitochondrial Lipids in the BAK-driven Membrane Permeabilization Process	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSIN; PORE FORMATION; OUTER-MEMBRANE; CELL-DEATH; BH3-ONLY PROTEINS; BILAYER-MEMBRANES; INDUCED APOPTOSIS; BCL-2 PROTEINS; BH3 DOMAINS; ACTIVATION	BAK is a key effector of mitochondrial outer membrane permeabilization (MOMP) whose molecular mechanism of action remains to be fully dissected in intact cells, mainly due to the inherent complexity of the intracellular apoptotic machinery. Here we show that the core features of the BAK-driven MOMP pathway can be reproduced in a highly simplified in vitro system consisting of recombinant human BAK lacking the carboxyl-terminal 21 residues (BAK Delta C) and tBID in combination with liposomes bearing an appropriate lipid environment. Using this minimalist reconstituted system we established that tBID suffices to trigger BAK Delta C membrane insertion, oligomerization, and pore formation. Furthermore, we demonstrate that tBID-activated BAK Delta C permeabilizes the membrane by forming structurally dynamic pores rather than a large proteinaceous channel of fixed size. We also identified two distinct roles played by mitochondrial lipids along the molecular pathway of BAK Delta C-induced membrane permeabilization. First, using several independent approaches, we showed that cardiolipin directly interacts with BAK Delta C, leading to a localized structural rearrangement in the protein that "primes" BAK Delta C for interaction with tBID. Second, we provide evidence that selected curvature-inducing lipids present in mitochondrial membranes specifically modulate the energetic expenditure required to create the BAK Delta C pore. Collectively, our results support the notion that BAK functions as a direct effector of MOMP akin to BAX and also adds significantly to the growing evidence indicating that mitochondrial membrane lipids are actively implicated in BCL-2 protein family function.	[Landeta, Olatz; Landajuela, Ane; Taneva, Stefka; Frolov, Vadim A.; Basanez, Gorka] Univ Basque Country, CSIC, Ctr Mixto, Unidad Biofis, Bilbao 48080, Spain; [Frolov, Vadim A.] Univ Basque Country, Dept Bioquim & Biol Mol, Leioa 48940, Spain; [Frolov, Vadim A.] Basque Fdn Sci, Bilbao 48011, Spain; [Gil, David; Valle, Mikel] Parque Tecnol Zamudio, CIC BIOGUNE Struct Biol Unit, Derio 48160, Spain; [Di Primo, Carmelo] Univ Bordeaux, INSERM, U869, Inst Europeen Chim & Biol, F-33607 Pessac, France; [Sot, Begona] MRC Ctr Prot Engn, Cambridge CB2 0QH, England; [Sot, Begona] MRC Lab Mol Biol, Cambridge CB2 0QH, England	Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Basque Foundation for Science; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; MRC Laboratory Molecular Biology; MRC Laboratory Molecular Biology	Basanez, G (corresponding author), Unidad Biofis CSIC Univ Basque Country, Barrio Sarriena S N, Leioa 48940, Spain.	gbzbaasg@lg.ehu.es	Carton, David Gil/M-9332-2019; Di primo, Carmelo/M-6984-2018; Frolov, Vadim/ABH-3889-2020; Sot, Begoña/H-2882-2015; Valle, Mikel/F-7598-2011	Carton, David Gil/0000-0003-4241-1302; Di primo, Carmelo/0000-0002-0509-8399; Frolov, Vadim/0000-0002-0653-5669; Sot, Begoña/0000-0001-8763-0651; Valle, Mikel/0000-0001-8268-6912; Landeta, Olatz/0000-0002-5494-0271	Ministerio de Ciencia e Innovacion [BFU2008-01637]; Consejo Superior de Investigaciones Cientificas; Basque government	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Consejo Superior de Investigaciones Cientificas; Basque government(Basque Government)	This work was supported by Grants BFU2008-01637 from the Ministerio de Ciencia e Innovacion (to G.B.).r Recipient of a predoctoral fellowship from the Consejo Superior de Investigaciones Cientificas.r Recipient of a predoctoral fellowship from the Basque government.	Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; Basanez G, 1999, P NATL ACAD SCI USA, V96, P5492, DOI 10.1073/pnas.96.10.5492; Basanez G, 2008, PLOS BIOL, V6, P1148, DOI 10.1371/journal.pbio.0060154; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Bleicken S, 2010, J BIOL CHEM, V285, P6636, DOI 10.1074/jbc.M109.081539; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Christenson E, 2008, J MOL BIOL, V381, P1168, DOI 10.1016/j.jmb.2008.06.037; Cocklin S, 2006, J MOL RECOGNIT, V19, P354, DOI 10.1002/jmr.784; Cristea IM, 2004, CHEM PHYS LIPIDS, V129, P133, DOI 10.1016/j.chemphyslip.2004.02.002; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; Dewson G, 2009, J CELL SCI, V122, P2801, DOI 10.1242/jcs.038166; Etxebarria A, 2009, J BIOL CHEM, V284, P4200, DOI 10.1074/jbc.M808050200; Garcia-Saez AJ, 2005, BIOPHYS J, V88, P3976, DOI 10.1529/biophysj.104.058008; Garcia-Saez AJ, 2007, BIOPHYS J, V93, P103, DOI 10.1529/biophysj.106.100370; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; George NM, 2007, GENE DEV, V21, P1937, DOI 10.1101/gad.1553607; Gillick K, 2008, J CELL SCI, V121, P618, DOI 10.1242/jcs.021303; Griffiths GJ, 2001, ONCOGENE, V20, P7668, DOI 10.1038/sj.onc.1204995; Hardwick JM, 2009, CELL, V138, P404, DOI 10.1016/j.cell.2009.07.003; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Konishi A, 2003, CELL, V114, P673, DOI 10.1016/S0092-8674(03)00719-0; Kristan KC, 2009, TOXICON, V54, P1125, DOI 10.1016/j.toxicon.2009.02.026; Kudla G, 2000, J BIOL CHEM, V275, P22713, DOI 10.1074/jbc.M003807200; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lee MT, 2004, BIOCHEMISTRY-US, V43, P3590, DOI 10.1021/bi036153r; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Lewis RNAH, 2009, BBA-BIOMEMBRANES, V1788, P2069, DOI 10.1016/j.bbamem.2009.03.014; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; Lucken-Ardjomande S, 2008, CELL DEATH DIFFER, V15, P929, DOI 10.1038/cdd.2008.9; Lucken-Ardjomande S, 2008, CELL DEATH DIFFER, V15, P484, DOI 10.1038/sj.cdd.4402280; Martinez-Caballero S, 2009, J BIOL CHEM, V284, P12235, DOI 10.1074/jbc.M806610200; McIntosh TJ, 2006, ANNU REV BIOPH BIOM, V35, P177, DOI 10.1146/annurev.biophys.35.040405.102022; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Montero J, 2008, CANCER RES, V68, P5246, DOI 10.1158/0008-5472.CAN-07-6161; Montessuit S, 2010, CELL, V142, P889, DOI 10.1016/j.cell.2010.08.017; Oh KJ, 2005, J BIOL CHEM, V280, P753, DOI 10.1074/jbc.M405428200; Pardo J, 2006, J CELL BIOL, V174, P509, DOI 10.1083/jcb.200604044; Qian S, 2008, P NATL ACAD SCI USA, V105, P17379, DOI 10.1073/pnas.0807764105; Rich RL, 2008, J MOL RECOGNIT, V21, P355, DOI 10.1002/jmr.928; Roucou X, 2002, BIOCHEM J, V368, P915, DOI 10.1042/BJ20020972; Saito M, 2000, NAT CELL BIOL, V2, P553, DOI 10.1038/35019596; Sandra F., 2006, CANCER RES, V65, P2668; Sato M, 2006, NAT METHODS, V3, P797, DOI 10.1038/nmeth930; Schafer B, 2009, MOL BIOL CELL, V20, P2276, DOI 10.1091/mbc.E08-10-1056; Schug ZT, 2009, BBA-BIOMEMBRANES, V1788, P2022, DOI 10.1016/j.bbamem.2009.05.004; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Siskind LJ, 2008, J BIOL CHEM, V283, P6622, DOI 10.1074/jbc.M706115200; Sobko AA, 2006, J BIOL CHEM, V281, P14408, DOI 10.1074/jbc.M513634200; Sorice M, 2009, FEBS LETT, V583, P2447, DOI 10.1016/j.febslet.2009.07.018; Sot B, 2007, J BIOL CHEM, V282, P29193, DOI 10.1074/jbc.M705544200; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Terrones O, 2008, J BIOL CHEM, V283, P7790, DOI 10.1074/jbc.M708814200; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Yethon JA, 2003, J BIOL CHEM, V278, P48935, DOI 10.1074/jbc.M306289200; Yin XM, 2006, GENE, V369, P7, DOI 10.1016/j.gene.2005.10.038; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	64	61	61	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8213	8230		10.1074/jbc.M110.165852	http://dx.doi.org/10.1074/jbc.M110.165852			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21196599	hybrid, Green Published			2022-12-27	WOS:000288013300052
J	Wang, Q; Traynor, JR				Wang, Qin; Traynor, John R.			Opioid-induced Down-Regulation of RGS4 ROLE OF UBIQUITINATION AND IMPLICATIONS FOR RECEPTOR CROSS-TALK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUROBLASTOMA SH-SY5Y CELLS; MESSENGER-RNA; DIFFERENTIAL MODULATION; ADENYLYL-CYCLASE; NEUROPATHIC PAIN; ENDOGENOUS RGS4; UP-REGULATION; RAT-BRAIN; PROTEIN; MU	Regulator of G protein signaling protein 4 (RGS4) acts as a GTPase accelerating protein to modulate mu- and delta- opioid receptor (MOR and DOR, respectively) signaling. In turn, exposure to MOR agonists leads to changes in RGS4 at the mRNA and/or protein level. Here we have used human neuroblastoma SH-SY5Y cells that endogenously express MOR, DOR, and RGS4 to study opioid-mediated down-regulation of RGS4. Overnight treatment of SH-SY5Y cells with the MOR agonist DAMGO or the DOR agonist DPDPE decreased RGS4 protein by similar to 60% accompanied by a profound loss of opioid receptors but with no change in RGS4 mRNA. The decrease in RGS4 protein was prevented by the pretreatment with pertussis toxin or the opioid antagonist naloxone. The agonist-induced down-regulation of RGS4 proteins was completely blocked by treatment with the proteasome inhibitors MG132 or lactacystin or high concentrations of leupeptin, indicating involvement of ubiquitin-proteasome and lysosomal degradation. Polyubiquitinated RGS4 protein was observed in the presence of MG132 or the specific proteasome inhibitor lactacystin and promoted by opioid agonist. The loss of opioid receptors was not prevented by MG132, demonstrating a different degradation pathway. RGS4 is a GTPase accelerating protein for both G alpha(i/o) and G alpha(q) proteins. After overnight treatment with DAMGO to reduce RGS4 protein, signaling at the G alpha(i/o)-coupled DOR and the G alpha(q)-coupled M-3 muscarinic receptor (M3R) was increased but not signaling of the alpha(2) adrenergic receptor or bradykinin BK2 receptor, suggesting the development of cross-talk between the DOR and M3R involving RGS4.	[Wang, Qin; Traynor, John R.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Traynor, John R.] Univ Michigan, Substance Abuse Res Ctr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Traynor, JR (corresponding author), Univ Michigan, Dept Pharmacol, 1301 MSRB 3,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	jtraynor@umich.edu			National Institutes of Health [DA04087]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004087] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA04087 (to J. R. T.).	Alt A, 2002, BRIT J PHARMACOL, V135, P217, DOI 10.1038/sj.bjp.0704430; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bishop GB, 2002, NEUROBIOL DIS, V10, P334, DOI 10.1006/nbdi.2002.0518; Bodenstein J, 2007, MOL PHARMACOL, V71, P1040, DOI 10.1124/mol.106.029397; Bradbury FA, 2009, J NEUROCHEM, V109, P1526, DOI 10.1111/j.1471-4159.2009.06082.x; Bushlin I, 2010, CURR OPIN PHARMACOL, V10, P80, DOI 10.1016/j.coph.2009.09.009; Cahill CM, 2001, J NEUROSCI, V21, P7598, DOI 10.1523/JNEUROSCI.21-19-07598.2001; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Chaturvedi K, 2001, J BIOL CHEM, V276, P12345, DOI 10.1074/jbc.M008054200; CHENG J, 1995, J NEUROCHEM, V65, P170; Connor M, 1996, BRIT J PHARMACOL, V117, P333, DOI 10.1111/j.1476-5381.1996.tb15195.x; Davydov IV, 2000, J BIOL CHEM, V275, P22931, DOI 10.1074/jbc.M001605200; Garnier M, 2003, J PHARMACOL EXP THER, V304, P1299, DOI 10.1124/jpet.102.043471; Georgoussi Z, 2006, CELL SIGNAL, V18, P771, DOI 10.1016/j.cellsig.2005.07.003; Gold SJ, 2003, EUR J NEUROSCI, V17, P971, DOI 10.1046/j.1460-9568.2003.02529.x; Gold SJ, 1997, J COMP NEUROL, V385, P491, DOI 10.1002/(SICI)1096-9861(19970908)385:4<491::AID-CNE1>3.0.CO;2-Z; Han MH, 2010, BIOL PSYCHIAT, V67, P761, DOI 10.1016/j.biopsych.2009.08.041; HEIKKILA J, 1991, EUR J PHARM-MOLEC PH, V208, P9, DOI 10.1016/0922-4106(91)90045-J; HIRST RA, 1995, BIOCHEM PHARMACOL, V49, P1633, DOI 10.1016/0006-2952(95)00075-B; Hislop JN, 2009, J BIOL CHEM, V284, P19361, DOI 10.1074/jbc.M109.001644; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; KAZMI SMI, 1986, BIOCHEM BIOPH RES CO, V137, P813, DOI 10.1016/0006-291X(86)91152-6; KAZMI SMI, 1989, BIOCHEM BIOPH RES CO, V158, P921, DOI 10.1016/0006-291X(89)92810-6; Krumins AM, 2004, J BIOL CHEM, V279, P2593, DOI 10.1074/jbc.M311600200; LAMBERT DG, 1989, EUR J PHARMACOL, V165, P71, DOI 10.1016/0014-2999(89)90771-1; Lan KL, 2000, J BIOL CHEM, V275, P33497, DOI 10.1074/jbc.M005785200; Leontiadis LJ, 2009, CELL SIGNAL, V21, P1218, DOI 10.1016/j.cellsig.2009.03.013; Levitt ES, 2011, MOL PHARMACOL, V79, P461, DOI 10.1124/mol.110.064816; Lopez-Gimenez JF, 2008, MOL PHARMACOL, V74, P1278, DOI 10.1124/mol.108.048272; MCDONALD RL, 1994, BIOCHEM PHARMACOL, V48, P23; Nakagawa T, 2001, EUR J PHARMACOL, V433, P29, DOI 10.1016/S0014-2999(01)01485-6; Neubig RR, 2002, NAT REV DRUG DISCOV, V1, P187, DOI 10.1038/nrd747; Pagano M, 2008, CELL SIGNAL, V20, P1190, DOI 10.1016/j.cellsig.2008.02.008; Qiu Y, 2003, J BIOL CHEM, V278, P36733, DOI 10.1074/jbc.M305857200; Schwendt M, 2007, NEUROREPORT, V18, P1261, DOI 10.1097/WNR.0b013e328240507a; Sunahara Roger K, 2002, Mol Interv, V2, P168, DOI 10.1124/mi.2.3.168; Talbot JN, 2010, J NEUROCHEM, V112, P1026, DOI 10.1111/j.1471-4159.2009.06519.x; Taymans JM, 2004, EUR J NEUROSCI, V19, P2249, DOI 10.1111/j.0953-816X.2004.03336.x; Traynor JR, 2005, MOL INTERV, V5, P30, DOI 10.1124/mi.5.1.7; Waldhoer M, 2005, P NATL ACAD SCI USA, V102, P9050, DOI 10.1073/pnas.0501112102; Wang Q, 2009, J BIOL CHEM, V284, P18357, DOI 10.1074/jbc.M109.015453; Watts VJ, 2005, PHARMACOL THERAPEUT, V106, P405, DOI 10.1016/j.pharmthera.2004.12.005; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549; Yan YB, 1997, J BIOL CHEM, V272, P11924, DOI 10.1074/jbc.272.18.11924; Zachariou V, 2008, BIOL PSYCHIAT, V63, P1013, DOI 10.1016/j.biopsych.2007.11.021; Zeng WZ, 1998, J BIOL CHEM, V273, P34687, DOI 10.1074/jbc.273.52.34687; Zhang WJ, 2009, BRAIN, V132, P778, DOI 10.1093/brain/awn330	48	23	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7854	7864		10.1074/jbc.M110.160911	http://dx.doi.org/10.1074/jbc.M110.160911			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21209077	Green Published, hybrid			2022-12-27	WOS:000288013300016
J	Cosgrove, S; Chotirmall, SH; Greene, CM; McElvaney, NG				Cosgrove, Sonya; Chotirmall, Sanjay H.; Greene, Catherine M.; McElvaney, Noel G.			Pulmonary Proteases in the Cystic Fibrosis Lung Induce Interleukin 8 Expression from Bronchial Epithelial Cells via a Heme/Meprin/Epidermal Growth Factor Receptor/Toll-like Receptor Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL ELASTASE; HEME; HEMOGLOBIN; DISEASE; ELAFIN; METALLOPROTEINASES; INFLAMMATION; SPECIFICITY; INDIVIDUALS; ACTIVATION	A high intrapulmonary protease burden is characteristic of cystic fibrosis (CF), and the resulting dysregulation of the protease/anti-protease balance has serious implications for inflammation in the CF lung. Because of this inflammation, micro-bleeds can occur releasing hemoglobin into the lung. The aim of this study was to investigate the effect of the protease-rich environment of the CF lung on human hemoglobin and to assess the proinflammatory effect of heme on CF bronchial epithelium. Here, we show that the Pseudomonas proteases (Pseudomonas elastase and alkaline protease) and the neutrophil proteases (neutrophil elastase (NE) and proteinase-3) are capable of almost complete degradation of hemoglobin in vitro but that NE is the predominant protease that cleaves hemoglobin in vivo in CF bronchoalveolar lavage fluid. One of the effects of this is the release of heme, and in this study we show that heme stimulates IL-8 and IL-10 protein production from Delta F508 CFBE41o(-) bronchial epithelial cells. In addition, heme-induced IL-8 expression utilizes a novel pathway involving meprin, EGF receptor, and MyD88. Meprin levels are elevated in CF cell lines and bronchial brushings, thus adding to the proinflammatory milieu. Interestingly, alpha(1)-antitrypsin, in addition to its ability to neutralize NE and protease-3, can also bind heme and neutralize heme-induced IL-8 from CFBE41o(-) cells. This study illustrates the proinflammatory effects of micro-bleeds in the CF lung, the process by which this occurs, and a potential therapeutic intervention.	[Cosgrove, Sonya; Chotirmall, Sanjay H.; Greene, Catherine M.; McElvaney, Noel G.] Royal Coll Surgeons Ireland, Beaumont Hosp, Dept Med, Resp Res Div, Dublin 9, Ireland	Royal College of Surgeons - Ireland	Greene, CM (corresponding author), Royal Coll Surgeons Ireland, Beaumont Hosp, Dept Med, Resp Res Div, Dublin 9, Ireland.	cmgreene@rcsi.ie	Greene, Catherine M/D-3513-2012; Chotirmall, Sanjay Haresh/K-4127-2015; McElvaney, Noel/A-6809-2010	Greene, Catherine M/0000-0003-2549-2569; Chotirmall, Sanjay Haresh/0000-0003-0417-7607; mcelvaney, Noel/0000-0002-0152-4370	Science Foundation Ireland; Health Research Board [SFI/08/US/B1676]; Medical Charities Research Group; United States Alpha One Foundation	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board; Medical Charities Research Group; United States Alpha One Foundation	This work was supported by Science Foundation Ireland, Health Research Board Grant SFI/08/US/B1676, Medical Charities Research Group, and United States Alpha One Foundation.	Alcorn JF, 2004, J BIOL CHEM, V279, P30871, DOI 10.1074/jbc.M400796200; Anson ML, 1938, J GEN PHYSIOL, V22, P79, DOI 10.1085/jgp.22.1.79; BALLA J, 1993, P NATL ACAD SCI USA, V90, P9285, DOI 10.1073/pnas.90.20.9285; Bergin DA, 2008, J BIOL CHEM, V283, P31736, DOI 10.1074/jbc.M803732200; Blishchenko EY, 1997, FEBS LETT, V414, P125, DOI 10.1016/S0014-5793(97)00991-5; BRITIGAN BE, 1993, INFECT IMMUN, V61, P5049, DOI 10.1128/IAI.61.12.5049-5055.1993; Byrne DP, 2010, BIOCHEM J, V425, P257, DOI 10.1042/BJ20090343; Chotirmall SH, 2010, AM J RESP CRIT CARE, V182, P62, DOI 10.1164/rccm.201001-0053OC; Dulon S, 2005, AM J RESP CELL MOL, V32, P411, DOI 10.1165/rcmb.2004-0274OC; Faller M, 2007, NAT STRUCT MOL BIOL, V14, P23, DOI 10.1038/nsmb1182; Figueiredo RT, 2007, J BIOL CHEM, V282, P20221, DOI 10.1074/jbc.M610737200; Fischer BM, 2009, CTS-CLIN TRANSL SCI, V2, P333, DOI 10.1111/j.1752-8062.2009.00151.x; Furuyama K, 2007, TOHOKU J EXP MED, V213, P1, DOI 10.1620/tjem.213.1; Gaggar A, 2008, J IMMUNOL, V180, P5662, DOI 10.4049/jimmunol.180.8.5662; Geraghty P, 2007, J IMMUNOL, V178, P5871, DOI 10.4049/jimmunol.178.9.5871; Greene CM, 2009, BRIT J PHARMACOL, V158, P1048, DOI 10.1111/j.1476-5381.2009.00448.x; Guyot N, 2008, J BIOL CHEM, V283, P32377, DOI 10.1074/jbc.M803707200; Guyot N, 2010, BIOL CHEM, V391, P705, DOI 10.1515/BC.2010.066; Horrigan FT, 2005, J GEN PHYSIOL, V126, P7, DOI 10.1085/jgp.200509262; Huy NT, 2005, ANAL BIOCHEM, V344, P289, DOI 10.1016/j.ab.2005.06.022; Ivanov VT, 1997, BIOPOLYMERS, V43, P171; KAO RC, 1988, J CLIN INVEST, V82, P1963, DOI 10.1172/JCI113816; Kelly E, 2010, RESP MED, V104, P763, DOI 10.1016/j.rmed.2010.01.016; KRAMER G, 1976, P NATL ACAD SCI USA, V73, P3078, DOI 10.1073/pnas.73.9.3078; KUNZELMANN K, 1993, AM J RESP CELL MOL, V8, P522, DOI 10.1165/ajrcmb/8.5.522; Liebau E, 2005, J BIOL CHEM, V280, P26121, DOI 10.1074/jbc.M503889200; MCELVANEY NG, 1991, LANCET, V337, P392, DOI 10.1016/0140-6736(91)91167-S; NAKAMURA H, 1992, J CLIN INVEST, V89, P1478, DOI 10.1172/JCI115738; Norman LP, 2003, CURR TOP DEV BIOL, V54, P145, DOI 10.1016/S0070-2153(03)54008-X; Oglesby IK, 2010, J IMMUNOL, V184, P1702, DOI 10.4049/jimmunol.0902669; Porto BN, 2007, J BIOL CHEM, V282, P24430, DOI 10.1074/jbc.M703570200; Rees DD, 1997, J PHARMACOL EXP THER, V283, P1201; Schechter AN, 2008, BLOOD, V112, P3927, DOI 10.1182/blood-2008-04-078188; Sil S, 2004, J BIOSCIENCES, V29, P281, DOI 10.1007/BF02702610; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Sunnarborg SW, 2002, J BIOL CHEM, V277, P12838, DOI 10.1074/jbc.M112050200; Taggart CC, 2005, AM J RESP CRIT CARE, V171, P1070, DOI 10.1164/rccm.200407-881PP; Tang XD, 2003, NATURE, V425, P531, DOI 10.1038/nature02003; Walsh DE, 2001, J BIOL CHEM, V276, P35494, DOI 10.1074/jbc.M103543200; Zani ML, 2009, PROTEIN SCI, V18, P579, DOI 10.1002/pro.64	40	46	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7692	7704		10.1074/jbc.M110.183863	http://dx.doi.org/10.1074/jbc.M110.183863			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21193404	Green Published, hybrid			2022-12-27	WOS:000287737300082
J	Magnan, R; Masri, B; Escrieut, C; Foucaud, M; Cordelier, P; Fourmy, D				Magnan, Remi; Masri, Bernard; Escrieut, Chantal; Foucaud, Magali; Cordelier, Pierre; Fourmy, Daniel			Regulation of Membrane Cholecystokinin-2 Receptor by Agonists Enables Classification of Partial Agonists as Biased Agonists	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED-RECEPTOR; B RECEPTOR; CARBOXYL-TERMINUS; ARRESTIN; INTERNALIZATION; ENDOCYTOSIS; TRAFFICKING; GASTRIN; DESENSITIZATION; ACTIVATION	Given the importance of G-protein-coupled receptors as pharmacological targets in medicine, efforts directed at understanding the molecular mechanism by which pharmacological compounds regulate their presence at the cell surface is of paramount importance. In this context, using confocal microscopy and bioluminescence resonance energy transfer, we have investigated internalization and intracellular trafficking of the cholecystokinin-2 receptor (CCK2R) in response to both natural and synthetic ligands with different pharmacological features. We found that CCK and gastrin, which are full agonists on CCK2R-induced inositol phosphate production, rapidly and abundantly stimulate internalization. Internalized CCK2R did not rapidly recycle to plasma membrane but instead was directed to late endosomes/lysosomes. CCK2R endocytosis involves clathrin-coated pits and dynamin and high affinity and prolonged binding of beta-arrestin1 or -2. Partial agonists and antagonists on CCK2R-induced inositol phosphate formation and ERK1/2 phosphorylation did not stimulate CCK2R internalization or beta-arrestin recruitment to the CCK2R but blocked full agonist-induced internalization and beta-arrestin recruitment. The extreme C-terminal region of the CCK2R (and more precisely phosphorylatable residues Ser(437)-Xaa(438-)Thr(439)-Thr(440)-Xaa(441)-Ser(442)-Thr(443)) were critical for beta-arrestin recruitment. However, this region and beta-arrestins were dispensable for CCK2R internalization. In conclusion, this study allowed us to classify the human CCK2R as a member of class B G-protein-coupled receptors with regard to its endocytosis features and identified biased agonists of the CCK2R. These new important insights will allow us to investigate the role of internalized CCK2R.beta-arrestin complexes in cancers expressing this receptor and to develop new diagnosis and therapeutic strategies targeting this receptor.	[Fourmy, Daniel] INSERM, U858 I2MR, Unite 858, F-31432 Toulouse 4, France; Univ Toulouse 3118, F-31062 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Federale Toulouse Midi-Pyrenees (ComUE)	Fourmy, D (corresponding author), INSERM, U858 I2MR, Unite 858, 1 Ave Jean Poulhes,BP 84225, F-31432 Toulouse 4, France.	Daniel.Fourmy@inserm.fr	Fourmy, Daniel/AAE-3703-2019; Masri, Bernard/N-9856-2018; Cordelier, Pierre/D-1150-2014	Fourmy, Daniel/0000-0001-9910-4827; Masri, Bernard/0000-0002-4027-2604; Cordelier, Pierre/0000-0003-2096-7967	Association pour la Recherche contre le Cancer [4870]; Ligue Nationale Contre le Cancer (Comite 31)	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Ligue Nationale Contre le Cancer (Comite 31)	This work was supported by Association pour la Recherche contre le Cancer Grant 4870 and the Ligue Nationale Contre le Cancer (Comite 31).	Arnould M, 2004, FEBS LETT, V568, P89, DOI 10.1016/j.febslet.2004.05.012; Bierkamp C, 2002, ONCOGENE, V21, P7656, DOI 10.1038/sj.onc.1205999; Cottrell GS, 2009, J BIOL CHEM, V284, P22411, DOI 10.1074/jbc.M109.026674; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; Dufresne M, 2006, PHYSIOL REV, V86, P805, DOI 10.1152/physrev.00014.2005; Fan GH, 2001, BIOCHEMISTRY-US, V40, P791, DOI 10.1021/bi001661b; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Foucaud M, 2006, MOL PHARMACOL, V69, P680, DOI 10.1124/mol.105.019992; Foucaud M, 2008, J BIOL CHEM, V283, P35860, DOI 10.1074/jbc.M805513200; FOURMY D, 1989, EUR J BIOCHEM, V185, P397, DOI 10.1111/j.1432-1033.1989.tb15128.x; Giebing G, 2005, CIRC RES, V97, P707, DOI 10.1161/01.RES.0000184670.58688.9F; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Herranz R, 2003, MED RES REV, V23, P559, DOI 10.1002/med.10042; Holliday ND, 2007, MOL ENDOCRINOL, V21, P3100, DOI 10.1210/me.2007-0254; HUGHES J, 1990, P NATL ACAD SCI USA, V87, P6728, DOI 10.1073/pnas.87.17.6728; Kalindjian SB, 2001, J MED CHEM, V44, P1125, DOI 10.1021/jm0010668; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; KOPIN AS, 1992, P NATL ACAD SCI USA, V89, P3605, DOI 10.1073/pnas.89.8.3605; Lan HX, 2009, MOL PHARMACOL, V75, P19, DOI 10.1124/mol.108.050542; Langer I, 2009, MOL PHARMACOL, V75, P502, DOI 10.1124/mol.108.051607; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Marco E, 2007, J BIOL CHEM, V282, P28779, DOI 10.1074/jbc.M700349200; Masri B, 2008, P NATL ACAD SCI USA, V105, P13656, DOI 10.1073/pnas.0803522105; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; MORODER L, 1981, H-S Z PHYSIOL CHEM, V362, P929, DOI 10.1515/bchm2.1981.362.2.929; Mundell SJ, 2010, BRIT J PHARMACOL, V159, P518, DOI 10.1111/j.1476-5381.2009.00598.x; Noble F, 1999, PHARMACOL REV, V51, P745; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Ouedraogo M, 2008, TRAFFIC, V9, P305, DOI 10.1111/j.1600-0854.2007.00691.x; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Pohl M, 1997, J BIOL CHEM, V272, P18179, DOI 10.1074/jbc.272.29.18179; Rajagopal K, 2005, J CLIN INVEST, V115, P2971, DOI 10.1172/JCI26950; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Roosterman D, 2008, ENDOCRINOLOGY, V149, P2200, DOI 10.1210/en.2007-1628; Royle SJ, 2002, J BIOL CHEM, V277, P35378, DOI 10.1074/jbc.M204844200; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tarasova NI, 1997, CELL TISSUE RES, V287, P325, DOI 10.1007/s004410050757; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Vatinel S, 2006, BBA-MOL CELL RES, V1763, P1098, DOI 10.1016/j.bbamcr.2006.07.003; Vines CM, 2003, J BIOL CHEM, V278, P41581, DOI 10.1074/jbc.C300291200; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; WANK SA, 1992, P NATL ACAD SCI USA, V89, P8691, DOI 10.1073/pnas.89.18.8691; Yaqub T, 2010, MOL PHARMACOL, V77, P547, DOI 10.1124/mol.109.060111	51	13	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6707	6719		10.1074/jbc.M110.196048	http://dx.doi.org/10.1074/jbc.M110.196048			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21156802	Green Published, hybrid			2022-12-27	WOS:000287476400078
J	Majerus, PW				Majerus, Philip W.			Wandering through the Laboratory	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							ACYL-CARRIER PROTEIN; INOSITOL POLYPHOSPHATE 1-PHOSPHATASE; FATTY ACID SYNTHESIS; PHOSPHOLIPASE-C ENZYMES; SUBSTRATE-BINDING SITE; HUMAN-PLATELETS; AFFINITY CHROMATOGRAPHY; 1,3,4-TRISPHOSPHATE 5/6-KINASE; GLUTATHIONE BIOSYNTHESIS; HETEROLOGOUS EXPRESSION		Washington Univ, Sch Med, Div Hematol, St Louis, MO 63110 USA	Washington University (WUSTL)	Majerus, PW (corresponding author), Washington Univ, Sch Med, Div Hematol, St Louis, MO 63110 USA.	phil@dom.wustl.edu						ALBERTS AW, 1964, BIOCHEMISTRY-US, V3, P1563, DOI 10.1021/bi00898a030; ALBERTS AW, 1965, BIOCHEMISTRY-US, V4, P2265, DOI 10.1021/bi00887a002; ALLEN RH, 1972, J BIOL CHEM, V247, P7702; ALLEN RH, 1972, J BIOL CHEM, V247, P7695; ALLEN RH, 1972, J BIOL CHEM, V247, P7709; BROZE GJ, 1980, J BIOL CHEM, V255, P1242; CALDWELL KK, 1991, J BIOL CHEM, V266, P18378; CONNOLLY TM, 1985, J BIOL CHEM, V260, P7868; Frederick JP, 2005, P NATL ACAD SCI USA, V102, P8454, DOI 10.1073/pnas.0503706102; HARTER HR, 1979, NEW ENGL J MED, V301, P577, DOI 10.1056/NEJM197909133011103; HOFMANN SL, 1982, J BIOL CHEM, V257, P6461; KANE WH, 1981, J BIOL CHEM, V256, P1002; LYONS RM, 1975, J CLIN INVEST, V56, P924, DOI 10.1172/JCI108172; Majerus PW, 2009, J LIPID RES, V50, pS249, DOI 10.1194/jlr.R800072-JLR200; MAJERUS PW, 1965, P NATL ACAD SCI USA, V53, P410, DOI 10.1073/pnas.53.2.410; MAJERUS PW, 1968, SCIENCE, V159, P428, DOI 10.1126/science.159.3813.428; MAJERUS PW, 1965, J BIOL CHEM, V240, P4723; MAJERUS PW, 1965, J BIOL CHEM, V240, P618; MAJERUS PW, 1964, P NATL ACAD SCI USA, V51, P1231, DOI 10.1073/pnas.51.6.1231; MAJERUS PW, 1971, J CLIN INVEST, V50, P1637, DOI 10.1172/JCI106652; MAJERUS PW, 1967, J BIOL CHEM, V242, P2325; MILETICH JP, 1978, J BIOL CHEM, V253, P6908; MINNICH V, 1971, J CLIN INVEST, V50, P507, DOI 10.1172/JCI106519; MITCHELL CA, 1989, J BIOL CHEM, V264, P8873; MOHLER DN, 1970, NEW ENGL J MED, V283, P1253, DOI 10.1056/NEJM197012032832304; NORRIS FA, 1995, J BIOL CHEM, V270, P16128, DOI 10.1074/jbc.270.27.16128; Norris FA, 1997, J BIOL CHEM, V272, P23859, DOI 10.1074/jbc.272.38.23859; PRESCOTT SM, 1981, J BIOL CHEM, V256, P579; ROTH GJ, 1977, BIOCHEMISTRY-US, V16, P4244, DOI 10.1021/bi00638a018; ROTH GJ, 1975, P NATL ACAD SCI USA, V72, P3073, DOI 10.1073/pnas.72.8.3073; SALEM HH, 1984, J BIOL CHEM, V259, P2246; SMITH JB, 1971, NATURE-NEW BIOL, V231, P235, DOI 10.1038/newbio231235a0; Ungewickell A, 2005, P NATL ACAD SCI USA, V102, P18854, DOI 10.1073/pnas.0509740102; Verbsky J, 2005, P NATL ACAD SCI USA, V102, P8448, DOI 10.1073/pnas.0503656102; WAKIL SJ, 1962, ANNU REV BIOCHEM, V31, P369, DOI 10.1146/annurev.bi.31.070162.002101; WEN DZ, 1987, BIOCHEMISTRY-US, V26, P4350, DOI 10.1021/bi00388a025; WILSON DB, 1984, J BIOL CHEM, V259, P1718; Wilson MP, 2009, P NATL ACAD SCI USA, V106, P9831, DOI 10.1073/pnas.0904172106; Wilson MP, 1996, J BIOL CHEM, V271, P11904, DOI 10.1074/jbc.271.20.11904; YORK JD, 1994, BIOCHEMISTRY-US, V33, P13164, DOI 10.1021/bi00249a002; YORK JD, 1993, P NATL ACAD SCI USA, V90, P5833, DOI 10.1073/pnas.90.12.5833; YORK JD, 1990, P NATL ACAD SCI USA, V87, P9548, DOI 10.1073/pnas.87.24.9548; Zou J, 2007, P NATL ACAD SCI USA, V104, P16834, DOI 10.1073/pnas.0708189104	43	1	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					4941	4945		10.1074/jbc.X110.212894	http://dx.doi.org/10.1074/jbc.X110.212894			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21169350	Green Published, hybrid			2022-12-27	WOS:000287230600001
J	Christian, F; Szaszak, M; Friedl, S; Drewianka, S; Lorenz, D; Goncalves, A; Furkert, J; Vargas, C; Schmieder, P; Gotz, F; Zuhlke, K; Moutty, M; Gottert, H; Joshi, M; Reif, B; Haase, H; Morano, I; Grossmann, S; Klukovits, A; Verli, J; Robert, G; Noack, C; Bergmann, M; Kass, R; Hampel, K; Kashin, D; Genieser, HG; Herberg, FW; Willoughby, D; Cooper, DMF; Baillie, GS; Houslay, MD; von Kries, JP; Zimmermann, B; Rosenthal, W; Klussmann, E				Christian, Frank; Szaszak, Marta; Friedl, Sabine; Drewianka, Stephan; Lorenz, Dorothea; Goncalves, Andrey; Furkert, Jens; Vargas, Carolyn; Schmieder, Peter; Goetz, Frank; Zuehlke, Kerstin; Moutty, Marie; Goettert, Hendrikje; Joshi, Mangesh; Reif, Bernd; Haase, Hannelore; Morano, Ingo; Grossmann, Solveig; Klukovits, Anna; Verli, Judit; Robert Gaspar; Noack, Claudia; Bergmann, Martin; Kass, Robert; Hampel, Kornelia; Kashin, Dmitry; Genieser, Hans-Gottfried; Herberg, Friedrich W.; Willoughby, Debbie; Cooper, Dermot M. F.; Baillie, George S.; Houslay, Miles D.; von Kries, Jens Peter; Zimmermann, Bastian; Rosenthal, Walter; Klussmann, Enno			Small Molecule AKAP-Protein Kinase A (PKA) Interaction Disruptors That Activate PKA Interfere with Compartmentalized cAMP Signaling in Cardiac Myocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL PRINCIPAL CELLS; POTENTIAL-DRUG TARGETS; ANCHORING PROTEIN; REGULATORY SUBUNITS; SCAFFOLDING PROTEINS; POTASSIUM CHANNEL; ADENYLYL CYCLASES; CA(V)1.2 CHANNELS; TROPONIN-I; PHOSPHORYLATION	A-kinase anchoring proteins (AKAPs) tether protein kinase A (PKA) and other signaling proteins to defined intracellular sites, thereby establishing compartmentalized cAMP signaling. AKAP-PKA interactions play key roles in various cellular processes, including the regulation of cardiac myocyte contractility. We discovered small molecules, 3,3'-diamino-4,4'-dihydroxydiphenylmethane (FMP-API-1) and its derivatives, which inhibit AKAP-PKA interactions in vitro and in cultured cardiac myocytes. The molecules bind to an allosteric site of regulatory subunits of PKA identifying a hitherto unrecognized region that controls AKAP-PKA interactions. FMP-API-1 also activates PKA. The net effect of FMP-API-1 is a selective interference with compartmentalized cAMP signaling. In cardiac myocytes, FMP-API-1 reveals a novel mechanism involved in terminating beta-adrenoreceptor-induced cAMP synthesis. In addition, FMP-API-1 leads to an increase in contractility of cultured rat cardiac myocytes and intact hearts. Thus, FMP-API-1 represents not only a novel means to study compartmentalized cAMP/PKA signaling but, due to its effects on cardiac myocytes and intact hearts, provides the basis for a new concept in the treatment of chronic heart failure.	[Christian, Frank; Szaszak, Marta; Friedl, Sabine; Lorenz, Dorothea; Goncalves, Andrey; Furkert, Jens; Vargas, Carolyn; Schmieder, Peter; Goetz, Frank; Zuehlke, Kerstin; Moutty, Marie; Goettert, Hendrikje; Joshi, Mangesh; Reif, Bernd; Grossmann, Solveig; von Kries, Jens Peter; Klussmann, Enno] Leibniz Inst Mol Pharmacol, D-13125 Berlin, Germany; [Drewianka, Stephan; Hampel, Kornelia; Zimmermann, Bastian] Biaffin GmbH & Co KG, D-34132 Kassel, Germany; [Goncalves, Andrey; Goetz, Frank; Zuehlke, Kerstin; Moutty, Marie; Haase, Hannelore; Morano, Ingo; Noack, Claudia; Bergmann, Martin; Rosenthal, Walter; Klussmann, Enno] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Klukovits, Anna; Verli, Judit; Robert Gaspar] Univ Szeged, Dept Pharmacodynam & Biopharm, H-6720 Szeged, Hungary; [Kass, Robert] Columbia Univ, Med Ctr, New York, NY 10032 USA; [Kashin, Dmitry; Genieser, Hans-Gottfried] Biol Life Sci Inst, D-28199 Bremen, Germany; [Herberg, Friedrich W.] Univ Kassel, Dept Biochem, D-34109 Kassel, Germany; [Willoughby, Debbie; Cooper, Dermot M. F.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Baillie, George S.; Houslay, Miles D.] Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland; [Rosenthal, Walter] Charite, D-14195 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Szeged University; Columbia University; Universitat Kassel; University of Cambridge; University of Glasgow; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Klussmann, E (corresponding author), Max Delbruck Ctr Mol Med MDC, Robert Rossle Str 10, D-13125 Berlin, Germany.	enno.klussmann@mdc-berlin.de	Gaspar, Robert/G-7954-2011; Houslay, Miles D/A-6825-2011; Houslay, Miles/AAM-5281-2020; Herberg, Friedrich W/B-5572-2015; Szaszak, Marta/G-7957-2011	Gaspar, Robert/0000-0002-1571-7579; Herberg, Friedrich W/0000-0001-7117-7653; Reif, Bernd/0000-0001-7368-7198; Houslay, Miles/0000-0002-3826-8091; Klussmann, Jens Peter/0000-0002-8223-7954; Genieser, Hans-Gottfried/0000-0002-4904-5790; Christian, Frank/0000-0001-8208-5930; Schmieder, Peter/0000-0001-9968-9327	Deutsche Forschungsgemeinschaft [KL1415/4-1, KL1415/4-2]; European Union [037189]; German Ministry of Education and Science [FKZ 0315097, 0315516]; Medical Research Council UK [G0600765]; Fondation Leducq [06CVD02]; Wellcome Trust [RG31760]; MRC [G0600765] Funding Source: UKRI; Medical Research Council [G0600765] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); German Ministry of Education and Science; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fondation Leducq(Leducq Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Deutsche Forschungsgemeinschaft Forschergruppe 806 Projects KL1415/4-1 and/4-2, European Union Project thera cAMP-proposals 037189, GoBio program of the German Ministry of Education and Science Grants FKZ 0315097 and 0315516, Medical Research Council UK Grant G0600765, Fondation Leducq Grant 06CVD02, and Wellcome Trust Grant RG31760.	Abdelaziz AI, 2004, J MOL MED-JMM, V82, P265, DOI 10.1007/s00109-004-0525-4; Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; Alvarez J, 2004, J BIOL CHEM, V279, P12456, DOI 10.1074/jbc.M312177200; Antos CL, 2001, CIRC RES, V89, P997, DOI 10.1161/hh2301.100003; Bauman AL, 2006, MOL CELL, V23, P925, DOI 10.1016/j.molcel.2006.07.025; Buchwald P, 2010, IUBMB LIFE, V62, P724, DOI 10.1002/iub.383; Carnegie GK, 2009, IUBMB LIFE, V61, P394, DOI 10.1002/iub.168; CARR DW, 1992, J BIOL CHEM, V267, P13376; Chen L, 2005, J BIOL CHEM, V280, P31347, DOI 10.1074/jbc.M505191200; Chu GX, 2000, J BIOL CHEM, V275, P38938, DOI 10.1074/jbc.M004079200; Dessauer CW, 2009, MOL PHARMACOL, V76, P935, DOI 10.1124/mol.109.059345; Di Benedetto G, 2008, CIRC RES, V103, P836, DOI 10.1161/CIRCRESAHA.108.174813; Dodge KL, 1999, ENDOCRINOLOGY, V140, P5165, DOI 10.1210/en.140.11.5165; Dodge KL, 1999, MOL ENDOCRINOL, V13, P1977, DOI 10.1210/me.13.12.1977; Dong WJ, 2007, BIOCHEMISTRY-US, V46, P9752, DOI 10.1021/bi700574n; El-Armouche A, 2009, HEART FAIL REV, V14, P225, DOI 10.1007/s10741-008-9132-8; Fink MA, 2001, CIRC RES, V88, P291, DOI 10.1161/01.RES.88.3.291; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; HAYES JS, 1980, J BIOL CHEM, V255, P5113; Henn V, 2004, J BIOL CHEM, V279, P26654, DOI 10.1074/jbc.M312835200; Herberg FW, 2000, J MOL BIOL, V298, P329, DOI 10.1006/jmbi.2000.3662; Houslay MD, 2007, CIRC RES, V100, P950, DOI 10.1161/01.RES.0000261934.56938.38; Huang LJS, 1997, J BIOL CHEM, V272, P8057, DOI 10.1074/jbc.272.12.8057; Hulme JT, 2006, P NATL ACAD SCI USA, V103, P16574, DOI 10.1073/pnas.0607294103; Hulme JT, 2003, P NATL ACAD SCI USA, V100, P13093, DOI 10.1073/pnas.2135335100; Hundsrucker C., 2008, V186, P483, DOI 10.1007/978-3-540-72843-6_20; Hundsrucker C, 2006, BIOCHEM J, V396, P297, DOI 10.1042/BJ20051970; Hundsrucker C, 2010, J BIOL CHEM, V285, P5507, DOI 10.1074/jbc.M109.047944; Kinderman FS, 2006, MOL CELL, V24, P397, DOI 10.1016/j.molcel.2006.09.015; Klussmann E, 1999, J BIOL CHEM, V274, P4934, DOI 10.1074/jbc.274.8.4934; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; Mauban JRH, 2009, PHYSIOLOGY, V24, P78, DOI 10.1152/physiol.00041.2008; McCahill A. C., 2008, V186, P125, DOI 10.1007/978-3-540-72843-6_6; McConnell BK, 2009, J BIOL CHEM, V284, P1583, DOI 10.1074/jbc.M806321200; Meyer B, 2004, E SCHERING RES FDN W, V44, P149; Newlon MG, 1999, NAT STRUCT BIOL, V6, P222; PACKER M, 1991, NEW ENGL J MED, V325, P1468, DOI 10.1056/NEJM199111213252103; Patel HH, 2010, J BIOL CHEM, V285, P27632, DOI 10.1074/jbc.M110.146589; Pierre S, 2009, NAT REV DRUG DISCOV, V8, P321, DOI 10.1038/nrd2827; Piggott LA, 2008, P NATL ACAD SCI USA, V105, P13835, DOI 10.1073/pnas.0712100105; Sanborn BM, 1998, REV REPROD, V3, P196; Sarma GN, 2010, STRUCTURE, V18, P155, DOI 10.1016/j.str.2009.12.012; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; Skroblin P, 2010, INT REV CEL MOL BIO, V283, P235, DOI 10.1016/S1937-6448(10)83005-9; Solaro RJ, 2008, BIOCHEM BIOPH RES CO, V369, P82, DOI 10.1016/j.bbrc.2007.12.114; Stefan E, 2007, J AM SOC NEPHROL, V18, P199, DOI 10.1681/ASN.2006020132; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Sumandea CA, 2011, J BIOL CHEM, V286, P530, DOI 10.1074/jbc.M110.148684; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Taylor SS, 2008, BBA-PROTEINS PROTEOM, V1784, P16, DOI 10.1016/j.bbapap.2007.10.002; Terrenoire C, 2009, J BIOL CHEM, V284, P9140, DOI 10.1074/jbc.M805366200; Wang WH, 1999, AM J PHYSIOL-RENAL, V277, pF826, DOI 10.1152/ajprenal.1999.277.6.F826; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Willoughby D, 2007, PHYSIOL REV, V87, P965, DOI 10.1152/physrev.00049.2006; Willoughby D, 2006, EMBO J, V25, P2051, DOI 10.1038/sj.emboj.7601113; Yin H, 2005, ANGEW CHEM INT EDIT, V44, P4130, DOI 10.1002/anie.200461786; Zaccolo M, 2006, EUR J CELL BIOL, V85, P693, DOI 10.1016/j.ejcb.2006.01.002	59	77	87	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9079	9096		10.1074/jbc.M110.160614	http://dx.doi.org/10.1074/jbc.M110.160614			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21177871	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000288247700039
J	Kreisman, LSC; Cobb, BA				Kreisman, Lori S. C.; Cobb, Brian A.			Glycoantigens Induce Human Peripheral Tr1 Cell Differentiation with Gut-homing Specialization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY T-CELLS; CHEMOKINE RECEPTOR 9; BACTEROIDES-FRAGILIS; ZWITTERIONIC POLYSACCHARIDES; CAPSULAR POLYSACCHARIDE; SYMBIOTIC BACTERIA; ABSCESS FORMATION; IMMUNE-RESPONSES; DENDRITIC CELLS; ANTIGEN	The carbohydrate antigen (glycoantigen) PSA from an intestinal commensal bacteria is able to down-regulate inflammatory bowel disease in model mice, suggesting that stimulation with PSA results in regulatory T cell (Treg) generation. However, mechanisms of how peripheral human T cells respond and home in response to commensal antigens are still not understood. Here, we demonstrate that a single exposure to PSA induces differentiation of human peripheral CD4(+) T cells into type-Tr1 Tregs. This is in contrast to mouse models where PSA induced the production of Foxp3(+) iTregs. The human PSA-induced Tr1 cells are profoundly anergic and exhibit nonspecific bystander suppression mediated by IL-10 secretion. Most surprisingly, glycoantigen exposure provoked expression of gut homing receptors on their surface. These findings reveal a mechanism for immune homeostasis in the gut whereby exposure to commensal glycoantigens provides the requisite information to responding T cells for proper tissue localization (gut) and function (anti-inflammatory/regulatory).	[Kreisman, Lori S. C.; Cobb, Brian A.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University	Cobb, BA (corresponding author), 10900 Euclid Ave,WRB 6532, Cleveland, OH 44106 USA.	brian.cobb@case.edu			National Institutes of Health [K22AI062707, DP2OD004225, R01GM082916]; American Asthma Foundation; Mt. Sinai Health Care Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K22AI062707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082916] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Asthma Foundation; Mt. Sinai Health Care Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants K22AI062707, DP2OD004225, and R01GM082916. This work was also supported by the American Asthma Foundation Early Excellence Award and the Mt. Sinai Health Care Foundation Scholars Program award (to B. A. C.).	Agace WW, 2000, CURR OPIN CELL BIOL, V12, P563, DOI 10.1016/S0955-0674(00)00132-0; Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Allakhverdi Z, 2006, J ALLERGY CLIN IMMUN, V118, P1342, DOI 10.1016/j.jaci.2006.07.034; Annacker O, 2005, J EXP MED, V202, P1051, DOI 10.1084/jem.20040662; Asseman C, 1998, GUT, V42, P157, DOI 10.1136/gut.42.2.157; Bacchetta R, 2002, EUR J IMMUNOL, V32, P2237, DOI 10.1002/1521-4141(200208)32:8<2237::AID-IMMU2237>3.0.CO;2-2; Brubaker JO, 1999, J IMMUNOL, V162, P2235; Brun V, 2009, INT IMMUNOPHARMACOL, V9, P609, DOI 10.1016/j.intimp.2009.01.032; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Choi YH, 2002, BIOCHEMISTRY-US, V41, P15144, DOI 10.1021/bi020491v; Chung DR, 2003, J IMMUNOL, V170, P1958, DOI 10.4049/jimmunol.170.4.1958; Chung DR, 2002, J EXP MED, V195, P1471, DOI 10.1084/jem.20020028; Cobb BA, 2004, CELL, V117, P677, DOI 10.1016/j.cell.2004.05.001; Cong YZ, 2002, J IMMUNOL, V169, P6112, DOI 10.4049/jimmunol.169.11.6112; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Di Nunzio S, 2009, BLOOD, V114, P4138, DOI 10.1182/blood-2009-04-214593; Elson CO, 2002, IMMUNOL RES, V26, P87, DOI 10.1385/IR:26:1-3:087; Gianfrani C, 2006, J IMMUNOL, V177, P4178, DOI 10.4049/jimmunol.177.6.4178; Groux H, 1997, NATURE, V389, P737, DOI 10.1038/39614; Hadley GA, 1997, J IMMUNOL, V159, P3748; Hinz S, 2007, CANCER RES, V67, P8344, DOI 10.1158/0008-5472.CAN-06-3304; Kreisman LSC, 2007, GLYCOBIOLOGY, V17, P46, DOI 10.1093/glycob/cwl056; Kunkel EJ, 2000, J EXP MED, V192, P761, DOI 10.1084/jem.192.5.761; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Meurens F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000677; OCHOAREPARAZ J, 2010, MUCOSAL IMMUNOL, V185, P4101; Papadakis KA, 2003, J IMMUNOL, V171, P159, DOI 10.4049/jimmunol.171.1.159; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Roncarolo MG, 2008, EUR J IMMUNOL, V38, P925, DOI 10.1002/eji.200838168; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Serafini G, 2009, HAEMATOL-HEMATOL J, V94, P1415, DOI 10.3324/haematol.2008.003129; Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299; Stephen TL, 2005, INFECT IMMUN, V73, P2184, DOI 10.1128/IAI.73.4.2184-2189.2005; Sundstedt A, 2003, J IMMUNOL, V170, P1240, DOI 10.4049/jimmunol.170.3.1240; TZIANABOS AO, 1993, SCIENCE, V262, P416, DOI 10.1126/science.8211161; TZIANABOS AO, 1992, J BIOL CHEM, V267, P18230; TZIANABOS AO, 1994, INFECT IMMUN, V62, P4881, DOI 10.1128/IAI.62.11.4881-4886.1994; Velez CD, 2009, IMMUNOLOGY, V127, P73, DOI 10.1111/j.1365-2567.2008.02924.x; Vicari AP, 1997, IMMUNITY, V7, P291, DOI 10.1016/S1074-7613(00)80531-2; WANG R, 2009, AM J IMMUNOL, V5, P101; Wang Y, 2000, P NATL ACAD SCI USA, V97, P13478, DOI 10.1073/pnas.97.25.13478; Wurbel MA, 2000, EUR J IMMUNOL, V30, P262, DOI 10.1002/1521-4141(200001)30:1<262::AID-IMMU262>3.0.CO;2-0; Youn BS, 1999, BLOOD, V94, P2533, DOI 10.1182/blood.V94.7.2533.419k37_2533_2536; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	49	32	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8810	8818		10.1074/jbc.M110.206011	http://dx.doi.org/10.1074/jbc.M110.206011			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21228275	hybrid, Green Published			2022-12-27	WOS:000288247700011
J	Nishiya, T; Matsumoto, K; Maekawa, S; Kajita, E; Horinouchi, T; Fujimuro, M; Ogasawara, K; Uehara, T; Miwa, S				Nishiya, Tadashi; Matsumoto, Kazuma; Maekawa, Satoshi; Kajita, Emi; Horinouchi, Takahiro; Fujimuro, Masahiro; Ogasawara, Kouetsu; Uehara, Takashi; Miwa, Soichi			Regulation of Inducible Nitric-oxide Synthase by the SPRY Domain- and SOCS Box-containing Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBCELLULAR-LOCALIZATION; PROTEASOMAL DEGRADATION; RAW-264.7 MACROPHAGES; SIGNALING PROPERTIES; INDUCED APOPTOSIS; STRUCTURAL BASIS; PATHWAY; SYSTEM; UBIQUITINATION; RECOGNITION	Inducible nitric-oxide synthase (iNOS, NOS2) plays a prominent role in macrophage bactericidal and tumoricidal activities. A relatively large amount of NO produced via iNOS, however, also targets the macrophage itself for apoptotic cell death. To uncover the intrinsic mechanisms of iNOS regulation, we have characterized the SPRY domain- and SOCS box-containing protein 1 (SPSB1), SPSB2, and SPSB4 that interact with the N-terminal region of iNOS in a D-I-N-N-N sequence-dependent manner. Fluorescence microscopy revealed that these SPSB proteins can induce the subcellular redistribution of iNOS from dense regions to diffused expression in a SOCS box-dependent manner. In immunoprecipitation studies, both Elongin C and Cullin-5, components of the multi-subunit E3 ubiquitin ligase, were found to bind to iNOS via SPSB1, SPSB2, or SPSB4. Consistently, iNOS was polyubiquitinated and degraded in a proteasome-dependent manner when SPSB1, SPSB2, or SPSB4 was expressed. SPSB1 and SPSB4 had a greater effect on iNOS regulation than SPSB2. The iNOS N-terminal fragment (residues 1-124 of human iNOS) could disrupt iNOS-SPSB interactions and inhibit iNOS degradation. In lipopolysaccharide-treated macrophages, this fragment attenuated iNOS ubiquitination and substantially prolonged iNOS lifetime, resulting in a corresponding increase in NO production and enhanced NO-dependent cell death. These results not only demonstrate the mechanism of SPSB-mediated iNOS degradation and the relative contributions of different SPSB proteins to iNOS regulation, but also show that iNOS levels are sophisticatedly regulated by SPSB proteins in activated macrophages to prevent overproduction of NO that could trigger detrimental effects, such as cytotoxicity.	[Nishiya, Tadashi; Matsumoto, Kazuma; Maekawa, Satoshi; Kajita, Emi; Horinouchi, Takahiro; Miwa, Soichi] Hokkaido Univ, Grad Sch Med, Dept Cellular Pharmacol, Sapporo, Hokkaido 0608638, Japan; [Fujimuro, Masahiro] Univ Yamanashi, Dept Mol Cell Biol, Interdisciplinary Grad Sch Med & Engn, Chuo 4093898, Japan; [Ogasawara, Kouetsu] Tohoku Univ, Dept Immunol, IDAC, Sendai, Miyagi 9808575, Japan; [Uehara, Takashi] Okayama Univ, Dept Med Pharmacol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan	Hokkaido University; University of Yamanashi; Tohoku University; Okayama University	Nishiya, T (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Cellular Pharmacol, N15W7, Sapporo, Hokkaido 0608638, Japan.	nishiya@med.hokudai.ac.jp	Horinouchi, Takahiro/G-1770-2012; Ogasawara, Kouetsu/G-9892-2011; Fujimuro, Masahiro/AAC-4727-2020; Miwa, Soichi/D-8468-2012	Fujimuro, Masahiro/0000-0002-5165-0789; Uehara, Takashi/0000-0002-8545-4006	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology; Ministry of Health, Labour, and Welfare of Japan; Smoking Research Foundation, Japan; Northtec Foundation; Takeda Science Foundation; Grants-in-Aid for Scientific Research [22310039] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Smoking Research Foundation, Japan; Northtec Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in part by Grants-in-Aid for Scientific Research (C) (to T. N.) and (B) (to S. M.) from the Japan Society for the Promotion of Science, a Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area) from the Ministry of Education, Culture, Sports, Science, and Technology (to T. U.), a Grant-in-Aid for Scientific Research from the Ministry of Health, Labour, and Welfare of Japan (to K. O.), the Smoking Research Foundation, Japan (to S. M.), the Northtec Foundation (to T. N.), and the Takeda Science Foundation (to T. N.). The authors declare no conflict of interest.	ALBINA JE, 1993, J IMMUNOL, V150, P5080; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Chen L, 2009, CELL IMMUNOL, V258, P38, DOI 10.1016/j.cellimm.2009.03.009; Filippakopoulos P, 2010, J MOL BIOL, V401, P389, DOI 10.1016/j.jmb.2010.06.017; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Guo FH, 2000, J IMMUNOL, V164, P5970, DOI 10.4049/jimmunol.164.11.5970; Havens CG, 2006, MOL CELL BIOL, V26, P4701, DOI 10.1128/MCB.00303-06; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hilbi H, 1997, PARASITOLOGY, V115, pS79, DOI 10.1017/S0031182097001790; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Kolodziejski PJ, 2004, P NATL ACAD SCI USA, V101, P18141, DOI 10.1073/pnas.0406711102; Kolodziejski PJ, 2002, P NATL ACAD SCI USA, V99, P12315, DOI 10.1073/pnas.192345199; Kuang ZH, 2010, J CELL BIOL, V190, P129, DOI 10.1083/jcb.200912087; Masters SL, 2006, NAT STRUCT MOL BIOL, V13, P77, DOI 10.1038/nsmb1034; MESSMER UK, 1995, MOL PHARMACOL, V47, P757; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Musial A, 2001, J BIOL CHEM, V276, P24268, DOI 10.1074/jbc.M100725200; Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Nicholson SE, 1998, J LEUKOCYTE BIOL, V63, P665, DOI 10.1002/jlb.63.6.665; Nishiya T, 2004, J BIOL CHEM, V279, P19008, DOI 10.1074/jbc.M311618200; Nishiya T, 2005, J BIOL CHEM, V280, P37107, DOI 10.1074/jbc.M504951200; Nishiya T, 2007, FEBS LETT, V581, P3223, DOI 10.1016/j.febslet.2007.06.008; Park SH, 2007, MOL BIOL CELL, V18, P153, DOI 10.1091/mbc.E06-04-0338; Prabhakar P, 2000, J BIOL CHEM, V275, P19416, DOI 10.1074/jbc.M001952200; Ricciardolo FLM, 2004, PHYSIOL REV, V84, P731, DOI 10.1152/physrev.00034.2003; SARIH M, 1993, BIOCHEM BIOPH RES CO, V191, P503, DOI 10.1006/bbrc.1993.1246; SCHWARTZ LM, 1990, NEURON, V5, P411, DOI 10.1016/0896-6273(90)90080-Y; Sha YB, 2009, MOL CELL BIOL, V29, P116, DOI 10.1128/MCB.00829-08; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; STUEHR DJ, 1989, J EXP MED, V169, P1543, DOI 10.1084/jem.169.5.1543; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; VODOVOTZ Y, 1995, J IMMUNOL, V154, P2914; Wang DK, 2005, J BIOL CHEM, V280, P16393, DOI 10.1074/jbc.M413897200; Webb JL, 2001, INFECT IMMUN, V69, P6391, DOI 10.1128/IAI.69.10.6391-6400.2001; Wheeler MA, 1997, J CLIN INVEST, V99, P110, DOI 10.1172/JCI119121; Woo JS, 2006, MOL CELL, V24, P967, DOI 10.1016/j.molcel.2006.11.009	43	50	50	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9009	9019		10.1074/jbc.M110.190678	http://dx.doi.org/10.1074/jbc.M110.190678			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21199876	Green Published, hybrid			2022-12-27	WOS:000288247700032
J	Varshney, AK; Wang, XB; Cook, E; Dutta, K; Scharff, MD; Goger, MJ; Fries, BC				Varshney, Avanish K.; Wang, Xiaobo; Cook, Emily; Dutta, Kaushik; Scharff, Matthew D.; Goger, Michael J.; Fries, Bettina C.			Generation, Characterization, and Epitope Mapping of Neutralizing and Protective Monoclonal Antibodies against Staphylococcal Enterotoxin B-induced Lethal Shock	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL SUPERANTIGENS; CRYSTAL-STRUCTURE; BINDING PROTEIN; TRANSGENIC MICE; TOXIC-SHOCK; IN-VITRO; VACCINATION; VACCINES; MUTANTS; SEPSIS	T-cell stimulating activity of Staphylococcal enterotoxin B (SEB) is an important factor in the pathogenesis of certain staphylococcal diseases including SEB mediated shock. SEB is one of the most potent superantigens known and treatment of SEB induced shock remains a challenge. We generated and characterized murine monoclonal antibodies (mAbs) to SEB in mice. We tested mAbs neutralize mitogenic effects of SEB in vitro and in vivo with T-cell proliferation assays and 2 murine models for SEB induced lethal shock (SEBILS). Epitope mapping suggests that all these mAbs recognize conformational epitopes that are destroyed by deleting the C terminus of the protein. Further site-directed mutagenesis identified potential residues involved in binding to SEB that differ between Methicillin resistant and sensitive Staphylococcus aureus strains. Only mAb 20B1 was effective as a monotherapy in treating SEBILS in HLA DR3 transgenic mice, which exhibit enhanced sensitivity to SEB. It is noteworthy that mAbs, 14G8 and 6D3 were not protective when given alone in the HLA DR3 mice but their efficacy of protection could be greatly enhanced when mAbs were co-administered simultaneously. Our data suggest combinations of defined mAbs may constitute a better treatment strategy and provide a new insight for the development of passive immunotherapy.	[Varshney, Avanish K.; Wang, Xiaobo; Cook, Emily; Fries, Bettina C.] Albert Einstein Coll Med, Dept Med Infect Dis, Bronx, NY 10461 USA; [Scharff, Matthew D.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Dutta, Kaushik; Goger, Michael J.] New York Struct Biol Ctr, New York, NY 10027 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Fries, BC (corresponding author), Albert Einstein Coll Med, Dept Med & Microbiol & Immunol, 1300 Morris Pk Ave,Ullmann 1223, Bronx, NY 10461 USA.	Bettina.Fries@einstein.yu.edu	Varshney, Avanish/E-8500-2012		National Institutes of Health [U54-AI057158-Lipkin, 5T32AI007506-Casadevall]; U.S. Dept. of Defense [W911NF0710053]; New York Structural Biology Center (NYSBC); New York State Office of Science, Technology, and Academic Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057158, T32AI007506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Dept. of Defense(United States Department of Defense); New York Structural Biology Center (NYSBC); New York State Office of Science, Technology, and Academic Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants U54-AI057158-Lipkin and 5T32AI007506-Casadevall, the U.S. Dept. of Defense Grant W911NF0710053; and the New York Structural Biology Center (NYSBC). NYSBC is a STAR center supported by the New York State Office of Science, Technology, and Academic Research.	ALAKHOV VY, 1990, BIOTECHNOL APPL BIOC, V12, P94; ALAKHOV VY, 1992, EUR J BIOCHEM, V209, P823, DOI 10.1111/j.1432-1033.1992.tb17353.x; Alexandrov A, 2001, BIOTECHNIQUES, V30, P1194, DOI 10.2144/01306bm01; Arad G, 2004, IMMUNOL LETT, V91, P141, DOI 10.1016/j.imlet.2003.11.003; Arrecubieta C, 2008, J INFECT DIS, V198, P571, DOI 10.1086/590210; Bachert C, 2008, CURR OPIN ALLERGY CL, V8, P34, DOI 10.1097/ACI.0b013e3282f4178f; Bakker ABH, 2005, J VIROL, V79, P9062, DOI 10.1128/JVI.79.14.9062-9068.2005; Bavari S, 1999, J INFECT DIS, V180, P1365, DOI 10.1086/314977; Bavari S, 1996, J INFECT DIS, V174, P338, DOI 10.1093/infdis/174.2.338; Boles JW, 2003, VACCINE, V21, P2791, DOI 10.1016/S0264-410X(03)00222-6; Casadevall A, 2002, NAT BIOTECHNOL, V20, P114, DOI 10.1038/nbt0202-114; Caughey B, 2003, NAT MED, V9, P819, DOI 10.1038/nm0703-819; Cheng S, 2003, J AUTOIMMUN, V21, P195, DOI 10.1016/S0896-8411(03)00120-3; Cook E, 2007, CLIN VACCINE IMMUNOL, V14, P1094, DOI 10.1128/CVI.00183-07; Darenberg J, 2004, CLIN INFECT DIS, V38, P836, DOI 10.1086/381979; DaSilva L, 2002, J INFECT DIS, V185, P1754, DOI 10.1086/340828; Dattamajumdar AK, 1996, IMMUNOGENETICS, V43, P141, DOI 10.1007/BF00176675; DELGARCIASUAREZ MM, 2004, INFECT IMMUN, V72, P4534; Faulkner L, 2005, J IMMUNOL, V175, P6870, DOI 10.4049/jimmunol.175.10.6870; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; Goudsmit J, 2006, J INFECT DIS, V193, P796, DOI 10.1086/500470; HAMAD ARA, 1994, J EXP MED, V180, P615, DOI 10.1084/jem.180.2.615; Holtfreter S, 2006, J INFECT DIS, V193, P1275, DOI 10.1086/503048; Holtfreter S, 2005, ARCH IMMUNOL THER EX, V53, P13; IANDOLO JJ, 1977, INFECT IMMUN, V16, P610, DOI 10.1128/IAI.16.2.610-616.1977; KAPPLER JW, 1992, J EXP MED, V175, P387, DOI 10.1084/jem.175.2.387; LeClaire RD, 2002, INFECT IMMUN, V70, P2278, DOI 10.1128/IAI.70.5.2278-2281.2002; LeClaire RD, 2001, ANTIMICROB AGENTS CH, V45, P460, DOI 10.1128/AAC.45.2.460-463.2001; Li HM, 1998, IMMUNITY, V9, P807, DOI 10.1016/S1074-7613(00)80646-9; Li HY, 2003, SHOCK, V20, P257, DOI 10.1097/00024382-200309000-00010; Liu Tao, 2006, J Huazhong Univ Sci Technolog Med Sci, V26, P63; MacCarthy T, 2009, DNA REPAIR, V8, P137, DOI 10.1016/j.dnarep.2008.09.006; METZROTH B, 1993, INFECT IMMUN, V61, P2445, DOI 10.1128/IAI.61.6.2445-2452.1993; MIETHKE T, 1992, J EXP MED, V175, P91, DOI 10.1084/jem.175.1.91; Nishi JI, 1997, J IMMUNOL, V158, P247; NORMANN SJ, 1970, J IMMUNOL, V104, P673; Papageorgiou AC, 1998, J MOL BIOL, V277, P61, DOI 10.1006/jmbi.1997.1577; Rajagopalan G, 2004, INFECT IMMUN, V72, P6733, DOI 10.1128/IAI.72.11.6733-6737.2004; Rajagopalan G, 2003, TISSUE ANTIGENS, V62, P149, DOI 10.1034/j.1399-0039.2003.00088.x; Rajagopalan G, 2006, SHOCK, V25, P647, DOI 10.1097/01.shk.0000209565.92445.7d; Rossi RE, 2004, INT ARCH ALLERGY IMM, V133, P261, DOI 10.1159/000076833; Rossi RJ, 2004, INT IMMUNOL, V16, P1751, DOI 10.1093/intimm/dxh176; Stiles BG, 2001, INFECT IMMUN, V69, P2031, DOI 10.1128/IAI.69.4.2031-2036.2001; SWAMINATHAN S, 1992, NATURE, V359, P801, DOI 10.1038/359801a0; Ulrich R. G., 2001, TXB MILITARY MED MED; Ulrich RG, 1998, TRENDS MICROBIOL, V6, P134, DOI 10.1016/S0966-842X(98)01247-5; Ulrich RG, 1998, VACCINE, V16, P1857, DOI 10.1016/S0264-410X(98)00176-5; Vabulas R, 1996, INFECT IMMUN, V64, P4567, DOI 10.1128/IAI.64.11.4567-4573.1996; Welsch JA, 2008, J INFECT DIS, V197, P1053, DOI 10.1086/528994; Woody MA, 1997, VACCINE, V15, P133, DOI 10.1016/S0264-410X(96)00166-1	50	48	53	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9737	9747		10.1074/jbc.M110.212407	http://dx.doi.org/10.1074/jbc.M110.212407			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21233204	hybrid, Green Published			2022-12-27	WOS:000288247700097
J	Wijeyesakere, SJ; Gafni, AA; Raghavan, M				Wijeyesakere, Sanjeeva J.; Gafni, Ari A.; Raghavan, Malini			Calreticulin Is a Thermostable Protein with Distinct Structural Responses to Different Divalent Cation Environments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; HEAT-SHOCK; IN-VITRO; CHAPERONE CALRETICULIN; CA2+ STORE; P-DOMAIN; CALCIUM; CALNEXIN; CONFORMATION; RECOGNITION	Calreticulin is a soluble calcium-binding chaperone of the endoplasmic reticulum (ER) that is also detected on the cell surface and in the cytosol. Calreticulin contains a single high affinity calcium-binding site within a globular domain and multiple low affinity sites within a C-terminal acidic region. We show that the secondary structure of calreticulin is remarkably thermostable at a given calcium concentration. Rather than corresponding to complete unfolding events, heat-induced structural transitions observed for calreticulin relate to tertiary structural changes that expose hydrophobic residues and reduce protein rigidity. The thermostability and the overall secondary structure content of calreticulin are impacted by the divalent cation environment, with the ER range of calcium concentrations enhancing stability, and calcium-depleting or high calcium environments reducing stability. Furthermore, magnesium competes with calcium for binding to calreticulin and reduces thermostability. The acidic domain of calreticulin is an important mediator of calcium-dependent changes in secondary structure content and thermostability. Together, these studies indicate interactions between the globular and acidic domains of calreticulin that are impacted by divalent cations. These interactions influence the structure and stability of calreticulin, and are likely to determine the multiple functional activities of calreticulin in different subcellular environments.	[Raghavan, Malini] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA; [Gafni, Ari A.] Univ Michigan, Dept Biophys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Raghavan, M (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, 5641 Med Sci Bldg 2, Ann Arbor, MI 48109 USA.	malinir@umich.edu			National Institutes of Health [AI 066131]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066131] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI 066131.	Afshar N, 2005, MOL CELL BIOL, V25, P8844, DOI 10.1128/MCB.25.20.8844-8853.2005; BAKSH S, 1991, J BIOL CHEM, V266, P21458; Bouvier M, 2000, BIOCHEMISTRY-US, V39, P14950, DOI 10.1021/bi0019545; Burdakov D, 2005, CELL CALCIUM, V38, P303, DOI 10.1016/j.ceca.2005.06.010; Conte IL, 2007, BIOCHEMISTRY-US, V46, P4671, DOI 10.1021/bi6026456; CONWAY EM, 1995, J BIOL CHEM, V270, P17011, DOI 10.1074/jbc.270.28.17011; Corbett EF, 2000, J BIOL CHEM, V275, P27177; Corbett EF, 1999, J BIOL CHEM, V274, P6203, DOI 10.1074/jbc.274.10.6203; Del Cid N, 2010, J BIOL CHEM, V285, P4520, DOI 10.1074/jbc.M109.085407; Ellgaard L, 2001, P NATL ACAD SCI USA, V98, P3133, DOI 10.1073/pnas.051630098; Fasolato C, 1998, MOL BIOL CELL, V9, P1513, DOI 10.1091/mbc.9.6.1513; Frickel EM, 2002, P NATL ACAD SCI USA, V99, P1954, DOI 10.1073/pnas.042699099; Gold LI, 2010, FASEB J, V24, P665, DOI 10.1096/fj.09-145482; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Jeffery E, 2011, J BIOL CHEM, V286, P2402, DOI 10.1074/jbc.M110.180877; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jorgensen CS, 2003, EUR J BIOCHEM, V270, P4140, DOI 10.1046/j.1432-1033.2003.03808.x; KELEPOURIS E, 1993, MINER ELECTROL METAB, V19, P277; Kim R, 2003, P NATL ACAD SCI USA, V100, P8151, DOI 10.1073/pnas.1032940100; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LE AQ, 1994, J BIOL CHEM, V269, P7514; Li Y, 2004, J CELL BIOL, V164, P35, DOI 10.1083/jcb.200307010; Li ZJ, 2001, BIOCHEMISTRY-US, V40, P11193, DOI 10.1021/bi010948l; Mancino L, 2002, P NATL ACAD SCI USA, V99, P5931, DOI 10.1073/pnas.092031799; Mattson MP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3114pe10; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; Nakamura K, 2001, J CELL BIOL, V154, P961, DOI 10.1083/jcb.200102073; NASH PD, 1994, MOL CELL BIOCHEM, V135, P71, DOI 10.1007/BF00925962; Ong DST, 2010, NAT CHEM BIOL, V6, P424, DOI 10.1038/nchembio.368; Pinton P, 2006, CELL DEATH DIFFER, V13, P1409, DOI 10.1038/sj.cdd.4401960; Rizvi SM, 2004, MOL CELL, V15, P913, DOI 10.1016/j.molcel.2004.09.001; Saito Y, 1999, EMBO J, V18, P6718, DOI 10.1093/emboj/18.23.6718; SAMBROOK JF, 1990, CELL, V61, P197, DOI 10.1016/0092-8674(90)90798-J; Schrag JD, 2001, MOL CELL, V8, P633, DOI 10.1016/S1097-2765(01)00318-5; Shaffer KL, 2005, DEV CELL, V9, P545, DOI 10.1016/j.devcel.2005.09.001; SONNICHSEN B, 1994, J CELL SCI, V107, P2705; Thammavongsa V, 2005, J BIOL CHEM, V280, P33497, DOI 10.1074/jbc.M503648200; Giraldo AMV, 2010, J BIOL CHEM, V285, P4544, DOI 10.1074/jbc.M109.034512; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; WOODY RW, 1994, EUR BIOPHYS J BIOPHY, V23, P253, DOI 10.1007/BF00213575; Xu W, 2000, J BIOL CHEM, V275, P36676, DOI 10.1074/jbc.M002041200; Yu CM, 2004, EXP EYE RES, V79, P249, DOI 10.1016/j.exer.2004.04.006; Zhang KZ, 2010, INT J CLIN EXP MED, V3, P33	46	30	31	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8771	8785		10.1074/jbc.M110.169193	http://dx.doi.org/10.1074/jbc.M110.169193			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21177861	hybrid, Green Published			2022-12-27	WOS:000288247700008
J	Zaarour, N; Defontaine, N; Demaretz, S; Azroyan, A; Cheval, L; Laghmani, K				Zaarour, Nancy; Defontaine, Nadia; Demaretz, Sylvie; Azroyan, Anie; Cheval, Lydie; Laghmani, Kamel			Secretory Carrier Membrane Protein 2 Regulates Exocytic Insertion of NKCC2 into the Cell Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THICK ASCENDING LIMB; CORE VESICLE EXOCYTOSIS; RECYCLING ENDOSOMES; SURFACE EXPRESSION; CHLORIDE CHANNEL; EPITHELIAL-CELLS; NA+-K+-2CL(-) COTRANSPORTER; SORTING ENDOSOMES; APICAL MEMBRANE; PLASMA-MEMBRANE	The renal-specific Na-K-2Cl co-transporter, NKCC2, plays a pivotal role in regulating body salt levels and blood pressure. NKCC2 mutations lead to type I Bartter syndrome, a life-threatening kidney disease. Regulation of NKCC2 trafficking behavior serves as a major mechanism in controlling NKCC2 activity across the plasma membrane. However, the identities of the protein partners involved in cell surface targeting of NKCC2 are largely unknown. To gain insight into these processes, we used a yeast two-hybrid system to screen a kidney cDNA library for proteins that interact with the NKCC2 C terminus. One binding partner we identified was SCAMP2 (secretory carrier membrane protein 2). Microscopic confocal imaging and co-immunoprecipitation assays confirmed NKCC2-SCAMP2 interaction in renal cells. SCAMP2 associated also with the structurally related co-transporter NCC, suggesting that the interaction with SCAMP2 is a common feature of sodium-dependent chloride co-transporters. Heterologous expression of SCAMP2 specifically decreased cell surface abundance as well as transport activity of NKCC2 across the plasma membrane. Co-immunolocalization experiments revealed that intracellularly retained NKCC2co-localizes with SCAMP2 in recycling endosomes. The rate of NKCC2 endocytic retrieval, assessed by the sodium 2-mercaptoethane sulfonate cleavage assay, was not affected by SCAMP2. The surface-biotinylatable fraction of newly inserted NKCC2 in the plasma membrane was reduced by SCAMP2, demonstrating that SCAMP2-induced decrease in surface NKCC2 is due to decreased exocytotic trafficking. Finally, a single amino acid mutation, cysteine 201 to alanine, within the conserved cytoplasmic E peptide of SCAMP2, which is believed to regulate exocytosis, abolished SCAMP2-mediated down-regulation of the co-transporter. Taken together, these data are consistent with a model whereby SCAMP2 regulates NKCC2 transit through recycling endosomes and limits the cell surface targeting of the co-transporter by interfering with its exocytotic trafficking.	[Zaarour, Nancy; Defontaine, Nadia; Demaretz, Sylvie; Azroyan, Anie; Cheval, Lydie; Laghmani, Kamel] CNRS, INSERM, Ctr Rech Cordeliers, UMRS 872,ERL7226, F-75006 Paris, France; [Zaarour, Nancy; Defontaine, Nadia; Demaretz, Sylvie; Azroyan, Anie; Cheval, Lydie; Laghmani, Kamel] Univ Paris 06, F-75006 Paris, France; [Zaarour, Nancy; Defontaine, Nadia; Demaretz, Sylvie; Azroyan, Anie; Cheval, Lydie; Laghmani, Kamel] Univ Paris 05, Fac Med, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Laghmani, K (corresponding author), UMRS 872 Equipe 3 ERL7226, 15 Rue Ecole Med, F-752270 Paris 06, France.	Kamel.Laghmani@crc.jussieu.fr	Laghmani, Kamel/AIE-9621-2022	Laghmani, Kamel/0000-0002-2167-5766; CHEVAL, LYDIE/0000-0003-2957-6487	INSERM (Paris, France); Fondation pour la Recherche Medicale; la Societe de Neprologie	INSERM (Paris, France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); la Societe de Neprologie	This work was supported by grants from INSERM (Paris, France).; Recipient of a thesis fellowship from the Fondation pour la Recherche Medicale and from la Societe de Neprologie.	Akhter S, 2002, AM J PHYSIOL-CELL PH, V283, pC927, DOI 10.1152/ajpcell.00613.2001; Amlal H, 1996, AM J PHYSIOL-CELL PH, V271, pC455, DOI 10.1152/ajpcell.1996.271.2.C455; Ang AL, 2004, J CELL BIOL, V167, P531, DOI 10.1083/jcb.200408165; Ares GR, 2010, AM J PHYSIOL-RENAL, V299, pF1193, DOI 10.1152/ajprenal.00307.2010; Ashton N, 2006, J HYPERTENS, V24, P2355, DOI 10.1097/HJH.0b013e3280104dd1; Bartz R, 2003, BIOCHEM BIOPH RES CO, V312, P663, DOI 10.1016/j.bbrc.2003.10.172; Benziane B, 2007, J BIOL CHEM, V282, P33817, DOI 10.1074/jbc.M700195200; Caceres PS, 2009, J BIOL CHEM, V284, P24965, DOI 10.1074/jbc.M109.037135; Caplan MJ, 1997, AM J PHYSIOL-RENAL, V272, pF425, DOI 10.1152/ajprenal.1997.272.4.F425; Carmosino M, 2008, MOL BIOL CELL, V19, P4341, DOI 10.1091/mbc.E08-05-0478; Castle A, 2005, J CELL SCI, V118, P3769, DOI 10.1242/jcs.02503; Cheng J, 2002, J BIOL CHEM, V277, P3520, DOI 10.1074/jbc.M110177200; Cresawn KO, 2007, EMBO J, V26, P3737, DOI 10.1038/sj.emboj.7601813; Diering GH, 2009, J BIOL CHEM, V284, P13892, DOI 10.1074/jbc.M807055200; Donowitz M, 2005, J PHYSIOL-LONDON, V567, P3, DOI 10.1113/jphysiol.2005.090399; DOUCET A, 1979, AM J PHYSIOL, V237, pF105, DOI 10.1152/ajprenal.1979.237.2.F105; Ellis MA, 2006, AM J PHYSIOL-RENAL, V291, pF707, DOI 10.1152/ajprenal.00161.2006; Fernandez-Chacon R, 2000, J NEUROSCI, V20, P7941; Fernandez-Chacon R, 2000, J BIOL CHEM, V275, P12752, DOI 10.1074/jbc.275.17.12752; Flatman PW, 2008, CURR OPIN NEPHROL HY, V17, P186, DOI 10.1097/MNH.0b013e3282f5244e; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gamba G, 2005, AM J PHYSIOL-RENAL, V288, pF245, DOI 10.1152/ajprenal.00311.2004; Gamba G, 1999, KIDNEY INT, V56, P1606, DOI 10.1046/j.1523-1755.1999.00712.x; Gimenez I, 2003, J BIOL CHEM, V278, P26946, DOI 10.1074/jbc.M303435200; Green EG, 1997, BIOCHEM BIOPH RES CO, V239, P612, DOI 10.1006/bbrc.1997.7520; Guo ZH, 2002, J BIOL CHEM, V277, P35357, DOI 10.1074/jbc.M202259200; Han CF, 2009, J IMMUNOL, V182, P2986, DOI 10.4049/jimmunol.0802002; Hannemann A, 2009, J BIOL CHEM, V284, P35348, DOI 10.1074/jbc.M109.060004; Hardel N, 2008, CARDIOVASC RES, V79, P52, DOI 10.1093/cvr/cvn062; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; Hoekstra D, 2004, J CELL SCI, V117, P2183, DOI 10.1242/jcs.01217; Hryciw DH, 2006, INT J BIOCHEM CELL B, V38, P1036, DOI 10.1016/j.biocel.2005.09.009; Hryciw DH, 2004, J BIOL CHEM, V279, P54996, DOI 10.1074/jbc.M411491200; Hu MC, 2001, J BIOL CHEM, V276, P26906, DOI 10.1074/jbc.M011338200; Hubbard C, 2000, MOL BIOL CELL, V11, P2933, DOI 10.1091/mbc.11.9.2933; Idkowiak-Baldys J, 2009, J BIOL CHEM, V284, P22322, DOI 10.1074/jbc.M109.026765; Johns TG, 2005, FASEB J, V19, P780, DOI 10.1096/fj.04-1766fje; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Liao H, 2008, AM J PHYSIOL-CELL PH, V294, pC797, DOI 10.1152/ajpcell.00493.2007; Liao H, 2007, BIOCHEMISTRY-US, V46, P10909, DOI 10.1021/bi701121j; Lin PJC, 2005, J CELL SCI, V118, P1885, DOI 10.1242/jcs.02315; Liu LX, 2002, MOL BIOL CELL, V13, P4266, DOI 10.1091/mbc.E02-03-0136; Lock JG, 2005, MOL BIOL CELL, V16, P1744, DOI 10.1091/mbc.E04-10-0867; Meade P, 2003, AM J PHYSIOL-RENAL, V284, pF1145, DOI 10.1152/ajprenal.00421.2002; Mohammad-Panah R, 2003, J BIOL CHEM, V278, P29267, DOI 10.1074/jbc.M304357200; Mount DB, 2006, AM J PHYSIOL-RENAL, V290, pF606, DOI 10.1152/ajprenal.00410.2005; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Muller HK, 2006, J BIOL CHEM, V281, P28901, DOI 10.1074/jbc.M602848200; Nielsen S, 1998, AM J PHYSIOL-RENAL, V275, pF885, DOI 10.1152/ajprenal.1998.275.6.F885; Ortiz PA, 2006, AM J PHYSIOL-RENAL, V290, pF608, DOI 10.1152/ajprenal.00248.2005; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Richardson C, 2008, J CELL SCI, V121, P3293, DOI 10.1242/jcs.029223; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Satoh AK, 2005, DEVELOPMENT, V132, P1487, DOI 10.1242/dev.01704; Simon DB, 1996, AM J PHYSIOL-RENAL, V271, pF961, DOI 10.1152/ajprenal.1996.271.5.F961; Sonnichsen B, 2000, J CELL BIOL, V149, P901, DOI 10.1083/jcb.149.4.901; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Thakker RV, 2000, KIDNEY INT, V57, P787, DOI 10.1046/j.1523-1755.2000.00916.x; URBE S, 1993, FEBS LETT, V334, P175, DOI 10.1016/0014-5793(93)81707-7; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9; Wang XY, 2000, J BIOL CHEM, V275, P29138, DOI 10.1074/jbc.M004410200; Ward ES, 2005, MOL BIOL CELL, V16, P2028, DOI 10.1091/mbc.E04-08-0735; Watanabe I, 2003, J PHYSIOL-LONDON, V550, P51, DOI 10.1113/jphysiol.2003.040337; Welker P, 2008, AM J PHYSIOL-RENAL, V295, pF789, DOI 10.1152/ajprenal.90227.2008; Yang XJ, 2000, AM J PHYSIOL-CELL PH, V279, pC410, DOI 10.1152/ajpcell.2000.279.2.C410; Zaarour N, 2009, J BIOL CHEM, V284, P21752, DOI 10.1074/jbc.M109.000679; Zhu J, 2003, BIOCHEM J, V375, P761, DOI 10.1042/BJ20030885	69	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9489	9502		10.1074/jbc.M110.166546	http://dx.doi.org/10.1074/jbc.M110.166546			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21205824	Green Published, hybrid			2022-12-27	WOS:000288247700076
J	Freire, T; Lo-Man, R; Bay, S; Leclerc, C				Freire, Teresa; Lo-Man, Richard; Bay, Sylvie; Leclerc, Claude			Tn Glycosylation of the MUC6 Protein Modulates Its Immunogenicity and Promotes the Induction of Th17-biased T Cell Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYPEPTIDE N-ACETYLGALACTOSAMINYLTRANSFERASES; C-TYPE LECTIN; DENDRITIC-CELLS; GASTRIC MUCIN; BREAST-CANCER; POSTTRANSLATIONAL MODIFICATIONS; THERAPEUTIC PROTEINS; LINKED GLYCOPEPTIDE; ANTIGEN RECOGNITION; ABERRANT EXPRESSION	The Tn antigen (alpha-GalNAc-O-Ser/Thr) is one of the most specific human cancer-associated structures. This antigen, together with mucins, the major carriers of O-glycosylated tumor antigens in adenocarcinomas, are being evaluated as anticancer immunotherapeutic targets. In particular, the MUC6 protein, which is normally expressed only in gastric tissues, has been detected in intestinal, pulmonary, colorectal, and breast carcinomas. To develop anti-cancer vaccines based on the Tn antigen, we produced MUC6 proteins with different Tn density by using mixtures of recombinant ppGalNAc-T1, -T2, and -T7. The obtained glycoproteins were characterized and analyzed for their immunological properties, as compared with the non-glycosylated MUC6. We show that these various MUC6: Tn glycoproteins were well recognized by both MUC6 and Tn-specific antibodies. However, Tn glycosylation of the MUC6 protein strongly affected their immunogenicity by partially abrogating Th1 cell responses, and promoting IL-17 responses. Moreover, the non-glycosylated MUC6 was more efficiently presented than MUC6:Tn glycoproteins to specific T CD4(+) hybridomas, suggesting that Tn glycosylation may affect MUC6 processing or MHC binding of the processed peptides. In conclusion, our results indicate that Tn glycosylation of the MUC6 protein strongly affects its B and T cell immunogenicity, and might favor immune escape of tumor cells.	[Leclerc, Claude] Inst Pasteur, Inserm U1041, Unite Regulat Immunitaire & Vaccinol, Dept Immunol, F-75724 Paris 15, France; [Freire, Teresa; Lo-Man, Richard; Leclerc, Claude] INSERM, U1041, Paris, France; [Freire, Teresa; Bay, Sylvie] Inst Pasteur, Dept Biol Struct & Chim, Unite Chim Biomol, F-75015 Paris, France; [Freire, Teresa; Bay, Sylvie] CNRS, URA 2128, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Leclerc, C (corresponding author), Inst Pasteur, Inserm U1041, Unite Regulat Immunitaire & Vaccinol, Dept Immunol, 25-28 Rue Dr Roux, F-75724 Paris 15, France.	claude.leclerc@pasteur.fr		Freire Gard, Teresa Ines/0000-0002-7808-8845	Institut Pasteur [PIC-PTR 278, PTR 262, DARRI 27237]; Ligue Nationale Contre le Cancer; Mutuelle Generale de l'Education Nationale Union; Fondation pour la Recherche Medicale; Vasand and Kusum Joshi; Comision Honoraria de Lucha contra el Cancer (Uruguay)	Institut Pasteur(European Commission); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Mutuelle Generale de l'Education Nationale Union; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Vasand and Kusum Joshi; Comision Honoraria de Lucha contra el Cancer (Uruguay)	This work was supported in part by Institut Pasteur Grants PIC-PTR 278, PTR 262, and DARRI 27237, the Ligue Nationale Contre le Cancer (Equipe Labelisee 2011) (to C. L.), and the Mutuelle Generale de l'Education Nationale Union.; Supported by Ligue Nationale contre le Cancer, Fondation pour la Recherche Medicale, Institut Pasteur, Vasand and Kusum Joshi, and Comision Honoraria de Lucha contra el Cancer (Uruguay). Present address: Dept. Inmunobiologia, Facultad de Medicina, Gral. Flores 2125, 11800 Montevideo, Uruguay.	Ajisaka K, 2000, BIOSCI BIOTECH BIOCH, V64, P1743, DOI 10.1271/bbb.64.1743; Anderton SM, 2004, CURR OPIN IMMUNOL, V16, P753, DOI 10.1016/j.coi.2004.09.001; Baldus SE, 2004, CRIT REV CL LAB SCI, V41, P189, DOI 10.1080/10408360490452040; Bartman AE, 1999, INT J CANCER, V80, P210; Bennett EP, 1999, FEBS LETT, V460, P226, DOI 10.1016/S0014-5793(99)01268-5; Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705; Carbone FR, 1997, GLYCOBIOLOGY, V7, P725, DOI 10.1093/glycob/7.6.725-d; Cheng LM, 2004, FEBS LETT, V566, P17, DOI 10.1016/j.febslet.2004.03.108; Cloos PAC, 2004, BIOGERONTOLOGY, V5, P139, DOI 10.1023/B:BGEN.0000031152.31352.8b; Corthay A, 1998, EUR J IMMUNOL, V28, P2580, DOI 10.1002/(SICI)1521-4141(199808)28:08<2580::AID-IMMU2580>3.0.CO;2-X; Cudic M, 2002, BIOORGAN MED CHEM, V10, P3859, DOI 10.1016/S0968-0896(02)00388-7; De Groot AS, 2007, TRENDS IMMUNOL, V28, P482, DOI 10.1016/j.it.2007.07.011; Denda-Nagai K, 2010, J BIOL CHEM, V285, P19193, DOI 10.1074/jbc.M110.113613; Dowling W, 2007, J VIROL, V81, P1821, DOI 10.1128/JVI.02098-06; Freire T, 2006, GLYCOBIOLOGY, V16, P390, DOI 10.1093/glycob/cwj082; Freire T, 2006, BIOCONJUGATE CHEM, V17, P559, DOI 10.1021/bc0502661; Freire T, 2005, CANCER RES, V65, P7880, DOI 10.1158/0008-5472.CAN-04-3746; Freire T, 2006, MINI-REV MED CHEM, V6, P1357, DOI 10.2174/138955706778992996; Freire T, 2010, BLOOD, V116, P3526, DOI 10.1182/blood-2010-04-279133; GalliStampino L, 1997, CANCER RES, V57, P3214; GENDLER SJ, 1995, ANNU REV PHYSIOL, V57, P607, DOI 10.1146/annurev.ph.57.030195.003135; George SK, 2001, J AM CHEM SOC, V123, P11117, DOI 10.1021/ja015570t; Gerken TA, 2002, J BIOL CHEM, V277, P49850, DOI 10.1074/jbc.M205851200; Grinstead JS, 2003, BIOCHEMISTRY-US, V42, P14293, DOI 10.1021/bi0301237; Guillem P, 2000, INT J CANCER, V88, P856, DOI 10.1002/1097-0215(20001215)88:6<856::AID-IJC3>3.0.CO;2-D; Hamamoto A, 2005, INT J ONCOL, V26, P891; Hanisch FG, 2003, EUR J IMMUNOL, V33, P3242, DOI 10.1002/eji.200324189; HARDING CV, 1993, J IMMUNOL, V151, P2419; HAURUM JS, 1994, J EXP MED, V180, P739, DOI 10.1084/jem.180.2.739; Hermeling S, 2004, PHARM RES-DORDR, V21, P897, DOI 10.1023/B:PHAM.0000029275.41323.a6; HILKENS J, 1992, TRENDS BIOCHEM SCI, V17, P359, DOI 10.1016/0968-0004(92)90315-Z; Hiltbold EM, 1999, CELL IMMUNOL, V194, P143, DOI 10.1006/cimm.1999.1512; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; ISHIOKA GY, 1992, J IMMUNOL, V148, P2446; Kagan E, 2005, CANCER IMMUNOL IMMUN, V54, P424, DOI 10.1007/s00262-004-0584-y; Kryczek I, 2007, J IMMUNOL, V178, P6730, DOI 10.4049/jimmunol.178.11.6730; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Leclerc C, 1997, J IMMUNOL, V158, P3252; LeibundGut-Landmann S, 2008, BLOOD, V112, P4971, DOI 10.1182/blood-2008-05-158469; Lo-Man R, 2004, CANCER RES, V64, P4987, DOI 10.1158/0008-5472.CAN-04-0252; Lo-Man R, 2001, J IMMUNOL, V166, P2849, DOI 10.4049/jimmunol.166.4.2849; Lo-Man R, 2000, INFECT IMMUN, V68, P3079, DOI 10.1128/IAI.68.6.3079-3089.2000; Marcaurelle LA, 2002, GLYCOBIOLOGY, V12, p69R, DOI 10.1093/glycob/12.6.69R; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; MOURITSEN S, 1994, EUR J IMMUNOL, V24, P1066, DOI 10.1002/eji.1830240509; Ninkovic T, 2007, J IMMUNOL, V179, P2380, DOI 10.4049/jimmunol.179.4.2380; OSINAGA E, 1994, BREAST CANCER RES TR, V32, P139, DOI 10.1007/BF00665765; Pang PC, 2009, J PROTEOME RES, V8, P4906, DOI 10.1021/pr9001756; Pereira MB, 2001, J CLIN PATHOL, V54, P210, DOI 10.1136/jcp.54.3.210; Rachagani S, 2009, BIOFACTORS, V35, P509, DOI 10.1002/biof.64; Reis CA, 2000, J HISTOCHEM CYTOCHEM, V48, P377, DOI 10.1177/002215540004800307; Ryan SO, 2009, BIOL CHEM, V390, P611, DOI 10.1515/BC.2009.070; Schuster O, 1999, J BIOMOL NMR, V14, P33, DOI 10.1023/A:1008397304851; Schwientek T, 2002, J BIOL CHEM, V277, P22623, DOI 10.1074/jbc.M202684200; Segal-Eiras A, 1997, Allergol Immunopathol (Madr), V25, P176; Sinclair AM, 2005, J PHARM SCI-US, V94, P1626, DOI 10.1002/jps.20319; Sorensen AL, 2006, GLYCOBIOLOGY, V16, P96, DOI 10.1093/glycob/cwj044; SPRINGER GF, 1995, CANCER DETECT PREV, V19, P374; Springer GF, 1997, J MOL MED, V75, P594, DOI 10.1007/s001090050144; Stepensky D, 2006, CLIN EXP IMMUNOL, V143, P139, DOI 10.1111/j.1365-2249.2005.02965.x; Suzuki N, 1996, J IMMUNOL, V156, P128; Ten Hagen KG, 2003, GLYCOBIOLOGY, V13, p1R, DOI 10.1093/glycob/cwg007; TORIBARA NW, 1993, J BIOL CHEM, V268, P5879; vanderBurg SH, 1996, J IMMUNOL, V156, P3308; Vlad AM, 2002, J EXP MED, V196, P1435, DOI 10.1084/jem.20020493; von Mensdorff-Pouilly S, 2005, GLYCOBIOLOGY, V15, P735, DOI 10.1093/glycob/cwi058; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470	67	37	38	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7797	7811		10.1074/jbc.M110.209742	http://dx.doi.org/10.1074/jbc.M110.209742			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21193402	hybrid, Green Published			2022-12-27	WOS:000288013300011
J	Yuan, W; Xu, M; Huang, C; Liu, N; Chen, S; Zhu, B				Yuan, Wen; Xu, Mo; Huang, Chang; Liu, Nan; Chen, She; Zhu, Bing			H3K36 Methylation Antagonizes PRC2-mediated H3K27 Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; H3 LYSINE-27 METHYLATION; TRITHORAX-GROUP PROTEIN; EMBRYONIC STEM-CELLS; DEVELOPMENTAL REGULATORS; DROSOPHILA-MELANOGASTER; POLYCOMB COMPLEXES; ACTIVE GENES; IN-VIVO; CHROMATIN	H3K27 methylation mediated by the histone methyltransferase complex PRC2 is critical for transcriptional regulation, Polycomb silencing, Drosophila segmentation, mammalian X chromosome inactivation, and cancer. PRC2-mediated H3K27 methylation can spread along the chromatin and propagate the repressive chromatin environment; thus, chromatin components that antagonize the activity of PRC2 are important for restraining Polycomb silencing. Here we report that in HeLa cells, H3 histones unmethylated at Lys-36 are mostly methylated at Lys-27, with the exception of newly synthesized H3. In addition, K27me3 rarely co-exists with K36me2 or K36me3 on the same histone H3 polypeptide. Moreover, PRC2 activity is greatly inhibited on nucleosomal substrates with preinstalled H3K36 methylation. These findings collectively identify H3K36 methylation as a chromatin component that restricts the PRC2-mediated spread of H3K27 methylation. Finally, we provide evidence that the controversial histone lysine methyltransferase Ash1, a known Trithorax group protein that antagonizes Polycomb silencing in vivo, is an H3K36-specific dimethylase, not an H3K4 methylase, further supporting the role of H3K36 methylation in antagonizing PRC2-mediated H3K27 methylation.	[Yuan, Wen; Xu, Mo; Huang, Chang; Liu, Nan; Chen, She; Zhu, Bing] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Yuan, Wen; Huang, Chang] China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China; [Xu, Mo] Peking Union Med Coll, Grad Program, Beijing 100730, Peoples R China; [Xu, Mo] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Liu, Nan] Beijing Normal Univ, Life Sci Coll, Beijing 100875, Peoples R China	National Institute of Biological Sciences, Beijing; China Agricultural University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Beijing Normal University	Zhu, B (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	zhubing@nibs.ac.cn		yuan, wen/0000-0003-0029-2544	Chinese Ministry of Science and Technology [2011CB965300, 2007AA02Z1A6]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	This work was supported by Chinese Ministry of Science and Technology Grants 2011CB965300 and 2007AA02Z1A6 (to B.Z.).	Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Allis CD, 2006, EPIGENETICS, P23; Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126; Bell O, 2007, EMBO J, V26, P4974, DOI 10.1038/sj.emboj.7601926; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Byrd KN, 2003, P NATL ACAD SCI USA, V100, P11535, DOI 10.1073/pnas.1933593100; Campos EI, 2009, ANNU REV GENET, V43, P559, DOI 10.1146/annurev.genet.032608.103928; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Garcia BA, 2007, NAT PROTOC, V2, P933, DOI 10.1038/nprot.2007.106; Gregory GD, 2007, MOL CELL BIOL, V27, P8466, DOI 10.1128/MCB.00993-07; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Jia GS, 2009, CELL RES, V19, P1217, DOI 10.1038/cr.2009.110; Klymenko T, 2004, EMBO REP, V5, P373, DOI 10.1038/sj.embor.7400111; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Mortensen P, 2010, J PROTEOME RES, V9, P393, DOI 10.1021/pr900721e; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Schwartz YB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000805; SHEARN A, 1989, GENETICS, V121, P517; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Tanaka Y, 2007, GENE, V397, P161, DOI 10.1016/j.gene.2007.04.027; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Xu M, 2010, SCIENCE, V328, P94, DOI 10.1126/science.1178994; Young NL, 2009, MOL CELL PROTEOMICS, V8, P2266, DOI 10.1074/mcp.M900238-MCP200; Yuan W, 2009, J BIOL CHEM, V284, P15701, DOI 10.1074/jbc.M808431200; Zee BM, 2010, J BIOL CHEM, V285, P3341, DOI 10.1074/jbc.M109.063784	44	349	358	1	41	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7983	7989		10.1074/jbc.M110.194027	http://dx.doi.org/10.1074/jbc.M110.194027			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21239496	hybrid, Green Published			2022-12-27	WOS:000288013300029
J	Kainov, DE; Muller, KH; Theisen, LL; Anastasina, M; Kaloinen, M; Muller, CP				Kainov, Denis E.; Mueller, Konstantin H.; Theisen, Linda L.; Anastasina, Maria; Kaloinen, Minttu; Muller, Claude P.			Differential Effects of NS1 Proteins of Human Pandemic H1N1/2009, Avian Highly Pathogenic H5N1, and Low Pathogenic H5N2 Influenza A Viruses on Cellular Pre-mRNA Polyadenylation and mRNA Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; INFECTED-CELLS; INITIATION; TARGETS; EXPRESSION; INTERACTS; BINDING; ACTIVATION; MACHINERY	The nonstructural protein NS1 of influenza A virus blocks the development of host antiviral responses by inhibiting polyadenylation of cellular pre-mRNA. NS1 also promotes the synthesis of viral proteins by stimulating mRNA translation. Here, we show that recombinant NS1 proteins of human pandemic H1N1/2009, avian highly pathogenic H5N1, and low pathogenic H5N2 influenza strains differentially affected these two cellular processes: NS1 of the two avian strains, in contrast to NS1 of H1N1/2009, stimulated translation of reporter mRNA in cell-free translation system; NS1 of H5N1 was an effective inhibitor of cellular pre-mRNA polyadenylation in A549 cells, unlike NS1 of H5N2 and H1N1/2009. We identified key amino acids in NS1 that contribute to its activity in these two basic cellular processes. Thus, we identified strain-specific differences between influenza virus NS1 proteins in pre-mRNA polyadenylation and mRNA translation.	[Kainov, Denis E.; Mueller, Konstantin H.; Theisen, Linda L.; Muller, Claude P.] Ctr Rech Publ Sante, Inst Immunol, Lab Natl Sante, L-1011 Luxembourg, Luxembourg; [Kainov, Denis E.; Anastasina, Maria; Kaloinen, Minttu] Univ Helsinki, Inst Mol Med Finland, FI-00014 Helsinki, Finland	Luxembourg Institute of Health; University of Helsinki	Muller, CP (corresponding author), Ctr Rech Publ Sante, Inst Immunol, Lab Natl Sante, L-1011 Luxembourg, Luxembourg.	Claude.Muller@lns.etat.lu	kainov, denis/I-5526-2019	kainov, denis/0000-0001-7716-6955; Anastasina, Maria/0000-0002-4555-6446	Centre de Recherche Public-Sante; European Cooperation in Science and Technology [B28]; Erkko; National Research Fund (Luxembourg); Center for International Mobility	Centre de Recherche Public-Sante; European Cooperation in Science and Technology(European Cooperation in Science and Technology (COST)); Erkko; National Research Fund (Luxembourg)(Luxembourg National Research Fund); Center for International Mobility	This work was supported by a grant from the Centre de Recherche Public-Sante, the European Cooperation in Science and Technology-B28, Erkko, the National Research Fund (Luxembourg), and Center for International Mobility Ph.D. fellowships.	Aragon T, 2000, MOL CELL BIOL, V20, P6259, DOI 10.1128/MCB.20.17.6259-6268.2000; Bornholdt ZA, 2008, NATURE, V456, P985, DOI 10.1038/nature07444; Burgui I, 2003, J GEN VIROL, V84, P3263, DOI 10.1099/vir.0.19487-0; Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; Das K, 2008, P NATL ACAD SCI USA, V105, P13093, DOI 10.1073/pnas.0805213105; DELALUNA S, 1995, J VIROL, V69, P2427, DOI 10.1128/JVI.69.4.2427-2433.1995; Ehrhardt C, 2010, MICROBES INFECT, V12, P81, DOI 10.1016/j.micinf.2009.09.007; Falcon AM, 1999, NUCLEIC ACIDS RES, V27, P2241, DOI 10.1093/nar/27.11.2241; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Gambotto A, 2008, LANCET, V371, P1464, DOI 10.1016/S0140-6736(08)60627-3; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2010, J VIROL, V84, P6909, DOI 10.1128/JVI.00081-10; Hale BG, 2010, P NATL ACAD SCI USA, V107, P1954, DOI 10.1073/pnas.0910715107; Heikkinen LS, 2008, J BIOL CHEM, V283, P5719, DOI 10.1074/jbc.M707195200; Kainov DE, 2003, J BIOL CHEM, V278, P48084, DOI 10.1074/jbc.M306928200; Kainov DE, 2010, DNA REPAIR, V9, P33, DOI 10.1016/j.dnarep.2009.10.002; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Kuo RL, 2009, J VIROL, V83, P1611, DOI 10.1128/JVI.01491-08; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Marion RM, 1997, NUCLEIC ACIDS RES, V25, P4271, DOI 10.1093/nar/25.21.4271; Moltedo B, 2009, J IMMUNOL, V183, P3569, DOI 10.4049/jimmunol.0900091; Murayama R, 2007, BIOCHEM BIOPH RES CO, V362, P880, DOI 10.1016/j.bbrc.2007.08.091; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7; Owoade AA, 2008, EMERG INFECT DIS, V14, P1731, DOI 10.3201/eid1411.080555; Salvatore M, 2002, J VIROL, V76, P1206, DOI 10.1128/JVI.76.3.1206-1212.2002; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; SCHOLTISSEK C, 1994, EUR J EPIDEMIOL, V10, P455, DOI 10.1007/BF01719674; Schote AB, 2007, MOL IMMUNOL, V44, P1436, DOI 10.1016/j.molimm.2006.04.021; Twu KY, 2006, J VIROL, V80, P3957, DOI 10.1128/JVI.80.8.3957-3965.2006; Wolff T, 1998, J VIROL, V72, P7170, DOI 10.1128/JVI.72.9.7170-7180.1998; Zhao C, 2010, P NATL ACAD SCI USA, V107, P2253, DOI 10.1073/pnas.0909144107	32	21	22	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7239	7247		10.1074/jbc.M110.203489	http://dx.doi.org/10.1074/jbc.M110.203489			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21163951	Green Published, hybrid			2022-12-27	WOS:000287737300040
J	Okamoto, Y; Shikano, S				Okamoto, Yukari; Shikano, Sojin			Phosphorylation-dependent C-terminal Binding of 14-3-3 Proteins Promotes Cell Surface Expression of HIV Co-receptor GPR15	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM LOCALIZATION; RETENTION/RETRIEVAL SIGNAL; GABA(B) RECEPTORS; MEMBRANE-PROTEINS; COUPLED RECEPTORS; RETENTION MOTIF; ER RETENTION; TRAFFICKING; TRANSPORT; INFECTION	Membrane trafficking is dictated by dynamic molecular interactions involving discrete determinants in the cargo proteins and the intracellular transport machineries. We have previously reported that cell surface expression of GPR15, a G protein-coupled receptor (GPCR) that serves as a co-receptor for HIV, is correlated with the mode III binding of 14-3-3 proteins to the receptor C terminus. Here we provide a mechanistic basis for the role of 14-3-3 in promoting the cell surface expression of GPR15. The Ala mutation of penultimate phospho-Ser (S359A) that abolishes 14-3-3 binding resulted in substantially reduced O-glycosylation and the cell surface expression of GPR15. The surface membrane protein CD8 fused with the C-terminal tail of GPR15(S359A) mutant was re-localized in the endoplasmic reticulum (ER). In the context of S359A mutation, the additional mutations in the upstream stretch of basic residues (RXR motif) restored O-glycosylation and the cell surface expression. The RXR motif was responsible for the interaction with coatomer protein I (COPI), which was inversely correlated with the 14-3-3 binding and cell surface expression. These results suggest that 14-3-3 binding promotes cell surface expression of GPR15 by releasing the receptor from ER retrieval/retention pathway that is mediated by the interaction of RXR motif and COPI. Moreover, 14-3-3 binding substantially increased the stability of GPR15 protein. Thus 14-3-3 proteins play multiple roles in biogenesis and trafficking of an HIV co-receptor GPR15 to control its cell surface density in response to the phosphorylation signal.	[Okamoto, Yukari; Shikano, Sojin] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Shikano, S (corresponding author), 900 S Ashland Ave, Chicago, IL 60607 USA.	sshikano@uic.edu			American Cancer Society-Illinois Division/LUNGevity Lung Cancer [2009-07001-00-00]	American Cancer Society-Illinois Division/LUNGevity Lung Cancer(American Cancer Society)	This work was supported in part by American Cancer Society-Illinois Division/LUNGevity Lung Cancer Grant 2009-07001-00-00 (to S. S.).	Arenzana-Seisdedos F, 2006, SEMIN IMMUNOL, V18, P387, DOI 10.1016/j.smim.2006.07.007; Bannert N, 2001, J EXP MED, V194, P1661, DOI 10.1084/jem.194.11.1661; Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603; Bernier V, 2004, TRENDS ENDOCRIN MET, V15, P222, DOI 10.1016/j.tem.2004.05.003; Blaak H, 2005, J VIROL, V79, P1686, DOI 10.1128/JVI.79.3.1686-1700.2005; Brock C, 2005, MOL BIOL CELL, V16, P5572, DOI 10.1091/mbc.E05-05-0400; Chiaw PK, 2009, CHEM BIOL, V16, P520, DOI 10.1016/j.chembiol.2009.04.005; Chung JJ, 2009, FEBS J, V276, P5547, DOI 10.1111/j.1742-4658.2009.07241.x; Clayton F, 2001, AM J PATHOL, V159, P1933, DOI 10.1016/S0002-9440(10)63040-4; Coblitz B, 2005, J BIOL CHEM, V280, P36263, DOI 10.1074/jbc.M507559200; Couve A, 1998, J BIOL CHEM, V273, P26361, DOI 10.1074/jbc.273.41.26361; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; Dong CM, 2010, J BIOL CHEM, V285, P20369, DOI 10.1074/jbc.M109.081521; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Dunham JH, 2009, TRENDS BIOTECHNOL, V27, P541, DOI 10.1016/j.tibtech.2009.06.005; Duvernay MT, 2005, CELL SIGNAL, V17, P1457, DOI 10.1016/j.cellsig.2005.05.020; Elbim C, 2008, J IMMUNOL, V181, P8613, DOI 10.4049/jimmunol.181.12.8613; Farzan M, 1997, J EXP MED, V186, P405, DOI 10.1084/jem.186.3.405; Gassmann M, 2005, MOL PHARMACOL, V68, P137, DOI 10.1124/mol.104.010256; Godde NJ, 2006, J CELL SCI, V119, P3296, DOI 10.1242/jcs.03065; Gurevich VV, 2008, TRENDS NEUROSCI, V31, P74, DOI 10.1016/j.tins.2007.11.007; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Hegedus T, 2006, BBA-BIOMEMBRANES, V1758, P565, DOI 10.1016/j.bbamem.2006.03.006; Hermosilla R, 2004, TRAFFIC, V5, P993, DOI 10.1111/j.1600-0854.2004.00239.x; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Iodice L, 2001, J BIOL CHEM, V276, P28920, DOI 10.1074/jbc.M103558200; Jeanclos EM, 2001, J BIOL CHEM, V276, P28281, DOI 10.1074/jbc.M011549200; Jin YT, 2006, EMBO J, V25, P1207, DOI 10.1038/sj.emboj.7601010; Johnson C, 2010, BIOCHEM J, V427, P69, DOI 10.1042/BJ20091834; Khalil H, 2005, J CELL SCI, V118, P4679, DOI 10.1242/jcs.02592; Kim YS, 2005, ENDOCRINOLOGY, V146, P3133, DOI 10.1210/en.2004-1455; KINGSLEY DM, 1984, P NATL ACAD SCI-BIOL, V81, P5454, DOI 10.1073/pnas.81.17.5454; Li QS, 2008, J INFECT DIS, V197, P420, DOI 10.1086/525046; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Maresca M, 2003, J BIOMED SCI, V10, P156, DOI 10.1159/000068089; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14649, DOI 10.1073/pnas.251554498; Michelsen K, 2007, J CELL BIOL, V179, P209, DOI 10.1083/jcb.200704142; Mrowiec T, 2006, BIOL CHEM, V387, P1227, DOI 10.1515/BC.2006.152; Nakamura T, 2010, J BIOL CHEM, V285, P16145, DOI 10.1074/jbc.M109.081315; Nasu-Nishimura Y, 2006, J NEUROSCI, V26, P7014, DOI 10.1523/JNEUROSCI.0573-06.2006; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; Pagano A, 2001, J NEUROSCI, V21, P1189; Paul G, 2009, GENOMICS, V94, P287, DOI 10.1016/j.ygeno.2009.07.004; Roth D, 2010, BIOCHEM J, V425, P195, DOI 10.1042/BJ20091064; Schumacher B, 2010, FEBS LETT, V584, P1443, DOI 10.1016/j.febslet.2010.02.065; Scott DB, 2003, NEUROPHARMACOLOGY, V45, P755, DOI 10.1016/S0028-3908(03)00250-8; Scott MGH, 2004, M S-MED SCI, V20, P78, DOI 10.1051/medsci/200420178; Sharma P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011496; Shikano S, 2005, NAT CELL BIOL, V7, P985, DOI 10.1038/ncb1297; Shikano S, 2003, P NATL ACAD SCI USA, V100, P5783, DOI 10.1073/pnas.1031748100; Shikano S, 2006, TRENDS CELL BIOL, V16, P370, DOI 10.1016/j.tcb.2006.05.006; Stepanchick A, 2010, CELL PHYSIOL BIOCHEM, V26, P363, DOI 10.1159/000320560; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Wang YL, 2000, CELL GROWTH DIFFER, V11, P211; Yuan HB, 2003, CURR BIOL, V13, P638, DOI 10.1016/S0960-9822(03)00208-2; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198; Zhang ZN, 2008, J CELL SCI, V121, P3243, DOI 10.1242/jcs.026856; Zuzarte M, 2009, J PHYSIOL-LONDON, V587, P929, DOI 10.1113/jphysiol.2008.164756	60	29	29	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7171	7181		10.1074/jbc.M110.199695	http://dx.doi.org/10.1074/jbc.M110.199695			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21189250	Green Published, hybrid			2022-12-27	WOS:000287737300034
J	Banerjee, D; Mandal, SM; Das, A; Hegde, ML; Das, S; Bhakat, KK; Boldogh, I; Sarkar, PS; Mitra, S; Hazra, TK				Banerjee, Dibyendu; Mandal, Santi M.; Das, Aditi; Hegde, Muralidhar L.; Das, Soumita; Bhakat, Kishor K.; Boldogh, Istvan; Sarkar, Partha S.; Mitra, Sankar; Hazra, Tapas K.			Preferential Repair of Oxidized Base Damage in the Transcribed Genes of Mammalian Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; HUMAN DNA GLYCOSYLASE; EXCISION-REPAIR; ESCHERICHIA-COLI; HNRNP-U; COCKAYNE-SYNDROME; ENDONUCLEASE-III; AP-ENDONUCLEASE; COUPLED REPAIR; ACTIVE GENE	Preferential repair of bulky DNA adducts from the transcribed genes via nucleotide excision repair is well characterized in mammalian cells. However, definitive evidence is lacking for similar repair of oxidized bases, the major endogenous DNA lesions. Here we show that the oxidized base-specific human DNA glycosylase NEIL2 associates with RNA polymerase II and the transcriptional regulator heterogeneous nuclear ribonucleoprotein-U (hnRNP-U), both in vitro and in cells. NEIL2 immunocomplexes from cell extracts preferentially repaired the mutagenic cytosine oxidation product 5-hydroxyuracil in the transcribed strand. In a reconstituted system, we also observed NEIL2-initiated transcription-dependent base excision repair of 5-hydroxyuracil in the transcribed strand, with hnRNP-U playing a critical role. Chromatin immunoprecipitation/reimmunoprecipitation studies showed association of NEIL2, RNA polymerase II, and hnRNP-U on transcribed but not on transcriptionally silent genes. Furthermore, NEIL2-depleted cells accumulated more DNA damage in active than in silent genes. These results strongly support the preferential role of NEIL2 in repairing oxidized bases in the transcribed genes of mammalian cells.	[Hazra, Tapas K.] Univ Texas Med Branch, Div Pulm Allergy & Crit Care Med, Dept Internal Med, Galveston, TX 77555 USA; [Banerjee, Dibyendu; Mandal, Santi M.; Das, Aditi; Hegde, Muralidhar L.; Das, Soumita; Bhakat, Kishor K.; Mitra, Sankar; Hazra, Tapas K.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA; [Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Sarkar, Partha S.] Univ Texas Med Branch, Dept Neurol & Neurosci & Cell Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Hazra, TK (corresponding author), Univ Texas Med Branch, Div Pulm Allergy & Crit Care Med, Dept Internal Med, 6-136 Med Res Bldg,Route 1079, Galveston, TX 77555 USA.	tkhazra@utmb.edu	Mandal, Santi M./AAF-7156-2020; BANERJEE, DIBYENDU/C-6656-2012; Bhakat, Kishor/C-8072-2012; Classen, Scott/AAY-8176-2020; Banerjee, Dibyendu/Y-4652-2019	Hegde, Muralidhar/0000-0001-7333-8123; Banerjee, Dibyendu/0000-0003-4244-9714	National Institutes of Health [CA102271, ES017353, CA81063]; NATIONAL CANCER INSTITUTE [P01CA092584, R01CA081063, R01CA102271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI062885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006676, R21ES017353, R01ES018948] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA102271 and ES017353 (to T. K. H.) and CA81063 (to S. M.).	Aygun O, 2008, P NATL ACAD SCI USA, V105, P8580, DOI 10.1073/pnas.0804424105; Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Berglund FM, 2009, BIOCHEM BIOPH RES CO, V381, P59, DOI 10.1016/j.bbrc.2009.02.019; BOHR VA, 1985, CELL, V40, P359, DOI 10.1016/0092-8674(85)90150-3; Bregeon D, 2003, MOL CELL, V12, P959, DOI 10.1016/S1097-2765(03)00360-5; BREIMER LH, 1990, MOL CARCINOGEN, V3, P188, DOI 10.1002/mc.2940030405; Caldecott KW, 1995, NUCLEIC ACIDS RES, V23, P4836, DOI 10.1093/nar/23.23.4836; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Charlet-Berguerand N, 2006, EMBO J, V25, P5481, DOI 10.1038/sj.emboj.7601403; Cook PR, 1999, SCIENCE, V284, P1790, DOI 10.1126/science.284.5421.1790; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; Das S, 2007, J BIOL CHEM, V282, P28474, DOI 10.1074/jbc.M704672200; de Waard H, 2003, DNA REPAIR, V2, P13, DOI 10.1016/S1568-7864(02)00188-X; Dou H, 2003, J BIOL CHEM, V278, P49679, DOI 10.1074/jbc.M308658200; Fousteri M, 2006, MOL CELL, V23, P471, DOI 10.1016/j.molcel.2006.06.029; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Gilbert C, 2004, MOL CELL, V14, P457, DOI 10.1016/S1097-2765(04)00239-4; Hazra TK, 2002, J BIOL CHEM, V277, P30417, DOI 10.1074/jbc.C200355200; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; Ikeda S, 1998, J BIOL CHEM, V273, P21585, DOI 10.1074/jbc.273.34.21585; Inukai N, 2004, J BIOL CHEM, V279, P8190, DOI 10.1074/jbc.M311412200; Jayaraman L, 1998, GENE DEV, V12, P462, DOI 10.1101/gad.12.4.462; Kathe SD, 2004, J BIOL CHEM, V279, P18511, DOI 10.1074/jbc.M313598200; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Kim MK, 1999, MOL CELL BIOL, V19, P6833; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Kukalev A, 2005, NAT STRUCT MOL BIOL, V12, P238, DOI 10.1038/nsmb904; Kumar D, 2009, J BIOL CHEM, V284, P1853, DOI 10.1074/jbc.M806289200; Kuraoka I, 2007, DNA REPAIR, V6, P841, DOI 10.1016/j.dnarep.2007.01.014; Lavrovsky Y, 2000, EXP GERONTOL, V35, P521, DOI 10.1016/S0531-5565(00)00118-2; Liu MM, 2010, P NATL ACAD SCI USA, V107, P4925, DOI 10.1073/pnas.0908307107; Lu RZ, 1997, CURR BIOL, V7, P397, DOI 10.1016/S0960-9822(06)00187-4; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Martens JHA, 2002, MOL CELL BIOL, V22, P2598, DOI 10.1128/MCB.22.8.2598-2606.2002; Mattern KA, 1996, J CELL BIOCHEM, V62, P275, DOI 10.1002/(SICI)1097-4644(199608)62:2<275::AID-JCB15>3.0.CO;2-K; Mellon I, 2005, MUTAT RES-FUND MOL M, V577, P155, DOI 10.1016/j.mrfmmm.2005.03.016; MELLON I, 1986, P NATL ACAD SCI USA, V83, P8878, DOI 10.1073/pnas.83.23.8878; Mellon I, 1996, P NATL ACAD SCI USA, V93, P1292, DOI 10.1073/pnas.93.3.1292; Minowa O, 2000, P NATL ACAD SCI USA, V97, P4156, DOI 10.1073/pnas.050404497; Morland I, 2002, NUCLEIC ACIDS RES, V30, P4926, DOI 10.1093/nar/gkf618; PARODI MT, 1989, CANCER CHEMOTH PHARM, V25, P114, DOI 10.1007/BF00692350; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; Spivak G, 2006, DNA REPAIR, V5, P13, DOI 10.1016/j.dnarep.2005.06.017; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Takao M, 2002, EMBO J, V21, P3486, DOI 10.1093/emboj/cdf350; Tornaletti S, 2001, J BIOL CHEM, V276, P45367, DOI 10.1074/jbc.M105282200; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003	52	114	114	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6006	6016		10.1074/jbc.M110.198796	http://dx.doi.org/10.1074/jbc.M110.198796			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21169365	Green Published, hybrid			2022-12-27	WOS:000287476400008
J	Brooks, IM; Tavalin, SJ				Brooks, Ian M.; Tavalin, Steven J.			Ca2+/Calmodulin-dependent Protein Kinase II Inhibitors Disrupt AKAP79-dependent PKC Signaling to GluA1 AMPA Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; GLUR1 SUBUNIT; REGULATORY PHOSPHORYLATION; GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY; GATING DOMAIN; CAMKII-ALPHA; K+ CHANNELS; CALMODULIN; AKAP79	GluA1 (formerly GluR1) AMPA receptor subunit phosphorylation at Ser-831 is an early biochemical marker for long-term potentiation and learning. This site is a substrate for Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) and protein kinase C (PKC). By directing PKC to GluA1, A-kinase anchoring protein 79 (AKAP79) facilitates Ser-831 phosphorylation and makes PKC a more potent regulator of GluA1 than CaMKII. PKC and CaM bind to residues 31-52 of AKAP79 in a competitive manner. Here, we demonstrate that common CaMKII inhibitors alter PKC and CaM interactions with AKAP79(31-52). Most notably, the classical CaMKII inhibitors KN-93 and KN-62 potently enhanced the association of CaM to AKAP79(31-52) in the absence (apoCaM) but not the presence of Ca2+. In contrast, apoCaM association to AKAP79(31-52) was unaffected by the control compound KN-92 or a mechanistically distinct CaMKII inhibitor (CaMKIINtide). In vitro studies demonstrated that KN-62 and KN-93, but not the other compounds, led to apoCaM-dependent displacement of PKC from AKAP79(31-52). In the absence of CaMKII activation, complementary cellular studies revealed that KN-62 and KN-93, but not KN-92 or CaMKIINtide, inhibited PKC-mediated phosphorylation of GluA1 in hippocampal neurons as well as AKAP79-dependent PKC-mediated augmentation of recombinant GluA1 currents. Buffering cellular CaM attenuated the ability of KN-62 and KN-93 to inhibit AKAP79-anchored PKC regulation of GluA1. Therefore, by favoring apoCaM binding to AKAP79, KN-62 and KN-93 derail the ability of AKAP79 to efficiently recruit PKC for regulation of GluA1. Thus, AKAP79 endows PKC with a pharmacological profile that overlaps with CaMKII.	[Brooks, Ian M.; Tavalin, Steven J.] Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Tavalin, SJ (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Pharmacol, 874 Union Ave, Memphis, TN 38163 USA.	stavalin@uthsc.edu		Brooks, Ian/0000-0003-2724-936X	National Institutes of Health [NS46661]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS46661 (to S.J.T.).	Anderson SM, 2008, NAT NEUROSCI, V11, P344, DOI 10.1038/nn2054; Ba MW, 2006, NEUROCHEM RES, V31, P1337, DOI 10.1007/s11064-006-9177-9; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Bevilaqua LR, 2005, NEUROSCIENCE, V136, P397, DOI 10.1016/j.neuroscience.2005.08.007; Bortolotto ZA, 1998, NEUROPHARMACOLOGY, V37, P535, DOI 10.1016/S0028-3908(98)00058-6; Caldeira MV, 2007, J BIOL CHEM, V282, P12619, DOI 10.1074/jbc.M700607200; Chai SH, 2007, J BIOL CHEM, V282, P22668, DOI 10.1074/jbc.M703624200; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; COGHLAN VM, 1995, SCIENCE, V267, P108, DOI 10.1126/science.7528941; Colbran RJ, 2004, CURR OPIN NEUROBIOL, V14, P318, DOI 10.1016/j.conb.2004.05.008; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Dell'Acqua ML, 2002, J BIOL CHEM, V277, P48796, DOI 10.1074/jbc.M207833200; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Fang L, 2003, MOL BRAIN RES, V118, P160, DOI 10.1016/j.molbrainres.2003.08.002; Faux MC, 1999, BIOCHEM J, V343, P443, DOI 10.1042/0264-6021:3430443; Faux MC, 1997, J BIOL CHEM, V272, P17038, DOI 10.1074/jbc.272.27.17038; Fu XZ, 2004, NEUROSCI RES, V48, P85, DOI 10.1016/j.neures.2003.09.009; FUKUNAGA K, 1995, J BIOL CHEM, V270, P6119, DOI 10.1074/jbc.270.11.6119; Gao L, 2006, BIOCHEM BIOPH RES CO, V345, P1606, DOI 10.1016/j.bbrc.2006.05.066; Gargett CE, 1997, BRIT J PHARMACOL, V120, P1483, DOI 10.1038/sj.bjp.0701081; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Guan Y, 2004, NEUROSCI LETT, V366, P201, DOI 10.1016/j.neulet.2004.05.051; Hoshi N, 2003, NAT NEUROSCI, V6, P564, DOI 10.1038/nn1062; Hoshi N, 2010, MOL CELL, V37, P541, DOI 10.1016/j.molcel.2010.01.014; Hu HL, 2007, CELL, V131, P160, DOI 10.1016/j.cell.2007.09.017; HUBER KM, 1995, NEUROREPORT, V6, P1281, DOI 10.1097/00001756-199506090-00013; Humphreys BD, 1998, MOL PHARMACOL, V54, P22, DOI 10.1124/mol.54.1.22; HVALBY O, 1994, P NATL ACAD SCI USA, V91, P4761, DOI 10.1073/pnas.91.11.4761; Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103; ITO I, 1991, NEUROSCI LETT, V121, P119, DOI 10.1016/0304-3940(91)90663-E; Jeske NA, 2009, PAIN, V146, P301, DOI 10.1016/j.pain.2009.08.002; Jones TL, 2005, PAIN, V117, P259, DOI 10.1016/j.pain.2005.06.003; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; Kramar EA, 2003, J BIOL CHEM, V278, P10722, DOI 10.1074/jbc.M210225200; Lecrux C, 2007, STROKE, V38, P3007, DOI 10.1161/STROKEAHA.107.491126; Ledoux J, 1999, J PHARMACOL EXP THER, V290, P1165; Lee HK, 2006, PHARMACOL THERAPEUT, V112, P810, DOI 10.1016/j.pharmthera.2006.06.003; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Ling DSF, 2002, NAT NEUROSCI, V5, P295, DOI 10.1038/nn829; Liu GX, 2004, EMBO J, V23, P2196, DOI 10.1038/sj.emboj.7600228; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Marley PD, 1996, BIOCHEM BIOPH RES CO, V221, P15, DOI 10.1006/bbrc.1996.0536; Menard C, 2005, NEUROSCI LETT, V389, P51, DOI 10.1016/j.neulet.2005.07.012; Nikandrova YA, 2010, J BIOL CHEM, V285, P923, DOI 10.1074/jbc.M109.033985; Oh JD, 2003, BRAIN RES, V971, P18, DOI 10.1016/S0006-8993(03)02348-5; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; Rezazadeh S, 2006, J PHARMACOL EXP THER, V317, P292, DOI 10.1124/jpet.105.097618; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Sandoz G, 2006, EMBO J, V25, P5864, DOI 10.1038/sj.emboj.7601437; Schumacher MA, 2004, STRUCTURE, V12, P849, DOI 10.1016/S0969-2126(04)00112-1; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Sharp JW, 2004, NEUROSCIENCE, V126, P1053, DOI 10.1016/j.neuroscience.2004.03.066; Shukla K, 2007, J BIOL CHEM, V282, P18100, DOI 10.1074/jbc.M702906200; Smyth JT, 2002, J BIOL CHEM, V277, P35061, DOI 10.1074/jbc.M202928200; Stanton PK, 1996, J NEUROPHYSIOL, V76, P2097, DOI 10.1152/jn.1996.76.3.2097; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Svenningsson P, 2002, P NATL ACAD SCI USA, V99, P3182, DOI 10.1073/pnas.052712799; Takagi Y, 2003, NEUROSCI LETT, V341, P33, DOI 10.1016/S0304-3940(03)00153-8; Tavalin SJ, 2002, J NEUROSCI, V22, P3044, DOI 10.1523/JNEUROSCI.22-08-03044.2002; Tavalin SJ, 2008, J BIOL CHEM, V283, P11445, DOI 10.1074/jbc.M709253200; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; Tsui J, 2006, J BIOL CHEM, V281, P13794, DOI 10.1074/jbc.M600966200; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yamauchi E, 2003, NAT STRUCT BIOL, V10, P226, DOI 10.1038/nsb900; Yue CP, 2001, MOL CELL ENDOCRINOL, V175, P149, DOI 10.1016/S0303-7207(01)00383-5; Yuen EY, 2007, J BIOL CHEM, V282, P16434, DOI 10.1074/jbc.M701283200; Zhang XM, 2008, NEURON, V59, P450, DOI 10.1016/j.neuron.2008.05.015; Zhao DY, 2004, J NEUROPHYSIOL, V92, P2853, DOI 10.1152/jn.00485.2004	80	19	21	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6697	6706		10.1074/jbc.M110.183558	http://dx.doi.org/10.1074/jbc.M110.183558			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21156788	Green Published, hybrid			2022-12-27	WOS:000287476400077
J	Nakamichi, Y; Maruyama, Y; Mikami, B; Hashimoto, W; Murata, K				Nakamichi, Yusuke; Maruyama, Yukie; Mikami, Bunzo; Hashimoto, Wataru; Murata, Kousaku			Structural Determinants in Streptococcal Unsaturated Glucuronyl Hydrolase for Recognition of Glycosaminoglycan Sulfate Groups	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SP GL1; CRYSTAL-STRUCTURE; FLAVOBACTERIUM-HEPARINUM; SUBSTRATE-SPECIFICITY; HYALURONIDASE GENE; ESCHERICHIA-COLI; DEGRADATION; PURIFICATION; PNEUMONIAE; PROTEIN	Pathogenic Streptococcus agalactiae produces polysaccharide lyases and unsaturated glucuronyl hydrolase (UGL), which are prerequisite for complete degradation of mammalian extracellular matrices, including glycosaminoglycans such as chondroitin and hyaluronan. Unlike the Bacillus enzyme, streptococcal UGLs prefer sulfated glycosaminoglycans. Here, we show the loop flexibility for substrate binding and structural determinants for recognition of glycosaminoglycan sulfate groups in S. agalactiae UGL (SagUGL). UGL also degraded unsaturated heparin disaccharides; this indicates that the enzyme released unsaturated iduronic and glucuronic acids from substrates. We determined the crystal structures of SagUGL wild-type enzyme and both substrate-free and substrate-bound D175N mutants by x-ray crystallography and noted that the loop over the active cleft exhibits flexible motion for substrate binding. Several residues in the active cleft bind to the substrate, unsaturated chondroitin disaccharide with a sulfate group at the C-6 position of GalNAc residue. The sulfate group is hydrogen-bonded to Ser-365 and Ser-368 and close to Lys-370. As compared with wild-type enzyme, S365H, S368G, and K370I mutants exhibited higher Michaelis constants toward the substrate. The conversion of SagUGL to Bacillus sp. GL1 UGL-like enzyme via site-directed mutagenesis demonstrated that Ser-365 and Lys-370 are essential for direct binding and for electrostatic interaction, respectively, for recognition of the sulfate group by SagUGL. Molecular conversion was also achieved in SagUGL Arg-236 with an affinity for the sulfate group at the C-4 position of the GalNAc residue. These residues binding to sulfate groups are frequently conserved in pathogenic bacterial UGLs, suggesting that the motif "R-//-SXX(S)XK" (where the hyphen and slash marks in the motif indicate the presence of over 100 residues in the enzyme and parentheses indicate that Ser-368 makes little contribution to enzyme activity) is crucial for degradation of sulfated glycosaminoglycans.	[Nakamichi, Yusuke; Maruyama, Yukie; Hashimoto, Wataru; Murata, Kousaku] Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Grad Sch Agr, Kyoto 6110011, Japan; [Mikami, Bunzo] Kyoto Univ, Lab Appl Struct Biol, Grad Sch Agr, Kyoto 6110011, Japan	Kyoto University; Kyoto University	Murata, K (corresponding author), Kyoto Univ, Lab Basic & Appl Mol Biotechnol, Grad Sch Agr, Kyoto 6110011, Japan.	kmurata@kais.kyoto-u.ac.jp	Nakamichi, Yusuke/Y-2830-2019; Nakamichi, Yusuke/H-1221-2018	Nakamichi, Yusuke/0000-0001-7089-663X; Nakamichi, Yusuke/0000-0001-7089-663X	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by grants-in-aid from the Japan Society for the Promotion of Science (to K. M. and W. H.) and by the Targeted Proteins Research Program (to W. H.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan. Part of this work was supported by research fellowships from the Japan Society for the Promotion of Science for Young Scientists (to Y. M.).	Auperin TC, 2005, J BIOL CHEM, V280, P18245, DOI 10.1074/jbc.M412391200; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BERRY AM, 1994, INFECT IMMUN, V62, P1101, DOI 10.1128/IAI.62.3.1101-1108.1994; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CHENG QO, 1995, J BACTERIOL, V177, P3721, DOI 10.1128/jb.177.13.3721-3727.1995; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490; Frick IM, 2003, EUR J BIOCHEM, V270, P2303, DOI 10.1046/j.1432-1033.2003.03600.x; Gandhi NS, 2008, CHEM BIOL DRUG DES, V72, P455, DOI 10.1111/j.1747-0285.2008.00741.x; Gase K, 1998, BBA-GENE STRUCT EXPR, V1398, P86, DOI 10.1016/S0167-4781(98)00045-1; GU KN, 1995, BIOCHEM J, V312, P569, DOI 10.1042/bj3120569; Hascall V., 2009, ESSENTIALS GLYCOBIOL, V15, P219; Hashimoto W, 1999, ARCH BIOCHEM BIOPHYS, V368, P367, DOI 10.1006/abbi.1999.1305; Hynes WL, 2000, FEMS MICROBIOL LETT, V184, P109, DOI 10.1016/S0378-1097(00)00029-X; Itoh T, 2004, J BIOL CHEM, V279, P31804, DOI 10.1074/jbc.M403288200; Itoh T, 2006, J BIOL CHEM, V281, P29807, DOI 10.1074/jbc.M604975200; Jedrzejas MJ, 2007, CELL MOL LIFE SCI, V64, P2799, DOI 10.1007/s00018-007-7125-8; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kwok JCF, 2008, RESTOR NEUROL NEUROS, V26, P131; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lauder RM, 2009, COMPLEMENT THER MED, V17, P56, DOI 10.1016/j.ctim.2008.08.004; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; LINDAHL U, 1978, ANNU REV BIOCHEM, V47, P385, DOI 10.1146/annurev.bi.47.070178.002125; Linhardt RJ, 2006, ADV PHARMACOL, V53, P187, DOI 10.1016/S1054-3589(05)53009-6; Maruyama Y, 2009, J BIOL CHEM, V284, P18059, DOI 10.1074/jbc.M109.005660; Mello LV, 2002, J BIOL CHEM, V277, P36678, DOI 10.1074/jbc.M205140200; Mori S, 2003, PROTEIN EXPRES PURIF, V29, P77, DOI 10.1016/S1046-5928(03)00019-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myette JR, 2009, J BIOL CHEM, V284, P35189, DOI 10.1074/jbc.M109.053835; Myette JR, 2009, J BIOL CHEM, V284, P35177, DOI 10.1074/jbc.M109.053801; Myette JR, 2002, BIOCHEMISTRY-US, V41, P7424, DOI 10.1021/bi012147o; NADER HB, 1990, J BIOL CHEM, V265, P16807; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PATON JC, 1993, ANNU REV MICROBIOL, V47, P89, DOI 10.1146/annurev.mi.47.100193.000513; PRITCHARD DG, 1994, ARCH BIOCHEM BIOPHYS, V315, P431, DOI 10.1006/abbi.1994.1521; Rostand KS, 1997, INFECT IMMUN, V65, P1; Sambrook J, 1989, MOL CLONING LABORATO; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sava IG, 2009, J BIOL CHEM, V284, P18194, DOI 10.1074/jbc.M901460200; Sawitzky D, 1996, MED MICROBIOL IMMUN, V184, P155, DOI 10.1007/BF02456129; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tkalec AL, 2000, APPL ENVIRON MICROB, V66, P29, DOI 10.1128/AEM.66.1.29-35.2000; Tonnaer ELGM, 2006, MICROBES INFECT, V8, P316, DOI 10.1016/j.micinf.2005.06.028; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	50	11	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6262	6271		10.1074/jbc.M110.182618	http://dx.doi.org/10.1074/jbc.M110.182618			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21147778	hybrid, Green Published			2022-12-27	WOS:000287476400036
J	Singaravelu, K; Nelson, C; Bakowski, D; de Brito, OM; Ng, SW; Di Capite, J; Powell, T; Scorrano, L; Parekh, AB				Singaravelu, Karthika; Nelson, Charmaine; Bakowski, Daniel; de Brito, Olga Martins; Ng, Siaw-Wei; Di Capite, Joseph; Powell, Trevor; Scorrano, Luca; Parekh, Anant B.			Mitofusin 2 Regulates STIM1 Migration from the Ca2+ Store to the Plasma Membrane in Cells with Depolarized Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATED CRAC CHANNELS; CURRENT I-CRAC; ACTIVATED CALCIUM CURRENT; MAST-CELLS; T-LYMPHOCYTES; ENDOPLASMIC-RETICULUM; RBL-1 CELLS; DEPLETION; ORAI1; INFLUX	Store-operated Ca2+ channels in the plasma membrane (PM) are activated by the depletion of Ca2+ from the endoplasmic reticulum (ER) and constitute a widespread and highly conserved Ca2+ influx pathway. After store emptying, the ER Ca2+ sensor STIM1 forms multimers, which then migrate to ER-PM junctions where they activate the Ca2+ release-activated Ca2+ channel Orai1. Movement of an intracellular protein to such specialized sites where it gates an ion channel is without precedence, but the fundamental question of how STIM1 migrates remains unresolved. Here, we show that trafficking of STIM1 to ER-PM junctions and subsequent Ca2+ release-activated Ca2+ channel activity is impaired following mitochondrial depolarization. We identify the dynamin-related mitochondrial protein mitofusin 2, mutations of which causes the inherited neurodegenerative disease Charcot-Marie-Tooth IIa in humans, as an important component of this mechanism. Our results reveal a molecular mechanism whereby a mitochondrial fusion protein regulates protein trafficking across the endoplasmic reticulum and reveals a homeostatic mechanism whereby mitochondrial depolarization can inhibit store-operated Ca2+ entry, thereby reducing cellular Ca2+ overload.	[Singaravelu, Karthika; Nelson, Charmaine; Bakowski, Daniel; Ng, Siaw-Wei; Di Capite, Joseph; Powell, Trevor; Parekh, Anant B.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [de Brito, Olga Martins; Scorrano, Luca] Dulbecco Telethon Inst, Venetian Inst Mol Med, I-35129 Padua, Italy; [Scorrano, Luca] Univ Geneva, Dept Cell Physiol & Med, CH-1211 Geneva, Switzerland	University of Oxford; Fondazione Telethon; Dulbecco Telethon Institute (DTI); Veneto Institute Molecular Medicine; University of Geneva	Parekh, AB (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Sherrington Bldg,Parks Rd, Oxford OX1 3PT, England.	anant.parekh@dpag.ox.ac.uk	Scorrano, Luca/A-6652-2008; Scorrano, Luca/K-3967-2019	Scorrano, Luca/0000-0002-8515-8928; Scorrano, Luca/0000-0002-8515-8928	Medical Research Council (United Kingdom); British Heart Foundation; Medical Research Council [G1000813] Funding Source: researchfish; MRC [G1000813] Funding Source: UKRI	Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (United Kingdom) and the British Heart Foundation.	Bach D, 2003, J BIOL CHEM, V278, P17190, DOI 10.1074/jbc.M212754200; Bakowski D, 2002, CELL CALCIUM, V32, P379, DOI 10.1016/S0143416002001914; Bakowski D, 2002, PFLUG ARCH EUR J PHY, V443, P892, DOI 10.1007/s00424-001-0775-8; Bakowski D, 2001, J PHYSIOL-LONDON, V532, P55, DOI 10.1111/j.1469-7793.2001.0055g.x; Bakowski D, 2007, CELL CALCIUM, V42, P333, DOI 10.1016/j.ceca.2007.01.005; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Chang WC, 2008, J BIOL CHEM, V283, P4622, DOI 10.1074/jbc.M705002200; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Chvanov M, 2008, PFLUG ARCH EUR J PHY, V457, P505, DOI 10.1007/s00424-008-0529-y; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Fierro L, 1999, J MEMBRANE BIOL, V168, P9, DOI 10.1007/s002329900493; Frieden M, 2004, J BIOL CHEM, V279, P22704, DOI 10.1074/jbc.M312366200; Giacomello M, 2010, MOL CELL, V38, P280, DOI 10.1016/j.molcel.2010.04.003; Gilabert JA, 2000, EMBO J, V19, P6401, DOI 10.1093/emboj/19.23.6401; Glitsch MD, 2002, EMBO J, V21, P6744, DOI 10.1093/emboj/cdf675; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Guillery O, 2008, BIOL CELL, V100, P315, DOI 10.1042/BC20070110; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Hoth M, 2000, P NATL ACAD SCI USA, V97, P10607, DOI 10.1073/pnas.180143997; Huang P, 2007, EUR J CELL BIOL, V86, P289, DOI 10.1016/j.ejcb.2007.04.002; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Lewis RS, 1999, ADV SEC MESS PHOSPH, V33, P279; Leyssens A, 1996, J PHYSIOL-LONDON, V496, P111, DOI 10.1113/jphysiol.1996.sp021669; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mignen O, 2007, J PHYSIOL-LONDON, V579, P703, DOI 10.1113/jphysiol.2006.122432; MOHR FC, 1990, AM J PHYSIOL, V258, pC217, DOI 10.1152/ajpcell.1990.258.2.C217; Moreau B, 2005, J BIOL CHEM, V280, P8776, DOI 10.1074/jbc.M409619200; Moreau B, 2006, CURR BIOL, V16, P1672, DOI 10.1016/j.cub.2006.06.059; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Ng SW, 2008, J BIOL CHEM, V283, P31348, DOI 10.1074/jbc.M804942200; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2003, J PHYSIOL-LONDON, V547, P333, DOI 10.1113/jphysiol.2002.034140; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Parekh A, 2009, CURR BIOL, V19, pR200, DOI 10.1016/j.cub.2009.01.012; Parekh AB, 2008, CELL CALCIUM, V44, P6, DOI 10.1016/j.ceca.2007.12.006; Parekh AB, 2007, CELL CALCIUM, V42, P111, DOI 10.1016/j.ceca.2007.02.012; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Quintana A, 2006, J BIOL CHEM, V281, P40302, DOI 10.1074/jbc.M607896200; Rojo M, 2002, J CELL SCI, V115, P1663; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; SCHILLING WP, 1989, J BIOL CHEM, V264, P12838; SILVERMAN HS, 1994, AM J PHYSIOL, V266, pC222, DOI 10.1152/ajpcell.1994.266.1.C222; Smyth JT, 2008, J CELL SCI, V121, P762, DOI 10.1242/jcs.023903; Smyth JT, 2007, J CELL SCI, V120, P3762, DOI 10.1242/jcs.015735; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wu MM, 2007, CELL CALCIUM, V42, P163, DOI 10.1016/j.ceca.2007.03.003; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yoon E, 2004, BIOCHEM BIOPH RES CO, V325, P117, DOI 10.1016/j.bbrc.2004.09.216; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	65	78	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2011	286	14								10.1074/jbc.M110.174029	http://dx.doi.org/10.1074/jbc.M110.174029			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	744EN	21220420	hybrid, Green Published			2022-12-27	WOS:000289077500034
J	Materia, S; Cater, MA; Klomp, LWJ; Mercer, JFB; La Fontaine, S				Materia, Stephanie; Cater, Michael A.; Klomp, Leo W. J.; Mercer, Julian F. B.; La Fontaine, Sharon			Clusterin (Apolipoprotein J), a Molecular Chaperone That Facilitates Degradation of the Copper-ATPases ATP7A and ATP7B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; WILSON-DISEASE PROTEIN; HEAT-SHOCK PROTEINS; MENKES PROTEIN; IDENTIFIES VARIANTS; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; TRAFFICKING; EXPRESSION; MUTATIONS	The copper-transporting P1B-type ATPases (Cu-ATPases) ATP7A and ATP7B are key regulators of physiological copper levels. They function to maintain intracellular copper homeostasis by delivering copper to secretory compartments and by trafficking toward the cell periphery to export excess copper. Mutations in the genes encoding ATP7A and ATP7B lead to copper deficiency and toxicity disorders, Menkes and Wilson diseases, respectively. This report describes the interaction between the Cu-ATPases and clusterin and demonstrates a chaperone-like role for clusterin in facilitating their degradation. Clusterin interacted with both ATP7A and ATP7B in mammalian cells. This interaction increased under conditions of oxidative stress and with mutations in ATP7B that led to its misfolding and mislocalization. A Wilson disease patient mutation (G85V) led to enhanced ATP7B turnover, which was further exacerbated when cells overexpressed clusterin. We demonstrated that clusterin-facilitated degradation of mutant ATP7B is likely to involve the lysosomal pathway. The knockdown and overexpression of clusterin increased and decreased, respectively, the Cu-ATPase-mediated copper export capacity of cells. These results highlight a new role for intracellular clusterin in mediating Cu-ATPase quality control and hence in the normal maintenance of copper homeostasis, and in promoting cell survival in the context of disease. Based on our findings, it is possible that variations in clusterin expression and function could contribute to the variable clinical expression of Menkes and Wilson diseases.	[Materia, Stephanie; Mercer, Julian F. B.; La Fontaine, Sharon] Deakin Univ, Sch Life & Environm Sci, Ctr Cellular & Mol Biol, Burwood, Vic 3125, Australia; [Materia, Stephanie; Mercer, Julian F. B.; La Fontaine, Sharon] Deakin Univ, Sch Life & Environm Sci, Strateg Res Ctr Mol & Med Res, Burwood, Vic 3125, Australia; [Cater, Michael A.] Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic 3002, Australia; [Klomp, Leo W. J.] Univ Med Ctr, Lab Metab & Endocrine Dis, NL-3584 EA Utrecht, Netherlands	Deakin University; Deakin University; Peter Maccallum Cancer Center; Utrecht University; Utrecht University Medical Center	La Fontaine, S (corresponding author), Deakin Univ, Sch Life & Environm Sci, Ctr Cellular & Mol Biol, 221 Burwood Hwy, Burwood, Vic 3125, Australia.	sharon.lafontaine@deakin.edu.au	Mercer, Julian/R-8583-2019; La Fontaine, Sharon/G-7113-2018	La Fontaine, Sharon/0000-0002-9948-074X	National Health and Medical Research Council of Australia (NHMRC); Dutch Digestive Disease Foundation [WS02-34]; Netherlands Organisation for Scientific Research (NWO) [912.04.106]; NWO Earth and Life Sciences [817.02.022]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Dutch Digestive Disease Foundation; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NWO Earth and Life Sciences	This work was supported by grants from The National Health and Medical Research Council of Australia (NHMRC; to S. L. and J. F. B. M.), an NHMRC biomedical research fellowship (to M. A. C.), and Dutch Digestive Disease Foundation Grant WS02-34, The Netherlands Organisation for Scientific Research (NWO) Program Grant 912.04.106, and NWO Earth and Life Sciences Grant 817.02.022 (to L. W. J. K.).	[Anonymous], 1995, METABOLIC BASIS INHE; ARONOW BJ, 1993, P NATL ACAD SCI USA, V90, P725, DOI 10.1073/pnas.90.2.725; Barnes N, 2009, TRAFFIC, V10, P767, DOI 10.1111/j.1600-0854.2009.00901.x; Bartee MY, 2009, BIOCHEMISTRY-US, V48, P5573, DOI 10.1021/bi900325k; Borm B, 2004, J PEDIATR-US, V145, P119, DOI 10.1016/j.jpeds.2004.04.033; Cater MA, 2006, GASTROENTEROLOGY, V130, P493, DOI 10.1053/j.gastro.2005.10.054; Cater MA, 2004, BIOCHEM J, V380, P805, DOI 10.1042/BJ20031804; de Bie P, 2007, J MED GENET, V44, P673, DOI 10.1136/jmg.2007.052746; de Bie P, 2007, GASTROENTEROLOGY, V133, P1316, DOI 10.1053/j.gastro.2007.07.020; DeMattos RB, 2004, NEURON, V41, P193, DOI 10.1016/S0896-6273(03)00850-X; Duc HH, 1998, EUR J HUM GENET, V6, P616; Guo Y, 2005, AM J PHYSIOL-GASTR L, V289, pG904, DOI 10.1152/ajpgi.00262.2005; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Humphreys DT, 1999, J BIOL CHEM, V274, P6875, DOI 10.1074/jbc.274.11.6875; Kapron JT, 1997, PROTEIN SCI, V6, P2120; Ke BX, 2006, AM J PHYSIOL-REG I, V290, pR1460, DOI 10.1152/ajpregu.00806.2005; La Fontaine S, 2001, HUM MOL GENET, V10, P361, DOI 10.1093/hmg/10.4.361; La Fontaine S, 2007, ARCH BIOCHEM BIOPHYS, V463, P149, DOI 10.1016/j.abb.2007.04.021; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lim CM, 2006, J BIOL CHEM, V281, P14006, DOI 10.1074/jbc.M512745200; Lutsenko S, 2007, PHYSIOL REV, V87, P1011, DOI 10.1152/physrev.00004.2006; Monty JF, 2005, J NUTR, V135, P2762, DOI 10.1093/jn/135.12.2762; Nagasaka H, 2009, J TOXICOL SCI, V34, pSP229, DOI 10.2131/jts.34.SP229; Nuutinen T, 2009, BRAIN RES REV, V61, P89, DOI 10.1016/j.brainresrev.2009.05.007; Nyasae L, 2007, AM J PHYSIOL-GASTR L, V292, pG1181, DOI 10.1152/ajpgi.00472.2006; Payne AS, 1998, P NATL ACAD SCI USA, V95, P10854, DOI 10.1073/pnas.95.18.10854; Poon S, 2000, BIOCHEMISTRY-US, V39, P15953, DOI 10.1021/bi002189x; Poon S, 2002, J BIOL CHEM, V277, P39532, DOI 10.1074/jbc.M204855200; Rice RH, 2009, CHEM-BIOL INTERACT, V181, P359, DOI 10.1016/j.cbi.2009.08.007; Stuehler B, 2004, J MOL MED, V82, P629, DOI 10.1007/s00109-004-0557-9; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; Trougakos IP, 2006, FREE RADICAL RES, V40, P1324, DOI 10.1080/10715760600902310; Tumer Z, 2010, EUR J HUM GENET, V18, P511, DOI 10.1038/ejhg.2009.187; van de Sluis BJA, 1999, HUM MOL GENET, V8, P501, DOI 10.1093/hmg/8.3.501; Van den Berghe PVE, 2007, BIOCHEM J, V407, P49, DOI 10.1042/BJ20070705; van den Berghe PVE, 2009, HEPATOLOGY, V50, P1783, DOI 10.1002/hep.23209; Wilson MR, 2008, MOL BIOSYST, V4, P42, DOI 10.1039/b712728f; Wyatt A, 2009, ADV CANCER RES, V104, P89, DOI 10.1016/S0065-230X(09)04006-8; Wyatt AR, 2009, J BIOL CHEM, V284, P21920, DOI 10.1074/jbc.M109.033688; Zoubeidi A, 2010, MOL CANCER RES, V8, P119, DOI 10.1158/1541-7786.MCR-09-0277	40	35	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10073	10083		10.1074/jbc.M110.190546	http://dx.doi.org/10.1074/jbc.M110.190546			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21242307	Green Published, hybrid			2022-12-27	WOS:000288547000022
J	Vukelic, S; Stojadinovic, O; Pastar, I; Rabach, M; Krzyzanowska, A; Lebrun, E; Davis, SC; Resnik, S; Brem, H; Tomic-Canic, M				Vukelic, Sasa; Stojadinovic, Olivera; Pastar, Irena; Rabach, Morgan; Krzyzanowska, Agata; Lebrun, Elizabeth; Davis, Stephen C.; Resnik, Sydney; Brem, Harold; Tomic-Canic, Marjana			Cortisol Synthesis in Epidermis Is Induced by IL-1 and Tissue Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICOTROPIN-RELEASING HORMONE; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; HUMAN SKIN; GLUCOCORTICOID SYNTHESIS; DIFFERENTIAL EXPRESSION; TRANSCRIPTION FACTOR; GENE-EXPRESSION; ADIPOSE-TISSUE; GROWTH-FACTORS; RETINOIC ACID	Glucocorticoids (GCs) are known inhibitors of wound healing. In this study we report the novel finding that both keratinocytes in vitro and epidermis in vivo synthesize cortisol and how this synthesis regulates wound healing. We show that epidermis expresses enzymes essential for cortisol synthesis, including steroid 11 beta-hydroxylase (CYP11B1), and an enzyme that controls negative feedback mechanism, 11 beta-hydroxysteroid dehydrogenase 2 (11 beta HSD2). We also found that cortisol synthesis in keratinocytes and skin can be stimulated by ACTH and inhibited by metyrapone (CYP11B1 enzyme inhibitor). Interestingly, IL-1 beta, the first epidermal signal of tissue injury, induces the expression of CYP11B1 and increases cortisol production by keratinocytes. Additionally, we found induction of CYP11B1 increased production of cortisol and activation of GR pathway during wound healing ex vivo and in vivo using human and porcine wound models, respectively. Conversely, inhibition of cortisol synthesis during wound healing increases IL-1 beta production, suggesting that cortisol synthesis in epidermis may serve as a local negative feedback to proinflammatory cytokines. Local GCs synthesis, therefore, may provide control of the initial proinflammatory response, preventing excessive inflammation upon tissue injury. Inhibition of GC synthesis accelerated wound closure in vivo, providing the evidence that modulation of cortisol synthesis in epidermis may be an important regulatory mechanism during wound healing.	[Stojadinovic, Olivera; Pastar, Irena; Lebrun, Elizabeth; Davis, Stephen C.; Resnik, Sydney; Tomic-Canic, Marjana] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Wound Healing & Regenerat Med Res Program, Miami, FL 33136 USA; [Vukelic, Sasa] Lenox Hill Hosp, Dept Med, New York, NY 10075 USA; [Rabach, Morgan] Suny Downstate Med Ctr, Dept Dermatol, Brooklyn, NY 11203 USA; [Krzyzanowska, Agata] Hosp Special Surg, New York, NY 10021 USA; [Brem, Harold] NYU, Sch Med, Dept Surg, Helen L & Martin S Kimmel Div,Wound Healing Ctr, New York, NY 10016 USA	University of Miami; Northwell Health; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; New York University	Tomic-Canic, M (corresponding author), Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Wound Healing & Regenerat Med Res Program, 1600 NW 10th Ave,RMSB,Rm 2023-A, Miami, FL 33136 USA.	mtcanic@med.miami.edu	Pastar, Irena/AAD-3626-2020	Pastar, Irena/0000-0003-0197-6198	National Institutes of Health [NR008029]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK090135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR008029] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This work was supported, in whole or in part, by National Institutes of Health Grant NR008029. Drs. Tomic-Canic and Brem have submitted a patent application "De novo synthesis of glucocorticoids in the epidermis and its uses and applications." This application has not yet been approved.	ALBISTON AL, 1994, MOL CELL ENDOCRINOL, V105, pR11, DOI 10.1016/0303-7207(94)90176-7; Arck PC, 2006, J INVEST DERMATOL, V126, P1697, DOI 10.1038/sj.jid.5700104; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Braun S, 2002, MOL CELL BIOL, V22, P5492, DOI 10.1128/MCB.22.15.5492-5505.2002; Brem H, 2007, J CLIN INVEST, V117, P1219, DOI 10.1172/JCI32169; Chabre O, 2000, J CLIN ENDOCR METAB, V85, P4060, DOI 10.1210/jc.85.11.4060; Coste A, 2007, P NATL ACAD SCI USA, V104, P13098, DOI 10.1073/pnas.0702440104; DAVIDSON VL, 1994, BIOCHEMISTRY-US, P433; Davis SC, 2008, OSTOMY WOUND MANAG, V54, P16; DEFAYE G, 1982, MOL CELL ENDOCRINOL, V27, P157, DOI 10.1016/0303-7207(82)90105-8; Ermak G, 1997, J INVEST DERMATOL, V108, P160, DOI 10.1111/1523-1747.ep12332925; Fallo F, 2002, EUR J ENDOCRINOL, V147, P795, DOI 10.1530/eje.0.1470795; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; Hardy RS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1993; Haselbeck RJ, 1997, DEV DYNAM, V208, P447, DOI 10.1002/(SICI)1097-0177(199704)208:4<447::AID-AJA1>3.0.CO;2-I; Ismaili N, 2004, ANN NY ACAD SCI, V1024, P86, DOI 10.1196/annals.1321.007; Ito N, 2005, FASEB J, V19, P1332, DOI 10.1096/fj.04-1968fje; Jho SH, 2005, J INVEST DERMATOL, V124, P1034, DOI 10.1111/j.0022-202X.2005.23691.x; Kayes-Wandover KM, 2000, J CLIN ENDOCR METAB, V85, P2519, DOI 10.1210/jc.85.7.2519; Kondo S, 1999, J INVEST DERM SYMP P, V4, P177, DOI 10.1038/sj.jidsp.5640205; Kratz G, 1998, MICROSC RES TECHNIQ, V42, P345, DOI 10.1002/(SICI)1097-0029(19980901)42:5<345::AID-JEMT5>3.0.CO;2-O; KUPPER TS, 1990, J INVEST DERMATOL, V94, pS146, DOI 10.1111/1523-1747.ep12876130; Lee B, 2005, J MOL BIOL, V345, P1083, DOI 10.1016/j.jmb.2004.11.027; LEE B, 2002, MOL MECH ACTION STER, P1; Li A, 2004, J CLIN INVEST, V113, P390, DOI 10.1172/JCI.200419140; Loots MAM, 1998, J INVEST DERMATOL, V111, P850, DOI 10.1046/j.1523-1747.1998.00381.x; Mast Bruce A., 1996, Wound Repair and Regeneration, V4, P411, DOI 10.1046/j.1524-475X.1996.40404.x; Mueller M, 2006, J EXP MED, V203, P2057, DOI 10.1084/jem.20060357; NICKOLOFF BJ, 1994, J AM ACAD DERMATOL, V30, P535, DOI 10.1016/S0190-9622(94)70059-1; Pastar I, 2010, MOL MED, V16, P92, DOI 10.2119/molmed.2009.00149; Pastar Irena, 2008, Surg Technol Int, V17, P105; Pullar CE, 2006, FASEB J, V20, P76, DOI 10.1096/fj.05-4188com; Quinkler M, 2003, J CLIN ENDOCR METAB, V88, P2384, DOI 10.1210/jc.2003-030138; Radoja N, 2000, MOL CELL BIOL, V20, P4328, DOI 10.1128/MCB.20.12.4328-4339.2000; RAPPOLEE DA, 1988, SCIENCE, V241, P708, DOI 10.1126/science.3041594; Reichrath J, 2007, HORM METAB RES, V39, P71, DOI 10.1055/s-2007-958715; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Robson Martin C., 1997, Wound Repair and Regeneration, V5, P12, DOI 10.1046/j.1524-475X.1997.50106.x; Rogoff D, 2001, J STEROID BIOCHEM, V78, P77, DOI 10.1016/S0960-0760(01)00076-0; Roupe KM, 2010, J INVEST DERMATOL, V130, P1167, DOI 10.1038/jid.2009.284; Rousseau K, 2007, FASEB J, V21, P1844, DOI 10.1096/fj.06-7398com; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sharp LL, 2005, NAT IMMUNOL, V6, P73, DOI 10.1038/ni1152; Slominski A, 2005, AM J PHYSIOL-ENDOC M, V288, pE701, DOI 10.1152/ajpendo.00519.2004; Slominski A, 2000, BBA-GEN SUBJECTS, V1474, P1, DOI 10.1016/S0304-4165(99)00215-9; SLOMINSKI A, 1995, FEBS LETT, V374, P113, DOI 10.1016/0014-5793(95)01090-2; Slominski A, 2004, ENDOCRINOLOGY, V145, P941, DOI 10.1210/en.2003-0851; Slominski A, 2001, FASEB J, V15, P1678, DOI 10.1096/fj.00-0850rev; Slominski A, 2007, MOL CELL ENDOCRINOL, V265, P143, DOI 10.1016/j.mce.2006.12.012; Slominski A, 2006, J INVEST DERMATOL, V126, P1177, DOI 10.1038/sj.jid.5700204; Slominski A, 2006, FRONT BIOSCI-LANDMRK, V11, P2230, DOI 10.2741/1966; Steinhoff M, 2001, CURR OPIN ALLERGY CL, V1, P469, DOI 10.1097/00130832-200110000-00014; Stojadinovic O, 2005, AM J PATHOL, V167, P59, DOI 10.1016/S0002-9440(10)62953-7; Stojadinovic O, 2007, J BIOL CHEM, V282, P4021, DOI 10.1074/jbc.M606262200; Thiboutot D, 2003, J INVEST DERMATOL, V120, P905, DOI 10.1046/j.1523-1747.2003.12244.x; Tiala I, 2007, J MOL MED, V85, P589, DOI 10.1007/s00109-006-0155-0; Tomic-Canic M, 1998, J DERMATOL SCI, V17, P167, DOI 10.1016/S0923-1811(98)00016-4; Tomic-Canic M, 2004, DERM CLIN BAS SCI, P25; Tomic-Canic M, 2007, WOUND REPAIR REGEN, V15, P71, DOI 10.1111/j.1524-475X.2006.00187.x; Tomlinson JW, 2007, J CLIN ENDOCR METAB, V92, P857, DOI 10.1210/jc.2006-2325; Tomlinson JW, 2001, ENDOCRINOLOGY, V142, P1982, DOI 10.1210/en.142.5.1982; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; VACCHIO MS, 1994, J EXP MED, V179, P1835, DOI 10.1084/jem.179.6.1835; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200; Young MJ, 2001, J CLIN ENDOCR METAB, V86, P5121, DOI 10.1210/jc.86.11.5121; Zhou ZF, 1998, MOL CELL ENDOCRINOL, V138, P61, DOI 10.1016/S0303-7207(98)00052-5; Zouboulis CC, 2007, HORM METAB RES, V39, P85, DOI 10.1055/s-2007-961807; Zouboulis CC, 2000, HORM RES, V54, P230, DOI 10.1159/000053265	68	140	141	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10265	10275		10.1074/jbc.M110.188268	http://dx.doi.org/10.1074/jbc.M110.188268			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21239489	Green Published, hybrid			2022-12-27	WOS:000288547000044
J	Watanabe, N; Lam, E				Watanabe, Naohide; Lam, Eric			Calcium-dependent Activation and Autolysis of Arabidopsis Metacaspase 2d	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; PORPHYROMONAS-GINGIVALIS; CYSTEINE PROTEINASE; CRYSTAL-STRUCTURE; APOPTOSIS; PROTEASE; YEAST; PURIFICATION; GINGIPAIN; THALIANA	Metacaspases (MCPs) are members of a new family of cysteine proteases found in plants, fungi, and protozoa that are structurally related to metazoan caspases. Recent studies showed that plant MCPs are arginine/lysine-specific cysteine proteases with caspase-like processing activities in vitro and in vivo, and some of the plant type II MCPs exhibit Ca2+ dependence for their endopeptidase activity in vitro. However, the mechanisms and biological relevance of Ca2+ dependence and self-processing of plant MCPs remains unclear. Here we show that recombinant AtMCP2d, the most abundantly expressed member of Arabidopsis type II MCPs at the transcriptional level, exhibits a strict Ca2+ dependence for its catalytic activation that is apparently mediated by intramolecular self-cleavage mechanism. However, rapid inactivation of AtMCP2d activity concomitant with Ca2+ induced self-processing at multiple internal sites was observed. Because active AtMCP2d can cleave its inactive form, intermolecular cleavage (autolysis) of AtMCP2d could also occur under our assay conditions. Ca2+-induced self-processing of recombinant AtMCP2d was found to correlate with the sequential appearance of at least six intermediates, including self-cleaved forms, during the proenzyme purification process. Six of these peptides were characterized, and the cleavage sites were mapped through N-terminal protein sequencing. Mutation analysis of AtMCP2d revealed that cleavage after Lys-225, which is a highly conserved residue among the six Arabidopsis type II MCPs, is critical for the catalytic activation by Ca2+, and we demonstrate that this residue is essential for AtMCP2d activation of H2O2-induced cell death in yeast. Together, our results provide clues to understand the mode of regulation for this class of proteases.	[Watanabe, Naohide; Lam, Eric] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Lam, E (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, 59 Dudley Rd, New Brunswick, NJ 08901 USA.	lam@aesop.rutgers.edu			National Science Foundation [IOS-0744709]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant IOS-0744709.	Belenghi B, 2007, J BIOL CHEM, V282, P1352, DOI 10.1074/jbc.M608931200; Bozhkov PV, 2005, P NATL ACAD SCI USA, V102, P14463, DOI 10.1073/pnas.0506948102; BUSH DS, 1995, ANNU REV PLANT PHYS, V46, P95, DOI 10.1146/annurev.pp.46.060195.000523; CHEN ZX, 1992, J BIOL CHEM, V267, P18896; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Eichinger A, 1999, EMBO J, V18, P5453, DOI 10.1093/emboj/18.20.5453; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Gonzalez IJ, 2007, INT J PARASITOL, V37, P161, DOI 10.1016/j.ijpara.2006.10.004; Guaragnella N, 2006, FEBS LETT, V580, P6880, DOI 10.1016/j.febslet.2006.11.050; Hauptmann P, 2006, MOL MICROBIOL, V59, P765, DOI 10.1111/j.1365-2958.2005.04981.x; He R, 2008, J BIOL CHEM, V283, P774, DOI 10.1074/jbc.M704185200; Hofius D, 2007, SEMIN CANCER BIOL, V17, P166, DOI 10.1016/j.semcancer.2006.12.001; KAHN S, 2010, J PLANT PHYSL, V167, P855; Koeplinger KA, 2000, PROTEIN EXPRES PURIF, V18, P378, DOI 10.1006/prep.2000.1205; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Lam E, 2004, NAT REV MOL CELL BIO, V5, P305, DOI 10.1038/nrm1358; Lampl N, 2010, J BIOL CHEM, V285, P13550, DOI 10.1074/jbc.M109.095075; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Lee N, 2007, EUKARYOT CELL, V6, P1745, DOI 10.1128/EC.00123-07; Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4; Margetts MB, 2000, PROTEIN EXPRES PURIF, V18, P262, DOI 10.1006/prep.2000.1193; Mikolajczyk J, 2003, J BIOL CHEM, V278, P10458, DOI 10.1074/jbc.M210564200; Moss CX, 2007, FEBS LETT, V581, P5635, DOI 10.1016/j.febslet.2007.11.009; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Potempa J, 2003, CURR PROTEIN PEPT SC, V4, P397, DOI 10.2174/1389203033487036; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; REDDY ASN, 1994, BIOCHEM BIOPH RES CO, V199, P1089, DOI 10.1006/bbrc.1994.1342; Safadi F, 1997, ARCH BIOCHEM BIOPHYS, V348, P143, DOI 10.1006/abbi.1997.0361; Sanmartin M, 2005, PLANT PHYSIOL, V137, P841, DOI 10.1104/pp.104.058552; Shi YG, 2002, MOL CELL, V9, P459, DOI 10.1016/S1097-2765(02)00482-3; Silva RD, 2005, MOL MICROBIOL, V58, P824, DOI 10.1111/j.1365-2958.2005.04868.x; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vercammen D, 2004, J BIOL CHEM, V279, P45329, DOI 10.1074/jbc.M406329200; Vercammen D, 2007, J CELL BIOL, V179, P375, DOI 10.1083/jcb.200705193; Vercammen D, 2006, J MOL BIOL, V364, P625, DOI 10.1016/j.jmb.2006.09.010; Wang CX, 2003, J BIOL CHEM, V278, P34467, DOI 10.1074/jbc.M300745200; Watanabe N, 2004, MOL PLANT PATHOL, V5, P65, DOI 10.1111/j.1364-3703.2004.00206.x; Watanabe N, 2005, J BIOL CHEM, V280, P14691, DOI 10.1074/jbc.M413527200; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	40	63	66	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 25	2011	286	12					10027	10040		10.1074/jbc.M110.194340	http://dx.doi.org/10.1074/jbc.M110.194340			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	737CU	21209078	Green Published, hybrid			2022-12-27	WOS:000288547000017
J	Luo, GZ; Costanzo, M; Boone, C; Dickson, RC				Luo, Guangzuo; Costanzo, Michael; Boone, Charles; Dickson, Robert C.			Nutrients and the Pkh1/2 and Pkc1 Protein Kinases Control mRNA Decay and P-body Assembly in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ANALYSIS; CYTOPLASMIC PROCESSING BODIES; TERMINATION FACTOR ERF3; SACCHAROMYCES-CEREVISIAE; POLY(A)-BINDING PROTEIN; TRANSLATION INITIATION; DEADENYLASE COMPLEX; GENE-EXPRESSION; TRANSCRIPTION FACTOR; CCR4-NOT COMPLEX	Regulated mRNA decay is essential for eukaryotic survival but the mechanisms for regulating global decay and coordinating it with growth, nutrient, and environmental cues are not known. Here we show that a signal transduction pathway containing the Pkh1/Pkh2 protein kinases and one of their effector kinases, Pkc1, is required for and regulates global mRNA decay at the deadenylation step in Saccharomyces cerevisiae. Additionally, many stresses disrupt protein synthesis and release mRNAs from polysomes for incorporation into P-bodies for degradation or storage. We find that the Pkh1/2-Pkc1 pathway is also required for stress-induced P-body assembly. Control of mRNA decay and P-body assembly by the Pkh-Pkc1 pathway only occurs in nutrient-poor medium, suggesting a novel role for these processes in evolution. Our identification of a signaling pathway for regulating global mRNA decay and P-body assembly provides a means to coordinate mRNA decay with other cellular processes essential for growth and long-term survival. Mammals may use similar regulatory mechanisms because components of the decay apparatus and signaling pathways are conserved.	[Luo, Guangzuo; Dickson, Robert C.] Univ Kentucky, Coll Med, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Luo, Guangzuo; Dickson, Robert C.] Univ Kentucky, Coll Med, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA; [Costanzo, Michael; Boone, Charles] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Costanzo, Michael; Boone, Charles] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada	University of Kentucky; University of Kentucky; University of Toronto; University of Toronto	Dickson, RC (corresponding author), 741 S Limestone, Lexington, KY 40536 USA.	bobd@uky.edu		Luo, Guangzuo/0000-0002-8518-5766	National Institutes of Health [GM41302]; National Center for Research Resources [P20-RR020171]; Canadian Institutes of Health and Research, Genome Canada; Ontario Genomics Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Canadian Institutes of Health and Research, Genome Canada(Genome CanadaCanadian Institutes of Health Research (CIHR)); Ontario Genomics Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM41302 and core facilities Grant P20-RR020171 from the National Center for Research Resources (to R. C. D.) and grants from the Canadian Institutes of Health and Research, Genome Canada, and the Ontario Genomics Institute (to C. B.).	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Bai YL, 1999, MOL CELL BIOL, V19, P6642; Brengues M, 2005, SCIENCE, V310, P486, DOI 10.1126/science.1115791; Brown CE, 1998, MOL CELL BIOL, V18, P6548, DOI 10.1128/MCB.18.11.6548; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; Cheadle C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-75; Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210; Coller J, 2004, ANNU REV BIOCHEM, V73, P861, DOI 10.1146/annurev.biochem.73.011303.074032; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Coller J, 2008, METHOD ENZYMOL, V448, P267, DOI 10.1016/S0076-6879(08)02614-1; Coller JM, 2001, RNA, V7, P1717, DOI 10.1017/S135583820101994X; Daugeron MC, 2001, NUCLEIC ACIDS RES, V29, P2448, DOI 10.1093/nar/29.12.2448; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Denis CL, 2003, PROG NUCLEIC ACID RE, V73, P221, DOI 10.1016/S0079-6603(03)01007-9; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Drgonova J, 1999, J CELL BIOL, V146, P373, DOI 10.1083/jcb.146.2.373; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Ezzeddine N, 2007, MOL CELL BIOL, V27, P7791, DOI 10.1128/MCB.01254-07; Fan JS, 2002, P NATL ACAD SCI USA, V99, P10611, DOI 10.1073/pnas.162212399; Fillman C, 2005, CURR OPIN CELL BIOL, V17, P326, DOI 10.1016/j.ceb.2005.04.002; Fischer N, 2002, EMBO J, V21, P2788, DOI 10.1093/emboj/21.11.2788; Franks TM, 2008, MOL CELL, V32, P605, DOI 10.1016/j.molcel.2008.11.001; Funakoshi Y, 2007, GENE DEV, V21, P3135, DOI 10.1101/gad.1597707; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370; Goldstrohm AC, 2007, J BIOL CHEM, V282, P109, DOI 10.1074/jbc.M609413200; Goldstrohm AC, 2008, METHOD ENZYMOL, V448, P77, DOI 10.1016/S0076-6879(08)02605-0; Gowrishankar G, 2006, BIOL CHEM, V387, P323, DOI 10.1515/BC.2006.043; Hata H, 1998, GENETICS, V148, P571; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; Hilgers V, 2006, RNA, V12, P1835, DOI 10.1261/rna.241006; Hosoda N, 2003, J BIOL CHEM, V278, P38287, DOI 10.1074/jbc.C300300200; Hu WQ, 2009, NATURE, V461, P225, DOI 10.1038/nature08265; Inagaki M, 1999, MOL CELL BIOL, V19, P8344; Jung US, 1999, MOL MICROBIOL, V34, P1049, DOI 10.1046/j.1365-2958.1999.01667.x; Kulkarni M, 2010, BIOCHEM SOC T, V38, P242, DOI 10.1042/BST0380242; Lagorce A, 2003, J BIOL CHEM, V278, P20345, DOI 10.1074/jbc.M211604200; LEVIN DE, 1992, J CELL BIOL, V116, P1221, DOI 10.1083/jcb.116.5.1221; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Mangus DA, 2004, MOL CELL BIOL, V24, P5521, DOI 10.1128/MCB.24.12.5521-5533.2004; Mangus DA, 1998, MOL CELL BIOL, V18, P7383, DOI 10.1128/MCB.18.12.7383; Mauxion F, 2008, EMBO J, V27, P1039, DOI 10.1038/emboj.2008.43; Meier KD, 2006, MOL BIOL CELL, V17, P1164, DOI 10.1091/mbc.E05-11-1039; Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022; Nissan T, 2008, METHOD ENZYMOL, V448, P507, DOI 10.1016/S0076-6879(08)02625-6; Ohn T, 2007, NUCLEIC ACIDS RES, V35, P3002, DOI 10.1093/nar/gkm196; PARAVICINI G, 1992, MOL CELL BIOL, V12, P4896, DOI 10.1128/MCB.12.11.4896; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Passos DO, 2008, METHOD ENZYMOL, V448, P409, DOI 10.1016/S0076-6879(08)02620-7; Peifer C, 2008, CHEMMEDCHEM, V3, P1810, DOI 10.1002/cmdc.200800195; Rendl LM, 2008, RNA, V14, P1328, DOI 10.1261/rna.955508; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Saini P, 2009, NATURE, V459, P118, DOI 10.1038/nature08034; Schwartz DC, 1999, MOL CELL BIOL, V19, P5247; Seay D, 2006, RNA, V12, P1594, DOI 10.1261/rna.145306; Semotok JL, 2005, CURR BIOL, V15, P284, DOI 10.1016/j.cub.2005.01.048; Sheth U, 2003, SCIENCE, V300, P805, DOI 10.1126/science.1082320; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Simon E, 2007, NUCLEIC ACIDS RES, V35, P6017, DOI 10.1093/nar/gkm452; Stoecklin G, 2006, EMBO REP, V7, P72, DOI 10.1038/sj.embor.7400572; Teixeira D, 2005, RNA, V11, P371, DOI 10.1261/rna.7258505; Teixeira D, 2007, MOL BIOL CELL, V18, P2274, DOI 10.1091/mbc.E07-03-0199; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong Amy Hin Yan, 2006, Methods Mol Biol, V313, P171; Tseng-Rogenski SSI, 2003, NUCLEIC ACIDS RES, V31, P4995, DOI 10.1093/nar/gkg712; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Valentini SR, 2002, GENETICS, V160, P393; Yamashita A, 2005, NAT STRUCT MOL BIOL, V12, P1054, DOI 10.1038/nsmb1016; Yao G, 2007, MOL CELL BIOL, V27, P6243, DOI 10.1128/MCB.00734-07; Zaessinger S, 2006, DEVELOPMENT, V133, P4573, DOI 10.1242/dev.02649; Zheng DH, 2008, J CELL BIOL, V182, P89, DOI 10.1083/jcb.200801196; Zuk D, 1998, EMBO J, V17, P2914, DOI 10.1093/emboj/17.10.2914	79	23	24	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					8759	8770		10.1074/jbc.M110.196030	http://dx.doi.org/10.1074/jbc.M110.196030			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21163942	hybrid, Green Published			2022-12-27	WOS:000288247700007
J	Miner, JJ; Shao, BJ; Wang, Y; Chichili, GR; Liu, ZH; Klopocki, AG; Yago, T; McDaniel, JM; Rodgers, W; Xia, LJ; McEver, RP				Miner, Jonathan J.; Shao, Bojing; Wang, Ying; Chichili, Gurunadh R.; Liu, Zhenghui; Klopocki, Arkadiusz G.; Yago, Tadayuki; McDaniel, J. Michael; Rodgers, William; Xia, Lijun; McEver, Rodger P.			Cytoplasmic Domain of P-selectin Glycoprotein Ligand-1 Facilitates Dimerization and Export from the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1-DERIVED O-GLYCANS; MYELOID CELLS; ERYTHROPOIETIN RECEPTOR; LINKED OLIGOSACCHARIDES; TRANSMEMBRANE DOMAIN; ENDOTHELIAL-CELLS; PLASMA-MEMBRANE; 1 PSGL-1; IN-VIVO; EXPRESSION	P-selectin glycoprotein ligand-1 (PSGL-1) is a homodimeric transmembrane mucin on leukocytes. During inflammation, reversible interactions of PSGL-1 with selectins mediate leukocyte rolling on vascular surfaces. The transmembrane domain of PSGL-1 is required for dimerization, and the cytoplasmic domain propagates signals that activate beta(2) integrins to slow rolling on integrin ligands. Leukocytes from knock-in "Delta CD" mice express a truncated PSGL-1 that lacks the cytoplasmic domain. Unexpectedly, they have 10-fold less PSGL-1 on their surfaces than WT leukocytes. Using glycosidases, proteases, Western blotting, confocal microscopy, cell-surface cross-linking, FRET, and pulse-chase metabolic labeling, we demonstrate that deleting the cytoplasmic domain impaired dimerization and delayed export of PSGL-1 from the endoplasmic reticulum (ER), markedly increasing a monomeric precursor in the ER and decreasing mature PSGL-1 on the cell surface. A monomeric full-length PSGL-1 made by substituting the transmembrane domain with that of CD43 exited the ER normally, revealing that dimerization was not required for ER export. Thus, the transmembrane and cytoplasmic domains cooperate to promote dimerization of PSGL-1. Furthermore, the cytoplasmic domain provides a key signal to export precursors of PSGL-1 from the ER to the Golgi apparatus en route to the cell surface.	[Chichili, Gurunadh R.; Liu, Zhenghui; Klopocki, Arkadiusz G.; Yago, Tadayuki; McDaniel, J. Michael; Rodgers, William; Xia, Lijun; McEver, Rodger P.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, Oklahoma City, OK 73104 USA; [Miner, Jonathan J.; Shao, Bojing; Wang, Ying; Xia, Lijun; McEver, Rodger P.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA; [Rodgers, William] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK 73104 USA; [Rodgers, William] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	McEver, RP (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Oklahoma Med Res Fdn, Cardiovasc Biol Res Program, 825 NE 13th St, Oklahoma City, OK 73104 USA.	rodger-mcever@omrf.org			National Institutes of Health [HL 03463, HL 085607]; Oklahoma Center for the Advancement of Science and Technology [HR08-084]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034363, P01HL085607, K08HL003463] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oklahoma Center for the Advancement of Science and Technology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL 03463 (to R. P. M.) and HL 085607 (to R. P. M. and L. X.). This work was also supported by Oklahoma Center for the Advancement of Science and Technology Grant HR08-084 (to W. R.).	BONIFACINO JS, 1991, EMBO J, V10, P2783, DOI 10.1002/j.1460-2075.1991.tb07827.x; Bruehl RE, 1997, J LEUKOCYTE BIOL, V61, P489, DOI 10.1002/jlb.61.4.489; Chichili GR, 2010, J BIOL CHEM, V285, P14737, DOI 10.1074/jbc.M109.097311; Dancourt J, 2010, ANNU REV BIOCHEM, V79, P777, DOI 10.1146/annurev-biochem-061608-091319; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Epperson TR, 2000, J BIOL CHEM, V275, P7839, DOI 10.1074/jbc.275.11.7839; Frenette PS, 2000, J EXP MED, V191, P1413, DOI 10.1084/jem.191.8.1413; Fu JX, 2008, J CLIN INVEST, V118, P3725, DOI 10.1172/JCI36077; Giraudo CG, 2003, MOL BIOL CELL, V14, P3753, DOI 10.1091/mbc.E03-02-0101; Hidalgo A, 2007, IMMUNITY, V26, P477, DOI 10.1016/j.immuni.2007.03.011; JOHNSTON GI, 1989, J BIOL CHEM, V264, P1816; Ju TZ, 2002, J BIOL CHEM, V277, P178, DOI 10.1074/jbc.M109060200; Kawar ZS, 2008, GLYCOBIOLOGY, V18, P441, DOI 10.1093/glycob/cwn020; Kobzdej MMA, 2002, BLOOD, V100, P4485, DOI 10.1182/blood-2002-06-1799; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kubatzky KF, 2001, CURR BIOL, V11, P110, DOI 10.1016/S0960-9822(01)00018-5; Kuwano Y, 2010, BLOOD, V116, P617, DOI 10.1182/blood-2010-01-266122; Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li FG, 1996, J BIOL CHEM, V271, P6342, DOI 10.1074/jbc.271.11.6342; Li FG, 1996, J BIOL CHEM, V271, P3255, DOI 10.1074/jbc.271.6.3255; Liu ZH, 2010, J EXP MED, V207, P2975, DOI 10.1084/jem.20101545; LORANT DE, 1995, J CLIN INVEST, V96, P171, DOI 10.1172/JCI118018; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; Miner JJ, 2008, BLOOD, V112, P2035, DOI 10.1182/blood-2008-04-149468; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Mo X, 2006, J BIOL CHEM, V281, P23050, DOI 10.1074/jbc.M600924200; MOORE KL, 1992, J CELL BIOL, V118, P445, DOI 10.1083/jcb.118.2.445; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; Mueller H, 2010, BLOOD, V115, P3118, DOI 10.1182/blood-2009-11-254185; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556; NORGARD KE, 1993, J BIOL CHEM, V268, P12764; Perez-Vilar J, 1999, J BIOL CHEM, V274, P31751, DOI 10.1074/jbc.274.45.31751; Ramachandran V, 2001, P NATL ACAD SCI USA, V98, P10166, DOI 10.1073/pnas.171248098; Robert J, 2005, J BIOL CHEM, V280, P2300, DOI 10.1074/jbc.M410655200; ROSE MC, 1984, J BIOL CHEM, V259, P3167; Ruan WM, 2004, J BIOL CHEM, V279, P3273, DOI 10.1074/jbc.M309311200; Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200; Serrador JM, 2002, EUR J IMMUNOL, V32, P1560, DOI 10.1002/1521-4141(200206)32:6<1560::AID-IMMU1560>3.0.CO;2-U; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; Sperandio M, 2003, J EXP MED, V197, P1355, DOI 10.1084/jem.20021854; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Vestweber D, 1999, PHYSIOL REV, V79, P181, DOI 10.1152/physrev.1999.79.1.181; Walcheck B, 1996, J CLIN INVEST, V98, P1081, DOI 10.1172/JCI118888; Wilkins PP, 1996, J BIOL CHEM, V271, P18732, DOI 10.1074/jbc.271.31.18732; Xia LJ, 2004, J CELL BIOL, V164, P451, DOI 10.1083/jcb.200311112; Xia LJ, 1998, BLOOD, V91, P1625, DOI 10.1182/blood.V91.5.1625.1625_1625_1632; Xia LJ, 2002, J CLIN INVEST, V109, P939; Yago T, 2010, BLOOD, V116, P485, DOI 10.1182/blood-2009-12-259556; Yago T, 2010, P NATL ACAD SCI USA, V107, P9204, DOI 10.1073/pnas.1003110107; Yang J, 1996, BLOOD, V87, P4176, DOI 10.1182/blood.V87.10.4176.bloodjournal87104176; Yang J, 1999, J EXP MED, V190, P1769, DOI 10.1084/jem.190.12.1769; Zarbock A, 2008, J EXP MED, V205, P2339, DOI 10.1084/jem.20072660; Zarbock A, 2007, IMMUNITY, V26, P773, DOI 10.1016/j.immuni.2007.04.011	58	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9577	9586		10.1074/jbc.M110.208777	http://dx.doi.org/10.1074/jbc.M110.208777			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21220419	Green Published, hybrid			2022-12-27	WOS:000288247700083
J	Yano, J; Walker, LM; Strickler, MA; Service, RJ; Yachandra, VK; Debus, RJ				Yano, Junko; Walker, Lee M.; Strickler, Melodie A.; Service, Rachel J.; Yachandra, Vittal K.; Debus, Richard J.			Altered Structure of the Mn4Ca Cluster in the Oxygen-evolving Complex of Photosystem II by a Histidine Ligand Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY-ABSORPTION SPECTROSCOPY; ECHO ENVELOPE MODULATION; FTIR DIFFERENCE SPECTROSCOPY; MANGANESE CLUSTER; D1 POLYPEPTIDE; THERMOSYNECHOCOCCUS-ELONGATUS; PHOTOSYNTHETIC APPARATUS; NITROGEN LIGATION; STRONTIUM EXAFS; PULSED EPR	The effect of replacing a histidine ligand on the properties of the oxygen-evolving complex (OEC) and the structure of the Mn4Ca cluster in Photosystem II (PSII) is studied by x-ray absorption spectroscopy using PSII core complexes from the Synechocystis sp. PCC 6803 D1 polypeptide mutant H332E. In the x-ray crystallographic structures of PSII, D1-His(332) has been assigned as a direct ligand of a manganese ion, and the mutation of this histidine ligand to glutamate has been reported to prevent the advancement of the OEC beyond the S(2)Yz(center dot) intermediate state. The manganese K-edge (1s core electron to 4p) absorption spectrum of D1-H332E shifts to a lower energy compared with that of the native WT samples, suggesting that the electronic structure of the manganese cluster is affected by the presence of the additional negative charge on the OEC of the mutant. The extended x-ray absorption spectrum shows that the geometric structure of the cluster is altered substantially from that of the native WT state, resulting in an elongation of manganese-ligand and manganese-manganese interactions in the mutant. The strontium-H332E mutant, in which calcium is substituted by strontium, confirms that strontium (calcium) is a part of the altered cluster. The structural perturbations caused by the D1-H332E mutation are much larger than those produced by any biochemical treatment or mutation examined previously with x-ray absorption spectroscopy. The substantial structural changes provide an explanation not only for the altered properties of the D1-H332E mutant but also the importance of the histidine ligand for proper assembly of the Mn4Ca cluster.	[Yano, Junko; Yachandra, Vittal K.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Walker, Lee M.; Strickler, Melodie A.; Service, Rachel J.; Debus, Richard J.] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Riverside	Yano, J (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, MS 66-0200,1 Cyclotron Rd, Berkeley, CA 94720 USA.	JYano@lbl.gov; richard.debus@ucr.edu			National Institutes of Health [GM 55302, GM 076232]; Department of Energy, Office of Science, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences [DE-AC02-05CH11231]; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Center for Research Resources; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R56GM055302, R01GM076232, R01GM055302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy, Office of Science, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences(United States Department of Energy (DOE)); Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM 55302 (to V.K.Y.) and GM 076232 (to R.J.D.). This work was also supported by the Department of Energy, Director, Office of Science, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences under Contract DE-AC02-05CH11231 (to J.Y. and V.K.Y.). Portions of this research were carried out at Stanford Synchrotron Radiation Laboratory, operated by Stanford University for the Department of Energy, Office of Basic Energy Sciences and supported by the Department of Energy, Office of Biological and Environmental Research and by the National Institutes of Health, National Center for Research Resources.	Allahverdiyeva Y, 2004, EUR J BIOCHEM, V271, P3523, DOI 10.1111/j.0014-2956.2004.04287.x; BALDWIN MJ, 1994, J AM CHEM SOC, V116, P11349, DOI 10.1021/ja00104a014; Boussac A, 2004, J BIOL CHEM, V279, P22809, DOI 10.1074/jbc.M401677200; BRITT RD, 1989, J AM CHEM SOC, V111, P3522, DOI 10.1021/ja00192a006; Burnap RL, 2004, PHYS CHEM CHEM PHYS, V6, P4803, DOI 10.1039/b407094a; CHU HA, 1994, BIOCHEMISTRY-US, V33, P6137, DOI 10.1021/bi00186a013; CHU HA, 1995, BIOCHEMISTRY-US, V34, P5859, DOI 10.1021/bi00017a017; Cinco RM, 1999, INORG CHEM, V38, P5988, DOI 10.1021/ic991003j; Cinco RM, 2004, BIOCHEMISTRY-US, V43, P13271, DOI 10.1021/bi036308v; Cinco RM, 1998, J PHYS CHEM B, V102, P8248, DOI 10.1021/jp981658q; Cinco RM, 2002, BIOCHEMISTRY-US, V41, P12928, DOI 10.1021/bi026569p; Dasgupta J, 2008, COORDIN CHEM REV, V252, P347, DOI 10.1016/j.ccr.2007.08.022; DAU H, 1995, BIOCHEMISTRY-US, V34, P5274, DOI 10.1021/bi00015a043; Dau H, 2005, PHYS SCRIPTA, VT115, P844; Debus RJ, 2008, COORDIN CHEM REV, V252, P244, DOI 10.1016/j.ccr.2007.09.022; Debus RJ, 2000, BIOCHEMISTRY-US, V39, P470, DOI 10.1021/bi9917737; Debus RJ, 2001, BIOCHEMISTRY-US, V40, P3690, DOI 10.1021/bi002394c; DEROSE VJ, 1994, J AM CHEM SOC, V116, P5239, DOI 10.1021/ja00091a031; DEROSE VJ, 1991, BIOCHEMISTRY-US, V30, P1335, DOI 10.1021/bi00219a025; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; George G. N., 2000, EXAFSPAK EDG FIT STA; GHANOTAKIS DF, 1984, FEBS LETT, V167, P127, DOI 10.1016/0014-5793(84)80846-7; GILCHRIST ML, 1996, THESIS U CALIFORNIA; Grabolle M, 2006, J BIOL CHEM, V281, P4580, DOI 10.1074/jbc.M509724200; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Latimer MJ, 1998, J PHYS CHEM B, V102, P8257, DOI 10.1021/jp981668r; LATIMER MJ, 1995, BIOCHEMISTRY-US, V34, P10898, DOI 10.1021/bi00034a024; LIANG W, 1994, BIOCHEMISTRY-US, V33, P4923, DOI 10.1021/bi00182a022; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; MCCARRICK RM, 2008, STRUCTURE PHOTOSYNTH; McEvoy JP, 2006, CHEM REV, V106, P4455, DOI 10.1021/cr0204294; Messinger J, 2001, J AM CHEM SOC, V123, P7804, DOI 10.1021/ja004307+; Mukhopadhyay S, 2004, CHEM REV, V104, P3981, DOI 10.1021/cr0206014; Newville M, 2001, J SYNCHROTRON RADIAT, V8, P322, DOI 10.1107/S0909049500016964; Pushkar YL, 2008, P NATL ACAD SCI USA, V105, P1879, DOI 10.1073/pnas.0707092105; Pushkar Y, 2007, J BIOL CHEM, V282, P7198, DOI 10.1074/jbc.M610505200; Rappaport F, 2008, COORDIN CHEM REV, V252, P259, DOI 10.1016/j.ccr.2007.07.016; Rehr JJ, 2000, REV MOD PHYS, V72, P621, DOI 10.1103/RevModPhys.72.621; Renger G, 2008, PHOTOSYNTH RES, V98, P53, DOI 10.1007/s11120-008-9345-7; Strickler MA, 2005, BIOCHEMISTRY-US, V44, P8571, DOI 10.1021/bi050653y; Strickler MA, 2007, BIOCHEMISTRY-US, V46, P3151, DOI 10.1021/bi062195e; Sugiura M, 2009, BIOCHEMISTRY-US, V48, P7856, DOI 10.1021/bi901067b; TANG XS, 1994, P NATL ACAD SCI USA, V91, P704, DOI 10.1073/pnas.91.2.704; YACHANDRA VK, 2005, PHOTOSYSTEM, V2; Yano J, 2007, PHOTOSYNTH RES, V91, P173; Yano J, 2005, J AM CHEM SOC, V127, P14974, DOI 10.1021/ja054873a; Yano J, 2005, P NATL ACAD SCI USA, V102, P12047, DOI 10.1073/pnas.0505207102; Yano J, 2008, INORG CHEM, V47, P1711, DOI 10.1021/ic7016837; Yano J, 2006, SCIENCE, V314, P821, DOI 10.1126/science.1128186; Yeagle GJ, 2008, INORG CHEM, V47, P1803, DOI 10.1021/ic701680c; Yeagle GJ, 2008, PHILOS T R SOC B, V363, P1157, DOI 10.1098/rstb.2007.2211; ZIMMERMANN JL, 1993, BIOCHEMISTRY-US, V32, P4831, DOI 10.1021/bi00069a019	53	10	10	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2011	286	11					9257	9267		10.1074/jbc.M110.205740	http://dx.doi.org/10.1074/jbc.M110.205740			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	733FE	21233216	Green Submitted, Green Published, hybrid			2022-12-27	WOS:000288247700056
J	Kim, DY; Gersbacher, MT; Inquimbert, P; Kovacs, DM				Kim, Doo Yeon; Gersbacher, Manuel T.; Inquimbert, Perrine; Kovacs, Dora M.			Reduced Sodium Channel Na(v)1.1 Levels in BACE1-null Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE BACE1; APP TRANSGENIC MICE; ALZHEIMERS-DISEASE; MOLECULAR-MECHANISMS; MULTIPLE-SCLEROSIS; NEURONAL-ACTIVITY; GAMMA-SECRETASE; CELL-ADHESION; MOUSE MODEL	The Alzheimer BACE1 enzyme cleaves numerous substrates, with largely unknown physiological consequences. We have previously identified the contribution of elevated BACE1 activity to voltage-gated sodium channel Na(v)1.1 density and neuronal function. Here, we analyzed physiological changes in sodium channel metabolism in BACE1-null mice. Mechanistically, we first confirmed that endogenous BACE1 requires its substrate, the beta-subunit Na-v beta 2, to regulate levels of the pore-forming alpha-subunit Na(v)1.1 in cultured primary neurons. Next, we analyzed sodium channel alpha-subunit levels in brains of BACE1-null mice at 1 and 3 months of age. At both ages, we found that Na(v)1.1 protein levels were significantly decreased in BACE1-null versus wild-type mouse brains, remaining unchanged in BACE1-heterozygous mouse brains. Interestingly, levels of Na(v)1.2 and Na(v)1.6 alpha-subunits also decreased in 1-month-old BACE1-null mice. In the hippocampus of BACE1-null mice, we found a robust 57% decrease of Na(v)1.1 levels. Next, we performed surface biotinylation studies in acutely dissociated hippocampal slices from BACE1-null mice. Hippocampal surface Na(v)1.1 levels were significantly decreased, but Na(v)1.2 surface levels were increased in BACE1-null mice perhaps as a compensatory mechanism for reduced surface Na(v)1.1. We also found that Na-v beta(2) processing and Na(v)1.1 mRNA levels were significantly decreased in brains of BACE1-null mice. This suggests a mechanism consistent with BACE1 activity regulating mRNA levels of the alpha-subunit Na(v)1.1 via cleavage of cell-surface Na-v beta(2). Together, our data show that endogenous BACE1 activity regulates total and surface levels of voltage-gated sodium channels in mouse brains. Both decreased Na(v)1.1 and elevated surface Na(v)1.2 may result in a seizure phenotype. Our data caution that therapeutic BACE1 activity inhibition in Alzheimer disease patients may affect Na(v)1 metabolism and alter neuronal membrane excitability in Alzheimer disease patients.	Harvard Univ, Massachusetts Gen Hosp, Sch Med,Neurobiol Dis Lab,Genet & Aging Res Unit, Massachusetts Gen Inst Neurodegenerat Dis, Charlestown, MA 02129 USA; [Inquimbert, Perrine] Childrens Hosp, Dept Neurol, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital		dora_kovacs@hms.harvard.edu		Inquimbert, Perrine/0000-0003-2625-1468	National Institutes of Health, NIA; NATIONAL INSTITUTE ON AGING [R01AG014713, R21AG031483] Funding Source: NIH RePORTER	National Institutes of Health, NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health grants from NIA (to D. M. K. and D. Y. K.).	Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2002, NOVART FDN SYMP, V241, P206; Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484; Chen CL, 2002, P NATL ACAD SCI USA, V99, P17072, DOI 10.1073/pnas.212638099; Craner MJ, 2005, GLIA, V49, P220, DOI 10.1002/glia.20112; Craner MJ, 2004, P NATL ACAD SCI USA, V101, P8168, DOI 10.1073/pnas.0402765101; Davis TH, 2004, J BIOL CHEM, V279, P51424, DOI 10.1074/jbc.M410830200; de Leon M J, 1995, Neuroimaging Clin N Am, V5, P1; Dominguez D, 2005, J BIOL CHEM, V280, P30797, DOI 10.1074/jbc.M505249200; Fukumoto H, 2002, ARCH NEUROL-CHICAGO, V59, P1381, DOI 10.1001/archneur.59.9.1381; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hitt BD, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-31; Hu XY, 2008, FASEB J, V22, P2970, DOI 10.1096/fj.08-106666; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Hu XY, 2010, J NEUROSCI, V30, P8819, DOI 10.1523/JNEUROSCI.1334-10.2010; Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Kim DY, 2007, NAT CELL BIOL, V9, P755, DOI 10.1038/ncb1602; Kim DY, 2005, J BIOL CHEM, V280, P23251, DOI 10.1074/jbc.M412938200; Kitazume S, 2003, J BIOL CHEM, V278, P14865, DOI 10.1074/jbc.M206262200; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lopez-Santiago LF, 2006, J NEUROSCI, V26, P7984, DOI 10.1523/JNEUROSCI.2211-06.2006; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; O'Connor T, 2008, NEURON, V60, P988, DOI 10.1016/j.neuron.2008.10.047; O'Malley HA, 2009, MOL CELL NEUROSCI, V40, P143, DOI 10.1016/j.mcn.2008.10.001; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; SCHMIDT JW, 1986, CELL, V46, P437, DOI 10.1016/0092-8674(86)90664-1; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Thomas-Crusells J, 2003, J NEUROSCI METH, V125, P159, DOI 10.1016/S0165-0270(03)00050-5; Tyler SJ, 2002, BIOCHEM BIOPH RES CO, V299, P373, DOI 10.1016/S0006-291X(02)02635-9; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2001, J MOL NEUROSCI, V17, P157, DOI 10.1385/JMN:17:2:157; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Velliquette RA, 2005, J NEUROSCI, V25, P10874, DOI 10.1523/JNEUROSCI.2350-05.2005; Waxman SG, 2004, TRENDS PHARMACOL SCI, V25, P584, DOI 10.1016/j.tips.2004.09.001; WESTENBROEK RE, 1992, J NEUROSCI, V12, P2259, DOI 10.1523/jneurosci.12-06-02259.1992; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Wolfe MS, 2008, CURR ALZHEIMER RES, V5, P158, DOI 10.2174/156720508783954767; Wong HK, 2005, J BIOL CHEM, V280, P23009, DOI 10.1074/jbc.M414648200; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754; Zacchetti D, 2007, NEURODEGENER DIS, V4, P117, DOI 10.1159/000101836; Zayas EM, 1996, J CLIN PSYCHIAT, V57, P46	48	66	74	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					8106	8116		10.1074/jbc.M110.134692	http://dx.doi.org/10.1074/jbc.M110.134692			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21190943	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-27	WOS:000288013300041
J	Tanaka, N; Shuman, S				Tanaka, Naoko; Shuman, Stewart			RtcB Is the RNA Ligase Component of an Escherichia coli RNA Repair Operon	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3'-TERMINAL PHOSPHATE CYCLASE; LACTIS GAMMA-TOXIN; POLYNUCLEOTIDE KINASE-PHOSPHATASE; CLOSTRIDIUM-THERMOCELLUM; MESSENGER-RNA; ANTICODON NUCLEASE; PHOSPHODIESTERASE ACTIVITIES; DEINOCOCCUS-RADIODURANS; CYTOTOXIC RIBONUCLEASE; CRYSTAL-STRUCTURE	RNA 2`,3`-cyclic phosphate ends play important roles in RNA metabolism as substrates for RNA ligases during tRNA restriction-repair and tRNA splicing. Diverse bacteria from multiple phyla encode a two-component RNA repair cassette, comprising Pnkp (polynucleotide kinase-phosphatase-ligase) and Hen1 (RNA 3`-terminal ribose 2`-O-methyltransferase), that heals and then seals broken tRNAs with 2`,3`-cyclic phosphate and 5`-OH ends. The Pnkp-Hen1 repair operon is absent in the majority of bacterial species, thereby raising the prospect that other RNA repair systems might be extant. A candidate component is RNA 3`-phosphate cyclase, a widely distributed enzyme that transforms RNA 3`-monophosphate termini into 2`,3`-cyclic phosphates but cannot seal the ends it produces. Escherichia coli RNA cyclase (RtcA) is encoded in a sigma(54)-regulated operon with RtcB, a protein of unknown function. Taking a cue from Pnkp-Hen1, we purified E. coli RtcB and tested it for RNA ligase activity. We report that RtcB per se seals broken tRNA-like stem-loop structures with 2`,3`-cyclic phosphate and 5`-OH ends to form a splice junction with a 2`-OH, 3`,5`-phosphodiester. We speculate that: (i) RtcB might afford bacteria a means to recover from stress-induced RNA damage; and (ii) RtcB homologs might catalyze tRNA repair or splicing reactions in archaea and eukarya.	[Tanaka, Naoko; Shuman, Stewart] Sloan Kettering Inst, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Amer Canc Soc, Atlanta, GA 30329 USA.	s-shuman@ski.mskcc.org			National Institutes of Health [GM46330]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046330, R37GM046330] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM46330 (to S.S.).	AMITSUR M, 1987, EMBO J, V6, P2499, DOI 10.1002/j.1460-2075.1987.tb02532.x; Billy E, 1999, J BIOL CHEM, V274, P34955, DOI 10.1074/jbc.274.49.34955; Blanga-Kanfi S, 2006, NUCLEIC ACIDS RES, V34, P3209, DOI 10.1093/nar/gkl415; Brooks MA, 2008, PROTEIN SCI, V17, P1336, DOI 10.1110/ps.035493.108; Chakravarty AK, 2011, J BIOL CHEM, V286, P4117, DOI 10.1074/jbc.M110.196766; Chan CM, 2009, SCIENCE, V326, P247, DOI 10.1126/science.1179480; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; Englert M, 2005, NUCLEIC ACIDS RES, V33, P388, DOI 10.1093/nar/gki174; FILIPOWICZ W, 1985, P NATL ACAD SCI USA, V82, P1316, DOI 10.1073/pnas.82.5.1316; FILIPOWICZ W, 1983, NUCLEIC ACIDS RES, V11, P1405, DOI 10.1093/nar/11.5.1405; Genschik P, 1998, J BIOL CHEM, V273, P25516, DOI 10.1074/jbc.273.39.25516; GREER CL, 1983, CELL, V32, P537, DOI 10.1016/0092-8674(83)90473-7; Ho CK, 2002, P NATL ACAD SCI USA, V99, P12709, DOI 10.1073/pnas.192184699; Jain R, 2010, RNA, V16, P316, DOI 10.1261/rna.1926510; Jain R, 2009, RNA, V15, P923, DOI 10.1261/rna.1492809; Keppetipola N, 2006, RNA, V12, P73, DOI 10.1261/rna.2196406; Keppetipola N, 2007, NUCLEIC ACIDS RES, V35, P7721, DOI 10.1093/nar/gkm868; Keppetipola N, 2007, NUCLEIC ACIDS RES, V35, P3624, DOI 10.1093/nar/gkm110; Keppetipola N, 2006, J BIOL CHEM, V281, P19251, DOI 10.1074/jbc.M602549200; Keppetipola N, 2009, RNA, V15, P1036, DOI 10.1261/rna.1637809; Klassen R, 2008, MOL MICROBIOL, V69, P681, DOI 10.1111/j.1365-2958.2008.06319.x; KONARSKA M, 1982, P NATL ACAD SCI-BIOL, V79, P1474, DOI 10.1073/pnas.79.5.1474; LASKI FA, 1983, J BIOL CHEM, V258, P1974; Lu J, 2005, RNA, V11, P1648, DOI 10.1261/rna.2172105; Lu J, 2008, NUCLEIC ACIDS RES, V36, P1072, DOI 10.1093/nar/gkm1121; Martins A, 2005, RNA, V11, P1271, DOI 10.1261/rna.2690505; Martins A, 2004, J BIOL CHEM, V279, P50654, DOI 10.1074/jbc.M407657200; Mori T, 2010, MOL BIOL CELL, V21, P3722, DOI 10.1091/mbc.E10-08-0693; Nandakumar J, 2008, MOL CELL, V31, P278, DOI 10.1016/j.molcel.2008.05.019; Nandakumar J, 2006, CELL, V127, P71, DOI 10.1016/j.cell.2006.08.038; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; Ogawa T, 1999, SCIENCE, V283, P2097, DOI 10.1126/science.283.5410.2097; Okada C, 2006, PROTEINS, V63, P1119, DOI 10.1002/prot.20912; Palm GJ, 2000, STRUCTURE, V8, P13, DOI 10.1016/S0969-2126(00)00076-9; PERKINS KK, 1985, P NATL ACAD SCI USA, V82, P684, DOI 10.1073/pnas.82.3.684; Raymond A, 2007, NUCLEIC ACIDS RES, V35, P839, DOI 10.1093/nar/gkl1090; REINBERG D, 1985, J BIOL CHEM, V260, P6088; Schwer B, 2004, P NATL ACAD SCI USA, V101, P2788, DOI 10.1073/pnas.0305859101; Tanaka N, 2010, STRUCTURE, V18, P449, DOI 10.1016/j.str.2010.01.016; Tanaka N, 2009, RNA, V15, P1865, DOI 10.1261/rna.1771509; Tomita K, 2000, P NATL ACAD SCI USA, V97, P8278, DOI 10.1073/pnas.140213797; Torchia C, 2008, NUCLEIC ACIDS RES, V36, P6218, DOI 10.1093/nar/gkn602; Xue S, 2006, SCIENCE, V312, P906, DOI 10.1126/science.1126629; Zhang YL, 2005, J BIOL CHEM, V280, P3143, DOI 10.1074/jbc.M411811200; Zofallova L, 2000, RNA, V6, P1019, DOI 10.1017/S1355838200000613	45	104	108	0	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 11	2011	286	10					7727	7731		10.1074/jbc.C111.219022	http://dx.doi.org/10.1074/jbc.C111.219022			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	730DQ	21224389	Green Published, hybrid			2022-12-27	WOS:000288013300003
J	Nagata, S; Morooka, N; Asaoka, K; Nagasawa, H				Nagata, Shinji; Morooka, Nobukatsu; Asaoka, Kiyoshi; Nagasawa, Hiromichi			Identification of a Novel Hemolymph Peptide That Modulates Silkworm Feeding Motivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOBACCO HORNWORM CATERPILLARS; MANDUCA-SEXTA; BOMBYX-MORI; LOCUSTA-MIGRATORIA; ARTIFICIAL DIET; BEHAVIOR; LARVAE; DROSOPHILA; STIMULATION; MECHANISMS	Phytophagous insects do not constantly chew their diets; most of their time is spent in a non-feeding quiescent state even though they live on or around their diets. Following starvation, phytophagous insect larvae exhibit enhanced foraging behaviors such as nibbling and walking similar to the sequential behavior that occurs prior to each meal. Although extensive physiological studies have revealed regularly occurring feeding behaviors in phytophagous insects, little has been elucidated regarding the mechanism at the molecular level. Here, we report identification and characterization of a novel 62-amino acid peptide, designated as hemolymph major anionic peptide (HemaP), from the hemolymph of Bombyx mori larvae that induces foraging behaviors. The endogenous HemaP levels are significantly increased by diet deprivation, whereas re-feeding after starvation returns them to basal levels. In larvae fed ad libitum, hemolymph HemaP levels fluctuate according to the feeding cycle, indicating that locomotor-associated feeding behaviors of B. mori larvae are initiated when HemaP levels exceed an unidentified threshold. Furthermore, administration of exogenous HemaP mimics the starvation-experienced state by affecting dopamine levels in the suboesophageal ganglion, which coordinates neck and mandible movements. These data strongly suggest that fluctuation of hemolymph HemaP levels modulates the regularly occurring feeding-motivated behavior in B. mori by triggering feeding initiation.	[Nagata, Shinji; Morooka, Nobukatsu; Nagasawa, Hiromichi] Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Asaoka, Kiyoshi] Natl Inst Agribiol Sci, Tsukuba, Ibaraki 3058634, Japan	University of Tokyo; National Institute of Agrobiological Sciences - Japan	Nagata, S (corresponding author), Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	anagashi@mail.ecc.u-tokyo.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan [18780083, 22780099]; NAITO Foundation	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NAITO Foundation(Naito Memorial Foundation)	This work was supported in part by Grants-in-Aid for Scientific Research (18780083 and 22780099) from the Ministry of Education, Science, Sports, and Culture of Japan, and supported the NAITO Foundation.	Agrawal N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006652; Bernays EA, 1998, PHYSIOL ENTOMOL, V23, P295, DOI 10.1046/j.1365-3032.1998.00103.x; Bernays EA, 2000, J INSECT PHYSIOL, V46, P825, DOI 10.1016/S0022-1910(99)00172-9; BOWDAN E, 1988, Journal of Insect Behavior, V1, P31, DOI 10.1007/BF01052502; BOWDAN E, 1988, ENTOMOL EXP APPL, V47, P127, DOI 10.1007/BF00367478; BRADY J, 1974, ADV INSECT PHYSIOL, V10, P1, DOI DOI 10.1016/S0065-2806(08)60129-0; Braunig P, 2004, J COMP NEUROL, V478, P164, DOI 10.1002/cne.20287; Brown SE, 2009, INSECT BIOCHEM MOLEC, V39, P792, DOI 10.1016/j.ibmb.2009.09.004; Graham LA, 2003, MOL CELL PROTEOMICS, V2, P541, DOI 10.1074/mcp.M300018-MCP200; Hardie SL, 2006, J NEUROSCI METH, V153, P243, DOI 10.1016/j.jneumeth.2005.11.001; HIRAO T, 1981, J SERICULTURAL SCI J, V50, P335; Hirashima A, 2007, J INSECT PHYSIOL, V53, P1242, DOI 10.1016/j.jinsphys.2007.06.018; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; Hwang JS, 2003, BIOTECHNOL LETT, V25, P997, DOI 10.1023/A:1024035424317; Kaufmann L, 2004, COMP BIOCHEM PHYS C, V138, P469, DOI 10.1016/j.cca.2004.08.007; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Miles CI, 1998, J EXP BIOL, V201, P1785; Nagata S, 2006, J INSECT PHYSIOL, V52, P807, DOI 10.1016/j.jinsphys.2006.04.008; REYNOLDS SE, 1986, PHYSIOL ENTOMOL, V11, P39, DOI 10.1111/j.1365-3032.1986.tb00389.x; ROHRBACHER J, 1994, J COMP PHYSIOL A, V175, P619; Sasaki K, 2005, NEUROSCI LETT, V374, P166, DOI 10.1016/j.neulet.2004.10.049; Sasaki K, 2006, J INSECT PHYSIOL, V52, P528, DOI 10.1016/j.jinsphys.2006.02.001; Selcho M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005897; Simpson S.J., 1990, P73; Simpson S.J., 1995, P137; SIMPSON SJ, 1986, ANIM BEHAV, V34, P480, DOI 10.1016/S0003-3472(86)80117-8; SIMPSON SJ, 1982, PHYSIOL ENTOMOL, V7, P325, DOI 10.1111/j.1365-3032.1982.tb00305.x; SIMPSON SJ, 1985, PHYSIOL ENTOMOL, V10, P443, DOI 10.1111/j.1365-3032.1985.tb00066.x; SIMPSON SJ, 1993, PHYSIOL ENTOMOL, V18, P395, DOI 10.1111/j.1365-3032.1993.tb00613.x; Socha R, 2008, COMP BIOCHEM PHYS B, V151, P305, DOI 10.1016/j.cbpb.2008.07.014; STOCKER RF, 1981, CELL TISSUE RES, V216, P513; TIMMINS WA, 1988, PHYSIOL ENTOMOL, V13, P303, DOI 10.1111/j.1365-3032.1988.tb00482.x; TIMMINS WA, 1992, PHYSIOL ENTOMOL, V17, P81, DOI 10.1111/j.1365-3032.1992.tb00993.x; van der Horst DJ, 2002, MOL CELL BIOCHEM, V239, P113, DOI 10.1023/A:1020541010547; Waldbauer G. P., 1968, P229, DOI 10.1016/S0065-2806(08)60230-1	35	9	9	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7161	7170		10.1074/jbc.M110.176016	http://dx.doi.org/10.1074/jbc.M110.176016			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21177851	Green Published, hybrid			2022-12-27	WOS:000287737300033
J	Rahaman, SO; Swat, W; Febbraio, M; Silverstein, RL				Rahaman, S. Ohidar; Swat, Wojciech; Febbraio, Maria; Silverstein, Roy L.			Vav Family Rho Guanine Nucleotide Exchange Factors Regulate CD36-mediated Macrophage Foam Cell Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCAVENGER RECEPTOR CD36; ATHEROSCLEROTIC LESION DEVELOPMENT; MONOCYTE-DERIVED MACROPHAGES; E-DEFICIENT MICE; OXIDATIVE BURST; OXIDIZED LDL; LIPID UPTAKE; REQUIRE VAV; PLATELET; PROTEINS	Lipid-laden macrophages or "foam cells" are the primary components of the fatty streak, the earliest atherosclerotic lesion. Although Vav family guanine nucleotide exchange factors impact processes highly relevant to atherogenesis and are involved in pathways common to scavenger receptor CD36 signaling, their role in CD36-dependent macrophage foam cell formation remains unknown. The goal of the present study was to determine the contribution of Vav proteins to CD36-dependent foam cell formation and to identify the mechanisms by which Vavs participate in the process. We found that CD36 contributes to activation of Vav-1, -2, and -3 in aortae from hyperlipidemic mice and that oxidatively modified LDL (oxLDL) induces activation of macrophage Vav in vitro in a CD36 and Src family kinase-dependent manner. CD36-dependent uptake of oxLDL in vitro and foam cell formation in vitro and in vivo was significantly reduced in Vav null macrophages. These studies for the first time link CD36 and Vavs in a signaling pathway required for macrophage foam cell formation.	[Rahaman, S. Ohidar; Silverstein, Roy L.] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Febbraio, Maria] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Swat, Wojciech] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA; [Febbraio, Maria; Silverstein, Roy L.] Cleveland Clin, Lerner Coll Med, Dept Mol Med, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Washington University (WUSTL); Case Western Reserve University; Cleveland Clinic Foundation	Rahaman, SO (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA.	rahamao@ccf.org; silverr2@ccf.org			National Institutes of Health [HL087018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087018] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL087018.	Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Curtis BR, 1996, TRANSFUSION, V36, P331, DOI 10.1046/j.1537-2995.1996.36496226147.x; Febbraio M, 2004, ARTERIOSCL THROM VAS, V24, P2333, DOI 10.1161/01.ATV.0000148007.06370.68; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Ghosh A, 2008, J CLIN INVEST, V118, P1934, DOI 10.1172/JCI34904; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Graham DB, 2007, J CLIN INVEST, V117, P3445, DOI 10.1172/JCI32729; Guy E, 2007, ATHEROSCLEROSIS, V192, P123, DOI 10.1016/j.atherosclerosis.2006.07.015; Harb D, 2009, CARDIOVASC RES, V83, P42, DOI 10.1093/cvr/cvp081; Janabi M, 2000, ARTERIOSCL THROM VAS, V20, P1953, DOI 10.1161/01.ATV.20.8.1953; Kennedy DJ, 2009, ARTERIOSCL THROM VAS, V29, P1481, DOI 10.1161/ATVBAHA.109.191940; Knowles JW, 2007, AM HEART J, V154, P1052, DOI 10.1016/j.ahj.2007.05.021; Kuchibhotla S, 2008, CARDIOVASC RES, V78, P185, DOI 10.1093/cvr/cvm093; Li AC, 2004, J CLIN INVEST, V114, P1564, DOI 10.1172/JCI200418730; Malhotra S, 2009, J BIOL CHEM, V284, P24088, DOI 10.1074/jbc.M109.014209; Marleau Sylvie, 2005, FASEB J, V19, P1869; Miletic AV, 2007, BLOOD, V109, P3360, DOI 10.1182/blood-2006-07-033662; Moore KJ, 2006, ARTERIOSCL THROM VAS, V26, P1702, DOI 10.1161/01.ATV.0000229218.97976.43; Moore KJ, 2005, J CLIN INVEST, V115, P2192, DOI 10.1172/JCI24061; NOZAKI S, 1995, J CLIN INVEST, V96, P1859, DOI 10.1172/JCI118231; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Pearce AC, 2004, J BIOL CHEM, V279, P53955, DOI 10.1074/jbc.M410355200; Podrez EA, 2000, J CLIN INVEST, V105, P1095, DOI 10.1172/JCI8574; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Swat W, 2005, IMMUNOL RES, V32, P259, DOI 10.1385/IR:32:1-3:259; Turner M, 2002, NAT REV IMMUNOL, V2, P476, DOI 10.1038/nri840; Wells CM, 2005, EXP CELL RES, V310, P303, DOI 10.1016/j.yexcr.2005.07.015; Wilkinson B, 2006, J BIOL CHEM, V281, P20842, DOI 10.1074/jbc.M600627200; YAMAMOTO N, 1990, BLOOD, V76, P1698; Zhao ZZ, 2005, ARTERIOSCL THROM VAS, V25, P168, DOI 10.1161/01.ATV.0000149145.00865.d9	34	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7010	7017		10.1074/jbc.M110.192450	http://dx.doi.org/10.1074/jbc.M110.192450			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21209086	Green Published, hybrid			2022-12-27	WOS:000287737300017
J	Wang, J; Grishin, N; Kinch, L; Cohen, JC; Hobbs, HH; Xie, XS				Wang, Jin; Grishin, Nick; Kinch, Lisa; Cohen, Jonathan C.; Hobbs, Helen H.; Xie, Xiao-Song			Sequences in the Nonconsensus Nucleotide-binding Domain of ABCG5/ABCG8 Required for Sterol Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILIARY CHOLESTEROL SECRETION; ABC-TRANSPORTERS; ATP-BINDING; DIETARY-CHOLESTEROL; MUTATIONS; RECONSTITUTION; ACCUMULATION; MECHANISM; MICE; LOOP	ATP-binding cassette transporters ABCG5 (G5) and ABCG8 (G8) form a heterodimer that transports cholesterol and plant sterols from hepatocytes into bile. Mutations that inactivate G5 or G8 cause hypercholesterolemia and premature atherosclerosis. We showed previously that the two nucleotide-binding domains (NBDs) in the heterodimer are not functionally equivalent; sterol transport is abolished by mutations in the consensus residues of NBD2 but not of NBD1. Here, we examined the structural requirements of NBD1 for sterol transport. Substitutions of the D-loop aspartate and Q-loop glutamine in either NBD did not impair sterol transport. The H-loop histidine of NBD2 (but not NBD1) was required for sterol transport. Exchange of the signature motifs between the NBDs did not interfere with sterol transport, whereas swapping the Walker A, Walker B, and signature motifs together resulted in failure to transport sterols. Selected substitutions within NBD1 altered substrate specificity: transport of plant sterols by the heterodimer was preserved, whereas transport of cholesterol was abolished. In summary, these data indicate that NBD1, although not required for ATP hydrolysis, is essential for normal function of G5G8 in sterol transport. Both the position and structural integrity of NBD2 are essential for sterol transport activity.	[Wang, Jin; Cohen, Jonathan C.; Hobbs, Helen H.; Xie, Xiao-Song] Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Grishin, Nick; Kinch, Lisa; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Cohen, Jonathan C.; Hobbs, Helen H.; Xie, Xiao-Song] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hobbs, HH (corresponding author), Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, MC8591, Dallas, TX 75390 USA.	helen.hobbs@utsouthwestern.edu; xiao-song.xie@utsouthwestern.edu		Kinch, Lisa/0000-0003-3041-2615	National Institutes of Health [HL72304]; NHLBI [RO1 HL72304]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL072304, R01HL072304] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL72304 and RO1 HL72304 from NHLBI.	Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Ambudkar SV, 2006, FEBS LETT, V580, P1049, DOI 10.1016/j.febslet.2005.12.051; Beaudet L, 1998, BIOCHEMISTRY-US, V37, P9073, DOI 10.1021/bi972656j; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Chen M, 2004, J BIOL CHEM, V279, P46073, DOI 10.1074/jbc.M404042200; Ernst R, 2008, P NATL ACAD SCI USA, V105, P5069, DOI 10.1073/pnas.0800191105; Graf GA, 2003, J BIOL CHEM, V278, P48275, DOI 10.1074/jbc.M310223200; Graf GA, 2002, J CLIN INVEST, V110, P659, DOI 10.1172/JCI200216000; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Moody JE, 2005, J BIOENERG BIOMEMBR, V37, P475, DOI 10.1007/s10863-005-9494-8; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Procko E, 2009, FASEB J, V23, P1287, DOI 10.1096/fj.08-121855; Procko E, 2009, CURR OPIN IMMUNOL, V21, P84, DOI 10.1016/j.coi.2009.02.003; SHYAMALA V, 1991, J BIOL CHEM, V266, P18714; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Wang J, 2008, BIOCHEMISTRY-US, V47, P5194, DOI 10.1021/bi800292v; Wang J, 2006, J BIOL CHEM, V281, P27894, DOI 10.1074/jbc.M605603200; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Yu LQ, 2004, J LIPID RES, V45, P301, DOI 10.1194/jlr.M300377-JLR200; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]; Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657; Zhang DW, 2006, J BIOL CHEM, V281, P4507, DOI 10.1074/jbc.M512277200	23	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2011	286	9					7308	7314		10.1074/jbc.M110.210880	http://dx.doi.org/10.1074/jbc.M110.210880			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	726PH	21209088	hybrid, Green Published			2022-12-27	WOS:000287737300047
J	Haeuptle, MA; Welti, M; Troxler, H; Hulsmeier, AJ; Imbach, T; Hennet, T				Haeuptle, Micha A.; Welti, Michael; Troxler, Heinz; Huelsmeier, Andreas J.; Imbach, Timo; Hennet, Thierry			Improvement of Dolichol-linked Oligosaccharide Biosynthesis by the Squalene Synthase Inhibitor Zaragozic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A REDUCTASE; CONGENITAL DISORDER; SELECTIVE-INHIBITION; GLYCOSYLATION; CHOLESTEROL; DEFICIENCY; PHOSPHATE; GENE; DERIVATIVES; MUTATIONS	The majority of congenital disorders of glycosylation (CDG) are caused by defects of dolichol (Dol)-linked oligosaccharide assembly, which lead to under-occupancy of N-glycosylation sites. Most mutations encountered in CDG are hypomorphic, thus leaving residual activity to the affected biosynthetic enzymes. We hypothesized that increased cellular levels of Dol-linked substrates might compensate for the low biosynthetic activity and thereby improve the output of protein N-glycosylation in CDG. To this end, we investigated the potential of the squalene synthase inhibitor zaragozic acid A to redirect the flow of the polyisoprene pathway toward Dol by lowering cholesterol biosynthesis. The addition of zaragozic acid A to CDG fibroblasts with a Dol-PMan synthase defect led to the formation of longer Dol-P species and to increased Dol-P-Man levels. This treatment was shown to decrease the pathologic accumulation of incomplete Dol pyrophosphate-GlcNAc(2)Man(5) in Dol-P-Man synthase-deficient fibroblasts. Zaragozic acid A treatment also decreased the amount of truncated protein N-linked oligosaccharides in these CDG fibroblasts. The increased cellular levels of Dol-P-Man and possibly the decreased cholesterol levels in zaragozic acid A-treated cells also led to increased availability of the glycosylphosphatidylinositol anchor as shown by the elevated cell-surface expression of the CD59 protein. This study shows that manipulation of the cellular Dol pool, as achieved by zaragozic acid A addition, may represent a valuable approach to improve N-linked glycosylation in CDG cells.	[Haeuptle, Micha A.; Welti, Michael; Huelsmeier, Andreas J.; Imbach, Timo; Hennet, Thierry] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Troxler, Heinz] Childrens Hosp Zurich, Div Clin Chem & Biochem, CH-8032 Zurich, Switzerland	University of Zurich; University Children's Hospital Zurich	Hennet, T (corresponding author), Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	thennet@access.uzh.ch		Hulsmeier, Andreas J./0000-0001-6987-8979	Swiss National Science Foundation [31003A-116039]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by Swiss National Science Foundation Grant 31003A-116039 (to T. H.).	ALBERTS AW, 1980, P NATL ACAD SCI-BIOL, V77, P3957, DOI 10.1073/pnas.77.7.3957; BAXTER A, 1992, J BIOL CHEM, V267, P11705; BERGSTROM JD, 1993, P NATL ACAD SCI USA, V90, P80, DOI 10.1073/pnas.90.1.80; BERGSTROM JD, 1995, ANNU REV MICROBIOL, V49, P607, DOI 10.1146/annurev.mi.49.100195.003135; CRICK DC, 1995, J NEUROCHEM, V65, P1365; De Praeter CM, 2000, AM J HUM GENET, V66, P1744, DOI 10.1086/302948; DeRossi C, 2006, J BIOL CHEM, V281, P5916, DOI 10.1074/jbc.M511982200; Eklund EA, 2005, GLYCOBIOLOGY, V15, P1084, DOI 10.1093/glycob/cwj006; ELMBERGER PG, 1989, BIOMED CHROMATOGR, V3, P20, DOI 10.1002/bmc.1130030106; Foulquier F, 2009, BBA-MOL BASIS DIS, V1792, P896, DOI 10.1016/j.bbadis.2008.10.020; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Freeze HH, 2009, BBA-MOL BASIS DIS, V1792, P835, DOI 10.1016/j.bbadis.2009.01.004; Grubenmann CE, 2002, HUM MOL GENET, V11, P2331, DOI 10.1093/hmg/11.19.2331; Haeuptle MA, 2008, AM J HUM GENET, V82, P600, DOI 10.1016/j.ajhg.2007.12.021; Haeuptle MA, 2009, HUM MUTAT, V30, P1628, DOI 10.1002/humu.21126; Haeuptle MA, 2010, ANAL BIOCHEM, V396, P133, DOI 10.1016/j.ab.2009.09.020; Hansske B, 2002, J CLIN INVEST, V109, P725, DOI 10.1172/JCI200214010; Hardre R, 2007, BIOORG MED CHEM LETT, V17, P152, DOI 10.1016/j.bmcl.2006.09.074; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hulsmeier AJ, 2007, MOL CELL PROTEOMICS, V6, P2132, DOI 10.1074/mcp.M700361-MCP200; Imbach T, 2000, J CLIN INVEST, V105, P233, DOI 10.1172/JCI8691; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; Keller RK, 1996, BBA-LIPID LIPID MET, V1303, P169, DOI 10.1016/0005-2760(96)00081-1; Kim S, 2000, J CLIN INVEST, V105, P191, DOI 10.1172/JCI7302; Kinoshita T, 1997, J BIOCHEM-TOKYO, V122, P251; KOGA T, 1990, BIOCHIM BIOPHYS ACTA, V1045, P115, DOI 10.1016/0005-2760(90)90139-O; Korner C, 1998, GLYCOBIOLOGY, V8, P165, DOI 10.1093/glycob/8.2.165; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Leroy JG, 2006, PEDIATR RES, V60, P643, DOI 10.1203/01.pdr.0000246802.57692.ea; LISCUM L, 1995, J BIOL CHEM, V270, P15443, DOI 10.1074/jbc.270.26.15443; Lubke T, 2001, NAT GENET, V28, P73, DOI 10.1038/88299; Marek KW, 1999, GLYCOBIOLOGY, V9, P1263; Marquardt T, 1999, BLOOD, V94, P3976, DOI 10.1182/blood.V94.12.3976.424k06_3976_3985; Matthijs G, 1997, NAT GENET, V16, P88, DOI 10.1038/ng0597-88; McTaggart F, 2001, AM J CARDIOL, V87, p28B; MUSCIO F, 1974, J BIOL CHEM, V249, P3746; Niehues R, 1998, J CLIN INVEST, V101, P1414, DOI 10.1172/JCI2350; Rutschow S, 2002, BIOORGAN MED CHEM, V10, P4043, DOI 10.1016/S0968-0896(02)00269-9; Shang J, 2004, J BIOL CHEM, V279, P9703, DOI 10.1074/jbc.M310837200; Silva M, 2007, CLIN THER, V29, P253, DOI 10.1016/j.clinthera.2007.02.008; Swiezewska E, 2005, PROG LIPID RES, V44, P235, DOI 10.1016/j.plipres.2005.05.002; Thiel C, 2006, MOL CELL BIOL, V26, P5615, DOI 10.1128/MCB.02391-05; Westphal V, 2001, MOL GENET METAB, V73, P77, DOI 10.1006/mgme.2001.3161; YAMADA K, 1986, ANAL BIOCHEM, V156, P380, DOI 10.1016/0003-2697(86)90268-X	44	18	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6085	6091		10.1074/jbc.M110.165795	http://dx.doi.org/10.1074/jbc.M110.165795			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21183681	Green Accepted, Green Published, hybrid			2022-12-27	WOS:000287476400017
J	Hsu, RJ; Lin, CC; Su, YF; Tsai, HJ				Hsu, Ren-Jun; Lin, Chiu-Chun; Su, Ying-Fang; Tsai, Huai-Jen			dickkopf-3-related Gene Regulates the Expression of Zebrafish myf5 Gene through Phosphorylated p38a-dependent Smad4 Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA SIGNAL-TRANSDUCTION; SUMO-1 MODIFICATION; CELL-MEMBRANE; CROSS-TALK; PATHWAY; MUSCLE; INDUCTION; PROTEINS; FAMILY; DIFFERENTIATION	Myf5 is a myogenic regulatory factor that functions in myogenesis. An intronic microRNA, miR-In300, located within zebrafish myf5 intron I, has been reported to silence myf5 through the targeting of dickkopf-3-related gene (dkk3r). However, the molecular mechanism underlying the control of myf5 expression by dkk3r is unknown. By injecting dkk3r-specific morpholino-oligonucleotide (dkk3r-MO) to knock down Dkk3r, we found that the phosphorylated p38a protein was reduced. Knockdown of p38a resulted in malformed somites and reduced myf5 transcripts, which photocopied the defects induced by injection of dkk3r-MO. To block the MAPK pathway, phosphorylation of p38 was inhibited by introduction of SB203580, which caused the down-regulation of myf5 expression. The GFP signal was dramatically decreased in somites when we injected p38a-MO into embryos derived from transgenic line Tg(myf5(80K):GFP), in which the GFP was driven by the myf5 promoter. Although these p38a-MO-induced defects were rescued by co-injection with p38a mRNA, they were not rescued with p38a mRNA containing a mutation at the phosphorylation domain. Moreover, overexpression of Smad2 or Smad3a enhanced myf5 expression, but the defects induced by the dominant negative form of either Smad2 or Smad3a equaled those of embryos injected with either dkk3r-MO or p38a-MO. These results support the involvement of Smad2 . Smad3a in p38a mediation. Overexpression of Smad4 enabled the rescue of myf5 defects in the dkk3r-MO-injected embryos, but knockdown of either dkk3r or p38a caused Smad4 protein to lose stability. Therefore, we concluded that Dkk3r regulates p38a phosphorylation to maintain Smad4 stability, in turn enabling the Smad2.Smad3a.Smad4 complex to form and activate the myf5 promoter.	[Hsu, Ren-Jun; Lin, Chiu-Chun; Su, Ying-Fang; Tsai, Huai-Jen] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 106, Taiwan	National Taiwan University	Tsai, HJ (corresponding author), Natl Taiwan Univ, Inst Mol & Cellular Biol, 1,Sect 4,Roosevelt Rd, Taipei 106, Taiwan.	hjtsai@ntu.edu.tw			National Science Council, Republic of China [NSC-97-2313-B-002-036-MY3]	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This study was supported by National Science Council, Republic of China, Grant NSC-97-2313-B-002-036-MY3.	BUCKINGHAM M, 1992, TRENDS GENET, V8, P144, DOI 10.1016/0168-9525(92)90373-C; Chen YH, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-1; Chen YH, 2001, GENESIS, V29, P22, DOI 10.1002/1526-968X(200101)29:1<22::AID-GENE1002>3.0.CO;2-Z; Coutelle O, 2001, DEV BIOL, V236, P136, DOI 10.1006/dbio.2001.0193; Descargues P, 2008, P NATL ACAD SCI USA, V105, P2487, DOI 10.1073/pnas.0712044105; Dick A, 2000, GENE, V246, P69, DOI 10.1016/S0378-1119(00)00056-1; Dziembowska M, 2007, BIOCHEM BIOPH RES CO, V354, P1101, DOI 10.1016/j.bbrc.2007.01.113; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Gum RJ, 1998, J BIOL CHEM, V273, P15605, DOI 10.1074/jbc.273.25.15605; Hacker A, 1998, DEVELOPMENT, V125, P3461; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Hirsinger E, 2001, DEVELOPMENT, V128, P107; Hoodless PA, 1999, DEV BIOL, V207, P364, DOI 10.1006/dbio.1998.9168; Hsu RJ, 2010, NUCLEIC ACIDS RES, V38, P4384, DOI 10.1093/nar/gkq148; Jia SJ, 2008, J BIOL CHEM, V283, P2418, DOI 10.1074/jbc.M707578200; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Krens SFG, 2006, GENE EXPR PATTERNS, V6, P1019, DOI 10.1016/j.modgep.2006.04.008; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Levy L, 2005, MOL CELL BIOL, V25, P8108, DOI 10.1128/MCB.25.18.8108-8125.2005; Lin CY, 2009, DEV BIOL, V331, P152, DOI 10.1016/j.ydbio.2009.04.029; Lin CY, 2004, GENE, V334, P63, DOI 10.1016/j.gene.2004.03.016; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Lin X, 2003, J BIOL CHEM, V278, P18714, DOI 10.1074/jbc.M302243200; Lindeman LC, 2009, METHODS MOL BIOL, V567, P75, DOI 10.1007/978-1-60327-414-2_5; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Meriane M, 2002, BIOL CELL, V94, P535, DOI 10.1016/S0248-4900(02)00023-0; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; Ohshima T, 2003, J BIOL CHEM, V278, P50833, DOI 10.1074/jbc.M307533200; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Pinho S, 2007, DIFFERENTIATION, V75, P957, DOI 10.1111/j.1432-0436.2007.00185.x; Pinsky BA, 2002, DEV CELL, V3, P4, DOI 10.1016/S1534-5807(02)00214-9; Pogoda HM, 2002, DEV DYNAM, V224, P334, DOI 10.1002/dvdy.10113; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Watanabe H, 2001, J BIOL CHEM, V276, P14466, DOI 10.1074/jbc.M005724200; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116	38	15	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6855	6864		10.1074/jbc.M110.161638	http://dx.doi.org/10.1074/jbc.M110.161638			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21159776	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000287476400092
J	Marq, JB; Hausmann, S; Veillard, N; Kolakofsky, D; Garcin, D				Marq, Jean-Baptiste; Hausmann, Stephane; Veillard, Nicolas; Kolakofsky, Daniel; Garcin, Dominique			Short Double-stranded RNAs with an Overhanging 5 ' ppp-Nucleotide, as Found in Arenavirus Genomes, Act as RIG-I Decoys	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIVIRAL RESPONSES; 5'-TRIPHOSPHATE RNA; INNATE IMMUNITY; RECOGNITION; VIRUSES; HELICASE; ACTIVATION; INDUCTION; PROMOTER; LIGAND	Arenavirus RNA genomes are initiated by a "prime and re-align" mechanism, such that the initiating GTP is found as a single unpaired (overhanging) nucleotide when the complementary genome ends anneal to form double-stranded (ds) RNA panhandle structures. dsRNAs modeled on these structures do not induce interferon (IFN), as opposed to blunt-ended (5') (ppp)dsRNA. This study examines whether these viral structures can also act as decoys, by trapping RIG-I in inactive dsRNA complexes. We examined the ability of various dsRNAs to activate the RIG-I ATPase (presumably a measure of helicase translocation on dsRNA) relative to their ability to induce IFN. We found that there is no simple relationship between these two properties, as if RIG-I can translocate on short dsRNAs without inducing IFN. Moreover, we found that (5') (ppp)dsRNAs with a single unpaired 5' ppp-nucleotide can in fact competitively inhibit the ability of blunt-ended (5') (ppp)dsRNAs to induce IFN when co-transfected into cells and that this inhibition is strongly dependent on the presence of the 5' ppp. In contrast, (5') (ppp)dsRNAs with a single unpaired 5' ppp-nucleotide does not inhibit poly(I-C)-induced IFN activation, which is independent of the presence of a 5' ppp group.	[Marq, Jean-Baptiste; Hausmann, Stephane; Veillard, Nicolas; Kolakofsky, Daniel; Garcin, Dominique] Univ Geneva, Sch Med, CMU, Dept Microbiol & Mol Med, CH-1211 Geneva, Switzerland	University of Geneva	Kolakofsky, D (corresponding author), Univ Geneva, Sch Med, CMU, Dept Microbiol & Mol Med, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.	Daniel.Kolakofsky@unige.ch			Swiss National Science Fund	Swiss National Science Fund(Swiss National Science Foundation (SNSF))	This work was supported by a grant from the Swiss National Science Fund.	Albarino CG, 2009, J VIROL, V83, P5606, DOI 10.1128/JVI.00276-09; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; GARCIN D, 1992, J VIROL, V66, P1370, DOI 10.1128/JVI.66.3.1370-1376.1992; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Hausmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003965; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; KING P, 1994, J BIOL CHEM, V269, P30609; Lu C, 2010, STRUCTURE, V18, P1032, DOI 10.1016/j.str.2010.05.007; Marq JB, 2010, J BIOL CHEM, V285, P18208, DOI 10.1074/jbc.M109.089425; Marq JB, 2009, J BIOL CHEM, V284, P25471, DOI 10.1074/jbc.M109.018895; Matranga C, 2010, J BIOL CHEM, V285, P25363, DOI 10.1074/jbc.M110.117010; Myong S, 2010, CURR OPIN STRUC BIOL, V20, P121, DOI 10.1016/j.sbi.2009.12.008; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; PALMER EL, 1977, J GEN VIROL, V36, P541, DOI 10.1099/0022-1317-36-3-541; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Plumet S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000279; Schlee M, 2010, MOL THER, V18, P1254, DOI 10.1038/mt.2010.90; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Straehle L, 2007, J VIROL, V81, P12227, DOI 10.1128/JVI.01300-07; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Takeuchi O, 2007, IMMUNOL REV, V220, P214, DOI 10.1111/j.1600-065X.2007.00562.x; Wang YL, 2010, NAT STRUCT MOL BIOL, V17, P781, DOI 10.1038/nsmb.1863; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2010, REV MED VIROL, V20, P4, DOI 10.1002/rmv.633; Zheng C, 2010, STRUCTURE, V18, P894, DOI 10.1016/j.str.2010.07.002; Zhou SH, 2010, J VIROL, V84, P9452, DOI 10.1128/JVI.00155-10; Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85	31	58	59	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6108	6116		10.1074/jbc.M110.186262	http://dx.doi.org/10.1074/jbc.M110.186262			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21159780	Green Published, hybrid			2022-12-27	WOS:000287476400020
J	Nishitsuji, K; Hosono, T; Uchimura, K; Michikawa, M				Nishitsuji, Kazuchika; Hosono, Takashi; Uchimura, Kenji; Michikawa, Makoto			Lipoprotein Lipase Is a Novel Amyloid beta (A beta)-binding Protein That Promotes Glycosaminoglycan-dependent Cellular Uptake of A beta in Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY LIPOPROTEINS; HEPARAN-SULFATE PROTEOGLYCANS; APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; RAT-BRAIN; MESSENGER-RNA; EXTRACELLULAR-MATRIX; DEGRADATION; MACROPHAGES; MICROGLIA	Lipoprotein lipase (LPL) is a member of a lipase family known to hydrolyze triglyceride molecules in plasma lipoprotein particles. LPL also plays a role in the binding of lipoprotein particles to cell-surface molecules, including sulfated glycosaminoglycans (GAGs). LPL is predominantly expressed in adipose and muscle but is also highly expressed in the brain where its specific roles are unknown. It has been shown that LPL is colocalized with senile plaques in Alzheimer disease (AD) brains, and its mutations are associated with the severity of AD pathophysiological features. In this study, we identified a novel function of LPL; that is, LPL binds to amyloid beta protein (A beta) and promotes cell-surface association and uptake of A beta in mouse primary astrocytes. The internalized A beta was degraded within 12 h, mainly in a lysosomal pathway. We also found that sulfated GAGs were involved in the LPL-mediated cellular uptake of A beta. Apolipoprotein E was dispensable in the LPL-mediated uptake of A beta. Our findings indicate that LPL is a novel A beta-binding protein promoting cellular uptake and subsequent degradation of A beta.	[Nishitsuji, Kazuchika; Hosono, Takashi; Uchimura, Kenji; Michikawa, Makoto] Natl Ctr Geriatr & Gerontol, Dept Alzheimers Dis Res, Aichi 4748511, Japan; [Uchimura, Kenji] Natl Ctr Geriatr & Gerontol, Sect Pathophysiol & Neurobiol, Aichi 4748511, Japan	National Center for Geriatrics & Gerontology; National Center for Geriatrics & Gerontology	Michikawa, M (corresponding author), Natl Ctr Geriatr & Gerontol, Dept Alzheimers Dis Res, Gengo 35, Aichi 4748511, Japan.	michi@ncgg.go.jp	Uchimura, Kenji/AFV-1802-2022; Uchimura, Kenji/C-9635-2014	Uchimura, Kenji/0000-0003-3009-248X; Uchimura, Kenji/0000-0003-3009-248X	Ministry of Education, Culture, Sports, Science, and Technology of Japan; National Institute of Biomedical Innovation; Ministry of Health, Labor, and Welfare of Japan [H20-007]; Japan Health Sciences Foundation; Grants-in-Aid for Scientific Research [21300145] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Health Sciences Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research on priority areas (Research on Pathomechanisms of Brain Disorders) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a grant from the Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, a grant from the Ministry of Health, Labor, and Welfare of Japan (Research on Dementia, Health, and Labor Sciences Research Grant H20-007), and a grant from the Japan Health Sciences Foundation (Research on Publicly Essential Drugs and Medical Devices).	AlAli SY, 1996, J ANAT, V188, P257; Auerbach BJ, 1996, J BIOL CHEM, V271, P1329, DOI 10.1074/jbc.271.3.1329; Bahr BA, 2002, J NEUROCHEM, V83, P481, DOI 10.1046/j.1471-4159.2002.01192.x; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Baum L, 1999, AM J MED GENET, V88, P136, DOI 10.1002/(SICI)1096-8628(19990416)88:2<136::AID-AJMG8>3.0.CO;2-D; BENGTSSON G, 1980, BIOCHEM J, V189, P625, DOI 10.1042/bj1890625; Blain JF, 2006, EUR J NEUROSCI, V24, P1245, DOI 10.1111/j.1460-9568.2006.05007.x; BRECHER P, 1979, J LIPID RES, V20, P464; Chua T, 1998, FEBS LETT, V436, P439, DOI 10.1016/S0014-5793(98)01161-2; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; ECKEL RH, 1984, P NATL ACAD SCI-BIOL, V81, P7604, DOI 10.1073/pnas.81.23.7604; EDWARDS IJ, 1995, ARTERIOSCL THROM VAS, V15, P400, DOI 10.1161/01.ATV.15.3.400; EDWARDS IJ, 1993, J LIPID RES, V34, P1155; EISENBERG S, 1992, J CLIN INVEST, V90, P2013, DOI 10.1172/JCI116081; FernandezBorja M, 1996, J LIPID RES, V37, P464; FUKUDA M, 1991, J BIOL CHEM, V266, P21327; GOLDBERG IJ, 1989, J LIPID RES, V30, P1569; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; HAVEL RJ, 1973, BIOCHEMISTRY-US, V12, P1828, DOI 10.1021/bi00733a026; Holtzman DM, 1999, J CLIN INVEST, V103, pR15, DOI 10.1172/JCI6179; Hsueh YP, 1999, J NEUROSCI, V19, P7415, DOI 10.1523/JNEUROSCI.19-17-07415.1999; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Koch S, 2001, J LIPID RES, V42, P1143; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Laabs TL, 2007, J NEUROSCI, V27, P14494, DOI 10.1523/JNEUROSCI.2807-07.2007; Majumdar A, 2007, MOL BIOL CELL, V18, P1490, DOI 10.1091/mbc.E06-10-0975; Mandrekar S, 2009, J NEUROSCI, V29, P4252, DOI 10.1523/JNEUROSCI.5572-08.2009; Matsunaga W, 2003, NEUROSCI LETT, V342, P129, DOI 10.1016/S0304-3940(03)00240-4; Michikawa M, 2001, J NEUROSCI, V21, P7226, DOI 10.1523/JNEUROSCI.21-18-07226.2001; MULDER M, 1993, J BIOL CHEM, V268, P9369; Nishida Y, 2009, J BIOL CHEM, V284, P33400, DOI 10.1074/jbc.M109.054056; Nixon RA, 2000, NEUROCHEM RES, V25, P1161, DOI 10.1023/A:1007675508413; Pillarisetti S, 1997, J BIOL CHEM, V272, P15753, DOI 10.1074/jbc.272.25.15753; POOLE B, 1981, J CELL BIOL, V90, P665, DOI 10.1083/jcb.90.3.665; REBECK GW, 1995, ANN NEUROL, V37, P211, DOI 10.1002/ana.410370212; Tanzi RE, 2004, NEURON, V43, P605, DOI 10.1016/j.neuron.2004.08.024; Tsuchida K, 2001, J BIOL CHEM, V276, P37155, DOI 10.1074/jbc.M105818200; WILLIAMS KJ, 1992, J BIOL CHEM, V267, P13284; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Xian XD, 2009, J NEUROSCI, V29, P4681, DOI 10.1523/JNEUROSCI.0297-09.2009; YACOUB LK, 1990, J LIPID RES, V31, P1845; ZANNIS VI, 1985, BIOCHEMISTRY-US, V24, P4450, DOI 10.1021/bi00337a028	45	50	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6393	6401		10.1074/jbc.M110.172106	http://dx.doi.org/10.1074/jbc.M110.172106			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21177248	hybrid, Green Published			2022-12-27	WOS:000287476400050
J	Sun, T; Guo, J; Shallow, H; Yang, TH; Xu, JM; Li, WT; Hanson, C; Wu, JG; Li, XA; Massaeli, H; Zhang, ST				Sun, Tao; Guo, Jun; Shallow, Heidi; Yang, Tonghua; Xu, Jianmin; Li, Wentao; Hanson, Christian; Wu, James G.; Li, Xian; Massaeli, Hamid; Zhang, Shetuan			The Role of Monoubiquitination in Endocytic Degradation of Human Ether-a-go-go-related Gene (hERG) Channels under Low K+ Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-KR; UBIQUITIN ISOPEPTIDASE; CARDIAC-ARRHYTHMIA; POTASSIUM CHANNELS; EXTRACELLULAR K+; MEMBRANE-PROTEIN; RECEPTOR; PROTEASOME; TRAFFICKING; SUFFICIENT	A reduction in extracellular K+ concentration ([K+](o)) causes cardiac arrhythmias and triggers internalization of the cardiac rapidly activating delayed rectifier potassium channel (I-Kr) encoded by the human ether-a-go-go-related gene (hERG). We investigated the role of ubiquitin (Ub) in endocytic degradation of hERG channels stably expressed in HEK cells. Under low K+ conditions, UbKO, a lysine-less mutant Ub that only supports monoubiquitination, preferentially interacted and selectively enhanced degradation of the mature hERG channels. Overexpression of Vps24 protein, also known as charged multivesicular body protein 3, significantly accelerated degradation of mature hERG channels, whereas knockdown of Vps24 impeded this process. Moreover, the lysosomal inhibitor bafilomycin A1 inhibited degradation of the internalized mature hERG channels. Thus, monoubiquitination directs mature hERG channels to degrade through the multivesicular body/lysosome pathway. Interestingly, the protease inhibitor lactacystin inhibited the low K+-induced hERG endocytosis and concomitantly led to an accumulation of monoubiquitinated mature hERG channels, suggesting that deubiquitination is also required for the endocytic degradation. Consistently, overexpression of the endosomal deubiquitinating enzyme signal transducing adaptor molecule-binding protein significantly accelerated whereas knockdown of endogenous signal transducing adaptor molecule-binding protein impeded degradation of the mature hERG channels under low K+ conditions. Thus, monoubiquitin dynamically mediates endocytic degradation of mature hERG channels under low K+ conditions.	[Sun, Tao; Guo, Jun; Shallow, Heidi; Yang, Tonghua; Xu, Jianmin; Li, Wentao; Hanson, Christian; Wu, James G.; Li, Xian; Massaeli, Hamid; Zhang, Shetuan] Queens Univ, Dept Physiol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Zhang, ST (corresponding author), Queens Univ, Dept Physiol, Botterell Hall,Rm 429,18 Stuart St, Kingston, ON K7L 3N6, Canada.	shetuan.zhang@queensu.ca		Zhang, Shetuan/0000-0002-2297-0193	Canadian Institutes of Health Research [MOP 72911]; Heart and Stroke Foundation of Ontario [T 6612]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This work was supported in part by Canadian Institutes of Health Research Grant MOP 72911 and Heart and Stroke Foundation of Ontario Grant T 6612 (to S.Z.).	Chen H, 2005, P NATL ACAD SCI USA, V102, P2766, DOI 10.1073/pnas.0409719102; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; Galan JM, 1997, EMBO J, V16, P5847, DOI 10.1093/emboj/16.19.5847; Gang H, 2006, J GEN PHYSIOL, V128, P55, DOI 10.1085/jgp.200609500; Geetha T, 2008, TRAFFIC, V9, P1146, DOI 10.1111/j.1600-0854.2008.00751.x; Gentzsch M, 2004, MOL BIOL CELL, V15, P2684, DOI 10.1091/mbc.E04-03-0176; Guo J, 2007, J PHARMACOL EXP THER, V321, P911, DOI 10.1124/jpet.107.120931; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hasdemir B, 2009, J BIOL CHEM, V284, P28453, DOI 10.1074/jbc.M109.025692; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Keating MT, 2001, CELL, V104, P569, DOI 10.1016/S0092-8674(01)00243-4; Laing JG, 1997, EXP CELL RES, V236, P482, DOI 10.1006/excr.1997.3747; Leithe E, 2009, J CELL SCI, V122, P3883, DOI 10.1242/jcs.053801; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lin DH, 2009, J BIOL CHEM, V284, P29614, DOI 10.1074/jbc.M109.041582; Lucero P, 2000, J BACTERIOL, V182, P241, DOI 10.1128/JB.182.1.241-243.2000; Massaeli H, 2010, J BIOL CHEM, V285, P27259, DOI 10.1074/jbc.M110.124909; Massaeli H, 2010, CIRC RES, V106, P1072, DOI 10.1161/CIRCRESAHA.109.215970; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Mosesson Y, 2003, J BIOL CHEM, V278, P21323, DOI 10.1074/jbc.C300096200; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Nickerson DP, 2007, EMBO REP, V8, P644, DOI 10.1038/sj.embor.7401004; Patrick GN, 2003, CURR BIOL, V13, P2073, DOI 10.1016/j.cub.2003.10.028; Pickart CM, 2000, TRENDS BIOCHEM SCI, V25, P544, DOI 10.1016/S0968-0004(00)01681-9; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; RODEN DM, 1986, AM HEART J, V111, P1088, DOI 10.1016/0002-8703(86)90010-4; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; van Kerkhof P, 2000, J BIOL CHEM, V275, P1575, DOI 10.1074/jbc.275.3.1575; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	43	30	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 25	2011	286	8					6751	6759		10.1074/jbc.M110.198408	http://dx.doi.org/10.1074/jbc.M110.198408			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	723AB	21177251	Green Published, hybrid			2022-12-27	WOS:000287476400082
J	Zhao, W; Wang, LJ; Zhang, M; Wang, P; Zhang, L; Yuan, C; Qi, JN; Qiao, Y; Kuo, PC; Gao, CJ				Zhao, Wei; Wang, Lijuan; Zhang, Meng; Wang, Peng; Zhang, Lei; Yuan, Chao; Qi, Jianni; Qiao, Yu; Kuo, Paul C.; Gao, Chengjiang			Peroxisome Proliferator-activated Receptor gamma Negatively Regulates IFN-beta Production in Toll-like Receptor (TLR) 3-and TLR4-stimulated Macrophages by Preventing Interferon Regulatory Factor 3 Binding to the IFN-beta Promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PPAR-GAMMA; I INTERFERON; ADAPTER PROTEIN; MEDIATED DEGRADATION; MURINE LUPUS; EXPRESSION; INFLAMMATION; AGONISTS	Toll-like receptors 3 and 4 utilize adaptor TRIF to activate interferon regulatory factor 3 (IRF3), resulting in IFN-beta production to mediate anti-viral and bacterial infection. Peroxisome proliferator-activated receptor (PPAR)-gamma is a ligand-activated transcription factor expressed in various immune cells and acts as a transcriptional repressor to inhibit the transcription of many proinflammatory cytokines. But, the function of PPAR-gamma in TLR3- and -4-mediated IFN-beta production is not well elucidated. Here, we have analyzed the effect of the PPAR-gamma agonists on IFN-beta production in peritoneal primary macrophages in response to LPS and poly(I:C). PPAR-gamma agonists inhibited LPS and poly(I:C)-induced IFN-beta transcription and secretion. siRNA knockdown of PPAR-gamma expression and transfection of PPAR-gamma expression plasmid demonstrated that PPAR-gamma agonist inhibits IFN-beta production in a PPAR-gamma-dependent manner. The ability of the PPAR-gamma agonist to inhibit IFN-beta production was confirmed in vivo as mice treated with troglitazone exhibited decreased levels of IFN-beta upon LPS and poly(I:C) challenge. Chromatin immunoprecipitation (CHIP) assay and electrophoretic mobility shift assay (EMSA) demonstrated that troglitazone treatment impaired IRF3 binding to the IFN-beta promoter. Furthermore, troglitazone could inhibit LPS and poly(I:C)-induced STAT1 phosphorylation and subsequent ISRE activation. These results demonstrate that PPAR-gamma negatively regulates IFN-beta production in TLR3- and 4-stimulated macrophages by preventing IRF3 binding to the IFN-beta promoter.	[Zhao, Wei; Wang, Lijuan; Zhang, Meng; Wang, Peng; Zhang, Lei; Yuan, Chao; Qi, Jianni; Qiao, Yu; Gao, Chengjiang] Shandong Univ, Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan 250012, Shandong, Peoples R China; [Zhao, Wei; Wang, Lijuan; Zhang, Meng; Wang, Peng; Zhang, Lei; Yuan, Chao; Qi, Jianni; Qiao, Yu; Gao, Chengjiang] Shandong Univ, Sch Med, Dept Immunol, Jinan 250012, Shandong, Peoples R China; [Kuo, Paul C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	Shandong University; Shandong University; Duke University	Gao, CJ (corresponding author), 44 Wenhua Western Rd, Jinan 250012, Shandong, Peoples R China.	cgao@sdu.edu.cn	WANG, Peng/GSN-5263-2022; ZHAO, WEI/C-9163-2011	Zhao, Wei/0000-0001-8440-2274; Gao, Chengjiang/0000-0002-9365-4497	Taishan Scholar Program of Shandong Province; Specialized Research Fund for the Doctoral Program of Higher Education of China [20090131110045]; Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry	Taishan Scholar Program of Shandong Province; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	This work was supported in part by the Taishan Scholar Program of Shandong Province, Specialized Research Fund for the Doctoral Program of Higher Education of China Grant 20090131110045, and the Scientific Research Foundation for the Returned Overseas Chinese Scholars of State Education Ministry (to G. C.).	An HZ, 2006, IMMUNITY, V25, P919, DOI 10.1016/j.immuni.2006.10.014; Appel S, 2005, BLOOD, V106, P3888, DOI 10.1182/blood-2004-12-4709; Aprahamian T, 2009, J IMMUNOL, V182, P340, DOI 10.4049/jimmunol.182.1.340; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bibeau-Poirier A, 2006, J IMMUNOL, V177, P5059, DOI 10.4049/jimmunol.177.8.5059; Bonfield TL, 2008, J IMMUNOL, V181, P235, DOI 10.4049/jimmunol.181.1.235; Chinetti G, 1998, J BIOL CHEM, V273, P25573, DOI 10.1074/jbc.273.40.25573; Cunard R, 2004, J IMMUNOL, V172, P7530, DOI 10.4049/jimmunol.172.12.7530; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Hertzog PJ, 2003, TRENDS IMMUNOL, V24, P534, DOI 10.1016/j.it.2003.08.006; Higgs R, 2008, J IMMUNOL, V181, P1780, DOI 10.4049/jimmunol.181.3.1780; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kapadia R, 2008, FRONT BIOSCI-LANDMRK, V13, P1813, DOI 10.2741/2802; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Lawrence T, 2002, NAT REV IMMUNOL, V2, P787, DOI 10.1038/nri915; Lefort S, 2007, J VIROL, V81, P10950, DOI 10.1128/JVI.00183-07; Lin RT, 1999, MOL CELL BIOL, V19, P959; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Mangini AJ, 2007, ANN NY ACAD SCI, V1108, P11, DOI 10.1196/annals.1422.002; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Park SJ, 2009, J IMMUNOL, V183, P3259, DOI 10.4049/jimmunol.0900231; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Straus DS, 2007, TRENDS IMMUNOL, V28, P551, DOI 10.1016/j.it.2007.09.003; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Welch JS, 2003, P NATL ACAD SCI USA, V100, P6712, DOI 10.1073/pnas.1031789100; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Zhao W, 2007, IMMUNOL LETT, V108, P137, DOI 10.1016/j.imlet.2006.11.008; Zhao W, 2010, J BIOL CHEM, V285, P20452, DOI 10.1074/jbc.M110.110312; Zhao WP, 2009, J IMMUNOL, V183, P2729, DOI 10.4049/jimmunol.0804341	37	48	50	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 18	2011	286	7					5519	5528		10.1074/jbc.M110.149823	http://dx.doi.org/10.1074/jbc.M110.149823			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	719SY	21148557	Green Published, hybrid			2022-12-27	WOS:000287230600061
J	Mellert, HS; Stanek, TJ; Sykes, SM; Rauscher, FJ; Schultz, DC; McMahon, SB				Mellert, Hestia S.; Stanek, Timothy J.; Sykes, Stephen M.; Rauscher, Frank J., III; Schultz, David C.; McMahon, Steven B.			Deacetylation of the DNA-binding Domain Regulates p53-mediated Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE ARREST; HISTONE DEACETYLASE-1; MDM2 INTERACTION; P53; ACETYLATION; INHIBITORS; REPRESSION; FAMILY; COREPRESSOR; ACTIVATION	In unstressed cells, the p53 tumor suppressor is highly unstable. DNA damage and other forms of cellular stress rapidly stabilize and activate p53. This process is regulated by a complex array of post-translational modifications that are dynamically deposited onto p53. Recent studies show that these modifications orchestrate p53-mediated processes such as cell cycle arrest and apoptosis. Cancer cells carry inherent genetic damage, but avoid arrest and apoptosis by inactivating p53. Defining the enzymatic machinery that regulates the stress-induced modification of p53 at single-residue resolution is critical to our understanding of the biochemical mechanisms that control this critical tumor suppressor. Specifically, acetylation of p53 at lysine 120, a DNA-binding domain residue mutated in human cancer, is essential for triggering apoptosis. Given the oncogenic properties of deacetylases and the success of deacetylase inhibitors as anticancer agents, we investigated the regulation of Lys(120) deacetylation using pharmacologic and genetic approaches. This analysis revealed that histone deacetylase 1 is predominantly responsible for the deacetylation of Lys(120). Furthermore, treatment with the clinical-grade histone deacetylase inhibitor entinostat enhances Lys(120) acetylation, an event that is mechanistically linked to its apoptotic effect. These data expand our understanding of the mechanisms controlling p53 function and suggest that regulation of p53 modification status at single-residue resolution by targeted therapeutics can selectively alter p53 pathway function. This knowledge may impact the rational application of deacetylase inhibitors in the treatment of human cancer.	[Stanek, Timothy J.; McMahon, Steven B.] Thomas Jefferson Univ, Kimmel Canc Ctr, Dept Canc Biol, Philadelphia, PA 19107 USA; [Mellert, Hestia S.] Univ Penn, Philadelphia, PA 19104 USA; [Sykes, Stephen M.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Rauscher, Frank J., III; Schultz, David C.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA	Jefferson University; University of Pennsylvania; Harvard University; Brigham & Women's Hospital; The Wistar Institute	McMahon, SB (corresponding author), 609 BLSB,233 S 10th St, Philadelphia, PA 19107 USA.	Steven.McMahon@jci.tju.edu	qiao, zhixin/I-3408-2012	Stanek, Timothy/0000-0001-9192-4978; McMahon, Steven/0000-0002-3405-1768	National Institutes of Health [CA090465, CA152786, CA098172]; Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE [R21CA152786, R01CA090465, R01CA098172] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA090465, CA152786, and CA098172 (to S. B. M.). This work was also supported by the Commonwealth Universal Research Enhancement Program, Pennsylvania Department of Health.	Bandyopadhyay D, 2004, CANCER RES, V64, P7706, DOI 10.1158/0008-5472.CAN-03-3897; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Basile V, 2006, J BIOL CHEM, V281, P2347, DOI 10.1074/jbc.M507712200; Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Cerna D, 2006, CURR TOP DEV BIOL, V73, P173, DOI 10.1016/S0070-2153(05)73006-4; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Duvic M, 2007, EXPERT OPIN INV DRUG, V16, P1111, DOI 10.1517/13543784.16.7.1111; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Escaffit F, 2007, MOL CELL BIOL, V27, P554, DOI 10.1128/MCB.00869-06; Frew AJ, 2009, CANCER LETT, V280, P125, DOI 10.1016/j.canlet.2009.02.042; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Habold C, 2008, J CELL MOL MED, V12, P607, DOI 10.1111/j.1582-4934.2007.00136.x; Hess-Stumpp H, 2007, INT J BIOCHEM CELL B, V39, P1388, DOI 10.1016/j.biocel.2007.02.009; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mai A, 2005, J MED CHEM, V48, P3344, DOI 10.1021/jm049002a; Marine JC, 2005, BIOCHEM BIOPH RES CO, V331, P750, DOI 10.1016/j.bbrc.2005.03.151; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Okamoto K, 2006, BIOCHEM BIOPH RES CO, V351, P216, DOI 10.1016/j.bbrc.2006.10.022; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Pfister S, 2008, INT J CANCER, V122, P1207, DOI 10.1002/ijc.23283; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Sinha S, 2010, EMBO J, V29, P830, DOI 10.1038/emboj.2009.395; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346	42	28	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB	2011	286	6					4264	4270		10.1074/jbc.M110.184663	http://dx.doi.org/10.1074/jbc.M110.184663			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	716MW	21148320	Green Published, hybrid			2022-12-27	WOS:000286975700025
